PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Curk, T; Marenduzzo, D; Dobnikar, J				Curk, Tine; Marenduzzo, Davide; Dobnikar, Jure			Chemotactic Sensing towards Ambient and Secreted Attractant Drives Collective Behaviour of E. coli	PLOS ONE			English	Article							PATTERNS	We simulate the dynamics of a suspension of bacterial swimmers, which chemotactically sense gradients in either ambient or self-secreted attractants (e.g. nutrient or aspartate respectively), or in both. Unlike previous mean field models based on a set of continuum partial differential equations, our model resolves single swimmers and therefore incorporates stochasticity and effects due to fluctuations in the bacterial density field. The algorithm we use is simple enough that we can follow the evolution of colonies of up to over a million bacteria for timescales relevant to pattern formation for E. coli growing in semisolid medium such as agar, or in confined geometries. Our results confirm previous mean field results that the patterns observed experimentally can be reproduced with a model incorporating chemoattractant secretion, chemotaxis (towards gradients in the chemoattractant field), and bacterial reproduction. They also suggest that further experiments with bacterial strains chemotactically moving up both nutrient and secreted attractant field may yield yet more dynamical patterns.	[Curk, Tine; Dobnikar, Jure] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Marenduzzo, Davide] Univ Edinburgh, Dept Phys, Edinburgh, Midlothian, Scotland; [Dobnikar, Jure] Jozef Stefan Inst, Dept Theoret Phys, Ljubljana, Slovenia	University of Cambridge; University of Edinburgh; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Dobnikar, J (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	jd489@cam.ac.uk	Dobnikar, Jure/C-8765-2011	Dobnikar, Jure/0000-0002-1169-6619; Curk, Tine/0000-0002-2167-5336; Marenduzzo, Davide/0000-0003-3974-4915	European Union [G-ERC COLSTRUCTION 227758, ITN-COMPLOIDS 234810]; Pan-European Research Infrastructure for High Performance Computing HPC-Europa2; Slovenian Research Agency [P1-0055]; EPSRC [EP/J007404/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J007404/1] Funding Source: researchfish	European Union(European Commission); Pan-European Research Infrastructure for High Performance Computing HPC-Europa2; Slovenian Research Agency(Slovenian Research Agency - Slovenia); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the 7th Framework Program of European Union through grants ARG-ERC COLSTRUCTION 227758 and ITN-COMPLOIDS 234810, by the Pan-European Research Infrastructure for High Performance Computing HPC-Europa2 (http://www.hpc-europa.org/), and by the Slovenian Research Agency through grant P1-0055 (J.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Baskaran A, 2009, P NATL ACAD SCI USA, V106, P15567, DOI 10.1073/pnas.0906586106; Ben-Jacob E, 2000, ADV PHYS, V49, P395, DOI 10.1080/000187300405228; Berg H C, 2003, E COLI MOTION; Brenner MP, 1998, BIOPHYS J, V74, P1677, DOI 10.1016/S0006-3495(98)77880-4; BUDRENE EO, 1995, NATURE, V376, P49, DOI 10.1038/376049a0; BUDRENE EO, 1991, NATURE, V349, P630, DOI 10.1038/349630a0; Cates ME, 2010, P NATL ACAD SCI USA, V107, P11715, DOI 10.1073/pnas.1001994107; Curk T, 2012, ADV EXP MED BIOL, V736, P381, DOI 10.1007/978-1-4419-7210-1_22; Elgeti J, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/38002; Esipov SE, 1998, J MATH BIOL, V36, P249, DOI 10.1007/s002850050100; Flores M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.148101; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Kalinin YV, 2009, BIOPHYS J, V96, P2439, DOI 10.1016/j.bpj.2008.10.027; Kawasaki K, 1997, J THEOR BIOL, V188, P177, DOI 10.1006/jtbi.1997.0462; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Li GL, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.078101; Matthaus F, 2009, BIOPHYS J, V97, P946, DOI 10.1016/j.bpj.2009.04.065; Matthaus F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018623; Murray J.D., 2001, MATH BIOL; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Park S, 2003, P NATL ACAD SCI USA, V100, P13910, DOI 10.1073/pnas.1935975100; SHAPIRO JA, 1995, BIOESSAYS, V17, P597, DOI 10.1002/bies.950170706; Tailleur J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.218103; Tyson R, 1999, P ROY SOC B-BIOL SCI, V266, P299, DOI 10.1098/rspb.1999.0637; WOODWARD DE, 1995, BIOPHYS J, V68, P2181; Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155	28	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74878	10.1371/journal.pone.0074878	http://dx.doi.org/10.1371/journal.pone.0074878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098352	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600010
J	Fitzpatrick, CJ; Gopalakrishnan, S; Cogan, ES; Yager, LM; Meyer, PJ; Lovic, V; Saunders, BT; Parker, CC; Gonzales, NM; Aryee, E; Flagel, SB; Palmer, AA; Robinson, TE; Morrow, JD				Fitzpatrick, Christopher J.; Gopalakrishnan, Shyam; Cogan, Elizabeth S.; Yager, Lindsay M.; Meyer, Paul J.; Lovic, Vedran; Saunders, Benjamin T.; Parker, Clarissa C.; Gonzales, Natalia M.; Aryee, Emmanuel; Flagel, Shelly B.; Palmer, Abraham A.; Robinson, Terry E.; Morrow, Jonathan D.			Variation in the Form of Pavlovian Conditioned Approach Behavior among Outbred Male Sprague-Dawley Rats from Different Vendors and Colonies: Sign-Tracking vs. Goal-Tracking	PLOS ONE			English	Article							INCENTIVE SALIENCE; LABORATORY ENVIRONMENT; GENETIC DRIFT; WISTAR RATS; MICE; INHIBITION; STIMULUS; STOCKS; ATTRIBUTION; EXPRESSION	Even when trained under exactly the same conditions outbred male Sprague-Dawley (SD) rats vary in the form of the Pavlovian conditioned approach response (CR) they acquire. The form of the CR (i.e. sign-tracking vs. goal-tracking) predicts to what degree individuals attribute incentive salience to cues associated with food or drugs. However, we have noticed variation in the incidence of these two phenotypes in rats obtained from different vendors. In this study, we quantified sign- and goal-tracking behavior in a reasonably large sample of SD rats obtained from two vendors (Harlan or Charles River), as well as from individual colonies operated by both vendors. Our sample of rats acquired from Harlan had, on average, more sign-trackers than goal-trackers, and vice versa for our sample of rats acquired from Charles River. Furthermore, there were significant differences among colonies of the same vendor. Although it is impossible to rule out environmental variables, SD rats at different vendors and barriers may have reduced phenotypic heterogeneity as a result of genetic variables, such as random genetic drift or population bottlenecks. Consistent with this hypothesis, we identified marked population structure among colonies from Harlan. Therefore, despite sharing the same name, investigators should be aware that important genetic and phenotypic differences exist among SD rats from different vendors or even from different colonies of the same vendor. If used judiciously this can be an asset to experimental design, but it can also be a pitfall for those unaware of the issue.	[Fitzpatrick, Christopher J.; Flagel, Shelly B.; Robinson, Terry E.; Morrow, Jonathan D.] Univ Michigan, Neurosci Grad Program, Ann Arbor, MI 48109 USA; [Gopalakrishnan, Shyam; Parker, Clarissa C.; Gonzales, Natalia M.; Aryee, Emmanuel; Palmer, Abraham A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Cogan, Elizabeth S.; Yager, Lindsay M.; Saunders, Benjamin T.; Robinson, Terry E.] Univ Michigan, Biopsychol Grad Program, Ann Arbor, MI 48109 USA; [Meyer, Paul J.; Lovic, Vedran; Flagel, Shelly B.; Robinson, Terry E.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Flagel, Shelly B.; Morrow, Jonathan D.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Palmer, Abraham A.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA	University of Michigan System; University of Michigan; University of Chicago; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Chicago	Morrow, JD (corresponding author), Univ Michigan, Neurosci Grad Program, Ann Arbor, MI 48109 USA.	jonmorro@umich.edu	Meyer, Paul/GQJ-8502-2022; Palmer, Abraham/L-2158-2014; Morrow, Jonathan D/M-9790-2016; Gopalakrishnan, Shyam/J-1546-2019; Flagel, Shelly B/G-5561-2012	Palmer, Abraham/0000-0003-3634-0747; Morrow, Jonathan D/0000-0002-3530-4544; Gopalakrishnan, Shyam/0000-0002-2004-6810; Flagel, Shelly B/0000-0002-7309-9908; Saunders, Benjamin/0000-0002-4733-1101; Lovic, Vedran/0000-0002-7622-2430; Cogan, Elizabeth/0000-0003-2075-4494	National Institute on Drug Abuse [PO1 DA031656, 5T32DA007281, F31 DA030801, T31 DA007281, T32 DA007268]; National Institute of Health [R01GM097737, R01DA021336, R01MH079103, T32GM07197]; University of Michigan Department of Psychiatry [U032826]; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197, R01GM097737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021336, F31DA030801, T32DA007268, T32DA007281, P01DA031656] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Department of Psychiatry; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the National Institute on Drug Abuse (PO1 DA031656 [TER]; 5T32DA007281 [CJF]; F31 DA030801 [BTS]; T31 DA007281 [LMY]; T32 DA007268 [PJM]), the National Institute of Health (R01GM097737, R01DA021336, and R01MH079103 [AAP]; T32GM07197 [NMG]), the University of Michigan Department of Psychiatry (U032826 [JDM]), the Chicago Biomedical Consortium (AAP), the Searle Funds at The Chicago Community Trust (AAP), and the Natural Sciences and Engineering Research Council of Canada (VL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinger KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004729; Beckmann JS, 2012, BEHAV BRAIN RES, V226, P331, DOI 10.1016/j.bbr.2011.09.021; Bert B, 2001, PHARMACOL BIOCHEM BE, V70, P411, DOI 10.1016/S0091-3057(01)00629-3; Bueno A, 2003, EXP TOXICOL PATHOL, V55, P287, DOI 10.1078/0940-2993-00327; Buhimschi IA, 2001, AM J OBSTET GYNECOL, V184, P686, DOI 10.1067/mob.2001.110448; Charles River Laboratories International Inc, 2011, INT GEN STAND IGS PR; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Festing MFW, 2010, TOXICOL PATHOL, V38, P681, DOI 10.1177/0192623310373776; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Flagel SB, 2009, NEUROPHARMACOLOGY, V56, P139, DOI 10.1016/j.neuropharm.2008.06.027; Fuller DD, 2001, PHYSIOL GENOMICS, V4, P175, DOI 10.1152/physiolgenomics.2001.4.3.175; GLICK SD, 1986, PHYSIOL BEHAV, V38, P67, DOI 10.1016/0031-9384(86)90133-2; HOGER H, 1992, EXP ANIM TOKYO, V41, P215, DOI 10.1538/expanim1978.41.2_215; Honndorf S, 2011, EPILEPSY RES, V94, P26, DOI 10.1016/j.eplepsyres.2010.12.012; Kearns DN, 2006, BEHAV BRAIN RES, V169, P193, DOI 10.1016/j.bbr.2006.01.005; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lovic V, 2011, BEHAV NEUROSCI, V125, P481, DOI 10.1037/a0024367; Marosi M, 2006, J NEUROSCI METH, V156, P231, DOI 10.1016/j.jneumeth.2006.03.010; Meyer PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038987; MILLER FP, 1968, SCIENCE, V162, P463, DOI 10.1126/science.162.3852.463; Oliff HS, 1997, J CEREBR BLOOD F MET, V17, P571, DOI 10.1097/00004647-199705000-00012; PAPAIOANNOU VE, 1980, LAB ANIM, V14, P11, DOI 10.1258/002367780780943015; Pare WP, 1997, PHYSIOL BEHAV, V62, P643, DOI 10.1016/S0031-9384(97)00191-1; Pecoraro N, 2006, PHYSIOL BEHAV, V89, P598, DOI 10.1016/j.physbeh.2006.07.019; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pollock DM, 1998, AM J PHYSIOL-REG I, V275, pR1719, DOI 10.1152/ajpregu.1998.275.5.R1719; Pritchard JK, 2000, GENETICS, V155, P945; Robinson TE, 2009, BIOL PSYCHIAT, V65, P869, DOI 10.1016/j.biopsych.2008.09.006; Saunders BT, 2011, NEUROPSYCHOPHARMACOL, V36, P1668, DOI 10.1038/npp.2011.48; Saunders BT, 2010, BIOL PSYCHIAT, V67, P730, DOI 10.1016/j.biopsych.2009.11.015; Shim S, 2009, EXP ANIM TOKYO, V58, P11, DOI 10.1538/expanim.58.11; Silver L.M., 1995, MOUSE GENETICS CONCE; Swerdlow NR, 2001, PHARMACOL BIOCHEM BE, V70, P219, DOI 10.1016/S0091-3057(01)00598-6; Tomie A, 2012, BEHAV BRAIN RES, V226, P571, DOI 10.1016/j.bbr.2011.10.021; Turnbull AV, 1999, NEUROENDOCRINOLOGY, V70, P186, DOI 10.1159/000054475; Yager LM, 2010, BEHAV BRAIN RES, V214, P30, DOI 10.1016/j.bbr.2010.04.021	41	86	86	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75042	10.1371/journal.pone.0075042	http://dx.doi.org/10.1371/journal.pone.0075042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098363	Green Submitted, gold, Green Published			2022-12-25	WOS:000325427100014
J	Fujiwara, T; Ikeda, T; Nagasaka, Y; Okitsu, Y; Katsuoka, Y; Fukuhara, N; Onishi, Y; Ishizawa, K; Ichinohasama, R; Tomosugi, N; Harigae, H				Fujiwara, Tohru; Ikeda, Takashi; Nagasaka, Yuki; Okitsu, Yoko; Katsuoka, Yuna; Fukuhara, Noriko; Onishi, Yasushi; Ishizawa, Kenichi; Ichinohasama, Ryo; Tomosugi, Naohisa; Harigae, Hideo			A Low-Molecular-Weight Compound K7174 Represses Hepcidin: Possible Therapeutic Strategy against Anemia of Chronic Disease	PLOS ONE			English	Article							INHIBITOR K-7174; IRON; INFLAMMATION; EXPRESSION; FERROPORTIN; INDUCTION; BINDING; GENE	Hepcidin is the principal iron regulatory hormone, controlling the systemic absorption and remobilization of iron from intracellular stores. The expression of the hepcidin gene, HAMP, is increased in patients with anemia of chronic disease. Previously, the synthetic compound K7174 was identified through chemical screening as a novel inhibitor of the adhesion of monocytes to cytokine-stimulated endothelial cells. K7174 also ameliorated anemia induced by inflammatory cytokines in mice, which suggests a possible involvement of hepcidin regulation. The present study was performed to assess the impact of K7174 on hepcidin expression in a human hematoma cell line and in mice in vivo. We first demonstrated that K7174 treatment in HepG2 cells significantly decreased HAMP expression. Then, we conducted microarray analysis to determine the molecular mechanism by which K7174 inhibits HAMP expression. Transcriptional profiling confirmed the downregulation of HAMP. Surprisingly, we found that K7174 strongly induced GDF15, known as a negative regulator of HAMP expression. Western blotting analysis as well as ELISA confirmed the induction of GDF15 by K7174 treatment. Furthermore, K7174-mediated HAMP suppression was rescued by the silencing of GDF15 expression. Interestingly, we found that K7174 also upregulates CEBPB. Promoter analysis and chromatin immunoprecipitation analysis revealed that CEBPB could contribute to K7174-mediated transcriptional activation of GDF15. Subsequently, we also examined whether K7174 inhibits hepcidin expression in mice. Quantitative RT-PCR analysis with liver samples from K7174-treated mice demonstrated significant upregulation of Gdf15 and downregulation of Hamp expression, as compared to control mice. Furthermore, serum hepcidin concentration was also significantly decreased in K7174-treated mice. In conclusion, K7174 inhibits hepcidin expression partly by inducing GDF15. K-7174 may be a potential therapeutic option to treat anemia of chronic disease.	[Fujiwara, Tohru; Ikeda, Takashi; Nagasaka, Yuki; Okitsu, Yoko; Katsuoka, Yuna; Fukuhara, Noriko; Onishi, Yasushi; Ishizawa, Kenichi; Harigae, Hideo] Tohoku Univ, Grad Sch, Dept Hematol & Rheumatol, Sendai, Miyagi 980, Japan; [Fujiwara, Tohru; Ichinohasama, Ryo; Harigae, Hideo] Tohoku Univ, Grad Sch, Sendai, Miyagi 980, Japan; [Ishizawa, Kenichi] Tohoku Univ Hosp, Clin Res Innovat & Educ Ctr, Sendai, Miyagi, Japan; [Tomosugi, Naohisa] Kanazawa Med Coll, Med Res Inst, Div Adv Med, Aging Res Unit, Kanazawa, Ishikawa, Japan	Tohoku University; Tohoku University; Tohoku University; Kanazawa Medical University	Fujiwara, T (corresponding author), Tohoku Univ, Grad Sch, Dept Hematol & Rheumatol, Sendai, Miyagi 980, Japan.	fujiwara-to@apple.email.ne.jp	Fujiwara, Tohru/GOG-9775-2022		Japan Society of the Promotion Science	Japan Society of the Promotion Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The research was supported by Japan Society of the Promotion Science (http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NC, 2004, J CLIN INVEST, V113, P1251, DOI 10.1172/JCI200421441; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Finberg KE, 2013, CURR OPIN HEMATOL, V20, P208, DOI 10.1097/MOH.0b013e32835f5a47; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara T, 2013, EXP HEMATOL, V41, P303, DOI 10.1016/j.exphem.2012.10.015; Fujiwara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040959; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Hattori A, 2012, BLOOD CELL MOL DIS, V48, P179, DOI 10.1016/j.bcmd.2012.01.002; Hayakawa K, 2010, J AM SOC NEPHROL, V21, P73, DOI 10.1681/ASN.2009040432; Imagawa S, 2003, FASEB J, V17, P1742, DOI 10.1096/fj.02-1134fje; Island ML, 2011, BIOCHEM J, V437, P477, DOI 10.1042/BJ20110225; Lee SH, 2010, CARCINOGENESIS, V31, P719, DOI 10.1093/carcin/bgq016; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nakano Y, 2004, BLOOD, V104, P4300, DOI 10.1182/blood-2004-04-1631; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Rizzo JD, 2010, BLOOD, V116, P4045, DOI 10.1182/blood-2010-08-300541; Shimada T, 2007, BIOCHEM BIOPH RES CO, V363, P355, DOI 10.1016/j.bbrc.2007.08.167; Shimizu S, 2013, BIOCHEM BIOPH RES CO, V430, P1277, DOI 10.1016/j.bbrc.2012.11.137; Solomon SD, 2010, NEW ENGL J MED, V363, P1146, DOI 10.1056/NEJMoa1005109; Steinbicker AU, 2011, BLOOD, V117, P4915, DOI 10.1182/blood-2010-10-313064; Sun CC, 2012, AM J HEMATOL, V87, P392, DOI 10.1002/ajh.23110; Takano Y, 2007, BIOCHEM BIOPH RES CO, V360, P470, DOI 10.1016/j.bbrc.2007.06.082; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Theurl I, 2011, BLOOD, V118, P4977, DOI 10.1182/blood-2011-03-345066; Umetani M, 2000, BIOCHEM BIOPH RES CO, V272, P370, DOI 10.1006/bbrc.2000.2784; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318	30	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75568	10.1371/journal.pone.0075568	http://dx.doi.org/10.1371/journal.pone.0075568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086573	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900047
J	Ishiga, Y; Ishiga, T; Uppalapati, SR; Mysore, KS				Ishiga, Yasuhiro; Ishiga, Takako; Uppalapati, Srinivasa Rao; Mysore, Kirankumar S.			Jasmonate ZIM-Domain (JAZ) Protein Regulates Host and Nonhost Pathogen-Induced Cell Death in Tomato and Nicotiana benthamiana	PLOS ONE			English	Article							SYRINGAE PV. TOMATO; PSEUDOMONAS-SYRINGAE; PHYTOTOXIN CORONATINE; SYMPTOM DEVELOPMENT; DEFENSE RESPONSES; METHYL JASMONATE; GENE-EXPRESSION; ARABIDOPSIS; RESISTANCE; DISEASE	The nonhost-specific phytotoxin coronatine (COR) produced by several pathovars of Pseudomonas syringae functions as a jasmonic acid-isoleucine (JA-Ile) mimic and contributes to disease development by suppressing plant defense responses and inducing reactive oxygen species in chloroplast. It has been shown that the F-box protein CORONATINE INSENSITIVE 1 (COI1) is the receptor for COR and JA-Ile. JASMONATE ZIM DOMAIN (JAZ) proteins act as negative regulators for JA signaling in Arabidopsis. However, the physiological significance of JAZ proteins in P. syringae disease development and nonhost pathogen-induced hypersensitive response (HR) cell death is not completely understood. In this study, we identified JAZ genes from tomato, a host plant for P. syringae pv. tomato DC3000 (Pst DC3000), and examined their expression profiles in response to COR and pathogens. Most JAZ genes were induced by COR treatment or inoculation with COR-producing Pst DC3000, but not by the COR-defective mutant DB29. Tomato SlJAZ2, SlJAZ6 and SlJAZ7 interacted with SlCOI1 in a COR-dependent manner. Using virus-induced gene silencing (VIGS), we demonstrated that SlJAZ2, SlJAZ6 and SlJAZ7 have no effect on COR-induced chlorosis in tomato and Nicotiana benthamiana. However, SlJAZ2-, SlJAZ6- and SlJAZ7-silenced tomato plants showed enhanced disease-associated cell death to Pst DC3000. Furthermore, we found delayed HR cell death in response to the nonhost pathogen Pst T1 or a pathogen-associated molecular pattern (PAMP), INF1, in SlJAZ2- and SlJAZ6-silenced N. benthamiana. These results suggest that tomato JAZ proteins regulate the progression of cell death during host and nonhost interactions.	[Ishiga, Yasuhiro; Ishiga, Takako; Uppalapati, Srinivasa Rao; Mysore, Kirankumar S.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA	Noble Research Institute	Ishiga, Y (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA.	yishiga@noble.org; ksmysore@noble.org	Ishiga, Yasuhiro/L-2987-2017; Ishiga, Yasuhiro/H-3814-2011; Mysore, Kirankumar/AAG-7112-2020	Ishiga, Yasuhiro/0000-0001-8871-8882; Mysore, Kirankumar/0000-0002-9805-5741; Ishiga, Yasuhiro/0000-0002-4449-3498	Samuel Roberts Noble Foundation	Samuel Roberts Noble Foundation	This work was funded by the Samuel Roberts Noble Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Brooks DM, 2004, MOL PLANT MICROBE IN, V17, P162, DOI 10.1094/MPMI.2004.17.2.162; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Chung HS, 2009, PHYTOCHEMISTRY, V70, P1547, DOI 10.1016/j.phytochem.2009.08.022; Demianski AJ, 2012, MOL PLANT PATHOL, V13, P46, DOI 10.1111/j.1364-3703.2011.00727.x; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Ishiga Y, 2009, NEW PHYTOL, V181, P147, DOI 10.1111/j.1469-8137.2008.02639.x; Ishiga Y, 2012, MOL PLANT MICROBE IN, V25, P294, DOI 10.1094/MPMI-05-11-0130; Ishiga Y, 2010, J GEN PLANT PATHOL, V76, P188, DOI 10.1007/s10327-010-0228-3; Ishiga Y, 2009, PLANT SIGNAL BEHAV, V4, P237, DOI 10.4161/psb.4.3.7915; Katou S, 2005, PLANT PHYSIOL, V139, P1914, DOI 10.1104/pp.105.066795; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; KEANE PJ, 1970, AUST J BIOL SCI, V23, P585, DOI 10.1071/BI9700585; Kloek AP, 2001, PLANT J, V26, P509, DOI 10.1046/j.1365-313x.2001.01050.x; Laurie-Berry N, 2006, MOL PLANT MICROBE IN, V19, P789, DOI 10.1094/MPMI-19-0789; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Moreno JE, 2013, PLANT PHYSIOL, V162, P1006, DOI 10.1104/pp.113.218164; Oh Y, 2012, PLANT PHYSIOL, V159, P769, DOI 10.1104/pp.112.193771; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Ryu CM, 2004, PLANT J, V40, P322, DOI 10.1111/j.1365-313X.2004.02211.x; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Sun JQ, 2011, MOL PLANT, V4, P607, DOI 10.1093/mp/ssr008; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Uppalapati SR, 2005, PLANT J, V42, P201, DOI 10.1111/j.1365-313X.2005.02366.x; Uppalapati SR, 2008, MOL PLANT MICROBE IN, V21, P383, DOI 10.1094/MPMI-21-4-0383; Uppalapati SR, 2007, MOL PLANT MICROBE IN, V20, P955, DOI 10.1094/MPMI-20-8-0955; Uppalapati SR, 2011, NEW PHYTOL, V189, P83, DOI 10.1111/j.1469-8137.2010.03470.x; Wangdi T, 2010, PLANT PHYSIOL, V152, P281, DOI 10.1104/pp.109.148106; WEILER EW, 1994, FEBS LETT, V345, P9, DOI 10.1016/0014-5793(94)00411-0; Yamada S, 2012, PLANT CELL PHYSIOL, V53, P2060, DOI 10.1093/pcp/pcs145; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x	35	38	42	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75728	10.1371/journal.pone.0075728	http://dx.doi.org/10.1371/journal.pone.0075728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086622	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900061
J	Bunda, S; Kommaraju, K; Heir, P; Ohh, M				Bunda, Severa; Kommaraju, Kamya; Heir, Pardeep; Ohh, Michael			SOCS-1 Mediates Ubiquitylation and Degradation of GM-CSF Receptor	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; COMMON BETA-SUBUNIT; ERYTHROPOIETIN RECEPTOR; TUMOR-SUPPRESSOR; ACTIVATION; BOX; PHOSPHORYLATION; UBIQUITINATION; INTERLEUKIN-3; PROTEIN	Granulocyte-macrophage colony-stimulating factor (GM-CSF) and the related cytokines interleukin (IL)-3 and IL-5 regulate the production and functional activation of hematopoietic cells. GM-CSF acts on monocytes/macrophages and granulocytes, and several chronic inflammatory diseases and a number of haematological malignancies such as Juvenile myelomonocytic leukaemia (JMML) are associated with deregulated GM-CSF receptor (GMR) signaling. The downregulation of GMR downstream signaling is mediated in part by the clearance of activated GMR via the proteasome, which is dependent on the ubiquitylation of beta c signaling subunit of GMR via an unknown E3 ubiquitin ligase. Here, we show that suppressor of cytokine signaling 1 (SOCS-1), best known for its ability to promote ubiquitin-mediated degradation of the non-receptor tyrosine kinase Janus kinase 2 (JAK2), also targets GMR beta c for ubiquitin-mediated degradation and attenuates GM-CSF-induced downstream signaling.	[Bunda, Severa; Kommaraju, Kamya; Heir, Pardeep; Ohh, Michael] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Ohh, Michael] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University of Toronto	Ohh, M (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	michael.ohh@utoronto.ca			Canadian Institutes of Health Research (CIHR) [MOP119356]; Cancer Research Society; Canadian Cancer Society [20110]; CIHR/Kidney Cancer Canada fellowship award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Canadian Cancer Society(Canadian Cancer Society (CCS)); CIHR/Kidney Cancer Canada fellowship award	This work was supported by funds from the Canadian Institutes of Health Research (CIHR, MOP119356), Cancer Research Society, and the Canadian Cancer Society (20110). S. B. is a recipient of the CIHR/Kidney Cancer Canada fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley CJ, 1997, BLOOD, V89, P1471, DOI 10.1182/blood.V89.5.1471.1471_1471_1482; Boyle K, 2009, CELL SIGNAL, V21, P394, DOI 10.1016/j.cellsig.2008.11.002; Bunda S, 2013, CANC RES; Emanuel PD, 2008, LEUKEMIA, V22, P1335, DOI 10.1038/leu.2008.162; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Lei JT, 2011, J BIOL CHEM, V286, P40091, DOI 10.1074/jbc.M111.273482; Loh ML, 2010, HEMATOL-AM SOC HEMAT, P357, DOI 10.1182/asheducation-2010.1.357; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Lopez AF, 2010, IUBMB LIFE, V62, P509, DOI 10.1002/iub.350; Martinez-Moczygemba M, 2001, J CLIN INVEST, V108, P1797, DOI 10.1172/JCI200113877; Martinez-Moczygemba M, 2007, J LEUKOCYTE BIOL, V81, P1137, DOI 10.1189/jlb.0706465; Metcalf D, 1999, LEUKEMIA, V13, P926, DOI 10.1038/sj.leu.2401440; Metcalf D, 2003, P NATL ACAD SCI USA, V100, P8436, DOI 10.1073/pnas.1032925100; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Perugini M, 2010, BLOOD, V115, P3346, DOI 10.1182/blood-2009-08-235846; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Russell RC, 2011, NAT MED, V17, P845, DOI 10.1038/nm.2370; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zahn S, 2000, CYTOKINE, V12, P1299, DOI 10.1006/cyto.2000.0718; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	24	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76370	10.1371/journal.pone.0076370	http://dx.doi.org/10.1371/journal.pone.0076370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086733	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000065
J	Kogure, T; Kinghorn, AD; Yan, I; Bolon, B; Lucas, DM; Grever, MR; Patel, T				Kogure, Takayuki; Kinghorn, A. Douglas; Yan, Irene; Bolon, Brad; Lucas, David M.; Grever, Michael R.; Patel, Tushar			Therapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular Cancer	PLOS ONE			English	Article							MESSENGER-RNAS; CARCINOMA; INITIATION; PATHWAYS; LYMPHOMA; DRUGS; HCC	Background & Aims: Although hepatocellular cancers (HCC) frequently arise in the setting of fibrosis and a hepatic regenerative response requiring new cell growth, therapeutic strategies for these cancers have not targeted protein synthesis. Silvestrol, a rocaglate isolated from Aglaia foveolata, can inhibit protein synthesis by modulating the initiation of translation through the eukaryotic initiation factor 4A. In this study, we evaluated the therapeutic efficacy of silvestrol for HCC. Methods: The efficacy of silvestrol was examined using human HCC cells in vitro using an orthotopic tumor cell xenograft model in a fibrotic liver. The impact of silvestrol on the liver was assessed in vivo in wild-type mice. Results: Silvestrol inhibited cell growth with an IC50 of 12.5-86 nM in four different HCC cell lines. In vitro, silvestrol increased apoptosis and caspase 3/7 activity accompanied by loss of mitochondrial membrane potential and decreased expression of Mcl-1 and Bcl-xL. A synergistic effect was observed when silvestrol was combined with other therapeutic agents, with a dose-reduction index of 3.42-fold with sorafenib and 1.75-fold with rapamycin at a fractional effect of 0.5. In vivo, an antitumor effect was observed with 0.4 mg/kg silvestrol compared to controls after one week, and survival of tumor-bearing mice was improved with a median survival time of 42 and 28 days in the silvestrol and control groups, respectively. The effect on survival was not observed in orthotopic xenografts in non-fibrotic livers. Silvestrol treatment in vivo did not alter liver structure. Conclusions: These data identify silvestrol as a novel, structurally unique drug with potent anticancer activity for HCC and support the potential value of targeting initiation of translation in the treatment of HCC.	[Kogure, Takayuki; Lucas, David M.; Grever, Michael R.; Patel, Tushar] Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA; [Kinghorn, A. Douglas; Lucas, David M.] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Bolon, Brad] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Kogure, Takayuki; Yan, Irene; Patel, Tushar] Mayo Clin, Dept Transplantat, Jacksonville, FL 32224 USA; [Kogure, Takayuki; Yan, Irene; Patel, Tushar] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Mayo Clinic; Mayo Clinic	Patel, T (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA.	patel.tushar@mayo.edu	patel, tushar/J-3976-2013; Lucas, David M/E-3555-2011; Kogure, Takayuki/AAI-3946-2021	patel, tushar/0000-0001-7021-9532; Kinghorn, A. Douglas/0000-0002-6647-8707	National Institutes of Health [DK069370]; National Cancer Institute [P01 CA125066]; NATIONAL CANCER INSTITUTE [P01CA125066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grant funding from the National Institutes of Health, DK069370 (TP) and National Cancer Institute, P01 CA125066 (ADK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinari L, 2012, CLIN CANCER RES, V18, P4600, DOI 10.1158/1078-0432.CCR-12-0839; Antonaci S, 2007, CURR PHARM DESIGN, V13, P3288, DOI 10.2174/138161207782360645; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; El Sous M, 2007, ANGEW CHEM INT EDIT, V46, P7835, DOI 10.1002/anie.200702700; Han ZG, 2012, ANNU REV GENOM HUM G, V13, P171, DOI 10.1146/annurev-genom-090711-163752; Hwang BY, 2004, J ORG CHEM, V69, P3350, DOI 10.1021/jo040120f; Kinghorn AD, 2011, J NAT PROD, V74, P1539, DOI 10.1021/np200391c; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Lindqvist L, 2009, FUTURE MED CHEM, V1, P1709, DOI 10.4155/FMC.09.122; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lucas DM, 2009, BLOOD, V113, P4656, DOI 10.1182/blood-2008-09-175430; Marquardt JU, 2012, J HEPATOL, V56, P267, DOI 10.1016/j.jhep.2011.07.007; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Rizell M, 2008, INT J CLIN ONCOL, V13, P66, DOI 10.1007/s10147-007-0733-3; Shuda M, 2000, ANTICANCER RES, V20, P2489; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Treiber G, 2009, EXPERT REV ANTICANC, V9, P247, DOI 10.1586/14737140.9.2.247; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Wang XL, 2012, WORLD J GASTROENTERO, V18, P2540, DOI 10.3748/wjg.v18.i20.2540; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670; Zhu AX, 2011, CANCER-AM CANCER SOC, V117, P5094, DOI 10.1002/cncr.26165	25	45	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76136	10.1371/journal.pone.0076136	http://dx.doi.org/10.1371/journal.pone.0076136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086701	gold, Green Submitted, Green Published			2022-12-25	WOS:000325220000060
J	Lambertucci, SA; Carrete, M; Speziale, KL; Hiraldo, F; Donazar, JA				Lambertucci, Sergio A.; Carrete, Martina; Speziale, Karina L.; Hiraldo, Fernando; Antonio Donazar, Jose			Population Sex Ratios: Another Consideration in the Reintroduction - Reinforcement Debate?	PLOS ONE			English	Article							ANDEAN CONDORS; CONSERVATION; VULTURES; WILD	Reintroduction or reinforcement (RorR) of wild populations is a common conservation strategy. Many conservation projects involve the release of individuals of poorly studied species. This may lead to inefficient results or negative impacts on the conservation efforts. Here, we provide new insights into the conservation implications and potential consequences of a skew in the sex ratio of released birds and of the number of birds supplemented for the demography of a long-lived dimorphic bird species, the Andean condor (Vultur gryphus). We demonstrate that a RorR conservation program may be less effective in conserving a species if the sex ratios of the releases and the recipient populations are not considered. We also show that releases can reduce population declines but only if carried out over long periods (i.e., several decades). This can mean high costs for release programs and the added challenge of maintaining programs over time. If RorR programs are to be implemented, bearing in mind the importance of properly assessing their effectiveness, we urge conservation researchers and managers to consider the implications of sex ratio biases for wild populations, and particularly for dimorphic species with sexually despotic behaviour.	[Lambertucci, Sergio A.; Speziale, Karina L.] Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina; [Carrete, Martina] Univ Pablo Olavide, Dept Phys Chem & Nat Syst, Seville, Spain; [Hiraldo, Fernando; Antonio Donazar, Jose] CSIC, Estac Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Lambertucci, SA (corresponding author), Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina.	slambertucci@comahue-conicet.gob.ar	Carrete, Martina/D-2618-2017; Carrete, Martina/A-6376-2009; Hiraldo, Fernando/AAA-8314-2019; Speziale, Karina/O-9415-2014	Carrete, Martina/0000-0002-0491-2950; Donazar, Jose Antonio/0000-0002-9433-9755; Speziale, Karina/0000-0003-2224-2097; LAMBERTUCCI, SERGIO/0000-0002-2624-2185	Fundacion BBVA (Fundacion Banco Bilbao Vizcaya Argentaria) [BIOCON 08 126]	Fundacion BBVA (Fundacion Banco Bilbao Vizcaya Argentaria)	Funding was provided through the Project BIOCON 08 126, from Fundacion BBVA (Fundacion Banco Bilbao Vizcaya Argentaria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bose M, 2007, ORYX, V41, P503, DOI 10.1017/S0030605307000312; Bruning D.F., 1984, International Zoo Yearbook, V23, P11; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Clout MN, 2002, BIOL CONSERV, V107, P13, DOI 10.1016/S0006-3207(01)00267-1; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Ewen JG, 2012, REINTRODUCTION BIOL; Ferguson-Lees J, 2001, RAPTORS WORLD; IUCN, 1998, IUCN GUID REINTR; Lacy RC, 2003, VORTEX STOCH SIM EXT; Lambertucci S, 2007, HORNERO, V22, P149; Lambertucci SA, 2008, J FIELD ORNITHOL, V79, P147, DOI 10.1111/j.1557-9263.2008.00156.x; Lambertucci SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046347; Lambertucci SA, 2011, BIOL CONSERV, V144, P1464, DOI 10.1016/j.biocon.2011.01.015; Lambertucci SA, 2010, ORYX, V44, P441, DOI 10.1017/S0030605310000451; Meretsky VJ, 2000, CONSERV BIOL, V14, P957, DOI 10.1046/j.1523-1739.2000.99113.x; Ministerio de Ambiente Vivienda y Desarrollo Territorial, 2006, PROGR NAC CONS COND, p[2006, 32]; Onichimowska Anna., 2012, KONIEC GRY; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Perez I, 2012, FRONT ECOL ENVIRON, V10, P494, DOI 10.1890/110175; Raptor AZA. TAG, 2010, AND COND VULTURGRYPH; Robertson BC, 2006, BIOL LETTERS, V2, P229, DOI 10.1098/rsbl.2005.0430; Sarrazin F, 2000, CONSERV BIOL, V14, P488, DOI 10.1046/j.1523-1739.2000.97305.x; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; White C.M., 1994, NEW WORLD VULTURES G	29	20	21	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75821	10.1371/journal.pone.0075821	http://dx.doi.org/10.1371/journal.pone.0075821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086641	Green Published, gold			2022-12-25	WOS:000325220000046
J	Parra-Bonilla, G; Alvarez, DF; Alexeyev, M; Vasauskas, A; Stevens, T				Parra-Bonilla, Glenda; Alvarez, Diego F.; Alexeyev, Mikhail; Vasauskas, Audrey; Stevens, Troy			Lactate Dehydrogenase A Expression Is Necessary to Sustain Rapid Angiogenesis of Pulmonary Microvascular Endothelium	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; VIVO GENE TRANSFECTION; CHRONIC LUNG-DISEASE; PROGENITOR CELLS; ARTERIAL-HYPERTENSION; CHRONIC INFLAMMATION; AIRWAY VASCULATURE; PLEXIFORM LESIONS; PROLIFERATION; CIRCULATION	Angiogenesis is a fundamental property of endothelium, yet not all endothelial cells display equivalent angiogenic responses; pulmonary microvascular endothelial cells undergo rapid angiogenesis when compared to endothelial cells isolated from conduit vessels. At present it is not clear how pulmonary microvascular endothelial cells fulfill the bioenergetic demands that are necessary to sustain such rapid blood vessel formation. We have previously established that pulmonary microvascular endothelial cells utilize aerobic glycolysis to generate ATP during growth, a process that requires the expression of lactate dehydrogenase A to convert pyruvate to lactate. Here, we test the hypothesis that lactate dehydrogenase A is required for pulmonary microvascular endothelial cells to sustain rapid angiogenesis. To test this hypothesis, Tet-On and Tet-Off conditional expression systems were developed in pulmonary microvascular endothelial cells, where doxycycline is utilized to induce lactate dehydrogenase A shRNA expression. Expression of LDH-A shRNA induced a time-dependent decrease in LDH-A protein, which corresponded with a decrease in glucose consumption from the media, lactate production and cell growth; re-expression of LDH-A rescued each of these parameters. LDH-A silencing greatly reduced network formation on Matrigel in vitro, and decreased blood vessel formation in Matrigel in vivo. These findings demonstrate that LDH-A is critically important for sustaining the rapid angiogenesis of pulmonary microvascular endothelial cells.	[Parra-Bonilla, Glenda; Alvarez, Diego F.; Stevens, Troy] Univ S Alabama, Dept Pharmacol, Mobile, AL 36688 USA; [Alvarez, Diego F.; Stevens, Troy] Univ S Alabama, Dept Med, Mobile, AL 36688 USA; [Alexeyev, Mikhail] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Vasauskas, Audrey] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Parra-Bonilla, Glenda; Alvarez, Diego F.; Alexeyev, Mikhail; Vasauskas, Audrey; Stevens, Troy] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama	Stevens, T (corresponding author), Univ S Alabama, Dept Pharmacol, Mobile, AL 36688 USA.	tstevens@jaguar1.usouthal.edu	Alvarez, Diego/AAT-3897-2020	Alvarez, Diego/0000-0001-8244-629X; Vasauskas, Audrey/0000-0002-1724-5923	American Heart Association;  [HL60024];  [HL66299]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR031286] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060024, P01HL066299, R37HL060024] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010944] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by HL60024 and HL66299 (to TS) and an American Heart Association Predoctoral Fellowship (to GPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Alexeyev MF, 2010, MOL BIOL REP, V37, P1987, DOI 10.1007/s11033-009-9647-7; Alvarez DF, 2008, AM J PHYSIOL-LUNG C, V294, pL419, DOI 10.1152/ajplung.00314.2007; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Clark J, 2008, AM J PHYSIOL-LUNG C, V294, pL431, DOI 10.1152/ajplung.00316.2007; Dai RP, 2008, J BIOL CHEM, V283, P26894, DOI 10.1074/jbc.M804307200; Davie NJ, 2006, AM J PATHOL, V168, P1793, DOI 10.2353/ajpath.2006.050754; Davie NJ, 2004, AM J PHYSIOL-LUNG C, V286, pL668, DOI 10.1152/ajplung.00108.2003; Dutly AE, 2005, AM J TRANSPLANT, V5, P248, DOI 10.1111/j.1600-6143.2004.00680.x; Ezaki T, 2001, AM J PATHOL, V158, P2043, DOI 10.1016/S0002-9440(10)64676-7; Farha S, 2007, J APPL PHYSIOL, V103, P1789, DOI 10.1152/japplphysiol.00614.2007; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; Foster DJ, 2004, AM J PHYSIOL-LUNG C, V287, pL1107, DOI 10.1152/ajplung.00119.2004; Gargett CE, 2001, REPRODUCTION, V121, P181, DOI 10.1530/rep.0.1210181; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOBSON B, 1984, BRIT J CANCER, V49, P405, DOI 10.1038/bjc.1984.66; Hopkins N, 2002, J ANAT, V201, P335, DOI 10.1046/j.1469-7580.2002.00096.x; Hopkins N, 2001, J APPL PHYSIOL, V91, P919, DOI 10.1152/jappl.2001.91.2.919; Howell K, 2003, J PHYSIOL-LONDON, V547, P133, DOI 10.1113/jphysiol.2002.030676; Howell K, 2009, AM J PHYSIOL-LUNG C, V296, pL1042, DOI 10.1152/ajplung.90327.2008; HUDLICKA O, 1992, PHYSIOL REV, V72, P369, DOI 10.1152/physrev.1992.72.2.369; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; Kwan ML, 2001, AM J PHYSIOL-LUNG C, V280, pL286, DOI 10.1152/ajplung.2001.280.2.L286; McDonald DM, 2001, AM J RESP CRIT CARE, V164, pS39, DOI 10.1164/ajrccm.164.supplement_2.2106065; Mitzner W, 2000, AM J PATHOL, V157, P93, DOI 10.1016/S0002-9440(10)64521-X; Montani D, 2011, AM J RESP CRIT CARE, V184, P116, DOI 10.1164/rccm.201006-0905OC; Morino S, 2007, EXP LUNG RES, V33, P15, DOI 10.1080/01902140601113070; Ono M, 2002, CIRCULATION, V106, pI264, DOI 10.1161/cir.0000032879.55215.f4; Parra-Bonilla G, 2010, AM J PHYSIOL-LUNG C, V299, pL513, DOI 10.1152/ajplung.00274.2009; Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; Reynolds LP, 1998, J ANIM SCI, V76, P1671; Schraufnagel DE, 1997, AM J PHYSIOL-LUNG C, V272, pL139, DOI 10.1152/ajplung.1997.272.1.L139; Shigemura N, 2005, CIRCULATION, V111, P1407, DOI 10.1161/01.CIR.0000158433.89103.85; Solodushko V, 2007, AM J PHYSIOL-LUNG C, V292, pL671, DOI 10.1152/ajplung.00304.2006; Starnes SL, 2000, J THORAC CARDIOV SUR, V120, P902, DOI 10.1067/mtc.2000.110248; Stevens T, 2005, CHEST, V128, p558S, DOI 10.1378/chest.128.6_suppl.558S; SYPNIEWSKA G, 1987, EUR J CLIN INVEST, V17, P202, DOI 10.1111/j.1365-2362.1987.tb01236.x; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; TUDER RM, 1994, AM J PATHOL, V144, P275; Voelkel NF, 2007, CHEST, V131, P874, DOI 10.1378/chest.06-2453; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Zhang JL, 2009, GASTROENTEROLOGY, V136, P1070, DOI 10.1053/j.gastro.2008.12.001	45	27	27	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75984	10.1371/journal.pone.0075984	http://dx.doi.org/10.1371/journal.pone.0075984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086675	Green Published, gold, Green Submitted			2022-12-25	WOS:000325220000055
J	Raychaudhuri, N; Fernando, R; Smith, TJ				Raychaudhuri, Nupur; Fernando, Roshini; Smith, Terry J.			Thyrotropin Regulates IL-6 Expression in CD34(+) Fibrocytes: Clear Delineation of Its cAMP-Independent Actions	PLOS ONE			English	Article							THYROID-STIMULATING HORMONE; KINASE-C-BETA; PROTEIN-KINASE; TSH RECEPTOR; CIRCULATING FIBROCYTES; GENE-EXPRESSION; T-CELLS; INTERLEUKIN-6 PRODUCTION; GRAVES OPHTHALMOPATHY; SERUM CONCENTRATIONS	IL-6 plays diverse roles in normal and disease-associated immunity such as that associated with Graves' disease (GD). In that syndrome, the orbit undergoes remodeling during a process known as thyroid-associated ophthalmopathy (TAO). Recently, CD34(+) fibrocytes were found to infiltrate the orbit in TAO where they transition into CD34(+) orbital fibroblasts. Surprisingly, fibrocytes display high levels of functional thyrotropin receptor (TSHR), the central antigen in GD. We report here that TSH and the pathogenic anti-TSHR antibodies that drive hyperthyroidism in GD induce IL-6 expression in fibrocytes and orbital fibroblasts. Unlike TSHR signaling in thyroid epithelium, that occurring in fibrocytes is completely independent of adenylate cyclase activation and cAMP generation. Instead TSH activates PDK1 and both AKT/PKB and PKC pathways. Expression and use of PKCbII switches to that of PKCm as fibrocytes transition to TAO orbital fibroblasts. This shift is imposed by CD34(-) orbital fibroblasts but reverts when CD34(+) fibroblasts are isolated. The up-regulation of IL-6 by TSH results from coordinately enhanced IL-6 gene promoter activity and increased IL-6 mRNA stability. TSH-dependent IL-6 expression requires activity at both CREB (-213 to -208 nt) and NF-kappa B (-78 to -62 nt) binding sites. These results provide novel insights into the molecular action of TSH and signaling downstream for TSHR in non-thyroid cells. Fibrocytes neither express adenylate cyclase nor generate cAMP and thus these findings are free from any influence of cAMP-related signaling. They identify potential therapeutic targets for TAO.	[Raychaudhuri, Nupur; Fernando, Roshini; Smith, Terry J.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Smith, Terry J.] Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrine & Diabet, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Smith, TJ (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	terrysmi@med.umich.edu	Smith, Terry/ABG-1360-2020	Smith, Terry/0000-0002-6279-9685	National Institutes of Health; Nuclear Energy Institute [EY008976, EY011708, DK063121, EY007003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011708, R01EY008976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nuclear Energy Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by grants from the National Institutes of Health (nih.gov); EY008976, EY011708, DK063121, and core Center for Vision Research grant EY007003 from the Nuclear Energy Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Antunes TT, 2005, OBES RES, V13, P2066, DOI 10.1038/oby.2005.256; Bell A, 2003, ARTERIOSCL THROM VAS, V23, pE65, DOI 10.1161/01.ATV.0000102520.84030.A1; Bell A, 2000, AM J PHYSIOL-CELL PH, V279, pC335, DOI 10.1152/ajpcell.2000.279.2.C335; BOTELHO LHP, 1988, METHOD ENZYMOL, V159, P159; Bowman JC, 1997, J CLIN INVEST, V100, P2189, DOI 10.1172/JCI119755; Brent GA, 2008, NEW ENGL J MED, V358, P2594, DOI 10.1056/NEJMcp0801880; Brown CY, 1996, P NATL ACAD SCI USA, V93, P13721, DOI 10.1073/pnas.93.24.13721; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Chen BL, 2005, J IMMUNOL, V175, P1310, DOI 10.4049/jimmunol.175.2.1310; Cheng L, 2008, AM J PHYSIOL-GASTR L, V295, pG493, DOI 10.1152/ajpgi.90214.2008; Chesney J, 1997, P NATL ACAD SCI USA, V94, P6307, DOI 10.1073/pnas.94.12.6307; Davidson LA, 1998, CARCINOGENESIS, V19, P253, DOI 10.1093/carcin/19.2.253; DAVIES TF, 1978, MOL CELL ENDOCRINOL, V9, P303, DOI 10.1016/0303-7207(78)90072-2; Davies TF, 2005, J CLIN INVEST, V115, P1972, DOI 10.1172/JCI26031; DECARLI M, 1993, J CLIN ENDOCR METAB, V77, P1120, DOI 10.1210/jc.77.5.1120; Douglas RS, 2010, J CLIN ENDOCR METAB, V95, P430, DOI 10.1210/jc.2009-1614; DREYER C, 1978, NUCLEIC ACIDS RES, V5, P3325, DOI 10.1093/nar/5.9.3325; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; ENDO T, 1995, J BIOL CHEM, V270, P10833, DOI 10.1074/jbc.270.18.10833; Fernando R, 2012, P NATL ACAD SCI USA, V109, P7427, DOI 10.1073/pnas.1202064109; Freson K, 2002, HUM MOL GENET, V11, P2741, DOI 10.1093/hmg/11.22.2741; Gillespie EF, 2012, J CLIN ENDOCR METAB, V97, pE740, DOI 10.1210/jc.2011-2514; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; GRUBECKLOEBENSTEIN B, 1994, J CLIN INVEST, V93, P2738, DOI 10.1172/JCI117289; GRUBECKLOEBENSTEIN B, 1989, CLIN EXP IMMUNOL, V77, P324; Hara T, 1999, ENDOCRINOLOGY, V140, P1724, DOI 10.1210/en.140.4.1724; HEUFELDER AE, 1993, THYROID, V3, P297, DOI 10.1089/thy.1993.3.297; Hirano T, 1998, Int Rev Immunol, V16, P249; Hiromatsu Y, 2000, J CLIN ENDOCR METAB, V85, P1194, DOI 10.1210/jc.85.3.1194; Iankov I, 2002, LEUKEMIA RES, V26, P363, DOI 10.1016/S0145-2126(01)00132-1; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; JAUME JC, 1994, J CLIN ENDOCR METAB, V78, P348, DOI 10.1210/jc.78.2.348; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Kazim M, 2002, ARCH OPHTHALMOL-CHIC, V120, P380; Kero J, 2007, J CLIN INVEST, V117, P2399, DOI 10.1172/JCI30380; Klein JR, 2003, AUTOIMMUNITY, V36, P417, DOI 10.1080/08916930310001603019; Konopatskaya O, 2011, BLOOD, V118, P416, DOI 10.1182/blood-2010-10-312199; Legrand-Poels S, 2000, BIOCHEM J, V349, P765, DOI 10.1042/bj3490765; LICHTENSTEIN A, 1995, CELL IMMUNOL, V162, P248, DOI 10.1006/cimm.1995.1076; MARCUS C, 1988, J CLIN INVEST, V82, P1793, DOI 10.1172/JCI113793; MARTIN CA, 1991, CELL IMMUNOL, V135, P245, DOI 10.1016/0008-8749(91)90269-H; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Miyazawa K, 1998, J BIOL CHEM, V273, P24832, DOI 10.1074/jbc.273.38.24832; Molnar I, 1997, AUTOIMMUNITY, V25, P91, DOI 10.3109/08916939708996275; Morshed SA, 2009, ENDOCRINOLOGY, V150, P519, DOI 10.1210/en.2008-0878; Motomura T, 1998, J BONE MINER RES, V13, P1084, DOI 10.1359/jbmr.1998.13.7.1084; MURAGUCHI A, 1981, J IMMUNOL, V127, P412; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Nguyen LQ, 2000, MOL ENDOCRINOL, V14, P1448, DOI 10.1210/me.14.9.1448; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; PASCHKE R, 1994, J CLIN ENDOCR METAB, V79, P1234, DOI 10.1210/jc.79.5.1234; Pham N, 2000, CURR BIOL, V10, pR577, DOI 10.1016/S0960-9822(00)00627-8; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Porcellini A, 2003, J BIOL CHEM, V278, P40621, DOI 10.1074/jbc.M307501200; Raychaudhuri S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011930; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Salvi M, 1996, J CLIN ENDOCR METAB, V81, P2976, DOI 10.1210/jc.81.8.2976; Salvi M, 2000, EUR J ENDOCRINOL, V143, P197, DOI 10.1530/eje.0.1430197; Sanders JL, 2000, J BONE MINER RES, V15, P885, DOI 10.1359/jbmr.2000.15.5.885; SAUNIER B, 1995, J BIOL CHEM, V270, P3693, DOI 10.1074/jbc.270.8.3693; SAUNIER B, 1993, EUR J BIOCHEM, V218, P1091, DOI 10.1111/j.1432-1033.1993.tb18469.x; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; SEHGAL PB, 1992, RES IMMUNOL, V143, P724, DOI 10.1016/0923-2494(92)80011-9; Sledge GW, 2006, SEMIN ONCOL, V33, pS15, DOI 10.1016/j.seminoncol.2006.03.019; Smith TJ, 2011, J CLIN ENDOCR METAB, V96, P3827, DOI 10.1210/jc.2011-1249; SMITH TJ, 1995, J CLIN ENDOCR METAB, V80, P2620, DOI 10.1210/jc.80.9.2620; Sunthornthepvarakul T, 2004, NEW ENGL J MED, V332, P155; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tayze T, 2008, ENDOCRINOLOGY, V149, P3062; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tsui S, 2008, J IMMUNOL, V181, P4397, DOI 10.4049/jimmunol.181.6.4397; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Vassart G, 1992, ENDOCR REV, V13, P96; WOLOSHIN PI, 1992, MOL ENDOCRINOL, V6, P1725, DOI 10.1210/me.6.10.1725; Zaballos MA, 2008, MOL ENDOCRINOL, V22, P1183, DOI 10.1210/me.2007-0093; ZAKARIJA M, 1987, ENDOCRIN METAB CLIN, V16, P343, DOI 10.1016/S0889-8529(18)30483-3; ZAKARIJA M, 1988, J CLIN INVEST, V81, P879, DOI 10.1172/JCI113398; Zhu JX, 2004, CANCER RES, V64, P4309, DOI 10.1158/0008-5472.CAN-03-4063	83	42	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75100	10.1371/journal.pone.0075100	http://dx.doi.org/10.1371/journal.pone.0075100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086448	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700053
J	Steffan, SA; Chikaraishi, Y; Horton, DR; Ohkouchi, N; Singleton, ME; Miliczky, E; Hogg, DB; Jones, VP				Steffan, Shawn A.; Chikaraishi, Yoshito; Horton, David R.; Ohkouchi, Naohiko; Singleton, Merritt E.; Miliczky, Eugene; Hogg, David B.; Jones, Vincent P.			Trophic Hierarchies Illuminated via Amino Acid Isotopic Analysis	PLOS ONE			English	Article							AQUATIC FOOD-WEB; STABLE-ISOTOPES; DISCRIMINATION FACTORS; LABORATORY EXPERIMENTS; NITROGEN ISOTOPES; DELTA-N-15 VALUES; CONSUMER-DIET; FRACTIONATION; ECOLOGY; POSITION	Food web ecologists have long sought to characterize the trophic niches of animals using stable isotopic analysis. However, distilling trophic position from isotopic composition has been difficult, largely because of the variability associated with trophic discrimination factors (inter-trophic isotopic fractionation and routing). We circumvented much of this variability using compound-specific isotopic analysis (CSIA). We examined the N-15 signatures of amino acids extracted from organisms reared in pure culture at four discrete trophic levels, across two model communities. We calculated the degree of enrichment at each trophic level and found there was a consistent trophic discrimination factor (similar to 7.6 parts per thousand). The constancy of the CSIA-derived discrimination factor permitted unprecedented accuracy in the measurement of animal trophic position. Conversely, trophic position estimates generated via bulk-N-15 analysis significantly underestimated trophic position, particularly among higher-order consumers. We then examined the trophic hierarchy of a free-roaming arthropod community, revealing the highest trophic position (5.07) and longest food chain ever reported using CSIA. High accuracy in trophic position estimation brings trophic function into sharper focus, providing greater resolution to the analysis of food webs.	[Steffan, Shawn A.] ARS, USDA, Madison, WI 53706 USA; [Steffan, Shawn A.; Singleton, Merritt E.; Hogg, David B.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Chikaraishi, Yoshito; Ohkouchi, Naohiko] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan; [Horton, David R.; Miliczky, Eugene] ARS, USDA, Yakima Area Res Lab, Wapato, WA USA; [Jones, Vincent P.] Washington State Univ, Ctr Tree Fruit Res & Extens, Dept Entomol, Wenatchee, WA 98801 USA	United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); United States Department of Agriculture (USDA); Washington State University	Steffan, SA (corresponding author), ARS, USDA, Madison, WI 53706 USA.	steffan2@wisc.edu	Steffan, Shawn/AFU-4054-2022; Chikaraishi, Yoshito/O-5250-2019; Ohkouchi, Naohiko/B-2071-2008	Chikaraishi, Yoshito/0000-0002-7506-1524; Steffan, Shawn/0000-0002-2219-6409; Ohkouchi, Naohiko/0000-0002-6355-7469	USDA-ARS [3655-21220-001-00D, 5352-22430-001-13]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding was provided by USDA-ARS appropriated funds (3655-21220-001-00D), as well as grant funds (5352-22430-001-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARROLL DP, 1984, ENVIRON ENTOMOL, V13, P469, DOI 10.1093/ee/13.2.469; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Caut S, 2008, FUNCT ECOL, V22, P255, DOI 10.1111/j.1365-2435.2007.01360.x; Caut S, 2010, J APPL ECOL, V47, P948, DOI 10.1111/j.1365-2664.2010.01832.x; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Chikaraishi Y., 2010, EARTH LIFE ISOTOPES, P37; Chikaraishi Y, 2007, MAR ECOL PROG SER, V342, P85, DOI 10.3354/meps342085; Chikaraishi Y, 2011, ECOL RES, V26, P835, DOI 10.1007/s11284-011-0844-1; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Cottingham KL, 2005, FRONT ECOL ENVIRON, V3, P145, DOI 10.1890/1540-9295(2005)003[0145:KWTDTL]2.0.CO;2; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DELRIO CM, 2005, PHYSL ECOLOGICAL ADA, P141; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Eggers T, 2000, TRENDS ECOL EVOL, V15, P265, DOI 10.1016/S0169-5347(00)01877-2; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Gibson G, 1997, 40392 NAT RES COUNC; Hannides CCS, 2009, LIMNOL OCEANOGR, V54, P50, DOI 10.4319/lo.2009.54.1.0050; HAYES JM, 1990, ORG GEOCHEM, V16, P1115, DOI 10.1016/0146-6380(90)90147-R; Lorrain A, 2009, MAR ECOL PROG SER, V391, P293, DOI 10.3354/meps08215; MACKO SA, 1987, CHEM GEOL, V65, P79, DOI 10.1016/0168-9622(87)90064-9; McCarthy MD, 2007, GEOCHIM COSMOCHIM AC, V71, P4727, DOI 10.1016/j.gca.2007.06.061; McClelland JW, 2003, DEEP-SEA RES PT I, V50, P849, DOI 10.1016/S0967-0637(03)00073-6; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McMahon KW, 2010, J ANIM ECOL, V79, P1132, DOI 10.1111/j.1365-2656.2010.01722.x; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; O'Brien DM, 2002, P NATL ACAD SCI USA, V99, P4413, DOI 10.1073/pnas.072346699; Ogawa NO, 2009, ECOL RES, P1; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Popp BN, 2007, TERR ECOL SER, V1, P173; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Schmidt K, 2004, MAR ECOL PROG SER, V266, P43, DOI 10.3354/meps266043; Schmidt SN, 2007, ECOLOGY, V88, P2793, DOI 10.1890/07-0121.1; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Spence KO, 2005, OECOLOGIA, V146, P89, DOI 10.1007/s00442-005-0170-9; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 1997, CAN J FISH AQUAT SCI, V54, P1142, DOI 10.1139/cjfas-54-5-1142; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; WAINRIGHT SC, 1993, MAR BIOL, V115, P481, DOI 10.1007/BF00349847; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x	45	93	93	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76152	10.1371/journal.pone.0076152	http://dx.doi.org/10.1371/journal.pone.0076152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086703	Green Published, gold			2022-12-25	WOS:000325218700122
J	Chen, YF; Tsai, HY; Wu, KJ; Siao, LR; Wood, WG				Chen, Yuh-Fung; Tsai, Huei-Yann; Wu, Kuo-Jen; Siao, Lian-Ru; Wood, W. Gibson			Pipoxolan Ameliorates Cerebral Ischemia via Inhibition of Neuronal Apoptosis and Intimal Hyperplasia through Attenuation of VSMC Migration and Modulation of Matrix Metalloproteinase-2/9 and Ras/MEK/ERK Signaling Pathways	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CAROTID-ARTERY LIGATION; IN-VITRO; NEOINTIMAL FORMATION; BALLOON ANGIOPLASTY; PROLIFERATION; EXPRESSION; REPLICATION; MECHANISMS; INVASION	Pipoxolan (PIPO) has anti-spasmodic effects, and it is used clinically to relieve smooth muscle spasms. Cerebrovascular disease is one of the leading causes of disability and death worldwide. The main aim of this study was to investigate the effects of PIPO on cerebral ischemia and vascular smooth muscle cell (VSMC) migration in vivo and in vitro. Cerebral infarction area, ratio of intima to media area (I/M ratio) and PCNA antibody staining of the carotid artery in vivo were measured. Cell viability of A7r5 cells, PDGF-BB-stimulated cell migration, and potential mechanisms of PIPO were evaluated by wound healing, transwell and Western blotting. PIPO (10 and 30 mg/kg p.o.) reduced: the cerebral infarction area; neurological deficit; TUNEL-positive cells; cleaved caspase 3-positive cells; intimal hyperplasia; and inhibited proliferating cell nuclear antigen (PCNA)-positive cells in rodents. PIPO (5, 10 and 15 mu M) significantly inhibited PDGF-BB-stimulated VSMC migration and reduced Ras, MEK, and p-ERK levels. Moreover, PIPO decreased levels of matrix metalloproteinases -2 and -9 in PDGF-BB-stimulated A7r5 cells. In summary, PIPO is protective in models of ischemia/reperfusion-induced cerebral infarction, carotid artery ligation-induced intimal hyperplasia and VSMC migration both in vivo and in vitro. PIPO could be potentially efficacious in preventing cerebrovascular and vascular diseases.	[Chen, Yuh-Fung; Wu, Kuo-Jen; Siao, Lian-Ru] China Med Univ, Coll Med, Dept Pharmacol, Taichung, Taiwan; [Chen, Yuh-Fung; Tsai, Huei-Yann] China Med Univ Hosp, Dept Pharm, Taichung, Taiwan; [Wood, W. Gibson] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Wood, W. Gibson] VA Med Ctr, Geriatr Res Educ & Clin Ctr, Minneapolis, MN USA	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Minnesota System; University of Minnesota Twin Cities; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Chen, YF (corresponding author), China Med Univ, Coll Med, Dept Pharmacol, Taichung, Taiwan.	yfchen@mail.cmu.edu.tw			China Medical University [CMU99-COL-42-1, CMU99-COL-42-2]; National Science Council, Taiwan, ROC [NSC101-2320-B-039-026]	China Medical University(China Medical University); National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was partially supported by grants from China Medical University (CMU99-COL-42-1, CMU99-COL-42-2) and National Science Council (NSC101-2320-B-039-026), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AH, 1998, J CLIN INVEST, V101, P1478, DOI 10.1172/JCI1584; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Berk BC, 2001, PHYSIOL REV, V81, P999, DOI 10.1152/physrev.2001.81.3.999; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; Chandrasekar B, 2000, J AM COLL CARDIOL, V35, P555, DOI 10.1016/S0735-1097(99)00596-3; Chen YF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/482428; Chlud K, 1969, Med Welt, V33, P1801; Cho A, 2002, CIRC RES, V91, P845, DOI 10.1161/01.RES.0000040420.17366.2E; DOLLERY CM, 1995, CIRC RES, V77, P863, DOI 10.1161/01.RES.77.5.863; Fateev IV, 2012, B EXP BIOL MED+, V152, P378, DOI 10.1007/s10517-012-1533-y; Felix W, 1969, DRUG RES, V19, P1860; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gennaro G, 2004, CIRCULATION, V110, P3367, DOI 10.1161/01.CIR.0000147773.86866.CD; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; GORELICK PB, 1986, NURS CLIN N AM, V21, P275; HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403; Hasso A N, 1994, Neuroimaging Clin N Am, V4, P733; Indolfi C, 1999, Cardiol Rev, V7, P324, DOI 10.1097/00045415-199911000-00010; Johnson C, 2004, ARTERIOSCL THROM VAS, V24, P54, DOI 10.1161/01.ATV.0000100402.69997.C3; Kumar A, 1997, CIRCULATION, V96, P4333; Kuzuya M, 2003, CIRCULATION, V108, P1375, DOI 10.1161/01.CIR.0000086463.15540.3C; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Marti-Vilalta JL, 1999, REV NEUROLOGIA, V28, P1016, DOI 10.33588/rn.2810.99061; MINEMATSU K, 1992, STROKE, V23, P1304, DOI 10.1161/01.STR.23.9.1304; MORSDORF K, 1970, PHARMACOLOGY, V3, P193, DOI 10.1159/000136072; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; PAILER M, 1968, MONATSH CHEM, V99, P891, DOI 10.1007/BF00913736; PAULY RR, 1994, CIRC RES, V75, P41, DOI 10.1161/01.RES.75.1.41; Peng CC, 2007, J ETHNOPHARMACOL, V109, P93, DOI 10.1016/j.jep.2006.07.009; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Shafi N, 2011, NEUROTHERAPEUTICS, V8, P425, DOI 10.1007/s13311-011-0041-5; Sorriento D, 2012, HYPERTENSION, V60, P129, DOI 10.1161/HYPERTENSIONAHA.111.189605; Terasoma K, 1971, Hinyokika Kiyo, V17, P592; Vali A F, 1972, Schweiz Rundsch Med Prax, V61, P893; WEXLER BC, 1979, AGE, V2, P39, DOI 10.1007/BF02432254; WEXLER BC, 1975, STROKE, V6, P432, DOI 10.1161/01.STR.6.4.432; Wu KJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/656150; Wu KJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/163106; Zempo N, 1996, ARTERIOSCL THROM VAS, V16, P28, DOI 10.1161/01.ATV.16.1.28	44	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75654	10.1371/journal.pone.0075654	http://dx.doi.org/10.1371/journal.pone.0075654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086601	gold, Green Submitted, Green Published			2022-12-25	WOS:000325025200058
J	Benson, EK; Mungamuri, SK; Attie, O; Kracikova, M; Sachidanandam, R; Manfredi, JJ; Aaronson, SA				Benson, E. K.; Mungamuri, S. K.; Attie, O.; Kracikova, M.; Sachidanandam, R.; Manfredi, J. J.; Aaronson, S. A.			p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes	ONCOGENE			English	Article						p53; p21; E2F4; RB; p130; transcriptional repression	ARF TUMOR-SUPPRESSOR; WILD-TYPE P53; CELL-CYCLE; TRANSCRIPTIONAL REPRESSION; NEGATIVE REGULATION; DOWN-REGULATION; POCKET PROTEIN; DIRECT BINDING; SURVIVIN GENE; TARGET GENES	The p53 tumor suppressor protein is a major sensor of cellular stresses, and upon stabilization, activates or represses many genes that control cell fate decisions. While the mechanism of p53-mediated transactivation is well established, several mechanisms have been proposed for p53-mediated repression. Here, we demonstrate that the cyclin-dependent kinase inhibitor p21 is both necessary and sufficient for the downregulation of known p53-repression targets, including survivin, CDC25C, and CDC25B in response to p53 induction. These same targets are similarly repressed in response to p16 overexpression, implicating the involvement of the shared downstream retinoblastoma (RB)-E2F pathway. We further show that in response to either p53 or p21 induction, E2F4 complexes are specifically recruited onto the promoters of these p53-repression targets. Moreover, abrogation of E2F4 recruitment via the inactivation of RB pocket proteins, but not by RB loss of function alone, prevents the repression of these genes. Finally, our results indicate that E2F4 promoter occupancy is globally associated with p53-repression targets, but not with p53 activation targets, implicating E2F4 complexes as effectors of p21-dependent p53-mediated repression.	[Benson, E. K.; Mungamuri, S. K.; Kracikova, M.; Manfredi, J. J.; Aaronson, S. A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Attie, O.; Sachidanandam, R.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Aaronson, SA (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, 1 Gustave L Levy Pl,Box 1130, New York, NY 10029 USA.	stuart.aaronson@mssm.edu	sachidanandam, ravi/Q-6916-2019	sachidanandam, ravi/0000-0001-9844-4459; Mungamuri, Sathish Kumar/0000-0002-0012-5298	Breast Cancer Research Foundation; National Cancer Institute [P01CA080058]; NCI [T32CA078207]; NATIONAL CANCER INSTITUTE [T32CA078207, P01CA080058] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants from the Breast Cancer Research Foundation and by Award Number P01CA080058 from the National Cancer Institute. EB was supported by the NCI Training Program in Cancer Biology (T32CA078207). We thank S Lee, Cutaneous Biology Research, MGH Harvard Medical School for helpful discussions.	Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Alarcon-Vargas D, 2002, CARCINOGENESIS, V23, P541, DOI 10.1093/carcin/23.4.541; Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Banerjee T, 2009, NUCLEIC ACIDS RES, V37, P2688, DOI 10.1093/nar/gkp110; Benson EK, 2010, J CELL SCI, V123, P2605, DOI 10.1242/jcs.067306; Bindra RS, 2006, CANCER BIOL THER, V5, P1400, DOI 10.4161/cbt.5.10.3454; Bohlig L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464916; Brooks CL, 2010, CELL RES, V20, P614, DOI 10.1038/cr.2010.53; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burger A, 2010, P NATL ACAD SCI USA, V107, P4016, DOI 10.1073/pnas.0915138107; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Crosby ME, 2004, CANCER BIOL THER, V3, P1208, DOI 10.4161/cbt.3.12.1494; Dalvai M, 2011, ONCOGENE, V30, P2282, DOI 10.1038/onc.2010.588; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Esteve PO, 2007, J BIOL CHEM, V282, P2615, DOI 10.1074/jbc.M606203200; Fang L, 1999, ONCOGENE, V18, P2789, DOI 10.1038/sj.onc.1202615; Godefroy N, 2004, NUCLEIC ACIDS RES, V32, P4480, DOI 10.1093/nar/gkh773; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; Hammond EM, 2006, MOL CELL BIOL, V26, P3492, DOI 10.1128/MCB.26.9.3492-3504.2006; Helmbold H, 2009, ONCOGENE, V28, P3456, DOI 10.1038/onc.2009.222; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kho PS, 2004, J BIOL CHEM, V279, P21183, DOI 10.1074/jbc.M311912200; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Komori H, 2005, EMBO J, V24, P3724, DOI 10.1038/sj.emboj.7600836; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Lammens T, 2009, TRENDS CELL BIOL, V19, P111, DOI 10.1016/j.tcb.2009.01.002; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lee BK, 2011, NUCLEIC ACIDS RES, V39, P3558, DOI 10.1093/nar/gkq1313; Li BQ, 2001, J BIOL CHEM, V276, P29729, DOI 10.1074/jbc.M101167200; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Mandinova A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001366; Matsui T, 2004, J BIOL CHEM, V279, P25093, DOI 10.1074/jbc.M403232200; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; Mungamuri SK, 2012, NAT STRUCT MOL BIOL, V19, P478, DOI 10.1038/nsmb.2271; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Rashid NN, 2011, J GEN VIROL, V92, P2620, DOI 10.1099/vir.0.035352-0; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Roperch JP, 1998, NAT MED, V4, P835, DOI 10.1038/nm0798-835; Rother K, 2007, CELL CYCLE, V6, P853, DOI 10.4161/cc.6.7.4017; Roy S, 2008, MOL CANCER THER, V7, P1931, DOI 10.1158/1535-7163.MCT-07-2353; Sengupta S, 2005, ONCOGENE, V24, P1738, DOI 10.1038/sj.onc.1208380; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; St Clair S, 2004, MOL CELL, V16, P725; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; Takahashi Y, 2000, GENE DEV, V14, P804; Tang XH, 2004, ONCOGENE, V23, P5759, DOI 10.1038/sj.onc.1207706; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; TSANG NM, 1994, RADIAT RES, V140, P172, DOI 10.2307/3578900; Ucar D, 2009, BIOINFORMATICS, V25, pI137, DOI 10.1093/bioinformatics/btp213; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wang B, 2010, CELL CYCLE, V9, P870, DOI 10.4161/cc.9.5.10825; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Zeng YX, 2011, CANCER RES, V71, P2781, DOI 10.1158/0008-5472.CAN-10-3483; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	69	69	69	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 24	2014	33	30					3959	3969		10.1038/onc.2013.378	http://dx.doi.org/10.1038/onc.2013.378			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8NA	24096481	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000339394700008
J	Williams, KA; Zhang, M; Xiang, SY; Hu, C; Wu, JY; Zhang, SP; Ryan, M; Cox, AD; Der, CJ; Fang, B; Koomen, J; Haura, E; Bepler, G; Nicosia, SV; Matthias, P; Wang, CG; Bai, WL; Zhang, XH				Williams, Kendra A.; Zhang, Mu; Xiang, Shengyan; Hu, Chen; Wu, Jheng-Yu; Zhang, Shengping; Ryan, Meagan; Cox, Adrienne D.; Der, Channing J.; Fang, Bin; Koomen, John; Haura, Eric; Bepler, Gerold; Nicosia, Santo V.; Matthias, Patrick; Wang, Chuangui; Bai, Wenlong; Zhang, Xiaohong			Extracellular Signal-regulated Kinase (ERK) Phosphorylates Histone Deacetylase 6 (HDAC6) at Serine 1035 to Stimulate Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; ERK; Histone Deacetylase; MAP Kinases (MAPKs); Protein Phosphorylation	MAP KINASES; ACETYLATION; ACTIVATION; MOTILITY; TUBULIN; POLYUBIQUITIN; CYTOSKELETON; DOMAIN; ALPHA	Background: HDAC6 plays an important role in cell migration. Results: ERK interacts with and phosphorylates HDAC6 to promote cell migration. Conclusion: ERK signaling pathway promotes cell migration, in part, through phosphorylating HDAC6. Significance: Inhibition of HDAC6 activity as well as the EGFR-Ras-Raf-MEK-ERK signaling pathway may cooperatively reduce cell migration. Histone deacetylase 6 (HDAC6) is well known for its ability to promote cell migration through deacetylation of its cytoplasmic substrates such as -tubulin. However, how HDAC6 itself is regulated to control cell motility remains elusive. Previous studies have shown that one third of extracellular signal-regulated kinase (ERK) is associated with the microtubule cytoskeleton in cells. Yet, no connection between HDAC6 and ERK has been discovered. Here, for the first time, we reveal that ERK binds to and phosphorylates HDAC6 to promote cell migration via deacetylation of -tubulin. We have identified two novel ERK-mediated phosphorylation sites: threonine 1031 and serine 1035 in HDAC6. Both sites were phosphorylated by ERK1 in vitro, whereas Ser-1035 was phosphorylated in response to the activation of EGFR-Ras-Raf-MEK-ERK signaling pathway in vivo. HDAC6-null mouse embryonic fibroblasts rescued by the nonphosphorylation mimicking mutant displayed significantly reduced cell migration compared with those rescued by the wild type. Consistently, the nonphosphorylation mimicking mutant exerted lower tubulin deacetylase activity in vivo compared with the wild type. These data indicate that ERK/HDAC6-mediated cell motility is through deacetylation of -tubulin. Overall, our results suggest that HDAC6-mediated cell migration could be governed by EGFR-Ras-Raf-MEK-ERK signaling.	[Williams, Kendra A.; Zhang, Mu; Xiang, Shengyan; Wu, Jheng-Yu; Nicosia, Santo V.; Bai, Wenlong; Zhang, Xiaohong] Univ S Florida, Dept Pathol & Cell Biol, Morsani Coll Med, Tampa, FL 33612 USA; [Hu, Chen; Zhang, Shengping; Wang, Chuangui] E China Normal Univ, Inst Biomed Sci, Coll Life Sci, Shanghai 200241, Peoples R China; [Ryan, Meagan; Cox, Adrienne D.; Der, Channing J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Cox, Adrienne D.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Cox, Adrienne D.; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Fang, Bin; Koomen, John] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Prote Core Facil, Tampa, FL 33612 USA; [Haura, Eric; Nicosia, Santo V.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Chem Biol & Mol Med Program, Tampa, FL 33612 USA; [Bai, Wenlong; Zhang, Xiaohong] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Biol & Evolut Program, Tampa, FL 33612 USA; [Bepler, Gerold] Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA; [Matthias, Patrick] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	State University System of Florida; University of South Florida; East China Normal University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Barbara Ann Karmanos Cancer Institute; Friedrich Miescher Institute for Biomedical Research	Zhang, XH (corresponding author), Univ S Florida, Dept Pathol & Cell Biol, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 64, Tampa, FL 33612 USA.	xzhang1@health.usf.edu	XIANG, SHENGYAN/C-3176-2013; Bai, Wenlong/A-8977-2013	XIANG, SHENGYAN/0000-0002-6940-3559; Bai, Wenlong/0000-0002-9536-0556; Der, Channing/0000-0002-7751-2747; Cox, Adrienne D./0000-0002-4901-2454	National Institutes of Health Grant from the NCI [R01CA164147]; James Esther King Biomedical Research Program [09KN-17]; a Moffitt Lung SPORE career development grant; Ovarian Cancer Research Fund; University of South Florida graduate student success diversity fellowship; NATIONAL CANCER INSTITUTE [R01CA164147, P50CA119997, P30CA076292, T32CA071341] Funding Source: NIH RePORTER	National Institutes of Health Grant from the NCI; James Esther King Biomedical Research Program; a Moffitt Lung SPORE career development grant; Ovarian Cancer Research Fund; University of South Florida graduate student success diversity fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by National Institutes of Health Grant R01CA164147 from the NCI. This work was also supported by New Investigator Grant 09KN-17 from the James Esther King Biomedical Research Program, a Moffitt Lung SPORE career development grant, and a grant from Ovarian Cancer Research Fund (to X. Z.) and a University of South Florida graduate student success diversity fellowship (to K. A. W.).	Bazzaro M, 2008, CLIN CANCER RES, V14, P7340, DOI 10.1158/1078-0432.CCR-08-0642; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kaluza D, 2011, EMBO J, V30, P4142, DOI 10.1038/emboj.2011.298; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kekatpure VD, 2009, J BIOL CHEM, V284, P7436, DOI 10.1074/jbc.M808999200; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lafarga V, 2012, EMBO J, V31, P856, DOI 10.1038/emboj.2011.466; Lee H, 2000, MOL ENDOCRINOL, V14, P1882, DOI 10.1210/me.14.11.1882; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Shen Z, 2011, MOL CELL ENDOCRINOL, V338, P58, DOI 10.1016/j.mce.2011.02.023; Tanimura S, 2002, J BIOL CHEM, V277, P28256, DOI 10.1074/jbc.M202866200; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200; Zhu JZ, 2011, EMBO J, V30, P4838, DOI 10.1038/emboj.2011.351	37	71	74	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33156	33170		10.1074/jbc.M113.472506	http://dx.doi.org/10.1074/jbc.M113.472506			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089523	hybrid, Green Published			2022-12-25	WOS:000328841700031
J	Ren, ZG; Cui, GY; Lu, HF; Chen, XH; Jiang, JW; Liu, H; He, Y; Ding, SM; Hu, ZH; Wang, WL; Zheng, SS				Ren, Zhigang; Cui, Guangying; Lu, Haifeng; Chen, Xinhua; Jiang, Jianwen; Liu, Hui; He, Yong; Ding, Songming; Hu, Zhenhua; Wang, Weilin; Zheng, Shusen			Liver Ischemic Preconditioning (IPC) Improves Intestinal Microbiota Following Liver Transplantation in Rats through 16s rDNA-Based Analysis of Microbial Structure Shift	PLOS ONE			English	Article							REPERFUSION INJURY; PREVENTION; PROTECTION; TRIAL; MICE	Background: Ischemia-reperfusion (I/R) injury is associated with intestinal microbial dysbiosis. The "gut-liver axis" closely links gut function and liver function in health and disease. Ischemic preconditioning (IPC) has been proven to reduce I/R injury in the surgery. This study aims to explore the effect of IPC on intestinal microbiota and to analyze characteristics of microbial structure shift following liver transplantation (LT). Methods: The LT animal models of liver and gut IPC were established. Hepatic graft function was assessed by histology and serum ALT/AST. Intestinal barrier function was evaluated by mucosal ultrastructure, serum endotoxin, bacterial translocation, fecal sIgA content and serum TNF-alpha. Intestinal bacterial populations were determined by quantitative PCR. Microbial composition was characterized by DGGE and specific bacterial species were determined by sequence analysis. Principal Findings: Liver IPC improved hepatic graft function expressed as ameliorated graft structure and reduced ALT/AST levels. After administration of liver IPC, intestinal mucosal ultrastructure improved, serum endotoxin and bacterial translocation mildly decreased, fecal sIgA content increased, and serum TNF-alpha decreased. Moreover, liver IPC promoted microbial restorations mainly through restoring Bifidobacterium spp., Clostridium clusters XI and Clostridium cluster XIVab on bacterial genus level. DGGE profiles indicated that liver IPC increased microbial diversity and species richness, and cluster analysis demonstrated that microbial structures were similar and clustered together between the NC group and Liver-IPC group. Furthermore, the phylogenetic tree of band sequences showed key bacteria corresponding to 10 key band classes of microbial structure shift induced by liver IPC, most of which were assigned to Bacteroidetes phylum. Conclusion: Liver IPC cannot only improve hepatic graft function and intestinal barrier function, but also promote restorations of intestinal microbiota following LT, which may further benefit hepatic graft by positive feedback of the "gut-liver axis".	[Ren, Zhigang; Chen, Xinhua; Jiang, Jianwen; He, Yong; Ding, Songming; Hu, Zhenhua; Wang, Weilin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China; [Ren, Zhigang; Chen, Xinhua; Jiang, Jianwen; He, Yong; Ding, Songming; Hu, Zhenhua; Wang, Weilin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Cui, Guangying; Lu, Haifeng] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Hui] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn	Ren, Zhigang/AAO-8576-2020		National Basic Research Program (973 Program) in China [2013CB531403, 2009CB522403]; National S & T Major Project of China [2012ZX10002-004]; NSFC for Innovative Research Group of China [81121002]; National Natural Science Foundation of China [81200331]	National Basic Research Program (973 Program) in China(National Basic Research Program of China); National S & T Major Project of China; NSFC for Innovative Research Group of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program (973 Program) in China (2013CB531403, 2009CB522403), National S & T Major Project of China (2012ZX10002-004), NSFC for Innovative Research Group of China (81121002) and National Natural Science Foundation of China (81200331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg F, 2011, SCAND J SURG, V100, P14, DOI 10.1177/145749691110000104; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Cai ZQP, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0277-1; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; CHASSAING B, 2013, HEPATOLOGY; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Clavien PA, 2000, ANN SURG, V232, P155, DOI 10.1097/00000658-200008000-00001; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Deschenes M, 1998, TRANSPLANTATION, V66, P302, DOI 10.1097/00007890-199808150-00005; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Er F, 2012, CIRCULATION, V126, P296, DOI 10.1161/CIRCULATIONAHA.112.096370; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glanemann M, 2001, ACTA ANAESTH SCAND, V45, P333, DOI 10.1034/j.1399-6576.2001.045003333.x; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hubscher SG, 2011, J HEPATOL, V55, P702, DOI 10.1016/j.jhep.2011.03.005; Jaeschke H, 1996, J HEPATOL, V25, P774, DOI 10.1016/S0168-8278(96)80253-4; KAMADA N, 1983, SURGERY, V93, P64; KELSEY R, 2012, NAT REV NEPHROL; Kim YW, 2012, NEUROSURGERY, V71, pE553, DOI 10.1227/01.neu.0000417720.26333.46; Li QR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020460; LLORISCARSI JM, 1993, TRANSPLANT P, V25, P3303; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Oh PL, 2012, AM J TRANSPLANT, V12, P753, DOI 10.1111/j.1600-6143.2011.03860.x; Peralta C, 1997, HEPATOLOGY, V25, P934, DOI 10.1002/hep.510250424; Petrowsky H, 2006, ANN SURG, V244, P921, DOI 10.1097/01.sla.0000246834.07130.5d; Ren ZG, 2011, HEPATOB PANCREAT DIS, V10, P489, DOI 10.1016/S1499-3872(11)60083-0; Shen XD, 2003, HEPATOLOGY, V37, P296, DOI 10.1053/jhep.2003.50066; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042027; Wiesner RH, 2001, LIVER TRANSPLANT, V7, pS60, DOI 10.1053/jlts.2001.29094; Xing HC, 2006, J GASTROEN HEPATOL, V21, P647, DOI 10.1111/j.1440-1746.2006.04306.x; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	35	40	45	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75950	10.1371/journal.pone.0075950	http://dx.doi.org/10.1371/journal.pone.0075950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098410	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500040
J	Zhang, XJ; Huang, YJ; Harvey, PR; Li, HM; Ren, Y; Li, JS; Wang, JN; Yang, HT				Zhang, Xinjian; Huang, Yujie; Harvey, Paul R.; Li, Hongmei; Ren, Yan; Li, Jishun; Wang, Jianing; Yang, Hetong			Isolation and Characterization of Carbendazim-degrading Rhodococcus erythropolis djl-11	PLOS ONE			English	Article							FUNGICIDE CARBENDAZIM; BIODEGRADATION; TOXICITY	Carbendazim (methyl 1H-benzimidazol-2-yl carbamate) is one of the most widely used fungicides in agriculture worldwide, but has been reported to have adverse effects on animal health and ecosystem function. A highly efficient carbendazim-degrading bacterium (strain dj1-11) was isolated from carbendazim-contaminated soil samples via enrichment culture. Strain dj1-11 was identified as Rhodococcus erythropolis based on morphological, physiological and biochemical characters, including sequence analysis of the 16S rRNA gene. In vitro degradation of carbendazim (1000 mg.L-1) by dj1-11 in minimal salts medium (MSM) was highly efficient, and with an average degradation rate of 333.33 mg.L-1.d(-1) at 28 degrees C. The optimal temperature range for carbendazim degradation by dj1-11 in MSM was 25-30 degrees C. Whilst strain dj1-11 was capable of metabolizing cabendazim as the sole source of carbon and nitrogen, degradation was significantly (P<0.05) increased by addition of 12.5 mM NH4NO3. Changes in MSM pH (4-9), substitution of NH4NO3 with organic substrates as N and C sources or replacing Mg2+ with Mn2+, Zn2+ or Fe2+ did not significantly affect carbendazim degradation by dj1-11. During the degradation process, liquid chromatography-mass spectrometry (LC-MS) detected the metabolites 2-aminobenzimidazole and 2-hydroxybenzimidazole. A putative carbendazim-hydrolyzing esterase gene was cloned from chromosomal DNA of djl-11 and showed 99% sequence homology to the mheI carbendazim-hydrolyzing esterase gene from Nocardioides sp. SG-4G.	[Zhang, Xinjian; Huang, Yujie; Harvey, Paul R.; Li, Hongmei; Ren, Yan; Li, Jishun; Wang, Jianing; Yang, Hetong] Shandong Acad Sci, Ctr Biotechnol, Shandong Prov Key Lab Appl Microbiol, Jinan, Shandong, Peoples R China; [Harvey, Paul R.] CSIRO Sustainable Agr Natl Res Flagship, Glen Osmond, SA, Australia; [Harvey, Paul R.] CSIRO Ecosyst Sci, Glen Osmond, SA, Australia	Qilu University of Technology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Yang, HT (corresponding author), Shandong Acad Sci, Ctr Biotechnol, Shandong Prov Key Lab Appl Microbiol, Jinan, Shandong, Peoples R China.	yanght@sdas.org	Harvey, Paul/C-7013-2008	Zhang, Xinjian/0000-0002-5839-6197; Li, Jishun/0000-0001-7615-7483	Ministry of Science and Technology of China [2010DFA32330]; Department of Science and Technology of Shandong province [2012GNC11004]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Department of Science and Technology of Shandong province	This work was supported by the grant 2010DFA32330 from the Ministry of Science and Technology of China (http://www.most.gov.cn), the grant 2012GNC11004 and Taishan Research Fellowship from Department of Science and Technology of Shandong province (http://www.sdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Boudina A, 2003, CHEMOSPHERE, V50, P649, DOI 10.1016/S0045-6535(02)00620-3; Chen Y, 2009, PHYTOPATHOLOGY, V99, P441, DOI 10.1094/PHYTO-99-4-0441; Fang H, 2010, BIODEGRADATION, V21, P939, DOI 10.1007/s10532-010-9353-0; Farag A, 2011, BIRTH DEFECTS RES B, V92, P122, DOI 10.1002/bdrb.20290; Goodfellow M, 1989, BERGEYS MANUAL SYSTE, V4, P2362; Holtman MA, 1997, APPL MICROBIOL BIOT, V47, P578, DOI 10.1007/s002530050976; Kiss A, 2009, J ENVIRON QUAL, V38, P157, DOI 10.2134/jeq2007.0504; Pandey G, 2010, APPL ENVIRON MICROB, V76, P2940, DOI 10.1128/AEM.02990-09; Sandahl M, 2000, J CHROMATOGR A, V893, P123, DOI 10.1016/S0021-9673(00)00697-X; Selmanoglu G, 2001, HUM EXP TOXICOL, V20, P625, DOI 10.1191/096032701718890603; STRINGER A, 1976, PESTIC SCI, V7, P459, DOI 10.1002/ps.2780070507; Wang YS, 2009, J HAZARD MATER, V172, P84, DOI 10.1016/j.jhazmat.2009.06.142; Wang ZC, 2010, CHEMOSPHERE, V81, P639, DOI 10.1016/j.chemosphere.2010.08.040; Xu JL, 2007, INT J SYST EVOL MICR, V57, P2754, DOI 10.1099/ijs.0.65095-0; Xu JL, 2006, CURR MICROBIOL, V53, P72, DOI 10.1007/s00284-005-0474-3; YARDEN O, 1990, CAN J MICROBIOL, V36, P15, DOI 10.1139/m90-004; Zhang LZ, 2009, INT J ENVIRON POLLUT, V38, P309, DOI 10.1504/IJEP.2009.027231	18	30	34	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74810	10.1371/journal.pone.0074810	http://dx.doi.org/10.1371/journal.pone.0074810			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098350	Green Submitted, gold, Green Published			2022-12-25	WOS:000325427100010
J	Maciel, IS; Silva, RBM; Morrone, FB; Calixto, JB; Campos, MM				Maciel, Izaque S.; Silva, Rodrigo B. M.; Morrone, Fernanda B.; Calixto, Joao B.; Campos, Maria M.			Synergistic Effects of Celecoxib and Bupropion in a Model of Chronic Inflammation-Related Depression in Mice	PLOS ONE			English	Article							TREATMENT-RESISTANT DEPRESSION; NECROSIS-FACTOR-ALPHA; INDOLEAMINE 2,3-DIOXYGENASE; MECHANICAL ALLODYNIA; INTERFERON-GAMMA; UP-REGULATION; DOUBLE-BLIND; MOUSE MODEL; BEHAVIOR; PAIN	This study was aimed to characterize the depression-like behaviour in the classical model of chronic inflammation induced by Complete Freund's Adjuvant (CFA). Male Swiss mice received an intraplantar (i.pl.) injection of CFA (50 mu l/paw) or vehicle. Behavioural and inflammatory responses were measured at different time-points (1 to 4 weeks), and different pharmacological tools were tested. The brain levels of IL-1 beta and BDNF, or COX-2 expression were also determined. CFA elicited a time-dependent edema formation and mechanical allodynia, which was accompanied by a significant increase in the immobility time in the tail suspension (TST) or forced-swimming (FST) depression tests. Repeated administration of the antidepressants imipramine (10 mg/kg), fluoxetine (20 mg/kg) and bupropion (30 mg/kg) significantly reversed depression-like behaviour induced by CFA. Predictably, the anti-inflammatory drugs dexamethasone (0.5 mg/kg), indomethacin (10 mg/kg) and celecoxib (30 mg/kg) markedly reduced CFA-induced edema. The oral treatment with the analgesic drugs dipyrone (30 and 300 mg/kg) or pregabalin (30 mg/kg) significantly reversed the mechanical allodyinia induced by CFA. Otherwise, either dipyrone or pregabalin (both 30 mg/kg) did not significantly affect the paw edema or the depressive-like behaviour induced by CFA, whereas the oral treatment with dipyrone (300 mg/kg) was able to reduce the immobility time in TST. Noteworthy, CFA-induced edema was reduced by bupropion (30 mg/kg), and depression behaviour was prevented by celecoxib (30 mg/kg). The co-treatment with bupropion and celecoxib (3 mg/kg each) significantly inhibited both inflammation and depression elicited by CFA. The same combined treatment reduced the brain levels of IL-1 beta, as well as COX-2 immunopositivity, whilst it failed to affect the reduction of BDNF levels. We provide novel evidence on the relationship between chronic inflammation and depression, suggesting that combination of antidepressant and anti-inflammatory agents bupropion and celecoxib might represent an attractive therapeutic strategy for depression.	[Maciel, Izaque S.; Silva, Rodrigo B. M.; Morrone, Fernanda B.; Campos, Maria M.] Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Med & Hlth Sci, Porto Alegre, RS, Brazil; [Morrone, Fernanda B.] Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Cellular & Mol Biol, Porto Alegre, RS, Brazil; [Morrone, Fernanda B.; Campos, Maria M.] Pontificia Univ Catolica Rio Grande do Sul, Inst Pharmacol & Toxicol, Porto Alegre, RS, Brazil; [Calixto, Joao B.] Univ Fed Santa Catarina, Dept Pharmacol, Florianopolis, SC, Brazil; [Morrone, Fernanda B.] Pontificia Univ Catolica Rio Grande do Sul, Fac Pharm, Porto Alegre, RS, Brazil; [Campos, Maria M.] Pontificia Univ Catolica Rio Grande do Sul, Fac Dent, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal de Santa Catarina (UFSC); Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Campos, MM (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Postgrad Program Med & Hlth Sci, Porto Alegre, RS, Brazil.	camposmmartha@yahoo.com	de Sousa Maciel, Izaque/AAD-9693-2020; Campos, Maria Martha M/J-8829-2015; Morrone, Fernanda B/K-7703-2015; Maciel, Izaque/I-1038-2014; Morrone, Fernanda/AAH-6044-2020; Silva, Rodrigo BM/O-7441-2017	de Sousa Maciel, Izaque/0000-0001-6597-5288; Campos, Maria Martha M/0000-0002-1153-3633; Morrone, Fernanda B/0000-0002-2709-2801; Morrone, Fernanda/0000-0002-2709-2801; Silva, Rodrigo BM/0000-0001-6284-7387; Campos, Maria/0000-0001-7738-9892; calixto, joao Batista/0000-0003-4041-7153	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [63]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao do Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); FINEP research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" (PUCRSINFRA) [01.11.0014-00]; PUCRS (PROBOLSAS Program)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao do Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); FINEP research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" (PUCRSINFRA); PUCRS (PROBOLSAS Program)	This work was supported by grants from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Fundacao do Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and FINEP research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" (PUCRSINFRA) # 01.11.0014-00. ISM and RBMS are a MSc. students in Medicine and Health Sciences, supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Edital no 63 Toxinologia and PUCRS (PROBOLSAS Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi SH, 2012, J AFFECT DISORDERS, V141, P308, DOI 10.1016/j.jad.2012.03.033; Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Akhondzadeh S, 2009, DEPRESS ANXIETY, V26, P607, DOI 10.1002/da.20589; Barichello T, 2012, J NEURAL TRANSM, V119, P653, DOI 10.1007/s00702-011-0749-8; Bay-Richter C, 2011, BEHAV BRAIN RES, V222, P193, DOI 10.1016/j.bbr.2011.03.060; Bernardi A, 2009, BRIT J PHARMACOL, V158, P1104, DOI 10.1111/j.1476-5381.2009.00244.x; Blatteau JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049069; Brustolim D, 2006, INT IMMUNOPHARMACOL, V6, P903, DOI 10.1016/j.intimp.2005.12.007; Caldarone BJ, 2003, PSYCHOPHARMACOLOGY, V170, P94, DOI 10.1007/s00213-003-1518-7; Capuron L, 2004, BIOL PSYCHIAT, V56, P819, DOI 10.1016/j.biopsych.2004.02.009; Carroll JC, 2011, J NEUROSCI, V31, P14436, DOI 10.1523/JNEUROSCI.3836-11.2011; Cassano P, 2006, PHARMACOGENOMICS J, V6, P381, DOI 10.1038/sj.tpj.6500385; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHEN CY, 2010, GEN HOSP PSYCHIAT, V32, pE647; Crown WH, 2002, J CLIN PSYCHIAT, V63, P963, DOI 10.4088/JCP.v63n1102; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; dos Santos DA, 2010, J ETHNOPHARMACOL, V127, P543, DOI 10.1016/j.jep.2009.09.061; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Farooq RK, 2012, BEHAV BRAIN RES, V231, P130, DOI 10.1016/j.bbr.2012.03.020; Fekadu A, 2009, J AFFECT DISORDERS, V116, P4, DOI 10.1016/j.jad.2008.10.014; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; Fu X, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-43; Galecki P, 2012, J AFFECT DISORDERS, V138, P360, DOI 10.1016/j.jad.2012.01.016; Guo JY, 2009, EUR J PHARMACOL, V612, P54, DOI 10.1016/j.ejphar.2009.03.076; Inoue N, 2009, J PHARMACOL SCI, V109, P600, DOI 10.1254/jphs.08287FP; Jesse CR, 2010, PSYCHOPHARMACOLOGY, V212, P513, DOI 10.1007/s00213-010-1977-6; Johansson D, 2012, PROG NEURO-PSYCHOPH, V39, P143, DOI 10.1016/j.pnpbp.2012.06.003; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kim EJ, 2001, BRAIN RES, V908, P1, DOI 10.1016/S0006-8993(01)02432-5; Kim H, 2012, J CLIN INVEST, V122, P2940, DOI 10.1172/JCI61884; Liu DX, 2011, NEUROPHARMACOLOGY, V61, P592, DOI 10.1016/j.neuropharm.2011.04.033; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Ma XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020955; MAES M, 1995, PSYCHONEUROENDOCRINO, V20, P111, DOI 10.1016/0306-4530(94)00066-J; Matsuzawa-Yanagida K, 2008, NEUROPSYCHOPHARMACOL, V33, P1952, DOI 10.1038/sj.npp.1301590; Moreau M, 2008, BRAIN BEHAV IMMUN, V22, P1087, DOI 10.1016/j.bbi.2008.04.001; Muller N, 2011, NEUROTOX RES, V19, P308, DOI 10.1007/s12640-010-9210-2; Murphy LB, 2012, ARTHRIT CARE RES, V64, P968, DOI 10.1002/acr.21685; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Narita M, 2006, NEUROPSYCHOPHARMACOL, V31, P739, DOI 10.1038/sj.npp.1300858; Nogawa S, 1997, J NEUROSCI, V17, P2746; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; O'Connor JC, 2009, J NEUROSCI, V29, P4200, DOI 10.1523/JNEUROSCI.5032-08.2009; Ohgi Y, 2013, PHARMACOL BIOCHEM BE, V103, P853, DOI 10.1016/j.pbb.2012.12.003; Park HJ, 2010, CAN J ANAESTH, V57, P664, DOI 10.1007/s12630-010-9318-0; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Recla Jill M, 2010, J Pain Res, V3, P89; Schmidt HD, 2011, NEUROPSYCHOPHARMACOL, V36, P2375, DOI 10.1038/npp.2011.151; Schmidt LS, 2010, PSYCHOPHARMACOLOGY, V207, P547, DOI 10.1007/s00213-009-1685-2; Pereira PJS, 2011, PAIN, V152, P2861, DOI 10.1016/j.pain.2011.09.016; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; Soncini R, 2012, NEUROSCI LETT, V516, P114, DOI 10.1016/j.neulet.2012.03.070; Souza AH, 2008, PAIN, V140, P115, DOI 10.1016/j.pain.2008.07.014; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tanti A, 2010, BRIT J PHARMACOL, V159, P1187, DOI 10.1111/j.1476-5381.2009.00585.x; Thase ME, 1998, J CLIN PSYCHIAT, V59, P5; Tynan RJ, 2012, BRAIN BEHAV IMMUN, V26, P469, DOI 10.1016/j.bbi.2011.12.011; Vartanian MG, 2006, EPILEPSY RES, V68, P189, DOI 10.1016/j.eplepsyres.2005.11.001; Viana AF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-98; Wichers M, 2009, BRIT J PSYCHIAT, V195, P498, DOI 10.1192/bjp.bp.108.056853; WITTCHEN HU, 1994, BRIT J PSYCHIAT, V165, P16, DOI 10.1192/S0007125000293240; Yamamoto H, 2009, NEUROPHARMACOLOGY, V57, P403, DOI 10.1016/j.neuropharm.2009.06.037; Yokoyama T, 2007, J PAIN, V8, P422, DOI 10.1016/j.jpain.2006.11.007; Yu H, 2011, ACTA PHARMACOL SIN, V32, P3, DOI 10.1038/aps.2010.184; Zanelati TV, 2010, BRIT J PHARMACOL, V159, P122, DOI 10.1111/j.1476-5381.2009.00521.x; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	70	57	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e77227	10.1371/journal.pone.0077227	http://dx.doi.org/10.1371/journal.pone.0077227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086771	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900114
J	Esteves, CL; Verma, M; Rog-Zielinska, E; Kelly, V; Sai, S; Breton, A; Donadeu, FX; Seckl, JR; Chapman, KE				Esteves, Cristina L.; Verma, Manu; Rog-Zielinska, Ewa; Kelly, Val; Sai, Shuji; Breton, Amandine; Donadeu, Francesc X.; Seckl, Jonathan R.; Chapman, Karen E.			Pro-Inflammatory Cytokine Induction of 11 beta-hydroxysteroid Dehydrogenase Type 1 in A549 Cells Requires Phosphorylation of C/EBP beta at Thr235	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; MAP KINASE PATHWAY; GLUCOCORTICOID METABOLISM; GENE-EXPRESSION; HUMAN OBESITY; TRANSCRIPTION; ACTIVATION; MECHANISM; TISSUE; PROMOTER	11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) converts inert glucocorticoids into active forms, thereby increasing intracellular glucocorticoid levels, important to restrain acute inflammation. 11 beta-HSD1 is induced by pro-inflammatory cytokines in a variety of cells. Here, we show 11 beta-HSD1 expression in human A549 epithelial cells is increased by pro-inflammatory cytokines (IL-1 alpha/TNF alpha) via the P2 promoter of the HSD11B1 gene. Inhibition of p38 MAPK attenuated the pro-inflammatory cytokine induction of mRNA encoding 11 beta-HSD1 as well as that encoding C/EBP beta. IL-1 alpha/TNF alpha-induced phosphorylation of C/EBP beta at Thr235 was also attenuated by p38 MAPK inhibition suggesting involvement of a p38 MAPK-C/EBP beta pathway. siRNA-mediated knock-down of C/EBP beta and NF-kappa B/RelA implicated both transcription factors in the IL-1 alpha/TNF alpha induction of HSD11B1 mRNA. Transient transfections of HSD11B1 promoter-reporter constructs identified the proximal region of the P2 promoter of HSD11B1 as essential for this induction. IL-1 alpha increased binding of C/EBP beta to the HSD11B1 P2 promoter, but this was not observed for NF-kappa B/RelA, suggesting indirect regulation by NF-kappa B/RelA. Ectopic expression of mutant chicken C/EBP beta constructs unable to undergo phosphorylation at the threonine equivalent to Thr235 attenuated the IL-1 alpha-induction of HSD11B1, whereas mimicking constitutive phosphorylation of Thr235 (by mutation to aspartate) increased basal expression of HSD11B1 mRNA without affecting IL-1 alpha-induced levels. These data clearly demonstrate a role for both C/EBP beta and NF-kappa B/RelA in the pro-inflammatory cytokine induction of HSD11B1 in human epithelial cells and show that p38 MAPK-induced phosphorylation of C/EBP beta at Thr235 is critical in this.	[Esteves, Cristina L.; Verma, Manu; Rog-Zielinska, Ewa; Kelly, Val; Sai, Shuji; Seckl, Jonathan R.; Chapman, Karen E.] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland; [Breton, Amandine; Donadeu, Francesc X.] Univ Edinburgh, Roslin Inst, Div Dev Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Chapman, KE (corresponding author), Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland.	Karen.Chapman@ed.ac.uk	Sai, Shuji/W-1456-2019; Esteves, Cristina/Y-5577-2019	Verma, Manu/0000-0002-5689-2808; Chapman, Karen/0000-0001-7777-6817	Wellcome Trust [WT083184]; Medical Research Council [MR/K026992/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust Programme Grant (grant number WT083184 to JRS and KEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahasan MM, 2012, ARTHRITIS RHEUM-US, V64, P2404, DOI 10.1002/art.34414; Arai N, 2007, ENDOCRINOLOGY, V148, P5268, DOI 10.1210/en.2007-0349; Atalar F, 2012, GENET MOL RES, V11, P3122, DOI 10.4238/2012.August.31.10; Balachandran A, 2008, ENDOCRINOLOGY, V149, P4069, DOI 10.1210/en.2008-0088; Bruley C, 2006, ENDOCRINOLOGY, V147, P2879, DOI 10.1210/en.2005-1621; Chapman KE, 2013, J STEROID BIOCHEM, V137, P82, DOI 10.1016/j.jsbmb.2013.02.002; Chapman KE, 2009, MOL CELL ENDOCRINOL, V301, P123, DOI 10.1016/j.mce.2008.09.031; Dahl JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1158; Esteves CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037953; Gout J, 2006, BIOCHIMIE, V88, P1115, DOI 10.1016/j.biochi.2006.05.020; Hadoke PWF, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0320-1; Hardy R, 2008, ANN RHEUM DIS, V67, P1204, DOI 10.1136/ard.2008.090662; Hardy RS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1993; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; Horie R, 2007, MICROBES INFECT, V9, P721, DOI 10.1016/j.micinf.2007.02.017; Ignatova ID, 2009, AM J PHYSIOL-ENDOC M, V296, pE367, DOI 10.1152/ajpendo.90531.2008; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Li HX, 2008, CYTOKINE, V41, P1, DOI 10.1016/j.cyto.2007.09.016; Malavasi ELV, 2010, ENDOCRINOLOGY, V151, P195, DOI 10.1210/en.2009-0663; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Sai S, 2008, MOL ENDOCRINOL, V22, P2049, DOI 10.1210/me.2007-0489; Sai S, 2011, LEUKEMIA RES, V35, P1644, DOI 10.1016/j.leukres.2011.07.002; Staab CA, 2011, CHEM-BIOL INTERACT, V191, P104, DOI 10.1016/j.cbi.2010.12.027; Svotelis A, 2005, BIOCHEM BIOPH RES CO, V328, P461, DOI 10.1016/j.bbrc.2005.01.002; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Wake DJ, 2003, J CLIN ENDOCR METAB, V88, P3983, DOI 10.1210/jc.2003-030286; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Williams LJS, 2000, J BIOL CHEM, V275, P30232, DOI 10.1074/jbc.M001286200; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Yang Z, 2009, ENDOCRINE, V36, P404, DOI 10.1007/s12020-009-9245-4; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	35	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75874	10.1371/journal.pone.0075874	http://dx.doi.org/10.1371/journal.pone.0075874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086653	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000050
J	Akhtar, Y; Isman, MB				Akhtar, Yasmin; Isman, Murray B.			Horizontal Transfer of Diatomaceous Earth and Botanical Insecticides in the Common Bed Bug, Cimex lectularius L.; Hemiptera: Cimicidae	PLOS ONE			English	Article							GERMAN-COCKROACH; ENTOMOPATHOGENIC FUNGI; ANT HYMENOPTERA; TRANSMISSION; AGGREGATION; COLEOPTERA; EFFICACY; TEMPERATURE; ARRESTMENT; INDOXACARB	Background: Horizontal transfer of insecticide occurs when insects contact or ingest an insecticide, return to an aggregation or a nest, and transfer the insecticide to other conspecific insects through contact. This phenomenon has been reported in a number of insects including social insects, however it has not been reported in bed bugs. Since horizontal transfer can facilitate the spread of insecticide into hard to reach spaces, it could contribute greatly to the management of these public health pests. Methodology/Results: To demonstrate horizontal transfer of diatomaceous earth and botanical insecticides in C. lectularius, an exposed (donor) bed bug, following a 10-minute acquisition period, was placed with unexposed (recipient) bed bugs. Mortality data clearly demonstrates that diatomaceous earth (DE 51) was actively transferred from a single exposed bug to unexposed bugs in a concentration dependent manner. LC50 values varied from 24.4 mg at 48 h to 5.1 mg at 216 h when a single exposed bed bug was placed with 5 unexposed bed bugs. LT50 values also exhibited a concentration response. LT50 values varied from 1.8 days to 8.4 days when a 'donor' bug exposed to 20 and 5 mg of dust respectively was placed with 5 'recipient' bugs. Dust was also actively transferred from adult bed bugs to the nymphs. In addition we observed horizontal transfer of botanical insecticides including neem, ryania, and rotenone to varying degrees. Conclusion/Significance: Our data clearly demonstrate horizontal transfer of diatomaceous earth and botanical insecticides in the common bed bug, C. lectularius. Use of a fluorescent dust provided visual confirmation that contaminated bed bugs transfer dust to untreated bed bugs in harborage. This result is important because bedbugs live in hard-to-reach places and interaction between conspecifics can be exploited for delivery and dissemination of management products directed at this public health pest.	[Akhtar, Yasmin; Isman, Murray B.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Isman, MB (corresponding author), Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V5Z 1M9, Canada.	murray.isman@ubc.ca	Akhtar, Yasmin/AAH-1096-2020	Isman, Murray/0000-0002-3285-1315	RJP Textile Ltd.; SemiosBIO Technologies Inc.	RJP Textile Ltd.; SemiosBIO Technologies Inc.	RJP Textile Ltd. and SemiosBIO Technologies Inc. have provided funding for bed bug research in the laboratory, but the research described in the manuscript is completely outside of the scope of the research funded by those companies. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ALLAN SA, 1994, EXP APPL ACAROL, V18, P691; Appel AG, 1999, ENVIRON ENTOMOL, V28, P979; Athanassiou CG, 2007, J STORED PROD RES, V43, P330, DOI 10.1016/j.jspr.2006.08.004; Athanassiou CG, 2005, J STORED PROD RES, V41, P47, DOI 10.1016/j.jspr.2003.12.001; Barbarin AM, 2012, J INVERTEBR PATHOL, V111, P82, DOI 10.1016/j.jip.2012.04.009; Benoit JB, 2007, AM J TROP MED HYG, V76, P987, DOI 10.4269/ajtmh.2007.76.987; Benoit JB, 2009, J MED ENTOMOL, V46, P572, DOI 10.1603/033.046.0323; Brinkman MA, 2001, FLA ENTOMOL, V84, P740, DOI 10.2307/3496418; Buczkowski G, 2001, PESTIC BIOCHEM PHYS, V71, P147, DOI 10.1006/pest.2001.2572; Buczkowski G, 2001, J ECON ENTOMOL, V94, P1229, DOI 10.1603/0022-0493-94.5.1229; Buczkowski G, 2008, J ECON ENTOMOL, V101, P894, DOI 10.1603/0022-0493(2008)101[894:HTOBIT]2.0.CO;2; Choe DH, 2008, J ECON ENTOMOL, V101, P1397, DOI 10.1603/0022-0493(2008)101[1397:HTOIIL]2.0.CO;2; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Domingue MJ, 2010, PHYSIOL ENTOMOL, V35, P203, DOI 10.1111/j.1365-3032.2010.00738.x; Ekesi S., 2007, Use of entomopathogenic fungi in biological pest management, P239; Faulde MK, 2006, J PEST SCI, V79, P155, DOI 10.1007/s10340-006-0127-8; Fields P, 2000, J STORED PROD RES, V36, P1, DOI 10.1016/S0022-474X(99)00021-1; Furlong MJ, 2001, BIOL CONTROL, V22, P288, DOI 10.1006/bcon.2001.0981; Haynes KF, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-117; Hu XP, 2005, PEST MANAG SCI, V61, P1209, DOI 10.1002/ps.1124; Hwang SW, 2005, EMERG INFECT DIS, V11, P533, DOI 10.3201/eid1104.041126; Klein MG, 1999, BIOCONTROL SCI TECHN, V9, P151, DOI 10.1080/09583159929730; le Patourel G, 2000, PEST MANAG SCI, V56, P732, DOI 10.1002/1526-4998(200009)56:9<732::AID-PS206>3.0.CO;2-F; Olson JF, 2009, J INSECT PHYSIOL, V55, P580, DOI 10.1016/j.jinsphys.2009.03.001; PINTO LJ, 2007, BED BUGS HDB COMPLET; Potter M.F., 2010, PEST WORLD       SEP, V18, P8; Quesada-Moraga E, 2004, J INVERTEBR PATHOL, V87, P51, DOI 10.1016/j.jip.2004.07.002; Romero A., 2007, Pest Control Technology, V35, P42; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Romero A, 2010, J INSECT PHYSIOL, V56, P1516, DOI 10.1016/j.jinsphys.2010.04.025; Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19; Siljander E, 2008, J CHEM ECOL, V34, P708, DOI 10.1007/s10886-008-9446-y; Siljander E, 2007, ENTOMOL EXP APPL, V125, P215, DOI 10.1111/j.1570-7458.2007.00617.x; Soeprono AM, 2004, J ECON ENTOMOL, V97, P1675, DOI 10.1603/0022-0493-97.5.1675; Statistix, 2000, AN SOFTW STAT 7 WIND; Usinger R, 1966, MON CIM; Zhu F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01456	37	22	24	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75626	10.1371/journal.pone.0075626	http://dx.doi.org/10.1371/journal.pone.0075626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086593	gold, Green Published, Green Submitted			2022-12-25	WOS:000325218700104
J	Ding, J; Tasker, C; Valere, K; Sihvonen, T; Descalzi-Montoya, DB; Lu, WY; Chang, TL				Ding, Jian; Tasker, Carley; Valere, Kimyata; Sihvonen, Tiina; Descalzi-Montoya, Dante B.; Lu, Wuyuan; Chang, Theresa L.			Anti-HIV Activity of Human Defensin 5 in Primary CD4+T Cells under Serum-Deprived Conditions Is a Consequence of Defensin-Mediated Cytotoxicity	PLOS ONE			English	Article							HUMAN ALPHA-DEFENSINS; VIRUS TYPE-1 INFECTION; HERPES-SIMPLEX-VIRUS; INNATE IMMUNITY; T-CELLS; ANTIMICROBIAL PEPTIDES; NEISSERIA-GONORRHOEAE; CERVICOVAGINAL FLUID; PROTEOMIC ANALYSIS; VAGINAL FLUID	Background: We have previously shown that human defensin 5 (HD5) promotes HIV infectivity in both primary CD4+ T cells and HeLa cells expressing CD4 and CCR5. HD5 is induced in response to sexually transmitted infections (STIs) such as Chlamydia trachomatis and Neisseria gonorrhoeae, suggesting it plays a role in STI-mediated enhancement of HIV transmission. In contrast to our findings, a recent study reports that HD5 has an anti-HIV effect in primary CD4+ T cells under serum-deprived conditions. To resolve these apparently contradictory observations, we investigated experimental parameters that might contribute to contrasting effects of HD5. Results: Serum-deprived culture conditions were associated with anti-HIV activity. In contrast to the dependence of the HIV enhancing effect on HD5 structure, the anti-HIV activity in serum-deprived primary CD4+ T cells was independent of HD5 structure as the linear peptide [Abu] HD5 exhibited similar anti-HIV activity. Under serum deprived conditions, HD5 blocked CD4-receptor-independent HIV-1(vsv) infection before or after viral entry. We found that HD5 and its linear form induced significant cell death in primary CD4+ T cells under serum-deprived culture conditions. HD5-mediated apoptosis was observed as early as 2 h after addition of defensins to serum-deprived primary CD4+ T cells. In contrast to primary CD4+ T cells, HD5 did not induce cytotoxicity and promote HIV infectivity of HeLa-CD4-CCR5 cells under serum-deprived conditions. Conclusions: These results indicate that under serum-deprived culture conditions HD5 is toxic for primary CD4+ T cells, warranting caution in data interpretation.	[Ding, Jian; Sihvonen, Tiina; Chang, Theresa L.] Rutgers Biomed & Hlth Sci New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Tasker, Carley; Valere, Kimyata; Chang, Theresa L.] Rutgers Biomed & Hlth Sci New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ USA; [Descalzi-Montoya, Dante B.] Rutgers Biomed & Hlth Sci New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ USA; [Tasker, Carley; Valere, Kimyata; Descalzi-Montoya, Dante B.] Rutgers Biomed & Hlth Sci New Jersey Med Sch, Grad Sch Biomed Sci, Newark, NJ USA; [Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Chang, TL (corresponding author), Rutgers Biomed & Hlth Sci New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA.	changth@umdnj.edu	Lu, Wuyuan/J-8452-2017; Lu, Wuyuan/B-2268-2010	Lu, Wuyuan/0000-0003-1318-9968; 	National Institutes of Health [AI081559]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by National Institutes of Health grant AI081559. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarbiou J, 2006, INFLAMM RES, V55, P119, DOI 10.1007/s00011-005-0062-9; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; CHEN BK, 1994, J VIROL, V68, P654, DOI 10.1128/JVI.68.2.654-660.1994; Classen S, 2007, J IMMUNOL, V178, P6931, DOI 10.4049/jimmunol.178.11.6931; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; Ding J, 2012, J IMMUNOL, V188, P992, DOI 10.4049/jimmunol.1102098; Ding JA, 2011, J INNATE IMMUN, V3, P208, DOI 10.1159/000322355; Ding J, 2009, J INNATE IMMUN, V1, P413, DOI 10.1159/000226256; Dugan AS, 2008, J BIOL CHEM, V283, P31125, DOI 10.1074/jbc.M805902200; Fan SR, 2008, INT J GYNECOL OBSTET, V103, P50, DOI 10.1016/j.ijgo.2008.05.020; Furci L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045208; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gounder AP, 2012, J BIOL CHEM, V287, P24554, DOI 10.1074/jbc.M112.354068; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guo J, 2011, J VIROL, V85, P9824, DOI 10.1128/JVI.05170-11; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; JONES DE, 1992, J BIOL CHEM, V267, P23216; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Meyerholz DK, 2004, J CLIN MICROBIOL, V42, P4780, DOI 10.1128/JCM.42.10.4780-4787.2004; NOVELLI F, 1994, J IMMUNOL, V152, P496; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Quayle AJ, 1998, AM J PATHOL, V152, P1247; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Rehaume LM, 2008, CRIT REV IMMUNOL, V28, P185, DOI 10.1615/CritRevImmunol.v28.i3.10; Ryan LK, 2011, J LEUKOCYTE BIOL, V90, P343, DOI 10.1189/jlb.0209079; Salzman NH, 2010, GUT MICROBES, V1, P401, DOI 10.4161/gmic.1.6.14076; Seidel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009737; Shaw JLV, 2007, J PROTEOME RES, V6, P2859, DOI 10.1021/pr0701658; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wehkamp J, 2006, FEBS LETT, V580, P5344, DOI 10.1016/j.febslet.2006.08.083; Wu Z, 2004, J PEPT RES, V64, P118, DOI 10.1111/j.1399-3011.2004.00179.x; Yang D, 2004, ARTHRITIS RHEUM, V50, P3401, DOI 10.1002/art.20604; Zegels G, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-63; Zegels G, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-17; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	45	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76038	10.1371/journal.pone.0076038	http://dx.doi.org/10.1371/journal.pone.0076038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086683	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700119
J	Dong, M; Yang, DF; Lang, QL; Zhou, W; Xu, SW; Xu, T				Dong, Miao; Yang, Dongfeng; Lang, Qiulei; Zhou, Wei; Xu, Shaowei; Xu, Tao			Microarray and Degradome Sequencing Reveal MicroRNA Differential Expression Profiles and Their Targets in Pinellia pedatisecta	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; MANNOSE-BINDING LECTIN; PLANT MICRORNA; SMALL RNAS; CONSERVED MICRORNAS; WIDE IDENTIFICATION; PARALLEL ANALYSIS; GENE-EXPRESSION; ARABIDOPSIS; ARGONAUTE1	MicroRNAs (miRNAs) are endogenous small non-coding RNAs which play a critical role in gene regulation in plants. Pinellia pedatisecta is one of the most important herbs in traditional Chinese medicine, but there are no microRNAs of Pinellia pedatisecta were deposited in miRBase and the research of the related miRNA biological functions is still insufficient. To detect Pinellia pedatisecta miRNAs and discover their expression difference with Pinellia ternata, we carried out a microarray profiling. A total of 101 miRNAs belonging to 22 miRNA families were detected both in Pinellia pedatisecta and Pinellia ternata respectively, among them 21 miRNAs showed their differentially expression. GO (gene ontology) term enrichment analysis of the target genes of differential expression miRNAs reveal that these miRNAs mainly affect the reproduction, transcription factor activity and plant developmental process. To elucidate the target function of miRNAs, we constructed a degradome library from Pinellia pedatisecta leaf. The result showed that a total of 18 transcript were identified as targets of miRNAs and further analysis indicated that miR156 and miR529 may function together to repress SPL14.	[Dong, Miao; Yang, Dongfeng; Zhou, Wei; Xu, Shaowei; Xu, Tao] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Lang, Qiulei] LC Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Xu, T (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	xutao1998cn@163.com			National Natural Science Fund of China [30772712]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Fund of China (No. 30772712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2009, RNA, V15, P2112, DOI 10.1261/rna.1774909; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Buhtz A, 2008, PLANT J, V53, P739, DOI 10.1111/j.1365-313X.2007.03368.x; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chuck G, 2010, DEVELOPMENT, V137, P1243, DOI 10.1242/dev.048348; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Frazier TP, 2011, MOL BIOTECHNOL, V49, P159, DOI 10.1007/s12033-011-9387-5; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kanaan Z, 2013, INNATE IMMUN-LONDON, V19, P203, DOI 10.1177/1753425912460557; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim SK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-411; Ko JH, 2006, NEW PHYTOL, V169, P469, DOI 10.1111/j.1469-8137.2005.01623.x; Lang QL, 2011, J ZHEJIANG UNIV-SC B, V12, P116, DOI 10.1631/jzus.B1000278; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Lin JA, 2007, J BIOSCIENCES, V32, P241, DOI 10.1007/s12038-007-0024-1; Lin J, 2006, BIOCELL, V30, P15; Liu DM, 2009, PHYSIOL PLANTARUM, V136, P223, DOI 10.1111/j.1399-3054.2009.01229.x; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lynn K, 1999, DEVELOPMENT, V126, P469; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Meng YJ, 2009, PLANTA, V230, P883, DOI 10.1007/s00425-009-0994-3; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.0960-7412.2010.04208.x, 10.1111/j.1365-313X.2010.04208.x]; Pradervand S, 2010, BIOTECHNIQUES, V48, P219, DOI 10.2144/000113367; Pulido A, 2010, J EXP BOT, V61, P1277, DOI 10.1093/jxb/erp397; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shomron N, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/594678; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Wang B, 2012, GENE, V498, P36, DOI 10.1016/j.gene.2012.01.075; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Xu T, 2012, GENE, V493, P267, DOI 10.1016/j.gene.2011.08.009; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029669; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x	60	6	10	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75978	10.1371/journal.pone.0075978	http://dx.doi.org/10.1371/journal.pone.0075978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086673	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700117
J	Matsudaira, K; Shimazu, A; Fujii, T; Kubota, K; Sawada, T; Kikuchi, N; Takahashi, M				Matsudaira, Ko; Shimazu, Akihito; Fujii, Tomoko; Kubota, Kazumi; Sawada, Takayuki; Kikuchi, Norimasa; Takahashi, Masaya			Workaholism as a Risk Factor for Depressive Mood, Disabling Back Pain, and Sickness Absence	PLOS ONE			English	Article							WORK ENGAGEMENT; JOB DEMANDS; STRAIN; MODEL; COST; NETHERLANDS; ILLNESS; SF-36	Objectives: Although it is understood that work-related factors, including job demands, job control, and workplace support, are associated with workers' health and well-being, the role played by personal characteristics, especially workaholism, has not been fully investigated. This study examined workaholism's associations with psychological ill health, low back pain with disability, and sickness absence among Japanese workers. Methods: A cross-sectional Internet survey was conducted using self-administered questionnaires. Data from 3,899 Japanese workers were analyzed. Workaholism was measured using the Dutch Workaholism Scale (DUWAS). Scores were divided into tertiles, where respondents were classified into three groups (high, middle, and low). Depressive mood as a measure of psychological ill health was assessed using the SF-36 mental health subscale, and low back pain using a standardized question. Sickness absence, except that due to physical injuries, was categorized either as absence due to mental health problems or to physical/somatic problems including the common cold. Multiple logistic regression analyses were conducted to examine the association between workaholism and depressive mood, low back pain with disability, and sickness absence, adjusting for demographic characteristics, job demand, job control, and workplace support. Results: Compared to the low workaholism group, the middle and high workaholism groups had significantly higher odds for depressive mood (Odds ratio (OR) = 1.93 and 3.62 for the middle and high groups, respectively), disabling back pain (ORs = 1.36 and 1.77 for the middle and high groups, respectively). Workaholism was more strongly associated with sickness absence due to mental health problems than that for other reasons (ORs = 1.76 vs. 1.21 for the middle group and 3.52 vs. 1.37 for the high groups). Conclusions: Workaholism is significantly associated with poor psychological health, disabling back pain, and sickness absence, particularly from mental health problems. Therefore, workaholism must be considered when addressing well-being of workers.	[Matsudaira, Ko; Fujii, Tomoko] Kanto Rosai Hosp, Clin Res Ctr Occupat Musculoskeletal Disorders, Kawasaki, Kanagawa, Japan; [Shimazu, Akihito; Kubota, Kazumi] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Bunkyo Ku, Tokyo, Japan; [Sawada, Takayuki; Kikuchi, Norimasa] CLIN STUDY SUPPORT Inc, Nagoya, Aichi, Japan; [Takahashi, Masaya] Natl Inst Occupat Safety & Hlth, Kawasaki, Kanagawa, Japan	University of Tokyo	Matsudaira, K (corresponding author), Kanto Rosai Hosp, Clin Res Ctr Occupat Musculoskeletal Disorders, Kawasaki, Kanagawa, Japan.	kohart801@gmail.com	kubota, kazumi/AAI-3036-2021; kubota, kazumi/AFS-2460-2022	Shimazu, Akihito/0000-0002-7172-0043	Japan Labor Health and Welfare Organization	Japan Labor Health and Welfare Organization(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a dissemination project on the 13 fields of occupational injuries and illness of the Japan Labor Health and Welfare Organization. No funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker A, 2010, SPINE, V35, P1714, DOI 10.1097/BRS.0b013e3181cd656f; Burke RJ, 2004, STRESS HEALTH, V20, P301, DOI 10.1002/smi.1025; Burke RJ, 2000, STRESS MEDICINE, V16, P11, DOI 10.1002/(SICI)1099-1700(200001)16:1<11::AID-SMI825>3.0.CO;2-U; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Hayden JA, 2009, J CLIN EPIDEMIOL, V62, P781, DOI 10.1016/j.jclinepi.2008.09.004; Johnson JV, 1994, PSYCHOSOCIAL PROCESS, P25; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kato M., 2000, MINISTRY LABOUR SPON, pp. 126; Kubota K, 2012, INT J BEHAV MED; Kubota K, 2010, IND HEALTH, V48, P864, DOI 10.2486/indhealth.MS1139; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P35; Melloh M, 2009, INT ORTHOP, V33, P301, DOI 10.1007/s00264-008-0707-8; Ministry of Health Labour and Welfare, 2009, NAT HLTH NUTR SURV 2; Ministry of Health Labour and Welfare, 2010, COMPR SURV LIV COND; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Schaufeli WB, 2008, APPL PSYCHOL-INT REV, V57, P173, DOI 10.1111/j.1464-0597.2007.00285.x; Schaufeli WB, 2009, CROSS-CULT RES, V43, P320, DOI 10.1177/1069397109337239; Scott KS, 1997, HUM RELAT, V50, P287, DOI 10.1177/001872679705000304; Shimazu A, 2011, SOC SCI MED, V73, P399, DOI 10.1016/j.socscimed.2011.05.049; Shimazu A, 2010, INT J BEHAV MED, V17, P154, DOI 10.1007/s12529-010-9077-x; Shimazu A, 2009, IND HEALTH, V47, P495, DOI 10.2486/indhealth.47.495; SPENCE JT, 1992, J PERS ASSESS, V58, P160, DOI 10.1207/s15327752jpa5801_15; Statistics Bureau Ministry of Internal Affairs and Communication, 2010, POP CENS; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Taris TW, 2008, WORK STRESS, V22, P153, DOI 10.1080/02678370701758074; Taris TW, 2005, APPL PSYCHOL-INT REV, V54, P37, DOI 10.1111/j.1464-0597.2005.00195.x; van der Doef M, 1998, PSYCHOL HEALTH, V13, P909, DOI 10.1080/08870449808407440; Van der Doef M, 1999, WORK STRESS, V13, P87, DOI 10.1080/026783799296084; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Waddell G, 2001, OCCUP MED-OXFORD, V51, P124, DOI 10.1093/occmed/51.2.124; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yamazaki Shin, 2005, Health Qual Life Outcomes, V3, P48	38	33	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75140	10.1371/journal.pone.0075140	http://dx.doi.org/10.1371/journal.pone.0075140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086457	Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700054
J	Smith, ME; Bozinovski, S; Malmhall, C; Sjostrand, M; Glader, P; Venge, P; Hiemstra, PS; Anderson, GP; Linden, A; Qvarfordt, I				Smith, Margaretha E.; Bozinovski, Steven; Malmhall, Carina; Sjostrand, Margareta; Glader, Pernilla; Venge, Per; Hiemstra, Pieter S.; Anderson, Gary P.; Linden, Anders; Qvarfordt, Ingemar			Increase in Net Activity of Serine Proteinases but Not Gelatinases after Local Endotoxin Exposure in the Peripheral Airways of Healthy Subjects	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NF-KAPPA-B; NEUTROPHIL LIPOCALIN HNL; MATRIX-METALLOPROTEINASE; LUNG INFLAMMATION; ALLERGEN CHALLENGE; CIGARETTE-SMOKE; INNATE IMMUNITY; LAVAGE FLUID; IN-VIVO	We tested the hypothesis that activation of the innate immune response induces an imbalance in the proteolytic homeostasis in the peripheral airways of healthy subjects, towards excess serine or gelatinase proteinase activity. During bronchoscopy, 18 healthy human subjects underwent intra-bronchial exposure to endotoxin and contra-lateral exposure to vehicle. Bronchoalveolar lavage (BAL) samples were harvested 24 or 48 hours (h) later. We quantified archetype proteinases, anti-proteinases, inflammatory BAL cells, and, importantly, total plus net proteinase activities using functional substrate assays. As expected, endotoxin exposure increased the concentrations of polymorphonuclear leukocytes (PMN's) and macrophages, of proteinases and the anti-proteinases tissue inhibitor of metalloproteinase-1, alpha-1-antitrypsin and, to a lesser extent, secretory leukoproteinase inhibitor, at both time points. Notably, at these time points, endotoxin exposure substantially increased the quantitative NE/SLPI ratio and the net serine proteinase activity corresponding to neutrophil elastase (NE). Endotoxin exposure also increased the total gelatinase activity corresponding to matrix metalloproteinase (MMP)-9; an activity dominating over that of MMP-2. However, endotoxin exposure had no impact on net gelatinolytic activity at 24 or 48 h after exposure. Thus, local activation of the innate immune response induces an imbalance towards increased net serine proteinase activity in the proteolytic homeostasis of the peripheral airways in healthy subjects. Hypothetically, this serine proteinase activity can contribute to tissue remodelling and hypersecretion via NE from PMN's, if it is triggered repeatedly, as might be the case in chronic inflammatory airway disorders.	[Smith, Margaretha E.; Malmhall, Carina; Sjostrand, Margareta; Glader, Pernilla; Linden, Anders; Qvarfordt, Ingemar] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Lung Immunol Grp, Gothenburg, Sweden; [Bozinovski, Steven; Anderson, Gary P.] Univ Melbourne, Dept Med & Pharmacol, Lung Dis Res Grp, Parkville, Vic 3052, Australia; [Venge, Per] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Hiemstra, Pieter S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Linden, Anders] Karolinska Univ Hosp, Karolinska Inst, Inst Environm Med, Unit Lung & Airway Res, Stockholm, Sweden; [Linden, Anders] Karolinska Univ Hosp, Lung Allergy Clin, Stockholm, Sweden	University of Gothenburg; University of Melbourne; Uppsala University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Linden, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Lung Immunol Grp, Gothenburg, Sweden.	anders.linden@ki.se	Hiemstra, Pieter S/K-8587-2018; /V-8478-2019	Hiemstra, Pieter S/0000-0002-0238-5982; Linden, Anders/0000-0003-1258-2928; Anderson, Gary/0000-0001-6580-3398; Bozinovski, Steven/0000-0001-6533-8641	Swedish Heart-Lung Fund [20100290]; Federal Project Funding; King Gustav V's and Queen Victoria's Freemason Foundation; Gothenburg Medical Society	Swedish Heart-Lung Fund(Swedish Heart-Lung Foundation); Federal Project Funding; King Gustav V's and Queen Victoria's Freemason Foundation; Gothenburg Medical Society	Funding from the Swedish Heart-Lung Fund (Project No. 20100290), Federal Project Funding according to the ALF/LUA agreement, King Gustav V's and Queen Victoria's Freemason Foundation and from Gothenburg Medical Society. No funding was obtained from the tobacco industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2003, ACTA ANAESTH SCAND, V47, P407, DOI 10.1034/j.1399-6576.2003.00059.x; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Baines KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018426; Betsuyaku T, 1999, AM J RESP CRIT CARE, V159, P1985, DOI 10.1164/ajrccm.159.6.9809043; BIRRER P, 1992, J APPL PHYSIOL, V73, P317, DOI 10.1152/jappl.1992.73.1.317; Bozinovski S, 2002, J BIOL CHEM, V277, P42808, DOI 10.1074/jbc.M207840200; CASTILLO MJ, 1979, ANAL BIOCHEM, V99, P53, DOI 10.1016/0003-2697(79)90043-5; Churg A, 2012, EUR RESPIR J, V39, P197, DOI 10.1183/09031936.00121611; Clemmensen SN, 2011, EUR J HAEMATOL, V86, P517, DOI 10.1111/j.1600-0609.2011.01601.x; Cosgrove S, 2011, J BIOL CHEM, V286, P7692, DOI 10.1074/jbc.M110.183863; Dabbagh K, 2001, J CELL PHYSIOL, V186, P73, DOI 10.1002/1097-4652(200101)186:1<73::AID-JCP1002>3.0.CO;2-Q; Doyen V, 2012, INFLAMMATION, V35, P33, DOI 10.1007/s10753-010-9286-0; DUBOIS RM, 1991, BLOOD, V77, P2724; Geraghty P, 2007, J IMMUNOL, V178, P5871, DOI 10.4049/jimmunol.178.9.5871; Glader P, 2010, EUR RESPIR J, V36, P1155, DOI 10.1183/09031936.00170609; Greene C, 2003, J INFECT DIS, V188, P769, DOI 10.1086/377238; Hiemstra PS, 1998, EUR RESPIR J, V12, P1200, DOI 10.1183/09031936.98.12051200; Hiltermann JTN, 1999, FREE RADICAL BIO MED, V27, P1448, DOI 10.1016/S0891-5849(99)00191-4; Ho SC, 2009, J IMMUNOL, V183, P411, DOI 10.4049/jimmunol.0803729; Hoogerwerf JJ, 2008, AM J RESP CRIT CARE, V178, P34, DOI 10.1164/rccm.200708-1261OC; Kelly EAB, 2000, AM J RESP CRIT CARE, V162, P1157; KJELDSEN L, 1993, BLOOD, V82, P3183; Korsgren M, 2012, CLIN PHYSIOL FUNCT I, V32, P71, DOI 10.1111/j.1475-097X.2011.01058.x; Kuwahara I, 2006, AM J PHYSIOL-LUNG C, V291, pL407, DOI 10.1152/ajplung.00471.2005; Mackarel AJ, 1999, AM J RESP CELL MOL, V20, P1209; Mattos W, 2002, CHEST, V122, P1543, DOI 10.1378/chest.122.5.1543; O'Grady NP, 2001, AM J RESP CRIT CARE, V163, P1591, DOI 10.1164/ajrccm.163.7.2009111; Ohnishi K, 1998, LAB INVEST, V78, P1077; Paone G, 2011, DIS MARKERS, V31, P91, DOI [10.1155/2011/139493, 10.3233/DMA-2011-0807]; Ratjen F, 2002, THORAX, V57, P930, DOI 10.1136/thorax.57.11.930; Sallenave JM, 1997, J LEUKOCYTE BIOL, V61, P695, DOI 10.1002/jlb.61.6.695; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Seveus L, 1997, HISTOCHEM CELL BIOL, V107, P423, DOI 10.1007/s004180050129; TETLEY TD, 1993, THORAX, V48, P560, DOI 10.1136/thx.48.5.560; Turino GM, 2011, AM J RESP CRIT CARE, V184, P637, DOI 10.1164/rccm.201103-0450PP; Vandenbroucke RE, 2011, EUR RESPIR J, V38, P1200, DOI 10.1183/09031936.00027411; Vernooy JHJ, 2004, CHEST, V126, P1802, DOI 10.1378/chest.126.6.1802; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Vlahos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033277; Witherden IR, 2004, AM J RESP CELL MOL, V30, P500, DOI 10.1165/rcmb.4890; Xu SY, 2000, BBA-PROTEIN STRUCT M, V1482, P298, DOI 10.1016/S0167-4838(00)00163-1; XU SY, 1994, J IMMUNOL METHODS, V171, P245, DOI 10.1016/0022-1759(94)90044-2	43	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75032	10.1371/journal.pone.0075032	http://dx.doi.org/10.1371/journal.pone.0075032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086430	Green Published, gold			2022-12-25	WOS:000326520200073
J	Inokuchi, H; Ito, R; Sekiguchi, T; Sekiguchi, M				Inokuchi, Hachiro; Ito, Riyoko; Sekiguchi, Takeshi; Sekiguchi, Mutsuo			Search for Proteins Required for Accurate Gene Expression under Oxidative Stress ROLES OF GUANYLATE KINASE AND RNA POLYMERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Expression; Oxidative Stress; Protein Synthesis; RNA Polymerase; RNA Synthesis; Guanylate Kinase	ESCHERICHIA-COLI MUTT; RPOB GENE; MSBA GENE; MUTATIONS; GUANINE; DNA; MUTAGENESIS; NUCLEOTIDE; DEOXYGUANOSINE; TRANSCRIPTION	Background: Oxygen radicals, formed in aerobically growing cells, oxidize guanine to 8-oxo-7,8-dihydroguanine, which causes base mispairing. Results: Guanylate kinase and RNA polymerase are most responsible for preventing transcriptional errors caused by oxidative stress. Conclusion: Mutations in the genes responsible for preventing phenotypic suppression were identified. Significance: This study reveals a mechanism by which bacterial cells protect themselves against oxidative damage to RNA. In aerobically growing cells, in which reactive oxygen species are produced, the guanine base is oxidized to 8-oxo-7,8-dihydroguanine, which can pair with adenine as well as cytosine. This mispairing causes alterations in gene expression, and cells possess mechanisms to prevent such outcomes. In Escherichia coli, 8-oxo-7,8-dihydroguanine-related phenotypic suppression of lacZ amber is enhanced by mutations in genes related to the prevention of abnormal protein synthesis under oxidative stress. A genome-wide search for the genes responsible, followed by DNA sequence determination, revealed that specific amino acid changes in guanylate kinase and in the and subunits of RNA polymerase cause elevated levels of phenotypic suppression, specifically under aerobic conditions. The involvement of the DnaB, DnaN, and MsbA proteins, which are involved in DNA replication and in preserving the membrane structure, was also noted. Interactions of these proteins with each other and also with other molecules may be important for preventing errors in gene expression.	[Inokuchi, Hachiro; Ito, Riyoko; Sekiguchi, Mutsuo] Fukuoka Dent Coll, Frontier Res Ctr, Fukuoka 8140193, Japan; [Inokuchi, Hachiro; Ito, Riyoko; Sekiguchi, Mutsuo] Fukuoka Dent Coll, Dept Biochem, Fukuoka 8140193, Japan; [Sekiguchi, Takeshi] Kyushu Univ, Dept Mol Biol, Grad Sch Med Sci, Fukuoka 8128582, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Kyushu University	Sekiguchi, M (corresponding author), Fukuoka Dent Coll, Frontier Res Ctr, Fukuoka 8140193, Japan.	mseki@college.fdcnet.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; MEXT	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, including the MEXT-supported Program for the Strategic Research Foundation at Private Universities and grants-in-aid for scientific research.	BERLYN MKB, 1996, ESCHERICHIA COLI SAL, P1715; BURGERS PMJ, 1981, P NATL ACAD SCI-BIOL, V78, P5391, DOI 10.1073/pnas.78.9.5391; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; DEMPLE B, 1980, NATURE, V287, P203, DOI 10.1038/287203a0; DRAKE JW, 1969, NATURE, V221, P1132, DOI 10.1038/2211132a0; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Fowler RG, 2003, DNA REPAIR, V2, P159, DOI 10.1016/S1568-7864(02)00193-3; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; GAIDAROV IO, 1993, FEBS LETT, V335, P81, DOI 10.1016/0014-5793(93)80444-Y; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Hayakawa H, 1999, BIOCHEMISTRY-US, V38, P3610, DOI 10.1021/bi982361l; Hayakawa H, 2001, BIOCHEMISTRY-US, V40, P9977, DOI 10.1021/bi010595q; Hible G, 2005, J MOL BIOL, V352, P1044, DOI 10.1016/j.jmb.2005.07.042; HOOPER ML, 1972, FEBS LETT, V22, P149, DOI 10.1016/0014-5793(72)80241-2; Ito R, 2005, BIOCHEMISTRY-US, V44, P6670, DOI 10.1021/bi047550k; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; KAROW M, 1993, MOL MICROBIOL, V7, P69, DOI 10.1111/j.1365-2958.1993.tb01098.x; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KOMINE Y, 1990, J MOL BIOL, V212, P579, DOI 10.1016/0022-2836(90)90224-A; LAGERKVIST U, 1958, J BIOL CHEM, V233, P143; Lane WJ, 2010, J MOL BIOL, V395, P671, DOI 10.1016/j.jmb.2009.10.062; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; MORIYA M, 1991, MUTAT RES, V254, P281, DOI 10.1016/0921-8777(91)90067-Y; NAKAYAMA N, 1984, J BIOL CHEM, V259, P97; NINIO J, 1991, BIOCHIMIE, V73, P1517, DOI 10.1016/0300-9084(91)90186-5; OESCHGER MP, 1966, J BIOL CHEM, V241, P5452; OHMORI H, 1984, GENE, V28, P159, DOI 10.1016/0378-1119(84)90253-1; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Polissi A, 1996, MOL MICROBIOL, V20, P1221, DOI 10.1111/j.1365-2958.1996.tb02642.x; Sakai A, 2006, GENES CELLS, V11, P767, DOI 10.1111/j.1365-2443.2006.00982.x; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; Sekiguchi T, 2013, J BIOL CHEM, V288, P8128, DOI 10.1074/jbc.M112.418723; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Takagi Y, 2012, J BIOL CHEM, V287, P21541, DOI 10.1074/jbc.M112.363010; Trinh V, 2006, MICROBIOL MOL BIOL R, V70, P12, DOI 10.1128/MMBR.70.1.12-36.2006; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; WOOD ML, 1990, BIOCHEMISTRY-US, V29, P7024, DOI 10.1021/bi00482a011; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Zhou YN, 2013, J BIOL CHEM, V288, P2700, DOI 10.1074/jbc.M112.429464	45	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32952	32962		10.1074/jbc.M113.507772	http://dx.doi.org/10.1074/jbc.M113.507772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097971	Green Published, hybrid			2022-12-25	WOS:000328841700013
J	Tsitsanou, KE; Drakou, CE; Thireou, T; Gruber, AV; Kythreoti, G; Azem, A; Fessas, D; Eliopoulos, E; Iatrou, K; Zographos, SE				Tsitsanou, Katerina E.; Drakou, Christina E.; Thireou, Trias; Gruber, Anna Vitlin; Kythreoti, Georgia; Azem, Abdussalam; Fessas, Dimitrios; Eliopoulos, Elias; Iatrou, Kostas; Zographos, Spyros E.			Crystal and Solution Studies of the "Plus-C" Odorant-binding Protein 48 from Anopheles gambiae CONTROL OF BINDING SPECIFICITY THROUGH THREE-DIMENSIONAL DOMAIN SWAPPING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Ultracentrifugation; Calorimetry; Chromatography; Crystal Structure; Fluorescence; Molecular Docking	MALARIA-TRANSMITTING MOSQUITO; ANOPHELES-GAMBIAE; MAMESTRA-BRASSICAE; VECTOR MOSQUITO; GYPSY-MOTH; EXPRESSION; MECHANISM; GENES; TEMPERATURE; RELEASE	Much physiological and behavioral evidence has been provided suggesting that insect odorant-binding proteins (OBPs) are indispensable for odorant recognition and thus are appealing targets for structure-based discovery and design of novel host-seeking disruptors. Despite the fact that more than 60 putative OBP-encoding genes have been identified in the malaria vector Anopheles gambiae, the crystal structures of only six of them are known. It is therefore clear that OBP structure determination constitutes the bottleneck for structure-based approaches to mosquito repellent/attractant discovery. Here, we describe the three-dimensional structure of an A. gambiae Plus-C group OBP (AgamOBP48), which exhibits the second highest expression levels in female antennae. This structure represents the first example of a three-dimensional domain-swapped dimer in dipteran species. A combined binding site is formed at the dimer interface by equal contribution of each monomer. Structural comparisons with the monomeric AgamOBP47 revealed that the major structural difference between the two Plus-C proteins localizes in their N- and C-terminal regions, and their concerted conformational change may account for monomer-swapped dimer conversion and furthermore the formation of novel binding pockets. Using a combination of gel filtration chromatography, differential scanning calorimetry, and analytical ultracentrifugation, we demonstrate the AgamOBP48 dimerization in solution. Eventually, molecular modeling calculations were used to predict the binding mode of the most potent synthetic ligand of AgamOBP48 known so far, discovered by ligand- and structure-based virtual screening. The structure-aided identification of multiple OBP binders represents a powerful tool to be employed in the effort to control transmission of the vector-borne diseases.	[Tsitsanou, Katerina E.; Drakou, Christina E.; Zographos, Spyros E.] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Athens 11635, Greece; [Thireou, Trias; Eliopoulos, Elias] Agr Univ Athens, Dept Agr Biotechnol, GR-11855 Athens, Greece; [Gruber, Anna Vitlin; Azem, Abdussalam] Tel Aviv Univ, Dept Biochem & Mol Biol, George E Wise Fac Life Sci, IL-69978 Tel Aviv, Israel; [Kythreoti, Georgia; Iatrou, Kostas] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Insect Mol Genet & Biotechnol Grp, Athens 15310, Greece; [Fessas, Dimitrios] Univ Milan, Dept Food Environm & Nutr Sci, I-20133 Milan, Italy	National Hellenic Research Foundation; Agricultural University of Athens; Tel Aviv University; National Centre of Scientific Research "Demokritos"; University of Milan	Zographos, SE (corresponding author), Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, 48 Vassileos Constantinou Ave, Athens 11635, Greece.	sez@eie.gr	Zographos, Spyros/H-9058-2013; Thireou, Trias/HCH-5951-2022	Zographos, Spyros/0000-0001-8455-2352; Eliopoulos, Elias/0000-0002-0919-0571; Thireou, Trias/0000-0002-6894-0774; Drakou, Christina/0000-0003-4793-0451; E. Tsitsanou, Katerina/0000-0001-9657-1390	European Community's Seventh Framework Programme under BioStruct-X Grant [283570]	European Community's Seventh Framework Programme under BioStruct-X Grant	We acknowledge the late Dr. Harald Biessmann and Dr. Marika F. Walter (Developmental Biology Center, University of California) for kindly providing the AgamOBP48 gene (GenBank (TM) accession number AF533512). Work at the Synchrotron Radiation Sources, MAX-lab, Lund, Sweden, and EMBL Hamburg Outstation, Germany, was supported by funding provided by the European Community's Seventh Framework Programme Grant FP7/2007-2013 under BioStruct-X Grant 283570.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andronopoulou E, 2006, INSECT MOL BIOL, V15, P797, DOI 10.1111/j.1365-2583.2006.00685.x; Ausili A, 2013, J PHOTOCH PHOTOBIO B, V118, P66, DOI 10.1016/j.jphotobiol.2012.11.004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARONE G, 1992, J THERM ANAL, V38, P2779, DOI 10.1007/BF01979752; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Boix E, 2001, METHOD ENZYMOL, V341, P287, DOI 10.1016/S0076-6879(01)41159-1; Cabrera M, 2007, J AM MOSQUITO CONTR, V23, P1, DOI 10.2987/8756-971X(2007)23[1:AAPMLB]2.0.CO;2; Campanacci V, 1999, EUR J BIOCHEM, V264, P707, DOI 10.1046/j.1432-1327.1999.00666.x; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Danty E, 1999, J NEUROSCI, V19, P7468, DOI 10.1523/JNEUROSCI.19-17-07468.1999; DAuria S, 1997, BIOCHEM J, V323, P833, DOI 10.1042/bj3230833; Davrazou F, 2011, J BIOL CHEM, V286, P34175, DOI 10.1074/jbc.M111.274712; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fessa D, 2007, PROTEINS, V67, P1002, DOI 10.1002/prot.21383; Fessas D, 2001, EUR J BIOCHEM, V268, P5439, DOI 10.1046/j.0014-2956.2001.02484.x; FOSTER WA, 1994, J AM MOSQUITO CONTR, V10, P288; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Honson N, 2003, CHEM SENSES, V28, P479, DOI 10.1093/chemse/28.6.479; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Lagarde A, 2011, J MOL BIOL, V414, P401, DOI 10.1016/j.jmb.2011.10.005; Lagarde A, 2011, BIOCHEM J, V437, P423, DOI 10.1042/BJ20110522; Leal Walter S., 2003, P447, DOI 10.1016/B978-012107151-6/50017-7; Leatherbarrow RJ., 2007, GRAFIT VERSION 6 0; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Medek P, 2007, JOURNAL WSCG, V15, P107; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pesenti ME, 2009, J MOL BIOL, V390, P981, DOI 10.1016/j.jmb.2009.05.067; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; Press WH, 1989, NUMERICAL RECIPES AR, P521; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schultze A, 2012, INSECT MOL BIOL, V21, P187, DOI 10.1111/j.1365-2583.2011.01125.x; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Tsitsanou KE, 2012, CELL MOL LIFE SCI, V69, P283, DOI 10.1007/s00018-011-0745-z; Vogt RG, 2002, J CHEM ECOL, V28, P2371, DOI 10.1023/A:1021009311977; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007; Ziemba BP, 2013, PROTEIN SCI, V22, P11, DOI 10.1002/pro.2179	60	28	33	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33427	33438		10.1074/jbc.M113.505289	http://dx.doi.org/10.1074/jbc.M113.505289			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097978	hybrid, Green Published			2022-12-25	WOS:000328841700055
J	Zhou, W; Jeyaraman, K; Yusoff, P; Shenolikar, S				Zhou, Wei; Jeyaraman, Krishna; Yusoff, Permeen; Shenolikar, Shirish			Phosphorylation at Tyrosine 262 Promotes GADD34 Protein Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Phosphotyrosine; Protein Turnover; Stress; Tyrosine Protein Phosphatase (Tyrosine Phosphatase); GADD34	ENDOPLASMIC-RETICULUM STRESS; INDUCED GENE-EXPRESSION; INITIATION-FACTOR 2; PHOSPHATASE 1B; GROWTH ARREST; TRANSCRIPTIONAL REGULATION; TRANSLATION; CANCER; PTP1B; SRC	Background: Proteasomal degradation of GADD34 dictates cell sensitivity to ER stress. Results: Phosphorylation at tyrosine 262 controls GADD34 protein turnover and cell fate following ER stress. Conclusion: Tyrosine 262 phosphorylation controls the cellular levels of GADD34, a key component of the stress-activated eIF2 phosphatase. Significance: Stress-induced GADD34 gene transcription and subsequent regulated GADD34 protein turnover control the feedback loop that ensures cell survival following ER stress. In mammalian cells, metabolic and environmental stress increases the phosphorylation of the eukaryotic translational initiation factor, eIF2, and attenuates global protein synthesis. Subsequent transcriptional activation of GADD34 assembles an eIF2 phosphatase that feeds back to restore mRNA translation. Active proteasomal degradation of GADD34 protein then reestablishes the sensitivity of cells to subsequent bouts of stress. Mass spectrometry established GADD34 phosphorylation on multiple serines, threonines, and tyrosines. Phosphorylation at tyrosine 262 enhanced the rate of the GADD34 protein turnover. Substrate-trapping studies identified TC-PTP (PTPN2) as a potential GADD34 phosphatase, recognizing phosphotyrosine 262. Reduced GADD34 protein levels in TC-PTP-null MEFs following ER stress emphasized the importance of TC-PTP in determining the cellular levels of GADD34 protein. The susceptibility of TC-PTP-null MEFs to ER stress-induced apoptosis was significantly ameliorated by ectopic expression of GADD34. The data suggested that GADD34 phosphorylation on tyrosine 262 modulates endoplasmic reticulum stress signaling and cell fate.	[Zhou, Wei; Jeyaraman, Krishna; Yusoff, Permeen; Shenolikar, Shirish] Duke NUS Grad Med Sch Singapore, Signature Res Program Cardiovasc & Metab Disorder, Singapore 169857, Singapore; [Shenolikar, Shirish] Duke NUS Grad Med Sch Singapore, Singapore 169857, Singapore; [Shenolikar, Shirish] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Shenolikar, Shirish] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	National University of Singapore; National University of Singapore; Duke University; Duke University	Shenolikar, S (corresponding author), Duke NUS Grad Med Sch, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 169857, Singapore.	shirish.shenolikar@duke-nus.edu.sg			Duke-NUS Graduate Medical School, Singapore; IRG grant from the National Medical Research Council, Singapore	Duke-NUS Graduate Medical School, Singapore; IRG grant from the National Medical Research Council, Singapore	This work was supported by funds from the Duke-NUS Graduate Medical School, Singapore and an IRG grant (to S. S.) from the National Medical Research Council, Singapore.	B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bettaieb A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034412; Bettaieb A, 2011, J BIOL CHEM, V286, P9225, DOI 10.1074/jbc.M110.186148; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Brush MH, 2008, MOL CELL BIOL, V28, P6989, DOI 10.1128/MCB.00724-08; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hollander MC, 2003, ONCOGENE, V22, P3827, DOI 10.1038/sj.onc.1206567; Hong M, 2005, J BIOL CHEM, V280, P16821, DOI 10.1074/jbc.M413753200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Panzhinskiy E, 2013, DIABETOLOGIA, V56, P598, DOI 10.1007/s00125-012-2782-z; Prahlad V, 2009, TRENDS CELL BIOL, V19, P52, DOI 10.1016/j.tcb.2008.11.002; Rechsteiner M, 1990, Semin Cell Biol, V1, P433; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Su Q, 2008, J BIOL CHEM, V283, P469, DOI 10.1074/jbc.M704612200; Wiede F, 2011, J CLIN INVEST, V121, P4758, DOI 10.1172/JCI59492; Zhang HM, 2010, MOL CELL PROTEOMICS, V9, P635, DOI 10.1074/mcp.M900314-MCP200; Zhou W, 2011, J BIOL CHEM, V286, P21687, DOI 10.1074/jbc.M110.212787; Zhu S, 2007, CANCER RES, V67, P10129, DOI 10.1158/0008-5472.CAN-06-4338	36	7	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33146	33155		10.1074/jbc.M113.504407	http://dx.doi.org/10.1074/jbc.M113.504407			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24092754	Green Published, hybrid			2022-12-25	WOS:000328841700030
J	He, QF; Fan, CH; Yu, M; Wallar, G; Zhang, ZF; Wang, LX; Zhang, XW; Hu, RY				He, Qingfang; Fan, Chunhong; Yu, Min; Wallar, Gina; Zhang, Zuo-Feng; Wang, Lixin; Zhang, Xinwei; Hu, Ruying			Associations of ACE Gene Insertion/Deletion Polymorphism, ACE Activity, and ACE mRNA Expression with Hypertension in a Chinese Population	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; BLOOD-PRESSURE; I/D POLYMORPHISM; DELETION; LINKAGE; SYSTEM; RISK; PCR	Background: The present study was designed to explore the association of angiotensin converting enzyme (ACE) gene insertion/deletion (I/D, rs4646994) polymorphism, plasma ACE activity, and circulating ACE mRNA expression with essential hypertension (EH) in a Chinese population. In addition, a new detection method for circulating ACE mRNA expression was explored. Methods: The research was approved by the ethics committee of Zhejiang Provincial Center for Disease Prevention and Control. Written informed consent was obtained prior to the investigation. 221 hypertensives (cases) and 221 normotensives (controls) were interviewed, subjected to a physical examination, and provided blood for biochemical and genetic tests. The ACE mRNA expression was analyzed by real time fluorescent quantitative Reverse Transcription PCR (FQ-RT-PCR). We performed logistic regression to assess associations of ACE I/D genotypes, ACE activity, and ACE mRNA expression levels with hypertension. Results: The results of the multivariate logistic regression analysis showed that the additive model (ID, DD versus II) of the ACE genotype revealed an association with hypertension with adjusted OR of 1.43(95% CI: 1.04-1.97), and ACE ID genotype with adjusted OR of 1.72(95% CI: 1.01-2.92), DD genotype with adjusted OR of 1.94(95% CI: 1.01-3.73), respectively. In addition, our data also indicate that plasma ACE activity (adjusted OR was 1.13(95% CI: 1.08-1.18)) was significantly related to hypertension. However, the plasma ACE mRNA expressions were not different between the cases and controls. Conclusion: ACE I/D polymorphism and ACE activity revealed significant influence on hypertension, while circulating ACE mRNA expression was not important factors associated with hypertension in this Chinese population. The detection of circulating ACE mRNA expression by FQ-RT-PCR might be a useful method for early screening and monitoring of EH.	[He, Qingfang; Yu, Min; Wang, Lixin; Zhang, Xinwei; Hu, Ruying] Zhejiang Prov Ctr Dis Prevent & Control, Hangzhou, Zhejiang, Peoples R China; [Fan, Chunhong] Zhejiang Med Coll, Hangzhou, Zhejiang, Peoples R China; [Wallar, Gina; Zhang, Zuo-Feng] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA	University of California System; University of California Los Angeles	Yu, M (corresponding author), Zhejiang Prov Ctr Dis Prevent & Control, Hangzhou, Zhejiang, Peoples R China.	minyuzj@gmail.com		Zhang, Zuo-Feng/0000-0002-4669-3995	Grand Science and Technology Projects of Zhejiang Province [2011C12032-1]; Medical and Health Science Research Fund of Zhejiang Province [2006A 019, 2007A 035, 2008 A034]; NATIONAL CANCER INSTITUTE [T32CA009142] Funding Source: NIH RePORTER	Grand Science and Technology Projects of Zhejiang Province; Medical and Health Science Research Fund of Zhejiang Province; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This paper was supported by Grand Science and Technology Projects of Zhejiang Province (project number 2011C12032-1) (http://www.zjkjt.gov.cn/), and by Medical and Health Science Research Fund of Zhejiang Province (project number 2006A 019, 2007A 035, and 2008 A034) (http://www.zjwst.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajala AR, 2012, AM J HYPERTENS, V25, P827, DOI 10.1038/ajh.2012.50; Ali A, 2012, J RENIN-ANGIO-ALDO S; Bernstein KE, 2006, HYPERTENSION, V47, P509, DOI 10.1161/01.HYP.0000196266.23639.c6; BONITHONKOPP C, 1994, CIRCULATION, V89, P952, DOI 10.1161/01.CIR.89.3.952; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Camos S, 2012, CLIN CHEM LAB MED, V50, P1749, DOI 10.1515/cclm-2012-0042; Cole JM, 2003, HYPERTENSION, V41, P313, DOI 10.1161/01.HYP.0000050650.52007.83; Danser AHJ, 2007, PHARMACOL THERAPEUT, V113, P607, DOI 10.1016/j.pharmthera.2006.12.001; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Ji LD, 2010, J HYPERTENS, V28, P419, DOI 10.1097/HJH.0b013e32833456b9; Jiang X, 2009, J HUM HYPERTENS, V23, P176, DOI 10.1038/jhh.2008.123; Kabadou IA, 2013, CLIN LAB, V59, P85, DOI 10.7754/Clin.Lab.2013.111105; Lely AT, 2007, CURR DIABETES REV, V3, P41, DOI 10.2174/157339907779802049; Ljungberg L, 2011, J RENIN-ANGIO-ALDO S, V12, P281, DOI 10.1177/1470320310391326; McKenzie CA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-23; Mizuiri S, 2001, KIDNEY INT, V60, P1124, DOI 10.1046/j.1523-1755.2001.0600031124.x; Nassar I, 2008, AM J HYPERTENS, V21, P200, DOI 10.1038/ajh.2007.38; Nawaz SK, 2009, BIOCHEM MEDICA, V19, P36; Oosterga M, 1997, CIRCULATION, V95, P2607, DOI 10.1161/01.CIR.95.12.2607; OVERLACK A, 1983, KLIN WOCHENSCHR, V61, P377, DOI 10.1007/BF01485031; Persu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059537; Rasyid Haerani, 2012, Acta Med Indones, V44, P280; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Sayed-Tabatabaei FA, 2006, CIRC RES, V98, P1123, DOI 10.1161/01.RES.0000223145.74217.e7; Smithies O, 2000, KIDNEY INT, V58, P2265, DOI 10.1046/j.1523-1755.2000.00411.x; Suehiro T, 2004, HUM GENET, V115, P91, DOI 10.1007/s00439-004-1136-4; Tascilar N, 2009, J NEUROL SCI, V285, P137, DOI 10.1016/j.jns.2009.06.016; TIRET L, 1992, AM J HUM GENET, V51, P197; Tsantes A.E., 2013, MINERVA ANESTESIOL; Zarouk WA, 2012, BRATISL MED J, V113, P14, DOI 10.4149/BLL_2012_003; Zhang CY, 2005, PROG BIOCHEM BIOPHYS, V32, P883; Zhu XF, 2000, AM J HUM GENET, V67, P1144; Zhu XF, 2001, AM J HUM GENET, V68, P1139, DOI 10.1086/320104	33	30	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75870	10.1371/journal.pone.0075870	http://dx.doi.org/10.1371/journal.pone.0075870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098401	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100023
J	Howard, BE; Hu, QW; Babaoglu, AC; Chandra, M; Borghi, M; Tan, XP; He, LY; Winter-Sederoff, H; Gassmann, W; Veronese, P; Heber, S				Howard, Brian E.; Hu, Qiwen; Babaoglu, Ahmet Can; Chandra, Manan; Borghi, Monica; Tan, Xiaoping; He, Luyan; Winter-Sederoff, Heike; Gassmann, Walter; Veronese, Paola; Heber, Steffen			High-Throughput RNA Sequencing of Pseudomonas-Infected Arabidopsis Reveals Hidden Transcriptome Complexity and Novel Splice Variants	PLOS ONE			English	Article							DEFENSE RESPONSES; IMMUNE-RESPONSE; GENE; RESISTANCE; PROTEINS; RPS4	We report the results of a genome-wide analysis of transcription in Arabidopsis thaliana after treatment with Pseudomonas syringae pathovar tomato. Our time course RNA-Seq experiment uses over 500 million read pairs to provide a detailed characterization of the response to infection in both susceptible and resistant hosts. The set of observed differentially expressed genes is consistent with previous studies, confirming and extending existing findings about genes likely to play an important role in the defense response to Pseudomonas syringae. The high coverage of the Arabidopsis transcriptome resulted in the discovery of a surprisingly large number of alternative splicing (AS) events - more than 44% of multi-exon genes showed evidence for novel AS in at least one of the probed conditions. This demonstrates that the Arabidopsis transcriptome annotation is still highly incomplete, and that AS events are more abundant than expected. To further refine our predictions, we identified genes with statistically significant changes in the ratios of alternative isoforms between treatments. This set includes several genes previously known to be alternatively spliced or expressed during the defense response, and it may serve as a pool of candidate genes for regulated alternative splicing with possible biological relevance for the defense response against invasive pathogens.	[Howard, Brian E.; Hu, Qiwen; Babaoglu, Ahmet Can; Heber, Steffen] N Carolina State Univ, Dept Comp Sci, Raleigh, NC 27695 USA; [Chandra, Manan; Borghi, Monica; Tan, Xiaoping; Veronese, Paola] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [He, Luyan; Winter-Sederoff, Heike] N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA; [Gassmann, Walter] Univ Missouri, Div Plant Sci, Columbia, MO USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Missouri System; University of Missouri Columbia	Howard, BE (corresponding author), N Carolina State Univ, Dept Comp Sci, Raleigh, NC 27695 USA.	itsbehoward@hotmail.com	Hu, Qiwen/A-8309-2019	Heber, Steffen/0000-0002-1050-3635; Gassmann, Walter/0000-0002-7527-0385; Borghi, Monica/0000-0003-1359-7611; Sederoff, Heike/0000-0002-0960-9678	National Science Foundation [IOS-0951512]; National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health [2T32ES007329-10]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007329] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by the National Science Foundation IOS-0951512 and by grant number 2T32ES007329-10 from the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Belhaj K, 2009, PLANT J, V58, P287, DOI 10.1111/j.1365-313X.2008.03779.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bove J, 2008, PLANT MOL BIOL, V67, P71, DOI 10.1007/s11103-008-9302-z; Chen ZY, 2000, MOL PLANT MICROBE IN, V13, P1312, DOI 10.1094/MPMI.2000.13.12.1312; Cui XF, 2007, PLANT CELL, V19, P1388, DOI 10.1105/tpc.107.051375; de Torres M, 2003, PLANT J, V33, P665, DOI 10.1046/j.1365-313X.2003.01653.x; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P1908, DOI 10.1073/pnas.020367497; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; English AC, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-102; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gassmann W, 2008, CURR TOP MICROBIOL, V326, P219; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hinsch M, 1996, MOL PLANT MICROBE IN, V9, P55, DOI 10.1094/MPMI-9-0055; Howard BE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S6; Jeong HJ, 2011, PLANT CELL PHYSIOL, V52, P2147, DOI 10.1093/pcp/pcr144; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawamura Y, 2009, PLANT CELL PHYSIOL, V50, P924, DOI 10.1093/pcp/pcp044; Kim SS, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-6; Knoth C, 2008, PLANT J, V55, P53, DOI 10.1111/j.1365-313X.2008.03486.x; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mamanova L, 2010, NAT METHODS, V7, P130, DOI [10.1038/NMETH.1417, 10.1038/nmeth.1417]; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Ner-Gaon H, 2004, PLANT J, V39, P877, DOI 10.1111/j.1365-313X.2004.02172.x; Nomura H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1926; Quirino BF, 2003, MOL PLANT PATHOL, V4, P517, DOI 10.1046/J.1364-3703.2003.00198.X; Rayson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031917; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rozen S, 2000, Methods Mol Biol, V132, P365; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Schenk PM, 2011, PLANT PHYSL BIOCH PP, V43, P997; Schilmiller AL, 2005, CURR OPIN PLANT BIOL, V8, P369, DOI 10.1016/j.pbi.2005.05.008; Tang DZ, 2005, PLANT J, V44, P245, DOI 10.1111/j.1365-313X.2005.02523.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Xu SH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002159; Zhang XC, 2007, PLANT PHYSIOL, V145, P1577, DOI 10.1104/pp.107.108720	45	56	61	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74183	10.1371/journal.pone.0074183	http://dx.doi.org/10.1371/journal.pone.0074183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098335	Green Submitted, gold, Green Published			2022-12-25	WOS:000325427100004
J	Li, HY; Chen, X; Guan, LZ; Qi, Q; Shu, G; Jiang, QY; Yuan, L; Xi, QY; Zhang, YL				Li, Hongyi; Chen, Xiao; Guan, Lizeng; Qi, Qien; Shu, Gang; Jiang, Qingyan; Yuan, Li; Xi, Qianyun; Zhang, Yongliang			MiRNA-181a Regulates Adipogenesis by Targeting Tumor Necrosis Factor-alpha (TNF-alpha) in the Porcine Model	PLOS ONE			English	Article							ADIPOCYTE GENE-EXPRESSION; STIMULATES LIPOLYSIS; NEGATIVE REGULATOR; ADIPOSE-TISSUE; PPAR-GAMMA; DIFFERENTIATION; MICRORNAS; TRANSCRIPTION; ACTIVATION; REPRESSION	Adipogenesis is tightly regulated by altering gene expression, and TNF-alpha is a multifunctional cytokine that plays an important role in regulating lipogenesis. MicroRNAs are strong post-transcriptional regulators of cell differentiation. In our previous work, we found high expression of miR-181a in a fat-rich pig breed. Using bioinformatic analysis, miR-181a was identified as a potential regulator of TNF-alpha. Here, we validated TNF-alpha as the target of miR-181a by a dual luciferase assay. In response to adipogenesis, a mimic or inhibitor was used to overexpress or reduce miR-181a expression in porcine pre-adipocytes, which were then induced into mature adipocytes. Overexpression of miR-181a accelerated accumulation of lipid droplets, increased the amount of triglycerides, and repressed TNF-alpha protein expression, while the inhibitor had the opposite effect. At the same time, TNF-alpha rescued the increased lipogenesis by miR181a mimics. Additionally, miR-181a suppression decreased the expression of fatty synthesis associated genes PDE3B (phosphodiesterase 3B), LPL (lipoprotein lipase), PPAR gamma (proliferator-activated receptor-gamma), GLUT1(glucose transporter), GLUT4, adiponectin and FASN (fatty acid synthase), as well as key lipolytic genes HSL (hormone-sensitive lipase) and ATGL (adipose triglyceride lipase) as revealed by quantitative real-time PCR. Our study provides the first evidence of the role of miR-181a in adipocyte differentiation by regulation of TNF-alpha, which may became a new therapeutic target for anti-obesity drugs.	[Li, Hongyi; Chen, Xiao; Guan, Lizeng; Qi, Qien; Shu, Gang; Jiang, Qingyan; Yuan, Li; Xi, Qianyun; Zhang, Yongliang] South China Agr Univ, ALLTECH SCAU Anim Nutr Control Res Alliance, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China; [Li, Hongyi] Longyan Univ, Coll Life Sci, Fujian Prov Key Lab Prevent Vet Med & Biotechnol, Fuzhou, Fujian, Peoples R China; [Yuan, Li] Xiamen Univ, Coll Life Sci, Xiamen, Peoples R China	South China Agricultural University; Longyan University; Xiamen University	Xi, QY (corresponding author), South China Agr Univ, ALLTECH SCAU Anim Nutr Control Res Alliance, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China.	xqy0228@scau.edu.cn; zhangyl@scau.edu.cn			Chinese Key Basic Plan [2009CB941600]; Chinese 973 Plan [2011CB944202]; Chinese Transgenic breeding Key Project [2014ZX08009-048B]; National Natural Science Foundation of China [31072105]	Chinese Key Basic Plan; Chinese 973 Plan(National Basic Research Program of China); Chinese Transgenic breeding Key Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese Key Basic Plan (No. 2009CB941600), Chinese 973 Plan (2011CB944202); the Chinese Transgenic breeding Key Project, (2014ZX08009-048B); and the National Natural Science Foundation of China (31072105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2010, EXP CELL RES, V316, P1681, DOI 10.1016/j.yexcr.2010.04.002; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BEUTLER B, 1985, NATURE, V316, P552, DOI 10.1038/316552a0; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Coenen KR, 2007, DIABETES, V56, P564, DOI 10.2337/db06-1375; Dodson MV, 2010, J FOOD SCI, V75, pR1, DOI 10.1111/j.1750-3841.2009.01396.x; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; German AJ, 2010, VET J, V185, P4, DOI 10.1016/j.tvjl.2010.04.004; Jain RG, 1999, J CELL PHYSIOL, V179, P58, DOI 10.1002/(SICI)1097-4652(199904)179:1<58::AID-JCP8>3.0.CO;2-1; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; KAWAKAMI M, 1987, J BIOCHEM-TOKYO, V101, P331, DOI 10.1093/oxfordjournals.jbchem.a121917; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kinoshita M, 2010, MOL ENDOCRINOL, V24, P1978, DOI 10.1210/me.2010-0054; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lee EK, 2010, MOL CELL BIOL, V31, P626; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Liu M, 2011, INT J ONCOL, V38, P1013, DOI 10.3892/ijo.2011.924; Loftus TM, 1997, CURR OPIN GENET DEV, V7, P603, DOI 10.1016/S0959-437X(97)80006-8; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; Ouyang YB, 2012, NEUROBIOL DIS, V45, P555, DOI 10.1016/j.nbd.2011.09.012; Poulos SP, 2010, MOL CELL ENDOCRINOL, V323, P20, DOI 10.1016/j.mce.2009.12.011; Qadir AS, 2011, BIOCHEM BIOPH RES CO, V408, P399, DOI 10.1016/j.bbrc.2011.04.029; RIO P, 2012, BLOOD; Romao JM, 2011, EXP BIOL MED, V236, P997, DOI 10.1258/ebm.2011.011101; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Stenvang Jan, 2012, Silence, V3, P1, DOI 10.1186/1758-907X-3-1; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Takada I, 2009, EXPERT OPIN THER TAR, V13, P593, DOI [10.1517/14728220902915310 , 10.1517/14728220902915310]; TORTI FM, 1985, SCIENCE, V229, P867, DOI 10.1126/science.3839597; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; WANG Z, 2009, MICRORNA INTERFERENC, P127, DOI DOI 10.1007/978-3-642-00489-6_7; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xie YF, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-20; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhao J, 2012, J IMMUNOL, V188, P1266, DOI 10.4049/jimmunol.1101976; Zhou GX, 2010, MEAT SCI, V86, P440, DOI 10.1016/j.meatsci.2010.05.031	53	88	101	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e71568	10.1371/journal.pone.0071568	http://dx.doi.org/10.1371/journal.pone.0071568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098322	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100002
J	Wiegering, A; Pfann, C; Uthe, FW; Otto, C; Rycak, L; Mader, U; Gasser, M; Waaga-Gasser, AM; Eilers, M; Germer, CT				Wiegering, Armin; Pfann, Christina; Uthe, Friedrich Wilhelm; Otto, Christoph; Rycak, Lukas; Maeder, Uwe; Gasser, Martin; Waaga-Gasser, Anna-Maria; Eilers, Martin; Germer, Christoph-Thomas			CIP2A Influences Survival in Colon Cancer and Is Critical for Maintaining Myc Expression	PLOS ONE			English	Article							INDUCED APOPTOSIS; UP-REGULATION; TRANSFORMATION; INHIBITOR; MIR-34A; PP2A	The cancerous inhibitor of protein phosphatase 2A (CIP2A) is an oncogenic factor that stabilises the c-Myc protein. CIP2A is overexpressed in several tumours, and expression levels are an independent marker for long-term outcome. To determine whether CIP2A expression is elevated in colon cancer and whether it might serve as a prognostic marker for survival, we analysed CIP2A mRNA expression by real-time PCR in 104 colon cancer samples. CIP2A mRNA was overexpressed in colon cancer samples and CIP2A expression levels correlated significantly with tumour stage. We found that CIP2A serves as an independent prognostic marker for disease-free and overall survival. Further, we investigated CIP2A-dependent effects on levels of c-Myc, Akt and on cell proliferation in three colon cancer cell lines by silencing CIP2A using small interfering (si) and short hairpin (sh) RNAs. Depletion of CIP2A substantially inhibited growth of colon cell lines and reduced c-Myc levels without affecting expression or function of the upstream regulatory kinase, Akt. Expression of CIP2A was found to be dependent on MAPK activity, linking elevated c-Myc expression to deregulated signal transduction in colon cancer.	[Wiegering, Armin; Otto, Christoph; Gasser, Martin; Waaga-Gasser, Anna-Maria; Germer, Christoph-Thomas] Univ Hosp Wuerzburg, Dept Gen Visceral Vasc & Paediat Surg, Dept Surg 1, Wurzburg, Germany; [Wiegering, Armin; Pfann, Christina; Uthe, Friedrich Wilhelm; Eilers, Martin] Univ Wurzburg, Dept Biochem & Mol Biol, D-97070 Wurzburg, Germany; [Rycak, Lukas] Univ Marburg, Inst Mol Biol & Tumor Res, Marburg, Germany; [Maeder, Uwe; Eilers, Martin; Germer, Christoph-Thomas] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; Philipps University Marburg; University of Wurzburg	Wiegering, A (corresponding author), Univ Hosp Wuerzburg, Dept Gen Visceral Vasc & Paediat Surg, Dept Surg 1, Wurzburg, Germany.	wiegering_a@chirurgie.uni-wuerzburg.de	; Wiegering, Armin/X-7541-2018	Eilers, Martin/0000-0002-0376-6533; Wiegering, Armin/0000-0001-7777-0909	university of Wurburg [IZKF B-186]; German Research Foundation (DFG); University of Wuerzburg	university of Wurburg; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	AW has funding from the university of Wurburg for a screen in comparison with APC the funding number is: IZKF B-186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript for this study. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. No current external other funding sources for this study.	Bockelman C, 2011, BRIT J CANCER, V105, P989, DOI 10.1038/bjc.2011.346; Bockelman C, 2012, CANC BIOL THER; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [DOI 10.1038/NATURE11252, 10.1038/nature11252]; Chen KF, 2011, MOL CANCER THER, V10, P892, DOI 10.1158/1535-7163.MCT-10-0794; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Fukazawa H, 2000, CANCER RES, V60, P2104; Huang CY, 2012, CANCER LETT, V317, P9, DOI 10.1016/j.canlet.2011.11.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Lin YC, 2012, ORAL ONCOL, V48, P585, DOI 10.1016/j.oraloncology.2012.01.012; Liu J, 2011, GYNECOL ONCOL, V122, P430, DOI 10.1016/j.ygyno.2011.04.031; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lucas CM, 2011, BLOOD, V117, P6660, DOI 10.1182/blood-2010-08-304477; Ren J, 2011, BRIT J CANCER, V105, P1905, DOI 10.1038/bjc.2011.492; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Teng HW, 2012, J GASTROINTEST SURG; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhao DP, 2010, J MED MICROBIOL, V59, P259, DOI 10.1099/jmm.0.014704-0	22	34	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75292	10.1371/journal.pone.0075292	http://dx.doi.org/10.1371/journal.pone.0075292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098375	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100018
J	Cejudo-Roman, A; Pinto, FM; Subiran, N; Ravina, CG; Fernandez-Sanchez, M; Perez-Hernandez, N; Perez, R; Pacheco, A; Irazusta, J; Candenas, L				Cejudo-Roman, Antonio; Pinto, Francisco M.; Subiran, Nerea; Ravina, Cristina G.; Fernandez-Sanchez, Manuel; Perez-Hernandez, Natalia; Perez, Ricardo; Pacheco, Alberto; Irazusta, Jon; Candenas, Luz			The Voltage-Gated Sodium Channel Na(v)1.8 Is Expressed in Human Sperm	PLOS ONE			English	Article							HUMAN SPERMATOZOA; CATSPER CHANNEL; MALE-FERTILITY; CA2+ CHANNEL; CAPACITATION; DIVERSITY; CALCIUM; TACHYKININS; ACTIVATION; PRINCIPAL	The role of Na+ fluxes through voltage-gated sodium channels in the regulation of sperm cell function remains poorly understood. Previously, we reported that several genes encoding voltage-gated Na+ channels were expressed in human testis and mature spermatozoa. In this study, we analyzed the presence and function of the TTX-resistant VGSC a subunit Na(v)1.8 in human capacitated sperm cells. Using an RT-PCR assay, we found that the mRNA of the gene SCN10A, that encode Na-v1.8, was abundantly and specifically expressed in human testis and ejaculated spermatozoa. The Na-v1.8 protein was detected in capacitated sperm cells using three different specific antibodies against this channel. Positive immunoreactivity was mainly located in the neck and the principal piece of the flagellum. The presence of Na-v1.8 in sperm cells was confirmed by Western blot. Functional studies demonstrated that the increases in progressive motility produced by veratridine, a voltage-gated sodium channel activator, were reduced in sperm cells preincubated with TTX (10 mu M), the Na-v1.8 antagonist A-803467, or a specific Na-v1.8 antibody. Veratridine elicited similar percentage increases in progressive motility in sperm cells maintained in Ca2+-containing or Ca2+-free solution and did not induce hyperactivation or the acrosome reaction. Veratridine caused a rise in sperm intracellular Na+, [Na+](i), and the sustained phase of the response was inhibited in the presence of A-803467. These results verify that the Na+ channel Na-v1.8 is present in human sperm cells and demonstrate that this channel participates in the regulation of sperm function.	[Cejudo-Roman, Antonio; Pinto, Francisco M.; Perez-Hernandez, Natalia; Perez, Ricardo; Candenas, Luz] Univ Seville, CSIC, IIQ, Seville, Spain; [Subiran, Nerea; Irazusta, Jon] Univ Basque Country, Fac Med & Odontol, Dept Fisiol, Leioa, Bizkaia, Spain; [Ravina, Cristina G.; Fernandez-Sanchez, Manuel] Inst Valenciano Infertilidad, Seville, Spain; [Pacheco, Alberto] Inst Madrileno Infertilidad, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ); University of Basque Country; University of Valencia	Candenas, L (corresponding author), Univ Seville, CSIC, IIQ, Seville, Spain.	luzcandenas@iiq.csic.es	Irazusta, Jon/ABB-1237-2020; Pinto, Francisco M./P-4995-2014; Subirán, Nerea/AAA-4395-2019; Perez-Afonso, Ricardo/L-5566-2015; Fernández-Sánchez, Manuel/O-6336-2018; Candenas, L./P-3247-2014; irazusta, Jon/H-8568-2015	Pinto, Francisco M./0000-0001-9694-9816; Subirán, Nerea/0000-0001-9202-1287; Fernández-Sánchez, Manuel/0000-0002-1214-2984; Candenas, L./0000-0001-7886-1095; Irazusta, Jon/0000-0002-6763-8602	Junta de Andalucia [P08-CVI-04185]; Ministerio de Economia y Competitividad, Spain [CTQ2011-25564]; European Union	Junta de Andalucia(Junta de Andalucia); Ministerio de Economia y Competitividad, Spain; European Union(European Commission)	This work was financially supported by grants from Junta de Andalucia (P08-CVI-04185) and Ministerio de Economia y Competitividad (CTQ2011-25564), Spain, with joint financing by FEDER and FSE funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Baldi E, 2009, MOL CELL ENDOCRINOL, V308, P39, DOI 10.1016/j.mce.2009.02.006; Battistone MA, 2013, MOL HUM REPROD, V19, P570, DOI 10.1093/molehr/gat033; Brenker C, 2012, EMBO J, V31, P1654, DOI 10.1038/emboj.2012.30; Candenas L, 2006, EUR J PHARMACOL, V541, P9, DOI 10.1016/j.ejphar.2006.04.025; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chang HX, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096578; Chang HX, 2011, BIOL REPROD, V85, P296, DOI 10.1095/biolreprod.110.089789; Chavez JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060578; Chen WY, 2009, BIOL REPROD, V80, P115, DOI 10.1095/biolreprod.108.068528; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Escoffier J, 2012, J CELL SCI, V125, P473, DOI 10.1242/jcs.093344; Garcia MA, 1999, MOL REPROD DEV, V52, P189, DOI 10.1002/(SICI)1098-2795(199902)52:2<189::AID-MRD10>3.0.CO;2-D; Garolla A, 2013, FERTIL STERIL, V99, P125, DOI 10.1016/j.fertnstert.2012.09.006; Garrido N, 2008, REPROD BIOMED ONLINE, V17, P855, DOI 10.1016/S1472-6483(10)60415-4; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Jimenez-Gonzalez MC, 2007, J CELL PHYSIOL, V213, P801, DOI 10.1002/jcp.21153; Kwon WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054192; Kwon WS, 2013, FERTIL STERIL, V99, P354, DOI 10.1016/j.fertnstert.2012.09.021; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Mahfouz R, 2010, FERTIL STERIL, V94, P2141, DOI 10.1016/j.fertnstert.2009.12.030; McGaraughty S, 2008, J PHARMACOL EXP THER, V324, P1204, DOI 10.1124/jpet.107.134148; O'Brien BJ, 2008, J COMP NEUROL, V508, P940, DOI 10.1002/cne.21701; Page NM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-4; Patak E, 2003, BRIT J PHARMACOL, V139, P523, DOI 10.1038/sj.bjp.0705279; Pinto FM, 2012, INT J ANDROL, V35, P63, DOI 10.1111/j.1365-2605.2011.01177.x; Pinto FM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-71; Plummer NW, 1999, GENOMICS, V57, P323, DOI 10.1006/geno.1998.5735; Publicover SJ, 2008, FRONT BIOSCI, V13, P5623; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Ravina CG, 2007, HUM REPROD, V22, P1617, DOI 10.1093/humrep/dem069; Rossato M, 2001, MOL HUM REPROD, V7, P119, DOI 10.1093/molehr/7.2.119; Smith JF, 2013, P NATL ACAD SCI USA, V110, P6823, DOI 10.1073/pnas.1216588110; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Torres-Flores V, 2011, HUM REPROD, V26, P2626, DOI 10.1093/humrep/der237; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verkerk AO, 2012, CIRC RES, V111, P333, DOI 10.1161/CIRCRESAHA.112.274035; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108	43	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76084	10.1371/journal.pone.0076084	http://dx.doi.org/10.1371/journal.pone.0076084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086692	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900079
J	Predescu, S; Knezevic, I; Bardita, C; Neamu, RF; Brovcovych, V; Predescu, D				Predescu, Sanda; Knezevic, Ivana; Bardita, Cristina; Neamu, Radu Florin; Brovcovych, Viktor; Predescu, Dan			Platelet Activating Factor-Induced Ceramide Micro-Domains Drive Endothelial NOS Activation and Contribute to Barrier Dysfunction	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; VASCULAR-PERMEABILITY; ENOS PHOSPHORYLATION; FACTOR PAF; CELLS; MEMBRANE; CAVEOLAE; RELEASE; PROTEIN; PULMONARY	The spatial and functional relationship between platelet activating factor-receptor (PAF-R) and nitric oxide synthase (eNOS) in the lateral plane of the endothelial plasma membrane is poorly characterized. In this study, we used intact mouse pulmonary endothelial cells (ECs) as well as endothelial plasma membrane patches and subcellular fractions to define a new microdomain of plasmalemma proper where the two proteins colocalize and to demonstrate how PAF-mediated nitric oxide (NO) production fine-tunes ECs function as gatekeepers of vascular permeability. Using fluorescence microscopy and immunogold labeling electron microscopy (EM) on membrane patches we demonstrate that PAF-R is organized as clusters and colocalizes with a subcellular pool of eNOS, outside recognizable vesicular profiles. Moreover, PAF-induced acid sphingomyelinase activation generates a ceramide-based microdomain on the external leaflet of plasma membrane, inside of which a signalosome containing eNOS shapes PAF-stimulated NO production. Real-time measurements of NO after PAF-R ligation indicated a rapid (5 to 15 min) increase in NO production followed by a > 45 min period of reduction to basal levels. Moreover, at the level of this new microdomain, PAF induces a dynamic phosphorylation/dephosphorylation of Ser, Thr and Tyr residues of eNOS that correlates with NO production. Altogether, our findings establish the existence of a functional partnership PAF-R/eNOS on EC plasma membrane, at the level of PAF-induced ceramide plasma membrane microdomains, outside recognized vesicular profiles.	[Predescu, Sanda; Knezevic, Ivana; Bardita, Cristina; Predescu, Dan] Rush Univ, Div Pulm & Crit Care, Dept Med & Pharmacol, Chicago, IL 60612 USA; [Neamu, Radu Florin] Emory Univ, Sch Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA USA; [Brovcovych, Viktor] Univ Illinois, Dept Pharmacol, Chicago, IL USA	Rush University; Emory University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Predescu, D (corresponding author), Rush Univ, Div Pulm & Crit Care, Dept Med & Pharmacol, Chicago, IL 60612 USA.	Dan_Predescu@rush.edu		Predescu, Sanda/0000-0002-9386-6756	National Institute of Health [HLO95430]; Rush University; American Heart Association [SDG0635175N]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rush University; American Heart Association(American Heart Association)	This work was supported by National Institute of Health grant HLO95430 to D. Predescu, start-up funds from Rush University and American Heart Association grant SDG0635175N to Sanda Predescu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andries LJ, 1998, CIRC RES, V82, P195; Axelrad TW, 2004, FASEB J, V18, P568, DOI 10.1096/fj.03-0479fje; BENVENISTE J, 1989, ADV PROSTAG THROMB L, V19, P355; BJORK J, 1983, EUR J PHARMACOL, V96, P87, DOI 10.1016/0014-2999(83)90532-0; Boo YC, 2006, FREE RADICAL BIO MED, V41, P144, DOI 10.1016/j.freeradbiomed.2006.03.024; BROCK TA, 1986, AM J PHYSIOL, V250, P1086, DOI 10.1152/ajpheart.1986.250.6.H1086; Brovkovych V, 1999, J PHARMACEUT BIOMED, V19, P135, DOI 10.1016/S0731-7085(98)00090-9; Bulotta S, 2006, EXP CELL RES, V312, P877, DOI 10.1016/j.yexcr.2005.12.014; BUSSOLINO F, 1994, J BIOL CHEM, V269, P2877; BUSSOLINO F, 1987, J IMMUNOL, V139, P2439; CAMUSSI G, 1983, INT ARCH ALLER A IMM, V70, P245, DOI 10.1159/000233331; CAMUSSI G, 1983, J IMMUNOL, V131, P2397; CHIGNARD M, 1979, NATURE, V279, P799, DOI 10.1038/279799a0; COOPER JA, 1987, J APPL PHYSIOL, V62, P1076, DOI 10.1152/jappl.1987.62.3.1076; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Duran WN, 2010, CARDIOVASC RES, V87, P254, DOI 10.1093/cvr/cvq139; Duran WN, 2000, MICROVASC RES, V60, P104, DOI 10.1006/mvre.2000.2250; Feron O, 1998, BIOCHEMISTRY-US, V37, P193, DOI 10.1021/bi972307p; Fleming I, 2010, PFLUG ARCH EUR J PHY, V459, P793, DOI 10.1007/s00424-009-0767-7; FOLDESFILEP E, 1987, BIOCHEM BIOPH RES CO, V148, P1412; Fulton D, 2008, CIRC RES, V102, P497, DOI 10.1161/CIRCRESAHA.107.162933; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Gorodeski GI, 2000, AM J PHYSIOL-CELL PH, V278, pC942, DOI 10.1152/ajpcell.2000.278.5.C942; Govers R, 2002, BIOCHEM J, V361, P193, DOI 10.1042/0264-6021:3610193; GRIGORIAN GY, 1987, CIRC RES, V61, P389, DOI 10.1161/01.RES.61.3.389; Haberkant P, 2008, J LIPID RES, V49, P251, DOI 10.1194/jlr.D700023-JLR200; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Heijnen HFG, 2004, J HISTOCHEM CYTOCHEM, V52, P1277, DOI 10.1369/jhc.4A6307.2004; Hickey MJ, 1997, EXP PHYSIOL, V82, P339, DOI 10.1113/expphysiol.1997.sp004029; HUMPHREY DM, 1984, LAB INVEST, V50, P16; Ihida K, 1999, J CELL SCI, V112, P285; Jacobson Julie, 2002, J Extra Corpor Technol, V34, P144; Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, pC1024, DOI 10.1152/ajpcell.00162.2005; Knezevic II, 2009, J BIOL CHEM, V284, P5381, DOI 10.1074/jbc.M808958200; Kojima H, 1998, CHEM PHARM BULL, V46, P373; Korzeniowski M, 2007, CELL PHYSIOL BIOCHEM, V20, P347, DOI 10.1159/000107520; Kuebler WM, 2010, CELL PHYSIOL BIOCHEM, V26, P29, DOI 10.1159/000315103; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; KURZCHALIA T, 1995, TRENDS CELL BIOL, V5, P187, DOI 10.1016/S0962-8924(00)88990-4; Lachmanovich E, 2003, J MICROSC-OXFORD, V212, P122, DOI 10.1046/j.1365-2818.2003.01239.x; Liu JW, 1996, BIOCHEMISTRY-US, V35, P13277, DOI 10.1021/bi961720e; MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674; Marrache AM, 2002, J IMMUNOL, V169, P6474, DOI 10.4049/jimmunol.169.11.6474; Michel T, 1999, BRAZ J MED BIOL RES, V32, P1361, DOI 10.1590/S0100-879X1999001100006; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Poisson C, 2009, J IMMUNOL, V183, P2747, DOI 10.4049/jimmunol.0802651; Predescu D, 1996, EUR J CELL BIOL, V69, P86; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; Predescu D, 1998, P NATL ACAD SCI USA, V95, P6175, DOI 10.1073/pnas.95.11.6175; PREDESCU D, 1994, P NATL ACAD SCI USA, V91, P3014, DOI 10.1073/pnas.91.8.3014; Predescu SA, 1997, AM J PHYSIOL-HEART C, V272, pH937, DOI 10.1152/ajpheart.1997.272.2.H937; Predescu SA, 2005, J BIOL CHEM, V280, P37130, DOI 10.1074/jbc.M505659200; Predescu SA, 2001, MOL BIOL CELL, V12, P1019, DOI 10.1091/mbc.12.4.1019; PRESCOTT SM, 1984, P NATL ACAD SCI-BIOL, V81, P3534, DOI 10.1073/pnas.81.11.3534; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Quest AFG, 2004, BIOCHEM CELL BIOL, V82, P129, DOI 10.1139/o03-071; Reiner M, 2001, J HISTOCHEM CYTOCHEM, V49, P1605, DOI 10.1177/002215540104901214; Sakoda T, 1995, MOL CELL BIOCHEM, V152, P143, DOI 10.1007/BF01076076; Sanchez FA, 2011, J BIOL CHEM, V286, P30409, DOI 10.1074/jbc.M111.234294; SESSA WC, 1993, CIRC RES, V72, P921, DOI 10.1161/01.RES.72.4.921; Singla S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-46; Sirois MG, 1997, AM J PHYSIOL-HEART C, V272, pH2746, DOI 10.1152/ajpheart.1997.272.6.H2746; Sot J, 2006, BIOPHYS J, V90, P903, DOI 10.1529/biophysj.105.067710; STOLZ DB, 1992, J CELL SCI, V103, P39; Walford G, 2003, J THROMB HAEMOST, V1, P2112, DOI 10.1046/j.1538-7836.2003.00345.x; Yang Y, 2010, EUR RESPIR J, V36, P417, DOI 10.1183/09031936.00095609; Zhang J, 2006, MICRON, V37, P14, DOI 10.1016/j.micron.2005.03.014	69	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75846	10.1371/journal.pone.0075846	http://dx.doi.org/10.1371/journal.pone.0075846			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086643	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900063
J	Rognoni, P; Lavatelli, F; Casarini, S; Palladini, G; Verga, L; Pedrazzoli, P; Valentini, G; Merlini, G; Perfetti, V				Rognoni, Paola; Lavatelli, Francesca; Casarini, Simona; Palladini, Giovanni; Verga, Laura; Pedrazzoli, Paolo; Valentini, Giovanna; Merlini, Giampaolo; Perfetti, Vittorio			A Strategy for Synthesis of Pathogenic Human Immunoglobulin Free Light Chains in E-coli	PLOS ONE			English	Article							GERMLINE GENE; PROTEINS; AMYLOIDOSIS; INVOLVEMENT; DYSFUNCTION; EXPRESSION; REGION; SERUM	Monoclonal immunoglobulin light chains are normally synthesized in excess compared to the heavy chain partners and can be detected in serum and urine ("free" LC). Occasionally free LC are per se cause of organ toxicity, as in free LC-related disorders. In AL amyloidosis, the most common of these conditions, free LC with peculiar biophysical properties related to their primary structure damage target organs and organize in amyloid fibrils. Unlimited availability of well-characterized free LC is instrumental to investigate the toxic effect of these proteins and to study their interactions with targets. We present a straightforward strategy to obtain recombinant monoclonal free LC by using a bacterial system. These proteins, expressed as inclusion bodies, were subjected to solubilization and refolding procedures to recover them in native form. To minimize differences from the circulating natural LC, full-length recombinant LC were expressed, i.e. complete of variable and constant regions, with the original amino acid sequence along the entire protein, and with no purification tags. The strategy was exploited to generate free LC from three AL amyloidosis patients. After purification, recombinant proteins were biochemically characterized and compared to the natural Bence Jones protein isolated from one of the patients. Results showed that the recombinant free LC were properly folded and formed homodimers in solution, similar to the natural Bence Jones protein used for comparison. Furthermore, as proof of pathogenicity, recombinant proteins formed amyloid fibrils in vitro. We believe that the present strategy represents a valuable tool to speed research in free LC-related disorders.	[Rognoni, Paola; Lavatelli, Francesca; Casarini, Simona; Palladini, Giovanni; Merlini, Giampaolo; Perfetti, Vittorio] Fdn IRCCS Policlin S Matteo, Amyloidosis Res & Treatment Ctr, Pavia, Italy; [Rognoni, Paola; Lavatelli, Francesca; Casarini, Simona; Palladini, Giovanni; Merlini, Giampaolo; Perfetti, Vittorio] Fdn IRCCS Policlin S Matteo, Biotechnol Res Labs, Pavia, Italy; [Rognoni, Paola; Lavatelli, Francesca; Casarini, Simona; Palladini, Giovanni; Merlini, Giampaolo; Perfetti, Vittorio] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Verga, Laura] Fdn IRCCS Policlin S Matteo, Pathol Unit, Pavia, Italy; [Pedrazzoli, Paolo] Fdn IRCCS Policlin S Matteo, Sect Oncol, Dept Hematol & Oncol, Pavia, Italy; [Valentini, Giovanna] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of Pavia	Perfetti, V (corresponding author), Fdn IRCCS Policlin S Matteo, Sect Oncol, Dept Hematol & Oncol, Pavia, Italy.	v.perfetti@smatteo.pv.it	Palladini, Giovanni/G-1763-2010; Verga, Laura/AAG-5105-2020; Rognoni, Paola/P-9092-2019; Perfetti, Vittorio/B-6795-2014; Lavatelli, Francesca/K-5741-2016; Pedrazzoli, Paolo/AAB-8690-2019; Merlini, Giampaolo/A-3817-2008	Palladini, Giovanni/0000-0001-5994-5138; Rognoni, Paola/0000-0001-6350-1919; Perfetti, Vittorio/0000-0003-4690-4892; Lavatelli, Francesca/0000-0002-7693-4825; Pedrazzoli, Paolo/0000-0002-9419-7160; Merlini, Giampaolo/0000-0001-7680-3254	Fondazione IRCCS Policlinico San Matteo by AIRC (Associazione Italiana per la Ricerca sul Cancro) [9965]; Italian Ministry of Health [GR-2010-2317596]; Amyloid Foundation; Fondazione Mintas, Ghislieri College, Pavia	Fondazione IRCCS Policlinico San Matteo by AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Amyloid Foundation; Fondazione Mintas, Ghislieri College, Pavia	This work was supported by Fondazione IRCCS Policlinico San Matteo, Grant 2009-2012 by AIRC (Associazione Italiana per la Ricerca sul Cancro) Special Program Molecular Clinical Oncology 5 per mille n. 9965, Italian Ministry of Health (GR-2010-2317596), Amyloid Foundation and Fondazione Mintas, Ghislieri College, Pavia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RS, 2003, BLOOD, V101, P3801, DOI 10.1182/blood-2002-09-2707; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Bradwell AR, 2001, CLIN CHEM, V47, P673; Brenner DA, 2004, CIRC RES, V94, P1008, DOI 10.1161/01.RES.0000126569.75419.74; BUCHNER J, 1991, BIO-TECHNOL, V9, P157, DOI 10.1038/nbt0291-157; Clark ED, 1999, METHOD ENZYMOL, V309, P217; Colombo R, 2009, ELECTROPHORESIS, V30, P1418, DOI 10.1002/elps.200800377; Comenzo RL, 2001, BLOOD, V98, P714, DOI 10.1182/blood.V98.3.714; Connors LH, 2007, BIOCHEMISTRY-US, V46, P14259, DOI 10.1021/bi7013773; Honegger A, 2001, J MOL BIOL, V309, P687, DOI 10.1006/jmbi.2001.4664; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Klimtchuk ES, 2010, BIOCHEMISTRY-US, V49, P9848, DOI 10.1021/bi101351c; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Lavatelli F, 2011, BBA-PROTEINS PROTEOM, V1814, P409, DOI 10.1016/j.bbapap.2010.12.012; Levinson RT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01278; Liao RL, 2001, CIRCULATION, V104, P1594, DOI 10.1161/circ.104.14.1594; Lilie H, 1998, CURR OPIN BIOTECH, V9, P497, DOI 10.1016/S0958-1669(98)80035-9; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Merlini G, 2006, BLOOD, V108, P2520, DOI 10.1182/blood-2006-03-001164; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Omtvedt LA, 2000, AMYLOID, V7, P227, DOI 10.3109/13506120009146437; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Palladini G, 2006, BLOOD, V107, P3854, DOI 10.1182/blood-2005-11-4385; Perfetti V, 2002, BLOOD, V100, P948, DOI 10.1182/blood-2002-01-0114; Perfetti V, 1996, ANAL BIOCHEM, V239, P107, DOI 10.1006/abio.1996.0297; Perfetti V, 2012, BLOOD, V119, P144, DOI 10.1182/blood-2011-05-355784; Raffen R, 1999, PROTEIN SCI, V8, P509; Ren RY, 2010, J BIOL CHEM, V285, P37672, DOI 10.1074/jbc.M110.149575; SAXENA VP, 1970, BIOCHEMISTRY-US, V9, P5015; Shi JR, 2010, P NATL ACAD SCI USA, V107, P4188, DOI 10.1073/pnas.0912263107; SKERRA A, 1993, CURR OPIN IMMUNOL, V5, P256, DOI 10.1016/0952-7915(93)90014-J; SOLOMON A, 1985, METHOD ENZYMOL, V116, P101; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j	36	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76022	10.1371/journal.pone.0076022	http://dx.doi.org/10.1371/journal.pone.0076022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086679	gold, Green Submitted, Green Published			2022-12-25	WOS:000325223900071
J	Kamsu, JM; Constans, JM; Lamberton, F; Courtheoux, P; Denise, P; Philoxene, B; Coquemont, M; Besnard, S				Kamsu, Jeanine Manuella; Constans, Jean-Marc; Lamberton, Franck; Courtheoux, Patrick; Denise, Pierre; Philoxene, Bruno; Coquemont, Maelle; Besnard, Stephane			Structural Layers of Ex Vivo Rat Hippocampus at 7T MRI	PLOS ONE			English	Article							MAGNETIC-RESONANCE MICROSCOPY; MOUSE-BRAIN; ALZHEIMERS-DISEASE; ANIMAL MRI; IN-VIVO; MEMORY; VOLUME; SEGMENTATION; MANGANESE; HISTOLOGY	Magnetic resonance imaging (MRI) applied to the hippocampus is challenging in studies of the neurophysiology of memory and the physiopathology of numerous diseases such as epilepsy, Alzheimer's disease, ischemia, and depression. The hippocampus is a well-delineated cerebral structure with a multi-layered organization. Imaging of hippocampus layers is limited to a few studies and requires high magnetic field and gradient strength. We performed one conventional MRI sequence on a 7T MRI in order to visualize and to delineate the multi-layered hippocampal structure ex vivo in rat brains. We optimized a volumic three-dimensional T2 Rapid Acquisition Relaxation Enhancement (RARE) sequence and quantified the volume of the hippocampus and one of its thinnest layers, the stratum granulare of the dentate gyrus. Additionally, we tested passive staining by gadolinium with the aim of decreasing the acquisition time and increasing image contrast. Using appropriated settings, six discrete layers were differentiated within the hippocampus in rats. In the hippocampus proper or Ammon's Horn (AH): the stratum oriens, the stratum pyramidale of, the stratum radiatum, and the stratum lacunosum moleculare of the CA1 were differentiated. In the dentate gyrus: the stratum moleculare and the stratum granulare layer were seen distinctly. Passive staining of one brain with gadolinium decreased the acquisition time by four and improved the differentiation between the layers. A conventional sequence optimized on a 7T MRI with a standard receiver surface coil will allow us to study structural layers (signal and volume) of hippocampus in various rat models of neuropathology (anxiety, epilepsia, neurodegeneration).	[Kamsu, Jeanine Manuella; Denise, Pierre; Philoxene, Bruno; Besnard, Stephane] Univ Caen, Unite Mixte Rech, UMR 1075, F-14032 Caen, France; [Constans, Jean-Marc] Ctr Hosp Univ Amiens, Serv Radiol, Amiens, France; [Lamberton, Franck] Univ Caen, CEA, CNRS, Unite Mixte Rech,UMR 6194, F-14032 Caen, France; [Lamberton, Franck] Univ Paris, F-75252 Paris, France; [Courtheoux, Patrick; Coquemont, Maelle] Ctr Hosp Univ Cote Nacre, Unite Imagerie Resonance Magnet Pole Imagerie, Caen, France; [Courtheoux, Patrick; Coquemont, Maelle] Univ Caen, Ctr Hosp Univ Cote Nacre, Hop Cote Nacre, Serv Histol, F-14032 Caen, France	Universite de Caen Normandie; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Besnard, S (corresponding author), Univ Caen, Unite Mixte Rech, UMR 1075, F-14032 Caen, France.	besnard-s@phycog.org	Besnard, stephane SB/O-7453-2015; Lamberton, Franck/GRO-7517-2022; Denise, Pierre/E-2174-2011	Denise, Pierre/0000-0002-9049-7692; Lamberton, Franck/0000-0002-4655-4397; Constans, Jean-Marc/0000-0002-6751-4378	Centre National d'Etude Spatiale	Centre National d'Etude Spatiale	This study was supported by a grant from the Centre National d'Etude Spatiale. Special thanks to Solene Collet (PhD student) and Valerie Fong-Constans (English revision). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; Benveniste H, 2002, PROG NEUROBIOL, V67, P393, DOI 10.1016/S0301-0082(02)00020-5; Benveniste H, 2000, NEUROIMAGE, V11, P601, DOI 10.1006/nimg.2000.0567; Besnard S, 2012, HIPPOCAMPUS, V22, P814, DOI 10.1002/hipo.20942; Beuf O, 2006, MAGN RESON MATER PHY, V19, P202, DOI 10.1007/s10334-006-0048-9; Boretius S, 2009, NEUROIMAGE, V47, P1252, DOI 10.1016/j.neuroimage.2009.05.095; Bouilleret V, 2011, J MAGN RESON IMAGING, V34, P774, DOI 10.1002/jmri.22669; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cahill LS, 2012, NEUROIMAGE, V60, P933, DOI 10.1016/j.neuroimage.2012.01.100; Dedeurwaerdere S, 2013, NEUROIMAGE, V68, P30, DOI 10.1016/j.neuroimage.2012.11.054; Dhenain M, 2006, MAGN RESON MED, V55, P687, DOI 10.1002/mrm.20810; Fujioka M, 2000, CEREBROVASC DIS, V10, P2, DOI 10.1159/000016018; Hosseini-Sharifabad M, 2007, J NEUROSCI METH, V162, P206, DOI 10.1016/j.jneumeth.2007.01.009; Johnson GA, 2007, NEUROIMAGE, V37, P82, DOI 10.1016/j.neuroimage.2007.05.013; Johnson GA, 2012, NEUROIMAGE, V62, P1848, DOI 10.1016/j.neuroimage.2012.05.041; Kalisch R, 2006, NEUROPSYCHOPHARMACOL, V31, P925, DOI 10.1038/sj.npp.1300910; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Redwine JM, 2003, P NATL ACAD SCI USA, V100, P1381, DOI 10.1073/pnas.242746599; Schmitz C, 2002, MOL PSYCHIATR, V7, P810, DOI 10.1038/sj.mp.4001118; Sharief AA, 2008, NEUROIMAGE, V39, P136, DOI 10.1016/j.neuroimage.2007.08.028; Shepherd TM., 2005, P INT SOC MAGN RESON, V13, P619; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; VANHOESEN GW, 1990, PROG BRAIN RES, V83, P445; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Wieshmann UC, 1999, J ANAT, V195, P131, DOI 10.1046/j.1469-7580.1999.19510131.x; Woermann FG, 1998, J NEUROL NEUROSUR PS, V65, P656, DOI 10.1136/jnnp.65.5.656; Wolf OT, 2002, BRAIN RES, V934, P87, DOI 10.1016/S0006-8993(02)02363-6; Wolf OT, 2002, BRAIN RES PROTOC, V10, P41; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Yushkevich PA, 2009, NEUROIMAGE, V44, P385, DOI 10.1016/j.neuroimage.2008.08.042	30	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76135	10.1371/journal.pone.0076135	http://dx.doi.org/10.1371/journal.pone.0076135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086700	gold, Green Published, Green Submitted			2022-12-25	WOS:000325220000059
J	Verissimo, CS; Elands, R; Cheng, S; Saaltink, DJ; ter Horst, JP; Alme, MN; Pont, C; van de Water, B; Havik, B; Fitzsimons, CP; Vreugdenhil, E				Verissimo, Carla S.; Elands, Rachel; Cheng, Sou; Saaltink, Dirk-Jan; ter Horst, Judith P.; Alme, Maria N.; Pont, Chantal; van de Water, Bob; Havik, Bjarte; Fitzsimons, Carlos P.; Vreugdenhil, Erno			Silencing of Doublecortin-Like (DCL) Results in Decreased Mitochondrial Activity and Delayed Neuroblastoma Tumor Growth	PLOS ONE			English	Article							CELL-PROLIFERATION; MICROTUBULE; BIOGENESIS; CYTOSKELETON; TRANSPORT; DIFFERENTIATION; TRANSCRIPTION; METABOLISM; MORPHOLOGY; EXPRESSION	Doublecortin-like (DCL) is a microtubule-binding protein crucial for neuroblastoma (NB) cell proliferation. We have investigated whether the anti-proliferative effect of DCL knockdown is linked to reduced mitochondrial activity. We found a delay in tumor development after DCL knockdown in vivo in doxycycline-inducible NB tumor xenografts. To understand the mechanisms underlying this tumor growth retardation we performed a series of in vitro experiments in NB cell lines. DCL colocalizes with mitochondria, interacts with the mitochondrial outer membrane protein OMP25/SYNJ2BP and DCL knockdown results in decreased expression of genes involved in oxidative phosphorylation. Moreover, DCL knockdown decreases cytochrome c oxidase activity and ATP synthesis. We identified the C-terminal Serine/Proline-rich domain and the second microtubule-binding area as crucial DCL domains for the regulation of cytochrome c oxidase activity and ATP synthesis. Furthermore, DCL knockdown causes a significant reduction in the proliferation rate of NB cells under an energetic challenge induced by low glucose availability. Together with our previous studies, our results corroborate DCL as a key player in NB tumor growth in which DCL controls not only mitotic spindle formation and the stabilization of the microtubule cytoskeleton, but also regulates mitochondrial activity and energy availability, which makes DCL a promising molecular target for NB therapy.	[Verissimo, Carla S.; Elands, Rachel; Saaltink, Dirk-Jan; ter Horst, Judith P.; Vreugdenhil, Erno] Leiden Univ, Med Ctr, Leiden Amsterdam Ctr Drug Res, Div Med Pharmacol, Leiden, Netherlands; [Cheng, Sou] Prosensa Therapeut BV, Leiden, Netherlands; [Alme, Maria N.] Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Dept Biomed, Bergen, Norway; [Pont, Chantal; van de Water, Bob] Leiden Univ, Med Ctr, Leiden Amsterdam Ctr Drug Res, Div Toxicol, Leiden, Netherlands; [Havik, Bjarte] Univ Bergen, Dept Clin Med, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway; [Havik, Bjarte] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Fitzsimons, Carlos P.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands; [Vreugdenhil, Erno] Leiden Univ, Med Ctr, Migraine Res Grp, Dept Human Genet, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; BioMarin Pharmaceutical Inc.; Prosensa; University of Bergen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bergen; University of Bergen; Haukeland University Hospital; University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Verissimo, CS (corresponding author), Univ Med Ctr Utrecht, Dept Mol Canc Res, Ctr Biomed Genet, Utrecht, Netherlands.	c.s.leiriaverissimo@umcutrecht.nl; e.vreugdenhil.HG@lumc.nl		Fitzsimons, Carlos P./0000-0002-1556-2650	Foundation Villa Joep; Top Institute Pharma (TI Pharma); Netherlands Organization for Scientific Research (NWO) [H64.09.016]	Foundation Villa Joep; Top Institute Pharma (TI Pharma); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Foundation Villa Joep and Top Institute Pharma (TI Pharma). CPF was supported by the Netherlands Organization for Scientific Research (NWO), grant H64.09.016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013; Appaix F, 2003, EXP PHYSIOL, V88, P175, DOI 10.1113/eph8802511; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Biasutto L, 2010, MITOCHONDRION, V10, P670, DOI 10.1016/j.mito.2010.06.004; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Breen EC, 2003, J CELL BIOCHEM, V88, P848, DOI 10.1002/jcb.10398; Coppi E, 2007, STEM CELLS, V25, P1840, DOI 10.1634/stemcells.2006-0669; D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Dijkmans Thomas Frederik, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P32; Dinkelmann MV, 2007, GENETICS, V177, P1609, DOI 10.1534/genetics.107.078386; Fitzsimons CP, 2008, MOL ENDOCRINOL, V22, P248, DOI 10.1210/me.2007-0233; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Garedew A, 2012, CELL METAB, V15, P466, DOI 10.1016/j.cmet.2012.03.003; Genkai N, 2006, ONCOL REP, V15, P1569; George RE, 2010, EXPERT OPIN PHARMACO, V11, P1467, DOI 10.1517/14656566.2010.482100; Gershon TR, 2005, NEOPLASIA, V7, P575, DOI 10.1593/neo.04637; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Kimura I, 2006, J NEUROSCI RES, V83, P1415, DOI 10.1002/jnr.20849; Kushner BH, 2001, J CLIN ONCOL, V19, P3397, DOI 10.1200/JCO.2001.19.14.3397; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lee CH, 2011, AM J PATHOL, V178, P2066, DOI 10.1016/j.ajpath.2011.01.056; Lee S, 2007, BIOCHEM BIOPH RES CO, V357, P111, DOI 10.1016/j.bbrc.2007.03.091; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li LN, 2013, CHINESE J CANCER RES, V25, P134, DOI 10.3978/j.issn.1000-9604.2013.03.02; Ligon LA, 2000, J COMP NEUROL, V427, P351, DOI 10.1002/1096-9861(20001120)427:3<351::AID-CNE3>3.0.CO;2-R; LINDEN M, 1989, J BIOENERG BIOMEMBR, V21, P507, DOI 10.1007/BF00762522; Liu LY, 2009, CELL ONCOL, V31, P393, DOI 10.3233/CLO-2009-0484; Liu LY, 2002, IN VITRO CELL DEV-AN, V38, P582; Losfeld ME, 2009, EXP CELL RES, V315, P357, DOI 10.1016/j.yexcr.2008.10.039; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Nelson NJ, 2011, J NATL CANCER I, V103, P1218, DOI 10.1093/jnci/djr323; Nemoto Y, 1999, EMBO J, V18, P2991, DOI 10.1093/emboj/18.11.2991; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Petrelli A, 2008, CURR MED CHEM, V15, P422; RACKER E, 1981, SCIENCE, V213, P303, DOI 10.1126/science.6264596; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ralph SJ, 2009, MOL NUTR FOOD RES, V53, P9, DOI 10.1002/mnfr.200800044; Rappaport L, 1998, MOL CELL BIOCHEM, V184, P101, DOI 10.1023/A:1006843113166; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2951, DOI 10.1089/ars.2011.3990; Saaltink DJ, 2012, J COMP NEUROL, V520, P2805, DOI 10.1002/cne.23144; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Scheller K, 2003, EXP PHYSIOL, V88, P129, DOI 10.1113/eph8802507; Seibler J, 2010, METHOD ENZYMOL, V477, P367, DOI 10.1016/S0076-6879(10)77019-1; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Smith DJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-259; Sureban SM, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-40; Tantin D, 2012, CELL METAB, V15, P413, DOI 10.1016/j.cmet.2012.03.012; van Noesel MM, 2004, GENE, V325, P1, DOI 10.1016/j.gene.2003.09.042; Verissimo CS, 2012, J PHARMACOL EXP THER, V342, P119, DOI 10.1124/jpet.111.188813; Verissimo CS, 2011, ENDOCR-RELAT CANCER, V18, pR213, DOI 10.1530/ERC-11-0251; Verissimo CS, 2010, ENDOCR-RELAT CANCER, V17, P399, DOI 10.1677/ERC-09-0301; Vreugdenhil E, 1999, J NEUROBIOL, V39, P41, DOI 10.1002/(SICI)1097-4695(199904)39:1<41::AID-NEU4>3.0.CO;2-X; Vreugdenhil E, 2007, EUR J NEUROSCI, V25, P635, DOI 10.1111/j.1460-9568.2007.05318.x; Wagner LM, 2009, J CELL BIOCHEM, V107, P46, DOI 10.1002/jcb.22094; WARBURG O, 1956, SCIENCE, V124, P269; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	66	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75752	10.1371/journal.pone.0075752	http://dx.doi.org/10.1371/journal.pone.0075752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086625	Green Published, gold			2022-12-25	WOS:000325220000039
J	Glukhov, SI; Rubtsov, MA; Alexeyevsky, DA; Alexeevski, AV; Razin, SV; Iarovaia, OV				Glukhov, Sergey I.; Rubtsov, Mikhail A.; Alexeyevsky, Daniil A.; Alexeevski, Andrei V.; Razin, Sergey V.; Iarovaia, Olga V.			The Broken MLL Gene Is Frequently Located Outside the Inherent Chromosome Territory in Human Lymphoid Cells Treated with DNA Topoisomerase II Poison Etoposide	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; ACUTE MYELOID-LEUKEMIA; TRANSLOCATIONS; REARRANGEMENTS; SECONDARY; CANCER; REPAIR; SITES; ARCHITECTURE; INHIBITORS	The mixed lineage leukaemia (MLL) gene is frequently rearranged in secondary leukaemias, in which it could fuse to a variety of different partners. Breakage in the MLL gene preferentially occurs within a similar to 8 kb region that possesses a strong DNA topoisomerase II cleavage site. It has been proposed that DNA topoisomerase II-mediated DNA cleavage within this and other regions triggers translocations that occur due to incorrect joining of broken DNA ends. To further clarify a possible mechanism for MLL rearrangements, we analysed the frequency of MLL cleavage in cells exposed to etoposide, a DNA topoisomerase II poison commonly used as an anticancer drug, and positioning of the broken 3'-end of the MLL gene in respect to inherent chromosomal territories. It was demonstrated that exposure of human Jurkat cells to etoposide resulted in frequent cleavage of MLL genes. Using MLL-specific break-apart probes we visualised cleaved MLL genes in similar to 17% of nuclei. Using confocal microscopy and 3D modelling, we demonstrated that in cells treated with etoposide and cultivated for 1 h under normal conditions, similar to 9% of the broken MLL alleles were present outside the chromosome 11 territory, whereas in both control cells and cells inspected immediately after etoposide treatment, virtually all MLL alleles were present within the chromosomal territory. The data are discussed in the framework of the "breakage first" model of juxtaposing translocation partners. We propose that in the course of repairing DNA topoisomerase II-mediated DNA lesions (removal of stalled DNA topoisomerase II complexes and non-homologous end joining), DNA ends acquire additional mobility, which allows the meeting and incorrect joining of translocation partners.	[Glukhov, Sergey I.; Rubtsov, Mikhail A.; Razin, Sergey V.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Mol Biol, Moscow, Russia; [Razin, Sergey V.; Iarovaia, Olga V.] Inst Gene Biol RAS, Moscow, Russia; [Razin, Sergey V.] LIA 1066 French Russian Joint Canc Res Lab, Villejuif, France; [Razin, Sergey V.] LIA 1066 French Russian Joint Canc Res Lab, Moscow, Russia; [Alexeevski, Andrei V.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Phys & Chem Biol, Moscow, Russia; [Alexeyevsky, Daniil A.; Alexeevski, Andrei V.] Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Moscow, Russia; [Alexeevski, Andrei V.] Sci Res Inst Syst Studies NIISI RAN, Moscow, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lomonosov Moscow State University; Lomonosov Moscow State University; Russian Academy of Sciences; Scientific Research Institute for System Analysis of the Russian Academy of Sciences (SRISA)	Razin, SV (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Dept Mol Biol, Moscow, Russia.	sergey.v.razin@usa.net	Rubtsov, Mikhail A/A-8435-2014; Razin, Sergey V/M-6701-2015; Glukhov, Sergey I/I-9526-2016; Iarovaia, Olga/AAV-2321-2021; Alexeevski, Andrei V/A-7935-2012; Alexeyevsky, Daniil/C-7762-2016	Razin, Sergey V/0000-0003-1976-8661; Glukhov, Sergey I/0000-0002-4913-0557; Alexeevski, Andrei V/0000-0001-7939-9939; Rubtsov, Mikhail/0000-0003-4947-1009; Alexeyevsky, Daniil/0000-0003-1459-1297	Ministry of Science and Education of the Russian Federation [14.740.12.1344, 16.740.11.0483, 16.740.11.0629, 8052, 8800]; Russian Foundation of Basic Research [11-04-00361, 12-04-93109_CNRS, 12-04-33031, 12-04-31338, 13-07-00969, 11-04-91340]; Presidium of the Russian Academy of Sciences; M.V.Lomonosov Moscow State University Program of Development; Ministry of Education and Science of Russian Federation	Ministry of Science and Education of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); M.V.Lomonosov Moscow State University Program of Development; Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation)	This work was supported by the Ministry of Science and Education of the Russian Federation (contracts 14.740.12.1344, 16.740.11.0483, 16.740.11.0629 and grants 8052, 8800), by the Russian Foundation of Basic Research (grants 11-04-00361, 12-04-93109_CNRS, 12-04-33031, 12-04-31338, 13-07-00969, 11-04-91340) and by the Presidium of the Russian Academy of Sciences (grant from the Program on Molecular and Cellular Biology to SVR). This work was supported in part by M.V.Lomonosov Moscow State University Program of Development. Some experiments were performed at User Facilities Center of M.V.Lomonosov Moscow State University under financial support of Ministry of Education and Science of Russian Federation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2006, DNA REPAIR, V5, P1075, DOI 10.1016/j.dnarep.2006.05.029; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Bystritskiy AA, 2004, CRIT REV EUKAR GENE, V14, P65, DOI 10.1615/CritRevEukaryotGeneExpr.v14.40; Chikamori K, 2010, CURR CANCER DRUG TAR, V10, P758, DOI 10.2174/156800910793605785; Cowell IG, 2012, P NATL ACAD SCI USA, V109, P8989, DOI 10.1073/pnas.1204406109; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; CREMER T, 1993, COLD SPRING HARB SYM, V58, P777, DOI 10.1101/SQB.1993.058.01.085; de Campos-Nebel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012541; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Felix CA, 1998, BBA-GENE STRUCT EXPR, V1400, P233, DOI 10.1016/S0167-4781(98)00139-0; Felix CA, 2006, DNA REPAIR, V5, P1093, DOI 10.1016/j.dnarep.2006.05.031; Fortune JM, 2000, PROG NUCLEIC ACID RE, V64, P221, DOI 10.1016/S0079-6603(00)64006-0; Harper DP, 2008, CANCER RES, V68, P10024, DOI 10.1158/0008-5472.CAN-08-2208; Heisig P, 2009, MUTAGENESIS, V24, P465, DOI 10.1093/mutage/gep035; Iannuccelli E, 2010, BIOINFORMATICS, V26, P696, DOI 10.1093/bioinformatics/btq013; Jakob B, 2009, P NATL ACAD SCI USA, V106, P3172, DOI 10.1073/pnas.0810987106; Joannides M, 2010, CLIN TRANSL ONCOL, V12, P8, DOI 10.1007/s12094-010-0460-5; Krawczyk PM, 2012, J CELL SCI, V125, P2127, DOI 10.1242/jcs.089847; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lieber MR, 2010, SUBCELL BIOCHEM, V50, P279, DOI 10.1007/978-90-481-3471-7_14; Lin CR, 2012, ADV CANCER RES, V113, P241, DOI 10.1016/B978-0-12-394280-7.00015-4; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Mahy NL, 2002, J CELL BIOL, V157, P579, DOI 10.1083/jcb.200111071; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; RATAIN MJ, 1992, ANN ONCOL, V3, P107, DOI 10.1093/oxfordjournals.annonc.a058121; Rowley JD, 1997, BLOOD, V90, P535; Rubtsov M. A., 2011, Biopolymers and Cell, V27, P398; Rubtsov MA, 2008, J CELL BIOCHEM, V104, P692, DOI 10.1002/jcb.21656; Savage JRK, 2000, SCIENCE, V290, P62, DOI 10.1126/science.290.5489.62; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Super HG, 1997, GENE CHROMOSOME CANC, V20, P185, DOI 10.1002/(SICI)1098-2264(199710)20:2<185::AID-GCC9>3.0.CO;2-#; SUPER HJG, 1993, BLOOD, V82, P3705; Wang Jing H, 2012, Front Med, V6, P263, DOI 10.1007/s11684-012-0215-5; Wilstermann AM, 2003, CURR TOP MED CHEM, V3, P321, DOI 10.2174/1568026033452519; Zhang YM, 2002, P NATL ACAD SCI USA, V99, P3070, DOI 10.1073/pnas.042702899; TITLE ERROR, DOI DOI 10.2174/092986710793361252.PUBMED:20939813	44	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75871	10.1371/journal.pone.0075871	http://dx.doi.org/10.1371/journal.pone.0075871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086652	Green Submitted, gold, Green Published			2022-12-25	WOS:000325218700115
J	Strauss, A; Smith, KG				Strauss, Alex; Smith, Kevin G.			Why Does Amphibian Chytrid (Batrachochytrium dendrobatidis) Not Occur Everywhere? An Exploratory Study in Missouri Ponds	PLOS ONE			English	Article							EMERGING DISEASE; PATHOGEN; FUNGUS; CHYTRIDIOMYCOSIS; SUSCEPTIBILITY; DISINFECTANTS; TRANSMISSION; BIODIVERSITY; PREVALENCE; PREDATION	The amphibian chytrid fungus, Batrachochytrium dendrobatidis (Bd), is a globally emerging pathogen that has caused widespread amphibian population declines, extirpations, and extinctions. However, Bd does not occur in all apparently suitable amphibian populations, even within regions where it is widespread, and it is often unclear why Bd occurs in some habitats but not others. In this study, we rigorously surveyed the amphibian and invertebrate biodiversity of 29 ponds in Missouri, screened resident amphibian larvae (Rana (Lithobates) sp.) for Bd infection, and characterized the aquatic physiochemical environment of each pond (temperature pH, conductivity, nitrogen, phosphorus, and chlorophyll-a). Our goal was to generate hypotheses toward answering the question, "Why does Bd not occur in all apparently suitable habitats?" Bd occurred in assayed amphibians in 11 of the 29 ponds in our study area (38% of ponds). We found no significant relationship between any single biotic or abiotic variable and presence of Bd. However, multivariate analyses (nonmetric multidimensional scaling and permutational tests of dispersion) revealed that ponds in which Bd occurred were a restricted subset of all ponds in terms of amphibian community structure, macroinvertebrate community structure, and pond physiochemistry. In other words, Bd ponds from 6 different conservation areas were more similar to each other than would be expected based on chance. The results of a structural equation model suggest that patterns in the occurrence of Bd among ponds are primarily attributable to variation in macroinvertebrate community structure. When combined with recent results showing that Bd can infect invertebrates as well as amphibians, we suggest that additional research should focus on the role played by non-amphibian biota in determining the presence, prevalence, and pathogenicity of Bd in amphibian populations.	[Smith, Kevin G.] Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Smith, KG (corresponding author), Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA.	kgs@wustl.edu	Smith, Kevin/A-5044-2010	Strauss, Alexander/0000-0003-0633-8443	Washington University's International Center for Advanced Renewable Energy and Sustainability; NSF [DEB-0816113]; Tyson Research Center; Direct For Biological Sciences [0816113] Funding Source: National Science Foundation	Washington University's International Center for Advanced Renewable Energy and Sustainability; NSF(National Science Foundation (NSF)); Tyson Research Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this study was provided by 1) Washington University's International Center for Advanced Renewable Energy and Sustainability (http://icares.wustl.edu/), NSF grant DEB-0816113 to KGS (http://www.nsf.gov/), and Tyson Research Center (http://tyson.wustl.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Berger L., 1999, DECLINES DISAPPEARAN, V1999, P23; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Bodinof CM, 2011, DIS AQUAT ORGAN, V96, P1, DOI 10.3354/dao02380; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Buck JC, 2011, BIODIVERS CONSERV, V20, P3549, DOI 10.1007/s10531-011-0147-4; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conradie W, 2011, AFR ZOOL, V46, P95, DOI 10.3377/004.046.0122; Daszak P, 1999, TRENDS ECOL EVOL, V14, P279, DOI 10.1016/S0169-5347(99)01665-1; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Frias-Alvarez P, 2008, ECOHEALTH, V5, P18, DOI 10.1007/s10393-008-0155-3; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Greer AL, 2008, OIKOS, V117, P1667, DOI 10.1111/j.1600-0706.2008.16783.x; Hamilton PT, 2012, FRESHWATER BIOL, V57, P676, DOI 10.1111/j.1365-2427.2011.02731.x; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; LaDeau SL, 2008, BIOSCIENCE, V58, P937, DOI 10.1641/B581007; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; MORIN PJ, 1983, ECOL MONOGR, V53, P119, DOI 10.2307/1942491; Murray KA, 2012, HUM ECOL RISK ASSESS, V18, P200, DOI 10.1080/10807039.2012.632310; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Ortiz-Santaliestra ME, 2011, CONSERV BIOL, V25, P975, DOI 10.1111/j.1523-1739.2011.01700.x; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Raffel TR, 2010, ECOHEALTH, V7, P526, DOI 10.1007/s10393-010-0358-2; Richards-Hrdlicka KL, 2013, DIS AQUAT ORGAN, V102, P169, DOI 10.3354/dao02552; Rohr JR, 2011, J APPL ECOL, V48, P174, DOI 10.1111/j.1365-2664.2010.01891.x; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Schmidt BR, 2009, AMPHIBIA-REPTILIA, V30, P313, DOI 10.1163/156853809788795245; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; Shapard EJ, 2012, MYCOPATHOLOGIA, V173, P121, DOI 10.1007/s11046-011-9470-2; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Smith KG, 2009, ECOL LETT, V12, P1069, DOI 10.1111/j.1461-0248.2009.01363.x; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Turner AM, 1997, J N AM BENTHOL SOC, V16, P694, DOI 10.2307/1468154; Van Sluys M, 2009, ECOHEALTH, V6, P576, DOI 10.1007/s10393-010-0278-1; Venesky MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024991; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190	49	14	14	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76035	10.1371/journal.pone.0076035	http://dx.doi.org/10.1371/journal.pone.0076035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086681	Green Published, gold			2022-12-25	WOS:000325218700118
J	Papasergi, S; Cariccio, VL; Pietrocola, G; Domina, M; D'Aliberti, D; Trunfio, MG; Signorino, G; Peppoloni, S; Biondo, C; Mancuso, G; Midiri, A; Rindi, S; Teti, G; Speziale, P; Felici, F; Beninati, C				Papasergi, Salvatore; Cariccio, Veronica Lanza; Pietrocola, Giampiero; Domina, Maria; D'Aliberti, Deborah; Trunfio, Maria Grazia; Signorino, Giacomo; Peppoloni, Samuele; Biondo, Carmelo; Mancuso, Giuseppe; Midiri, Angelina; Rindi, Simonetta; Teti, Giuseppe; Speziale, Pietro; Felici, Franco; Beninati, Concetta			Immunogenic Properties of Streptococcus agalactiae FbsA Fragments	PLOS ONE			English	Article							FIBRINOGEN-BINDING PROTEIN; HUMAN EPITHELIAL-CELLS; STAPHYLOCOCCUS-AUREUS; HYPERVARIABLE REGION; TOXOPLASMA-GONDII; NEONATAL SEPSIS; CDNA LIBRARIES; LAMBDA-DISPLAY; INFECTIONS; ADHERENCE	Several species of Gram-positive bacteria can avidly bind soluble and surface-associated fibrinogen (Fng), a property that is considered important in the pathogenesis of human infections. To gain insights into the mechanism by which group B Streptococcus (GBS), a frequent neonatal pathogen, interacts with Fng, we have screened two phage displayed genomic GBS libraries. All of the Fng-binding phage clones contained inserts encoding fragments of FbsA, a protein displaying multiple repeats. Since the functional role of this protein is only partially understood, representative fragments were recombinantly expressed and analyzed for Fng binding affinity and ability to induce immune protection against GBS infection. Maternal immunization with 6pGST, a fragment containing five repeats, significantly protected mouse pups against lethal GBS challenge and these protective effects could be recapitulated by administration of anti-6pGST serum from adult animals. Notably, a monoclonal antibody that was capable of neutralizing Fng binding by 6pGST, but not a non-neutralizing antibody, could significantly protect pups against lethal GBS challenge. These data suggest that FbsA-Fng interaction promotes GBS pathogenesis and that blocking such interaction is a viable strategy to prevent or treat GBS infections.	[Papasergi, Salvatore; Cariccio, Veronica Lanza; Domina, Maria; D'Aliberti, Deborah; Trunfio, Maria Grazia; Signorino, Giacomo; Biondo, Carmelo; Mancuso, Giuseppe; Midiri, Angelina; Teti, Giuseppe; Beninati, Concetta] Univ Messina, Metchnikoff Lab, Messina, Italy; [Pietrocola, Giampiero; Rindi, Simonetta; Speziale, Pietro] Univ Pavia, Biochem Unit, Dept Mol Med, I-27100 Pavia, Italy; [Peppoloni, Samuele] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy; [Felici, Franco] Univ Molise, DiBT, Dept Biosci & Terr, Pesche, Isernia, Italy	University of Messina; University of Pavia; Universita di Modena e Reggio Emilia; University of Molise	Teti, G (corresponding author), Univ Messina, Metchnikoff Lab, Messina, Italy.	gteti@unime.it	Felici, Franco/H-5693-2012; Peppoloni, Samuele/L-2177-2016; papasergi, salvatore/AAE-8818-2021; Biondo, Carmelo/AAA-3391-2019; Domina, Maria/K-7883-2016	Felici, Franco/0000-0003-2205-5195; Peppoloni, Samuele/0000-0003-4191-6974; Midiri, Angelina/0000-0002-4128-9678; Domina, Maria/0000-0002-0445-8356; Mancuso, Giuseppe/0000-0001-5454-3228; PIETROCOLA, GIAMPIERO/0000-0002-7069-8155; BENINATI, Concetta/0000-0001-8305-1337; Signorino, Giacomo/0000-0002-5366-6020	Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN) from the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) of Italy	Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN) from the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) of Italy(Ministry of Education, Universities and Research (MIUR))	The work was supported by grants Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN) 2003, 2005 and 2008 from the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2007, CURR MED CHEM, V14, P2925, DOI 10.2174/092986707782360015; Al Safadi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014658; Beghetto E, 2003, INT J PARASITOL, V33, P163, DOI 10.1016/S0020-7519(02)00256-4; Beghetto E, 2001, INT J PARASITOL, V31, P1659, DOI 10.1016/S0020-7519(01)00288-0; Beghetto E, 2006, FEMS MICROBIOL LETT, V262, P14, DOI 10.1111/j.1574-6968.2006.00360.x; Camacho-Gonzalez A, 2013, PEDIATR CLIN N AM, V60, P367, DOI 10.1016/j.pcl.2012.12.003; Cardaci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036588; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Dramsi S, 2012, MICROBES INFECT, V14, P1044, DOI 10.1016/j.micinf.2012.07.004; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; EDWARDS MS, 1983, PEDIATR RES, V17, P685, DOI 10.1203/00006450-198308000-00017; Flick MJ, 2013, BLOOD, V121, P1783, DOI 10.1182/blood-2012-09-453894; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Gutekunst H, 2004, INFECT IMMUN, V72, P3495, DOI 10.1128/IAI.72.6.3495-3504.2004; Jonsson IM, 2005, J INFECT DIS, V192, P1456, DOI 10.1086/491478; Lannergard J, 2011, CELL HOST MICROBE, V10, P147, DOI 10.1016/j.chom.2011.06.011; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Magliani W, 1998, NAT MED, V4, P705, DOI 10.1038/nm0698-705; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; McAdow M, 2012, J INNATE IMMUN, V4, P141, DOI 10.1159/000333447; Ohlsson A, 2013, COCHRANE DB SYST REV, V1; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Pietrocola G, 2005, BLOOD, V105, P1052, DOI 10.1182/blood-2004-06-2149; Poyart C, 2008, EMERG INFECT DIS, V14, P1647, DOI 10.3201/eid1410.080185; Rajagopal L, 2009, FUTURE MICROBIOL, V4, P201, DOI 10.2217/17460913.4.2.201; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Rosenau A, 2007, INFECT IMMUN, V75, P1310, DOI 10.1128/IAI.00996-06; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P939, DOI 10.1097/01.inf.0000239267.42561.06; Schubert A, 2004, INFECT IMMUN, V72, P6197, DOI 10.1128/IAI.72.11.6197-6205.2004; Schubert A, 2002, MOL MICROBIOL, V46, P557, DOI 10.1046/j.1365-2958.2002.03177.x; Senn BM, 2011, VACCINE, V29, P4116, DOI 10.1016/j.vaccine.2011.03.100; Seo HW, 2012, BMC VET RES, V8, P1, DOI 10.1186/1746-6148-8-194; Tenenbaum T, 2005, INFECT IMMUN, V73, P4404, DOI 10.1128/IAI.73.7.4404-4409.2005; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Waldemarsson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007279; WIBAWAN WT, 1992, J VET MED B, V39, P376, DOI 10.1111/j.1439-0450.1992.tb01183.x; WILSON CB, 1985, J INFECT DIS, V152, P323, DOI 10.1093/infdis/152.2.323	37	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75266	10.1371/journal.pone.0075266	http://dx.doi.org/10.1371/journal.pone.0075266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086487	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200034
J	Sanchez-Jimenez, C; Izquierdo, JM				Sanchez-Jimenez, Carmen; Izquierdo, Jose M.			T-cell Intracellular Antigen (TIA)-Proteins Deficiency in Murine Embryonic Fibroblasts Alters Cell Cycle Progression and Induces Autophagy	PLOS ONE			English	Article							BINDING PROTEIN TIAR; MESSENGER-RNA; MICROARRAY DATA; DNA; GENE; IDENTIFICATION; NORMALIZATION; TRANSCRIPTION; LYMPHOCYTES; MICROSCOPY	Mice lacking either T-cell intracellular antigen 1 (TIA1) or TIA1 related/like protein (TIAR/TIAL1) show high rates of embryonic lethality, suggesting a relevant role for these proteins during embryonic development. However, intrinsic molecular and cellular consequences of either TIA1 or TIAR deficiency remain poorly defined. By using genome-wide expression profiling approach, we demonstrate that either TIA1 or TIAR inactivation broadly alter normal development-associated signalling pathways in murine embryonic fibroblasts (MEF). Indeed, these analyses highlighted alterations of cytokine-cytokine and ECM-receptor interactions and Wnt, MAPK, TGF-beta dependent signalling pathways. Consistent with these results, TIA1 and TIAR knockout (KO) MEF show reduced rates of cell proliferation, cell cycle progression delay and increased cell size. Furthermore, TIA-proteins deficiency also caused metabolic deficiencies, increased ROS levels and DNA damage, promoting a gentle rise of cell death. Concomitantly, high rates of autophagy were detected in both TIA1 and TIAR KO MEF with induction of the formation of autophagosomes, as evidenced by the up-regulation of the LC3B protein, and autolysosomes, measured by colocalization of LC3B and LAMP1, as a survival mechanism attempt. Taken together, these observations support that TIA proteins orchestrate a transcriptome programme to activate specific developmental decisions. This program is likely to contribute to mouse physiology starting at early stages of the embryonic development. TIA1/TIAR might function as cell sensors to maintain homeostasis and promote adaptation/survival responses to developmental stress.	[Sanchez-Jimenez, Carmen; Izquierdo, Jose M.] Univ Autonoma Madrid CSIC UAM, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Izquierdo, JM (corresponding author), Univ Autonoma Madrid CSIC UAM, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	jmizquierdo@cbm.uam.es		Izquierdo, Jose M/0000-0002-7942-4046	Ministerio de Ciencia e Innovacion-FEDER [BFU2008-00354, BFU2011-29653]; Fundacion Ramon Areces, Spain	Ministerio de Ciencia e Innovacion-FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces, Spain	This work was supported by grants from Ministerio de Ciencia e Innovacion-FEDER (BFU2008-00354 and BFU2011-29653). The CBMSO receives an institutional grant from Fundacion Ramon Areces, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Gal-Mark N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000717; Gottschald OR, 2010, J MOL CELL BIOL, V2, P345, DOI 10.1093/jmcb/mjq032; Hayashi M, 2006, NAT MED, V12, P128, DOI 10.1038/nm1327; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Izquierdo JM, 2007, J BIOL CHEM, V282, P19410, DOI 10.1074/jbc.M700688200; Izquierdo JM, 2011, BIOCHEM J, V435, P337, DOI 10.1042/BJ20101030; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; Kharraz Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011352; Kim HS, 2007, MOL CELL BIOL, V27, P6806, DOI 10.1128/MCB.01036-07; Kim HS, 2011, NUCLEIC ACIDS RES, V39, P1117, DOI 10.1093/nar/gkq837; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; McAlinden A, 2007, J BIOL CHEM, V282, P24444, DOI 10.1074/jbc.M702717200; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Oliveros JC., 2007, FIESTA BIOINFOGP INT; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Pua HH, 2009, AUTOPHAGY, V5, P745, DOI 10.4161/auto.5.5.8702; Reyes R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r87; Sanchez-Jimenez C, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-4; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Soultanakis RP, 2000, FREE RADICAL BIO MED, V28, P987, DOI 10.1016/S0891-5849(00)00185-4; Suswam EA, 2005, NUCLEIC ACIDS RES, V33, P4507, DOI 10.1093/nar/gki763; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Yamasaki S, 2007, J BIOL CHEM, V282, P30070, DOI 10.1074/jbc.M706273200	45	26	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75127	10.1371/journal.pone.0075127	http://dx.doi.org/10.1371/journal.pone.0075127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086455	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200027
J	Canivell, S; Ruano, EG; Siso-Almirall, A; Kostov, B; Gonzalez-de Paz, L; Fernandez-Rebollo, E; Hanzu, F; Parrizas, M; Novials, A; Gomis, R				Canivell, Silvia; Ruano, Elena G.; Siso-Almirall, Antoni; Kostov, Belchin; Gonzalez-de Paz, Luis; Fernandez-Rebollo, Eduardo; Hanzu, Felicia; Parrizas, Marcelina; Novials, Anna; Gomis, Ramon			Gastric Inhibitory Polypeptide Receptor Methylation in Newly Diagnosed, Drug-Naive Patients with Type 2 Diabetes: A Case-Control Study	PLOS ONE			English	Article							BETA-CELL FUNCTION; DNA METHYLATION; INSULIN-RESISTANCE; HOMEOSTASIS MODEL; GENE-EXPRESSION; GENOME; ASSOCIATION; GLUCOSE; OBESITY; MELLITUS	GIP action in type 2 diabetic (T2D) patients is altered. We hypothesized that methylation changes could be present in GIP receptor of T2D patients. This study aimed to assess the differences in DNA methylation profile of GIPR promoter between T2D patients and age-and Body Mass Index (BMI)-matched controls. We included 93 T2D patients (cases) that were uniquely on diet (without any anti-diabetic pharmacological treatment). We matched one control (with oral glucose tolerance test negative, non diabetic), by age and BMI, for every case. Cytokines and hormones were determined by ELISA. DNA was extracted from whole blood and DNA methylation was assessed using the Sequenom EpiTYPER system. Our results showed that T2D patients were more insulin resistant and had a poorer beta cell function than their controls. Fasting adiponectin was lower in T2D patients as compared to controls (7.0 +/- 3.8 mu gr/mL vs. 10.0 +/- 4.2 mu gr/mL). Levels of IL 12 in serum were almost double in T2D patients (52.8 +/- 58.3 pg/mL vs. 29.7 +/- 37.4 pg/mL). We found that GIPR promoter was hypomethylated in T2D patients as compared to controls. In addition, HOMA-IR and fasting glucose correlated negatively with mean methylation of GIPR promoter, especially in T2D patients. This case-control study confirms that newly diagnosed, drug-naive T2D patients are more insulin resistant and have worse beta cell function than age- and BMI-matched controls, which is partly related to changes in the insulin-sensitizing metabolites (adiponectin), in the proinflammatory profile (IL12) and we suggest in the methylation pattern of GIPR. Our study provides novel findings on GIPR promoter methylation profile which may improve our ability to understand type 2 diabetes pathogenesis.	[Canivell, Silvia; Hanzu, Felicia; Novials, Anna; Gomis, Ramon] Hosp Clin Barcelona, Inst Invest Biomed August Pi I Sunyer, Dept Endocrinol & Nutr, Barcelona, Spain; [Canivell, Silvia; Siso-Almirall, Antoni; Kostov, Belchin; Gonzalez-de Paz, Luis] Inst Invest Biomed August Pi I Sunyer, Transverse Grp Res Primary Care, Les Corts Primary Hlth Care Ctr, Barcelona, Spain; [Canivell, Silvia; Ruano, Elena G.; Fernandez-Rebollo, Eduardo; Hanzu, Felicia; Parrizas, Marcelina; Novials, Anna; Gomis, Ramon] Inst Invest Biomed August Pi I Sunyer, Diabet & Obes Lab, Barcelona, Spain; [Ruano, Elena G.; Fernandez-Rebollo, Eduardo; Novials, Anna; Gomis, Ramon] Spanish Biomed Res Ctr Diabet & Associated Metab, Barcelona, Spain; [Siso-Almirall, Antoni; Gomis, Ramon] Univ Barcelona, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Gomis, R (corresponding author), Hosp Clin Barcelona, Inst Invest Biomed August Pi I Sunyer, Dept Endocrinol & Nutr, Barcelona, Spain.	RGOMIS@clinic.ub.es	, EFR1981/AAV-6334-2020; Parrizas, Marcelina/AAS-3629-2021	, EFR1981/0000-0002-4378-7590; Parrizas, Marcelina/0000-0003-1296-8302; Kostov, Belchin/0000-0002-2126-3892; Gonzalez de Paz, Luis/0000-0002-4767-8121; Hanzu, Felicia Alexandra/0000-0002-2399-4023; Novials, Anna/0000-0003-0465-2949; Siso Almirall, Antoni/0000-0001-9832-2689; Canivell, Silvia/0000-0002-0280-5035	FIS [PI 1000219]; MEDIGENE [279171]; EC; Spanish Ministry of Science and Innovation [SAF 2010-19527]; Spanish Ministry of Science and Innovation; BIOTRACK Postdoctoral Fellowship in Institut d'Investigacions Biomediques August Pi i Sunyer; European Community [229673]	FIS(Instituto de Salud Carlos III); MEDIGENE; EC(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); BIOTRACK Postdoctoral Fellowship in Institut d'Investigacions Biomediques August Pi i Sunyer; European Community(European Commission)	This work was supported by the FIS Grant PI 1000219, the MEDIGENE project, grant agreement number 279171, funded by the EC Seventh Framework Programme theme FP7-HEALTH-2011 and by the Spanish Ministry of Science and Innovation (under de the grant agreement number SAF 2010-19527). CIBER de Diabetes y Enfermedades Metabolicas is an initiative of the Spanish Ministry of Science and Innovation. The Rio Hortega Grant from the Spanish Ministry of Science and Innovation was awarded to Silvia Canivell. Eduardo Fernandez-Rebollo (EF-R) has been the recipient of a BIOTRACK Postdoctoral Fellowship in Institut d'Investigacions Biomediques August Pi i Sunyer, supported by the European Community's Seventh Framework Programme (EC FP7/2009-2013) under the agreement no. 229673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlqvist E, 2013, DIABETES; American Diabetes Association, 2011, DIABETES CARE S1, V35, pS11; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bluher M, 2005, EXP CLIN ENDOCR DIAB, V113, P534, DOI 10.1055/s-2005-872851; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Holst JJ, 1997, DIABETOLOGIA, V40, P984, DOI 10.1007/s001250050779; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lehtovirta M, 2010, DIABETOLOGIA, V53, P1314, DOI 10.1007/s00125-010-1746-4; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Mari A, 2010, DIABETOLOGIA, V53, P749, DOI 10.1007/s00125-009-1647-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Mishra M, 2011, DIABETES RES CLIN PR, V94, P255, DOI 10.1016/j.diabres.2011.07.037; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Murea Mariana, 2012, Rev Diabet Stud, V9, P6, DOI 10.1900/RDS.2012.9.6; Relton CL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000356; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Slomko H, 2012, ENDOCRINOLOGY, V153, P1025, DOI 10.1210/en.2011-1759; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Taylor-Fishwick DA, 2013, DIABETOLOGIA, V56, P126, DOI 10.1007/s00125-012-2732-9; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861; Volkmar M, 2012, EMBO J; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008	30	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75474	10.1371/journal.pone.0075474	http://dx.doi.org/10.1371/journal.pone.0075474			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086540	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200104
J	Strafella, E; Bracci, M; Staffolani, S; Manzella, N; Giantomasi, D; Valentino, M; Amati, M; Tomasetti, M; Santarelli, L				Strafella, Elisabetta; Bracci, Massimo; Staffolani, Sara; Manzella, Nicola; Giantomasi, Daniele; Valentino, Matteo; Amati, Monica; Tomasetti, Marco; Santarelli, Lory			Occupational Styrene Exposure Induces Stress-Responsive Genes Involved in Cytoprotective and Cytotoxic Activities	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; LIVER-REGENERATION; OXIDATIVE STRESS; DNA-DAMAGE; WORKERS; CANCER; EXPRESSION; INJURY; MICE; HEAT-SHOCK-PROTEIN-70	Objective: The aim of this study was to evaluate the expression of a panel of genes involved in toxicology in response to styrene exposure at levels below the occupational standard setting. Methods: Workers in a fiber glass boat industry were evaluated for a panel of stress- and toxicity-related genes and associated with biochemical parameters related to hepatic injury. Urinary styrene metabolites (MA+PGA) of subjects and environmental sampling data collected for air at workplace were used to estimate styrene exposure. Results: Expression array analysis revealed massive upregulation of genes encoding stress-responsive proteins (HSPA1L, EGR1, IL-6, IL-1 beta, TNSF10 and TNF alpha) in the styrene-exposed group; the levels of cytokines released were further confirmed in serum. The exposed workers were then stratified by styrene exposure levels. EGR1 gene upregulation paralleled the expression and transcriptional protein levels of IL-6, TNSF10 and TNF alpha in styrene exposed workers, even at low level. The activation of the EGR1 pathway observed at low-styrene exposure was associated with a slight increase of hepatic markers found in highly exposed subjects, even though they were within normal range. The ALT and AST levels were not affected by alcohol consumption, and positively correlated with urinary styrene metabolites as evaluated by multiple regression analysis. Conclusion: The pro-inflammatory cytokines IL-6 and TNF alpha are the primary mediators of processes involved in the hepatic injury response and regeneration. Here, we show that styrene induced stress responsive genes involved in cytoprotection and cytotoxicity at low-exposure, that proceed to a mild subclinical hepatic toxicity at high-styrene exposure.	[Strafella, Elisabetta; Bracci, Massimo; Staffolani, Sara; Manzella, Nicola; Giantomasi, Daniele; Valentino, Matteo; Amati, Monica; Tomasetti, Marco; Santarelli, Lory] Polytech Univ Marche, Dept Clin & Mol Sci, Ancona, Italy	Marche Polytechnic University	Bracci, M (corresponding author), Polytech Univ Marche, Dept Clin & Mol Sci, Ancona, Italy.	m.bracci@univpm.it	Santarelli, Lory/AAU-4494-2020; Bracci, Massimo/K-1192-2018	Bracci, Massimo/0000-0003-3901-5376; santarelli, lory/0000-0003-1015-7098	National Institute of Occupational Injury Insurance (INAIL)	National Institute of Occupational Injury Insurance (INAIL)	This study was supported by National Institute of Occupational Injury Insurance (INAIL). The institute had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Conference of the Governmental Industrial Hygienist (ACGIH), 2003, STYR MON ACGIH DOC T; AXELSON O, 1978, SCAND J WORK ENV HEA, V4, P215, DOI 10.5271/sjweh.2745; Boffetta P, 2009, J OCCUP ENVIRON MED, V51, P1275, DOI 10.1097/JOM.0b013e3181ad49b2; Brodkin CA, 2001, OCCUP ENVIRON MED, V58, P95, DOI 10.1136/oem.58.2.95; Calderwood SK, 2008, INT J HYPERTHER, V24, P31, DOI 10.1080/02656730701858305; Carlson GP, 2011, DRUG CHEM TOXICOL, V34, P440, DOI 10.3109/01480545.2011.562899; Cocco P, 2010, OCCUP ENVIRON MED, V67, P341, DOI 10.1136/oem.2009.046839; Collins JJ, 2013, EPIDEMIOLOGY, V24, P195, DOI 10.1097/EDE.0b013e318281a30f; Costa C, 2012, J TOXICOL ENV HEAL A, V75, P735, DOI 10.1080/15287394.2012.688488; Czaja MJ, 2002, ANTIOXID REDOX SIGN, V4, P759, DOI 10.1089/152308602760598909; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Godderis L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039205; HARKONEN H, 1984, SCAND J WORK ENV HEA, V10, P59, DOI 10.5271/sjweh.2369; HATAYAMA T, 1993, J BIOCHEM-TOKYO, V114, P592, DOI 10.1093/oxfordjournals.jbchem.a124222; Hirasawa F, 2007, BIOMED RES-TOKYO, V28, P323, DOI 10.2220/biomedres.28.323; Kaplowitz N, 1996, Prog Liver Dis, V14, P131; Lacour Sandrine, 2005, Cancer Biomarkers, V1, P29; Laffon B, 2001, J CHROMATOGR B, V753, P385, DOI 10.1016/S0378-4347(00)00583-1; LAVNIKOVA N, 1993, J LEUKOCYTE BIOL, V54, P322, DOI 10.1002/jlb.54.4.322; Liao YJ, 2004, J BIOL CHEM, V279, P43107, DOI 10.1074/jbc.M407969200; Liu SF, 1999, CIRCULATION, V100, P1330, DOI 10.1161/01.CIR.100.12.1330; LORIMER WV, 1978, SCAND J WORK ENV HEA, V4, P220, DOI 10.5271/sjweh.2743; MILLER RR, 1994, CRIT REV TOXICOL, V24, pS1, DOI 10.3109/10408449409020137; Mogel I, 2011, TOXICOLOGY, V289, P28, DOI 10.1016/j.tox.2011.07.006; Pritchard MT, 2010, J HEPATOL, V53, P655, DOI 10.1016/j.jhep.2010.04.017; Pritchard MT, 2005, ALCOHOL CLIN EXP RES, V29, p146S, DOI 10.1097/01.alc.0000189286.81943.51; Sati PC, 2011, HUM EXP TOXICOL, V30, P1743, DOI 10.1177/0960327111401436; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Singh R, 2010, CURR PHARM DESIGN, V16, P796, DOI 10.2174/138161210790883499; Srivastava SP, 1982, J APPL TOXICOL, V2, P219, DOI 10.1002/jat.2550020411; Streetz KL, 2003, HEPATOLOGY, V38, P218, DOI 10.1053/jhep.2003.50268; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Teoh NC, 2011, J GASTROEN HEPATOL, V26, P180, DOI 10.1111/j.1440-1746.2010.06584.x; THIESS AM, 1978, SCAND J WORK ENV HEA, V4, P203, DOI 10.5271/sjweh.2746; Unoshima M, 2001, J LAB CLIN MED, V137, P28, DOI 10.1067/mlc.2001.111514; Vodicka P, 2006, DRUG METAB REV, V38, P805, DOI 10.1080/03602530600952222; Won YL, 2011, SAF HEALTH WORK-KR, V2, P365, DOI 10.5491/SHAW.2011.2.4.365; Wongvijitsuk S, 2011, INT J HYG ENVIR HEAL, V214, P127, DOI 10.1016/j.ijheh.2010.09.007	40	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75401	10.1371/journal.pone.0075401	http://dx.doi.org/10.1371/journal.pone.0075401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086524	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200100
J	Vite, A; Gandjbakhch, E; Prost, C; Fressart, V; Fouret, P; Neyroud, N; Gary, F; Donal, E; Varnous, S; Fontaine, G; Fornes, P; Hidden-Lucet, F; Komajda, M; Charron, P; Villard, E				Vite, Alexia; Gandjbakhch, Estelle; Prost, Catherine; Fressart, Veronique; Fouret, Pierre; Neyroud, Nathalie; Gary, Francoise; Donal, Erwan; Varnous, Shaida; Fontaine, Guy; Fornes, Paul; Hidden-Lucet, Francoise; Komajda, Michel; Charron, Philippe; Villard, Eric			Desmosomal Cadherins Are Decreased in Explanted Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patient Hearts	PLOS ONE			English	Article							DILATED CARDIOMYOPATHY; NUCLEAR PLAKOGLOBIN; MOLECULAR-GENETICS; CLINICAL IMPACT; NAXOS-DISEASE; WOOLLY HAIR; MUTATIONS; KERATODERMA; DYSPLASIA; DIAGNOSIS	Aims: Arrhythmogenic right ventricular Dysplasia/cardiomyopathy (ARVD/C) is an autosomal dominant inherited cardiomyopathy associated with ventricular arrhythmia, heart failure and sudden death. Genetic studies have demonstrated the central role of desmosomal proteins in this disease, where 50% of patients harbor a mutation in a desmosmal gene. However, clinical diagnosis of the disease remains difficult and molecular mechanisms appears heterogeneous and poorly understood. The aim of this study was to characterize the expression profile of desmosomal proteins in explanted ARVD/C heart samples, in order to identify common features of the disease. Methods and Results: We examined plakophilin-2, desmoglein-2, desmocollin-2, plakoglobin and beta-catenin protein expression levels from seven independent ARVD/C heart samples compared to two ischemic, five dilated cardiomyopathy and one healthy heart sample as controls. Ventricular and septum sections were examined by immunoblot analysis of total heart protein extracts and by immunostaining. Immunoblots indicated significant decreases in desmoglein-2 and desmocollin-2, independent of any known underlying mutations, whereas immune-histochemical analysis showed normal localization of all desmosomal proteins. Quantitative RT-PCR revealed normal DSG2 and DSC2 mRNA transcript levels, suggesting increased protein turn-over rather than transcriptional down regulation. Conclusion: Reduced cardiac desmoglein-2 and desmocollin-2 levels appear to be specifically associated with ARVD/C, independent of underlying mutations. These findings highlight a key role of desmosomal cadherins in the pathophysiology of ARVD/C. Whether these reductions could be considered as specific markers for ARVD/C requires replication analysis.	[Vite, Alexia; Gandjbakhch, Estelle; Fouret, Pierre; Neyroud, Nathalie; Gary, Francoise; Komajda, Michel; Charron, Philippe; Villard, Eric] Univ Paris, Hop Pitie Salpetriere, UPMC, F-75252 Paris, France; [Vite, Alexia; Gandjbakhch, Estelle; Neyroud, Nathalie; Gary, Francoise; Komajda, Michel; Charron, Philippe; Villard, Eric] Hop La Pitie Salpetriere, Inst Natl Sante & Rech Med UMR S956, ICAN, Paris, France; [Gandjbakhch, Estelle; Varnous, Shaida; Fontaine, Guy; Hidden-Lucet, Francoise; Komajda, Michel; Charron, Philippe] Hop La Pitie Salpetriere, Inst Cardiol AP HP, Paris, France; [Prost, Catherine] Univ Paris 08, Lab Histol & Therapie Gen, Bobigny, France; [Prost, Catherine] Univ Paris 05, Dept Pathol, Hop Necker Enfants Malad, Paris, France; [Fressart, Veronique] Hop La Pitie Salpetriere, Unite Cardiogenet, Serv Biochim Metabol, Paris, France; [Fouret, Pierre] Hop La Pitie Salpetriere, Serv Anat Pathol, Paris, France; [Donal, Erwan] Hop Pontchaillou, Dept Cardiol, Rennes, France; [Fornes, Paul] Hop Univ, Dept Pathol, F-51092 Reims, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-VIII; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Rennes; CHU de Reims	Villard, E (corresponding author), Univ Paris, Hop Pitie Salpetriere, UPMC, F-75252 Paris, France.	eric.villard@upmc.fr	donal, erwan/ABC-9736-2020; Villard, Eric/AAI-2464-2021; Neyroud, Nathalie/D-1013-2017; villard, eric/AAH-2868-2021	Villard, Eric/0000-0001-9801-7297; Neyroud, Nathalie/0000-0003-3382-7680; Vite, Alexia/0000-0002-6589-8996; Charron, Philippe/0000-0002-1782-1118; gandjbakhch, estelle/0000-0002-4846-5021; hidden-lucet, francoise/0000-0003-1257-5357	Assistance Publique - Hopitaux de Paris (PHRC programme hospitalier de recherche clinique) [AOM05073]; Federation Francaise de Cardiologie; Societe francaise de cardiologie; Ligue contre la Cardiomyopathie	Assistance Publique - Hopitaux de Paris (PHRC programme hospitalier de recherche clinique); Federation Francaise de Cardiologie; Societe francaise de cardiologie; Ligue contre la Cardiomyopathie	This work was supported by grants from Assistance Publique - Hopitaux de Paris (PHRC programme hospitalier de recherche clinique AOM05073), "Federation Francaise de Cardiologie," "Societe francaise de cardiologie," and "Ligue contre la Cardiomyopathie". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimaki A, 2007, AM J HUM GENET, V81, P964, DOI 10.1086/521633; Asimaki A, 2009, NEW ENGL J MED, V360, P1075, DOI 10.1056/NEJMoa0808138; Awad MM, 2008, NAT CLIN PRACT CARD, V5, P258, DOI 10.1038/ncpcardio1182; Basso C, 2006, EUR HEART J, V27, P1847, DOI 10.1093/eurheartj/ehl095; Basso C, 2009, LANCET, V373, P1289, DOI 10.1016/S0140-6736(09)60256-7; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Christensen AH, 2010, J MED GENET, V47, P736, DOI 10.1136/jmg.2010.077891; Corrado D, 2006, CIRCULATION, V113, P1634, DOI 10.1161/CIRCULATIONAHA.105.616490; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; Elliott P, 2010, CIRC-CARDIOVASC GENE, V3, P314, DOI 10.1161/CIRCGENETICS.110.937805; Fontaine G, 1999, ANNU REV MED, V50, P17, DOI 10.1146/annurev.med.50.1.17; Fontaine GH, 2011, EUR HEART J, V32, P1049, DOI 10.1093/eurheartj/ehr088; Fressart V, 2010, EUROPACE, V12, P861, DOI 10.1093/europace/euq104; Gaertner A, 2012, PHYSIOL GENOMICS, V44, P99, DOI 10.1152/physiolgenomics.00094.2011; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Gehmlich K, 2012, CARDIOVASC PATHOL, V21, P275, DOI 10.1016/j.carpath.2011.09.005; Gehmlich K, 2011, HEART RHYTHM, V8, P711, DOI 10.1016/j.hrthm.2011.01.010; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Hulot JS, 2004, CIRCULATION, V110, P1879, DOI 10.1161/01.CIR.0000143375.93288.82; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Kaplan SR, 2004, HEART RHYTHM, V1, P3, DOI 10.1016/j.hrthm.2004.01.001; Kaplan SR, 2004, CARDIOVASC PATHOL, V13, P26, DOI 10.1016/S1054-8807(03)00107-8; Kim C, 2013, NATURE, V494, P105, DOI 10.1038/nature11799; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi R, 2011, CIRC RES, V109, P1342, DOI 10.1161/CIRCRESAHA.111.255075; Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1093/eurheartj/ehq025, 10.1161/CIRCULATIONAHA.108.840827]; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Munkholm J, 2012, AM J CARDIOL, V109, P272, DOI 10.1016/j.amjcard.2011.08.044; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Pilichou K, 2011, CIRC-CARDIOVASC GENE, V4, P318, DOI 10.1161/CIRCGENETICS.110.959031; Quarta G, 2011, CIRCULATION, V123, P2701, DOI 10.1161/CIRCULATIONAHA.110.976936; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; van Tintelen JP, 2007, CURR OPIN CARDIOL, V22, P185, DOI 10.1097/HCO.0b013e3280d942c4	36	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75082	10.1371/journal.pone.0075082	http://dx.doi.org/10.1371/journal.pone.0075082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086444	Green Submitted, Green Published, gold			2022-12-25	WOS:000326520200081
J	Cao, KJ; Ryvkin, P; Hwang, YC; Johnson, FB; Wang, LS				Cao, Kajia; Ryvkin, Paul; Hwang, Yih-Chii; Johnson, F. Brad; Wang, Li-San			Analysis of Nonlinear Gene Expression Progression Reveals Extensive Pathway and Age-Specific Transitions in Aging Human Brains	PLOS ONE			English	Article							TRANSCRIPTIONAL PROFILES; ALZHEIMERS-DISEASE; OXIDATIVE DAMAGE; AMYLOID-BETA; FATTY-ACIDS; DNA-DAMAGE; BIOLOGY; STRESS; KEGG; RNA	Several recent gene expression studies identified hundreds of genes that are correlated with age in brain and other tissues in human. However, these studies used linear models of age correlation, which are not well equipped to model abrupt changes associated with particular ages. We developed a computational algorithm for age estimation in which the expression of each gene is treated as a dichotomized biomarker for whether the subject is older or younger than a particular age. In addition, for each age-informative gene our algorithm identifies the age threshold with the most drastic change in expression level, which allows us to associate genes with particular age periods. Analysis of human aging brain expression datasets from three frontal cortex regions showed that different pathways undergo transitions at different ages, and the distribution of pathways and age thresholds varies across brain regions. Our study reveals age-correlated expression changes at particular age points and allows one to estimate the age of an individual with better accuracy than previously published methods.	[Cao, Kajia; Johnson, F. Brad; Wang, Li-San] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Ryvkin, Paul; Hwang, Yih-Chii] Univ Penn, Genom & Computat Biol Grad Grp, Philadelphia, PA 19104 USA; [Cao, Kajia; Wang, Li-San] Univ Penn, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA; [Johnson, F. Brad; Wang, Li-San] Univ Penn, Inst Aging, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Wang, LS (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA.	lswang@mail.med.upenn.edu			University of Pennsylvania Research Foundation; National Institute on Aging [U01-AG032984, P30-AG010124]; National Institute of Neurological Disorders and Stroke [P50-NS053488]; National Human Genome Research Institute [T32-HG000046]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG032984, P30AG010124] Funding Source: NIH RePORTER	University of Pennsylvania Research Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research is funded by a University of Pennsylvania Research Foundation Pilot Grant (to KC and LSW); the National Institute on Aging (U01-AG032984 and P30-AG010124 to LSW), National Institute of Neurological Disorders and Stroke (P50-NS053488 to LSW), and National Human Genome Research Institute (T32-HG000046 to PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7; Bergman A, 2007, PLOS COMPUT BIOL, V3, P1648, DOI 10.1371/journal.pcbi.0030170; BEZARD J, 1994, REPROD NUTR DEV, V34, P539, DOI 10.1051/rnd:19940603; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bourre J M, 2004, J Nutr Health Aging, V8, P163; Cao K, 2010, PLOS ONE, V5, P5; Cook PE, 2007, NAT PROTOC, V2, P2796, DOI 10.1038/nprot.2007.396; Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; David-Eden H, 2008, NUCLEIC ACIDS RES, V36, P4641, DOI 10.1093/nar/gkn433; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034; Forester BP, 2010, NMR BIOMED, V23, P242, DOI 10.1002/nbm.1444; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Fry RC, 2003, MECH AGEING DEV, V124, P839, DOI 10.1016/S0047-6374(03)00144-1; Fu CX, 2006, MECH AGEING DEV, V127, P905, DOI 10.1016/j.mad.2006.09.006; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Girardot F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-69; Golden TR, 2006, EXP GERONTOL, V41, P1040, DOI 10.1016/j.exger.2006.06.034; Golden TR, 2008, AGING CELL, V7, P850, DOI 10.1111/j.1474-9726.2008.00433.x; Hall M, 2007, KNOWL-BASED SYST, V20, P120, DOI 10.1016/j.knosys.2006.11.008; Hawse JR, 2004, EXP EYE RES, V79, P935, DOI 10.1016/j.exer.2004.04.007; Ho JWK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S16; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kooperberg C, 1997, J AM STAT ASSOC, V92, P117, DOI 10.2307/2291455; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Langley P., 1992, ANAL BAYESIAN CLASSI; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Manke Thomas, 2005, Genome Inform, V16, P159; Masoro E, 2006, HDB BIOL AGING; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; Nakamura E, 2003, J GERONTOL A-BIOL, V58, P196; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Sandberg R, 2001, GENOME RES, V11, P1404, DOI 10.1101/gr.186401; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Simpson JE, 2011, NEUROBIOL AGING; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tsugita A, 2000, ELECTROPHORESIS, V21, P1853, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1853::AID-ELPS1853>3.3.CO;2-P; Uauy R, 2006, NUTR REV, V64, pS24, DOI 10.1301/nr.2006.may.S24-S33; Ueno Linda Massako, 2003, Journal of Physiological Anthropology and Applied Human Science, V22, P37, DOI 10.2114/jpa.22.37; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wu JZ, 2007, GERMA BACKGROUND ADJ; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yehuda S, 2002, NEUROBIOL AGING, V23, P843, DOI 10.1016/S0197-4580(02)00074-X; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zhan M, 2007, GENOME RES, V17, P1236, DOI 10.1101/gr.6216607	60	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74578	10.1371/journal.pone.0074578	http://dx.doi.org/10.1371/journal.pone.0074578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098339	Green Submitted, gold, Green Published			2022-12-25	WOS:000325483600006
J	Polfus, LM; Smith, JA; Shimmin, LC; Bielak, LF; Morrison, AC; Kardia, SLR; Peyser, PA; Hixson, JE				Polfus, Linda M.; Smith, Jennifer A.; Shimmin, Lawrence C.; Bielak, Lawrence F.; Morrison, Alanna C.; Kardia, Sharon L. R.; Peyser, Patricia A.; Hixson, James E.			Genome-Wide Association Study of Gene by Smoking Interactions in Coronary Artery Calcification	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; DISEASE RISK-FACTORS; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; PROINSULIN LEVELS; PROGNOSTIC VALUE; HEART-DISEASE; CALCIUM; EVENTS; METAANALYSIS	Many GWAS have identified novel loci associated with common diseases, but have focused only on main effects of individual genetic variants rather than interactions with environmental factors (GxE). Identification of GxE interactions is particularly important for coronary heart disease (CHD), a major preventable source of morbidity and mortality with strong non-genetic risk factors. Atherosclerosis is the major cause of CHD, and coronary artery calcification (CAC) is directly correlated with quantity of coronary atherosclerotic plaque. In the current study, we tested for genetic variants influencing extent of CAC via interaction with smoking (GxS), by conducting a GxS discovery GWAS in Genetic Epidemiology Network of Arteriopathy (GENOA) sibships (N = 915 European Americans) followed by replication in Framingham Heart Study (FHS) sibships (N = 1025 European Americans). Generalized estimating equations accounted for the correlation within sibships in strata-specific groups of smokers and nonsmokers, as well as GxS interaction. Primary analysis found SNPs that showed suggestive associations (p <= 10(-5)) in GENOA GWAS, but these index SNPs did not replicate in FHS. However, secondary analysis was able to replicate candidate gene regions in FHS using other SNPs (+/-250 kb of GENOA index SNP). In smoker and nonsmoker groups, replicated genes included TCF7L2 (p = 6.0610(-5)) and WWOX (p = 4.5610(-6)); and TNFRSF8 (p = 7.8610(-5)), respectively. For GxS interactions, replicated genes included TBC1D4 (p = 6.9610(-5)) and ADAMTS9 (P = 7.1610(-5)). Interestingly, these genes are involved in inflammatory pathways mediated by the NF-kappa B axis. Since smoking is known to induce chronic and systemic inflammation, association of these genes likely reflects roles in CAC development via inflammatory pathways. Furthermore, the NF-kappa B axis regulates bone remodeling, a key physiological process in CAC development. In conclusion, GxS GWAS has yielded evidence for novel loci that are associated with CAC via interaction with smoking, providing promising new targets for future population-based and functional studies of CAC development.	[Polfus, Linda M.; Shimmin, Lawrence C.; Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Smith, Jennifer A.; Bielak, Lawrence F.; Kardia, Sharon L. R.; Peyser, Patricia A.; Hixson, James E.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan	Hixson, JE (corresponding author), Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.	James.E.Hixson@uth.tmc.edu		Smith, Jennifer Ann/0000-0002-3575-5468; Hixson, James/0000-0002-0849-9315; Morrison, Alanna/0000-0001-6381-4296	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL091988, R01HL87660]; Burroughs Wellcome Fund; Houston Laboratory and Population Science Training Program in Gene-Environment Interaction of the Brown Foundation Institute of Molecular Medicine of UTHealth Medical School (BWF) [1008200]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091988, R01HL087660] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Houston Laboratory and Population Science Training Program in Gene-Environment Interaction of the Brown Foundation Institute of Molecular Medicine of UTHealth Medical School (BWF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health (R01HL091988 to J.E.H., R01HL87660 to S. L. R. K.), and in part by a training fellowship from the Burroughs Wellcome Fund - The Houston Laboratory and Population Science Training Program in Gene-Environment Interaction of the Brown Foundation Institute of Molecular Medicine of UTHealth Medical School (BWF Grant No. 1008200 to L. M. P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; Baud'huin M, 2007, CELL MOL LIFE SCI, V64, P2334, DOI 10.1007/s00018-007-7104-0; Bielinski SJ, 2008, DIABETOLOGIA, V51, P968, DOI 10.1007/s00125-008-1004-1; Botman SL, 2000, VITAL HLTH STAT, V130, P1; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Del Mare S, 2011, AM J CANCER RES, V1, P585; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gokulakrisnan A, 2011, MOL CELL BIOCHEM, V354, P1, DOI 10.1007/s11010-011-0785-6; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hoff JA, 2003, ANN EPIDEMIOL, V13, P163, DOI 10.1016/S1047-2797(02)00277-6; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Levinger I, 2011, ARTHRITIS RHEUM-US, V63, P1343, DOI 10.1002/art.30287; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Loos RJF, 2007, DIABETES, V56, P1943, DOI 10.2337/db07-0055; Muendlein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017978; North KE, 2007, ATHEROSCLEROSIS, V193, P11, DOI 10.1016/j.atherosclerosis.2006.08.015; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; O'Malley PG, 2000, AM J CARDIOL, V85, P945, DOI 10.1016/S0002-9149(99)00906-6; Peyser PA, 2002, CIRCULATION, V106, P304, DOI 10.1161/01.CIR.0000022664.21832.5D; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramos E, 2011, DIABETOLOGIA, V54, P783, DOI 10.1007/s00125-010-2002-7; Roivainen M, 2000, CIRCULATION, V101, P252, DOI 10.1161/01.CIR.101.3.252; Rumberger JA, 2010, VASC HEALTH RISK MAN, V6, P579; Saez ME, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-148; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Turner ST, 2006, ATHEROSCLEROSIS, V185, P340, DOI 10.1016/j.atherosclerosis.2005.06.010; Ueno H, 2006, CARDIOVASC TOXICOL, V6, P39, DOI 10.1385/CT:6:1:39; Vasan RS, 2009, JAMA-J AM MED ASSOC, V302, P168, DOI 10.1001/jama.2009.978-a; Venuraju SM, 2010, J AM COLL CARDIOL, V55, P2049, DOI 10.1016/j.jacc.2010.03.013; Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	40	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74642	10.1371/journal.pone.0074642	http://dx.doi.org/10.1371/journal.pone.0074642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098343	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600008
J	Edwards, TG; Vidmar, TJ; Koeller, K; Bashkin, JK; Fisher, C				Edwards, Terri G.; Vidmar, Thomas J.; Koeller, Kevin; Bashkin, James K.; Fisher, Chris			DNA Damage Repair Genes Controlling Human Papillomavirus (HPV) Episome Levels under Conditions of Stability and Extreme Instability	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; MRN COMPLEX; REPLICATION; IMIDAZOLE; INFECTION; PATHWAY; PHOSPHODIESTERASE; DIFFERENTIATION; RAD9-HUS1-RAD1; POLYAMIDES	DNA damage response (DDR) genes and pathways controlling the stability of HPV episomal DNA are reported here. We set out to understand the mechanism by which a DNA-binding, N-methylpyrrole-imidazole hairpin polyamide (PA25) acts to cause the dramatic loss of HPV DNA from cells. Southern blots revealed that PA25 alters HPV episomes within 5 hours of treatment. Gene expression arrays identified numerous DDR genes that were specifically altered in HPV16 episome-containing cells (W12E) by PA25, but not in HPV-negative (C33A) cells or in cells with integrated HPV16 (SiHa). A siRNA screen of 240 DDR genes was then conducted to identify enhancers and repressors of PA25 activity. Serendipitously, the screen also identified many novel genes, such as TDP1 and TDP2, regulating normal HPV episome stability. MRN and 9-1-1 complexes emerged as important for PA25-mediated episome destruction and were selected for follow-up studies. Mre11, along with other homologous recombination and dsDNA break repair genes, was among the highly significant PA25 repressors. The Mre11 inhibitor Mirin was found to sensitize HPV episomes to PA25 resulting in a similar to 5-fold reduction of the PA25 IC50. A novel assay that couples end-labeling of DNA to Q-PCR showed that PA25 causes strand breaks within HPV DNA, and that Mirin greatly enhances this activity. The 9-1-1 complex member Rad9, a representative PA25 enhancer, was transiently phosphorylated in response to PA25 treatment suggesting that it has a role in detecting and signaling episome damage by PA25 to the cell. These results establish that DNA-targeted compounds enter cells and specifically target the HPV episome. This action leads to the activation of numerous DDR pathways and the massive elimination of episomal DNA from cells. Our findings demonstrate that viral episomes can be targeted for elimination from cells by minor groove binding agents, and implicate DDR pathways as important mediators of this process.	[Edwards, Terri G.; Bashkin, James K.; Fisher, Chris] NanoVir, Kalamazoo, MI USA; [Vidmar, Thomas J.] BioStat Consultants, Portage, MI USA; [Koeller, Kevin; Bashkin, James K.] Univ Missouri, Dept Chem & Biochem, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis	Fisher, C (corresponding author), NanoVir, Kalamazoo, MI USA.	chris.fisher@nanovirpharm.com	Bashkin, James K./F-5327-2010; Edwards, Terri G/L-4710-2018	Bashkin, James K./0000-0001-6735-4733; 	NIH [AI062182, AI068159, AI083803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI062182, R41AI068159, R01AI083803, R42AI062182, R42AI068159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI062182, AI068159, and AI083803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird EE, 1996, J AM CHEM SOC, V118, P6141, DOI 10.1021/ja960720z; Balakrishnan L, 2009, J BIOL CHEM, V284, P15158, DOI 10.1074/jbc.M109.000505; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Chen HC, 2011, JNCI-J NATL CANCER I, V103, P1387, DOI 10.1093/jnci/djr283; Chenoweth DM, 2010, J AM CHEM SOC, V132, P14521, DOI 10.1021/ja105068b; Chenoweth DM, 2009, P NATL ACAD SCI USA, V106, P13175, DOI 10.1073/pnas.0906532106; Dickinson LA, 2004, CHEM BIOL, V11, P1583, DOI 10.1016/j.chembiol.2004.09.004; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Edwards TG, 2011, ANTIVIR RES, V91, P177, DOI 10.1016/j.antiviral.2011.05.014; Edwards TG, 2013, J VIROL, V87, P11; Fradet-Turcotte A, 2011, J VIROLOGY; Garner-Hamrick PA, 2002, VIROLOGY, V301, P334, DOI 10.1006/viro.2002.1558; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Gillespie KA, 2012, J VIROL, V86, P9520, DOI 10.1128/JVI.00247-12; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hoffmann R, 2006, J VIROL, V80, P4431, DOI 10.1128/JVI.80.9.4431-4439.2006; Hong SY, 2011, J VIROL, V85, P9486, DOI 10.1128/JVI.05007-11; Hoskins EE, 2009, ONCOGENE, V28, P674, DOI 10.1038/onc.2008.416; Hoskins EE, 2012, J VIROL, V86, P8131, DOI 10.1128/JVI.00408-12; Howley PM, 2007, FIELDS VIROLOGY, V2, P2299; Hunt RA, 2011, NUCLEIC ACIDS RES, V39, P4265, DOI 10.1093/nar/gkq1362; Kastan MB, 2008, MOL CANCER RES, V6, P517, DOI 10.1158/1541-7786.MCR-08-0020; Kravchenko J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030736; Kutler DI, 2003, J NATL CANCER I, V95, P1718, DOI 10.1093/jnci/djg091; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Lu ZM, 2004, J BIOL CHEM, V279, P35664, DOI 10.1074/jbc.M403385200; McBride AA, 2012, BBA-GENE REGUL MECH, V1819, P820, DOI 10.1016/j.bbagrm.2012.01.011; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Molho-Pessach Vered, 2007, Curr Probl Dermatol, V35, P39, DOI 10.1159/000106409; Moody CA, 2007, P NATL ACAD SCI USA, V104, P19541, DOI 10.1073/pnas.0707947104; Moody CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000605; Nickols NG, 2013, MOL CANCER THER, V12, P675, DOI 10.1158/1535-7163.MCT-12-1040; Nikitin PA, 2011, FUTURE VIROL, V6, P813, DOI 10.2217/FVL.11.55; Nitiss JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003370; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Querol-Audi J, 2012, P NATL ACAD SCI USA, V109, P8528, DOI 10.1073/pnas.1121116109; Sakakibara N, 2011, J VIROL, V85, P8981, DOI 10.1128/JVI.00541-11; Sambrook J., 2012, MOL CLONING LAB MANU, V4th, DOI DOI 10.1016/0003-2697(90)90595-Z; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Spangle JM, 2010, J VIROL, V84, P9398, DOI 10.1128/JVI.00974-10; Stanley MA, 2012, CLIN MICROBIOL REV, V25, P215, DOI 10.1128/CMR.05028-11; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Synold TW, 2012, CANCER CHEMOTH PHARM, V70, P617, DOI 10.1007/s00280-012-1954-3; Turnell AS, 2012, J GEN VIROL, V93, P2076, DOI 10.1099/vir.0.044412-0; van Zeeburg HJT, 2008, J NATL CANCER I, V100, P1649, DOI 10.1093/jnci/djn366; Walker WL, 1997, P NATL ACAD SCI USA, V94, P5634, DOI 10.1073/pnas.94.11.5634; Wang S, 2012, BIOCHEMISTRY-US, V51, P9796, DOI 10.1021/bi301327v; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035159; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	56	38	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75406	10.1371/journal.pone.0075406	http://dx.doi.org/10.1371/journal.pone.0075406			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098381	Green Published, gold			2022-12-25	WOS:000325434500029
J	Hellmuth, C; Demmelmair, H; Schmitt, I; Peissner, W; Bluher, M; Koletzko, B				Hellmuth, Christian; Demmelmair, Hans; Schmitt, Isabel; Peissner, Wolfgang; Blueher, Matthias; Koletzko, Berthold			Association between Plasma Nonesterified Fatty Acids Species and Adipose Tissue Fatty Acid Composition	PLOS ONE			English	Article							METABOLISM; BIOSYNTHESIS; MOBILIZATION; BIOMARKERS; LIPIDOMICS; RELEASE; INSULIN; OBESITY; STORAGE; HUMANS	Fatty acid composition of adipose tissue (AT) is an established long-term biomarker for fatty acid (FA) intake and status, but AT samples are not easily available. Nonesterified FA composition in plasma (pNEFA) may be a good indicator of AT FA composition, because pNEFA are mainly generated by AT lipolysis. We investigated the correlation of 42 pNEFA and subcutaneous as well as visceral AT FA in 27 non-diabetic women with a median BMI of 36 kg/m(2) (Q(0.25): 25 kg/m(2); Q(0.75): 49 kg/m(2)). Close correlations of pNEFA and AT FA were found for odd-chain FA (15:0 r = 0.838 and 0.862 for subcutaneous and visceral AT, respectively) and omega-3 FA (22:6 r = 0.719/0.535), while no significant or low correlations were found for other FA including 18:1 (r = 0.384/0.325) and 20:4 (r = 0.386/0.266). Close correlations of pNEFA and AT FA were found for essential fatty acids, like 18:2 (r = 0.541/0.610) and 20:5 (r = 0.561/0.543). The lower correlation for some pNEFA species with AT FA indicates that the variation of most pNEFA is significantly affected by other FA sources and flux of FA to tissue, in addition to release from AT. A relevant influence of BMI on the level of correlation was shown for saturated FA. NEFA analysis in fasted plasma can serve as a virtual AT biopsy for some FA, and as a biomarker for intake of dairy products and sea fish.	[Hellmuth, Christian; Demmelmair, Hans; Schmitt, Isabel; Peissner, Wolfgang; Koletzko, Berthold] Univ Munich, Med Ctr, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp, Munich, Germany; [Blueher, Matthias] Univ Hosp Leipzig, Clin Endocrinol & Nephrol, Dept Internal Med, Leipzig, Germany	University of Munich; Leipzig University	Koletzko, B (corresponding author), Univ Munich, Med Ctr, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp, Munich, Germany.	office.koletzko@med.lmu.de	Hellmuth, Christian/C-2575-2017	Hellmuth, Christian/0000-0001-9778-497X	"Kompetenznetz Adipositas" ("Competence Network for Adiposity"); German Federal Ministry of Education and Research [01GI0826, 01GI1128]; Commission of the European Communities [FP7-212652]; Munich Center of Health Sciences (McHealth); Deutsche Forschungsgemeinschaft (DFG) for the Clinical Research group "Atherobesity" [KFO 152]	"Kompetenznetz Adipositas" ("Competence Network for Adiposity"); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Commission of the European Communities(European Commission); Munich Center of Health Sciences (McHealth); Deutsche Forschungsgemeinschaft (DFG) for the Clinical Research group "Atherobesity"(German Research Foundation (DFG))	This work was supported financially by the "Kompetenznetz Adipositas" ("Competence Network for Adiposity") funded by the German Federal Ministry of Education and Research (FKZ, grant 01GI0826 and FKZ, grant 01GI1128). Further support by the Commission of the European Communities, within the seventh Framework Programme, NUTRIMENTHE, grant FP7-212652, and by the Munich Center of Health Sciences (McHealth) is gratefully acknowledged. This manuscript does not necessarily reflect the views of the Commission and in no way anticipates the future policy in this area. This work was additionally supported by a grant from Deutsche Forschungsgemeinschaft (DFG) for the Clinical Research group "Atherobesity" KFO 152 (project BL 833/1-1) (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AH, 2011, DIABETES, V60, P2300, DOI 10.2337/db11-0219; Baylin A, 2002, AM J CLIN NUTR, V76, P750, DOI 10.1093/ajcn/76.4.750; Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085; Caron-Jobin M, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2011.19; Connor WE, 1996, J LIPID RES, V37, P290; Decsi T, 1998, EUR J CLIN NUTR, V52, P541, DOI 10.1038/sj.ejcn.1600607; Frayn KN, 2012, AM J PHYSIOL-ENDOC M, V302, pE468, DOI 10.1152/ajpendo.00527.2011; Garaulet M, 2001, AM J CLIN NUTR, V74, P585; Garaulet M, 2011, NUTRITION, V27, P170, DOI 10.1016/j.nut.2010.01.004; Garland M, 1998, AM J CLIN NUTR, V67, P25, DOI 10.1093/ajcn/67.1.25; Halliwell KJ, 1996, J LIPID RES, V37, P1842; Hellmuth C, 2012, ANAL CHEM, V84, P1483, DOI 10.1021/ac202602u; HIRSCH J, 1960, AM J CLIN NUTR, V8, P499, DOI 10.1093/ajcn/8.4.499; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Jensen MD, 2002, J ROY SOC MED, V95, P3; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Klingler M, 2011, LIPIDS, V46, P981, DOI 10.1007/s11745-011-3576-7; Koenker R., 2013, QUANTREG QUANTILE RE; Koutsari C, 2012, DIABETES, V61, P329, DOI 10.2337/db11-0748; Kremmyda LS, 2011, BIOMED PAP, V155, P195, DOI 10.5507/bp.2011.052; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; LEAF DA, 1995, AM J CLIN NUTR, V62, P68, DOI 10.1093/ajcn/62.1.68; MALCOM GT, 1989, AM J CLIN NUTR, V50, P288, DOI 10.1093/ajcn/50.2.288; Mansson Helena Lindmark, 2008, Food Nutr Res, V52, DOI 10.3402/fnr.v52i0.1821; Mittendorfer B, 2003, DIABETES, V52, P1641, DOI 10.2337/diabetes.52.7.1641; Ozogul Y, 2009, INT J FOOD SCI NUTR, V60, P464, DOI [10.1080/09637480701838175, 10.1080/09637480701425650]; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Pettinella C, 2007, J CHROMATOGR B, V850, P168, DOI 10.1016/j.jchromb.2006.11.023; Raclot T, 1997, BIOCHEM J, V324, P911, DOI 10.1042/bj3240911; Raclot T, 2003, PROG LIPID RES, V42, P257, DOI 10.1016/S0163-7827(02)00066-8; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Sprecher H, 1999, PROSTAG LEUKOTR ESS, V60, P317, DOI 10.1016/S0952-3278(99)80006-4; Sprecher H, 1999, LIPIDS, V34, pS153, DOI 10.1007/BF02562271; Summers LKM, 2000, AM J CLIN NUTR, V71, P1470; Sun Q, 2007, AM J CLIN NUTR, V86, P929, DOI 10.1093/ajcn/86.4.929; Teegala SM, 2009, J AOAC INT, V92, P1250; Teusink B, 2003, DIABETES, V52, P614, DOI 10.2337/diabetes.52.3.614; Votruba SB, 2007, DIABETES, V56, P2589, DOI 10.2337/db07-0439; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Wolk A, 1998, AM J CLIN NUTR, V68, P291, DOI 10.1093/ajcn/68.2.291; Wolk A, 2001, J NUTR, V131, P828, DOI 10.1093/jn/131.3.828; Xie BG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/805683; Yli-Jama P, 2001, Eur J Intern Med, V12, P107, DOI 10.1016/S0953-6205(01)00119-4	44	43	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74927	10.1371/journal.pone.0074927	http://dx.doi.org/10.1371/journal.pone.0074927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098359	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500017
J	Krezymon, A; Richetin, K; Halley, H; Roybon, L; Lassalle, JM; Frances, B; Verret, L; Rampon, C				Krezymon, Alice; Richetin, Kevin; Halley, Helene; Roybon, Laurent; Lassalle, Jean-Michel; Frances, Bernard; Verret, Laure; Rampon, Claire			Modifications of Hippocampal Circuits and Early Disruption of Adult Neurogenesis in the Tg2576 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							INDUCED NEURONAL DYSFUNCTION; DENTATE GRANULE CELLS; AMYLOID-BETA PROTEIN; NEUROPEPTIDE-Y; COGNITIVE IMPAIRMENTS; TRANSGENIC MICE; A-BETA; MEMORY; BRAIN; GYRUS	At advanced stages of Alzheimer's disease, cognitive dysfunction is accompanied by severe alterations of hippocampal circuits that may largely underlie memory impairments. However, it is likely that anatomical remodeling in the hippocampus may start long before any cognitive alteration is detected. Using the well-described Tg2576 mouse model of Alzheimer's disease that develops progressive age-dependent amyloidosis and cognitive deficits, we examined whether specific stages of the disease were associated with the expression of anatomical markers of hippocampal dysfunction. We found that these mice develop a complex pattern of changes in their dentate gyrus with aging. Those include aberrant expression of neuropeptide Y and reduced levels of calbindin, reflecting a profound remodeling of inhibitory and excitatory circuits in the dentate gyrus. Preceding these changes, we identified severe alterations of adult hippocampal neurogenesis in Tg2576 mice. We gathered converging data in Tg2576 mice at young age, indicating impaired maturation of new neurons that may compromise their functional integration into hippocampal circuits. Thus, disruption of adult hippocampal neurogenesis occurred before network remodeling in this mouse model and therefore may account as an early event in the etiology of Alzheimer's pathology. Ultimately, both events may constitute key components of hippocampal dysfunction and associated cognitive deficits occurring in Alzheimer's disease.	[Krezymon, Alice; Richetin, Kevin; Halley, Helene; Lassalle, Jean-Michel; Frances, Bernard; Verret, Laure; Rampon, Claire] Univ Toulouse UPS, Ctr Rech Cognit Anim, Toulouse, France; [Krezymon, Alice; Richetin, Kevin; Halley, Helene; Lassalle, Jean-Michel; Frances, Bernard; Verret, Laure; Rampon, Claire] Ctr Rech Cognit Anim, CNRS, Toulouse, France; [Roybon, Laurent] Lund Univ, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Lund University	Rampon, C (corresponding author), Univ Toulouse UPS, Ctr Rech Cognit Anim, Toulouse, France.	claire.rampon@univ-tlse3.fr	Verret, Laure/D-2219-2011; Verret, Laure/D-9224-2017; Richetin, kevin/R-2040-2016	Verret, Laure/0000-0001-5272-6063; Verret, Laure/0000-0001-5272-6063; Richetin, kevin/0000-0001-7859-9517; rampon, claire/0000-0001-8551-8682	Agence Nationale pour la Recherche [ANR-06-JCJC, ANR-10-05-MALZ]; Centre National de la Recherche Scientifique (CNRS); University of Toulouse; Region Midi-Pyrenees; France Alzheimer Association; Singer-Polignac Foundation; Philippe Foundation Awards; French Ministry of Research	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Toulouse; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); France Alzheimer Association; Singer-Polignac Foundation; Philippe Foundation Awards; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	C. Rampon acknowledges the support of the Agence Nationale pour la Recherche (ANR-06-JCJC and ANR-10-05-MALZ); the Centre National de la Recherche Scientifique (CNRS), the University of Toulouse, and the Region Midi-Pyrenees; L. Verret was supported by ANR-06-JCJC, the France Alzheimer Association, the Singer-Polignac Foundation, and the Philippe Foundation Awards. A. Krezymon and K. Richetin were supported by the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017669; Alpar A, 2006, BRAIN RES, V1099, P189, DOI 10.1016/j.brainres.2006.04.109; Arendash GW, 2002, PHYSIOL BEHAV, V75, P643, DOI 10.1016/S0031-9384(02)00640-6; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Busche MA, 2012, P NATL ACAD SCI USA, V109, P8740, DOI 10.1073/pnas.1206171109; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Cotel MC, 2008, BRAIN RES, V1222, P207, DOI 10.1016/j.brainres.2008.05.052; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Couillard-Despres S, 2011, GERONTOLOGY, V57, P559, DOI 10.1159/000323481; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dickey CA, 2003, J NEUROSCI, V23, P5219; Dong H, 2004, NEUROSCIENCE, V127, P601, DOI 10.1016/j.neuroscience.2004.05.040; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Faure A, 2011, NEUROBIOL AGING, V32, P407, DOI 10.1016/j.neurobiolaging.2009.03.009; Freir DB, 2011, NEUROBIOL AGING, V32, P2211, DOI 10.1016/j.neurobiolaging.2010.01.001; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Ihunwo AO, 2010, ACTA NEUROBIOL EXP, V70, P362; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Klinger M, 2003, INT J DEV NEUROSCI, V21, P357, DOI 10.1016/j.ijdevneu.2003.08.001; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Lassalle JM, 2008, BEHAV BRAIN RES, V191, P104, DOI 10.1016/j.bbr.2008.03.017; Lazarov O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00081; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Marin-Burgin A, 2012, BEHAV BRAIN RES, V227, P391, DOI 10.1016/j.bbr.2011.07.001; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mitchell JC, 2009, HUM MOL GENET, V18, P4492, DOI 10.1093/hmg/ddp408; Morgenstern NA, 2013, MOL CELL NEUROSCI, V56, P298, DOI 10.1016/j.mcn.2013.07.003; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Palop JJ, 2010, NEUROMOL MED, V12, P48, DOI 10.1007/s12017-009-8097-7; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Pathania M, 2010, NEUROPHARMACOLOGY, V58, P865, DOI 10.1016/j.neuropharm.2010.01.010; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Popovic M, 2008, NEUROSCIENCE, V155, P182, DOI 10.1016/j.neuroscience.2008.05.023; Rabinovici GD, 2009, BEHAV NEUROL, V21, P117, DOI [10.3233/BEN-2009-0232, 10.1155/2009/609839]; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Roybon L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004779; Sala C, 2002, NEUROSIGNALS, V11, P213, DOI 10.1159/000065433; Scharfman HE, 2006, EXP SUPPL, V95, P193; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Song J, 2012, DEV NEUROBIOL, V72, P1032, DOI 10.1002/dneu.22014; SPERK G, 1992, NEUROSCIENCE, V50, P831, DOI 10.1016/0306-4522(92)90207-I; Sperk G, 2007, PROG BRAIN RES, V163, P285, DOI 10.1016/S0079-6123(07)63017-9; Stewart S, 2011, J ALZHEIMERS DIS, V26, P105, DOI 10.3233/JAD-2011-101827; SUN B, 2009, CELL STEM CELL, V6, P10; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Takahashi H, 2010, BRAIN STRUCT FUNCT, V214, P145, DOI 10.1007/s00429-010-0242-4; Trouche S, 2009, P NATL ACAD SCI USA, V106, P5919, DOI 10.1073/pnas.0811054106; Unger C, 2005, MOL CELL NEUROSCI, V30, P218, DOI 10.1016/j.mcn.2005.07.012; Verret L, 2007, PSYCHONEUROENDOCRINO, V32, pS26, DOI 10.1016/j.psyneuen.2007.04.014; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Verret L, 2013, NEUROBIOL AGING, V34, P211, DOI 10.1016/j.neurobiolaging.2012.05.013; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	74	58	61	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76497	10.1371/journal.pone.0076497	http://dx.doi.org/10.1371/journal.pone.0076497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086745	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900103
J	Scheuplein, F; Thariath, A; Macdonald, S; Truneh, A; Mashal, R; Schaub, R				Scheuplein, Felix; Thariath, Abraham; Macdonald, Susan; Truneh, Alemseged; Mashal, Robert; Schaub, Robert			A Humanized Monoclonal Antibody Specific for Invariant Natural Killer T (iNKT) Cells for In Vivo Depletion	PLOS ONE			English	Article							NKT CELLS; PULMONARY INFLAMMATION; ACTIVATION; DISEASE; RECOVERY; INJURY	Invariant Natural Killer T (iNKT) cells are a subset of T cells recognizing glycolipid antigens presented by CD1d. Human iNKT cells express a conserved T cell receptor (TCR)-alpha chain (V alpha 24-J alpha 18) paired with a specific beta chain, V beta 11. The cells are both innate-like, with rapid cytokine release, and adaptive-like, including thymic positive selection. Over activation of iNKT cells can mediate tissue injury and inflammation in multiple organ systems and play a role in mediating the pathology associated with clinically important inflammatory diseases. At the same time, iNKT cell activation can play a role in protecting against infectious disease and cancer or modulate certain autoimmune diseases through its impact on both the innate and adaptive immune system. This suggests that approaches to cause iNKT cell reduction and/or depletion could treat inflammatory diseases while approaches to promote activation may have therapeutic potential in certain infections, cancer or autoimmune disease. This report summarizes the characterization of a humanized monoclonal depleting antibody (NKTT120) in the cynomolgus macaque. NKTT120 is being developed to treat iNKT mediated inflammation that is associated with chronic inflammatory conditions like sickle cell disease and asthma. NKTT120 binds to human iTCRs and to FC gamma RI and FC gamma RIII and has been shown to kill target cells in an ADCC assay at low concentrations consistent with the FC gamma R binding. iNKT cells were depleted within 24 hours in cynomolgus macaques, but T cell, B cell, and NK cell frequencies were unchanged. iNKT cell recovery was dose and time dependent. T cell dependent antigen responses were not impaired by NKTT120 mediated iNKT depletion as measured by response to KLH challenge. NKTT120 administration did not induce an inflammatory cytokine release at doses up to 10 mg/kg. These data support the use of NKTT120 as an intervention in inflammatory diseases where iNKT reduction or depletion could be beneficial.	[Scheuplein, Felix; Thariath, Abraham; Macdonald, Susan; Truneh, Alemseged; Mashal, Robert; Schaub, Robert] NKT Therapeut Inc, Waltham, MA 02451 USA		Scheuplein, F (corresponding author), NKT Therapeut Inc, Waltham, MA 02451 USA.	FScheuplein@NKTRX.com	Truneh, Alem/ABB-7891-2020		NKT Therapeutics	NKT Therapeutics	This work was done as part of development of NKTT120. The work was self-funded by NKT Therapeutics (www.nktrx.com). There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Beziat V, 2010, CLIN IMMUNOL, V135, P364, DOI 10.1016/j.clim.2010.01.010; Bienemann K, 2011, SCAND J IMMUNOL, V74, P406, DOI 10.1111/j.1365-3083.2011.02591.x; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Exley MA, 2008, EUR J IMMUNOL, V38, P1756, DOI 10.1002/eji.200737389; Field JJ, 2013, BLOOD, V121, P3329, DOI 10.1182/blood-2012-11-465963; Field JJ, 2011, CLIN IMMUNOL, V140, P177, DOI 10.1016/j.clim.2011.03.002; Haraguchi K, 2004, BONE MARROW TRANSPL, V34, P595, DOI 10.1038/sj.bmt.1704582; JENDRO MC, 1995, ARTHRITIS RHEUM, V38, P1242, DOI 10.1002/art.1780380912; Leveque D, 2005, ANTICANCER RES, V25, P2327; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Montoya CJ, 2007, IMMUNOLOGY, V122, P1, DOI 10.1111/j.1365-2567.2007.02647.x; Osman Y, 2000, EUR J IMMUNOL, V30, P1919, DOI 10.1002/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3; Rubio MT, 2012, BLOOD, V120, P2144, DOI 10.1182/blood-2012-01-404673; Stewart R, 2011, PROTEIN ENG DES SEL, V24, P671, DOI 10.1093/protein/gzr015; Van Kaer L, 2007, CURR OPIN IMMUNOL, V19, P354, DOI 10.1016/j.coi.2007.03.001; Van Kaer L, 2011, CELL TISSUE RES, V343, P43, DOI 10.1007/s00441-010-1023-3; Wallace KL, 2010, BLOOD, V116, P5010, DOI 10.1182/blood-2010-06-290643; Wallace KL, 2009, BLOOD, V114, P667, DOI 10.1182/blood-2009-02-205492; Wu L, 2009, CURR MOL MED, V9, P4, DOI 10.2174/156652409787314534	20	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76692	10.1371/journal.pone.0076692	http://dx.doi.org/10.1371/journal.pone.0076692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086759	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900108
J	Courtial, N; Mucke, C; Herkt, S; Kolodziej, S; Hussong, H; Lausen, J				Courtial, Nadine; Muecke, Christian; Herkt, Stefanie; Kolodziej, Stephan; Hussong, Helge; Lausen, Joern			The T-Cell Oncogene Tal2 Is a Target of PU.1 and Upregulated during Osteoclastogenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; STEM-CELLS; CHROMOSOMAL TRANSLOCATION; DIFFERENTIATION; LEUKEMIA; BROWSER; NFATC1; SCL; LYL-1	Transcription factors play a crucial role in regulating differentiation processes during human life and are important in disease. The basic helix-loop-helix transcription factors Tal1 and Lyl1 play a major role in the regulation of gene expression in the hematopoietic system and are involved in human leukemia. Tal2, which belongs to the same family of transcription factors as Tal1 and Lyl1, is also involved in human leukaemia. However, little is known regarding the expression and regulation of Tal2 in hematopoietic cells. Here we show that Tal2 is expressed in hematopoietic cells of the myeloid lineage. Interestingly, we found that usage of the Tal2 promoter is different in human and mouse cells. Two promoters, hP1 and hP2 drive Tal2 expression in human erythroleukemia K562 cells, however in mouse RAW cells only the mP1 promoter is used. Furthermore, we found that Tal2 expression is upregulated during oesteoclastogenesis. We show that Tal2 is a direct target gene of the myeloid transcription factor PU.1, which is a key transcription factor for osteoclast gene expression. Strikingly, PU.1 binding to the P1 promoter is conserved between mouse and human, but PU.1 binding to P2 was only detected in human K562 cells. Additionally, we provide evidence that Tal2 influences the expression of the osteoclastic differentiation gene TRACP. These findings provide novel insight into the expression control of Tal2 in hematopoietic cells and reveal a function of Tal2 as a regulator of gene expression during osteoclast differentiation.	[Courtial, Nadine; Muecke, Christian; Herkt, Stefanie; Kolodziej, Stephan; Hussong, Helge; Lausen, Joern] Inst Biomed Res, Frankfurt, Germany		Lausen, J (corresponding author), Inst Biomed Res, Frankfurt, Germany.	lausen@em.uni-frankfurt.de			LOEWE initiative Onkogene Signaltransduktion Frankfurt; LOEWE Center for Cell and Gene Therapy Frankfurt; Hessisches Ministerium fur Wissenschaft und Kunst [III L 4-518/55.004, III L 4-518/17004]; Deutsche Forschungsgemeinschaft [SPP-1463, LA 1389/5-1]; Georg-Speyer-Haus; German Federal Ministry of Health; Ministry of Higher Education, Research and the Arts of the state of Hessen	LOEWE initiative Onkogene Signaltransduktion Frankfurt; LOEWE Center for Cell and Gene Therapy Frankfurt; Hessisches Ministerium fur Wissenschaft und Kunst; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Georg-Speyer-Haus; German Federal Ministry of Health; Ministry of Higher Education, Research and the Arts of the state of Hessen	This work was supported in part by the LOEWE initiative Onkogene Signaltransduktion Frankfurt, the LOEWE Center for Cell and Gene Therapy Frankfurt, Hessisches Ministerium fur Wissenschaft und Kunst, III L 4-518/55.004 and III L 4-518/17004, the Deutsche Forschungsgemeinschaft (SPP-1463, LA 1389/5-1) and institutional funds of the Georg-Speyer-Haus. The Georg-Speyer-Haus is funded jointly by the German Federal Ministry of Health and the Ministry of Higher Education, Research and the Arts of the state of Hessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; BAER R, 1993, SEMIN CANCER BIOL, V4, P341; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P2031, DOI 10.1073/pnas.86.6.2031; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bucher K, 2000, DEV BIOL, V227, P533, DOI 10.1006/dbio.2000.9920; Capron C, 2006, BLOOD, V107, P4678, DOI 10.1182/blood-2005-08-3145; Chan WYI, 2007, BLOOD, V109, P1908, DOI 10.1182/blood-2006-05-023226; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; Conley AB, 2008, BIOINFORMATICS, V24, P1563, DOI 10.1093/bioinformatics/btn243; Courtial N, 2012, FASEB J, V26, P523, DOI 10.1096/fj.11-190850; Curtis DJ, 2012, STEM CELLS, V30, P1053, DOI 10.1002/stem.1093; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; FINGER LR, 1989, P NATL ACAD SCI USA, V86, P5039, DOI 10.1073/pnas.86.13.5039; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Guo Y, 2012, ONCOL REP, V27, P286, DOI 10.3892/or.2011.1483; Helfrich MH, 2003, MICROSC RES TECHNIQ, V61, P514, DOI 10.1002/jemt.10375; Herglotz J, 2012, ONCOGENE; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; Mori S, 1999, MOL BRAIN RES, V64, P199, DOI 10.1016/S0169-328X(98)00323-4; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pinheiro P, 2004, GENE EXPR PATTERNS, V4, P85, DOI 10.1016/S1567-133X(03)00145-5; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Tsuneto M, 2005, STEM CELLS, V23, P134, DOI 10.1634/stemcells.2004-0154; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; XIA Y, 1994, ONCOGENE, V9, P1437; XIA Y, 1991, P NATL ACAD SCI USA, V88, P11416, DOI 10.1073/pnas.88.24.11416; Yavropoulou M. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P204	44	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76637	10.1371/journal.pone.0076637	http://dx.doi.org/10.1371/journal.pone.0076637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086757	Green Submitted, Green Published, gold			2022-12-25	WOS:000325220000071
J	Ko, BS; Lu, YJ; Yao, WL; Liu, TA; Tzean, SS; Shen, TL; Liou, JY				Ko, Bor-Sheng; Lu, Yi-Jhu; Yao, Wen-Ling; Liu, Tzu-An; Tzean, Shean-Shong; Shen, Tang-Long; Liou, Jun-Yang			Cordycepin Regulates GSK-3 beta/beta-Catenin Signaling in Human Leukemia Cells	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; ACUTE MYELOID-LEUKEMIA; MOUSE MELANOMA-CELLS; BETA-CATENIN; STEM-CELLS; CARCINOMA CELLS; WNT; EXPRESSION; 3'-DEOXYADENOSINE; METASTASIS	Background: Leukemia stem cells (LSCs) are a limitless cell source for the initiation and maintenance of leukemia. Activation of the Wnt/beta-catenin pathway is required for the survival and development of LSCs. Therefore, targeting beta-catenin is considered a therapeutic strategy for the treatment of leukemia. The goal of this study was to explore whether cordycepin, an active component of the traditional medicine Cordyceps sinensis, regulates beta-catenin expression in leukemia cells. Methodology and Principal Findings: In this study, we found that cordycepin significantly suppressed cell proliferation in all malignant cancer cells, including U937, K562, A549, HepG2, SK-Hep1 and MCF7 in a dose-dependent manner. However, cordycepin reduced beta-catenin levels in U937, K562 and THP1 leukemia cells and had no effect on other solid cancer cells. In addition, treatment with cordycepin significantly suppressed leukemia colony formation in soft agar assay. Cordycepin enhanced proteasome-dependent degradation and inhibited nuclear translocation of beta-catenin in leukemia cells. Cordycepin-reduced beta-catenin stability was restored by the addition of a pharmacological inhibitor of GSK-3 beta, indicating that cordycepin-suppressed beta-catenin stability is mediated by the activation of GSK-3 beta. Furthermore, cordycepin abolished the effect of Wnt3a-induced beta-catenin in leukemia cells. In addition, cordycepin-impaired beta-catenin is regulated by Akt activation but is not significantly influenced by AMPK or mTOR signal pathways. Significance: Our findings show for the first time that codycepin selectively reduces beta-catenin stability in leukemia but not in other solid tumor cells. This suppressive effect is mediated by regulating GSK-3 beta. A synergistic combination of cordycepin with other treatments should be used as a novel strategy to eradicate leukemia via elimination of LSCs.	[Ko, Bor-Sheng; Lu, Yi-Jhu; Yao, Wen-Ling; Liu, Tzu-An; Liou, Jun-Yang] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Ko, Bor-Sheng] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Yao, Wen-Ling; Tzean, Shean-Shong; Shen, Tang-Long] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Liou, Jun-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan	Liou, JY (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	jliou@nhri.org.tw	Liou, Jun-Yang/B-1065-2010	KO, BOR-SHENG/0000-0002-7965-7579; Shen, Tang-Long/0000-0001-6264-3608	National Health Research Institutes [01A1-CSPP07-014, 01A1-CSPP16-014]; National Science Council of Taiwan [101-2321-B-400-011, 100-2314-B-002-062]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by The National Health Research Institutes (01A1-CSPP07-014, 01A1-CSPP16-014) and The National Science Council (101-2321-B-400-011, 100-2314-B-002-062) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buenz EJ, 2005, J ETHNOPHARMACOL, V96, P19, DOI 10.1016/j.jep.2004.09.029; Chang TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040193; Chen LS, 2008, BRIT J HAEMATOL, V140, P682, DOI 10.1111/j.1365-2141.2007.06955.x; Chen Y, 2010, J AGR FOOD CHEM, V58, P11645, DOI 10.1021/jf1028976; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eaves CJ, 2010, NEW ENGL J MED, V362, P2326, DOI 10.1056/NEJMcibr1003522; Heidel FH, 2012, CELL STEM CELL, V10, P412, DOI 10.1016/j.stem.2012.02.017; Hu Y, 2009, LEUKEMIA, V23, P109, DOI 10.1038/leu.2008.262; Jen CY, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen084; Jeong JW, 2011, TOXICOL IN VITRO, V25, P817, DOI 10.1016/j.tiv.2011.02.001; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kleber M, 2004, CURR OPIN CELL BIOL, V16, P681, DOI 10.1016/j.ceb.2004.08.006; Kleppe M, 2012, CELL STEM CELL, V10, P351, DOI 10.1016/j.stem.2012.03.006; Ko BS, 2010, LIFE SCI, V86, P199, DOI 10.1016/j.lfs.2009.12.003; Kodama EN, 2000, BIOCHEM PHARMACOL, V59, P273, DOI 10.1016/S0006-2952(99)00325-1; Kunnev D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-318; Lee EJ, 2010, PHYTOTHER RES, V24, P1755, DOI 10.1002/ptr.3132; Lee HJ, 2012, INVEST NEW DRUG, V30, P1917, DOI 10.1007/s10637-012-9859-x; Lee SJ, 2010, FOOD CHEM TOXICOL, V48, P277, DOI 10.1016/j.fct.2009.09.042; Lee SJ, 2009, ARCH BIOCHEM BIOPHYS, V490, P103, DOI 10.1016/j.abb.2009.09.001; Liu TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057968; Liu TA, 2011, AM J PATHOL, V179, P2698, DOI 10.1016/j.ajpath.2011.08.010; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Matsuda H, 2009, CHEM PHARM BULL, V57, P411, DOI 10.1248/cpb.57.411; Nakamura K, 2006, ANTICANCER RES, V26, P43; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; OLSSON I, 1983, CANCER RES, V43, P5862; Paterson RRM, 2008, PHYTOCHEMISTRY, V69, P1469, DOI 10.1016/j.phytochem.2008.01.027; Rodman LE, 1997, TOXICOL APPL PHARM, V147, P39, DOI 10.1006/taap.1997.8264; Soman G, 2009, J IMMUNOL METHODS, V348, P83, DOI 10.1016/j.jim.2009.07.010; Thomadaki H, 2008, CANCER CHEMOTH PHARM, V61, P703, DOI 10.1007/s00280-007-0533-5; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wehbe-Janek H, 2007, ANTICANCER RES, V27, P3143; Wong YY, 2010, J BIOL CHEM, V285, P2610, DOI 10.1074/jbc.M109.071159; Wu WC, 2007, CANCER CHEMOTH PHARM, V60, P103, DOI 10.1007/s00280-006-0354-y; Yoshikawa N, 2008, N-S ARCH PHARMACOL, V377, P591, DOI 10.1007/s00210-007-0218-y; Yoshikawa N, 2009, ANTICANCER RES, V29, P3857; Ysebaert L, 2006, LEUKEMIA, V20, P1211, DOI 10.1038/sj.leu.2404239; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	41	31	32	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76320	10.1371/journal.pone.0076320	http://dx.doi.org/10.1371/journal.pone.0076320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086728	Green Submitted, gold, Green Published			2022-12-25	WOS:000325220000063
J	Carbonnelle, D; Vignard, V; Sehedic, D; Moreau-Aubry, A; Florenceau, L; Charpentier, M; Mikulits, W; Labarriere, N; Lang, F				Carbonnelle, Delphine; Vignard, Virginie; Sehedic, Delphine; Moreau-Aubry, Agnes; Florenceau, Laetitia; Charpentier, Maud; Mikulits, Wolfgang; Labarriere, Nathalie; Lang, Francois			The Melanoma Antigens MELOE-1 and MELOE-2 Are Translated from a Bona Fide Polycistronic mRNA Containing Functional IRES Sequences	PLOS ONE			English	Article							OPEN READING FRAME; DROSOPHILA-MELANOGASTER; MEDIATED TRANSLATION; CANCER ANTIGEN; LAMININ B1; T-CELLS; REGION; GENE; IMMUNOTHERAPY; ENTRY	Our previous studies on melanoma antigens identified two new polypeptides, named MELOE-1 and MELOE-2, that are involved in immunosurveillance. Intriguingly, these antigens are coded by distinct open reading frames (ORF) of the meloe mRNA which is significantly expressed only in the melanocytic lineage. In addition, MELOE-1 and -2 specific T cell clones recognized melanoma cells but very poorly normal melanocytes suggesting differential translation of meloe in normal vs tumor cells. This prompted us to elucidate the mechanisms of translation of these antigens in melanoma cells. We first demonstrated that no splicing event or cryptic promoter could generate shorter meloe transcripts containing only one of the two ORFs. Triggering meloe RNA degradation with a siRNA close to the ORF coding for MELOE-2 abrogated expression of both MELOE-1 and MELOE-2, thus confirming that the two ORFs are always associated. Next we showed, in a bicistronic reporter system, that IRES activities could be detected upstream of MELOE-1 and MELOE-2 and finally confirmed their translation from full length meloe cDNA in melanoma cells with eGFP constructs. In conclusion, meloe is a polycistronic mRNA that generates both MELOE-1 and MELOE-2 antigens through IRES-dependent translation in melanoma cells and that may explain their tumor specificity.	[Carbonnelle, Delphine; Vignard, Virginie; Sehedic, Delphine; Moreau-Aubry, Agnes; Florenceau, Laetitia; Charpentier, Maud; Labarriere, Nathalie; Lang, Francois] INSERM, U892, Nantes, France; [Carbonnelle, Delphine; Vignard, Virginie; Sehedic, Delphine; Moreau-Aubry, Agnes; Florenceau, Laetitia; Charpentier, Maud; Labarriere, Nathalie; Lang, Francois] Univ Nantes, Nantes, France; [Carbonnelle, Delphine; Vignard, Virginie; Sehedic, Delphine; Moreau-Aubry, Agnes; Florenceau, Laetitia; Charpentier, Maud; Labarriere, Nathalie; Lang, Francois] CNRS, UMR 6299, Nantes, France; [Vignard, Virginie] CHU Nantes, F-44035 Nantes 01, France; [Mikulits, Wolfgang] Ctr Comprehens Canc, Inst Canc Res, Vienna, Austria	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; CHU de Nantes	Lang, F (corresponding author), INSERM, U892, Nantes, France.	francois.lang@univ-nantes.fr	Vignard, Virginie/K-7540-2015; Charpentier, Maud/K-6843-2015; Mikulits, Wolfgang/AAH-4043-2021; Florenceau, Laetitia/K-7428-2015; Aubry, Agnes/K-8771-2015; LANG, François/K-7403-2015; Labarriere, Nathalie/H-8876-2015	Vignard, Virginie/0000-0002-6702-2824; Florenceau, Laetitia/0000-0003-1284-414X; LANG, François/0000-0002-0762-4647; Labarriere, Nathalie/0000-0002-1407-6546; Mikulits, Wolfgang/0000-0003-4612-7106; MOREAU-AUBRY, Agnes/0000-0001-5540-3374	Association pour la Recherche sur le Cancer [SFI20111203534]	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by grant #SFI20111203534 from the Association pour la Recherche sur le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse CA, 1999, INT J CANCER, V82, P442, DOI 10.1002/(SICI)1097-0215(19990730)82:3<442::AID-IJC19>3.3.CO;2-Q; Andrews J, 1996, GENETICS, V143, P1699; Brogna S, 1997, EMBO J, V16, P2023, DOI 10.1093/emboj/16.8.2023; Butterfield LH, 1997, GENE, V191, P129, DOI 10.1016/S0378-1119(96)00789-5; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Godet Y, 2008, J EXP MED, V205, P2673, DOI 10.1084/jem.20081356; Godet Y, 2010, EUR J IMMUNOL, V40, P1786, DOI 10.1002/eji.200940132; Godet Y, 2010, CANCER IMMUNOL IMMUN, V59, P431, DOI 10.1007/s00262-009-0762-z; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Holcik M, 2005, RNA, V11, P1605, DOI 10.1261/rna.2158605; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Jean D, 2008, BIOCHEM J, V413, P125, DOI 10.1042/BJ20071255; Kanamori Y, 2010, J BIOL CHEM, V285, P36933, DOI 10.1074/jbc.M110.180398; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Kozak M, 2007, GENE, V403, P194, DOI 10.1016/j.gene.2007.08.017; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; Liu H, 2000, GENETICS, V154, P1735; Moreau-Aubry A, 2000, J EXP MED, V191, P1617, DOI 10.1084/jem.191.9.1617; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Petz M, 2007, NUCLEIC ACIDS RES, V35, P2473, DOI 10.1093/nar/gkm096; Petz M, 2012, NUCLEIC ACIDS RES, V40, P290, DOI 10.1093/nar/gkr717; Ramanathan P, 2008, RNA BIOL, V5, P149, DOI 10.4161/rna.5.3.6676; Reiss J, 1999, AM J HUM GENET, V64, P706, DOI 10.1086/302296; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosenberg SA, 2002, J IMMUNOL, V168, P2402, DOI 10.4049/jimmunol.168.5.2402; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Starck SR, 2011, CELL MOL LIFE SCI, V68, P1471, DOI 10.1007/s00018-011-0655-0; Tautz Diethard, 2009, Briefings in Functional Genomics & Proteomics, V8, P68, DOI 10.1093/bfgp/eln054; van der Bruggen P, 2013, CANC IMMUN; Wall AA, 2005, J BIOL CHEM, V280, P27670, DOI 10.1074/jbc.M500255200; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; Wang RF, 1998, J IMMUNOL, V161, P3596; Xiong Z, 2006, J IMMUNOL, V177, P4907, DOI 10.4049/jimmunol.177.7.4907	35	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75233	10.1371/journal.pone.0075233	http://dx.doi.org/10.1371/journal.pone.0075233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086473	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700058
J	Cong, ZJ; Hu, LH; Bian, ZQ; Ye, GY; Yu, MH; Gao, YH; Li, ZS; Yu, ED; Zhong, M				Cong, Zhi-Jie; Hu, Liang-Hao; Bian, Zheng-Qian; Ye, Guang-Yao; Yu, Min-Hao; Gao, Yun-He; Li, Zhao-Shen; Yu, En-Da; Zhong, Ming			Systematic Review of Anastomotic Leakage Rate According to an International Grading System Following Anterior Resection for Rectal Cancer	PLOS ONE			English	Review							TOTAL MESORECTAL EXCISION; RISK-FACTORS; DEFUNCTIONING STOMA; COLORECTAL ANASTOMOSIS; J-POUCH; LAPAROSCOPIC RESECTION; COLOANAL ANASTOMOSIS; LOOP ILEOSTOMY; COLONIC POUCH; SURGERY	Background: A generally acceptable definition and a severity grading system for anastomotic leakages (ALs) following rectal resection were not available until 2010, when the International Study Group of Rectal Cancer (ISGRC) proposed a definition and a grading system for AL. Methods: A search for published data was performed using the MEDLINE database (2000 to December 5, 2012) to perform a systematic review of the studies that described AL, grade AL according to the grading system, pool data, and determine the average rate of AL for each grade after anterior resection (AR) for rectal cancer. Results: A total of 930 abstracts were retrieved; 40 articles on AR, 25 articles on low AR (LAR), and 5 articles on ultralow AR (ULAR) were included in the review and analysis. The pooled overall AL rate of AR was 8.58% (2,085/24,288); the rate of the asymptomatic leakage (Grade A) was 2.57%, that of AL that required active intervention without relaparotomy (Grade B) was 2.37%, and that of AL that required relaparotomy (Grade C) was 5.40%. The pooled rate of AL that required relaparotomy was higher in AR (5.40%) than in LAR (4.70%) and in ULAR (1.81%), which could be attributed to the higher rate of protective defunctioning stoma in LAR (40.72%) and ULAR (63.44%) compared with that in AR (30.11%). Conclusions: The new grading system is simple that the ALs of each grade can be easily extracted from past publications, therefore likely to be accepted and applied in future studies.	[Cong, Zhi-Jie; Bian, Zheng-Qian; Ye, Guang-Yao; Yu, Min-Hao; Gao, Yun-He; Zhong, Ming] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Colorectal Surg, Shanghai 200030, Peoples R China; [Cong, Zhi-Jie; Hu, Liang-Hao; Li, Zhao-Shen; Yu, En-Da] Second Mil Med Univ, Changhai Hosp, Digest Endoscopy Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University	Yu, ED (corresponding author), Second Mil Med Univ, Changhai Hosp, Digest Endoscopy Ctr, Shanghai, Peoples R China.	dryuenda@gmail.com; drzhongm@126.com	ye, guangyao/AAV-9151-2021					Akagi T, 2012, SURG LAPARO ENDO PER, V22, P52, DOI 10.1097/SLE.0b013e31824019fc; Akasu T, 2010, J GASTROINTEST SURG, V14, P104, DOI 10.1007/s11605-009-1067-4; Akiyoshi T, 2011, AM J SURG, V202, P259, DOI 10.1016/j.amjsurg.2010.11.014; Beirens K, 2012, ACTA CHIR BELG, V112, P10, DOI 10.1080/00015458.2012.11680789; Bell SW, 2003, BRIT J SURG, V90, P1261, DOI 10.1002/bjs.4219; Bennis M, 2012, ANN SURG, V255, P504, DOI 10.1097/SLA.0b013e31824485c4; Bianchi PP, 2007, DIS COLON RECTUM, V50, P2047, DOI 10.1007/s10350-007-9055-9; Biondo S, 2013, SURGERY, V153, P383, DOI 10.1016/j.surg.2012.08.012; Bittorf B, 2003, LANGENBECK ARCH SURG, V387, P406, DOI 10.1007/s00423-003-0349-7; Brennan DJ, 2007, DIS COLON RECTUM, V50, P302, DOI 10.1007/10350-006-0811-z; Bretagnol F, 2007, BRIT J SURG, V94, P1266, DOI 10.1002/bjs.5524; Chamlou R, 2007, ANN SURG, V246, P916, DOI 10.1097/SLA.0b013e31815c29ff; Chen WR, 2011, J SURG ONCOL, V104, P493, DOI 10.1002/jso.21965; Choi Dong Hyun, 2010, J Korean Soc Coloproctol, V26, P265, DOI 10.3393/jksc.2010.26.4.265; Chude GG, 2008, HEPATO-GASTROENTEROL, V55, P1562; Cong ZJ, 2009, WORLD J SURG, V33, P1292, DOI 10.1007/s00268-009-0008-4; Dehni N, 1998, BRIT J SURG, V85, P1114; den Dulk M, 2009, BRIT J SURG, V96, P1066, DOI 10.1002/bjs.6694; Eberl T, 2008, AM J SURG, V196, P592, DOI 10.1016/j.amjsurg.2007.10.023; Eckmann C, 2004, INT J COLORECTAL DIS, V19, P128, DOI 10.1007/s00384-003-0498-8; Eriksen MT, 2005, COLORECTAL DIS, V7, P51, DOI 10.1111/j.1463-1318.2004.00700.x; Ferenschild FTJ, 2009, INT J COLORECTAL DIS, V24, P923, DOI 10.1007/s00384-009-0732-0; Fouda E, 2011, J GASTROINTEST SURG, V15, P137, DOI 10.1007/s11605-010-1364-y; Fujita S, 2012, LANCET ONCOL, V13, P616, DOI 10.1016/S1470-2045(12)70158-4; Fukunaga Y, 2010, SURG ENDOSC, V24, P145, DOI 10.1007/s00464-009-0551-y; Gastinger I, 2005, BRIT J SURG, V92, P1137, DOI 10.1002/bjs.5045; Glancy DG, 2012, COLORECTAL DIS, V14, P453, DOI 10.1111/j.1463-1318.2011.02682.x; GOLIGHER JC, 1977, BRIT J SURG, V64, P609, DOI 10.1002/bjs.1800640902; Gong H, 2013, CELL BIOCHEM BIOPHYS, V65, P491, DOI 10.1007/s12013-012-9445-z; Hallbook O, 1996, BRIT J SURG, V83, P60, DOI 10.1002/bjs.1800830119; Ho YH, 2002, ANN SURG, V236, P49, DOI 10.1097/00000658-200207000-00009; Ito M, 2008, INT J COLORECTAL DIS, V23, P703, DOI 10.1007/s00384-008-0470-8; Joh YG, 2009, DIS COLON RECTUM, V52, P91, DOI 10.1007/DCR.0b013e3181973d7f; Jung SH, 2008, DIS COLON RECTUM, V51, P902, DOI 10.1007/s10350-008-9272-x; Kanellos D, 2010, TECH COLOPROCTOL, V14, pS35, DOI 10.1007/s10151-010-0620-1; Kanellos I, 2004, Tech Coloproctol, V8 Suppl 1, ps79, DOI 10.1007/s10151-004-0119-8; Kanellos I, 2002, Tech Coloproctol, V6, P153, DOI 10.1007/s101510200035; Khalil El-Sayed Ashraf, 2004, J Egypt Natl Canc Inst, V16, P210; Kim JS, 2009, J AM COLL SURGEONS, V209, P694, DOI 10.1016/j.jamcollsurg.2009.09.021; Kim SH, 2008, DIS COLON RECTUM, V51, P844, DOI 10.1007/s10350-008-9256-x; Kruschewski M, 2011, COLORECTAL DIS, V13, P284, DOI 10.1111/j.1463-1318.2009.02140.x; Kruschewski M, 2007, INT J COLORECTAL DIS, V22, P919, DOI 10.1007/s00384-006-0260-0; Law WL, 2004, SURG ENDOSC, V18, P1592, DOI 10.1007/s00464-003-9249-8; Law WL, 2000, AM J SURG, V179, P92, DOI 10.1016/S0002-9610(00)00252-X; Lee MR, 2006, HEPATO-GASTROENTEROL, V53, P682; Leester B, 2002, Acta Chir Iugosl, V49, P67; Lefebure B, 2008, INT J COLORECTAL DIS, V23, P283, DOI 10.1007/s00384-007-0380-1; Lin JK, 2011, J GASTROINTEST SURG, V15, P2251, DOI 10.1007/s11605-011-1721-5; Liu HB, 2011, INT SURG, V96, P13; Maggiori L, 2011, COLORECTAL DIS, V13, P632, DOI 10.1111/j.1463-1318.2010.02252.x; Marusch F, 2002, DIS COLON RECTUM, V45, P1164, DOI 10.1007/s10350-004-6384-9; Matthiessen P, 2004, Colorectal Dis, V6, P462, DOI 10.1111/j.1463-1318.2004.00657.x; Matthiessen P, 2007, ANN SURG, V246, P207, DOI 10.1097/SLA.0b013e3180603024; Merkel S, 2001, Colorectal Dis, V3, P154, DOI 10.1046/j.1463-1318.2001.00232.x; Miyajima N, 2009, SURG ENDOSC, V23, P113, DOI 10.1007/s00464-008-0078-7; Mroczkowski Pawel, 2011, Pol Przegl Chir, V83, P144, DOI 10.2478/v10035-011-0022-8; Nesbakken A, 2005, COLORECTAL DIS, V7, P576, DOI 10.1111/j.1463-1318.2005.00870.x; Nesbakken A, 2001, BRIT J SURG, V88, P400, DOI 10.1046/j.1365-2168.2001.01719.x; Ogiso S, 2010, SURG ENDOSC, V24, P2822, DOI 10.1007/s00464-010-1057-3; Peeters KCMJ, 2005, BRIT J SURG, V92, P211, DOI 10.1002/bjs.4806; Peng JJ, 2010, AM J SURG, V199, P753, DOI 10.1016/j.amjsurg.2009.03.026; Penninckx F, 2012, COLORECTAL DIS, V14, pE413, DOI 10.1111/j.1463-1318.2012.02977.x; Ptok H, 2007, BRIT J SURG, V94, P1548, DOI 10.1002/bjs.5707; Rahbari NN, 2010, SURGERY, V147, P339, DOI 10.1016/j.surg.2009.10.012; Rondelli F, 2012, EJSO-EUR J SURG ONC, V38, P1065, DOI 10.1016/j.ejso.2012.07.110; Rutegard M, 2012, BRIT J SURG, V99, P127, DOI 10.1002/bjs.7712; Scheidbach H, 2002, SURG ENDOSC, V16, P7, DOI 10.1007/s00464-001-8314-4; Schmidt O, 2003, EUR J SURG ONCOL, V29, P239, DOI 10.1053/ejso.2002.1416; Shin US, 2010, INT J COLORECTAL DIS, V25, P843, DOI 10.1007/s00384-010-0938-1; Shiomi A, 2011, INT J COLORECTAL DIS, V26, P79, DOI 10.1007/s00384-010-1036-0; Smith JD, 2012, ANN SURG, V256, P1034, DOI 10.1097/SLA.0b013e318257d2c1; Tocchi A, 2000, DIS COLON RECTUM, V43, P951, DOI 10.1007/BF02237357; Tsujinaka S, 2008, INT J COLORECTAL DIS, V23, P67, DOI 10.1007/s00384-007-0369-9; Ulrich AB, 2009, DIS COLON RECTUM, V52, P412, DOI 10.1007/DCR.0b013e318197e1b1; Vlot EA, 2005, SURG TODAY, V35, P629, DOI 10.1007/s00595-005-2999-2; Vorobiev GI, 2004, BRIT J SURG, V91, P1506, DOI 10.1002/bjs.4330; Warschkow R, 2011, ANN SURG ONCOL, V18, P2772, DOI 10.1245/s10434-011-1696-1; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Wong NY, 2005, DIS COLON RECTUM, V48, P2076, DOI 10.1007/s10350-005-0146-1; Xiao L, 2011, WORLD J SURG, V35, P1367, DOI 10.1007/s00268-011-1053-3; Yamamoto S, 2012, SURG LAPARO ENDO PER, V22, P239, DOI 10.1097/SLE.0b013e31824fbb56; Z'graggen K, 2001, ANN SURG, V234, P780, DOI 10.1097/00000658-200112000-00009; Zhao WT, 2013, WORLD J SURG, V37, P227, DOI 10.1007/s00268-012-1812-9; Zhu QL, 2010, WORLD J GASTROENTERO, V16, P4605, DOI 10.3748/wjg.v16.i36.4605	84	61	68	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75519	10.1371/journal.pone.0075519	http://dx.doi.org/10.1371/journal.pone.0075519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086552	Green Submitted, gold, Green Published			2022-12-25	WOS:000325218700095
J	Kyostila, K; Lappalainen, AK; Lohi, H				Kyostila, Kaisa; Lappalainen, Anu K.; Lohi, Hannes			Canine Chondrodysplasia Caused by a Truncating Mutation in Collagen-Binding Integrin Alpha Subunit 10	PLOS ONE			English	Article							MESSENGER-RNA DECAY; SKELETAL DYSPLASIAS; SULFATE TRANSPORTER; GROWTH; GENE; DWARFISM; RECEPTOR; BONE; CHONDROCYTE; CARTILAGE	The skeletal dysplasias are disorders of the bone and cartilage tissues. Similarly to humans, several dog breeds have been reported to suffer from different types of genetic skeletal disorders. We have studied the molecular genetic background of an autosomal recessive chondrodysplasia that affects the Norwegian Elkhound and Karelian Bear Dog breeds. The affected dogs suffer from disproportionate short stature dwarfism of varying severity. Through a genome-wide approach, we mapped the chondrodysplasia locus to a 2-Mb region on canine chromosome 17 in nine affected and nine healthy Elkhounds (p(raw) = 7.42x10(-6), p(genome-wide) = 0.013). The associated locus contained a promising candidate gene, cartilage specific integrin alpha 10 (ITGA10), and mutation screening of its 30 exons revealed a nonsense mutation in exon 16 (c.2083C>T; p.Arg695*) that segregated fully with the disease in both breeds (p = 2.5x10(-23)). A 24% mutation carrier frequency was indicated in NEs and an 8% frequency in KBDs. The ITGA10 gene product, integrin receptor alpha 10-subunit combines into a collagen-binding alpha 10 beta 1 integrin receptor, which is expressed in cartilage chondrocytes and mediates chondrocyte-matrix interactions during endochondral ossification. As a consequence of the nonsense mutation, the alpha 10-protein was not detected in the affected cartilage tissue. The canine phenotype highlights the importance of the alpha 10 beta 1 integrin in bone growth, and the large animal model could be utilized to further delineate its specific functions. Finally, this study revealed a candidate gene for human chondrodysplasias and enabled the development of a genetic test for breeding purposes to eradicate the disease from the two dog breeds.	[Kyostila, Kaisa; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Kyostila, Kaisa; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Kyostila, Kaisa; Lohi, Hannes] Folkhalsan Inst Genet, Dept Mol Genet, Helsinki, Finland; [Lappalainen, Anu K.] Univ Helsinki, Fac Vet Med, Dept Equine & Small Anim Med, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Lohi, H (corresponding author), Univ Helsinki, Res Programs Unit, Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011	Lohi, Hannes/0000-0003-1087-5532	Academy of Finland; Sigrid Juselius Foundation; Biocentrum Helsinki; Jane and Aatos Erkko Foundation; University of Helsinki	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Jane and Aatos Erkko Foundation; University of Helsinki	This study was supported partly by the Academy of Finland, the Sigrid Juselius Foundation, Biocentrum Helsinki, the Jane and Aatos Erkko Foundation and the University of Helsinki Research Funds. HL is a member of Biocentrum Helsinki and KK is a student in the Helsinki Graduate Program in Biotechnology and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed JN, 2013, DIS MODEL MECH, V6, P755, DOI 10.1242/dmm.011668; Ali BR, 2010, HUM MOL GENET, V19, P2239, DOI 10.1093/hmg/ddq103; Alman BA, 2008, CLIN GENET, V73, P24, DOI 10.1111/j.1399-0004.2007.00933.x; Arnaout MA, 2002, IMMUNOL REV, V186, P125, DOI 10.1034/j.1600-065X.2002.18612.x; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Baldridge D, 2010, ANNU REV GENOM HUM G, V11, P189, DOI 10.1146/annurev-genom-082908-150158; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bargal R, 2009, AM J HUM GENET, V84, P80, DOI 10.1016/j.ajhg.2008.12.004; Bengtsson T, 2005, J CELL SCI, V118, P929, DOI 10.1242/jcs.01678; Bengtsson T, 2001, MATRIX BIOL, V20, P565, DOI 10.1016/S0945-053X(01)00164-0; BINGEL SA, 1982, AM J PATHOL, V107, P219; BINGEL SA, 1994, J AM VET MED ASSOC, V205, P845; Boyko AR, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-216; BREUR GJ, 1989, J AM VET MED ASSOC, V195, P606; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Camper L, 2001, CELL TISSUE RES, V306, P107, DOI 10.1007/s004410100385; CARRIG CB, 1977, J AM VET MED ASSOC, V170, P49; Everts RE, 2000, VET QUART, V22, P63, DOI 10.1080/01652176.2000.9695027; FLETCH SM, 1973, J AM VET MED ASSOC, V162, P357; Foldynova-Trantirkova S, 2012, HUM MUTAT, V33, P29, DOI 10.1002/humu.21636; Frischknecht M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060149; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Goldstein O, 2010, MAMM GENOME, V21, P398, DOI 10.1007/s00335-010-9276-4; Gullberg DE, 2002, PROG HISTOCHEM CYTO, V37, P9; Hanssen I, 1998, J SMALL ANIM PRACT, V39, P10, DOI 10.1111/j.1748-5827.1998.tb03662.x; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hecht JT, 2005, MATRIX BIOL, V23, P525, DOI 10.1016/j.matbio.2004.09.006; Huang LL, 2012, WIRES RNA, V3, P807, DOI 10.1002/wrna.1137; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kano K, 2008, MOL ENDOCRINOL, V22, P1866, DOI 10.1210/me.2007-0310; Karam R, 2013, BBA-GENE REGUL MECH, V1829, P624, DOI 10.1016/j.bbagrm.2013.03.002; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Karniski LP, 2001, HUM MOL GENET, V10, P1485, DOI 10.1093/hmg/10.14.1485; Krakow D, 2010, GENET MED, V12, P327, DOI 10.1097/GIM.0b013e3181daae9b; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LAVELLE RB, 1984, AUST VET J, V61, P268, DOI 10.1111/j.1751-0813.1984.tb15544.x; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Martinez S, 2000, CAN J VET RES, V64, P243; Martinez S, 2007, CAN J VET RES, V71, P66; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; Mertz EL, 2012, J BIOL CHEM, V287, P22030, DOI 10.1074/jbc.M110.116467; MEYERS VN, 1983, J AM VET MED ASSOC, V183, P975; Mortier GR, 2001, EUR J RADIOL, V40, P161, DOI 10.1016/S0720-048X(01)00397-7; Mundlos S, 1997, FASEB J, V11, P227, DOI 10.1096/fasebj.11.4.9068611; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Neff MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051917; Neu-Yilik G, 2011, RNA, V17, P843, DOI 10.1261/rna.2401811; Newman B, 2003, CLIN GENET, V63, P241, DOI 10.1034/j.1399-0004.2003.00046.x; Nishimura G, 2005, HUM MUTAT, V26, P36, DOI 10.1002/humu.20179; Nissenson RA, 1998, ENDOCRINOLOGY, V139, P4753, DOI 10.1210/en.139.12.4753; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Patterson DF, 2000, J VET INTERN MED, V14, P1, DOI 10.1892/0891-6640(2000)14[1:CAMITA]2.0.CO;2; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Popova SN, 2007, ACTA PHYSIOL, V190, P179, DOI 10.1111/j.1748-1716.2007.01718.x; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RISER WH, 1980, J AM VET MED ASSOC, V176, P335; SANDE RD, 1982, AM J PATHOL, V106, P224; SANDE RD, 1983, VET CLIN N AM-SMALL, V13, P71, DOI 10.1016/S0195-5616(83)50005-3; Schibler L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007633; SCHMID TM, 1985, DEV BIOL, V107, P373, DOI 10.1016/0012-1606(85)90319-7; Schwartz NB, 2002, GLYCOBIOLOGY, V12, p57R, DOI 10.1093/glycob/12.4.57R; SMART ME, 1971, CANADIAN VET J, V12, P31; Smit JJ, 2011, VET J, V187, P269, DOI 10.1016/j.tvjl.2009.11.009; Superti-Furga A, 2001, AM J MED GENET, V106, P282, DOI 10.1002/ajmg.10233; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016; Young AE, 2008, ANIM BIOTECHNOL, V19, P1, DOI 10.1080/10495390701638328; Young AE, 2006, MAMM GENOME, V17, P761, DOI 10.1007/s00335-005-0163-3; Zhang Y, 2011, J BONE MINER RES, V26, P604, DOI 10.1002/jbmr.225	83	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75621	10.1371/journal.pone.0075621	http://dx.doi.org/10.1371/journal.pone.0075621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086591	gold, Green Published, Green Submitted			2022-12-25	WOS:000325218700103
J	Nomura, J; Busso, N; Ives, A; Tsujimoto, S; Tamura, M; So, A; Yamanaka, Y				Nomura, Johji; Busso, Nathalie; Ives, Annette; Tsujimoto, Syunsuke; Tamura, Mizuho; So, Alexander; Yamanaka, Yoshihiro			Febuxostat, an Inhibitor of Xanthine Oxidase, Suppresses Lipopolysaccharide-Induced MCP-1 Production via MAPK Phosphatase-1-Mediated Inactivation of JNK	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PROINFLAMMATORY CYTOKINE BIOSYNTHESIS; SELECTIVE INHIBITOR; ATHEROSCLEROSIS; OXIDOREDUCTASE	Excess reactive oxygen species (ROS) formation can trigger various pathological conditions such as inflammation, in which xanthine oxidase (XO) is one major enzymatic source of ROS. Although XO has been reported to play essential roles in inflammatory conditions, the molecular mechanisms underlying the involvement of XO in inflammatory pathways remain unclear. Febuxostat, a selective and potent inhibitor of XO, effectively inhibits not only the generation of uric acid but also the formation of ROS. In this study, therefore, we examined the effects of febuxostat on lipopolysaccharide (LPS)-mediated inflammatory responses. Here we show that febuxostat suppresses LPS-induced MCP-1 production and mRNA expression via activating MAPK phosphatase-1 (MKP-1) which, in turn, leads to dephosphorylation and inactivation of JNK in macrophages. Moreover, these effects of febuxostat are mediated by inhibiting XO-mediated intracellular ROS production. Taken together, our data suggest that XO mediates LPS-induced phosphorylation of JNK through ROS production and MKP-1 inactivation, leading to MCP-1 production in macrophages. These studies may bring new insights into the novel role of XO in regulating inflammatory process through MAPK phosphatase, and demonstrate the potential use of XO inhibitor in modulating the inflammatory processes.	[Nomura, Johji; Tsujimoto, Syunsuke; Tamura, Mizuho; Yamanaka, Yoshihiro] Teijin Pharma Ltd, Pharmaceut Dept Res Labs, Teijin Inst Biomed Res, Tokyo, Japan; [Busso, Nathalie; Ives, Annette; So, Alexander] Univ Lausanne, Serv Rheumatol, Ctr Hosp Univ Vaudois, Dept Appareil Locomoteur, Lausanne, Switzerland	Teijin Pharma Limited; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Nomura, J (corresponding author), Teijin Pharma Ltd, Pharmaceut Dept Res Labs, Teijin Inst Biomed Res, Tokyo, Japan.	j.nomura@teijin.co.jp		Ives, Annette/0000-0002-7407-960X	Teijin Pharma Limited	Teijin Pharma Limited(Teijin Pharma Limited)	This study was supported by Teijin Pharma Limited. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Becker MA, 2004, NUCLEOS NUCLEOT NUCL, V23, P1111, DOI 10.1081/NCN-200027372; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Brandes RP, 1999, HYPERTENSION, V33, P1243, DOI 10.1161/01.HYP.33.5.1243; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Cape JL, 2009, ARCH BIOCHEM BIOPHYS, V484, P190, DOI 10.1016/j.abb.2009.01.010; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Cirillo P, 2009, J AM SOC NEPHROL, V20, P545, DOI 10.1681/ASN.2008060576; Comhair SAA, 2002, AM J PHYSIOL-LUNG C, V283, pL246, DOI 10.1152/ajplung.00491.2001; Engberding N, 2004, CIRCULATION, V110, P2175, DOI 10.1161/01.CIR.0000144303.24894.1C; Filippin LI, 2008, CLIN EXP IMMUNOL, V152, P415, DOI 10.1111/j.1365-2249.2008.03634.x; Hassoun PM, 1998, AM J RESP CRIT CARE, V158, P299, DOI 10.1164/ajrccm.158.1.9709116; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kayyali US, 2001, J BIOL CHEM, V276, P14359, DOI 10.1074/jbc.M010100200; Khosravan R, 2008, J CLIN PHARMACOL, V48, P1014, DOI 10.1177/0091270008322035; Kushiyama A, 2012, ARTERIOSCL THROM VAS, V32, P291, DOI 10.1161/ATVBAHA.111.234559; Li LW, 2009, INT J CLIN EXP MED, V2, P48; Malik UZ, 2011, FREE RADICAL BIO MED, V51, P179, DOI 10.1016/j.freeradbiomed.2011.04.004; Nakai K, 2006, P NATL ACAD SCI USA, V103, P4616, DOI 10.1073/pnas.0510352103; Omori H, 2012, CLIN EXP NEPHROL, V16, P549, DOI 10.1007/s10157-012-0609-3; OSADA Y, 1993, EUR J PHARMACOL, V241, P183, DOI 10.1016/0014-2999(93)90201-R; Park JG, 2011, BMB REP, V44, P497, DOI 10.5483/BMBRep.2011.44.8.497; Schroder K, 2006, FREE RADICAL BIO MED, V41, P1353, DOI 10.1016/j.freeradbiomed.2006.03.026; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Tsuda H, 2012, BIOCHEM BIOPH RES CO, V427, P266, DOI 10.1016/j.bbrc.2012.09.032; Wright RM, 2004, AM J RESP CELL MOL, V30, P479, DOI 10.1165/rcmb.2003-0309OC; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	27	55	57	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75527	10.1371/journal.pone.0075527	http://dx.doi.org/10.1371/journal.pone.0075527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086554	gold, Green Published, Green Submitted			2022-12-25	WOS:000325218700096
J	Singleton, CK; Xiong, YH				Singleton, Charles K.; Xiong, Yanhua			Loss of the Histidine Kinase DhkD Results in Mobile Mounds during Development of Dictyostelium discoideum	PLOS ONE			English	Article							CELL-CELL ADHESION; 3-DIMENSIONAL SCROLL WAVES; PATTERN-FORMATION; GENE-EXPRESSION; TERMINAL DIFFERENTIATION; PRESTALK; PROTEIN; RESISTANCE; EVOLUTION; MOVEMENT	Background: Histidine kinases are receptors for sensing cellular and environmental signals, and in response to the appropriate cue they initiate phosphorelays that regulate the activity of response regulators. The Dictyostelium discoideum genome encodes 15 histidine kinases that function to regulate several processes during the multicellular developmental program, including the slug to culmination transition, osmoregulation, and spore differentiation. While there are many histidine kinases, there is only a single response regulator, RegA. Not surprisingly given the ubiquitous involvement of cAMP in numerous processes of development in Dictyostelium, RegA is a cAMP phosphodiesterase that is activated upon receiving phosphates through a phosphorelay. Hence, all of the histidine kinases characterized to date regulate developmental processes through modulating cAMP production. Here we investigate the function of the histidine kinase DhkD. Principal Findings: The dhkD gene was disrupted, and the resulting cells when developed gave a novel phenotype. Upon aggregation, which occurred without streaming, the mounds were motile, a phenotype termed the pollywog stage. The pollywog phenotype was dependent on a functional RegA. After a period of random migration, the pollywogs attempted to form fingers but mostly generated aberrant structures with no tips. While prestalk and prespore cell differentiation occurred with normal timing, proper patterning did not occur. In contrast, wild type mounds are not motile, and the cAMP chemotactic movement of cells within the mound facilitates proper prestalk and prespore patterning, tip formation, and the vertical elongation of the mound into a finger. Conclusions: We postulate that DhkD functions to ensure the proper cAMP distribution within mounds that in turn results in patterning, tip formation and the transition of mounds to fingers. In the absence of DhkD, aberrant cell movements in response to an altered cAMP distribution result in mound migration, a lack of proper patterning, and an inability to generate normal finger morphology.	[Singleton, Charles K.; Xiong, Yanhua] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Singleton, CK (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	charles.k.singleton@vanderbilt.edu			Vanderbilt College of Arts and Sciences	Vanderbilt College of Arts and Sciences	The work was supported by the Vanderbilt College of Arts and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjard C, 2005, P NATL ACAD SCI USA, V102, P7607, DOI 10.1073/pnas.0501820102; ANJARD C, 2006, ICTYOSTELIUM HISTIDI, P1; Anjard C, 2008, DEVELOPMENT, V135, P819, DOI 10.1242/dev.018051; BRETSCHNEIDER T, 1995, P NATL ACAD SCI USA, V92, P4387, DOI 10.1073/pnas.92.10.4387; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Clow PA, 2000, DEVELOPMENT, V127, P2715; COCUCCI SM, 1970, J CELL BIOL, V45, P399, DOI 10.1083/jcb.45.2.399; Das S, 2011, J BIOL CHEM, V286, P38649, DOI 10.1074/jbc.M111.284182; DINGERMANN T, 1989, GENE, V85, P353, DOI 10.1016/0378-1119(89)90428-9; Dormann D, 1997, J CELL SCI, V110, P1831; Dormann D, 2001, DEVELOPMENT, V128, P4535; EGELHOFF TT, 1989, MOL CELL BIOL, V9, P1965, DOI 10.1128/MCB.9.5.1965; Giusti C, 2010, MOL BIOL CELL, V21, P1825, DOI 10.1091/mbc.E09-11-0976; JERMYN KA, 1989, NATURE, V340, P144, DOI 10.1038/340144a0; Kirsten JH, 2005, DEV BIOL, V287, P146, DOI 10.1016/j.ydbio.2005.08.043; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; MATSUKUMA S, 1979, J EMBRYOL EXP MORPH, V50, P243; MEE JD, 1986, BIOCHEM CELL BIOL, V64, P722, DOI 10.1139/o86-099; NEWELL PC, 1982, J GEN MICROBIOL, V128, P1639; Pekovich SR, 1998, J NUTR, V128, P683, DOI 10.1093/jn/128.4.683; Puta F, 1998, FOLIA BIOL-PRAGUE, V44, P185; Roisin-Bouffay C, 2000, MOL CELL, V6, P953, DOI 10.1016/S1097-2765(05)00082-1; Schaap P, 2011, DEV GROWTH DIFFER, V53, P452, DOI 10.1111/j.1440-169X.2011.01263.x; Schuster SC, 1996, EMBO J, V15, P3880, DOI 10.1002/j.1460-2075.1996.tb00762.x; Shaulsky G, 1998, DEVELOPMENT, V125, P691; SIEGERT F, 1992, P NATL ACAD SCI USA, V89, P6433, DOI 10.1073/pnas.89.14.6433; SIEGERT F, 1995, CURR BIOL, V5, P937, DOI 10.1016/S0960-9822(95)00184-9; Singleton CK, 2006, EUKARYOT CELL, V5, P991, DOI 10.1128/EC.00058-06; Singleton CK, 1998, DEV BIOL, V203, P345, DOI 10.1006/dbio.1998.9049; SINGLETON CK, 1987, DEV BIOL, V119, P433, DOI 10.1016/0012-1606(87)90047-9; Siu CH, 2004, SEMIN CELL DEV BIOL, V15, P633, DOI 10.1016/j.semcdb.2004.09.004; Siu CH, 2011, DEV GROWTH DIFFER, V53, P518, DOI 10.1111/j.1440-169X.2011.01267.x; STERNFELD J, 1981, DIFFERENTIATION, V20, P10, DOI 10.1111/j.1432-0436.1981.tb01150.x; Tekinay T, 2003, EUKARYOT CELL, V2, P618, DOI 10.1128/EC.2.3.618-626.2003; Thomason PA, 1999, J BIOL CHEM, V274, P27379, DOI 10.1074/jbc.274.39.27379; Thomason PA, 2006, DEV BIOL, V292, P358, DOI 10.1016/j.ydbio.2006.01.010; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; Thompson CRL, 2004, DEV GROWTH DIFFER, V46, P363; Umeda T, 2004, J THEOR BIOL, V226, P215, DOI 10.1016/j.jtbi.2003.08.016; Varney TR, 2002, DEVELOPMENT, V129, P2381; Vasiev B, 2003, J THEOR BIOL, V223, P347, DOI 10.1016/S0022-5193(03)00103-6; Vasiev B, 1999, BIOPHYS J, V76, P595, DOI 10.1016/S0006-3495(99)77228-0; Wang J, 2000, DEV BIOL, V227, P734, DOI 10.1006/dbio.2000.9881; Wang N, 1996, EMBO J, V15, P3890, DOI 10.1002/j.1460-2075.1996.tb00763.x; Weijer CJ, 2004, CURR OPIN GENET DEV, V14, P392, DOI 10.1016/j.gde.2004.06.006; ZHANG Q, 1995, THESIS VANDERBILT U; Zinda MJ, 1998, DEV BIOL, V196, P171, DOI 10.1006/dbio.1998.8854	49	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75618	10.1371/journal.pone.0075618	http://dx.doi.org/10.1371/journal.pone.0075618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086589	Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700102
J	Benevides, L; Cardoso, CR; Milanezi, CM; Castro-Filice, LS; Barenco, PVC; Sousa, RO; Rodrigues, RM; Mineo, JR; Silva, JS; Silva, NM				Benevides, Luciana; Cardoso, Cristina R.; Milanezi, Cristiane M.; Castro-Filice, Leticia S.; Barenco, Paulo V. C.; Sousa, Romulo O.; Rodrigues, Rosangela M.; Mineo, Jose R.; Silva, Joao S.; Silva, Neide M.			Toxoplasma gondii Soluble Tachyzoite Antigen Triggers Protective Mechanisms against Fatal Intestinal Pathology in Oral Infection of C57BL/6 Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LAMINA PROPRIA; IFN-GAMMA; INTRAEPITHELIAL LYMPHOCYTES; IL-12 PRODUCTION; T-CELLS; PERORAL INFECTION; INTERFERON-GAMMA; RESISTANCE; RECEPTOR	Toxoplasma gondii induces a potent IL-12 response early in infection that results in IFN-gamma-dependent control of parasite growth. It was previously shown that T. gondii soluble tachyzoite antigen (STAg) injected 48 hr before intraperitoneal infection reduces lipoxin A(4) and 5-lipoxygenase (5-LO)-dependent systemic IL-12 and IFN-gamma production as well as hepatic immunopathology. This study investigated the ability of STAg-pretreatment to control the fatal intestinal pathology that develops in C57BL/6 mice orally infected with 100 T. gondii cysts. STAg-pretreatment prolonged the animals' survival by decreasing tissue parasitism and pathology, mainly in the ilea. Protection was associated with decreases in the systemic IFN-gamma levels and IFN-gamma and TNF message levels in the ilea and with increased TGF-beta production in this tissue, but protection was independent of 5-LO and IL-4. STAg-pretreatment decreased CD4(+) T cell, NK cell, CD11b(+) monocyte and CD11b(+)CD11c(+) dendritic cell numbers in the lamina propria and increased CD8(+) T cells in the intestinal epithelial compartment. In parallel, decreases were observed in iNOS and IL-17 expression in this organ. These results demonstrate that pretreatment with STAg can induce the recruitment of protective CD8(+) T cells to the intraepithelial compartment and decrease proinflammatory immune mechanisms that promote intestinal pathology in T. gondii infection.	[Benevides, Luciana; Milanezi, Cristiane M.; Silva, Joao S.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Biochem & Immunol, BR-14049 Ribeirao Preto, SP, Brazil; [Cardoso, Cristina R.] Univ Sao Paulo, Dept Clin Anal Toxicol Bromatol, Ribeirao Preto Coll Pharmaceut Sci, BR-14049 Ribeirao Preto, SP, Brazil; [Castro-Filice, Leticia S.; Barenco, Paulo V. C.; Sousa, Romulo O.; Mineo, Jose R.; Silva, Neide M.] Univ Fed Uberlandia, Inst Biomed Sci, BR-38400 Uberlandia, MG, Brazil; [Rodrigues, Rosangela M.] Univ Fed Goias, Goiania, Go, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Uberlandia; Universidade Federal de Goias	Silva, NM (corresponding author), Univ Fed Uberlandia, Inst Biomed Sci, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	nmsilva@icbim.ufu.br	Barenco, Paulo Victor/A-2221-2015; Benevides, Luciana/D-2715-2012; Ribeiro de Barros Cardoso, Cristina/AGO-5764-2022; de Barros Cardoso, Cristina Ribeiro/L-8396-2017; Silva, Neide/C-7813-2013; SILVA, NEIDE MARIA/AAQ-7995-2020; Mineo, Jose R/B-4151-2009; Silva, Joao/A-4484-2008	Ribeiro de Barros Cardoso, Cristina/0000-0002-6156-3144; de Barros Cardoso, Cristina Ribeiro/0000-0002-6156-3144; Silva, Neide/0000-0002-3615-1340; Mineo, Jose R/0000-0002-9010-7228; Silva, Joao/0000-0002-3410-3927; Czarnewski, Paulo/0000-0001-8150-4021	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [00355-11, 20/12, APQ-04312-10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [481482/2010-5]; Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); FAPEMIG [20/12]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [grants 00355-11, 20/12; APQ-04312-10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [grant 481482/2010-5]; Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); and Rede Mineira which received funding from FAPEMIG [grant 20/12]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Alexander J, 1998, INT J PARASITOL, V28, P113, DOI 10.1016/S0020-7519(97)00168-9; Aliberti J, 2002, NAT IMMUNOL, V3, P76, DOI 10.1038/ni745; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Aliberti J, 2002, J EXP MED, V196, P1253, DOI 10.1084/jem.20021183; Arstila T, 2000, J EXP MED, V191, P823, DOI 10.1084/jem.191.5.823; Buzoni-Gatel D, 2006, CELL MICROBIOL, V8, P535, DOI 10.1111/j.1462-5822.2006.00692.x; Buzoni-Gatel D, 2001, GASTROENTEROLOGY, V120, P914, DOI 10.1053/gast.2001.22432a; Cerwenka A, 1999, MICROBES INFECT, V1, P1291, DOI 10.1016/S1286-4579(99)00255-5; CHARDES T, 1994, J IMMUNOL, V153, P4596; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Egan CE, 2011, MUCOSAL IMMUNOL, V4, P658, DOI 10.1038/mi.2011.31; Egan CE, 2009, MUCOSAL IMMUNOL, V2, P527, DOI 10.1038/mi.2009.105; Fux B, 2003, INFECT IMMUN, V71, P6392, DOI 10.1128/IAI.71.11.6392-6401.2003; GAZZINELLI RT, 1991, J IMMUNOL, V146, P286; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Guiton R, 2010, J INFECT DIS, V202, P427, DOI 10.1086/653738; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; KHAN IA, 1995, PARASITE IMMUNOL, V17, P185, DOI 10.1111/j.1365-3024.1995.tb00888.x; Khan IA, 2006, PLOS PATHOG, V2, P484, DOI 10.1371/journal.ppat.0020049; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liesenfeld O, 1999, PARASITE IMMUNOL, V21, P365, DOI 10.1046/j.1365-3024.1999.00237.x; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Ma GY, 2009, EXP PARASITOL, V122, P41, DOI 10.1016/j.exppara.2009.01.011; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Mennechet FJD, 2002, J IMMUNOL, V168, P2988, DOI 10.4049/jimmunol.168.6.2988; Mennechet FJD, 2004, EUR J IMMUNOL, V34, P1059, DOI 10.1002/eji.200324416; Moustakas A, 2001, J CELL SCI, V114, P4359; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Passos ST, 2010, J IMMUNOL, V184, P1776, DOI 10.4049/jimmunol.0901843; REIS, 1999, IMMUNITY, V11, P637, DOI DOI 10.1016/S1074-7613(00)80138-7.PUBMED:10591188; REIS, 1997, J EXP MED, V186, P1819, DOI DOI 10.1084/JEM.186.11.1819.PUBMED:9382881; Resende MG, 2008, AN ACAD BRAS CIENC, V80, P85, DOI 10.1590/S0001-37652008000100005; Saleh M, 2011, IMMUNITY, V34, P293, DOI 10.1016/j.immuni.2011.03.008; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Silva NM, 2009, EXP PARASITOL, V123, P65, DOI 10.1016/j.exppara.2009.05.011; Suzuki Y, 1996, J IMMUNOL, V157, P2564; Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375; Vossenkamper A, 2004, EUR J IMMUNOL, V34, P3197, DOI 10.1002/eji.200424993; Wang S, 2013, TRANSPL P, V45, P677, DOI 10.1016/j.transproceed.2012.02.036; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	52	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75138	10.1371/journal.pone.0075138	http://dx.doi.org/10.1371/journal.pone.0075138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086456	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200028
J	Aller, E; Sanchez-Sanchez, AV; Chicote, JU; Garcia-Garcia, G; Udaondo, P; Cavalle, L; Piquer-Gil, M; Garcia-Espana, A; Diaz-Llopis, M; Millan, JM; Mullor, JL				Aller, Elena; Sanchez-Sanchez, Ana V.; Chicote, Javier U.; Garcia-Garcia, Gema; Udaondo, Patricia; Cavalle, Laura; Piquer-Gil, Marina; Garcia-Espana, Antonio; Diaz-Llopis, Manuel; Millan, Jose M.; Mullor, Jose L.			Analysis of the Ush2a Gene in Medaka Fish (Oryzias latipes)	PLOS ONE			English	Article							USHER-SYNDROME; RETINITIS-PIGMENTOSA; PROTEIN; ZEBRAFISH; MUTATIONS; EXPRESSION; HEARING; MODEL; CILIOPATHIES; DEAFNESS	Patients suffering from Usher syndrome (USH) exhibit sensorineural hearing loss, retinitis pigmentosa (RP) and, in some cases, vestibular dysfunction. USH is the most common genetic disorder affecting hearing and vision and is included in a group of hereditary pathologies associated with defects in ciliary function known as ciliopathies. This syndrome is clinically classified into three types: USH1, USH2 and USH3. USH2 accounts for well over one-half of all Usher cases and mutations in the USH2A gene are responsible for the majority of USH2 cases, but also for atypical Usher syndrome and recessive nonsyndromic RP. Because medaka fish (Oryzias latypes) is an attractive model organism for genetic-based studies in biomedical research, we investigated the expression and function of the USH2A ortholog in this teleost species. Ol-Ush2a encodes a protein of 5.445 aa codons, containing the same motif arrangement as the human USH2A. Ol-Ush2a is expressed during early stages of medaka fish development and persists into adulthood. Temporal Ol-Ush2a expression analysis using whole mount in situ hybridization (WMISH) on embryos at different embryonic stages showed restricted expression to otoliths and retina, suggesting that Ol-Ush2a might play a conserved role in the development and/or maintenance of retinal photoreceptors and cochlear hair cells. Knockdown of Ol-Ush2a in medaka fish caused embryonic developmental defects (small eyes and heads, otolith malformations and shortened bodies with curved tails) resulting in late embryo lethality. These embryonic defects, observed in our study and in other ciliary disorders, are associated with defective cell movement specifically implicated in left-right (LR) axis determination and planar cell polarity (PCP).	[Aller, Elena; Millan, Jose M.] CIBER Enfermedades Raras CIBERER, Valencia, Spain; [Aller, Elena; Sanchez-Sanchez, Ana V.; Garcia-Garcia, Gema; Udaondo, Patricia; Cavalle, Laura; Piquer-Gil, Marina; Diaz-Llopis, Manuel; Millan, Jose M.; Mullor, Jose L.] IIS La Fe, Grp Invest Enfermedades Neurosensoriales, Valencia, Spain; [Chicote, Javier U.; Garcia-Espana, Antonio] Univ Rovira & Virgili, Inst Invest Sanitaria Rovira & Virgili IISPV, Hosp Joan XXIII, Unitat Recerca, E-43007 Tarragona, Spain; [Udaondo, Patricia; Diaz-Llopis, Manuel] Hosp Univ La Fe, Serv Oftalmol, Valencia, Spain; [Cavalle, Laura] Hosp Univ La Fe, Serv Otorrinolaringol, Valencia, Spain; [Millan, Jose M.] Hosp Univ La Fe, Unidad Genet & Diagnost Prenatal, Valencia, Spain; [Mullor, Jose L.] Biopolo La Fe Hosp La Fe, Bionos SL, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe	Aller, E (corresponding author), CIBER Enfermedades Raras CIBERER, Valencia, Spain.	elenaller@yahoo.es; jlmullor@iislafe.es	garcia-españa, antonio/I-4756-2015; García-García, Gema/J-9387-2015; Garcia, Gema/AEN-8767-2022; Aller, Elena/A-4803-2010	garcia-españa, antonio/0000-0002-9957-3161; García-García, Gema/0000-0002-2113-0600; Aller, Elena/0000-0001-7973-5250; UGARTE CHICOTE, JAVIER/0000-0001-6771-8584; Piquer Gil, Marina/0000-0003-1941-7175; Udaondo, Patricia/0000-0002-5241-0066	Conselleria de Sanitat de la Comunitat Valenciana [GE-011/10]; Fondo de Investigaciones Sanitarias, FIS [PI10/01825]; Ministerio de Economia y Competitividad [BFU2009-10808]; MICINN (Spain) [CSD-2010-00065]; Research Stabilization Program of the Instituto de Salud Carlos III-Institut Catala de la Salut in Catalonia	Conselleria de Sanitat de la Comunitat Valenciana; Fondo de Investigaciones Sanitarias, FIS(Instituto de Salud Carlos III); Ministerio de Economia y Competitividad(Spanish Government); MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Research Stabilization Program of the Instituto de Salud Carlos III-Institut Catala de la Salut in Catalonia	This work was supported by grants from the "Conselleria de Sanitat de la Comunitat Valenciana" (GE-011/10) and from the "Fondo de Investigaciones Sanitarias, FIS" (PI10/01825) and Ministerio de Economia y Competitividad BFU2009-10808. The authors would like to thank MICINN (Spain) for financial support (Projects CONSOLIDER INGENIO CSD-2010-00065). AGE is supported by the Research Stabilization Program of the Instituto de Salud Carlos III-Institut Catala de la Salut in Catalonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato A, 2005, HUM MOL GENET, V14, P3921, DOI 10.1093/hmg/ddi416; Aller E, 2004, EUR J HUM GENET, V12, P407, DOI 10.1038/sj.ejhg.5201138; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baux D, 2007, HUM MUTAT, V28, P781, DOI 10.1002/humu.20513; Camp E, 2009, STEM CELLS, V27, P2081, DOI 10.1002/stem.133; Caron A, 2012, DEVELOPMENT, V139, P514, DOI 10.1242/dev.071746; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dreyer B, 2008, HUM MUTAT, V29, P451, DOI 10.1002/humu.9524; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; Ebermann I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Garcia-Espana A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004680; Garcia-Garcia G, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-65; Gibert Y, 2005, GENE, V353, P200, DOI 10.1016/j.gene.2005.05.015; Glover G, 2012, MOL VIS, V18, P2309; Hyodo-Taguchi Y, 1996, FISH BIOL J MEDAKA, V8, p[29, 30]; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Khanna H, 2005, J BIOL CHEM, V280, P33580, DOI 10.1074/jbc.M505827200; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; Lu B, 2010, INVEST OPHTH VIS SCI, V51, P2269, DOI 10.1167/iovs.09-4526; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Millan JM, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/417217; Pearsall N, 2002, HEARING RES, V174, P55, DOI 10.1016/S0378-5955(02)00635-4; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Phillips JB, 2011, DIS MODEL MECH, V4, P786, DOI 10.1242/dmm.006429; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Seiler C, 2005, DEVELOPMENT, V132, P615, DOI 10.1242/dev.01591; Shu XH, 2011, INVEST OPHTH VIS SCI, V52, P2960, DOI 10.1167/iovs.10-6800; Shu XH, 2010, HUM MOL GENET, V19, P657, DOI 10.1093/hmg/ddp533; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Tucker RP, 2010, BIOL BULL-US, V218, P105, DOI 10.1086/BBLv218n2p105; van Reeuwijk J, 2011, HUM MOL GENET, V20, pR149, DOI 10.1093/hmg/ddr354; van Wijk E, 2004, AM J HUM GENET, V74, P738, DOI 10.1086/383096; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Williams DS, 2008, VISION RES, V48, P433, DOI 10.1016/j.visres.2007.08.015; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; YAMAMOTO T, 1975, MEDAKA KILLIFISH BIO; Yokoi H, 2007, DEV BIOL, V304, P326, DOI 10.1016/j.ydbio.2006.12.043	47	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74995	10.1371/journal.pone.0074995	http://dx.doi.org/10.1371/journal.pone.0074995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086419	Green Submitted, Green Published, gold			2022-12-25	WOS:000326520200069
J	Chen, PF; Zhang, J; Zhan, Y; Su, JJ; Du, YR; Xu, GL; Shi, YF; Siebenlist, U; Zhang, XR				Chen, Pengfei; Zhang, Jun; Zhan, Yu; Su, Juanjuan; Du, Yarui; Xu, Guoliang; Shi, Yufang; Siebenlist, Ulrich; Zhang, Xiaoren			Established Thymic Epithelial Progenitor/Stem Cell-Like Cell Lines Differentiate into Mature Thymic Epithelial Cells and Support T Cell Development	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NEGATIVE SELECTION; MICROENVIRONMENT; IDENTIFICATION; PROLIFERATION; MAINTENANCE; GENERATION; ANTIGENS; DNMT3A; GROWTH	Common thymic epithelial progenitor/stem cells (TEPCs) differentiate into cortical and medullary thymic epithelial cells (TECs), which are required for the development and selection of thymocytes. Mature TEC lines have been widely established. However, the establishment of TEPC lines is rarely reported. Here we describe the establishment of thymic epithelial stomal cell lines, named TSCs, from fetal thymus. TSCs express some of the markers present on tissue progenitor/stem cells such as Sca-1. Gene expression profiling verifies the thymic identity of TSCs. RANK stimulation of these cells induces expression of autoimmune regulator (Aire) and Aire-dependent tissue-restricted antigens (TRAs) in TSCs in vitro. TSCs could be differentiated into medullary thymic epithelial cell-like cells with exogenously expressed NF-kappa B subunits ReIB and p52. Importantly, upon transplantation under the kidney capsules of nude mice, TSCs are able to differentiate into mature TEC-like cells that can support some limited development of T cells in vivo. These findings suggest that the TSC lines we established bear some characteristics of TEPC cells and are able to differentiate into functional TEC-like cells in vitro and in vivo. The cloned TEPC-like cell lines may provide useful tools to study the differentiation of mature TEC cells from precursors.	[Chen, Pengfei; Zhan, Yu; Su, Juanjuan; Shi, Yufang; Zhang, Xiaoren] Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai, Peoples R China; [Chen, Pengfei; Zhan, Yu; Su, Juanjuan; Shi, Yufang; Zhang, Xiaoren] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Zhang, Jun] Bengbu Med Coll, Affiliated Hosp 1, Dept Transfus, Bengbu, Anhui, Peoples R China; [Du, Yarui; Xu, Guoliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China; [Siebenlist, Ulrich] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Bengbu Medical College; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zhang, XR (corresponding author), Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai, Peoples R China.	xrzhang@sibs.ac.cn	Shi, Yufang/AAE-4431-2020; Su, Juanjuan/C-4040-2018	Shi, Yufang/0000-0001-8964-319X; Su, Juanjuan/0000-0002-6159-1954	National Basic Research program [2011CB946102]; National Natural Science Foundation of China [90919017, 30972695, 31270937]; Chinese Academy of Sciences [KSCX1-YW-22]; National Key Programs on Infectious Disease [2008ZX10002-014]; National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000722] Funding Source: NIH RePORTER	National Basic Research program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Programs on Infectious Disease; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Basic Research program (2011CB946102), the National Natural Science Foundation of China (90919017, 30972695 and 31270937), Knowledge Innovation Project of Chinese Academy of Sciences (KSCX1-YW-22), National Key Programs on Infectious Disease (2008ZX10002-014) and with support from the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Baik S, 2013, EUR J IMMUNOL, V43, P589, DOI 10.1002/eji.201243209; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blanpain C, 2007, NAT CELL BIOL, V9, P731, DOI 10.1038/ncb0707-731; Boehm T, 2008, CURR OPIN IMMUNOL, V20, P178, DOI 10.1016/j.coi.2008.03.001; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen W F, 1992, Eur Cytokine Netw, V3, P43; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Depreter MGL, 2008, P NATL ACAD SCI USA, V105, P961, DOI 10.1073/pnas.0711170105; FAAS SJ, 1993, EUR J IMMUNOL, V23, P1201, DOI 10.1002/eji.1830230602; FARR AG, 1989, CELL IMMUNOL, V119, P427, DOI 10.1016/0008-8749(89)90256-6; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Guerder S, 2012, CURR OPIN IMMUNOL, V24, P99, DOI 10.1016/j.coi.2012.01.008; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Liu B, 2013, DEVELOPMENT, V140, P780, DOI 10.1242/dev.085035; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Medawar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003441; Murumagi A, 2003, J BIOL CHEM, V278, P19784, DOI 10.1074/jbc.M210437200; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Papadopoulou AS, 2012, NAT IMMUNOL, V13, P181, DOI 10.1038/ni.2193; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rossi SW, 2007, EUR J IMMUNOL, V37, P2411, DOI 10.1002/eji.200737275; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Zhang XR, 2007, IMMUNITY, V27, P438, DOI 10.1016/j.immuni.2007.07.017; Zhu MZ, 2008, IMMUNITY, V29, P386, DOI 10.1016/j.immuni.2008.09.001	39	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75222	10.1371/journal.pone.0075222	http://dx.doi.org/10.1371/journal.pone.0075222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086471	Green Submitted, Green Published, gold			2022-12-25	WOS:000326520200090
J	Gilbert, MK; Bland, JM; Shockey, JM; Cao, H; Hinchliffe, DJ; Fang, DD; Naoumkina, M				Gilbert, Matthew K.; Bland, John M.; Shockey, Jay M.; Cao, Heping; Hinchliffe, Doug J.; Fang, David D.; Naoumkina, Marina			A Transcript Profiling Approach Reveals an Abscisic Acid-Specific Glycosyltransferase (UGT73C14) Induced in Developing Fiber of Ligon lintless-2 Mutant of Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							PLANT-GROWTH SUBSTANCES; UDP-GLYCOSYLTRANSFERASE; GENOMICS APPROACH; EXPRESSION; METABOLISM; GENE; TRISTETRAPROLIN; GLYCOSYLATION; BIOSYNTHESIS; HYDROLYSIS	Ligon lintless-2, a monogenic dominant cotton (Gossypium hirsutum L.) fiber mutation, causing extreme reduction in lint fiber length with no pleiotropic effects on vegetative growth, represents an excellent model system to study fiber elongation. A UDP-glycosyltransferase that was highly expressed in developing fibers of the mutant Ligon lintless-2 was isolated. The predicted amino acid sequence showed similar to 53% similarity with Arabidopsis UGT73C sub-family members and the UDP-glycosyltransferase was designated as UGT73C14. When expressed in Escherichia coli as a recombinant protein with a maltose binding protein tag, UGT73C14 displayed enzymatic activity toward ABA and utilized UDP-glucose and UDP-galactose as the sugar donors. The recombinant UGT73C14 converted natural occurring isoform (+)-cis, trans-ABA better than (+)-trans, trans-ABA and (-)-cis, trans-ABA. Transgenic Arabidopsis plants constitutively overexpressing UGT73C14 did not show phenotypic changes under standard growth conditions. However, the increased glycosylation of ABA resulted in phenotypic changes in post-germinative growth and seedling establishment, confirming in vivo activity of UGT73C14 for ABA. This suggests that the expression level of UGT73C14 is regulated by the observed elevated levels of ABA in developing fibers of the Li-2 mutant line and may be involved in the regulation of ABA homeostasis.	[Gilbert, Matthew K.; Fang, David D.; Naoumkina, Marina] USDA ARS, So Reg Res Ctr, Cotton Fiber Biosci Res Unit, New Orleans, LA USA; [Bland, John M.] USDA ARS, So Reg Res Ctr, Food Proc & Sensory Qual Res Unit, New Orleans, LA USA; [Shockey, Jay M.; Cao, Heping] USDA ARS, So Reg Res Ctr, Commod Utilizat Res Unit, New Orleans, LA USA; [Hinchliffe, Doug J.] USDA ARS, So Reg Res Ctr, Cotton Chem & Utilizat Res Unit, New Orleans, LA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Naoumkina, M (corresponding author), USDA ARS, So Reg Res Ctr, Cotton Fiber Biosci Res Unit, POB 19687, New Orleans, LA USA.	marina.naoumkina@ars.usda.gov	Cao, Heping/AAC-1666-2021; FANG, DAVID/AAV-5774-2020	FANG, DAVID/0000-0003-0036-5459; Cao, Heping/0000-0002-0958-1468; Bland, John/0000-0003-1167-7415; Shockey, Jay/0000-0002-5057-5457	United States Department of Agriculture-Agricultural Research Service [6435-21000-017-00D]; Cotton Incorporated project [12-210]	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Cotton Incorporated project	This research was funded by United States Department of Agriculture-Agricultural Research Service project number 6435-21000-017-00D and Cotton Incorporated project number 12-210. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; BEASLEY CA, 1974, AM J BOT, V61, P188, DOI 10.2307/2441189; BEASLEY CA, 1973, AM J BOT, V60, P130, DOI 10.2307/2441099; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; BOYER GL, 1982, PLANT PHYSIOL, V70, P227, DOI 10.1104/pp.70.1.227; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao HP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-73; Cao HP, 2004, BIOCHEMISTRY-US, V43, P13724, DOI 10.1021/bi049014y; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; CARPITA NC, 1981, J BIOL CHEM, V256, P308; Chen JG, 1997, J PLANT GROWTH REGUL, V16, P181, DOI 10.1007/PL00006994; Chen XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030056; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dietz KJ, 2000, J EXP BOT, V51, P937, DOI 10.1093/jexbot/51.346.937; Dowd MK, 2001, IND CROP PROD, V14, P113, DOI 10.1016/S0926-6690(00)00094-7; DRUMMOND AJ, 2011, ENEIOUS V6 1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FRANZ G, 1969, PHYTOCHEMISTRY, V8, P737, DOI 10.1016/S0031-9422(00)85845-8; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Hinchliffe DJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-445; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; Jones P, 2001, PLANTA, V213, P164, DOI 10.1007/s004250000492; Karaca M, 2002, J HERED, V93, P221, DOI 10.1093/jhered/93.3.221; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim JH, 2006, BIOSCI BIOTECH BIOCH, V70, P1471, DOI 10.1271/bbb.60006; Kubo A, 2004, ARCH BIOCHEM BIOPHYS, V429, P198, DOI 10.1016/j.abb.2004.06.021; LEHMANN H, 1988, J PLANT PHYSIOL, V132, P98, DOI 10.1016/S0176-1617(88)80191-3; LESHEM Y, 1974, BIOCHEM BIOPH RES CO, V57, P526, DOI 10.1016/0006-291X(74)90964-4; Lim EK, 2005, TETRAHEDRON-ASYMMETR, V16, P143, DOI 10.1016/j.tetasy.2004.11.062; Lim EK, 2004, EMBO J, V23, P2915, DOI 10.1038/sj.emboj.7600295; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; Mansoor S, 2012, TRENDS BIOTECHNOL, V30, P521, DOI 10.1016/j.tibtech.2012.06.003; Modolo LV, 2007, PLANT MOL BIOL, V64, P499, DOI 10.1007/s11103-007-9167-6; Naoumkina MA, 2010, PLANT CELL, V22, P850, DOI 10.1105/tpc.109.073270; NARBUTH EV, 1990, J HERED, V81, P131; Paquette S, 2003, PHYTOCHEMISTRY, V62, P399, DOI 10.1016/S0031-9422(02)00558-7; Paquette SM, 2009, PHYTOCHEMISTRY, V70, P1940, DOI 10.1016/j.phytochem.2009.08.024; Piotrowska A, 2011, PHYTOCHEMISTRY, V72, P2097, DOI 10.1016/j.phytochem.2011.08.012; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Priest DM, 2006, PLANT J, V46, P492, DOI 10.1111/j.1365-313X.2006.02701.x; Priest DM, 2005, FEBS LETT, V579, P4454, DOI 10.1016/j.febslet.2005.06.084; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDERMANN H, 1992, TRENDS BIOCHEM SCI, V17, P82, DOI 10.1016/0968-0004(92)90507-6; Shibuya M, 2010, FEBS LETT, V584, P2258, DOI 10.1016/j.febslet.2010.03.037; Taliercio EW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-22; Tamura K, 2011, MOL BIOL EVOL; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vilaro F, 2006, ANAL BIOANAL CHEM, V386, P306, DOI 10.1007/s00216-006-0664-2; Vogt T, 1999, PLANT J, V19, P509, DOI 10.1046/j.1365-313X.1999.00540.x; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; Weaver S, 2010, METHODS, V50, P271, DOI 10.1016/j.ymeth.2010.01.003; Xu ZJ, 2002, PLANT PHYSIOL, V129, P1285, DOI 10.1104/pp.001784; Zeevaart JAD, 1999, N COMP BIOC, V33, P189; Zhang HP, 2009, ACTA PHYSIOL PLANT, V31, P979, DOI 10.1007/s11738-009-0313-4; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; ZUCKERKANDL EMILE, 1965, P97	60	19	23	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75268	10.1371/journal.pone.0075268	http://dx.doi.org/10.1371/journal.pone.0075268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086489	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200094
J	Mirzoyan, Z; Pandur, P				Mirzoyan, Zhasmine; Pandur, Petra			The Iroquois Complex Is Required in the Dorsal Mesoderm to Ensure Normal Heart Development in Drosophila	PLOS ONE			English	Article							HOMEOBOX GENES; CELL FATES; TRANSCRIPTION-FACTORS; SIGNALING PATHWAYS; BOX GENES; TINMAN; PANNIER; SPECIFICATION; POLARITY; PROTEIN	Drosophila heart development is an invaluable system to study the orchestrated action of numerous factors that govern cardiogenesis. Cardiac progenitors arise within specific dorsal mesodermal regions that are under the influence of temporally coordinated actions of multiple signaling pathways. The Drosophila Iroquois complex (Iro-C) consists of the three homeobox transcription factors araucan (ara), caupolican (caup) and mirror (mirr). The Iro-C has been shown to be involved in tissue patterning leading to the differentiation of specific structures, such as the lateral notum and dorsal head structures and in establishing the dorsal-ventral border of the eye. A function for Iro-C in cardiogenesis has not been investigated yet. Our data demonstrate that loss of the whole Iro complex, as well as loss of either ara/caup or mirr only, affect heart development in Drosophila. Furthermore, the data indicate that the GATA factor Pannier requires the presence of Iro-C to function in cardiogenesis. Furthermore, a detailed expression pattern analysis of the members of the Iro-C revealed the presence of a possibly novel subpopulation of Even-skipped expressing pericardial cells and seven pairs of heart-associated cells that have not been described before. Taken together, this work introduces Iro-C as a new set of transcription factors that are required for normal development of the heart. As the members of the Iro-C may function, at least partly, as competence factors in the dorsal mesoderm, our results are fundamental for future studies aiming to decipher the regulatory interactions between factors that determine different cell fates in the dorsal mesoderm.	[Mirzoyan, Zhasmine; Pandur, Petra] Univ Ulm, Inst Biochem & Mol Biol, D-89069 Ulm, Germany	Ulm University	Pandur, P (corresponding author), Univ Ulm, Inst Biochem & Mol Biol, D-89069 Ulm, Germany.	petra.pandur@uni-ulm.de			Deutsche Forschungsgemeinschaft [SFB497, TP8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant to P.P. from the Deutsche Forschungsgemeinschaft (SFB497, TP8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AD, 2003, DEVELOPMENT, V130, P3015, DOI 10.1242/dev.00488; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Azpiazu N, 1996, GENE DEV, V10, P3183, DOI 10.1101/gad.10.24.3183; Bate Michael, 1993, P1013; Bilioni A, 2005, P NATL ACAD SCI USA, V102, P14671, DOI 10.1073/pnas.0502480102; BODMER R, 1993, DEVELOPMENT, V118, P719; Broihier HT, 1998, DEVELOPMENT, V125, P655; Bruneau BG, 2001, MOL CELL BIOL, V21, P1730, DOI 10.1128/MCB.21.5.1730-1736.2001; Calleja M, 2000, DEVELOPMENT, V127, P3971; Calleja M, 2002, GENE, V292, P1, DOI 10.1016/S0378-1119(02)00628-5; Carmena A, 1998, GENE DEV, V12, P3910, DOI 10.1101/gad.12.24.3910; Carmena A, 2002, DEV BIOL, V244, P226, DOI 10.1006/dbio.2002.0606; Carrasco-Rando M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002186; Cavodeassi F, 2000, DEVELOPMENT, V127, P1921; Cavodeassi F, 1999, DEVELOPMENT, V126, P4933; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Chartier A, 2002, DEVELOPMENT, V129, P3241; Christoffels VM, 2000, DEV BIOL, V224, P263, DOI 10.1006/dbio.2000.9801; de Navascues J, 2007, DEVELOPMENT, V134, P1779, DOI 10.1242/dev.02844; Diez del Corral R, 1999, GENE DEV, V13, P1754, DOI 10.1101/gad.13.13.1754; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; Frasch M, 1999, ADV D BIOCH, V5, P1, DOI 10.1016/S1064-2722(08)60015-8; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0; Fuchs A, 2012, P NATL ACAD SCI USA, V109, P1572, DOI 10.1073/pnas.1115190109; Gajewski K, 1999, DEVELOPMENT, V126, P5679; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Grigorian M, 2011, DEV BIOL, V353, P105, DOI 10.1016/j.ydbio.2011.02.024; Haenlin M, 1997, GENE DEV, V11, P3096, DOI 10.1101/gad.11.22.3096; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Herranz H, 2001, DEVELOPMENT, V128, P4837; Ikmi A, 2008, DEV BIOL, V317, P634, DOI 10.1016/j.ydbio.2007.12.034; Jagla T, 2002, DEVELOPMENT, V129, P1037; Johnson AN, 2011, DEVELOPMENT, V138, P4627, DOI 10.1242/dev.071464; Kehl BT, 1998, DEVELOPMENT, V125, P1217; Kim KH, 2012, CIRC RES, V110, P1513, DOI 10.1161/CIRCRESAHA.112.265041; Klinedinst SL, 2003, DEVELOPMENT, V130, P3027, DOI 10.1242/dev.00517; Knirr S, 1999, DEVELOPMENT, V126, P4525; Kremser T, 1999, DEV BIOL, V216, P327, DOI 10.1006/dbio.1999.9425; LaBeau EM, 2009, MECH DEVELOP, V126, P478, DOI 10.1016/j.mod.2009.01.001; Lee HH, 2005, DEVELOPMENT, V132, P1429, DOI 10.1242/dev.01687; LEISS D, 1988, DEVELOPMENT, V104, P525; Letizia A, 2007, DEVELOPMENT, V134, P1337, DOI 10.1242/dev.02823; Leyns L, 1996, MECH DEVELOP, V59, P63, DOI 10.1016/0925-4773(96)00577-1; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Liu JD, 2006, DEV BIOL, V290, P373, DOI 10.1016/j.ydbio.2005.11.033; Lockwood WK, 2002, MECH DEVELOP, V114, P13, DOI 10.1016/S0925-4773(02)00044-8; Mann T, 2009, DEVELOPMENT, V136, P317, DOI 10.1242/dev.022533; Matsumoto K, 2004, NAT NEUROSCI, V7, P605, DOI 10.1038/nn1249; McNeill H, 1997, GENE DEV, V11, P1073, DOI 10.1101/gad.11.8.1073; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Park M, 1998, MECH DEVELOP, V75, P117, DOI 10.1016/S0925-4773(98)00098-7; Park MY, 1996, DEV BIOL, V177, P104, DOI 10.1006/dbio.1996.0149; Pichaud F, 2000, MECH DEVELOP, V96, P15, DOI 10.1016/S0925-4773(00)00372-5; RAMAIN P, 1993, DEVELOPMENT, V119, P1277; Reim I, 2005, DEVELOPMENT, V132, P4911, DOI 10.1242/dev.02077; Reim I, 2003, DEVELOPMENT, V130, P3187, DOI 10.1242/dev.00548; Riechmann V, 1997, DEVELOPMENT, V124, P2915; Sotillos S, 2010, DEV BIOL, V340, P571, DOI 10.1016/j.ydbio.2010.02.015; Su MT, 1999, DEVELOPMENT, V126, P3241; Togel M, 2008, DEV BIOL, V318, P29, DOI 10.1016/j.ydbio.2008.02.043; Venkatesh TV, 2000, GENESIS, V26, P55, DOI 10.1002/(SICI)1526-968X(200001)26:1<55::AID-GENE8>3.0.CO;2-A; Ward EJ, 2000, DEVELOPMENT, V127, P4959; WU XS, 1995, DEV BIOL, V169, P619, DOI 10.1006/dbio.1995.1174; Yang CH, 1999, DEVELOPMENT, V126, P5857; Yin ZZ, 1997, DEVELOPMENT, V124, P4971; Yin ZZ, 1998, DEV GENET, V22, P187; Zaffran S, 2006, DEVELOPMENT, V133, P4073, DOI 10.1242/dev.02586; Zecca M, 2002, DEVELOPMENT, V129, P1369; Zeidler MP, 1999, GENE DEV, V13, P1342, DOI 10.1101/gad.13.10.1342; Zhang SS, 2011, P NATL ACAD SCI USA, V108, P13576, DOI 10.1073/pnas.1106911108; Zhao DB, 2000, DEV GENES EVOL, V210, P449, DOI 10.1007/s004270000081; Zmojdzian M, 2013, CELL TISSUE RES, V354, P639, DOI 10.1007/s00441-013-1644-4	74	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76498	10.1371/journal.pone.0076498	http://dx.doi.org/10.1371/journal.pone.0076498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086746	Green Published, gold			2022-12-25	WOS:000326520200138
J	Amini, ZN; Muller, UF				Amini, Zhaleh N.; Mueller, Ulrich F.			Low Selection Pressure Aids the Evolution of Cooperative Ribozyme Mutations in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cooperativity; Escherichia coli; Evolution; Ribozyme; RNA Catalysis	TERMINATION FACTOR-RHO; RNA INTERVENING SEQUENCE; IN-VITRO EVOLUTION; TRANSSPLICING RIBOZYMES; ESCHERICHIA-COLI; MESSENGER-RNA; SELF-CLEAVAGE; BENEFICIAL MUTATIONS; RIBONUCLEASE-P; VIVO SELECTION	Background: Ribozyme evolution experiments in cells can help our understanding of natural RNA evolution. Results: During an experimental RNA evolution, the emergence of four cooperative mutations was more efficient under low than under high selection pressure. Conclusion: Low selective pressure can facilitate the evolution of cooperative RNA mutations. Significance: Understanding RNA evolution in biology requires understanding the effects of evolutionary parameters in cells. Understanding the evolution of functional RNA molecules is important for our molecular understanding of biology. Here we tested experimentally how two evolutionary parameters, selection pressure and recombination, influenced the evolution of an evolving RNA population. This was done using four parallel evolution experiments that employed low or gradually increasing selection pressure, and recombination events either at the end or dispersed throughout the evolution. As model system, a trans-splicing group I intron ribozyme was evolved in Escherichia coli cells over 12 rounds of selection and amplification, including mutagenesis and recombination. The low selection pressure resulted in higher efficiency of the evolved ribozyme populations, whereas differences in recombination did not have a strong effect. Five mutations were responsible for the highest efficiency. The first mutation swept quickly through all four evolving populations, whereas the remaining four mutations accumulated later and more efficiently under low selection pressure. To determine why low selection pressure aided this evolution, all evolutionary intermediates between the wild type and the 5-mutation variant were constructed, and their activities at three different selection pressures were determined. The resulting fitness profiles showed a high cooperativity among the four late mutations, which can explain why high selection pressure led to inefficient evolution. These results show experimentally how low selection pressure can benefit the evolution of cooperative mutations in functional RNAs.	[Amini, Zhaleh N.; Mueller, Ulrich F.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Muller, UF (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ufmuller@ucsd.edu			National Institutes of Health Molecular Biophysics Training Grant [T32 GM008326]; Hellman Family Foundation [2011/12, 2012/13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326] Funding Source: NIH RePORTER	National Institutes of Health Molecular Biophysics Training Grant; Hellman Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Molecular Biophysics Training Grant T32 GM008326 (to Susan Taylor). This work was also supported by Grants 2011/12 and 2012/13 from the Hellman Family Foundation (to U. F. M.).	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Ayre BG, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf141; Ayre BG, 1999, P NATL ACAD SCI USA, V96, P3507, DOI 10.1073/pnas.96.7.3507; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; BUZAYAN JM, 1986, P NATL ACAD SCI USA, V83, P8859, DOI 10.1073/pnas.83.23.8859; Byun J, 2003, RNA, V9, P1254, DOI 10.1261/rna.5450203; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Chen X, 2009, RNA, V15, P2035, DOI 10.1261/rna.1635209; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Cooper TF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-11; Dayie KT, 2008, RNA, V14, P1697, DOI 10.1261/rna.1154408; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Fiskaa T, 2010, NEW BIOTECHNOL, V27, P194, DOI 10.1016/j.nbt.2010.02.013; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Guo F, 2002, RNA, V8, P647, DOI 10.1017/S1355838202029011; Haugen P, 2004, RNA, V10, P1084, DOI 10.1261/rna.5202704; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; HUTCHINS CJ, 1986, NUCLEIC ACIDS RES, V14, P3627, DOI 10.1093/nar/14.9.3627; INOUE T, 1985, P NATL ACAD SCI USA, V82, P648, DOI 10.1073/pnas.82.3.648; Kastanos E, 2004, BIOCHEM BIOPH RES CO, V322, P930, DOI 10.1016/j.bbrc.2004.07.203; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kohler U, 1999, J MOL BIOL, V285, P1935, DOI 10.1006/jmbi.1998.2447; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-22; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Lau MWL, 2009, CHEM BIOL, V16, P815, DOI 10.1016/j.chembiol.2009.07.005; Leconte AM, 2013, BIOCHEMISTRY-US, V52, P1490, DOI 10.1021/bi3016185; Lehman N, 2000, J MOL EVOL, V50, P481, DOI 10.1007/s002390010051; LEHMAN N, 1993, NATURE, V361, P182, DOI 10.1038/361182a0; Meluzzi D, 2012, RNA, V18, P590, DOI 10.1261/rna.029884.111; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Olson KE, 2012, RNA, V18, P581, DOI 10.1261/rna.028472.111; Ordoukhanian P, 1999, CHEM BIOL, V6, P881, DOI 10.1016/S1074-5521(00)80007-1; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Rogers CS, 2002, J CLIN INVEST, V110, P1783, DOI 10.1172/JCI200216481; Roth A., 2013, NAT CHEM BI IN PRESS; Ryu KJ, 2003, MOL THER, V7, P386, DOI 10.1016/S1525-0016(02)00063-1; SAVILLE BJ, 1990, CELL, V61, P685, DOI 10.1016/0092-8674(90)90480-3; Schmitt T, 1999, CHEM BIOL, V6, P857, DOI 10.1016/S1074-5521(00)80005-8; SHARMEEN L, 1988, J VIROL, V62, P2674, DOI 10.1128/JVI.62.8.2674-2679.1988; SHAW WV, 1967, J BIOL CHEM, V242, P687; Soll SJ, 2007, GENETICS, V175, P267, DOI 10.1534/genetics.106.066142; Song MS, 2006, FEBS LETT, V580, P5033, DOI 10.1016/j.febslet.2006.08.021; SULLENGER BA, 1994, NATURE, V371, P619, DOI 10.1038/371619a0; TRITTON TR, 1979, ARCH BIOCHEM BIOPHYS, V197, P10, DOI 10.1016/0003-9861(79)90212-1; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Unwalla HJ, 2008, MOL THER, V16, P1113, DOI 10.1038/mt.2008.54; Valadkhan S, 2005, CURR OPIN CHEM BIOL, V9, P603, DOI 10.1016/j.cbpa.2005.10.008; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; Voytek SB, 2009, P NATL ACAD SCI USA, V106, P7780, DOI 10.1073/pnas.0903397106; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7993, DOI 10.1021/bi963180r; WANG Y, 1993, J BIOL CHEM, V268, P13947; Watanabe T, 2000, P NATL ACAD SCI USA, V97, P8490, DOI 10.1073/pnas.150104097; WEINER MP, 1994, PCR METH APPL, V4, pS131; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Weissman DB, 2009, THEOR POPUL BIOL, V75, P286, DOI 10.1016/j.tpb.2009.02.006; Wieland M, 2008, ANGEW CHEM INT EDIT, V47, P2604, DOI 10.1002/anie.200703700; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Wright MC, 1997, SCIENCE, V276, P614, DOI 10.1126/science.276.5312.614; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	69	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33096	33106		10.1074/jbc.M113.511469	http://dx.doi.org/10.1074/jbc.M113.511469			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089519	Green Published, hybrid			2022-12-25	WOS:000328841700025
J	Mavrommatis, E; Arslan, AD; Sassano, A; Hua, YJ; Kroczynska, B; Platanias, LC				Mavrommatis, Evangelos; Arslan, Ahmet Dirim; Sassano, Antonella; Hua, Youjia; Kroczynska, Barbara; Platanias, Leonidas C.			Expression and Regulatory Effects of Murine Schlafen (Slfn) Genes in Malignant Melanoma and Renal Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antiviral Agents; Cell Death; Innate Immunity; Interferon; Signal Transduction; Signaling; Schlafen	ACTIVATED PROTEIN-KINASE; INTERFERON-ALPHA; GROWTH; FAMILY; INDUCTION	Background: The role of Slfn genes in antineoplastic responses is yet to be defined. Results: Murine Slfn genes are up-regulated in an IFN-dependent manner in melanoma, and RCC cells and members of this family differentially suppress proliferation and anchorage-independent malignant cell growth. Conclusion: Slfns play important roles in controlling malignant melanoma and RCC tumorigenesis. Significance: Modulation of Slfn expression may provide a novel approach for the treatment of malignancies. There is emerging evidence that the IFN-inducible family of Slfn genes and proteins play important roles in cell cycle progression and control of cellular proliferation, but the precise functional roles of different Slfn members in the regulation of tumorigenesis remain unclear. In the present study, we undertook a systematic analysis on the expression and functional relevance of different mouse Slfn genes in malignant melanoma and renal cell carcinoma cells. Our studies demonstrate that several mouse Slfn genes are up-regulated in response to IFN treatment of mouse melanoma and renal cell carcinoma cells, including Slfn1, Slfn2, Slfn4, Slfn5, and Slfn8. Our data show that Slfn2 and Slfn3 play essential roles in the control of mouse malignant melanoma cell proliferation and/or anchorage-independent growth, suggesting key and non-overlapping roles for these genes in the control of malignant melanoma tumorigenesis. In renal cell carcinoma cells, in addition to Slfn2 and Slfn3, Slfn5 also exhibits important antineoplastic effects. Altogether, our findings indicate important functions for distinct mouse Slfn genes in the control of tumorigenesis and provide evidence for differential involvement of distinct members of this gene family in controlling tumorigenesis. They also raise the potential of future therapeutic approaches involving modulation of expression of members of this family of genes in malignant melanoma and renal cell carcinoma.	[Mavrommatis, Evangelos; Arslan, Ahmet Dirim; Sassano, Antonella; Hua, Youjia; Kroczynska, Barbara; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Sch Med, Chicago, IL 60611 USA; [Mavrommatis, Evangelos; Sassano, Antonella; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Chicago, IL 60612 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu			National Institutes of Health [CA161796, CA155566, CA77816]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA161796, R01CA077816, R01CA155566, T32CA070085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA161796, CA155566, and CA77816. This work was also supported by a Merit Review grant from the Department of Veterans Affairs.	Ahmadi S, 2011, Pak J Biol Sci, V14, P1002; Ascierto PA, 2013, CRIT REV ONCOL HEMAT, V85, P149, DOI 10.1016/j.critrevonc.2012.07.004; Bell TA, 2006, GENETICS, V172, P411, DOI 10.1534/genetics.105.047118; Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; Bukowski RM, 2010, EXPERT OPIN PHARMACO, V11, P2351, DOI 10.1517/14656566.2010.499126; Bustos O, 2009, GENE, V447, P1, DOI 10.1016/j.gene.2009.07.006; Condamine T, 2010, J LEUKOCYTE BIOL, V87, P451, DOI 10.1189/jlb.0609410; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Horton MR, 2010, NAT IMMUNOL, V11, P281, DOI 10.1038/ni0410-281; Katsoulidis E, 2010, J BIOL CHEM, V285, P40333, DOI 10.1074/jbc.M110.151076; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Lee NK, 2008, CELL SIGNAL, V20, P2302, DOI 10.1016/j.cellsig.2008.08.019; Mavrommatis E, 2013, J INTERF CYTOK RES, V33, P206, DOI 10.1089/jir.2012.0133; Moschos S, 2005, CANC TREAT, V126, P207, DOI 10.1007/0-387-24361-5_9; Neumann B, 2008, BIOCHEM BIOPH RES CO, V370, P62, DOI 10.1016/j.bbrc.2008.03.032; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; Patel BB, 2009, AM J PHYSIOL-GASTR L, V296, pG955, DOI 10.1152/ajpgi.90726.2008; Patel VB, 2009, BIOCHEM BIOPH RES CO, V388, P752, DOI 10.1016/j.bbrc.2009.08.094; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Sohn WJ, 2007, MOL IMMUNOL, V44, P3273, DOI 10.1016/j.molimm.2007.03.001; Tefferi A, 2011, J CLIN ONCOL, V29, P573, DOI 10.1200/JCO.2010.29.8711; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; van Zuylen WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015723; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Yuan LS, 2010, AM J PHYSIOL-GASTR L, V298, pG994, DOI 10.1152/ajpgi.00517.2009	28	26	26	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33006	33015		10.1074/jbc.M113.460741	http://dx.doi.org/10.1074/jbc.M113.460741			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089532	Green Published, hybrid			2022-12-25	WOS:000328841700017
J	Nakashima, M; Nandakumar, J; Sullivan, KD; Espinosa, JM; Cech, TR				Nakashima, Mai; Nandakumar, Jayakrishnan; Sullivan, Kelly D.; Espinosa, Joaquin M.; Cech, Thomas R.			Inhibition of Telomerase Recruitment and Cancer Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cancer; Cell Biology; Telomerase; Telomeres; TPP1	TERT PROMOTER MUTATIONS; CATALYTIC SUBUNIT; TPP1; PROCESSIVITY; HOLOENZYME; MECHANISM; APOPTOSIS; MELANOMA; BIBR1532; GLIOMAS	Background: A specific surface of the TPP1 protein, called the TEL patch, mediates telomerase recruitment in human cells. Results: TEL patch deficiency caused cancer cell death, which was exacerbated by inhibition of telomerase enzymatic activity. Conclusion: TEL patch mutations are detrimental to cancer cell viability. Significance: This work encourages the development of new combinational cancer therapies that involve simultaneous inhibition of telomerase recruitment and telomerase activity. Continued proliferation of human cells requires maintenance of telomere length, usually accomplished by telomerase. Telomerase is recruited to chromosome ends by interaction with a patch of amino acids (the TEL patch, for TPP1 glutamate (E) and leucine (L)-rich patch) on the surface of telomere protein TPP1. In previous studies, interruption of this interaction by mutation prevented telomere extension in HeLa cells, but the cell culture continued to grow. We now show that the telomerase inhibitor BIBR1532 acts together with TEL patch mutations to inhibit the growth of HeLa cell lines and that apoptosis is a prominent mechanism of death of these cells. Survivor cells take over the population beginning around 40 days in culture. These cells no longer express the TEL patch mutant TPP1, apparently because of silencing of the expression cassette, a survival mechanism that would not be available to cancer cells. These results provide hope that inhibiting the binding of telomerase to the TEL patch of TPP1, perhaps together with a modest inhibition of the telomerase enzyme, could comprise an effective anticancer therapy for the approximate to 90% of human tumors that are telomerase-positive.	[Nakashima, Mai; Nandakumar, Jayakrishnan; Sullivan, Kelly D.; Espinosa, Joaquin M.; Cech, Thomas R.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Nakashima, Mai; Nandakumar, Jayakrishnan; Cech, Thomas R.] Univ Colorado, Dept Chem & Biochem, BioFrontiers Inst, Boulder, CO 80309 USA; [Sullivan, Kelly D.; Espinosa, Joaquin M.; Cech, Thomas R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Cech, TR (corresponding author), Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA.	thomas.cech@colorado.edu	Core, BioFrontiers Advanced Light Microscopy/O-6175-2019	Nandakumar, Jayakrishnan/0000-0001-9146-2785; SULLIVAN, KELLY/0000-0003-2725-0205	National Institutes of Health [K99CA167644, R01GM099705, R01CA117907]; NATIONAL CANCER INSTITUTE [R00CA167644, R01CA117907, K99CA167644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants K99CA167644 (to J. N.), R01GM099705 (to T. R. C.), and R01CA117907 (to J. M. E.).	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; El-Daly H, 2005, BLOOD, V105, P1742, DOI 10.1182/blood-2003-12-4322; Eller MS, 2002, EXP CELL RES, V276, P185, DOI 10.1006/excr.2002.5531; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu XL, 2013, ENDOCR-RELAT CANCER, V20, P603, DOI 10.1530/ERC-13-0210; Liu XL, 2013, CELL CYCLE, V12, P1637, DOI 10.4161/cc.24662; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pascolo E, 2002, J BIOL CHEM, V277, P15566, DOI 10.1074/jbc.M201266200; Sexton AN, 2012, J BIOL CHEM, V287, P34455, DOI 10.1074/jbc.M112.394767; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	27	35	38	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33171	33180		10.1074/jbc.M113.518175	http://dx.doi.org/10.1074/jbc.M113.518175			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097987	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000328841700032
J	Peng, M; Zhang, H; Jaafar, L; Risinger, JI; Huang, S; Mivechi, NF; Ko, L				Peng, Min; Zhang, Hao; Jaafar, Lahcen; Risinger, John I.; Huang, Shuang; Mivechi, Nahid F.; Ko, Lan			Human Ovarian Cancer Stroma Contains Luteinized Theca Cells Harboring Tumor Suppressor Gene GT198 Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ovarian Cancer; Ovary; Steroid Hormone; Stromal Cell; Tumor Microenvironment; Tumor Suppressor Gene; Theca Cell	SURFACE EPITHELIUM; ENZYME-ACTIVITY; ORIGIN; PATHOGENESIS; BREAST; PROMOTERS; P450C17; BIOLOGY; PROTEIN; RAD51	Ovarian cancer is a highly lethal gynecological cancer, and its causes remain to be understood. Using a recently identified tumor suppressor gene, GT198 (PSMC3IP), as a unique marker, we searched for the identity of GT198 mutant cells in ovarian cancer. GT198 has germ line mutations in familial and early onset breast and ovarian cancers and recurrent somatic mutations in sporadic fallopian tube cancers. GT198 protein has been shown as a steroid hormone receptor coregulator and also as a crucial factor in DNA repair. In this study, using GT198 as a marker for microdissection, we find that ovarian tumor stromal cells harboring GT198 mutations are present in various types of ovarian cancer including high and low grade serous, endometrioid, mucinous, clear cell, and granulosa cell carcinomas and in precursor lesions such as inclusion cysts. The mutant stromal cells consist of a luteinized theca cell lineage at various differentiation stages including CD133(+), CD44(+), and CD34(+) cells, although the vast majority of them are differentiated overexpressing steroidogenic enzyme CYP17, a theca cell-specific marker. In addition, wild type GT198 suppresses whereas mutant GT198 protein stimulates CYP17 expression. The chromatin-bound GT198 on the human CYP17 promoter is decreased by overexpressing mutant GT198 protein, implicating the loss of wild type suppression in mutant cells. Together, our results suggest that GT198 mutant luteinized theca cells overexpressing CYP17 are common in ovarian cancer stroma. Because first hit cancer gene mutations would specifically mark cancer-inducing cells, the identification of mutant luteinized theca cells may add crucial evidence in understanding the cause of human ovarian cancer.	[Peng, Min; Jaafar, Lahcen; Mivechi, Nahid F.; Ko, Lan] Georgia Regents Univ, Ctr Canc, Augusta, GA 30912 USA; [Huang, Shuang] Georgia Regents Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Peng, Min] Wuhan Univ, Renmin Hosp, Ctr Oncol, Wuhan 430060, Hubei, Peoples R China; [Zhang, Hao] Shantou Univ, Coll Med, Canc Res Ctr, Shantou 515041, Guangdong, Peoples R China; [Risinger, John I.] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI 49503 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Wuhan University; Shantou University; Michigan State University	Ko, L (corresponding author), Georgia Regents Univ, Ctr Canc, 1410 Laney Walker Blvd,CN 3155, Augusta, GA 30912 USA.	LKO@gru.edu		Ko, Lan/0000-0002-0089-9090	Georgia Cancer Coalition Distinguished Cancer Scholar Award; National Nature Science Foundation of China [81102024]; National Institutes of Health [CA062130]; NATIONAL CANCER INSTITUTE [R01CA062130] Funding Source: NIH RePORTER	Georgia Cancer Coalition Distinguished Cancer Scholar Award; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Georgia Cancer Coalition Distinguished Cancer Scholar Award (to L. K.) and National Nature Science Foundation of China Grant 81102024 (to M. P.). This work was also supported, in whole or in part, by National Institutes of Health Grant CA062130 (to N. F. M.).	Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Bapat SA, 2010, REPRODUCTION, V140, P33, DOI 10.1530/REP-09-0389; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; Chodosh LA, 1998, J MAMMARY GLAND BIOL, V3, P389, DOI 10.1023/A:1018784031651; Dharia S, 2004, BIOL REPROD, V71, P83, DOI 10.1095/biolreprod.103.026732; Dubeau L, 1999, GYNECOL ONCOL, V72, P437, DOI 10.1006/gyno.1998.5275; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; EASTON DF, 1993, AM J HUM GENET, V52, P678; Enomoto R, 2004, J BIOL CHEM, V279, P35263, DOI 10.1074/jbc.M402481200; FIENBERG R, 1971, OBSTET GYNECOL, V37, P158; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Foster R, 2013, CANCER LETT, V338, P147, DOI 10.1016/j.canlet.2012.10.023; Furuya Mitsuko, 2012, Cancers (Basel), V4, P701, DOI 10.3390/cancers4030701; Gilep AA, 2011, BBA-PROTEINS PROTEOM, V1814, P200, DOI 10.1016/j.bbapap.2010.06.021; GODWIN AK, 1992, HEMATOL ONCOL CLIN N, V6, P829; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HELZLSOUER KJ, 1995, JAMA-J AM MED ASSOC, V274, P1926, DOI 10.1001/jama.274.24.1926; Ko L, 2002, MOL CELL BIOL, V22, P357, DOI 10.1128/MCB.22.1.357-369.2002; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Magoffin DA, 2005, INT J BIOCHEM CELL B, V37, P1344, DOI 10.1016/j.biocel.2005.01.016; Mandai M, 2009, INT J CLIN ONCOL, V14, P383, DOI 10.1007/s10147-009-0935-y; Mehrad M, 2010, ADV ANAT PATHOL, V17, P293, DOI 10.1097/PAP.0b013e3181ecdee1; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Orisaka M, 2006, BIOL REPROD, V75, P734, DOI 10.1095/biolreprod.105.050344; Peng Min, 2013, Genes Cancer, V4, P15, DOI 10.1177/1947601913486344; Peng Min, 2013, Genes Cancer, V4, P26, DOI 10.1177/1947601913486345; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Ponzone R, 1998, EUR J CANCER, V34, P966, DOI 10.1016/S0959-8049(98)00060-4; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; ROME RM, 1981, OBSTET GYNECOL, V57, P705; Satoh T, 2009, ENDOCRINOLOGY, V150, P3283, DOI 10.1210/en.2008-1122; SCULLY RE, 1964, OBSTET GYNECOL, V24, P667; Song ZJ, 2011, MED HYPOTHESES, V77, P356, DOI 10.1016/j.mehy.2011.05.014; Vicus D, 2010, GYNECOL ONCOL, V118, P299, DOI 10.1016/j.ygyno.2010.05.011; Wickenheisser JK, 2000, J CLIN ENDOCR METAB, V85, P2304, DOI 10.1210/jc.85.6.2304; Young JM, 2010, REPRODUCTION, V140, P489, DOI 10.1530/REP-10-0094; Zangen D, 2011, AM J HUM GENET, V89, P572, DOI 10.1016/j.ajhg.2011.09.006; Zhang PL, 1996, MOL ENDOCRINOL, V10, P147, DOI 10.1210/me.10.2.147	44	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33387	33397		10.1074/jbc.M113.485581	http://dx.doi.org/10.1074/jbc.M113.485581			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097974	Green Published, hybrid			2022-12-25	WOS:000328841700052
J	Marzoq, AJ; Giese, N; Hoheisel, JD; Alhamdani, MSS				Marzoq, Aseel J.; Giese, Nathalia; Hoheisel, Joerg D.; Alhamdani, Mohamed Saiel Saeed			Proteome Variations in Pancreatic Stellate Cells upon Stimulation with Proinflammatory Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Microarray; Pancreatic Cancer; Proteomics; Stromal Cell; Tumor Necrosis Factor (TNF); Pancreatic Stellate Cell; Antibody Microarray	TUMOR-NECROSIS-FACTOR; CORNEAL NEOVASCULARIZATION; STROMA INTERACTIONS; MAMMALIAN TISSUE; MATRIX SYNTHESIS; CANCER; INTERLEUKIN-6; EXPRESSION; FIBROSIS; MICROENVIRONMENT	Pancreatic stellate cells are key mediators in chronic pancreatitis and play a central role in the development of pancreatic fibrosis, stromal formation, and progression of pancreatic cancer. This study was aimed at investigating molecular changes at the level of the proteome that are associated with the activation of pancreatic stellate cells by proinflammatory factors, namely TNF-, FGF2, IL6, and chemokine (C-C motif) ligand 4 (CCL4). They were added individually to cells growing in serum-free medium next to controls in medium supplemented with serum, thus containing a mixture of them all, or in serum-free medium alone. Variations were detected by means of a microarray of 810 antibodies targeting relevant proteins. All tested factors triggered increased proliferation and migration. Further analysis showed that TNF- is the prime factor responsible for the activation of pancreatic stellate cells. CCL4 is associated with cellular neovascularization, whereas FGF2 and IL6 induction led to better cellular survival and decreased apoptotic activity of the stellate cells. The identified direct effects of individual cytokines on human pancreatic stellate cells provide new insights about their contribution to pancreatic cancer promotion.	[Marzoq, Aseel J.; Hoheisel, Joerg D.; Alhamdani, Mohamed Saiel Saeed] Deutsch Krebsforschungszentrum DKFZ, Div Funct Genome Anal, D-69120 Heidelberg, Germany; [Giese, Nathalia] Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Alhamdani, MSS (corresponding author), Deutsch Krebsforschungszentrum, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	m.alhamdani@dkfz.de			European Union as part of the Affinomics consortium; Deutscher Akademischer Austauschdienst (DAAD)	European Union as part of the Affinomics consortium; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported in part by the European Union as part of the Affinomics consortium.; Recipient of a long-term fellowship from the Deutscher Akademischer Austauschdienst (DAAD).	ADAMSON GM, 1992, ARCH BIOCHEM BIOPHYS, V294, P223, DOI 10.1016/0003-9861(92)90161-O; Adebanjo OA, 1998, J CELL BIOL, V142, P1347, DOI 10.1083/jcb.142.5.1347; Alhamdani MSS, 2012, J PROTEOMICS, V75, P3747, DOI 10.1016/j.jprot.2012.04.042; Alhamdani MSS, 2010, PROTEOMICS, V10, P3203, DOI 10.1002/pmic.201000170; Alhamdani MSS, 2010, J PROTEOME RES, V9, P963, DOI 10.1021/pr900844q; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 2008, LANGENBECK ARCH SURG, V393, P891, DOI 10.1007/s00423-008-0279-5; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Campbell V, 2000, CYTOKINE, V12, P487, DOI 10.1006/cyto.1999.0584; Caruso JA, 2010, CANCER RES, V70, P7125, DOI 10.1158/0008-5472.CAN-10-1547; CATHCART R, 1984, METHOD ENZYMOL, V105, P352; Duner S, 2010, PANCREATOLOGY, V10, P673, DOI 10.1159/000320711; Edmonds C, 2008, CANCER BIOL THER, V7, P1816; EPSTEIN RJ, 1990, CORNEA, V9, P318; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Erkan M., 2010, Experimental Oncology, V32, P128; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Fidler IJ, 2002, DIFFERENTIATION, V70, P498, DOI 10.1046/j.1432-0436.2002.700904.x; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; HILL HR, 1991, J EXP MED, V173, P767, DOI 10.1084/jem.173.3.767; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Infante JR, 2007, J CLIN ONCOL, V25, P319, DOI 10.1200/JCO.2006.07.8824; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jesnowski R, 2005, LAB INVEST, V85, P1276, DOI 10.1038/labinvest.3700329; Karayiannakis AJ, 2001, ANTICANCER RES, V21, P1355; Law HKW, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-74; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li R, 2012, METAB BRAIN DIS, V27, P91, DOI 10.1007/s11011-011-9270-x; Lin YJ, 2006, ENDOCRINOLOGY, V147, P1278, DOI 10.1210/en.2005-0790; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lowenfels AB, 2005, J CELL BIOCHEM, V95, P649, DOI 10.1002/jcb.20461; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Mahali S, 2011, J BIOL CHEM, V286, P34903, DOI 10.1074/jbc.M111.279190; Martin B., 2012, PLOS ONE, V7; Masamune A, 2002, PANCREAS, V25, P78, DOI 10.1097/00006676-200207000-00018; Masamune A, 2008, AM J PHYSIOL-GASTR L, V294, pG99, DOI 10.1152/ajpgi.00272.2007; Masamune A, 2009, CLIN GASTROENTEROL H, V7, pS48, DOI 10.1016/j.cgh.2009.07.038; Matsubara J, 2010, MOL CELL PROTEOMICS, V9, P695, DOI 10.1074/mcp.M900234-MCP200; Mews P, 2002, GUT, V50, P535, DOI 10.1136/gut.50.4.535; Mroczko B, 2010, J CLIN LAB ANAL, V24, P256, DOI 10.1002/jcla.20395; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Paulo JA, 2011, J PROTEOMICS, V75, P708, DOI 10.1016/j.jprot.2011.09.009; Paulo JA, 2011, J PROTEOME RES, V10, P4835, DOI 10.1021/pr2006318; Poch B, 2007, LANGENBECK ARCH SURG, V392, P353, DOI 10.1007/s00423-006-0140-7; Reichenbach V, 2012, J PHARMACOL EXP THER, V340, P629, DOI 10.1124/jpet.111.188078; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Schneider E, 2001, AM J PHYSIOL-CELL PH, V281, pC532, DOI 10.1152/ajpcell.2001.281.2.C532; Schroder C, 2011, METHODS MOL BIOL, V785, P203, DOI 10.1007/978-1-61779-286-1_14; Schroder C, 2010, MOL CELL PROTEOMICS, V9, P1271, DOI 10.1074/mcp.M900419-MCP200; Shi WY, 2010, CURR EYE RES, V35, P967, DOI 10.3109/02713683.2010.502294; Shimizu K, 2008, J GASTROENTEROL, V43, P823, DOI 10.1007/s00535-008-2249-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tian XD, 2012, HEPATO-GASTROENTEROL, V59, P1604, DOI 10.5754/hge10366; Tomlins C, 2010, CARCINOGENESIS, V31, P2155, DOI 10.1093/carcin/bgq200; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Wara AK, 2011, BLOOD, V118, P6450, DOI 10.1182/blood-2011-06-363713; Wehr AY, 2011, PANCREAS, V40, P557, DOI 10.1097/MPA.0b013e318214efaf; Yang F, 2010, OCUL IMMUNOL INFLAMM, V18, P390, DOI 10.3109/09273948.2010.483315; Yokoyama Y, 2009, SURG TODAY, V39, P466, DOI 10.1007/s00595-008-3904-6; Zeh H. J., 2005, Cancer Biomarkers, V1, P259; Zhou G, 2012, BIOTECHNOL LETT, V34, P1235, DOI 10.1007/s10529-012-0908-5	64	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32517	32527		10.1074/jbc.M113.488387	http://dx.doi.org/10.1074/jbc.M113.488387			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24089530	hybrid, Green Published			2022-12-25	WOS:000328681700035
J	Pham, DM; Byrkit, M; Pham, HV; Pham, T; Nguyen, CT				Duc Minh Pham; Mona Byrkit; Hoang Van Pham; Trung Pham; Chien Thang Nguyen			Improving Pharmacy Staff Knowledge and Practice on Childhood Diarrhea Management in Vietnam: Are Educational Interventions Effective?	PLOS ONE			English	Article							PRIVATE PHARMACIES; DISPENSING PRACTICES; PRESCRIPTION	Background: In many developing countries, private pharmacies play an important role in providing health information and services to local communities for common health issues. The aim of this study was to ascertain medium-term impact of educational interventions on knowledge and practice of pharmacy staff regarding management of childhood diarrhea in Vietnam. Methods: This was a pre- and post-intervention study with 32 and 44 months difference from the time of the baseline survey to the conclusion of trainings and the time of the end-line survey, respectively. Interventions included in-class training for pharmacy staff, printed materials at the pharmacy, and supportive supervision. Knowledge/reported practice and actual practice of pharmacy staff were measured before and after interventions. Results: After interventions, significant improvements (p<0.01) were observed for all indexes related to pharmacy staff's knowledge about childhood diarrhea; for instance, 31% and 60% of surveyed staff asked about weight of the child and accompanying symptoms of childhood diarrhea, respectively, an increase from 11% and 45% at the baseline. Oral rehydration solution (ORS) was the most frequently reported product recommended (97% to 99%), but probiotics and antidiarrheals were the products most frequently prescribed at pharmacies. Public health facilities remained the preferred choice for referrals from pharmacies, but the use of private clinics was increasing. Consultations and advice provided to caregivers also improved, but considerable gaps between knowledge and actual practice of staff in real pharmacy settings remained. Conclusions: Educational interventions were effective in improving pharmacy staff knowledge and practice regarding management of childhood diarrhea. Knowledge and actual practice of staff in real pharmacy settings did not always correlate; there is need for a stronger regulatory and law enforcement system. Interventions to improve pharmacy practice in developing countries should be focused, comprehensive, and evidence-based.	[Duc Minh Pham; Mona Byrkit; Trung Pham; Chien Thang Nguyen] PATH, Hanoi, Vietnam; [Hoang Van Pham] Inst Social & Med Studies, Hanoi, Vietnam; [Duc Minh Pham] Management Sci Hlth, Hanoi, Vietnam		Pham, DM (corresponding author), PATH, Hanoi, Vietnam.	minhp1974@gmail.com		Pham, Minh D./0000-0002-5932-3491	Atlantic philanthropies [15336]	Atlantic philanthropies	This study was supported by the Atlantic philanthropies, grant application number 15336 (http://www.atlanticphilanthropies.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktekin M, 1998, PUBLIC HEALTH, V112, P323, DOI 10.1016/S0033-3506(98)00263-7; Association VS, 2011, STAT DAT SOC POS 63; BARRON PM, 1989, S AFR MED J, V76, P487; BERIH AA, 1989, PUBLIC HEALTH, V103, P455, DOI 10.1016/S0033-3506(89)80056-3; Chalker J, 2005, SOC SCI MED, V60, P131, DOI 10.1016/j.socscimed.2004.04.019; Chuc NTK, 2002, J CLIN EPIDEMIOL, V55, P1148, DOI 10.1016/S0895-4356(02)00458-4; Chuc NTK, 2001, ANN PHARMACOTHER, V35, P1283, DOI 10.1345/aph.10313; Das B. P., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1562; Driesen Annelies, 2009, Int J Pharm Pract, V17, P215; Garcia PJ, 2012, PLOS ONE, V7; GOODBURN E, 1991, BMJ-BRIT MED J, V302, P440, DOI 10.1136/bmj.302.6774.440; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Hoa NB, 2011, TROP MED INT HEALTH, V16, P1260, DOI 10.1111/j.1365-3156.2011.02823.x; Hussain A., 2012, Eastern Mediterranean Health Journal, V18, P635; IGUN UA, 1987, SOC SCI MED, V24, P689, DOI 10.1016/0277-9536(87)90312-1; IGUN UA, 1994, SOC SCI MED, V39, P797, DOI 10.1016/0277-9536(94)90041-8; IGUN UA, 1994, J DIARRHOEAL DIS RES, V12, P65; Isenbarger DW, 2001, EPIDEMIOLOGY INFECT, P127; Karim R, 2004, INT J CLIN PRACT, V58, P264, DOI 10.1111/j.1368-5031.2004.0095.x; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lonnroth K, 2003, INT J TUBERC LUNG D, V7, P1147; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Nsimba SED, 2007, TROP DOCT, V37, P197, DOI 10.1258/004947507782333099; Nsimba Stephen E D, 2007, East Afr J Public Health, V4, P5; Nyazema N, 2007, J ANTIMICROB CHEMOTH, V59, P718, DOI 10.1093/jac/dkm013; Minh PD, 2013, TROP MED INT HEALTH, V18, P426, DOI 10.1111/tmi.12062; Qidwai Waris, 2006, J Coll Physicians Surg Pak, V16, P743; RossDegnan D, 1996, HEALTH POLICY PLANN, V11, P308, DOI 10.1093/heapol/11.3.308; Saengcharoen Woranuch, 2010, Int J Pharm Pract, V18, P323, DOI 10.1111/j.2042-7174.2010.00066.x; Smith F, 2009, PHARM WORLD SCI, V31, P351, DOI 10.1007/s11096-009-9294-z; Sokar-Todd BH, 2003, J SOCIAL ADM PHARM, P20; TOMSON G, 1986, LANCET, V2, P620; Van Duong D, 1997, INT J PHARM PRACTICE, V5, P97; Vietnam CPAHCSCo, 2010, 2009 VIETN POP HOUS; Wachter DA, 1999, TROP MED INT HEALTH, V4, P782, DOI 10.1046/j.1365-3156.1999.00476.x; WATSON MC, 2006, INT J PHARM PRACT, V14, P83; WHO, 1993, DIARRH DIS CONTR PRO; [WHO (World Health Organization of the United Nations) WHO Department of Health Statistics and Information Systems of the Innovation Information Evidence and Research Cluster], 2012, WORLD HLTH STAT 2012, P180; Zamora Gutierrez A D, 1995, Bull Pan Am Health Organ, V29, P322	39	25	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74882	10.1371/journal.pone.0074882	http://dx.doi.org/10.1371/journal.pone.0074882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232HM	24098355	Green Submitted, Green Published, gold			2022-12-25	WOS:000325483600011
J	Lu, X; Liu, JF; Fu, WX; Zhou, JP; Luo, YR; Ding, XD; Liu, Y; Zhang, Q				Lu, Xin; Liu, JianFeng; Fu, WeiXuan; Zhou, JiaPeng; Luo, YanRu; Ding, XiangDong; Liu, Yang; Zhang, Qin			Genome-Wide Association Study for Cytokines and Immunoglobulin G in Swine	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INTERLEUKIN-10; BLOOD; PIGS; EXPRESSION; GAMMA	Increased disease resistance through improved immune capacity would be beneficial for the welfare and productivity of farm animals. To identify genomic regions responsible for immune capacity traits in swine, a genome-wide association study was conducted. In total, 675 pigs were included. At 21 days of age, all piglets were vaccinated with modified live classical swine fever vaccine. Blood samples were sampled when the piglets were 20 and 35 days of age, respectively. Four traits, including Interferon-gamma (IFN-gamma) and Interleukin 10 (IL-10) levels, the ratio of IFN-gamma to IL-10 and Immunoglobulin G (IgG) blocking percentage to CSFV in serum were measured. All the samples were genotyped for 62,163 single nucleotide polymorphisms (SNP) using the Illumina porcineSNP60k BeadChip. After quality control, 46,079 SNPs were selected for association tests based on a single-locus regression model. To tackle the issue of multiple testing, 10,000 permutations were performed to determine the chromosome-wise and genome-wise significance level. In total, 32 SNPs with chromosome-wise significance level (including 4 SNPs with genome-wise significance level) were identified. These SNPs account for 3.23% to 13.81% of the total phenotypic variance individually. For the four traits, the numbers of significant SNPs range from 5 to 15, which jointly account for 37.52%, 82.94%, 26.74% and 24.16% of the total phenotypic variance of IFN-gamma, IL-10, IFN-gamma/IL-10, and IgG, respectively. Several significant SNPs are located within the QTL regions reported in previous studies. Furthermore, several significant SNPs fall into the regions which harbour a number of known immunity-related genes. Results herein lay a preliminary foundation for further identifying the causal mutations affecting swine immune capacity in follow-up studies.	[Lu, Xin; Liu, JianFeng; Fu, WeiXuan; Zhou, JiaPeng; Luo, YanRu; Ding, XiangDong; Liu, Yang; Zhang, Qin] China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod, Minist Agr, Beijing 100094, Peoples R China; [Lu, Xin] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Fu, WeiXuan] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of Delaware	Zhang, Q (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding & Reprod, Minist Agr, Beijing 100094, Peoples R China.	qzhang@cau.edu.cn		Liu, Jian-Feng/0000-0002-5766-7864	National Natural Science Foundations of China [30972092]; National High Technology Research and Development Program of China (863 Program) [2011AA100302]; National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms [2009ZX08009-146B]; Natural Science Foundations of Beijing [6102016]; New-Century Training Programme Foundation for the Talents by the State Education Commission of China [NETC-10-0783]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms; Natural Science Foundations of Beijing; New-Century Training Programme Foundation for the Talents by the State Education Commission of China; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	The authors appreciate the financial support provided by the National Natural Science Foundations of China (30972092), the National High Technology Research and Development Program of China (863 Program 2011AA100302), the National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms (2009ZX08009-146B), the Natural Science Foundations of Beijing (6102016), New-Century Training Programme Foundation for the Talents by the State Education Commission of China (NETC-10-0783), and Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chung HK, 2003, J COMP PATHOL, V129, P205, DOI 10.1016/S0021-9975(03)00036-7; Conley ME, 2003, J CLIN INVEST, V112, P1636, DOI 10.1172/JCI20408; de Groot J, 2005, IMMUNOLOGY, V115, P495, DOI 10.1111/j.1365-2567.2005.02184.x; Diaz MA, 2003, VET IMMUNOL IMMUNOP, V93, P81, DOI 10.1016/S0165-2427(03)00071-0; Doster AR, 2010, J VET SCI, V11, P177, DOI 10.4142/jvs.2010.11.3.177; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Flori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022717; Flori Laurence, 2011, BMC Proc, V5 Suppl 4, pS32, DOI 10.1186/1753-6561-5-S4-S32; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gomez-Laguna J, 2010, J COMP PATHOL, V142, P51, DOI 10.1016/j.jcpa.2009.07.004; Hamilton GR, 2001, HUMAN IGG SUBCLASSES; Jensen J, 1994, P 5 WORLD C GEN APPL; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Jonasson R, 2006, J MED MICROBIOL, V55, P845, DOI 10.1099/jmm.0.46538-0; Kruse R, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-32; Kyriakis SC, 2002, J COMP PATHOL, V126, P38, DOI 10.1053/jcpa.2001.0520; Laman JD, 1998, IMMUNOL TODAY, V19, P489, DOI 10.1016/S0167-5699(98)01320-6; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Lu X, 2011, ANIM GENET, V42, P1, DOI 10.1111/j.1365-2052.2010.02071.x; Lu X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-488; Lu X, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-79; Maes M, 1999, ADV EXP MED BIOL, V461, P25; MALLARD BA, 1989, VET IMMUNOL IMMUNOP, V21, P139, DOI 10.1016/0165-2427(89)90062-7; Meulenbroek AJ, 1996, HUMAN IGG SUBCLASSES, P125; MOSMANN TR, 1991, IMMUNOPARASITOL TOD, pA49; Muller A, 2002, IMMUNOBIOLOGY, V205, P35, DOI 10.1078/0171-2985-00109; Nicholson LB, 1996, CURR OPIN IMMUNOL, V8, P837, DOI 10.1016/S0952-7915(96)80013-6; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Reiner G, 2008, ANIM GENET, V39, P163, DOI 10.1111/j.1365-2052.2008.01700.x; Rentzos M, 2009, ACTA NEUROL SCAND, V119, P332, DOI 10.1111/j.1600-0404.2008.01103.x; Sawada A, 2003, J CLIN INVEST, V112, P1707, DOI 10.1172/JCI18937; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Segundo FDS, 2010, J VIROL, V84, P2063, DOI 10.1128/JVI.01874-09; Shahabi S, 2006, MED HYPOTHESES, V67, P900, DOI 10.1016/j.mehy.2006.03.039; Sigal LH, 1997, ANNU REV IMMUNOL, V15, P63, DOI 10.1146/annurev.immunol.15.1.63; Thacker EL, 1999, J CLIN MICROBIOL, V37, P620, DOI 10.1128/JCM.37.3.620-627.1999; Tribout T, 2010, J ANIM SCI, V88, P2856, DOI 10.2527/jas.2009-2356; Vandenbroeck K, 2003, TRENDS PHARMACOL SCI, V24, P284, DOI 10.1016/S0165-6147(03)00131-7; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang J, 2012, ANIM GENET, DOI [10.1111/j.1365-2052.2012.02366.x, DOI 10.1111/J.1365-2052.2012.02366.X.[]; Yazawa S, 2004, VET MICROBIOL, V98, P221, DOI 10.1016/j.vetmic.2003.11.005	46	9	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74846	10.1371/journal.pone.0074846	http://dx.doi.org/10.1371/journal.pone.0074846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098351	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500015
J	Pedro, MP; Vilcaes, AA; Tomatis, VM; Oliveira, RG; Gomez, GA; Daniotti, JL				Pedro, Maria P.; Vilcaes, Aldo A.; Tomatis, Vanesa M.; Oliveira, Rafael G.; Gomez, Guillermo A.; Daniotti, Jose L.			2-Bromopalmitate Reduces Protein Deacylation by Inhibition of Acyl-Protein Thioesterase Enzymatic Activities	PLOS ONE			English	Article							GROWTH-ASSOCIATED PROTEIN-43; H-RAS; PLASMA-MEMBRANE; DISTINCT ROLES; IN-VIVO; PALMITOYLATION; TRAFFICKING; LOCALIZATION; LYSOPHOSPHOLIPASE; EXPRESSION	S-acylation, the covalent attachment of palmitate and other fatty acids on cysteine residues, is a reversible post-translational modification that exerts diverse effects on protein functions. S-acylation is catalyzed by protein acyltransferases (PAT), while deacylation requires acyl-protein thioesterases (APT), with numerous inhibitors for these enzymes having already been developed and characterized. Among these inhibitors, the palmitate analog 2-brompalmitate (2-BP) is the most commonly used to inhibit palmitoylation in cells. Nevertheless, previous results from our laboratory have suggested that 2-BP could affect protein deacylation. Here, we further investigated in vivo and in vitro the effect of 2-BP on the acylation/deacylation protein machinery, with it being observed that 2-BP, in addition to inhibiting PAT activity in vivo, also perturbed the acylation cycle of GAP-43 at the level of depalmitoylation and consequently affected its kinetics of membrane association. Furthermore, 2-BP was able to inhibit in vitro the enzymatic activities of human APT1 and APT2, the only two thioesterases shown to mediate protein deacylation, through an uncompetitive mechanism of action. In fact, APT1 and APT2 hydrolyzed both the monomeric form as well as the micellar state of the substrate palmitoyl-CoA. On the basis of the obtained results, as APTs can mediate deacylation on membrane bound and unbound substrates, this suggests that the access of APTs to the membrane interface is not a necessary requisite for deacylation. Moreover, as the enzymatic activity of APTs was inhibited by 2-BP treatment, then the kinetics analysis of protein acylation using 2-BP should be carefully interpreted, as this drug also inhibits protein deacylation.	[Pedro, Maria P.; Vilcaes, Aldo A.; Oliveira, Rafael G.; Daniotti, Jose L.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, Ctr Invest Quim Biol Cordoba, RA-5000 Cordoba, Argentina; [Tomatis, Vanesa M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Gomez, Guillermo A.] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld, Australia	National University of Cordoba; University of Queensland; University of Queensland	Daniotti, JL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, Ctr Invest Quim Biol Cordoba, RA-5000 Cordoba, Argentina.	daniotti@dqb.fcq.unc.edu.ar	Tomatis, Vanesa/D-5367-2017; Gomez, Guillermo/J-2993-2014	Tomatis, Vanesa/0000-0003-4379-8502; Gomez, Guillermo/0000-0002-0494-2404; Oliveira, Rafael Gustavo/0000-0001-5948-5338	Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); CONICET (Argentina)	Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by Grants from Secretaria de Ciencia y Tecnologia (SECyT)-Universidad Nacional de Cordoba (UNC) (www.secyt.unc.edu.ar), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (www.conicet.gov.ar) and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (www.agencia.gov.ar). M.P.P. is a recipient of CONICET (Argentina) fellowship. R.G.O. and J.L.D. are career investigators of CONICET (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Chamberlain LH, 2013, BIOCHEM SOC T, V41, P62, DOI 10.1042/BST20120243; Chenette EJ, 2005, J BIOL CHEM, V280, P13784, DOI 10.1074/jbc.M411300200; COLEMAN RA, 1992, BIOCHIM BIOPHYS ACTA, V1125, P203, DOI 10.1016/0005-2760(92)90046-X; De Moliner KL, 2005, J NEUROSCI RES, V79, P652, DOI 10.1002/jnr.20388; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Denny JB, 2004, EUR J BIOCHEM, V271, P2480, DOI 10.1111/j.1432-1033.2004.04179.x; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Draper JM, 2007, J LIPID RES, V48, P1873, DOI 10.1194/jlr.M700179-JLR200; Draper JM, 2009, MOL MEMBR BIOL, V26, P5, DOI 10.1080/09687680802683839; Ducker CE, 2006, MOL CANCER THER, V5, P1647, DOI 10.1158/1535-7163.MCT-06-0114; Duncan JA, 2002, J BIOL CHEM, V277, P31740, DOI 10.1074/jbc.M202505200; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Eisenberg S, 2013, BIOCHEM SOC T, V41, P79, DOI 10.1042/BST20120268; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Fishburn CS, 1999, J BIOL CHEM, V274, P18793, DOI 10.1074/jbc.274.26.18793; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Gomez GA, 2007, FEBS J, V274, P2210, DOI 10.1111/j.1742-4658.2007.05758.x; Montoro AG, 2009, BIOCHEM J, V419, P301, DOI 10.1042/BJ20080921; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Kong E, 2013, J BIOL CHEM, V288, P9112, DOI 10.1074/jbc.M112.421073; Liang XQ, 2002, J BIOL CHEM, V277, P33032, DOI 10.1074/jbc.M204607200; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; MAGGIO B, 1994, BBA-BIOMEMBRANES, V1190, P137, DOI 10.1016/0005-2736(94)90043-4; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; RANSAC S, 1991, METHOD ENZYMOL, V197, P49; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Sugimoto H, 1996, J BIOL CHEM, V271, P7705, DOI 10.1074/jbc.271.13.7705; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Toyoda T, 1999, BBA-MOL CELL BIOL L, V1437, P182, DOI 10.1016/S1388-1981(99)00007-4; Trenchi A, 2009, BIOCHEM J, V421, P357, DOI 10.1042/BJ20090484; Wang AJ, 1997, J BIOL CHEM, V272, P22030, DOI 10.1074/jbc.272.35.22030; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329; Zimmermann TJ, 2013, CHEMBIOCHEM, V14, P115, DOI 10.1002/cbic.201200571	54	39	39	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75232	10.1371/journal.pone.0075232	http://dx.doi.org/10.1371/journal.pone.0075232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098372	gold, Green Published, Green Submitted			2022-12-25	WOS:000325434500025
J	Domingues, PH; Teodosio, C; Otero, A; Sousa, P; Ortiz, J; Macias, MDG; Goncalves, JM; Nieto, AB; Lopes, MC; de Oliveira, C; Orfao, A; Tabernero, MD				Henriques Domingues, Patricia; Teodosio, Cristina; Otero, Alvaro; Sousa, Pablo; Ortiz, Javier; Garcia Macias, Maria del Carmen; Maria Goncalves, Jesus; Belen Nieto, Ana; Celeste Lopes, Maria; de Oliveira, Catarina; Orfao, Alberto; Dolores Tabernero, Maria			Association between Inflammatory Infiltrates and Isolated Monosomy 22/del(22q) in Meningiomas	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; GENE-EXPRESSION PROFILES; CELL-CYCLE DISTRIBUTION; CANCER-THERAPY; IMMUNE CELLS; TUMOR-CELLS; NK CELLS; MACROPHAGE; PROGNOSIS; ACTIVATION	Meningiomas contain highly variable levels of infiltrating tissue macrophages (TiMa) and other immune cells. In this study we investigated the potential association between the number and immunophenotype of inflammatory and other immune cells infiltrating the tumor as evaluated by multiparameter flow cytometry, and the clinico-biological, cytogenetic and gene expression profile (GEP) of 75 meningioma patients. Overall, our results showed a close association between the amount and cellular composition of the inflammatory and other immune cell infiltrates and the cytogenetic profile of the tumors. Notably, tumors with isolated monosomy 22/del(22q) showed greater numbers of TiMa, NK cells and (recently)-activated CD69(+) lymphocytes versus meningiomas with diploid and complex karyotypes. In addition, in the former cytogenetic subgroup of meningiomas, tumor-infiltrating TiMa also showed a more activated and functionally mature phenotype, as reflected by a greater fraction of CD69(+), CD63(+), CD16(+) and CD33(+) cells. GEP at the mRNA level showed a unique GEP among meningiomas with an isolated monosomy 22/del(22q) versus all other cases, which consisted of increased expression of genes involved in inflammatory/immune response, associated with an M1 TiMa phenotype. Altogether, these results suggest that loss of expression of specific genes coded in chromosome 22 (e. g. MIF) is closely associated with an increased homing and potentially also anti-tumoral effect of TiMa, which could contribute to explain the better outcome of this specific good-prognosis cytogenetic subgroup of meningiomas.	[Henriques Domingues, Patricia; Celeste Lopes, Maria; de Oliveira, Catarina] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Henriques Domingues, Patricia; Celeste Lopes, Maria; de Oliveira, Catarina] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Henriques Domingues, Patricia; Teodosio, Cristina; Belen Nieto, Ana; Orfao, Alberto; Dolores Tabernero, Maria] Univ Salamanca, Ctr Canc Res CIC IBMCC, CSIC USAL, IBSAL, E-37008 Salamanca, Spain; [Henriques Domingues, Patricia; Teodosio, Cristina; Belen Nieto, Ana; Orfao, Alberto; Dolores Tabernero, Maria] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain; [Otero, Alvaro; Sousa, Pablo; Maria Goncalves, Jesus] Univ Hosp Salamanca, Neurosurg Serv, Salamanca, Spain; [Ortiz, Javier] Univ Hosp Salamanca, Pathol Serv, Salamanca, Spain; [Garcia Macias, Maria del Carmen] CSIC USAL, Ctr Canc Res CIC IBMCC, Mol Pathol Serv, Salamanca, Spain; [Dolores Tabernero, Maria] Univ Hosp Salamanca, Inst Estudios Ciencias Salud Castilla & Leon IECS, Salamanca, Spain; [Dolores Tabernero, Maria] Univ Hosp Salamanca, Res Unit, Salamanca, Spain	Universidade de Coimbra; Universidade de Coimbra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Tabernero, MD (corresponding author), Univ Salamanca, Ctr Canc Res CIC IBMCC, CSIC USAL, IBSAL, E-37008 Salamanca, Spain.	taberner@usal.es	Lopes, Maria/GXF-7507-2022; Orfao, Alberto/B-5801-2017; Estella, Jesús María Gonçalves/AAB-4324-2021	Estella, Jesús María Gonçalves/0000-0002-7433-3137; Nieto-Librero, Ana B./0000-0001-6643-247X; Lopes, Maria/0000-0002-6469-0894; Teodosio, Cristina/0000-0002-2097-7199; Oliveira, Catarina/0000-0001-6942-4328	Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [PIC/IC/83108/2007]; Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Madrid, Spain) [FIS/FEDER 06/0312, RETICC RD06/0020/0035]; Caja Burgos (Spain); Fundacion MMA (Madrid, Spain) [exp 75312010, 87692011]; FCT [SFRH/BD/64799/2009]; IECSCYL (Soria, Spain)	Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Madrid, Spain); Caja Burgos (Spain); Fundacion MMA (Madrid, Spain); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); IECSCYL (Soria, Spain)	This work was partially supported by grants from the Fundacao para a Ciencia e Tecnologia (PIC/IC/83108/2007, FCT, Portugal), Fondo de Investigaciones Sanitarias (FIS/FEDER 06/0312 and RETICC RD06/0020/0035, Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Madrid, Spain), Caja Burgos (Spain), and Fundacion MMA (exp 75312010 and 87692011, Madrid, Spain). Patricia Domingues is supported by grant (SFRH/BD/64799/2009) from FCT. Maria Dolores Tabernero is supported by IECSCYL (Soria, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREESEN R, 1990, J LEUKOCYTE BIOL, V47, P490, DOI 10.1002/jlb.47.6.490; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bowdridge S, 2010, NAT IMMUNOL, V11, P879, DOI 10.1038/ni1010-879; Braga Montelli Terezinha de Cresci, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P8; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Cruz I, 2005, AM J CLIN PATHOL, V123, P66, DOI 10.1309/WP3QWKVJFYDHHXQD; Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902; Tabernero MD, 2009, BRAIN PATHOL, V19, P409, DOI 10.1111/j.1750-3639.2008.00191.x; Domingues PH, 2012, AM J PATHOL, V181, P1749, DOI 10.1016/j.ajpath.2012.07.033; Duff MD, 2007, J SURG RES, V142, P119, DOI 10.1016/j.jss.2006.12.542; Erdag G, 2012, CANCER RES, V72, P1070, DOI 10.1158/0008-5472.CAN-11-3218; Espinosa AB, 2006, CLIN CANCER RES, V12, P772, DOI 10.1158/1078-0432.CCR-05-1480; Fersching DMI, 2012, ANTICANCER RES, V32, P2047; Frankenberger M, 2000, AM J RESP CELL MOL, V23, P419, DOI 10.1165/ajrcmb.23.3.4182; Garcia Garcia J, 1992, CIR ESPAN, V51, P16; Geldhof AB, 2002, BLOOD, V100, P4049, DOI 10.1182/blood-2001-11-0106; Grund S, 2009, NEUROPATH APPL NEURO, V35, P82, DOI 10.1111/j.1365-2990.2008.00960.x; Ishizaki S, 2012, LIFE SCI, V90, P657, DOI 10.1016/j.lfs.2012.03.018; Jochems C, 2011, EXP BIOL MED, V236, P567, DOI 10.1258/ebm.2011.011007; Kaji K, 2001, J IMMUNOL, V166, P3256, DOI 10.4049/jimmunol.166.5.3256; Kalala JP, 2004, IN VIVO, V18, P411; Kamimura A, 2000, CANCER, V89, P334, DOI 10.1002/1097-0142(20000715)89:2<334::AID-CNCR18>3.0.CO;2-N; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Louis DN, 2007, MENINGIAS WHO CLASSI, P163; Maillo A, 2007, NEURO-ONCOLOGY, V9, P438, DOI 10.1215/15228517-2007-026; Matarraz S, 2011, CYTOM PART B-CLIN CY, V80B, P354, DOI 10.1002/cyto.b.20605; Mitchell RA, 2004, CELL SIGNAL, V16, P13, DOI 10.1016/j.cellsig.2003.07.002; Muramaki M, 2006, ONCOL REP, V15, P253; PAZBOUZA JI, 1994, PATHOL RES PRACT, V190, P682, DOI 10.1016/S0344-0338(11)80747-8; Pfistershammer K, 2004, J IMMUNOL, V173, P6000, DOI 10.4049/jimmunol.173.10.6000; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Rendon BE, 2009, EXP MOL PATHOL, V86, P180, DOI 10.1016/j.yexmp.2009.01.001; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; ROSSI ML, 1988, J CLIN PATHOL, V41, P314, DOI 10.1136/jcp.41.3.314; Sayagues JM, 2004, J MOL DIAGN, V6, P316, DOI 10.1016/S1525-1578(10)60527-2; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Tabernero MD, 2007, ONCOLOGIST, V12, P1225, DOI 10.1634/theoncologist.12-10-1225; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Wang XB, 2012, J NEURO-ONCOL, V106, P43, DOI 10.1007/s11060-011-0640-3; Wang ZQ, 2001, IMMUNOLOGY, V102, P331, DOI 10.1046/j.1365-2567.2001.01171.x; Zheng YX, 2012, WORLD J GASTROENTERO, V18, P2253, DOI 10.3748/wjg.v18.i18.2253	43	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74798	10.1371/journal.pone.0074798	http://dx.doi.org/10.1371/journal.pone.0074798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098347	gold, Green Published			2022-12-25	WOS:000325427100008
J	Wang, LG; Liu, X; Zhang, LC; Yan, H; Luo, WZ; Liang, J; Cheng, DX; Chen, SK; Ma, XJ; Song, X; Zhao, KB; Wang, LX				Wang, Ligang; Liu, Xin; Zhang, Longchao; Yan, Hua; Luo, Weizhen; Liang, Jing; Cheng, Duxue; Chen, Shaokang; Ma, Xiaojun; Song, Xin; Zhao, Kebin; Wang, Lixian			Genome-Wide Copy Number Variations Inferred from SNP Genotyping Arrays Using a Large White and Minzhu Intercross Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; HIDDEN-MARKOV MODEL; METABOLIC-RATE; QTL ANALYSIS; ASSOCIATION; GENES; SUSCEPTIBILITY; REPRESENTATION; SYSTEM; IMPACT	Copy number variations (CNVs) are one of the main contributors to genetic diversity in animals and are broadly distributed in the genomes of swine. Investigating the performance and evolutionary impacts of pig CNVs requires comprehensive knowledge of their structure and function within and between breeds. In the current study, 4 different programs (i.e., GADA, PennCNV, QuantiSNP, and cnvPartition) were used to analyze Porcine SNP60 genotyping data of 585 pigs from one Large White x Minzhu intercross population to detect copy number variant regions (CNVRs). Overlapping CNVRs recalled by at least 2 programs were used to construct a powerful and comprehensive CNVR map, which contained249 CNVRs (i.e., 70 gains, 43 losses, and 136 gains/losses) and covered 26.22% of the regions in the swine genome. Ten CNVRs, representing different predicted statuses, were selected for validation via quantitative real-time PCR (QPCR); 9/10 CNVRs (i.e., 90%) were validated. When being traced back to the F0 generation, 58 events were identified in only Minzhu F0 parents and 2 events were identified in only Large White F0 parents. A series of CNVR function analyses were performed. Some of the CNVRs functions were predicted, and several interesting CNVRs for meat quality traits and hematological parameters were obtained. A comprehensive and lower false rate genome-wide CNV map was constructed for Large White and Minzhu pig genomes in this study. Our results may provide an important basis for determining the relationship between CNVRs and important qualitative and quantitative traits. In addition, it can help to further understand genetic processes in pigs.	[Wang, Ligang; Liu, Xin; Zhang, Longchao; Yan, Hua; Luo, Weizhen; Liang, Jing; Cheng, Duxue; Ma, Xiaojun; Zhao, Kebin; Wang, Lixian] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China; [Chen, Shaokang] China Agr Univ, State Key Lab Agrobiotechnol, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Song, Xin] Sichuan Agr Univ, Coll Vet Med, Yaan, Sichuan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs; China Agricultural University; Sichuan Agricultural University	Zhang, LC (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China.	zhlchias@163.com; iaswlx@263.net			National Key Technology R&D Program of China [2011BAD28B01]; earmarked fund for Modern Agro-industry Technology Research System; National Technology Program of China [2011ZX08006-003]; Chinese Academy of Agricultural Sciences Foundation [2011cj-5, 2012ZL069]	National Key Technology R&D Program of China(National Key Technology R&D Program); earmarked fund for Modern Agro-industry Technology Research System; National Technology Program of China; Chinese Academy of Agricultural Sciences Foundation(Chinese Academy of Sciences)	This research was supported by the National Key Technology R&D Program of China (No.2011BAD28B01), earmarked fund for Modern Agro-industry Technology Research System, National Technology Program of China (No.2011ZX08006-003) and Chinese Academy of Agricultural Sciences Foundation (No.2011cj-5 and No.2012ZL069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballester M, 2004, BIOTECHNIQUES, V37, P610, DOI 10.2144/04374ST06; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Castle JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-244; Cho IC, 2011, ANIM GENET, V42, P621, DOI 10.1111/j.1365-2052.2011.02204.x; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Durovcova V, 2010, PHYSIOL RES, V59, P415, DOI 10.33549/physiolres.931801; Duthie CA, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-27; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Hasin Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000249; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu GS, 2008, MAMM GENOME, V19, P429, DOI 10.1007/s00335-008-9132-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo WZ, 2012, INT J BIOL SCI, V8, P870, DOI 10.7150/ijbs.4027; Luo WZ, 2012, INT J BIOL SCI, V8, P580, DOI 10.7150/ijbs.3614; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; McKinney C, 2010, ANN RHEUM DIS, V69, P1711, DOI 10.1136/ard.2009.123588; Mizoguchi Y, 2010, ANIM GENET, V41, P436, DOI 10.1111/j.1365-2052.2010.02022.x; Munoz Maria, 2012, Frontiers in Genetics, V2, P101, DOI 10.3389/fgene.2011.00101; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; Nii M, 2006, ANIM GENET, V37, P342, DOI 10.1111/j.1365-2052.2006.01485.x; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Quintanilla R, 2011, J ANIM SCI, V89, P2963, DOI 10.2527/jas.2011-3974; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041	53	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74879	10.1371/journal.pone.0074879	http://dx.doi.org/10.1371/journal.pone.0074879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098353	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100011
J	Asaminew, T; Gelaw, Y; Bekele, S; Solomon, B				Asaminew, Tsedeke; Gelaw, Yeshigeta; Bekele, Sisay; Solomon, Berhan			Retinal Detachment in Southwest Ethiopia: A Hospital Based Prospective Study	PLOS ONE			English	Article							DISEASES	Purpose: The incidence of retinal detachment in Blacks is generally considered to be low though there are few supporting studies in Africa. This study, thus, aimed at describing the clinical profile of patients with retinal detachment in Southwest Ethiopia. Methods: A hospital-based study was done on all consecutive retinal detachment patients who presented to Jimma University Hospital over six months period. A semi-structured questionnaire was used to collect patients' sociodemographic characteristics and clinical history. Comprehensive anterior and posterior segment eye examinations were done and risk factors were sought for. Statistical tests were considered significant if P < 0.05. Results: A total of 94 eyes of 80 patients (1.5%) had retinal detachment (RD) and about 69% of patients were symptomatic for over a month before presentation. The mean age was 41.4 years (SD +/- 16.5). Fourteen patients (17.5%) had bilateral RD. At presentation, 61 eyes (64.9%) were blind from RD and 11 (13.8%) patients were bilaterally blind from RD. Rhegmatogenous RD was seen in 55 eyes (58.5%) and tractional RD in 22 eyes (23.4%). The most common risk factors were ocular trauma (32 eyes, 34.0%), myopia (23 eyes, 24.5%), posterior uveitis (13 eyes, 13.8%) and diabetic retinopathy (9 eyes, 9.6%). Most retinal breaks (25 eyes, 43.1%) were superotemporal and horse-shoe tear was the most common (19 eyes, 20.2%). Macula was off in 77 eyes (81.9%) and 38 eyes (69.1% of RRD eyes) had grade C proliferative vitreoretinopathy (PVR). Macular status was significantly associated with PVR (P=0.011), and duration of symptoms (RR=1.25, 95% CI: 1.059-1.475, P=0.040). Conclusions: A significant numbers of patients with ocular problem had retinal detachment, and nearly two third of the patients presented late. Trauma and myopia were the most important risk factors. People should be educated to improve their health seeking behavior and use eye safety precautions to prevent ocular trauma.	[Asaminew, Tsedeke; Gelaw, Yeshigeta; Bekele, Sisay; Solomon, Berhan] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Ophthalmol, Jimma, Ethiopia	Jimma University	Gelaw, Y (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Dept Ophthalmol, Jimma, Ethiopia.	dryeshi@yahoo.com		Alemu, Tsedeke Asaminew/0000-0002-7083-5957	Jimma University; Light-for the World	Jimma University; Light-for the World	This study was financially supported by Jimma University and Light-for the World. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIOSE A, 1979, ANN OPHTHALMOL, V11, P1067; Ahmadieh H, 2000, EUR J OPHTHALMOL, V10, P153, DOI 10.1177/112067210001000211; AVSHALOM A, 1967, AM J OPHTHALMOL, V64, P384, DOI 10.1016/0002-9394(67)92000-4; BERHANE Y, 2007, HLTH DEVICES, V21, P185; CARRERAS FJ, 1995, BRIT J OPHTHALMOL, V79, P926, DOI 10.1136/bjo.79.10.926; CHUMBLEY LC, 1977, S AFR MED J, V52, P316; Comer MB, 2000, EYE, V14, P572, DOI 10.1038/eye.2000.145; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; FOOS RY, 1983, AM J OPHTHALMOL, V96, P644, DOI 10.1016/S0002-9394(14)73423-3; GORDON YJ, 1980, DOC OPHTHALMOL, V49, P285, DOI 10.1007/BF01886621; Haile M, 1996, E AFR MED J, V73, P703; Kaimbo K, 1986, Bull Soc Belge Ophtalmol, V218, P83; Krohn J, 2000, ACTA OPHTHALMOL SCAN, V78, P354, DOI 10.1034/j.1600-0420.2000.078003354.x; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; PETERS AL, 1995, S AFR MED J, V85, P158; Rowe JA, 1999, OPHTHALMOLOGY, V106, P154, DOI 10.1016/S0161-6420(99)90018-0; Solomon B, 2011, ETHIOP J HEALTH DEV, V25, P31; Sullivan PM, 1997, EYE, V11, P869, DOI 10.1038/eye.1997.223; WEISS H, 1978, ANN OPHTHALMOL, V10, P799; Yorston D, 2002, EYE, V16, P353, DOI 10.1038/sj.eye.6700188; Yorston DB, 2002, OPHTHALMOLOGY, V109, P2279, DOI 10.1016/S0161-6420(02)01284-8	21	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75693	10.1371/journal.pone.0075693	http://dx.doi.org/10.1371/journal.pone.0075693			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086614	Green Submitted, gold, Green Published			2022-12-25	WOS:000325223900058
J	Kleftogiannis, D; Kalnis, P; Bajic, VB				Kleftogiannis, Dimitrios; Kalnis, Panos; Bajic, Vladimir B.			Comparing Memory-Efficient Genome Assemblers on Stand-Alone and Cloud Infrastructures	PLOS ONE			English	Article							SEQUENCE; MILLIONS; VELVET; READS	A fundamental problem in bioinformatics is genome assembly. Next-generation sequencing (NGS) technologies produce large volumes of fragmented genome reads, which require large amounts of memory to assemble the complete genome efficiently. With recent improvements in DNA sequencing technologies, it is expected that the memory footprint required for the assembly process will increase dramatically and will emerge as a limiting factor in processing widely available NGS-generated reads. In this report, we compare current memory-efficient techniques for genome assembly with respect to quality, memory consumption and execution time. Our experiments prove that it is possible to generate draft assemblies of reasonable quality on conventional multi-purpose computers with very limited available memory by choosing suitable assembly methods. Our study reveals the minimum memory requirements for different assembly programs even when data volume exceeds memory capacity by orders of magnitude. By combining existing methodologies, we propose two general assembly strategies that can improve short-read assembly approaches and result in reduction of the memory footprint. Finally, we discuss the possibility of utilizing cloud infrastructures for genome assembly and we comment on some findings regarding suitable computational resources for assembly.	[Kleftogiannis, Dimitrios; Kalnis, Panos] KAUST, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal, Saudi Arabia; [Bajic, Vladimir B.] KAUST, Comp Elect & Math Sci & Engn Div CEMSE, CBRC, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Bajic, VB (corresponding author), KAUST, Comp Elect & Math Sci & Engn Div CEMSE, CBRC, Thuwal, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Kalnis, Panos/H-2826-2014; Bajic, Vladimir/D-2810-2009	Kalnis, Panos/0000-0002-5060-1360; Bajic, Vladimir/0000-0001-5435-4750; Kleftogiannis, Dimitrios/0000-0003-1086-821X	KAUST	KAUST(King Abdullah University of Science & Technology)	DK and PK are supported by the KAUST Base Research Fund of PK. VBB is supported by the KAUST Base Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Burrows M, 1994, BLOCK SORTING LOSSLE; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; CHIKHI R, 2012, LECT NOTES COMPUTER; Compeau PEC, 2011, NAT BIOTECHNOL, V29, P987, DOI 10.1038/nbt.2023; Conway TC, 2011, BIOINFORMATICS, V27, P479, DOI 10.1093/bioinformatics/btq697; DeFrancesco L, 2012, NAT BIOTECHNOL, V30, P126, DOI 10.1038/nbt0212-126a; DELABASTIDE M, 2007, CURR PROTOC BIOINFOR, pCH11, DOI DOI 10.1002/0471250953.BI1104S17; DiGuistini S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r94; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Howe A, 2012, ILLUMINA SEQUENCING; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Jackman SD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-202; KHAYYAT Z, 2013, P EUROSYS 2013 C PRA; Knuth D E, 1997, ART COMPUTER PROGRAM, V2; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; LI Y, 2013, VLDB C TREN IN PRESS; Liu YC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-354; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Pell J, 2012, P NATL ACAD SCI USA, V109, P13272, DOI 10.1073/pnas.1121464109; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; SANGER F, 1977, J MOL BIOL, V25, P441; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schmidt B, 2009, BIOINFORMATICS, V25, P2279, DOI 10.1093/bioinformatics/btp374; Schwarz E. M., 2013, REFERENCE FREE ALGOR; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Simpson JT, 2010, BIOINFORMATICS, V26, pi367, DOI 10.1093/bioinformatics/btq217; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Ye CX, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S6-S1; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	44	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75505	10.1371/journal.pone.0075505	http://dx.doi.org/10.1371/journal.pone.0075505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086547	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900044
J	McCusker, CD; Gardiner, DM				McCusker, Catherine D.; Gardiner, David M.			Positional Information Is Reprogrammed in Blastema Cells of the Regenerating Limb of the Axolotl (Ambystoma mexicanum)	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; INTERCALARY REGENERATION; PATTERN REGULATION; WOUND EPITHELIUM; AMPHIBIAN LIMB; APICAL CAP; DISTAL; ORGANIZATION; FORELIMBS; DEDIFFERENTIATION	The regenerating region of an amputated salamander limb, known as the blastema, has the amazing capacity to replace exactly the missing structures. By grafting cells from different stages and regions of blastemas induced to form on donor animals expressing Green Fluorescent Protein (GFP), to non-GFP host animals, we have determined that the cells from early stage blastemas, as well as cells at the tip of late stage blastemas are developmentally labile such that their positional identity is reprogrammed by interactions with more proximal cells with stable positional information. In contrast, cells from the adjacent, more proximal stump tissues as well as the basal region of late bud blastemas are positionally stable, and thus form ectopic limb structures when grafted. Finally, we have found that a nerve is required to maintain the blastema cells in a positionally labile state, thus indicating a role for reprogramming cues in the blastema microenvironment.	[McCusker, Catherine D.; Gardiner, David M.] Univ Calif Irvine, Dept Dev & Cellular Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Gardiner, DM (corresponding author), Univ Calif Irvine, Dept Dev & Cellular Biol, Irvine, CA 92697 USA.	dmgardin@uci.edu			American Cancer Society [PF-12-145-01-DDC]; US Army Research Office Multidisciplinary University Research Initiative (MURI) [TUL 589-09/10]; National Science Foundation through Ambystoma Genetic Stock Center at the University of Kentucky, Lexington	American Cancer Society(American Cancer Society); US Army Research Office Multidisciplinary University Research Initiative (MURI)(MURI); National Science Foundation through Ambystoma Genetic Stock Center at the University of Kentucky, Lexington	Catherine McCusker was supported by a Postdoctoral Fellowship, PF-12-145-01-DDC from the American Cancer Society. Additional support was provided by the US Army Research Office Multidisciplinary University Research Initiative (MURI) (TUL 589-09/10) and the National Science Foundation through its support of the Ambystoma Genetic Stock Center at the University of Kentucky, Lexington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando T, 2009, DEVELOPMENT, V136, P2235, DOI 10.1242/dev.035204; BRYANT SV, 1987, AM ZOOL, V27, P675; BRYANT SV, 1976, DEV BIOL, V50, P212, DOI 10.1016/0012-1606(76)90079-8; BRYANT SV, 1981, SCIENCE, V212, P993, DOI 10.1126/science.212.4498.993; Christensen RN, 2001, J EXP ZOOL, V290, P529, DOI 10.1002/jez.1097; DUNIS DA, 1977, DEV BIOL, V56, P97, DOI 10.1016/0012-1606(77)90157-9; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Ferris DR, 2010, DEV GROWTH DIFFER, V52, P715, DOI 10.1111/j.1440-169X.2010.01208.x; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; FRENCH V, 1978, J EMBRYOL EXP MORPH, V47, P53; GARDINER DM, 1989, J EXP ZOOL, V251, P47, DOI 10.1002/jez.1402510107; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; HORTON C, 1995, DEV DYNAM, V202, P312, DOI 10.1002/aja.1002020310; ITEN LE, 1975, DEV BIOL, V44, P119, DOI 10.1016/0012-1606(75)90381-4; Khan P, 2002, DEV BIOL, V250, P383, DOI 10.1006/dbio.2002.0801; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; MADEN M, 1980, J EMBRYOL EXP MORPH, V56, P201; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Mariani FV, 2010, REGEN MED, V5, P451, DOI 10.2217/RME.10.27; Mercader N, 2005, DEVELOPMENT, V132, P4131, DOI 10.1242/dev.01976; Mescher AL, 2000, WOUND REPAIR REGEN, V8, P110, DOI 10.1046/j.1524-475x.2000.00110.x; MICHAEL M. I., 1961, ARCH BIOL, V72, P301; MILOJEVIC BD, 1924, W ROUX ARCH, V103, P80; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; MORGAN TH, 1901, REGENERATION, P62; Mori AD, 2004, CURR OPIN CARDIOL, V19, P211, DOI 10.1097/00001573-200405000-00004; Mullen LM, 1996, DEVELOPMENT, V122, P3487; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Nacu E, 2013, DEVELOPMENT, V140, P513, DOI 10.1242/dev.081752; Nacu E, 2011, ANNU REV CELL DEV BI, V27, P409, DOI 10.1146/annurev-cellbio-092910-154115; Naiche LA, 2011, DEV DYNAM, V240, P2290, DOI 10.1002/dvdy.22731; Neufeld DA, 1996, ANAT RECORD, V246, P155; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; NIAZI IA, 1985, ROUX ARCH DEV BIOL, V194, P355, DOI 10.1007/BF00877373; Ohgo S, 2010, DEV BIOL, V338, P148, DOI 10.1016/j.ydbio.2009.11.026; PESCITELLI MJ, 1980, DEV BIOL, V79, P255, DOI 10.1016/0012-1606(80)90115-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rageh MAE, 2002, J EXP ZOOL, V292, P255, DOI 10.1002/jez.10015; ROLLMANDINSMORE C, 1982, J EXP ZOOL, V223, P51, DOI 10.1002/jez.1402230109; ROSE M, 1962, TISSUE ARC CONTROL R; Satoh A, 2008, DEV BIOL, V319, P321, DOI 10.1016/j.ydbio.2008.04.030; Satoh A, 2007, DEV BIOL, V312, P231, DOI 10.1016/j.ydbio.2007.09.021; Satoh A, 2008, DEV GROWTH DIFFER, V50, P743, DOI 10.1111/j.1440-169X.2008.01072.x; Schilling TF, 2001, DEV BIOL, V231, P201, DOI 10.1006/dbio.2000.9997; Schwidefsky G, 1934, ROUX ARCH DEV BIOL, V132, P57; Shimokawa Takashi, 2012, Okajimas Folia Anatomica Japonica, V89, P75; SINGER M, 1964, J EXP ZOOL, V155, P105, DOI 10.1002/jez.1401550108; SINGER MARCUS, 1952, QUART REV BIOL, V27, P169, DOI 10.1086/398873; Song SH, 2000, P NATL ACAD SCI USA, V97, P8658, DOI 10.1073/pnas.140210697; STINSON BD, 1963, J EXP ZOOL, V153, P37, DOI 10.1002/jez.1401530105; STOCUM DL, 1968, DEV BIOL, V18, P457, DOI 10.1016/0012-1606(68)90052-3; STOCUM DL, 1977, J EXP ZOOL, V201, P451, DOI 10.1002/jez.1402010312; STOCUM DL, 1980, J EXP ZOOL, V212, P361, DOI 10.1002/jez.1402120308; STOCUM DL, 1984, DIFFERENTIATION, V27, P13, DOI 10.1111/j.1432-0436.1984.tb01403.x; STOCUM DL, 1975, DEV BIOL, V45, P112, DOI 10.1016/0012-1606(75)90246-8; STOCUM DL, 1982, J EMBRYOL EXP MORPH, V71, P193; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; THORNTON CS, 1957, J EXP ZOOL, V134, P357, DOI 10.1002/jez.1401340209; WALLACE H, 1981, ERTEBR LIMBS REGENER; Weiss P, 1925, W ROUX ARCH ENTWICKL, V104, P359; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171	63	55	55	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e77064	10.1371/journal.pone.0077064	http://dx.doi.org/10.1371/journal.pone.0077064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086768	Green Published, gold			2022-12-25	WOS:000325223900112
J	Shen, HW; Shi, WX; Wang, J; Wang, M; Li, J; Zhang, C; Nie, K; Yang, MJ; Zhang, Y; Li, AH; Tan, WJ; Ma, XJ				Shen, Hongwei; Shi, Weixian; Wang, Ji; Wang, Miao; Li, Jin; Zhang, Chen; Nie, Kai; Yang, Mengjie; Zhang, Yi; Li, Aihua; Tan, Wenjie; Ma, Xuejun			Development of a New Resequencing Pathogen Microarray Based Assay for Detection of Broad-Spectrum Respiratory Tract Viruses in Patients with Community-Acquired Pneumonia	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; IDENTIFICATION; ETIOLOGY; AGE	A Resequencing Pathogen Microarray (RPM) is a single, highly multiplexed assay for detecting and differentiating similarly related pathogens by using closely overlapping probe sets to determine a target organism's nucleotide sequence. In this study, a new RPM (RPM-IVDC1) that consisted of 224-bp detector tiles corresponding to 9 influenza A subtypes, 11 rhinoviruses, 28 enteroviruses and 38 other respiratory viruses was developed and optimized to provide individual and simultaneous detection sensitivities ranging from 15 to 750 genomic copies for 16 common respiratory pathogens. A total of 110 consecutive patients with community-acquired pneumonia (CAP) admitted to 5 district general hospitals in Beijing during a 1-year period were assessed using the new assay. Among the children (under age 5) and adult patients (above age 18), respiratory syncytial virus (RSV) and rhinovirus (RV) were the most common etiological agents, respectively, which is consistent with reference assays. Atypical pathogens that may cause CAP-like illness, including rubella virus, measles virus, influenza type C virus, human herpesvirus (HHV) were also detected. The results show the capability of RPM-IVDC1 for the accurate detection and identification of multiple virus types, which may be of significant use in epidemic surveillance and outbreak investigations of atypical pathogens.	[Shen, Hongwei; Wang, Ji; Wang, Miao; Li, Jin; Zhang, Chen; Nie, Kai; Yang, Mengjie; Zhang, Yi; Tan, Wenjie; Ma, Xuejun] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China; [Shen, Hongwei] Futian Dist Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China; [Shi, Weixian] Beijing Ctr Dis Control & Prevent, Inst Infect Dis & Endem Dis Control, Beijing, Peoples R China; [Li, Aihua] Beijing Ctr Dis Control & Prevent, Inst Immunizat & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Tan, WJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China.	tanwj28@yahoo.cn; maxj@ivdc.chinacdc.cn	Nie, Kai/L-5389-2019		China Mega-Project for Infectious Disease [2011ZX10004-001, 2012ZX10004-215, 2013ZX10004-202, 2014ZX10004003-003, 2014ZX10004002-004]	China Mega-Project for Infectious Disease	This work was supported by the China Mega-Project for Infectious Disease (2011ZX10004-001, 2012ZX10004-215, 2013ZX10004-202, 2014ZX10004003-003, 2014ZX10004002-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Brown PD, 1998, LANCET, V352, P1295, DOI 10.1016/S0140-6736(98)02239-9; Bruynseels P, 2003, LANCET, V362, P1536, DOI 10.1016/S0140-6736(03)14740-X; Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09; Claytor D, 1995, Crit Care Nurse, V15, P43; Cone R W, 1995, Semin Respir Infect, V10, P254; Endimiani A, 2011, CLIN INFECT DIS, V52, pS373, DOI 10.1093/cid/cir054; Ginocchio CC, 2007, J CLIN VIROL, V40, pS11, DOI 10.1016/S1386-6532(07)70004-5; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Lauderdale TL, 2005, RESP MED, V99, P1079, DOI 10.1016/j.rmed.2005.02.026; LESKI T, 2011, MASSIVELY MULTIPLEXE; Leski TA, 2012, FUTURE MICROBIOL, V7, P625, DOI [10.2217/FMB.12.30, 10.2217/fmb.12.30]; Li J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-189; Lieberman D, 1996, EUR RESPIR J, V9, P2630, DOI 10.1183/09031936.96.09122630; Lin B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000419; Lin BC, 2007, J CLIN MICROBIOL, V45, P443, DOI 10.1128/JCM.01870-06; Lin BC, 2009, J CLIN MICROBIOL, V47, P988, DOI 10.1128/JCM.01346-08; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Malanoski AP, 2006, NUCLEIC ACIDS RES, V34, P5300, DOI 10.1093/nar/gkl565; McManus Terence E, 2009, Ulster Med J, V78, P137; Metzgar D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008995; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; MORIUCHI H, 1991, J PEDIATR-US, V118, P235, DOI 10.1016/S0022-3476(05)80489-5; Murdoch DR, 2009, J CLIN MICROBIOL, V47, P3405, DOI 10.1128/JCM.01685-09; Nolte FS, 2008, CLIN INFECT DIS, V47, pS123, DOI 10.1086/591392; PETHER JVS, 1989, LANCET, V1, P1210; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P397, DOI 10.1164/ajrccm.160.2.9808045; Stein RT, 2007, PEDIATR PULM, V42, P1095, DOI 10.1002/ppul.20652; Tabone T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-580; Templeton KE, 2005, CLIN INFECT DIS, V41, P345, DOI 10.1086/431588; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; UNICEF, 2007, PROTECTING THE WORLD'S CHILDREN: IMPACT OF THE CONVENTION ON THE RIGHTS OF THE CHILD IN DIVERSE LEGAL SYSTEMS, P1; *UNICEF O, 2006, PNEUM FORG KILL CHIL; Wong S, 2009, J CLIN MICROBIOL, V47, P3839, DOI 10.1128/JCM.01469-09	34	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75704	10.1371/journal.pone.0075704	http://dx.doi.org/10.1371/journal.pone.0075704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086618	gold, Green Submitted, Green Published			2022-12-25	WOS:000325223900060
J	Staedler, YM; Masson, D; Schonenberger, J				Staedler, Yannick M.; Masson, David; Schoenenberger, Juerg			Plant Tissues in 3D via X-Ray Tomography: Simple Contrasting Methods Allow High Resolution Imaging	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ARABIDOPSIS; ROOTS; VISUALIZATION; SEEDS; MICROTOMOGRAPHY; ARCHITECTURE; MICROCT; CT	Computed tomography remains strongly underused in plant sciences despite its high potential in delivering detailed 3D phenotypical information because of the low X-ray absorption of most plant tissues. Existing protocols to study soft tissues display poor performance, especially when compared to those used on animals. More efficient protocols to study plant material are therefore needed. Flowers of Arabidopsis thaliana and Marcgravia caudata were immersed in a selection of contrasting agents used to treat samples for transmission electron microscopy. Grayscale values for floral tissues and background were measured as a function of time. Contrast was quantified via a contrast index. The thick buds of Marcgravia were scanned to determine which contrasting agents best penetrate thick tissues. The highest contrast increase with cytoplasm-rich tissues was obtained with phosphotungstate, whereas osmium tetroxide and bismuth tatrate displayed the highest contrast increase with vacuolated tissues. Phosphotungstate also displayed the best sample penetration. Furthermore, infiltration with phosphotungstate allowed imaging of all plants parts at a high resolution of 3 mm, which approaches the maximum resolution of our equipment: 1.5 mm. The high affinity of phosphotungstate for vasculature, cytoplasm-rich tissue, and pollen causes these tissues to absorb more X-rays than the surrounding tissues, which, in turn, makes these tissues appear brighter on the scan data. Tissues with different brightness can then be virtually dissected from each other by selecting the bracket of grayscale to be visualized. Promising directions for the future include in silico phenotyping and developmental studies of plant inner parts (e. g., ovules, vasculature, pollen, and cell nuclei) via virtual dissection as well as correlations of quantitative phenotypes with omics datasets. Therefore, this work represents a crucial improvement of previous methods, allowing new directions of research to be undertaken in areas ranging from morphology to systems biology.	[Staedler, Yannick M.; Schoenenberger, Juerg] Univ Vienna, Dept Struct & Funct Bot, Vienna, Austria; [Masson, David] MeteoSwiss, Fed Off Meteorol & Climatol, Zurich, Switzerland	University of Vienna; Federal Office of Meteorology & Climatology (MeteoSwiss)	Staedler, YM (corresponding author), Univ Vienna, Dept Struct & Funct Bot, Vienna, Austria.	yannick.staedler@univie.ac.at	Schönenberger, Jürg/AAE-6479-2020; Schönenberger, Jürg/D-3413-2014	Schönenberger, Jürg/0000-0001-6791-2731; Schönenberger, Jürg/0000-0001-6791-2731; Staedler, Yannick/0000-0002-5962-7313; Stadler, Yannick/0000-0002-6328-1503; Staedler, Yannick Marc/0000-0002-0688-6995	University of Vienna	University of Vienna	Source of funding: University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellaire A, 2012, 23 INT C AR RES VIEN, P178; Brodersen CR, 2011, NEW PHYTOL, V191, P1168, DOI 10.1111/j.1469-8137.2011.03754.x; BROOKS RA, 1977, J COMPUT ASSIST TOMO, V1, P487, DOI 10.1097/00004728-197710000-00016; Cloetens P, 2006, P NATL ACAD SCI USA, V103, P14626, DOI 10.1073/pnas.0603490103; DeVore ML, 2006, AM J BOT, V93, P1848, DOI 10.3732/ajb.93.12.1848; Dhondt S, 2010, TRENDS PLANT SCI, V15, P419, DOI 10.1016/j.tplants.2010.05.002; Friis EM, 2007, NATURE, V450, P549, DOI 10.1038/nature06278; Gamisch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072688; Goebel JC, 2008, BIO-MED MATER ENG, V18, P247, DOI 10.3233/BME-2008-0533; Gregory PJ, 2003, PLANT SOIL, V255, P351, DOI 10.1023/A:1026179919689; Hamza MA, 2001, AUST J SOIL RES, V39, P1387, DOI 10.1071/SR98057; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Heeraman DA, 1997, PLANT SOIL, V189, P167, DOI 10.1023/A:1004258818538; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; Hounsfield G N, 1976, J Can Assoc Radiol, V27, P135; HOUNSFIELD GN, 1980, SCIENCE, V210, P22, DOI 10.1126/science.6997993; Jain A. K., 1989, FUNDAMENTALS DIGITAL; Jiang N, 2012, COMPUT ELECTRON AGR, V85, P123, DOI 10.1016/j.compag.2012.04.004; Kaestner A, 2006, GEODERMA, V136, P459, DOI 10.1016/j.geoderma.2006.04.009; Kaminuma E, 2005, PLANT CELL PHYSIOL, V46, pS62; Kaminuma E, 2008, PLANT J, V56, P470, DOI 10.1111/j.1365-313X.2008.03609.x; Korte N, 2012, PLANT BIOLOGY, V14, P537, DOI 10.1111/j.1438-8677.2011.00546.x; Korte N, 2011, MICROSC RES TECHNIQ, V74, P364, DOI 10.1002/jemt.20917; Leroux O, 2011, ANN BOT-LONDON, V108, P307, DOI 10.1093/aob/mcr161; Leroux O, 2009, J MICROSC-OXFORD, V233, P1, DOI 10.1111/j.1365-2818.2008.03088.x; Matsushima U, 2012, POSTHARVEST BIOL TEC, V72, P27, DOI 10.1016/j.postharvbio.2012.04.013; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Milien M, 2012, SCI HORTIC-AMSTERDAM, V144, P130, DOI 10.1016/j.scienta.2012.06.045; Perret JS, 2007, SOIL BIOL BIOCHEM, V39, P391, DOI 10.1016/j.soilbio.2006.07.018; Pierret A, 1999, GEODERMA, V90, P307, DOI 10.1016/S0016-7061(98)00136-0; Pika-Biolzi M, 2000, RIV ITAL PALEONTOL S, V106, P369, DOI 10.13130/2039-4942/6151; Quintana Laura, 2011, Cold Spring Harb Protoc, V2011, P586, DOI 10.1101/pdb.top116; Rengle A, 2009, IEEE T BIO-MED ENG, V56, P2891, DOI 10.1109/TBME.2008.2006015; Schneider JE, 2003, MAGN RESON MATER PHY, V16, P43, DOI 10.1007/s10334-003-0002-z; Sharpe J., 2009, ADV IMAGING BIOL MED, P199; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Tracy SR, 2010, J EXP BOT, V61, P311, DOI 10.1093/jxb/erp386; van der Niet T, 2010, TRENDS PLANT SCI, V15, P423, DOI 10.1016/j.tplants.2010.05.005; von Balthazar M, 2007, AM J BOT, V94, P2041, DOI 10.3732/ajb.94.12.2041; Weninger WJ, 2006, ANAT EMBRYOL, V211, P213, DOI 10.1007/s00429-005-0073-x; Yamauchi D, 2012, AIP CONF PROC, V1466, P237, DOI 10.1063/1.4742298	43	98	102	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75295	10.1371/journal.pone.0075295	http://dx.doi.org/10.1371/journal.pone.0075295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086499	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900043
J	Wongkulab, P; Wipasa, J; Chaiwarith, R; Supparatpinyo, K				Wongkulab, Panuwat; Wipasa, Jiraprapa; Chaiwarith, Romanee; Supparatpinyo, Khuanchai			Autoantibody to Interferon-gamma Associated with Adult-Onset Immunodeficiency in Non-HIV Individuals in Northern Thailand	PLOS ONE			English	Article							MYCOBACTERIAL INFECTION; PATIENT; RECURRENT	Background: Autoantibody to interferon-gamma (IFN-gamma) has been reported to be associated with adult-onset immunodeficiency in patients from Asian countries. This study aimed to determine the prevalence of autoantibody to IFN-gamma among non-HIV patients in northern Thailand who were repeatedly infected with unusual intracellular pathogens. Methods: A cross-sectional, case-control study was conducted between March 2011 and March 2012 at Chiang Mai University Hospital. 20 cases, non-HIV, aged 18-60 years, presented with at least 2 episodes of culture or histopathology proven opportunistic infections were enrolled. Controls comprised 20 HIV-infected patients and 20 healthy adults who were age-and sex-matched with cases. Enzyme-linked immunosorbent assay (ELISA) was used to detect the presence of antibody to IFN-gamma. Results: 11 participants in each group were female. The mean ages were 48.1 +/- 6.4, 48.3 +/- 6.3, and 47.1 +/- 6.5 years among cases, HIV-infected, and healthy controls, respectively. The opportunistic infections among 20 cases included disseminated non-tuberculous mycobacterial (NTM) infection (19 patients/24 episodes), disseminated penicilliosis marneffei (12 patients/12 episodes), and non-typhoidal Salmonella bacteremia (7 patients/8 episodes). At the cutoff level of 99 percentile of controls, the prevalence of autoantibody to IFN-gamma were 100%, 0%, and 0%, among cases, HIV-infected, and healthy controls, respectively(p-value <0.001). The mean concentrations of antibody to IFN-gamma were 3.279 +/- 0.662 and 0.939 +/- 0.630 O.D. among cases with and without active opportunistic infection, respectively (p-value <0.001). Conclusions: In northern Thailand, autoantibody to IFN-gamma was strongly associated with adult-onset immunodeficiency. The level of antibody to IFN-gamma in patients who had active opportunistic infection was relatively higher than those without active infection.	[Wongkulab, Panuwat; Chaiwarith, Romanee; Supparatpinyo, Khuanchai] Chiang Mai Univ, Fac Med, Dept Med, Chiang Mai 50000, Thailand; [Wipasa, Jiraprapa; Supparatpinyo, Khuanchai] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand	Chiang Mai University; Chiang Mai University	Supparatpinyo, K (corresponding author), Chiang Mai Univ, Fac Med, Dept Med, Chiang Mai 50000, Thailand.	khuanchai.s@gmail.com		Chaiwarith, Romanee/0000-0002-1241-5954	National Research University Project under Thailand's Office of the Higher Education Commission	National Research University Project under Thailand's Office of the Higher Education Commission	This work was supported by the National Research University Project under Thailand's Office of the Higher Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2010, CELLULAR MOL IMMUNOL, P3; Baerlecken N, 2009, CLIN INFECT DIS, V49, pE76, DOI 10.1086/605581; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; CARUSO A, 1989, J BIOL REG HOMEOS AG, V3, P8; Chen YP, 2008, APMIS, V116, P850, DOI 10.1111/j.1600-0463.2008.00935.x; Chetchotisakd P, 2007, CLIN INFECT DIS, V45, P421, DOI 10.1086/520030; Doffinger R, 2005, CURR OPIN RHEUMATOL, V17, P440, DOI 10.1097/01.bor.0000166387.70475.dd; Doffinger R, 2004, CLIN INFECT DIS, V38, pE10, DOI 10.1086/380453; Hoflich C, 2004, BLOOD, V103, P673, DOI 10.1182/blood-2003-04-1065; Kampitak T, 2011, INFECTION, V39, P65, DOI 10.1007/s15010-010-0067-3; Kampmann B, 2005, J CLIN INVEST, V115, P2480, DOI 10.1172/JCI19316; Koya T, 2009, J INFECT CHEMOTHER, V15, P118, DOI 10.1007/s10156-008-0662-8; Patel SY, 2005, J IMMUNOL, V175, P4769, DOI 10.4049/jimmunol.175.7.4769; SUPPARATPINYO K, 1994, LANCET, V344, P110, DOI 10.1016/S0140-6736(94)91287-4; Tanaka Y, 2007, INTERNAL MED, V46, P1005, DOI 10.2169/internalmedicine.46.6452; Tang BSF, 2010, CLIN VACCINE IMMUNOL, V17, P1132, DOI 10.1128/CVI.00053-10; Vergis EN, 2000, INFECT DIS CLIN N AM, V14, P809, DOI 10.1016/S0891-5520(05)70135-5	18	59	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76371	10.1371/journal.pone.0076371	http://dx.doi.org/10.1371/journal.pone.0076371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086734	gold, Green Submitted, Green Published			2022-12-25	WOS:000325223900098
J	Ying, SB; Dunnebier, T; Si, J; Hamann, U				Ying, Shibo; Duennebier, Thomas; Si, Jing; Hamann, Ute			Estrogen Receptor Alpha and Nuclear Factor Y Coordinately Regulate the Transcription of the SUMO-Conjugating UBC9 Gene in MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							NF-Y; PROGESTERONE-RECEPTOR; COVALENT MODIFICATION; INDUCTION PROPERTIES; ANDROGEN RECEPTOR; SUMOYLATION; EXPRESSION; PROTEIN; ACTIVATION; MECHANISMS	UBC9 encodes a protein that conjugates small ubiquitin-related modifier (SUMO) to target proteins thereby changing their functions. Recently, it was noted that UBC9 expression and activity play a role in breast tumorigenesis and response to anticancer drugs. However, the underlying mechanism is poorly understood. To investigate the transcriptional regulation of the UBC9 gene, we identified and characterized its promoter and cis-elements. Promoter activity was tested using luciferase reporter assays. The binding of transcription factors to the promoter was detected by chromatin immunoprecipitation (ChIP), and their functional role was confirmed by siRNA knockdown. UBC9 mRNA and protein levels were measured by quantitative reverse transcription PCR and Western blot analysis, respectively. An increased expression of UBC9 mRNA and protein was found in MCF-7 breast cancer cells treated with 17 beta-estradiol (E-2). Analysis of various deletion mutants revealed a 137 bp fragment upstream of the transcription initiation site to be sufficient for reporter gene transcription. Mutations of putative estrogen receptor alpha (ER-alpha) (one imperfect estrogen response element, ERE) and/or nuclear factor Y (NF-Y) binding sites (two CCAAT boxes) markedly reduced promoter activity. Similar results were obtained in ER-negative MDA-MB-231 cells except that the ERE mutation did not affect promoter activity. Additionally, promoter activity was stimulated upon E-2 treatment and overexpression of ER-alpha or NF-YA in MCF-7 cells. ChIP confirmed direct binding of both transcription factors to the UBC9 promoter in vivo. Furthermore, UBC9 expression was diminished by ER-alpha and NF-Y siRNAs on the mRNA and protein levels. In conclusion, we identified the proximal UBC9 promoter and provided evidence that ER-alpha and NF-Y regulate UBC9 expression on the transcriptional level in response to E-2 in MCF-7 cells. These findings may contribute to a better understanding of the regulation of UBC9 in ER-positive breast cancer and be useful for the development of cancer therapies targeting UBC9.	[Ying, Shibo; Duennebier, Thomas; Si, Jing; Hamann, Ute] Deutsch Krebsforschungszentrum DKFZ, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Hamann, U (corresponding author), Deutsch Krebsforschungszentrum DKFZ, Heidelberg, Germany.	u.hamann@dkfz-heidelberg.de	Ying, Shibo/K-2514-2016	Ying, Shibo/0000-0001-5275-9383	Deutsche Krebshilfe [109335]; Deutsches Krebsforschungszentrum, Heidelberg, Germany	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsches Krebsforschungszentrum, Heidelberg, Germany	The work was supported by the Deutsche Krebshilfe grant 109335 and the Deutsches Krebsforschungszentrum, Heidelberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafiz H, 2002, J BIOL CHEM, V277, P33950, DOI 10.1074/jbc.M204573200; Acconcia F, 2006, CANCER LETT, V238, P1, DOI 10.1016/j.canlet.2005.06.018; Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Caretti A, 2012, INT J BIOCHEM CELL B, V44, P84, DOI 10.1016/j.biocel.2011.09.010; Chang YL, 2007, INT J BIOCHEM CELL B, V39, P1035, DOI 10.1016/j.biocel.2007.02.002; Chauchereau A, 2003, J BIOL CHEM, V278, P12335, DOI 10.1074/jbc.M207148200; Cheskis BJ, 2007, J CELL PHYSIOL, V213, P610, DOI 10.1002/jcp.21253; Cho SY, 2005, MOL ENDOCRINOL, V19, P290, DOI 10.1210/me.2004-0134; Cicatiello L, 2000, MOL CELL ENDOCRINOL, V165, P199, DOI 10.1016/S0303-7207(00)00243-4; del Val C, 2010, THEOR CHEM ACC, V125, P583, DOI 10.1007/s00214-009-0643-8; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dunnebier T, 2010, BREAST CANCER RES TR, V121, P185, DOI 10.1007/s10549-009-0530-y; Dunnebier T, 2009, INT J CANCER, V125, P596, DOI 10.1002/ijc.24286; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Fang S, 2003, SEMIN CANCER BIOL, V13, P5, DOI 10.1016/S1044-579X(02)00095-0; Faus H, 2006, BIOMED PHARMACOTHER, V60, P520, DOI 10.1016/j.biopha.2006.07.082; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Ge YB, 2002, BBA-GENE STRUCT EXPR, V1579, P73, DOI 10.1016/S0167-4781(02)00509-2; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hsieh YL, 2013, EMBO J, V32, P791, DOI 10.1038/emboj.2013.5; Ishimaru F, 1997, BLOOD, V89, P4136, DOI 10.1182/blood.V89.11.4136; Jordan VC, 2009, CANCER RES, V69, P1243, DOI 10.1158/0008-5472.CAN-09-0029; Karamouzis MV, 2008, BREAST CANCER RES TR, V107, P195, DOI 10.1007/s10549-007-9552-5; Kaul S, 2002, J BIOL CHEM, V277, P12541, DOI 10.1074/jbc.M112330200; Kawabe Y, 2000, J BIOL CHEM, V275, P20963, DOI 10.1074/jbc.C000273200; Kobayashi S, 2004, ENDOCR RES, V30, P617, DOI 10.1081/ERC-200043789; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; Lee WR, 2006, J CELL BIOCHEM, V99, P209, DOI 10.1002/jcb.20902; LI XY, 1992, J BIOL CHEM, V267, P8984; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Mo YY, 2004, CANCER RES, V64, P2793, DOI 10.1158/0008-5472.CAN-03-2410; Moschos SJ, 2007, ONCOGENE, V26, P4216, DOI 10.1038/sj.onc.1210216; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Nakshatri H, 1996, J BIOL CHEM, V271, P28784, DOI 10.1074/jbc.271.46.28784; Ngwenya S, 2003, ENDOCRINOLOGY, V144, P1675, DOI 10.1210/en.2002-0009; Poukka H, 1999, J BIOL CHEM, V274, P19441, DOI 10.1074/jbc.274.27.19441; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Synowiec E, 2010, MUTAT RES-FUND MOL M, V694, P31, DOI 10.1016/j.mrfmmm.2010.09.002; Tomasi ML, 2012, HEPATOLOGY, V56, P982, DOI 10.1002/hep.25701; WAKELING AE, 1992, J STEROID BIOCHEM, V43, P173, DOI 10.1016/0960-0760(92)90204-V; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Xirodimas DP, 2002, FEBS LETT, V528, P207, DOI 10.1016/S0014-5793(02)03310-0; Xu J, 2009, INT J ONCOL, V34, P939, DOI 10.3892/ijo_00000220; Yang SH, 2013, EMBO J, V32, P773, DOI 10.1038/emboj.2013.21; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4; Zhao ZQ, 2012, BMB REP, V45, P641, DOI 10.5483/BMBRep.2012.45.11.097; Zhu S, 2010, ONCOGENE, V29, P1763, DOI 10.1038/onc.2009.459	61	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75695	10.1371/journal.pone.0075695	http://dx.doi.org/10.1371/journal.pone.0075695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086615	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900059
J	Stanzani, M; Lewis, RE; Fiacchini, M; Ricci, P; Tumietto, F; Viale, P; Ambretti, S; Baccarani, M; Cavo, M; Vianelli, N				Stanzani, Marta; Lewis, Russell E.; Fiacchini, Mauro; Ricci, Paolo; Tumietto, Fabio; Viale, Pierluigi; Ambretti, Simone; Baccarani, Michele; Cavo, Michele; Vianelli, Nicola			A Risk Prediction Score for Invasive Mold Disease in Patients with Hematological Malignancies	PLOS ONE			English	Article							CELL TRANSPLANT RECIPIENTS; VERSUS-HOST-DISEASE; FUNGAL-INFECTIONS; PULMONARY ASPERGILLOSIS; NEUTROPENIC PATIENTS; MARROW; GRAFT; PROPHYLAXIS; PROGNOSIS; CONTAMINATION	Background: A risk score for invasive mold disease (IMD) in patients with hematological malignancies could facilitate patient screening and improve the targeted use of antifungal prophylaxis. Methods: We retrospectively analyzed 1,709 hospital admissions of 840 patients with hematological malignancies (2005-2008) to collect data on 17 epidemiological and treatment-related risk factors for IMD. Multivariate regression was used to develop a weighted risk score based on independent risk factors associated with proven or probable IMD, which was prospectively validated during 1,746 hospital admissions of 855 patients from 2009-2012. Results: Of the 17 candidate variables analyzed, 11 correlated with IMD by univariate analysis, but only 4 risk factors (neutropenia, lymphocytopenia or lymphocyte dysfunction in allogeneic hematopoietic stem cell transplant recipients, malignancy status, and prior IMD) were retained in the final multivariate model, resulting in a weighted risk score 0-13. A risk score of < 6 discriminated patients with low (< 1%) versus higher incidence rates (> 5%) of IMD, with a negative predictive value (NPV) of 0.99, (95% CI 0.98-0.99). During 2009-2012, patients with a calculated risk score at admission of < 6 had significantly lower 90-day incidence rates of IMD compared to patients with scores > 6 (0.9% vs. 10.6%, P < 0.001). Conclusion: An objective, weighted risk score for IMD can accurately discriminate patients with hematological malignancies at low risk for developing mold disease, and could possibly facilitate "screening-out" of low risk patients less likely to benefit from intensive diagnostic monitoring or mold-directed antifungal prophylaxis.	[Stanzani, Marta; Fiacchini, Mauro; Ricci, Paolo; Baccarani, Michele; Cavo, Michele; Vianelli, Nicola] Univ Bologna, Lorenzo & Ariosto Seragnoli SOrsola Malpighi Hosp, Dept Hematol & Clin Oncol, Inst Hematol, Bologna, Italy; [Lewis, Russell E.; Tumietto, Fabio; Viale, Pierluigi] Univ Bologna, SOrsola Malpighi Hosp, Clin Infect Dis, Dept Internal Med Geriatr & Nephrol Dis, Bologna, Italy; [Ambretti, Simone] Univ Bologna, SOrsola Malpighi Hosp, Operat Unit Microbiol, Dept Hematol Oncol & Lab Med, Bologna, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Stanzani, M (corresponding author), Univ Bologna, Lorenzo & Ariosto Seragnoli SOrsola Malpighi Hosp, Dept Hematol & Clin Oncol, Inst Hematol, Bologna, Italy.	marta.stanzani2@unibo.it	CAVO, MICHELE/AAK-8274-2020; Lewis, Russell E/A-4616-2015; Vianelli, Nicola/AAD-1676-2021	CAVO, MICHELE/0000-0003-4514-3227; Lewis, Russell E/0000-0002-2002-4339; Stanzani, Marta/0000-0003-1569-3447; Vianelli, Nicola/0000-0001-5886-036X	Gilead Inc.; AIL foundation	Gilead Inc.(Gilead Sciences); AIL foundation	Database development was supported by an unrestricted grant from Gilead Inc. and the AIL foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam MF, 2002, SCAND J INFECT DIS, V34, P819, DOI 10.1080/0036554021000026954; Berthelot P, 2006, CLIN MICROBIOL INFEC, V12, P738, DOI 10.1111/j.1469-0691.2006.01499.x; Cornely OA, 2007, CLIN INFECT DIS, V44, P1289, DOI 10.1086/514341; Cornely OA, 2007, NEW ENGL J MED, V356, P348, DOI 10.1056/NEJMoa061094; Cornet M, 1999, INFECT CONT HOSP EP, V20, P508, DOI 10.1086/501661; de Pauw BE, 2005, CLIN INFECT DIS, V41, P1251, DOI 10.1086/496933; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; de Pauw BE, 2011, J ANTIMICROB CHEMOTH, V66, pi55, DOI 10.1093/jac/dkq442; El-Cheikh J, 2010, LEUKEMIA LYMPHOMA, V51, P1705, DOI 10.3109/10428194.2010.500433; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Fukuda T, 2003, BLOOD, V102, P827, DOI 10.1182/blood-2003-02-0456; Garcia-Vidal C, 2008, CLIN INFECT DIS, V47, P1041, DOI 10.1086/591969; Garnacho-Montero J, 2005, CRIT CARE, V9, pR191, DOI 10.1186/cc3488; Gavalda J, 2005, CLIN INFECT DIS, V41, P52, DOI 10.1086/430602; GERSON SL, 1984, ANN INTERN MED, V100, P345, DOI 10.7326/0003-4819-100-3-345; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Grigg A, 2008, TRANSPL INFECT DIS, V10, P3, DOI 10.1111/j.1399-3062.2007.00259.x; Grow WB, 2002, BONE MARROW TRANSPL, V29, P15, DOI 10.1038/sj.bmt.1703332; Herbrecht R, 2012, ANN NY ACAD SCI, V1272, P23, DOI 10.1111/j.1749-6632.2012.06829.x; Labbe AC, 2007, BIOL BLOOD MARROW TR, V13, P1192, DOI 10.1016/j.bbmt.2007.06.013; Lionakis MS, 2003, LANCET, V362, P1828, DOI 10.1016/S0140-6736(03)14904-5; Mahieu LM, 2000, J HOSP INFECT, V45, P191, DOI 10.1053/jhin.2000.0773; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Martino R, 2006, BLOOD, V108, P2928, DOI 10.1182/blood-2006-03-008706; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Muhlemann K, 2005, LEUKEMIA, V19, P545, DOI 10.1038/sj.leu.2403674; O'Brien Susan N, 2003, Hematology Am Soc Hematol Educ Program, P438; Ostrosky-Zeichner L, 2011, MYCOSES, V54, P46, DOI 10.1111/j.1439-0507.2009.01756.x; Pagano L, 2006, HAEMATOLOGICA, V91, P1068; Pagano L, 2010, HAEMATOL-HEMATOL J, V95, P644, DOI 10.3324/haematol.2009.012054; Park BJ, 2011, EMERG INFECT DIS, V17, P1855, DOI 10.3201/eid1710.110087; Parulekar W, 1998, ORAL ONCOL, V34, P63, DOI 10.1016/S1368-8375(97)00065-1; Rondinelli PIP, 2006, J PEDIAT HEMATOL ONC, V28, P665, DOI 10.1097/01.mph.0000212996.94929.0b; Post MJ, 2007, TRANSPL INFECT DIS, V9, P189, DOI 10.1111/j.1399-3062.2007.00219.x; Robin M, 2007, BIOL BLOOD MARROW TR, V13, P1304, DOI 10.1016/j.bbmt.2007.07.007; Rogers TR, 2011, BRIT J HAEMATOL, V153, P681, DOI 10.1111/j.1365-2141.2011.08650.x; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Soubani AO, 2002, HAEMATOLOGIA, V32, P427; Thio CL, 2000, INFECT CONT HOSP EP, V21, P18, DOI 10.1086/501691; Thursky K, 2004, BONE MARROW TRANSPL, V34, P115, DOI 10.1038/sj.bmt.1704543; Ullmann AJ, 2007, NEW ENGL J MED, V356, P335, DOI 10.1056/NEJMoa061098; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; Uys A, 2004, SUPPORT CARE CANCER, V12, P555, DOI 10.1007/s00520-004-0614-5; van der Velden WJFM, 2011, CURR OPIN INFECT DIS, V24, P554, DOI 10.1097/QCO.0b013e32834ab1f4; VAZQUEZ JA, 1995, INFECT DIS CLIN N AM, V9, P97; Verweij PE, 2000, JAMA-J AM MED ASSOC, V284, P2875, DOI 10.1001/jama.284.22.2875; Wingard JR, 2008, CANCER, V112, P2309, DOI 10.1002/cncr.23441	49	51	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75531	10.1371/journal.pone.0075531	http://dx.doi.org/10.1371/journal.pone.0075531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086555	Green Published, gold			2022-12-25	WOS:000325220000024
J	Tepper, N; Noor, E; Amador-Noguez, D; Haraldsdottir, HS; Milo, R; Rabinowitz, J; Liebermeister, W; Shlomi, T				Tepper, Naama; Noor, Elad; Amador-Noguez, Daniel; Haraldsdottir, Hulda S.; Milo, Ron; Rabinowitz, Josh; Liebermeister, Wolfram; Shlomi, Tomer			Steady-State Metabolite Concentrations Reflect a Balance between Maximizing Enzyme Efficiency and Minimizing Total Metabolite Load	PLOS ONE			English	Article							GENOME-SCALE RECONSTRUCTION; ESCHERICHIA-COLI; FLUX ANALYSIS; CLOSTRIDIUM-ACETOBUTYLICUM; KNOCKOUT STRATEGIES; NETWORKS; MODELS; THERMODYNAMICS; CONSTRAINTS; PERTURBATIONS	Steady-state metabolite concentrations in a microorganism typically span several orders of magnitude. The underlying principles governing these concentrations remain poorly understood. Here, we hypothesize that observed variation can be explained in terms of a compromise between factors that favor minimizing metabolite pool sizes (e. g. limited solvent capacity) and the need to effectively utilize existing enzymes. The latter requires adequate thermodynamic driving force in metabolic reactions so that forward flux substantially exceeds reverse flux. To test this hypothesis, we developed a method, metabolic tug-of-war (mTOW), which computes steady-state metabolite concentrations in microorganisms on a genome-scale. mTOW is shown to explain up to 55% of the observed variation in measured metabolite concentrations in E. coli and C. acetobutylicum across various growth media. Our approach, based strictly on first thermodynamic principles, is the first method that successfully predicts high-throughput metabolite concentration data in bacteria across conditions.	[Tepper, Naama; Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Noor, Elad; Milo, Ron] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Amador-Noguez, Daniel; Rabinowitz, Josh] Princeton Univ, Princeton, NJ 08544 USA; [Haraldsdottir, Hulda S.] Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland; [Liebermeister, Wolfram] Charite, Inst Biochem, D-13353 Berlin, Germany	Technion Israel Institute of Technology; Weizmann Institute of Science; Princeton University; University of Iceland; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Shlomi, T (corresponding author), Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel.	tomersh@cs.technion.ac.il	Milo, Hilla/C-8767-2016; Rabinowitz, Joshua/GPP-4019-2022; Noor, Elad/AAN-9042-2020; Liebermeister, Wolfram/AAC-7326-2020	Rabinowitz, Joshua/0000-0002-1247-4727; Noor, Elad/0000-0001-8776-4799; Liebermeister, Wolfram/0000-0002-2568-2381; Milo, Ron/0000-0003-1641-2299	Israel Ministry of Science; NATIONAL CANCER INSTITUTE [R01CA163591] Funding Source: NIH RePORTER	Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	TS was supported by a grant from the Israel Ministry of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiamah DA, 2010, BIOINFORMATICS, V26, P1324, DOI 10.1093/bioinformatics/btq136; Alberty R. A., 2003, THERMODYNAMICS BIOCH; Alberty RA, 2011, BIOPHYS CHEM, V155, P89, DOI 10.1016/j.bpc.2011.03.007; Amador-Noguez D, 2011, APPL ENVIRON MICROB, V77, P7984, DOI 10.1128/AEM.05374-11; Atkinson DE., 1969, CURR TOP CELL REGUL, V1, P29, DOI [10.1016/B978-0-12-152801-0.50007-9, DOI 10.1016/B978-0-12-152801-0.50007, DOI 10.1016/B978-0-12-152801-0]; Bar-Even A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002166; Beard DA, 2002, BIOPHYS J, V83, P79, DOI 10.1016/S0006-3495(02)75150-3; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bonarius HPJ, 1997, TRENDS BIOTECHNOL, V15, P308, DOI 10.1016/S0167-7799(97)01067-6; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Bulik S, 2009, FEBS J, V276, P410, DOI 10.1111/j.1742-4658.2008.06784.x; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Cakir T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100085; Canelas AB, 2011, METAB ENG; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Christopher S, 2007, BIOPHYS J, V92, P1792, DOI [10.1529/biophysj.106.093138, DOI 10.1529/BI0PHYSJ.106.093138.PUBMED:17172310]; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Goldberg RN, 2004, BIOINFORMATICS, V20, P2874, DOI 10.1093/bioinformatics/bth314; Gross C, 1996, CELL MOL BIOL; Haraldsdottir H, 2012, QUANTITATIVE ASSIGNM; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Hjersted JL, 2007, BIOTECHNOL BIOENG, V97, P1190, DOI 10.1002/bit.21332; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jankowski MD, 2008, BIOPHYS J, V95, P1487, DOI 10.1529/biophysj.107.124784; Jol SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002415; Klitgord N, 2010, INFORM, V22, P41; KOCH AL, 1967, J THEOR BIOL, V15, P75, DOI 10.1016/0022-5193(67)90045-8; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; Kurland CG, 1996, MOL MICROBIOL, V21, P1, DOI 10.1046/j.1365-2958.1996.5901313.x; Lee J, 2008, APPL MICROBIOL BIOT, V80, P849, DOI 10.1007/s00253-008-1654-4; Mavrovouniotis ML, 1990, BIOTECHNOL BIOENG, V38, P803, DOI [10.1002/bit.260380716, DOI 10.1002/BIT.260380716.PUBMED:18595046]; Mavrovouniotis ML, 1993, IDENTIFICATION LOCAL, V1, P275; Moriya H, 2006, PLOS GENET, V2, P1034, DOI 10.1371/journal.pgen.0020111; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Nathan D, 2004, NATURE REV MICROBIOL, V2; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Noor E, 2012, BIOINFORMATICS; Noor EH, 2013, PLOS COMPUT BI UNPUB; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Rummel R. J., 1976, UNDERSTANDING CORREL; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; SCHUSTER R, 1993, COMPUT APPL BIOSCI, V9, P79; SCHUSTER S, 1991, J MATH BIOL, V29, P425, DOI 10.1007/BF00160470; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tepper N, 2010, METABOLIC NETW UNPUB; Tepper N, 2010, BIOINFORMATICS, V26, P536, DOI 10.1093/bioinformatics/btp704; Van Dien SJ, 2002, BIOTECHNOL BIOENG, V78, P296, DOI 10.1002/bit.10200; Vojinovic V, 2009, BIOTECHNOL BIOENG, V103, P780, DOI 10.1002/bit.22309; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4	59	41	43	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75370	10.1371/journal.pone.0075370	http://dx.doi.org/10.1371/journal.pone.0075370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086517	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000018
J	Abraham, R; Mudaliar, P; Padmanabhan, A; Sreekumar, E				Abraham, Rachy; Mudaliar, Prashant; Padmanabhan, Aiswaria; Sreekumar, Easwaran			Induction of Cytopathogenicity in Human Glioblastoma Cells by Chikungunya Virus	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TUMOR-NECROSIS-FACTOR; RIG-I; VIRAL-INFECTIONS; INNATE IMMUNITY; GLIAL-CELLS; ER STRESS; DEATH	Chikungunya virus (CHIKV), an arthritogenic old-world alphavirus, has been implicated in the central nervous system (CNS) infection in infants and elderly patients. Astrocytes are the major immune cells of the brain parenchyma that mediate inflammation. In the present study we found that a local isolate of CHIKV infect and activate U-87 MG cells, a glioblastoma cell line of human astrocyte origin. The infection kinetics were similar in infected U-87 MG cells and the human embryo kidney (HEK293) cells as indicated by immunofluorescence and plaque assays, 24h post-infection (p.i.). In infected U-87 MG cells, apoptosis was detectable from 48h p.i. evidenced by DNA fragmentation, PARP cleavage, loss of mitochondrial membrane potential, nuclear condensation and visible cytopathic effects in a dose and time-dependent manner. XBP1 mRNA splicing and eIF2 alpha phosphorylation studies indicated the occurrence of endoplasmic reticulum stress in infected cells. In U-87 MG cells stably expressing a green fluorescent protein-tagged light chain-3 (GFP-LC3) protein, CHIKV infection showed increased autophagy response. The infection led to an enhanced expression of the mRNA transcripts of the pro-inflammatory cytokines IL-1 beta, TNF-alpha, IL-6 and CXCL9 within 24h p.i. Significant up-regulation of the proteins of RIG-I like receptor (RLR) pathway, such as RIG-I and TRAF-6, was observed indicating the activation of the cytoplasmic-cellular innate immune response. The overall results show that the U-87 MG cell line is a potential in vitro model for in depth study of these molecular pathways in response to CHIKV infection. The responses in these cells of CNS origin, which are inherently defective in Type I interferon response, could be analogous to that occurring in infants and very old patients who also have a compromised interferon-response. The results also point to the intriguing possibility of using this virus for studies to develop oncolytic virus therapy approaches against glioblastoma, a highly aggressive malignancy.	[Abraham, Rachy; Mudaliar, Prashant; Padmanabhan, Aiswaria; Sreekumar, Easwaran] Rajiv Gandhi Ctr Biotechnol, Viral Dis Biol Program, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Sreekumar, E (corresponding author), Rajiv Gandhi Ctr Biotechnol, Viral Dis Biol Program, Thiruvananthapuram, Kerala, India.	esreekumar@rgcb.res.in	Abraham, Rachy/AAO-2298-2021	Abraham, Rachy/0000-0003-3180-2447	Department of Science and Technology, and University Grants Commission (UGC); Rajiv Gandhi Centre for Biotechnology and Department of Biotechnology, Govt. of India [BT/PR5315/MED/29/476/2012]	Department of Science and Technology, and University Grants Commission (UGC); Rajiv Gandhi Centre for Biotechnology and Department of Biotechnology, Govt. of India	The study was supported by research fellowships to RA and PM from Department of Science and Technology, and University Grants Commission (UGC); and grants from Rajiv Gandhi Centre for Biotechnology and Department of Biotechnology (Grant No. BT/PR5315/MED/29/476/2012), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abere B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034800; Arpino C, 2009, REV MED VIROL, V19, P121, DOI 10.1002/rmv.606; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Brodie C, 1997, GLIA, V19, P275; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; da Conceicao TM, 2013, VIROLOGY, V435, P281, DOI 10.1016/j.virol.2012.09.038; Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006; Dhanwani R, 2012, VIRUS RES, V163, P563, DOI 10.1016/j.virusres.2011.12.009; Diniz JAP, 2006, AM J TROP MED HYG, V75, P691, DOI 10.4269/ajtmh.2006.75.691; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Fouillet A, 2012, AUTOPHAGY, V8, P915, DOI 10.4161/auto.19716; Furr SR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00201; Furr SR, 2010, GLIA, V58, P1620, DOI 10.1002/glia.21034; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Griffin DE, 2010, PROG NEUROBIOL, V91, P95, DOI 10.1016/j.pneurobio.2009.12.003; Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181; Joubert PE, 2012, AUTOPHAGY, V8, P1261, DOI 10.4161/auto.20751; Joubert PE, 2012, J EXP MED, V209, P1029, DOI 10.1084/jem.20110996; Kaur P, 2013, ANTIMICROB AGENTS CH, V57, P155, DOI 10.1128/AAC.01467-12; Kelvin AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001279; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; KRAUS E, 1992, EUR J IMMUNOL, V22, P175, DOI 10.1002/eji.1830220126; Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178; Lam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046396; Lewthwaite P, 2009, EMERG INFECT DIS, V15, P329, DOI 10.3201/eid1502.080902; Li YG, 2013, INTERVIROLOGY, V56, P6, DOI 10.1159/000339985; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; MONATH TP, 1983, LAB INVEST, V48, P399; Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307; Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761; Noret M, 2012, J INFECT DIS, V206, P455, DOI 10.1093/infdis/jis368; OLOPADE OI, 1992, CANCER RES, V52, P2523; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Pyndiah M N, 2012, Med Trop (Mars), V72 Spec No, P63; Rathore APS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-36; Rosello A, 2012, CLIN EXP IMMUNOL, V168, P52, DOI 10.1111/j.1365-2249.2011.04544.x; RUBIO N, 1990, J GEN VIROL, V71, P2867, DOI 10.1099/0022-1317-71-12-2867; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Sam IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050476; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Savarin C, 2008, CURR OPIN PHARMACOL, V8, P472, DOI 10.1016/j.coph.2008.05.002; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Sgorbissa A, 2011, APOPTOSIS, V16, P1229, DOI 10.1007/s10495-011-0639-4; Shi JY, 2012, ACTA BIOCH BIOPH SIN, V44, P375, DOI 10.1093/abbs/gms010; SINDERMANN J, 1993, MECH AGEING DEV, V70, P149, DOI 10.1016/0047-6374(93)90066-Z; Skaper SD, 2007, ANN NY ACAD SCI, V1122, P23, DOI 10.1196/annals.1403.002; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Sreekumar E, 2010, VIRUS GENES, V40, P14, DOI 10.1007/s11262-009-0411-9; Sriram S, 2011, J NEUROIMMUNOL, V239, P13, DOI 10.1016/j.jneuroim.2011.08.012; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120; Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623; Thon-Hon VG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-213; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; Vosters O, 2010, CLIN EXP IMMUNOL, V162, P494, DOI 10.1111/j.1365-2249.2010.04267.x; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; White LK, 2011, J VIROL, V85, P606, DOI 10.1128/JVI.00767-10; Wikan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031102; Wintachai P, 2012, J MED VIROL, V84, P1757, DOI 10.1002/jmv.23403; Wollmann G, 2005, J VIROL, V79, P6005, DOI 10.1128/JVI.79.10.6005-6022.2005; Yoboua F, 2010, J VIROL, V84, P7267, DOI 10.1128/JVI.00142-10; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	69	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75854	10.1371/journal.pone.0075854	http://dx.doi.org/10.1371/journal.pone.0075854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086645	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700114
J	Knapp, M; Nedved, O				Knapp, Michal; Nedved, Oldrich			Gender and Timing during Ontogeny Matter: Effects of a Temporary High Temperature on Survival, Body Size and Colouration in Harmonia axyridis	PLOS ONE			English	Article							SEASONAL PHENOTYPIC PLASTICITY; LIFE-HISTORY TRAITS; COLEOPTERA-COCCINELLIDAE; DEPENDENT DEVELOPMENT; THERMAL REQUIREMENTS; SEXUAL-DIMORPHISM; LADYBIRD BEETLE; IMMUNE FUNCTION; MANDUCA-SEXTA; FRUIT-FLY	The ambient temperature experienced during development is a crucial factor affecting survival and adult phenotype in ectotherms. Moreover, the exact response of individuals to different temperature regimes is frequently sex-specific. This sex-specific response can result in varying levels of sexual dimorphism according to the experienced conditions. The majority of studies have investigated the effects of temperature on individuals reared under a constant temperature regime throughout their whole preimaginal development, whereas information on stage-dependent variation in temperature effects is scarce. Here we investigate how the stage at which elevated temperature is experienced influences survival, adult body size and colouration in the harlequin ladybird Harmonia axyridis form succinea. The effects of timing of exposure to elevated temperature on the adult phenotype are assessed separately for males and females. Control individuals were reared at a constant temperature of 20 degrees C. Beetles in other treatments were additionally exposed to 33 degrees C for 48 hours during the following developmental stages: egg, 1st to 2nd larval instar, 3rd larval instar, 4th larval instar and pupa. Exposure to an elevated temperature during the early developmental stages resulted in lower survival, but the adult phenotype of survivors was almost unaffected. Exposure to an elevated temperature during the later developmental stages (4th larval instar or pupa) resulted in the decreased melanisation of elytra, decreased structural body size and increased dry mass. Furthermore, the timing of high temperature exposure affected the degree of sexual dimorphism in elytral melanisation and dry mass. We demonstrate that the effects of elevated temperature can vary according to the developmental stage at exposure. Detailed information on how ambient temperature affects the developmental biology of ectotherms is crucial for modeling population growth and predicting the spread of invasive species such as Harmonia axyridis.	[Knapp, Michal] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Nedved, Oldrich] Univ South Bohemia, Dept Zool, Fac Sci, Ceske Budejovice, Czech Republic; [Nedved, Oldrich] Biol Ctr AS CR, Inst Entomol, Dept Biochem & Physiol, Ceske Budejovice, Czech Republic	Czech University of Life Sciences Prague; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Knapp, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	knapp@fzp.czu.cz	Nedvěd, Oldřich/H-7816-2014; Knapp, Michal/AAF-4864-2020	Nedvěd, Oldřich/0000-0001-9932-3456; Knapp, Michal/0000-0003-4487-7317	Ministry of Agriculture of the Czech Republic [QH82047]; Czech University of Life Sciences Prague [42900/1312/3166]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic); Czech University of Life Sciences Prague	The study was supported by Grant no. QH82047 awarded by the Ministry of Agriculture of the Czech Republic and partially by Grant no. 42900/1312/3166 awarded by the Czech University of Life Sciences Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelghany AY, 2010, J ECON ENTOMOL, V103, P1909, DOI 10.1603/EC10054; Acar EB, 2005, ENVIRON ENTOMOL, V34, P241, DOI 10.1603/0046-225X-34.2.241; Acar EB, 2004, ENVIRON ENTOMOL, V33, P832, DOI 10.1603/0046-225X-33.4.832; Amarasekare P, 2012, FUNCT ECOL, V26, P959, DOI 10.1111/j.1365-2435.2012.02000.x; Angilletta MJ, 2003, AM NAT, V162, P332; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Armitage SAO, 2005, HEREDITY, V94, P650, DOI 10.1038/sj.hdy.6800675; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Awad M, 2013, BIOCONTROL IN PRESS; Belyakova NA, 2011, J EVOL BIOCHEM PHYS+, V47, P552, DOI 10.1134/S0022093011060068; Berkvens N, 2008, BIOCONTROL, V53, P201, DOI 10.1007/s10526-007-9128-7; Bezzerides AL, 2007, BEHAV ECOL SOCIOBIOL, V61, P1401, DOI 10.1007/s00265-007-0371-9; Boina D, 2004, J ECON ENTOMOL, V97, P2168, DOI 10.1603/0022-0493-97.6.2168; Briscoe NJ, 2012, OIKOS, V121, P1464, DOI 10.1111/j.1600-0706.2011.20049.x; Brown PMJ, 2011, BIOCONTROL, V56, P623, DOI 10.1007/s10526-011-9379-1; Budriene A, 2013, CR BIOL, V336, P57, DOI 10.1016/j.crvi.2013.03.001; CARREL JE, 1993, EXPERIENTIA, V49, P171, DOI 10.1007/BF01989424; Castro CF, 2011, FLA ENTOMOL, V94, P923, DOI 10.1653/024.094.0429; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.013; Cotter SC, 2008, J EVOLUTION BIOL, V21, P1744, DOI 10.1111/j.1420-9101.2008.01587.x; David JR, 2011, J GENET, V90, P295, DOI 10.1007/s12041-011-0076-8; Dmitriew C, 2010, AM NAT, V175, P640, DOI 10.1086/652470; Dolenska M, 2009, BIOL J LINN SOC, V98, P234, DOI 10.1111/j.1095-8312.2009.01277.x; Duyck PF, 2002, B ENTOMOL RES, V92, P461, DOI 10.1079/BER2002188; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; Ellers J, 2003, EVOLUTION, V57, P1100, DOI 10.1111/j.0014-3820.2003.tb00319.x; Fairbairn DJ, 2005, AM NAT, V166, pS69, DOI 10.1086/444600; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; Folguera G, 2010, J INSECT PHYSIOL, V56, P1679, DOI 10.1016/j.jinsphys.2010.06.015; Forsman A, 1999, J EVOLUTION BIOL, V12, P391; Forster J, 2012, FUNCT ECOL, V26, P483, DOI 10.1111/j.1365-2435.2011.01958.x; Freitak D, 2012, BIOL LETTERS, V8, P860, DOI 10.1098/rsbl.2012.0273; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hu YW, 2011, ECOL ENTOMOL, V36, P111, DOI 10.1111/j.1365-2311.2010.01251.x; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; Hukusima S., 1970, RES B FAC AGR GIFU U, V29, P53; Karl I, 2008, OECOLOGIA, V155, P215, DOI 10.1007/s00442-007-0902-0; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; Ketola T, 2012, J EVOLUTION BIOL, V25, P847, DOI 10.1111/j.1420-9101.2012.02475.x; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; Knapp M, 2012, ENTOMOL EXP APPL, V143, P185, DOI 10.1111/j.1570-7458.2012.01247.x; Kooi RE, 1999, J INSECT PHYSIOL, V45, P201, DOI 10.1016/S0022-1910(98)00093-6; Lamana ML, 1998, ENVIRON ENTOMOL, V27, P1001, DOI 10.1093/ee/27.4.1001; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Michie LJ, 2010, J EVOLUTION BIOL, V23, P1699, DOI 10.1111/j.1420-9101.2010.02043.x; Michie LJ, 2011, EVOL ECOL, V25, P1259, DOI 10.1007/s10682-011-9476-8; Moya-Larano J, 2008, J ANIM ECOL, V77, P1099, DOI 10.1111/j.1365-2656.2008.01433.x; Nedved O, IOBC B IN PRESS; Nedved O, 2011, ZOOKEYS, P77, DOI 10.3897/zookeys.106.1242; Nedvedova T, 2013, IOBC B IN PRESS; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Ohashi K, 2005, ENVIRON ENTOMOL, V34, P432, DOI 10.1603/0046-225X-34.2.432; Pappas ML, 2011, J APPL ENTOMOL, V135, P359, DOI 10.1111/j.1439-0418.2010.01579.x; Petersen C, 2000, PHYSIOL ENTOMOL, V25, P35, DOI 10.1046/j.1365-3032.2000.00163.x; Pinheiro J., 2019, NLME LINEAR NONLINEA; Potter KA, 2011, FUNCT ECOL, V25, P548, DOI 10.1111/j.1365-2435.2010.01807.x; Punzalan D, 2008, P ROY SOC B-BIOL SCI, V275, P483, DOI 10.1098/rspb.2007.1585; R Development Core Team, 2012, R LANG ENV STAT COMP; Reed TE, 2010, P ROY SOC B-BIOL SCI, V277, P3391, DOI 10.1098/rspb.2010.0771; Ricalde MP, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.3301; SCHANDERL H, 1985, AGRONOMIE, V5, P417, DOI 10.1051/agro:19850505; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi ZH, 2010, J INSECT PHYSIOL, V56, P1696, DOI 10.1016/j.jinsphys.2010.06.013; Stathas GJ, 2011, ENVIRON ENTOMOL, V40, P1541, DOI 10.1603/EN10240; STEARNS SC, 1977, ANNU REV ECOL SYST, V8, P145, DOI 10.1146/annurev.es.08.110177.001045; Steigenga MJ, 2009, J THERM BIOL, V34, P244, DOI 10.1016/j.jtherbio.2009.03.001; Stillwell RC, 2010, P ROY SOC B-BIOL SCI, V277, P3819, DOI 10.1098/rspb.2010.0895; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Stoehr AM, 2008, ECOL ENTOMOL, V33, P137, DOI 10.1111/j.1365-2311.2007.00931.x; Strobbe F, 2004, BIOL J LINN SOC, V83, P187, DOI 10.1111/j.1095-8312.2004.00379.x; Tammaru T, 2010, EVOL ECOL, V24, P161, DOI 10.1007/s10682-009-9297-1; Teder T, 2005, ECOL ENTOMOL, V30, P342, DOI 10.1111/j.0307-6946.2005.00693.x; Trenberth KE, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018020; vanderHave TM, 1996, J THEOR BIOL, V183, P329, DOI 10.1006/jtbi.1996.0224; Vigneron JP, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031907; Woods HA, 2004, J EXP BIOL, V207, P2267, DOI 10.1242/jeb.00991	78	47	51	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74984	10.1371/journal.pone.0074984	http://dx.doi.org/10.1371/journal.pone.0074984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086415	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700046
J	Lombard, F; Guidi, L; Kiorboe, T				Lombard, Fabien; Guidi, Lionel; Kiorboe, Thomas			Effect of Type and Concentration of Ballasting Particles on Sinking Rate of Marine Snow Produced by the Appendicularian Oikopleura dioica	PLOS ONE			English	Article							ZOOPLANKTON FECAL PELLETS; LARVACEAN HOUSES; CARBON FLUX; VELOCITY; EXPORT; SEDIMENTATION; AGGREGATION; DEPOSITION; TRANSPORT; HUXLEYI	Ballast material (organic, opal, calcite, lithogenic) is suggested to affect sinking speed of aggregates in the ocean. Here, we tested this hypothesis by incubating appendicularians in suspensions of different algae or Saharan dust, and observing the sinking speed of the marine snow formed by their discarded houses. We show that calcite increases the sinking speeds of aggregates by similar to 100% and lithogenic material by similar to 150% while opal only has a minor effect. Furthermore the effect of ballast particle concentration was causing a 33 m d(-1) increase in sinking speed for a 5x10(5) mu m(3) ml(-1) increase in particle concentration, near independent on ballast type. We finally compare our observations to the literature and stress the need to generate aggregates similar to those in nature in order to get realistic estimates of the impact of ballast particles on sinking speeds.	[Lombard, Fabien; Kiorboe, Thomas] Tech Univ Denmark, Sect Oceanog & Climate, Natl Inst Aquat Resources, Ctr Ocean Life, Charlottenlund, Denmark; [Lombard, Fabien; Guidi, Lionel] Univ Paris 06, UMR 7093, Lab Oceanog Villefranche Sur Mer, Observ Oceanol Villefranche Sur Mer, F-75252 Paris 05, France	Technical University of Denmark; UDICE-French Research Universities; Sorbonne Universite	Lombard, F (corresponding author), Tech Univ Denmark, Sect Oceanog & Climate, Natl Inst Aquat Resources, Ctr Ocean Life, Charlottenlund, Denmark.	lombard@obs-vlfr.fr	Kiørboe, Thomas/ABI-4733-2020; Guidi, Lionel/B-3977-2012; Lombard, Fabien/H-6702-2012	Kiørboe, Thomas/0000-0002-3265-336X; Guidi, Lionel/0000-0002-6669-5744; Lombard, Fabien/0000-0002-8626-8782	Marie Curie Intra-European Fellowship [221696]; French program Agence Nationale de la Recherche [ANR-10-PDOC-005-01]; Danish Council for Independent Research; Villum Fonden [00007178] Funding Source: researchfish	Marie Curie Intra-European Fellowship(European Commission); French program Agence Nationale de la Recherche(French National Research Agency (ANR)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Villum Fonden(Villum Fonden)	Funding was provided by a Marie Curie Intra-European Fellowship 221696 award to F. L. and the French program Agence Nationale de la Recherche ANR-10-PDOC-005-01 "Ecogely" to F. L. The Danish Council for Independent Research provided further support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna JL, 2000, LIMNOL OCEANOGR, V45, P608, DOI 10.4319/lo.2000.45.3.0608; ALLDREDGE AL, 1988, LIMNOL OCEANOGR, V33, P339, DOI 10.4319/lo.1988.33.3.0339; ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; Alldredge AL., 2005, RESPONSE MARINE ECOS, P309, DOI DOI 10.1093/PLANKT/FBI133; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Biermann A, 2010, BIOGEOSCIENCES, V7, P1017, DOI 10.5194/bg-7-1017-2010; Bouquet JM, 2009, J PLANKTON RES, V31, P359, DOI 10.1093/plankt/fbn132; Boyd PW, 2007, PROG OCEANOGR, V72, P276, DOI 10.1016/j.pocean.2006.10.007; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Burd AB, 2010, DEEP-SEA RES PT II, V57, P1557, DOI 10.1016/j.dsr2.2010.02.022; De La Rocha CL, 2007, DEEP-SEA RES PT II, V54, P639, DOI 10.1016/j.dsr2.2007.01.004; De La Rocha CL, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003156; Engel A, 2009, DEEP-SEA RES PT II, V56, P1396, DOI 10.1016/j.dsr2.2008.11.027; FENAUX R, 1985, B MAR SCI, V37, P498; Flood Per R., 1998, P105; FOWLER SW, 1986, PROG OCEANOGR, V16, P147, DOI 10.1016/0079-6611(86)90032-7; Francois R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001722; Gorsky G, 1999, J GEOPHYS RES-OCEANS, V104, P3381, DOI 10.1029/98JC01850; Guerzoni S, 1999, PROG OCEANOGR, V44, P147, DOI 10.1016/S0079-6611(99)00024-5; Guidi L, 2008, DEEP-SEA RES PT I, V55, P1364, DOI 10.1016/j.dsr.2008.05.014; Guidi L, 2009, LIMNOL OCEANOGR, V54, P1951, DOI 10.4319/lo.2009.54.6.1951; Guieu C, 2010, BIOGEOSCIENCES, V7, P2765, DOI 10.5194/bg-7-2765-2010; Hamm CE, 2002, LIMNOL OCEANOGR, V47, P1790, DOI 10.4319/lo.2002.47.6.1790; Hansen JLS, 1996, MAR ECOL PROG SER, V141, P205, DOI 10.3354/meps141205; Henson SA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004099; Iversen MH, 2010, DEEP-SEA RES PT I, V57, P771, DOI 10.1016/j.dsr.2010.03.007; Jouandet MP, 2011, LIMNOL OCEANOGR, V56, P1130, DOI 10.4319/lo.2011.56.3.1130; Kiorboe T, 2000, LIMNOL OCEANOGR, V45, P479, DOI 10.4319/lo.2000.45.2.0479; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Lam PJ, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003868; Le Moigne FAC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052980; LOGAN BE, 1995, WATER RES, V29, P443, DOI 10.1016/0043-1354(94)00186-B; Lombard F, 2005, MAR ECOL PROG SER, V301, P149, DOI 10.3354/meps301149; Lombard F, 2011, LIMNOL OCEANOGR, V56, P1504, DOI 10.4319/lo.2011.56.4.1504; Lombard F, 2010, MAR ECOL PROG SER, V398, P109, DOI 10.3354/meps08273; Lombard F, 2009, J MARINE SYST, V76, P151, DOI [10.1016/j.jmarsys.2009.1001.1004., DOI 10.1016/J.JMARSYS.2009.1001.1004.PUBMED:20628532]; Lombard F, 2010, DEEP-SEA RES PT I, V57, P1304, DOI 10.1016/j.dsr.2010.06.008; McDonnell AMP, 2010, LIMNOL OCEANOGR, V55, P2085, DOI 10.4319/lo.2010.55.5.2085; Passow U, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002579; Passow U, 2001, CONT SHELF RES, V21, P327, DOI 10.1016/S0278-4343(00)00101-1; Ploug H, 2008, LIMNOL OCEANOGR, V53, P1878, DOI 10.4319/lo.2008.53.5.1878; Poulton AJ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002712; Riley JS, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004085; Robison BH, 2005, SCIENCE, V308, P1609, DOI 10.1126/science.1109104; Sanders R, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042574; Sato R, 2003, MAR ECOL PROG SER, V259, P163, DOI 10.3354/meps259163; Tiselius P, 1996, J PLANKTON RES, V18, P133, DOI 10.1093/plankt/18.2.133; Turner JT, 2002, AQUAT MICROB ECOL, V27, P57, DOI 10.3354/ame027057; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; Wilson JD, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004398	50	23	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75676	10.1371/journal.pone.0075676	http://dx.doi.org/10.1371/journal.pone.0075676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086610	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700108
J	Babaoglan, AB; Housden, BE; Furriols, M; Bray, SJ				Babaoglan, A. Burcu; Housden, Ben E.; Furriols, Marc; Bray, Sarah J.			Deadpan Contributes to the Robustness of the Notch Response	PLOS ONE			English	Article							PAN-NEURAL GENE; CELL FATE; E(SPL) COMPLEX; DROSOPHILA; SEGMENTATION; EXPRESSION; ENHANCER; MEDIATE; SPLIT; ACTIVATION	Notch signaling regulates many fundamental events including lateral inhibition and boundary formation to generate very reproducible patterns in developing tissues. Its targets include genes of the bHLH hairy and Enhancer of split [E(spl)] family, which contribute to many of these developmental decisions. One member of this family in Drosophila, deadpan (dpn), was originally found to have functions independent of Notch in promoting neural development. Employing genome-wide chromatin-immunoprecipitation we have identified several Notch responsive enhancers in dpn, demonstrating its direct regulation by Notch in a range of contexts including the Drosophila wing and eye. dpn expression largely overlaps that of several E(spl) genes and the combined knock-down leads to more severe phenotypes than either alone. In addition, Dpn contributes to the establishment of Cut expression at the wing dorsal-ventral (D/V) boundary; in its absence Cut expression is delayed. Furthermore, over-expression of Dpn inhibits expression from E(spl) gene enhancers, but not vice versa, suggesting that dpn contributes to a feed-back mechanism that limits E(spl) gene expression following Notch activation. Thus the combined actions of dpn and E(spl) appear to provide a mechanism that confers an initial rapid output from Notch activity which becomes self-limited via feedback between the targets.	[Babaoglan, A. Burcu; Housden, Ben E.; Furriols, Marc; Bray, Sarah J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge	Bray, SJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	sjb32@cam.ac.uk		Furriols, Marc/0000-0002-0656-1912; Housden, Benjamin/0000-0001-9134-4279; Bray, Sarah/0000-0002-1642-599X	MRC programme [G0800034]; BBSRC [BB/J008842/1] Funding Source: UKRI; MRC [G0800034, G0500926] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J008842/1] Funding Source: researchfish; Medical Research Council [G0800034, G0500926] Funding Source: researchfish	MRC programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Research supported by an MRC programme grant G0800034 to SJB (http://www.mrc.ac.uk/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Canon J, 2003, GENE DEV, V17, P838, DOI 10.1101/gad.1064803; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; de Celis JF, 1998, DEVELOPMENT, V125, P4617; deCelis JF, 1996, DEVELOPMENT, V122, P2719; Djiane A, 2013, EMBO J, V32, P60, DOI 10.1038/emboj.2012.326; Heitzler P, 1996, DEVELOPMENT, V122, P161; Housden BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003162; Housden B, 2012, G3-GENES GENOM GENET, V2, P79, DOI 10.1534/g3.111.001321; JENNINGS B, 1995, DEVELOPMENT, V121, P3745; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; KRAMATSCHEK B, 1994, DEVELOPMENT, V120, P815; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Ligoxygakis P, 1999, DEVELOPMENT, V126, P2205; McDonald JA, 1998, GENE DEV, V12, P3603, DOI 10.1101/gad.12.22.3603; Nakagoshi H, 1998, GENE DEV, V12, P2724, DOI 10.1101/gad.12.17.2724; Preston CR, 1996, GENETICS, V144, P1623; ROARK M, 1995, GENE DEV, V9, P2384, DOI 10.1101/gad.9.19.2384; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; San Juan BP, 2012, BIOL OPEN, V1, P667, DOI 10.1242/bio.20121172; San-Juan BP, 2011, DEV BIOL, V352, P70, DOI 10.1016/j.ydbio.2011.01.019; Schroter C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001364; Shankaran SS, 2007, DEV BIOL, V304, P615, DOI 10.1016/j.ydbio.2007.01.004; TATA F, 1995, MECH DEVELOP, V51, P305, DOI 10.1016/0925-4773(95)00377-0; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; XU T, 1993, DEVELOPMENT, V117, P1223; Zacharioudaki E, 2012, DEVELOPMENT, V139, P1258, DOI 10.1242/dev.071779; Zhu SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046724	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75632	10.1371/journal.pone.0075632	http://dx.doi.org/10.1371/journal.pone.0075632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086596	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200057
J	Ma, M; Baumgartner, M				Ma, Min; Baumgartner, Martin			Filopodia and Membrane Blebs Drive Efficient Matrix Invasion of Macrophages Transformed by the Intracellular Parasite Theileria annulata	PLOS ONE			English	Article							ERM PROTEINS; CELL MOTILITY; SUSCEPTIBLE CATTLE; ACTIN DYNAMICS; B-LYMPHOCYTES; IN-VIVO; MIGRATION; KINASE; LAMELLIPODIA; METASTASIS	Recent technical advances have broadened our understanding of processes that govern mammalian cell migration in health and disease but many of the molecular and morphological alterations that precede and accompany movement of cells - in particular in three-dimensional (3D) environments - are still incompletely understood. In this manuscript, using high-resolution and time-lapse microscopy imaging approaches, we describe morphodynamic processes during rounded/amoeboid cell invasion and molecules associated with the cellular invasion structures. We used macrophages infected with the intracellular protozoan parasite Theileria annulata, which causes Tropical Theileriosis in susceptible ruminants such as domestic cattle. T. annulata transforms its host cell that, as a result, acquires many characteristics of human cancer cells including a markedly increased potential to migrate, disseminate and expand in the body of the host animal. Hence, virulence of the disease is associated with the capability of infected cells to disseminate inside the host. Using T. annulata-transformed macrophages as a model system, we described a novel mode of rounded/amoeboid macrophage migration. We show that filopodia-like membrane extensions at the leading edge lead the way and further evolve in blebbing membrane protrusions to promote progressive expansion of the matrix. Associated with focal invasion structures we detected ezrin, radixin, moesin-family proteins and their regulatory kinase MAP4K4. Furthermore, we linked Rho-kinase activity to contractile force generation, which is essential for infected cell motility. Thus, the motility mode of these parasite-transformed macrophages contrasts with those described so far in human macrophages such as the tunneling or mesenchymal modes, which require engulfment, compaction and ingestion of matrix or proteolytic matrix degradation, respectively. Together, our data reveal protrusion dynamics at the leading edge of invading cells in 3D at unprecedented temporal and spatial resolution and suggest a novel mode of rounded/amoeboid invasive cell motility that exploits actin-driven filopodia formation in combination with pressure-driven membrane blebs.	[Ma, Min; Baumgartner, Martin] Univ Childrens Hosp Zurich, Div Neurooncol Expt Infect Dis & Canc Res, Dept Oncol, Zurich, Switzerland	University Children's Hospital Zurich	Baumgartner, M (corresponding author), Univ Childrens Hosp Zurich, Div Neurooncol Expt Infect Dis & Canc Res, Dept Oncol, Zurich, Switzerland.	Martin.Baumgartner@kispi.uzh.ch	Baumgartner, Martin/D-2749-2017	Baumgartner, Martin/0000-0001-9539-7204	Swiss National Science Foundation [SNF_31003A_127025/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation (grant SNF_31003A_127025/1); http://www.snf.ch/E/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson RE, 1996, PARASITOLOGY, V113, P449, DOI 10.1017/S0031182000081518; Amieva MR, 1999, J CELL SCI, V112, P111; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Baumgartner M, 2000, CELL MICROBIOL, V2, P329, DOI 10.1046/j.1462-5822.2000.00062.x; Baumgartner M, 2003, BLOOD, V101, P1874, DOI 10.1182/blood-2002-02-0456; Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; Baumgartner M, 2011, CURR OPIN MICROBIOL, V14, P436, DOI 10.1016/j.mib.2011.07.003; Baumgartner M, 2011, CELL MICROBIOL, V13, P538, DOI 10.1111/j.1462-5822.2010.01553.x; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chaussepied M, 1998, MOL BIOCHEM PARASIT, V94, P215, DOI 10.1016/S0166-6851(98)00070-X; Chaussepied M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001197; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Dessauge G, 2005, ONCOGENE, V24, P1075, DOI 10.1038/sj.onc.1208314; Dobbelaere D., 2009, INTRACELLULAR NICHES, P613, DOI [10.1002/9783527629176., DOI 10.1002/9783527629176]; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Forsyth LMG, 1999, J COMP PATHOL, V120, P39, DOI 10.1053/jcpa.1998.0256; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Haubert D, 2007, EMBO J, V26, P3308, DOI 10.1038/sj.emboj.7601778; Jensen K, 2008, INT J PARASITOL, V38, P313, DOI 10.1016/j.ijpara.2007.08.007; Kramer N, 2013, MUTAT RES-REV MUTAT, V752, P10, DOI 10.1016/j.mrrev.2012.08.001; Lizundia R, 2006, CANCER RES, V66, P6105, DOI 10.1158/0008-5472.CAN-05-3861; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McGuire K, 2004, VET IMMUNOL IMMUNOP, V99, P87, DOI 10.1016/j.vetimm.2004.01.003; Moreau MF, 1999, INFECT IMMUN, V67, P6678; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Reichardt Peter, 2007, Methods Mol Biol, V380, P253; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Schnittger L, 2002, MOL BIOCHEM PARASIT, V120, P247, DOI 10.1016/S0166-6851(02)00013-0; Somerville RPT, 1998, PARASITOLOGY, V116, P223, DOI 10.1017/S0031182097002151; Torka R, 2006, EXP CELL RES, V312, P3857, DOI 10.1016/j.yexcr.2006.08.025; Van Goethem E, 2011, EUR J CELL BIOL, V90, P224, DOI 10.1016/j.ejcb.2010.07.011; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yu XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030605	43	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75577	10.1371/journal.pone.0075577	http://dx.doi.org/10.1371/journal.pone.0075577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086576	Green Submitted, Green Published, gold			2022-12-25	WOS:000325025200050
J	Schokoroy, S; Juster, D; Kloog, Y; Pinkas-Kramarski, R				Schokoroy, Sari; Juster, Dolly; Kloog, Yoel; Pinkas-Kramarski, Ronit			Disrupting the Oncogenic Synergism between Nucleolin and Ras Results in Cell Growth Inhibition and Cell Death	PLOS ONE			English	Article							G-RICH OLIGONUCLEOTIDES; COLON-CANCER CELLS; TUMOR-GROWTH; FARNESYLTHIOSALICYLIC ACID; IN-VITRO; CYCLE ARREST; ANTAGONIST; SUPPRESSION; MIGRATION; PROTEIN	Background: The ErbB receptors, Ras proteins and nucleolin are major contributors to malignant transformation. The pleiotropic protein nucleolin can bind to both Ras protein and ErbB receptors. Previously, we have demonstrated a crosstalk between Ras, nucleolin and the ErbB1 receptor. Activated Ras facilitates nucleolin interaction with ErbB1 and stabilizes ErbB1 levels. The three oncogenes synergistically facilitate anchorage independent growth and tumor growth in nude mice. Methodology/Principal Findings: In the present study we used several cancer cell lines. The effect of Ras and nucleolin inhibition was determined using cell growth, cell death and cell motility assays. Protein expression was determined by immunohistochemistry. We found that inhibition of Ras and nucleolin reduces tumor cell growth, enhances cell death and inhibits anchorage independent growth. Our results reveal that the combined treatment affects Ras and nucleolin levels and localization. Our study also indicates that Salirasib (FTS, Ras inhibitor) reduces cell motility, which is not affected by the nucleolin inhibitor. Conclusions/Significance: These results suggest that targeting both nucleolin and Ras may represent an additional avenue for inhibiting cancers driven by these oncogenes.	[Schokoroy, Sari; Juster, Dolly; Kloog, Yoel; Pinkas-Kramarski, Ronit] Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel	Tel Aviv University	Pinkas-Kramarski, R (corresponding author), Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel.	lironit@post.tau.ac.il		Pinkas-Kramarski, Ronit/0000-0002-1000-369X	Israel Science Foundation [848/ 12]; Kauffman Prostate Cancer Research Fund	Israel Science Foundation(Israel Science Foundation); Kauffman Prostate Cancer Research Fund	This work was supported by the Israel Science Foundation (Grant no. 848/ 12)and by the Kauffman Prostate Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonson Z, 1998, BBA-MOL BASIS DIS, V1406, P40, DOI 10.1016/S0925-4439(97)00077-X; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Charette N, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-256; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; Dapic V, 2002, BIOCHEMISTRY-US, V41, P367, DOI [10.1021/bi011335b, DOI 10.1021/BI011335B.PUBMED:11772036]; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Di Segni A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002310; Di-Segni A., 2009, BREAST CANC PATHOGEN, P77; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Elad G, 1999, BBA-MOL CELL RES, V1452, P228, DOI 10.1016/S0167-4889(99)00144-5; Erlich S, 2006, BIOCHEM PHARMACOL, V72, P427, DOI 10.1016/j.bcp.2006.05.007; Etienne-Manneville S, 2006, METHOD ENZYMOL, V406, P565, DOI 10.1016/S0076-6879(06)06044-7; Farin K, 2011, CANCER RES, V71, P2140, DOI 10.1158/0008-5472.CAN-10-2887; Farin K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006128; Goldberg L, 2006, CANCER RES, V66, P11709, DOI 10.1158/0008-5472.CAN-06-1878; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Halaschek-Wiener J, 2000, MOL MED, V6, P693, DOI 10.1007/BF03402049; Harris AL, 1992, MONOG NATL CANC I, P181; Ireson CR, 2006, MOL CANCER THER, V5, P2957, DOI 10.1158/1535-7163.MCT-06-0172; Kloog Y, 2000, MOL MED TODAY, V6, P398, DOI 10.1016/S1357-4310(00)01789-5; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; MAROM M, 1995, J BIOL CHEM, V270, P22263, DOI 10.1074/jbc.270.38.22263; McPherson RA, 2004, PROSTATE, V58, P325, DOI 10.1002/pros.10336; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Reyes-Reyes EM, 2010, CANCER RES, V70, P8617, DOI 10.1158/0008-5472.CAN-10-0920; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rotblat B, 2008, METHOD ENZYMOL, V439, P467, DOI 10.1016/S0076-6879(07)00432-6; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Stepanova V, 2008, BLOOD, V112, P100, DOI 10.1182/blood-2007-07-104455; Storck S, 2008, BIOL CELL; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; Takaoka A, 1998, ONCOGENE, V16, P1443, DOI 10.1038/sj.onc.1201648; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Weis B, 1999, ONCOGENE, V18, P2579, DOI 10.1038/sj.onc.1202602; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Zundelevich A, 2007, MOL CANCER THER, V6, P1765, DOI 10.1158/1535-7163.MCT-06-0706	42	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75269	10.1371/journal.pone.0075269	http://dx.doi.org/10.1371/journal.pone.0075269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086490	gold, Green Published, Green Submitted			2022-12-25	WOS:000325025200035
J	Slocum, MG; Orzell, SL				Slocum, Matthew G.; Orzell, Steve L.			A Structural Equation Model Analysis of Relationships among ENSO, Seasonal Descriptors and Wildfires	PLOS ONE			English	Article							EVERGLADES-NATIONAL-PARK; FIRE REGIMES; EL-NINO; WINTER PRECIPITATION; SOUTHERN-OSCILLATION; FLORIDA; RAINFALL; CLIMATE; TEMPERATURE; HURRICANES	Seasonality drives ecological processes through networks of forcings, and the resultant complexity requires creative approaches for modeling to be successful. Recently ecologists and climatologists have developed sophisticated methods for fully describing seasons. However, to date the relationships among the variables produced by these methods have not been analyzed as networks, but rather with simple univariate statistics. In this manuscript we used structural equation modeling (SEM) to analyze a proposed causal network describing seasonality of rainfall for a site in south-central Florida. We also described how this network was influenced by the El Nino-Southern Oscillation (ENSO), and how the network in turn affected the site's wildfire regime. Our models indicated that wet and dry seasons starting later in the year (or ending earlier) were shorter and had less rainfall. El Nino conditions increased dry season rainfall, and via this effect decreased the consistency of that season's drying trend. El Nino conditions also negatively influenced how consistent the moistening trend was during the wet season, but in this case the effect was direct and did not route through rainfall. In modeling wildfires, our models showed that area burned was indirectly influenced by ENSO via its effect on dry season rainfall. Area burned was also indirectly reduced when the wet season had consistent rainfall, as such wet seasons allowed fewer wildfires in subsequent fire seasons. Overall area burned at the study site was estimated with high accuracy (R-2 score = 0.63). In summary, we found that by using SEMs, we were able to clearly describe causal patterns involving seasonal climate, ENSO and wildfire. We propose that similar approaches could be effectively applied to other sites where seasonality exerts strong and complex forcings on ecological processes.	[Slocum, Matthew G.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Orzell, Steve L.] Avon Pk Air Force Range, Avon Pk, FL USA	Louisiana State University System; Louisiana State University	Slocum, MG (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	mateo457@yahoo.com			Avon Park Air Force Range, Department of Defense, USA	Avon Park Air Force Range, Department of Defense, USA(United States Department of Defense)	Funding was obtained from the Avon Park Air Force Range, Department of Defense, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz P, 2004, ECOL LETT, V7, P547, DOI 10.1111/j.1461-0248.2004.00612.x; Anderson TM, 2011, J ECOL, V99, P797, DOI 10.1111/j.1365-2745.2011.01795.x; Arbuckle JL, 2011, IBM SPSS AMOS 20 USE, P653; Baiser B, 2008, ANIM CONSERV, V11, P190, DOI 10.1111/j.1469-1795.2008.00167.x; Basille M, 2013, ECOGRAPHY, V36, P220, DOI 10.1111/j.1600-0587.2011.07367.x; Beckage B, 2003, FRONT ECOL ENVIRON, V1, P235, DOI 10.2307/3868010; Beckage B, 2003, ECOLOGY, V84, P3124, DOI 10.1890/02-0183; Bove MC, 1998, B AM METEOROL SOC, V79, P2477, DOI 10.1175/1520-0477(1998)079<2477:EOENOO>2.0.CO;2; Brenner J., 1991, Fire Management Notes, V52, P28; Brolley JM, 2007, AGR FOREST METEOROL, V145, P84, DOI 10.1016/j.agrformet.2007.04.003; BROWNE MW, 1989, MULTIVAR BEHAV RES, V24, P445, DOI 10.1207/s15327906mbr2404_4; Camberlin P, 2003, CLIMATE RES, V23, P159, DOI 10.3354/cr023159; Chen E., 1990, ECOSYSTEMS FLORIDA, P11; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; DOUGLAS AV, 1981, MON WEATHER REV, V109, P2377, DOI 10.1175/1520-0493(1981)109<2377:OASRBA>2.0.CO;2; Duncan BW, 2010, CAN J FOREST RES, V40, P286, DOI 10.1139/X09-193; Forister ML, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.13001; Gill AM, 2008, INT J WILDLAND FIRE, V17, P688, DOI 10.1071/WF07145; Gimenez O, 2012, METHODS ECOL EVOL, V3, P427, DOI 10.1111/j.2041-210X.2011.00150.x; Goodrick SL, 2009, INT J WILDLAND FIRE, V18, P476, DOI 10.1071/WF07034; Goswami BN, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023216; Grace J.B., 2006, STRUCT EQ MOD NAT; GRAY WM, 1984, MON WEATHER REV, V112, P1649, DOI 10.1175/1520-0493(1984)112<1649:ASHFPI>2.0.CO;2; Hagemeyer B, 1999, 20 C SEVERE LOCAL ST; Hanley DE, 2003, J CLIMATE, V16, P1249, DOI 10.1175/1520-0442(2003)16<1249:AQEOEI>2.0.CO;2; Hardy JW, 2003, PHYS GEOGR, V24, P120, DOI 10.2747/0272-3646.24.2.120; Howell DC, 1987, STAT METHODS PSYCHOL; Jones C. S., 1999, FLORIDA GEOGRAPHER, V30, P55; Landsea CW, 1999, CLIMATIC CHANGE, V42, P89, DOI 10.1023/A:1005416332322; Le Page Y, 2008, ATMOS CHEM PHYS, V8, P1911, DOI 10.5194/acp-8-1911-2008; Lee SY, 2004, MULTIVAR BEHAV RES, V39, P653, DOI 10.1207/s15327906mbr3904_4; Lima CHR, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007485; Meyn A, 2007, PROG PHYS GEOG, V31, P287, DOI 10.1177/0309133307079365; Moritz MA, 2005, P NATL ACAD SCI USA, V102, P17912, DOI 10.1073/pnas.0508985102; Moses CS, 2013, J PALEOLIMNOL, V49, P5, DOI 10.1007/s10933-012-9635-0; Orzell S. L., 2006, LAND FIRE WATER FLOR, P136; Philander S.G.H., 2004, OUR AFFAIR EL NINO W; Platt W.J., 2006, LAND FIRE WATER, P3; Roman-Cuesta RM, 2003, ECOL APPL, V13, P1177, DOI 10.1890/1051-0761(2003)13[1177:EAHFIF]2.0.CO;2; Ropelewski CF, 1989, J CLIMATE, V2, P268, DOI 10.1175/1520-0442(1989)002<0268:PPAWTH>2.0.CO;2; ROPELEWSKI CF, 1986, MON WEATHER REV, V114, P2352, DOI 10.1175/1520-0493(1986)114<2352:NAPATP>2.0.CO;2; Rueda M, 2008, J ARID ENVIRON, V72, P1698, DOI 10.1016/j.jaridenv.2008.03.006; Shipley B., 2000, CAUSE CORRELATIONS B; Slocum MG, 2007, NAT AREA J, V27, P41, DOI 10.3375/0885-8608(2007)27[41:DNAAFR]2.0.CO;2; Slocum MG, 2010, J APPL METEOROL CLIM, V49, P2559, DOI 10.1175/2010JAMC2532.1; Slocum MG, 2010, ECOSYSTEMS, V13, P828, DOI 10.1007/s10021-010-9357-y; Slocum MG, 2003, RESTOR ECOL, V11, P91, DOI 10.1046/j.1526-100X.2003.00115.x; Smith SR, 1998, MON WEATHER REV, V126, P3102, DOI 10.1175/1520-0493(1998)126<3102:ROMLTC>2.0.CO;2; Snyder JR, 1991, P TALL TIMBERS FIRE, V17, P303; Stein BA, 2008, BIOSCIENCE, V58, P339, DOI 10.1641/B580409; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; van der Heijden GMF, 2009, J BIOGEOGR, V36, P1561, DOI 10.1111/j.1365-2699.2009.02099.x; Vieyra L, 2009, ECOLOGY, V90, P1084, DOI 10.1890/07-2009.1	55	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75946	10.1371/journal.pone.0075946	http://dx.doi.org/10.1371/journal.pone.0075946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086670	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200072
J	Yan, BB; Singla, RD; Abdelli, LS; Singal, PK; Singla, DK				Yan, Binbin; Singla, Reetu D.; Abdelli, Latifa S.; Singal, Pawan K.; Singla, Dinender K.			Regulation of PTEN/Akt Pathway Enhances Cardiomyogenesis and Attenuates Adverse Left Ventricular Remodeling following Thymosin beta 4 Overexpressing Embryonic Stem Cell Transplantation in the Infarcted Heart	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CARDIOMYOCYTE DIFFERENTIATION; CARDIAC DIFFERENTIATION; INHIBIT APOPTOSIS; THERAPY; REPAIR; NEOVASCULARIZATION; PEPTIDE; DISEASE; NOTCH	Thymosin beta 4 (T beta 4), a small G-actin sequestering peptide, mediates cell proliferation, migration, and angiogenesis. Whether embryonic stem (ES) cells, overexpressing T beta 4, readily differentiate into cardiac myocytes in vitro and in vivo and enhance cardioprotection following transplantation post myocardial infarction (MI) remains unknown. Accordingly, we established stable mouse ES cell lines, RFP-ESCs and T beta 4-ESCs, expressing RFP and an RFP-T beta 4 fusion protein, respectively. In vitro, the number of spontaneously beating embryoid bodies (EBs) was significantly increased in T beta 4-ESCs at day 9, 12 and 15, compared with RFP-ESCs. Enhanced expression of cardiac transcriptional factors GATA-4, Mef2c and Txb6 in T beta 4-EBs, as confirmed with real time-PCR analysis, was accompanied by the increased number of EB areas stained positive for sarcomeric alpha-actin in T beta 4-EBs, compared with the RFP control, suggesting a significant increase in functional cardiac myocytes. Furthermore, we transplanted T beta 4-ESCs into the infarcted mouse heart and performed morphological and functional analysis 2 weeks after MI. There was a significant increase in newly formed cardiac myocytes associated with the Notch pathway, a decrease in apoptotic nuclei mediated by an increase in Akt and a decrease in levels of PTEN. Cardiac fibrosis was significantly reduced, and left ventricular function was significantly augmented in the T beta 4-ESC transplanted group, compared with controls. It is concluded that genetically modified T beta 4-ESCs, potentiates their ability to turn into cardiac myocytes in vitro as well as in vivo. Moreover, we also demonstrate that there was a significant decrease in both cardiac apoptosis and fibrosis, thus improving cardiac function in the infarcted heart.	[Yan, Binbin; Singla, Reetu D.; Abdelli, Latifa S.; Singla, Dinender K.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Singal, Pawan K.] Univ Manitoba, St Boniface Gen Hosp, Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB, Canada	State University System of Florida; University of Central Florida; University of Manitoba; Children's Hospital Research Institute of Manitoba	Singla, DK (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	dsingla@mail.ucf.edu			National Heart, Lung, and Blood Institute [1R01-HL-090646-01, 1R01HL094467-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090646, R01HL094467] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by in part grants from the National Heart, Lung, and Blood Institute (1R01-HL-090646-01 and 1R01HL094467-01 to DKS). Dr. PKS is the holder of the Naranjan Dhalla Chair from the St. Boniface Hospital & Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli LS, 2012, CAN J PHYSIOL PHARM, V90, P307, DOI [10.1139/Y11-130, 10.1139/y11-130]; Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Boyle AJ, 2006, CIRCULATION, V114, P339, DOI 10.1161/CIRCULATIONAHA.105.590653; Choi SC, 2004, EXP MOL MED, V36, P515, DOI 10.1038/emm.2004.66; Crockford D, 2007, ANN NY ACAD SCI, V1112, P385, DOI 10.1196/annals.1415.051; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Glass C, 2011, AM J PHYSIOL-HEART C, V301, pH2038, DOI 10.1152/ajpheart.00271.2011; Grant D S, 1999, Angiogenesis, V3, P125, DOI 10.1023/A:1009041911493; Grepin C, 1997, DEVELOPMENT, V124, P2387; Gude NA, 2008, CIRC RES, V102, P1025, DOI 10.1161/CIRCRESAHA.107.164749; HANNAPPEL E, 1985, ARCH BIOCHEM BIOPHYS, V240, P236, DOI 10.1016/0003-9861(85)90028-1; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hinkel R, 2008, CIRCULATION, V117, P2232, DOI 10.1161/CIRCULATIONAHA.107.758904; Ho JH, 2010, J ORTHOP RES, V28, P131, DOI 10.1002/jor.20956; Hodgson DM, 2004, AM J PHYSIOL-HEART C, V287, pH471, DOI 10.1152/ajpheart.01247.2003; Keyes KT, 2010, AM J PHYSIOL-HEART C, V298, pH1198, DOI 10.1152/ajpheart.00915.2009; Kumar D, 2005, BIOCHEM BIOPH RES CO, V332, P135, DOI 10.1016/j.bbrc.2005.04.098; Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161; Li YX, 2011, CIRCULATION, V123, P866, DOI 10.1161/CIRCULATIONAHA.110.947531; Menard C, 2005, LANCET, V366, P1005, DOI 10.1016/S0140-6736(05)67380-1; Narita N, 1997, DEVELOPMENT, V124, P3755; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Philp D, 2003, FASEB J, V17, P385, DOI 10.1096/fj.03-0244fje; Philp D, 2003, FASEB J, V17, P2103, DOI 10.1096/fj.03-0121fje; Puceat M, 2008, METHODS, V45, P168, DOI 10.1016/j.ymeth.2008.03.003; Reinecke H, 2008, CIRC RES, V103, P1058, DOI 10.1161/CIRCRESAHA.108.180588; SAFER D, 1990, P NATL ACAD SCI USA, V87, P2536, DOI 10.1073/pnas.87.7.2536; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1308, DOI 10.1152/ajpheart.01277.2006; Smart N, 2007, ANN NY ACAD SCI, V1112, P171, DOI 10.1196/annals.1415.000; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Srivastava D, 2007, ANN NY ACAD SCI, V1112, P161, DOI 10.1196/annals.1415.048; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Taha MF, 2007, INT J CARDIOL, V120, P92, DOI 10.1016/j.ijcard.2006.08.118; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tomfscot A, 2007, STEM CELLS, V25, P2200, DOI 10.1634/stemcells.2007-0133; Wen JY, 2007, J CELL BIOCHEM, V102, P149, DOI 10.1002/jcb.21285; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91	40	22	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75580	10.1371/journal.pone.0075580	http://dx.doi.org/10.1371/journal.pone.0075580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086577	Green Published, gold			2022-12-25	WOS:000325025200051
J	Kuriki, S; Yokosawa, K; Takahashi, M				Kuriki, Shinya; Yokosawa, Koichi; Takahashi, Makoto			Neural Representation of Scale Illusion: Magnetoencephalographic Study on the Auditory Illusion Induced by Distinctive Tone Sequences in the Two Ears	PLOS ONE			English	Article							STEADY-STATE RESPONSES; AMPLITUDE-MODULATION; BINAURAL INTERACTION; EVOKED-POTENTIALS; OCTAVE ILLUSION; BRAIN-STEM; CORTEX; CAT; MECHANISMS; ORGANIZATION	The auditory illusory perception "scale illusion" occurs when a tone of ascending scale is presented in one ear, a tone of descending scale is presented simultaneously in the other ear, and vice versa. Most listeners hear illusory percepts of smooth pitch contours of the higher half of the scale in the right ear and the lower half in the left ear. Little is known about neural processes underlying the scale illusion. In this magnetoencephalographic study, we recorded steady-state responses to amplitude-modulated short tones having illusion-inducing pitch sequences, where the sound level of the modulated tones was manipulated to decrease monotonically with increase in pitch. The steady-state responses were decomposed into right- and left-sound components by means of separate modulation frequencies. It was found that the time course of the magnitude of response components of illusion-perceiving listeners was significantly correlated with smooth pitch contour of illusory percepts and that the time course of response components of stimulus-perceiving listeners was significantly correlated with discontinuous pitch contour of stimulus percepts in addition to the contour of illusory percepts. The results suggest that the percept of illusory pitch sequence was represented in the neural activity in or near the primary auditory cortex, i.e., the site of generation of auditory steady-state response, and that perception of scale illusion is maintained by automatic low-level processing.	[Kuriki, Shinya] Tokyo Denki Univ, Res Ctr Sci & Technol, Inzai, Japan; [Yokosawa, Koichi] Hokkaido Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Takahashi, Makoto] Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan	Tokyo Denki University; Hokkaido University; Hokkaido University	Kuriki, S (corresponding author), Tokyo Denki Univ, Res Ctr Sci & Technol, Inzai, Japan.	skuriki@mail.dendai.ac.jp			Ministry of Education, Science and Culture of Japan [19300152]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding provided by Grant-in-Aids for Scientific Research (19300152) from the Ministry of Education, Science and Culture of Japan (URL:http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brancucci A, 2009, PSYCHOL RES-PSYCH FO, V73, P303, DOI 10.1007/s00426-008-0153-7; Bregman A.S., 1990, AUDITORY SCENE ANAL; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; DAVIDSON B, 1987, PERCEPT PSYCHOPHYS, V41, P601, DOI 10.3758/BF03210492; Deouell LY, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.015.2007; DEUTSCH D, 1975, J ACOUST SOC AM, V57, P1156, DOI 10.1121/1.380573; DEUTSCH D, 1974, NATURE, V251, P307, DOI 10.1038/251307a0; Draganova R, 2008, CEREB CORTEX, V18, P1193, DOI 10.1093/cercor/bhm153; Engelien A, 2000, HEARING RES, V148, P153, DOI 10.1016/S0378-5955(00)00148-9; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; FRISINA RD, 1990, HEARING RES, V44, P99, DOI 10.1016/0378-5955(90)90074-Y; Fujiki N, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0003.2002; GAESE BH, 1995, EUR J NEUROSCI, V7, P438, DOI 10.1111/j.1460-9568.1995.tb00340.x; GALAMBOS R, 1982, ANN NY ACAD SCI, V388, P722, DOI 10.1111/j.1749-6632.1982.tb50841.x; Herdman AT, 2002, BRAIN TOPOGR, V15, P69, DOI 10.1023/A:1021470822922; IMIG TJ, 1977, BRAIN RES, V138, P241, DOI 10.1016/0006-8993(77)90743-0; Jamison HL, 2006, CEREB CORTEX, V16, P1266, DOI 10.1093/cercor/bhj068; JOHNSON B W, 1988, Brain Topography, V1, P117, DOI 10.1007/BF01129176; Kaneko K, 2003, HEARING RES, V183, P1, DOI 10.1016/S0378-5955(03)00186-2; Karino S, 2006, J NEUROPHYSIOL, V96, P1927, DOI 10.1152/jn.00859.2005; KELLY JB, 1994, J NEUROPHYSIOL, V71, P904, DOI 10.1152/jn.1994.71.3.904; Krishna BS, 2000, J NEUROPHYSIOL, V84, P255, DOI 10.1152/jn.2000.84.1.255; Kuriki S, 2013, HEARING RES, V296, P25, DOI 10.1016/j.heares.2012.11.002; KUWADA S, 1979, SCIENCE, V206, P586, DOI 10.1126/science.493964; Lamminmaki S, 2000, NEUROREPORT, V11, P1469, DOI 10.1097/00001756-200005150-00021; Lamminmaki S, 2012, J ACOUST SOC AM, V132, P1747, DOI 10.1121/1.4740474; LEE YS, 1984, BRAIN, V107, P115, DOI 10.1093/brain/107.1.115; LITTMAN T, 1994, BRAIN RES, V640, P286, DOI 10.1016/0006-8993(94)91884-8; MAKELA JP, 1990, HEARING RES, V45, P41, DOI 10.1016/0378-5955(90)90181-N; Maki A, 2009, EAR HEARING, V30, P584, DOI 10.1097/AUD.0b013e3181acfb57; MCPHERSON DL, 1993, HEARING RES, V66, P91, DOI 10.1016/0378-5955(93)90263-Z; MULLERPREUSS P, 1994, HEARING RES, V80, P197, DOI 10.1016/0378-5955(94)90111-2; Okamoto H, 2009, CEREB CORTEX, V19, P2290, DOI 10.1093/cercor/bhn245; PANDYA DN, 1995, REV NEUROL, V151, P486; Pantev C, 1996, HEARING RES, V101, P62, DOI 10.1016/S0378-5955(96)00133-5; Pratt H, 2009, CLIN NEUROPHYSIOL, V120, P1514, DOI 10.1016/j.clinph.2009.06.014; PREUSS A, 1990, EXP BRAIN RES, V79, P207; RHODE WS, 1994, J NEUROPHYSIOL, V71, P1797, DOI 10.1152/jn.1994.71.5.1797; Ross J, 1996, NEUROREPORT, V8, P303, DOI 10.1097/00001756-199612200-00060; SCHREINER CE, 1988, HEARING RES, V32, P49, DOI 10.1016/0378-5955(88)90146-3; Schwarz DWF, 2005, CLIN NEUROPHYSIOL, V116, P658, DOI 10.1016/j.clinph.2004.09.014; Snyder JS, 2006, J COGNITIVE NEUROSCI, V18, P1, DOI 10.1162/089892906775250021; SPYDELL JD, 1985, ELECTROEN CLIN NEURO, V62, P193, DOI 10.1016/0168-5597(85)90014-0; Steinmann I, 2011, NEUROIMAGE, V54, P495, DOI 10.1016/j.neuroimage.2010.07.064; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; WERNICK JS, 1968, J NEUROPHYSIOL, V31, P428, DOI 10.1152/jn.1968.31.3.428; Wong WYS, 2004, EAR HEARING, V25, P57, DOI 10.1097/01.AUD.0000111257.11898.64; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	48	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75990	10.1371/journal.pone.0075990	http://dx.doi.org/10.1371/journal.pone.0075990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086676	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200128
J	Mackie, A; Keseler, IM; Nolan, L; Karp, PD; Paulsen, IT				Mackie, Amanda; Keseler, Ingrid M.; Nolan, Laura; Karp, Peter D.; Paulsen, Ian T.			Dead End Metabolites - Defining the Known Unknowns of the E. coli Metabolic Network	PLOS ONE			English	Article							ESCHERICHIA-COLI; IN-VIVO; ACTIVE-TRANSPORT; INDUCIBLE SYSTEM; GENETIC-ANALYSIS; LIPOIC ACID; PATHWAY; BIOTIN; IDENTIFICATION; CATABOLISM	The EcoCyc database is an online scientific database which provides an integrated view of the metabolic and regulatory network of the bacterium Escherichia coli K-12 and facilitates computational exploration of this important model organism. We have analysed the occurrence of dead end metabolites within the database-these are metabolites which lack the requisite reactions (either metabolic or transport) that would account for their production or consumption within the metabolic network. 127 dead end metabolites were identified from the 995 compounds that are contained within the EcoCyc metabolic network. Their presence reflects either a deficit in our representation of the network or in our knowledge of E. coli metabolism. Extensive literature searches resulted in the addition of 38 transport reactions and 3 metabolic reactions to the database and led to an improved representation of the pathway for Vitamin B12 salvage. 39 dead end metabolites were identified as components of reactions that are not physiologically relevant to E. coli K-12-these reactions are properties of purified enzymes in vitro that would not be expected to occur in vivo. Our analysis led to improvements in the software that underpins the database and to the program that finds dead end metabolites within EcoCyc. The remaining dead end metabolites in the EcoCyc database likely represent deficiencies in our knowledge of E. coli metabolism.	[Mackie, Amanda; Nolan, Laura; Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Keseler, Ingrid M.; Karp, Peter D.] SRI Int, Menlo Pk, CA 94025 USA	Macquarie University; SRI International	Paulsen, IT (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	ian.paulsen@mq.edu.au	Nolan, Laura/AEZ-3347-2022; Karp, Peter/C-3514-2012; Paulsen, Ian/K-3832-2012	Karp, Peter/0000-0002-5876-6418; Paulsen, Ian/0000-0001-9015-9418	National Institute of General Medical Sciences of the National Institutes of Health [U24GM077678]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U24GM077678] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work on this project was supported by National Institute of General Medical Sciences of the National Institutes of Health [U24GM077678]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas M, 2010, EUR J CELL BIOL, V89, P888, DOI 10.1016/j.ejcb.2010.06.013; BELLION E, 1983, BIOCHIM BIOPHYS ACTA, V735, P337, DOI 10.1016/0005-2736(83)90147-5; BLACKWELL CM, 1976, BIOCHEM SOC T, V4, P495, DOI 10.1042/bst0040495; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BOOS W, 1981, J BACTERIOL, V146, P725, DOI 10.1128/JB.146.2.725-732.1981; BRADBEER C, 1978, J BIOL CHEM, V253, P1347; BURLINGAME R, 1983, J BACTERIOL, V155, P113, DOI 10.1128/JB.155.1.113-121.1983; Cai H, 1999, J BIOL CHEM, V274, P13470, DOI 10.1074/jbc.274.19.13470; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; DYKHUIZEN D, 1973, J BACTERIOL, V115, P662, DOI 10.1128/JB.115.2.662-667.1973; Fujisawa H, 2003, BBA-PROTEINS PROTEOM, V1645, P89, DOI 10.1016/S1570-9639(02)00533-2; Green ML, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-76; GUTH A, 1980, J BACTERIOL, V143, P538, DOI 10.1128/JB.143.1.538-539.1980; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; Herzberg M, 2006, J BACTERIOL, V188, P587, DOI 10.1128/JB.188.2.587-598.2006; Hughes JA, 2006, CAN J MICROBIOL, V52, P599, DOI 10.1139/W06-008; IIZUKA M, 1989, J BACTERIOL, V171, P6039, DOI 10.1128/jb.171.11.6039-6042.1989; Iqbal S, 2004, J BACTERIOL, V186, P6118, DOI 10.1128/jb.186.18.6118-6123.2004; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; JONES PW, 1984, J GEN MICROBIOL, V130, P299; Karp PD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-401; Karp PD, 2007, NUCLEIC ACIDS RES, V35, P7577, DOI 10.1093/nar/gkm740; KENLEY JS, 1978, J BIOL CHEM, V253, P1341; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Lacourciere GM, 2002, J BACTERIOL, V184, P1940, DOI 10.1128/JB.184.7.1940-1946.2002; LAWRENCE JG, 1995, J BACTERIOL, V177, P6371, DOI 10.1128/jb.177.22.6371-6380.1995; LINDBLOWKULL C, 1985, J BACTERIOL, V163, P1267, DOI 10.1128/JB.163.3.1267-1269.1985; Liu GF, 2009, J BACTERIOL, V191, P6394, DOI 10.1128/JB.00552-09; Loh KD, 2006, P NATL ACAD SCI USA, V103, P5114, DOI 10.1073/pnas.0600521103; MORRIS DR, 1967, J BACTERIOL, V94, P1516, DOI 10.1128/JB.94.5.1516-1519.1967; MORRIS TW, 1995, J BACTERIOL, V177, P1; Muller HM, 2004, PLOS BIOL, V2, P1984, DOI 10.1371/journal.pbio.0020309; NAGASAWA T, 1988, ARCH MICROBIOL, V149, P413, DOI 10.1007/BF00425580; Nie L, 2008, BIOCHEMISTRY-US, V47, P7744, DOI 10.1021/bi800595f; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; PARROTT S, 1987, J GEN MICROBIOL, V133, P347; PAULI G, 1972, EUR J BIOCHEM, V29, P553, DOI 10.1111/j.1432-1033.1972.tb02021.x; PIERSON DE, 1990, J BACTERIOL, V172, P2194, DOI 10.1128/jb.172.4.2194-2198.1990; PRAKASH O, 1974, J BACTERIOL, V120, P785, DOI 10.1128/JB.120.2.785-791.1974; Putra SR, 1998, TETRAHEDRON LETT, V39, P23, DOI 10.1016/S0040-4039(97)10458-0; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Ren Y, 2004, J BIOL CHEM, V279, P11042, DOI 10.1074/jbc.M310032200; Rippa V, 2011, DNA REPAIR, V10, P934, DOI 10.1016/j.dnarep.2011.06.001; Rizk SS, 2006, PROTEIN SCI, V15, P1745, DOI 10.1110/ps.062135206; Sauer E, 2004, ANTIMICROB AGENTS CH, V48, P4532, DOI 10.1128/AAC.48.12.4532-4541.2004; SCHAEFLER S, 1967, J BACTERIOL, V93, P254, DOI 10.1128/JB.93.1.254-263.1967; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Smith AAT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002540; SOLOMON LR, 1971, BIOCHEM BIOPH RES CO, V44, P299, DOI 10.1016/0006-291X(71)90599-7; STONER GL, 1975, J BIOL CHEM, V250, P4029; TANG CT, 1977, ANTIMICROB AGENTS CH, V11, P147, DOI 10.1128/AAC.11.1.147; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Thanbichler M, 1999, J BACTERIOL, V181, P662, DOI 10.1128/JB.181.2.662-665.1999; TOEWS ML, 1979, J BIOL CHEM, V254, P1761; Wiame E, 2004, BIOCHEM J, V378, P1047, DOI 10.1042/BJ20031527; Wiame E, 2002, J BIOL CHEM, V277, P42523, DOI 10.1074/jbc.M200863200; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005; YAMASAKI H, 1973, J BACTERIOL, V116, P1280, DOI 10.1128/JB.116.3.1280-1286.1973; Yang KC, 2009, J BACTERIOL, V191, P4667, DOI 10.1128/JB.00235-09; Zayas CL, 2007, J BACTERIOL, V189, P2210, DOI 10.1128/JB.01665-06; Zhai YF, 2002, PROTEIN SCI, V11, P2196, DOI 10.1110/ps.0209002; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016	65	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75210	10.1371/journal.pone.0075210	http://dx.doi.org/10.1371/journal.pone.0075210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086468	Green Submitted, Green Published, gold			2022-12-25	WOS:000326520200089
J	Sanders, JL; Watral, V; Clarkson, K; Kent, ML				Sanders, Justin L.; Watral, Virginia; Clarkson, Keri; Kent, Michael L.			Verification of Intraovum Transmission of a Microsporidium of Vertebrates: Pseudoloma neurophilia Infecting the Zebrafish, Danio rerio	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RENIBACTERIUM-SALMONINARUM; VERTICAL TRANSMISSION; TRANSOVARIAL TRANSMISSION; OVIPLEISTOPHORA-OVARIAE; CYPRINID FISH; N. SP.; EVOLUTION; DISEASE; MODEL	Direct transmission from parents to offspring, referred to as vertical transmission, occurs within essentially all major groups of pathogens. Several microsporidia (Phylum Microsporidia) that infect arthropods employ this mode of transmission, and various lines of evidence have suggested this might occur with certain fish microsporidia. The microsporidium, Pseudoloma neurophilia, is a common pathogen of the laboratory zebrafish, Danio rerio. We previously verified that this parasite is easily transmitted horizontally, but previous studies also indicated that maternal transmission occurs. We report here direct observation of Pseudoloma neurophilia in the progeny of infected zebrafish that were reared in isolation, including microscopic visualization of the parasite in all major stages of development. Histological examination of larval fish reared in isolation from a group spawn showed microsporidian spores in the resorbing yolk sac of a fish. Infections were also observed in three of 36 juvenile fish. Eggs from a second group spawn of 30 infected fish were examined using a stereomicroscope and the infection was observed from 4 to 48 hours post-fertilization in two embryos. Intraovum infections were detected in embryos from 4 of 27 pairs of infected fish that were spawned based on qPCR detection of P. neurophilia DNA. The prevalence of intraovum infections from the four spawns containing infected embryos was low (similar to 1%) based on calculation of prevalence using a maximum likelihood analysis for pooled samples. Parasite DNA was detected in the water following spawning of 11 of the infected pairs, suggesting there was also potential for extraovum transmission in these spawning events. Our study represents the first direct observation of vertical transmission within a developing embryo of a microsporidian parasite in a vertebrate. The low prevalence of vertical transmission in embryos is consistent with observations of some other fish pathogens that are also readily transmitted by both vertical and horizontal routes.	[Sanders, Justin L.; Watral, Virginia; Kent, Michael L.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Clarkson, Keri; Kent, Michael L.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Sanders, JL (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	Justin.Sanders@oregonstate.edu	Sanders, Justin L./AAC-6406-2020; Sanders, Justin/F-5977-2011	Sanders, Justin L./0000-0001-9970-7628; 	National Institutes of Health [NIH NCRR 5R24RR017386-02, NIH NCRR P40 RR12546-03S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017386, P40RR012546] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the National Institutes of Health (NIH NCRR 5R24RR017386-02 and NIH NCRR P40 RR12546-03S1). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Balbiani G, 1882, CR HEBD ACAD SCI, V95, P1168; Becnel James J., 1999, P447; Brown AMV, 2010, DIS AQUAT ORGAN, V91, P35, DOI 10.3354/dao02246; Brown LL, 1997, DIS AQUAT ORGAN, V29, P213, DOI 10.3354/dao029213; BRUNO DW, 1986, DIS AQUAT ORGAN, V1, P83; Cali A, 2012, J EUKARYOT MICROBIOL, V59, P40, DOI 10.1111/j.1550-7408.2011.00591.x; CANNING EU, 1986, MICROSPORIDIA VERTEB; Corradi Nicolas, 2009, Fungal Biology Reviews, V23, P1, DOI 10.1016/j.fbr.2009.05.001; Docker MF, 1997, DIS AQUAT ORGAN, V29, P41, DOI 10.3354/dao029041; Dunn AM, 2001, ADV PARASIT, V48, P57, DOI 10.1016/S0065-308X(01)48005-5; Ebert D, 1996, PARASITOL TODAY, V12, P96, DOI 10.1016/0169-4758(96)80668-5; Evelyn T, 1984, ACUIGRUP FISH DIS 4, P111; EVELYN TPT, 1984, J FISH DIS, V7, P173, DOI 10.1111/j.1365-2761.1984.tb00921.x; EWALD PW, 1987, ANN NY ACAD SCI, V503, P295, DOI 10.1111/j.1749-6632.1987.tb40616.x; Ferguson JA, 2007, DIS AQUAT ORGAN, V76, P205, DOI 10.3354/dao076205; FRYER JL, 1981, ANNU REV MICROBIOL, V35, P273, DOI 10.1146/annurev.mi.35.100181.001421; HART NH, 1983, J EXP ZOOL, V227, P277, DOI 10.1002/jez.1402270212; HERRE EA, 1993, SCIENCE, V259, P1442, DOI 10.1126/science.259.5100.1442; Holt R. A., 1993, P3; HUNT RD, 1972, J INFECT DIS, V126, P212, DOI 10.1093/infdis/126.2.212; Kent ML, 2011, DIS AQUAT ORGAN, V95, P73, DOI 10.3354/dao02333; Kent ML, 2003, BIOSECURITY IN AQUACULTURE PRODUCTION SYSTEMS: EXCLUSION OF PATHOGENS AND OTHER UNDESIRABLES, P43; Kent ML, 2003, J FISH DIS, V26, P423, DOI 10.1046/j.1365-2761.2003.00467.x; LaPatra S, 1991, P 2 INT S VIR LOW VE, P261; Matthews JL, 2001, J EUKARYOT MICROBIOL, V48, P227, DOI 10.1111/j.1550-7408.2001.tb00307.x; MAURAND J, 1988, J FISH DIS, V11, P251, DOI 10.1111/j.1365-2761.1988.tb00546.x; Meyers T, 1998, J AQUAT ANIM HEALTH, DOI [10.1577/1548-8667(1998) 0102.0.CO, DOI 10.1577/1548-8667(1998)0102.0.CO]; Meyers T, 1990, J AQUAT ANIM LDOTS, P37; Mulcahy D, 1985, J FISH DIS; Murray KN, 2011, COMPARATIVE MED, V61, P322; NAGELI KW, 1857, BOT Z, V15, P760; Pascho RJ, 1998, J VET DIAGN INVEST, V10, P60, DOI 10.1177/104063879801000111; Pekkarinen M, 2002, DIS AQUAT ORGAN, V48, P133, DOI 10.3354/dao048133; Peterson TS, 2011, DIS AQUAT ORGAN, V95, P175, DOI 10.3354/dao02346; Phelps HA, 2005, ZEBRAFISH, V2, P87, DOI 10.1089/zeb.2005.2.87; Phelps NBD, 2008, J AQUAT ANIM HEALTH, V20, P45, DOI 10.1577/H07-029.1; Phelps NBD, 2007, DIS AQUAT ORGAN, V76, P215, DOI 10.3354/dao076215; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Sanders JL, 2012, ILAR J, V53, P106, DOI 10.1093/ilar.53.2.106; Sanders JL, 2011, DIS AQUAT ORGAN, V96, P145, DOI 10.3354/dao02375; SMITH JE, 1991, PARASITOL TODAY, V7, P146, DOI 10.1016/0169-4758(91)90283-T; Stead S. M., 2002, HDB SALMON FARMING; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; SUMMERFELT R C, 1970, Journal of Wildlife Diseases, V6, P457; Summerfelt RC, 1972, STUDIES TRANSMISSION, P1; SUMMERFELT ROBERT C., 1964, TRANS AMER FISH SOC, V93, P6, DOI 10.1577/1548-8659(1964)93[6:ANMPFT]2.0.CO;2; Terry RS, 2004, P ROY SOC B-BIOL SCI, V271, P1783, DOI 10.1098/rspb.2004.2793; Terry RS, 1999, J EUKARYOT MICROBIOL, V46, P492, DOI 10.1111/j.1550-7408.1999.tb06066.x; Traver D, 2003, ADV IMMUNOL, V81, P253; Traxler GS, 1997, DIS AQUAT ORGAN, V28, P31, DOI 10.3354/dao028031; van der Sar AM, 2004, TRENDS MICROBIOL, V12, P451, DOI 10.1016/j.tim.2004.08.001; Vaney C, 1901, CR HEBD ACAD SCI, V133, P644; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Whipps CM, 2006, J AM ASSOC LAB ANIM, V45, P36; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; Williams BAP, 2011, MYCOTA, V14, P25; Williams CJ, 2005, J AQUAT ANIM HEALTH, V17, P386, DOI 10.1577/H04-066.1; [No title captured]	59	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76064	10.1371/journal.pone.0076064	http://dx.doi.org/10.1371/journal.pone.0076064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086686	Green Submitted, gold, Green Published			2022-12-25	WOS:000326520200129
J	Pinto, VI; Senini, VW; Wang, YQ; Kazembe, MP; McCulloch, CA				Pinto, Vanessa I.; Senini, Vincent W.; Wang, Yongqiang; Kazembe, Mwayi P.; McCulloch, Christopher A.			Filamin A protects cells against force-induced apoptosis by stabilizing talin-and vinculin-containing cell adhesions	FASEB JOURNAL			English	Article						periodontal ligament; mechanoprotection; cell death; anoikis; integrins	PERIODONTAL-LIGAMENT; TOOTH MOVEMENT; INTEGRIN BINDING; ACTIN; PHOSPHORYLATION; STRETCH; FILGAP; DEATH; EXPRESSION; MECHANISM	In mechanically loaded tissues such as weight-bearing joints, myocardium, and periodontal ligament, pathophysiological forces can disrupt cell-matrix contacts, which can induce cell death, leading to tissue and organ dysfunction. Protection against force-induced cell death may be mediated by filamin A (FLNa), an actin-binding protein that regulates 1 integrin-mediated cell adhesion. We examined the affect of filamin expression on collagen distribution and cell death in the periodontal ligament, a force-loaded tissue. Conditional deletion of FLNa in fibroblasts was associated with 2-fold increase of acellular areas in periodontal ligament and 7-fold higher proportions of apoptotic cells. In cultured fibroblasts with FLNa knockdown, we examined the affect of supraphysiological forces (1 pN/m(2) cell area; applied through the 1 integrin) on recruitment of talin and vinculin to focal adhesions and on apoptosis. Compared with the wild type, FLNa-knockdown cells exhibited 3-fold increases in floating cells after overnight force application and a 2-fold increase in cell detachment. Force induced time-dependent reductions (P<0.05) in the numbers of activated 1 integrin-, talin-, and vinculin-stained adhesions in FLNa-knockdown compared with those in wild-type cells. We conclude that FLNa protects against apoptosis in force-loaded cells, and this protection is mediated by enhanced formation and maturation of matrix adhesions.Pinto, V. I., Senini, V. W., Wang, Y., Kazembe, M. P., McCulloch, C. A. Filamin A protects cells against force-induced apoptosis by stabilizing talin and vinculin-containing cell adhesions.	[Pinto, Vanessa I.; Senini, Vincent W.; Wang, Yongqiang; Kazembe, Mwayi P.; McCulloch, Christopher A.] Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON M5S 3E2, Canada	University of Toronto	Pinto, VI (corresponding author), Univ Toronto, Room 244,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	v.pinto@utoronto.ca			Canadian Institute of Health Research [MOP-490422]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	The authors gratefully acknowledge Cheung Lo for his assistance in the mandible dissections and explant cultures. Research was supported by Canadian Institute of Health Research operating grant MOP-490422 to C.A.M.	ATRIZADEH F, 1971, Journal of Periodontal Research, V6, P159, DOI 10.1111/j.1600-0765.1971.tb00604.x; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Chen HS, 2009, BIOPHYS J, V97, P3095, DOI 10.1016/j.bpj.2009.08.059; CHENG W, 1995, J CLIN INVEST, V96, P2247, DOI 10.1172/JCI118280; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Das M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026355; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; GLOGAUER M, 1995, AM J PHYSIOL-CELL PH, V269, pC1093, DOI 10.1152/ajpcell.1995.269.5.C1093; Glogauer M, 1997, J CELL SCI, V110, P11; Goult BT, 2013, J BIOL CHEM, V288, P8238, DOI 10.1074/jbc.M112.438119; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Hao Y, 2009, ARCH ORAL BIOL, V54, P864, DOI 10.1016/j.archoralbio.2009.05.012; Hsieh MH, 2005, INT REV CYTOL, V245, P45, DOI 10.1016/S0074-7696(05)45003-2; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Jeon PD, 1999, AM J ORTHOD DENTOFAC, V115, P267, DOI 10.1016/S0889-5406(99)70328-8; Kainulainen T, 2002, J BIOL CHEM, V277, P21998, DOI 10.1074/jbc.M200715200; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim C., ANN REV CELL DEV BIO, V27, P321; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim H, 2008, EXP CELL RES, V314, P834, DOI 10.1016/j.yexcr.2007.11.022; Kim H, 2010, EXP CELL RES, V316, P1829, DOI 10.1016/j.yexcr.2010.02.007; Kurol J, 1998, ANGLE ORTHOD, V68, P161; Lee HS, 2013, MOL BIOL CELL, V24, P1354, DOI 10.1091/mbc.E12-09-0695; Lee SE, 2008, BIOPHYS J, V95, P2027, DOI 10.1529/biophysj.107.124487; LINDSKOG S, 1985, Endodontics and Dental Traumatology, V1, P96; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Mak BC, 2008, J BIOL CHEM, V283, P23462, DOI 10.1074/jbc.M803194200; MCCULLOCH CAG, 1989, CELL TISSUE RES, V255, P129; MCCULLOCH CAG, 1983, J PERIODONTAL RES, V18, P339, DOI 10.1111/j.1600-0765.1983.tb00369.x; MCCULLOCH CAG, 1983, AM J ANAT, V167, P43, DOI 10.1002/aja.1001670105; McCulloch CAG, 2000, PERIODONTOL 2000, V24, P56, DOI 10.1034/j.1600-0757.2000.2240104.x; Mohammad I, 2012, FASEB J, V26, P3260, DOI 10.1096/fj.11-202051; Naveh GRS, 2013, J STRUCT BIOL, V181, P108, DOI 10.1016/j.jsb.2012.10.008; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pentikainen U, 2009, J MOL BIOL, V393, P644, DOI 10.1016/j.jmb.2009.08.035; Rajshankar D, 2012, FASEB J, V26, P4429, DOI 10.1096/fj.12-207381; REITAN K, 1967, AMER J ORTHODONTICS, V53, P721, DOI 10.1016/0002-9416(67)90118-2; Ritter N, 2007, CELL TISSUE RES, V328, P537, DOI 10.1007/s00441-007-0382-x; Rygh P, 1974, Nor Tannlaegeforen Tid, V84, P352; Shifrin Y, 2012, BIOCHEM J, V445, P57, DOI 10.1042/BJ20112119; Shifrin Y, 2009, MOL BIOL CELL, V20, P1269, DOI 10.1091/mbc.E08-08-0872; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Shyu KG, 2009, CLIN SCI, V116, P377, DOI 10.1042/CS20080163; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Trombetta JM, 2010, J HISTOCHEM CYTOCHEM, V58, P871, DOI 10.1369/jhc.2010.956144; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Verborgt O, 2002, J BONE MINER RES, V17, P907, DOI 10.1359/jbmr.2002.17.5.907; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Von Bohl M, 2004, ANGLE ORTHOD, V74, P16; Wang Q, 2006, J BIOL CHEM, V281, P31093, DOI 10.1074/jbc.M606392200; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Zhong W, 2008, ORAL DIS, V14, P270, DOI 10.1111/j.1601-0825.2007.01375.x	59	26	26	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					453	463		10.1096/fj.13-233759	http://dx.doi.org/10.1096/fj.13-233759			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24097310	Green Submitted			2022-12-25	WOS:000333526100042
J	Kazantseva, J; Kivil, A; Tints, K; Kazantseva, A; Neuman, T; Palm, K				Kazantseva, Jekaterina; Kivil, Anri; Tints, Kairit; Kazantseva, Anna; Neuman, Toomas; Palm, Kaia			Alternative Splicing Targeting the hTAF4-TAFH Domain of TAF4 Represses Proliferation and Accelerates Chondrogenic Differentiation of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							TATA-BINDING PROTEIN; TRANSCRIPTIONAL ACTIVATION; TFIID COMPLEX; PROMOTES OSTEOGENESIS; P53 PLAYS; COACTIVATOR; SUBUNIT; IDENTIFICATION; PROGRESSION; REGULATORS	Transcription factor IID (TFIID) activity can be regulated by cellular signals to specifically alter transcription of particular subsets of genes. Alternative splicing of TFIID subunits is often the result of external stimulation of upstream signaling pathways. We studied tissue distribution and cellular expression of different splice variants of TFIID subunit TAF4 mRNA and biochemical properties of its isoforms in human mesenchymal stem cells (hMSCs) to reveal the role of different isoforms of TAF4 in the regulation of proliferation and differentiation. Expression of TAF4 transcripts with exons VI or VII deleted, which results in a structurally modified hTAF4-TAFH domain, increases during early differentiation of hMSCs into osteoblasts, adipocytes and chondrocytes. Functional analysis data reveals that TAF4 isoforms with the deleted hTAF4-TAFH domain repress proliferation of hMSCs and preferentially promote chondrogenic differentiation at the expense of other developmental pathways. This study also provides initial data showing possible cross-talks between TAF4 and TP53 activity and switching between canonical and non-canonical WNT signaling in the processes of proliferation and differentiation of hMSCs. We propose that TAF4 isoforms generated by the alternative splicing participate in the conversion of the cellular transcriptional programs from the maintenance of stem cell state to differentiation, particularly differentiation along the chondrogenic pathway.	[Kazantseva, Jekaterina; Kivil, Anri; Tints, Kairit; Kazantseva, Anna; Neuman, Toomas; Palm, Kaia] Protobios LLC, Tallinn, Estonia; [Kivil, Anri; Kazantseva, Anna; Palm, Kaia] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia	Protobios LLC; Tallinn University of Technology	Palm, K (corresponding author), Protobios LLC, Tallinn, Estonia.	kaia@protobios.com	Kazantseva, Jekaterina/M-1037-2016; Kazantseva, Jekaterina/AAA-2882-2021; Palm, Kaia/AGF-0479-2022	Kazantseva, Jekaterina/0000-0001-6108-5499; 	Enterprise of Estonia; Estonian Ministry of Education and Research	Enterprise of Estonia; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This study was supported by Protobios's grants from the Enterprise of Estonia and baseline financing from Estonian Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Aoyagi N, 2000, J CELL BIOL, V150, pF45, DOI 10.1083/jcb.150.2.F45; Armesilla-Diaz A, 2009, EXP CELL RES, V315, P3598, DOI 10.1016/j.yexcr.2009.08.004; Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bereczki O, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-57; Bieniossek C., 2013, NATURE; Boyer-Guittaut M, 2005, J BIOL CHEM, V280, P9937, DOI 10.1074/jbc.M414149200; Bradley EW, 2010, MOL ENDOCRINOL, V24, P1581, DOI 10.1210/me.2010-0037; Brunkhorst A, 2004, BIOCHEM BIOPH RES CO, V325, P574, DOI 10.1016/j.bbrc.2004.10.078; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Buschmann T, 2001, J BIOL CHEM, V276, P13852, DOI 10.1074/jbc.M007955200; CHANG J, 1995, J BIOL CHEM, V270, P25014, DOI 10.1074/jbc.270.42.25014; Cheng HC, 2011, MOL BIOL REP, V38, P5161, DOI 10.1007/s11033-010-0665-2; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; D'Alessio JA, 2011, P NATL ACAD SCI USA, V108, P3906, DOI 10.1073/pnas.1100640108; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; Deato MDE, 2008, COLD SH Q B, V73, P217, DOI 10.1101/sqb.2008.73.028; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eizenberg O, 1996, MOL CELL BIOL, V16, P5178; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; Freiman RN, 2009, BBA-GENE REGUL MECH, V1789, P161, DOI 10.1016/j.bbagrm.2009.01.005; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Gary RK, 2005, ANAL BIOCHEM, V343, P329, DOI 10.1016/j.ab.2005.06.003; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gegonne A, 2012, MOL CELL BIOL, V32, P1984, DOI 10.1128/MCB.06305-11; Geles KG, 2006, P NATL ACAD SCI USA, V103, P2594, DOI 10.1073/pnas.0510764103; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Guermah M, 2003, MOL CELL, V12, P991, DOI 10.1016/S1097-2765(03)00396-4; Guven-Ozkan T, 2008, CELL, V135, P149, DOI 10.1016/j.cell.2008.07.040; Im GI, 2010, TISSUE ENG PT A, V16, P2405, DOI 10.1089/ten.TEA.2009.0359; Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Kauts ML, 2013, STEM CELL RES, V10, P166, DOI 10.1016/j.scr.2012.11.004; Kazantseva A, 2009, J NEUROCHEM, V109, P807, DOI 10.1111/j.1471-4159.2009.06005.x; Kim NH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001744; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; Li HH, 2004, MOL CELL, V13, P867, DOI 10.1016/S1097-2765(04)00123-6; Lin TM, 2007, BIOCHEM BIOPH RES CO, V361, P883, DOI 10.1016/j.bbrc.2007.07.116; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Ma G, 2012, J MOL CELL BIOL, V4, P118, DOI 10.1093/jmcb/mjs006; Marr MT, 2006, GENE DEV, V20, P1458, DOI 10.1101/gad.1418806; Marr MT, 2009, P NATL ACAD SCI USA, V106, P1295, DOI 10.1073/pnas.0812990106; Maston GA, 2012, ELIFE, V1, DOI 10.7554/eLife.00068; Metzger D, 1999, EMBO J, V18, P4823, DOI 10.1093/emboj/18.17.4823; Molchadsky A, 2010, CARCINOGENESIS, V31, P1501, DOI 10.1093/carcin/bgq101; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Ohler U, 2010, DEVELOPMENT, V137, P15, DOI 10.1242/dev.035493; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Perletti L, 2001, BMC Mol Biol, V2, P4, DOI 10.1186/1471-2199-2-4; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Pointud JC, 2003, J CELL SCI, V116, P1847, DOI 10.1242/jcs.00391; Sadra A, 2000, ANAL BIOCHEM, V278, P235, DOI 10.1006/abio.1999.4453; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Stuyver LJ, 2003, ANTIMICROB AGENTS CH, V47, P244, DOI 10.1128/AAC.47.1.244-254.2003; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; Tatarakis A, 2008, MOL CELL, V31, P531, DOI 10.1016/j.molcel.2008.07.013; Tataria M, 2006, J PEDIATR SURG, V41, P624, DOI 10.1016/j.jpedsurg.2005.12.001; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Voronina E, 2007, DEV BIOL, V303, P715, DOI 10.1016/j.ydbio.2006.12.011; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Wei YF, 2007, NAT STRUCT MOL BIOL, V14, P653, DOI 10.1038/nsmb1258; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wright KJ, 2009, P NATL ACAD SCI USA, V106, P55, DOI 10.1073/pnas.0811914106	72	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74799	10.1371/journal.pone.0074799	http://dx.doi.org/10.1371/journal.pone.0074799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098348	Green Submitted, gold, Green Published			2022-12-25	WOS:000325434500014
J	Umhau, JC; Zhou, WY; Thada, S; Demar, J; Hussein, N; Bhattacharjee, AK; Ma, KZ; Majchrzak-Hong, S; Herscovitch, P; Salem, N; Urish, A; Hibbeln, JR; Cunnane, SC; Rapoport, SI; Hirvonen, J				Umhau, John C.; Zhou, Weiyin; Thada, Shantalaxmi; Demar, James; Hussein, Nahed; Bhattacharjee, Abesh K.; Ma, Kaizong; Majchrzak-Hong, Sharon; Herscovitch, Peter; Salem, Norman, Jr.; Urish, Abigail; Hibbeln, Joseph R.; Cunnane, Stephen C.; Rapoport, Stanley I.; Hirvonen, Jussi			Brain Docosahexaenoic Acid [DHA] Incorporation and Blood Flow Are Increased in Chronic Alcoholics: A Positron Emission Tomography Study Corrected for Cerebral Atrophy	PLOS ONE			English	Article							ALPHA-LINOLENIC ACID; FATTY-ACIDS; DOCOSAPENTAENOIC ACID; METABOLISM; CONSUMPTION; TURNOVER; DEPRIVATION; PLASMA; RATS; NEUROINFLAMMATION	Objective: Chronic alcohol dependence has been associated with disturbed behavior, cerebral atrophy and a low plasma concentration of docosahexaenoic acid (DHA, 22:6n-3), particularly if liver disease is present. In animal models, excessive alcohol consumption is reported to reduce brain DHA concentration, suggesting disturbed brain DHA metabolism. We hypothesized that brain DHA metabolism also is abnormal in chronic alcoholics. Methods: We compared 15 non-smoking chronic alcoholics, studied within 7 days of their last drink, with 22 non-smoking healthy controls. Using published neuroimaging methods with positron emission tomography (PET), we measured regional coefficients (K*) and rates (J(in)) of DHA incorporation from plasma into the brain of each group using [1-C-11]DHA, and regional cerebral blood flow (rCBF) using [O-15]water. Data were partial volume error corrected for brain atrophy. Plasma unesterified DHA concentration also was quantified. Results: Mean K* for DHA was significantly and widely elevated by 10-20%, and rCBF was elevated by 7%-34%, in alcoholics compared with controls. Unesterified plasma DHA did not differ significantly between groups nor did whole brain J(in), the product of K* and unesterified plasma DHA concentration. Discussion: Significantly higher values of K* for DHA in alcoholics indicate increased brain avidity for DHA, thus a brain DHA metabolic deficit vis-a-vis plasma DHA availability. Higher rCBF in alcoholics suggests increased energy consumption. These changes may reflect a hypermetabolic state related to early alcohol withdrawal, or a general brain metabolic change in chronic alcoholics.	[Umhau, John C.; Zhou, Weiyin; Urish, Abigail] NIAAA, Lab Clin & Translat Studies, NIH, Bethesda, MD USA; [Thada, Shantalaxmi; Herscovitch, Peter] NIH, PET Dept, Bethesda, MD 20892 USA; [Demar, James; Bhattacharjee, Abesh K.; Ma, Kaizong; Rapoport, Stanley I.] NIA, Brain Physiol & Metab Sect, Neurosci Lab, NIH, Bethesda, MD 20892 USA; [Demar, James; Hussein, Nahed; Majchrzak-Hong, Sharon; Salem, Norman, Jr.; Hibbeln, Joseph R.] NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD USA; [Cunnane, Stephen C.] Univ Sherbrooke, Dept Med, Sherbrook, PQ, Canada; [Hirvonen, Jussi] Univ Turku, Dept Radiol, Turku, Finland; [Hirvonen, Jussi] Univ Turku, Turku PET Ctr, Turku, Finland	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Sherbrooke; University of Turku; University of Turku	Umhau, JC (corresponding author), NIAAA, Lab Clin & Translat Studies, NIH, Bethesda, MD USA.	Umhau@nih.gov	Majchrzak, Sharon/F-1830-2013; Hussein, Nahed/AAL-1240-2020; Hirvonen, Jussi/H-2521-2012; Hirvonen, Jussi/AAC-1864-2020	Majchrzak, Sharon/0000-0001-8934-7294; Hussein, Nahed/0000-0001-5113-105X	National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIA; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000115, ZIAAA000262] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Intramural Research Programs of the National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA), and NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN JJ, 1992, J LIPID RES, V33, P1871; ALLING C, 1984, SCAND J CLIN LAB INV, V44, P283, DOI 10.3109/00365518409083809; AVELDANO MI, 1983, J LIPID RES, V24, P83; Basselin M, 2011, J CEREBR BLOOD F MET, V31, P486, DOI 10.1038/jcbfm.2010.111; Basselin M, 2010, J LIPID RES, V51, P3166, DOI 10.1194/jlr.M008334; Bazan NG, 2013, PROSTAG LEUKOTR ESS, V88, P127, DOI 10.1016/j.plefa.2012.08.008; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOURRE JM, 1989, J NUTR, V119, P1880, DOI 10.1093/jn/119.12.1880; Brown J, 2009, NEUROCHEM RES, V34, P260, DOI 10.1007/s11064-008-9765-y; Buydens-Branchey L, 2009, AM J ADDICTION, V18, P73, DOI 10.1080/10550490802544003; Chang MCJ, 1997, BRAIN RES, V755, P74, DOI 10.1016/S0006-8993(97)00088-7; Chen CH, 2012, ALCOHOL CLIN EXP RES, V36, P625, DOI 10.1111/j.1530-0277.2011.01662.x; Christie IC, 2008, ALCOHOL, V42, P269, DOI 10.1016/j.alcohol.2008.03.132; Contreras MA, 2000, J NEUROCHEM, V75, P2392, DOI 10.1046/j.1471-4159.2000.0752392.x; DEGEORGE JJ, 1991, J NEUROCHEM, V56, P352, DOI 10.1111/j.1471-4159.1991.tb02603.x; DeMar JC, 2005, J NEUROCHEM, V94, P1063, DOI 10.1111/j.1471-4159.2005.03258.x; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DEVONSHIRE RE, 1976, PFLUG ARCH EUR J PHY, V364, P161, DOI 10.1007/BF00585185; ECKARDT MJ, 1978, BIOL PSYCHIAT, V13, P551; Eintrei C, 1999, BRIT J ANAESTH, V82, P596, DOI 10.1093/bja/82.4.596; Gazdzinski S, 2010, ALCOHOL CLIN EXP RES, V34, P2089, DOI 10.1111/j.1530-0277.2010.01305.x; Giovacchini G, 2004, J NUCL MED, V45, P1471; Giovacchini G, 2002, J CEREBR BLOOD F MET, V22, P1453, DOI 10.1097/01.WCB.0000033209.60867.7A; HERSCOVITCH P, 1983, J NUCL MED, V24, P782; Ibanez V, 1998, NEUROLOGY, V50, P1585, DOI 10.1212/WNL.50.6.1585; Igarashi M, 2007, J LIPID RES, V48, P152, DOI 10.1194/jlr.M600396-JLR200; Igarashi M, 2012, BBA-MOL CELL BIOL L, V1821, P1235, DOI 10.1016/j.bbalip.2011.11.002; Igarashi M, 2012, J NEUROCHEM, V120, P985, DOI 10.1111/j.1471-4159.2011.07597.x; Ilbanez V, 2004, BRAIN RES BULL, V63, P147, DOI 10.1016/j.brainresbull.2004.02.003; Lands W., 1976, ENZYMES BIOL MEMBRAN, V2, P3; Manzo-Avalos S, 2010, INT J ENV RES PUB HE, V7, P4281, DOI 10.3390/ijerph7124281; MELGAARD B, 1990, ACTA NEUROL SCAND, V82, P87; NICOLAS JM, 1993, J NUCL MED, V34, P1452; Pawlosky RJ, 2004, ALCOHOL, V34, P27, DOI 10.1016/j.alcohol.2004.07.009; Pawlosky RJ, 2001, ALCOHOL CLIN EXP RES, V25, P1758, DOI 10.1097/00000374-200112000-00011; PAWLOSKY RJ, 1995, AM J CLIN NUTR, V61, P1284, DOI 10.1093/ajcn/61.6.1284; Pires PW, 2013, AM J PHYSIOL-HEART C, V304, pH1598, DOI 10.1152/ajpheart.00490.2012; Pita ML, 1997, THROMB HAEMOSTASIS, V78, P808; Purdon A.D., 2007, HDB NEUROCHEMISTRY M, P401; Purdon AD, 1998, BIOCHEM J, V335, P313, DOI 10.1042/bj3350313; Rapoport SI, 2001, J LIPID RES, V42, P678; Rapoport Stanley I., 1995, P1401; Reivich M, 1974, Res Publ Assoc Res Nerv Ment Dis, V53, P125; ROBINSON PJ, 1986, AM J PHYSIOL, V251, pR1212, DOI 10.1152/ajpregu.1986.251.6.R1212; ROBINSON PJ, 1992, BRAIN RES REV, V17, P187, DOI 10.1016/0165-0173(92)90016-F; ROGERS RL, 1983, J AM GERIATR SOC, V31, P540, DOI 10.1111/j.1532-5415.1983.tb02198.x; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rousset OG, 1998, J NUCL MED, V39, P904; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; SALEM N, 1993, ALCOHOL, CELL MEMBRANES, AND SIGNAL TRANSDUCTION IN BRAIN, P33; Siennicki-Lantz A, 2002, AGING CLIN EXP RES, V14, P108; Smith QR, 2001, J MOL NEUROSCI, V16, P167, DOI 10.1385/JMN:16:2-3:167; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; Suzuki Y, 2002, ALCOHOL CLIN EXP RES, V26, p95S, DOI 10.1097/01.ALC.0000026984.37262.82; Tan EK, 2010, ANN NEUROL, V67, P148, DOI 10.1002/ana.21663; Umhau JC, 2009, J LIPID RES, V50, P1259, DOI 10.1194/jlr.M800530-JLR200; VICTOR M, 1973, ANN NY ACAD SCI, V215, P210, DOI 10.1111/j.1749-6632.1973.tb28273.x; VOLKOW ND, 1992, AM J PSYCHIAT, V149, P1016; WAKU K, 1992, BIOCHIM BIOPHYS ACTA, V1124, P101, DOI 10.1016/0005-2760(92)90085-A; Wong DF, 2003, ALCOHOL RES HEALTH, V27, P161; Zheng JS, 2012, LIPIDS, V47, P549, DOI 10.1007/s11745-012-3671-4; Zubieta JK, 2005, AM J PSYCHIAT, V162, P567, DOI 10.1176/appi.ajp.162.3.567	63	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75333	10.1371/journal.pone.0075333	http://dx.doi.org/10.1371/journal.pone.0075333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098376	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500026
J	Dornbusch, J; Zacharis, A; Meinhardt, M; Erdmann, K; Wolff, I; Froehner, M; Wirth, MP; Zastrow, S; Fuessel, S				Dornbusch, Juana; Zacharis, Aristeidis; Meinhardt, Matthias; Erdmann, Kati; Wolff, Ingmar; Froehner, Michael; Wirth, Manfred P.; Zastrow, Stefan; Fuessel, Susanne			Analyses of Potential Predictive Markers and Survival Data for a Response to Sunitinib in Patients with Metastatic Renal Cell Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTORS; CARBONIC-ANHYDRASE-IX; VHL GENE MUTATION; CLEAR-CELL; PATHOLOGICAL FEATURES; TUMOR AGGRESSIVENESS; ANTITUMOR-ACTIVITY; PROGNOSTIC-FACTORS; VEGF EXPRESSION	Background: Patients with metastatic clear cell renal cell carcinoma (ccRCC) are frequently treated with tyrosine kinase inhibitors (TKI) such as sunitinib. It inhibits angiogenic pathways by mainly targeting the receptors of VEGF and PDGF. In ccRCC, angiogenesis is characterized by the inactivation of the von Hippel-Lindau gene (VHL) which in turn leads to the induction of HIF1 alpha target genes such as CA9 and VEGF. Furthermore, the angiogenic phenotype of ccRCC is also reflected by endothelial markers (CD31, CD34) or other tumor-promoting factors like Ki67 or survivin. Methods: Tissue microarrays from primary tumor specimens of 42 patients with metastatic ccRCC under sunitinib therapy were immunohistochemically stained for selected markers related to angiogenesis. The prognostic and predictive potential of theses markers was assessed on the basis of the objective response rate which was evaluated according to the RECIST criteria after 3, 6, 9 months and after last report (12-54 months) of sunitinib treatment. Additionally, VHL copy number and mutation analyses were performed on DNA from cryo-preserved tumor tissues of 20 ccRCC patients. Results: Immunostaining of HIF-1 alpha, CA9, Ki67, CD31, pVEGFR1, VEGFR1 and -2, pPDGFR alpha and -beta was significantly associated with the sunitinib response after 6 and 9 months as well as last report under therapy. Furthermore, HIF-1 alpha, CA9, CD34, VEGFR1 and -3 and PDGRF alpha showed significant associations with progression-free survival (PFS) and overall survival (OS). In multivariate Cox proportional hazards regression analyses high CA9 membrane staining and a response after 9 months were independent prognostic factors for longer OS. Frequently observed copy number loss and mutation of VHL gene lead to altered expression of VHL, HIF-1 alpha, CA9, and VEGF. Conclusions: Immunoexpression of HIF-1 alpha, CA9, Ki67, CD31, pVEGFR1, VEGFR1 and -2, pPDGFR alpha and -beta in the primary tumors of metastatic ccRCC patients might support the prediction of a good response to sunitinib treatment.	[Dornbusch, Juana; Zacharis, Aristeidis; Erdmann, Kati; Wolff, Ingmar; Froehner, Michael; Wirth, Manfred P.; Zastrow, Stefan; Fuessel, Susanne] Tech Univ Dresden, Dept Urol, Dresden, Germany; [Meinhardt, Matthias] Tech Univ Dresden, Inst Pathol, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Dornbusch, J (corresponding author), Tech Univ Dresden, Dept Urol, Dresden, Germany.	juana.dornbusch@uniklinikum-dresden.de	Zastrow, Stefan/ABF-3692-2021; Wolff, Ingmar/C-6059-2014; Wolff, Ingmar/ABG-7840-2021; Wolff, Ingmar/Y-4974-2019	Wolff, Ingmar/0000-0003-4197-6643	Juergen Manchot Foundation	Juergen Manchot Foundation	This work was supported by the Juergen Manchot Foundation. http://www.manchot.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz SA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-15; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Biswas S, 2012, CARCINOGENESIS, V33, P1717, DOI 10.1093/carcin/bgs222; Bleumer I, 2003, EUR UROL, V44, P65, DOI 10.1016/S0302-2838(03)00191-X; Bono P, 2011, ACTA ONCOL, V50, P569, DOI 10.3109/0284186X.2010.543696; Buchner A, 2006, CANCER, V106, P1514, DOI 10.1002/cncr.21775; Bui MHT, 2004, J UROLOGY, V171, P2461, DOI 10.1097/01.ju.0000116444.08690.e2; Bui MHT, 2003, CLIN CANCER RES, V9, P802; Byun SS, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.09.024; CHOUEIRI TK, 2008, J CLIN ONCOL, V26; Choueiri TK, 2008, J UROLOGY, V180, P860, DOI 10.1016/j.juro.2008.05.015; Choueiri TK, 2010, BJU INT, V105, P1247, DOI 10.1111/j.1464-410X.2009.08972.x; Escudier B, 2012, ANN ONCOL, V23, P309, DOI 10.1093/annonc/mds352; Escudier BJ, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.e15118; Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x; Fujita T, 2012, INT J UROL, V19, P908, DOI 10.1111/j.1442-2042.2012.03071.x; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Geretti E, 2007, CELL ADHES MIGR, V1, DOI 10.4161/cam.1.2.4490; Grunwald V, 2012, ONCOTARGETS THER, V5, P111, DOI 10.2147/OTT.S23273; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Kim JJ, 2012, CANCER-AM CANCER SOC, V118, P1946, DOI 10.1002/cncr.26491; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Laird A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060483; Lei Y, 2010, MOL CELL BIOCHEM, V344, P23, DOI 10.1007/s11010-010-0525-3; Li XS, 2011, CHINESE MED J-PEKING, V124, P2920, DOI 10.3760/cma.j.issn.0366-6999.2011.18.023; Liang YX, 2009, CANCER INVEST, V27, P788, DOI 10.1080/07357900802709167; Malaguarnera M, 2001, EUR J CLIN PHARMACOL, V57, P267, DOI 10.1007/s002280100321; Matsuda D, 2008, CANCER LETT, V272, P260, DOI 10.1016/j.canlet.2008.06.015; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mendel DB, 2003, CLIN CANCER RES, V9, P327; MICHAELSON MD, 2011, J CLIN ONCOL, V29; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Lopez CM, 2012, INVEST NEW DRUG, V30, P2443, DOI 10.1007/s10637-012-9836-4; Nyhan MJ, 2011, CELL ONCOL, V34, P225, DOI 10.1007/s13402-011-0029-5; Patard JJ, 2009, BRIT J CANCER, V101, P1417, DOI 10.1038/sj.bjc.6605298; Patard JJ, 2008, INT J CANCER, V123, P395, DOI 10.1002/ijc.23496; Patel PH, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.5008; Paule B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010715; Penzvalto Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059503; Rini BI, 2008, J CLIN ONCOL, V26, P3743, DOI 10.1200/JCO.2007.15.5416; Rini BI, 2006, BJU INT, V98, P756, DOI 10.1111/j.1464-410X.2006.06376.x; Rini BI, 2011, JNCI-J NATL CANCER I, V103, P763, DOI 10.1093/jnci/djr128; Rini BI, 2010, CLIN CANCER RES, V16, P1348, DOI 10.1158/1078-0432.CCR-09-2273; Sakai I, 2013, BJU INT, V112, pE211, DOI 10.1111/j.1464-410X.2012.11655.x; Sandlund J, 2007, TUMOR BIOL, V28, P158, DOI 10.1159/000102980; Sauter G, 2003, NAT REV DRUG DISCOV, V2, P962, DOI 10.1038/nrd1254; Schraml P, 2003, AM J PATHOL, V163, P1013, DOI 10.1016/S0002-9440(10)63461-X; Schultz L, 2011, AM J SURG PATHOL, V35, P1549, DOI 10.1097/PAS.0b013e31822895e5; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Sun M, 2011, EUR UROL, V60, P644, DOI 10.1016/j.eururo.2011.06.041; Tawfik OW, 2007, ARCH PATHOL LAB MED, V131, P261; Terakawa T, 2013, UROL ONCOL-SEMIN ORI, V31, P493, DOI 10.1016/j.urolonc.2011.02.012; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Turner KJ, 2002, CANCER RES, V62, P2957; van der Veldt AAM, 2011, CLIN CANCER RES, V17, P620, DOI 10.1158/1078-0432.CCR-10-1828; Wang P, 2012, MOL CARCINOGEN, V51, P586, DOI 10.1002/mc.20829; Yao M, 2002, JNCI-J NATL CANCER I, V94, P1569; Yilmazer D, 2007, INT UROL NEPHROL, V39, P691, DOI 10.1007/s11255-006-9123-4; Young AC, 2009, CLIN CANCER RES, V15, P7582, DOI 10.1158/1078-0432.CCR-09-2131; Yuasa T, 2012, BJU INT, V109, P1349, DOI 10.1111/j.1464-410X.2011.10534.x; Zurita AJ, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mdr047	64	44	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76386	10.1371/journal.pone.0076386	http://dx.doi.org/10.1371/journal.pone.0076386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086736	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900100
J	Kessler, SK; Minhas, P; Woods, AJ; Rosen, A; Gorman, C; Bikson, M				Kessler, Sudha Kilaru; Minhas, Preet; Woods, Adam J.; Rosen, Alyssa; Gorman, Casey; Bikson, Marom			Dosage Considerations for Transcranial Direct Current Stimulation in Children: A Computational Modeling Study	PLOS ONE			English	Article							MOTOR CORTEX; EXCITABILITY; THICKNESS; SKULL; FEM	Transcranial direct current stimulation (tDCS) is being widely investigated in adults as a therapeutic modality for brain disorders involving abnormal cortical excitability or disordered network activity. Interest is also growing in studying tDCS in children. Limited empirical studies in children suggest that tDCS is well tolerated and may have a similar safety profile as in adults. However, in electrotherapy as in pharmacotherapy, dose selection in children requires special attention, and simple extrapolation from adult studies may be inadequate. Critical aspects of dose adjustment include 1) differences in neurophysiology and disease, and 2) variation in brain electric fields for a specified dose due to gross anatomical differences between children and adults. In this study, we used high-resolution MRI derived finite element modeling simulations of two healthy children, ages 8 years and 12 years, and three healthy adults with varying head size to compare differences in electric field intensity and distribution. Multiple conventional and high-definition tDCS montages were tested. Our results suggest that on average, children will be exposed to higher peak electrical fields for a given applied current intensity than adults, but there is likely to be overlap between adults with smaller head size and children. In addition, exposure is montage specific. Variations in peak electrical fields were seen between the two pediatric models, despite comparable head size, suggesting that the relationship between neuroanatomic factors and bioavailable current dose is not trivial. In conclusion, caution is advised in using higher tDCS doses in children until 1) further modeling studies in a larger group shed light on the range of exposure possible by applied dose and age and 2) further studies correlate bioavailable dose estimates from modeling studies with empirically tested physiologic effects, such as modulation of motor evoked potentials after stimulation.	[Kessler, Sudha Kilaru; Woods, Adam J.; Rosen, Alyssa; Gorman, Casey] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kessler, Sudha Kilaru; Woods, Adam J.; Rosen, Alyssa; Gorman, Casey] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Minhas, Preet] CUNY City Coll, New York, NY 10031 USA; [Woods, Adam J.; Bikson, Marom] Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; City University of New York (CUNY) System; City College of New York (CUNY); University of Pennsylvania; Pennsylvania Medicine	Kessler, SK (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	kesslers@email.chop.edu	Kessler, Sudha Kilaru/AAG-1637-2020	Woods, Adam/0000-0002-0786-0236; Kessler, Sudha/0000-0002-9325-9972	Clayton's Hope Foundation; National Institutes of Health, National Institute of Neurological Disorders and Stroke [K12NS049453]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS049453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	Clayton's Hope Foundation; National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Clayton's Hope Foundation and National Institutes of Health, National Institute of Neurological Disorders and Stroke K12NS049453 (SK Kessler). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELOYE A, 1975, AM J PHYS ANTHROPOL, V43, P23, DOI 10.1002/ajpa.1330430105; Antal A, 2011, CEPHALALGIA, V31, P820, DOI 10.1177/0333102411399349; Auvichayapat N, 2013, BRAIN STIMUL, V6, P696, DOI 10.1016/j.brs.2013.01.009; Ball WS, 2012, CEREB CORTEX, V22, P1, DOI 10.1093/cercor/bhr018; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Beauchamp MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024981; Bikson M, 2012, CLIN EEG NEUROSCI, V43, P176, DOI 10.1177/1550059412445138; Bikson M, 2012, BRAIN STIMUL, V5, P430, DOI 10.1016/j.brs.2011.06.001; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Cella M, 2010, BRIT J CLIN PHARMACO, V70, P597, DOI 10.1111/j.1365-2125.2009.03591.x; Datta A, 2008, J NEURAL ENG, V5, P163, DOI 10.1088/1741-2560/5/2/007; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; Datta A, 2010, NEUROIMAGE, V52, P1268, DOI 10.1016/j.neuroimage.2010.04.252; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Dell'Osso B, 2012, EUR PSYCHIAT, V27, P513, DOI 10.1016/j.eurpsy.2011.02.008; Dmochowski JP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046011; Faria P, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066017; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Kabakov AY, 2012, J NEUROPHYSIOL, V107, P1881, DOI 10.1152/jn.00715.2011; Kamida T, 2011, BEHAV BRAIN RES, V217, P99, DOI 10.1016/j.bbr.2010.08.050; Kessler SK, 2012, BRAIN STIMUL, V5, P155, DOI 10.1016/j.brs.2011.02.007; Lynnerup N, 2001, FORENSIC SCI INT, V117, P45, DOI 10.1016/S0379-0738(00)00447-3; Mattai A, 2011, BRAIN STIMUL, V4, P275, DOI 10.1016/j.brs.2011.01.001; NELLHAUS G, 1968, PEDIATRICS, V41, P106; Neuling Toralf, 2012, Front Psychiatry, V3, P83; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Peterchev AV, 2012, BRAIN STIMUL, V5, P435, DOI 10.1016/j.brs.2011.10.001; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Sadleir RJ, 2010, NEUROIMAGE, V51, P1310, DOI 10.1016/j.neuroimage.2010.03.052; Tadini L, 2011, J ECT, V27, P134, DOI 10.1097/YCT.0b013e3181e631a8; Truong DQ, 2012, IEEE ENG MED BIO, P6587, DOI 10.1109/EMBC.2012.6347504; Varga ET, 2011, EPILEPSY RES, V97, P142, DOI 10.1016/j.eplepsyres.2011.07.016; Yook SW, 2011, ANN REHABIL MED-ARM, V35, P579, DOI 10.5535/arm.2011.35.4.579; YOUNG SJ, 2012, J CHILD NEUROL; Zaghi Soroush, 2009, J Pain Manag, V2, P339	39	124	126	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76112	10.1371/journal.pone.0076112	http://dx.doi.org/10.1371/journal.pone.0076112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086698	Green Published, gold			2022-12-25	WOS:000325223900082
J	Ferreyra, C; Vargas, F; Rodriguez-Gomez, I; Perez-Abud, R; O'Valle, F; Osuna, A				Ferreyra, Carla; Vargas, Felix; Rodriguez-Gomez, Isabel; Perez-Abud, Rocio; O'Valle, Francisco; Osuna, Antonio			Preconditioning with Triiodothyronine Improves the Clinical Signs and Acute Tubular Necrosis Induced by Ischemia/Reperfusion in Rats	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ISCHEMIA-REPERFUSION INJURY; B-ALPHA PHOSPHORYLATION; THYROID-HORMONE; POLY(ADP-RIBOSE) POLYMERASE; THYROXINE TREATMENT; OXIDATIVE STRESS; GENE-EXPRESSION; KIDNEY; LIVER	Background: Renal ischemia/reperfusion (I/R) injury is manifested by acute renal failure (ARF) and acute tubular necrosis (ATN). The aim of this study was to evaluate the effectiveness of preconditioning with 3, 3, 5 triiodothyronine (T-3) to prevent I/R renal injury. Methodology/Principal Findings: The rats were divided into four groups: sham-operated, placebo-treated (SO-P), sham-operated T-3-treated (SO-T-3), I/R-injured placebo-treated (IR-P), and I/R-injured T-3-treated (IR-T-3) groups. At 24 h before ischemia, the animals received a single dose of T-3 (100 mu g/kg). Renal function and plasma, urinary, and tissue variables were studied at 4, 24, and 48 h of reperfusion, including biochemical, oxidative stress, and inflammation variables, PARP-1 immunohistochemical expression, and ATN morphology. In comparison to the SO groups, the IR-P groups had higher plasma urea and creatinine levels and greater proteinuria (at all reperfusion times) and also showed: increased oxidative stress-related plasma, urinary, and tissue variables; higher plasma levels of IL6 (proinflammatory cytokine); increased glomerular and tubular nuclear PARP-1 expression; and a greater degree of ATN. The IR-T-3 group showed a marked reduction in all of these variables, especially at 48 h of reperfusion. No significant differences were observed between SO-P and SO-T-3 groups. Conclusions: This study demonstrates that preconditioning rats with a single dose of T-3 improves the clinical signs and ATN of renal I/R injury. These beneficial effects are accompanied by reductions in oxidative stress, inflammation, and renal PARP-1 expression, indicating that this sequence of factors plays an important role in the ATN induced by I/R injury.	[Ferreyra, Carla; Perez-Abud, Rocio; Osuna, Antonio] Hosp Virgen de las Nieves, Serv Nefrol, Unidad Expt, Granada, Spain; [Vargas, Felix; Rodriguez-Gomez, Isabel] Fac Med, Dept Fisiol, Granada, Spain; [O'Valle, Francisco] Fac Med, Dept Anat Patol, Granada, Spain; [O'Valle, Francisco] Fac Med, Inst Biomed Regenerat, Granada, Spain	Hospital Universitario Virgen de las Nieves	Vargas, F (corresponding author), Fac Med, Dept Fisiol, Granada, Spain.	fvargas@ugr.es	Osuna, Antonio/H-1896-2015; Rodriguez-Gomez, Isabel/K-8829-2014; OValle, Francisco/AAA-9151-2019	Rodriguez-Gomez, Isabel/0000-0001-6490-6643; 	Ministry of Education and Science [SAF2009-12294]; Carlos III Health Institute of the Spanish Ministry of Health and Consumer Affairs (Red de Investigacion Renal) [REDinREN 012/0021/0025]	Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Carlos III Health Institute of the Spanish Ministry of Health and Consumer Affairs (Red de Investigacion Renal)	This research was supported by a grant (SAF2009-12294) from the Ministry of Education and Science and from the Carlos III Health Institute of the Spanish Ministry of Health and Consumer Affairs (Red de Investigacion Renal, REDinREN 012/0021/0025). "FEDER una manera de hacer Europa." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayrak O, 2008, WORLD J UROL, V26, P285, DOI 10.1007/s00345-008-0253-4; CRONIN RE, 1985, AM J PHYSIOL, V248, pF332, DOI 10.1152/ajprenal.1985.248.3.F332; CRONIN RE, 1986, AM J PHYSIOL, V251, pF408, DOI 10.1152/ajprenal.1986.251.3.F408; Delbridge MS, 2007, TRANSPL P, V39, P2983, DOI 10.1016/j.transproceed.2007.04.028; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fernandez V, 2005, J ENDOCRINOL, V186, P539, DOI 10.1677/joe.1.06261; Fernandez V, 2005, FREE RADICAL RES, V39, P411, DOI 10.1080/10715760400029637; Fernandez V, 2007, HEPATOLOGY, V45, P170, DOI 10.1002/hep.21476; HUMES HD, 1992, AM J PHYSIOL, V262, pF540, DOI 10.1152/ajprenal.1992.262.4.F540; Jang HR, 2009, J MOL MED, V87, P859, DOI 10.1007/s00109-009-0491-y; Legrand M, 2008, MOL MED, V14, P502, DOI 10.2119/2008-00006.Legrand; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; LO CS, 1976, J BIOL CHEM, V251, P7834; Martin DR, 2000, AM J PHYSIOL-REG I, V279, pR1834, DOI 10.1152/ajpregu.2000.279.5.R1834; Maxwell SRJ, 1997, INT J CARDIOL, V58, P95, DOI 10.1016/S0167-5273(96)02854-9; MICHAEL UF, 1991, J AM SOC NEPHROL, V1, P1236; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nath KA, 2000, AM J MED, V109, P665, DOI 10.1016/S0002-9343(00)00612-4; Noiri E, 2001, AM J PHYSIOL-RENAL, V281, pF948, DOI 10.1152/ajprenal.0071.2001; O'Valle F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007138; Parra C, 2010, TRANSPL P, V42, P245, DOI 10.1016/j.transproceed.2009.11.018; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Radhakrishnan J, 2006, KIDNEY INT, V69, P17, DOI 10.1038/sj.ki.5000094; SCHRAUFSTATTER IU, 1986, P NATL ACAD SCI USA, V83, P4908, DOI 10.1073/pnas.83.13.4908; Schulte-Wissermann H, 1977, VIRCHOWS ARCH B, V23, P163; Senturk H, 2008, WORLD J UROL, V26, P401, DOI 10.1007/s00345-008-0256-1; STRAUB E, 1971, Z GES EXP MED, V155, P32, DOI 10.1007/BF02045981; STRAUB E, 1971, Z GES EXP MED, V154, P177, DOI 10.1007/BF02048389; SUTTER PM, 1988, PEDIATR NEPHROL, V2, P1, DOI 10.1007/BF00870370; Tapia G, 2003, FREE RADICAL BIO MED, V35, P257, DOI 10.1016/S0891-5849(03)00209-0; Thiemermann C, 1997, P NATL ACAD SCI USA, V94, P679, DOI 10.1073/pnas.94.2.679; Thurman JM, 2007, CLIN IMMUNOL, V123, P7, DOI 10.1016/j.clim.2006.09.008; Yang B, 2010, J SURG RES, V164, pE315, DOI 10.1016/j.jss.2010.07.044; Yelamos J, 2002, INMUNOLOGIA, V21, P219; Yu SY, 2005, J SURG RES, V128, P28, DOI 10.1016/j.jss.2005.04.025; ZAGER RA, 1984, KIDNEY INT, V26, P689, DOI 10.1038/ki.1984.204; Zheng JF, 2005, AM J PHYSIOL-RENAL, V288, pF387, DOI 10.1152/ajprenal.00436.2003	39	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e74960	10.1371/journal.pone.0074960	http://dx.doi.org/10.1371/journal.pone.0074960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086411	gold, Green Published, Green Submitted			2022-12-25	WOS:000325220000012
J	Hanson, E; Nilsson, S; Jood, K; Norrving, B; Engstrom, G; Blomstrand, C; Lindgren, A; Melander, O; Jern, C				Hanson, Ellen; Nilsson, Staffan; Jood, Katarina; Norrving, Bo; Engstrom, Gunnar; Blomstrand, Christian; Lindgren, Arne; Melander, Olle; Jern, Christina			Genetic Variants of Coagulation Factor XI Show Association with Ischemic Stroke Up to 70 Years of Age	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; MYOCARDIAL-INFARCTION; VENOUS THROMBOSIS; CEREBROVASCULAR EVENTS; REDUCED INCIDENCE; RISK-FACTORS; YOUNG-WOMEN; DEFICIENCY; CONTRIBUTES; PROTECTION	Background and Purpose: Coagulation factor XI (FXI) has an important role in the propagation and stabilization of a thrombus upon vessel injury. High FXI levels have been implicated in thrombotic diseases including ischemic stroke. The aim of our study was to investigate whether FXI gene (F11) variants are associated with ischemic stroke. Methods: The discovery sample, the Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS), included 844 patients with ischemic stroke and 668 controls, all aged 18-70 years. Replication was performed in the Lund Stroke Register (LSR) and Malmo Diet and Cancer study (MDC), together including 1213 patients and 788 controls up to 70 years of age, and in total 3145 patients and 1793 controls (18-102 years). Seven F11 single-nucleotide polymorphisms (SNPs) were selected using a tagging approach. Results: The SNPs rs3733403, rs925451, and rs1593 showed independent associations with overall ischemic stroke in SAHLSIS, ORs of 0.74 (95% CI 0.59-0.94), 1.24 (95% CI 1.06-1.46), and 0.70 (95% CI 0.55-0.90), respectively. The association for rs925451 was replicated in the LSR and MDC sample in a pre-specified analysis of subjects aged 70 years or younger, OR of 1.16 (95% CI 1.00-1.34), whereas no SNP was replicated when all ages were included. In line with this, one F11 haplotype was associated with overall ischemic stroke in the discovery sample and in the replication sample <= 70 years. Conclusions: We found significant associations between F11 variation and overall ischemic stroke up to 70 years of age. These findings motivate further studies on the role of F11 in ischemic stroke, especially in younger individuals.	[Hanson, Ellen; Jood, Katarina; Blomstrand, Christian; Jern, Christina] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden; [Nilsson, Staffan] Chalmers, Dept Math Stat, S-41296 Gothenburg, Sweden; [Norrving, Bo; Lindgren, Arne] Lund Univ, Dept Clin Sci Lund, Lund, Sweden; [Norrving, Bo; Lindgren, Arne] Skane Univ Hosp, Dept Neurol, Lund, Sweden; [Engstrom, Gunnar; Melander, Olle] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden	University of Gothenburg; Chalmers University of Technology; Lund University; Lund University; Skane University Hospital; Lund University	Hanson, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden.	ellen.hanson@neuro.gu.se		Melander, Olle/0000-0002-2581-484X; Engstrom, Gunnar/0000-0002-8618-9152; Nilsson, Staffan/0000-0003-4748-0446; Norrving, Bo/0000-0002-8024-5096	Swedish Research Council [K2011-65X-14605-09-6, K2010-61X-20378-04-3, 2011-3891]; Swedish state [ALFGBG-148861]; Swedish Heart and Lung Foundation [20100256, 20100244, 20100228]; Lund University; Region Skane; Freemasons Lodge of Instruction EOS in Lund; King Gustav V and Queen Victoria's Foundation; Promobilia; Swedish Stroke Association; Goteborg Foundation for Neurological Research; Rune and Ulla Amlov; John and Brit Wennerstrom; Per-Olov Ahl; Wilhelm and Martina Lundgren; Emelle Foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish state; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Lund University; Region Skane; Freemasons Lodge of Instruction EOS in Lund; King Gustav V and Queen Victoria's Foundation; Promobilia; Swedish Stroke Association; Goteborg Foundation for Neurological Research; Rune and Ulla Amlov; John and Brit Wennerstrom; Per-Olov Ahl; Wilhelm and Martina Lundgren; Emelle Foundations	This study was supported by the Swedish Research Council (K2011-65X-14605-09-6, K2010-61X-20378-04-3, and 2011-3891), the Swedish state (ALFGBG-148861), the Swedish Heart and Lung Foundation (20100256, 20100244 and 20100228), Lund University, Region Skane, the Freemasons Lodge of Instruction EOS in Lund, King Gustav V and Queen Victoria's Foundation, Promobilia, the Swedish Stroke Association, the Goteborg Foundation for Neurological Research, the Rune and Ulla Amlov, John and Brit Wennerstrom, Per-Olov Ahl, the Wilhelm and Martina Lundgren, and the Emelle Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Austin H, 2011, J THROMB HAEMOST, V9, P489, DOI 10.1111/j.1538-7836.2011.04185.x; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Cushman M, 2009, BLOOD, V114, P2878, DOI 10.1182/blood-2009-05-219915; de Moerloose P, 2007, SEMIN HEMATOL, V44, P106, DOI 10.1053/j.seminhematol.2007.01.008; Delluc A, 2010, THROMB HAEMOSTASIS, V103, P1161, DOI 10.1160/TH09-07-0430; Doggen CJM, 2006, BLOOD, V108, P4045, DOI 10.1182/blood-2005-12-023697; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Hallstrom B, 2007, ACTA NEUROL SCAND, V115, P49, DOI 10.1111/j.1600-0404.2006.00738.x; Jood K, 2005, STROKE, V36, P1383, DOI 10.1161/01.STR.0000169944.46025.09; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kravtsov DV, 2009, BLOOD, V114, P452, DOI 10.1182/blood-2009-02-203604; Li CR, 2005, STROKE, V36, P234, DOI 10.1161/01.STR.0000152328.66493.0a; Li Y, 2009, J THROMB HAEMOST, V7, P1802, DOI 10.1111/j.1538-7836.2009.03544.x; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Olsson S, 2011, EUR J NEUROL, V18, P1272, DOI 10.1111/j.1468-1331.2011.03377.x; Olsson S, 2012, STROKE, V43, P2278, DOI 10.1161/STROKEAHA.111.647446; Sabater-Lleal M, 2012, ARTERIOSCL THROM VAS, V32, P2008, DOI 10.1161/ATVBAHA.112.248492; Salomon O, 2003, J THROMB HAEMOST, V1, P658, DOI 10.1046/j.1538-7836.2003.00195.x; Salomon O, 2008, BLOOD, V111, P4113, DOI 10.1182/blood-2007-10-120139; Salomon O, 2011, THROMB HAEMOSTASIS, V105, P269, DOI 10.1160/TH10-05-0307; Schumacher WA, 2010, ARTERIOSCL THROM VAS, V30, P388, DOI 10.1161/ATVBAHA.109.197178; Siegerink B, 2010, CIRCULATION, V122, P1854, DOI 10.1161/CIRCULATIONAHA.110.943738; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Suri MFK, 2010, CEREBROVASC DIS, V29, P497, DOI 10.1159/000297966; Tanis B, 2006, EUR J HAEMATOL, V77, P67, DOI 10.1111/j.1600-0609.2006.00656.x; Undas A, 2011, THROMB RES, V128, pE62, DOI 10.1016/j.thromres.2011.06.010; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Woodruff RS, 2011, J THROMB THROMBOLYS, V32, P9, DOI 10.1007/s11239-011-0578-5; Yamashita A, 2006, J THROMB HAEMOST, V4, P1496, DOI 10.1111/j.1538-7836.2006.01973.x; Yang DT, 2006, AM J CLIN PATHOL, V126, P411, DOI 10.1309/QC259F09UNMKVP0R	32	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75286	10.1371/journal.pone.0075286	http://dx.doi.org/10.1371/journal.pone.0075286			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086496	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700069
J	Botanov, Y; Ilardi, SS				Botanov, Yevgeny; Ilardi, Stephen S.			The Acute Side Effects of Bright Light Therapy: A Placebo-Controlled Investigation	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; CONSENSUS REPORT; NONSEASONAL DEPRESSION; CIRCADIAN-RHYTHMS; CONTROLLED-TRIAL; MORNING LIGHT; DOUBLE-BLIND; SLEEP PHASE; PHOTOTHERAPY; MELATONIN	Despite the emergence of numerous clinical and non-clinical applications of bright light therapy (LT) in recent decades, the prevalence and severity of LT side effects have not yet been fully explicated. A few adverse LT effects -headache, eye strain, irritability, and nausea-have been consistently reported among depressed individuals and other psychiatric cohorts, but there exists little published evidence regarding LT side effects in non-clinical populations, who often undergo LT treatment of considerably briefer duration. Accordingly, in the present study we examined, in a randomized sample of healthy young adults, the acute side effects of exposure to a single 30-minute session of bright white light (10,000 lux) versus dim red light (< 500 lux). Across a broad range of potential side effects, repeated-measures analyses of variance revealed no significant group-by-time (Pre, Post) interactions. In other words, bright light exposure was not associated with a significantly higher incidence of any reported side effect than was the placebo control condition. Nevertheless, small but statistically significant increases in both eye strain and blurred vision were observed among both the LT and control groups. Overall, these results suggest that the relatively common occurrence of adverse side effects observed in the extant LT literature may not fully extend to non-clinical populations, especially for healthy young adults undergoing LT for a brief duration.	[Botanov, Yevgeny; Ilardi, Stephen S.] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA	University of Kansas	Botanov, Y (corresponding author), Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA.	ybotanov@ku.edu	Botanov, Yevgeny/AAH-9507-2020					Ancoli-Israel S, 2002, J AM GERIATR SOC, V50, P282, DOI 10.1046/j.1532-5415.2002.50060.x; Boivin DB, 2002, J BIOL RHYTHM, V17, P266, DOI 10.1177/07430402017003010; Boulos Z, 1995, J BIOL RHYTHM, V10, P167, DOI 10.1177/074873049501000209; Braun DL, 1999, COMPR PSYCHIAT, V40, P442, DOI 10.1016/S0010-440X(99)90088-3; Brinkhuijsen M, 2003, J AFFECT DISORDERS, V74, P307, DOI 10.1016/S0165-0327(03)00003-X; Burgess HJ, 2002, SLEEP MED REV, V6, P407, DOI 10.1053/smrv.2001.0215; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Daansen PJ, 2010, NEUROENDOCRINOL LETT, V31, P290; DELTITO JA, 1991, J AFFECT DISORDERS, V23, P231, DOI 10.1016/0165-0327(91)90105-2; Eastman CI, 1995, J BIOL RHYTHM, V10, P157, DOI 10.1177/074873049501000208; Erickson K, 2005, AM J PSYCHIAT, V162, P2171, DOI 10.1176/appi.ajp.162.11.2171; Goel N, 2005, PSYCHOL MED, V35, P945, DOI 10.1017/S0033291705005027; Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656; KELLOGG JH, 2003, LIGHT THERAPEUTICS P; Kogan AO, 1998, AM J PSYCHIAT, V155, P293; Krasnik C, 2005, AM J OBSTET GYNECOL, V193, P658, DOI 10.1016/j.ajog.2005.01.055; Kripke DF, 1998, J AFFECT DISORDERS, V49, P109, DOI 10.1016/S0165-0327(98)00005-6; LABBATE LA, 1994, J CLIN PSYCHIAT, V55, P189; LACK L, 1993, SLEEP, V16, P436, DOI 10.1093/sleep/16.5.436; Lack L, 2005, SLEEP, V28, P616, DOI 10.1093/sleep/28.5.616; Lam RW, 2006, AM J PSYCHIAT, V163, P805, DOI 10.1176/appi.ajp.163.5.805; Lam RW, 1999, PSYCHIAT RES, V86, P185, DOI 10.1016/S0165-1781(99)00043-8; LAM RW, 1994, AM J PSYCHIAT, V151, P744; Lambert GW, 2002, LANCET, V360, P1840, DOI 10.1016/S0140-6736(02)11737-5; LEVITT AJ, 1993, AM J PSYCHIAT, V150, P650; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; Neumeister A, 2001, PSYCHOL MED, V31, P1467, DOI 10.1017/S003329170105434z; Nowak L, 2011, WESTERN J NURS RES, V33, P933, DOI 10.1177/0193945910386248; Oren DA, 2002, AM J PSYCHIAT, V159, P666, DOI 10.1176/appi.ajp.159.4.666; OREN DA, 1991, COMPR PSYCHIAT, V32, P147, DOI 10.1016/0010-440X(91)90007-Y; OREN DA, 1991, J NEURAL TRANSM-GEN, V83, P85, DOI 10.1007/BF01244455; Rastad C, 2008, J AFFECT DISORDERS, V108, P291, DOI 10.1016/j.jad.2007.10.009; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; ROSENTHAL NE, 1990, SLEEP, V13, P354; Rybak YE, 2007, COMPR PSYCHIAT, V48, P562, DOI 10.1016/j.comppsych.2007.05.008; Sit D, 2007, BIPOLAR DISORD, V9, P918, DOI 10.1111/j.1399-5618.2007.00451.x; Strigo IA, 2008, ARCH GEN PSYCHIAT, V65, P1275, DOI 10.1001/archpsyc.65.11.1275; Strigo IA, 2008, PSYCHOSOM MED, V70, P338, DOI 10.1097/PSY.0b013e3181656a48; Terman M, 1995, J BIOL RHYTHM, V10, P135, DOI 10.1177/074873049501000206; Terman M, 2005, CNS SPECTRUMS, V10, P647, DOI 10.1017/S1092852900019611; Terman M, 1999, J CLIN PSYCHIAT, V60, P799; Thomas L, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-29; Vanderkooy JD, 2002, CAN J PSYCHIAT, V47, P174, DOI 10.1177/070674370204700208; VOLZ HP, 1991, PHARMACOPSYCHIATRY, V24, P141, DOI 10.1055/s-2007-1014458; WEHR TA, 1989, AM J PSYCHIAT, V146, P829; WETTERBERG L, 1978, J NEURAL TRANSM-SUPP, V13, P389; Willis GL, 2007, CHRONOBIOL INT, V24, P521, DOI 10.1080/07420520701420717; Wirz-Justice A, 2009, CHRONOTHERAPEUTICS A; Wirz-Justice A, 2011, J CLIN PSYCHIAT, V72, P986, DOI 10.4088/JCP.10m06188blu; Zimmerman M, 2010, J CLIN PSYCHIAT, V71, P484, DOI 10.4088/JCP.08m04978blu	50	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75893	10.1371/journal.pone.0075893	http://dx.doi.org/10.1371/journal.pone.0075893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	226HG	24086658	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200068
J	Grube, MM; Koennecke, HC; Walter, G; Meisel, A; Sobesky, J; Nolte, CH; Wellwood, I; Heuschmann, PU				Grube, Maike Miriam; Koennecke, Hans-Christian; Walter, Georg; Meisel, Andreas; Sobesky, Jan; Nolte, Christian Hans; Wellwood, Ian; Heuschmann, Peter Ulrich		Berlin Stroke Register BSR	Influence of Acute Complications on Outcome 3 Months after Ischemic Stroke	PLOS ONE			English	Article							HOSPITAL MEDICAL COMPLICATIONS; QUALITY-OF-CARE; TERM MORTALITY; BARTHEL-INDEX; RANKIN SCALE; RISK-FACTORS; TRIAL; RELIABILITY; DEPENDENCY; PREDICTORS	Background: Early medical complications are potentially modifiable factors influencing in-hospital outcome. We investigated the influence of acute complications on mortality and poor outcome 3 months after ischemic stroke. Methods: Data were obtained from patients admitted to one of 13 stroke units of the Berlin Stroke Registry (BSR) who participated in a 3-months-follow up between June 2010 and September 2012. We examined the influence of the cumulative number of early in-hospital complications on mortality and poor outcome (death, disability or institutionalization) 3 months after stroke using multivariable logistic regression analyses and calculated attributable fractions to determine the impact of early complications on mortality and poor outcome. Results: A total of 2349 ischemic stroke patients alive at discharge from acute care were included in the analysis. Older age, stroke severity, pre-stroke dependency and early complications were independent predictors of mortality 3 months after stroke. Poor outcome was independently associated with older age, stroke severity, pre-stroke dependency, previous stroke and early complications. More than 60% of deaths and poor outcomes were attributed to age, pre-stroke dependency and stroke severity and in-hospital complications contributed to 12.3% of deaths and 9.1% of poor outcomes 3 months after stroke. Conclusion: The majority of deaths and poor outcomes after stroke were attributed to non-modifiable factors. However, early in-hospital complications significantly affect outcome in patients who survived the acute phase after stroke, underlining the need to improve prevention and treatment of complications in hospital.	[Grube, Maike Miriam; Meisel, Andreas; Sobesky, Jan; Nolte, Christian Hans; Wellwood, Ian] Charite, Neurol Klin, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany; [Grube, Maike Miriam] Kings Coll London, Div Hlth & Social Care Res, London, England; [Koennecke, Hans-Christian] Vivantes Klinikum Friedrichshain, Berlin, Germany; [Walter, Georg] Vivantes Klinikum Spandau, Berlin, Germany; [Heuschmann, Peter Ulrich] Univ Wurzburg, Univ Hosp Wurzburg, Inst Clin Epidemiol & Biometry, Ctr Clin Studies,Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; King's College London; University of Wurzburg	Grube, MM (corresponding author), Charite, Neurol Klin, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany.	maike.grube@charite.de	Nolte, Christian/AAA-2651-2022	Nolte, Christian/0000-0001-5577-1775; Sobesky, Jan/0000-0001-5459-3655; Meisel, Andreas/0000-0001-7233-5342	Federal Ministry of Education and Research (BMBF) through the Center for Stroke Research Berlin [01 EO 0801]	Federal Ministry of Education and Research (BMBF) through the Center for Stroke Research Berlin	The study was supported by the Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/) through the Center for Stroke Research Berlin (01 EO 0801). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KK, 2011, STROKE, V42, P2806, DOI 10.1161/STROKEAHA.111.619049; Appelros P, 2003, STROKE, V34, P122, DOI 10.1161/01.STR.0000047852.05842.3C; Balami JS, 2011, LANCET NEUROL, V10, P357, DOI 10.1016/S1474-4422(10)70313-6; Berger K, 1999, FORTSCHR NEUROL PSYC, V67, P81, DOI 10.1055/s-2007-993985; Bravata DM, 2003, STROKE, V34, P699, DOI 10.1161/01.STR.0000057578.26828.78; Diserens K, 2012, CLIN REHABIL, V26, P451, DOI 10.1177/0269215511425541; Grau AJ, 2001, STROKE, V32, P2559, DOI 10.1161/hs1101.098524; Grube MM, 2012, STROKE, V43, P3325, DOI 10.1161/STROKEAHA.112.669580; Hankey GJ, 2003, CEREBROVASC DIS, V16, P14, DOI 10.1159/000069936; Heuschmann PU, 2011, NEUROLOGY, V76, P159, DOI 10.1212/WNL.0b013e318206ca1e; Heuschmann PU, 2005, FORTSCHR NEUROL PSYC, V73, P74, DOI 10.1055/s-2004-830172; Hong KS, 2008, EUR J NEUROL, V15, P1324, DOI 10.1111/j.1468-1331.2008.02310.x; Ingeman A, 2008, MED CARE, V46, P63, DOI 10.1097/MLR.0b013e3181484b91; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Johnston KC, 1998, STROKE, V29, P447, DOI 10.1161/01.STR.29.2.447; Kelly AG, 2012, NEUROLOGY, V79, P941, DOI 10.1212/WNL.0b013e318266fc40; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Koennecke H-C, 2008, BERLINER SCHLAGANFAL, V9, P24; Kolominsky-Rabas PL, 2002, FORTSCHR NEUROL PSYC, V70, P657, DOI 10.1055/s-2002-35857; Koton S, 2010, NEUROEPIDEMIOLOGY, V34, P90, DOI 10.1159/000264826; Kumar S, 2010, LANCET NEUROL, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; Middleton S, 2011, LANCET, V378, P1699, DOI 10.1016/S0140-6736(11)61485-2; Minnerup J, 2012, STROKE, V43, P295, DOI 10.1161/STROKEAHA.111.642363; Palnum KD, 2009, STROKE, V40, P1134, DOI 10.1161/STROKEAHA.108.543819; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Saposnik G, 2008, STROKE, V39, P2318, DOI 10.1161/STROKEAHA.107.510362; Schneider K, 2009, NERVENHEILKUNDE, V28, P114, DOI 10.1055/s-0038-1628584; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Wang PL, 2013, CHINESE MED J-PEKING, V126, P1236, DOI 10.3760/cma.j.issn.0366-6999.20122573; Wang PL, 2012, CHINESE MED J-PEKING, V125, P2449, DOI 10.3760/cma.j.issn.0366-6999.2012.14.010; Ward A, 2005, EUR J NEUROL, V12, P264, DOI 10.1111/j.1468-1331.2004.00949.x	31	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75719	10.1371/journal.pone.0075719	http://dx.doi.org/10.1371/journal.pone.0075719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086621	Green Submitted, Green Published, gold			2022-12-25	WOS:000325025200060
J	Tellez, J; Van Vliet, K; Tseng, YS; Finn, JD; Tschernia, N; Almeida-Porada, G; Arruda, VR; Agbandje-McKenna, M; Porada, CD				Tellez, Joseph; Van Vliet, Kim; Tseng, Yu-Shan; Finn, Jonathan D.; Tschernia, Nick; Almeida-Porada, Graca; Arruda, Valder R.; Agbandje-McKenna, Mavis; Porada, Christopher D.			Characterization of Naturally-Occurring Humoral Immunity to AAV in Sheep	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS TYPE-2; ADENO-ASSOCIATED VIRUS; GENE-THERAPY; NEUTRALIZING ANTIBODIES; PREEXISTING IMMUNITY; VIRAL VECTORS; FACTOR-IX; LIVER; IDENTIFICATION; DELIVERY	AAV vectors have shown great promise for clinical gene therapy (GT), but pre-existing human immunity against the AAV capsid often limits transduction. Thus, testing promising AAV-based GT approaches in an animal model with similar pre-existing immunity could better predict clinical outcome. Sheep have long been used for basic biological and preclinical studies. Moreover, we have re-established a line of sheep with severe hemophilia A (HA). Given the impetus to use AAV-based GT to treat hemophilia, we characterized the pre-existing ovine humoral immunity to AAV. ELISA revealed naturally-occurring antibodies to AAV1, AAV2, AAV5, AAV6, AAV8, and AAV9. For AAV2, AAV8, and AAV9 these inhibit transduction in a luciferase-based neutralization assay. Epitope mapping identified peptides that were common to the capsids of all AAV serotypes tested (AAV2, AAV5, AAV8 and AAV9), with each animal harboring antibodies to unique and common capsid epitopes. Mapping using X-ray crystallographic AAV capsid structures demonstrated that these antibodies recognized both surface epitopes and epitopes located within regions of the capsid that are internal or buried in the capsid structure. These results suggest that sheep harbor endogenous AAV, which induces immunity to both intact capsid and to capsid epitopes presented following proteolysis during the course of infection. In conclusion, their clinically relevant physiology and the presence of naturally-occurring antibodies to multiple AAV serotypes collectively make sheep a unique model in which to study GT for HA, and other diseases, and develop strategies to circumvent the clinically important barrier of pre-existing AAV immunity.	[Tellez, Joseph; Tschernia, Nick] Univ Nevada, Dept Anim Biotechnol, Reno, NV 89557 USA; [Van Vliet, Kim; Tseng, Yu-Shan; Agbandje-McKenna, Mavis] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Finn, Jonathan D.; Arruda, Valder R.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; [Almeida-Porada, Graca; Porada, Christopher D.] Wake Forest Inst Regenerat Med, Winston Salem, NC USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; State University System of Florida; University of Florida; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Wake Forest University	Porada, CD (corresponding author), Wake Forest Inst Regenerat Med, Winston Salem, NC USA.	cporada@wakehealth.edu	Van Vliet, Kim/AAK-7368-2021	Almeida-Porada, Maria da Graca/0000-0002-6715-865X; Van Vliet, Kim/0000-0001-7802-9514; Tschernia, Nicholas/0000-0002-2389-9974	Wake Forest University Health Sciences Translational Science Institute [20667]; NIH [R01 GM082946]; University of Florida College of Medicine Research Funds;  [NIH-HD43038];  [NIH- PO1HL64190]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL064190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082946] Funding Source: NIH RePORTER	Wake Forest University Health Sciences Translational Science Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida College of Medicine Research Funds; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH-HD43038 and Wake Forest University Health Sciences Translational Science Institute 20667 Clinical Pilot Award to CDP; NIH- PO1HL64190 to VRA; NIH R01 GM082946 and University of Florida College of Medicine Research Funds to MA-M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbandje-McKenna M, 2011, METHODS MOL BIOL, V807, P47, DOI 10.1007/978-1-61779-370-7_3; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bartel M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00204; Bell CL, 2012, J VIROL, V86, P7326, DOI 10.1128/JVI.00448-12; Bello AJ, 2012, MOL THER, V20, pS46; Binny Christopher J, 2012, Methods Mol Biol, V891, P109, DOI 10.1007/978-1-61779-873-3_6; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Bueler H, 1999, BIOL CHEM, V380, P613, DOI 10.1515/BC.1999.078; Carter PJ, 2000, INT J MOL MED, V6, P17; CLARKE JK, 1979, ARCH VIROL, V60, P171, DOI 10.1007/BF01348034; David AL, 2011, HUM GENE THER, V22, P419, DOI 10.1089/hum.2010.007; DiMattia MA, 2012, J VIROL, V86, P6947, DOI 10.1128/JVI.07232-11; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Excoffon KJDA, 2009, P NATL ACAD SCI USA, V106, P3865, DOI 10.1073/pnas.0813365106; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; Govindasamy L, 2006, J VIROL, V80, P11556, DOI 10.1128/JVI.01536-06; Grieger JC, 2005, ADV BIOCHEM ENG BIOT, V99, P119, DOI 10.1007/10_005; Gurda BL, 2012, J VIROL, V86, P7739, DOI 10.1128/JVI.00218-12; Herzog RW, 2007, MOL THER, V15, P649, DOI 10.1038/sj.mt.6300123; Hurlbut GD, 2010, MOL THER, V18, P1983, DOI 10.1038/mt.2010.175; Ito T, 2009, ANN CLIN BIOCHEM, V46, P508, DOI 10.1258/acb.2009.009077; Jimenez-Clavero MA, 2000, VIROLOGY, V270, P76, DOI 10.1006/viro.2000.0256; Karman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034684; Kern A, 2003, J VIROL, V77, P11072, DOI 10.1128/JVI.77.20.11072-11081.2003; Li C, 2012, GENE THER, V19, P288, DOI 10.1038/gt.2011.90; Li H, 2009, MOL THER, V17, P1215, DOI 10.1038/mt.2009.79; Lochrie MA, 2006, J VIROL, V80, P821, DOI 10.1128/JVI.80.2.821-834.2006; Lochrie MA, 2006, VIROLOGY, V353, P68, DOI 10.1016/j.virol.2006.05.023; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mariani JA, 2011, EUR J HEART FAIL, V13, P247, DOI 10.1093/eurjhf/hfq234; Mingozzi F, 2012, BLOOD, V120, p2050a; Mingozzi F, 2007, CURR GENE THER, V7, P316, DOI 10.2174/156652307782151425; Mitchell AM, 2010, CURR GENE THER, V10, P319; Moskalenko M, 2000, J VIROL, V74, P1761, DOI 10.1128/JVI.74.4.1761-1766.2000; Nam HJ, 2007, J VIROL, V81, P12260, DOI 10.1128/JVI.01304-07; Nathwani AC, 2002, BLOOD, V100, P1662, DOI 10.1182/blood-2002-02-0589; Nathwani A, 2010, BLOOD, V116, P114, DOI 10.1182/blood.V116.21.248.248; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Opie SR, 2003, J VIROL, V77, P6995, DOI 10.1128/JVI.77.12.6995-7006.2003; Ortolano S, 2012, RECENT PATENTS ENDOC, V6, P47, DOI 10.2174/187221412799015245; Popa-Wagner R, 2012, J VIROL, V86, P9163, DOI 10.1128/JVI.00282-12; Porada CD, 2010, J THROMB HAEMOST, V8, P276, DOI 10.1111/j.1538-7836.2009.03697.x; Rapti K, 2012, MOL THER, V20, P73, DOI 10.1038/mt.2011.177; Scallan CD, 2006, BLOOD, V107, P1810, DOI 10.1182/blood-2005-08-3229; Sharma A, 2010, EXP EYE RES, V91, P440, DOI 10.1016/j.exer.2010.06.020; Shin JH, 2012, HUM GENE THER, V23, P287, DOI 10.1089/hum.2011.125; Vandenberghe LH, 2007, CURR GENE THER, V7, P325, DOI 10.2174/156652307782151416; Veron P, 2012, J IMMUNOL, V188, P6418, DOI 10.4049/jimmunol.1200620; Wang JH, 2011, J MOL CELL CARDIOL, V50, P793, DOI 10.1016/j.yjmcc.2010.10.017; Wang LL, 2011, HUM GENE THER, V22, P1389, DOI 10.1089/hum.2011.031; Warrington KH, 2006, HUM GENET, V119, P571, DOI 10.1007/s00439-006-0165-6; White JD, 2011, GENE THER, V18, P546, DOI 10.1038/gt.2010.168; Wobus CE, 2000, J VIROL, V74, P9281, DOI 10.1128/JVI.74.19.9281-9293.2000; Wu P, 2000, J VIROL, V74, P8635, DOI 10.1128/JVI.74.18.8635-8647.2000; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4	56	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75142	10.1371/journal.pone.0075142	http://dx.doi.org/10.1371/journal.pone.0075142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086458	gold, Green Submitted, Green Published			2022-12-25	WOS:000325025200029
J	Rhein, VF; Carroll, J; Ding, SJ; Fearnley, IM; Walker, JE				Rhein, Virginie F.; Carroll, Joe; Ding, Shujing; Fearnley, Ian M.; Walker, John E.			NDUFAF7 Methylates Arginine 85 in the NDUFS2 Subunit of Human Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transport; Mitochondria; Protein Methylation; Respiratory Chain; Assembly; Complex I; Dimethylarginine; Methyltransferase	NUCLEAR-ENCODED SUBUNITS; AMINO-ACID-SEQUENCE; MITOCHONDRIAL COMPLEX; POSTTRANSLATIONAL MODIFICATIONS; FUNCTIONAL EXPRESSION; HISTONE DEMETHYLATION; LYSINE METHYLATION; PROTEIN; METHYLTRANSFERASE; IDENTIFICATION	Background: Arginine 85 of NDUFS2, a subunit of mitochondrial complex I, is symmetrically dimethylated. Results: NDUFAF7, a protein methylase in the matrix of mitochondria, modifies arginine 85 of NDUFS2 during assembly of complex I. Conclusion: Methylation of arginine 85 of NDUFS2 is required for assembly of complex I. Significance: The arginine protein methylase, NDUFAF7, is an assembly factor for human complex I. Complex I (NADH ubiquinone oxidoreductase) in mammalian mitochondria is an L-shaped assembly of 44 subunits. One arm is embedded in the inner membrane with the other protruding approximate to 100 into the matrix of the organelle. The extrinsic arm contains binding sites for NADH and the primary electron acceptor FMN, and it provides a scaffold for seven iron-sulfur clusters that form an electron pathway linking FMN to the terminal electron acceptor, ubiquinone, which is bound in the region of the junction between the arms. The membrane arm contains four antiporter-like domains, probably energetically coupled to the quinone site and involved in pumping protons from the matrix into the intermembrane space contributing to the proton motive force. Complex I is put together from preassembled subcomplexes. Their compositions have been characterized partially, and at least 12 extrinsic assembly factor proteins are required for the assembly of the complex. One such factor, NDUFAF7, is predicted to belong to the family of S-adenosylmethionine-dependent methyltransferases characterized by the presence in their structures of a seven--strand protein fold. In the present study, the presence of NDUFAF7 in the mitochondrial matrix has been confirmed, and it has been demonstrated that it is a protein methylase that symmetrically dimethylates the -N-G,N-G atoms of residue Arg-85 in the NDUFS2 subunit of complex I. This methylation step occurs early in the assembly of complex I and probably stabilizes a 400-kDa subcomplex that forms the initial nucleus of the peripheral arm and its juncture with the membrane arm.	[Rhein, Virginie F.; Carroll, Joe; Ding, Shujing; Fearnley, Ian M.; Walker, John E.] Med Res Council Mitochondrial Biol Unit, Cambridge CB2 0XY, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Walker, JE (corresponding author), Med Res Council Mitochondrial Biol Unit, Cambridge CB2 0XY, England.	walker@mrc-mbu.cam.ac.uk		Walker, John/0000-0001-7929-2162	Medical Research Council; Swiss National Fund Stipendium [PBBSP3-130953]; Swiss Novartis Foundation; Medical Research Council [MC_U105663148] Funding Source: researchfish; MRC [MC_U105663148] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Fund Stipendium; Swiss Novartis Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council.; Recipient of a Medical Research Council Career Development Fellowship, Swiss National Fund Stipendium PBBSP3-130953, and a fellowship from the Swiss Novartis Foundation.	Angerer H, 2012, BBA-BIOENERGETICS, V1817, P1776, DOI 10.1016/j.bbabio.2012.03.021; AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P894; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; BLOXHAM DP, 1982, BIOCHEMISTRY-US, V21, P2028, DOI 10.1021/bi00538a009; Bremang M, 2013, MOL BIOSYST, V9, P2231, DOI 10.1039/c3mb00009e; Brule H, 2004, BIOCHEMISTRY-US, V43, P9243, DOI 10.1021/bi049671q; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Carilla-Latorre S, 2010, J CELL SCI, V123, P1674, DOI 10.1242/jcs.066076; Carroll J, 2005, MOL CELL PROTEOMICS, V4, P693, DOI 10.1074/mcp.M500014-MCP200; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Carroll J, 2013, J BIOL CHEM, V288, P24799, DOI 10.1074/jbc.M113.488106; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Ching YP, 2002, GENOMICS, V79, P2, DOI 10.1006/geno.2001.6670; Chujo T, 2012, RNA, V18, P2269, DOI 10.1261/rna.035600.112; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Clason T, 2010, J STRUCT BIOL, V169, P81, DOI 10.1016/j.jsb.2009.08.017; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Dibrov E, 1997, J BIOL CHEM, V272, P9175; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Efremov RG, 2011, CURR OPIN STRUC BIOL, V21, P532, DOI 10.1016/j.sbi.2011.07.002; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; EVANS CT, 1988, BIOCHEM BIOPH RES CO, V157, P1231, DOI 10.1016/S0006-291X(88)81006-4; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fisk JC, 2013, MOL CELL PROTEOMICS, V12, P302, DOI 10.1074/mcp.M112.022533; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007; Hoefs SJG, 2011, EUR J HUM GENET, V19, P270, DOI 10.1038/ejhg.2010.204; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Jonassen T, 2000, J BIOL CHEM, V275, P12381, DOI 10.1074/jbc.275.17.12381; Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Liu JM, 2000, NUCLEIC ACIDS RES, V28, P3445, DOI 10.1093/nar/28.18.3445; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; McKenzie M, 2011, J MOL BIOL, V414, P413, DOI 10.1016/j.jmb.2011.10.012; Mckenzie M, 2010, IUBMB LIFE, V62, P497, DOI 10.1002/iub.335; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; Rendon OZ, 2012, HUM MOL GENET, V21, P3815, DOI 10.1093/hmg/dds209; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Saveanu C, 2001, J BIOL CHEM, V276, P15861, DOI 10.1074/jbc.M010864200; Scacco S, 2003, J BIOL CHEM, V278, P44161, DOI 10.1074/jbc.M307615200; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smith AC, 2009, MOL CELL PROTEOMICS, V8, P1324, DOI 10.1074/mcp.M800373-MCP200; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; van den Bosch BJC, 2012, J MED GENET, V49, P10, DOI 10.1136/jmedgenet-2011-100466; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Young MJ, 2008, YEAST, V25, P903, DOI 10.1002/yea.1644; Zehmer JK, 2008, J CELL SCI, V121, P1852, DOI 10.1242/jcs.012013; Zehmer JK, 2009, J CELL SCI, V122, P3694, DOI 10.1242/jcs.054700	83	76	78	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33016	33026		10.1074/jbc.M113.518803	http://dx.doi.org/10.1074/jbc.M113.518803			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089531	hybrid, Green Published			2022-12-25	WOS:000328841700018
J	Hess, A; Yu, LC; Klein, I; De Mazancourt, M; Jebrak, G; Mal, H; Brugiere, O; Fournier, M; Courbage, M; Dauriat, G; Schouman-Clayes, E; Clerici, C; Mangin, L				Hess, Agathe; Yu, Lianchun; Klein, Isabelle; De Mazancourt, Marine; Jebrak, Gilles; Mal, Herve; Brugiere, Olivier; Fournier, Michel; Courbage, Maurice; Dauriat, Gaelle; Schouman-Clayes, Elisabeth; Clerici, Christine; Mangin, Laurence			Neural Mechanisms Underlying Breathing Complexity	PLOS ONE			English	Article							PRE-BOTZINGER COMPLEX; RESPIRATORY RHYTHM GENERATION; DEFAULT-MODE; CHAOTIC DYNAMICS; BRAIN; FLUCTUATIONS; NETWORK; NEURONS; ROBUST; FMRI	Breathing is maintained and controlled by a network of automatic neurons in the brainstem that generate respiratory rhythm and receive regulatory inputs. Breathing complexity therefore arises from respiratory central pattern generators modulated by peripheral and supra-spinal inputs. Very little is known on the brainstem neural substrates underlying breathing complexity in humans. We used both experimental and theoretical approaches to decipher these mechanisms in healthy humans and patients with chronic obstructive pulmonary disease (COPD). COPD is the most frequent chronic lung disease in the general population mainly due to tobacco smoke. In patients, airflow obstruction associated with hyperinflation and respiratory muscles weakness are key factors contributing to load-capacity imbalance and hence increased respiratory drive. Unexpectedly, we found that the patients breathed with a higher level of complexity during inspiration and expiration than controls. Using functional magnetic resonance imaging (fMRI), we scanned the brain of the participants to analyze the activity of two small regions involved in respiratory rhythmogenesis, the rostral ventro-lateral (VL) medulla (pre-Botzinger complex) and the caudal VL pons (parafacial group). fMRI revealed in controls higher activity of the VL medulla suggesting active inspiration, while in patients higher activity of the VL pons suggesting active expiration. COPD patients reactivate the parafacial to sustain ventilation. These findings may be involved in the onset of respiratory failure when the neural network becomes overwhelmed by respiratory overload We show that central neural activity correlates with airflow complexity in healthy subjects and COPD patients, at rest and during inspiratory loading. We finally used a theoretical approach of respiratory rhythmogenesis that reproduces the kernel activity of neurons involved in the automatic breathing. The model reveals how a chaotic activity in neurons can contribute to chaos in airflow and reproduces key experimental fMRI findings.	[Hess, Agathe; Yu, Lianchun; De Mazancourt, Marine; Courbage, Maurice; Mangin, Laurence] Univ Paris 07, CNRS, Lab Mat & Syst Complexes, UMR 7057, Paris, France; [Hess, Agathe; Klein, Isabelle; Schouman-Clayes, Elisabeth] Hop Bichat Claude Bernard, AP HP, Serv Radiol, F-75877 Paris 18, France; [Yu, Lianchun] Lanzhou Univ, Inst Theoret Phys, Lanzhou 730000, Peoples R China; [Klein, Isabelle] Univ Paris 07, INSERM, U698, Paris, France; [De Mazancourt, Marine] Ecole Normale Super, F-75231 Paris, France; [Jebrak, Gilles; Mal, Herve; Brugiere, Olivier; Fournier, Michel; Dauriat, Gaelle] Hop Bichat Claude Bernard, AP HP, Serv Pneumol, F-75877 Paris 18, France; [Clerici, Christine; Mangin, Laurence] Hop Bichat Claude Bernard, AP HP, Dept Physiol Explorat Fonct, F-75877 Paris 18, France; [Clerici, Christine] Univ Paris 07, INSERM, U700, Paris, France; [Mangin, Laurence] Hop Bichat Claude Bernard, AP HP, Ctr Invest Clin, F-75877 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Lanzhou University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mangin, L (corresponding author), Univ Paris 07, CNRS, Lab Mat & Syst Complexes, UMR 7057, Paris, France.	laurence.mangin@bch.aphp.fr		Courbage, Maurice/0000-0001-6615-9039	PHRC [P100136]; BQR Paris 7 University; Fond de Dotation Recherche Respiratoire; National Natural Science Foundation of China [11105062]	PHRC; BQR Paris 7 University; Fond de Dotation Recherche Respiratoire; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by PHRC P100136 AP-HP; BQR Paris 7 University; Fond de Dotation Recherche Respiratoire; Dr Lianchun Yu was partially supported by National Natural Science Foundation of China (Grants 11105062) No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham KA, 2002, J PHYSIOL-LONDON, V541, P653, DOI 10.1113/jphysiol.2001.013462; Barahona M, 1996, NATURE, V381, P215, DOI 10.1038/381215a0; Barnes PJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000220; Birn RM, 2008, NEUROIMAGE, V40, P644, DOI 10.1016/j.neuroimage.2007.11.059; Caubit X, 2010, J NEUROSCI, V30, P9465, DOI 10.1523/JNEUROSCI.1765-10.2010; Chang C, 2009, NEUROIMAGE, V47, P1381, DOI 10.1016/j.neuroimage.2009.04.048; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Courbage M, 2007, CHAOS, V17, DOI 10.1063/1.2795435; Courbage M, 2004, CHAOS, V14, P1148, DOI 10.1063/1.1821691; Courbage M, 2010, INT J BIFURCAT CHAOS, V20, P1631, DOI 10.1142/S0218127410026733; DANGELO E, 1991, J APPL PHYSIOL, V70, P2602, DOI 10.1152/jappl.1991.70.6.2602; Del Negro CA, 2002, BIOPHYS J, V82, P206, DOI 10.1016/S0006-3495(02)75387-3; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Evans KC, 2009, NEUROIMAGE, V47, P961, DOI 10.1016/j.neuroimage.2009.05.025; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Fiamma MN, 2006, AM J PHYSIOL, V292, pR1985; Fortuna MG, 2008, J NEUROSCI, V28, P2506, DOI 10.1523/JNEUROSCI.5595-07.2008; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GOZAL D, 1995, P NATL ACAD SCI USA, V92, P6607, DOI 10.1073/pnas.92.14.6607; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; Gray P, 2011, NATURE NEUROSC, V4, P927; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hopkinson NS, 2011, RESP PHYSIOL NEUROBI, V141, P1; Jacono PJ, 2010, RESP PHYSIOL NEUROBI, V178, P429; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jiang GH, 2011, NEUROIMAGE, V57, P149, DOI 10.1016/j.neuroimage.2011.04.004; Jolley CJ, 2009, EUR RESPIR J, V33, P289, DOI 10.1183/09031936.00093408; Kantz H., 2004, NONLINEAR TIME SERIE; Lavezzi AM, 2008, NEUROPATHOLOGY, V28, P10, DOI 10.1111/j.1440-1789.2007.00824.x; LIEBERT W, 1991, EUROPHYS LETT, V14, P521, DOI 10.1209/0295-5075/14/6/004; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mangin L, 2008, RESP PHYSIOL NEUROBI, V161, P189, DOI 10.1016/j.resp.2008.02.006; Mangin L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016297; Mangin L, 2009, AM J PHYSIOL-REG I, V296, pR1088, DOI 10.1152/ajpregu.90862.2008; McKay LC, 2003, J APPL PHYSIOL, V95, P1170, DOI 10.1152/japplphysiol.00641.2002; Milsom WK, 2010, AM J PHYSIOL-REG I, V299, pR1, DOI 10.1152/ajpregu.00069.2010; Murphy PB, 2011, THORAX, V66, P602, DOI 10.1136/thx.2010.151332; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Onimaru H, 2006, J APPL PHYSIOL, V100, P2094, DOI 10.1152/japplphysiol.00119.2006; Pagliardini S, 2011, J NEUROSCI, V31, P2895, DOI 10.1523/JNEUROSCI.5338-10.2011; Pattinson KTS, 2009, NEUROIMAGE, V44, P295, DOI 10.1016/j.neuroimage.2008.09.007; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Peng T, 2013, MAGN RES IM IN PRESS; Poon CS, 1997, NATURE, V389, P492, DOI 10.1038/39043; Poon CS, 2001, P NATL ACAD SCI USA, V98, P7107, DOI 10.1073/pnas.131173198; Que CL, 2001, J APPL PHYSIOL, V91, P1131, DOI 10.1152/jappl.2001.91.3.1131; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Samara Z, 2009, RESP PHYSIOL NEUROBI, V165, P82, DOI 10.1016/j.resp.2008.10.015; Schmidt M, 2010, ANESTHESIOLOGY, V112, P670, DOI 10.1097/ALN.0b013e3181cea375; Schwarzacher SW, 2011, BRAIN, V134, P24, DOI 10.1093/brain/awq327; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Smith GD, 2000, J NEUROPHYSIOL, V83, P588, DOI 10.1152/jn.2000.83.1.588; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thoby-Brisson M, 2009, NAT NEUROSCI, V12, P1028, DOI 10.1038/nn.2354; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Wittmeier S, 2008, P NATL ACAD SCI USA, V105, P18000, DOI 10.1073/pnas.0809377105; Yan S, 2000, EUR RESPIR J, V16, P684, DOI 10.1034/j.1399-3003.2000.16d20.x; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982	67	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75740	10.1371/journal.pone.0075740	http://dx.doi.org/10.1371/journal.pone.0075740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098396	gold, Green Published, Green Submitted			2022-12-25	WOS:000325483600022
J	Sapkota, D; Costea, DE; Ibrahim, SO; Johannessen, AC; Bruland, O				Sapkota, Dipak; Costea, Daniela Elena; Ibrahim, Salah O.; Johannessen, Anne C.; Bruland, Ove			S100A14 Interacts with S100A16 and Regulates Its Expression in Human Cancer Cells	PLOS ONE			English	Article							YEAST 2-HYBRID SYSTEM; PROTEIN; FAMILY; CARCINOMA; CALCIUM; ROLES; DIFFERENTIATION; PROTEASOME; MTS1	Both S100A14 and S100A16 are members of the multifunctional S100 protein family. Formation of homo/heterodimers is considered to be one of the major mechanisms for S100 proteins to execute their diverse cellular functions. By employing a classical Yeast two hybrid (Y-2 H) screen, we identified S100A16 as the single interaction partner of S100A14. This interaction was verified by co-immunoprecipitation, double indirect immunofluorescence and double immunostaining in specimens of oral squamous cell carcinoma and normal oral mucosa. The functional significance of this interaction was examined by employing retroviral mediated over-expression and knock-down of these proteins in several cancer cell-lines. Over-expression and knock-down of S100A14 led to concomitant up-and down-regulation of S100A16 protein in the cell-lines examined. However, there was no up-regulation of S100A16 mRNA upon S100A14 over-expression, indicating that modulation of S100A16 expression was not due to enhanced transcriptional activity but possibly by post-transcriptional regulation. In contrary, over-expression of S100A16 was associated neither with the up-regulation of S100A14 mRNA nor its protein, suggesting a unidirectional regulation between S100A14 and S100A16. Cellular treatment with protein synthesis inhibitor cycloheximide demonstrated a time-dependent intracellular degradation of both S100A16 and S100A14 proteins. Additionally, regulation of S100A16 and S100A14 degradation was found to be independent of the classical proteasomal and lysosomal pathways of protein degradation. Further studies will therefore be necessary to understand the functional significance of this interaction and the mechanisms on how S100A14 is involved in the regulation of S100A16 expression.	[Sapkota, Dipak; Costea, Daniela Elena; Johannessen, Anne C.] Univ Bergen, Haukeland Univ Hosp, Gade Lab Pathol, Dept Clin Med, Bergen, Norway; [Ibrahim, Salah O.] Univ Bergen, Dept Clin Dent, Bergen, Norway; [Johannessen, Anne C.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Bruland, Ove] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Sapkota, D (corresponding author), Univ Bergen, Haukeland Univ Hosp, Gade Lab Pathol, Dept Clin Med, Bergen, Norway.	Dipak.Sapkota@gades.uib.no	Johannessen, Anne Christine/B-8929-2017; Costea, Daniela Elena/AAB-9705-2020	Johannessen, Anne Christine/0000-0001-5403-2380; Costea, Daniela-Elena/0000-0001-7673-0358; Sapkota, Dipak/0000-0003-0061-825X	University of Bergen; Bergen Medical Research Foundation	University of Bergen; Bergen Medical Research Foundation	This study was funded by the University of Bergen (post-doctoral fund, DS) and Bergen Medical Research Foundation (DEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; Babini E, 2011, J BIOL INORG CHEM, V16, P243, DOI 10.1007/s00775-010-0721-3; Bertini I, 2012, J BIOL INORG CHEM, V18, P1; Chan A, 2011, APPL IMMUNOHISTO M M, V19, P376, DOI 10.1097/PAI.0b013e31820251c0; Deloulme JC, 2003, MICROSC RES TECHNIQ, V60, P560, DOI 10.1002/jemt.10298; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HALACHMI D, 1993, FEBS LETT, V316, P73, DOI 10.1016/0014-5793(93)81739-M; Harper LJ, 2007, J ORAL PATHOL MED, V36, P594, DOI 10.1111/j.1600-0714.2007.00617.x; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Jin QE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019375; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Lin P, 2000, P NATL ACAD SCI USA, V97, P674, DOI 10.1073/pnas.97.2.674; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V313, P237, DOI 10.1016/j.bbrc.2003.11.115; Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Pietas A, 2002, GENOMICS, V79, P513, DOI 10.1006/geno.2002.6744; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; PRIME SS, 1990, J PATHOL, V160, P259, DOI 10.1002/path.1711600313; Renshaw S, 2007, IMMUNOHISTOCHEMISTRY; Sapkota D, 2008, J ORAL PATHOL MED, V37, P607, DOI 10.1111/j.1600-0714.2008.00683.x; Sapkota D, 2012, ORAL ONCOL, V48, P219, DOI 10.1016/j.oraloncology.2011.10.001; Sapkota D, 2011, EUR J CANCER, V47, P600, DOI 10.1016/j.ejca.2010.10.012; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; Tarabykina S, 2000, FEBS LETT, V475, P187, DOI 10.1016/S0014-5793(00)01652-5; TEIGELKAMP S, 1991, J BIOL CHEM, V266, P13462; Thomas GJ, 2001, J INVEST DERMATOL, V117, P67, DOI 10.1046/j.0022-202x.2001.01379.x; Wang HY, 2010, ONCOL REP, V23, P45, DOI 10.3892/or_00000604; Yang Q, 1999, EXP CELL RES, V246, P501, DOI 10.1006/excr.1998.4314; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	33	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76058	10.1371/journal.pone.0076058	http://dx.doi.org/10.1371/journal.pone.0076058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086685	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900074
J	Lemay, DG; Pollard, KS; Martin, WF; Zadrowski, CF; Hernandez, J; Korf, I; German, JB; Rijnkels, M				Lemay, Danielle G.; Pollard, Katherine S.; Martin, William F.; Zadrowski, Courtneay Freeman; Hernandez, Joseph; Korf, Ian; German, J. Bruce; Rijnkels, Monique			From Genes to Milk: Genomic Organization and Epigenetic Regulation of the Mammary Transcriptome	PLOS ONE			English	Article							EXPRESSION; MOUSE; BIOINFORMATICS; IDENTIFICATION; NEIGHBORHOOD; PRINCIPLES; LACTATION; PATTERNS; DOMAINS	Even in genomes lacking operons, a gene's position in the genome influences its potential for expression. The mechanisms by which adjacent genes are co-expressed are still not completely understood. Using lactation and the mammary gland as a model system, we explore the hypothesis that chromatin state contributes to the co-regulation of gene neighborhoods. The mammary gland represents a unique evolutionary model, due to its recent appearance, in the context of vertebrate genomes. An understanding of how the mammary gland is regulated to produce milk is also of biomedical and agricultural importance for human lactation and dairying. Here, we integrate epigenomic and transcriptomic data to develop a comprehensive regulatory model. Neighborhoods of mammary-expressed genes were determined using expression data derived from pregnant and lactating mice and a neighborhood scoring tool, G-NEST. Regions of open and closed chromatin were identified by ChIP-Seq of histone modifications H3K36me3, H3K4me2, and H3K27me3 in the mouse mammary gland and liver tissue during lactation. We found that neighborhoods of genes in regions of uniquely active chromatin in the lactating mammary gland, compared with liver tissue, were extremely rare. Rather, genes in most neighborhoods were suppressed during lactation as reflected in their expression levels and their location in regions of silenced chromatin. Chromatin silencing was largely shared between the liver and mammary gland during lactation, and what distinguished the mammary gland was mainly a small tissue-specific repertoire of isolated, expressed genes. These findings suggest that an advantage of the neighborhood organization is in the collective repression of groups of genes via a shared mechanism of chromatin repression. Genes essential to the mammary gland's uniqueness are isolated from neighbors, and likely have less tolerance for variation in expression, properties they share with genes responsible for an organism's survival.	[Lemay, Danielle G.; Korf, Ian] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Martin, William F.; German, J. Bruce] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Gladstone Inst, Inst Human Genet, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Zadrowski, Courtneay Freeman; Hernandez, Joseph; Rijnkels, Monique] Baylor Coll Med, USDA ARS Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Baylor College of Medicine; United States Department of Agriculture (USDA)	Lemay, DG (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	dglemay@ucdavis.edu; rijnkel@bcm.edu		Lemay, Danielle/0000-0003-3318-0485	NIH [1R21HD05376, 1R03HD05609]; USDA [6200-51000-048]; California Dairy Research Foundation [09 GEB-01 NH]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); California Dairy Research Foundation	Funding was provided by NIH (1R21HD05376, 1R03HD05609) to MR, USDA (6200-51000-048) to MR, and California Dairy Research Foundation (09 GEB-01 NH) to JBG, MR, and KSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De S, 2009, GENOME RES, V19, P785, DOI 10.1101/gr.086165.108; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Harr B, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj010; Kabotyanski EB, 2009, J BIOL CHEM, V284, P22815, DOI 10.1074/jbc.M109.032490; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kress C, 2010, J MAMMARY GLAND BIOL, V15, P73, DOI 10.1007/s10911-010-9169-x; Lemay DG, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-253; Lemay DG, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-56; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018; Pritchard C, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r26; Purmann A, 2007, GENOMICS, V89, P580, DOI 10.1016/j.ygeno.2007.01.010; Rijnkels M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053270; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Rudolph MC, 2003, J MAMMARY GLAND BIOL, V8, P287, DOI 10.1023/B:JOMG.0000010030.73983.57; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Sinha AU, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-82; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Turk R, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-57; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Yanai I, 2009, GENOME RES, V19, P2214, DOI 10.1101/gr.093815.109; Yu PF, 2013, GENOME RES, V23, P352, DOI 10.1101/gr.144949.112; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	34	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75030	10.1371/journal.pone.0075030	http://dx.doi.org/10.1371/journal.pone.0075030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086428	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000013
J	Nolle, A; van Haastert, ES; Zwart, R; Hoozemans, JJM; Scheper, W				Nolle, Anna; van Haastert, Elise S.; Zwart, Rob; Hoozemans, Jeroen J. M.; Scheper, Wiep			Ubiquilin 2 Is Not Associated with Tau Pathology	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ALZHEIMERS-DISEASE; ACCUMULATION; DEGENERATION; HIPPOCAMPUS; AUTOPHAGY; CHAPERONE; NEURONS	Accumulation of aberrant proteins in inclusion bodies is a hallmark of many neurodegenerative diseases. Impairment of proteolytic systems is a common event in these protein misfolding diseases. Recently, mutations in the UBQLN 2 gene encoding ubiquilin 2 have been identified in X-linked amyotrophic lateral sclerosis (ALS). Furthermore, ubiquilin 2 is associated with inclusions in familial and sporadic ALS/dementia, synucleinopathies and polyglutamine diseases. Ubiquilin 2 exerts a regulatory role in proteostasis and thus it has been suggested that ubiquilin 2 pathology may be a common event in neurodegenerative diseases. Tauopathies, a heterogenous group of neurodegenerative diseases accompanied with dementia, are characterized by inclusions of the microtubule-binding protein tau. In the present study, we investigate whether ubiquilin 2 is connected with tau pathology in Alzheimer's disease (AD), supranuclear palsy (PSP) and Pick's disease (PiD) and familial cases with frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). We show that ubiquilin 2 positive inclusions are absent in these tauopathies. Furthermore, we find decreased ubiquilin 2 protein levels in AD patients, but our results do not indicate a correlation with tau pathology. Our data show no evidence for involvement of ubiquilin 2 and indicate that other mechanisms underly the proteostatic disturbances in tauopathies.	[Nolle, Anna; Zwart, Rob; Scheper, Wiep] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [van Haastert, Elise S.; Hoozemans, Jeroen J. M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Scheper, Wiep] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Scheper, W (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.scheper@amc.uva.nl	Scheper, Wiep/AAI-7323-2020	Hoozemans, Jeroen/0000-0002-2888-8967; Scheper, Wiep/0000-0002-1431-4559	Internationale Stichting Alzheimer Onderzoek (ISAO) [10502]	Internationale Stichting Alzheimer Onderzoek (ISAO)	This study was financially supported by Internationale Stichting Alzheimer Onderzoek (ISAO #10502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P825, DOI 10.1007/s00401-012-0970-z; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Fecto F, 2012, MUSCLE NERVE, V45, P157, DOI 10.1002/mus.23278; Ford DL, 2006, BIOCHEM J, V399, P397, DOI 10.1042/BJ20060441; Goedert M, 2011, J MOL NEUROSCI, V45, P425, DOI 10.1007/s12031-011-9593-4; Haapasalo Annakaisa, 2011, Commun Integr Biol, V4, P428, DOI 10.4161/cib.4.4.15283; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Kamboh MI, 2006, MOL PSYCHIATR, V11, P273, DOI 10.1038/sj.mp.4001775; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Mori F, 2012, ACTA NEUROPATHOL, V124, P149, DOI 10.1007/s00401-012-0999-z; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Nijholt DAT, 2011, CURR MED CHEM, V18, P2459; Nijholt DAT, 2012, J PATHOL, V226, P693, DOI 10.1002/path.3969; Probst A, 2001, ACTA NEUROPATHOL, V102, P636, DOI 10.1007/s004010100420; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Satoh J, 2013, NEUROPATHOL APPL NEU; Stieren ES, 2011, J BIOL CHEM, V286, P35689, DOI 10.1074/jbc.M111.243147; Viswanathan J, 2011, TRAFFIC, V12, P330, DOI 10.1111/j.1600-0854.2010.01149.x; Wu SL, 2002, BBA-MOL CELL RES, V1542, P41, DOI 10.1016/S0167-4889(01)00164-1; Zhang Can, 2009, Discov Med, V8, P18; Zhou XK, 2006, P NATL ACAD SCI USA, V103, P17214, DOI 10.1073/pnas.0602954103	26	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76598	10.1371/journal.pone.0076598	http://dx.doi.org/10.1371/journal.pone.0076598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086754	gold, Green Published, Green Submitted			2022-12-25	WOS:000325220000070
J	Attema, JL; Bert, AG; Lim, YY; Kolesnikoff, N; Lawrence, DM; Pillman, KA; Smith, E; Drew, PA; Khew-Goodall, Y; Shannon, F; Goodall, GJ				Attema, Joanne L.; Bert, Andrew G.; Lim, Yat-Yuen; Kolesnikoff, Natasha; Lawrence, David M.; Pillman, Katherine A.; Smith, Eric; Drew, Paul A.; Khew-Goodall, Yeesim; Shannon, Frances; Goodall, Gregory J.			Identification of an Enhancer That Increases miR-200b similar to 200a similar to 429 Gene Expression in Breast Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MIR-200 FAMILY; ACTIVE CHROMATIN; REPRESSORS ZEB1; NONCODING RNAS; FEEDBACK LOOP; TRANSCRIPTION; MICRORNAS; REGULATORS; PROMOTERS	The miR-200b similar to 200a similar to 429 gene cluster is a key regulator of EMT and cancer metastasis, however the transcription-based mechanisms controlling its expression during this process are not well understood. We have analyzed the miR-200b similar to 200a similar to 429 locus for epigenetic modifications in breast epithelial and mesenchymal cell lines using chromatin immunoprecipitation assays and DNA methylation analysis. We discovered a novel enhancer located approximately 5.1kb upstream of the miR-200b similar to 200a similar to 429 transcriptional start site. This region was associated with the active enhancer chromatin signature comprising H3K4me1, H3K27ac, RNA polymerase II and CpG dinucleotide hypomethylation. Luciferase reporter assays revealed the upstream enhancer stimulated the transcription of the miR-200b similar to 200a similar to 429 minimal promoter region approximately 27-fold in breast epithelial cells. Furthermore, we found that a region of the enhancer was transcribed, producing a short, GC-rich, mainly nuclear, non-polyadenylated RNA transcript designated miR-200b eRNA. Over-expression of miR-200b eRNA had little effect on miR-200b similar to 200a similar to 429 promoter activity and its production did not correlate with miR-200b similar to 200a similar to 429 gene expression. While additional investigations of miR-200b eRNA function will be necessary, it is possible that miR-200b eRNA may be involved in the regulation of miR-200b similar to 200a similar to 429 gene expression and silencing. Taken together, these findings reveal the presence of a novel enhancer, which contributes to miR-200b similar to 200a similar to 429 transcriptional regulation in epithelial cells.	[Attema, Joanne L.; Bert, Andrew G.; Lim, Yat-Yuen; Kolesnikoff, Natasha; Pillman, Katherine A.; Khew-Goodall, Yeesim; Goodall, Gregory J.] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Lim, Yat-Yuen; Goodall, Gregory J.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Lim, Yat-Yuen] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Lawrence, David M.] Ctr Canc Biol, ACRF Canc Genom Facil, Adelaide, SA, Australia; [Smith, Eric] Univ Adelaide, Discipline Surg, Adelaide, SA, Australia; [Drew, Paul A.] Flinders Univ S Australia, Sch Nursing & Midwifery, Bedford Pk, SA 5042, Australia; [Shannon, Frances] Univ Canberra, Off Deputy Vice Chancellor Res, Bruce, ACT, Australia; [Attema, Joanne L.; Lawrence, David M.; Khew-Goodall, Yeesim; Goodall, Gregory J.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Centre for Cancer Biology; SA Pathology; University of Adelaide; Universiti Malaya; Centre for Cancer Biology; University of Adelaide; Flinders University South Australia; University of Canberra; University of Adelaide	Attema, JL (corresponding author), SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia.	joanne.attema@health.sa.gov.au; greg.goodall@health.sa.gov.au	Smith, Eric/ABG-7104-2020; Lim, Yat Yuen/I-6495-2013; Smith, Eric/Y-1350-2019; Pillman, Katherine A/M-5723-2019	Lim, Yat Yuen/0000-0001-8617-6063; Smith, Eric/0000-0003-2958-3492; Pillman, Katherine A/0000-0002-5869-889X; Bert, Andrew/0000-0003-3876-1537; Drew, Paul/0000-0001-5661-4771; Lawrence, David/0000-0001-5464-5830	National Health and Medical Research Council [APP1008440]; Swedish Medical Research Council (Vetenskapsradet) [521-2009-2873]; Lund University Faculty of Medicine; Hemato-Linne Program; National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Swedish Medical Research Council (Vetenskapsradet)(Swedish Medical Research Council (SMRC)Swedish Research Council); Lund University Faculty of Medicine; Hemato-Linne Program; National Breast Cancer Foundation	This work was supported by a Project Grant APP1008440 from the National Health and Medical Research Council to GG and FS, and by funds from the Swedish Medical Research Council (Vetenskapsradet, 521-2009-2873), Lund University Faculty of Medicine and The Hemato-Linne Program to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Boussouar F, 2008, CELL CYCLE, V7, P3499, DOI 10.4161/cc.7.22.6975; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Flynn RA, 2012, CURR OPIN GENET DEV, V22, P172, DOI 10.1016/j.gde.2011.11.002; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Himes SR, 2001, J LEUKOCYTE BIOL, V70, P812; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Jin FL, 2011, TRANSCR-AUSTIN, V2, P226, DOI 10.4161/trns.2.5.17712; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Lim YY, 2013, J CELL SCI, V126, P2256, DOI 10.1242/jcs.122275; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pike JW, 2011, J BONE MINER RES, V26, P1155, DOI 10.1002/jbmr.317; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Van Bortle K, 2012, ANNU REV CELL DEV BI, V28, P163, DOI 10.1146/annurev-cellbio-101011-155824; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Zentner GE, 2012, J BIOL CHEM, V287, P30888, DOI 10.1074/jbc.R111.296491	49	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75517	10.1371/journal.pone.0075517	http://dx.doi.org/10.1371/journal.pone.0075517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086551	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700094
J	Grasman, J				Grasman, Johan			Reconstruction of the Drive Underlying Food Intake and Its Control by Leptin and Dieting	PLOS ONE			English	Article							WEIGHT; KINETICS; PATTERNS	The intake of food and the expenditure of calories is modelled by a system of differential equations. The state variables are the amount of calories stored in adipose tissue and the level of plasma leptin. The model has as input a drive that controls the intake of food. This drive consists of a collective of physiological and psychological incentives to eat or to stop eating. An individual based approach is presented by which the parameters of the system can be set using data of a subject. The method of analysis is fully worked out using weight data of two persons. The model is prone to extensions by transferring incentives being part of the input to the collection of state variables.	Univ Wageningen & Res Ctr, Wageningen, Netherlands	Wageningen University & Research	Grasman, J (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	johan.grasman@wur.nl						Amigo Isaac, 2007, Psychol Health Med, V12, P321, DOI 10.1080/13548500600621545; BLACK DR, 1991, INT J OBESITY, V15, P623; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; Dardeno TA, 2010, FRONT NEUROENDOCRIN, V31, P377, DOI 10.1016/j.yfrne.2010.06.002; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Grasman J, 2009, ENCY COMPLEXITY S 18, V18, P7602; Grasman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047139; Klein S, 1996, DIABETES, V45, P984, DOI 10.2337/diabetes.45.7.984; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Leibel RL, 2008, INT J OBESITY, V32, pS98, DOI 10.1038/ijo.2008.245; Lowe MR, 2005, OBES RES, V13, P797, DOI 10.1038/oby.2005.90; Nicklas TA, 2001, J AM COLL NUTR, V20, P599, DOI 10.1080/07315724.2001.10719064; Pearcey SM, 2002, AM J CLIN NUTR, V76, P107, DOI 10.1093/ajcn/76.1.107; Peters J C, 2002, Obes Rev, V3, P69, DOI 10.1046/j.1467-789X.2002.00059.x; Pontzer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040503; Prentice A. M., 2001, BNF Nutrition Bulletin, V26, P13, DOI 10.1046/j.1467-3010.2001.00100.x; Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579; Speakman JR, 2011, DIS MODEL MECH, V4, P733, DOI 10.1242/dmm.008698; Tomiyama AJ, 2012, PHYSIOL BEHAV, V107, P34, DOI 10.1016/j.physbeh.2012.04.021; Wong SL, 2004, J CLIN ENDOCR METAB, V89, P2672, DOI 10.1210/jc.2003-031931; Woodworth RS., 1918, DYNAMIC PSYCHOL, DOI 10.7312/wood90908	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e74997	10.1371/journal.pone.0074997	http://dx.doi.org/10.1371/journal.pone.0074997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086420	Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700047
J	Lodi, S; Phillips, A; Fidler, S; Hawkins, D; Gilson, R; McLean, K; Fisher, M; Post, F; Johnson, AM; Walker-Nthenda, L; Dunn, D; Porter, K				Lodi, Sara; Phillips, Andrew; Fidler, Sarah; Hawkins, David; Gilson, Richard; McLean, Ken; Fisher, Martin; Post, Frank; Johnson, Anne M.; Walker-Nthenda, Louise; Dunn, David; Porter, Kholoud		UK Register HIV	Role of HIV Infection Duration and CD4 Cell Level at Initiation of Combination Anti-Retroviral Therapy on Risk of Failure	PLOS ONE			English	Article							DRUG-RESISTANCE MUTATIONS; INDIVIDUALS; PREDICTORS; COHORT	Background: The development of HIV drug resistance and subsequent virological failure are often cited as potential disadvantages of early cART initiation. However, their long-term probability is not known, and neither is the role of duration of infection at the time of initiation. Methods: Patients enrolled in the UK Register of HIV seroconverters were followed-up from cART initiation to last HIV-RNA measurement. Through survival analysis we examined predictors of virologic failure (2HIV-RNA >= 400 c/l while on cART) including CD4 count and HIV duration at initiation. We also estimated the cumulative probabilities of failure and drug resistance (from the available HIV nucleotide sequences) for early initiators (cART within 12 months of seroconversion). Results: Of 1075 starting cART at a median (IQR) CD4 count 272 (190,370) cells/mm(3) and HIV duration 3 (1,6) years, virological failure occurred in 163 (15%). Higher CD4 count at initiation, but not HIV infection duration at cART initiation, was independently associated with lower risk of failure (p=0.033 and 0.592 respectively). Among 230 patients initiating cART early, 97 (42%) discontinued it after a median of 7 months; cumulative probabilities of resistance and failure by 8 years were 7% (95% CI 4,11) and 19% (13,25), respectively. Conclusion: Although the rate of discontinuation of early cART in our cohort was high, the long-term rate of virological failure was low. Our data do not support early cART initiation being associated with increased risk of failure and drug resistance.	[Lodi, Sara; Walker-Nthenda, Louise; Dunn, David; Porter, Kholoud] UCL, MRC, London, England; [Lodi, Sara] Inst Salud Carlos III, Madrid, Spain; [Phillips, Andrew; Johnson, Anne M.] UCL, London, England; [Fidler, Sarah] Imperial Coll NHS Trust, London, England; [Hawkins, David] Chelsea & Westminster Hosp, London, England; [Gilson, Richard] Mortimer Market Ctr, London, England; [Gilson, Richard] Univ Coll London Hosp, London, England; [McLean, Ken] Charing Cross Hosp, London, England; [Fisher, Martin] Brighton & Sussex Univ Hosp Natl Hlth Serv Trust, Brighton, E Sussex, England; [Post, Frank] Kings Coll London, London, England	University of London; University College London; Instituto de Salud Carlos III; University of London; University College London; Imperial College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Imperial College London; University of London; King's College London	Porter, K (corresponding author), UCL, MRC, London, England.	kp@ctu.mrc.ac.uk	Phillips, Andrew N/B-4427-2008	Phillips, Andrew N/0000-0003-2384-4807; delpech, valerie/0000-0002-9952-8109; Ong, Edmund/0000-0002-6594-0509; Anderson, Jane/0000-0001-5294-8707; Fidler, Sarah/0000-0003-1676-7583; Johnson, Anne/0000-0003-1330-7100; Kennedy, Nicholas/0000-0003-1106-3827; Porter, Kholoud/0000-0002-9226-6206; Dunn, David/0000-0003-1836-4446; fox, Julie/0000-0002-0583-8019	Medical Research Council; MRC [MC_UU_12023/15, MC_U122886351] Funding Source: UKRI; Medical Research Council [MC_U122886351, MC_UU_12023/15] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10244] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The UK Register of HIV Seroconversion is funded by the Medical Research Council. No current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, HIV TESTING NEW HIV; Asboe D, 2012, HIV MED, V13, P1, DOI 10.1111/j.1468-1293.2011.00971.x; Audelin AM, 2009, ANTIVIR THER, V14, P995, DOI 10.3851/IMP1412; BABIKER AG, 2012, CLIN TRIALS, P1; Bannister WP, 2011, J ANTIMICROB CHEMOTH, V66, P901, DOI 10.1093/jac/dkr006; BERAL V, 1996, EPIDEMIOL INFECT, V117, P305; CLEMENTS M, 2003, ME HIV, V4, P332; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Department of agriculture forestry and fisheries, 2012, GUID US ANT AG HIV 1, P1; Dorrucci M, 2005, AIDS, V19, P331; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; *EUR AIDSCLINICAL, 2012, CLIN MAN TREATM HIV; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gupta R, 2008, CLIN INFECT DIS, V47, P712, DOI 10.1086/590943; Harrigan PR, 2010, CLIN INFECT DIS, V50, P1286, DOI 10.1086/651685; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Health Protection Agency, 2012, HIV UK 2012 REP; JAIN V, 2012, 19 INT C AIDS WASH D; Lodi S, 2010, AIDS, V24, P2697, DOI 10.1097/QAD.0b013e32833ef6c4; Miettinen O S, 1983, Stat Med, V2, P267, DOI 10.1002/sim.4780020222; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Pillay D, 2005, J INFECT DIS, V192, P967, DOI 10.1086/432763; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; *STANF U, 2011, HIV DRUG RES DAT; Uy J, 2009, JAIDS-J ACQ IMM DEF, V51, P450, DOI 10.1097/QAI.0b013e3181acb630; von Wyl V, 2012, CLIN INFECT DIS, V54, P131, DOI 10.1093/cid/cir728; WHO, 2010, ANT THER HIV INF AD; 2013, N ENGL J ME, V368, P207	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75608	10.1371/journal.pone.0075608	http://dx.doi.org/10.1371/journal.pone.0075608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086588	Green Published, gold			2022-12-25	WOS:000325025200055
J	Zhao, YL; Zhang, L; Qiao, Y; Zhou, XL; Wu, GD; Wang, LJ; Peng, YH; Dong, XL; Huang, H; Si, LN; Zhang, XY; Zhang, L; Li, JH; Wang, W; Zhou, LY; Gao, X				Zhao, Yanli; Zhang, Lina; Qiao, Yu; Zhou, Xiaoling; Wu, Guodong; Wang, Lujing; Peng, Yahui; Dong, Xingli; Huang, Hui; Si, Lining; Zhang, Xueying; Zhang, Lei; Li, Jihong; Wang, Wei; Zhou, Lingyun; Gao, Xu			Heme Oxygenase-1 Prevents Cardiac Dysfunction in Streptozotocin-Diabetic Mice by Reducing Inflammation, Oxidative Stress, Apoptosis and Enhancing Autophagy	PLOS ONE			English	Article							SIGNALING PATHWAY; NADPH OXIDASE; CELL-DEATH; PROTECTIVE ROLE; GROWTH-FACTOR; CARDIOMYOPATHY; HEART; MECHANISMS; EXPRESSION; KINASE	Heme oxygenase-1 (HO-1) has been implicated in cardiac dysfunction, oxidative stress, inflammation, apoptosis and autophagy associated with heart failure, and atherosclerosis, in addition to its recognized role in metabolic syndrome and diabetes. Numerous studies have presented contradictory findings about the role of HO-1 in diabetic cardiomyopathy (DCM). In this study, we explored the role of HO-1 in myocardial dysfunction, myofibril structure, oxidative stress, inflammation, apoptosis and autophagy using a streptozotocin (STZ)-induced diabetes model in mice systemically overexpressing HO-1 (Tg-HO-1) or mutant HO-1 (Tg-mutHO-1). The diabetic mouse model was induced by multiple peritoneal injections of STZ. Two months after injection, left ventricular (LV) function was measured by echocardiography. In addition, molecular biomarkers related to oxidative stress, inflammation, apoptosis and autophagy were evaluated using classical molecular biological/biochemical techniques. Mice with DCM exhibited severe LV dysfunction, myofibril structure disarray, aberrant cardiac oxidative stress, inflammation, apoptosis, autophagy and increased levels of HO-1. In addition, we determined that systemic overexpression of HO-1 ameliorated left ventricular dysfunction, myofibril structure disarray, oxidative stress, inflammation, apoptosis and autophagy in DCM mice. Furthermore, serine/threonine-specific protein kinase (Akt) and AMP-activated protein kinase (AMPK) phosphorylation is normally inhibited in DCM, but overexpression of the HO-1 gene restored the phosphorylation of these kinases to normal levels. In contrast, the functions of HO-1 in DCM were significantly reversed by overexpression of mutant HO-1. This study underlines the unique roles of HO-1, including the inhibition of oxidative stress, inflammation and apoptosis and the enhancement of autophagy, in the pathogenesis of DCM.	[Zhao, Yanli; Zhang, Lina; Qiao, Yu; Zhou, Xiaoling; Wu, Guodong; Wang, Lujing; Peng, Yahui; Dong, Xingli; Huang, Hui; Zhang, Xueying; Zhang, Lei; Li, Jihong; Wang, Wei; Zhou, Lingyun; Gao, Xu] Harbin Med Univ, Dept Biochem, Harbin, Heilongjiang, Peoples R China; [Zhao, Yanli] Qinghai Univ, Coll Med, Dept Biochem, Xining, Qinghai, Peoples R China; [Gao, Xu] Harbin Med Univ, Minist Educ, Key Lab Cardiovasc Med Res, Harbin, Heilongjiang, Peoples R China; [Gao, Xu] Harbin Med Univ, State Prov Key Labs Biomed Pharmaceut China, Harbin, Heilongjiang, Peoples R China; [Si, Lining] Qinghai Univ, Sch Med, Affiliated Hosp, Dept Critical Care Med, Xining, Qinghai, Peoples R China; [Zhang, Lina] Daqing Oilfield Gen Hosp, Dept Clin Lab, Daqing, Heilongjiang, Peoples R China	Harbin Medical University; Qinghai University; Harbin Medical University; Harbin Medical University; Qinghai University	Zhou, LY (corresponding author), Harbin Med Univ, Dept Biochem, Harbin, Heilongjiang, Peoples R China.	zhoulingy@tom.com; gaoxu_671227@163.com	si, lining/GWD-0263-2022; zhao, yan/GWC-9174-2022; gao, xu/U-4765-2019; Dong, Xingli/AAH-8374-2021		National Natural Science Foundation of Regional China [81060162, 81001033]; Natural Science Foundation of Innovation Team of China [81121003]	National Natural Science Foundation of Regional China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Innovation Team of China	This work was supported by the National Natural Science Foundation of Regional China (No.81060162, No.81001033) and the Natural Science Foundation of Innovation Team of China (No.81121003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2004, AM J PHYSIOL-HEART C, V287, pH2468, DOI 10.1152/ajpheart.01187.2003; Abraham NG, 2003, CIRC RES, V93, P507, DOI 10.1161/01.RES.0000091828.36599.34; Aki T, 2003, ONCOGENE, V22, P8529, DOI 10.1038/sj.onc.1207197; Avogaro A, 2003, J CLIN ENDOCR METAB, V88, P1753, DOI 10.1210/jc.2002-021025; Bao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012371; Bodiga VL, 2013, HEART FAIL REV; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Bowman MAH, 2011, J HEART LUNG TRANSPL, V30, P1303, DOI 10.1016/j.healun.2011.06.004; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Cacciapaglia F, 2011, AUTOIMMUN REV, V10, P631, DOI 10.1016/j.autrev.2011.04.014; Cao J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00160; Cao J, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-37; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Chen David, 2008, Crit Care Med, V36, pS9, DOI 10.1097/01.CCM.0000297160.48694.90; Chen SL, 2004, FREE RADICAL RES, V38, P1301, DOI 10.1080/10715760400017228; Delucchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039836; Deswal A, 2001, CIRCULATION, V103, P2055; Durante W, 2011, FRONT BIOSCI-LANDMRK, V16, P2372, DOI 10.2741/3860; El-Remessy AB, 2011, DIABETOLOGIA, V54, P1567, DOI 10.1007/s00125-011-2061-4; Falcao-Pires I, 2012, HEART FAIL REV, V17, P325, DOI 10.1007/s10741-011-9257-z; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Farhangkhoee H, 2003, J MOL CELL CARDIOL, V35, P1439, DOI 10.1016/j.yjmcc.2003.09.007; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Gallego M, 2009, CAN J PHYSIOL PHARM, V87, P77, DOI 10.1139/Y08-106; Gao X, 2011, EUR J PHARMACOL, V659, P199, DOI 10.1016/j.ejphar.2011.03.021; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Haines DD, 2012, ACTA PHYSIOL, V204, P487, DOI 10.1111/j.1748-1716.2011.02387.x; He CY, 2013, DIABETES, V62, P1270, DOI 10.2337/db12-0533; Hong F, 2001, LIFE SCI, V68, P1095, DOI 10.1016/S0024-3205(00)01012-2; Hsueh W, 2007, CIRC RES, V100, P1415, DOI 10.1161/01.RES.0000266449.37396.1f; Hui Y, 2012, J CARDIOVASC PHARM, V60, P474, DOI 10.1097/FJC.0b013e31826c1c13; Huynh K, 2013, FREE RADICAL BIO MED, V60, P307, DOI 10.1016/j.freeradbiomed.2013.02.021; Khong FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022777; Khullar M, 2010, CAN J PHYSIOL PHARM, V88, P233, DOI 10.1139/Y10-016; Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KWAK JY, 1991, BIOCHIM BIOPHYS ACTA, V1076, P369, DOI 10.1016/0167-4838(91)90478-I; Lacombe VA, 2007, AM J PHYSIOL-REG I, V293, pR1787, DOI 10.1152/ajpregu.00059.2007; Lecour S, 2011, EUR HEART J, V32, P680, DOI 10.1093/eurheartj/ehq484; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; Lorenzo O, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/652097; Luchner A, 2001, CARDIOVASC RES, V51, P601, DOI 10.1016/S0008-6363(01)00316-9; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Mano Y, 2011, CIRC J, V75, P1717, DOI 10.1253/circj.CJ-10-1199; Martinet W, 2007, TRENDS MOL MED, V13, P482, DOI 10.1016/j.molmed.2007.08.004; McCann FJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0049894, 10.1371/journal.pone.0052013]; Mougiakakos D, 2011, BLOOD, V117, P4826, DOI 10.1182/blood-2010-12-324038; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Octavia Y, 2012, FREE RADICAL BIO MED, V52, P291, DOI 10.1016/j.freeradbiomed.2011.10.482; Orozco LD, 2007, CIRC RES, V100, P1703, DOI 10.1161/CIRCRESAHA.107.151720; Pereira L, 2006, DIABETES, V55, P608, DOI 10.2337/diabetes.55.03.06.db05-1284; Rajesh M, 2012, DIABETES, V61, P716, DOI 10.2337/db11-0477; Rajesh M, 2010, J AM COLL CARDIOL, V56, P2115, DOI 10.1016/j.jacc.2010.07.033; Raphael J, 2006, J PHARMACOL EXP THER, V318, P186, DOI 10.1124/jpet.105.100537; Ren J, 2004, ENDOCRINE, V25, P73, DOI 10.1385/ENDO:25:2:073; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schilling JD, 2012, AM J PHYSIOL-HEART C, V303, pH1366, DOI 10.1152/ajpheart.00111.2012; Selvaraju V, 2012, TOXICOL MECH METHOD, V22, P330, DOI 10.3109/15376516.2012.666648; Soliman H, 2012, AM J PHYSIOL-HEART C, V303, pH989, DOI 10.1152/ajpheart.00416.2012; Son SM, 2007, DIABETES RES CLIN PR, V77, pS65, DOI 10.1016/j.diabres.2007.01.036; Sun LA, 2011, J SURG RES, V166, pE187, DOI 10.1016/j.jss.2010.11.917; Van Linthout S, 2007, DIABETOLOGIA, V50, P1977, DOI 10.1007/s00125-007-0719-8; Wang GW, 2010, CIRCULATION, V121, P1912, DOI 10.1161/CIRCULATIONAHA.109.905471; Watanabe K, 2010, CURR CARDIOL REV, V6, P280, DOI 10.2174/157340310793566145; Wu ML, 2011, ANTIOXID REDOX SIGN, V15, P1835, DOI 10.1089/ars.2010.3726; Xie ZL, 2011, AUTOPHAGY, V7, P1254, DOI 10.4161/auto.7.10.16740; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36; Yu XY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016239, 10.1371/journal.pone.0028397]; Zhou LY, 2011, ANAT REC, V294, P112, DOI 10.1002/ar.21284; Zou MH, 2013, AUTOPHAGY, V9, P624, DOI 10.4161/auto.23577	73	108	114	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75927	10.1371/journal.pone.0075927	http://dx.doi.org/10.1371/journal.pone.0075927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086665	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200071
J	Brameier, M; Ibing, W; Hofer, K; Montag, J; Stahl-Hennig, C; Motzkus, D				Brameier, Markus; Ibing, Wiebke; Hoefer, Katharina; Montag, Judith; Stahl-Hennig, Christiane; Motzkus, Dirk			Mapping the Small RNA Content of Simian Immunodeficiency Virions (SIV)	PLOS ONE			English	Article							SMALL NONCODING RNAS; VIRUS-LIKE PARTICLES; MESSENGER-RNA; T-CELLS; 7SL RNA; TRANSLATIONAL REPRESSION; REVERSE TRANSCRIPTION; HIV-1-INFECTED CELLS; STRUCTURAL DOMAIN; CELLULAR RNAS	Recent evidence indicates that regulatory small non-coding RNAs are not only components of eukaryotic cells and vesicles, but also reside within a number of different viruses including retroviral particles. Using ultra-deep sequencing we have comprehensively analyzed the content of simian immunodeficiency virions (SIV), which were compared to mock-control preparations. Our analysis revealed that more than 428,000 sequence reads matched the SIV (mac)239 genome sequence. Among these we could identify 12 virus-derived small RNAs (vsRNAs) that were highly abundant. Beside known retrovirus-enriched small RNAs, like 7SL-RNA, tRNA(Lys3) and tRNA(Lys) isoacceptors, we also identified defined fragments derived from small ILF3/NF90-associated RNA snaR-A14, that were enriched more than 50 fold in SIV. We also found evidence that small nucleolar RNAs U2 and U12 were underrepresented in the SIV preparation, indicating that the relative number or the content of co-isolated exosomes was changed upon infection. Our comprehensive atlas of SIV-incorporated small RNAs provides a refined picture of the composition of retrovirions, which gives novel insights into viral packaging.	[Brameier, Markus] German Primate Ctr, Primate Genet Lab, Gottingen, Germany; [Ibing, Wiebke; Hoefer, Katharina; Montag, Judith; Stahl-Hennig, Christiane; Motzkus, Dirk] German Primate Ctr, Unit Infect Models, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ)	Motzkus, D (corresponding author), German Primate Ctr, Unit Infect Models, Gottingen, Germany.	dmotzkus@dpz.eu		, Judith/0000-0002-4663-6966; Hofer, Katharina/0000-0002-7472-9887	Department "Unit of Infection Models"	Department "Unit of Infection Models"	The funding was derived from the budget of the Department "Unit of Infection Models" headed by CSH at the German Primate Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDOVINI A, 1990, J VIROL, V64, P1920, DOI 10.1128/JVI.64.5.1920-1926.1990; Althaus CF, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-27; Bechtel J, 2005, J VIROL, V79, P10138, DOI 10.1128/JVI.79.16.10138-10146.2005; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; BRANLANT C, 1982, EMBO J, V1, P1259, DOI 10.1002/j.1460-2075.1982.tb00022.x; Bresnahan WA, 2000, SCIENCE, V288, P2373, DOI 10.1126/science.288.5475.2373; Cho HDD, 2002, J BIOL CHEM, V277, P3447, DOI 10.1074/jbc.M109559200; Cliffe AR, 2009, J VIROL, V83, P2321, DOI 10.1128/JVI.02303-08; Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611; D'Souza V, 2005, NAT REV MICROBIOL, V3, P643, DOI 10.1038/nrmicro1210; DAS AT, 1995, J VIROL, V69, P3090, DOI 10.1128/JVI.69.5.3090-3097.1995; Das AT, 1997, J GEN VIROL, V78, P837, DOI 10.1099/0022-1317-78-4-837; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; Didierlaurent L, 2011, NUCLEIC ACIDS RES, V39, P8915, DOI 10.1093/nar/gkr577; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Greijer AE, 2000, J VIROL, V74, P9078, DOI 10.1128/JVI.74.19.9078-9082.2000; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hoque M, 2011, J MOL BIOL, V410, P917, DOI 10.1016/j.jmb.2011.03.060; Houzet L, 2007, NUCLEIC ACIDS RES, V35, P2695, DOI 10.1093/nar/gkm153; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848; JIANG M, 1993, J VIROL, V67, P3246, DOI 10.1128/JVI.67.6.3246-3253.1993; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Keene SE, 2010, J VIROL, V84, P9070, DOI 10.1128/JVI.00714-10; Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Klase ZA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-15; KLEIMAN L, 1991, BIOCHEM BIOPH RES CO, V174, P1272, DOI 10.1016/0006-291X(91)91559-U; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; LIAUTARD JP, 1982, J MOL BIOL, V162, P623, DOI 10.1016/0022-2836(82)90392-8; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maute RL, 2013, P NATL ACAD SCI USA, V110, P1404, DOI 10.1073/pnas.1206761110; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Mussil B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-77; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; NORLEY SG, 1993, BIOLOGICALS, V21, P251, DOI 10.1006/biol.1993.1082; Onafuwa-Nuga AA, 2006, RNA, V12, P542, DOI 10.1261/rna.2306306; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Parrott AM, 2007, NUCLEIC ACIDS RES, V35, P6249, DOI 10.1093/nar/gkm668; Parrott AM, 2011, NUCLEIC ACIDS RES, V39, P1485, DOI 10.1093/nar/gkq856; Pavon-Eternod M, 2010, RNA, V16, P267, DOI 10.1261/rna.1928110; Pederson T, 2010, RNA, V16, P1865, DOI 10.1261/rna.2266510; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; SALAHUDDIN SZ, 1983, VIROLOGY, V129, P51, DOI 10.1016/0042-6822(83)90395-1; Schopman NCT, 2012, VIRUS RES, V169, P438, DOI 10.1016/j.virusres.2012.06.017; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Sciortino MT, 2001, J VIROL, V75, P8105, DOI 10.1128/JVI.75.17.8105-8116.2001; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wang SW, 2002, J VIROL, V76, P11853, DOI 10.1128/JVI.76.23.11853-11865.2002; WASSARMAN KM, 1992, MOL CELL BIOL, V12, P1276, DOI 10.1128/MCB.12.3.1276; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707	69	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75063	10.1371/journal.pone.0075063	http://dx.doi.org/10.1371/journal.pone.0075063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086438	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200078
J	Contreras-Ruiz, L; Regenfuss, B; Mir, FA; Kearns, J; Masli, S				Contreras-Ruiz, Laura; Regenfuss, Birgit; Mir, Fayaz Ahmad; Kearns, James; Masli, Sharmila			Conjunctival Inflammation in Thrombospondin-1 Deficient Mouse Model of Sjogren's Syndrome	PLOS ONE			English	Article							FLOW-CYTOMETRIC ANALYSIS; ROR-GAMMA-T; OCULAR SURFACE; DENDRITIC CELLS; CUTTING EDGE; EXPRESSION; LIGATION; RECEPTOR; PATHWAY; DISEASE	Lacrimal gland inflammation during autoimmune Sjogren's syndrome (SS) leads to ocular surface inflammation Keratoconjunctivitis sicca (KCS). This condition afflicts both the cornea and conjunctiva that form the ocular surface. Thrombospondin-1 (TSP-1) deficiency in mice results in lacrimal gland and corneal inflammation that resembles the human disease. In this study we report conjunctival pathology in this mouse model of SS. We found that TSP-1 null mice develop inflammation in the conjunctiva and associated loss of goblet cell function similar to that seen in patients with SS. Increased expression of Th1 (IFN-gamma, TNF-alpha) and Th17 (IL-6, IL-17A) inflammatory cytokines and related transcription factors (Tbet and ROR gamma t) were detected in TSP-1 null conjunctiva as well as their draining lymph nodes (LNs). The conjunctival inflammation was also accompanied by an increase in local lymphatic vessels. Interestingly, migration of antigen-bearing dendritic cells (DCs) from the ocular surface to the LNs was dependent on the TSP-1 available in the tissue. These results not only reveal potential immunopathogenic mechanisms underlying KCS in SS but also highlight the therapeutic potential of TSP-1.	Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA USA; Harvard Univ, Sch Med, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Masli, S (corresponding author), Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.	smasli@bu.edu			National Institute of Health [EY015472]; NATIONAL EYE INSTITUTE [R01EY015472] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by National Institute of Health grant EY015472. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Argueso P, 2002, INVEST OPHTH VIS SCI, V43, P1004; Avice MN, 2000, J IMMUNOL, V165, P4624, DOI 10.4049/jimmunol.165.8.4624; Brignole F, 2000, INVEST OPHTH VIS SCI, V41, P1356; Calonge M, 2004, EXP EYE RES, V78, P457, DOI 10.1016/j.exer.2003.09.009; Chen L, 2005, INVEST OPHTH VIS SCI, V46, P4536, DOI 10.1167/iovs.05-0975; Cursiefen C, 2011, J EXP MED, V208, P1083, DOI 10.1084/jem.20092277; Doyen V, 2003, J EXP MED, V198, P1277, DOI 10.1084/jem.20030705; Grimbert P, 2006, J IMMUNOL, V177, P3534, DOI 10.4049/jimmunol.177.6.3534; HOFFMAN RW, 1984, ARTHRITIS RHEUM, V27, P157, DOI 10.1002/art.1780270206; HU YF, 1992, AM J PHYSIOL, V263, pE607, DOI 10.1152/ajpendo.1992.263.4.E607; Hyon JY, 2007, CORNEA, V26, pS13, DOI 10.1097/ICO.0b013e31812f6782; Jonsson R, 2011, IMMUNOL LETT, V141, P1, DOI 10.1016/j.imlet.2011.06.007; Kassan SS, 2004, ARCH INTERN MED, V164, P1275, DOI 10.1001/archinte.164.12.1275; Katsifis GE, 2007, CLIN REV ALLERG IMMU, V32, P252, DOI 10.1007/s12016-007-8011-8; Koufakis DI, 2006, INVEST OPHTH VIS SCI, V47, P541, DOI 10.1167/iovs.05-0804; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Masli S, 2006, INT IMMUNOL, V18, P689, DOI 10.1093/intimm/dxl006; Nguyen CQ, 2007, J IMMUNOL, V179, P2318, DOI 10.4049/jimmunol.179.4.2318; Nguyen CQ, 2009, OCUL SURF, V7, P11, DOI 10.1016/S1542-0124(12)70289-6; PFLUGFELDER SC, 1990, OPHTHALMOLOGY, V97, P985; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; Pisella PJ, 2000, OPHTHALMOLOGY, V107, P1841, DOI 10.1016/S0161-6420(00)00347-X; Powell N, 2010, MUCOSAL IMMUNOL, V3, P567, DOI 10.1038/mi.2010.53; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; RAPHAEL M, 1988, HISTOPATHOLOGY, V13, P191, DOI 10.1111/j.1365-2559.1988.tb02024.x; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Saban DR, 2010, J IMMUNOL, V185, P4691, DOI 10.4049/jimmunol.1001133; Saeki H, 1999, J IMMUNOL, V162, P2472; Sarfati M, 2008, CURR DRUG TARGETS, V9, P842, DOI 10.2174/138945008785909310; Schlereth S, 2012, AM J PATHOL, V180, P2351, DOI 10.1016/j.ajpath.2012.02.015; Sekiyama E, 2006, INVEST OPHTH VIS SCI, V47, P1352, DOI 10.1167/iovs.05-1305; Stern ME, 2002, INVEST OPHTH VIS SCI, V43, P2609; Turpie B, 2009, AM J PATHOL, V175, P1136, DOI 10.2353/ajpath.2009.081058; Villani E, 2007, INVEST OPHTH VIS SCI, V48, P2017, DOI 10.1167/iovs.06-1129; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wakamatsu TH, 2010, INVEST OPHTH VIS SCI, V51, P144, DOI 10.1167/iovs.08-2722; Yoon KC, 2007, CORNEA, V26, P431, DOI 10.1097/ICO.0b013e31803dcda2; Yu DF, 2012, EXP EYE RES, V103, P22, DOI 10.1016/j.exer.2012.07.005; Zamiri P, 2005, INVEST OPHTH VIS SCI, V46, P908, DOI 10.1167/iovs.04-0362; Zhang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036822	41	47	50	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75937	10.1371/journal.pone.0075937	http://dx.doi.org/10.1371/journal.pone.0075937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086667	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200125
J	Rajpara, N; Vinothkumar, K; Mohanty, P; Singh, AK; Singh, R; Sinha, R; Nag, D; Koley, H; Bhardwaj, AK				Rajpara, Neha; Vinothkumar, Kittappa; Mohanty, Priyabrata; Singh, Arun Kumar; Singh, Rajesh; Sinha, Ritam; Nag, Dhrubajyoti; Koley, Hemanta; Bhardwaj, Ashima Kushwaha			Synergistic Effect of Various Virulence Factors Leading to High Toxicity of Environmental V. cholerae Non-O1/Non-O139 Isolates Lacking ctx Gene : Comparative Study with Clinical Strains	PLOS ONE			English	Article							VIBRIO-CHOLERAE; MOLECULAR ANALYSIS; TOXIN GENE; NON-O1; O1; PROTEASE; OUTBREAK; PATHOGENICITY; DIARRHEA; HEMAGGLUTININ	Background: Vibrio cholerae non-O1/non-O139 serogroups have been reported to cause sporadic diarrhoea in humans. Cholera toxins have been mostly implicated for hypersecretion of ions and water into the small intestine. Though most of the V. cholerae non-O1/non-O139 strains lack these cholera toxins, several other innate virulence factors contribute towards their pathogenicity. The environmental isolates may thus act as reservoirs for potential spreading of these virulence genes in the natural environment which may cause the emergence of epidemic-causing organisms. Results: The environmental isolates of vibrios were obtained from water samples, zooplanktons and phytoplanktons, from a village pond in Gandhinagar, Gujarat, India. They were confirmed as Vibrio cholerae non-O1/non-O139 using standard biochemical and serotyping tests. PCR experiments revealed that the isolates lacked ctxA, ctxB, tcpA, zot and ace genes whereas other pathogenicity genes like toxR, rtxC, hlyA, hapA and prtV were detected in these isolates. Compared with epidemic strain V. cholerae O1 El Tor N16961, culture supernatants from most of these isolates caused higher cytotoxicity to HT29 cells and higher hemolytic, hemagglutinin and protease activities. In rabbit ileal loop assays, the environmental isolates showed only 2-4 folds lesser fluid accumulation in comparison to N16961 and a V. cholerae clinical isolate IDH02365 of 2009. Pulsed Field Gel electrophoresis and Random amplification of Polymorphic DNA indicated that these isolates showed considerable diversity and did not share the same clonal lineage even though they were derived from the same water source. All the isolates showed resistance to one or more antibiotics. Conclusion: Though these environmental isolates lacked the cholera toxins, they seem to have adopted other survival strategies by optimally utilising a diverse array of several other toxins. The current findings indicate the possibility that these isolates could cause some gastroenteric inflammation when ingested and may serve as progenitors for overt disease-causing organisms.	[Rajpara, Neha; Vinothkumar, Kittappa; Mohanty, Priyabrata; Bhardwaj, Ashima Kushwaha] Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Dept Human Hlth & Dis, Gandhinagar, Gujarat, India; [Singh, Arun Kumar; Singh, Rajesh] Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Dept Cell Biol, Gandhinagar, Gujarat, India; [Sinha, Ritam; Nag, Dhrubajyoti; Koley, Hemanta] Natl Inst Cholera & Enter Dis, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Bhardwaj, AK (corresponding author), Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Dept Human Hlth & Dis, Gandhinagar, Gujarat, India.	ashima.bhardwaj@gmail.com			Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [BT/PR/11634/INF/22/104/2008]; Puri Foundation for Education in India; Indian Council of Medical Research, New Delhi, India [AMR/49/11-ECDI, F/815/2011-ECD-II]; Gujarat State Biotechnology Mission [GSBTM/MD/PROJECTS/SSA/3386/2012-13]	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Puri Foundation for Education in India; Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); Gujarat State Biotechnology Mission	This work was partially supported by the grant BT/PR/11634/INF/22/104/2008 from the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India. The authors thankfully acknowledge the partial funding received from The Puri Foundation for Education in India. N.R. and P. M. are the recipients of Senior Research Fellowships from Indian Council of Medical Research, New Delhi, India with grant numbers AMR/49/11-ECDI and F/815/2011-ECD-II respectively. K. V. is recipient of Junior Research Fellowship from Gujarat State Biotechnology Mission GSBTM/MD/PROJECTS/SSA/3386/2012-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; Bag PK, 2008, APPL ENVIRON MICROB, V74, P5635, DOI 10.1128/AEM.00029-08; BAGCHI K, 1993, J CLIN MICROBIOL, V31, P1315, DOI 10.1128/JCM.31.5.1315-1317.1993; Begum K, 2006, CELL MOL IMMUNOL, V3, P115; Bidinost C., 2004, Rev. argent. microbiol., V36, P158; Chakraborty R, 2005, J MED MICROBIOL, V54, P707, DOI 10.1099/jmm.0.45820-0; Chakraborty S, 2001, J MED MICROBIOL, V50, P879, DOI 10.1099/0022-1317-50-10-879; Chen Y, 2007, INFECT IMMUN, V75, P2645, DOI 10.1128/IAI.01317-06; Chow KH, 2001, J CLIN MICROBIOL, V39, P2594, DOI 10.1128/JCM.39.7.2594-2597.2001; CLSI, 2010, PERF STAND ANT SUSC; COLWELL RR, 1981, APPL ENVIRON MICROB, V41, P555, DOI 10.1128/AEM.41.2.555-558.1981; DALSGAARD A, 1995, J CLIN MICROBIOL, V33, P2715, DOI 10.1128/JCM.33.10.2715-2722.1995; DE SN, 1953, J PATHOL BACTERIOL, V66, P559, DOI 10.1002/path.1700660228; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Faruque SM, 2004, DNA CELL BIOL, V23, P723, DOI 10.1089/dna.2004.23.723; Faruque SM, 2003, INFECT IMMUN, V71, P1020, DOI 10.1128/IAI.71.2.1020-1025.2003; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Ghosh A, 2006, INFECT IMMUN, V74, P2937, DOI 10.1128/IAI.74.5.2937-2946.2006; HASAN NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI DOI 10.1073/pnas.1207359109; HONDA T, 1987, INFECT IMMUN, V55, P451, DOI 10.1128/IAI.55.2.451-454.1987; HONDA T, 1989, INFECT IMMUN, V57, P2799, DOI 10.1128/IAI.57.9.2799-2803.1989; HUQ A, 1984, APPL ENVIRON MICROB, V48, P420, DOI 10.1128/AEM.48.2.420-424.1984; HUQ A, 1995, LANCET, V345, P1249, DOI 10.1016/S0140-6736(95)92038-2; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; ISLAM MS, 1990, CAN J MICROBIOL, V36, P464, DOI 10.1139/m90-081; KARAOLIS DKR, 1995, J BACTERIOL, V177, P3191, DOI 10.1128/jb.177.11.3191-3198.1995; Khuntia HK, 2008, AM J TROP MED HYG, V78, P819, DOI 10.4269/ajtmh.2008.78.819; Koley H, 1999, J MED MICROBIOL, V48, P51, DOI 10.1099/00222615-48-1-51; Kumar P, 2009, J MED MICROBIOL, V58, P234, DOI 10.1099/jmm.0.002089-0; KUMAR P, 2005, INDIAN J COMMUN MED, V30, P146; Kumar P, 2008, APPL BIOCHEM BIOTECH, V151, P256, DOI 10.1007/s12010-008-8184-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mukhopadhyay AK, 2001, J BACTERIOL, V183, P4737, DOI 10.1128/JB.183.16.4737-4746.2001; Nandi B, 2000, J CLIN MICROBIOL, V38, P4145, DOI 10.1128/JCM.38.11.4145-4151.2000; OLSVIK O, 1993, J CLIN MICROBIOL, V31, P22, DOI 10.1128/JCM.31.1.22-25.1993; Parsons MB, 2007, FOODBORNE PATHOG DIS, V4, P285, DOI 10.1089/fpd.2007.0089; Rajpara N, 2009, INT J ANTIMICROB AG, V34, P220, DOI 10.1016/j.ijantimicag.2009.03.020; Rivera ING, 2001, APPL ENVIRON MICROB, V67, P2421, DOI 10.1128/AEM.67.6.2421-2429.2001; Rudra S, 1996, INDIAN J MED RES, V103, P71; Sharma C, 1998, J CLIN MICROBIOL, V36, P756, DOI 10.1128/JCM.36.3.756-763.1998; Shinoda S, 2011, BIOCONTROL SCI, V16, P1, DOI 10.4265/bio.16.1; Sikora AE, 2011, J BIOL CHEM, V286, P16555, DOI 10.1074/jbc.M110.211078; Singh DV, 1996, J MED MICROBIOL, V45, P35, DOI 10.1099/00222615-45-1-35; Singh DV, 2001, APPL ENVIRON MICROB, V67, P910, DOI 10.1128/AEM.67.2.910-921.2001; Syngkon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013122; Thungapathra M, 2002, ANTIMICROB AGENTS CH, V46, P2948, DOI 10.1128/AAC.46.9.2948-2955.2002; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; WHO, 1987, WHOCDD833	49	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76200	10.1371/journal.pone.0076200	http://dx.doi.org/10.1371/journal.pone.0076200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086707	gold, Green Published, Green Submitted			2022-12-25	WOS:000326520200130
J	Liu, XD; Tian, YY; Lu, N; Gin, T; Cheng, CHK; Chan, MTV				Liu, Xiaodong; Tian, Yuanyuan; Lu, Na; Gin, Tony; Cheng, Christopher H. K.; Chan, Matthew T. V.			Stat3 Inhibition Attenuates Mechanical Allodynia through Transcriptional Regulation of Chemokine Expression in Spinal Astrocytes	PLOS ONE			English	Article							NEUROPATHIC PAIN; CORD; INFLAMMATION; FRACTALKINE; MICROGLIA; CANCER; INJURY; RATS; MICE; GLIA	Background: Signal transducer and activator of transcription 3 (Stat3) is known to induce cell proliferation and inflammation by regulating gene transcription. Recent studies showed that Stat3 modulates nociceptive transmission by reducing spinal astrocyte proliferation. However, it is unclear whether Stat3 also contributes to the modulation of nociceptive transmission by regulating inflammatory response in spinal astrocytes. This study aimed at investigating the role of Stat3 on neuroinflammation during development of pain in rats after intrathecal injection of lipopolysaccharide (LPS). Methods: Stat3 specific siRNA oligo and synthetic selective inhibitor (Stattic) were applied to block the activity of Stat3 in primary astrocytes or rat spinal cord, respectively. LPS was used to induce the expression of proinflammatory genes in all studies. Immunofluorescence staining of cells and slices of spinal cord was performed to monitor Stat3 activation. The impact of Stat3 inhibition on proinflammatory genes expression was determined by cytokine antibody array, enzyme-linked immunosorbent assay and real-time polymerase chain reaction. Mechanical allodynia, as determined by the threshold pressure that could induce hind paw withdrawal after application of standardized von Frey filaments, was used to detect the effects of Stat3 inhibition after pain development with intrathecal LPS injection. Results: Intrathecal injection of LPS activated Stat3 in reactive spinal astrocytes. Blockade of Stat3 activity attenuated mechanical allodynia significantly and was correlated with a lower number of reactive astrocytes in the spinal dorsal horn. In vitro study demonstrated that Stat3 modulated inflammatory response in primary astrocytes by transcriptional regulation of chemokine expression including Cx3cl1, Cxcl5, Cxcl10 and Ccl20. Similarly, inhibition of Stat3 reversed the expression of these chemokines in the spinal dorsal horn. Conclusions: Stat3 acted as a transcriptional regulator of reactive astrocytes by modulating chemokine expression. Stat3 regulated inflammatory response in astrocytes and contributed to pain modulation. Blockade of Stat3 represents a new target for pain control.	[Liu, Xiaodong; Tian, Yuanyuan; Lu, Na; Gin, Tony; Chan, Matthew T. V.] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Shatin, Hong Kong, Peoples R China; [Cheng, Christopher H. K.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Cheng, CHK (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	chkcheng@cuhk.edu.hk; mtvchan@cuhk.edu.hk	LAU, Greg/AAA-2538-2019; Liu, Xiaodong/J-9827-2019; GIN, Tony/J-2521-2013; CHENG, Ki Christopher/R-9641-2018; Chan, Matthew/J-2884-2013	Liu, Xiaodong/0000-0002-5915-4499; GIN, Tony/0000-0001-7283-6761; CHENG, Ki Christopher/0000-0001-8970-9048; Chan, Matthew/0000-0002-3574-7855	Direct Grant for Research [2041564]; Chinese University of Hong Kong; Australian and New Zealand College of Anaesthetists [AEG13/001]	Direct Grant for Research; Chinese University of Hong Kong(Chinese University of Hong Kong); Australian and New Zealand College of Anaesthetists	This work was supported by a Direct Grant for Research (2041564), The Chinese University of Hong Kong and an Academic Enhancement Grant of the Australian and New Zealand College of Anaesthetists (AEG13/001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Dawes JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002193; DIXON WJ, 1965, J AM STAT ASSOC, V60, P967, DOI 10.2307/2283398; Dominguez E, 2010, J NEUROSCI, V30, P5754, DOI 10.1523/JNEUROSCI.5007-09.2010; Fu ES, 2010, PAIN, V148, P509, DOI 10.1016/j.pain.2010.01.001; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Lindia JA, 2005, J PAIN, V6, P434, DOI 10.1016/j.jpain.2005.02.001; Meares GP, 2012, GLIA, V60, P771, DOI 10.1002/glia.22307; Milligan E, 2005, EUR J NEUROSCI, V22, P2775, DOI 10.1111/j.1460-9568.2005.04470.x; Milligan ED, 2004, EUR J NEUROSCI, V20, P2294, DOI 10.1111/j.1460-9568.2004.03709.x; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Park SJ, 2012, J IMMUNOL, V188, P5132, DOI 10.4049/jimmunol.1101600; Reeve AJ, 2000, EUR J PAIN-LONDON, V4, P247, DOI 10.1053/eujp.2000.0177; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Tang J, 2012, J EVID BASED COMPLEM, V2012, P13; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; White FA, 2007, P NATL ACAD SCI USA, V104, P20151, DOI 10.1073/pnas.0709250104; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhong JX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009593	27	38	41	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75804	10.1371/journal.pone.0075804	http://dx.doi.org/10.1371/journal.pone.0075804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098399	Green Submitted, Green Published, gold			2022-12-25	WOS:000325483600024
J	Bazile, C; Siegler, IA; Benguigui, N				Bazile, Christophe; Siegler, Isabelle A.; Benguigui, Nicolas			Major Changes in a Rhythmic Ball-Bouncing Task Occur at Age 7 Years	PLOS ONE			English	Article							TEMPORAL ELEMENTS; COORDINATION; CHILDREN; INFORMATION; PERCEPTION; PATTERNS; ADAPTATION; STABILITY; SYNCHRONIZATION; PREDICTION	The aim of the study was to investigate the development of a rhythmical skill of children aged from 5 to 12 years old. Five age groups (5-6, 7-8, 9-10, 11-12, and young adults) performed a virtual ball bouncing task (16 forty-second long test trials). Task performances, racket oscillation, ball-racket impacts as well as the ball-racket coupling were analysed. The results showed a change in both performance and behaviour at the age of 7 years old. Before this age, children exhibited restricted perceptual-motor coordination with a high frequency of racket oscillation and a poor level of performance. After the age of 7, cycle-to-cycle adaptive coordination based on visual information was progressively acquired leading to increasing performance levels with age. Overall these results revealed a rapid change in capability to perform the ball bouncing task across age with a late emergence of the required coordination and significant change in the coordination at the age of 7.	[Bazile, Christophe; Siegler, Isabelle A.] Univ Paris 11, Lab CIAMS Complex Innovat Act Motrices & Sport, Orsay, France; [Benguigui, Nicolas] Normandie Univ, Caen, France; [Benguigui, Nicolas] UNICAEN, Lab CESAMS Ctr Etud Sport & Act MotriceS, Caen, France	UDICE-French Research Universities; Universite Paris Saclay; Universite de Caen Normandie	Siegler, IA (corresponding author), Univ Paris 11, Lab CIAMS Complex Innovat Act Motrices & Sport, Orsay, France.	isabelle.siegler@u-psud.fr	Benguigui, Nicolas/A-5611-2008	Siegler, Isabelle/0000-0002-5140-7682	ministere de l'enseignement superieur et de la recherche	ministere de l'enseignement superieur et de la recherche(Estonian Research CouncilEuropean Commission)	The research has been supported by a grant "contrat doctoral" from ministere de l'enseignement superieur et de la recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON GJ, 1974, J MOTOR BEHAV, V6, P217, DOI 10.1080/00222895.1974.10734998; BARD C, 1983, CAN J PSYCHOL, V37, P390, DOI 10.1037/h0080742; Benguigui N, 2008, BRIT J DEV PSYCHOL, V26, P389, DOI 10.1348/026151008X295146; Broderick MP, 1999, J MOTOR BEHAV, V31, P165, DOI 10.1080/00222899909600986; Butterfield SA, 2012, PERCEPT MOTOR SKILL, V114, P261, DOI 10.2466/10.11.25.PMS.114.1.261-274; Clizbe D, 2010, MOTOR CONTROL, V14, P59, DOI 10.1123/mcj.14.1.59; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Debrabant J, 2012, HUM MOVEMENT SCI, V31, P801, DOI 10.1016/j.humov.2011.09.006; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Ferrel-Chapus C, 2002, EXP BRAIN RES, V144, P506, DOI 10.1007/s00221-002-1064-2; FISCHMAN MG, 1992, RES Q EXERCISE SPORT, V63, P349, DOI 10.1080/02701367.1992.10608755; Fitzpatrick P, 1996, CHILD DEV, V67, P2691, DOI 10.2307/1131747; Getchell N, 2003, J EXP CHILD PSYCHOL, V85, P120, DOI 10.1016/S0022-0965(03)00059-6; Getchell N, 2007, MOTOR CONTROL, V11, P1; Getchell N, 2006, DEV PSYCHOBIOL, V48, P675, DOI 10.1002/dev.20186; HAY L, 1991, ACTA PSYCHOL, V77, P203, DOI 10.1016/0001-6918(91)90035-X; Hove MJ, 2013, PSYCHOL RES-PSYCH FO, V77, P388, DOI 10.1007/s00426-012-0441-0; Konczak J, 2003, J MOTOR BEHAV, V35, P41, DOI 10.1080/00222890309602120; Konczak J, 2009, J MOTOR BEHAV, V41, P243, DOI 10.3200/JMBR.41.3.243-252; Kugler P.N., 1987, INFORM NATURAL LAW S; Lambert J, 2005, NEUROSCI LETT, V377, P1, DOI 10.1016/j.neulet.2004.11.058; Lantero DA, 2007, J MOTOR BEHAV, V39, P139, DOI 10.3200/JMBR.39.2.139-157; Lefebvre C, 1998, ADAPT PHYS ACT Q, V15, P299, DOI 10.1123/apaq.15.4.299; MANYAM VJ, 1986, PERCEPTION, V15, P313, DOI 10.1068/p150313; Morice AHP, 2008, J NEUROSCI METH, V169, P255, DOI 10.1016/j.jneumeth.2007.11.020; Morice AHP, 2007, EXP BRAIN RES, V181, P249, DOI 10.1007/s00221-007-0924-1; Olivier I, 1997, PERCEPT MOTOR SKILL, V85, P123; REDON C, 1994, HUM MOVEMENT SCI, V13, P95, DOI 10.1016/0167-9457(94)90030-2; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Ringenbach SDR, 2005, ECOL PSYCHOL, V17, P1, DOI 10.1207/s15326969eco1701_1; Robertson SD, 2001, J MOTOR BEHAV, V33, P114, DOI 10.1080/00222890109603144; Rosengren K.S., 2003, DEV MOVEMENT COORDIN, V1st, P56; Savelsbergh GJP, 2000, INT J SPORT PSYCHOL, V31, P467; Schaal S, 1996, J MOTOR BEHAV, V28, P165, DOI 10.1080/00222895.1996.9941743; Schneiberg S, 2002, EXP BRAIN RES, V146, P142, DOI 10.1007/s00221-002-1156-z; Siegler IA, 2013, EXP BRAIN RES, V226, P603, DOI 10.1007/s00221-013-3475-7; Siegler IA, 2010, J EXP PSYCHOL HUMAN, V36, P729, DOI 10.1037/a0016462; SMOLL FL, 1975, PERCEPT MOTOR SKILL, V40, P140, DOI 10.2466/pms.1975.40.1.140; SMOLL FL, 1974, J MOTOR BEHAV, V6, P53, DOI 10.1080/00222895.1974.10734979; SMOLL FL, 1974, PERCEPT MOTOR SKILL, V39, P767, DOI 10.2466/pms.1974.39.2.767; Sternad D, 2001, J EXP PSYCHOL HUMAN, V27, P1163, DOI 10.1037//0096-1523.27.5.1163; THELEN E, 1982, DEV PSYCHOL, V18, P760, DOI 10.1037/0012-1649.18.5.760; THELEN E, 1981, DEV PSYCHOL, V17, P237, DOI 10.1037/0012-1649.17.3.237; THELEN E, 1979, ANIM BEHAV, V27, P699, DOI 10.1016/0003-3472(79)90006-X; Volman MJM, 2000, PSYCHOL RES-PSYCH FO, V63, P62, DOI 10.1007/PL00008168; VONHOFSTEN C, 1984, J EXP CHILD PSYCHOL, V38, P208, DOI 10.1016/0022-0965(84)90122-X; VONHOFSTEN C, 1982, DEV PSYCHOL, V18, P450, DOI 10.1037/0012-1649.18.3.450; VONHOFSTEN C, 1980, J EXP CHILD PSYCHOL, V30, P369, DOI 10.1016/0022-0965(80)90043-0; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; WILKENING F, 1981, COGNITIVE PSYCHOL, V13, P231, DOI 10.1016/0010-0285(81)90009-8	50	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74127	10.1371/journal.pone.0074127	http://dx.doi.org/10.1371/journal.pone.0074127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098332	Green Published, gold			2022-12-25	WOS:000325434500010
J	Mezlini, AM; Wang, B; Deshwar, A; Morris, Q; Goldenberg, A				Mezlini, Aziz M.; Wang, Bo; Deshwar, Amit; Morris, Quaid; Goldenberg, Anna			Identifying Cancer Specific Functionally Relevant miRNAs from Gene Expression and miRNA-to-Gene Networks Using Regularized Regression	PLOS ONE			English	Article							PROGNOSTIC-FACTOR; MICRORNA; HYPOXIA; HSA-MIR-210; MIR-210; MARKER	Identifying microRNA signatures for the different types and subtypes of cancer can result in improved detection, characterization and understanding of cancer and move us towards more personalized treatment strategies. However, using microRNA's differential expression (tumour versus normal) to determine these signatures may lead to inaccurate predictions and low interpretability because of the noisy nature of miRNA expression data. We present a method for the selection of biologically active microRNAs using gene expression data and microRNA-to-gene interaction network. Our method is based on a linear regression with an elastic net regularization. Our simulations show that, with our method, the active miRNAs can be detected with high accuracy and our approach is robust to high levels of noise and missing information. Furthermore, our results on real datasets for glioblastoma and prostate cancer are confirmed by microRNA expression measurements. Our method leads to the selection of potentially functionally important microRNAs. The associations of some of our identified miRNAs with cancer mechanisms are already confirmed in other studies (hypoxia related hsa-mir-210 and apoptosis-related hsa-mir-296-5p). We have also identified additional miRNAs that were not previously studied in the context of cancer but are coherently predicted as active by our method and may warrant further investigation. The code is available in Matlab and R and can be downloaded on http://www.cs.toronto.edu/goldenberg/Anna_Goldenberg/Current_Research.html.	[Mezlini, Aziz M.; Wang, Bo; Goldenberg, Anna] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Mezlini, Aziz M.; Wang, Bo; Goldenberg, Anna] SickKids Res Inst, Toronto, ON, Canada; [Deshwar, Amit] Univ Toronto, Edward S Rogers Sr Dept Elect & Comp Engn, Toronto, ON, Canada; [Morris, Quaid] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Goldenberg, A (corresponding author), Univ Toronto, Dept Comp Sci, Toronto, ON, Canada.	anna.goldenberg@utoronto.ca	Wang, Bo/HDO-6738-2022; Morris, Quaid/ABE-8343-2020	Wang, Bo/0000-0002-9620-3413; Morris, Quaid/0000-0002-2760-6999				Alshalalfa M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-112; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cheng P., 2009, J REPROD CONTRACEP, V20, pl; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gee HE, 2010, CANCER-AM CANCER SOC, V116, P2148, DOI 10.1002/cncr.25009; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Quon G, 2012, COMPUTATIONAL PURIFI; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498	19	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e73168	10.1371/journal.pone.0073168	http://dx.doi.org/10.1371/journal.pone.0073168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098326	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500004
J	Nau, F; Yu, BN; Martin, D; Nichols, CD				Nau, Felix, Jr.; Yu, Bangning; Martin, David; Nichols, Charles D.			Serotonin 5-HT2A Receptor Activation Blocks TNF-alpha Mediated Inflammation In Vivo	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DISEASE; ATHEROSCLEROSIS; MECHANISMS; EXPRESSION; PROTEINS; SYSTEM; RNA	Tumor necrosis factor alpha (TNF-alpha) plays a key role in inflammation, and its production and signaling contribute to many inflammatory related diseases. Recently, we discovered that selective activation of serotonin 5-HT2A receptors with the agonist (R)-DOI produces a super-potent blockade of proinflammatory markers in primary rat aortic smooth muscle cells. Here, we demonstrate that systemic administration of (R)-DOI can block the systemic effects of TNF-alpha in whole animal, with potent anti-inflammatory effects in the aortic arch and small intestine. This includes blockade of TNF-alpha-induced expression of pro-inflammatory cell adhesion (Icam-1, Vcam-1), cytokine (Il-6, IL-1b), and chemokine (Mcp-1, Cx3cl1) genes, and expression of VCAM-1 protein in the intestine. Further, systemic (R)-DOI also prevents the TNF-alpha-induced increase of circulating IL-6. Importantly, utilizing receptor selective antagonists, we have demonstrated that the mechanism underlying the systemic anti-inflammatory effects of (R)-DOI is activation of serotonin 5-HT2A receptors. Our results highlight a powerful new role for the serotonin 5-HT2A receptor in inflammatory processes, and indicate that agonism of serotonin receptors may represent an effective and novel approach to develop powerful small molecule therapeutics for inflammatory diseases and conditions such as atherosclerosis and inflammatory bowel disease.	[Nau, Felix, Jr.; Yu, Bangning; Martin, David; Nichols, Charles D.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Nichols, CD (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA.	cnich1@lsuhsc.edu	Nichols, Charles D/F-7153-2012	Nichols, Charles D/0000-0002-0615-0646	NHLBI [R21HL095961]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095961] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	CDN was supported by a NHLBI grant R21HL095961. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern GP, 2011, CURR OPIN PHARMACOL, V11, P29, DOI 10.1016/j.coph.2011.02.004; AMARENCO P, 1994, NEW ENGL J MED, V331, P1474, DOI 10.1056/NEJM199412013312202; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Canal CE, 2012, DRUG TEST ANAL, V4, P556, DOI 10.1002/dta.1333; Comet MA, 2007, EUR J NEUROSCI, V26, P345, DOI 10.1111/j.1460-9568.2007.05673.x; Crowell MD, 2004, BRIT J PHARMACOL, V141, P1285, DOI 10.1038/sj.bjp.0705762; Fox MA, 2010, PSYCHOPHARMACOLOGY, V212, P13, DOI 10.1007/s00213-009-1694-1; Furrer K, 2011, P NATL ACAD SCI USA, V108, P2945, DOI 10.1073/pnas.1012531108; Garvin Brian, 2008, Curr Gastroenterol Rep, V10, P363, DOI 10.1007/s11894-008-0070-3; GERSHON MD, 2001, ALIMENT PHARM THER, V13, P15, DOI DOI 10.1046/J.1365-2036.1999.00002.X-I2; Gershon Michael D, 2012, Trans Am Clin Climatol Assoc, V123, P268; Henninger DD, 1997, J IMMUNOL, V158, P1825; Hummon AB, 2007, BIOTECHNIQUES, V42, P467, DOI 10.2144/000112401; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kubera M, 2005, PSYCHIAT RES, V134, P251, DOI 10.1016/j.psychres.2004.01.014; Lee TW, 2010, GASTROENTEROL CLIN N, V39, P543, DOI 10.1016/j.gtc.2010.08.018; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Markoutsaki T, 2011, J CLIN GASTROENTEROL, V45, P514, DOI 10.1097/MCG.0b013e318205e13b; Meneses A, 1999, NEUROSCI BIOBEHAV R, V23, P1111, DOI 10.1016/S0149-7634(99)00067-6; Mossner R, 1998, BRAIN BEHAV IMMUN, V12, P249, DOI 10.1006/brbi.1998.0532; Neal KB, 2009, J PHYSIOL-LONDON, V587, P567, DOI 10.1113/jphysiol.2008.160416; Ngo Benjamin, 2010, Curr Mol Pharmacol, V3, P145; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Nishiyama T, 2009, EUR J PHARMACOL, V614, P122, DOI 10.1016/j.ejphar.2009.03.041; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sanger GJ, 2008, TRENDS PHARMACOL SCI, V29, P465, DOI 10.1016/j.tips.2008.06.008; Schmid CL, 2008, P NATL ACAD SCI USA, V105, P1079, DOI 10.1073/pnas.0708862105; Smith RL, 2003, PSYCHOPHARMACOLOGY, V166, P61, DOI 10.1007/s00213-002-1252-6; Spiller R, 2007, NEUROGASTROENT MOTIL, V19, P25, DOI 10.1111/j.1365-2982.2007.00965.x; Spiller R, 2008, NEUROPHARMACOLOGY, V55, P1072, DOI 10.1016/j.neuropharm.2008.07.016; Stefulj J, 2000, BRAIN BEHAV IMMUN, V14, P219, DOI 10.1006/brbi.1999.0579; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Villalon CM, 2007, N-S ARCH PHARMACOL, V376, P45, DOI 10.1007/s00210-007-0179-1; Watts SW, 2011, CARDIOVASC THER, V29, P54, DOI 10.1111/j.1755-5922.2010.00173.x; Yu BN, 2008, J PHARMACOL EXP THER, V327, P316, DOI 10.1124/jpet.108.143461	37	90	94	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75426	10.1371/journal.pone.0075426	http://dx.doi.org/10.1371/journal.pone.0075426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098382	Green Submitted, Green Published, gold			2022-12-25	WOS:000325434500030
J	Gupta, A; Rohlfsen, C; Leppo, MK; Chacko, VP; Wang, YB; Steenbergen, C; Weiss, RG				Gupta, Ashish; Rohlfsen, Cory; Leppo, Michelle K.; Chacko, Vadappuram P.; Wang, Yibin; Steenbergen, Charles; Weiss, Robert G.			Creatine Kinase-Overexpression Improves Myocardial Energetics, Contractile Dysfunction and Survival in Murine Doxorubicin Cardiotoxicity	PLOS ONE			English	Article							ANTHRACYCLINE-INDUCED CARDIOTOXICITY; ADRIAMYCIN-INDUCED CARDIOTOXICITY; ENERGY PHOSPHATE-METABOLISM; PERFUSED RAT-HEART; MAGNETIC-RESONANCE; INDUCED APOPTOSIS; ATP DEPLETION; MOUSE HEART; INACTIVATION; CARDIOMYOPATHY	Doxorubicin (DOX) is a commonly used life-saving antineoplastic agent that also causes dose-dependent cardiotoxicity. Because ATP is absolutely required to sustain normal cardiac contractile function and because impaired ATP synthesis through creatine kinase (CK), the primary myocardial energy reserve reaction, may contribute to contractile dysfunction in heart failure, we hypothesized that impaired CK energy metabolism contributes to DOX-induced cardiotoxicity. We therefore overexpressed the myofibrillar isoform of CK (CK-M) in the heart and determined the energetic, contractile and survival effects of CK-M following weekly DOX (5mg/kg) administration using in vivo(31)P MRS and H-1 MRI. In control animals, in vivo cardiac energetics were reduced at 7 weeks of DOX protocol and this was followed by a mild but significant reduction in left ventricular ejection fraction (EF) at 8 weeks of DOX, as compared to baseline. At baseline, CK-M overexpression (CK-M-OE) increased rates of ATP synthesis through cardiac CK (CK flux) but did not affect contractile function. Following DOX however, CK-M-OE hearts had better preservation of creatine phosphate and higher CK flux and higher EF as compared to control DOX hearts. Survival after DOX administration was significantly better in CK-M-OE than in control animals (p<0.02). Thus CK-M-OE attenuates the early decline in myocardial high-energy phosphates and contractile function caused by chronic DOX administration and increases survival. These findings suggest that CK impairment plays an energetic and functional role in this DOX-cardiotoxicity model and suggests that metabolic strategies, particularly those targeting CK, offer an appealing new strategy for limiting DOX-associated cardiotoxicity.	[Gupta, Ashish; Rohlfsen, Cory; Leppo, Michelle K.; Weiss, Robert G.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Gupta, Ashish; Chacko, Vadappuram P.; Weiss, Robert G.] Johns Hopkins Univ, Sch Med, Dept Radiol, Div Magnet Resonance Res, Baltimore, MD 21205 USA; [Wang, Yibin] Univ Calif Los Angeles, Los Angeles, CA USA; [Steenbergen, Charles] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; University of California System; University of California Los Angeles; Johns Hopkins University	Weiss, RG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	rweiss@jhmi.edu		Wang, Yibin/0000-0003-0852-0767	National Institutes of Health [HL-63030, HL61912, HL-39752]; Clarence Doodeman Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039752, R29HL039752, R01HL063030, R01HL061912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clarence Doodeman Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL-63030 and HL61912 (to RGW), HL-39752 (to CS) and funds from the Clarence Doodeman Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akki A, 2013, AM J PHYSIOL-HEART C, V304, pH633, DOI 10.1152/ajpheart.00771.2011; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; BIANCHI C, 1987, EXP MOL PATHOL, V46, P123, DOI 10.1016/0014-4800(87)90036-0; BUJA LM, 1973, CANCER-AM CANCER SOC, V32, P771, DOI 10.1002/1097-0142(197310)32:4<771::AID-CNCR2820320407>3.0.CO;2-A; DeAtley SM, 1999, TOXICOLOGY, V134, P51, DOI 10.1016/S0300-483X(99)00039-6; Diotte NM, 2009, BBA-MOL CELL RES, V1793, P427, DOI 10.1016/j.bbamcr.2008.10.014; DOROSHOW JH, 1980, J CLIN INVEST, V65, P128, DOI 10.1172/JCI109642; E MY, 2008, CARDIOLOGY, V111, P119, DOI 10.1159/000119699; Eidenschink AB, 2000, CARDIOL YOUNG, V10, P610; Ewer MS, 2010, NAT REV CARDIOL, V7, P564, DOI 10.1038/nrcardio.2010.121; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Gupta A, 2012, J CLIN INVEST, V122, P291, DOI 10.1172/JCI57426; Gupta A, 2011, CIRC-CARDIOVASC IMAG, V4, P42, DOI 10.1161/CIRCIMAGING.110.959320; Gupta A, 2009, AM J PHYSIOL-HEART C, V297, pH59, DOI 10.1152/ajpheart.00178.2009; Horenstein MS, 2000, MOL GENET METAB, V71, P436, DOI 10.1006/mgme.2000.3043; Jeyaseelan R, 1997, J BIOL CHEM, V272, P5828, DOI 10.1074/jbc.272.9.5828; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; Maslov MY, 2007, AM J PHYSIOL-HEART C, V292, pH387, DOI 10.1152/ajpheart.00737.2006; Maslov MY, 2010, AM J PHYSIOL-HEART C, V299, pH332, DOI 10.1152/ajpheart.00727.2009; Mihm MJ, 2002, BRIT J PHARMACOL, V135, P581, DOI 10.1038/sj.bjp.0704495; Mihm MJ, 2001, CARDIOVASC RES, V49, P798, DOI 10.1016/S0008-6363(00)00307-2; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; MIURA T, 1994, BIOL PHARM BULL, V17, P1220; Miura T, 2000, BIOCHEM PHARMACOL, V60, P95, DOI 10.1016/S0006-2952(00)00303-8; Muraoka S, 2004, FREE RADICAL RES, V38, P963, DOI 10.1080/10715760400000919; Naumova AV, 2003, AM J PHYSIOL-HEART C, V285, pH1976, DOI 10.1152/ajpheart.00474.2003; NERI GC, 1991, ONCOLOGY, V48, P327; NICOLAY K, 1987, BIOCHIM BIOPHYS ACTA, V929, P5, DOI 10.1016/0167-4889(87)90234-5; OHHARA H, 1981, J MOL CELL CARDIOL, V13, P741, DOI 10.1016/0022-2828(81)90256-X; OLSON RD, 1990, FASEB J, V4, P3076, DOI 10.1096/fasebj.4.13.2210154; PELIKAN PCD, 1986, J CARDIOVASC PHARM, V8, P1058, DOI 10.1097/00005344-198609000-00026; PRAGA C, 1979, CANCER TREAT REP, V63, P827; Ryding ADS, 2001, J ENDOCRINOL, V171, P1, DOI 10.1677/joe.0.1710001; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; SERAYDARIAN MW, 1977, J MOL CELL CARDIOL, V9, P375, DOI 10.1016/S0022-2828(77)80004-7; Simunek T, 2009, PHARMACOL REP, V61, P154; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; STEINBERG JS, 1987, CANCER, V60, P1213, DOI 10.1002/1097-0142(19870915)60:6<1213::AID-CNCR2820600609>3.0.CO;2-V; STEINHERZ LJ, 1991, JAMA-J AM MED ASSOC, V266, P1672, DOI 10.1001/jama.266.12.1672; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; THOMAS C, 1994, FREE RADICAL RES, V21, P387, DOI 10.3109/10715769409056591; Tokarska-Schlattner M, 2005, AM J PHYSIOL-HEART C, V289, pH37, DOI 10.1152/ajpheart.01057.2004; Tokarska-Schlattner M, 2002, MOL PHARMACOL, V61, P516, DOI 10.1124/mol.61.3.516; Tokarska-Schlattner M, 2006, J MOL CELL CARDIOL, V41, P389, DOI 10.1016/j.yjmcc.2006.06.009; Tokarska-Schlattner M, 2006, CR BIOL, V329, P657, DOI 10.1016/j.crvi.2005.08.007; TOLEIKIS A I, 1988, Biokhimiya, V53, P649; Vyssokikh MY, 2003, ACTA BIOCHIM POL, V50, P389; WALLIMANN T, 1994, CURR BIOL, V4, P42, DOI 10.1016/S0960-9822(00)00008-7; Xu MF, 2001, LIFE SCI, V68, P889, DOI 10.1016/S0024-3205(00)00990-5; Zhou SY, 2001, CANCER RES, V61, P771	52	42	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74675	10.1371/journal.pone.0074675	http://dx.doi.org/10.1371/journal.pone.0074675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098344	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100006
J	Giezendanner, S; Walther, S; Razavi, N; Van Swam, C; Fisler, MS; Soravia, LM; Andreotti, J; Schwab, S; Jann, K; Wiest, R; Horn, H; Muller, TJ; Dierks, T; Federspiel, A				Giezendanner, Stephanie; Walther, Sebastian; Razavi, Nadja; Van Swam, Claudia; Fisler, Melanie Sarah; Soravia, Leila Maria; Andreotti, Jennifer; Schwab, Simon; Jann, Kay; Wiest, Roland; Horn, Helge; Mueller, Thomas Joerg; Dierks, Thomas; Federspiel, Andrea			Alterations of White Matter Integrity Related to the Season of Birth in Schizophrenia: A DTI Study	PLOS ONE			English	Article							PRENATAL IMMUNE CHALLENGE; RECENT-ONSET SCHIZOPHRENIA; BIPOLAR DISORDER; 1ST-EPISODE SCHIZOPHRENIA; CORPUS-CALLOSUM; STRUCTURAL ABNORMALITIES; GENERAL-POPULATION; VOXELWISE ANALYSIS; BRAIN; MRI	In schizophrenia there is a consistent epidemiological finding of a birth excess in winter and spring. Season of birth is thought to act as a proxy indicator for harmful environmental factors during foetal maturation. There is evidence that prenatal exposure to harmful environmental factors may trigger pathologic processes in the neurodevelopment, which subsequently increase the risk of schizophrenia. Since brain white matter alterations have repeatedly been found in schizophrenia, the objective of this study was to investigate whether white matter integrity was related to the season of birth in patients with schizophrenia. Thirty-four patients with schizophrenia and 33 healthy controls underwent diffusion tensor imaging. Differences in the fractional anisotropy maps of schizophrenia patients and healthy controls born in different seasons were analysed with tract-based spatial statistics. A significant main effect of season of birth and an interaction of group and season of birth showed that patients born in summer had significantly lower fractional anisotropy in widespread white matter regions than those born in the remainder of the year. Additionally, later age of schizophrenia onset was found in patients born in winter months. The current findings indicate a relationship of season of birth and white matter alterations in schizophrenia and consequently support the neurodevelopmental hypothesis of early pathological mechanisms in schizophrenia.	[Giezendanner, Stephanie; Walther, Sebastian; Razavi, Nadja; Van Swam, Claudia; Fisler, Melanie Sarah; Soravia, Leila Maria; Andreotti, Jennifer; Schwab, Simon; Jann, Kay; Horn, Helge; Mueller, Thomas Joerg; Dierks, Thomas; Federspiel, Andrea] Univ Bern, Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland; [Wiest, Roland] Univ Bern, Inselspital, Univ Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Wiest, Roland] Univ Bern, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Giezendanner, S (corresponding author), Univ Bern, Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland.	giezendanner@puk.unibe.ch; federpsiel@puk.unibe.ch	Walther, Sebastian/E-3486-2010; Jann, Kay/AAF-2154-2020; Müller, Thomas/D-1212-2010; Schwab, Simon/ABI-8495-2020; Dierks, Thomas/B-7092-2012	Walther, Sebastian/0000-0003-4026-3561; Müller, Thomas/0000-0001-9315-8138; Schwab, Simon/0000-0002-1588-2689; Dierks, Thomas/0000-0002-4173-5308; Jann, Kay/0000-0003-3574-0538; Giezendanner, Stephanie/0000-0001-5660-9446; Soravia, Leila Maria/0000-0002-4924-7771	Swiss National Science Foundation [SNSF: 32003B-112578, SNSF: 2003B-124947]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by The Swiss National Science Foundation (http://www.snf.ch/D/Seiten/default.aspx) (SNSF: 32003B-112578 and SNSF: 2003B-124947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson JLR, 2007, NONLINEAR REGISTRATI; Andreasen NC, 2011, BIOL PSYCHIAT, V70, P672, DOI 10.1016/j.biopsych.2011.05.017; [Anonymous], 2010, R LANG ENV STAT COMP; APA, 1994, DIAGN STAT MAN MENT; Ardekani BA, 2003, NEUROREPORT, V14, P2025, DOI 10.1097/00001756-200311140-00004; Barkovich AJ, 2000, AM J NEURORADIOL, V21, P1099; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BOYD JH, 1986, SCHIZOPHRENIA BULL, V12, P173, DOI 10.1093/schbul/12.2.173; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Cheung V, 2008, PSYCHOL MED, V38, P877, DOI 10.1017/S0033291707001808; DAMATO T, 1994, PSYCHIAT RES-NEUROIM, V55, P65, DOI 10.1016/0925-4927(94)90001-9; De Peri L, 2012, CURR PHARM DESIGN, V18, P486, DOI 10.2174/138161212799316253; DEGREEF G, 1988, BIOL PSYCHIAT, V24, P461, DOI 10.1016/0006-3223(88)90186-2; DeQuardo JR, 1996, SCHIZOPHR RES, V20, P275, DOI 10.1016/0920-9964(95)00003-8; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Fatemi SH, 2008, SCHIZOPHR RES, V99, P56, DOI 10.1016/j.schres.2007.11.018; Fatemi SH, 2009, SCHIZOPHR RES, V112, P46, DOI 10.1016/j.schres.2009.04.014; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Fatemi SH, 2002, MOL PSYCHIATR, V7, P633, DOI 10.1038/sj.mp.4001046; Federspiel A, 2006, NEUROBIOL DIS, V22, P702, DOI 10.1016/j.nbd.2006.01.015; Frangou S, 1996, BRIT MED BULL, V52, P587; Fujiwara H, 2007, SCHIZOPHR RES, V95, P215, DOI 10.1016/j.schres.2007.05.044; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Henze R, 2012, NEUROSCI LETT, V513, P178, DOI 10.1016/j.neulet.2012.02.032; Hori H, 2012, PSYCHIAT RES, V195, P69, DOI 10.1016/j.psychres.2011.07.028; Hubl D, 2004, ARCH GEN PSYCHIAT, V61, P658, DOI 10.1001/archpsyc.61.7.658; Kanaan R, 2009, BRIT J PSYCHIAT, V194, P236, DOI 10.1192/bjp.bp.108.054320; Karlsgodt KH, 2008, BIOL PSYCHIAT, V63, P512, DOI 10.1016/j.biopsych.2007.06.017; Kasprian G, 2008, NEUROIMAGE, V43, P213, DOI 10.1016/j.neuroimage.2008.07.026; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Knochel C, 2012, SCHIZOPHR RES, V140, P129, DOI 10.1016/j.schres.2012.06.001; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kubicki M, 2005, NEUROIMAGE, V26, P1109, DOI 10.1016/j.neuroimage.2005.03.026; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006354; Mamah D, 2010, PSYCHIAT RES-NEUROIM, V183, P144, DOI 10.1016/j.pscychresns.2010.04.013; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McGrath JJ, 2006, SCHIZOPHR RES, V81, P91, DOI 10.1016/j.schres.2005.07.017; Messias E, 2004, ARCH GEN PSYCHIAT, V61, P985, DOI 10.1001/archpsyc.61.10.985; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; Mitelman SA, 2007, SCHIZOPHR RES, V92, P211, DOI 10.1016/j.schres.2006.12.029; Miyata J, 2010, SCHIZOPHR RES, V119, P232, DOI 10.1016/j.schres.2009.12.038; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; Mori T, 2007, PSYCHIAT RES-NEUROIM, V154, P133, DOI 10.1016/j.pscychresns.2006.09.004; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nolte N, 1999, HUMAN BRAIN; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037021; Patel S, 2011, SCHIZOPHR RES, V129, P149, DOI 10.1016/j.schres.2011.03.014; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Peters BD, 2008, NEUROPSYCHOBIOLOGY, V58, P19, DOI 10.1159/000154476; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Rapoport JL, 2011, INT J DEV NEUROSCI, V29, P251, DOI 10.1016/j.ijdevneu.2010.10.003; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; SACCHETTI E, 1992, BRIT J PSYCHIAT, V160, P390, DOI 10.1192/bjp.160.3.390; Sacchetti E., 1987, ETIOPATHOGENETIC HYP, P93; Seal ML, 2008, SCHIZOPHR RES, V101, P106, DOI 10.1016/j.schres.2007.12.489; Sigmundsson T, 2001, AM J PSYCHIAT, V158, P234, DOI 10.1176/appi.ajp.158.2.234; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Szeszko PR, 2008, NEUROPSYCHOPHARMACOL, V33, P976, DOI 10.1038/sj.npp.1301480; Tandon R, 2008, SCHIZOPHR RES, V102, P1, DOI 10.1016/j.schres.2008.04.011; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Tochigi M, 2004, NEUROSCI LETT, V365, P120, DOI 10.1016/j.neulet.2004.04.064; Tochigi M, 2004, NEUROSCI RES, V48, P1, DOI 10.1016/j.neures.2003.09.002; Torrey EF, 1997, SCHIZOPHR RES, V28, P1, DOI 10.1016/S0920-9964(97)00092-3; Walterfang M, 2011, EXPERT REV NEUROTHER, V11, P971, DOI [10.1586/ern.11.76, 10.1586/ERN.11.76]; Walther S, 2011, NEUROBIOL DIS, V42, P276, DOI 10.1016/j.nbd.2011.01.017; Werring DJ, 2000, BRAIN, V123, P1667, DOI 10.1093/brain/123.8.1667; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; ZIPURSKY RB, 1987, BIOL PSYCHIAT, V22, P1288, DOI 10.1016/0006-3223(87)90040-0	75	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75508	10.1371/journal.pone.0075508	http://dx.doi.org/10.1371/journal.pone.0075508			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228WY	24086548	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900045
J	Tsuzuki, S; Morimoto, N; Hosokawa, S; Matsushita, T				Tsuzuki, Shinya; Morimoto, Nao; Hosokawa, Shinichi; Matsushita, Takeji			Associations of Maternal and Neonatal Serum Trace Element Concentrations with Neonatal Birth Weight	PLOS ONE			English	Article							MULTIPLE MICRONUTRIENT SUPPLEMENTATION; DOUBLE-BLIND; ZINC SUPPLEMENTATION; CONTROLLED-TRIAL; GROWTH; SELENIUM; NEPAL	Background: Trace elements play important nutritional roles in neonates. Our objective was to examine whether there are differences in maternal/neonatal serum trace element concentrations between mature infants and premature infants. Methods: During 2012, 44 infants born at National Center for Global Health and Medicine, Tokyo, Japan, were enrolled. Serum samples were collected to measure serum iron, zinc, copper, and selenium concentrations 5 days after birth. Maternal serum samples were obtained before delivery and cord blood was taken at delivery to measure the same trace elements. We compared the results between term group whose birth weight were >= 2500 g and gestational age were >= 37 weeks and premature group whose birth weight were <2500 g or gestational age were <37 weeks. Variables significantly different between two groups were included in linear regression models to identify significant predictors of birth weight. Values of P<0.05 were considered statistically significant. Results: Serum selenium concentrations were lower in premature group than in term group (43.3 +/- 7.0 mu g/L vs. 52.0 +/- 8.9 mu g/L, P = 0.001). Maternal serum selenium concentrations were also significantly lower in the mothers of premature group than in the mothers of term group (79.3 +/- 19.3 mu g/L vs. 94.1 +/- 18.1 mu g/L, P = 0.032). There were no significant differences in neonatal or maternal iron, zinc, or copper concentrations between two groups. Multivariate linear regression analysis showed that, except for gestational age, only maternal serum selenium was significantly associated with birth weight (P = 0.015). Conclusions: Serum selenium concentrations were lower in premature group and their mothers compared with the term group. The maternal serum selenium concentration was positively correlated with birth weight. These results suggest that maternal serum selenium concentration may influence neonatal birth weight.	[Tsuzuki, Shinya; Morimoto, Nao; Hosokawa, Shinichi; Matsushita, Takeji] Natl Ctr Global Hlth & Med, Dept Pediat, Tokyo, Japan	National Center for Global Health & Medicine - Japan	Tsuzuki, S (corresponding author), Natl Ctr Global Hlth & Med, Dept Pediat, Tokyo, Japan.	shinyatsuzuki@yahoo.co.jp	Tsuzuki, Shinya/S-7286-2019; Tsuzuki, Shinya/S-7286-2019	Tsuzuki, Shinya/0000-0002-8504-1244; Tsuzuki, Shinya/0000-0001-5732-846X	National Center for Global Health and Medicine [113-4]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported by a grant for the National Center for Global Health and Medicine (113-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DARLOW BA, 1995, PEDIATRICS, V96, P314; GIMENEZ FG, 2003, AN PEDIATR, V59, P149; Haider BA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub3; Hiten DM, 2011, OXIDATIVE MED CELLUL; Iannotti LL, 2008, AM J CLIN NUTR, V88, P154, DOI 10.1093/ajcn/88.1.154; Kaestel P, 2005, EUR J CLIN NUTR, V59, P1081, DOI 10.1038/sj.ejcn.1602215; Khadem N, 2012, IRAN RED CRESCENT ME, V14, P240; Kon N, 2010, BRAIN DEV-JPN, V32, P849, DOI 10.1016/j.braindev.2009.12.003; Osendarp SJM, 2001, LANCET, V357, P1080, DOI 10.1016/S0140-6736(00)04260-4; Osrin D, 2005, LANCET, V365, P955, DOI 10.1016/S0140-6736(05)71084-9; Roberfroid D, 2008, AM J CLIN NUTR, V88, P1330, DOI 10.3945/ajcn.2008.26296; Shin YH, 2013, J KOREAN MED SCI, V28, P580, DOI 10.3346/jkms.2013.28.4.580; SOO TL, 1988, ARCH DIS CHILD, V63, P79, DOI 10.1136/adc.63.1.79; Sugiura T, 2005, ACTA PAEDIATR, V94, P1333, DOI 10.1080/08035250510027354; Vaidya A, 2008, LANCET, V371, P492, DOI 10.1016/S0140-6736(08)60172-5; Xinxo Sonela, 2013, Mater Sociomed, V25, P6, DOI 10.5455/msm.2013.25.6-8	16	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75627	10.1371/journal.pone.0075627	http://dx.doi.org/10.1371/journal.pone.0075627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086594	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900051
J	Gottardo, R; Bailer, RT; Korber, BT; Gnanakaran, S; Phillips, J; Shen, XY; Tomaras, GD; Turk, E; Imholte, G; Eckler, L; Wenschuh, H; Zerweck, J; Greene, K; Gao, HM; Berman, PW; Francis, D; Sinangil, F; Lee, C; Nitayaphan, S; Rerks-Ngarm, S; Kaewkungwal, J; Pitisuttithum, P; Tartaglia, J; Robb, ML; Michael, NL; Kim, JH; Zolla-Pazner, S; Haynes, BF; Mascola, JR; Self, S; Gilbert, P; Montefiori, DC				Gottardo, Raphael; Bailer, Robert T.; Korber, Bette T.; Gnanakaran, S.; Phillips, Joshua; Shen, Xiaoying; Tomaras, Georgia D.; Turk, Ellen; Imholte, Gregory; Eckler, Larry; Wenschuh, Holger; Zerweck, Johannes; Greene, Kelli; Gao, Hongmei; Berman, Phillip W.; Francis, Donald; Sinangil, Faruk; Lee, Carter; Nitayaphan, Sorachai; Rerks-Ngarm, Supachai; Kaewkungwal, Jaranit; Pitisuttithum, Punnee; Tartaglia, James; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Zolla-Pazner, Susan; Haynes, Barton F.; Mascola, John R.; Self, Steve; Gilbert, Peter; Montefiori, David C.			Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; DEPENDENT CELLULAR CYTOTOXICITY; RECOMBINANT GLYCOPROTEIN-120 VACCINE; CD4 BINDING-SITE; ENVELOPE PROTEIN; NEUTRALIZING ANTIBODIES; CONFORMATIONAL EPITOPE; TRANSMEMBRANE PROTEIN; BROAD NEUTRALIZATION	Neutralizing and non-neutralizing antibodies to linear epitopes on HIV-1 envelope glycoproteins have potential to mediate antiviral effector functions that could be beneficial to vaccine-induced protection. Here, plasma IgG responses were assessed in three HIV-1 gp120 vaccine efficacy trials (RV144, Vax003, Vax004) and in HIV-1-infected individuals by using arrays of overlapping peptides spanning the entire consensus gp160 of all major genetic subtypes and circulating recombinant forms (CRFs) of the virus. In RV144, where 31.2% efficacy against HIV-1 infection was seen, dominant responses targeted the C1, V2, V3 and C5 regions of gp120. An analysis of RV144 case-control samples showed that IgG to V2 CRF01_AE significantly inversely correlated with infection risk (OR=0.54, p=0.0042), as did the response to other V2 subtypes (OR=0.60-0.63, p=0.016-0.025). The response to V3 CRF01_AE also inversely correlated with infection risk but only in vaccine recipients who had lower levels of other antibodies, especially Env-specific plasma IgA (OR=0.49, p=0.007) and neutralizing antibodies (OR=0.5, p=0.008). Responses to C1 and C5 showed no significant correlation with infection risk. In Vax003 and Vax004, where no significant protection was seen, serum IgG responses targeted the same epitopes as in RV144 with the exception of an additional C1 reactivity in Vax003 and infrequent V2 reactivity in Vax004. In HIV-1 infected subjects, dominant responses targeted the V3 and C5 regions of gp120, as well as the immunodominant domain, heptad repeat 1 (HR-1) and membrane proximal external region (MPER) of gp41. These results highlight the presence of several dominant linear B cell epitopes on the HIV-1 envelope glycoproteins. They also generate the hypothesis that IgG to linear epitopes in the V2 and V3 regions of gp120 are part of a complex interplay of immune responses that contributed to protection in RV144.	[Gottardo, Raphael; Imholte, Gregory; Self, Steve; Gilbert, Peter] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Bailer, Robert T.; Turk, Ellen; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Korber, Bette T.; Gnanakaran, S.; Phillips, Joshua] Los Alamos Natl Lab, Los Alamos, NM USA; [Shen, Xiaoying; Tomaras, Georgia D.; Greene, Kelli; Gao, Hongmei; Haynes, Barton F.; Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Eckler, Larry; Wenschuh, Holger; Zerweck, Johannes] JPT Peptide Technol GmbH, Berlin, Germany; [Berman, Phillip W.] Univ Calif Santa Cruz, Baskin Sch Engn, Santa Cruz, CA 95064 USA; [Francis, Donald; Sinangil, Faruk; Lee, Carter] Global Solut Infect Dis, San Francisco, CA USA; [Nitayaphan, Sorachai] US Army Med Component, Dept Retrovirol, AFRIMS, Bangkok, Thailand; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Kaewkungwal, Jaranit] Mahidol Univ, Fac Trop Med, Ctr Excellence Biomed & Publ Hlth Informat BIOPHI, Bangkok, Thailand; [Pitisuttithum, Punnee] Mahidol Univ, Vaccine Trial Ctr, Bangkok 10700, Thailand; [Pitisuttithum, Punnee] Mahidol Univ, Dept Clin Trop Med, Bangkok 10700, Thailand; [Tartaglia, James] Sanofi Pasteur, Dept Res & Dev, Swiftwater, PA USA; [Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Zolla-Pazner, Susan] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Zolla-Pazner, Susan] NYU, Sch Med, New York, NY USA	Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Energy (DOE); Los Alamos National Laboratory; Duke University; University of California System; University of California Santa Cruz; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; Mahidol University; Mahidol University; Mahidol University; Sanofi-Aventis; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); New York University	Montefiori, DC (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.	david.montefiori@duke.edu	Phillips, Joshua/AAZ-6380-2020; Gottardo, Raphael/HCH-3169-2022; Zolla-Pazner, Susan/S-1864-2019; Tomaras, Georgia/J-5041-2016; Mascola, John/AAI-7193-2021	Phillips, Joshua/0000-0002-4619-6083; Zolla-Pazner, Susan/0000-0002-0750-2666; Gnanakaran, S/0000-0002-9368-3044; Gottardo, Raphael/0000-0002-3867-0232; Korber, Bette/0000-0002-2026-5757; Kaewkungwal, Jaranit/0000-0001-7916-8460	Bill & Melinda Gates Foundation [38619]; U.S. Army Medical Research and Material Command (USAMRMC) [Y1-AI-2642-12]; National Institutes of Allergy and Infectious Diseases [Y1-AI-2642-12]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; New York University School of Medicine [692526]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068635] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); U.S. Army Medical Research and Material Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); New York University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by a grant from the Bill & Melinda Gates Foundation (#38619) to DCM as part of the Collaboration for AIDS Vaccine Discovery (www.cavd.org), and by an Interagency Agreement Y1-AI-2642-12 between U.S. Army Medical Research and Material Command (USAMRMC), the National Institutes of Allergy and Infectious Diseases, and by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development. This work was also supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD) and New York University School of Medicine (Contract No. 692526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binley JM, 1996, AIDS RES HUM RETROV, V12, P911, DOI 10.1089/aid.1996.12.911; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Diskin R, 2010, NAT STRUCT MOL BIOL, V17, P608, DOI 10.1038/nsmb.1796; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11; Ferrari G, 2011, J VIROL, V85, P7029, DOI 10.1128/JVI.00171-11; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Forthal DN, 2001, J VIROL, V75, P6953, DOI 10.1128/JVI.75.15.6953-6961.2001; FUNG MSC, 1992, J VIROL, V66, P848, DOI 10.1128/JVI.66.2.848-856.1992; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; GNANN JW, 1987, J VIROL, V61, P2639, DOI 10.1128/JVI.61.8.2639-2641.1987; Gorny MK, 2000, J VIROL, V74, P6186, DOI 10.1128/JVI.74.13.6186-6192.2000; GOUDSMIT J, 1990, INTERVIROLOGY, V31, P327, DOI 10.1159/000150169; GRAHAM BS, 1994, J INFECT DIS, V170, P782, DOI 10.1093/infdis/170.4.782; GRIFFISS JM, 1983, J IMMUNOL, V130, P2882; Guilhaudis L, 2002, EUR J BIOCHEM, V269, P4860, DOI 10.1046/j.1432-1033.2002.03187.x; Haneuse S, 2011, J STAT SOFTW, V43, P1; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Hochleitner EO, 2000, J IMMUNOL, V164, P4156, DOI 10.4049/jimmunol.164.8.4156; Holl V, 2006, BLOOD, V107, P4466, DOI 10.1182/blood-2005-08-3490; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huang YT, 2005, J IMMUNOL, V174, P4828, DOI 10.4049/jimmunol.174.8.4828; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imholte GC, 2013, J IMMUNOL METHODS; JARVIS GA, 1991, J IMMUNOL, V147, P1962; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; KOUP RA, 1989, J VIROL, V63, P584, DOI 10.1128/JVI.63.2.584-590.1989; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; MATHEW GD, 1981, INT J CANCER, V27, P175, DOI 10.1002/ijc.2910270208; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Moog C, 2013, MUCOSAL IMMUNOL, DOI [10.1038/mi.2013.23, DOI 10.1038/MI.2013.23.PUBMED:23591718.[]; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nyambi PN, 2000, J VIROL, V74, P7096, DOI 10.1128/JVI.74.15.7096-7107.2000; Nyambi PN, 1998, J VIROL, V72, P9384, DOI 10.1128/JVI.72.11.9384-9391.1998; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PALKER TJ, 1987, P NATL ACAD SCI USA, V84, P2479, DOI 10.1073/pnas.84.8.2479; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pincus SH, 1997, J IMMUNOL, V158, P3511; PINCUS SH, 1993, J CLIN INVEST, V91, P1987, DOI 10.1172/JCI116420; PINCUS SH, 1992, AIDS RES HUM RETROV, V8, P1347, DOI 10.1089/aid.1992.8.1347; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Plotkin SA, 2008, CLIN VACC IMMUNOL, V17, P1055; Quan CP, 1998, EUR J IMMUNOL, V28, P4001, DOI 10.1002/(SICI)1521-4141(199812)28:12<4001::AID-IMMU4001>3.3.CO;2-T; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Smalls-Mantey A, 2012, J VIROL, V86, P8672, DOI 10.1128/JVI.00287-12; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; TYLER DS, 1990, J IMMUNOL, V145, P3276; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Yates NL, 2013, HIV 1 ENV V1 V UNPUB; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2013, VACCINE INDUCE UNPUB; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629; ZOLLAPAZNER S, 1995, J VIROL, V69, P3807, DOI 10.1128/JVI.69.6.3807-3815.1995; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	93	185	190	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75665	10.1371/journal.pone.0075665	http://dx.doi.org/10.1371/journal.pone.0075665			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086607	Green Submitted, Green Published, gold			2022-12-25	WOS:000325220000034
J	Huang, TC; Wang, YC; Kao, CH				Huang, Tzung-Chi; Wang, Yao-Ching; Kao, Chia-Hung			Thoracic Tumor Volume Delineation in 4D-PET/CT by Low Dose Interpolated CT for Attenuation Correction	PLOS ONE			English	Article							4-DIMENSIONAL COMPUTED-TOMOGRAPHY; LUNG-CANCER; PET IMAGES; TARGET VOLUME; AVERAGE CT; RADIOTHERAPY; MOTION; 3D	Purpose: 4D-PET/CT imaging is an excellent solution for reducing the breathing-induced effects in both CT and PET images. In 4D-PET/CT, 4D-CT images are selected to match those of 4D-PET phase by phase and the corresponding phases are used for attenuation correction in 4D-PET. However, the high radiation dose that patients acquire while undergoing 4D-CT imaging for diagnostic purposes remains a concern. This study aims to assess low-dose interpolated CT (ICT) for PET attenuation correction (PETICT) in thoracic tumor volume delineation. Methods and Materials: Twelve thoracic cancer patients (10 esophageal and 2 lung cancer cases) were recruited. All patients underwent 4D-PET/CT scans. The optical flow method based on image intensity gradient was applied to calculate the motion displacement in three dimensions for each voxel on two original extreme CT phases in the respiratory cycle, end-inspiration and end-expiration. The interpolated CTs were generated from two phases of the original 4D-CT using motion displacement. Results: Tumor motion due to respiration was estimated in the anterior-posterior dimension, the lateral dimension and the superior-inferior dimension by the optical flow method. The PETICT and ICT (4D-PETICT/ICT) matched each other spatially in all the phases. The distortion of tumor shape and size resulting from respiratory motion artifacts were not observed in 4D-PETICT. The tumor volume measured by 4D-PETICT/ICT correlated to the tumor volume measured by 4D-PET/CT (p = 0.98). Conclusions: 4D-PETICT consistently represented the interpretation of FDG uptake as effectively as 4D-PET. 4D-PETICT/ICT is a low-dose alternative to 4D-CT and significantly improves the interpretation of PET and CT images, while solving the respiratory motion problem as effectively as 4D-PET/CT.	[Huang, Tzung-Chi] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Wang, Yao-Ching] China Med Univ Hosp, Div Radiat Oncol, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Huang, TC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw	huang, tzungchi/O-4434-2015		National Science Council of Taiwan [NSC 102-2221-E-039-010-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by National Science Council of Taiwan (NSC 102-2221-E-039-010-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristophanous M, 2012, INT J RADIAT ONCOL, V82, pe99, DOI [10.1016/j.ijrobp.2010.12.060, DOI 10.1016/J.IJR0BP.2010.12.060]; Ashamalla H, 2005, INT J RADIAT ONCOL, V63, P1016, DOI 10.1016/j.ijrobp.2005.04.021; Britton KR, 2007, INT J RADIAT ONCOL, V68, P1036, DOI 10.1016/j.ijrobp.2007.01.021; Ekberg L, 1998, RADIOTHER ONCOL, V48, P71, DOI 10.1016/S0167-8140(98)00046-2; Huang TC, 2013, PLOS ONE, V8; Huang TC, 2011, PHYS MED BIOL, V56, P2559, DOI 10.1088/0031-9155/56/8/014; Liu HH, 2007, INT J RADIAT ONCOL, V68, P531, DOI 10.1016/j.ijrobp.2006.12.066; Messa C, 2006, Q J NUCL MED MOL IM, V50, P4; Mok G, 2011, IEEE T BIOMED ENG, V60, P1927; Nehmeh SA, 2004, MED PHYS, V31, P3179, DOI 10.1118/1.1809778; Nehmeh SA, 2002, J NUCL MED, V43, P876; Pan TS, 2005, J NUCL MED, V46, P1481; Park SJ, 2008, PHYS MED BIOL, V53, P3661, DOI 10.1088/0031-9155/53/13/018; Pevsner A, 2005, MED PHYS, V32, P2358, DOI 10.1118/1.1943809; Shimizu S, 2000, INT J RADIAT ONCOL, V46, P1127, DOI 10.1016/S0360-3016(99)00352-1; Wolthaus JWH, 2005, PHYS MED BIOL, V50, P1569, DOI 10.1088/0031-9155/50/7/017; Wu TH, 2010, NUCL INSTRUM METH A, V619, P361, DOI 10.1016/j.nima.2009.11.001; Yaremko B, 2005, PHYS MED BIOL, V50, P5969, DOI 10.1088/0031-9155/50/24/014; Zhang G, 2010, MED DOSIM, V35, P143, DOI 10.1016/j.meddos.2009.05.001	19	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75903	10.1371/journal.pone.0075903	http://dx.doi.org/10.1371/journal.pone.0075903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086662	gold, Green Submitted, Green Published			2022-12-25	WOS:000325220000052
J	Lin, XJ; Miao, P; Wang, JX; Yuan, FL; Guan, YJ; Tang, YH; He, XS; Wang, YT; Yang, GY				Lin, Xiaojie; Miao, Peng; Wang, Jixian; Yuan, Falei; Guan, Yongjing; Tang, Yaohui; He, Xiaosong; Wang, Yongting; Yang, Guo-Yuan			Surgery-Related Thrombosis Critically Affects the Brain Infarct Volume in Mice Following Transient Middle Cerebral Artery Occlusion	PLOS ONE			English	Article							POSTERIOR COMMUNICATING ARTERY; ACUTE ISCHEMIC-STROKE; BLOOD-FLOW; REPERFUSION; PERFUSION; MODEL; RATS; CRANIECTOMY; ANGIOGRAPHY; ANTAGONIST	Transient middle cerebral artery occlusion (tMCAO) model is widely used to mimic human focal ischemic stroke in order to study ischemia/reperfusion brain injury in rodents. In tMCAO model, intraluminal suture technique is widely used to achieve ischemia and reperfusion. However, variation of infarct volume in this model often requires large sample size, which hinders the progress of preclinical research. Our previous study demonstrated that infarct volume was related to the success of reperfusion although the reason remained unclear. The aim of present study is to explore the relationship between focal thrombus formation and model reproducibility with respect to infarct volume. We hypothesize that suture-induced thrombosis causes infarct volume variability due to insufficient reperfusion after suture withdrawal. Seventy-two adult male CD-1 mice underwent 90 minutes of tMCAO with or without intraperitoneal administration of heparin. Dynamic synchrotron radiation microangiography (SRA) and laser speckle contrast imaging (LSCI) were performed before and after tMCAO to observe the cerebral vascular morphology and to measure the cerebral blood flow in vivo. Infarct volume and neurological score were examined to evaluate severity of ischemic brain injury. We found that the rate of successful reperfusion was much higher in heparin-treated mice compared to that in heparin-free mice according to the result of SRA and LSCI at 1 and 3 hours after suture withdrawal (p<0.05). Pathological features and SRA revealed that thrombus formed in the internal carotid artery, middle cerebral artery or anterior cerebral artery, which blocked reperfusion following tMCAO. LSCI showed that cortical collateral circulation could be disturbed by thrombi. Our results demonstrated that suture-induced thrombosis was a critical element, which affects the success of reperfusion. Appropriate heparin management provides a useful approach for improving reproducibility of reperfusion model in mice.	[Lin, Xiaojie; Miao, Peng; Wang, Jixian; Yuan, Falei; Tang, Yaohui; He, Xiaosong; Wang, Yongting; Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Neurosci & Neuroengn Ctr, Med X Res Inst, Shanghai 200030, Peoples R China; [Lin, Xiaojie; Miao, Peng; Wang, Jixian; Yuan, Falei; Tang, Yaohui; He, Xiaosong; Wang, Yongting; Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Guan, Yongjing] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200030, Peoples R China; [Miao, Peng] Shanghai Univ, Sch Commun & Informat Engn, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai University	Wang, YT (corresponding author), Shanghai Jiao Tong Univ, Neurosci & Neuroengn Ctr, Med X Res Inst, Shanghai 200030, Peoples R China.	yongting.wang@gmail.com; gyyang0626@gmail.com	Wang, Yongting/C-2916-2014; Tang, Yaohui/AAE-9746-2019	Tang, Yaohui/0000-0002-9603-2650; Miao, Peng/0000-0002-1919-2204	National Basic Research Program (973 Program) [2010CB834306]; National Natural Science Foundation of China [U1232205]; KC Wong Foundation	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); KC Wong Foundation	This study was supported by the National Basic Research Program (973 Program 2010CB834306 (GYY, YTW), the National Natural Science Foundation of China (Project #U1232205) and KC Wong Foundation (GYY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage GA, 2010, J CEREBR BLOOD F MET, V30, P1432, DOI 10.1038/jcbfm.2010.73; Ayata C, 2013, J CEREBR BLOOD F MET, V33, P954, DOI 10.1038/jcbfm.2013.38; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Cai J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033366; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; DeFazio RA, 2012, J CEREBR BLOOD F MET, V32, P2012, DOI 10.1038/jcbfm.2012.102; Duong TQ, 2012, TRANSL STROKE RES, V3, P8, DOI 10.1007/s12975-011-0140-y; Furuya K, 2004, J NEUROSURG, V100, P97, DOI 10.3171/jns.2004.100.1.0097; Guan YJ, 2012, STROKE, V43, P888, DOI 10.1161/STROKEAHA.111.636456; Huang J, 2013, STROKE, V44, P190, DOI 10.1161/STROKEAHA.112.670299; KAWAMURA S, 1991, ACTA NEUROCHIR, V109, P126, DOI 10.1007/BF01403007; KAWAMURA S, 1994, SURG NEUROL, V41, P368, DOI 10.1016/0090-3019(94)90029-9; Kidoguchi K, 2006, STROKE, V37, P1856, DOI 10.1161/01.STR.0000226904.96059.a6; KUGE Y, 1995, STROKE, V26, P1655, DOI 10.1161/01.STR.26.9.1655; LAING RJ, 1993, STROKE, V24, P294, DOI 10.1161/01.STR.24.2.294; LINDSBERG PJ, 1991, ANN NEUROL, V30, P117, DOI 10.1002/ana.410300202; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lu HY, 2012, STROKE, V43, P838, DOI 10.1161/STROKEAHA.111.635235; MEMEZAWA H, 1995, BRAIN RES, V670, P48, DOI 10.1016/0006-8993(94)01251-C; Miao P, 2010, IEEE T BIO-MED ENG, V57, P1152, DOI 10.1109/TBME.2009.2037434; Miao P, 2010, OPT EXPRESS, V18, P218, DOI 10.1364/OE.18.000218; Moens AL, 2005, INT J CARDIOL, V100, P179, DOI 10.1016/j.ijcard.2004.04.013; Molina CA, 2011, STROKE, V42, pS16, DOI 10.1161/STROKEAHA.110.598763; Quartermain D, 2003, CEREBROVASC DIS, V16, P346, DOI 10.1159/000072556; Schmid-Elsaesser R, 1998, STROKE, V29, P2162, DOI 10.1161/01.STR.29.10.2162; Schwenke DO, 2008, J APPL PHYSIOL, V104, P88, DOI 10.1152/japplphysiol.00610.2007; Shah Zahoor Ahmad, 2006, J Stroke Cerebrovasc Dis, V15, P133, DOI 10.1016/j.jstrokecerebrovasdis.2006.04.002; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P280, DOI 10.1097/01.WCB.0000110048.43905.E5; Shen Q, 2011, J CEREBR BLOOD F MET, V31, P2076, DOI 10.1038/jcbfm.2011.64; Shih YYI, 2012, RADIOLOGY, V264, P234, DOI 10.1148/radiol.12112033; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Strong AJ, 2006, J CEREBR BLOOD F MET, V26, P645, DOI 10.1038/sj.jcbfm.9600240; Tanaka Y, 2011, J CEREBR BLOOD F MET, V31, P1403, DOI 10.1038/jcbfm.2010.228; Wang Z, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.125001; Yang GY, 1997, BRAIN RES, V751, P181, DOI 10.1016/S0006-8993(96)01277-2; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; Yuan Falei, 2013, Front Biosci (Elite Ed), V5, P517; Yuan FL, 2012, J NEUROTRAUM, V29, P1499, DOI 10.1089/neu.2011.2105; Zhang H, 2010, J CEREBR BLOOD F MET, V30, P923, DOI 10.1038/jcbfm.2010.10; ZHAO Q, 1994, BRAIN RES, V649, P253, DOI 10.1016/0006-8993(94)91071-5; Zhou J, 2011, J CEREBR BLOOD F MET, V31, P924, DOI 10.1038/jcbfm.2010.171	41	33	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75561	10.1371/journal.pone.0075561	http://dx.doi.org/10.1371/journal.pone.0075561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086572	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200048
J	Hernandes, MS; Santos, GDR; Cafe-Mendes, CC; Lima, LS; Scavone, C; Munhoz, CD; Britto, LRG				Hernandes, Marina S.; Santos, Graziella D. R.; Cafe-Mendes, Cecilia C.; Lima, Larissa S.; Scavone, Cristoforo; Munhoz, Carolina D.; Britto, Luiz R. G.			Microglial Cells Are Involved in the Susceptibility of NADPH Oxidase Knockout Mice to 6-Hydroxy-Dopamine-Induced Neurodegeneration	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; TNF-ALPHA; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; ACTIVATION; MODEL; MINOCYCLINE; DEGENERATION; GLUTATHIONE	We explored the impact of Nox-2 in modulating inflammatory-mediated microglial responses in the 6-hydroxydopamine (6-OHDA)-induced Parkinson's disease (PD) model. Nox1 and Nox2 gene expression were found to increase in striatum, whereas a marked increase of Nox2 expression was observed in substantia nigra (SN) of wild-type (wt) mice after PD induction. Gp91(phox-/-) 6-OHDA-lesioned mice exhibited a significant reduction in the apomorphine-induced rotational behavior, when compared to wt mice. Immunolabeling assays indicated that striatal 6-OHDA injections reduced the number of dopaminergic (DA) neurons in the SN of wt mice. In gp91(phox-/-) 6-OHDA-lesioned mice the DA degeneration was negligible, suggesting an involvement of Nox in 6-OHDA-mediated SN degeneration. Gp91(phox-/-) 6-OHDA-lesioned mice treated with minocycline, a tetracycline derivative that exerts multiple anti-inflammatory effects, including microglial inhibition, exhibited increased apomorphine-induced rotational behavior and degeneration of DA neurons after 6-OHDA injections. The same treatment also increased TNF-alpha release and potentiated NF-kappa B activation in the SN of gp91(phox-/-6-)OHDA-lesioned mice. Our results demonstrate for the first time that inhibition of microglial cells increases the susceptibility of gp91(phox-/-) 6-OHDA lesioned mice to develop PD. Blockade of microglia leads to NF-kappa B activation and TNF-alpha release into the SN of gp91(phox-/-) 6-OHDA lesioned mice, a likely mechanism whereby gp91(phox-/-) 6-OHDA lesioned mice may be more susceptible to develop PD after microglial cell inhibition. Nox2 adds an essential level of regulation to signaling pathways underlying the inflammatory response after PD induction.	[Hernandes, Marina S.; Santos, Graziella D. R.; Cafe-Mendes, Cecilia C.; Britto, Luiz R. G.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Lima, Larissa S.; Scavone, Cristoforo; Munhoz, Carolina D.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Hernandes, MS (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil.	marinash@icb.usp.br	Scavone, Cristoforo/ABB-8279-2021; Scavone, Cristoforo/AFK-9950-2022; Scavone, Cristoforo/C-1580-2012; Café-Mendes, Cecilia C/O-9432-2014; Munhoz, Carolina Demarchi/N-7219-2014	Scavone, Cristoforo/0000-0002-1206-0882; Scavone, Cristoforo/0000-0002-1206-0882; Scavone, Cristoforo/0000-0002-1206-0882; Munhoz, Carolina Demarchi/0000-0002-8656-5234	FAPESP; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the official brazilian agencies FAPESP and CNPq, in addition to the Applied Neuroscience Nucleus (NAPNA, University of Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2004, BBA-MOL CELL RES, V1742, P81, DOI 10.1016/j.bbamcr.2004.09.006; Babior BM, 2002, ANTIOXID REDOX SIGN, V4, P35, DOI 10.1089/152308602753625834; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Barcia C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.17; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block ML, 2006, FASEB J, V20, P251, DOI 10.1096/fj.05-4553com; BOKA G, 1994, NEUROSCI LETT, V172, P151, DOI 10.1016/0304-3940(94)90684-X; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Choi DH, 2012, ANTIOXID REDOX SIGN, V16, P1033, DOI 10.1089/ars.2011.3960; Choi SH, 2012, J NEUROCHEM, V120, P292, DOI 10.1111/j.1471-4159.2011.07572.x; Ezcurra ALD, 2010, NEUROBIOL DIS, V37, P630, DOI 10.1016/j.nbd.2009.11.018; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Fox C, 2005, J CEREBR BLOOD F MET, V25, P1138, DOI 10.1038/sj.jcbfm.9600121; Gao HM, 2003, J NEUROSCI, V23, P6181; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; Glezer I, 2003, NEUROPHARMACOLOGY, V45, P1120, DOI 10.1016/S0028-3908(03)00279-X; Guerra MC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-128; He Y, 2001, BRAIN RES, V909, P187, DOI 10.1016/S0006-8993(01)02681-6; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Hernandes MS, 2010, NEUROSCIENCE, V170, P1249, DOI 10.1016/j.neuroscience.2010.07.065; Hernandes MS, 2012, CURR NEUROPHARMACOL, V10, P321, DOI 10.2174/157015912804143540; Hernandes MS, 2012, NEUROSCI LETT, V521, P104, DOI 10.1016/j.neulet.2012.05.051; Hussain AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039945; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Ibi M, 2006, FREE RADICAL BIO MED, V40, P1785, DOI 10.1016/j.freeradbiomed.2006.01.009; Kawamoto EM, 2012, J NEUROSCI RES, V90, P213, DOI 10.1002/jnr.22745; Kim HJ, 2007, ANTIOXID REDOX SIGN, V9, P301, DOI 10.1089/ars.2006.1456; Kumar A, 2012, BRAIN RES, V1438, P48, DOI 10.1016/j.brainres.2011.12.028; Laurindo FRM, 2008, ANTIOXID REDOX SIGN, V10, P1101, DOI 10.1089/ars.2007.2011; LOEFFLER DA, 1994, CLIN NEUROPHARMACOL, V17, P370, DOI 10.1097/00002826-199408000-00009; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Mangano EN, 2012, NEUROBIOL AGING, V33, P1411, DOI 10.1016/j.neurobiolaging.2011.02.016; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052587; Munhoz CD, 2006, J NEUROSCI, V26, P3813, DOI 10.1523/JNEUROSCI.4398-05.2006; Nazemi S, 2012, PHARMACOL BIOCHEM BE, V102, P520, DOI 10.1016/j.pbb.2012.07.001; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Pestana RRF, 2010, NEUROSCI LETT, V484, P187, DOI 10.1016/j.neulet.2010.08.049; Pranski EL, 2013, NEUROBIOL DIS, V54, P264, DOI 10.1016/j.nbd.2012.12.018; Rodriguez-Pallares J, 2007, J NEUROCHEM, V103, P145, DOI 10.1111/j.1471-4159.2007.04699.x; Rodriguez-Pallares J, 2008, NEUROBIOL DIS, V31, P58, DOI 10.1016/j.nbd.2008.03.003; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Soliman ML, 2013, J NEUROIMMUNE PHARM, V8, P287, DOI 10.1007/s11481-012-9426-4; Tarabin V, 2004, N-S ARCH PHARMACOL, V369, P563, DOI 10.1007/s00210-004-0938-1; Vallet P, 2005, NEUROSCIENCE, V132, P233, DOI 10.1016/j.neuroscience.2004.12.038; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Zawada WM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-129; Zeevalk GD, 2005, ANTIOXID REDOX SIGN, V7, P1117, DOI 10.1089/ars.2005.7.1117; Zemke D, 2004, CLIN NEUROPHARMACOL, V27, P293, DOI 10.1097/01.wnf.0000150867.98887.3e; Zhang W, 2004, FASEB J, V18, P589, DOI 10.1096/fj.03-0983fje	51	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75532	10.1371/journal.pone.0075532	http://dx.doi.org/10.1371/journal.pone.0075532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086556	gold, Green Published, Green Submitted			2022-12-25	WOS:000326520200110
J	Kawamichi, H; Sasaki, AT; Matsunaga, M; Yoshihara, K; Takahashi, HK; Tanabe, HC; Sadato, N				Kawamichi, Hiroaki; Sasaki, Akihiro T.; Matsunaga, Masahiro; Yoshihara, Kazufumi; Takahashi, Haruka K.; Tanabe, Hiroki C.; Sadato, Norihiro			Medial Prefrontal Cortex Activation Is Commonly Invoked by Reputation of Self and Romantic Partners	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PERSPECTIVE-TAKING; BRAIN; OTHERS; FMRI; REPRESENTATION; METAANALYSIS; INFORMATION; ADJUSTMENT; EVOLUTION	The reputation of others influences partner selection in human cooperative behaviors through verbal reputation representation. Although the way in which humans represent the verbal reputations of others is a pivotal issue for social neuroscience, the neural correlates underlying the representation of verbal reputations of others are unclear. Humans primarily depend on self-evaluation when assessing reputation of self. Likewise, humans might primarily depend on self-evaluation of others when representing their reputation. As interaction promotes the formation of more nuanced, individualized impressions of an interaction partner, humans tend to form self-evaluations of persons with whom they are intimate in their daily life. Thus, we hypothesized that the representation of reputation of others is modulated by intimacy due to one's own evaluation formation of that person. To test this hypothesis, we conducted a functional magnetic resonance imaging experiment with 11 pairs of romantic partners while they viewed an evaluation of a target person (self, partner [intimate other], or stranger [non-intimate other]), made by other evaluators. When compared with strangers, viewing evaluations of self and partner activated overlapping regions in the medial prefrontal cortex. Verbal reputation of self-specific activation was found in the precuneus, which represents self-related processing. The data suggest that midline structures represent reputation of self. In addition, intimacy-modulated activation in the medial prefrontal cortex suggests that the verbal reputation of intimate others is represented similarly to reputation of self. These results suggest that the reputation representation in the medial prefrontal cortex is engaged by verbal reputation of self and intimate others stemming from both own and other evaluators' judgments.	[Kawamichi, Hiroaki; Takahashi, Haruka K.; Tanabe, Hiroki C.; Sadato, Norihiro] Natl Inst Physiol Sci, Dept Cerebral Res, Okazaki, Aichi 444, Japan; [Sasaki, Akihiro T.] Osaka City Univ, Dept Physiol, Grad Sch Med, Osaka, Japan; [Sasaki, Akihiro T.] RIKEN, Pathophysiol & Hlth Sci Team, Ctr Life Sci Technol, Kobe, Hyogo, Japan; [Matsunaga, Masahiro] Aichi Med Univ, Dept Hlth & Psychosocial Med, Sch Med, Nagakute, Aichi 48011, Japan; [Yoshihara, Kazufumi] Kyushu Univ, Grad Sch Med Sci, Dept Psychosomat Med, Fukuoka 812, Japan; [Takahashi, Haruka K.; Sadato, Norihiro] Grad Univ Adv Studies Sokendai, Dept Physiol Sci, Okazaki, Aichi, Japan; [Tanabe, Hiroki C.] Nagoya Univ, Grad Sch Environm Studies, Dept Social & Human Environm, Nagoya, Aichi 4648601, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Osaka Metropolitan University; RIKEN; Aichi Medical University; Kyushu University; Graduate University for Advanced Studies - Japan; Nagoya University	Kawamichi, H (corresponding author), Natl Inst Physiol Sci, Dept Cerebral Res, Okazaki, Aichi 444, Japan.	kawami@nips.ac.jp	Sasaki, Akihiro/AAH-9765-2021; Sasaki, Akihiro/C-3658-2017	Sasaki, Akihiro/0000-0002-2249-4975; Sasaki, Akihiro/0000-0002-2249-4975; Sadato, Norihiro/0000-0002-9786-3907; Kawamichi, Hiroaki/0000-0002-6172-8906; Takahashi, Haruka/0000-0002-6946-7982	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [23101507, 22101007]; Japan Society for the Promotion of Science [21220005, 23700505, 25750407, 23650224]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partly supported by Scientific Research on Innovative Areas grants no. 23101507 (H. K.) and no. 22101007 (H. C. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), by a Grant-in-Aid for Scientific Research (S) no. 21220005 (N.S.), by Grants-in-Aid for Young Scientists (B) no. 23700505 and no. 25750407 (H. K.), and by a Challenging Exploratory Research grant no. 23650224 (H. C. T.) from the Japan Society for the Promotion of Science. Part of this study is the result of "Development of biomarker candidates for social behavior" carried out under the strategic research program for brain sciences by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Ames DR, 2004, J PERS SOC PSYCHOL, V87, P573, DOI 10.1037/0022-3514.87.5.573; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; Apps MAJ, 2013, NEUROIMAGE, V64, P1, DOI 10.1016/j.neuroimage.2012.09.010; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; BEM DJ, 1967, PSYCHOL REV, V74, P183, DOI 10.1037/h0024835; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cooley Charles H., 1902, HUMAN NATURE SOCIAL; Craik FIM, 1999, PSYCHOL SCI, V10, P26, DOI 10.1111/1467-9280.00102; D'Argembeau A, 2007, J COGNITIVE NEUROSCI, V19, P935, DOI 10.1162/jocn.2007.19.6.935; Eisenberger NI, 2011, J COGNITIVE NEUROSCI, V23, P3448, DOI 10.1162/jocn_a_00027; Epley N, 2004, J PERS SOC PSYCHOL, V87, P327, DOI 10.1037/0022-3514.87.3.327; FISKE ST, 1990, ADV EXP SOC PSYCHOL, V23, P1, DOI 10.1016/S0065-2601(08)60317-2; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; HERR PM, 1991, J CONSUM RES, V17, P454, DOI 10.1086/208570; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Izuma K, 2010, SOC NEUROSCI-UK, V5, P133, DOI 10.1080/17470910903202559; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; KENNY DA, 1993, PSYCHOL BULL, V114, P145, DOI 10.1037/0033-2909.114.1.145; KINCH JW, 1963, AM J SOCIOL, V68, P481, DOI 10.1086/223404; Krienen FM, 2010, J NEUROSCI, V30, P13906, DOI 10.1523/JNEUROSCI.2180-10.2010; Lamm C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001292; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; RAUB W, 1990, AM J SOCIOL, V96, P626, DOI 10.1086/229574; Resnick P, 2000, COMMUN ACM, V43, P45, DOI 10.1145/355112.355122; RUBIN Z, 1970, J PERS SOC PSYCHOL, V16, P265, DOI 10.1037/h0029841; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Seger CA, 2004, NEUROPSYCHOLOGIA, V42, P1168, DOI 10.1016/j.neuropsychologia.2004.02.003; Shamay-Tsoory SG, 2005, NEUROIMAGE, V27, P468, DOI 10.1016/j.neuroimage.2005.05.012; Tamir DI, 2010, P NATL ACAD SCI USA, V107, P10827, DOI 10.1073/pnas.1003242107; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; Vanderwal T, 2008, NEUROIMAGE, V41, P1437, DOI 10.1016/j.neuroimage.2008.03.058; Wallace H.M., 2012, HDB SELF IDENTITY, P124; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; Zaki J, 2009, P NATL ACAD SCI USA, V106, P11382, DOI 10.1073/pnas.0902666106	52	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74958	10.1371/journal.pone.0074958	http://dx.doi.org/10.1371/journal.pone.0074958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086409	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200061
J	Nars, A; Lafitte, C; Chabaud, M; Drouillard, S; Melida, H; Danoun, S; Le Costaouec, T; Rey, T; Benedetti, J; Bulone, V; Barker, DG; Bono, JJ; Dumas, B; Jacquet, C; Heux, L; Fliegmann, J; Bottin, A				Nars, Amaury; Lafitte, Claude; Chabaud, Mireille; Drouillard, Sophie; Melida, Hugo; Danoun, Saieda; Le Costaouec, Tinaig; Rey, Thomas; Benedetti, Julie; Bulone, Vincent; Barker, David George; Bono, Jean-Jacques; Dumas, Bernard; Jacquet, Christophe; Heux, Laurent; Fliegmann, Judith; Bottin, Arnaud			Aphanomyces euteiches Cell Wall Fractions Containing Novel Glucan-Chitosaccharides Induce Defense Genes and Nuclear Calcium Oscillations in the Plant Host Medicago truncatula	PLOS ONE			English	Article							CA2+ SPIKING; MOLECULAR-PATTERNS; CHITIN OLIGOMERS; PERCEPTION; OOMYCETE; PATHOGEN; ELICITORS; RESPONSES; PROTEINS; SYNTHASE	N-acetylglucosamine-based saccharides (chitosaccharides) are components of microbial cell walls and act as molecular signals during host-microbe interactions. In the legume plant Medicago truncatula, the perception of lipochitooligosaccharide signals produced by symbiotic rhizobia and arbuscular mycorrhizal fungi involves the Nod Factor Perception (NFP) lysin motif receptor-like protein and leads to the activation of the so-called common symbiotic pathway. In rice and Arabidopsis, lysin motif receptors are involved in the perception of chitooligosaccharides released by pathogenic fungi, resulting in the activation of plant immunity. Here we report the structural characterization of atypical chitosaccharides from the oomycete pathogen Aphanomyces euteiches, and their biological activity on the host Medicago truncatula. Using a combination of biochemical and biophysical approaches, we show that these chitosaccharides are linked to beta-1,6-glucans, and contain a beta-(1,3; 1,4)-glucan backbone whose beta-1,3-linked glucose units are substituted on their C-6 carbon by either glucose or N-acetylglucosamine residues. This is the first description of this type of structural motif in eukaryotic cell walls. Glucan-chitosaccharide fractions of A. euteiches induced the expression of defense marker genes in Medicago truncatula seedlings independently from the presence of a functional Nod Factor Perception protein. Furthermore, one of the glucan-chitosaccharide fractions elicited calcium oscillations in the nucleus of root cells. In contrast to the asymmetric oscillatory calcium spiking induced by symbiotic lipochitooligosaccharides, this response depends neither on the Nod Factor Perception protein nor on the common symbiotic pathway. These findings open new perspectives in oomycete cell wall biology and elicitor recognition and signaling in legumes.	[Nars, Amaury; Lafitte, Claude; Danoun, Saieda; Rey, Thomas; Benedetti, Julie; Dumas, Bernard; Jacquet, Christophe; Fliegmann, Judith; Bottin, Arnaud] Univ Toulouse UPS, Lab Rech Sci Vegetales, UMR 5546, Castanet Tolosan, France; [Nars, Amaury; Lafitte, Claude; Danoun, Saieda; Rey, Thomas; Benedetti, Julie; Dumas, Bernard; Jacquet, Christophe; Fliegmann, Judith; Bottin, Arnaud] CNRS, UMR5546, Castanet Tolosan, France; [Chabaud, Mireille; Benedetti, Julie; Barker, David George; Bono, Jean-Jacques; Fliegmann, Judith] INRA, Lab Interact Plantes Microorganismes, UMR 441, F-31326 Castanet Tolosan, France; [Chabaud, Mireille; Benedetti, Julie; Barker, David George; Bono, Jean-Jacques; Fliegmann, Judith] CNRS, Lab Interact Plantes Microorganismes, UMR 2594, Castanet Tolosan, France; [Drouillard, Sophie; Le Costaouec, Tinaig; Heux, Laurent] CNRS, CERMAV, Grenoble, France; [Melida, Hugo; Bulone, Vincent] AlbaNova Univ Ctr, Sch Biotechnol, Royal Inst Technol, Div Glycosci, Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Royal Institute of Technology	Bottin, A (corresponding author), Univ Toulouse UPS, Lab Rech Sci Vegetales, UMR 5546, Castanet Tolosan, France.	bottin@lrsv.ups-tlse.fr	Bulone, Vincent/C-8492-2019; BOTTIN, Arnaud/ABF-6872-2020; Rey, Thomas/AAF-4454-2019; Rey, Thomas/K-8969-2019; Mélida, Hugo/G-8779-2015; Dumas, Bernard/D-1751-2009; Bulone, Vincent/D-7469-2013; jacquet, Christophe/B-2563-2009	Bulone, Vincent/0000-0003-2809-4160; Rey, Thomas/0000-0002-9454-074X; Mélida, Hugo/0000-0003-1792-0113; Dumas, Bernard/0000-0002-4138-3533; jacquet, Christophe/0000-0002-7377-5638; Fliegmann, Judith/0000-0003-1021-8006	Region Midi-Pyrenees; CNRS [INEE 36]; French Agence Nationale de la Recherche [ANR-08-BLAN-0208-01]	Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Agence Nationale de la Recherche(French National Research Agency (ANR))	This work is part of the "Laboratoire d'Excellence" (LABEX) entitled TULIP (ANR -10-LABX-41); it was funded by the Region Midi-Pyrenees, the CNRS (PhD grant INEE 36 to AN), and the French Agence Nationale de la Recherche (ANR-08-BLAN-0208-01 "Sympasignal"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Asiegbu FO, 1996, EUR J FOREST PATHOL, V26, P315; Aziz A, 2007, J EXP BOT, V58, P1463, DOI 10.1093/jxb/erm008; Badreddine I, 2008, EUKARYOT CELL, V7, P1980, DOI 10.1128/EC.00091-08; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; BERTKE CC, 1992, MYCOLOGIA, V84, P571, DOI 10.2307/3760323; BERTKE CC, 1992, BOT MAR, V35, P147, DOI 10.1515/botm.1992.35.2.147; Blank CE, 2011, J MOL EVOL, V73, P188, DOI 10.1007/s00239-011-9467-y; Blum M, 2012, PEST MANAG SCI, V68, P1171, DOI 10.1002/ps.3279; Blum M, 2012, FUNGAL BIOL-UK, V116, P529, DOI 10.1016/j.funbio.2012.02.003; Blum M, 2010, MOL PLANT PATHOL, V11, P227, DOI 10.1111/j.1364-3703.2009.00604.x; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; BULONE V, 1992, EXP MYCOL, V16, P8, DOI 10.1016/0147-5975(92)90037-R; Burton RA, 2009, MOL PLANT, V2, P873, DOI 10.1093/mp/ssp063; Cabib E, 2005, J BIOL CHEM, V280, P9170, DOI 10.1074/jbc.M414005200; CAMPOSTAKAKI GM, 1982, J GEN MICROBIOL, V128, P207; Chabaud M, 2011, NEW PHYTOL, V189, P347, DOI 10.1111/j.1469-8137.2010.03464.x; CHEONG JJ, 1991, PLANT CELL, V3, P127, DOI 10.1105/tpc.3.2.127; CHERIF M, 1993, CAN J MICROBIOL, V39, P213, DOI 10.1139/m93-030; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DIETRICH SMC, 1975, AN ACAD BRAS CIENC, V47, P155; Djebali N, 2009, MOL PLANT MICROBE IN, V22, P1043, DOI 10.1094/MPMI-22-9-1043; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fliegmann J, 2004, J BIOL CHEM, V279, P1132, DOI 10.1074/jbc.M308552200; Fliegmann J, 2011, PLANT PHYSIOL BIOCH, V49, P709, DOI 10.1016/j.plaphy.2011.04.004; Fontaine T, 2000, J BIOL CHEM, V275, P41528; Francia D, 2011, PLANT PHYSIOL BIOCH, V49, P963, DOI 10.1016/j.plaphy.2011.04.008; FREY R., 1950, BER SCHWEIZ BOT GES, V60, P199; Gaulin E, 2007, MOL PLANT PATHOL, V8, P539, DOI [10.1111/j.1364-3703.2007.00413.x, 10.1111/j.1364-3703.2007.00413.X]; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Genre A, 2013, NEW PHYTOL, V198, P179, DOI 10.1111/nph.12146; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Grenville-Briggs L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024500; Guerriero G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001070; Gust AA, 2012, TRENDS PLANT SCI, V17, P495, DOI 10.1016/j.tplants.2012.04.003; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Heux L, 2000, BIOMACROMOLECULES, V1, P746, DOI 10.1021/bm000070y; KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170; Kombrink A, 2011, MICROBES INFECT, V13, P1168, DOI 10.1016/j.micinf.2011.07.010; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; Leclercq J, 2008, J PLANT PHYSIOL, V165, P766, DOI 10.1016/j.jplph.2007.02.008; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; LIN CC, 1970, ARCH MIKROBIOL, V72, P111, DOI 10.1007/BF00409517; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Melida H, 2013, EUKARYOT CELL, V12, P194, DOI 10.1128/EC.00288-12; Mithofer A, 2001, FEBS LETT, V508, P191, DOI 10.1016/S0014-5793(01)03054-X; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nars A, 2013, PLANT CELL REP, V32, P489, DOI 10.1007/s00299-012-1380-3; Navazio L, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-41; Nyamsuren O, 2003, PHYSIOL MOL PLANT P, V63, P17, DOI 10.1016/j.pmpp.2003.09.001; OKINAKA Y, 1995, PLANT PHYSIOL, V109, P839, DOI 10.1104/pp.109.3.839; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Pauly N, 2001, CELL CALCIUM, V30, P413, DOI 10.1054/ceca.2001.0250; Phillips AJ, 2008, TRENDS MICROBIOL, V16, P13, DOI 10.1016/j.tim.2007.10.013; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Rey T, 2013, NEW PHYTOL, V198, P875, DOI 10.1111/nph.12198; Ruiz-Herrera Jose, 2002, FEMS Yeast Research, V1, P247, DOI 10.1016/S1567-1356(01)00049-6; RUPLEY JA, 1964, BIOCHIM BIOPHYS ACTA, V83, P245, DOI 10.1016/0926-6526(64)90001-1; SELVENDRAN R R, 1985, P39; Shibuya N, 2001, PHYSIOL MOL PLANT P, V59, P223, DOI 10.1006/pmpp.2001.0364; Sieberer BJ, 2009, PLANT PHYSIOL, V151, P1197, DOI 10.1104/pp.109.142851; Silipo A, 2010, GLYCOBIOLOGY, V20, P406, DOI 10.1093/glycob/cwp201; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Vadassery J, 2009, PLANT J, V59, P193, DOI 10.1111/j.1365-313X.2009.03867.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; WALDMULLER T, 1992, PLANTA, V188, P498, DOI 10.1007/BF00197041; Werner S, 2002, FEMS MICROBIOL LETT, V208, P169, DOI 10.1111/j.1574-6968.2002.tb11077.x; Yim NH, 2008, BIOL PHARM BULL, V31, P1041, DOI 10.1248/bpb.31.1041; Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963; Zhu XH, 2010, EMBO J, V29, P1007, DOI 10.1038/emboj.2009.402	74	32	32	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75039	10.1371/journal.pone.0075039	http://dx.doi.org/10.1371/journal.pone.0075039			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086432	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200075
J	Stone, CM				Stone, Christopher M.			Transient Population Dynamics of Mosquitoes during Sterile Male Releases: Modelling Mating Behaviour and Perturbations of Life History Parameters	PLOS ONE			English	Article							ANOPHELES-GAMBIAE DIPTERA; DENGUE VECTOR MOSQUITO; AEDES-AEGYPTI; BODY-SIZE; DENSITY-DEPENDENCE; SPERM COMPETITION; FEMALE POLYGAMY; HOST-SEEKING; CULICIDAE; LARVAL	The release of genetically-modified or sterile male mosquitoes offers a promising form of mosquito-transmitted pathogen control, but the insights derived from our understanding of male mosquito behaviour have not fully been incorporated into the design of such genetic control or sterile-male release methods. The importance of aspects of male life history and mating behaviour for sterile-male release programmes were investigated by projecting a stage-structured matrix model over time. An elasticity analysis of transient dynamics during sterile-male releases was performed to provide insight on which vector control methods are likely to be most synergistic. The results suggest that high mating competitiveness and mortality costs of released males are required before the sterile-release method becomes ineffective. Additionally, if released males suffer a mortality cost, older males should be released due to their increased mating capacity. If released males are of a homogenous size and size-assortative mating occurs in nature, this can lead to an increase in the abundance of large females and reduce the efficacy of the population-suppression effort. At a high level of size-assortative mating, the disease transmission potential of the vector population increases due to male releases, arguing for the release of a heterogeneously-sized male population. The female population was most sensitive to perturbations of density-dependent components of larval mortality and female survivorship and fecundity. These findings suggest source reduction might be a particularly effective complement to mosquito control based on the sterile insect technique (SIT). In order for SIT to realize its potential as a key component of an integrated vector-management strategy to control mosquito-transmitted pathogens, programme design of sterile-male release programmes must account for the ecology, behaviour and life history of mosquitoes. The model used here takes a step in this direction and can easily be modified to investigate additional aspects of mosquito behaviour or species-specific ecology.	[Stone, Christopher M.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Stone, Christopher M.] Univ Basel, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Stone, CM (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	c.stone@unibas.ch		Stone, Christopher/0000-0001-9535-2583	Bill & Melinda Gates Foundation [OPP1032350]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was partly supported by Bill & Melinda Gates Foundation project OPP1032350. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Ameneshewa B, 1996, MED VET ENTOMOL, V10, P170, DOI 10.1111/j.1365-2915.1996.tb00724.x; Barclay HJ, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P147, DOI 10.1007/1-4020-4051-2_6; BARCLAY HJ, 1991, THEOR POPUL BIOL, V40, P105, DOI 10.1016/0040-5809(91)90048-K; Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026086; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; BERRYMAN AA, 1967, CAN ENTOMOL, V99, P858, DOI 10.4039/Ent99858-8; Bonsall MB, 2010, ISR J ECOL EVOL, V56, P353, DOI 10.1560/IJEE.56.3-4.353; Boyer S, 2011, MED VET ENTOMOL, V25, P454, DOI 10.1111/j.1365-2915.2011.00962.x; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; CASWELL H, 2008, DEMOGR RES, V18, P27; Caswell H, 2007, ECOL LETT, V10, P1, DOI 10.1111/j.1461-0248.2006.01001.x; Catteruccia F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S7; Charlwood JD, 2002, MED VET ENTOMOL, V16, P109, DOI 10.1046/j.0269-283x.2002.00342.x; CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; DAME D, 2009, MALARIA J S2, pS2; Damiens D, 2012, J MED ENTOMOL, V49, P1001, DOI 10.1603/ME11289; Dao A, 2010, J MED ENTOMOL, V47, P769, DOI 10.1603/ME10052; DYE C, 1984, J ANIM ECOL, V53, P247, DOI 10.2307/4355; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Ferguson HM, 2005, TRENDS ECOL EVOL, V20, P202, DOI 10.1016/j.tree.2005.02.003; GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; Godfray HCJ, 2013, J ANIM ECOL, V82, P15, DOI 10.1111/1365-2656.12003; GWADZ RW, 1970, MOSQ NEWS, V30, P355; Helinski MEH, 2012, BEHAV ECOL SOCIOBIOL, V66, P1131, DOI 10.1007/s00265-012-1365-9; Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225; Klowden MJ, 2006, J INSECT PHYSIOL, V52, P679, DOI 10.1016/j.jinsphys.2006.03.006; KLOWDEN MJ, 1988, J AM MOSQUITO CONTR, V4, P73; KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; LYIMO EO, 1993, MED VET ENTOMOL, V7, P328, DOI 10.1111/j.1365-2915.1993.tb00700.x; Maiga H, 2012, J VECTOR ECOL, V37, P289, DOI 10.1111/j.1948-7134.2012.00230.x; Muriu SM, 2013, J ANIM ECOL, V82, P166, DOI 10.1111/1365-2656.12002; NASCI RS, 1991, J MED ENTOMOL, V28, P522, DOI 10.1093/jmedent/28.4.522; Nghabi KR, 2008, ANIM BEHAV, V76, P105, DOI 10.1016/j.anbehav.2008.01.014; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Pletcher SD, 2000, J GERONTOL A-BIOL, V55, pB381, DOI 10.1093/gerona/55.8.B381; Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395; ROGERS DJ, 1984, INSECT SCI APPL, V5, P419, DOI 10.1017/S1742758400008766; Roitberg BD, 2010, PHYSIOL ENTOMOL, V35, P46, DOI 10.1111/j.1365-3032.2009.00709.x; Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001; Snow J.W., 1988, P3; SPIELMAN A, 1967, BIOL BULL-US, V132, P404, DOI 10.2307/1539644; STEINWASCHER K, 1982, ENVIRON ENTOMOL, V11, P150, DOI 10.1093/ee/11.1.150; Stone CM, 2009, J MED ENTOMOL, V46, P1327, DOI 10.1603/033.046.0611; Stone CM, 2013, ECOL CONT VECTOR-BOR, V3, P35; Stone CM, 2012, AM J TROP MED HYG, V87, P727, DOI 10.4269/ajtmh.2012.12-0123; Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111; TAKKEN W, 1986, B ENTOMOL RES, V76, P275, DOI 10.1017/S0007485300014747; Takken W, 1998, J MED ENTOMOL, V35, P639, DOI 10.1093/jmedent/35.5.639; Thailayil J, 2011, P NATL ACAD SCI USA, V108, P13677, DOI 10.1073/pnas.1104738108; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Tripet F, 2003, AM J TROP MED HYG, V68, P1; VERHOEK BA, 1994, ENTOMOL EXP APPL, V72, P167, DOI 10.1007/BF02383551; Vreysen MJB, 2006, ANN ENTOMOL SOC AM, V99, P607, DOI 10.1603/0013-8746(2006)99[607:MOPMIA]2.0.CO;2; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; White SM, 2010, J APPL ECOL, V47, P1329, DOI 10.1111/j.1365-2664.2010.01880.x; WILLIAMS RW, 1980, MOSQ NEWS, V40, P597; Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x	67	12	12	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76228	10.1371/journal.pone.0076228	http://dx.doi.org/10.1371/journal.pone.0076228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086715	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000326520200134
J	Zhao, ZJ; Mai, ZL; Ou, LL; Duan, XL; Zeng, GH				Zhao, Zhijian; Mai, Zanlin; Ou, Lili; Duan, Xiaolu; Zeng, Guohua			Serum Estradiol and Testosterone Levels in Kidney Stones Disease with and without Calcium Oxalate Components in Naturally Postmenopausal Women	PLOS ONE			English	Article							SEX-HORMONES; REPLACEMENT THERAPY; ESTROGEN; EXPRESSION; EXCRETION; CITRATE; RISK	Objective: Epidemiological data reveal that the overall risk for kidney stones disease is lower for women compared to age-matched men. However, the beneficial effect for the female sex is lost upon menopause, a time corresponding to the onset of fall in estrogen levels. The aim of this study was to describe the serum estradiol (E2) and testosterone (T) characteristics of naturally postmenopausal women with kidney stones. Methods: 113 naturally postmenopausal women with newly diagnosed kidney stones (aged 57.4 +/- 4.98 years) and 84 age frequency matched stone-free controls (56.9 +/- 4.56 years) were validly recruited in the case-control study. The odds ratios (ORs) for the associations between sex hormones and kidney stones were estimated with logistic regression models, adjusting for demographic data and medical history. Patients were also stratified analyzed according to stone components (calcium oxalate stones [COS]; non-calcium oxalate stones [NCOS]). Results: Serum E2 (21.1 vs. 31.1 pg/ml) was significantly lower in kidney stones patients compared to controls. Post-hoc analysis demonstrated that this effect was driven by COS patients (p<0.001). According to tertiles of the E2 levels, a significant higher frequency of COS was seen in the lowest E2 group (p<0.001). Multiple logistic regression analysis identified E2 level as a strong factor that was independently associated with the risk for COS (per 1 SD increase, OR=0.951, 95% confidence interval [CI] = 0.919-0.985; highest: lowest tertile, OR=0.214, 95% CI = 0.069-0.665). However, serum T levels did not significantly differ among the groups. Conclusions: Naturally postmenopausal women with higher remaining estradiol levels appear less likely to suffer from kidney calcium oxalate stones. However, no correlation was found between serum T level and kidney stones. These findings support the hypothesis that higher postmenopausal endogenous estrogens may protect against kidney stones with ageing.	[Zhao, Zhijian; Mai, Zanlin; Ou, Lili; Duan, Xiaolu; Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Zhao, Zhijian; Mai, Zanlin; Ou, Lili; Duan, Xiaolu; Zeng, Guohua] Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Zeng, GH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China.	gzgyzgh@vip.tom.com			National Natural Science Foundation, China [81170652]; Science and Technology Education Department of the Ministry of Health, China [201002010]	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Science and Technology Education Department of the Ministry of Health, China	This work was financed by a grant from National Natural Science Foundation, China (No. 81170652) and Science and Technology Education Department of the Ministry of Health, China (No. 201002010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Curhan GC, 2001, KIDNEY INT, V59, P2290, DOI 10.1046/j.1523-1755.2001.0590062290.x; Dey J, 2002, J UROLOGY, V167, P169, DOI 10.1016/S0022-5347(05)65405-5; Fan J, 1999, J AM SOC NEPHROL, V10, pS376; Genazzani AD, 2007, DRUG AGING, V24, P173, DOI 10.2165/00002512-200724030-00001; Heller HJ, 2002, J UROLOGY, V168, P1923, DOI 10.1016/S0022-5347(05)64264-4; Hsu YJ, 2010, KIDNEY INT, V77, P601, DOI 10.1038/ki.2009.522; Iguchi M, 1999, KIDNEY INT, V56, P479, DOI 10.1046/j.1523-1755.1999.00586.x; JOHNSON CM, 1979, KIDNEY INT, V16, P624, DOI 10.1038/ki.1979.173; Lee YH, 1996, J UROLOGY, V156, P502, DOI 10.1016/S0022-5347(01)65914-7; Li JY, 2010, J UROLOGY, V184, P2360, DOI 10.1016/j.juro.2010.08.009; MARSHALL V, 1975, BRIT J UROL, V47, P117, DOI 10.1111/j.1464-410X.1975.tb03930.x; McEwen BS, 1999, J CLIN ENDOCR METAB, V84, P1790, DOI 10.1210/jc.84.6.1790; MCKANE WR, 1995, J CLIN ENDOCR METAB, V80, P3458, DOI 10.1210/jc.80.12.3458; NORDIN BE, J CLIN ENDOCRINOL ME, V60, P651; Nordin BEC, 1999, OSTEOPOROSIS INT, V9, P351, DOI 10.1007/s001980050158; Oz OK, 2007, J BONE MINER RES, V22, P1893, DOI 10.1359/JBMR.070808; PARKS JH, 1986, KIDNEY INT, V30, P85, DOI 10.1038/ki.1986.155; RANNEVIK G, 1995, MATURITAS, V21, P103, DOI 10.1016/0378-5122(94)00869-9; SCHEY HM, 1979, J UROLOGY, V122, P288, DOI 10.1016/S0022-5347(17)56370-3; SCHORR R, 1942, SCIENCE, V95, P606, DOI DOI 10.1126/SCIENCE.95.2476.606; Semins MJ, 2010, J UROLOGY, V183, P571, DOI 10.1016/j.juro.2009.09.085; SOUCIE JM, 1994, KIDNEY INT, V46, P893, DOI 10.1038/ki.1994.347; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Taylor EN, 2006, AM J KIDNEY DIS, V48, P905, DOI 10.1053/j.ajkd.2006.09.004; Van Abel M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022423.34922.2A; Watson JM, 2010, J ENDOUROL, V24, P1183, DOI 10.1089/end.2010.0113; Yoshihara H, 1999, J UROLOGY, V161, P668, DOI 10.1016/S0022-5347(01)61992-X; Yoshioka I, 2010, UROLOGY, V75, P907, DOI 10.1016/j.urology.2009.09.094	28	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75513	10.1371/journal.pone.0075513	http://dx.doi.org/10.1371/journal.pone.0075513			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086550	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200107
J	Daniels, SI; Soule, EE; Davidoff, KS; Bernbaum, JG; Hu, DS; Maeda, K; Stahl, SJ; Naiman, NE; Waheed, AA; Freed, EO; Wingfield, P; Yarchoan, R; Davis, DA				Daniels, Sarah I.; Soule, Erin E.; Davidoff, Katharine S.; Bernbaum, John G.; Hu, Duosha; Maeda, Kenji; Stahl, Stephen J.; Naiman, Nicole E.; Waheed, Abdul A.; Freed, Eric O.; Wingfield, Paul; Yarchoan, Robert; Davis, David A.			Activation of virus uptake through induction of macropinocytosis with a novel polymerizing peptide	FASEB JOURNAL			English	Article						retrovirus; cytochalasin D; cellular uptake; endocytosis	HUMAN-IMMUNODEFICIENCY-VIRUS; THERAPEUTIC AGENTS; HIV-1 REPLICATION; TYPE-1 PROTEASE; VIRAL VECTORS; PROTEINS; DELIVERY; CELLS; INHIBITION; BETA	A 27-aa peptide (P27) was previously shown to decrease the accumulation of human immunodeficiency virus type 1 (HIV-1) in the supernatant of chronically infected cells; however, the mechanism was not understood. Here, we show that P27 prevents virus accumulation by inducing macropinocytosis (MPC). Treatment of HIV-1- and human T-cell lymphotropic virus type 1 (HTLV-1)-infected cells with 2-10 M P27 caused cell membrane ruffling and uptake of virus and polymerized forms of the peptide into large vacuoles. As demonstrated by electron microscopy, activation of MPC did not require virus or cells infected with virus, as P27 initiated its own uptake in the absence of virus. Inhibitors of MPC, Cytochalasin D and amiloride, decreased P27-mediated uptake of soluble dextran and inhibited P27-induced virus uptake by >60%, which provides further evidence that P27 induces MPC. In CD4(+) HeLa cells, HIV-1 infection was enhanced by P27 up to 4-fold, and P27 increased infection at concentrations as low as 20 nM. The 5-aa C-terminal domain of P27 was necessary for virus uptake and may be responsible for the polymerization of P27 into fibrils. These forms of P27 may play a key role in triggering MPC, making this peptide a useful tool for studying virus uptake and infection, as well as MPC of other macromolecules.Daniels, S.I., Soule, E.E., Davidoff, K.S., Bernbaum, J.G., Hu, D., Maeda, K., Stahl, S.J., Naiman, N.E., Waheed, A.E., Freed, E.O., Wingfield, P., Yarchoan, R., Davis. D.A. Activation of virus uptake through induction of macropinocytosis with a novel polymerizing peptide.	[Daniels, Sarah I.; Soule, Erin E.; Davidoff, Katharine S.; Hu, Duosha; Maeda, Kenji; Naiman, Nicole E.; Yarchoan, Robert; Davis, David A.] NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, Frederick, MD 21701 USA; [Waheed, Abdul A.; Freed, Eric O.] NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, Frederick, MD 21701 USA; [Stahl, Stephen J.; Wingfield, Paul] NIAMSD, Prot Express Lab, NIH, Bethesda, MD 20892 USA; [Bernbaum, John G.] NIAID, Supporting Integrated Res Facil, Div Clin Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Davis, DA (corresponding author), NIH, 10 Ctr Dr,Bldg 10,Rm 6N106,MSC 1868, Bethesda, MD 20892 USA.	dadavis@helix.nih.gov	Maeda, Kenji/B-7708-2019	Maeda, Kenji/0000-0002-9424-1491; Naiman, Nicole/0000-0002-6116-555X; Wingfield, Paul/0000-0002-9515-4752	Intramural Research Program of the Center for Cancer Research; National Cancer Institute; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; NATIONAL CANCER INSTITUTE [ZIABC010775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Intramural Research Program of the Center for Cancer Research, the National Cancer Institute, the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and National Institute of Allergy and Infectious Diseases. The authors thank Yuki Takamatsu and Philippe Kieffer for technical help with flow cytometry and flow cytometry analysis.	Aghi M, 2005, CURR OPIN MOL THER, V7, P419; Amand HL, 2008, BIOCHEM BIOPH RES CO, V371, P621, DOI 10.1016/j.bbrc.2008.04.039; Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453; Asai D, 2010, J CONTROL RELEASE, V141, P52, DOI 10.1016/j.jconrel.2009.08.025; Borgmann K, 2011, AIDS RES HUM RETROV, V27, P853, DOI [10.1089/aid.2010.0295, 10.1089/AID.2010.0295]; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Davis DA, 1999, J VIROL, V73, P1156, DOI 10.1128/JVI.73.2.1156-1164.1999; Davis DA, 2006, ANTIVIR RES, V72, P89, DOI 10.1016/j.antiviral.2006.03.015; Davis DA, 2009, BIOCHEM J, V419, P497, DOI 10.1042/BJ20082068; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Eguchi A, 2001, J BIOL CHEM, V276, P26204, DOI 10.1074/jbc.M010625200; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Fonseca SB, 2009, ADV DRUG DELIVER REV, V61, P953, DOI 10.1016/j.addr.2009.06.001; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Ganguly S, 2008, OLIGONUCLEOTIDES, V18, P277, DOI 10.1089/oli.2008.0140; Glorioso JC, 2003, J NEUROVIROL, V9, P165, DOI 10.1080/13550280390193984; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Maeda K, 2001, J BIOL CHEM, V276, P35194, DOI 10.1074/jbc.M105670200; Mandel RJ, 2006, MOL THER, V13, P463, DOI 10.1016/j.ymthe.2005.11.009; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Morozov VA, 1999, VIROLOGY, V255, P279, DOI 10.1006/viro.1998.9578; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Morris SJ, 2002, ARCH VIROL, V147, P961, DOI 10.1007/s00705-001-0779-x; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; NAGY K, 1983, INT J CANCER, V32, P321, DOI 10.1002/ijc.2910320310; Nakase I, 2009, MOL THER, V17, P1868, DOI 10.1038/mt.2009.192; NAVIA MA, 1989, NATURE, V337, P615, DOI 10.1038/337615a0; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; Overmeyer JH, 2008, MOL CANCER RES, V6, P965, DOI 10.1158/1541-7786.MCR-07-2036; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Raghu H, 2009, J VIROL, V83, P4895, DOI 10.1128/JVI.02498-08; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Sandgren KJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000866; Turner JJ, 2005, NUCLEIC ACIDS RES, V33, P6837, DOI 10.1093/nar/gki991; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Vocero-Akbani AM, 1999, NAT MED, V5, P29, DOI 10.1038/4710; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; WINGFIELD PT, 1991, BIOCHEMISTRY-US, V30, P7527, DOI 10.1021/bi00244a023; Wojtowicz WM, 2002, J BIOL CHEM, V277, P35019, DOI 10.1074/jbc.M203518200; Zhang H, 2008, J MOL BIOL, V378, P565, DOI 10.1016/j.jmb.2008.02.066	48	2	2	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					106	116		10.1096/fj.13-238113	http://dx.doi.org/10.1096/fj.13-238113			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24097312	Green Published			2022-12-25	WOS:000333526100013
J	Bode, A; Lynch, JW				Bode, Anna; Lynch, Joseph W.			Analysis of Hyperekplexia Mutations Identifies Transmembrane Domain Rearrangements That Mediate Glycine Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cys Loop Receptors; Glycine Receptors; Patch Clamp; Receptor Structure-Function; Site-directed Mutagenesis	GATED ION-CHANNEL; X-RAY-STRUCTURE; GABA(A) RECEPTOR; CHLORIDE CHANNEL; AGONIST BINDING; OPEN STATE; PAIN; LOOP; MECHANISMS; GEPHYRIN	Pentameric ligand-gated ion channels (pLGICs) mediate numerous physiological processes and are therapeutic targets for a wide range of clinical indications. Elucidating the structural differences between their closed and open states may help in designing improved drugs that bias receptors toward the desired conformational state. We recently showed that two new hyperekplexia mutations, Q226E and V280M, induced spontaneous activity in 1 glycine receptors. Gln-226, located near the top of transmembrane (TM) 1, is closely apposed to Arg-271 at the top of TM2 in the neighboring subunit. Using mutant cycle analysis, we inferred that Q226E induces activation via an enhanced electrostatic attraction to Arg-271. This would tilt the top of TM2 toward TM1 and hence away from the pore axis to open the channel. We also concluded that the increased side chain volume of V280M, in the TM2-TM3 loop, exerts a steric repulsion against Ile-225 at the top of TM1 in the neighboring subunit. We infer that this steric repulsion would tilt the top of TM3 radially outwards against the stationary TM1 and thus provide space for TM2 to relax away from the pore axis to create an open channel. Because the transmembrane domain movements inferred from this functional analysis are consistent with the structural differences evident in the x-ray atomic structures of closed and open state bacterial pLGICs, we propyose that the model of pLGIC activation as outlined here may be broadly applicable across the eukaryotic pLGIC receptor family.	[Bode, Anna; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au			National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia and the Australian Research Council.	Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Dutertre S, 2012, J BIOL CHEM, V287, P40216, DOI 10.1074/jbc.R112.408229; Eichler SA, 2008, J CELL MOL MED, V12, P2848, DOI 10.1111/j.1582-4934.2008.00357.x; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Kruger W, 2005, NEUROSCI LETT, V380, P340, DOI 10.1016/j.neulet.2005.01.065; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Manzke T, 2010, J CLIN INVEST, V120, P4118, DOI 10.1172/JCI43029; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; RAJENDRA S, 1994, J BIOL CHEM, V269, P18739; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Richardson BD, 2012, BRAIN RES, V1485, P77, DOI 10.1016/j.brainres.2012.02.014; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Specht CG, 2013, NEURON, V79, P308, DOI 10.1016/j.neuron.2013.05.013; Thomas RH, 2010, J PEDIATR NEUROL, V8, P11, DOI 10.3233/JPN-2010-0359; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Wang QA, 2010, J BIOL CHEM, V285, P40373, DOI 10.1074/jbc.M110.161513; Xiong W, 2012, J EXP MED, V209, P1121, DOI 10.1084/jem.20120242; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2	36	19	19	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33760	33771		10.1074/jbc.M113.513804	http://dx.doi.org/10.1074/jbc.M113.513804			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24097980	Green Published, hybrid			2022-12-25	WOS:000327250200022
J	Jang, YH; Byun, YH; Lee, KH; Park, ES; Lee, YH; Lee, YJ; Lee, J; Kim, KH; Seong, BL				Jang, Yo Han; Byun, Young Ho; Lee, Kwang-Hee; Park, Eun-Sook; Lee, Yun Ha; Lee, Yoon-Jae; Lee, Jinhee; Kim, Kyun-Hwan; Seong, Baik Lin			Host Defense Mechanism-Based Rational Design of Live Vaccine	PLOS ONE			English	Article							INFLUENZA-A VIRUS; FACTOR-INDUCED APOPTOSIS; CELL-DEATH APOPTOSIS; CASPASE FAMILY; CLEAVAGE SITE; NS1 PROTEIN; B VIRUSES; IN-VIVO; NUCLEOPROTEIN; INFECTION	Live attenuated vaccine (LAV), mimicking natural infection, provides an excellent protection against microbial infection. The development of LAV, however, still remains highly empirical and the rational design of clinically useful LAV is scarcely available. Apoptosis and caspase activation are general host antiviral responses in virus-infected cells. Utilizing these tightly regulated host defense mechanisms, we present a novel apoptosis-triggered attenuation of viral virulence as a rational design of live attenuated vaccine with desired levels of safety, efficacy, and productivity. Mutant influenza viruses carrying caspase recognition motifs in viral NP and the interferon-antagonist NS1 proteins were highly attenuated both in vitro and in vivo by caspase-mediated cleavage of those proteins in infected cells. Both viral replication and interferon-resistance were substantially reduced, resulting in a marked attenuation of virulence of the virus. Despite pronounced attenuation, the viruses demonstrated high growth phenotype in embryonated eggs at lower temperature, ensuring its productivity. A single dose vaccination with the mutant virus elicited high levels of systemic and mucosal antibody responses and provided complete protection against both homologous and heterologous lethal challenges in mouse model. While providing a practical means to generate seasonal or pandemic influenza live vaccines, the sensitization of viral proteins to pathogen-triggered apoptotic signals presents a potentially universal, mechanism-based rational design of live vaccines against many viral infections.	[Jang, Yo Han; Byun, Young Ho; Lee, Kwang-Hee; Lee, Yun Ha; Lee, Yoon-Jae; Lee, Jinhee; Seong, Baik Lin] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea; [Park, Eun-Sook; Kim, Kyun-Hwan] Konkuk Univ, Sch Med, IBST, Dept Pharmacol, Seoul, South Korea; [Seong, Baik Lin] Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea	Yonsei University; Konkuk University; Konkuk University Medical Center; Yonsei University	Seong, BL (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea.	blseong@yonsei.ac.kr	Lee, Yoon Jae/HGE-5712-2022	Park, Eun-Sook/0000-0002-6652-9404; Kim, Kyun-Hwan/0000-0001-5266-072X	Ministry for Health, Welfare and Family Affairs of Republic of Korea [A085105]	Ministry for Health, Welfare and Family Affairs of Republic of Korea	This work was supported by a grant from the Korea Healthcare Technology R&D project of Ministry for Health, Welfare and Family Affairs of Republic of Korea [grant number A085105]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ada GL, 1990, NEW GENERATION VACCI, P19; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Belshe Robert, 2004, Expert Rev Vaccines, V3, P643, DOI 10.1586/14760584.3.6.643; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; CHANOCK RM, 1988, VACCINE, V6, P129, DOI 10.1016/S0264-410X(88)80014-8; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chien CY, 1997, NAT STRUCT BIOL, V4, P891, DOI 10.1038/nsb1197-891; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; FESQ H, 1994, IMMUNOBIOLOGY, V190, P175, DOI 10.1016/S0171-2985(11)80292-5; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Jang YH, 2012, CLIN EXP VACCINE RES, V1, P35, DOI 10.7774/cevr.2012.1.1.35; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lauring AS, 2010, NAT BIOTECHNOL, V28, P573, DOI 10.1038/nbt.1635; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le TVL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018780; Lee KH, 2006, VACCINE, V24, P1966, DOI 10.1016/j.vaccine.2005.10.051; Lipatov AS, 2008, ARCH VIROL, V153, P427, DOI 10.1007/s00705-007-0003-8; Maassab HF, 1999, REV MED VIROL, V9, P237, DOI 10.1002/(SICI)1099-1654(199910/12)9:4&lt;237::AID-RMV252&gt;3.0.CO;2-G; MAASSAB HF, 1985, VACCINE, V3, P355, DOI 10.1016/0264-410X(85)90124-0; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; MORI I, 1995, J GEN VIROL, V76, P2869, DOI 10.1099/0022-1317-76-11-2869; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NEUMANN G, 1994, VIROLOGY, V202, P477, DOI 10.1006/viro.1994.1365; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Perez JT, 2009, NAT BIOTECHNOL, V27, P572, DOI 10.1038/nbt.1542; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Robert BB, 2004, VIRUS RES, V103, P177; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schultz-Cherry S, 2001, J VIROL, V75, P7875, DOI 10.1128/JVI.75.17.7875-7881.2001; SILVERMAN RB, 1995, METHOD ENZYMOL, V249, P240; Silverman RB, 1992, ENZYME INHIBITION IN, P146; Song MS, 2009, J VIROL, V83, P12325, DOI 10.1128/JVI.01373-09; Stech J, 2005, NAT MED, V11, P683, DOI 10.1038/nm1256; Steegenga WT, 1998, ONCOGENE, V16, P349, DOI 10.1038/sj.onc.1201540; TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Watanabe S, 2009, J VIROL, V83, P5947, DOI 10.1128/JVI.00450-09; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Zhirnov Oleg P, 2009, J Mol Genet Med, V3, P124; Zhirnov OP, 2009, VIROLOGY, V394, P57, DOI 10.1016/j.virol.2009.08.013	53	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75043	10.1371/journal.pone.0075043	http://dx.doi.org/10.1371/journal.pone.0075043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098364	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500019
J	Ollivier, M; Tresset, A; Hitte, C; Petit, C; Hughes, S; Gillet, B; Duffraisse, M; Pionnier-Capitan, M; Lagoutte, L; Arbogast, RM; Balasescu, A; Boroneant, A; Mashkour, M; Vigne, JD; Hanni, C				Ollivier, Morgane; Tresset, Anne; Hitte, Christophe; Petit, Coraline; Hughes, Sandrine; Gillet, Benjamin; Duffraisse, Marilyne; Pionnier-Capitan, Maud; Lagoutte, Laetitia; Arbogast, Rose-Marie; Balasescu, Adrian; Boroneant, Adina; Mashkour, Marjan; Vigne, Jean-Denis; Haenni, Catherine			Evidence of Coat Color Variation Sheds New Light on Ancient Canids	PLOS ONE			English	Article							DOG DOMESTICATION; URSUS-ARCTOS; BROWN BEAR; POPULATIONS; MULTIPLE; GENETICS; SEQUENCE; HISTORY; REVEAL; ORIGIN	We have used a paleogenetics approach to investigate the genetic landscape of coat color variation in ancient Eurasian dog and wolf populations. We amplified DNA fragments of two genes controlling coat color, Mc1r (Melanocortin 1 Receptor) and CBD103 (canine-beta-defensin), in respectively 15 and 19 ancient canids (dogs and wolf morphotypes) from 14 different archeological sites, throughout Asia and Europe spanning from ca. 12 000 B.P. (end of Upper Palaeolithic) to ca. 4000 B.P. (Bronze Age). We provide evidence of a new variant (R301C) of the Melanocortin 1 receptor (Mc1r) and highlight the presence of the beta-defensin melanistic mutation (CDB103-K locus) on ancient DNA from dog-and wolf-morphotype specimens. We show that the dominant K-B allele (CBD103), which causes melanism, and R301C (Mc1r), the variant that may cause light hair color, are present as early as the beginning of the Holocene, over 10 000 years ago. These results underline the genetic diversity of prehistoric dogs. This diversity may have partly stemmed not only from the wolf gene pool captured by domestication but also from mutations very likely linked to the relaxation of natural selection pressure occurring in-line with this process.	[Ollivier, Morgane; Petit, Coraline; Hughes, Sandrine; Gillet, Benjamin; Duffraisse, Marilyne; Pionnier-Capitan, Maud; Haenni, Catherine] Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, CNRS,UMR5242, F-69365 Lyon 07, France; [Tresset, Anne; Pionnier-Capitan, Maud; Mashkour, Marjan; Vigne, Jean-Denis] MNHN, CNRS, UMR Archeozool Archeobot Soc Prat & Environm 7209, Dept Ecol & Gest Biodiversite, Paris, France; [Hitte, Christophe; Lagoutte, Laetitia] Univ Rennes 1, Inst Genet & Dev Rennes, CNRS, UMR6290, Rennes, France; [Gillet, Benjamin; Haenni, Catherine] Ecole Normale Super Lyon, CNRS, French Natl Platform Paleogenet, PALGENE, F-69364 Lyon 07, France; [Arbogast, Rose-Marie] CNRS, UMR Maison Interuniv Sci Homme Alsace 7044, Strasbourg, France; [Balasescu, Adrian] Natl Museum Romanian Hist, Ctr Natl Rech Pluridisciplinaires, Bucharest, Romania; [Boroneant, Adina] Romanian Acad, Inst Archaeol Vasile Parvan, Bucharest, Romania	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Romanian Academy of Sciences	Hanni, C (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, CNRS,UMR5242, F-69365 Lyon 07, France.	catherine.hanni@ens-lyon.fr	Gillet, Benjamin/ABD-6704-2020; Balasescu, Adrian/L-6149-2013; Boroneanț, Adina/N-5002-2015; Ollivier, Morgane/AAA-6059-2019; Mashkour, Marjan/B-5724-2018	Balasescu, Adrian/0000-0001-7834-5111; Ollivier, Morgane/0000-0002-8361-4221; Hitte, Christophe/0000-0003-1714-437X; Mashkour, Marjan/0000-0003-3630-9459	CNRS; ENS de Lyon; Romanian National Authority for Scientific Research, CNS - UEFISCDI [PN-II-ID-PCE-2011-3-0982]	CNRS(Centre National de la Recherche Scientifique (CNRS)); ENS de Lyon; Romanian National Authority for Scientific Research, CNS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	The following organizations supported this work: CNRS (http://www.cnrs.fr/), ENS de Lyon (http://www.ens-lyon.eu/) and the Romanian National Authority for Scientific Research, CNS - UEFISCDI for the grant it provided (project number PN-II-ID-PCE-2011-3-0982, http://www.seera-ei.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Benecke N, 1996, ACTA PRAEHISTORICA A, V28, P213; Blankenberg D, 2010, CURRENT PROTOCOLS MO, V19; Boyko AR, 2009, P NATL ACAD SCI USA, V106, P13903, DOI 10.1073/pnas.0902129106; Calvignac S, 2009, DIVERS DISTRIB, V15, P742, DOI 10.1111/j.1472-4642.2009.00586.x; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; DAVIS SJM, 1978, NATURE, V276, P608, DOI 10.1038/276608a0; Everts RE, 2000, ANIM GENET, V31, P194, DOI 10.1046/j.1365-2052.2000.00639.x; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Germonpre M, 2012, J ARCHAEOL SCI, V39, P184, DOI 10.1016/j.jas.2011.09.022; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; Newton JM, 2000, MAMM GENOME, V11, P24, DOI 10.1007/s003350010005; Orlando L, 2006, CURR BIOL, V16, pR400, DOI 10.1016/j.cub.2006.05.019; Ovodov ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022821; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pionnier-Capitan M, 2010, THESIS ENS LYON; Pionnier-Capitan M, 2011, J ARCHAEOL SCI, V38, P2123, DOI 10.1016/j.jas.2011.02.028; Randi E, 2002, CONSERV GENET, V3, P31; Rompler H, 2006, SCIENCE, V313, P62, DOI 10.1126/science.1128994; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; Turnbull PF, 1974, FIELDIANA ANTHR, V63; Vigne JD, 2005, MUNIBE, V51, P279; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wayne RK, 2007, TRENDS GENET, V23, P557, DOI 10.1016/j.tig.2007.08.013	39	22	22	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75110	10.1371/journal.pone.0075110	http://dx.doi.org/10.1371/journal.pone.0075110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098367	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500021
J	Guan, CQ; Meng, WJ; Yao, R; Glenberg, AM				Guan, Connie Qun; Meng, Wanjin; Yao, Ru; Glenberg, Arthur M.			The Motor System Contributes to Comprehension of Abstract Language	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; FMRI EVIDENCE; REPRESENTATIONS; MODULATION; INTEGRATION; SENTENCES; COGNITION; MOVEMENT; BEHAVIOR; IMAGERY	If language comprehension requires a sensorimotor simulation, how can abstract language be comprehended? We show that preparation to respond in an upward or downward direction affects comprehension of the abstract quantifiers "more and more" and "less and less" as indexed by an N400-like component. Conversely, the semantic content of the sentence affects the motor potential measured immediately before the upward or downward action is initiated. We propose that this bidirectional link between motor system and language arises because the motor system implements forward models that predict the sensory consequences of actions. Because the same movement (e. g., raising the arm) can have multiple forward models for different contexts, the models can make different predictions depending on whether the arm is raised, for example, to place an object or raised as a threat. Thus, different linguistic contexts invoke different forward models, and the predictions constitute different understandings of the language.	[Guan, Connie Qun] Univ Sci & Technol Beijing, Beijing 100083, Peoples R China; [Guan, Connie Qun; Meng, Wanjin] Florida State Univ, Tallahassee, FL 32306 USA; [Guan, Connie Qun; Meng, Wanjin] Florida Ctr Reading Res, Tallahassee, FL USA; [Meng, Wanjin; Yao, Ru] Natl Inst Educ Sci, Beijing, Peoples R China; [Glenberg, Arthur M.] Arizona State Univ, Tempe, AZ 85069 USA; [Glenberg, Arthur M.] Univ Wisconsin, Madison, WI USA	University of Science & Technology Beijing; State University System of Florida; Florida State University; Arizona State University; Arizona State University-Tempe; University of Wisconsin System; University of Wisconsin Madison	Glenberg, AM (corresponding author), Arizona State Univ, Tempe, AZ 85069 USA.	glenberg@asu.edu		Glenberg, Arthur/0000-0002-9281-3687	National Social Science Foundation Grant [13BYY070]; National Office for Education Sciences Planning Grant [DBA120179]; Engineering Research Institute Foundations of USTB Grant [YJ2012-019]; U.S. National Science Foundation grants [1020367, 1324807]	National Social Science Foundation Grant; National Office for Education Sciences Planning Grant; Engineering Research Institute Foundations of USTB Grant; U.S. National Science Foundation grants(National Science Foundation (NSF))	This research was supported by National Social Science Foundation Grant (13BYY070), National Office for Education Sciences Planning Grant (DBA120179), Engineering Research Institute Foundations of USTB Grant (YJ2012-019) to Connie Qun Guan. Arthur Glenberg was partially supported by U.S. National Science Foundation grants 1020367 and 1324807. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the U.S. National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman JM, 2001, ANN NY ACAD SCI, V935, P107, DOI 10.1111/j.1749-6632.2001.tb03476.x; Anderson ML, 2003, ARTIF INTELL, V149, P91, DOI 10.1016/S0004-3702(03)00054-7; Aravena P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011751; Arbib MA, 2008, J PHYSIOL-PARIS, V102, P4, DOI 10.1016/j.jphysparis.2008.03.001; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; BARRETT SE, 1990, BRAIN COGNITION, V14, P201, DOI 10.1016/0278-2626(90)90029-N; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bernardis P, 2008, EXP BRAIN RES, V184, P599, DOI 10.1007/s00221-007-1256-x; Boot I, 2011, EXP PSYCHOL, V58, P162, DOI 10.1027/1618-3169/a000082; Borghi A.M., 2009, P ANN C COGENTIVE SC, P2304; Borghi AM, 2010, NEUROPSYCHOLOGIA, V48, P63; Boroditsky L, 2002, PSYCHOL SCI, V13, P185, DOI 10.1111/1467-9280.00434; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Boulenger V, 2012, NEUROIMAGE, V59, P3502, DOI 10.1016/j.neuroimage.2011.11.011; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Chiel HJ, 1997, TRENDS NEUROSCI, V20, P553, DOI 10.1016/S0166-2236(97)01149-1; Clark A, 1998, ANALYSIS, V58, P7, DOI 10.1111/1467-8284.00096; Clark A, 1998, BEING THERE PUTTING; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Desai RH, 2011, J COGNITIVE NEUROSCI, V23, P2376, DOI 10.1162/jocn.2010.21596; Fodor J. A., 1975, LANGUAGE THOUGHT; Fodor J. A, 1983, MODULARITY MIND; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Gentilucci M, 2008, Q J EXP PSYCHOL, V61, P944, DOI 10.1080/17470210701625683; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 2008, Q J EXP PSYCHOL, V61, P905, DOI 10.1080/17470210701625550; Glenberg AM, 2012, CORTEX, V48, P905, DOI 10.1016/j.cortex.2011.04.010; Grush R, 2004, BEHAV BRAIN SCI, V27, P377, DOI 10.1017/S0140525X04000093; Guan CQ, J BEHAV PSYCHOL RES; Hatta A, 2009, NEUROSCI LETT, V459, P105, DOI 10.1016/j.neulet.2009.05.005; Havas DA, 2010, PSYCHOL SCI, V21, P895, DOI 10.1177/0956797610374742; Holcomb PJ, 1999, J EXP PSYCHOL LEARN, V25, P721, DOI 10.1037/0278-7393.25.3.721; Hurley S, 2004, PERSPECTIVES IMITATI; Ibanez A, 2010, NEUROSCI LETT, V471, P48, DOI 10.1016/j.neulet.2010.01.009; Kan IP, 2003, COGN NEUROPSYCHOL, V20, P525, DOI 10.1080/02643290244000257; Kiefer M, 2012, CORTEX, V48, P805, DOI 10.1016/j.cortex.2011.04.006; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; KRISTEVA R, 1990, ELECTROEN CLIN NEURO, V75, P410, DOI 10.1016/0013-4694(90)90086-Y; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Lakoff G., 2003, METAPHORS WE LIVE; Langston W, 2002, DISCOURSE PROCESS, V34, P281, DOI 10.1207/S15326950DP3403_3; Lesage E, 2012, CURR BIOL, V22, pR794, DOI 10.1016/j.cub.2012.07.006; Luu P, 2000, J NEUROSCI, V20, P464, DOI 10.1523/JNEUROSCI.20-01-00464.2000; McPherson WB, 1999, PSYCHOPHYSIOLOGY, V36, P53, DOI 10.1017/S0048577299971196; Noe Alva, 2002, VISION MIND SELECTED, P1; Pecher D., 2005, GROUNDING COGNITION; Pickering MJ, 2007, TRENDS COGN SCI, V11, P105, DOI 10.1016/j.tics.2006.12.002; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Raposo A, 2009, NEUROPSYCHOLOGIA, V47, P388, DOI 10.1016/j.neuropsychologia.2008.09.017; Richardson DC, 2003, COGNITIVE SCI, V27, P767, DOI 10.1016/S0364-0213(03)00064-8; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rueschemeyer SA, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00183; Sato M, 2008, BRAIN LANG, V105, P83, DOI 10.1016/j.bandl.2007.10.001; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; Sell AJ, 2012, PSYCHON B REV, V19, P708, DOI 10.3758/s13423-012-0263-5; Sell AJ, 2011, BRAIN LANG, V117, P39, DOI 10.1016/j.bandl.2010.07.003; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P1444, DOI 10.1016/S1388-2457(02)00195-5; Smith AL, 2006, BRAIN RES, V1071, P165, DOI 10.1016/j.brainres.2005.11.084; Speer NK, 2005, J MEM LANG, V53, P125, DOI 10.1016/j.jml.2005.02.009; TALMY L, 1988, COGNITIVE SCI, V12, P49, DOI 10.1016/0364-0213(88)90008-0; Van Petten C, 2006, BRAIN LANG, V97, P279, DOI 10.1016/j.bandl.2005.11.003; Varela F., 1991, EMBODIED MIND; West WC, 2002, COGNITIVE BRAIN RES, V13, P363, DOI 10.1016/S0926-6410(01)00129-X; West WC, 2000, J COGNITIVE NEUROSCI, V12, P1024, DOI 10.1162/08989290051137558; WHEELER Michael, 2005, RECONSTRUCTING COGNI; Willems RM, 2008, J COGNITIVE NEUROSCI, V20, P1235, DOI 10.1162/jocn.2008.20085; Willems RM, 2007, BRAIN LANG, V101, P278, DOI 10.1016/j.bandl.2007.03.004; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; Yee E, 2013, PSYCHOL SCI, V24, P909, DOI 10.1177/0956797612464658	75	34	34	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75183	10.1371/journal.pone.0075183	http://dx.doi.org/10.1371/journal.pone.0075183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VP	24086463	Green Published, gold, Green Submitted			2022-12-25	WOS:000325220000015
J	Sreedevi, G; Prasad, YG; Prabhakar, M; Rao, GR; Vennila, S; Venkateswarlu, B				Sreedevi, Gudapati; Prasad, Yenumula Gerard; Prabhakar, Mathyam; Rao, Gubbala Ramachandra; Vennila, Sengottaiyan; Venkateswarlu, Bandi			Bioclimatic Thresholds, Thermal Constants and Survival of Mealybug, Phenacoccus solenopsis (Hemiptera: Pseudococcidae) in Response to Constant Temperatures on Hibiscus	PLOS ONE			English	Article							MACONELLICOCCUS-HIRSUTUS HEMIPTERA; INTRINSIC OPTIMUM TEMPERATURE; DEPENDENT DEVELOPMENT; LIFE-HISTORY; DIAMONDBACK MOTH; HOST PLANTS; RATE MODEL; COTTON; TINSLEY; REQUIREMENTS	Temperature-driven development and survival rates of the mealybug, Phenacoccus solenopsis Tinsley (Hemiptera: Pseudococcidae) were examined at nine constant temperatures (15, 20, 25, 27, 30, 32, 35 and 40 degrees C) on hibiscus (Hibiscus rosa-sinensis L.). Crawlers successfully completed development to adult stage between 15 and 35 degrees C, although their survival was affected at low temperatures. Two linear and four nonlinear models were fitted to describe developmental rates of P. solenopsis as a function of temperature, and for estimating thermal constants and bioclimatic thresholds (lower, optimum and upper temperature thresholds for development: T-min, T-opt and T-max, respectively). Estimated thresholds between the two linear models were statistically similar. Ikemoto and Takai's linear model permitted testing the equivalence of lower developmental thresholds for life stages of P. solenopsis reared on two hosts, hibiscus and cotton. Thermal constants required for completion of cumulative development of female and male nymphs and for the whole generation were significantly lower on hibiscus (222.2, 237.0, 308.6 degree-days, respectively) compared to cotton. Three nonlinear models performed better in describing the developmental rate for immature instars and cumulative life stages of female and male and for generation based on goodness-of-fit criteria. The simplified beta type distribution function estimated T-opt values closer to the observed maximum rates. Thermodynamic SSI model indicated no significant differences in the intrinsic optimum temperature estimates for different geographical populations of P. solenopsis. The estimated bioclimatic thresholds and the observed survival rates of P. solenopsis indicate the species to be high-temperature adaptive, and explained the field abundance of P. solenopsis on its host plants.	[Sreedevi, Gudapati; Prasad, Yenumula Gerard; Prabhakar, Mathyam; Rao, Gubbala Ramachandra; Venkateswarlu, Bandi] Cent Res Inst Dryland Agr, Div Crop Sci, Hyderabad, Andhra Pradesh, India; [Vennila, Sengottaiyan] Natl Ctr Integrated Pest Management, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Research Institute of Dryland Agriculture; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre for Integrated Pest Management	Prasad, YG (corresponding author), Cent Res Inst Dryland Agr, Div Crop Sci, Hyderabad, Andhra Pradesh, India.	ygprasad@gmail.com		venkateswarlu, B/0000-0001-7654-8193	National Agricultural Innovation Project [(NAIP)-C4/ C2046]	National Agricultural Innovation Project	This work was supported by National Agricultural Innovation Project (NAIP)-C4/ C2046 sub project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akintola A. J., 2008, Agricultural Journal, V3, P1, DOI 10.3923/ijar.2008.1.26; Amarasekare KG, 2008, J ECON ENTOMOL, V101, P1798, DOI 10.1603/0022-0493-101.6.1798; Amjad Ali, 2012, Journal of Agricultural Research (Lahore), V50, P89; Arif MI, 2009, INT J AGRIC BIOL, V11, P163; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; CAREY JR, 1984, ECOL ENTOMOL, V9, P261, DOI 10.1111/j.1365-2311.1984.tb00850.x; Charleston K., 2010, AUSTR COTTON GROWER, V31, P18; Chong JH, 2003, ANN ENTOMOL SOC AM, V96, P539, DOI 10.1603/0013-8746(2003)096[0539:TEOTDS]2.0.CO;2; Chong JH, 2008, ENVIRON ENTOMOL, V37, P323, DOI 10.1603/0046-225X(2008)37[323:LHOTMM]2.0.CO;2; Culik MP, 2005, ZOOTAXA, P1; Damos PT, 2008, J ECON ENTOMOL, V101, P1557, DOI 10.1603/0022-0493(2008)101[1557:TBAMOA]2.0.CO;2; Faraway J.J., 2005, LINEAR MODELS R; FUCHS TW, 1991, SOUTHWEST ENTOMOL, V16, P215; Gilbert N, 1996, CAN ENTOMOL, V128, P1, DOI 10.4039/Ent1281-1; Hameed A, 2012, PAK J ZOOL, V44, P685; Hodgson C, 2008, ZOOTAXA, P1; Ikemoto T, 2000, ENVIRON ENTOMOL, V29, P671, DOI 10.1603/0046-225X-29.4.671; Ikemoto T, 2005, ENVIRON ENTOMOL, V34, P1377, DOI 10.1603/0046-225X-34.6.1377; Ikemoto T, 2012, J INSECT SCI, V10, P1744; Institute SAS, 2009, PROC US MAN VERS 9 2; Jandricic SE, 2010, ENVIRON ENTOMOL, V39, P1631, DOI 10.1603/EN09351; Jarosik V, 2011, J ECON ENTOMOL, V104, P1870, DOI 10.1603/EC11247; Kontodimas DC, 2004, ENVIRON ENTOMOL, V33, P1, DOI 10.1603/0046-225X-33.1.1; Kuang XJ, 2012, INSECT SCI, V19, P121, DOI 10.1111/j.1744-7917.2011.01428.x; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; Lu Yongyue, 2011, Scientific Research and Essays, V6, P6459; Ma J, 2011, PLANT QUARANTINE, V25, p5 ; Marchioro CA, 2011, NEOTROP ENTOMOL, V40, P533, DOI 10.1590/S1519-566X2011000500003; Prasad Y. G., 2011, Journal of Biological Control, V25, P198; Prasad YG, 2012, CROP PROT, V39, P81, DOI 10.1016/j.cropro.2012.03.027; Regniere J, 2012, J INSECT PHYSIOL, V58, P634, DOI 10.1016/j.jinsphys.2012.01.010; Serrano MS, 2002, FLA ENTOMOL, V85, P417, DOI 10.1653/0015-4040(2002)085[0417:EOHPAA]2.0.CO;2; Shi PJ, 2012, ENVIRON ENTOMOL, V41, P714, DOI 10.1603/EN12058; Shi PJ, 2011, ENVIRON ENTOMOL, V40, P462, DOI 10.1603/EN10265; Shi PJ, 2010, ENVIRON ENTOMOL, V39, P2033, DOI 10.1603/EN10136; Tinsley J.B., 1898, CAN ENTOMOL, V30, P47, DOI [DOI 10.4039/ENT3047-2, 10.4039/Ent3047-2]; Tran LT, 2012, ENVIRON ENTOMOL, V41, P1190, DOI 10.1603/EN12124; Trudgill DL, 2005, ANN APPL BIOL, V146, P1, DOI 10.1111/j.1744-7348.2005.04088.x; VANRIJN PCJ, 1995, B ENTOMOL RES, V85, P285, DOI 10.1017/S0007485300034386; Vennila S, 2011, TECHNICAL B NATL CTR, V26; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; Wang YP, 2010, AGR FOREST ENTOMOL, V12, P403, DOI 10.1111/j.1461-9563.2010.00490.x; Wang Ying-Ying, 2012, Acta Entomologica Sinica, V55, P77; Williams D., 1992, MEALYBUGS CENTRAL S; WORNER SP, 1992, ENVIRON ENTOMOL, V21, P689, DOI 10.1093/ee/21.4.689; Wu San-An, 2009, Chinese Bulletin of Entomology, V46, P159; Zahiri B, 2010, ENVIRON ENTOMOL, V39, P177, DOI 10.1603/EN08239; Zalucki Myron P., 2005, Insect Science, V12, P45, DOI 10.1111/j.1672-9609.2005.00007.x	49	17	22	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75636	10.1371/journal.pone.0075636	http://dx.doi.org/10.1371/journal.pone.0075636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086597	Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700105
J	Ferrer, T; Arechiga-Figueroa, IA; Shapiro, MS; Tristani-Firouzi, M; Sanchez-Chapula, JA				Ferrer, Tania; Arechiga-Figueroa, Ivan Arael; Shapiro, Mark S.; Tristani-Firouzi, Martin; Sanchez-Chapula, Jose A.			Tamoxifen Inhibition of Kv7.2/Kv7.3 Channels	PLOS ONE			English	Article							RECEPTOR-MEDIATED INHIBITION; POTASSIUM CHANNELS; K+ CURRENTS; PHOSPHATIDYLINOSITOL; PIP2; NEURONS; BLOCKS; CELLS; KCNQ2; GATE	KCNQ genes encode five Kv7 K+ channel subunits (Kv7.1-Kv7.5). Four of these (Kv7.2-Kv7.5) are expressed in the nervous system. Kv7.2 and Kv7.3 are the principal molecular components of the slow voltage-gated M-channel, which regulates neuronal excitability. In this study, we demonstrate that tamoxifen, an estrogen receptor antagonist used in the treatment of breast cancer, inhibits Kv7.2/Kv7.3 currents heterologously expressed in human embryonic kidney HEK-293 cells. Current inhibition by tamoxifen was voltage independent but concentration-dependent. The IC50 for current inhibition was 1.68 +/- 0.44 mu M. The voltage-dependent activation of the channel was not modified. Tamoxifen inhibited Kv7.2 homomeric channels with a higher potency (IC50 = 0.74 +/- 0.16 mu M). The mutation Kv7.2 R463E increases phosphatidylinositol-4,5-bisphosphate (PIP2) -channel interaction and diminished dramatically the inhibitory effect of tamoxifen compared with that for wild type Kv7.2. Conversely, the mutation Kv7.2 R463Q, which decreases PIP2 -channel interaction, increased tamoxifen potency. Similar results were obtained on the heteromeric Kv7.2 R463Q/Kv7.3 and Kv7.2 R463E/Kv7.3 channels, compared to Kv7.2/Kv7.3 WT. Overexpression of type 2A PI(4) P5-kinase (PIP5K 2A) significantly reduced tamoxifen inhibition of Kv7.2/Kv7.3 and Kv7.2 R463Q channels. Our results suggest that tamoxifen inhibited Kv7.2/Kv7.3 channels by interfering with PIP2-channel interaction because of its documented interaction with PIP2 and the similar effect of tamoxifen on various PIP2 sensitive channels.	[Ferrer, Tania; Arechiga-Figueroa, Ivan Arael; Sanchez-Chapula, Jose A.] Univ Colima, Ctr Univ Invest Biomed, Unidad Invest Carlos Mendez, Colima, Col Mexico, Mexico; [Shapiro, Mark S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Tristani-Firouzi, Martin] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT USA; [Tristani-Firouzi, Martin] Univ Utah, Div Pediat Cardiol, Salt Lake City, UT USA	Colegio de Mexico; Universidad de Colima; University of Texas System; University of Texas Health San Antonio; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ferrer, T (corresponding author), Univ Colima, Ctr Univ Invest Biomed, Unidad Invest Carlos Mendez, Colima, Col Mexico, Mexico.	tania@ucol.mx		ARECHIGA FIGUEROA, IVAN ARAEL/0000-0003-3124-7148	SEP-Conacyt (Mexico) [CB-2010-01-153394, CB-2008-01-105941]; FRABA (Mexico) [725/11]; National Institutes of Health (USA) [R01 NS043394]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043394] Funding Source: NIH RePORTER	SEP-Conacyt (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FRABA (Mexico); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by SEP-Conacyt (Mexico) grant CB-2010-01-153394 and FRABA (Mexico) grant 725/11 (to T.F.), by SEP-CONACYT (Mexico) grant CB-2008-01-105941 (to J.A.S.-C.) and by National Institutes of Health (USA), grant R01 NS043394 (to M.S.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN SP, 1995, BRIT J PHARMACOL, V115, P1163, DOI 10.1111/j.1476-5381.1995.tb15019.x; ALLAN D, 1975, BIOCHEM J, V148, P471, DOI 10.1042/bj1480471; Allen MC, 1998, EUR J PHARMACOL, V354, P261, DOI 10.1016/S0014-2999(98)00454-3; Bender K, 2002, FEBS LETT, V529, P356, DOI 10.1016/S0014-5793(02)03426-9; Bian JS, 2004, AM J PHYSIOL-HEART C, V287, pH2154, DOI 10.1152/ajpheart.00120.2004; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Gomez-Posada JC, 2010, J NEUROSCI, V30, P9316, DOI 10.1523/JNEUROSCI.0851-10.2010; COEZY E, 1982, CANCER RES, V42, P317; COLE MP, 1971, BRIT J CANCER, V25, P270, DOI 10.1038/bjc.1971.33; CONRAD MJ, 1981, BIOCHEMISTRY-US, V20, P808, DOI 10.1021/bi00507a024; Cooper EC, 2001, EPILEPSIA, V42, P49, DOI 10.1046/j.1528-1157.2001.0420s5049.x; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; FRIEDMAN ZY, 1993, J PHARMACOL EXP THER, V267, P617; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; He JY, 2003, AM J PHYSIOL-HEART C, V285, pH661, DOI 10.1152/ajpheart.00686.2002; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Hernandez CC, 2009, J GEN PHYSIOL, V134, P437, DOI 10.1085/jgp.200910313; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; JORDAN VC, 1975, EUR J CANCER, V11, P205, DOI 10.1016/0014-2964(75)90119-X; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Liu XK, 1998, J PHARMACOL EXP THER, V287, P877; Lopez-Izquierdo A, 2010, EUR J PHARMACOL, V638, P33, DOI 10.1016/j.ejphar.2010.04.026; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Ponce-Balbuena D, 2010, J PHARMACOL SCI, V113, P66, DOI 10.1254/jphs.10024FP; Ponce-Balbuena D, 2009, J PHARMACOL EXP THER, V331, P563, DOI 10.1124/jpet.109.156075; Punke MA, 2007, ANESTH ANALG, V104, P1256, DOI 10.1213/01.ane.0000260310.63117.a2; Robbins J, 2006, J NEUROSCI, V26, P7950, DOI 10.1523/JNEUROSCI.2138-06.2006; Roche JP, 2002, BRIT J PHARMACOL, V137, P1173, DOI 10.1038/sj.bjp.0704989; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2006, PFLUG ARCH EUR J PHY, V453, P293, DOI 10.1007/s00424-006-0092-3; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; ZHANG JJ, 1994, J CLIN INVEST, V94, P1690, DOI 10.1172/JCI117514	37	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e76085	10.1371/journal.pone.0076085	http://dx.doi.org/10.1371/journal.pone.0076085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086693	Green Published, gold			2022-12-25	WOS:000325025200073
J	Xia, PC; Okumura, J; Yan, PP; Xie, MR; Wu, SL; Zhuang, MZ; Zheng, J; Zhang, CY; Zhang, MY; Kato, M; Cai, GX; Yamamoto, T				Xia, Pincang; Okumura, Junko; Yan, Pingping; Xie, Meirong; Wu, Shouli; Zhuang, Meizhu; Zheng, Jian; Zhang, Chunyang; Zhang, Mingya; Kato, Masaya; Cai, GuoXi; Yamamoto, Taro			Steps towards Preventive HIV Treatment in Fujian, China: Problems Identified via an Assessment of Initial Antiretroviral Therapy Provision	PLOS ONE			English	Article							INDIVIDUALS; FAILURE; COHORT; ADULTS	Background: At the end of 2009, a total of 501 AIDS patients were receiving antiretroviral therapy (ART) in Fujian Province in China, yet there were no assessments to determine treatment efficacy and HIV-1 preventive potency under the current health care delivery system. Methods: During the period of 2005-2009, we assessed the outcomes of initial ART by following up 381 patients for 12 months in Fujian Province. CD4(+) T-lymphocyte (CD4) count, plasma viral load (VL), and patient characteristics were analysed. The results were compared between 4 groups divided by the baseline CD4 values at the 25, 50 (median), and 75 percentiles. Findings: Over three-quarters of the subjects reported heterosexual contact as the probable route of transmission. After 12 months of ART, CD4 recovery varied between the 4 groups (P < 0.001), but VL sharply declined regardless of the baseline CD4 count (P = 0.136). Although this VL decline indicates the potency of ART as an HIV-1 prevention tool, the time between positive diagnosis and ART initiation suggests serious delay in both diagnosis and treatment; the medians of periods for the lowest and highest baseline CD4 quartiles were 1.2 and 9.6 months, respectively. Conclusion: Current limitations in VL determination make it difficult to assess the efficacy of initial ART, and delays in diagnosis and treatment suggest that subjects contributed to HIV-1 transmission while they were not receiving ART. The current National Free ART scheme does not provide free treatment for sexually transmitted infection (STI), and there is no link between ART and the STI care delivery system. This may interfere with the HIV-1 preventive potency of ART. We highly recommend establishing a collaborating mechanism with STI care, strengthening the VL determination system, and promoting HIV tests and early ART initiation.	[Xia, Pincang; Yan, Pingping; Xie, Meirong; Wu, Shouli; Zheng, Jian; Zhang, Chunyang; Zhang, Mingya] Fujian Ctr Dis Control & Prevent, Dept STDs & HIV AIDS Control & Prevent, Fuzhou, Fujian Province, Peoples R China; [Xia, Pincang; Okumura, Junko; Cai, GuoXi; Yamamoto, Taro] Nagasaki Univ, Inst Trop Med, Dept Int Hlth, Nagasaki 852, Japan; [Xia, Pincang; Okumura, Junko; Cai, GuoXi; Yamamoto, Taro] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Zhuang, Meizhu] Beitang Dist Ctr Dis Control & Prevent, Dept Dis Control & Prevent, Wuxi, Jiangsu, Peoples R China; [Kato, Masaya] World Hlth Org Vietnam Country Off, Hanoi, Vietnam	Nagasaki University; Nagasaki University; World Health Organization	Okumura, J (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Int Hlth, Nagasaki 852, Japan.	jokumura@nagasaki-u.ac.jp	Okumura, Junko/AAX-6070-2020	Okumura, Junko/0000-0002-1744-7824; CAI, Guoxi/0000-0001-8551-5852	Japan China Sasakawa Medical Fellowship; Youth Foundation of the Fujian Center for Disease Control and Prevention	Japan China Sasakawa Medical Fellowship; Youth Foundation of the Fujian Center for Disease Control and Prevention	This study was supported by the Japan China Sasakawa Medical Fellowship and the Youth Foundation of the Fujian Center for Disease Control and Prevention. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Chen K, 2005, J CHINA AIDS STI, V11, P34; Chinese Centre for Disease Control and Prevention (Chinese CDC), 2007, CHIN FREE ARTS MAN 2; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Garnett GP, 2012, CURR OPIN HIV AIDS, V7, P157, DOI 10.1097/COH.0b013e3283504ab7; Granich R, 2011, CURR HIV RES, V9, P446, DOI 10.2174/157016211798038597; Gsponer T, 2012, AIDS, V26, P57, DOI 10.1097/QAD.0b013e32834e1b5f; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Ministry of Health in People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Rojanawiwat A, 2009, JPN J INFECT DIS, V62, P32; State council office, 2006, CHIN ACT PLAN RED PR; UNAIDS, 2009, BACKGR INF EP RESP; Vernazza P, 2008, B MED SUISSES, V89, P165; WHO, 2010, ANT THER HIV INF AD; Yan Y, 2007, STRAITS SCI, V1, P75; Yao X, 2012, JAIDS-J ACQ IMM DEF, V60, P328, DOI 10.1097/QAI.0b013e31824f19f5; Zhang F., 2005, CHINA FREE ART MANUA	20	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e76483	10.1371/journal.pone.0076483	http://dx.doi.org/10.1371/journal.pone.0076483			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086744	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200076
J	Nakatani, Y; Suzuki, M; Tokunaga, M; Maeda, J; Sakai, M; Ishihara, H; Yoshinaga, T; Takenaka, O; Zhang, MR; Suhara, T; Higuchi, M				Nakatani, Yosuke; Suzuki, Michiyuki; Tokunaga, Masaki; Maeda, Jun; Sakai, Miyuki; Ishihara, Hiroki; Yoshinaga, Takashi; Takenaka, Osamu; Zhang, Ming-Rong; Suhara, Tetsuya; Higuchi, Makoto			A Small-Animal Pharmacokinetic/Pharmacodynamic PET Study of Central Serotonin 1A Receptor Occupancy by a Potential Therapeutic Agent for Overactive Bladder	PLOS ONE			English	Article							LOWER URINARY-TRACT; POSITRON-EMISSION-TOMOGRAPHY; 5-HT1A RECEPTORS; RATS; MICTURITION; ANTAGONIST; BRAIN; CYTOCHROME-P450; NAD-299; BINDING	Serotonin 1A (5-HT1A) receptors have been mechanistically implicated in micturition control, and there has been a need for an appropriate biomarker surrogating the potency of a provisional drug acting on this receptor system for developing a new therapeutic approach to overactive bladder (OAB). Here, we analyzed the occupancy of 5-HT1A receptors in living Sprague-Dawley rat brains by a novel candidate drug for OAB, E2110, using positron emission tomography (PET) imaging, and assessed the utility of a receptor occupancy (RO) assay to establish a pharmacodynamic index translatable between animals and humans. The plasma concentrations inducing 50% RO (EC50) estimated by both direct and effect compartment models were in good agreement. Dose-dependent therapeutic effects of E2110 on dysregulated micturition in different rat models of pollakiuria were also consistently explained by achievement of 5-HT1A RO by E2110 in a certain range (>= 60%). Plasma drug concentrations inducing this RO range and EC50 would accordingly be objective indices in comparing pharmacokinetics-RO relationships between rats and humans. These findings support the utility of PET RO and plasma pharmacokinetic assays with the aid of adequate mathematical models in determining the in vivo characteristics of a drug acting on 5-HT1A receptors and thereby counteracting OAB.	[Nakatani, Yosuke; Suzuki, Michiyuki; Sakai, Miyuki; Ishihara, Hiroki; Yoshinaga, Takashi; Takenaka, Osamu] Eisai & Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki, Japan; [Nakatani, Yosuke; Suzuki, Michiyuki; Tokunaga, Masaki; Maeda, Jun; Zhang, Ming-Rong; Suhara, Tetsuya; Higuchi, Makoto] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba, Chiba, Japan; [Nakatani, Yosuke; Zhang, Ming-Rong; Suhara, Tetsuya; Higuchi, Makoto] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan	Eisai Co Ltd; National Institutes for Quantum Science & Technology; Tohoku University	Higuchi, M (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba, Chiba, Japan.	mhiguchi@nirs.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Japan Advanced Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanades S, 2011, J CEREBR BLOOD F MET, V31, P944, DOI 10.1038/jcbfm.2010.175; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Andree B, 2003, PSYCHOPHARMACOLOGY, V167, P37, DOI 10.1007/s00213-002-1355-0; Chapple C, 2005, EUR UROL, V48, P5, DOI 10.1016/j.eururo.2005.02.024; Cheng CL, 2010, AM J PHYSIOL-RENAL, V298, pF771, DOI 10.1152/ajprenal.00266.2009; Chovan JP, 2007, XENOBIOTICA, V37, P459, DOI 10.1080/00498250701245250; de Groat WC, 2006, BRIT J PHARMACOL, V147, pS25, DOI 10.1038/sj.bjp.0706604; Kapur S, 2000, J PSYCHIATR NEUROSCI, V25, P161; KATO R, 1992, TOXICOL LETT, V64-5, P661, DOI 10.1016/0378-4274(92)90245-F; Kershen Richard T, 2004, Curr Urol Rep, V5, P359, DOI 10.1007/s11934-004-0083-x; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; LECCI A, 1992, J PHARMACOL EXP THER, V262, P181; Leonardi A, 1997, Application, Patent No. [WO 9731637-A1, 9731637]; McCarron JA, 1996, J LABELLED COMPD RAD, V38, P941, DOI 10.1002/(SICI)1099-1344(199610)38:10<941::AID-JLCR906>3.3.CO;2-P; Pehrson R, 2002, N-S ARCH PHARMACOL, V366, P528, DOI 10.1007/s00210-002-0650-y; Rabiner EA, 2002, J PHARMACOL EXP THER, V301, P1144, DOI 10.1124/jpet.301.3.1144; Raje S, 2008, CLIN PHARMACOL THER, V83, P86, DOI 10.1038/sj.clpt.6100232; Ramage AG, 2006, BRIT J PHARMACOL, V147, pS120, DOI 10.1038/sj.bjp.0706504; Saijo T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042589; Scheife R, 2005, CLIN THER, V27, P144, DOI 10.1016/j.clinthera.2005.02.014; Sheiner LB, 1979, CLIN PHARMACOL THER, V40, P86; Tai YC, 2005, J NUCL MED, V46, P455; Testa R, 1999, J PHARMACOL EXP THER, V290, P1258	23	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75040	10.1371/journal.pone.0075040	http://dx.doi.org/10.1371/journal.pone.0075040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086433	Green Submitted, gold, Green Published			2022-12-25	WOS:000326520200076
J	Pham, VL; Nakayama, M; Itoh, Y; Ishigaki, H; Kitano, M; Arikata, M; Ishida, H; Kitagawa, N; Shichinohe, S; Okamatsu, M; Sakoda, Y; Tsuchiya, H; Nakamura, S; Kida, H; Ogasawara, K				Van Loi Pham; Nakayama, Misako; Itoh, Yasushi; Ishigaki, Hirohito; Kitano, Mitsutaka; Arikata, Masahiko; Ishida, Hideaki; Kitagawa, Naoko; Shichinohe, Shintaro; Okamatsu, Masatoshi; Sakoda, Yoshihiro; Tsuchiya, Hideaki; Nakamura, Shinichiro; Kida, Hiroshi; Ogasawara, Kazumasa			Pathogenicity of Pandemic H1N1 Influenza A Virus in Immunocompromised Cynomolgus Macaques	PLOS ONE			English	Article							EXPERIMENTAL-INFECTION; CYCLOSPORIN-A; H5N1 VIRUS; CYCLOPHOSPHAMIDE; PATHOGENESIS; VACCINATION; IMMUNE; EPIDEMIOLOGY; TRANSMISSION; POPULATIONS	Pandemic (H1N1) 2009 influenza virus spread throughout the world since most people did not have immunity against the virus. In the post pandemic phase when many humans might possess immunity against the pandemic virus, one of the concerns is infection in immunocompromised people. Therefore, we used an immunosuppressed macaque model to examine pathogenicity of the pandemic (H1N1) 2009 virus under an immunocompromised condition. The virus in nasal samples of immunosuppressed macaques infected with the pandemic (H1N1) 2009 virus was detected longer after infection than was the virus in nasal samples of immunocompetent macaques. As expected, not only virus amounts but also virus propagation sites in the immunosuppressed macaques were larger than those in lungs of the immunocompetent macaques when they were infected with the pandemic virus. Immunosuppressed macaques possessed low levels of immune cells producing cytokines and chemokines, but levels of inflammatory cytokines/chemokine interleukin (IL)-6, IL-18, and monocyte chemotactic protein (MCP)-1 in lungs of the immunosuppressed macaques were higher than those in lungs of the immunocompetent macaques, though the differences were not statistically significant. Therefore, under an immunosuppressive condition, the pandemic influenza (H1N1) 2009 virus might cause more severe morbidity with high cytokine/chemokine production by the host innate immune system than that seen in macaques under the immunocompetent condition.	[Van Loi Pham; Nakayama, Misako; Itoh, Yasushi; Ishigaki, Hirohito; Kitano, Mitsutaka; Arikata, Masahiko; Ishida, Hideaki; Kitagawa, Naoko; Ogasawara, Kazumasa] Shiga Univ Med Sci, Dept Pathol, Div Pathol & Dis Regulat, Otsu, Shiga 52021, Japan; [Arikata, Masahiko] Shiga Univ Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Otsu, Shiga 52021, Japan; [Tsuchiya, Hideaki; Nakamura, Shinichiro] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Otsu, Shiga 52021, Japan; [Shichinohe, Shintaro; Okamatsu, Masatoshi; Sakoda, Yoshihiro; Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Microbiol Lab, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Hokkaido University; Hokkaido University	Itoh, Y (corresponding author), Shiga Univ Med Sci, Dept Pathol, Div Pathol & Dis Regulat, Otsu, Shiga 52021, Japan.	yasushii@belle.shiga-med.ac.jp	Ishigaki, Hirohito/AAO-7458-2020; Shichinohe, Shintaro/C-7937-2017	Ishigaki, Hirohito/0000-0002-5249-8598; Shichinohe, Shintaro/0000-0002-8783-2103; Itoh, Yasushi/0000-0001-7462-2193; Nakayama, Misako/0000-0001-8611-0662	Regional Research and Development Resources Utilization Program, Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan; Research Center for Zoonosis Control, Hokkaido University; Japan Initiative for Global Research Network on Infectious Diseases; JSPS KAKENHI [22390076]	Regional Research and Development Resources Utilization Program, Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Center for Zoonosis Control, Hokkaido University; Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Regional Research and Development Resources Utilization Program, Japan Science and Technology Agency, the Grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan, for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University and the Japan Initiative for Global Research Network on Infectious Diseases, and Grant-in-Aid for Scientific Research (B) JSPS KAKENHI Grant number 22390076. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almansa Raquel, 2012, Enferm Infecc Microbiol Clin, V30 Suppl 4, P18, DOI 10.1016/S0213-005X(12)70100-3; [Anonymous], 2009, N ENGL J MED, V362; Arikata M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037220; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Buss JL, 2011, ANN TRANSPL, V16, P88; Carlson CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001136; Chan MCW, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-102; CHERNAK E, 1995, CLIN INFECT DIS, V20, P170, DOI 10.1093/clinids/20.1.170; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Confalonieri M, 2012, Monaldi Arch Chest Dis, V77, P94; COOK RM, 1983, AGENTS ACTIONS, V13, P98, DOI 10.1007/BF01994290; Cooksley CD, 2005, CANCER-AM CANCER SOC, V104, P618, DOI 10.1002/cncr.21203; Cordero E, 2012, EUR J CLIN MICROBIOL, V31, P547, DOI 10.1007/s10096-011-1346-3; de la Rosa-Zamboni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050116; Evseenko VA, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-77; Green LC, 2004, MICROBES INFECT, V6, P996, DOI 10.1016/j.micinf.2004.05.012; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Herfst S, 2010, VET PATHOL, V47, P1040, DOI 10.1177/0300985810374836; HUANG KL, 1983, INFECT IMMUN, V40, P421, DOI 10.1128/IAI.40.1.421-424.1983; HURD J, 1975, INFECT IMMUN, V11, P886, DOI 10.1128/IAI.11.5.886-889.1975; Ison MG, 2006, J INFECT DIS, V193, P760, DOI 10.1086/500465; Itoh Y, 2008, VACCINE, V26, P562, DOI 10.1016/j.vaccine.2007.11.031; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kao CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031162; Kawakami C, 2009, JPN J INFECT DIS, V62, P83; Kolappaswamy K, 2008, J AM ASSOC LAB ANIM, V47, P64; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kozak W, 1998, ANN NY ACAD SCI, V856, P33, DOI 10.1111/j.1749-6632.1998.tb08310.x; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Lednicky JA, 1998, J VIROL, V72, P3980, DOI 10.1128/JVI.72.5.3980-3990.1998; Liu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037277; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Makkoch J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051275; Masri MA, 2003, MOL IMMUNOL, V39, P1073, DOI 10.1016/S0161-5890(03)00075-0; Mazzone PJ, 2001, EUR RESPIR J, V18, P971, DOI 10.1183/09031936.01.00215201; Meerveld-Eggink A, 2011, ANN ONCOL, V22, P2031, DOI 10.1093/annonc/mdq728; Morlighem JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018956; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Nakae H, 2003, PANCREAS, V26, P134, DOI 10.1097/00006676-200303000-00008; Nakajima N, 2013, MODERN PATHOL, V26, P357, DOI 10.1038/modpathol.2012.193; Nelli RK, 2012, J VIROL, V86, P9201, DOI 10.1128/JVI.00244-12; Nicholls JM, 2012, J VIROL METHODS, V179, P409, DOI 10.1016/j.jviromet.2011.11.006; Nilsberth C, 2009, ENDOCRINOLOGY, V150, P1850, DOI 10.1210/en.2008-0806; OHTAKI S, 1986, ACTA PATHOL JAPON, V36, P1537; Rerolle JP, 2004, SCAND J INFECT DIS, V36, P513, DOI 10.1080/00365540410020244; Sakabe S, 2011, J GEN VIROL, V92, P1428, DOI 10.1099/vir.0.030346-0; SCHILTKNECHT E, 1985, CELL IMMUNOL, V91, P227, DOI 10.1016/0008-8749(85)90046-2; Schroder C, 2006, TRANSPLANTATION, V81, P1165, DOI 10.1097/01.tp.0000203170.77195.e4; Schuurman HJ, 2005, TOXICOLOGY, V213, P1, DOI 10.1016/j.tox.2005.03.017; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; Siberry GK, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/627974; SINGER SH, 1972, INFECT IMMUN, V5, P957, DOI 10.1128/IAI.5.6.957-960.1972; Soesman NMR, 2000, J MED VIROL, V61, P85, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;85::AID-JMV14&gt;3.0.CO;2-H; Sogawa H, 2008, TRANSPLANTATION, V86, P615, DOI 10.1097/TP.0b013e3181821bac; SOLBACH W, 1984, BLOOD, V64, P1022; Tan CS, 2009, J INFECT DIS, V199, P881, DOI 10.1086/597117; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Van Reeth K, 2000, VET MICROBIOL, V74, P109, DOI 10.1016/S0378-1135(00)00171-1; Viasus Diego, 2012, Enferm Infecc Microbiol Clin, V30 Suppl 4, P54, DOI 10.1016/S0213-005X(12)70106-4; Wumba R, 2012, INT J GEN MED, V5, P603, DOI 10.2147/IJGM.S32344; Xu T, 2009, EUR RESPIR J, V33, P852, DOI 10.1183/09031936.00130507	62	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75910	10.1371/journal.pone.0075910	http://dx.doi.org/10.1371/journal.pone.0075910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086663	Green Submitted, gold, Green Published			2022-12-25	WOS:000326520200124
J	Wood, ACL; Rowden, AA; Compton, TJ; Gordon, DP; Probert, PK				Wood, Anna C. L.; Rowden, Ashley A.; Compton, Tanya J.; Gordon, Dennis P.; Probert, P. Keith			Habitat-Forming Bryozoans in New Zealand: Their Known and Predicted Distribution in Relation to Broad-Scale Environmental Variables and Fishing Effort	PLOS ONE			English	Article							DISTRIBUTION MODELS IMPLICATIONS; FOVEAUX STRAIT; SPECIES DISTRIBUTIONS; BIOGENIC REEFS; MARINE; PERFORMANCE; SHELF; CHEILOSTOMATA; CONSERVATION; BIODIVERSITY	Frame-building bryozoans occasionally occur in sufficient densities in New Zealand waters to generate habitat for other macrofauna. The environmental conditions necessary for bryozoans to generate such habitat, and the distributions of these species, are poorly known. Bryozoan-generated habitats are vulnerable to bottom fishing, so knowledge of species' distributions is essential for management purposes. To better understand these distributions, presence records were collated and mapped, and habitat suitability models were generated (Maxent, 1 km(2) grid) for the 11 most common habitat-forming bryozoan species: Arachnopusia unicornis, Cellaria immersa, Cellaria tenuirostris, Celleporaria agglutinans, Celleporina grandis, Cinctipora elegans, Diaperoecia purpurascens, Galeopsis porcellanicus, Hippomenella vellicata, Hornera foliacea, and Smittoidea maunganuiensis. The models confirmed known areas of habitat, and indicated other areas as potentially suitable. Water depth, vertical water mixing, tidal currents, and water temperature were useful for describing the distribution of the bryozoan species at broad scales. Areas predicted as suitable for multiple species were identified, and these 'hotspots' were compared to fishing effort data. This showed a potential conflict between fishing and the conservation of bryozoan-generated habitat. Fishing impacts are known from some sites, but damage to large areas of habitat-forming bryozoans is likely to have occurred throughout the study area. In the present study, spatial error associated with the use of historic records and the coarse native resolution of the environmental variables limited both the resolution at which the models could be interpreted and our understanding of the ecological requirements of the study species. However, these models show species distribution modelling has potential to further our understanding of habitat-forming bryozoan ecology and distribution. Importantly, comparisons between hotspots of suitable habitat and the distribution of bottom fishing in the study area highlight the need for management measures designed to mitigate the impact of seafloor disturbance on bryozoan-generated habitat in New Zealand waters.	[Wood, Anna C. L.; Probert, P. Keith] Univ Otago, Dept Marine Sci, Dunedin, New Zealand; [Rowden, Ashley A.; Compton, Tanya J.; Gordon, Dennis P.] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Compton, Tanya J.] Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Netherlands	University of Otago; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Wood, ACL (corresponding author), Univ Otago, Dept Marine Sci, Dunedin, New Zealand.	anna.wood@otago.ac.nz	Rowden, Ashley/ABG-6010-2020; Rowden, Ashley/O-9358-2019	Rowden, Ashley/0000-0003-2975-2524	NIWA's Coasts and Oceans Research Programme 2, Marine Biological Resources: Discovery and definition of the marine biota of New Zealand [2012/13 SCI]	NIWA's Coasts and Oceans Research Programme 2, Marine Biological Resources: Discovery and definition of the marine biota of New Zealand	AAR and DPG were funded by NIWA's Coasts and Oceans Research Programme 2, Marine Biological Resources: Discovery and definition of the marine biota of New Zealand (2012/13 SCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Allnutt TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028969; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; ANDREWS PB, 1973, NEW ZEAL J GEOL GEOP, V16, P793, DOI 10.1080/00288306.1973.10555227; Arkema KK, 2009, MAR ECOL PROG SER, V388, P207, DOI 10.3354/meps08140; Auster PJ, 1998, CONSERV BIOL, V12, P1198, DOI 10.1046/j.1523-1739.1998.0120061198.x; Baird SJ, 2011, 73 MIN FISH; Batson PB, 2000, 200046  MIN FISH; Beentjes MP, 2010, 201029  MIN FISH; Beentjes MP, 2009, 200957 MIN FISH; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Boardman RS, 1992, MORPHOLOGY ANATOMY S, V70, P81; BRADSTOCK M, 1983, NEW ZEAL J MAR FRESH, V17, P159, DOI 10.1080/00288330.1983.9515993; Carter L., 1975, NEW ZEAL J MAR FRESH, V9, P423, DOI [10.1080/00288330.1975.9515579, DOI 10.1080/00288330.1975.9515579]; Cocito S, 2001, MEDITERRANEAN ECOSYSTEMS: STRUCTURES AND PROCESSES, P241; Compton TJ, 2013, J BIOGEOGR, V40, P75, DOI 10.1111/j.1365-2699.2012.02761.x; Cranfield HJ, 1999, AQUAT CONSERV, V9, P461, DOI 10.1002/(SICI)1099-0755(199909/10)9:5<461::AID-AQC353>3.0.CO;2-Z; Cranfield HJ, 2004, J SEA RES, V52, P109, DOI 10.1016/j.seares.2003.12.003; Cranfield HJ, 2003, CONT SHELF RES, V23, P1337, DOI 10.1016/S0278-4343(03)00122-5; Cryer M, 2000, DISTRIBUTION STRUCTU; Cuffey R. J, 1977, Proceedings int Coral Reef Symp, V3, P339; Cuffey RJ, 1979, ADV BRYOZOOLOGY, P345; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Davies RWD, 2009, MAR POLICY, V33, P661, DOI 10.1016/j.marpol.2009.01.003; Department of Conservation and Ministry of Fisheries, 2011, BROAD SCALE GAP ANAL, V50; Dudik M, 2004, LECT NOTES COMPUT SC, V3120, P472, DOI 10.1007/978-3-540-27819-1_33; Edgar GJ, 2010, AQUAT CONSERV, V20, P297, DOI 10.1002/aqc.1079; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; FLEMING C. A., 1952, NEW ZEALAND JOUR SCI AND TECHNOL SER B, V34, P73; Froude VA, 2004, AREA BASED RESTRICTI, P169; GARNER D M, 1969, New Zealand Journal of Marine and Freshwater Research, V3, P201; Gordon DP, 1989, MARINE FAUNA NZ BRYO, P1; Gorman R, 2000, 6 INT WORKSH WAV HIN, P12; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Grange K.R., 2003, 4 MIN FISH, P22; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; Gutt J, 1998, POLAR BIOL, V20, P229, DOI 10.1007/s003000050300; Hadfield M, 2002, PHYS VARIABLES NZ MA, P64; Hageman SJ, 2003, PALAIOS, V18, P510, DOI 10.1669/0883-1351(2003)018<0510:PSOCBF>2.0.CO;2; Hageman SJ, 1995, AUST J EARTH SCI, V42, P571, DOI 10.1080/08120099508728226; Handley S, 2006, NEL2006002; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARGRAVE BT, 1973, J FISH RES BOARD CAN, V30, P1317, DOI 10.1139/f73-212; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Howell KL, 2011, BIOL CONSERV, V144, P2656, DOI 10.1016/j.biocon.2011.07.025; Jiang WM, 2002, AQUAT CONSERV, V12, P257, DOI 10.1002/aqc.495; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Jones CD, 2011, MAR POLICY, V35, P732, DOI 10.1016/j.marpol.2011.02.004; LAGAAIJ R., 1965, MICROPALEONTOLOGY, V11, P39, DOI 10.2307/1484817; Leathwick JR, 2009, DEV BENTHIC OPTIMISE; Lisbjerg D, 2000, J EXP MAR BIOL ECOL, V244, P285, DOI 10.1016/S0022-0981(99)00147-1; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lombardi C, 2008, J MAR BIOL ASSOC UK, V88, P711, DOI 10.1017/S0025315408001525; Mace J., 1981, CATCH, V8, P15; McKinney FK, 2000, CAH BIOL MAR, V41, P1; Michael KP, 2001, 200168 MIN FISH, P24; Millar CS, 2012, J NAT CONSERV, V20, P18, DOI 10.1016/j.jnc.2011.07.004; *MIN AGR PESC AL, 2010, SUP PROD AGR, P20; Ministry of Fisheries, 2010, NAT FISH PLAN DEEPW; Ministry of Fisheries, 2009, NZ MAX BEN US FISH E; Morgado EH, 2001, SCI MAR, V65, P173, DOI 10.3989/scimar.2001.65n3173; MORRIS PA, 1976, J PALEONTOL, V50, P1143; NELSON CS, 1988, SEDIMENT GEOL, V60, P301, DOI 10.1016/0037-0738(88)90126-1; Osborne PE, 2009, DIVERS DISTRIB, V15, P671, DOI 10.1111/j.1472-4642.2009.00572.x; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pinkerton M. H., 2005, CASE 2 CLIMATOLOGY N; Pinkerton MH, 2006, NEW ZEAL J MAR FRESH, V40, P227, DOI 10.1080/00288330.2006.9517417; PROBERT PK, 1979, NEW ZEAL J MAR FRESH, V13, P379, DOI 10.1080/00288330.1979.9515814; PROBERT PK, 1993, DEEP-SEA RES PT I, V40, P1003, DOI 10.1016/0967-0637(93)90086-I; Raes N, 2012, NAT CONSERVACAO, V10, P127, DOI 10.4322/natcon.2012.020; Rowden AA, 2004, BIODIVERS CONSERV, V13, P2695, DOI 10.1007/s10531-004-2143-4; Rowden AA, 2007, 200710 MIN FISH; Saxton F, 1980, CATCH, V7, P12; Seo C, 2009, BIOL LETTERS, V5, P39, DOI 10.1098/rsbl.2008.0476; Smith AM, 2001, PALAEOGEOGR PALAEOCL, V175, P201, DOI 10.1016/S0031-0182(01)00372-8; Smith F, 1999, ECOLOGY, V80, P51, DOI 10.2307/176979; Snelder TH, 2007, ENVIRON MANAGE, V39, P12, DOI 10.1007/s00267-005-0206-2; STEBBING AR, 1971, MAR BIOL, V9, P267, DOI 10.1007/BF00351389; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Taylor Paul D., 2000, P195, DOI 10.1017/CBO9780511535505.015; Taylor PD, 2004, NEW ZEAL J GEOL GEOP, V47, P57, DOI 10.1080/00288306.2004.9515037; Taylor PD, 2003, NEW ZEAL J MAR FRESH, V37, P653, DOI 10.1080/00288330.2003.9517196; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Tracey DM, 2011, MAR ECOL PROG SER, V430, P1, DOI 10.3354/meps09164; Turner SJ, 1999, FISHERIES MANAG ECOL, V6, P401, DOI 10.1046/j.1365-2400.1999.00167.x; Uddstrom MJ, 1999, J GEOPHYS RES-OCEANS, V104, P20729, DOI 10.1029/1999JC900167; Uttley GH, 1972, NZ OCEANOGRAPHIC I M, p[57, 61]; VOOREN C M, 1975, New Zealand Journal of Marine and Freshwater Research, V9, P121; Walters RA, 2001, NEW ZEAL J MAR FRESH, V35, P567, DOI 10.1080/00288330.2001.9517023; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; WILLAN RC, 1981, NEW ZEAL J ZOOL, V8, P229, DOI 10.1080/03014223.1981.10427964; Wood ACL, 2012, AQUAT CONSERV, V22, P547, DOI 10.1002/aqc.2236	97	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75160	10.1371/journal.pone.0075160	http://dx.doi.org/10.1371/journal.pone.0075160			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086460	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200087
J	Tawk, L; Lacroix, C; Gueirard, P; Kent, R; Gorgette, O; Thiberge, S; Mercereau-Puijalon, O; Menard, R; Barale, JC				Tawk, Lina; Lacroix, Celine; Gueirard, Pascale; Kent, Robyn; Gorgette, Olivier; Thiberge, Sabine; Mercereau-Puijalon, Odile; Menard, Robert; Barale, Jean-Christophe			A Key Role for Plasmodium Subtilisin-like SUB1 Protease in Egress of Malaria Parasites from Host Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hepatocyte; Malaria; Molecular Genetics; Plasmodium; Protease; Conditional Mutagenesis; Egress; Subtilisin	MEROZOITE SURFACE PROTEIN-1; CELL INVASION; CONDITIONAL MUTAGENESIS; ERYTHROCYTIC CYCLE; CYSTEINE PROTEASE; WESTERN CAMBODIA; FALCIPARUM; BERGHEI; LIVER; ARTEMISININ	Background: The subtilisin-like SUB1 is involved in Plasmodium egress from erythrocytes. Results: Using conditional mutagenesis, we show that SUB1 plays an essential role during Plasmodium hepatic stages. Conclusion: SUB1 has a dual pivotal role in parasite egress from host hepatocytes and erythrocytes. Significance: Its critical involvement in hepatic and erythrocytic parasite development qualifies SUB1 as a multistage drug target. In their mammalian host, Plasmodium parasites have two obligatory intracellular development phases, first in hepatocytes and subsequently in erythrocytes. Both involve an orchestrated process of invasion into and egress from host cells. The Plasmodium SUB1 protease plays a dual role at the blood stage by enabling egress of the progeny merozoites from the infected erythrocyte and priming merozoites for subsequent erythrocyte invasion. Here, using conditional mutagenesis in P. berghei, we show that SUB1 plays an essential role at the hepatic stage. Stage-specific sub1 invalidation during prehepatocytic development showed that SUB1-deficient parasites failed to rupture the parasitophorous vacuole membrane and to egress from hepatocytes. Furthermore, mechanically released parasites were not adequately primed and failed to establish a blood stage infection in vivo. The critical involvement of SUB1 in both pre-erythrocytic and erythrocytic developmental phases qualifies SUB1 as an attractive multistage target for prophylactic and therapeutic anti-Plasmodium intervention strategies.	[Tawk, Lina; Kent, Robyn; Gorgette, Olivier; Mercereau-Puijalon, Odile; Barale, Jean-Christophe] Inst Pasteur, Unite Immunol Mol Parasites, Dept Parasitol & Mycol, F-75015 Paris, France; [Tawk, Lina; Kent, Robyn; Gorgette, Olivier; Mercereau-Puijalon, Odile; Barale, Jean-Christophe] CNRS, URA2581, F-75015 Paris, France; [Lacroix, Celine; Gueirard, Pascale; Thiberge, Sabine; Menard, Robert] Inst Pasteur, Dept Parasitol & Mycol, Unite Biol & Genet Paludisme, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Barale, JC (corresponding author), Inst Pasteur, Unite Immunol Mol Parasites, URA CNRS 2581, Dept Parasitol & Mycol, 28 Rue Dr Roux, F-75724 Paris 15, France.	jean-christophe.barale@pasteur.fr	Mercereau-Puijalon, Odile/AAA-2242-2020	Thiberge, Sabine/0000-0001-5507-0602; Kent, Robyn/0000-0002-2584-4694	Institut Carnot-Pasteur Maladies Infectieuses; gence Nationale pour la Recherche [ANR-11-RPIB-002]; "Fondation Roux" from the Pasteur Institute	Institut Carnot-Pasteur Maladies Infectieuses; gence Nationale pour la Recherche; "Fondation Roux" from the Pasteur Institute	This work was supported by grants from the "Institut Carnot-Pasteur Maladies Infectieuses" and "Agence Nationale pour la Recherche" Grant ANR-11-RPIB-002 (to J. C. B.).; Supported by the "Institut Carnot-Pasteur Maladies Infectieuses" and a fellow of the "Fondation Roux" from the Pasteur Institute.	Abkarian M, 2011, BLOOD, V117, P4118, DOI 10.1182/blood-2010-08-299883; Agarwal S, 2013, CELL MICROBIOL, V15, P910, DOI 10.1111/cmi.12086; Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Barale JC, 1997, MOL BIOCHEM PARASIT, V87, P169, DOI 10.1016/S0166-6851(97)00065-0; Bastianelli G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021812; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Bouillon A, 2013, J BIOL CHEM, V288, P18561, DOI 10.1074/jbc.M113.456764; Chandramohanadas R, 2009, SCIENCE, V324, P794, DOI 10.1126/science.1171085; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Combe A, 2009, CELL HOST MICROBE, V5, P386, DOI 10.1016/j.chom.2009.03.008; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Falae A, 2010, J BIOL CHEM, V285, P3282, DOI 10.1074/jbc.M109.070367; Giovannini D, 2011, CELL HOST MICROBE, V10, P591, DOI 10.1016/j.chom.2011.10.012; Girardin SE, 1998, FEBS LETT, V431, P333, DOI 10.1016/S0014-5793(98)00787-X; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Holder AA, 2009, PARASITOLOGY, V136, P1445, DOI 10.1017/S0031182009990515; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Ishino T, 2009, CELL MICROBIOL, V11, P1329, DOI 10.1111/j.1462-5822.2009.01333.x; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Kafsack Bjorn F.C., 2010, Communicative & Integrative Biology, V3, P18; Kauth CW, 2006, J BIOL CHEM, V281, P31517, DOI 10.1074/jbc.M604641200; Kooij TWA, 2005, PLOS PATHOG, V1, P349, DOI 10.1371/journal.ppat.0010044; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Lacroix C, 2011, NAT PROTOC, V6, P1412, DOI 10.1038/nprot.2011.363; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Pachebat JA, 2001, MOL BIOCHEM PARASIT, V117, P83, DOI 10.1016/S0166-6851(01)00336-X; Putrianti ED, 2010, CELL MICROBIOL, V12, P725, DOI 10.1111/j.1462-5822.2009.01419.x; Roggwiller E, 1997, MOL BIOCHEM PARASIT, V86, P49, DOI 10.1016/S0166-6851(97)02848-X; Roiko MS, 2009, CELL MICROBIOL, V11, P1444, DOI 10.1111/j.1462-5822.2009.01357.x; Ruecker A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.400820; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Schmidt-Christensen A, 2008, CELL MICROBIOL, V10, P1723, DOI 10.1111/j.1462-5822.2008.01162.x; STAFFORD WHL, 1994, MOL BIOCHEM PARASIT, V66, P157, DOI 10.1016/0166-6851(94)90048-5; Sturm A, 2007, MED MICROBIOL IMMUN, V196, P127, DOI 10.1007/s00430-007-0044-3; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Sultan AA, 1999, INFECT IMMUN, V67, P2602, DOI 10.1128/IAI.67.5.2602-2606.1999; Thiberge S, 2007, NAT PROTOC, V2, P1811, DOI 10.1038/nprot.2007.257; Trucco C, 2001, MOL BIOCHEM PARASIT, V112, P91, DOI 10.1016/S0166-6851(00)00350-9; Uzureau P, 2004, CELL MICROBIOL, V6, P65, DOI 10.1046/j.1462-5822.2003.00343.x; WHO Global Malaria Programme, 2011, WORLD MALARIA REPORT; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Witkowski B, 2013, ANTIMICROB AGENTS CH, V57, P914, DOI 10.1128/AAC.01868-12; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Zhang M, 2012, P NATL ACAD SCI USA, V109, P3956, DOI 10.1073/pnas.1121567109	50	29	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33336	33346		10.1074/jbc.M113.513234	http://dx.doi.org/10.1074/jbc.M113.513234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089525	Green Published, hybrid			2022-12-25	WOS:000328841700048
J	Li, L; Sun, GQ; Liang, SJ; Li, JJ; Li, TY; Wang, Z; Liu, W; Yang, SM; Liu, YJ; Wang, XL; Li, JY				Li, Lin; Sun, Guoqing; Liang, Shujia; Li, Jianjian; Li, Tianyi; Wang, Zhe; Liu, Wei; Yang, Shaomin; Liu, Yongjian; Wang, Xiaolin; Li, Jingyun			Different Distribution of HIV-1 Subtype and Drug Resistance Were Found among Treatment Naive Individuals in Henan, Guangxi, and Yunnan Province of China	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; GENETIC DIVERSITY; BLOOD-DONORS; MUTATIONS; TYPE-1; SEX; MEN; PREVALENCE; MANAGEMENT	Yunnan, Guangxi and Henan are the provinces with the most severe HIV epidemic in China, which were also among the first group of areas providing free ART in 2004. However, little comprehensive data are available on prevalence of HIV subtype and baseline drug resistance in drug-naive populations. In this study, 1746 treatment-naive HIV-positive individuals were randomly selected from new-reported cases in Henan, Guangxi and Yunnan. Among of them, subtypes and drug resistance of 1159 strains were determined by amplifying and sequencing full-length pol genes. Significantly different distributions of HIV subtypes prevalent in three provinces were identified (P<0.01). CRF08_BC was found dominant in Yunnan (59.8%), while CRF01_AE was dominant in Guangxi (77.3%) and subtype B was dominant in Henan province (93.9%). The total prevalence of drug resistance was 7.1%. The highest prevalence of HIV drug resistance was found in Henan (12.2%), followed by Yunnan (5.6%) and Guangxi (3.3%). The results of this study suggest that genetic drug-resistance should be tested before initiation of ART in China, especially in Henan province. Furthermore, the prevalence of HIV drug resistant strains should be considered separately in different areas in China before the change of different free ART regimens.	[Li, Lin; Li, Tianyi; Liu, Yongjian; Wang, Xiaolin; Li, Jingyun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept AIDS Res, Beijing, Peoples R China; [Sun, Guoqing; Wang, Zhe] Henan Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Liang, Shujia; Liu, Wei] Guangxi Ctr Dis Prevent & Control, Nanning, Peoples R China; [Li, Jianjian; Yang, Shaomin] Yunnan Prov Hosp Infect Dis, AIDS Care Ctr YNACC, Kunming, Yunnan, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Li, JY (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept AIDS Res, Beijing, Peoples R China.	lijy@nic.bmi.ac.cn	Liu, Yong/GWQ-6163-2022		National Key S&T Special Projects on Major Infectious Diseases [2012ZX10001-002]; National Natural Science Foundation of China [81072348, 81273137]	National Key S&T Special Projects on Major Infectious Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key S&T Special Projects on Major Infectious Diseases (Grant No. 2012ZX10001-002) and the National Natural Science Foundation of China (No. 81072348, 81273137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; Chen M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-382; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Li Han-ping, 2011, Zhonghua Yi Xue Za Zhi, V91, P1443; Li J, 2009, CHINESE MED J-PEKING, V122, P1081, DOI 10.3760/cma.j.issn.0366-6999.2009.09.013; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046777; Li L, 2011, INFECT GENET EVOL, V11, P1487, DOI 10.1016/j.meegid.2011.05.017; Li L, 2010, AIDS RES HUM RETROV, V26, P699, DOI 10.1089/aid.2010.0026; Li Z, 2012, AIDS, V26, P877, DOI 10.1097/QAD.0b013e328351430d; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Ma LY, 2010, AIDS RES HUM RETROV, V26, P1007, DOI 10.1089/aid.2009.0252; Paredes R, 2010, ANTIVIR RES, V85, P245, DOI 10.1016/j.antiviral.2009.09.015; Pingen M, 2012, ANTIVIR THER, V17, P1621, DOI 10.3851/IMP2267; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Shang H, 2012, NATURE, V485, P576, DOI 10.1038/485576a; SHAO Y, 2004, REPORT 2 NATL HIV MO; Smith DM, 2005, AIDS, V19, P1251, DOI 10.1097/01.aids.0000180095.12276.ac; State Council AIDS Working Committee Office and Un Theme Group on HIV/AIDS in China, 2008, JOINT ASS HIV AIDS P; Su QJ, 2012, AIDS RES HUM RETROV, V28, P725, DOI [10.1089/AID.2011.0246, 10.1089/aid.2011.0246]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsibris AMN, 2010, J VIROL, V84, P5458, DOI 10.1128/JVI.02524-09; Turner D, 2006, AIDS REV, V8, P17; VERCAUTEREN JAM, 2006, 15 INT HIV DRUG RES, pS111; Volberding PA, 2010, LANCET, V376, P49, DOI 10.1016/S0140-6736(10)60676-9; Wainberg Mark A, 2012, Mol Biol Int, V2012, P256982, DOI 10.1155/2012/256982; Wainberg MA, 2010, VIRUSES-BASEL, V2, P2493, DOI 10.3390/v2112493; Wang WH, 2011, CURR HIV RES, V9, P136, DOI 10.2174/157016211795569096; Wang X, 2012, AIDS RES HUM RETROV, V28, P1637, DOI [10.1089/aid.2012.0164, 10.1089/AID.2012.0164]; Yao X, 2012, JAIDS-J ACQ IMM DEF, V60, P328, DOI 10.1097/QAI.0b013e31824f19f5; YONG W, 2013, S CHINA J PREV MED, V39, P6; Yuan Yuan, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P619; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; Zhao B, 2011, AIDS RES HUM RETROV, V27, P1047, DOI [10.1089/aid.2010.0119, 10.1089/AID.2010.0119]	36	30	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75777	10.1371/journal.pone.0075777	http://dx.doi.org/10.1371/journal.pone.0075777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098398	Green Submitted, gold, Green Published			2022-12-25	WOS:000325483600023
J	Gomes, T; Vinhas, SA; Reis-Santos, B; Palaci, M; Peres, RL; Aguiar, PP; Ribeiro, FKC; Marques, HS; Dettoni, VD; Johnson, JL; Riley, LW; Maciel, EL				Gomes, Teresa; Vinhas, Solange Alves; Reis-Santos, Barbara; Palaci, Moises; Peres, Renata Lyrio; Aguiar, Paola P.; Correa Ribeiro, Fabiola Karla; Marques, Hebert Silva; Dettoni, Valderio do Valle; Johnson, John L.; Riley, Lee W.; Maciel, Ethel Leonor			Extrapulmonary Tuberculosis: Mycobacterium tuberculosis Strains and Host Risk Factors in a Large Urban Setting in Brazil	PLOS ONE			English	Article							IDENTIFICATION; EPIDEMIOLOGY; PULMONARY; LINEAGE	Background: Factors related to the development of extrapulmonary forms of tuberculosis (EPTB) are still poorly understood, particularly in high-endemic countries like Brazil. The objective of the paper is to determine host and Mycobacterium tuberculosis (MTB) strain-related factors associated with the development of EPTB in Espirito Santo state, Brazil. Methods and Findings: We conducted a retrospective laboratory-based surveillance study of new tuberculosis (TB) cases diagnosed in Espirito Santo state, Brazil between 1998 and 2007. We genotyped 612 isolates of MTB from 606 TB patients using spoligotyping and IS6110-restriction fragment length polymorphism (RFLP) typing and compared sociodemographic and clinical characteristics of patients with pulmonary TB (PTB) and EPTB. Among 606 patients, 464 (77%) had PTB, 79 (13%) had EPTB, 51 (8%) had both, and 12 (2%) had miliary TB. The IS6110 RFLP analysis demonstrated that 250 (41%) isolates belonged to clustered RFLP patterns, 27 (11%) of which were from EPTB. We identified 73 clusters including 35 (48%) composed of 2 isolates each. By spoligotyping, 506 (83%) MTB isolates fell into known patterns and 106 (17%) fell into patterns with no family assignment; 297 (48%) isolates belonged to the Latin-American Mediterranean family. Higher school level (4-7 years OR: 0.16 95% CI 0.34-0.73 and > 8 years of education, OR 0.06 95% CI 0.009-0.50) white ethnicity (OR: 2.54 95% CI 1.03-6.25) and HIV infection (OR: 16.83 95% CI 5.23-54.18) were associated with EPTB. No specific strain lineage or percentage of clustering was associated with EPTB. Conclusions: These results demonstrate that risk factors for EPTB are related more to host than to MTB strain lineage characteristics.	[Gomes, Teresa; Vinhas, Solange Alves; Reis-Santos, Barbara; Palaci, Moises; Peres, Renata Lyrio; Aguiar, Paola P.; Correa Ribeiro, Fabiola Karla; Marques, Hebert Silva; Maciel, Ethel Leonor] Univ Fed Espirito Santo, Grad Program Infect Dis, Vitoria, Brazil; [Dettoni, Valderio do Valle] Univ Fed Espirito Santo, TB Control Program, Vitoria, Brazil; [Johnson, John L.] Case Western Reserve Univ, Dept Med, Div Infect Dis, TB Res Unit, Cleveland, OH 44106 USA; [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Maciel, Ethel Leonor] Univ Fed Espirito Santo, Grad Program Publ Hlth, Vitoria, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Case Western Reserve University; University of California System; University of California Berkeley; Universidade Federal do Espirito Santo	Maciel, EL (corresponding author), Univ Fed Espirito Santo, Grad Program Infect Dis, Vitoria, Brazil.	ethel.maciel@gmail.com	Maciel, Ethel Leonor LN/G-1027-2012; Tuberculose, Inct/K-2302-2013; Reis-Santos, Barbara/A-3149-2014	Maciel, Ethel Leonor LN/0000-0003-4826-3355; Reis-Santos, Barbara/0000-0001-6952-0352	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; Fundacao de Amparo a Pesquisa do Espirito Santo (Fapes); Tuberculosis Research Unit at Case Western Reserve University; United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health and Human Services [NO1-AI95383, HHSN266200700022C/NO1-AI-70022, ICOHRTA 5 U2R TW006883-02]; FOGARTY INTERNATIONAL CENTER [U2RTW006883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095383] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Espirito Santo (Fapes); Tuberculosis Research Unit at Case Western Reserve University; United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Human Genome Research Institute (NHGRI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil and Fundacao de Amparo a Pesquisa do Espirito Santo (Fapes). The laboratory work for this study was supported, in part, by the Tuberculosis Research Unit at Case Western Reserve University, established with funds from the United States National Institutes of Allergy and Infectious Diseases, National Institutes of Health and Human Services, under contract NO1-AI95383 and HHSN266200700022C/NO1-AI-70022 and ICOHRTA 5 U2R TW006883-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedetti A, 2010, AM J EPIDEMIOL, V172, P318, DOI 10.1093/aje/kwq124; Borgdorff MW, 2011, AM J EPIDEMIOL, V174, P243, DOI 10.1093/aje/kwr061; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; CDC, 2011, REP TUB US; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Coscolla Mireilla, 2010, Drug Discov Today Dis Mech, V7, pe43, DOI 10.1016/j.ddmec.2010.09.004; da Roza DL, 2012, REV SOC BRAS MED TRO, V45, P607, DOI 10.1590/S0037-86822012000500013; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; *EP MDSSDVESDDV, 2008, MAN NAC VIG LAB TUB; Fiske CT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-16; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Garcia-Rodriguez JF, 2011, ENFERM INFEC MICR CL, V29, P502, DOI 10.1016/j.eimc.2011.03.005; Garcia de Viedma D, 2005, J INFECT DIS, V192, P2059, DOI [10.1086/498245, DOI 10.1086/498245.PUBMED:16288368]; Gibson JF, 2010, MOL PHYLOGENET EVOL, V56, P1126, DOI 10.1016/j.ympev.2010.05.005; GOMES T, 2013, THESIS U FEDERAL ESP; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kingkaew N, 2009, INT J INFECT DIS, V13, P722, DOI 10.1016/j.ijid.2008.11.013; Lari N, 2009, CLIN MICROBIOL INFEC, V15, P538, DOI 10.1111/j.1469-0691.2009.02712.x; Maciel E, 2012, PROMOCAO SAUDE DIVER; Mazza-Stalder J, 2012, REV MAL RESPIR, V29, P566, DOI 10.1016/j.rmr.2011.05.021; *MIN PLAN, 2012, CONT POP; *MIN SAUD, 2011, MAN REC CONTR TUB BR, P32; *MIN SAUD, 2012, B EP ESP TUB, P43; *MIN SAUD, 2012, SER HIST TAX MORT TU; Nicol MP, 2005, J CLIN MICROBIOL, V43, P5779, DOI 10.1128/JCM.43.11.5779-5781.2005; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Ong A, 2004, CLIN INFECT DIS, V38, P25, DOI 10.1086/380448; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Razanamparany VR, 2002, J CLIN MICROBIOL, V40, P3964, DOI 10.1128/JCM.40.11.3964-3969.2002; RIEDER HL, 1990, AM REV RESPIR DIS, V141, P347, DOI 10.1164/ajrccm/141.2.347; Sankar MM, 2013, TUBERCULOSIS, V93, P75, DOI 10.1016/j.tube.2012.10.005; Seiscento M, 2009, J BRAS PNEUMOL, V35, P548, DOI 10.1590/S1806-37132009000600008; Suresh Kp, 2012, J Hum Reprod Sci, V5, P7, DOI 10.4103/0974-1208.97779; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VINHAS SP, 2012, TUBERCULOSI IN PRESS; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; *WHO, 2011, GLOB TB CONTR; *WHO, 2012, TUB COUNTR PROF; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644; 2011, SISTEMA NACL VIGILAN, P5	44	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74517	10.1371/journal.pone.0074517	http://dx.doi.org/10.1371/journal.pone.0074517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098337	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500012
J	Koffman, J; Gao, W; Goddard, C; Burman, R; Jackson, D; Shaw, P; Barnes, F; Silber, E; Higginson, IJ				Koffman, Jonathan; Gao, Wei; Goddard, Cassie; Burman, Rachel; Jackson, Diana; Shaw, Pauline; Barnes, Fiona; Silber, Eli; Higginson, Irene J.			Progression, Symptoms and Psychosocial Concerns among Those Severely Affected by Multiple Sclerosis: A Mixed-Methods Cross-Sectional Study of Black Caribbean and White British People	PLOS ONE			English	Article							AFRICAN-AMERICANS; PALLIATIVE CARE; VULNERABLE POPULATIONS; DIAGNOSTIC-CRITERIA; ETHNIC-GROUPS; SEVERITY; PREVALENCE; DISABILITY; CANCER; EXPERIENCES	Objective: Multiple sclerosis is now more common among minority ethnic groups in the UK but little is known about their experiences, especially in advanced stages. We examine disease progression, symptoms and psychosocial concerns among Black Caribbean (BC) and White British (WB) people severely affected by MS. Design: Mixed methods study of 43 BC and 43 WB people with MS (PwMS) with an Expanded Disability Status Scale (EDSS) >= 6 involving data from in clinical records, face-to-face structured interviews and a nested-qualitative component. Progression Index (PI) and Multiple Sclerosis Severity Score (MSSS) were calculated. To control for selection bias, propensity scores were derived for each patient and adjusted for in the comparative statistical analysis; qualitative data were analysed using the framework approach. Results: Median EDSS for both groups was (6.5; range: 6.0-9.0). Progression Index (PI) and Multiple Sclerosis Severity Score (MSSS) based on neurological assessment of current EDSS scores identified BC PwMS were more likely to have aggressive disease (PI F = 4.04, p = 0.048, MSSS F = 10.30, p < 0.001). Patients' reports of the time required to reach levels of functional decline equivalent to different EDSS levels varied by group; EDSS 4: BC 2.7 years v/s WB 10.2 years (U = 258.50, p = 0.013), EDSS 6: 6.1 years BC v/s WB 12.7 years (U = 535.500, p = 0.011), EDSS 8: BC 8.7 years v/s WB 10.2 years. Both groups reported high symptom burden. BC PwMS were more cognitively impaired than WB PwMS (F = 9.65, p = 0.003). Thematic analysis of qualitative interviews provides correspondence with quantitative findings; more BC than WB PwMS referred to feelings of extreme frustration and unresolved loss/confusion associated with their rapidly advancing disease. The interviews also reveal the centrality, meanings and impact of common MS-related symptoms. Conclusions: Delays in diagnosis should be avoided and more frequent reviews may be justified by healthcare services. Culturally acceptable interventions to better support people who perceive MS as an assault on identity should be developed to help them achieve normalisation and enhance self-identity.	[Koffman, Jonathan; Gao, Wei; Goddard, Cassie; Burman, Rachel; Jackson, Diana; Higginson, Irene J.] Kings Coll London, Sch Med, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London, England; [Shaw, Pauline; Barnes, Fiona; Silber, Eli] Kings Coll Hosp NHS Fdn Trust, Dept Neurol, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust	Koffman, J (corresponding author), Kings Coll London, Sch Med, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London, England.	jonathan.koffman@kcl.ac.uk	Gao, Wei/G-8653-2011; Harding, Richard/G-9729-2012; Higginson, Irene Julie/C-7309-2012	Gao, Wei/0000-0001-8298-3415; Higginson, Irene Julie/0000-0002-3687-1313; Koffman, Jonathan/0000-0001-8513-5681	MS Society, United Kingdom [922/09]; National Institute for Health Research [NF-SI-0611-10209] Funding Source: researchfish	MS Society, United Kingdom; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by a grant (922/09) from the MS Society, United Kingdom. www.mssociety.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshami E, 1998, NEUROLOGY, V50, pA210; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Bhopal R, 1997, BRIT MED J, V314, P1751, DOI 10.1136/bmj.314.7096.1751; Buchanan RJ, 2004, MULT SCLER J, V10, P660, DOI 10.1191/1352458504ms1086oa; Buchanan RJ, 2010, ETHNIC DIS, V20, P451; Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512; Corbin J., 2015, BASICS QUALITATIVE R; Cree BAC, 2004, NEUROLOGY, V63, P2039, DOI 10.1212/01.WNL.0000145762.60562.5D; Cree B, 2010, NEUROLOGY, V74, P532, DOI 10.1212/WNL.0b013e3181d0374f; Curry LA, 2013, CIRC-CARDIOVASC QUAL, V6, P119, DOI 10.1161/CIRCOUTCOMES.112.967885; DEAN G, 1976, BMJ-BRIT MED J, V1, P861, DOI 10.1136/bmj.1.6014.861; Department of Health, 2008, END LIF CAR STRAT PR; Department of Health, 2012, 4 DEP HLTH; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Edmonds P, 2007, PALLIATIVE MED, V21, P101, DOI 10.1177/0269216307076333; ELIAN M, 1990, J NEUROL NEUROSUR PS, V53, P906, DOI 10.1136/jnnp.53.10.906; Evans N, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-141; Vasconcelos CCF, 2010, MULT SCLER J, V16, P597, DOI 10.1177/1352458509360987; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Goldman Myla D, 2010, Ther Adv Neurol Disord, V3, P229, DOI 10.1177/1756285610374117; GREWAL I, 2006, HLTH SOCIAL RES MULT; Gruenewald DA, 2004, MULT SCLER J, V10, P690, DOI 10.1191/1352458504ms1116rr; Gunaratnam Y., 2003, RES RACEETHNICITY; Hearn J, 1999, QUAL HEALTH CARE, V8, P219, DOI 10.1136/qshc.8.4.219; Higginson IJ, 2013, BMC MED, V11, P2013; Higginson Irene J, 2004, Health Qual Life Outcomes, V2, P68, DOI 10.1186/1477-7525-2-68; Higginson IJ, 2006, J PALLIATIVE CARE, V22, P158, DOI 10.1177/082585970602200306; Higginson IJ, 2009, J PAIN SYMPTOM MANAG, V38, P816, DOI 10.1016/j.jpainsymman.2009.07.002; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Howard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043061; Hubbard G, 2010, HEALTH-LONDON, V14, P131, DOI 10.1177/1363459309353294; International Organization for Migration, 2009, FACTS FIG; Jeannin S, 2007, REV NEUROL-FRANCE, V163, P440, DOI 10.1016/S0035-3787(07)90419-1; Johnson SK, 2007, STRESS HEALTH, V23, P207, DOI 10.1002/smi.1138; Kaufman MD, 2003, AM J PHYS MED REHAB, V82, P582, DOI 10.1097/01.phm.0000078199.99484.E2; Kister I, 2010, NEUROLOGY, V75, P217, DOI 10.1212/WNL.0b013e3181e8e72a; Koffman J, 2008, PALLIATIVE MED, V22, P350, DOI 10.1177/0269216308090168; Koffman J, 2003, J ROY SOC MED, V96, P10, DOI 10.1258/jrsm.96.1.10; Koffman J, 2009, J MED ETHICS, V35, P440, DOI 10.1136/jme.2008.027839; Koffman J, 2008, SOC SCI MED, V67, P780, DOI 10.1016/j.socscimed.2008.05.004; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Loftis JM, 2004, J AFFECT DISORDERS, V82, P175, DOI 10.1016/j.jad.2004.04.002; Macklin R, 1998, KENNEDY INST ETHIC J, V8, P1, DOI 10.1353/ken.1998.0005; Marrie RA, 2006, NEUROLOGY, V66, P1235, DOI 10.1212/01.wnl.0000208505.81912.82; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Moran-Ellis J, 2006, QUAL RES, V6, P45, DOI [10.1177/1468794106058870, DOI 10.1177/1468794106058870]; Moss-Morris R, 2012, J CONSULTING CLIN PS; Nickel PJ, 2006, THEOR MED BIOETH, V27, P245, DOI 10.1007/s11017-006-9000-2; O'Cathain Alicia, 2010, BMJ, V341, pc4587, DOI 10.1136/bmj.c4587; Office for National Statistics, 2004, ETHN ID; Patten SB, 2005, MULT SCLER J, V11, P175, DOI 10.1191/1352458505ms1144oa; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER S, 1982, ACTA NEUROL SCAND, V66, P355; Quest T, 2003, ACAD EMERG MED, V10, P1294, DOI 10.1197/S1069-6563(03)00502-5; Richie J., 1994, ANAL QUALITATIVE DAT; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Ross KA, 2010, NEUROLOGY, V75, P2097, DOI 10.1212/WNL.0b013e318200d7b9; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Sheikh A, 2004, BMJ-BRIT MED J, V329, P87, DOI 10.1136/bmj.38061.593935.F7; Taylor BV, 2010, MULT SCLER J, V16, P1422, DOI 10.1177/1352458510379614; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75431	10.1371/journal.pone.0075431	http://dx.doi.org/10.1371/journal.pone.0075431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098384	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500032
J	Chang, TY; Kuan, WC; Huang, KL; Chang, CH; Chang, YJ; Wong, HF; Lee, TH; Liu, HL				Chang, Ting-Yu; Kuan, Wan-Chun; Huang, Kuo-Lun; Chang, Chien-Hung; Chang, Yeu-Jhy; Wong, Ho-Fai; Lee, Tsong-Hai; Liu, Ho-Ling			Heterogeneous Cerebral Vasoreactivity Dynamics in Patients with Carotid Stenosis	PLOS ONE			English	Article							CEREBROVASCULAR REACTIVITY; HEMODYNAMIC-RESPONSE; ARTERY STENOSIS; BRAIN; STROKE; RISK; HYPERPERFUSION; RESERVE; LEVEL; MRI	Cerebral vasoreactivity (CVR) can be assessed by functional MRI (fMRI) using hypercapnia challenges. In normal subjects, studies have shown temporal variability of CVR blood oxygenation level-dependent responses among different brain regions. In the current study, we analyzed the variability of BOLD CVR dynamics by fMRI with a breath-holding task in 17 subjects with unilateral carotid stenosis before they received carotid stenting. Great heterogeneity of CVR dynamics was observed when comparing BOLD responses between ipsilateral and contralateral hemispheres in each patient, especially in middle cerebral artery (MCA) territories. While some subjects (n=12) had similar CVR responses between either hemisphere, the others (n=5) had a poorly correlated pattern of BOLD changes between ipsilateral and contralateral hemispheres. In the latter group, defined as impaired CVR, post-stenting perfusion tended to be more significantly increased. Our data provides the first observation of divergent temporal BOLD responses during breath holding in patients with carotid stenosis. The development of collateral circulation and the derangement of cerebral hemodynamics can be detected through this novel analysis of the different patterns of BOLD changes. The results also help in prediction of robust increase of perfusion or hyperperfusion after carotid stenting.	[Chang, Ting-Yu; Huang, Kuo-Lun; Chang, Chien-Hung; Chang, Yeu-Jhy; Lee, Tsong-Hai] Chang Gung Univ, Linkou Med Ctr, Chang Gung Mem Hosp, Dept Neurol,Stroke Ctr, Tao Yuan, Taiwan; [Chang, Ting-Yu; Huang, Kuo-Lun; Chang, Chien-Hung; Chang, Yeu-Jhy; Lee, Tsong-Hai] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Kuan, Wan-Chun; Liu, Ho-Ling] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Wong, Ho-Fai; Liu, Ho-Ling] Chang Gung Mem Hosp, Dept Med Imaging & Intervent, Tao Yuan, Taiwan; [Liu, Ho-Ling] Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lee, TH (corresponding author), Chang Gung Univ, Linkou Med Ctr, Chang Gung Mem Hosp, Dept Neurol,Stroke Ctr, Tao Yuan, Taiwan.	thlee@adm.cgmh.org.tw; hlaliu@mail.cgu.edu.tw	Lee, Tsong Hai/C-1235-2011	Chang, Ting-Yu/0000-0003-4642-7352	National Science Council of Taiwan [NSC99-2628-B-182-028-MY2]; Medical Research Project, Chang Gung Memorial Hospital [CMRPG390581]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Medical Research Project, Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by the National Science Council of Taiwan (NSC99-2628-B-182-028-MY2) and the Medical Research Project, Chang Gung Memorial Hospital (CMRPG390581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blockley NP, 2011, MAGN RESON MED, V65, P1278, DOI 10.1002/mrm.22719; Bokkers RPH, 2011, J NEUROL NEUROSUR PS, V82, P1011, DOI 10.1136/jnnp.2010.233338; Bokkers RPH, 2010, RADIOLOGY, V256, P201, DOI 10.1148/radiol.10091262; Bright MG, 2009, NEUROIMAGE, V48, P166, DOI 10.1016/j.neuroimage.2009.05.026; Cantin S, 2011, NEUROIMAGE, V58, P579, DOI 10.1016/j.neuroimage.2011.06.070; Carusone LM, 2002, AM J NEURORADIOL, V23, P1222; Chang C, 2008, NEUROIMAGE, V43, P90, DOI 10.1016/j.neuroimage.2008.06.030; Chang TY, 2009, AM J NEURORADIOL, V30, P1330, DOI 10.3174/ajnr.A1589; Derdeyn CP, 1999, NEUROLOGY, V53, P251, DOI 10.1212/WNL.53.2.251; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Furtner M, 2009, SLEEP MED, V10, P875, DOI 10.1016/j.sleep.2008.09.011; GIBBS JM, 1984, LANCET, V1, P310; Gupta A, 2012, STROKE, V43, P2884, DOI 10.1161/STROKEAHA.112.663716; Hajjar I, 2010, HYPERTENSION, V56, P859, DOI 10.1161/HYPERTENSIONAHA.110.160002; Hosoda K, 1998, NEUROSURGERY, V42, P988, DOI 10.1097/00006123-199805000-00019; Hosoda K, 2003, STROKE, V34, P1187, DOI 10.1161/01.STR.0000068781.31429.BE; Hosoda K, 2001, STROKE, V32, P1567, DOI 10.1161/01.STR.32.7.1567; Hsu YY, 2010, J MAGN RESON IMAGING, V31, P78, DOI 10.1002/jmri.22015; Kaku Y, 2004, AM J NEURORADIOL, V25, P1403; KLEINSCHMIDT A, 1995, STROKE, V26, P106, DOI 10.1161/01.STR.26.1.106; Lavi S, 2006, AM J PHYSIOL-HEART C, V291, pH1856, DOI 10.1152/ajpheart.00014.2006; Leoni RF, 2008, NEUROIMAGE, V41, P1192, DOI 10.1016/j.neuroimage.2008.03.035; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; Lythgoe DJ, 1999, MAGN RESON IMAGING, V17, P495, DOI 10.1016/S0730-725X(98)00211-2; Markus H, 2001, BRAIN, V124, P457, DOI 10.1093/brain/124.3.457; Murphy K, 2011, NEUROIMAGE, V54, P369, DOI 10.1016/j.neuroimage.2010.07.059; Novak V, 2011, DIABETES CARE, V34, P2438, DOI 10.2337/dc11-0969; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Romero JR, 2009, CURR CARDIOL REV, V5, P279, DOI 10.2174/157340309789317887; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Silvestrini M, 2006, STROKE, V37, P1010, DOI 10.1161/01.STR.0000206439.62025.97; Tanaka H, 2006, AM J NEURORADIOL, V27, P1770; Tong YJ, 2011, NEUROIMAGE, V56, P2047, DOI 10.1016/j.neuroimage.2011.03.071; van der Zande FHR, 2005, NEURORADIOLOGY, V47, P114, DOI 10.1007/s00234-004-1274-3; Vesely A, 2001, MAGNET RESON MED, V45, P1011, DOI 10.1002/mrm.1134; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE; Ziyeh S, 2005, STROKE, V36, P751, DOI 10.1161/01.STR.0000157593.03470.3d	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76072	10.1371/journal.pone.0076072	http://dx.doi.org/10.1371/journal.pone.0076072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086687	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900075
J	Gehrie, EA; Nian, H; Young, PP				Gehrie, Eric A.; Nian, Hui; Young, Pampee P.			Brown Recluse Spider Bite Mediated Hemolysis: Clinical Features, a Possible Role for Complement Inhibitor Therapy, and Reduced RBC Surface Glycophorin A as a Potential Biomarker of Venom Exposure	PLOS ONE			English	Article							LOXOSCELES-RECLUSA; HUMAN-ERYTHROCYTES; ANEMIA; ECULIZUMAB	Background: The venom of Loxosceles reclusa (Brown Recluse spider) can cause a severe, life-threatening hemolysis in humans for which no therapy is currently available in the USA beyond supportive measures. Because this hemolysis is uncommon, relatively little is known about its clinical manifestation, diagnosis, or management. Here, we aimed to clarify the clinical details of envenomation, to determine the efficacy of the complement inhibitor eculizumab to prevent the hemolysis in vitro, and to investigate markers of exposure to Brown Recluse venom. Study Design and Methods: We performed a 10-year chart review of cases of Brown Recluse spider bite-mediated hemolysis at our institution. We also designed an in vitro assay to test the efficacy of eculizumab to inhibit hemolysis of venom exposed red blood cells. Finally, we compared levels of CD55, CD59 and glycophorin A on venom exposed versus venom-nave cells. Results: Most victims of severe Brown Recluse spider mediated hemolysis at our institution are children and follow an unpredictable clinical course. Brown Recluse spider bite mediated hemolysis is reduced by 79.2% (SD=18.8%) by eculizumab in vitro. Erythrocyte glycophorin A, but not CD55 or CD59, is reduced after red blood cells are incubated with venom in vitro. Conclusion: Taken together, our laboratory data and clinical observations indicate that L. reclusa venom exposure results in non-specific antibody and complement fixation on red blood cells, resulting in complement mediated hemolysis that is curtailed by the complement inhibitor eculizumab in vitro. Glycophorin A measurement by flow cytometry may help to identify victims of L. reclusa envenomation.	[Gehrie, Eric A.; Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Nian, Hui] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Young, Pampee P.] Tennessee Valley Vet Affairs Hosp, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Young, PP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.	pampee.young@vanderbilt.edu	Gehrie, Eric Abraham/H-9196-2019	Gehrie, Eric Abraham/0000-0002-5354-3899	Vanderbilt University Medical Center Department of Pathology, Microbiology and Immunology, Vanderbilt CTSA grant from NCRR/NIH [1UL1RR024975-01]; vial of eculizumab from Alexion Pharmaceuticals, Inc; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	Vanderbilt University Medical Center Department of Pathology, Microbiology and Immunology, Vanderbilt CTSA grant from NCRR/NIH; vial of eculizumab from Alexion Pharmaceuticals, Inc; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by a Clinical and Translational Enhancement Award from the Vanderbilt University Medical Center Department of Pathology, Microbiology and Immunology, Vanderbilt CTSA grant 1UL1RR024975-01 from NCRR/NIH, and by a research grant and a vial of eculizumab from Alexion Pharmaceuticals, Inc, www.alxn.com (all to EG and PYY). The funders had no role in study design, data collection and analysis, or decision to publish. The manuscript was reviewed by Alexion prior to submission but no changes were requested or required.	Algren DA, 2011, ANN EMERG MED, V57, P419, DOI 10.1016/j.annemergmed.2010.10.020; BRADY MT, 2011, AAP NEWS, V32, P1; Brain M, 2010, TRANSFUSION, V50, P292, DOI 10.1111/j.1537-2995.2009.02445.x; BRUCE LJ, 1994, BLOOD, V84, P916; DANKBAR DT, 1987, TRANSFUSION, V27, P534; de Roodt AR, 2007, CLIN TOXICOL, V45, P678, DOI 10.1080/15563650701397001; Dowling MM, 2012, BLOOD, V120, P3891, DOI 10.1182/blood-2012-01-406314; Elbahlawan LM, 2005, PEDIATR EMERG CARE, V21, P177; Fu S, 2004, AM J TRANSPLANT, V4, P65, DOI 10.1046/j.1600-6143.2003.00293.x; FUTRELL JM, 1979, AM J PATHOL, V95, P675; FUTRELL JM, 1979, TOXICON, V17, P355, DOI 10.1016/0041-0101(79)90263-0; Garratty G, 1997, VOX SANG, V72, P124, DOI 10.1046/j.1423-0410.1997.7220124.x; Garratty G, 1995, BLOOD, V86, P260; HARDMAN JT, 1983, TRANSFUSION, V23, P233, DOI 10.1046/j.1537-2995.1983.23383224902.x; Hostetler MA, 2003, J EMERG MED, V25, P277, DOI 10.1016/S0736-4679(03)00202-6; Kurpiewski G, 1981, Int J Tissue React, V3, P39; Lane L, 2011, PEDIATR DERMATOL, V28, P685, DOI 10.1111/j.1525-1470.2010.01302.x; Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043; Lonze BE, 2010, NEW ENGL J MED, V362, P1744, DOI 10.1056/NEJMc0910965; McDade J, 2010, J PEDIATR-US, V156, P155, DOI 10.1016/j.jpeds.2009.07.021; MCGLASSON DL, 2010, CLIN LAB SCI, V22, P216; MORGAN BB, 1977, TOXICON, V16, P85; PHARMACEUTICALS A, 2011, PACK INS SOL EC; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Roth A, 2009, BLOOD, V113, P3885, DOI 10.1182/blood-2009-01-196329; SHENKELBRUNNER H, 2000, HUMAN BLOOD GROUPS C, P304; Stoecker William V, 2009, Mo Med, V106, P425; Swanson DL, 2006, CLIN DERMATOL, V24, P213, DOI 10.1016/j.clindermatol.2005.11.006; Swanson DL, 2005, NEW ENGL J MED, V352, P700, DOI 10.1056/NEJMra041184; Tambourgi DV, 2010, TOXICON, V56, P1113, DOI 10.1016/j.toxicon.2010.01.021; Tambourgi DV, 2005, J INVEST DERMATOL, V124, P725, DOI 10.1111/j.0022-202X.2005.23654.x; TAMBOURGI DV, 1995, J IMMUNOL, V155, P4459; Tambourgi DV, 2000, BLOOD, V95, P683, DOI 10.1182/blood.V95.2.683; TANNER MJA, 1976, BIOCHEM J, V153, P271, DOI 10.1042/bj1530271; Vetter RS, 2011, TOXICON, V58, P623, DOI 10.1016/j.toxicon.2011.09.009; Vetter RS, 2009, SOUTH MED J, V102, P518, DOI 10.1097/SMJ.0b013e3181a0abb3; Wright SW, 1997, ANN EMERG MED, V30, P28, DOI 10.1016/S0196-0644(97)70106-9	37	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76558	10.1371/journal.pone.0076558	http://dx.doi.org/10.1371/journal.pone.0076558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086749	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900105
J	Grashorn, W; Sprenger, C; Forkmann, K; Wrobel, N; Bingel, U				Grashorn, Wiebke; Sprenger, Christian; Forkmann, Katarina; Wrobel, Nathalie; Bingel, Ulrike			Age-Dependent Decline of Endogenous Pain Control: Exploring the Effect of Expectation and Depression	PLOS ONE			English	Article							NOXIOUS INHIBITORY CONTROLS; SUBNUCLEUS-RETICULARIS-DORSALIS; HOSPITAL ANXIETY; SEX-DIFFERENCES; MODULATION; INVOLVEMENT; ACTIVATION; ANALGESIA; GENDER; HORN	Although chronic pain affects all age ranges, it is particularly common in the elderly. One potential explanation for the high prevalence of chronic pain in the older population is impaired functioning of the descending pain inhibitory system which can be studied in humans using conditioned pain modulation (CPM) paradigms. In this study we investigated (i) the influence of age on CPM and (ii) the role of expectations, depression and gender as potential modulating variables of an age-related change in CPM. 64 healthy volunteers of three different age groups (young = 20-40 years, middle-aged = 41-60 years, old = 61-80 years) were studied using a classical CPM paradigm that combined moderate heat pain stimuli to the right forearm as test stimuli (TS) and immersion of the contralateral foot into ice water as the conditioning stimulus (CS). The CPM response showed an age-dependent decline with strong CPM responses in young adults but no significant CPM responses in middle-aged and older adults. These age-related changes in CPM responses could not be explained by expectations of pain relief or depression. Furthermore, changes in CPM responses did not differ between men and women. Our results strongly support the notion of a genuine deterioration of descending pain inhibitory mechanisms with age.	[Grashorn, Wiebke; Forkmann, Katarina; Wrobel, Nathalie; Bingel, Ulrike] Univ Med Ctr Hamburg Eppendorf UKE, Dept Neurol, Hamburg, Germany; [Sprenger, Christian; Bingel, Ulrike] Univ Med Ctr Hamburg Eppendorf UKE, Dept Syst Neurosci, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Grashorn, W (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Dept Neurol, Hamburg, Germany.	w.grashorn@uke.uni-hamburg.de			German Research Foundation [SFB 936/1]; Federal Ministry of Education and Research [01GQ0808]; LIIRA Grant by Pfizer	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); LIIRA Grant by Pfizer	This work was supported by grants from the German Research Foundation (SFB 936/1), the Federal Ministry of Education and Research (01GQ0808) and the LIIRA Grant by Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt-Nielsen L, 2008, PAIN, V140, P465, DOI 10.1016/j.pain.2008.09.027; Arnow BA, 2006, PSYCHOSOM MED, V68, P262, DOI 10.1097/01.psy.0000204851.15499.fc; Baad-Hansen L, 2005, PAIN, V116, P359, DOI 10.1016/j.pain.2005.05.006; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bie BH, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-37; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BOUHASSIRA D, 1992, BRAIN RES, V595, P353, DOI 10.1016/0006-8993(92)91071-L; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; CHETELAT G, 2013, NEUROIMAGE; CHITOUR D, 1982, BRAIN RES, V236, P329, DOI 10.1016/0006-8993(82)90718-1; CORMIER S, 2012, J PAIN; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Eaton WW, 1997, ARCH GEN PSYCHIAT, V54, P993; Edwards RR, 2003, PAIN, V101, P155, DOI 10.1016/S0304-3959(02)00324-X; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; France CR, 1999, PAIN, V81, P77, DOI 10.1016/S0304-3959(98)00272-3; Gibson SJ, 2004, CLIN J PAIN, V20, P227, DOI 10.1097/00002508-200407000-00004; Gibson Stephen J, 2007, Expert Rev Neurother, V7, P627, DOI 10.1586/14737175.7.6.627; Goffaux P, 2007, PAIN, V130, P137, DOI 10.1016/j.pain.2006.11.011; Granot M, 2008, PAIN, V136, P142, DOI 10.1016/j.pain.2007.06.029; Lariviere M, 2007, CLIN J PAIN, V23, P506, DOI 10.1097/AJP.0b013e31806a23e8; Lautenbacher S, 2012, PAIN MED, V13, pS44, DOI 10.1111/j.1526-4637.2012.01326.x; LEBARS D, 1992, PAIN, V48, P13, DOI 10.1016/0304-3959(92)90126-V; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Moont R, 2011, PAIN, V152, P1469, DOI 10.1016/j.pain.2011.01.036; Nir RR, 2012, PAIN, V153, P170, DOI 10.1016/j.pain.2011.10.010; Piche M, 2009, J NEUROSCI, V29, P14236, DOI 10.1523/JNEUROSCI.2341-09.2009; Popescu A, 2010, PAIN, V150, P309, DOI 10.1016/j.pain.2010.05.013; Potvin S, 2009, J PAIN, V10, P969, DOI 10.1016/j.jpain.2009.03.013; PRICE DD, 1988, PAIN, V34, P245, DOI 10.1016/0304-3959(88)90119-4; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; Quiton RL, 2007, PAIN, V132, pS134, DOI 10.1016/j.pain.2007.09.001; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Riley JL, 2010, PAIN, V150, P153, DOI 10.1016/j.pain.2010.04.020; Sandrini G, 2006, CEPHALALGIA, V26, P782, DOI 10.1111/j.1468-2982.2006.01130.x; SCHOUENBORG J, 1985, BRAIN RES, V328, P23, DOI 10.1016/0006-8993(85)91318-6; Sprenger C, 2011, PAIN, V152, P428, DOI 10.1016/j.pain.2010.11.018; Tamnes CK, 2013, NEUROIMAGE, V68, P63, DOI 10.1016/j.neuroimage.2012.11.039; Tauscher J, 2001, NEUROPSYCHOPHARMACOL, V24, P522, DOI 10.1016/S0893-133X(00)00227-X; Tousignant-Laflamme Y, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/693912; Tracey I, 2012, CELL, V148, P1308, DOI 10.1016/j.cell.2012.03.004; Villanueva L, 1996, PAIN, V67, P231, DOI 10.1016/0304-3959(96)03121-1; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Washington LL, 2000, PAIN, V89, P89, DOI 10.1016/S0304-3959(00)00352-3; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	42	43	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75629	10.1371/journal.pone.0075629	http://dx.doi.org/10.1371/journal.pone.0075629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086595	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900052
J	Rudra, S; Skibbens, RV				Rudra, Soumya; Skibbens, Robert V.			Chl1 DNA Helicase Regulates Scc2 Deposition Specifically during DNA-Replication in Saccharomyces cerevisiae	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DE-LANGE-SYNDROME; WARSAW BREAKAGE SYNDROME; ROBERTS-SYNDROME; BUDDING YEAST; S-PHASE; ESTABLISHMENT FACTOR; NIPPED-B; BIOCHEMICAL-CHARACTERIZATION; ACETYLTRANSFERASE ACTIVITY	The conserved family of cohesin proteins that mediate sister chromatid cohesion requires Scc2, Scc4 for chromatin-association and Eco1/Ctf7 for conversion to a tethering competent state. A popular model, based on the notion that cohesins form huge ring-like structures, is that Scc2, Scc4 function is essential only during G1 such that sister chromatid cohesion results simply from DNA replisome passage through pre-loaded cohesin rings. In such a scenario, cohesin deposition during G1 is temporally uncoupled from Eco1-dependent establishment reactions that occur during S-phase. Chl1 DNA helicase (homolog of human ChlR1/DDX11 and BACH1/BRIP1/FANCJ helicases implicated in Fanconi anemia, breast and ovarian cancer and Warsaw Breakage Syndrome) plays a critical role in sister chromatid cohesion, however, the mechanism through which Chl1 promotes cohesion remains poorly understood. Here, we report that Chl1 promotes Scc2 loading unto DNA such that both Scc2 and cohesin enrichment to chromatin are defective in chl1 mutant cells. The results further show that both Chl1 expression and chromatin-recruitment are tightly regulated through the cell cycle, peaking during S-phase. Importantly, kinetic ChIP studies reveals that Chl1 is required for Scc2 chromatin-association specifically during S-phase, but not during G1. Despite normal chromatin enrichment of both Scc2 and cohesin during G1, chl1 mutant cells exhibit severe chromosome segregation and cohesion defects - revealing that G1-loaded cohesins is insufficient to promote cohesion. Based on these findings, we propose a new model wherein S-phase cohesin loading occurs during DNA replication and in concert with both cohesion establishment and chromatin assembly reactions - challenging the notion that DNA replication fork navigates through or around pre-loaded cohesin rings.	[Rudra, Soumya; Skibbens, Robert V.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Lehigh University	Skibbens, RV (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	rvs3@lehigh.edu		Skibbens, Robert/0000-0003-4216-8306	National Institute of General Medical Sciences [2R15GM083269-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110631, R15GM083269] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	RVS is supported by an award from the National Institute of General Medical Sciences (2R15GM083269-02). Any opinions, findings, and conclusions or recommendations expressed in this study are those of the authors and do not necessarily reflect the views of the National Institutes of General Medical Sciences or Lehigh University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann J, 1997, J BIOL CHEM, V272, P3823, DOI 10.1074/jbc.272.6.3823; [Anonymous], ANNU REV CELL DEV BI, V24, P105, DOI [10.1146/annurev.cellbio.24.110707.175350, DOI 10.1146/ANNUREV.CELLBI0.24.110707.175350.PUBMED:18616427]; Bellows AM, 2003, NUCLEIC ACIDS RES, V31, P6334, DOI 10.1093/nar/gkg811; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Bernard P, 2006, CURR BIOL, V16, P875, DOI 10.1016/j.cub.2006.03.037; Borges V, 2013, CHROMOSOMA, V122, P121, DOI 10.1007/s00412-013-0396-y; Bylund GO, 2005, MOL CELL BIOL, V25, P5445, DOI 10.1128/MCB.25.13.5445-5455.2005; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cantor SB, 2006, CELL CYCLE, V5, P164, DOI 10.4161/cc.5.2.2338; Capo-Chichi JM, 2013, HUM MUTAT, V34, P103, DOI 10.1002/humu.22226; Chen ZM, 2012, G3-GENES GENOM GENET, V2, P1161, DOI 10.1534/g3.112.003327; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Deardorff MA, 2012, AM J HUM GENET, V90, P1014, DOI 10.1016/j.ajhg.2012.04.019; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Farina A, 2008, J BIOL CHEM, V283, P20925, DOI 10.1074/jbc.M802696200; Gartenberg M, 2009, CHROMOSOME RES, V17, P229, DOI 10.1007/s10577-008-9012-z; Gause M, 2010, MOL CELL BIOL, V30, P4940, DOI 10.1128/MCB.00642-10; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; GERRING SL, 1990, EMBO J, V9, P4347, DOI 10.1002/j.1460-2075.1990.tb07884.x; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Gordillo M, 2008, HUM MOL GENET, V17, P2172, DOI 10.1093/hmg/ddn116; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Guacci V, 2012, MOL BIOL CELL, V23, P729, DOI 10.1091/mbc.E11-08-0696; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Hirota Y, 2000, NUCLEIC ACIDS RES, V28, P917, DOI 10.1093/nar/28.4.917; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Inoue A, 2011, EXP CELL RES, V317, P2522, DOI 10.1016/j.yexcr.2011.08.006; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kogut I, 2009, GENE DEV, V23, P2345, DOI 10.1101/gad.1819409; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Laha S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-83; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Leman AR, 2013, GENES-BASEL, V4, P1, DOI 10.3390/genes4010001; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Maradeo ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015381; Maradeo ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004707; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Mc Intyre J, 2007, EMBO J, V26, P3783, DOI 10.1038/sj.emboj.7601793; McNairn AJ, 2009, CHROMOSOME RES, V17, P155, DOI 10.1007/s10577-008-9007-9; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; Milutinovich M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030012; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Morita A, 2012, DEV GROWTH DIFFER, V54, P588, DOI 10.1111/j.1440-169X.2012.01362.x; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Ocampo-Hafalla MT, 2011, J CELL SCI, V124, P685, DOI 10.1242/jcs.073866; Ogiwara H, 2007, BIOCHEM BIOPH RES CO, V354, P222, DOI 10.1016/j.bbrc.2006.12.185; Onn I, 2011, P NATL ACAD SCI USA, V108, P12198, DOI 10.1073/pnas.1107504108; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Rudra S, 2013, J CELL SCI, V126, P31, DOI 10.1242/jcs.116566; Rudra S, 2012, CELL CYCLE, V11, P2114, DOI 10.4161/cc.20547; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Skibbens RV, 2008, INT REV CEL MOL BIO, V269, P283, DOI 10.1016/S1937-6448(08)01005-8; Skibbens RV, 2007, J CELL SCI, V120, P2471, DOI 10.1242/jcs.011999; Skibbens RV, 2010, TRENDS CELL BIOL, V20, P507, DOI 10.1016/j.tcb.2010.06.003; Skibbens RV, 2000, GENOME RES, V10, P1664, DOI 10.1101/gr.153600; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; Song JH, 2012, J BIOL CHEM, V287, P34325, DOI 10.1074/jbc.M112.400192; Suhasini AN, 2013, MUTAT RES-REV MUTAT, V752, P138, DOI 10.1016/j.mrrev.2012.12.004; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Whelan G, 2012, NUCLEUS-PHILA, V3, P330, DOI 10.4161/nucl.20440; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2012, NUCLEIC ACIDS RES, V40, P4247, DOI 10.1093/nar/gks039; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Xiong B, 2010, ANNU REV BIOCHEM, V79, P131, DOI 10.1146/annurev-biochem-061708-092640; Zhang B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005232; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048	109	33	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75435	10.1371/journal.pone.0075435	http://dx.doi.org/10.1371/journal.pone.0075435			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086532	Green Published, gold, Green Submitted			2022-12-25	WOS:000325220000021
J	Tweya, H; Feldacker, C; Estill, J; Jahn, A; Ng'ambi, W; Ben-Smith, A; Keiser, O; Bokosi, M; Egger, M; Speight, C; Gumulira, J; Phiri, S				Tweya, Hannock; Feldacker, Caryl; Estill, Janne; Jahn, Andreas; Ng'ambi, Wingston; Ben-Smith, Anne; Keiser, Olivia; Bokosi, Mphatso; Egger, Matthias; Speight, Colin; Gumulira, Joe; Phiri, Sam			Are They Really Lost? "True" Status and Reasons for Treatment Discontinuation among HIV Infected Patients on Antiretroviral Therapy Considered Lost to Follow Up in Urban Malawi	PLOS ONE			English	Article							OUTCOMES; MORTALITY; LILONGWE; PROGRAMS; FAILURE; ART	Introduction: Patients who are lost to follow-up (LTFU) while on antiretroviral therapy (ART) pose challenges to the long-term success of ART programs. We describe the extent to which patients considered LTFU are misclassified as true disengagement from care when they are still alive on ART and explain reasons for ART discontinuation using our active tracing program to further improve ART retention programs and policies. Methods: We identified adult ART patients who missed clinic appointment by more than 3 weeks between January 2006 and December 2010, assuming that such patients would miss their doses of antiretroviral drugs. Patients considered LTFU who consented during ART registration were traced by phone or home visits; true ART status after tracing was documented. Reasons for ART discontinuation were also recorded for those who stopped ART. Results: Of the 4,560 suspected LTFU cases, 1,384 (30%) could not be traced. Of the 3,176 successfully traced patients, 952 (30%) were dead and 2,224 (70%) were alive, of which 2,183 (99.5%) started ART according to phone-based self-reports or physical verification during in-person interviews. Of those who started ART, 957 (44%) stopped ART and 1,226 (56%) reported still taking ART at the time of interview by sourcing drugs from another clinic, using alternative ART sources or making brief ART interruptions. Among 940 cases with reasons for ART discontinuations, failure to remember (17%), too weak/sick (12%), travel (46%), and lack of transport to the clinic (16%) were frequently cited; reasons differed by gender. Conclusion: The LTFU category comprises sizeable proportions of patients still taking ART that may potentially bias retention estimates and misdirect resources at the clinic and national levels if not properly accounted for. Clinics should consider further decentralization efforts, increasing drug allocations for frequent travels, and improving communication on patient transfers between clinics to increase retention and adherence.	[Tweya, Hannock] Int Union TB & Lung Dis, Paris, France; [Tweya, Hannock; Feldacker, Caryl; Ng'ambi, Wingston; Bokosi, Mphatso; Speight, Colin; Gumulira, Joe; Phiri, Sam] Lighthouse Trust, Lilongwe, Malawi; [Tweya, Hannock; Estill, Janne; Keiser, Olivia; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Feldacker, Caryl; Jahn, Andreas] Univ Washington, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA; [Jahn, Andreas] Minist Hlth, Dept HIV andAIDS, Cent Monitoring & Evaluat Div, Lilongwe, Malawi; [Ben-Smith, Anne] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA	University of Bern; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tweya, H (corresponding author), Int Union TB & Lung Dis, Paris, France.	h_tweya@lighthouse.org.mw	Jahn, Andreas/ABB-7796-2020	Jahn, Andreas/0000-0003-4645-1600; Keiser, Olivia/0000-0001-8191-2789; Egger, Matthias/0000-0001-7462-5132; Feldacker, Caryl/0000-0002-8152-6754	International Union Against Tuberculosis and Lung Disease, Paris, France; US Department of Health and Human Services, Health Resources and Services Administration (HRSA) [U91HA06801]; Swiss National Science Foundation	International Union Against Tuberculosis and Lung Disease, Paris, France; US Department of Health and Human Services, Health Resources and Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Hannock Tweya is supported as an Operational Research Fellow by the International Union Against Tuberculosis and Lung Disease, Paris, France. Caryl Feldacker was supported with funding from Cooperative Agreement U91HA06801 from the US Department of Health and Human Services, Health Resources and Services Administration (HRSA). Olivia Keiser is supported by a PROSPER grant from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker F, 2008, J AMBUL CARE MANAG, V31, P128, DOI 10.1097/01.JAC.0000314703.34795.44; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Castelnuovo B, 2009, INT J STD AIDS, V20, P123, DOI 10.1258/ijsa.2008.008174; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Douglas GP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000319; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Feldacker C, 2011, SOC SCI MED, V72, P717, DOI 10.1016/j.socscimed.2011.01.003; Geng EH, 2013, JAIDS-J ACQ IMM DEF, V63, pE64, DOI 10.1097/QAI.0b013e31828af5a6; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Luebbert J, 2012, CLIN INFECT DIS, V55, P441, DOI 10.1093/cid/cis438; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; MoH, 2006, GUID US ANT THER MAL; MOH, 2012, INT HIV PROGR REP JU; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	23	54	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75761	10.1371/journal.pone.0075761	http://dx.doi.org/10.1371/journal.pone.0075761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086627	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000041
J	Willems, MCM; van der Vliet, JA; Lomme, RMLM; Hendriks, T				Willems, Martine C. M.; van der Vliet, J. Adam; Lomme, Roger M. L. M.; Hendriks, Thijs			Tacrolimus Does Not Affect Early Wound Healing in a Rodent Model of Bowel Anastomoses and Abdominal Wall Closure	PLOS ONE			English	Article							TRANSPLANT RECIPIENTS; KIDNEY-TRANSPLANTATION; SIROLIMUS; COMPLICATIONS; RAT; STRENGTH	Background: Use of immunosuppressant drugs has been associated with complications in wound healing. The calcineurin inhibitor tacrolimus is thought to have a relatively low complication rate, but preclinical research has yielded contradictory data, prompting the current comprehensive study Methods: Three groups of 33 male Wistar rats received a daily subcutaneous dose of 0,5, 2 or 5 mg/kg tacrolimus. A control group received saline. On day 0 a resection of 1 cm ileum and 1 cm colon was performed, and end-to-end anastomoses were constructed. Ten rats of each group were killed on day 3 and day 5 and the remaining animals on day 7. Both anastomoses and the wound in the abdominal wall were analyzed. Wound strength was the primary outcome parameter. Results: Mean strength of the abdominal wall increased significantly over time in all groups (p<0.0001). Both the breaking strength and the bursting pressure of the ileum and colon anastomoses followed the same pattern. No differences were observed between control and experimental groups. In addition, no consistent differences were found between groups regarding wound hydroxyproline content and the activities of matrix metalloproteinase-2 and -9. Conclusion: Tacrolimus does not affect early wound healing.	[Willems, Martine C. M.; van der Vliet, J. Adam; Lomme, Roger M. L. M.; Hendriks, Thijs] Radboud Univ Nijmegen, Med Ctr, Dept Surg, Div Vasc & Transplantat Surg, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Willems, MCM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Surg, Div Vasc & Transplantat Surg, NL-6525 ED Nijmegen, Netherlands.	mwillems@flevoziekenhuis.nl	Lomme, Roger/P-6623-2015; van der Vliet, J. Adam/L-4721-2015	Lomme, Roger/0000-0002-4856-9234	UMCN St Radboud University	UMCN St Radboud University	The research was funded by the UMCN St Radboud University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anil Kumar, 2005, TRANSPLANTATION, V80, P807, DOI [10.1097/01.tp.0000173378.28790.0b, DOI 10.1097/01.TP.0000173378.28790.0B.PUBMED:16210969]; Bouzas-Mosquera A, 2008, TRANSPL P, V40, P3027, DOI 10.1016/j.transproceed.2008.09.021; Dean PG, 2004, TRANSPLANTATION, V77, P1555, DOI 10.1097/01.TP.0000123082.31092.53; DEWAARD JWD, 1995, BRIT J CANCER, V72, P456, DOI 10.1038/bjc.1995.355; Grim SA, 2006, TRANSPLANT P, V38, P3520, DOI 10.1016/j.transproceed.2006.10.065; Kapoor A, 2008, DRUGS, V68, P11, DOI 10.2165/00003495-200868001-00003; Kita J, 1999, TRANSPLANT P, V31, P2789, DOI 10.1016/S0041-1345(99)00568-0; Kiyama T, 2002, WOUND REPAIR REGEN, V10, P308, DOI 10.1046/j.1524-475X.2002.t01-1-10506.x; Kobashigawa JA, 2006, AM J TRANSPLANT, V6, P1377, DOI 10.1111/j.1600-6143.2006.01290.x; Kuppahally S, 2006, AM J TRANSPLANT, V6, P986, DOI 10.1111/j.1600-6143.2006.01282.x; Raptis D, 2012, INT J COLORECTAL DIS, V27, P299, DOI 10.1007/s00384-011-1337-y; Schaffer M, 2005, J INVEST SURG, V18, P71, DOI 10.1080/08941930590926294; Schaffer MR, 1998, TRANSPLANTATION, V65, P813; Siemonsma MA, 2003, SURGERY, V133, P268, DOI 10.1067/msy.2003.27; Staatz CE, 2004, CLIN PHARMACOKINET, V43, P623, DOI 10.2165/00003088-200443100-00001; Vliet JAD, 2006, TRANSPLANTATION, V82, P1477, DOI 10.1097/01.tp.0000246078.09845.9c; Vicari-Christensen M, 2009, PROG TRANSPLANT, V19, P277, DOI 10.7182/prtr.19.3.22u4114wn0l01140; Wasserberg N, 2004, WORLD J SURG, V28, P69, DOI 10.1007/s00268-003-7028-2; Webster A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003961.pub2; Willems MCM, 2010, WOUND REPAIR REGEN, V18, P98, DOI 10.1111/j.1524-475X.2009.00558.x; Wszola M, 2013, TRANSPLANTATION, V95, P878, DOI 10.1097/TP.0b013e318281b953	21	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76348	10.1371/journal.pone.0076348	http://dx.doi.org/10.1371/journal.pone.0076348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086731	Green Published, gold, Green Submitted			2022-12-25	WOS:000325220000064
J	Albertin, W; da Silva, T; Rigoulet, M; Salin, B; Masneuf-Pomarede, I; de Vienne, D; Sicard, D; Bely, M; Marullo, P				Albertin, Warren; da Silva, Telma; Rigoulet, Michel; Salin, Benedicte; Masneuf-Pomarede, Isabelle; de Vienne, Dominique; Sicard, Delphine; Bely, Marina; Marullo, Philippe			The Mitochondrial Genome Impacts Respiration but Not Fermentation in Interspecific Saccharomyces Hybrids	PLOS ONE			English	Article							BAYANUS VAR. UVARUM; OXIDATIVE PHOSPHORYLATIONS; DNA MOLECULES; YEAST; CEREVISIAE; WINE; INHERITANCE; EVOLUTION; SEQUENCE; FITNESS	In eukaryotes, mitochondrial DNA (mtDNA) has high rate of nucleotide substitution leading to different mitochondrial haplotypes called mitotypes. However, the impact of mitochondrial genetic variant on phenotypic variation has been poorly considered in microorganisms because mtDNA encodes very few genes compared to nuclear DNA, and also because mitochondrial inheritance is not uniparental. Here we propose original material to unravel mitotype impact on phenotype: we produced interspecific hybrids between S. cerevisiae and S. uvarum species, using fully homozygous diploid parental strains. For two different interspecific crosses involving different parental strains, we recovered 10 independent hybrids per cross, and allowed mtDNA fixation after around 80 generations. We developed PCR-based markers for the rapid discrimination of S. cerevisiae and S. uvarum mitochondrial DNA. For both crosses, we were able to isolate fully isogenic hybrids at the nuclear level, yet possessing either S. cerevisiae mtDNA (Sc-mtDNA) or S. uvarum mtDNA (Su-mtDNA). Under fermentative conditions, the mitotype has no phenotypic impact on fermentation kinetics and products, which was expected since mtDNA are not necessary for fermentative metabolism. Alternatively, under respiratory conditions, hybrids with Sc-mtDNA have higher population growth performance, associated with higher respiratory rate. Indeed, far from the hypothesis that mtDNA variation is neutral, our work shows that mitochondrial polymorphism can have a strong impact on fitness components and hence on the evolutionary fate of the yeast populations. We hypothesize that under fermentative conditions, hybrids may fix stochastically one or the other mt-DNA, while respiratory environments may increase the probability to fix Sc-mtDNA.	[Albertin, Warren; Masneuf-Pomarede, Isabelle; Bely, Marina; Marullo, Philippe] Univ Bordeaux, ISW, EA 4577, Unite Rech Enol, Villenave Dornon, France; [Albertin, Warren; Masneuf-Pomarede, Isabelle] Bordeaux Sci Agro, Gradignan, France; [da Silva, Telma] INRA, UMR 0320, UMR Genet Vegetale 8120, Gif Sur Yvette, France; [Rigoulet, Michel; Salin, Benedicte] CNRS, Inst Biochem & Genet Cell, UMR 5095, Bordeaux, France; [Rigoulet, Michel; Salin, Benedicte] Univ Bordeaux, IBGC, UMR 5095, Bordeaux, France; [de Vienne, Dominique; Sicard, Delphine] Univ Paris 11, UMR 0320, UMR Genet Vegetale 8120, Gif Sur Yvette, France; [Marullo, Philippe] BIOLAFFORT, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS)	Marullo, P (corresponding author), Univ Bordeaux, ISW, EA 4577, Unite Rech Enol, Villenave Dornon, France.	philippe.marullo@u-bordeaux2.fr		Sicard, Delphine/0000-0002-6570-3212; Marullo, Philippe/0000-0002-3594-5173; Albertin, Warren/0000-0002-7385-9882; Masneuf-Pomarede, Isabelle/0000-0002-8806-8944				Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Aigle M, 1984, AM SOC BREW CHEM, V42, P1; Albertin W, 2009, J EVOLUTION BIOL, V22, P2157, DOI 10.1111/j.1420-9101.2009.01828.x; Albertin W, 2011, APPL ENVIRON MICROB, V77, P2772, DOI 10.1128/AEM.02547-10; Ballard JWO, 2010, MOL ECOL, V19, P1523, DOI 10.1111/j.1365-294X.2010.04594.x; BEAUVOIT B, 1993, EUR J BIOCHEM, V214, P163, DOI 10.1111/j.1432-1033.1993.tb17909.x; BELLIS M, 1987, NUCLEIC ACIDS RES, V15, P6749, DOI 10.1093/nar/15.16.6749; Belloch C, 2000, INT J SYST EVOL MICR, V50, P405, DOI 10.1099/00207713-50-1-405; Blein-Nicolas M, 2013, MOL BIOL EVOL, V30, P1368, DOI 10.1093/molbev/mst050; Bolnick DI, 2008, GENETICS, V178, P1037, DOI 10.1534/genetics.107.081364; Borneman AR, 2012, FEMS YEAST RES, V12, P88, DOI 10.1111/j.1567-1364.2011.00773.x; Burger G, 2013, GENOME BIOL EVOL, V5, P418, DOI 10.1093/gbe/evt008; Burgess KS, 2004, AM J BOT, V91, P1802, DOI 10.3732/ajb.91.11.1802; Burton RS, 2007, GENE, V403, P53, DOI 10.1016/j.gene.2007.07.026; Chou JY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000432; De Vero L, 2003, ANN MICROBIOL, V53, P219; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; delaBastide PY, 1997, APPL ENVIRON MICROB, V63, P3426, DOI 10.1128/AEM.63.9.3426-3431.1997; Demuyter C, 2004, J APPL MICROBIOL, V97, P1140, DOI 10.1111/j.1365-2672.2004.02394.x; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Devin A, 2006, J BIOL CHEM, V281, P26779, DOI 10.1074/jbc.M604800200; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; DUBOURDIEU D, 1987, Connaissance de la Vigne et du Vin, V21, P267; Dujon B., 1981, MOL BIOL YEAST SACCH, P505; Emelyanov VV, 2003, EUR J BIOCHEM, V270, P1599, DOI 10.1046/j.1432-1033.2003.03499.x; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Fernandez AI, 2008, J ANIM SCI, V86, P1283, DOI 10.2527/jas.2007-0568; Fernandez-Espinar MT, 2000, ANTON LEEUW INT J G, V78, P87; Fontanillas P, 2005, MOL ECOL, V14, P661, DOI 10.1111/j.1365-294X.2004.02414.x; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Groth C, 2000, MOL BIOL EVOL, V17, P1833, DOI 10.1093/oxfordjournals.molbev.a026284; Hadjivasiliou Z, 2012, P ROY SOC B-BIOL SCI, V279, P1865, DOI 10.1098/rspb.2011.1871; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hutter A, 1998, APPL MICROBIOL BIOT, V49, P511, DOI 10.1007/s002530051206; James AC, 2003, GENETICS, V164, P187; Johnson JA, 2003, MOL ECOL, V12, P3335, DOI 10.1046/j.1365-294X.2003.02013.x; Kitagaki H, 2007, J BIOSCI BIOENG, V104, P227, DOI 10.1263/jbb.104.227; Langkjaer RB, 2003, NUCLEIC ACIDS RES, V31, P3081, DOI 10.1093/nar/gkg423; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002; Marinoni G, 1999, J BACTERIOL, V181, P6488, DOI 10.1128/JB.181.20.6488-6496.1999; Marullo P, 2006, FEMS YEAST RES, V6, P268, DOI 10.1111/j.1567-1364.2006.00034.x; Marullo P, 2004, FEMS YEAST RES, V4, P711, DOI 10.1016/j.femsyr.2004.01.006; Marullo P, 2009, FEMS YEAST RES, V9, P1148, DOI 10.1111/j.1567-1364.2009.00550.x; MAZAT JP, 1986, BIOCHIM BIOPHYS ACTA, V849, P7, DOI 10.1016/0005-2728(86)90090-3; McCauley DE, 2003, MOL ECOL, V12, P777, DOI 10.1046/j.1365-294X.2003.01764.x; McCullough MJ, 1998, J CLIN MICROBIOL, V36, P1035, DOI 10.1128/JCM.36.4.1035-1038.1998; Meadows Robin, 2010, PLoS Biol, V8, pe1000433, DOI 10.1371/journal.pbio.1000433; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Nakao Y, 2009, DNA RES, V16, P115, DOI 10.1093/dnares/dsp003; Naumov GI, 2000, RES MICROBIOL, V151, P683, DOI 10.1016/S0923-2508(00)90131-1; Niemi AK, 2005, EUR J HUM GENET, V13, P965, DOI 10.1038/sj.ejhg.5201438; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; OConnorCox ESC, 1996, J I BREWING, V102, P19, DOI 10.1002/j.2050-0416.1996.tb00890.x; Pichaud N, 2012, J BIOENERG BIOMEMBR, P1; Pichaud N, 2012, EVOLUTION, V66, P3189, DOI 10.1111/j.1558-5646.2012.01683.x; Prochazka E, 2012, FEMS YEAST RES, V12, P819, DOI 10.1111/j.1567-1364.2012.00833.x; Pulvirenti A, 2000, ANN MICROBIOL, V50, P61; Pulvirenti A, 2005, CAN J MICROBIOL, V51, P759, DOI [10.1139/W05-062, 10.1139/w05-062]; Rainieri S, 2008, FEMS YEAST RES, V8, P586, DOI 10.1111/j.1567-1364.2008.00363.x; Rand DM, 2006, GENETICS, V172, P329, DOI 10.1534/genetics.105.046698; RIGOULET M, 1987, EUR J BIOCHEM, V168, P275, DOI 10.1111/j.1432-1033.1987.tb13417.x; Rosenfeld E, 2002, YEAST, V19, P1299, DOI 10.1002/yea.918; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANFORD JC, 1982, EUPHYTICA, V31, P1, DOI 10.1007/BF00028300; SANFORD JC, 1979, AM POTATO J, V56, P531, DOI 10.1007/BF02855968; Serra A, 2005, INT J FOOD MICROBIOL, V104, P257, DOI 10.1016/j.ijfoodmicro.2005.03.006; Solieri L, 2008, YEAST, V25, P485, DOI 10.1002/yea.1600; Solieri L, 2010, TRENDS MICROBIOL, V18, P521, DOI 10.1016/j.tim.2010.08.001; Spirek M, 2000, CURR GENET, V38, P202, DOI 10.1007/s002940000155; Sulo P, 2003, FEMS YEAST RES, V4, P97, DOI 10.1016/S1567-1356(03)00109-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ter Linde JJM, 2002, YEAST, V19, P825, DOI 10.1002/yea.879; Tieleman BI, 2009, P ROY SOC B-BIOL SCI, V276, P1685, DOI 10.1098/rspb.2008.1946; Tiffin P, 2001, P ROY SOC B-BIOL SCI, V268, P861, DOI 10.1098/rspb.2000.1578; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; VEZINHET F, 1990, APPL MICROBIOL BIOT, V32, P568, DOI 10.1007/BF00173729; Wallin IE, 1923, AM NAT, V57, P255, DOI 10.1086/279919; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; WILLIAM J, 1995, TRENDS ECOL EVOL, V10, P485, DOI 10.1016/S0169-5347(00)89195-8; Yashin AI, 2000, J GERONTOL A-BIOL, V55, pB319, DOI 10.1093/gerona/55.7.B319; Zeyl C, 2005, EVOLUTION, V59, P910; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	92	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75121	10.1371/journal.pone.0075121	http://dx.doi.org/10.1371/journal.pone.0075121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086452	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200083
J	Paez-Colasante, X; Seaberg, B; Martinez, TL; Kong, L; Sumner, CJ; Rimer, M				Paez-Colasante, Ximena; Seaberg, Bonnie; Martinez, Tara L.; Kong, Lingling; Sumner, Charlotte J.; Rimer, Mendell			Improvement of Neuromuscular Synaptic Phenotypes without Enhanced Survival and Motor Function in Severe Spinal Muscular Atrophy Mice Selectively Rescued in Motor Neurons	PLOS ONE			English	Article							MOUSE MODEL; GENE-EXPRESSION; SMN EXPRESSION; PROTEIN; MUSCLE; JUNCTIONS; RESTORATION; SMN-DELTA-7; DEFECTS; ABSENCE	In the inherited childhood neuromuscular disease spinal muscular atrophy (SMA), lower motor neuron death and severe muscle weakness result from the reduction of the ubiquitously expressed protein survival of motor neuron (SMN). Although SMA mice recapitulate many features of the human disease, it has remained unclear if their short lifespan and motor weakness are primarily due to cell-autonomous defects in motor neurons. Using Hb9(Cre) as a driver, we selectively raised SMN expression in motor neurons in conditional SMA Delta 7 mice. Unlike a previous study that used choline acetyltransferase (ChAT(Cre+)) as a driver on the same mice, and another report that used Hb9(Cre) as a driver on a different line of conditional SMA mice, we found no improvement in survival, weight, motor behavior and presynaptic neurofilament accumulation. However, like in ChAT(Cre+) mice, we detected rescue of endplate size and mitigation of neuromuscular junction (NMJ) denervation status. The rescue of endplate size occurred in the absence of an increase in myofiber size, suggesting endplate size is determined by the motor neuron in these animals. Real time-PCR showed that the expression of spinal cord SMN transcript was sharply reduced in Hb9(Cre+) SMA mice relative to ChAT(Cre+) SMA mice. This suggests that our lack of overall phenotypic improvement is most likely due to an unexpectedly poor recombination efficiency driven by Hb9(Cre). Nonetheless, the low levels of SMN were sufficient to rescue two NMJ structural parameters indicating that these motor neuron cell autonomous phenotypes are very sensitive to changes in motoneuronal SMN levels. Our results directly suggest that even those therapeutic interventions with very modest effects in raising SMN in motor neurons may provide mitigation of neuromuscular phenotypes in SMA patients.	[Paez-Colasante, Ximena; Seaberg, Bonnie; Rimer, Mendell] Texas A&M Hlth Sci Ctr, Coll Med, Dept Neurosci & Expt Therapeut, Bryan, TX USA; [Paez-Colasante, Ximena; Rimer, Mendell] Texas A&M Inst Neurosci, Bryan, TX USA; [Martinez, Tara L.; Kong, Lingling; Sumner, Charlotte J.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Sumner, Charlotte J.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Johns Hopkins University; Johns Hopkins University	Rimer, M (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Neurosci & Expt Therapeut, Bryan, TX USA.	mjrimer@medicine.tamhsc.edu		Paez-Colasante, Ximena/0000-0001-8005-3302	National Institutes of Health (NIH) [1R03NS071141]; Texas Brain and Spine Institute, Bryan, Texas; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS062869]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062869, R03NS071141] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Brain and Spine Institute, Bryan, Texas; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health (NIH) Grant 1R03NS071141 to M.R. X.P.-C. was supported in part by a stipend from the Texas Brain and Spine Institute, Bryan, Texas. C.J.S was supported by National Institute of Neurological Disorders and Stroke (NINDS) grant R01NS062869. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P2660; Bowerman M, 2012, NEUROMUSCULAR DISORD, V22, P263, DOI 10.1016/j.nmd.2011.09.007; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; El-Khodor BF, 2008, EXP NEUROL, V212, P29, DOI 10.1016/j.expneurol.2008.02.025; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Hammond SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015887; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lee AJH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046353; Lee YI, 2011, DEV BIOL, V356, P432, DOI 10.1016/j.ydbio.2011.05.667; Li XM, 2008, NAT NEUROSCI, V11, P262, DOI 10.1038/nn2053; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz CM, 2011, J CLIN INVEST, V121, P3029, DOI 10.1172/JCI57291; Martinez TL, 2012, J NEUROSCI, V32, P8703, DOI 10.1523/JNEUROSCI.0204-12.2012; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Oberdoerffer P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng140; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Schreml J, 2013, EUR J HUM GENET, V21, P643, DOI 10.1038/ejhg.2012.222; Torres-Benito L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026164; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017	34	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75866	10.1371/journal.pone.0075866	http://dx.doi.org/10.1371/journal.pone.0075866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086650	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200123
J	Wootton, JT; Forester, JD				Wootton, J. Timothy; Forester, James D.			Complex Population Dynamics in Mussels Arising from Density-Linked Stochasticity	PLOS ONE			English	Article							ECOLOGICAL TIME-SERIES; ENVIRONMENTAL STOCHASTICITY; INTERTIDAL COMMUNITY; SPECIES INTERACTIONS; NATURAL DISTURBANCE; LARGE HERBIVORES; MARKOV-MODELS; SOAY SHEEP; CHAOS; NOISE	Population fluctuations are generally attributed to the deterministic consequences of strong non-linear interactions among organisms, or the effects of random stochastic environmental variation superimposed upon the deterministic skeleton describing population change. Analysis of the population dynamics of the mussel Mytilus californianus taken in 16 plots over 18-years found no evidence that these processes explained observed strong fluctuations. Instead, population fluctuations arose because environmental stochasticity varied with abundance, which we term density-linked stochasticity. This phenomenon arises from biologically relevant mechanisms: recruitment variation and transmission of disturbance among neighboring individuals. Density-linked stochasticity is probably present frequently in populations, as it arises naturally from several general ecological processes, including stage structure variation with density, ontogenetic niche shifts, and local transmission of stochastic perturbations. More thoroughly characterizing and interpreting deviations from the mean behavior of a system will lead to better ecological prediction and improved insight into the important processes affecting populations and ecosystems.	[Wootton, J. Timothy; Forester, James D.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Wootton, JT (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	twootton@uchicago.edu	Forester, James/A-3298-2012; Wootton, J. Timothy/F-3191-2015	Forester, James/0000-0002-5392-9556; Wootton, J. Timothy/0000-0002-7715-0344	Andrew W. Mellon Foundation; U.S.EPA STAR Center for Integrating Statistics and the Environmental Sciences at the University of Chicago; National Science Foundation [OCE 0117801, OCE 0452687, DEB 0919420]; Division Of Environmental Biology [0919420] Funding Source: National Science Foundation	Andrew W. Mellon Foundation; U.S.EPA STAR Center for Integrating Statistics and the Environmental Sciences at the University of Chicago; National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by the Andrew W. Mellon Foundation, the U.S.EPA STAR Center for Integrating Statistics and the Environmental Sciences at the University of Chicago, and National Science Foundation Grants OCE 0117801, OCE 0452687 and DEB 0919420. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JC, 1993, NATURE, V364, P229, DOI 10.1038/364229a0; Amarasekare P, 2004, AM NAT, V164, P310, DOI 10.1086/422858; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; BIGGS BJF, 1995, J PHYCOL, V31, P233, DOI 10.1111/j.0022-3646.1995.00233.x; Bjornstad ON, 2001, NATURE, V409, P1001, DOI 10.1038/35059003; Bloomfield P., 1976, FOURIER ANAL TIME SE; Broitman BR, 2008, ECOL MONOGR, V78, P403, DOI 10.1890/06-1805.1; Burnham K.P., 2007, MODEL SELECTION INFE, V2nd; Burton PJ, 2002, SILVA FENN, V36, P329, DOI 10.14214/sf.566; Calder WA., 1984, SIZE FUNCTION LIFE H; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; CHENG B, 1992, J ROY STAT SOC B MET, V54, P427; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Coulson T, 2008, ECOLOGY, V89, P1661, DOI 10.1890/07-1099.1; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Coulson T, 2004, TRENDS ECOL EVOL, V19, P359, DOI 10.1016/j.tree.2004.05.008; Crowder M.J., 1978, J R STAT SOC C-APPL, V27, P34, DOI DOI 10.2307/2346223; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Denny MW, 2004, ECOL MONOGR, V74, P513, DOI 10.1890/03-4043; DWYER G, 1991, ECOLOGY, V72, P559, DOI 10.2307/2937196; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; Ellner SP, 1998, AM NAT, V151, P425, DOI 10.1086/286130; Fraterrigo JM, 2008, ECOL LETT, V11, P756, DOI 10.1111/j.1461-0248.2008.01191.x; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Greenman JV, 2003, AM NAT, V161, P225, DOI 10.1086/345784; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; HASSELL MP, 1975, J ANIM ECOL, V44, P283, DOI 10.2307/3863; HASTINGS A, 1991, ECOLOGY, V72, P896, DOI 10.2307/1940591; Ives AR, 1998, ECOLOGY, V79, P1039, DOI 10.1890/0012-9658(1998)079[1039:CDISTM]2.0.CO;2; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; Kendall BE, 1998, ECOL APPL, V8, P184, DOI 10.2307/2641320; Kilpatrick AM, 2003, NATURE, V422, P65, DOI 10.1038/nature01471; Krkosek M, 2011, P ROY SOC B-BIOL SCI, V278, P2060, DOI 10.1098/rspb.2010.2335; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Malamud BD, 1998, SCIENCE, V281, P1840, DOI 10.1126/science.281.5384.1840; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, AM NAT, V110, P573, DOI 10.1086/283092; MAY RM, 1973, ECOLOGY, V54, P315, DOI 10.2307/1934339; Menge BA, 2009, ECOL MONOGR, V79, P379, DOI 10.1890/08-2086.1; Minnich RA, 1997, INT J WILDLAND FIRE, V7, P221, DOI 10.1071/WF9970221; MORRIS WF, 1990, ECOLOGY, V71, P1849, DOI 10.2307/1937593; NICHOLSON AJ, 1957, COLD SPRING HARB SYM, V22, P153, DOI 10.1101/SQB.1957.022.01.017; PAINE R T, 1974, Oecologia (Berlin), V15, P93, DOI 10.1007/BF00345739; PAINE RT, 1981, ECOL MONOGR, V51, P145, DOI 10.2307/2937261; PETERSEN JH, 1984, J EXP MAR BIOL ECOL, V82, P147, DOI 10.1016/0022-0981(84)90100-X; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POSSINGHAM HP, 1994, AM NAT, V143, P563, DOI 10.1086/285620; POWER ME, 1987, AM MIDL NAT, V117, P333, DOI 10.2307/2425975; Richards SA, 1999, P ROY SOC B-BIOL SCI, V266, P2383, DOI 10.1098/rspb.1999.0935; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rier ST, 2006, HYDROBIOLOGIA, V561, P131, DOI 10.1007/s10750-005-1610-6; ROBLES C, 1995, ECOLOGY, V76, P565, DOI 10.2307/1941214; Rohani P, 2002, AM NAT, V159, P469, DOI 10.1086/339467; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; ROUGHGARDEN J, 1985, ECOLOGY, V66, P54, DOI 10.2307/1941306; SAUER JR, 1983, J WILDLIFE MANAGE, V47, P31, DOI 10.2307/3808049; SCHAFFER WM, 1985, ECOLOGY, V66, P93, DOI 10.2307/1941309; SPRUGEL DG, 1981, SCIENCE, V211, P390, DOI 10.1126/science.211.4480.390; Stenseth NC, 2004, P ROY SOC B-BIOL SCI, V271, P1985, DOI 10.1098/rspb.2004.2794; STRONG DR, 1986, TRENDS ECOL EVOL, V1, P39, DOI 10.1016/0169-5347(86)90071-6; Suchanek T. H., 1979, THESIS U WASHINGTON; TAYLOR LR, 1980, J ANIM ECOL, V49, P209, DOI 10.2307/4285; TURCHIN P, 1990, NATURE, V344, P660, DOI 10.1038/344660a0; TURCHIN P, 1992, ECOLOGY, V73, P289, DOI 10.2307/1938740; Vogel S., 1988, LIFES DEVICES PHYS W; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WHITE PS, 1979, BOT REV, V45, P229, DOI 10.1007/BF02860857; Wootton JT, 2013, B MAR SCI, V89, P337, DOI 10.5343/bms.2011.1125; Wootton JT, 2010, ECOLOGY, V91, P42, DOI 10.1890/08-1868.1; WOOTTON JT, 1993, ECOLOGY, V74, P195, DOI 10.2307/1939514; Wootton JT, 2004, ECOL LETT, V7, P653, DOI 10.1111/j.1461-0248.2004.00621.x; Wootton JT, 2001, ECOLOGY, V82, P580, DOI 10.2307/2679881; Wootton JT, 2001, NATURE, V413, P841, DOI 10.1038/35101595; Worrall JJ, 2005, J ECOL, V93, P178, DOI 10.1111/j.1365-2745.2004.00937.x; Yoccoz NG, 2006, CLIMATE RES, V32, P139, DOI 10.3354/cr032139	83	5	5	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75700	10.1371/journal.pone.0075700	http://dx.doi.org/10.1371/journal.pone.0075700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086617	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200119
J	Zhang, LL; Guo, S; Schwab, JH; Nielsen, GP; Choy, E; Ye, SN; Zhang, Z; Mankin, H; Hornicek, FJ; Duan, ZF				Zhang, Linlin; Guo, Shang; Schwab, Joseph H.; Nielsen, G. Petur; Choy, Edwin; Ye, Shunan; Zhang, Zhan; Mankin, Henry; Hornicek, Francis J.; Duan, Zhenfeng			Tissue Microarray Immunohistochemical Detection of Brachyury Is Not a Prognostic Indicator in Chordoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR BRACHYURY; CANCER; TARGET; EXPRESSION; GENE	Brachyury is a marker for notochord-derived tissues and neoplasms, such as chordoma. However, the prognostic relevance of brachyury expression in chordoma is still unknown. The improvement of tissue microarray technology has provided the opportunity to perform analyses of tumor tissues on a large scale in a uniform and consistent manner. This study was designed with the use of tissue microarray to determine the expression of brachyury. Brachyury expression in chordoma tissues from 78 chordoma patients was analyzed by immunohistochemical staining of tissue microarray. The clinicopathologic parameters, including gender, age, location of tumor and metastatic status were evaluated. Fifty-nine of 78 (75.64%) tumors showed nuclear staining for brachyury, and among them, 29 tumors (49.15%) showed 1+ (<= 30% positive cells) staining, 15 tumors (25.42%) had 2+ (31% to 60% positive cells) staining, and 15 tumors (25.42%) demonstrated 3+ (61% to 100% positive cells) staining. Brachyury nuclear staining was detected more frequently in sacral chordomas than in chordomas of the mobile spine. However, there was no significant relationship between brachyury expression and other clinical variables. By Kaplan-Meier analysis, brachyury expression failed to produce any significant relationship with the overall survival rate. In conclusion, brachyury expression is not a prognostic indicator in chordoma.	[Zhang, Linlin; Guo, Shang; Schwab, Joseph H.; Choy, Edwin; Ye, Shunan; Zhang, Zhan; Mankin, Henry; Hornicek, Francis J.; Duan, Zhenfeng] Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Sarcoma Biol Lab, Boston, MA 02114 USA; [Zhang, Linlin; Zhang, Zhan] Zhengzhou Univ, Affiliated Hosp 3, Dept Pathol, Zhengzhou 450052, Peoples R China; [Nielsen, G. Petur] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Guo, Shang] Shanghai Jiao Tong Univ, Dept Orthopaed, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China	Harvard University; Massachusetts General Hospital; Zhengzhou University; Harvard University; Massachusetts General Hospital; Shanghai Jiao Tong University	Duan, ZF (corresponding author), Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Sarcoma Biol Lab, Boston, MA 02114 USA.	zduan@partners.org	zhang, linlin/ABE-9743-2021	zhang, linlin/0000-0003-0204-7972	Stephan L. Harris Fund; Jennifer Hunter Yates Foundation	Stephan L. Harris Fund; Jennifer Hunter Yates Foundation	This project was supported by a grant from the Stephan L. Harris Fund and the Jennifer Hunter Yates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Barresi V, 2012, AM J SURG PATHOL, V36, P1052, DOI 10.1097/PAS.0b013e31824f4ce3; Bydon M, 2012, EXPERT OPIN THER TAR; Chugh R, 2007, ONCOLOGIST, V12, P1344, DOI 10.1634/theoncologist.12-11-1344; Franco R, 2011, EXPERT REV ANTICANC, V11, P859, DOI [10.1586/ERA.11.65, 10.1586/era.11.65]; Hamilton DH, 2012, SEMIN ONCOL, V39, P358, DOI 10.1053/j.seminoncol.2012.02.005; HEALEY JH, 1989, ORTHOP CLIN N AM, V20, P417; Huang B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.208; Jambhekar NA, 2010, ARCH PATHOL LAB MED, V134, P1181, DOI 10.1043/2009-0476-OA.1; Kilic N, 2011, EUR J CANCER, V47, P1080, DOI 10.1016/j.ejca.2010.11.015; Le LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018846; Nelson AC, 2012, J PATHOL, V228, P274, DOI 10.1002/path.4082; Palena C, 2007, CLIN CANCER RES, V13, P2471, DOI 10.1158/1078-0432.CCR-06-2353; Pinder SE, 2013, J CLIN PATHOL, V66, P169, DOI 10.1136/jclinpath-2012-201091; Presneau N, 2011, J PATHOL, V223, P327, DOI 10.1002/path.2816; Roselli M, 2012, CLIN CANCER RES, V18, P3868, DOI 10.1158/1078-0432.CCR-11-3211; Satoh N, 2012, EVOL DEV, V14, P56, DOI 10.1111/j.1525-142X.2011.00522.x; Shen J, 2011, J CLIN NEUROSCI, V18, P96, DOI 10.1016/j.jocn.2010.03.066; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Simon R, 2010, METHODS MOL BIOL, V664, P1, DOI 10.1007/978-1-60761-806-5_1; Vujovic S, 2006, J PATHOL, V209, P157, DOI 10.1002/path.1969; Walcott BP, 2012, LANCET ONCOL, V13, pE69, DOI 10.1016/S1470-2045(11)70337-0; Yang C, 2010, SPINE, V35, P1257, DOI 10.1097/BRS.0b013e3181c2a8b0; Yang XHR, 2009, NAT GENET, V41, P1176, DOI 10.1038/ng.454	24	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75851	10.1371/journal.pone.0075851	http://dx.doi.org/10.1371/journal.pone.0075851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086644	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200122
J	Gorbatenko, A; Olesen, CW; Morup, N; Thiel, G; Kallunki, T; Valen, E; Pedersen, SF				Gorbatenko, Andrej; Olesen, Christina W.; Morup, Nina; Thiel, Gerald; Kallunki, Tuula; Valen, Eivind; Pedersen, Stine F.			ErbB2 upregulates the Na+,HCO3 (-)-cotransporter NBCn1/SLC4A7 in human breast cancer cells via Akt, ERK, Src, and Kruppel-like factor 4	FASEB JOURNAL			English	Article						HER2; MCF-7; KLF4	TRANSCRIPTION START-SITE; PH CONTROL; RECEPTOR; SP1; NBCN1; GENE; IDENTIFICATION; ACTIVATION; EXPRESSION; PROMOTER	Misregulation of acid-base transport plays central roles in cancer development. We previously demonstrated the strong up-regulation of the Na+,HCO3- cotransporter NBCn1 (SLC4A7) in MCF-7 breast cancer cells by a truncated, constitutively active ErbB2 (HER2) receptor, NErbB2, and showed that NBCn1 expression and activity are increased in breast cancer tissue from patients. Here, we present the first in-depth characterization of an SLC4A7 promoter and identify its minimal NErbB2-sensitive region. Inhibition or siRNA-mediated knockdown of PI3K, Akt1, ERK1/2, or Src decreased the NBCn1 protein level in NErbB2-expressing MCF-7 cells by approximate to 50, 60, 30 and 35%, respectively. Further, knockdown of the transcription factor Kruppel-like factor 4 (KLF4) reduced NBCn1 protein expression by approximate to 40%, and KLF4 overexpression increased NBCn1 expression by 50-80%. In contrast, knockdown of the closely related transcription factor specificity protein 1 (Sp1) or transfection with dominant-negative Sp1 increased NBCn1 expression by approximate to 35 and approximate to 50%, respectively. NBCn1 expression was also increased by stimulation of full-length ErbB1, -2, and -3 receptors in SKBr3 cells (1.5- and 2-fold by NRG1 or EGF, respectively) or after their exogenous expression in MCF-7 cells. Finally, stimulation with NRG1 or EGF more than doubled acid extrusion capacity in SKBr3 cells. In conclusion, NBCn1 is strongly upregulated by ErbB receptor signaling in a manner involving opposite effects of KLF4 and Sp1, transcription factors with central roles in cancer development. ErbB-induced up-regulation of NBCn1-mediated acid extrusion may play important physiological and pathophysiological roles in the breast epithelium and other tissues with high ErbB receptor levels.Gorbatenko, A., Olesen, C. W., MOrup, N., Thiel, G., Kallunki, T., Valen, E., Pedersen, S. F. ErbB2 upregulates the Na+,HCO3--cotransporter NBCn1/SLC4A7 in human breast cancer cells via Akt, ERK, Src, and Kruppel-like factor 4.	[Gorbatenko, Andrej; Olesen, Christina W.; Morup, Nina; Pedersen, Stine F.] Univ Copenhagen, Dept Biol, Sect Cell & Dev Biol, DK-2100 Copenhagen, Denmark; [Thiel, Gerald] Univ Saarland, Med Ctr, Homburg, Germany; [Kallunki, Tuula] Danish Canc Soc Res Ctr, Unit Cell Death & Metab, Copenhagen, Denmark; [Valen, Eivind] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of Copenhagen; Saarland University; Danish Cancer Society; Harvard University	Pedersen, SF (corresponding author), Univ Copenhagen, Dept Biol, 13 Univ Pk, DK-2100 Copenhagen, Denmark.	sfpedersen@bio.ku.dk	Pedersen, Stine Falsig/M-8347-2014; Pedersen, Stine Falsig/O-1133-2019; Nygaard, Nina Mørup/GSD-9456-2022; Valen, Eivind/A-8617-2011	Pedersen, Stine Falsig/0000-0002-3044-7714; Pedersen, Stine Falsig/0000-0002-3044-7714; Nygaard, Nina Mørup/0000-0002-7332-4116; Valen, Eivind/0000-0003-1840-6108; Kallunki, Tuula/0000-0002-8571-383X; Gorbatenko, Andrej/0000-0002-0077-1679	Danish Cancer Society [R2-A273-09-S2]; Danish Council for Independent Research-Medical Sciences [12-127290]; Lundbeck Foundation [R83-A8139]	Danish Cancer Society(Danish Cancer Society); Danish Council for Independent Research-Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	UDELTA;NErbB2 and vector control MCF-7 cells and full length ErbB1-4 plasmids were kind gifts from Jesper Nylandsted (Danish Cancer Society, Copenhagen, Denmark). DN-STAT3 constructs and corresponding control plasmids were gifts from Heehyoung Lee (Beckman Research Institute, Duarte, CA, USA); PMT3, PMT3-KLF4 and TDA(WT) x2-pGL2-TATA-Luc constructs were kind gifts from Vincent Yang (Department of Medicine, Stony Brook University, Stony Brook, NY, USA); and the enhancerless Renilla luciferase control plasmid pHRG-B was a gift from Andras Kapus (University of Toronto, Toronto, ON, USA). NBCn1 antibodies were a gift from Jeppe Praetorius (Aarhus University, Aarhus, Denmark). Vibe Nylander, Anni Bech Nielsen, and Katrine Franklin Mark are gratefully acknowledged for expert technical assistance. This work was funded by the Danish Cancer Society (R2-A273-09-S2); Danish Council for Independent Research-Medical Sciences (12-127290); and the Lundbeck Foundation (R83-A8139). Part of this work has previously been presented in abstract form (60).	Al-Sarraj A, 2005, J CELL BIOCHEM, V94, P153, DOI 10.1002/jcb.20305; Allen LF, 2003, SEMIN ONCOL, V30, P65, DOI 10.1053/j.seminoncol.2003.08.009; Alroy I, 1999, MOL CELL BIOL, V19, P1961; Bae JS, 2013, J BIOL CHEM, V288, P6295, DOI 10.1074/jbc.M112.392001; Boedtkjer E, 2012, CURR PHARM DESIGN, V18, P1345, DOI 10.2174/138161212799504830; Boedtkjer E, 2013, INT J CANCER, V132, P1288, DOI 10.1002/ijc.27782; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; Brockhoff G, 2001, CYTOMETRY, V44, P338, DOI 10.1002/1097-0320(20010801)44:4<338::AID-CYTO1125>3.0.CO;2-V; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2236; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Egeblad M, 2001, INT J CANCER, V94, P185, DOI 10.1002/ijc.1459; Esparis-Ogando A, 2002, MOL CELL BIOL, V22, P270, DOI 10.1128/MCB.22.1.270-285.2002; Fiske WH, 2009, EXP CELL RES, V315, P583, DOI 10.1016/j.yexcr.2008.10.043; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Gorbatenko A, 2013, FASEB J, V27; Gorbatenko A, 2011, J CELL PHYSIOL, V226, P2857, DOI 10.1002/jcp.22628; Hernandez A, 2012, CURR PHARM DESIGN, V18, P1383, DOI 10.2174/138161212799504821; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Larsen AM, 2012, CHEMMEDCHEM, V7, P1808, DOI 10.1002/cmdc.201200335; Lauritzen G, 2010, EXP CELL RES, V316, P2538, DOI 10.1016/j.yexcr.2010.06.005; Lauritzen G, 2012, CANCER LETT, V317, P172, DOI 10.1016/j.canlet.2011.11.023; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Long JR, 2010, CANCER EPIDEM BIOMAR, V19, P2357, DOI 10.1158/1055-9965.EPI-10-0054; Matsukawa R, 2011, J HYPERTENS, V29, P1735, DOI 10.1097/HJH.0b013e32834937d6; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Moon JS, 2011, J BIOL CHEM, V286, P23808, DOI 10.1074/jbc.M111.236737; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; Niu GL, 2001, CANCER RES, V61, P3276; Odiete O, 2012, CIRC RES, V111, P1376, DOI 10.1161/CIRCRESAHA.112.267286; Parks SK, 2011, J CELL PHYSIOL, V226, P299, DOI 10.1002/jcp.22400; Pedersen K, 2009, MOL CELL BIOL, V29, P3319, DOI 10.1128/MCB.01803-08; Peng SH, 2011, BREAST CANCER RES TR, V127, P309, DOI 10.1007/s10549-011-1459-5; Pinheiro C, 2012, J BIOENERG BIOMEMBR, V44, P127, DOI 10.1007/s10863-012-9428-1; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Poulsen KA, 2007, AM J PHYSIOL-CELL PH, V293, pC1605, DOI 10.1152/ajpcell.00012.2007; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Snead CM, 2011, EUR J ORAL SCI, V119, P136, DOI 10.1111/j.1600-0722.2011.00867.x; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Stutz AM, 2009, EUR J HUM GENET, V17, P1481, DOI 10.1038/ejhg.2009.64; Su HW, 2009, AM J PHYSIOL-CELL PH, V296, pC13, DOI 10.1152/ajpcell.00263.2008; SZOLLOSI J, 1995, CANCER RES, V55, P5400; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Valen E, 2011, TRENDS GENET, V27, P475, DOI 10.1016/j.tig.2011.08.001; VANDERHORNE VS, 2009, MOL CANCER RES, V7, P592; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zeng FH, 2009, EXP CELL RES, V315, P602, DOI 10.1016/j.yexcr.2008.08.005; Zhang DH, 2005, MOL CELL PROTEOMICS, V4, P1686, DOI 10.1074/mcp.M400221-MCP200; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229	60	31	31	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					350	363		10.1096/fj.13-233288	http://dx.doi.org/10.1096/fj.13-233288			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24088818				2022-12-25	WOS:000333526100033
J	Xing, BW; Wang, LM; Guo, DG; Huang, JY; Espenel, C; Kreitzer, G; Zhang, JJ; Guo, L; Huang, XY				Xing, Bowen; Wang, Limin; Guo, Dagang; Huang, Jianyun; Espenel, Cedric; Kreitzer, Geri; Zhang, J. Jillian; Guo, Lin; Huang, Xin-Yun			Atypical Protein Kinase C lambda Is Critical for Growth Factor Receptor-induced Dorsal Ruffle Turnover and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Migration; Cell Signaling; Growth Factors; Protein Kinase C (PKC); Signal Transduction; Growth Factor Receptor	ASYMMETRIC DIVISION; DROSOPHILA RIC-8; MITOTIC SPINDLE; EXCHANGE FACTOR; ACTIN; SYNEMBRYN; COMPLEX; DIFFERENTIATION; REORGANIZATION; LOCALIZATION	Background: Growth factors induce actin cytoskeletal reorganization and cell migration in fibroblast cells. Results: Genetic inactivation of aPKC in mouse embryonic fibroblast cells inhibits PDGF-induced dorsal ruffle turnover and cell migration. Conclusion: Our results demonstrate a critical role for aPKC in PDGF-induced dorsal ruffle turnover and cell migration. Significance: These data will advance our understanding of the regulation of cell morphology induced by growth factors. G(13), a member of the heterotrimeric G proteins, is critical for actin cytoskeletal reorganization and cell migration. Previously we have shown that G(13) is essential for both G protein-coupled receptor and receptor tyrosine kinase-induced actin cytoskeletal reorganization such as dynamic dorsal ruffle turnover and cell migration. Ric-8A, a non-receptor guanine nucleotide exchange factor for some heterotrimeric G proteins, is critical for coupling receptor tyrosine kinases to G(13). Here, we show that PDGF can induce phosphorylation of Ric-8A. Atypical protein kinase C (aPKC) is required for Ric-8A phosphorylation. Furthermore, aPKC is required for PDGF-induced dorsal ruffle turnover and cell migration as demonstrated by both down-regulation of aPKC protein levels in cells by RNA interference and by studies in aPKC knock-out cells. Moreover, phosphorylation of Ric-8A modulates its subcellular localization. Hence, aPKC is critical for PDGF-induced actin cytoskeletal reorganization and cell migration.	[Xing, Bowen; Wang, Limin; Guo, Lin] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Wang, Limin; Guo, Dagang; Huang, Jianyun; Zhang, J. Jillian; Huang, Xin-Yun] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA; [Espenel, Cedric; Kreitzer, Geri] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA	Wuhan University; Cornell University; Cornell University	Huang, XY (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA.	xyhuang@med.cornell.edu	Wang, Limin/AAX-4273-2020	Wang, Limin/0000-0001-5998-2609; espenel, cedric/0000-0002-8246-2879	National Institutes of Health [HL91525, GM087575]; 111 Project of China [B06018]; National Science Foundation of China [31028015, 31221061]; Irma T. Hirschl Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 111 Project of China(Ministry of Education, China - 111 Project); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Irma T. Hirschl Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant HL91525 (to X.-Y. H.) and was supported in part by the 111 Project of China (B06018), the National Science Foundation of China (Grants 31028015 and 31221061) (to L. G.), and National Institutes of Health Grant GM087575 and the Irma T. Hirschl Trust (to G. K.).	Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; Dhanasekaran Danny N, 2006, Sci STKE, V2006, ppe31, DOI 10.1126/stke.3472006pe31; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Guo DG, 2007, CELL, V128, P341, DOI 10.1016/j.cell.2006.11.048; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; MELLSTROM K, 1983, J MUSCLE RES CELL M, V4, P589, DOI 10.1007/BF00712117; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 2000, GENETICS, V156, P1649; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; SCHLIWA M, 1984, J CELL BIOL, V99, P1045, DOI 10.1083/jcb.99.3.1045; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Soloff RS, 2004, J IMMUNOL, V173, P3250, DOI 10.4049/jimmunol.173.5.3250; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2004, METHOD ENZYMOL, V390, P377; Thomas CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023197; Tonissoo T, 2006, BEHAV BRAIN RES, V167, P42, DOI 10.1016/j.bbr.2005.08.025; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Wang CH, 2012, STRUCTURE, V20, P791, DOI 10.1016/j.str.2012.02.022; Wang DW, 2006, J BIOL CHEM, V281, P32660, DOI 10.1074/jbc.M604588200; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Wang LM, 2011, J BIOL CHEM, V286, P31055, DOI 10.1074/jbc.M111.253427; WARN R, 1993, SYM SOC EXP BIOL, V47, P325; Wooten MW, 2000, MOL CELL BIOL, V20, P4494, DOI 10.1128/MCB.20.13.4494-4504.2000; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200	46	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32827	32836		10.1074/jbc.M113.489427	http://dx.doi.org/10.1074/jbc.M113.489427			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24092753	hybrid, Green Published			2022-12-25	WOS:000328841700002
J	Liu, CF; Drocourt, D; Puzo, G; Wang, JY; Riviere, M				Liu, Chia-Fang; Drocourt, Daniel; Puzo, Germain; Wang, Jiu-Yao; Riviere, Michel			Innate Immune Response of Alveolar Macrophage to House Dust Mite Allergen Is Mediated through TLR2/-4 Co-Activation	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; TOLL-LIKE RECEPTORS; IFN-GAMMA RELEASE; T-BET EXPRESSION; DENDRITIC CELLS; AIRWAY INFLAMMATION; CD14 PROMOTER; INDUCTION; ASTHMA; IL-12	House dust mite, Dermatophagoides pteronyssinus (Der p), is one of the major allergens responsible for allergic asthma. However, the putative receptors involved in the signalization of Der p to the innate immune cells are still poorly defined as well as the impact of their activation on the outcome of the allergen-induced cell response. We previously reported that the HDM activation of mouse alveolar macrophages (AM) involves the TLR4/CD14 cell surface receptor complex. Here using a TLR ligand screening essay, we demonstrate that HDM protein extract engages the TLR2, in addition to the TLR4, in engineered TLR-transfected HEK cells but also in the MH-S mouse alveolar macrophage cell line model. Moreover we found that the concomitant recruitment of the MH-S cell's TLR2 and TLR4 receptors by the HDM extract activates the MyD88-dependent signaling pathway and leads to the secretion of the NF-kappa B regulated pro-inflammatory factors NO and TNF-alpha. However unlike with the canonical TLR4 ligand (i.e. the bacterial LPS) mobilization of TLR4 by the HDM extract induces a reduced production of the IL-12 proinflammatory cytokine and fails to trigger the expression of the T-bet transcription factor. Finally we demonstrated that HDM extract down-regulates LPS induced IL-12 and T-bet expression through a TLR2 dependent mechanism. Therefore, we propose that the simultaneous engagement of the TLR2 and TLR4 receptors by the HDM extract results in a cross regulated original activation pattern of the AM which may contribute to the Th2 polarization of the allergen-induced immune response. The deciphering of these cross-regulation networks is of prime importance to open the way for original therapeutic strategies taking advantage of these receptors and their associated signaling pathways to treat allergic asthma.	[Liu, Chia-Fang; Puzo, Germain; Riviere, Michel] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Liu, Chia-Fang; Puzo, Germain; Riviere, Michel] Univ Toulouse 3, Univ Toulouse, Inst Pharmacol & Biol Struct, F-31062 Toulouse, France; [Liu, Chia-Fang; Wang, Jiu-Yao] Natl Cheng Kung Univ, Inst Basic Med, Tainan 70101, Taiwan; [Drocourt, Daniel] CAYLA Invivogen, Toulouse, France; [Wang, Jiu-Yao] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); National Cheng Kung University; National Cheng Kung University	Riviere, M (corresponding author), CNRS, Inst Pharmacol & Biol Struct, Toulouse, France.	Michel.Riviere@ipbs.fr			CNRS (France); NSC (Taiwan); FIT (French Institute in Taiwan: Fourier Grants); NSC (Grants for Graduate Students Study Abroad Program); NCKU of Tainan (Taiwan); IPBS, Toulouse (France)	CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); NSC (Taiwan)(Ministry of Science and Technology, Taiwan); FIT (French Institute in Taiwan: Fourier Grants); NSC (Grants for Graduate Students Study Abroad Program); NCKU of Tainan (Taiwan); IPBS, Toulouse (France)	This work was supported by an International Joint Project for Scientific Cooperation from the CNRS (France) and the NSC (Taiwan). Chia Fang Liu was supported by the FIT (French Institute in Taiwan: Fourier Grants), the NSC (Grants for Graduate Students Study Abroad Program), the NCKU of Tainan (Taiwan) and the IPBS, Toulouse (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht I, 2004, EMBO REP, V5, P172, DOI 10.1038/sj.embor.7400078; Alcaide P, 2007, J EXP MED, V204, P431, DOI 10.1084/jem.20060626; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Aune TM, 2009, IMMUNOLOGY, V126, P299, DOI 10.1111/j.1365-2567.2008.03026.x; Boasen J, 2005, J ALLERGY CLIN IMMUN, V116, P185, DOI 10.1016/j.jaci.2005.03.015; Bottcher I, 2008, IMMUNOLOGY, V123, P139, DOI 10.1111/j.1365-2567.2007.02754.x; Careau E, 2004, AM J RESP CELL MOL, V31, P22, DOI 10.1165/rcmb.2003-0229OC; Chiou YL, 2009, J CELL PHYSIOL, V220, P311, DOI 10.1002/jcp.21764; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Ferreira DS, 2012, CLIN EXP ALLERGY, V42, P1459, DOI 10.1111/j.1365-2222.2012.04047.x; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; Goldman M, 2007, CLIN EXP IMMUNOL, V147, P208, DOI 10.1111/j.1365-2249.2006.03296.x; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Heckman KL, 2008, EUR J IMMUNOL, V38, P2464, DOI 10.1002/eji.200737952; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; Jacquet A, 2011, TRENDS MOL MED, V17, P604, DOI 10.1016/j.molmed.2011.05.014; Kashyap M, 2011, J IMMUNOL, V187, P1207, DOI 10.4049/jimmunol.1100355; Koch A, 2007, RESP MED, V101, P1321, DOI 10.1016/j.rmed.2006.10.010; Kraan TCTMV, 1997, J IMMUNOL, V158, P5560; Kreutz M, 1997, IMMUNOLOGY, V92, P396, DOI 10.1046/j.1365-2567.1997.00365.x; Lauener RP, 2002, LANCET, V360, P465, DOI 10.1016/S0140-6736(02)09641-1; Liu CF, 2005, CLIN EXP ALLERGY, V35, P1615, DOI 10.1111/j.1365-2222.2005.02387.x; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P403, DOI 10.1513/pats.200508-090JS; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Parkinson T, 2008, CURR OPIN MOL THER, V10, P21; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Ryu JH, 2013, J ALLERGY CLIN IMMUN, V131, P549, DOI 10.1016/j.jaci.2012.07.050; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sackesen C, 2005, ALLERGY, V60, P1485, DOI 10.1111/j.1398-9995.2005.00874.x; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Stewart GA, 1996, CLIN EXP ALLERGY, V26, P1020, DOI 10.1111/j.1365-2222.1996.tb00641.x; Tan CY, 2006, J HUM GENET, V51, P59, DOI 10.1007/s10038-005-0323-z; Taylor RC, 2006, J ALLERGY CLIN IMMUN, V117, P1148, DOI 10.1016/j.jaci.2006.02.014; Tesse R, 2011, ALLERGY, V66, P307, DOI 10.1111/j.1398-9995.2010.02489.x; Thomas WR, 2011, J ALLERGY CLIN IMMUN, V127, P855, DOI 10.1016/j.jaci.2010.12.1084; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168; Ye YL, 2011, AM J PHYSIOL-LUNG C, V300, pL216, DOI 10.1152/ajplung.00165.2010; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183	42	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75983	10.1371/journal.pone.0075983	http://dx.doi.org/10.1371/journal.pone.0075983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098413	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100031
J	Alho, I; Costa, L; Bicho, M; Coelho, C				Alho, Irina; Costa, Luis; Bicho, Manuel; Coelho, Constanca			Low Molecular Weight Protein Tyrosine Phosphatase Isoforms Regulate Breast Cancer Cells Migration through a RhoA Dependent Mechanism	PLOS ONE			English	Article							RECEPTOR; GROWTH; EPHA2; ACP1	Low molecular weight protein tyrosine phosphatase (LMW-PTP) has been associated with cell proliferation control through dephosphorylation and inactivation of growth factor receptors such as PDGF-R and EphA2, and with cellular adhesion and migration through p190RhoGap and RhoA. We aim to clarify the role of two main LMW-PTP isoforms in breast cancer tumorigenesis. We used a siRNA-mediated loss-of-function in MDA-MB-435 breast cancer cell line to study the role of the two main LMW-PTP isoforms, fast and slow, in breast cancer tumorigenesis and migration. Our results show that the siRNAs directed against total LMW-PTP and LMW-PTP slow isoform enhanced cell motility in an invasive breast cancer cell line, MDA-MB-435, with no changes in the proliferation and invasive potential of cells. The total LMW-PTP knockdown caused a more pronounced increase of cell migration. Suppression of total LMW-PTP decreased RhoA activation and suppression of the LMW-PTP slow isoform caused a small but significant increase in RhoA activation. We propose that the increase or decrease in RhoA activation induces changes in stress fibers formation and consequently alter the adhesive and migratory potential of cells. These findings suggest that the two main isoforms of LMW-PTP may act differentially, with the fast isoform having a more prominent role in tumor cell migration. In addition, our results highlight functional specificity among LMW-PTP isoforms, suggesting hitherto unknown roles for these proteins in breast cancer biology. Novel therapeutic approaches targeting LMW-PTP, considering the expression of these two isoforms and not LMW-PTP as a whole, should be investigated.	[Alho, Irina; Bicho, Manuel; Coelho, Constanca] Fac Med Lisbon, Ctr Cardiol, Genet Lab, Lisbon, Portugal; [Alho, Irina; Costa, Luis] Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal; [Costa, Luis] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Dept Oncol, Med Oncol Serv, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria	Coelho, C (corresponding author), Fac Med Lisbon, Ctr Cardiol, Genet Lab, Lisbon, Portugal.	constancacoelho@fm.ul.pt	Costa, Luis AM/E-5117-2015	Bicho, Manuel/0000-0002-5773-5687; Coelho, Constanca/0000-0002-5331-2257; Duarte, Irina/0000-0002-3190-7479; Costa, Luis/0000-0002-4782-7318	Fundacao para a Ciencia e Tecnologia, FCT [SFRH/BD/44716/2008]	Fundacao para a Ciencia e Tecnologia, FCT(Portuguese Foundation for Science and Technology)	Irina Alho is supported by Fundacao para a Ciencia e Tecnologia, FCT grant: SFRH/BD/44716/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho I, 2013, ANTICANCER RES, V33, P1983; Balcerczyk A, 2005, BIOCHEM PHARMACOL, V69, P1263, DOI 10.1016/j.bcp.2005.01.010; BOTTINI E, 1995, HUM GENET, V96, P629, DOI 10.1007/BF00210290; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Chiarugi P, 2004, ONCOGENE, V23, P3905, DOI 10.1038/sj.onc.1207508; CHIARUGI P, 1995, FEBS LETT, V372, P49, DOI 10.1016/0014-5793(95)00947-8; DISSING J, 1991, J BIOL CHEM, V266, P20619; Fang BW, 2008, J CELL SCI, V121, P358, DOI 10.1242/jcs.017145; Ferreira PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044312; Malentacchi F, 2005, BIOCHEM BIOPH RES CO, V334, P875, DOI 10.1016/j.bbrc.2005.06.176; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Raugei G, 2002, CELL MOL LIFE SCI, V59, P941, DOI 10.1007/s00018-002-8481-z; Souza ACS, 2009, CELL MOL LIFE SCI, V66, P1140, DOI 10.1007/s00018-008-8501-8; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Taddei ML, 2006, INT J CANCER, V118, P2082, DOI 10.1002/ijc.21602; Taddei ML, 2002, CANCER RES, V62, P6489; Walker-Daniels J, 2003, AM J PATHOL, V162, P1037, DOI 10.1016/S0002-9440(10)63899-0	19	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76307	10.1371/journal.pone.0076307	http://dx.doi.org/10.1371/journal.pone.0076307			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086724	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900095
J	Cui, Q; Zhang, QL; Takahashi, H				Cui, Qian; Zhang, Qinglin; Takahashi, Hidehiko			The Neural Mechanism of Encountering Misjudgment by the Justice System	PLOS ONE			English	Article							FUNCTIONAL MAGNETIC-RESONANCE; ROSTRAL ANTERIOR CINGULATE; DECISION-MAKING; DETECTING DECEPTION; REWARD PREDICTION; FRONTAL-CORTEX; BRAIN ACTIVITY; LIE-DETECTION; ERROR; STRIATUM	Although misjudgment is an issue of primary concern to the justice system and public safety, the response to misjudgment by the human brain remains unclear. We used fMRI to record neural activity in participants that encountered four possible judgments by the justice system with two basic components: whether the judgment was right or wrong [accuracy: right vs. wrong (misjudgment)] and whether the judgment was positive or negative [valence: positive vs. negative]. As hypothesized, the rostral ACC specifically processes the accuracy of judgment, being more active for misjudgment than for right judgment, while the striatum was uniquely responsible for the valence of judgment, being recruited to a larger extent by positive judgment compared to negative judgment. Furthermore, the activity in the rACC for positive misjudgments was positively correlated with that for negative misjudgments, which confirmed the misjudgment-specificity of the rACC. These results demonstrate that the brain can distinguish a misjudgment from a right judgment and regard a misjudgment as an emotionally arousing stimulus, independent of whether it is positive or negative, while positive judgment is considered as hedonic information, regardless of whether it is right or wrong. Our study is the first to reveal the neural mechanism that underlies judgment processing. This mechanism may constitute the basis of future studies to develop a novel marker for the detection of lies.	[Cui, Qian; Zhang, Qinglin] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Cui, Qian; Takahashi, Hidehiko] Kyoto Univ, Dept Psychiat, Grad Sch Med, Kyoto, Japan; [Cui, Qian; Zhang, Qinglin] Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China	Southwest University - China; Kyoto University; Southwest University - China	Zhang, QL (corresponding author), Southwest Univ, Fac Psychol, Chongqing, Peoples R China.	zhangql@swu.edu.cn; hidehiko@kuhp.kyoto-u.ac.jp		Takahashi, Hidehiko/0000-0002-5102-1982	Takeda Science Foundation; Casio Science Foundation; Brain Science Foundation; National Natural Science Foundation of China [30970892, 31170983];  [23120009];  [23680045]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Casio Science Foundation; Brain Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; 	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas: Prediction and Decision Making (23120009); a Grant-in-Aid for Young Scientist A (23680045); a research grant from Takeda Science Foundation, a research grant from Casio Science Foundation; a research grant from Brain Science Foundation; and the National Natural Science Foundation of China (30970892, 31170983). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Conti R. P., 1999, J CREDIBILITY ASSESS, V2, P14; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2005, NEUROIMAGE, V27, P885, DOI 10.1016/j.neuroimage.2005.05.047; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; de Bruijn ERA, 2009, J NEUROSCI, V29, P12183, DOI 10.1523/JNEUROSCI.1751-09.2009; De Cremer D, 2007, ADV PSYCHOL JUSTICE, Vviii; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Elliott R, 2003, J NEUROSCI, V23, P303; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Furman HP, 2003, COLO LAW, V32, P11; GEHRING WJ, 1992, J EXP PSYCHOL HUMAN, V18, P198, DOI 10.1037/0096-1523.18.1.198; Gould Jon B., 2010, J CRIM LAW CRIM, V100, P2010; Gudjonsson G.H., 2012, NEW ENGLAND LAW REV, V46, P689; Gudjonsson Gisli H, 2003, Crim Behav Ment Health, V13, P159, DOI 10.1002/cbm.539; Hakun JG, 2008, NEUROCASE, V14, P59, DOI 10.1080/13554790801992792; Hogan AM, 2006, BRAIN, V129, P2177, DOI 10.1093/brain/awl160; Jocham G, 2009, J NEUROSCI, V29, P7489, DOI 10.1523/JNEUROSCI.0349-09.2009; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Kozel F Andrew, 2009, Open Forensic Sci J, V2, P6; Kozel FA, 2009, J FORENSIC SCI, V54, P220, DOI 10.1111/j.1556-4029.2008.00927.x; Kozel FA, 2005, BIOL PSYCHIAT, V58, P605, DOI 10.1016/j.biopsych.2005.07.040; Kozel FA, 2004, J NEUROPSYCH CLIN N, V16, P295, DOI 10.1176/appi.neuropsych.16.3.295; Kozel FA, 2004, BEHAV NEUROSCI, V118, P852, DOI 10.1037/0735-7044.118.4.852; Langleben DD, 2008, LEGAL CRIMINOL PSYCH, V13, P1, DOI 10.1348/135532507X251641; Langleben DD, 2002, NEUROIMAGE, V15, P727, DOI 10.1006/nimg.2001.1003; Laurens KR, 2003, BRAIN, V126, P610, DOI 10.1093/brain/awg056; Leo R. A., 2009, J PSYCHIAT LAW, V38, P9; Leo RA., 2005, J CONTEMP CRIM JUST, V21, P201, DOI DOI 10.1177/104398620527747S; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Nee DE, 2011, NEUROIMAGE, V54, P528, DOI 10.1016/j.neuroimage.2010.08.027; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Ricciardelli R, 2009, CAN J CRIMINOL CRIM, V51, P411, DOI 10.3138/cjccj.51.3.411; Shane MS, 2008, NEUROIMAGE, V42, P450, DOI 10.1016/j.neuroimage.2007.12.067; Sip KE, 2008, TRENDS COGN SCI, V12, P48, DOI 10.1016/j.tics.2007.11.008; Spence SA, 2004, J ROY SOC MED, V97, P6, DOI 10.1258/jrsm.97.1.6; Spence SA, 2001, NEUROREPORT, V12, P2849, DOI 10.1097/00001756-200109170-00019; Swanner JK, 2010, LAW HUMAN BEHAV, V34, P418, DOI 10.1007/s10979-009-9212-x; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Takahashi H, 2008, CEREB CORTEX, V18, P898, DOI 10.1093/cercor/bhm120; Takahashi H, 2009, SCIENCE, V323, P937, DOI 10.1126/science.1165604; Taylor SF, 2006, J NEUROSCI, V26, P4063, DOI 10.1523/JNEUROSCI.4709-05.2006; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; Wolpe PR, 2005, AM J BIOETHICS, V5, P39, DOI 10.1080/15265160590923367; Yoshida K, 2012, NAT NEUROSCI, V15, P1307, DOI 10.1038/nn.3180; 1991, BMJ, V302, P1194	54	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75434	10.1371/journal.pone.0075434	http://dx.doi.org/10.1371/journal.pone.0075434			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086531	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700087
J	Peng, QX; Cai, HB; Sun, XG; Li, X; Mo, ZX; Shi, J				Peng, Qiuxian; Cai, Hongbing; Sun, Xuegang; Li, Xin; Mo, Zhixian; Shi, Jue			Alocasia cucullata Exhibits Strong Antitumor Effect In Vivo by Activating Antitumor Immunity	PLOS ONE			English	Article							CANCER; CELLS; IMMUNOTHERAPY; GLIOBLASTOMA; INFLAMMATION; MACROPHAGES; MIGRATION; RANTES	Chinese herbal medicines have long been used to treat various illnesses by modulating the human immune response. In this study, we investigate the immuno-modulating effect and antitumor activity of Alocasia Cucullata (AC), a Chinese herb traditionally used to treat infection and cancer. We found that the whole water extract of AC roots could significantly attenuate tumor growth in mouse tumor models. The median survival time of the AC-treated mice was 43 days, 16 days longer than that of the control group. Moreover, the AC-treated mice showed substantially higher induction of key antitumor cytokines, such as IL-2, IFN-gamma, and TNF-alpha, indicating that AC may exert antitumor effect by activating antitumor immunity. To further pinpoint the cellular and molecular mechanism of AC, we studied the dose response of a human monocytic cell line, THP-1, to the whole water extract of AC. Treatment of the AC extract significantly induced THP-1 differentiation into macrophage-like cells and the differentiated THP-1 showed expression of specific macrophage surface markers, such as CD11b and CD14, as well as productions of antitumor cytokines, e.g. IFN-gamma and TNF-alpha. Our data thus point to AC as potentially a new, alternative immuno-modulating herbal remedy for anticancer treatment.	[Peng, Qiuxian; Cai, Hongbing; Sun, Xuegang; Li, Xin; Mo, Zhixian; Shi, Jue] Southern Med Univ, Sch Chinese Med, Guangzhou, Guangdong, Peoples R China; [Peng, Qiuxian; Shi, Jue] Hong Kong Baptist Univ, Ctr Quantitat Syst Biol, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Peng, Qiuxian; Shi, Jue] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China	Southern Medical University - China; Hong Kong Baptist University; Hong Kong Baptist University	Mo, ZX (corresponding author), Southern Med Univ, Sch Chinese Med, Guangzhou, Guangdong, Peoples R China.	cherrymo@fimmu.com; jshi@hkbu.edu.hk	Shi, Jue/J-9714-2014	Shi, Jue/0000-0003-4061-3496; Mo, Zhixian/0000-0002-4100-7298	faculty research fund of HKBU [FRG2/09-10/019]; Special Program for Key Basic Research of the Ministry of Science and Technology China [2006CB708516]; Guangzhou Municipal research grant [201300000152]	faculty research fund of HKBU; Special Program for Key Basic Research of the Ministry of Science and Technology China; Guangzhou Municipal research grant	The work was supported by faculty research fund of HKBU #FRG2/09-10/019) to J. Shi, the Special Program for Key Basic Research of the Ministry of Science and Technology China (No. 2006CB708516) to Z. Mo and the Guangzhou Municipal research grant (#201300000152) to H. Cai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Candolfi M, 2011, NEOPLASIA, V13, P947, DOI 10.1593/neo.11024; Chow KKH, 2013, MOL THER, V21, P629, DOI 10.1038/mt.2012.210; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Diesner SC, 2012, THER DELIV, V3, P377, DOI 10.4155/TDE.11.146; Fiorenza S, 2012, J IMMUNOL, V189, P5622, DOI 10.4049/jimmunol.1200709; Gao YH, 2005, J MED FOOD, V8, P159, DOI 10.1089/jmf.2005.8.159; Ghosh AK, 2012, CANCER LETT, V324, P91, DOI 10.1016/j.canlet.2012.05.002; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guo J, 2002, GENE THER, V9, P793, DOI 10.1038/sj.gt.3301688; Hou XueWen, 1998, Journal of South China Agricultural University, V19, P106; Ina K, 2013, ANTI-CANCER AGENT ME, V13, P681, DOI 10.2174/1871520611313050002; Kaur A, 2005, BIOTECHNOL LETT, V27, P1815, DOI 10.1007/s10529-005-3559-y; [雷霄 Lei Xiao], 2012, [中国医药工业杂志, Chinese Journal of Pharmaceuticals], V43, P340; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; MEGYERI P, 1990, J LEUKOCYTE BIOL, V47, P70, DOI 10.1002/jlb.47.1.70; Overwijk WW, 2011, CURR PROTOC IMMUNOL; Ramakrishnan R, 2011, CANCER IMMUNOL IMMUN, V60, P419, DOI 10.1007/s00262-010-0930-1; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tundup S, 2012, ANN NY ACAD SCI, V1253, pE1, DOI 10.1111/j.1749-6632.2012.06618.x; Wettergren Y, 2012, CANCER-AM CANCER SOC, V118, P2935, DOI 10.1002/cncr.26595; Yang XY, 2010, VACCINE, V28, P737, DOI 10.1016/j.vaccine.2009.10.065; Yoon TJ, 2008, APPL MICROBIOL BIOT, V80, P1087, DOI 10.1007/s00253-008-1607-y; Yoshino Shigefumi, 2008, Gan To Kagaku Ryoho, V35, P2239; Zang YCQ, 2000, BRAIN, V123, P1874, DOI 10.1093/brain/123.9.1874; Zhu KJ, 2000, CHINESE MED J-PEKING, V113, P1124	26	12	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75328	10.1371/journal.pone.0075328	http://dx.doi.org/10.1371/journal.pone.0075328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086508	gold, Green Published, Green Submitted			2022-12-25	WOS:000325218700076
J	Chen, BD; Wang, WD; Shen, T; Qi, RM				Chen, Beidong; Wang, Wendong; Shen, Tao; Qi, Ruomei			Thioredoxin1 Downregulates Oxidized Low-Density Lipoprotein-Induced Adhesion Molecule Expression via Smad3 Protein	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; ENDOTHELIAL-CELLS; APOPTOSIS; INHIBITOR; BINDING; ATHEROSCLEROSIS; RESPONSIVENESS; ATHEROGENESIS; DISRUPTION	Atherosclerosis is a chronic inflammation disease that is initiated by endothelial cell injury. Oxidized low-density lipoprotein (ox-LDL) is directly associated with chronic vascular inflammation. To understand whether thioredoxin1 (Trx1) participates in an antiinflammatory defense mechanism in atherosclerosis, we investigated the effect of Trx1 on the expression of two adhesion molecules, vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1), in human umbilical vein endothelial cells (HUVECs). Thioredoxin1 and dominant-negative mutant thioredoxin1 (TD) were transiently overexpressed using adenovirus vector gene transfer. Our data showed that Trx1 overexpression suppressed ox-LDL-induced adhesion molecule expression in HUVECs. The overexpression of Trx1 promoted ox-LDL-induced Smad3 phosphorylation and nuclear translocation. A co-immunoprecipitation assay indicated that Smad3 continued to interact with Trx1 with or without ox-LDL stimulation. These results suggest that Trx1 inherently suppresses VCAM-1 and ICAM-1 expression in vascular endothelia and may prevent the initiation of atherosclerosis by attenuating adhesion molecule expression. The enhancement of Smad3 phosphorylation and nuclear expression appears to be primarily responsible for the Trx1-induced downregulation of adhesion molecules.	[Qi, Ruomei] Beijing Inst Geriatr, Key Lab Geriatr, Beijing, Peoples R China; Beijing Hosp, Minist Hlth, Beijing, Peoples R China	Beijing Hospital	Qi, RM (corresponding author), Beijing Inst Geriatr, Key Lab Geriatr, Beijing, Peoples R China.	ruomeiqi@163.com	Wang, Wendong/O-7502-2018	Wang, Wendong/0000-0001-9104-1622	National Natural Science Foundation of China [30900627, 81270379, 81200221]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (no. 30900627, 81270379, 81200221). The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Chen BD, 2010, AM J PHYSIOL-CELL PH, V298, pC1170, DOI 10.1152/ajpcell.00223.2009; Chen CL, 2007, J CELL SCI, V120, P3509, DOI 10.1242/jcs.006916; Chen HJ, 2001, CIRC RES, V89, P1155, DOI 10.1161/hh2401.100598; CHUNG BH, 1980, J LIPID RES, V21, P284; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Fan Jianglin, 2003, J Atheroscler Thromb, V10, P63; Feinberg MW, 2005, PANMINERVA MED, V47, P169; Guo LL, 2012, J CELL PHYSIOL, V227, P3185, DOI 10.1002/jcp.24005; Hashimoto S, 1999, BIOCHEM BIOPH RES CO, V258, P443, DOI 10.1006/bbrc.1999.0658; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kaplan ZS, 2011, HEMATOL-AM SOC HEMAT, P51, DOI 10.1182/asheducation-2011.1.51; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lutz M, 2002, CELL SIGNAL, V14, P977, DOI 10.1016/S0898-6568(02)00058-X; Massague J, 2000, GENE DEV, V14, P627; Masutani H, 2005, CELL DEATH DIFFER, V12, P991, DOI 10.1038/sj.cdd.4401625; Miranda-Vizuete A, 2001, J BIOL CHEM, V276, P31567, DOI 10.1074/jbc.M101760200; Miyazono K, 2000, CYTOKINE GROWTH F R, V11, P15, DOI 10.1016/S1359-6101(99)00025-8; Moustakas A, 2001, J CELL SCI, V114, P4359; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Norata GD, 2005, CIRCULATION, V111, P2805, DOI 10.1161/CIRCULATIONAHA.104.472886; OBLONG JE, 1994, J BIOL CHEM, V269, P11714; Powis G, 2000, FREE RADICAL BIO MED, V29, P312, DOI 10.1016/S0891-5849(00)00313-0; Powis G, 2001, ANNU REV BIOPH BIOM, V30, P421, DOI 10.1146/annurev.biophys.30.1.421; ROBERTS AB, 1993, GROWTH FACTORS, V8, P1; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sakamoto Y, 2005, ATHEROSCLEROSIS, V183, P85, DOI 10.1016/j.atherosclerosis.2005.02.032; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Watanabe R, 2010, PHARMACOL THERAPEUT, V127, P261, DOI 10.1016/j.pharmthera.2010.04.004; Watson JA, 1999, BIOCHEM J, V343, P301, DOI 10.1042/0264-6021:3430301; World CJ, 2006, J MOL MED-JMM, V84, P997, DOI 10.1007/s00109-006-0109-6; Yakmovych I, 2001, FASEB J, V15, P553; Yamawaki H, 2003, CIRC RES, V93, P1029, DOI 10.1161/01.RES.0000102869.39150.23; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	45	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76226	10.1371/journal.pone.0076226	http://dx.doi.org/10.1371/journal.pone.0076226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086714	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200133
J	Luo, M; Lu, XP; Zhu, R; Zhang, ZH; Chow, CC; Li, R; Simons, SS				Luo, Min; Lu, Xinping; Zhu, Rong; Zhang, Zhenhuan; Chow, Carson C.; Li, Rong; Simons, S. Stoney, Jr.			A Conserved Protein Motif Is Required for Full Modulatory Activity of Negative Elongation Factor Subunits NELF-A and NELF-B in Modifying Glucocorticoid Receptor-regulated Gene Induction Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Transcription; Glucocorticoid Receptor; Mathematical Modeling; Steroid Hormone; Transcription Factors; EC50; Gene Induction; NELF-A and NELF-B; Cofactor Action; Competitive Decelerator	RNA-POLYMERASE; CHROMATIN ACCESSIBILITY; POL-II; TRANSCRIPTION; PROMOTER; IDENTIFICATION; EXPRESSION; BRCA1; COFACTOR; DOMAIN	NELF-B is a BRCA1-interacting protein and subunit (with NELF-A, -C/D, and -E) of the human negative elongation factor (NELF) complex, which participates in RNA polymerase II pausing shortly after transcription initiation, especially for synchronized gene expression. We now report new activities of NELF-B and other NELF complex subunits, which are to attenuate glucocorticoid receptor (GR)-mediated gene induction, reduce the partial agonist activity of an antagonist, and increase the EC50 of an agonist during nonsynchronized expression of exogenous and endogenous reporters. Stable knockdown of endogenous NELF-B has the opposite effects on an exogenous gene. The GR ligand-binding domain suffices for these biological responses. ChIP assays reveal that NELF-B diminishes GR recruitment to promoter regions of two endogenous genes. Using a new competition assay, NELF-A and NELF-B are each shown to act independently as competitive decelerators at two steps after the site of GR action and before or at the site of reporter gene activity. A common motif in each NELF was identified that is required for full activity of both NELF-A and NELF-B. These studies allow us to position the actions of two new modulators of GR-regulated transactivation, NELF-A and NELF-B, relative to other factors in the overall gene induction sequence.	[Luo, Min; Lu, Xinping; Zhu, Rong; Zhang, Zhenhuan; Simons, S. Stoney, Jr.] NIDDK, Steroid Hormones Sect, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Chow, Carson C.] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA; [Li, Rong] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Simons, SS (corresponding author), NIDDK, LERB, NIH, Bldg 10,8N-307B, Bethesda, MD 20892 USA.	stoneys@helix.nih.gov			National Institutes of Health, the NIDDK; Voelcker Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK057800, ZIADK047041, ZIADK075069] Funding Source: NIH RePORTER	National Institutes of Health, the NIDDK; Voelcker Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institutes of Health, the NIDDK, and a Voelcker Scholar Award (to R. L.).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2007, INT J BIOL SCI, V3, P486; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Awasthi S, 2012, MOL CELL ENDOCRINOL, V355, P121, DOI 10.1016/j.mce.2012.02.001; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Blackford JA, 2012, J BIOL CHEM, V287, P40982, DOI 10.1074/jbc.M112.414805; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Chinenov Y, 2008, P NATL ACAD SCI USA, V105, P20185, DOI 10.1073/pnas.0810863105; Cho SY, 2005, MOL ENDOCRINOL, V19, P290, DOI 10.1210/me.2004-0134; Chow CC, 2011, METHOD ENZYMOL, P465, DOI [10.1016/S0076-6879(11)87016-3, 10.1016/B978-0-12-381270-4.00016-0]; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Dougherty EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030225; Fromm HJ, 1975, INITIAL RATE ENZYME; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; He YZ, 2007, MOL CELL BIOL, V27, P1467, DOI 10.1128/MCB.01360-06; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; Ianculescu I, 2012, J BIOL CHEM, V287, P4000, DOI 10.1074/jbc.M111.300194; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kim Y, 2006, J STEROID BIOCHEM, V100, P3, DOI 10.1016/j.jsbmb.2006.03.003; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Kunz S, 2003, MOL ENDOCRINOL, V17, P2566, DOI 10.1210/me.2003-0164; Lagha M, 2013, CELL, V153, P976, DOI 10.1016/j.cell.2013.04.045; LEACH KL, 1979, J BIOL CHEM, V254, P1884; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lee GS, 2011, BIOCHEMISTRY-US, V50, P356, DOI 10.1021/bi101792d; Luca F., 2013, PLOS ONE, V8; Luo M, 2009, HUM IMMUNOL, V70, P785, DOI 10.1016/j.humimm.2009.07.029; McChesney PA, 2006, CANCER RES, V66, P1346, DOI 10.1158/0008-5472.CAN-05-3593; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ong KM, 2010, P NATL ACAD SCI USA, V107, P7107, DOI 10.1073/pnas.0911095107; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Segel IH., 1993, ENZYME KINETICS BEHA; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Simons SS, 2008, BIOESSAYS, V30, P744, DOI 10.1002/bies.20792; Simons SS, 2010, CURR OPIN PHARMACOL, V10, P613, DOI 10.1016/j.coph.2010.08.001; SIMONS SS, 1980, J ORG CHEM, V45, P3084, DOI 10.1021/jo01303a030; Simons SS, 2003, TRENDS PHARMACOL SCI, V24, P253, DOI 10.1016/S0165-6147(03)00101-9; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Sun J, 2007, J STEROID BIOCHEM, V107, P131, DOI 10.1016/j.jsbmb.2007.05.031; Sun JL, 2011, J BIOL CHEM, V286, P36248, DOI 10.1074/jbc.M111.269167; Sun JL, 2010, J BIOL CHEM, V285, P6443, DOI 10.1074/jbc.M109.084285; Sun YG, 2008, MOL CELL ENDOCRINOL, V295, P59, DOI 10.1016/j.mce.2008.05.008; Tao YG, 2008, BIOCHEMISTRY-US, V47, P7648, DOI 10.1021/bi800472w; Unden AL, 2005, CLIN ENDOCRINOL, V63, P94, DOI 10.1111/j.1365-2265.2005.02306.x; van der Laan S, 2008, ENDOCRINOLOGY, V149, P725, DOI 10.1210/en.2007-1234; Wang Q, 2004, MOL ENDOCRINOL, V18, P1376, DOI 10.1210/me.2003-0421; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; WILLMANN T, 1986, NATURE, V324, P688, DOI 10.1038/324688a0; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamaguchi Y, 2013, BBA-GENE REGUL MECH, V1829, P98, DOI 10.1016/j.bbagrm.2012.11.007; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Zhang ZH, 2013, J BIOL CHEM, V288, P42, DOI 10.1074/jbc.M112.427740; Zhao QH, 2003, INT IMMUNOPHARMACOL, V3, P1803, DOI 10.1016/j.intimp.2003.08.005	63	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34055	34072		10.1074/jbc.M113.512426	http://dx.doi.org/10.1074/jbc.M113.512426			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24097989	Green Published, hybrid			2022-12-25	WOS:000327250200049
J	van Spronsen, M; van Battum, EY; Kuijpers, M; Vangoor, VR; Rietman, ML; Pothof, J; Gumy, LF; van IJcken, WFJ; Akhmanova, A; Pasterkamp, RJ; Hoogenraad, CC				van Spronsen, Myrrhe; van Battum, Eljo Y.; Kuijpers, Marijn; Vangoor, Vamshidhar R.; Rietman, M. Liset; Pothof, Joris; Gumy, Laura F.; van IJcken, Wilfred F. J.; Akhmanova, Anna; Pasterkamp, R. Jeroen; Hoogenraad, Casper C.			Developmental and Activity-Dependent miRNA Expression Profiling in Primary Hippocampal Neuron Cultures	PLOS ONE			English	Article							REGULATES NEURITE OUTGROWTH; DENDRITIC SPINE MORPHOLOGY; MICRORNA EXPRESSION; AMPA RECEPTORS; MICROARRAY ANALYSIS; CONDITIONAL LOSS; BRAIN; MOUSE; DEGRADATION; GENE	MicroRNAs (miRNAs) are evolutionarily conserved non-coding RNAs of similar to 22 nucleotides that regulate gene expression at the level of translation and play vital roles in hippocampal neuron development, function and plasticity. Here, we performed a systematic and in-depth analysis of miRNA expression profiles in cultured hippocampal neurons during development and after induction of neuronal activity. MiRNA profiling of primary hippocampal cultures was carried out using locked nucleic-acid-based miRNA arrays. The expression of 264 different miRNAs was tested in young neurons, at various developmental stages (stage 2-4) and in mature fully differentiated neurons (stage 5) following the induction of neuronal activity using chemical stimulation protocols. We identified 210 miRNAs in mature hippocampal neurons; the expression of most neuronal miRNAs is low at early stages of development and steadily increases during neuronal differentiation. We found a specific subset of 14 miRNAs with reduced expression at stage 3 and showed that sustained expression of these miRNAs stimulates axonal outgrowth. Expression profiling following induction of neuronal activity demonstrates that 51 miRNAs, including miR-134, miR-146, miR-181, miR-185, miR-191 and miR-200a show altered patterns of expression after NMDA receptor-dependent plasticity, and 31 miRNAs, including miR-107, miR-134, miR-470 and miR-546 were upregulated by homeostatic plasticity protocols. Our results indicate that specific miRNA expression profiles correlate with changes in neuronal development and neuronal activity. Identification and characterization of miRNA targets may further elucidate translational control mechanisms involved in hippocampal development, differentiation and activity-depended processes.	[van Spronsen, Myrrhe; Kuijpers, Marijn; Gumy, Laura F.; Akhmanova, Anna; Hoogenraad, Casper C.] Univ Utrecht, Fac Sci, Utrecht, Netherlands; [van Spronsen, Myrrhe; Kuijpers, Marijn; Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [van Battum, Eljo Y.; Vangoor, Vamshidhar R.; Rietman, M. Liset; Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [Pothof, Joris; Akhmanova, Anna] Erasmus MC, Dept Cell Biol & Genet, Rotterdam, Netherlands; [van IJcken, Wilfred F. J.] Erasmus MC, Ctr Biom, Rotterdam, Netherlands	Utrecht University; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Hoogenraad, CC (corresponding author), Univ Utrecht, Fac Sci, Utrecht, Netherlands.	c.hoogenraad@uu.nl	van ijcken, willem/N-9805-2018; Vangoor, Vamshidhar/AAR-3865-2021; kuijpers, marijn/F-2248-2013; Hoogenraad, Casper/B-8866-2011	van ijcken, willem/0000-0002-0421-8301; kuijpers, marijn/0000-0003-1187-0290; Hoogenraad, Casper/0000-0002-2666-0758; Vangoor, Vamshi/0000-0003-0751-9772; Pasterkamp, Jeroen/0000-0003-1631-6440	Netherlands Organization for Scientific Research (NWOALW-VICI); Netherlands Organization for Health Research and Development (ZonMW-TOP); European Science Foundation (EURYI); EMBO Young Investigators Program (YIP); Human Frontier Science Program (HFSP-CDA); CTMM, the Center for Translational Molecular Medicine [EMINENCE(01C-204)]	Netherlands Organization for Scientific Research (NWOALW-VICI); Netherlands Organization for Health Research and Development (ZonMW-TOP)(Netherlands Organization for Health Research and Development); European Science Foundation (EURYI)(European Science Foundation (ESF)); EMBO Young Investigators Program (YIP)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP-CDA)(Human Frontier Science Program); CTMM, the Center for Translational Molecular Medicine	This work was supported by the Netherlands Organization for Scientific Research (NWOALW-VICI, A.A., C.C.H.), the Netherlands Organization for Health Research and Development (ZonMW-TOP, R.J.P., C.C.H.), the European Science Foundation (EURYI, C.C.H.), EMBO Young Investigators Program (YIP, C.C.H.) and the Human Frontier Science Program (HFSP-CDA, R.J.P., C.C.H.). This research was partly performed within the framework of CTMM, the Center for Translational Molecular Medicine, project EMINENCE(01C-204) (R.J.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10; Agostini M, 2011, P NATL ACAD SCI USA, V108, P21099, DOI 10.1073/pnas.1112063108; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Dabrowski M, 2003, J NEUROCHEM, V85, P1279, DOI 10.1046/j.1471-4159.2003.01753.x; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Eacker SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025068; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; FLETCHER TL, 1989, DEV BIOL, V136, P446, DOI 10.1016/0012-1606(89)90269-8; Forero DA, 2010, HUM MUTAT, V31, P1195, DOI 10.1002/humu.21344; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Holleman A, 2011, ONCOGENE, V30, P4386, DOI 10.1038/onc.2011.148; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Jones EV, 2012, METHODS MOL BIOL, V814, P341, DOI 10.1007/978-1-61779-452-0_22; Juhila J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021495; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kan AA, 2012, CELL MOL LIFE SCI, V69, P3127, DOI 10.1007/s00018-012-0992-7; Kapitein LC, 2010, METHOD CELL BIOL, V97, P111, DOI 10.1016/S0091-679X(10)97007-6; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kye MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024682; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Li QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026000; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Ling KH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-176; Lippi G, 2011, J CELL BIOL, V194, P889, DOI 10.1083/jcb.201103006; Liu NK, 2011, PHYSIOL GENOMICS, V43, P571, DOI 10.1152/physiolgenomics.00168.2010; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; McKiernan RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035921; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Natera-Naranjo O, 2010, RNA, V16, P1516, DOI 10.1261/rna.1833310; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Park CS, 2009, J MOL NEUROSCI, V38, P50, DOI 10.1007/s12031-008-9158-3; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Pitto L, 2009, PHYSIOL GENOMICS, V39, P210, DOI 10.1152/physiolgenomics.00085.2009; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Provost P, 2010, BRAIN RES, V1338, P58, DOI 10.1016/j.brainres.2010.03.069; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Shinohara Y, 2011, BIOCHEM BIOPH RES CO, V409, P293, DOI 10.1016/j.bbrc.2011.05.004; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Swanger SA, 2011, CURR OPIN GENET DEV, V21, P414, DOI 10.1016/j.gde.2011.04.002; Vo NK, 2010, CURR OPIN NEUROBIOL, V20, P457, DOI 10.1016/j.conb.2010.04.002; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wen Z, 2011, CURR OPIN NEUROBIOL, V4, P40; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Yuan Y, 2010, J CLIN NEUROSCI, V17, P774, DOI 10.1016/j.jocn.2009.10.009; Zhang Y, 2013, J NEUROSCI, V33, P6885, DOI 10.1523/JNEUROSCI.5180-12.2013; Zhou SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044768	100	59	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74907	10.1371/journal.pone.0074907	http://dx.doi.org/10.1371/journal.pone.0074907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098357	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600012
J	Mhurchu, CN; Eyles, H; Schilling, C; Yang, Q; Kaye-Blake, W; Genc, M; Blakely, T				Mhurchu, Cliona Ni; Eyles, Helen; Schilling, Chris; Yang, Qing; Kaye-Blake, William; Genc, Murat; Blakely, Tony			Food Prices and Consumer Demand: Differences across Income Levels and Ethnic Groups	PLOS ONE			English	Article							SYSTEMS; INTERVENTIONS; SMOKING; OBESITY; BURDEN; POLICY; TAXES	Background: Targeted food pricing policies may improve population diets. To assess their effects on inequalities, it is important to determine responsiveness to price changes across income levels and ethnic groups. Objective: Our goal was to estimate price elasticity (PE) values for major commonly consumed food groups in New Zealand, by income and ethnicity. PE values represent percentage change in demand associated with 1% change in price of that good (own-PE) or another good (cross-PE). Design: We used food expenditure data from national household economic surveys in 2007/08 and 2009/10 and Food Price Index data from 2007 and 2010. Adopting an Almost Ideal Demand System approach, own-PE and cross-PE estimates were derived for 24 food categories, household income quintiles, and two ethnic groups (Maori and non-Maori). Results: Own-PE estimates (with two exceptions) ranged from -0.44 to -1.78. Cross-PE estimates were generally small; only 31% of absolute values were greater than 0.10. Excluding the outlier 'energy drinks', nine of 23 food groups had significantly stronger own-PEs for the lowest versus highest income quintiles (average regression-based difference across food groups -0.30 (95% CI -0.62 to 0.02)). Six own-PEs were significantly stronger among Maori; the average difference for Maori: non-Maori across food groups was -0.26 (95% CI -0.52 to 0.00). Conclusions: Food pricing policies have potential to improve population diets. The greater sensitivity of low-income households and Maori to price changes suggests the beneficial effects of such policies on health would be greatest for these groups.	[Mhurchu, Cliona Ni; Eyles, Helen] Univ Auckland, Natl Inst Hlth Innovat, Auckland 1, New Zealand; [Schilling, Chris; Yang, Qing; Kaye-Blake, William] New Zealand Inst Econ Res Inc, Wellington, New Zealand; [Genc, Murat] Univ Otago, Dept Econ, Dunedin, New Zealand; [Blakely, Tony] Univ Otago, Dept Publ Hlth, Wellington, New Zealand	University of Auckland; New Zealand Institute for Plant & Food Research Ltd; University of Otago; University of Otago	Mhurchu, CN (corresponding author), Univ Auckland, Natl Inst Hlth Innovat, Auckland 1, New Zealand.	c.nimhurchu@nihi.auckland.ac.nz	Genc, Murat/AAE-1568-2019	Kaye-Blake, William/0000-0002-9029-2531; Genc, Murat/0000-0002-5443-2146; Blakely, Tony/0000-0002-6995-4369; Ni Mhurchu, Cliona/0000-0002-1144-9167	Health Research Council of New Zealand [10/077]; National Heart Foundation [1380]; Heart Foundation of New Zealand [1463]	Health Research Council of New Zealand(Health Research Council of New Zealand); National Heart Foundation(National Heart Foundation of Australia); Heart Foundation of New Zealand	This research was funded by the Health Research Council of New Zealand (10/077). CNM was supported by the National Heart Foundation Senior Fellowship (Grant 1380). HE was supported by a Heart Foundation of New Zealand research fellowship (Grant 1463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Blakely T, 2005, SOC SCI MED, V61, P2233, DOI 10.1016/j.socscimed.2005.02.011; Blakely T, 2005, DECADES DISPARITY; Chern W.S., 2002, 0206 ESA UN FAO AGR; Crawford I, 2003, J ECONOMETRICS, V114, P221, DOI 10.1016/S0304-4076(03)00083-6; Davis C, 2010, ANAL US HOUSEHOLD DA; DEATON A, 1980, AM ECON REV, V70, P312; Engelhard C.L., 2009, REDUCING OBESITY POL; Epstein LH, 2012, AM J CLIN NUTR, V95, P789, DOI 10.3945/ajcn.111.024380; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fantuzzi K, 2008, CARBONATED SOFT DRIN; Green R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3703; HEIEN D, 1990, J BUS ECON STAT, V8, P365, DOI 10.2307/1391973; Holt M.T., 2009, QUANTIFYING CONSUMER; *I MED, 2009, LOC GOV ACT PREV CHI; Jha P, 2006, DRUG ALCOHOL REV, V25, P597, DOI 10.1080/09595230600944511; Lawes C, 2006, NEW ZEAL MED J, V119, P16; Ministry of Agriculture Fisheries and Food, 2000, NAT FOOD SURV 2000 A; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; Park JL, 1996, AM J AGR ECON, V78, P290, DOI 10.2307/1243703; Perloff J. M., 2007, MICROECONOMICS, V4th; Powell LM, 2009, MILBANK Q, V87, P229, DOI 10.1111/j.1468-0009.2009.00554.x; Seale Jr J., 2003, TECHNICAL B USDA; STIGLER GJ, 1985, J LAW ECON, V28, P555, DOI 10.1086/467101; Thomas S, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.023911; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; Ulubasoglu M, 2010, FOOD DEMAND ELASTICI; World Health Organization, 2008, 2008 2013 ACT PLAN G; Zheng ZhiHao, 2010, Journal of Agricultural and Applied Economics, V42, P337	30	53	54	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75934	10.1371/journal.pone.0075934	http://dx.doi.org/10.1371/journal.pone.0075934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098408	Green Submitted, Green Published, gold			2022-12-25	WOS:000325434500039
J	Silva-Boghossian, CM; Colombo, APV; Tanaka, M; Rayo, C; Xiao, YZ; Siqueira, WL				Silva-Boghossian, Carina M.; Colombo, Ana Paula V.; Tanaka, Marcia; Rayo, Carolina; Xiao, Yizhi; Siqueira, Walter L.			Quantitative Proteomic Analysis of Gingival Crevicular Fluid in Different Periodontal Conditions	PLOS ONE			English	Article							MASS-SPECTROMETRY; ANTIMICROBIAL PEPTIDES; PROTEINS; DISEASES; SEPARATION; DISCOVERY; BACTERIA; HEALTHY; RISK	Aim: To quantify the proteome composition of the GCF in periodontal health (HH) and in sites with different clinical conditions in chronic periodontitis (CP) subjects. Material and Methods: 5 subjects with HH and 5 with CP were submitted to full-mouth periodontal examination, and GCF sampling. Sites in the CP group were classified and sampled as periodontitis (P, probing depth, PD>4 mm), gingivitis (G, PD <= 3mm with bleeding on probing, BOP), and healthy sites (H, PD <= 3mm without BOP). GCF proteins were subjected to liquid chromatography electrospray ionization mass spectrometry for identification, characterization and quantification. Results: 230 proteins were identified; 145 proteins were detected in HH, 214 in P, 154 in G, and 133 in H. Four proteins were exclusively detected at HH, 43 proteins at P, 7 proteins at G, and 1 protein at H. Compared to HH group, 35 and 6 proteins were more abundant in P and G (p<0.001), respectively; and 4, 15 and 37 proteins were less abundant in P, G and H (p <= 0.01), respectively. Conclusions: There are marked differences in the GCF proteome according to disease profile. Comprehension of the role of the identified proteins in the etiopathogenesis of periodontal disease may lead to biomarkers definition.	[Silva-Boghossian, Carina M.; Tanaka, Marcia; Rayo, Carolina; Xiao, Yizhi; Siqueira, Walter L.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada; [Silva-Boghossian, Carina M.] Univ Fed Rio de Janeiro, Div Grad Periodont, Dept Dent Clin, Rio De Janeiro, Brazil; [Silva-Boghossian, Carina M.; Colombo, Ana Paula V.] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil	Western University (University of Western Ontario); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Siqueira, WL (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada.	walter.siqueira@uwo.ca	Tanaka, Marcia Hiromi/J-7804-2012; Siqueira, Walter/ABE-4069-2021; Silva-Boghossian, Carina Maciel/G-9440-2012; Siqueira, Walter/ABE-8924-2020; Colombo, Ana Paula Vieira/B-9188-2019	Tanaka, Marcia Hiromi/0000-0002-6594-2301; Silva-Boghossian, Carina Maciel/0000-0002-4500-4350; Siqueira, Walter/0000-0003-1921-3658; Colombo, Ana Paula Vieira/0000-0002-2061-1840	Natural Sciences and Engineering Research Council of Canada (NSERC) [371813]; Canadian Institutes of Health Research (CIHR) [106657, 97577]; Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF grant) [25116]; National Council for Scientific and Technological Development (CNPq); Coordination of Improvement of Higher Education Personnel (CAPES); CIHR New Investigator Award [113166]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF grant)(Canada Foundation for Innovation); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC grant #371813), the Canadian Institutes of Health Research (CIHR grant # 106657 and grant # 97577), the Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF grant # 25116), National Council for Scientific and Technological Development (CNPq), and Coordination of Improvement of Higher Education Personnel (CAPES). W. L. S. is recipient of a CIHR New Investigator Award (grant # 113166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; Baliban RC, 2012, J CLIN PERIODONTOL, V39, P203, DOI 10.1111/j.1600-051X.2011.01805.x; Bostanci N, 2010, J PROTEOME RES, V9, P2191, DOI 10.1021/pr900941z; Bostanci N, 2013, J PROTEOME RES, V12, P657, DOI 10.1021/pr300761e; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Carneiro LG, 2012, J PERIODONTAL RES, V47, P248, DOI 10.1111/j.1600-0765.2011.01429.x; Champagne CME, 2003, PERIODONTOL 2000, V31, P167, DOI 10.1034/j.1600-0757.2003.03110.x; da Silva-Boghossian CM, 2011, ARCH ORAL BIOL, V56, P899, DOI 10.1016/j.archoralbio.2011.02.009; Doerr A, 2013, NAT METHODS, V10, P23, DOI 10.1038/nmeth.2286; Duan XT, 2009, J PROTEOME RES, V8, P2838, DOI 10.1021/pr900001t; Genco RJ, 2013, PERIODONTOL 2000, V62, P59, DOI 10.1111/j.1600-0757.2012.00457.x; Gillette MA, 2013, NAT METHODS, V10, P28, DOI 10.1038/nmeth.2309; Goodson JM, 2003, PERIODONTOL 2000, V31, P43, DOI 10.1034/j.1600-0757.2003.03104.x; Grant MM, 2012, J PERIODONTAL RES, V47, P2, DOI 10.1111/j.1600-0765.2011.01387.x; Grant MM, 2010, J PROTEOME RES, V9, P4732, DOI 10.1021/pr100446f; Kido J, 2012, J PERIODONTAL RES, V47, P488, DOI 10.1111/j.1600-0765.2011.01458.x; Lee Motoyama, 2007, BIOCHEM BIOPH RES CO, V357, P828, DOI [10.1016/j.bbrc.2007.03.112, DOI 10.1016/J.BBRC.2007.03.112.PUBMED:17448443]; Ngo LH, 2010, J PROTEOME RES, V9, P1683, DOI 10.1021/pr900775s; Nibali L, 2008, J PERIODONTAL RES, V43, P627, DOI 10.1111/j.1600-0765.2007.01039.x; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Puklo M, 2008, ORAL MICROBIOL IMMUN, V23, P328, DOI 10.1111/j.1399-302X.2008.00433.x; Siqueira WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042204; SOCRANSKY SS, 1994, BIOTECHNIQUES, V17, P788; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Tonetti M S, 1999, Ann Periodontol, V4, P39, DOI 10.1902/annals.1999.4.1.39; Tsuchida S, 2013, PROTEOMICS, V13, P2339, DOI 10.1002/pmic.201200510; Tsuchida S, 2012, PROTEOMICS, V12, P2190, DOI 10.1002/pmic.201100655; Vitkov L, 2009, J PERIODONTAL RES, V44, P664, DOI 10.1111/j.1600-0765.2008.01175.x; Weinberg A, 1998, CRIT REV ORAL BIOL M, V9, P399, DOI 10.1177/10454411980090040201	30	48	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75898	10.1371/journal.pone.0075898	http://dx.doi.org/10.1371/journal.pone.0075898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098404	Green Submitted, Green Published, gold			2022-12-25	WOS:000325427100025
J	Matsumoto, Y; Niimi, N; Kohyama, K				Matsumoto, Yoh; Niimi, Naoko; Kohyama, Kuniko			Development of a New DNA Vaccine for Alzheimer Disease Targeting a Wide Range of A beta Species and Amyloidogenic Peptides	PLOS ONE			English	Article							IMMUNIZATION; MODEL	It has recently been determined that not only A beta oligomers, but also other A beta species and amyloidogenic peptides are neurotoxic in Alzheimer disease (AD) and play a pivotal role in AD pathogenesis. In the present study, we attempted to develop new DNA vaccines targeting a wide range of A beta species. For this purpose, we first performed in vitro assays with newly developed vaccines to evaluate A beta production and A beta secretion abilities and then chose an IgL-A beta x4-Fc-IL-4 vaccine (designated YM3711) for further studies. YM3711 was vaccinated to mice, rabbits and monkeys to evaluate anti-A beta species antibody-producing ability and A beta reduction effects. It was found that YM3711 vaccination induced significantly higher levels of antibodies not only to A beta 1-42 but also to AD-related molecules including A beta pE3-42, A beta oligomers and A beta fibrils. Importantly, YM3711 significantly reduced these A beta species in the brain of model mice. Binding and competition assays using translated YM3711 protein products clearly demonstrated that a large part of antibodies induced by YM3711 vaccination are directed at conformational epitopes of the A beta complex and oligomers. Taken together, we demonstrate that YM3711 is a powerful DNA vaccine targeting a wide range of AD-related molecules and is worth examining in preclinical and clinical trials.	[Matsumoto, Yoh; Niimi, Naoko; Kohyama, Kuniko] Tokyo Metropolitan Inst Neurosci, Dept Mol Neuropathol, Tokyo, Japan; [Matsumoto, Yoh; Niimi, Naoko; Kohyama, Kuniko] Tokyo Metropolitan Inst Neurosci, Dept Immunotherapy Dev, Tokyo, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Matsumoto, Y (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Mol Neuropathol, Tokyo, Japan.	matsumoto-yo@igakuken.or.jp		Niimi, Naoko/0000-0001-9222-1596	Health and Labor Sciences Research Grants for Research on Psychiatric and Neurological Diseases and Mental Health; Japan Society for the Promotion of Science; "Welfare and Health Fund" of the Tokyo Metropolitan Government	Health and Labor Sciences Research Grants for Research on Psychiatric and Neurological Diseases and Mental Health; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); "Welfare and Health Fund" of the Tokyo Metropolitan Government	This study was supported in part by Health and Labor Sciences Research Grants for Research on Psychiatric and Neurological Diseases and Mental Health and by Grants-in-Aid from the Japan Society for the Promotion of Science. Y. M. was also supported by the "Welfare and Health Fund" of the Tokyo Metropolitan Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christensen DZ, 2010, ACTA NEUROPATHOL, V119, P555, DOI 10.1007/s00401-010-0666-1; Citron M, 2002, NAT NEUROSCI, V5, P1055, DOI 10.1038/nn940; Fonte J, 2001, J ALZHEIMERS DIS, V3, P209; Ghiso J, 2006, BRAIN PATHOL, V16, P71; Goni F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013391; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jang H, 2010, J PHYS CHEM B, V114, P9445, DOI 10.1021/jp104073k; Janus C, 2000, NEUROBIOL AGING, V21, P541, DOI 10.1016/S0197-4580(00)00107-X; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Okura Y, 2006, P NATL ACAD SCI USA, V103, P9619, DOI 10.1073/pnas.0600966103; Okura Y, 2009, HUM VACCINES, V5, P373, DOI 10.4161/hv.5.6.7815; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rocha S, 2009, BIOCHEM BIOPH RES CO, V380, P397, DOI 10.1016/j.bbrc.2009.01.090; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; St George-Hyslop PH, 2008, LANCET, V372, P180, DOI 10.1016/S0140-6736(08)61047-8; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Wisniewski T, 2010, EXPERT REV VACCINES, V9, P1441, DOI [10.1586/erv.10.131, 10.1586/ERV.10.131]; Wisniewski T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S5	32	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75203	10.1371/journal.pone.0075203	http://dx.doi.org/10.1371/journal.pone.0075203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086465	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900036
J	Tripurani, SK; Wee, G; Lee, KB; Smith, GW; Wang, L; Yao, JB				Tripurani, Swamy K.; Wee, Gabbine; Lee, Kyung-Bon; Smith, George W.; Wang, Lei; Yao, Jianbo			MicroRNA-212 Post-Transcriptionally Regulates Oocyte-Specific Basic-Helix-Loop-Helix Transcription Factor, Factor in the Germline Alpha (FIGLA), during Bovine Early Embryogenesis	PLOS ONE			English	Article							EARLY EMBRYONIC-DEVELOPMENT; MESSENGER-RNA; GENE-EXPRESSION; MATURATION; PROFILES; BIOGENESIS; TRANSITION; MIR-212; MIR-132; ACTIN	Factor in the germline alpha (FIGLA) is an oocyte-specific basic helix-loop-helix transcription factor essential for primordial follicle formation and expression of many genes required for folliculogenesis, fertilization and early embryonic survival. Here we report the characterization of bovine FIGLA gene and its regulation during early embryogenesis. Bovine FIGLA mRNA expression is restricted to gonads and is detected in fetal ovaries harvested as early as 90 days of gestation. FIGLA mRNA and protein are abundant in germinal vesicle and metaphase II stage oocytes, as well as in embryos from pronuclear to eight-cell stage but barely detectable at morula and blastocyst stages, suggesting that FIGLA might be a maternal effect gene. Recent studies in zebrafish and mice have highlighted the importance of non-coding small RNAs (microRNAs) as key regulatory molecules targeting maternal mRNAs for degradation during embryonic development. We hypothesized that FIGLA, as a maternal transcript, is regulated by microRNAs during early embryogenesis. Computational predictions identified a potential microRNA recognition element (MRE) for miR-212 in the 3' UTR of the bovine FIGLA mRNA. Bovine miR-212 is expressed in oocytes and tends to increase in four-cell and eight-cell stage embryos followed by a decline at morula and blastocyst stages. Transient transfection and reporter assays revealed that miR-212 represses the expression of FIGLA in a MRE dependent manner. In addition, ectopic expression of miR-212 mimic in bovine early embryos dramatically reduced the expression of FIGLA protein. Collectively, our results demonstrate that FIGLA is temporally regulated during bovine early embryogenesis and miR-212 is an important negative regulator of FIGLA during the maternal to zygotic transition in bovine embryos.	[Tripurani, Swamy K.; Wang, Lei; Yao, Jianbo] W Virginia Univ, Lab Anim Biotechnol & Genom, Div Anim & Nutr Sci, Morgantown, WV 26506 USA; [Wee, Gabbine; Lee, Kyung-Bon; Smith, George W.] Michigan State Univ, Lab Mammalian Reprod Biol & Genom, E Lansing, MI 48824 USA; [Wee, Gabbine; Lee, Kyung-Bon; Smith, George W.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Smith, George W.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	West Virginia University; Michigan State University; Michigan State University; Michigan State University	Yao, JB (corresponding author), W Virginia Univ, Lab Anim Biotechnol & Genom, Div Anim & Nutr Sci, Morgantown, WV 26506 USA.	jianbo.yao@mail.wvu.edu			National Research Initiative Competitive Grant, USDA National Institute of Food and Agriculture [2008-35203-19094]; Agriculture and Food Research Initiative, Competitive Grant, USDA National Institute of Food and Agriculture [2009-65203-05706]; West Virginia Agricultural and Forestry Experiment Station (Hatch project) [427]	National Research Initiative Competitive Grant, USDA National Institute of Food and Agriculture; Agriculture and Food Research Initiative, Competitive Grant, USDA National Institute of Food and Agriculture; West Virginia Agricultural and Forestry Experiment Station (Hatch project)	This work was supported by National Research Initiative Competitive Grant #2008-35203-19094 from the USDA National Institute of Food and Agriculture (GWS), Agriculture and Food Research Initiative, Competitive Grant #2009-65203-05706 from the USDA National Institute of Food and Agriculture (JY) and funds from the West Virginia Agricultural and Forestry Experiment Station (Hatch project No. 427). It is published with the approval of the director of the West Virginia Agricultural and Forestry Experiment Station as scientific paper No. 3188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Andreu-Vieyra C, 2006, TRENDS ENDOCRIN MET, V17, P136, DOI 10.1016/j.tem.2006.03.010; BACHVAROVA R, 1985, DEV BIOL, V108, P325, DOI 10.1016/0012-1606(85)90036-3; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bayne RAL, 2004, MOL HUM REPROD, V10, P373, DOI 10.1093/molehr/gah056; Begemann G, 2008, ZEBRAFISH, V5, P111, DOI 10.1089/zeb.2008.0528; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bettegowda A, 2006, MOL REPROD DEV, V73, P267, DOI 10.1002/mrd.20333; Bettegowda A, 2007, FRONT BIOSCI-LANDMRK, V12, P3713, DOI 10.2741/2346; Bortvin Alex, 2004, BMC Developmental Biology, V4; Brevini TAL, 2004, MOL REPROD DEV, V69, P375, DOI 10.1002/mrd.20140; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Foygel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004109; Gibs R, 2006, BOVINE GENOMIC SEQUE, P1; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gougelet A, 2011, INT J CANCER, V129, P680, DOI 10.1002/ijc.25715; Hu W, 2010, MOL CELL BIOL, V30, P3661, DOI 10.1128/MCB.00201-10; Huntriss J, 2002, MOL HUM REPROD, V8, P1087, DOI 10.1093/molehr/8.12.1087; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Kanamori A, 2000, MOL REPROD DEV, V55, P31, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;31::AID-MRD5&gt;3.0.CO;2-7; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Liang LF, 1997, DEVELOPMENT, V124, P4939; Lingenfelter BM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-40; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Onichtchouk D, 2003, DEV DYNAM, V228, P393, DOI 10.1002/dvdy.10392; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; Pennetier S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-26; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Roberts RM, 2009, SCIENCE, V324, P468, DOI 10.1126/science.1168521; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Spruce T, 2010, DEV CELL, V19, P207, DOI 10.1016/j.devcel.2010.07.014; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tejomurtula J, 2009, BIOL REPROD, V81, P333, DOI 10.1095/biolreprod.109.077396; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Tripurani SK, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-25; Tripurani SK, 2011, ENDOCRINOLOGY, V152, P1013, DOI 10.1210/en.2010-1134; Tripurani SK, 2010, ANIM REPROD SCI, V120, P16, DOI 10.1016/j.anireprosci.2010.03.001; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Villalba A, 2011, CURR OPIN GENET DEV, V21, P452, DOI 10.1016/j.gde.2011.04.006; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wada R, 2010, INT J CANCER, V127, P1106, DOI 10.1002/ijc.25126; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yurttas P, 2008, DEVELOPMENT, V135, P2627, DOI 10.1242/dev.016329; Zhao H, 2008, AM J HUM GENET, V82, P1342, DOI 10.1016/j.ajhg.2008.04.018	60	24	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76114	10.1371/journal.pone.0076114	http://dx.doi.org/10.1371/journal.pone.0076114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086699	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900083
J	Geiler-Samerotte, KA; Hashimoto, T; Dion, MF; Budnik, BA; Airoldi, EM; Drummond, DA				Geiler-Samerotte, Kerry A.; Hashimoto, Tatsunori; Dion, Michael F.; Budnik, Bogdan A.; Airoldi, Edoardo M.; Drummond, D. Allan			Quantifying Condition-Dependent Intracellular Protein Levels Enables High-Precision Fitness Estimates	PLOS ONE			English	Article							GROWTH-RATE; CELL-CYCLE; YEAST; MASS; SELECTION	Countless studies monitor the growth rate of microbial populations as a measure of fitness. However, an enormous gap separates growth-rate differences measurable in the laboratory from those that natural selection can distinguish efficiently. Taking advantage of the recent discovery that transcript and protein levels in budding yeast closely track growth rate, we explore the possibility that growth rate can be more sensitively inferred by monitoring the proteomic response to growth, rather than growth itself. We find a set of proteins whose levels, in aggregate, enable prediction of growth rate to a higher precision than direct measurements. However, we find little overlap between these proteins and those that closely track growth rate in other studies. These results suggest that, in yeast, the pathways that set the pace of cell division can differ depending on the growth-altering stimulus. Still, with proper validation, protein measurements can provide high-precision growth estimates that allow extension of phenotypic growth-based assays closer to the limits of evolutionary selection.	[Drummond, D. Allan] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Geiler-Samerotte, Kerry A.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Hashimoto, Tatsunori; Airoldi, Edoardo M.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Dion, Michael F.; Budnik, Bogdan A.; Airoldi, Edoardo M.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Airoldi, Edoardo M.] Broad Inst Harvard & MIT, Cambridge, MA USA	University of Chicago; New York University; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Geiler-Samerotte, KA (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	kas25@nyu.edu	Budnik, Bogdan/AGG-8824-2022; Drummond, D. Allan/A-1250-2015; Budnik, Bogdan/AAH-9987-2019	Budnik, Bogdan/0000-0003-3622-2003; Drummond, D. Allan/0000-0001-7018-7059; Airoldi, Edoardo/0000-0002-3512-0542; Dion, Michael/0000-0002-0434-4236	National Institutes of Health [1R01GM088344-01, P50GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096193, P50GM068763, R01GM088344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants 1R01GM088344-01 and P50GM068763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi EM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000257; Akashi H, 2012, GENETICS, V192, P15, DOI 10.1534/genetics.112.140178; Aparicio F, 2005, PLANT PHYSIOL, V138, P529, DOI 10.1104/pp.104.058958; Blomberg A, 2011, CURR OPIN BIOTECH, V22, P94, DOI 10.1016/j.copbio.2010.10.013; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Bryan AK, 2010, P NATL ACAD SCI USA, V107, P999, DOI 10.1073/pnas.0901851107; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Geiler-Samerotte KA, 2011, P NATL ACAD SCI USA, V108, P680, DOI 10.1073/pnas.1017570108; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Lee MV, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.48; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Slavov N, 2011, MOL BIOL CELL, V22, P1997, DOI 10.1091/mbc.E11-02-0132; Sugio A, 2009, PLANT CELL, V21, P642, DOI 10.1105/tpc.108.062596	21	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75320	10.1371/journal.pone.0075320	http://dx.doi.org/10.1371/journal.pone.0075320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086506	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700074
J	Polidarova, L; Sladek, M; Novakova, M; Parkanova, D; Sumova, A				Polidarova, Lenka; Sladek, Martin; Novakova, Marta; Parkanova, Daniela; Sumova, Alena			Increased Sensitivity of the Circadian System to Temporal Changes in the Feeding Regime of Spontaneously Hypertensive Rats - A Potential Role for Bmal2 in the Liver	PLOS ONE			English	Article							FOOD-ANTICIPATORY ACTIVITY; TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; GENE-EXPRESSION; DAILY RHYTHMS; PPAR-GAMMA; CLOCK; IDENTIFICATION; ENTRAINMENT; MECHANISM	The mammalian timekeeping system generates circadian oscillations that rhythmically drive various functions in the body, including metabolic processes. In the liver, circadian clocks may respond both to actual feeding conditions and to the metabolic state. The temporal restriction of food availability to improper times of day (restricted feeding, RF) leads to the development of food anticipatory activity (FAA) and resets the hepatic clock accordingly. The aim of this study was to assess this response in a rat strain exhibiting complex pathophysiological symptoms involving spontaneous hypertension, an abnormal metabolic state and changes in the circadian system, i.e., in spontaneously hypertensive rats (SHR). The results revealed that SHR were more sensitive to RF compared with control rats, developing earlier and more pronounced FAA. Whereas in control rats, the RF only redistributed the activity profiles into two bouts (one corresponding to FAA and the other corresponding to the dark phase), in SHR the RF completely phase-advanced the locomotor activity according to the time of food presentation. The higher behavioral sensitivity to RF was correlated with larger phase advances of the hepatic clock in response to RF in SHR. Moreover, in contrast to the controls, RF did not suppress the amplitude of the hepatic clock oscillation in SHR. In the colon, no significant differences in response to RF between the two rat strains were detected. The results suggested the possible involvement of the Bmal2 gene in the higher sensitivity of the hepatic clock to RF in SHR because, in contrast to the Wistar rats, the rhythm of Bmal2 expression was advanced similarly to that of Bmal1 under RF. Altogether, the data demonstrate a higher behavioral and circadian responsiveness to RF in the rat strain with a cardiovascular and metabolic pathology and suggest a likely functional role for the Bmal2 gene within the circadian clock.	[Polidarova, Lenka; Sladek, Martin; Novakova, Marta; Parkanova, Daniela; Sumova, Alena] Acad Sci Czech Republ, Inst Physiol, Dept Neurohumoral Regulat, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Sumova, A (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Neurohumoral Regulat, Vvi, Prague, Czech Republic.	sumova@biomed.cas.cz	Sumova, Alena/C-3390-2012; Polidarova, Lenka/K-3550-2017; Sládek, Martin/C-3383-2012	Sumova, Alena/0000-0003-4126-5470; Polidarova, Lenka/0000-0001-9087-6388; Sládek, Martin/0000-0002-9744-9386	Czech Science Foundation [P303110668];  [RVO:67985823]	Czech Science Foundation(Grant Agency of the Czech Republic); 	The study was supported by the Czech Science Foundation, grant No. P303110668, and by Research Project RVO:67985823. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Alessi MC, 2006, ARTERIOSCL THROM VAS, V26, P2200, DOI 10.1161/01.ATV.0000242905.41404.68; BOLLES RC, 1962, J COMP PHYSIOL PSYCH, V55, P760, DOI 10.1037/h0046716; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Carneiro BTS, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00083; Challet E, 1997, J BIOL RHYTHM, V12, P65, DOI 10.1177/074873049701200108; COLEMAN GJ, 1982, PHYSIOL BEHAV, V29, P107, DOI 10.1016/0031-9384(82)90373-0; Cui H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017339; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Djordjevic J, 2007, GEN COMP ENDOCR, V153, P217, DOI 10.1016/j.ygcen.2007.02.004; Dolinsky VW, 2010, HYPERTENSION, V56, P412, DOI 10.1161/HYPERTENSIONAHA.110.154732; DRUCKERCOLIN R, 1984, BRAIN RES, V311, P353, DOI 10.1016/0006-8993(84)90099-4; Escobar C, 1998, AM J PHYSIOL-REG I, V274, pR1309, DOI 10.1152/ajpregu.1998.274.5.R1309; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gachon F, 2011, P NATL ACAD SCI USA, V108, P4794, DOI 10.1073/pnas.1002862108; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; HONMA KI, 1983, PHYSIOL BEHAV, V30, P905, DOI 10.1016/0031-9384(83)90256-1; Hoogerwerf WA, 2007, GASTROENTEROLOGY, V133, P1250, DOI 10.1053/j.gastro.2007.07.009; Hung MS, 2006, HUM MOL GENET, V15, P2732, DOI 10.1093/hmg/ddl209; Ikeda M, 2000, BIOCHEM BIOPH RES CO, V275, P493, DOI 10.1006/bbrc.2000.3248; Imaki T, 1998, J NEUROENDOCRINOL, V10, P635, DOI 10.1046/j.1365-2826.1998.00249.x; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; Kawai M, 2010, P NATL ACAD SCI USA, V107, P10508, DOI 10.1073/pnas.1000788107; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; Lee YH, 2013, EXP PHYSIOL, V98, P1145, DOI 10.1113/expphysiol.2013.072298; Li ZF, 2010, PEPTIDES, V31, P297, DOI 10.1016/j.peptides.2009.11.018; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Maemura K, 2000, J BIOL CHEM, V275, P36847, DOI 10.1074/jbc.C000629200; Masri S, 2012, ANN NY ACAD SCI, V1264, P103, DOI 10.1111/j.1749-6632.2012.06649.x; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; MISTLBERGER RE, 1995, BEHAV NEUROSCI, V109, P790, DOI 10.1037/0735-7044.109.4.790; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; NAGAI K, 1978, BRAIN RES, V142, P384, DOI 10.1016/0006-8993(78)90648-0; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Ohno T, 2007, NUCLEIC ACIDS RES, V35, P648, DOI 10.1093/nar/gkl868; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Pravenec M, 2008, HYPERTENSION, V51, P148, DOI 10.1161/HYPERTENSIONAHA.107.100743; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sasaki M, 2009, J BIOL CHEM, V284, P25149, DOI 10.1074/jbc.M109.040758; Schmutz I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021325; Schoenhard JA, 2002, AM J PHYSIOL-CELL PH, V283, pC103, DOI 10.1152/ajpcell.00541.2001; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Shi SQ, 2010, CURR BIOL, V20, P316, DOI 10.1016/j.cub.2009.12.034; Silver R, 2010, SLEEP BIOL RHYTHMS, V8, P120, DOI 10.1111/j.1479-8425.2010.00438.x; Sladek M, 2004, P NATL ACAD SCI USA, V101, P6231, DOI 10.1073/pnas.0401149101; Sladek M, 2007, GASTROENTEROLOGY, V133, P1240, DOI 10.1053/j.gastro.2007.05.053; Sladek M, 2007, AM J PHYSIOL-REG I, V292, pR1224, DOI 10.1152/ajpregu.00184.2006; Sladek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046951; STEPHAN FK, 1989, J BIOL RHYTHM, V4, P467, DOI 10.1177/074873048900400406; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Svoboda DS, 2012, J PROTEOMICS, V75, P1752, DOI 10.1016/j.jprot.2011.12.011; SWISLOCKI A, 1993, AM J MED SCI, V306, P282, DOI 10.1097/00000441-199311000-00002; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takasu NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048892; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104	72	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75690	10.1371/journal.pone.0075690	http://dx.doi.org/10.1371/journal.pone.0075690			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086613	Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700109
J	Salmeron, C; de la Serrana, DG; Jimenez-Amilburu, V; Fontanillas, R; Navarro, I; Johnston, IA; Gutierrez, J; Capilla, E				Salmeron, Cristina; de la Serrana, Daniel Garcia; Jimenez-Amilburu, Vanesa; Fontanillas, Ramon; Navarro, Isabel; Johnston, Ian A.; Gutierrez, Joaquim; Capilla, Encarnacion			Characterisation and Expression of Calpain Family Members in Relation to Nutritional Status, Diet Composition and Flesh Texture in Gilthead Sea Bream (Sparus aurata)	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; BASS DICENTRARCHUS-LABRAX; MUSCLE-SPECIFIC CALPAIN; SKELETAL-MUSCLE; ATLANTIC SALMON; GROWTH DYNAMICS; MU-CALPAIN; TENDERNESS; FISH; QUALITY	Calpains are non-lysosomal calcium-activated neutral proteases involved in a wide range of cellular processes including muscle proteolysis linked to post-mortem flesh softening. The aims of this study were (a) to characterise several members of the calpain system in gilthead sea bream and (b) to examine their expression in relation to nutritional status and muscle tenderisation. We identified the complete open reading frame of gilthead sea bream calpains1-3, sacapn1, sacapn2, sacapn3, and two paralogs of the calpain small subunit1, sacapns1a and sacapns1b. Proteins showed 63-90% sequence identity compared with sequences from mammals and other teleost fishes, and the characteristic domain structure of vertebrate calpains. Transcripts of sacapn1, sacapn2, sacapns1a and sacapns1b had a wide tissue distribution, whereas sacapn3 was almost exclusively detected in skeletal muscle. Next, we assessed transcript expression in skeletal muscle following alteration of nutritional status by (a) fasting and re-feeding or (b) feeding four experimental diets with different carbohydrate-to-protein ratios. Fasting significantly reduced plasma glucose and increased free fatty acids and triglycerides, together with a significant increase in sacapns1b expression. Following 7 days of re-feeding, plasma parameters returned to fed values and sacapn1, sacapn2, sacapns1a and sacapns1b expression was significantly reduced. Furthermore, an increase in dietary carbohydrate content (11 to 39%) diminished growth but increased muscle texture, which showed a significant correlation with decreased sacapn1 and sacapns1a expression, whilst the other calpains remained unaffected. This study has demonstrated that calpain expression is modulated by nutritional status and diet composition in gilthead sea bream, and that the expression of several calpain members is correlated with muscle texture, indicating their potential use as molecular markers for flesh quality in aquaculture production.	[Salmeron, Cristina; Jimenez-Amilburu, Vanesa; Navarro, Isabel; Gutierrez, Joaquim; Capilla, Encarnacion] Univ Barcelona, Fac Biol, Dept Physiol & Immunol, Barcelona, Spain; [de la Serrana, Daniel Garcia; Johnston, Ian A.] Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews, Fife, Scotland; [Fontanillas, Ramon] Skretting Aquaculture Res Ctr, Stavanger, Norway	University of Barcelona; University of St Andrews	Capilla, E (corresponding author), Univ Barcelona, Fac Biol, Dept Physiol & Immunol, Barcelona, Spain.	ecapilla@ub.edu	Navarro, Isabel/L-9318-2014; Johnston, Ian A/D-6592-2013; Gutierrez, Joaquim/H-2836-2015; Johnston, Ian A./AAE-2044-2019; Salmeron, Cristina/CAG-8357-2022; Garcia de la serrana, Daniel/R-9956-2018; Fontanillas, Ramon/AAR-6368-2021; Capilla, Encarnación/L-6143-2014	Navarro, Isabel/0000-0002-2641-0361; Johnston, Ian A/0000-0002-7796-5754; Gutierrez, Joaquim/0000-0002-3126-2236; Garcia de la serrana, Daniel/0000-0001-6630-3379; Fontanillas, Ramon/0000-0002-1572-8171; Capilla, Encarnación/0000-0002-0863-9728; Sanyal, Subhabrata/0000-0003-2590-2732; Salmeron, Cristina/0000-0003-2259-3807	MICINN [AGL2009-12427, AGL2010-17324]; Catalonian Government [2009SGR-00402]; Xarxa de Referencia d'R+D+I en Aquicultura; European Union [FP7-222719]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Catalonian Government; Xarxa de Referencia d'R+D+I en Aquicultura; European Union(European Commission)	EC is a Ramon y Cajal researcher fellow from the "Ministerio de Ciencia e Innovaci" (MICINN). This work was supported by funds from the MICINN (AGL2009-12427 and AGL2010-17324), the Catalonian Government (2009SGR-00402) and the "Xarxa de Referencia d'R+D+I en Aquicultura" and the European Union through the project LIFECYCLE (FP7-222719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami-Durante H, 2010, AQUACULTURE, V303, P50, DOI 10.1016/j.aquaculture.2010.03.012; APROMAR, 2012, LA ACUICULTURA MARIN; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Bonnal C, 2001, MAR BIOTECHNOL, V3, P172, DOI 10.1007/s101260000059; Casas E, 2006, J ANIM SCI, V84, P520, DOI 10.2527/2006.843520x; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Cleveland BM, 2012, AQUACULTURE, V338, P228, DOI 10.1016/j.aquaculture.2012.01.032; de la Serrana DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051884; de la Serrana DG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-181; de Morree A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011940; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; EMORI Y, 1986, J BIOL CHEM, V261, P9472; Enes P, 2011, REV FISH SCI, V19, P201, DOI 10.1080/10641262.2011.579363; FAUCONNEAU B, 1993, SCI ALIMENT, V13, P173; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Geesink GH, 2006, J ANIM SCI, V84, P2834, DOI 10.2527/jas.2006-122; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Grigorakis K, 2003, AQUACULTURE, V225, P109, DOI 10.1016/S0044-8486(03)00283-7; Hunter R, 1987, THE MEASUREMENT OF A; Hurling R, 1996, J TEXTURE STUD, V27, P679, DOI 10.1111/j.1745-4603.1996.tb01001.x; Ibarz A, 2011, J COMP PHYSIOL B, V181, P209, DOI 10.1007/s00360-010-0516-4; Ilian MA, 2001, J AGR FOOD CHEM, V49, P1990, DOI 10.1021/jf0010026; Ilian MA, 2001, J ANIM SCI, V79, P122; Jekely G, 1999, J MOL EVOL, V49, P272, DOI 10.1007/PL00006549; JOHNSTON IA, 1980, J COMP PHYSIOL, V135, P147, DOI 10.1007/BF00691204; Johnston IA, 1998, J EXP BIOL, V201, P623; Johnston IA, 2004, AQUACULTURE, V237, P281, DOI 10.1016/j.aquaculture.2004.04.026; Johnston IA, 2002, AQUACULTURE, V210, P259, DOI 10.1016/S0044-8486(01)00862-6; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kemp CM, 2010, MEAT SCI, V84, P248, DOI 10.1016/j.meatsci.2009.06.008; KIESSLING A, 1991, AQUACULTURE, V93, P335, DOI 10.1016/0044-8486(91)90225-V; KOOHMARAIE M, 1987, MEAT SCI, V19, P187, DOI 10.1016/0309-1740(87)90056-8; Lepage SE, 2008, DEV DYNAM, V237, P819, DOI 10.1002/dvdy.21459; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Albors O, 2008, AQUACULTURE, V277, P39, DOI 10.1016/j.aquaculture.2008.02.015; Macqueen DJ, 2010, MOL BIOL EVOL, V27, P1886, DOI 10.1093/molbev/msq071; Macqueen DJ, 2010, GENE, V453, P45, DOI 10.1016/j.gene.2010.01.002; Martin CI, 2005, J EXP BIOL, V208, P2083, DOI 10.1242/jeb.01605; Martin SAM, 2002, PFLUG ARCH EUR J PHY, V445, P257, DOI 10.1007/s00424-002-0916-8; Nagaraj NS, 2006, J FOOD BIOCHEM, V30, P269, DOI 10.1111/j.1745-4514.2006.00066.x; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nathanailides C., 1996, Aquaculture Research, V27, P885, DOI 10.1046/j.1365-2109.1996.t01-1-00819.x; Navarro Isabel, 1995, Biochemistry and Molecular Biology of Fishes, V4, P393; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Page BT, 2002, J ANIM SCI, V80, P3077; Parr T, 1999, J ANIM SCI, V77, P661; Preziosa E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059404; Ravulapalli R, 2005, BIOCHEM J, V388, P585, DOI 10.1042/BJ20041821; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Salem M, 2005, COMP BIOCHEM PHYS B, V141, P488, DOI 10.1016/j.cbpc.2005.05.012; Salem M, 2005, COMP BIOCHEM PHYS B, V140, P63, DOI 10.1016/j.cbpc.2004.09.007; Salem M, 2004, ANIM BIOTECHNOL, V15, P145, DOI [10.1081/ABIO-200036706, 10.1081/labt-200036706]; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Suarez MD, 2009, AQUACULTURE, V288, P106, DOI 10.1016/j.aquaculture.2008.11.007; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TOTLAND GK, 1987, AQUACULTURE, V66, P299, DOI 10.1016/0044-8486(87)90115-3; Valente LMP, 2011, FOOD CONTROL, V22, P708, DOI 10.1016/j.foodcont.2010.11.001; vandenHemelGrooten HNA, 1997, J ANIM SCI, V75, P968	61	46	47	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75349	10.1371/journal.pone.0075349	http://dx.doi.org/10.1371/journal.pone.0075349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086513	Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700079
J	Young, D; Mayer, F; Vidotto, N; Schweizer, T; Berth, R; Abramowski, D; Shimshek, DR; van der Putten, PH; Schmid, P				Young, Douglas; Mayer, Franziska; Vidotto, Nella; Schweizer, Tatjana; Berth, Ramon; Abramowski, Dorothee; Shimshek, Derya R.; van der Putten, P. Herman; Schmid, Peter			Mutant Huntingtin Gene-Dose Impacts on Aggregate Deposition, DARPP32 Expression and Neuroinflammation in HdhQ150 Mice	PLOS ONE			English	Article							IN MOUSE MODEL; MICROGLIAL ACTIVATION; INTRANUCLEAR INCLUSIONS; MONOCLONAL-ANTIBODIES; TRINUCLEOTIDE REPEAT; NEUROTROPHIC FACTOR; CAG REPEAT; DISEASE; PROTEIN; EXON-1	Huntington's disease (HD) is an autosomal dominant, progressive and fatal neurological disorder caused by an expansion of CAG repeats in exon-1 of the huntingtin gene. The encoded poly-glutamine stretch renders mutant huntingtin prone to aggregation. HdhQ150 mice genocopy a pathogenic repeat (similar to 150 CAGs) in the endogenous mouse huntingtin gene and model predominantly pre-manifest HD. Treating early is likely important to prevent or delay HD, and HdhQ150 mice may be useful to assess therapeutic strategies targeting pre-manifest HD. This requires appropriate markers and here we demonstrate, that pre-symptomatic HdhQ150 mice show several dramatic mutant huntingtin gene-dose dependent pathological changes including: (i) an increase of neuronal intra-nuclear inclusions (NIIs) in brain, (ii) an increase of extranuclear aggregates in dentate gyrus, (iii) a decrease of DARPP32 protein and (iv) an increase in glial markers of neuroinflammation, which curiously did not correlate with local neuronal mutant huntingtin inclusion-burden. HdhQ150 mice developed NIIs also in all retinal neuron cell-types, demonstrating that retinal NIIs are not specific to human exon-1 R6 HD mouse models. Taken together, the striking and robust mutant huntingtin gene-dose related changes in aggregate-load, DARPP32 levels and glial activation markers should greatly facilitate future testing of therapeutic strategies in the HdhQ150 HD mouse model.	[Young, Douglas; Mayer, Franziska; Vidotto, Nella; Schweizer, Tatjana; Berth, Ramon; Abramowski, Dorothee; Shimshek, Derya R.; van der Putten, P. Herman; Schmid, Peter] Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland	Novartis	Shimshek, DR (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland.	derya.shimshek@novartis.com; PeSchmid@aol.com		Shimshek, Derya/0000-0001-8602-7850				Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; Batcha AH, 2012, NEUROBIOL DIS, V45, P887, DOI 10.1016/j.nbd.2011.12.004; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P189, DOI 10.1016/j.brainresbull.2011.03.014; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hadzi TC, 2012, NEUROLOGY, V79, P1708, DOI 10.1212/WNL.0b013e31826e9a5d; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Helmlinger D, 2002, HUM MOL GENET, V11, P3351, DOI 10.1093/hmg/11.26.3351; Heng MY, 2007, J NEUROSCI, V27, P8989, DOI 10.1523/JNEUROSCI.1830-07.2007; Heng MY, 2010, HUM MOL GENET, V19, P3702, DOI 10.1093/hmg/ddq285; Hickey MA, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-12; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Krauss S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2514; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; Li Y, 2012, P NATL ACAD SCI USA, V109, P15491, DOI 10.1073/pnas.1212899109; Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marcellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044457; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Moller T, 2010, J NEURAL TRANSM, V117, P1001, DOI 10.1007/s00702-010-0430-7; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; Petrasch-Parwez E, 2005, ACTA NEUROPATHOL, V110, P523, DOI 10.1007/s00401-005-1092-7; Petrasch-Parwez E, 2004, J COMP NEUROL, V479, P181, DOI 10.1002/cne.20327; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Runne H, 2008, J NEUROSCI, V28, P9723, DOI 10.1523/JNEUROSCI.3044-08.2008; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; Squitieri F, 2003, BRAIN, V126, P946, DOI 10.1093/brain/awg077; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; Tai YF, 2007, BRAIN RES BULL, V72, P148, DOI 10.1016/j.brainresbull.2006.10.029; Thomas EA, 2011, HUM MOL GENET, V20, P1049, DOI 10.1093/hmg/ddq548; van Dellen A, 2000, NEUROREPORT, V11, P3751, DOI 10.1097/00001756-200011270-00032; Vonsattel Jean Paul G, 2011, Handb Clin Neurol, V100, P83, DOI 10.1016/B978-0-444-52014-2.00004-5; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Wang YL, 2005, NEUROSCI RES, V53, P241, DOI 10.1016/j.neures.2005.06.021; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Weiss A, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-11; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	59	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75108	10.1371/journal.pone.0075108	http://dx.doi.org/10.1371/journal.pone.0075108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086450	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200082
J	Van Cor-Hosmer, SK; Kim, DH; Daly, MB; Daddacha, W; Kim, B				Van Cor-Hosmer, Sarah K.; Kim, Dong-Hyun; Daly, Michele B.; Daddacha, Waaqo; Kim, Baek			Restricted 5 '-End Gap Repair of HIV-1 Integration Due to Limited Cellular dNTP Concentrations in Human Primary Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Polymerase; DNA Repair; HIV-1; Macrophages; Monocytes; DNA Gap Filling; Integration; dNTP	IMMUNODEFICIENCY-VIRUS TYPE-1; RETROVIRAL DNA INTEGRATION; CENTRAL POLYPURINE TRACT; REVERSE-TRANSCRIPTASE; POLYMERASE-BETA; IN-VITRO; REPLICATION; PROTEIN; SAMHD1; INFECTION	Background: The cellular DNA repair machinery completes the 5-end gap repair of HIV-1 integration. Results: The 5-end DNA gap repair of HIV-1 integration depends on dNTP availability in macrophages, monocytes, and CD4(+) T cells. Conclusion: 5-End DNA gap repair is a rate-limiting step in HIV-1 integration in macrophages and monocytes due to limited cellular dNTPs. Significance: Availability of cellular dNTP and polymerase controls HIV-1 integration kinetics. HIV-1 proviral DNA integration into host chromosomal DNA is only partially completed by the viral integrase, leaving two single-stranded DNA gaps with 5-end mismatched viral DNA flaps. It has been inferred that these gaps are repaired by the cellular DNA repair machinery. Here, we investigated the efficiency of gap repair at integration sites in different HIV-1 target cell types. First, we found that the general gap repair machinery in macrophages was attenuated compared with that in dividing CD4(+) T cells. In fact, the repair in macrophages was heavily reliant upon host DNA polymerase (Pol ). Second, we tested whether the poor dNTP availability found in macrophages is responsible for the delayed HIV-1 proviral DNA integration in this cell type because the K-m value of Pol is much higher than the dNTP concentrations found in macrophages. Indeed, with the use of a modified quantitative AluI PCR assay, we demonstrated that the elevation of cellular dNTP concentrations accelerated DNA gap repair in macrophages at HIV-1 proviral DNA integration sites. Finally, we found that human monocytes, which are resistant to HIV-1 infection, exhibited severely restricted gap repair capacity due not only to the very low levels of dNTPs detected but also to the significantly reduced expression of Pol . Taken together, these results suggest that the low dNTP concentrations found in macrophages and monocytes can restrict the repair steps necessary for HIV-1 integration.	[Van Cor-Hosmer, Sarah K.; Daddacha, Waaqo] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14627 USA; [Kim, Dong-Hyun; Kim, Baek] Kyung Hee Univ, Coll Pharm, Seoul 130701, South Korea; [Daly, Michele B.; Kim, Baek] Emory Univ, Ctr Drug Discovery, Dept Pediat, Emory Ctr AIDS Res, Atlanta, GA 30322 USA	University of Rochester; Kyung Hee University; Emory University	Kim, B (corresponding author), Emory Univ, Ctr Drug Discovery, Dept Pediat, Hlth Sci Res Bldg,1760 Haygood Dr, Atlanta, GA 30322 USA.	baek.kim@emory.edu			National Institutes of Health [AI049781, F31 GM095190]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049815, R01AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM095190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI049781 (to B. K.) and F31 GM095190 (to W. D.).	Akbari M, 2009, DNA REPAIR, V8, P834, DOI 10.1016/j.dnarep.2009.04.002; Albright AV, 2000, AIDS RES HUM RETROV, V16, P1527, DOI 10.1089/088922200750006056; Amie SM, 2013, VIROLOGY, V436, P247, DOI 10.1016/j.virol.2012.11.010; Bauer M, 2011, P NATL ACAD SCI USA, V108, P21105, DOI 10.1073/pnas.1111919109; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; CHARNEAU P, 1992, J VIROL, V66, P2814, DOI 10.1128/JVI.66.5.2814-2820.1992; Clapham PR, 2002, J GEN VIROL, V83, P1809, DOI 10.1099/0022-1317-83-8-1809; COLLIN M, 1994, VIROLOGY, V200, P114, DOI 10.1006/viro.1994.1169; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Espeseth AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017612; FUJIWARA T, 1988, CELL, V54, P497, DOI 10.1016/0092-8674(88)90071-2; Gavegnano C., 2012, MOL BIOL INT, V2012; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Imoto S, 2008, BIOCHEMISTRY-US, V47, P4306, DOI 10.1021/bi7021427; Jamburuthugoda VK, 2008, J BIOL CHEM, V283, P9206, DOI 10.1074/jbc.M710149200; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; Johnson A, 2005, CURR BIOL, V15, pR90, DOI 10.1016/j.cub.2005.01.025; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Kennedy EM, 2012, J BIOL CHEM, V287, P14280, DOI 10.1074/jbc.M112.348482; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kraynov VS, 2000, BIOCHEMISTRY-US, V39, P16008, DOI 10.1021/bi0008480; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855; MASTRO AM, 1986, CELL TISSUE KINET, V19, P557, DOI 10.1111/j.1365-2184.1986.tb00756.x; Michelini Z, 2010, J VIROL METHODS, V168, P272, DOI 10.1016/j.jviromet.2010.06.004; Neil S, 2001, J VIROL, V75, P5448, DOI 10.1128/JVI.75.12.5448-5456.2001; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; OBRIEN WA, 1994, J LEUKOCYTE BIOL, V56, P273, DOI 10.1002/jlb.56.3.273; Operario DJ, 2006, J BIOL CHEM, V281, P32113, DOI 10.1074/jbc.M604665200; Operario DJ, 2005, VIROLOGY, V335, P106, DOI 10.1016/j.virol.2005.02.010; Romani B, 2012, CURR OPIN VIROL, V2, P755, DOI 10.1016/j.coviro.2012.09.010; Simsek D, 2011, CELL CYCLE, V10, P3636, DOI 10.4161/cc.10.21.18094; Singh J, 1996, J BIOL CHEM, V271, P28391, DOI 10.1074/jbc.271.45.28391; Skasko M, 2008, J VIROL, V82, P7716, DOI 10.1128/JVI.00120-08; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004; Van Cor-Hosmer SK, 2012, VIROLOGY, V422, P393, DOI 10.1016/j.virol.2011.11.004; Van Cor-Hosmer SK, 2010, VIROLOGY, V406, P253, DOI 10.1016/j.virol.2010.07.028; Vatakis DN, 2007, J VIROL, V81, P3574, DOI 10.1128/JVI.02569-06; Weiss KK, 2002, J BIOL CHEM, V277, P22662, DOI 10.1074/jbc.M200202200; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000; Yoder KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017862	48	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33253	33262		10.1074/jbc.M113.486787	http://dx.doi.org/10.1074/jbc.M113.486787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097986	hybrid, Green Published			2022-12-25	WOS:000328841700039
J	Roy, U; Bulot, C; Bentrup, KHZ; Mondal, D				Roy, Upal; Bulot, Christine; Bentrup, Kerstin Honer Zu; Mondal, Debasis			Specific Increase in MDR1 Mediated Drug-Efflux in Human Brain Endothelial Cells following Co-Exposure to HIV-1 and Saquinavir	PLOS ONE			English	Article							P-GLYCOPROTEIN EXPRESSION; MULTIDRUG-RESISTANCE PROTEIN-1; NECROSIS-FACTOR-ALPHA; IN-VITRO MODEL; PROTEASE INHIBITORS; TRANSPORT ACTIVITY; BARRIER; MODULATION; LIPOPOLYSACCHARIDE; PERMEABILITY	Persistence of HIV-1 reservoirs within the Central Nervous System (CNS) remains a significant challenge to the efficacy of potent anti-HIV-1 drugs. The primary human Brain Microvascular Endothelial Cells (HBMVEC) constitutes the Blood Brain Barrier (BBB) which interferes with anti-HIV drug delivery into the CNS. The ATP binding cassette (ABC) transporters expressed on HBMVEC can efflux HIV-1 protease inhibitors (HPI), enabling the persistence of HIV-1 in CNS. Constitutive low level expression of several ABC-transporters, such as MDR1 (a.k.a. P-gp) and MRPs are documented in HBMVEC. Although it is recognized that inflammatory cytokines and exposure to xenobiotic drug substrates (e.g HPI) can augment the expression of these transporters, it is not known whether concomitant exposure to virus and anti-retroviral drugs can increase drug-efflux functions in HBMVEC. Our in vitro studies showed that exposure of HBMVEC to HIV-1 significantly up-regulates both MDR1 gene expression and protein levels; however, no significant increases in either MRP-1 or MRP-2 were observed. Furthermore, calcein-AM dye-efflux assays using HBMVEC showed that, compared to virus exposure alone, the MDR1 mediated drug-efflux function was significantly induced following concomitant exposure to both HIV-1 and saquinavir (SQV). This increase in MDR1 mediated drug-efflux was further substantiated via increased intracellular retention of radiolabeled [H-3-] SQV. The crucial role of MDR1 in H-3-SQV efflux from HBMVEC was further confirmed by using both a MDR1 specific blocker (PSC-833) and MDR1 specific siRNAs. Therefore, MDR1 specific drug-efflux function increases in HBMVEC following co-exposure to HIV-1 and SQV which can reduce the penetration of HPIs into the infected brain reservoirs of HIV-1. A targeted suppression of MDR1 in the BBB may thus provide a novel strategy to suppress residual viral replication in the CNS, by augmenting the therapeutic efficacy of HAART drugs.	[Roy, Upal; Bulot, Christine; Mondal, Debasis] Tulane Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70118 USA; [Bentrup, Kerstin Honer Zu] Tulane Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70118 USA	Tulane University; Tulane University	Roy, U (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70118 USA.	uroy@fiu.edu	ROY, UPAL/C-6126-2012	Roy, Upal/0000-0002-0325-567X	National Institute of Allergy and Infectious Diseases (NIAID; National Institutes of Health (NIH) [R21-AI064048]; Louisiana Board of Regents (LA-BORSF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064048] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Louisiana Board of Regents (LA-BORSF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the National Institute of Allergy and Infectious Diseases (NIAID; National Institutes of Health (NIH); #R21-AI064048) and Louisiana Board of Regents (LA-BORSF) to DM. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039112; Andras IE, 2011, METHODS MOL BIOL, V762, P355, DOI 10.1007/978-1-61779-185-7_26; Banks WA, 2006, CURR HIV RES, V4, P259, DOI 10.2174/157016206777709447; Bauer B, 2005, EXP BIOL MED, V230, P118; Bauer B, 2007, MOL PHARMACOL, V71, P667, DOI 10.1124/mol.106.029512; Bentrup KHZ, 2006, MICROBES INFECT, V8, P1813, DOI 10.1016/j.micinf.2006.02.020; Brandmann M, 2012, J NEUROCHEM, V120, P78, DOI 10.1111/j.1471-4159.2011.07544.x; Chelucci C, 1998, BLOOD, V91, P1225, DOI 10.1182/blood.V91.4.1225; Cooper I, 2012, J BIOL CHEM, V287, P44676, DOI 10.1074/jbc.M112.395384; Dohgu S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-167; Eilers M, 2008, EXP BIOL MED, V233, P1149, DOI 10.3181/0802-RM-59; Golden PL, 1999, BRAIN RES, V819, P143, DOI 10.1016/S0006-8993(98)01305-5; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; Hayashi K, 2005, J NEUROCHEM, V93, P1231, DOI 10.1111/j.1471-4159.2005.03114.x; Hayashi K, 2006, J CEREBR BLOOD F MET, V26, P1052, DOI 10.1038/sj.jcbfm.9600254; Hua J, 2005, GYNECOL ONCOL, V98, P31, DOI 10.1016/j.ygyno.2005.03.042; Huang Y, 2005, CELL MOL IMMUNOL, V2, P113; Iqbal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043022; Konig J, 2005, INT J CANCER, V115, P359, DOI 10.1002/ijc.20831; Kyosseva SV, 2004, INT REV NEUROBIOL, V59, P201; Langmann T, 2003, CLIN CHEM, V49, P230, DOI 10.1373/49.2.230; Limtrakul P, 2007, MOL CELL BIOCHEM, V296, P85, DOI 10.1007/s11010-006-9302-8; Louboutin JP, 2010, NEUROBIOL DIS, V38, P313, DOI 10.1016/j.nbd.2010.02.007; Miller DS, 2008, PHARMACOL REV, V60, P196, DOI 10.1124/pr.107.07109; Miller DS, 2010, TRENDS PHARMACOL SCI, V31, P246, DOI 10.1016/j.tips.2010.03.003; Miller F, 2012, VIRULENCE, V3, P222, DOI 10.4161/viru.19697; Mishra R, 2013, J NEUROSCI, V33, P5992, DOI 10.1523/JNEUROSCI.4796-12.2013; Mizutani T, 2008, CURR DRUG METAB, V9, P167, DOI 10.2174/138920008783571756; Namanja HA, 2012, J AM CHEM SOC, V134, P2976, DOI 10.1021/ja206867t; Pal D, 2011, LIFE SCI, V88, P959, DOI 10.1016/j.lfs.2010.09.012; Poller B, 2010, CELL MOL NEUROBIOL, V30, P63, DOI 10.1007/s10571-009-9431-1; Potschka H, 2010, PHARMACOL THERAPEUT, V125, P118, DOI 10.1016/j.pharmthera.2009.10.004; Price TO, 2005, BRAIN RES, V1045, P57, DOI 10.1016/j.brainres.2005.03.031; Pu H, 2003, MOL CELL NEUROSCI, V24, P224, DOI 10.1016/S1044-7431(03)00171-4; Rao VV, 1999, P NATL ACAD SCI USA, V96, P3900, DOI 10.1073/pnas.96.7.3900; Shaik N, 2008, J PHARM SCI-US, V97, P5421, DOI 10.1002/jps.21372; Sulova Z, 2008, TOXICOL IN VITRO, V22, P96, DOI 10.1016/j.tiv.2007.08.011; Tang Y, 2007, GENE THER, V14, P523, DOI 10.1038/sj.gt.3302888; Thomas Hilary, 2003, Cancer Control, V10, P159; Toborek M, 2003, J NEUROCHEM, V84, P169, DOI 10.1046/j.1471-4159.2003.01543.x; Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x; Turriziani O, 2008, J MED VIROL, V80, P766, DOI 10.1002/jmv.21152; von Wedel-Parlow M, 2009, J NEUROCHEM, V111, P111, DOI 10.1111/j.1471-4159.2009.06305.x; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; Xu RF, 2012, BRAIN RES, V1436, P13, DOI 10.1016/j.brainres.2011.11.052; Zastre JA, 2009, J NEUROSCI RES, V87, P1023, DOI 10.1002/jnr.21898	46	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75374	10.1371/journal.pone.0075374	http://dx.doi.org/10.1371/journal.pone.0075374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098380	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600017
J	Cui, L; Yang, DB; Yan, XJ; Rui, CH; Wang, ZY; Yuan, HZ				Cui, Li; Yang, Daibin; Yan, Xiaojing; Rui, Changhui; Wang, Zhenying; Yuan, Huizhu			Molecular Cloning, Characterization and Expression Profiling of a Ryanodine Receptor Gene in Asian Corn Borer, Ostrinia furnacalis (Guenee)	PLOS ONE			English	Article							CA2+ RELEASE CHANNEL; MUSCLE SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; ANTHRANILIC DIAMIDES; PLUTELLA-XYLOSTELLA; MESSENGER-RNA; BINDING-SITE; DOMAIN; IDENTIFICATION; FLUBENDIAMIDE	Ryanodine receptor (RyR) Ca2+ release channel is the target of diamide insecticides, which show selective insecticidal activity against lepidopterous insects. To study the molecular mechanisms underlying the species-specific action of diamide insecticides, we have cloned and characterized the entire cDNA sequence of RyR from Ostrinia furnacalis (named as OfRyR). The OfRyR mRNA has an Open Reading Frame of 15324 bp nucleotides and encodes a 5108 amino acid polypeptide that displays 79-97% identity with other insects RyR proteins and shows the greatest identity with Cnaphalocrocis medinalis RyR (97%). Quantitative real-time PCR showed that the OfRyR was expressed at the lowest level in egg and the highest level in adult. The relative expression level of OfRyR in first, third and fifth-instar larva were 1.28, 1.19 and 1.99 times of that in egg. Moreover, two alternative splicing sites were identified in the OfRyR gene. One pair of mutually exclusive exons (a/b) were present in the central part of the predicted SPRY domain, and an optional exon (c) was located between the third and fourth RyR domains. Diagnostic PCR demonstrated that exons a and b existed in all developmental stages of OfRyR cDNA, but exon c was not detected in the egg cDNA. And the usage frequencies of these exons showed a significant difference between different developmental stages. These results provided the crucial basis for the functional expression of OfRyR and for the discovery of compound with potentially selective insect activtity.	[Cui, Li; Yang, Daibin; Yan, Xiaojing; Rui, Changhui; Wang, Zhenying; Yuan, Huizhu] Chinese Acad Agr Sci, Inst Plant Protect, Minist Agr, Key Lab Integrated Pest Management Crops, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Yuan, HZ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Minist Agr, Key Lab Integrated Pest Management Crops, Beijing 100193, Peoples R China.	hzhyuan@ippcaas.cn			National Basic Research Program of China [2010CB126106]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (2010CB126106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bhat MB, 1997, BIOPHYS J, V73, P1329, DOI 10.1016/S0006-3495(97)78166-9; Chen WL, 2012, SEED WORLD, V5, P13; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; D'Cruz AA, 2013, PROTEIN SCI, V22, P1, DOI 10.1002/pro.2185; Du GG, 1998, J BIOL CHEM, V273, P31867, DOI 10.1074/jbc.273.48.31867; Dulhunty AF, 2003, CLIN EXP PHARMACOL P, V30, P713, DOI 10.1046/j.1440-1681.2003.03904.x; Ebbinghaus-Kintscher U, 2006, CELL CALCIUM, V39, P21, DOI 10.1016/j.ceca.2005.09.002; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; George CH, 2004, MOL BIOL CELL, V15, P2627, DOI 10.1091/mbc.E03-09-0688; George CH, 2007, CIRC RES, V100, P874, DOI 10.1161/01.RES.0000260804.77807.cf; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Guo L, 2012, PEST MANAG SCI, V68, P1605, DOI 10.1002/ps.3357; INUI M, 1987, J BIOL CHEM, V262, P15637; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kato K, 2009, BIOCHEMISTRY-US, V48, P10342, DOI 10.1021/bi900866s; Kimura T, 2009, CELL CALCIUM, V45, P264, DOI 10.1016/j.ceca.2008.11.005; Lahm GP, 2007, BIOORG MED CHEM LETT, V17, P6274, DOI 10.1016/j.bmcl.2007.09.012; Lahm GP, 2005, BIOORG MED CHEM LETT, V15, P4898, DOI 10.1016/j.bmcl.2005.08.034; Liu S, 2003, NUCLEIC ACIDS RES, V31, P4828, DOI 10.1093/nar/gkg668; Masaki T, 2006, MOL PHARMACOL, V69, P1733, DOI 10.1124/mol.105.020339; Nauen R, 2006, PEST MANAG SCI, V62, P690, DOI 10.1002/ps.1254; OGAWA Y, 1994, CRIT REV BIOCHEM MOL, V29, P229, DOI 10.3109/10409239409083482; Ogawa Y, 1999, MOL CELL BIOCH; Ottini L, 1996, BIOCHEM J, V315, P207, DOI 10.1042/bj3150207; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; Sun LN, 2012, GENE, V511, P265, DOI 10.1016/j.gene.2012.09.027; Tae H, 2011, CHANNELS, V5, P148, DOI 10.4161/chan.5.2.14407; TAKESHIMA H, 1993, ANN NY ACAD SCI, V707, P165, DOI 10.1111/j.1749-6632.1993.tb38051.x; TAKESHIMA H, 1994, FEBS LETT, V337, P81, DOI 10.1016/0014-5793(94)80634-9; Tohnishi M, 2005, J PESTIC SCI, V30, P354, DOI 10.1584/jpestics.30.354; Wang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036623; WIERENGA RK, 1983, NATURE, V302, P842, DOI 10.1038/302842a0; Xiong H, 1998, BIOCHEMISTRY-US, V37, P4804, DOI 10.1021/bi971198b; Yamaguchi N, 2001, J BIOL CHEM, V276, P22579, DOI 10.1074/jbc.M102729200; ZARKA A, 1993, EUR J BIOCHEM, V213, P147, DOI 10.1111/j.1432-1033.1993.tb17744.x; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	40	18	22	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75825	10.1371/journal.pone.0075825	http://dx.doi.org/10.1371/journal.pone.0075825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098400	gold, Green Published, Green Submitted			2022-12-25	WOS:000325427100022
J	Paccou, J; Boudot, C; Mary, A; Kamel, S; Drueke, TB; Fardellone, P; Massy, Z; Brazier, M; Mentaverri, R				Paccou, Julien; Boudot, Cedric; Mary, Aurelien; Kamel, Said; Drueeke, Tilman Bernhard; Fardellone, Patrice; Massy, Ziad; Brazier, Michel; Mentaverri, Romuald			Determination and Modulation of Total and Surface Calcium-Sensing Receptor Expression in Monocytes In Vivo and In Vitro	PLOS ONE			English	Article							EXTRACELLULAR CALCIUM; CELL-LINE; (CA-O(2+))-SENSING RECEPTOR; RHEUMATOID-ARTHRITIS; VITAMIN-D; GENE	Expression of the calcium-sensing receptor (CaSR) has previously been demonstrated in human circulating monocytes (HCM). The present study was designed to measure CaSR expression in HCM and to examine its potential modulation by pro-inflammatory cytokines, Ca2+, vitamin D sterols in U937 cell line. Twenty healthy volunteers underwent blood sampling with subsequent isolation of peripheral blood mononuclear cells (PBMC) at 3 visits. Flow cytometry analysis (FACS) was performed initially (V1) and 19 days later (V2) to examine intra-and intersubject fluctuations of total and surface CaSR expression in HCM and 15 weeks later (V3) to study the effect of vitamin D supplementation. In vitro experiments were conducted to assess the effects of pro-inflammatory cytokines, calcidiol, calcitriol and Ca2+ on CaSR expression in U937 cell line. By FACS analysis, more than 95% of HCM exhibited cell surface CaSR staining. In contrast, CaSR staining failed to detect surface CaSR expression in other PBMC. After cell permeabilization, total CaSR expression was observed in more than 95% of all types of PBMC. Both total and surface CaSR expression in HCM showed a high degree of intra-assay reproducibility (<3%) and a moderate intersubject fluctuation. In response to vitamin D supplementation, there was no significant change for both total and surface CaSR expression. In the in vitro study, U937 cells showed strong total and surface CaSR expression, and both were moderately increased in response to calcitriol exposure. Neither total nor surface CaSR expression was modified by increasing Ca2+ concentrations. Total CaSR expression was concentration dependently decreased by TNF alpha exposure. In conclusion, CaSR expression can be easily measured by flow cytometry in human circulating monocytes. In the in vitro study, total and surface CaSR expression in the U937 cell line were increased by calcitriol but total CaSR expression was decreased by TNF alpha stimulation.	[Paccou, Julien; Fardellone, Patrice] Univ Hosp Amiens, Dept Rheumatol, Amiens, France; [Paccou, Julien; Boudot, Cedric; Mary, Aurelien; Kamel, Said; Drueeke, Tilman Bernhard; Fardellone, Patrice; Massy, Ziad; Brazier, Michel; Mentaverri, Romuald] Univ Picardie Jules Verne, INSERM, UFR Med Pharm, U1088, Amiens, France; [Massy, Ziad] Univ Hosp Ambroise Pare, Dept Clin Nephrol, Boulogne Billancourt, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Paccou, J (corresponding author), Univ Hosp Amiens, Dept Rheumatol, Amiens, France.	julienpaccou@yahoo.fr	Kamel, Said/HGA-7781-2022; DRUEKE, Tilman B./B-4958-2010	DRUEKE, Tilman B./0000-0002-0700-7681; paccou, julien/0000-0001-6599-8623				Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Brown EM, 1999, VITAM HORM, V55, P1; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Canaff L, 2002, J BIOL CHEM, V277, P30337, DOI 10.1074/jbc.M201804200; Canaff L, 2008, J BIOL CHEM, V283, P13586, DOI 10.1074/jbc.M708087200; Davignon JL, 2013, RHEUMATOLOGY, V52, P590, DOI 10.1093/rheumatology/kes304; Freichel M, 1996, ENDOCRINOLOGY, V137, P3842, DOI 10.1210/en.137.9.3842; Grant MP, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002208; Gratchev A, 2012, IMMUNOBIOLOGY, V217, P476, DOI 10.1016/j.imbio.2012.01.008; House MG, 1997, J BONE MINER RES, V12, P1959, DOI 10.1359/jbmr.1997.12.12.1959; Kanatani N, 1999, BIOCHEM BIOPH RES CO, V261, P144, DOI 10.1006/bbrc.1999.0932; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Lin KI, 1998, BIOCHEM BIOPH RES CO, V249, P325, DOI 10.1006/bbrc.1998.9124; Liu YZ, 2005, J BIOL CHEM, V280, P29011, DOI 10.1074/jbc.M501164200; Olszak IT, 2000, J CLIN INVEST, V105, P1299, DOI 10.1172/JCI9799; Quinn SJ, 1998, J BIOL CHEM, V273, P19579, DOI 10.1074/jbc.273.31.19579; Rushworth SA, 2011, J IMMUNOL, V187, P702, DOI 10.4049/jimmunol.1004117; Souberbielle JC, 2008, ANN ENDOCRINOL-PARIS, V69, P501, DOI 10.1016/j.ando.2008.07.010; Tintut Y, 2002, CIRCULATION, V105, P650, DOI 10.1161/hc0502.102969; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034641; Yamaguchi T, 1998, J BONE MINER RES, V13, P1530, DOI 10.1359/jbmr.1998.13.10.1530; Yamaguchi T, 1998, J BONE MINER RES, V13, P1390, DOI 10.1359/jbmr.1998.13.9.1390; Yamaguchi T, 1998, BIOCHEM BIOPH RES CO, V246, P501, DOI 10.1006/bbrc.1998.8648	23	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74800	10.1371/journal.pone.0074800	http://dx.doi.org/10.1371/journal.pone.0074800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098349	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100009
J	Olli, S; Rangaraj, N; Nagaraj, R				Olli, Sudar; Rangaraj, Nandini; Nagaraj, Ramakrishnan			Effect of Selectively Introducing Arginine and D-Amino Acids on the Antimicrobial Activity and Salt Sensitivity in Analogs of Human Beta-Defensins	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITIES; STAPHYLOCOCCUS-AUREUS; HUMAN BETA-DEFENSIN-1; MAMMALIAN DEFENSINS; INDUCIBLE PEPTIDE; DISULFIDE BONDS; ALPHA-DEFENSINS; IMMUNE-SYSTEM; HUMAN SKIN; CONFORMATIONS	We have examined the antimicrobial activity of C-terminal analogs of human beta-defensins HBD-1and-3 wherein lysines have been selectively replaced by L- and D-arginines and L-isoleucine substituted with its D-enantiomer. The analogs exhibited antibacterial and antifungal activities. Physiological concentration of NaCl did not attenuate the activity of the peptides against Gram-negative bacteria considerably, while some attenuation of activity was observed against S. aureus. Variable attenuation of activity was observed in the presence of Ca2+ and Mg2+. Introduction of D-amino acids abrogated the need for a disulfide bridge for exhibiting activity. Confocal images of carboxyfluorescein (CF) labeled peptides indicated initial localization on the membrane and subsequent translocation into the cell. Analogs corresponding to cationic rich segments of human defensins substituted with L- and D-arginine, could be attractive candidates for development as future therapeutic drugs.	[Olli, Sudar; Rangaraj, Nandini; Nagaraj, Ramakrishnan] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Nagaraj, R (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	nraj@ccmb.res.in			CSIR Network [NWP-05]; Department of Science and Technology, India [SR/WOS-A/LS-197/2010]; JC Bose Fellowship from the Department of Science and Technology, India	CSIR Network(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, India(Department of Science & Technology (India)); JC Bose Fellowship from the Department of Science and Technology, India(Department of Science & Technology (India))	This work was supported by funding from CSIR Network project NWP-05 and Department of Science and Technology, India SR/WOS-A/LS-197/2010. RN is the recipient of JC Bose Fellowship from the Department of Science and Technology, India. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2009, BIOCHEMISTRY-US, V48, P7229, DOI 10.1021/bi900670d; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; Brissette CA, 2002, INFECT IMMUN, V70, P3982, DOI 10.1128/IAI.70.7.3982-3984.2002; Chandrababu KB, 2009, BIOCHEMISTRY-US, V48, P6052, DOI 10.1021/bi900154f; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; Fulton C, 1997, LANCET, V350, P1750, DOI 10.1016/S0140-6736(05)63574-X; Ganz T, 2005, COMB CHEM HIGH T SCR, V8, P209, DOI 10.2174/1386207053764594; Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; Jung S, 2011, ANTIMICROB AGENTS CH, V55, P954, DOI 10.1128/AAC.00872-10; Kluver E, 2006, J PEPT SCI, V12, P243, DOI 10.1002/psc.749; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Krishnakumari V, 2003, BIOCHEMISTRY-US, V42, P9307, DOI 10.1021/bi034403y; Krishnakumari V, 2006, PEPTIDES, V27, P2607, DOI 10.1016/j.peptides.2006.06.004; Krishnakumari V, 2009, ANTIMICROB AGENTS CH, V53, P256, DOI 10.1128/AAC.00470-08; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Llenado RA, 2009, INFECT IMMUN, V77, P5035, DOI 10.1128/IAI.00695-09; Mandal M, 2002, PEPTIDES, V23, P413, DOI 10.1016/S0196-9781(01)00628-3; Mandal M, 2002, J PEPT RES, V59, P95, DOI 10.1034/j.1399-3011.2002.01945.x; Niyonsaba F, 2006, CRIT REV IMMUNOL, V26, P545, DOI 10.1615/CritRevImmunol.v26.i6.60; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pazgier M, 2007, CURR PHARM DESIGN, V13, P3096, DOI 10.2174/138161207782110381; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Scudiero O, 2010, ANTIMICROB AGENTS CH, V54, P2312, DOI 10.1128/AAC.01550-09; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Seo ES, 2010, BIOCHEMISTRY-US, V49, P10486, DOI 10.1021/bi1011749; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Sitaram N, 1999, BBA-BIOMEMBRANES, V1462, P29, DOI 10.1016/S0005-2736(99)00199-6; Starner TD, 2002, INFECT IMMUN, V70, P5287, DOI 10.1128/IAI.70.9.5287-5289.2002; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Tomita T, 2000, MICROBIOL IMMUNOL, V44, P749, DOI 10.1111/j.1348-0421.2000.tb02559.x; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Varkey J, 2005, ANTIMICROB AGENTS CH, V49, P4561, DOI 10.1128/AAC.49.11.4561-4566.2005; Weber PJA, 1998, BIOORG MED CHEM LETT, V8, P597, DOI 10.1016/S0960-894X(98)00084-5; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yu QT, 2000, J BIOL CHEM, V275, P3943, DOI 10.1074/jbc.275.6.3943; Zhao CQ, 1996, FEBS LETT, V396, P319, DOI 10.1016/0014-5793(96)01123-4; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200; Zucht H D, 1998, Eur J Med Res, V3, P315	55	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e77031	10.1371/journal.pone.0077031	http://dx.doi.org/10.1371/journal.pone.0077031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086767	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900111
J	Shaw, PG; Chaerkady, R; Wang, T; Vasilatos, S; Huang, Y; Van Houten, B; Pandey, A; Davidson, NE				Shaw, Patrick G.; Chaerkady, Raghothama; Wang, Tao; Vasilatos, Shauna; Huang, Yi; Van Houten, Bennett; Pandey, Akhilesh; Davidson, Nancy E.			Integrated Proteomic and Metabolic Analysis of Breast Cancer Progression	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; AMINO-ACIDS; EXPRESSION; HYPOXIA; MCF10AT; MODEL; RESPIRATION; IMPAIRMENT; GROWTH; CELLS	One of the most persistent hallmarks of cancer biology is the preference of tumor cells to derive energy through glycolysis as opposed to the more efficient process of oxidative phosphorylation (OXPHOS). However, little is known about the molecular cascades by which oncogenic pathways bring about this metabolic switch. We carried out a quantitative proteomic and metabolic analysis of the MCF10A derived cell line model of breast cancer progression that includes parental cells and derivatives representing three different tumor grades of Ras-driven cancer with a common genetic background. A SILAC (Stable Isotope Labeling by Amino acids in Cell culture) labeling strategy was used to quantify protein expression in conjunction with subcellular fractionation to measure dynamic subcellular localization in the nucleus, cytosol and mitochondria. Protein expression and localization across cell lines were compared to cellular metabolic rates as a measure of oxidative phosphorylation (OXPHOS), glycolysis and cellular ATP. Investigation of the metabolic capacity of the four cell lines revealed that cellular OXPHOS decreased with breast cancer progression independently of mitochondrial copy number or electron transport chain protein expression. Furthermore, glycolytic lactate secretion did not increase in accordance with cancer progression and decreasing OXPHOS capacity. However, the relative expression and subcellular enrichment of enzymes critical to lactate and pyruvate metabolism supported the observed extracellular acidification profiles. This analysis of metabolic dysfunction in cancer progression integrated with global protein expression and subcellular localization is a novel and useful technique for determining organelle-specific roles of proteins in disease.	[Shaw, Patrick G.; Wang, Tao; Vasilatos, Shauna; Huang, Yi; Van Houten, Bennett; Davidson, Nancy E.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Davidson, Nancy E.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Wang, Tao; Vasilatos, Shauna; Huang, Yi; Van Houten, Bennett; Davidson, Nancy E.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Shaw, Patrick G.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA; [Chaerkady, Raghothama; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA; [Chaerkady, Raghothama; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Pandey, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	pandey@jhmi.edu; davidsonne@upmc.edu	Pandey, Akhilesh/B-4127-2009; Van Houten, Bennett/K-2284-2019; Huang, Yi/AAW-7892-2021	Pandey, Akhilesh/0000-0001-9943-6127; Huang, Yi/0000-0002-9982-117X	Breast Cancer Research Foundation; NCI [T32 CA09110, U54 RR 020839]; NIH roadmap grant for Technology Centers of Networks and Pathways [U54 GM103250]; National Heart, Lung and Blood Institute [HHSN268201000032C]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH roadmap grant for Technology Centers of Networks and Pathways(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was partially supported by the Breast Cancer Research Foundation, NCI Training Grant T32 CA09110, U54 RR 020839, an NIH roadmap grant for Technology Centers of Networks and Pathways (U54 GM103250) and a contract from the National Heart, Lung and Blood Institute (HHSN268201000032C) to A.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayley JP, 2010, CURR OPIN GENET DEV, V20, P324, DOI 10.1016/j.gde.2010.02.008; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Buchanan NS, 2007, INT J ONCOL, V31, P941; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Choong LY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011030; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Dawson PJ, 1996, AM J PATHOL, V148, P313; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Hansen WJ, 2002, MOL CELL BIOL, V22, P1947, DOI 10.1128/MCB.22.6.1947-1960.2002; Harsha HC, 2008, NAT PROTOC, V3, P505, DOI 10.1038/nprot.2008.2; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kim SH, 2009, INT J CANCER, V124, P2813, DOI 10.1002/ijc.24278; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Lee JJ, 2010, CARCINOGENESIS, V31, P427, DOI 10.1093/carcin/bgp326; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lim S, 2009, J PROTEOME RES, V8, P4062, DOI 10.1021/pr900430n; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Marella NV, 2009, CANCER RES, V69, P5946, DOI 10.1158/0008-5472.CAN-09-0420; Moelans CB, 2010, MODERN PATHOL, V23, P1029, DOI 10.1038/modpathol.2010.84; NIEMINEN AL, 1994, AM J PHYSIOL, V267, pC67, DOI 10.1152/ajpcell.1994.267.1.C67; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Shen J, 2010, MITOCHONDRION, V10, P62, DOI 10.1016/j.mito.2009.09.004; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; SOULE HD, 1990, CANCER RES, V50, P6075; Sun CH, 2010, J CELL PHYSIOL, V225, P673, DOI 10.1002/jcp.22262; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Wang JB, 2009, J CELL SCI, V122, P2024, DOI 10.1242/jcs.044644; WARBURG O, 1956, SCIENCE, V124, P269; Worsham MJ, 2006, BREAST CANCER RES TR, V96, P177, DOI 10.1007/s10549-005-9077-8; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yang D, 2010, CANCER BIOL THER, V9, P122, DOI 10.4161/cbt.9.2.10379	41	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76220	10.1371/journal.pone.0076220	http://dx.doi.org/10.1371/journal.pone.0076220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086712	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900087
J	Stres, B; Sul, WJ; Murovec, B; Tiedje, JM				Stres, Blaz; Sul, Woo Jun; Murovec, Bostjan; Tiedje, James M.			Recently Deglaciated High-Altitude Soils of the Himalaya: Diverse Environments, Heterogenous Bacterial Communities and Long-Range Dust Inputs from the Upper Troposphere	PLOS ONE			English	Article							SIZE DISTRIBUTION; MICROBIAL COMMUNITIES; CHEMICAL-COMPOSITION; TIBETAN PLATEAU; ICE CORES; SEA-LEVEL; DEPOSITION; MICROORGANISMS; PRECIPITATION; AEROSOLS	Background: The Himalaya with its altitude and geographical position forms a barrier to atmospheric transport, which produces much aqueous-particle monsoon precipitation and makes it the largest continuous ice-covered area outside polar regions. There is a paucity of data on high-altitude microbial communities, their native environments and responses to environmental-spatial variables relative to seasonal and deglaciation events. Methodology/Principal Findings: Soils were sampled along altitude transects from 5000 m to 6000 m to determine environmental, spatial and seasonal factors structuring bacterial communities characterized by 16 S rRNA gene deep sequencing. Dust traps and fresh-snow samples were used to assess dust abundance and viability, community structure and abundance of dust associated microbial communities. Significantly different habitats among the altitude-transect samples corresponded to both phylogenetically distant and closely-related communities at distances as short as 50 m showing high community spatial divergence. High within-group variability that was related to an order of magnitude higher dust deposition obscured seasonal and temporal rearrangements in microbial communities. Although dust particle and associated cell deposition rates were highly correlated, seasonal dust communities of bacteria were distinct and differed significantly from recipient soil communities. Analysis of closest relatives to dust OTUs, HYSPLIT back-calculation of airmass trajectories and small dust particle size (4-12 mu m) suggested that the deposited dust and microbes came from distant continental, lacustrine and marine sources, e. g. Sahara, India, Caspian Sea and Tibetan plateau. Cyanobacteria represented less than 0.5% of microbial communities suggesting that the microbial communities benefitted from (co)deposited carbon which was reflected in the psychrotolerant nature of dust-particle associated bacteria. Conclusions/Significance: The spatial, environmental and temporal complexity of the high-altitude soils of the Himalaya generates ongoing disturbance and colonization events that subject heterogeneous microniches to stochastic colonization by far away dust associated microbes and result in the observed spatially divergent bacterial communities.	[Stres, Blaz] Univ Ljubljana, Dept Anim Sci, Domzale, Slovenia; [Sul, Woo Jun; Tiedje, James M.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Sul, Woo Jun] Chung Ang Univ, Dept Syst Biotechnol, Anseong, South Korea; [Murovec, Bostjan] Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia	University of Ljubljana; Michigan State University; Chung Ang University; University of Ljubljana	Tiedje, JM (corresponding author), Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.	tiedjej@msu.edu	Sul, Woo Jun/A-9291-2012; Stres, Blaz/AAF-7279-2020	Sul, Woo Jun/0000-0002-7016-1454; Stres, Blaz/0000-0003-2972-2907	U.S. Department of Energy, Office of Science [DE-SC000460]; World Class University program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [R33-10076]; Slovenian Research Agency [PO-0562-0481]	U.S. Department of Energy, Office of Science(United States Department of Energy (DOE)); World Class University program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The authors acknowledge financial support from the U.S. Department of Energy, Office of Science, grant DE-SC000460, the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R33-10076) and Slovenian Research Agency contract PO-0562-0481. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato P, 2007, FEMS MICROBIOL ECOL, V59, P242, DOI 10.1111/j.1574-6941.2006.00199.x; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bahadur J, 1993, IAHS PUBL, V218; Bardgett RD, 2007, BIOLOGY LETT, V3, P487, DOI 10.1098/rsbl.2007.0242; Barros AP, 2004, NAT HAZARD EARTH SYS, V4, P29, DOI 10.5194/nhess-4-29-2004; Bhattarai BK, 2011, ADV ATMOS SCI, V28, P789, DOI 10.1007/s00376-010-9222-0; Bloem J., 1995, MOL MICROBIAL ECOLOG, P1; Bonasoni P, 2010, ATMOS CHEM PHYS, V10, P7515, DOI 10.5194/acp-10-7515-2010; Carrico CM, 2003, ATMOS ENVIRON, V37, P2811, DOI 10.1016/S1352-2310(03)00197-3; Chatterjee A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011122; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Creamean JM, 2013, SCIENCE, V339, P1572, DOI 10.1126/science.1227279; Das PK, 1972, MONSOONS; Decesari S, 2009, ATMOS CHEM PHYS DISC, V9, P25487, DOI DOI 10.5194/ACPD-9-25487-2009; DeLeon-Rodriguez N, 2013, P NATL ACAD SCI USA, V110, P2575, DOI 10.1073/pnas.1212089110; Formenti P, 2011, ATMOS CHEM PHYS, V11, P8231, DOI 10.5194/acp-11-8231-2011; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hara K, 2012, ATMOS ENVIRON, V47, P20, DOI 10.1016/j.atmosenv.2011.11.050; Hidy GM, 2003, ATMOS ENVIRON, V37, P1231, DOI 10.1016/S1352-2310(02)01024-5; Huneeus N, 2011, ATMOS CHEM PHYS, V11, P7781, DOI 10.5194/acp-11-7781-2011; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Kansakar SR, 2004, INT J CLIMATOL, V24, P1645, DOI 10.1002/joc.1098; Kastovska K, 2005, MICROB ECOL, V50, P396, DOI 10.1007/s00248-005-0246-4; Kellenberg TW, 2006, OBJECT ORIENTED LAND; Kessler MA, 2003, SCIENCE, V299, P380, DOI 10.1126/science.1077309; King AJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1055; Kok JF, 2011, P NATL ACAD SCI USA, V108, P1016, DOI 10.1073/pnas.1014798108; Lang TJ, 2004, J METEOROL SOC JPN, V82, P829, DOI 10.2151/jmsj.2004.829; Lee HN, 2006, WATER AIR SOIL POLL, V169, P137, DOI 10.1007/s11270-006-1895-8; Liu Y, 2009, FRONT EARTH SCI CHIN, V3, P80, DOI [DOI 10.1007/S11707-009-0016-6, 10.1007/s11707-009-0016-6]; Liu Z, 2008, ATMOS CHEM PHYS, V8, P5045, DOI 10.5194/acp-8-5045-2008; Matsuoka N, 2001, EARTH-SCI REV, V55, P107, DOI 10.1016/S0012-8252(01)00057-5; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mori I, 2002, ATMOS ENVIRON, V36, P4569, DOI 10.1016/S1352-2310(02)00489-2; Mori I, 2003, ATMOS ENVIRON, V37, P4253, DOI 10.1016/S1352-2310(03)00535-1; Morris CE, 2011, BIOGEOSCIENCES, V8, P17, DOI 10.5194/bg-8-17-2011; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nickling W.G., 2009, GEOMORPHOLOGY DESERT, P517; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Sapkota A, 2007, HOLOCENE, V17, P561, DOI 10.1177/0959683607078981; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt SK, 2008, P ROY SOC B-BIOL SCI, V275, P2793, DOI 10.1098/rspb.2008.0808; Schutte UME, 2010, MOL ECOL, V19, P54, DOI 10.1111/j.1365-294X.2009.04479.x; Schutte UME, 2009, ISME J, V3, P1258, DOI 10.1038/ismej.2009.71; Singh S, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004854; Smith DJ, 2012, MICROB ECOL, V64, P973, DOI 10.1007/s00248-012-0088-9; Smith TW, 2010, ECOGRAPHY, V33, P648, DOI 10.1111/j.1600-0587.2009.06105.x; Stres B, 2010, FEMS MICROBIOL ECOL, V74, P323, DOI 10.1111/j.1574-6941.2010.00951.x; Sul WJ, 2011, P NATL ACAD SCI USA, V108, P14637, DOI 10.1073/pnas.1111435108; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Thomas JK, 2005, OVERVIEW GLACIERS GL; WAKE CP, 1994, TELLUS B, V46, P220, DOI 10.1034/j.1600-0889.1994.t01-2-00005.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Wu GJ, 2010, TELLUS B, V62, P197, DOI [10.1111/j.1600-0889.2010.00457.x, 10.1111/J.1600-0889.2010.00457.x]; Wu GJ, 2009, J GLACIOL, V55, P859, DOI 10.3189/002214309790152492; Xiang SR, 2009, FEMS MICROBIOL ECOL, V70, P165, DOI 10.1111/j.1574-6941.2009.00759.x; Yamaguchi N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00525; Yoshimura Y, 1997, ARCTIC ALPINE RES, V29, P126, DOI 10.2307/1551843	64	46	48	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76440	10.1371/journal.pone.0076440	http://dx.doi.org/10.1371/journal.pone.0076440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086740	gold, Green Submitted, Green Published			2022-12-25	WOS:000325220000066
J	Venhoranta, H; Pausch, H; Wysocki, M; Szczerbal, I; Hanninen, R; Taponen, J; Uimari, P; Flisikowski, K; Lohi, H; Fries, R; Switonski, M; Andersson, M				Venhoranta, Heli; Pausch, Hubert; Wysocki, Michal; Szczerbal, Izabela; Hanninen, Reetta; Taponen, Juhani; Uimari, Pekka; Flisikowski, Krzysztof; Lohi, Hannes; Fries, Ruedi; Switonski, Marek; Andersson, Magnus			Ectopic KIT Copy Number Variation Underlies Impaired Migration of Primordial Germ Cells Associated with Gonadal Hypoplasia in Cattle (Bos taurus)	PLOS ONE			English	Article							WHITE COAT COLOR; C-KIT; PHENOTYPE; INDICUS; BULLS; TOOL; XY	Impaired migration of primordial germ cells during embryonic development causes hereditary gonadal hypoplasia in both sexes of Northern Finncattle and Swedish Mountain cattle. The affected gonads exhibit a lack of or, in rare cases, a reduced number of germ cells. Most affected animals present left-sided gonadal hypoplasia. However, right-sided and bilateral cases are also found. This type of gonadal hypoplasia prevails in animals with white coat colour. Previous studies indicated that gonadal hypoplasia is inherited in an autosomal recessive fashion with incomplete penetrance. In order to identify genetic regions underlying gonadal hypoplasia, a genome-wide association study (GWAS) and a copy number variation (CNV) analysis were performed with 94 animals, including 21 affected animals, using bovine 777,962 SNP arrays. The GWAS and CNV results revealed two significantly associated regions on bovine chromosomes (BTA) 29 and 6, respectively (P=2.19 x 10(-13) and P=5.65 x 10(-6)). Subsequent cytogenetic and PCR analyses demonstrated that homozygosity of a similar to 500 kb chromosomal segment translocated from BTA6 to BTA29 (Cs-29 allele) is the underlying genetic mechanism responsible for gonadal hypoplasia. The duplicated segment includes the KIT gene that is known to regulate the migration of germ cells and precursors of melanocytes. This duplication is also one of the two translocations associated with colour sidedness in various cattle breeds.	[Venhoranta, Heli; Taponen, Juhani; Andersson, Magnus] Univ Helsinki, Dept Prod Anim Med, Saarentaus, Finland; [Pausch, Hubert; Wysocki, Michal; Fries, Ruedi] Tech Univ Munich, Chair Anim Breeding, Freising Weihenstephan, Germany; [Szczerbal, Izabela; Switonski, Marek] Univ Life Sci, Dept GeneticsandAnim Breeding, Poznan, Poland; [Hanninen, Reetta; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Res Programs Unit, Helsinki, Finland; [Hanninen, Reetta; Lohi, Hannes] Folkhalsan Res Inst, Helsinki, Finland; [Uimari, Pekka] Agrifood Res Finland, MTT, Biotechnol & Food Res, Jokioinen, Finland; [Flisikowski, Krzysztof] Tech Univ Munich, Chair Livestock Biotechnol, Freising Weihenstephan, Germany	University of Helsinki; Technical University of Munich; Poznan University of Life Sciences; University of Helsinki; Folkhalsan Research Center; Natural Resources Institute Finland (Luke); Technical University of Munich	Venhoranta, H (corresponding author), Univ Helsinki, Dept Prod Anim Med, Saarentaus, Finland.	heli.venhoranta@helsinki.fi	Pausch, Hubert/B-7637-2018; Lohi, Hannes/F-4596-2011; Szczerbal, Izabela/AFM-9268-2022; Pausch, Hubert/U-5934-2019	Lohi, Hannes/0000-0003-1087-5532; Pausch, Hubert/0000-0002-0501-6760; Fries, Ruedi/0000-0002-4657-1787; Uimari, Pekka/0000-0002-5349-3932; Szczerbal, Izabela/0000-0002-4238-0414; Switonski, Marek/0000-0003-2539-9508	Academy of Finland; Finnish Veterinary Foundation; Orion-Farmos research foundation; Emil Aaltonen Foundation; Niemi Foundation; German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding"	Academy of Finland(Academy of Finland); Finnish Veterinary Foundation; Orion-Farmos research foundation; Emil Aaltonen Foundation; Niemi Foundation; German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding"	Funding from the Academy of Finland, Finnish Veterinary Foundation, Orion-Farmos research foundation, Emil Aaltonen Foundation and Niemi Foundation is highly appreciated. HP was funded by the German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 1999, EQUINE VET J, V31, P336, DOI 10.1111/j.2042-3306.1999.tb03813.x; Bernex F, 1996, DEVELOPMENT, V122, P3023; Bidarkar Sandeep S, 2005, Semin Pediatr Surg, V14, P118, DOI 10.1053/j.sempedsurg.2005.01.008; Brenig B, 2013, ANIM GENET, V44, P450, DOI 10.1111/age.12029; BUEHR M, 1993, DEV DYNAM, V198, P182, DOI 10.1002/aja.1001980304; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Durkin K, 2012, NATURE, V482, P81, DOI 10.1038/nature10757; Eriksson K, 1943, LUND HAKAN OHLSSONS, V155; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Haase B, 2009, ANIM GENET, V40, P623, DOI 10.1111/j.1365-2052.2009.01893.x; KAY GW, 1985, S AFR J ANIM SCI, V15, P58; KAY GW, 1992, J REPROD FERTIL, V96, P537; Lachman HM, 2007, AM J MED GENET B, V144B, P259, DOI 10.1002/ajmg.b.30498; Lagerlof N., 1961, Zuchthygiene, Fortpflanzungsstorungen und Besamung der Haustiere, V5, P141; LAGERLOF N, 1953, CORNELL VET, V43, P64; LAGERLOF N, 1953, CORNELL VET, V43, P52; LAUVERGNE JJ, 1970, J HERED, V61, P43, DOI 10.1093/oxfordjournals.jhered.a108031; Makinen A, 1999, EQUINE VET J, V31, P346, DOI 10.1111/j.2042-3306.1999.tb03829.x; Marklund S, 1998, GENOME RES, V8, P826, DOI 10.1101/gr.8.8.826; Moller MJ, 1996, MAMM GENOME, V7, P822, DOI 10.1007/s003359900244; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; OGAWA M, 1993, DEVELOPMENT, V117, P1089; Olson T, 1999, GENETICS OF CATTLE, P33; Palmieri C, 2011, THERIOGENOLOGY, V75, P393, DOI 10.1016/j.theriogenology.2010.09.020; Pretorius A, 1979, AFRIKANERBEES JOERNA, V25, P40; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Romagnoli S, 2006, VET CLIN N AM-SMALL, V36, P573, DOI 10.1016/j.cvsm.2005.12.007; Rozen S, 2000, Methods Mol Biol, V132, P365; Settergren I, 1964, STOCKH ALMQVIST WIKS, V108; Tarbashevich K, 2010, CURR OPIN CELL BIOL, V22, P715, DOI 10.1016/j.ceb.2010.09.005; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weksberg R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-180; Wriedt C, 1925, J HERED, V16, P51, DOI 10.1093/oxfordjournals.jhered.a102551; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	37	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75659	10.1371/journal.pone.0075659	http://dx.doi.org/10.1371/journal.pone.0075659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086604	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000032
J	Moon, SH; Kim, SM; Park, SJ; Kim, H; Bae, D; Choi, YS; Chung, HM				Moon, Sung-Hwan; Kim, Sun-Mi; Park, Soon-Jung; Kim, Hojin; Bae, Daekyeong; Choi, Yong-Soo; Chung, Hyung-Min			Development of a Xeno-Free Autologous Culture System for Endothelial Progenitor Cells Derived from Human Umbilical Cord Blood	PLOS ONE			English	Article							INDUCED PLURIPOTENT STEM; MOUSE MODEL; NEOVASCULARIZATION; TRANSPLANTATION; DIFFERENTIATION; IDENTIFICATION; PRECURSOR; SERUM	Despite promising preclinical outcomes in animal models, a number of challenges remain for human clinical use. In particular, expanding a large number of endothelial progenitor cells (EPCs) in vitro in the absence of animal-derived products is the most critical hurdle remaining to be overcome to ensure the safety and efficiency of human therapy. To develop in vitro culture conditions for EPCs derived from human cord blood (hCB-EPCs), we isolated extracts (UCE) and collagen (UC-collagen) from umbilical cord tissue to replace their animal-derived counterparts. UC-collagen and UCE efficiently supported the attachment and proliferation of hCB-EPCs in a manner comparable to that of animal-derived collagen in the conventional culture system. Our developed autologous culture system maintained the typical characteristics of hCB-EPCs, as represented by the expression of EPC-associated surface markers. In addition, the therapeutic potential of hCB-EPCs was confirmed when the transplantation of hCB-EPCs cultured in this autologous culture system promoted limb salvage in a mouse model of hindlimb ischemia and was shown to contribute to attenuating muscle degeneration and fibrosis. We suggest that the umbilical cord represents a source for autologous biomaterials for the in vitro culture of hCB-EPCs. The main characteristics and therapeutic potential of hCB-EPCs were not compromised in developed autologous culture system. The absence of animal-derived products in our newly developed in vitro culture removes concerns associated with secondary contamination. Thus, we hope that this culture system accelerates the realization of therapeutic applications of autologous hCB-EPCs for human vascular diseases.	[Moon, Sung-Hwan; Park, Soon-Jung; Chung, Hyung-Min] Konkuk Univ, Sch Med, Dept Stem Cell Biol, Seoul, South Korea; [Kim, Sun-Mi; Kim, Hojin; Choi, Yong-Soo] CHA Univ, Dept Appl Biosci, Songnam, South Korea; [Park, Soon-Jung; Bae, Daekyeong; Choi, Yong-Soo; Chung, Hyung-Min] CHA Bio & Diostech Co Ltd, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Pochon Cha University	Choi, YS (corresponding author), CHA Univ, Dept Appl Biosci, Songnam, South Korea.	yschoi@cha.ac.kr; stemchung@gmail.com		Choi, Yong-Soo/0000-0001-8445-8067; Moon, Sunghwan/0000-0003-1858-0261	Bio & Medical Technology Development Program of the National Research Foundation (NRF); South Korean government (MEST) [2011-0019487]	Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); South Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF), which is funded by the South Korean government (MEST) (No. 2011-0019487). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151; Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770; Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038; Choi JS, 2009, J CONTROL RELEASE, V139, P2, DOI 10.1016/j.jconrel.2009.05.034; Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Escobedo-Lucea C, 2010, METHODS MOL BIOL, V584, P55, DOI 10.1007/978-1-60761-369-5_3; Fadini GP, 2008, DIABETOLOGIA, V51, P1091, DOI 10.1007/s00125-008-1021-0; Finney MR, 2006, BIOL BLOOD MARROW TR, V12, P585, DOI 10.1016/j.bbmt.2005.12.037; GIARD DJ, 1987, IN VITRO CELL DEV B, V23, P691, DOI 10.1007/BF02620982; Hattori F, 2012, TRANSPLANT REV-ORLAN, V26, P223, DOI 10.1016/j.trre.2011.09.003; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kawamoto A, 2009, STEM CELLS, V27, P2857, DOI 10.1002/stem.207; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376; Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014; Masuda H, 2003, CARDIOVASC RES, V58, P390, DOI 10.1016/S0008-6363(02)00785-X; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Moon SH, 2011, BIOMATERIALS, V32, P6445, DOI 10.1016/j.biomaterials.2011.05.026; Okano S, 2006, AM J VET RES, V67, P1020, DOI 10.2460/ajvr.67.6.1020; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Shin KS, 2010, CELL PROLIFERAT, V43, P435, DOI 10.1111/j.1365-2184.2010.00693.x; Sobolewski K, 1997, BIOL NEONATE, V71, P11; Suarez Y, 2007, J IMMUNOL, V179, P7488, DOI 10.4049/jimmunol.179.11.7488; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang XG, 2007, J AM COLL CARDIOL, V49, P1566, DOI 10.1016/j.jacc.2006.12.037; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zisch AH, 2004, CURR OPIN BIOTECH, V15, P424, DOI 10.1016/j.copbio.2004.08.005	33	8	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75224	10.1371/journal.pone.0075224	http://dx.doi.org/10.1371/journal.pone.0075224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086472	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200030
J	Wang, Q; Xiang, B; Deng, W; Wu, JY; Li, ML; Ma, XH; Wang, YC; Jiang, LJ; McAlonan, G; Chua, SE; Sham, PC; Hu, X; Li, T				Wang, Qiang; Xiang, Bo; Deng, Wei; Wu, Junyao; Li, Mingli; Ma, Xiaohong; Wang, Yingcheng; Jiang, Lijun; McAlonan, Grainne; Chua, Siew E.; Sham, Pak C.; Hu, Xun; Li, Tao			Genome-Wide Association Analysis with Gray Matter Volume as a Quantitative Phenotype in First-Episode Treatment-Naive Patients with Schizophrenia	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; CYTOARCHITECTONIC MAPS; ONSET SCHIZOPHRENIA; COMMON VARIANTS; ABNORMALITIES; GENETICS; GENES; HIPPOCAMPAL; THROMBOXANE; INFARCTION	Reduced Gray matter (GM) volume is a core feature of schizophrenia. Mapping genes that is associated with the heritable disease-related phenotypes may be conducive to elucidate the pathogenesis of schizophrenia. This study aims to identify the common genetic variants that underlie the deficits of GM volume in schizophrenia. High-resolution T1 images and whole genome genotyping data were obtained from 74 first-episode treatment-naive patients with schizophrenia and 51 healthy controls in the Mental Health Centre of the West China Hospital, Sichuan University. All participants were scanned using a 3T MR imaging system and were genotyped using the HumanHap660 Bead Array. Reduced GM volumes in three brain areas including left hOC3v in the collateral sulcus of visual cortex (hOC3vL), left cerebellar vermis lobule 10 (vermisL10) and right cerebellar vermis lobule 10 (vermisR10) were found in patients with schizophrenia. There was a group by genotype interaction when genotypes from genome-wide scan were subsequently considered in the case-control analyses. SNPs from three genes or chromosomal regions (TBXAS1, PIK3C2G and HS3ST5) were identified to predict the changes of GM volume in hOC3vL, vermisL10 and vermisR10. These results also highlighted the usefulness of endophenotype in exploring the pathogenesis of neuropsychiatric diseases such as schizophrenia although further independent replication studies are needed in the future.	[Wang, Qiang; Deng, Wei; Li, Mingli; Ma, Xiaohong; Wang, Yingcheng; Jiang, Lijun; Li, Tao] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu 610064, Sichuan, Peoples R China; [Xiang, Bo; Wu, Junyao; Ma, Xiaohong; Wang, Yingcheng; Li, Tao] Sichuan Univ, West China Hosp, Psychiat Lab, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Chua, Siew E.; Sham, Pak C.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [McAlonan, Grainne] Kings Coll London, Inst Psychiat, Dept Forens & Neurodev Sci, London, England; [Hu, Xun] Sichuan Univ, West China Hosp, Biobank, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; University of Hong Kong; University of London; King's College London; Sichuan University	Hu, X (corresponding author), Sichuan Univ, West China Hosp, Biobank, Chengdu 610064, Sichuan, Peoples R China.	hxxhu99@163.com; litaohx@scu.edu.cn	Deng, Wei/AAU-9945-2020; Deng, Wei/GWC-9207-2022; McAlonan, Grainne/G-1541-2011	McAlonan, Grainne/0000-0002-4466-2343; Li, Tao/0000-0003-3831-901X; Ma, Xiaohong/0000-0003-2627-9946	National Nature Science Foundation of China [81130024, 30530300, 30125014, 30971056, 81271479]; National Basic Research Program of China (973 Program) [2007CB512301]; Ph.D. Programs Foundation of Ministry of Education of China [20110181110014]; National Key Technology R & D Program of the Ministry of Science and Technology of China [2012BAI01B06]; NARSAD Independent Investigator Award; Wellcome Trust (International Collaborative award)	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); National Key Technology R & D Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); NARSAD Independent Investigator Award(NARSAD); Wellcome Trust (International Collaborative award)(Wellcome Trust)	This work was partly funded by National Nature Science Foundation of China (81130024, 30530300 and 30125014, T. L.); the National Basic Research Program of China (973 Program 2007CB512301, T. L.), the Ph.D. Programs Foundation of Ministry of Education of China (20110181110014, T. L.), National Key Technology R & D Program of the Ministry of Science and Technology of China during the 12th Five-Year Plan (2012BAI01B06, T. L.), NARSAD Independent Investigator Award (T. L.), and the Wellcome Trust (International Collaborative award to T. L. and D. A. C.); National Nature Science Foundation of China (30971056 and 81271479, Q. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Brown GG, 2011, PSYCHIAT RES-NEUROIM, V194, P149, DOI 10.1016/j.pscychresns.2011.05.005; Brun CC, 2009, NEUROIMAGE, V48, P37, DOI 10.1016/j.neuroimage.2009.05.022; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Dutt A, 2009, PSYCHOL MED, V39, P1783, DOI 10.1017/S0033291709990316; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; GOTTESMAN II, 1987, SCHIZOPHRENIA BULL, V13, P23, DOI 10.1093/schbul/13.1.23; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Hu MR, 2013, SCHIZOPHR RES, V144, P37, DOI 10.1016/j.schres.2012.12.018; Jacobson S, 2010, NEUROIMAGE, V49, P1875, DOI 10.1016/j.neuroimage.2009.09.015; Jungerius BJ, 2008, MOL PSYCHIATR, V13, P1060, DOI 10.1038/sj.mp.4002080; Kakeda S, 2010, NEURORADIOLOGY, V52, P711, DOI 10.1007/s00234-010-0717-2; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Leung M, 2011, SCHIZOPHRENIA BULL, V37, P199, DOI 10.1093/schbul/sbp099; Li MX, 2009, BIOINFORMATICS, V25, P1449, DOI 10.1093/bioinformatics/btp183; Maloku E, 2011, NEUROPSYCHOPHARMACOL, V36, P1366, DOI 10.1038/npp.2011.21; Matsuo K, 2009, NEUROPSYCHOPHARMACOL, V34, P1904, DOI 10.1038/npp.2009.23; McGuffin P, 1999, NEW ENGL J MED, V341, P370; Miyata J, 2009, SCHIZOPHR RES, V111, P78, DOI 10.1016/j.schres.2009.03.010; Mochizuki H, 2003, J BIOL CHEM, V278, P26780, DOI 10.1074/jbc.M301861200; Owen MJ, 2004, MOL PSYCHIATR, V9, P14, DOI 10.1038/sj.mp.4001444; Park SA, 2009, BMB REP, V42, P200, DOI 10.5483/BMBRep.2009.42.4.200; Penttila J, 2008, J AM ACAD CHILD PSY, V47, P1125, DOI 10.1097/CHI.0b013e3181825aa7; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rametti G, 2010, SCHIZOPHR RES, V121, P66, DOI 10.1016/j.schres.2010.05.016; Rasser PE, 2010, NEUROIMAGE, V53, P1175, DOI 10.1016/j.neuroimage.2010.07.018; Rijsdijk FV, 2005, PSYCHOL MED, V35, P1399, DOI 10.1017/S0033291705005167; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rottschy C, 2007, HUM BRAIN MAPP, V28, P1045, DOI 10.1002/hbm.20348; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Stein JL, 2010, NEUROIMAGE, V53, P1160, DOI 10.1016/j.neuroimage.2010.02.032; Takao H, 2010, J MAGN RESON IMAGING, V31, P221, DOI 10.1002/jmri.22017; Tsujita Y, 2000, ATHEROSCLEROSIS, V153, P261, DOI 10.1016/S0021-9150(00)00593-1; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Voets NL, 2008, NEUROIMAGE, V43, P665, DOI 10.1016/j.neuroimage.2008.08.013; Watson DR, 2012, BEHAV BRAIN RES, V227, P91, DOI 10.1016/j.bbr.2011.10.034; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979	49	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75083	10.1371/journal.pone.0075083	http://dx.doi.org/10.1371/journal.pone.0075083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086445	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200024
J	Errington, TM; Macara, IG				Errington, Timothy M.; Macara, Ian G.			Depletion of the Adaptor Protein NCK Increases UV-Induced p53 Phosphorylation and Promotes Apoptosis	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; ATM; IDENTIFICATION; EXPRESSION; DOMAIN; INHIBITION; REVEALS; BINDING; BREAKS; GENES	The cellular response to DNA damage requires the coordination of many proteins involved in diverse molecular processes. Discrete molecular pathways are becoming increasingly well understood, but the interconnectivity and coordination of multiple pathways remains less clear. We now show that NCK, an adapter protein involved in cytoskeletal responses to tyrosine kinase receptor signaling, accumulates in the nucleus in response to DNA damage and this translocation can be blocked by specific inhibition of the ATR protein kinase. Strikingly, HeLa cells depleted of NCK undergo apoptosis shortly after UV irradiation, as monitored by caspase-3 cleavage and PARP cleavage. This rapid, hyperactive apoptosis in NCK depleted cells might be p53 dependent, because loss of NCK also increased UV-induced p53 phosphorylation. Importantly, depletion of SOCS7, which is necessary for NCK nuclear translocation, phenocopies NCK depletion, indicating the nuclear accumulation of NCK is responsible for these molecular events. There are two NCK isoforms that have mostly redundant functions, and although NCK2 appears to have a greater contribution, depletion of NCK1 or NCK2, led to increased p53 phosphorylation and early apoptosis after UV exposure. These data reveal a novel function for NCK in regulating p53 phosphorylation and apoptosis, and provide evidence for interconnectedness of growth factor signaling proteins and the DNA damage response.	[Errington, Timothy M.] Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Macara, Ian G.] Vanderbilt Univ, Ctr Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	University of Virginia; Vanderbilt University	Macara, IG (corresponding author), Vanderbilt Univ, Ctr Med, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	ian.g.macara@vanderbilt.edu		Errington, Tim/0000-0002-4959-5143	National Institutes of Health, DHHS [RO1GM50526]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066306, R01GM050526] Funding Source: NIH RePORTER	National Institutes of Health, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, DHHS, through grant RO1GM50526. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Braverman LE, 1999, J BIOL CHEM, V274, P5542, DOI 10.1074/jbc.274.9.5542; Buday L, 1999, BBA-REV BIOMEMBRANES, V1422, P187, DOI 10.1016/S0304-4157(99)00005-2; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; Chen M, 1998, J BIOL CHEM, V273, P25171, DOI 10.1074/jbc.273.39.25171; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Dogusan Z, 2000, J NEUROIMMUNOL, V109, P34, DOI 10.1016/S0165-5728(00)00300-3; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hussain S. Perwez, 2006, Journal of Nippon Medical School, V73, P54; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Labelle-Cote M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-443; Lal A, 2005, MOL CELL PROBE, V19, P385, DOI 10.1016/j.mcp.2005.06.007; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; LEHMANN JM, 1990, NUCLEIC ACIDS RES, V18, P1048, DOI 10.1093/nar/18.4.1048; Lettau M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-1; Liu WJ, 2008, CARCINOGENESIS, V29, P263, DOI 10.1093/carcin/bgm251; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Matuoka K, 1997, BIOCHEM BIOPH RES CO, V239, P488, DOI 10.1006/bbrc.1997.7492; McCarty JH, 1998, BIOESSAYS, V20, P913, DOI 10.1002/(SICI)1521-1878(199811)20:11<913::AID-BIES6>3.0.CO;2-T; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1998, CANCER RES, V58, P4375; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Smith JA, 2005, CANCER RES, V65, P1027; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200	37	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76204	10.1371/journal.pone.0076204	http://dx.doi.org/10.1371/journal.pone.0076204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086708	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200131
J	Gil-Mohapel, J; Brocardo, PS; Choquette, W; Gothard, R; Simpson, JM; Christie, BR				Gil-Mohapel, Joana; Brocardo, Patricia S.; Choquette, Will; Gothard, Russ; Simpson, Jessica M.; Christie, Brian R.			Hippocampal Neurogenesis Levels Predict WATERMAZE Search Strategies in the Aging Brain	PLOS ONE			English	Article							GENERATED GRANULE CELLS; TRANSGENIC MOUSE MODEL; AGE-RELATED DECLINE; DENTATE GYRUS; ADULT NEUROGENESIS; SYNAPTIC PLASTICITY; LIFE-SPAN; DIETARY RESTRICTION; VOLUNTARY EXERCISE; PRENATAL STRESS	The hippocampus plays a crucial role in the formation of spatial memories, and it is thought that adult hippocampal neurogenesis may participate in this form of learning. To better elucidate the relationship between neurogenesis and spatial learning, we examined both across the entire life span of mice. We found that cell proliferation, neuronal differentiation, and neurogenesis significantly decrease with age, and that there is an abrupt reduction in these processes early on, between 1.5-3 months of age. After this, the neurogenic capacity continues to decline steadily. The initial abrupt decline in adult neurogenesis was paralleled by a significant reduction in Morris Water Maze performance, however overall learning and memory remained constant thereafter. Further analysis of the search strategies employed revealed that reductions in neurogenesis in the aging brain were strongly correlated with the adoption of spatially imprecise search strategies. Overall, performance measures of learning and memory in the Morris Water Maze were maintained at relatively constant levels in aging animals due to an increase in the use of spatially imprecise search strategies.	[Gil-Mohapel, Joana; Brocardo, Patricia S.; Choquette, Will; Gothard, Russ; Simpson, Jessica M.; Christie, Brian R.] Univ Victoria, Isl Med Program, Div Med Sci, Victoria, BC, Canada; [Choquette, Will; Simpson, Jessica M.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Gothard, Russ] Univ Victoria, Dept Psychol, Victoria, BC, Canada; [Christie, Brian R.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Christie, Brian R.] Univ British Columbia, Program Neurosci, Vancouver, BC V5Z 1M9, Canada; [Christie, Brian R.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of Victoria; University of Victoria; University of Victoria; University of British Columbia; University of British Columbia; University of British Columbia	Christie, BR (corresponding author), Univ Victoria, Isl Med Program, Div Med Sci, Victoria, BC, Canada.	brain64@uvic.ca	Brocardo, Patricia S/N-8522-2016; Christie, Brian Ross/AAF-3766-2019; Gil-Mohapel, Joana/AAP-8871-2021; S Brocardo, Patricia/N-7407-2018	Christie, Brian Ross/0000-0002-6830-0160; Gil-Mohapel, Joana/0000-0003-4982-1662; S Brocardo, Patricia/0000-0002-1680-5909	Natural Sciences and Engineering Research Council of Canada (NSERC); Michael Smith Foundation for Health Research (MSFHR); Canadian Bureau for International Education; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Counsel of Technological and Scientific Development, Brazil); NSERC; MSFHR; Canadian Institutes of Health Research (CIHR); Canada Foundation for Innovation (CFI)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canadian Bureau for International Education; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Counsel of Technological and Scientific Development, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); MSFHR(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	J.G.M. acknowledges postdoctoral funding from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Michael Smith Foundation for Health Research (MSFHR). P. S. B. acknowledges post-doctoral funding from the Canadian Bureau for International Education and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Counsel of Technological and Scientific Development, Brazil). J.M.S. was supported by scholarships from NSERC and MSFHR. B. R. C. is a Michael Smith Senior Scholar and is supported by grants from NSERC, the Canadian Institutes of Health Research (CIHR), MSFHR, and the Canada Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Alpar A, 2010, BRAIN RES, V1330, P9, DOI 10.1016/j.brainres.2010.03.026; ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amrein I, 2010, BRAIN RES, V1328, P12, DOI 10.1016/j.brainres.2010.02.075; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Bizon JL, 2004, AGING CELL, V3, P227, DOI 10.1111/j.1474-9728.2004.00099.x; Bohbot VD, 2007, HIPPOCAMPUS, V17, P863, DOI 10.1002/hipo.20313; Bondolfi L, 2004, NEUROBIOL AGING, V25, P333, DOI 10.1016/S0197-4580(03)00083-6; Brocardo P., 2012, NEUROGENESIS RES NEW, P1; BROCARDO PS, 2012, COGNITIVE BEHAV THER, P37; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Brunet JF, 1999, BIOESSAYS, V21, P313, DOI 10.1002/(SICI)1521-1878(199904)21:4<313::AID-BIES7>3.0.CO;2-C; Burgess N, 2002, Q J EXP PSYCHOL-A, V55, P1057, DOI 10.1080/02724980244000224; Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Clapcote SJ, 2004, BEHAV BRAIN RES, V152, P35, DOI 10.1016/j.bbr.2003.09.030; Cooper-Kuhn CM, 2002, DEV BRAIN RES, V134, P13, DOI 10.1016/S0165-3806(01)00243-7; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Epp JR, 2010, HIPPOCAMPUS, V20, P866, DOI 10.1002/hipo.20692; Epp JR, 2009, HIPPOCAMPUS, V19, P1040, DOI 10.1002/hipo.20546; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Flurkey K, 2007, FACULTY RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; GILMOHAPEL J, 2010, ADULT NEUROGENESIS C, P125; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Harrist A, 2004, SYNAPSE, V54, P200, DOI 10.1002/syn.20081; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jabes A, 2010, EUR J NEUROSCI, V31, P273, DOI 10.1111/j.1460-9568.2009.07061.x; James LE, 2001, PSYCHOL SCI, V12, P485, DOI 10.1111/1467-9280.00390; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kannangara TS, 2011, NEUROBIOL AGING, V32, P2279, DOI 10.1016/j.neurobiolaging.2009.12.025; Kannangara TS, 2009, HIPPOCAMPUS, V19, P889, DOI 10.1002/hipo.20514; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kee N, 2007, NAT PROTOC, V2, P3033, DOI 10.1038/nprot.2007.415; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1998, NAT MED, V4, P555, DOI 10.1038/nm0598-555; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; KEMPERMANN G, 2006, ADULT NEUROGENESIS S; Kerr AL, 2010, NEUROSCIENCE, V171, P214, DOI 10.1016/j.neuroscience.2010.08.008; Klempin F, 2007, EUR ARCH PSY CLIN N, V257, P271, DOI 10.1007/s00406-007-0731-5; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Koehl M, 2009, EUR J NEUROSCI, V29, P635, DOI 10.1111/j.1460-9568.2009.06608.x; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lassalle JM, 2000, NEUROBIOL LEARN MEM, V73, P243, DOI 10.1006/nlme.1999.3931; Lazic SE, 2012, NEUROBIOL AGING, V33, P1664, DOI 10.1016/j.neurobiolaging.2011.03.008; Lazic SE, 2012, J R SOC INTERFACE, V9, P907, DOI 10.1098/rsif.2011.0510; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Leuner B, 2004, J NEUROSCI, V24, P7477, DOI 10.1523/JNEUROSCI.0204-04.2004; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Limoli CL, 2004, RADIAT RES, V161, P17, DOI 10.1667/RR3112; Lipp HP, 1998, CURR OPIN NEUROBIOL, V8, P272, DOI 10.1016/S0959-4388(98)80151-7; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manda K, 2009, J PINEAL RES, V46, P71, DOI 10.1111/j.1600-079X.2008.00632.x; Manev H, 2001, EUR J PHARMACOL, V411, P67, DOI 10.1016/S0014-2999(00)00904-3; Martinez-Canabal A, 2013, HIPPOCAMPUS, V23, P66, DOI 10.1002/hipo.22054; Meziane H, 2007, GENES BRAIN BEHAV, V6, P192, DOI 10.1111/j.1601-183X.2006.00249.x; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Morgenstern NA, 2008, J PHYSIOL-LONDON, V586, P3751, DOI 10.1113/jphysiol.2008.154807; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; Rivas-Arancibia S, 2010, TOXICOL SCI, V113, P187, DOI 10.1093/toxsci/kfp252; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Sharma V.K., 2009, J BIOSCI TECH, V1, P15; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Simon M, 2005, BRAIN RES, V1049, P244, DOI 10.1016/j.brainres.2005.05.006; Simpson JM, 2011, NEUROBIOL DIS, V41, P249, DOI 10.1016/j.nbd.2010.09.012; Siwak-Tapp CT, 2007, NEUROBIOL LEARN MEM, V88, P249, DOI 10.1016/j.nlm.2007.05.001; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Speisman RB, 2013, BRAIN BEHAV IMMUN, V28, P25, DOI 10.1016/j.bbi.2012.09.013; Speisman RB, 2013, NEUROBIOL AGING, V34, P263, DOI 10.1016/j.neurobiolaging.2012.05.023; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; UND V, 2007, CELL TISSUE RES, V329, P409; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Wolfer DP, 1998, EUR J NEUROSCI, V10, P708, DOI 10.1046/j.1460-9568.1998.00089.x; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008; Xavier GF, 2009, PROG NEURO-PSYCHOPH, V33, P762, DOI 10.1016/j.pnpbp.2009.03.036; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	117	74	76	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75125	10.1371/journal.pone.0075125	http://dx.doi.org/10.1371/journal.pone.0075125			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086453	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200084
J	Hiblot, J; Gotthard, G; Elias, M; Chabriere, E				Hiblot, Julien; Gotthard, Guillaume; Elias, Mikael; Chabriere, Eric			Differential Active Site Loop Conformations Mediate Promiscuous Activities in the Lactonase SsoPox	PLOS ONE			English	Article							QUORUM-QUENCHING LACTONASE; RAY DIFFRACTION ANALYSIS; DIRECTED EVOLUTION; THERMOSTABLE PHOSPHOTRIESTERASE; SULFOLOBUS-SOLFATARICUS; STRUCTURAL BASIS; CRYSTALLIZATION; HOMOLOG; MODEL	Enzymes are proficient catalysts that enable fast rates of Michaelis-complex formation, the chemical step and products release. These different steps may require different conformational states of the active site that have distinct binding properties. Moreover, the conformational flexibility of the active site mediates alternative, promiscuous functions. Here we focused on the lactonase SsoPox from Sulfolobus solfataricus. SsoPox is a native lactonase endowed with promiscuous phosphotriesterase activity. We identified a position in the active site loop (W263) that governs its flexibility, and thereby affects the substrate specificity of the enzyme. We isolated two different sets of substitutions at position 263 that induce two distinct conformational sampling of the active loop and characterized the structural and kinetic effects of these substitutions. These sets of mutations selectively and distinctly mediate the improvement of the promiscuous phosphotriesterase and oxo-lactonase activities of SsoPox by increasing active-site loop flexibility. These observations corroborate the idea that conformational diversity governs enzymatic promiscuity and is a key feature of protein evolvability.	[Hiblot, Julien; Gotthard, Guillaume; Chabriere, Eric] Univ Mediterranee, URMITE, Fac Med, CNRS IRD,UMR 6236, Marseille, France; [Elias, Mikael] Weizmann Inst Sci Biol Chem, Rehovot, Israel	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Elias, M (corresponding author), Weizmann Inst Sci Biol Chem, Rehovot, Israel.	mikael.elias@gmx.fr; eric.chabriere@univmed.fr	Hiblot, Julien/AAA-4452-2020; Elias, Mikael/AAH-9385-2021	Hiblot, Julien/0000-0002-7883-8079; Elias, Mikael/0000-0003-0406-7539	Direction Generale de l'Armement (DGA), France [REI. 2009 34 0045]; Vaincre La Mucoviscidose, France; DGA; IEF Marie Curie program [252836]	Direction Generale de l'Armement (DGA), France; Vaincre La Mucoviscidose, France; DGA; IEF Marie Curie program	This work was granted by Direction Generale de l'Armement (DGA), France (REI. 2009 34 0045) and Vaincre La Mucoviscidose, France. JH and GG are PhD students granted by DGA. ME is a fellow supported by the IEF Marie Curie program (grant No. 252836). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Afriat-Jurnou L, 2012, BIOCHEMISTRY-US, V51, P6047, DOI 10.1021/bi300694t; Amara N, 2011, CHEM REV, V111, P195, DOI 10.1021/cr100101c; Ashani Y, 2010, CHEM-BIOL INTERACT, V187, P362, DOI 10.1016/j.cbi.2010.02.039; Ben-David M, 2013, J MOL BIOL, V425, P1028, DOI 10.1016/j.jmb.2013.01.009; Ben-David M, 2012, J MOL BIOL, V418, P181, DOI 10.1016/j.jmb.2012.02.042; Chow JY, 2010, J BIOL CHEM, V285, P40911, DOI 10.1074/jbc.M110.177139; Chow JY, 2009, BIOCHEMISTRY-US, V48, P4344, DOI 10.1021/bi9004045; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Del Vecchio P, 2009, EXTREMOPHILES, V13, P461, DOI 10.1007/s00792-009-0231-9; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELLUSGUR E, 2013, J MOL BIOL; Dickschat JS, 2010, NAT PROD REP, V27, P343, DOI 10.1039/b804469b; Duan K, 2007, J BACTERIOL, V189, P4827, DOI 10.1128/JB.00043-07; DUMAS DP, 1989, J BIOL CHEM, V264, P19659; Elias M, 2008, J MOL BIOL, V379, P1017, DOI 10.1016/j.jmb.2008.04.022; Elias M, 2007, ACTA CRYSTALLOGR F, V63, P553, DOI 10.1107/S1744309107023512; Elias M, 2012, J BIOL CHEM, V287, P11, DOI 10.1074/jbc.R111.257329; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gotthard G, 2011, ACTA CRYSTALLOGR F, V67, P354, DOI 10.1107/S1744309110053819; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta RD, 2011, NAT CHEM BIOL, V7, P120, DOI [10.1038/nchembio.510, 10.1038/NCHEMBIO.510]; Hawwa R, 2009, ARCH BIOCHEM BIOPHYS, V488, P109, DOI 10.1016/j.abb.2009.06.005; Hawwa R, 2009, J MOL BIOL, V393, P36, DOI 10.1016/j.jmb.2009.06.083; Hiblot J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047028; Hiblot J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00779; Hou L, 2007, J BIOL CHEM, V282, P23264, DOI 10.1074/jbc.M700868200; Jackson CJ, 2009, P NATL ACAD SCI USA, V106, P21631, DOI 10.1073/pnas.0907548106; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; KOSHLAND DE, 1994, ANGEW CHEM INT EDIT, V33, P2375; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merone L, 2005, EXTREMOPHILES, V9, P297, DOI 10.1007/s00792-005-0445-4; Merone L, 2010, BIORESOURCE TECHNOL, V101, P9204, DOI 10.1016/j.biortech.2010.06.102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NG FS, 2010, APPL ENV MICROBIOL; Popat R, 2008, BRIT MED BULL, V87, P63, DOI 10.1093/bmb/ldn030; Porzio E, 2007, BIOCHIMIE, V89, P625, DOI 10.1016/j.biochi.2007.01.007; Roodveldt C, 2005, BIOCHEMISTRY-US, V44, P12728, DOI 10.1021/bi051021e; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Sigman JA, 2005, BIOCHEM J, V388, P255, DOI 10.1042/BJ20041481; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tokuriki N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2246; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiang DF, 2009, BIOCHEMISTRY-US, V48, P2237, DOI 10.1021/bi802274f; XUE B, 2012, BIOCHEMISTRY-US, V51, P10120, DOI DOI 10.1021/BI3011829.PUBMED:23088324	49	57	60	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75272	10.1371/journal.pone.0075272	http://dx.doi.org/10.1371/journal.pone.0075272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086491	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200095
J	Sominskaya, I; Skrastina, D; Petrovskis, I; Dishlers, A; Berza, I; Mihailova, M; Jansons, J; Akopjana, I; Stahovska, I; Dreilina, D; Ose, V; Pumpens, P				Sominskaya, Irina; Skrastina, Dace; Petrovskis, Ivars; Dishlers, Andris; Berza, Ieva; Mihailova, Maria; Jansons, Juris; Akopjana, Inara; Stahovska, Irina; Dreilina, Dzidra; Ose, Velta; Pumpens, Paul			A VLP Library of C-Terminally Truncated Hepatitis B Core Proteins: Correlation of RNA Encapsidation with a Th1/Th2 Switch in the Immune Responses of Mice	PLOS ONE			English	Article							VIRUS CORE; CAPSID PROTEIN; ESCHERICHIA-COLI; ANTIGEN; PARTICLES; EXPRESSION; SURFACE; DOMAIN; CELLS; GENE	An efficient pBR327-and Ptrp-based E. coli expression system was used to generate a large-scale library of virus like particles (VLP) formed by recombinant hepatitis B virus (HBV) core (HBc) protein derivatives. To construct the library, the gene of HBc protein of the genotype D/subtype ayw2 virus was gradually truncated from the 3'-end and twenty-two HBc variants (with truncation up to 139 aa) were expressed at high levels. The proteins were purified by salt precipitation and gel filtration. Background RNA binding was observed for VLPs formed by HBc1-149, which lacked all C-terminal Arg blocks, and the addition of three Arg residues (HBc1-152) only slightly increased RNA binding. The presence of two Arg blocks (proteins HBc1-162 and HBc1-163) resulted in approximately half of the typical level of RNA binding, and the presence of three blocks (protein HBc1-171) led to approximately 85% of the typical level of binding. Only a small increase in the level of RNA binding was found for the HBc1-175 VLPs, which contained all four Arg blocks but lacked the last 8 aa of the full-length HBc protein. VLPs containing high levels of RNA had higher antigenicity according to an ELISA with anti-HBc mAbs than the VLPs formed by HBc variants without C-terminal Arg blocks and lacking RNA. The results indicate that the VLPs were stabilised by nucleic acids. The immunogenicity in BALB/c mice was comparable for VLPs formed by different HBc proteins, but a clear switch from a Th1 response to a Th2 response occurred after the loss of encapsidated RNA. We did not observe significant differences in lymphocyte proliferation in vitro for the tested VLP variants; however, the loss of RNA encapsidation correlated with a decreased level of IFN-gamma induction, which is a measure of the potential CTL activity of immunogens.	[Sominskaya, Irina; Skrastina, Dace; Petrovskis, Ivars; Dishlers, Andris; Berza, Ieva; Mihailova, Maria; Jansons, Juris; Akopjana, Inara; Stahovska, Irina; Dreilina, Dzidra; Ose, Velta; Pumpens, Paul] Latvian Biomed Res & Study Ctr, Dept Prot Engn, Riga, Latvia	Latvian Biomedical Research & Study Centre	Dishlers, A (corresponding author), Latvian Biomed Res & Study Ctr, Dept Prot Engn, Riga, Latvia.	Irina@biomed.lu.lv	Jansons, Juris/AAJ-6158-2020; Pumpens, Paul/A-2163-2008	Jansons, Juris/0000-0003-0845-4392; Petrovskis, Ivars/0000-0002-1382-3466; Sominska, Irina/0000-0002-1932-369X; Dishlers, Andris/0000-0002-0112-3948	ERAF [2010/0224/2DP/2.1.1.1.0/10/APIA/VIAA/164 2010/0211/2DP/2.1.1.1.0/10/APIA/VIAA/048.]	ERAF	This work was supported by grants ERAF Nr. (2010/0224/2DP/2.1.1.1.0/10/APIA/VIAA/164 and 2010/0211/2DP/2.1.1.1.0/10/APIA/VIAA/048.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAMES B, 1993, VIROLOGY, V194, P597, DOI 10.1006/viro.1993.1299; BICHKO V, 1993, MOL IMMUNOL, V30, P221, DOI 10.1016/0161-5890(93)90051-C; BICHKO V, 1985, FEBS LETT, V185, P208, DOI 10.1016/0014-5793(85)80771-7; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; BORISOVA GP, 1984, DOKL AKAD NAUK SSSR+, V279, P1245; BORISOVA GP, 1988, DOKL AKAD NAUK SSSR+, V298, P1474; BUNDULE MA, 1990, DOKL AKAD NAUK SSSR+, V312, P993; Cao TH, 2001, J VIROL, V75, P6359, DOI 10.1128/JVI.75.14.6359-6366.2001; Cardinale D, 2012, TRENDS BIOTECHNOL, V30, P369, DOI 10.1016/j.tibtech.2012.04.001; Cooper A, 2005, J IMMUNOL, V175, P3165, DOI 10.4049/jimmunol.175.5.3165; CROWTHER RA, 1994, CELL, V77, P943, DOI 10.1016/0092-8674(94)90142-2; DISLERS A, 2008, DISIERS A; EDMAN JC, 1981, NATURE, V291, P503, DOI 10.1038/291503a0; Freivalds J, 2011, PROTEIN EXPRES PURIF, V75, P218, DOI 10.1016/j.pep.2010.09.010; GALLINA A, 1989, J VIROL, V63, P4645, DOI 10.1128/JVI.63.11.4645-4652.1989; HATTON T, 1992, J VIROL, V66, P5232, DOI 10.1128/JVI.66.9.5232-5241.1992; HILDITCH CM, 1990, J GEN VIROL, V71, P2755, DOI 10.1099/0022-1317-71-11-2755; Kann M, 1999, J CELL BIOL, V145, P45, DOI 10.1083/jcb.145.1.45; KENNEY JM, 1995, STRUCTURE, V3, P1009, DOI 10.1016/S0969-2126(01)00237-4; KNISKERN PJ, 1986, GENE, V46, P135, DOI 10.1016/0378-1119(86)90177-0; LANFORD RE, 1990, VIROLOGY, V176, P222, DOI 10.1016/0042-6822(90)90247-O; Lee BO, 2009, J IMMUNOL, V182, P6670, DOI 10.4049/jimmunol.0803683; MACHIDA A, 1989, MOL IMMUNOL, V26, P413; MACHIDA A, 1991, J VIROL, V65, P6024, DOI 10.1128/JVI.65.11.6024-6030.1991; Mechtcheriakova IA, 2006, J VIROL METHODS, V131, P10, DOI 10.1016/j.jviromet.2005.06.020; Milich DR, 1997, P NATL ACAD SCI USA, V94, P14648, DOI 10.1073/pnas.94.26.14648; MILICH DR, 1995, J VIROL, V69, P2776, DOI 10.1128/JVI.69.5.2776-2785.1995; MISSALE G, 1993, J EXP MED, V177, P751, DOI 10.1084/jem.177.3.751; MIYANOHARA A, 1986, J VIROL, V59, P176, DOI 10.1128/JVI.59.1.176-180.1986; NASSAL M, 1988, GENE, V66, P279, DOI 10.1016/0378-1119(88)90364-2; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; OUCHTERLONY O, 1949, ACTA PATHOL MIC SC, V26, P507; PASEK M, 1979, NATURE, V282, P575, DOI 10.1038/282575a0; Pumpens Paul, 2009, P205; PUSHKO P, 1994, VIROLOGY, V202, P912, DOI 10.1006/viro.1994.1413; Pushko P, 2013, INTERVIROLOGY, V56, P141, DOI 10.1159/000346773; Riedl P, 2002, EUR J IMMUNOL, V32, P1709, DOI 10.1002/1521-4141(200206)32:6<1709::AID-IMMU1709>3.0.CO;2-D; Riedl P, 2002, J IMMUNOL, V168, P4951, DOI 10.4049/jimmunol.168.10.4951; Rolland D, 2001, J CHROMATOGR B, V753, P51, DOI 10.1016/S0378-4347(00)00538-7; Roseman AM, 2012, J MOL BIOL, V423, P63, DOI 10.1016/j.jmb.2012.06.032; Roseman AM, 2005, P NATL ACAD SCI USA, V102, P15821, DOI 10.1073/pnas.0504874102; SEIFER M, 1994, J VIROL, V68, P5548, DOI 10.1128/JVI.68.9.5548-5555.1994; Skrastina D, 2008, VACCINE, V26, P1972, DOI 10.1016/j.vaccine.2008.02.030; Sominskaya I, 2010, CLIN VACCINE IMMUNOL, V17, P1027, DOI 10.1128/CVI.00468-09; TAKEHARA K, 1988, J GEN VIROL, V69, P2763, DOI 10.1099/0022-1317-69-11-2763; Tsuda S, 1998, VOX SANG, V74, P148, DOI 10.1046/j.1423-0410.1998.7430148.x; Vanlandschoot P, 2005, J GEN VIROL, V86, P75, DOI 10.1099/vir.0.80580-0; Watts NR, 2002, EMBO J, V21, P876, DOI 10.1093/emboj/21.5.876; Weigand K, 2010, J GEN VIROL, V91, P59, DOI 10.1099/vir.0.013698-0; Whitacre DC, 2009, EXPERT REV VACCINES, V8, P1565, DOI 10.1586/ERV.09.121; WINGFIELD PT, 1995, BIOCHEMISTRY-US, V34, P4919, DOI 10.1021/bi00015a003; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Zeltins A, 2013, MOL BIOTECHNOL, V53, P92, DOI 10.1007/s12033-012-9598-4; ZHOU S, 1992, P NATL ACAD SCI USA, V89, P10046, DOI 10.1073/pnas.89.21.10046; Zlotnick A, 1996, BIOCHEMISTRY-US, V35, P7412, DOI 10.1021/bi9604800	55	25	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75938	10.1371/journal.pone.0075938	http://dx.doi.org/10.1371/journal.pone.0075938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086668	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200126
J	Li, T; Lu, H; Shen, C; Lahiri, SK; Wason, MS; Mukherjee, D; Yu, L; Zhao, J				Li, T.; Lu, H.; Shen, C.; Lahiri, S. K.; Wason, M. S.; Mukherjee, D.; Yu, L.; Zhao, J.			Identification of epithelial stromal interaction 1 as a novel effector downstream of Kruppel-like factor 8 in breast cancer invasion and metastasis	ONCOGENE			English	Article						KLF8; EPSTI1; VCP; NF-kappa B; invasion and metastasis; breast cancer	FOCAL ADHESION KINASE; HUMAN SOMATIC-CELLS; MESENCHYMAL TRANSITION; KLF8 TRANSCRIPTION; CYCLIN D1; ACTIVATION; VCP/P97; TARGET; EPSTI1; GENE	Kruppel-like factor 8 (KLF8) is a transcriptional factor critical for metastatic progression of breast cancer. Epithelial stromal interaction 1 (EPSTI1), a recently identified stromal fibroblast-induced gene in non-invasive breast cancer cells is highly overexpressed in invasive breast carcinomas. The function and regulation of EPSTI1, however, remain largely unknown. In this paper, we report a novel KLF8 to EPSTI1 signaling pathway in breast cancer. Using various expression analyses, we revealed a high co-overexpression of KLF8 and EPSTI1 in invasive human breast cancer cells and patient tumors. Ectopic overexpression of KLF8 in the non-invasive MCF-10A cells induced the EPSTI1 expression, whereas KLF8 knockdown from the invasive, MDA-MB-231 cells decreased the EPSTI1 expression. Promoter activation and binding analyses indicated that KLF8 promoted the EPSTI1 expression by directly acting on the EPSTI1 gene promoter. EPSTI1 knockdown dramatically reduced the KLF8-promoted MCF-10A cell invasion, and ectopic expression of EPSTI1 in the non-invasive MCF-7 cells is sufficient to induce the cell invasion. Experiments using nude mice demonstrated that the ectopic EPSTI1 granted the MCF-7 cells capability of both invasive growth in the breasts and metastasis to the lungs. Using co-immunoprecipitation coupled with mass spectrometry, we discovered that EPSTI1 interacts with the valosin-containing protein (VCP), resulting in the degradation of I kappa B alpha and subsequent activation of NF-kappa B in the nucleus. These findings suggest a novel KLF8 to EPSTI1 to VCP to NF-kappa B signaling mechanism potentially critical for breast cancer invasion and metastasis.	[Li, T.; Lu, H.; Shen, C.; Lahiri, S. K.; Wason, M. S.; Mukherjee, D.; Yu, L.; Zhao, J.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Zhao, J (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	Jihe.Zhao@ucf.edu	Li, Tianshu/L-6426-2014; Lahiri, Satadru/J-3483-2019	Li, Tianshu/0000-0002-9972-4644; 	NCI [CA132977]; Susan G. Komen for the Cure breast cancer foundation [KG090444, KG080616]; NATIONAL CANCER INSTITUTE [R01CA132977] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen for the Cure breast cancer foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We appreciate Dr Vladimir Ponomarev of Memorial Sloan-Kettering Cancer Center for kindly providing the trimodal imaging reporter vector SFG-nTGL and Dr Qishan Lin of UAlbany for helping with the mass spectrometry. This work was supported by grants from NCI (CA132977) and Susan G. Komen for the Cure breast cancer foundation (KG090444 and KG080616) to JZ.	Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Buess M, 2009, NEOPLASIA, V11, P987, DOI 10.1593/neo.09670; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; de Neergaard M, 2010, AM J PATHOL, V176, P1229, DOI 10.2353/ajpath.2010.090648; Ding SZ, 2013, TOXICOL APPL PHARM, V269, P61, DOI 10.1016/j.taap.2013.03.006; Gudjonsson T, 2003, METHODS, V30, P247, DOI 10.1016/S1046-2023(03)00031-8; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Lahiri SK, 2012, AM J TRANSL RES, V4, P357; Lu H, 2014, ONCOGENE, V33, P10, DOI 10.1038/onc.2012.545; Lu H, 2012, J BIOL CHEM, V287, P43720, DOI 10.1074/jbc.M112.418053; Lu H, 2011, J BIOL CHEM, V286, P20335, DOI 10.1074/jbc.M110.215632; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Moserle L, 2008, CANCER RES, V68, P5658, DOI 10.1158/0008-5472.CAN-07-6341; Nielsen HL, 2002, GENOMICS, V79, P703, DOI 10.1006/geno.2002.6755; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Schnell O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030429; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Urvalek AM, 2011, AM J TRANSL RES, V3, P121; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Wang XH, 2008, J BIOL CHEM, V283, P13934, DOI 10.1074/jbc.M709300200; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang T, 2012, PLOS ONE, V7, P6; Zhang H, 2013, J CANCER RES CLIN, V139, P1033, DOI 10.1007/s00432-012-1363-3; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zhao JH, 2000, J CELL SCI, V113, P3063; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5; Zubair A, 2013, CURR ALLERGY ASTHM R, V13, P44, DOI 10.1007/s11882-012-0300-5	35	30	31	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 25	2014	33	39					4746	4755		10.1038/onc.2013.415	http://dx.doi.org/10.1038/onc.2013.415			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AR0ED	24096480	Green Accepted			2022-12-25	WOS:000343239500005
J	Chen, GF; Shi, XJ; Sun, C; Li, M; Zhou, Q; Zhang, C; Huang, J; Qiu, Y; Wen, XY; Zhang, Y; Zhang, YS; Yang, SZ; Lu, LX; Zhang, JP; Yuan, QL; Lu, JW; Xu, GT; Xue, YY; Jin, ZB; Jiang, CZ; Ying, M; Liu, XQ				Chen, Guangfeng; Shi, Xiujuan; Sun, Chen; Li, Min; Zhou, Qing; Zhang, Chen; Huang, Jun; Qiu, Yu; Wen, Xiangyi; Zhang, Yan; Zhang, Yushan; Yang, Shuzhang; Lu, Lixia; Zhang, Jieping; Yuan, Qionglan; Lu, Jianwei; Xu, Guotong; Xue, Yunyun; Jin, Zibing; Jiang, Cizhong; Ying, Ming; Liu, Xiaoqing			VEGF-Mediated Proliferation of Human Adipose Tissue-Derived Stem Cells	PLOS ONE			English	Article							HUMAN BONE-MARROW; MICRORNA BIOGENESIS	Human adipose tissue-derived stem cells (ADSCs) are an attractive multipotent stem cell source with therapeutic applicability across diverse fields for the repair and regeneration of acute and chronically damaged tissues. In recent years, there has been increasing interest in ADSC for tissue engineering applications. However, the mechanisms underlying the regulation of ADSC proliferation are not fully understood. Here we show that 47 transcripts are up-regulated while 23 are down-regulated in ADSC compared to terminally differentiated cells based on global mRNA profiling and microRNA profiling. Among the up-regulated genes, the expression of vascular endothelial growth factor (VEGF) is fine-tuned by miR-199a-5p. Further investigation indicates that VEGF accelerates ADSC proliferation whereas the multipotency of ADSC remains stable in terms of adipogenic, chondrogenic and osteogenic potentials after VEGF treatment, suggesting that VEGF may serve as an excellent supplement for accelerating ADSC proliferation during in vitro expansion.	[Chen, Guangfeng; Shi, Xiujuan; Sun, Chen; Zhang, Chen; Huang, Jun; Qiu, Yu; Wen, Xiangyi; Zhang, Yan; Zhang, Yushan; Yang, Shuzhang; Lu, Lixia; Zhang, Jieping; Yuan, Qionglan; Lu, Jianwei; Xu, Guotong; Xue, Yunyun; Ying, Ming; Liu, Xiaoqing] Tongji Univ, Sch Med, Peoples Hosp 10, Shanghai 200092, Peoples R China; [Li, Min; Zhou, Qing; Jiang, Cizhong] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China; [Jin, Zibing] Wenzhou Med Coll, Hosp Eye, Div Ophthalm Genet, Wenzhou, Peoples R China; [Jin, Zibing] Wenzhou Med Coll, Sch Ophthalmol & Optometry, Lab Stem Cell & Retinal Regenerat, Wenzhou, Peoples R China; [Ying, Ming; Liu, Xiaoqing] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Marine Bioresources & Ecol, Shenzhen, Peoples R China	Tongji University; Tongji University; Wenzhou Medical University; Wenzhou Medical University; Shenzhen University	Jiang, CZ (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China.	czjiang@tongji.edu.cn; yingming@szu.edu.cn; xqliu@tongji.edu.cn	Jin, Zi-Bing/J-6810-2014; Jin, Zi-Bing/AAE-4106-2019	Jin, Zi-Bing/0000-0003-0515-698X; Jin, Zi-Bing/0000-0003-0515-698X	Ministry of Science and Technology of China [2010CB945600, 2010CB944901, 2011CB965100]; National Natural Science Foundation of China [91019017, 81202550, 81100673, 81070738]; Shanghai Science Foundation [11PJ1407800]; Ministry of Education of China [IRT1168]; Shenzhen Science and Technology Innovation Committee [JCYJ20120613172906373]; Program for Eastern Scholar at Shanghai	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science Foundation; Ministry of Education of China(Ministry of Education, China); Shenzhen Science and Technology Innovation Committee; Program for Eastern Scholar at Shanghai	This work was supported by the Ministry of Science and Technology of China (2010CB945600, 2010CB944901, 2011CB965100), the National Natural Science Foundation of China (91019017, 81202550, 81100673, 81070738), Shanghai Science Foundation (#11PJ1407800), the Ministry of Education of China (IRT1168), Shenzhen Science and Technology Innovation Committee (JCYJ20120613172906373), and the Program for Eastern Scholar at Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boquest AC, 2006, METH MOL B, V325, P35; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Cawthorn WP, 2012, TRENDS ENDOCRIN MET, V23, P270, DOI 10.1016/j.tem.2012.01.003; Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; Locke M, 2011, STEM CELLS, V29, P404, DOI 10.1002/stem.593; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Okada M, 2010, BBA-GEN SUBJECTS, V1800, P956, DOI 10.1016/j.bbagen.2010.04.004; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rodriguez AM, 2005, BIOCHIMIE, V87, P125, DOI 10.1016/j.biochi.2004.11.007; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tapp H, 2009, EXP BIOL MED, V234, P1, DOI [10.3181/0805-MR-170, 10.3181/0805/MR-170]; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Xiao ZF, 2007, CELL RES, V17, P73, DOI 10.1038/sj.cr.7310126; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	33	28	30	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e73673	10.1371/journal.pone.0073673	http://dx.doi.org/10.1371/journal.pone.0073673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098328	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600002
J	Sahdo, B; Fransen, K; Idosa, BA; Eriksson, P; Soderquist, B; Kelly, A; Sarndahl, E				Sahdo, Berolla; Fransen, Karin; Idosa, Berhane Asfaw; Eriksson, Per; Soderquist, Bo; Kelly, Anne; Sarndahl, Eva			Cytokine Profile in a Cohort of Healthy Blood Donors Carrying Polymorphisms in Genes Encoding the NLRP3 Inflammasome	PLOS ONE			English	Article							AUTOINFLAMMATORY DISEASES; RHEUMATOID-ARTHRITIS; CIAS1 MUTATIONS; IL-1 FAMILY; CARD8; SUSCEPTIBILITY; ACTIVATION; NALP3; INTERLEUKIN-1-BETA; DEFICIENCY	Background: The NLRP3 inflammasome has been recognized as one of the key components of the innate immunity by sensing a diversity of insults. Inflammasome activation results in the maturation of the pro-inflammatory cytokines interleukin (IL)-1 beta and IL-18. Increased production of IL-1 beta is found in patients with gain-of-function polymorphisms in genes encoding the NLRP3 inflammasome. Since approximately 5% of the Swedish population are heterozygote carriers of these combined gene variants, their impact on inflammasome status and a relationship on disease development is therefore highly relevant to study. The present study investigates levels of inflammasome-produced cytokines as a measure of inflammasome activation in healthy individuals carrying Q705K polymorphism in the NLRP3 gene combined with C10X in the CARD8 gene. Materials and Methods: Genotyping of 1006 healthy blood donors was performed for the polymorphisms Q705K in the NLRP3 and C10X in the CARD8 genes. IL-1 beta, IL-18, IL-33, as well as a number of other pro-inflammatory cytokines, were analyzed by Luminex or ELISA in plasma from individuals carrying the polymorphisms and in age and gender matched non-carrier controls. Results & Discussion: The prevalence of the polymorphisms was in line with previous studies. Plasma levels of IL-1 beta and IL-33 were elevated among carriers of combined Q705K+C10X polymorphisms compared to controls, whereas no difference was found for IL-18 and the other cytokines measured. Moreover, carriers of C10X or Q705K per se had similar plasma levels of IL-1 beta as non-carriers. These data suggest that the combined polymorphisms create inflammasomes with increased basal activation state, which might provide a more favourable innate immune response. In spite of this, it could also represent the mechanisms by which the inflammatory loop is triggered into a long-term inflammatory phenotype.	[Sahdo, Berolla; Fransen, Karin; Idosa, Berhane Asfaw; Kelly, Anne; Sarndahl, Eva] Univ Orebro, Sch Hlth & Med Sci, Dept Clin Med, Orebro, Sweden; [Eriksson, Per] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Rheumatol, Linkoping, Sweden; [Soderquist, Bo] Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden; [Soderquist, Bo; Sarndahl, Eva] Univ Orebro, Fac Med & Hlth, Orebro, Sweden	Orebro University; Linkoping University; Orebro University; Orebro University	Sahdo, B (corresponding author), Univ Orebro, Sch Hlth & Med Sci, Dept Clin Med, Orebro, Sweden.	berolla.sahdo@oru.se; eva.sarndahl@oru.se		Idosa, Berhane Asfaw/0000-0002-8060-2049; Fransen, Karin/0000-0002-9826-0462; Soderquist, Bo/0000-0001-5939-2932	Research committee of the County Council of Orebro; Nyckelfonden at Orebro University Hospital; Sund's Foundation for Rheumatic Research; King Gustaf V Memorial Foundation; Swedish Research Council [ES: K2010-57X-21435-01-3]	Research committee of the County Council of Orebro; Nyckelfonden at Orebro University Hospital; Sund's Foundation for Rheumatic Research; King Gustaf V Memorial Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported by grants from the Research committee of the County Council of Orebro, Nyckelfonden at Orebro University Hospital, The Sund's Foundation for Rheumatic Research, King Gustaf V Memorial Foundation and the Swedish Research Council (ES: K2010-57X-21435-01-3; www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 2007, ARTHRITIS RHEUM-US, V56, P1273, DOI 10.1002/art.22491; AREND WP, 1990, J CLIN INVEST, V85, P1694, DOI 10.1172/JCI114622; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Barker BR, 2011, CURR OPIN IMMUNOL, V23, P591, DOI 10.1016/j.coi.2011.07.005; Blomgran R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031326; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chitkara P, 2007, PEDIATR INFECT DIS J, V26, P353, DOI 10.1097/01.inf.0000258777.86510.da; de Menthiere CS, 2003, NUCLEIC ACIDS RES, V31, P282, DOI 10.1093/nar/gkg031; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Eriksson P, 2012, PLOS ONE IN PRESS; Fontalba A, 2008, DEMENT GERIATR COGN, V26, P247, DOI 10.1159/000160956; Fontalba A, 2007, J IMMUNOL, V179, P4867, DOI 10.4049/jimmunol.179.7.4867; Forsblad-D'Elia H, 2013, SCAND J RHEUMATOL; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Hanamsagar R, 2011, J NEUROCHEM; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; Henderson C, 2010, CURR OPIN RHEUMATOL, V22, P567, DOI 10.1097/BOR.0b013e32833ceff4; Hoffman HM, 2009, NAT REV RHEUMATOL, V5, P249, DOI 10.1038/nrrheum.2009.40; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Kastbom A, 2008, RHEUMATOLOGY, V47, P415, DOI 10.1093/rheumatology/kem372; Kastbom A, 2010, ANN RHEUM DIS, V69, P723, DOI 10.1136/ard.2008.106989; Ko DC, 2009, AM J HUM GENET, V85, P214, DOI 10.1016/j.ajhg.2009.07.012; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P792, DOI 10.1016/j.biocel.2010.01.008; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Paramel GV, 2013, CLIN SCI LOND; Pontillo A, 2010, AUTOIMMUNITY, V43, P583, DOI 10.3109/08916930903540432; Pontillo A, 2011, AM J GASTROENTEROL, V106, P539, DOI 10.1038/ajg.2010.474; Porksen G, 2004, EUR J HAEMATOL, V73, P123, DOI 10.1111/j.1600-0609.2004.00270.x; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Roberts RL, 2010, GENES IMMUN, V11, P351, DOI 10.1038/gene.2010.11; Schoultz I, 2009, AM J GASTROENTEROL, V104, P1180, DOI 10.1038/ajg.2009.29; Serrano M, 2009, PEDIATR NEUROL, V41, P448, DOI 10.1016/j.pediatrneurol.2009.06.008; Smith DE, 2011, J LEUKOCYTE BIOL, V89, P383, DOI 10.1189/jlb.0810470; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Ting TV, 2007, PEDIATR NEUROL, V36, P338, DOI 10.1016/j.pediatrneurol.2006.12.008; Ungerback J, 2012, CARCINOGENESIS, V33, P2126, DOI 10.1093/carcin/bgs256; Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286; Verma D, 2010, ARTHRITIS RHEUM-US, V62, P2138, DOI 10.1002/art.27489; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1	44	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75457	10.1371/journal.pone.0075457	http://dx.doi.org/10.1371/journal.pone.0075457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098386	Green Submitted, gold, Green Published			2022-12-25	WOS:000325483600018
J	Habersetzer, J; Larrieu, I; Priault, M; Salin, B; Rossignol, R; Brethes, D; Paumard, P				Habersetzer, Johann; Larrieu, Isabelle; Priault, Muriel; Salin, Benedicte; Rossignol, Rodrigue; Brethes, Daniel; Paumard, Patrick			Human F1F0 ATP Synthase, Mitochondrial Ultrastructure and OXPHOS Impairment: A (Super-)Complex Matter?	PLOS ONE			English	Article							MEMBRANE-SPANNING SEGMENT; INHIBITOR PROTEIN; MAMMALIAN MITOCHONDRIA; CRISTAE MORPHOLOGY; NATIVE PAGE; GXXXG MOTIF; SUBUNIT-E; YEAST; DIMERIZATION; COMPLEX	Mitochondrial morphogenesis is a key process of cell physiology. It is essential for the proper function of this double membrane-delimited organelle, as it ensures the packing of the inner membrane in a very ordered pattern called cristae. In yeast, the mitochondrial ATP synthase is able to form dimers that can assemble into oligomers. Two subunits (e and g) are involved in this supramolecular organization. Deletion of the genes encoding these subunits has no effect on the ATP synthase monomer assembly or activity and only affects its dimerization and oligomerization. Concomitantly, the absence of subunits e and g and thus, of ATP synthase supercomplexes, promotes the modification of mitochondrial ultrastructure suggesting that ATP synthase oligomerization is involved in cristae morphogenesis. We report here that in mammalian cells in culture, the shRNA-mediated down-regulation of subunits e and g affects the stability of ATP synthase and results in a 50% decrease of the available functional enzyme. Comparable to what was shown in yeast, when subunits e and g expression are repressed, ATP synthase dimers and oligomers are less abundant when assayed by native electrophoresis. Unexpectedly, mammalian ATP synthase dimerization/oligomerization impairment has functional consequences on the respiratory chain leading to a decrease in OXPHOS activity. Finally these structural and functional alterations of the ATP synthase have a strong impact on the organelle itself leading to the fission of the mitochondrial network and the disorganization of mitochondrial ultrastructure. Unlike what was shown in yeast, the impairment of the ATP synthase oligomerization process drastically affects mitochondrial ATP production. Thus we propose that mutations or deletions of genes encoding subunits e and g may have physiopathological implications.	[Habersetzer, Johann; Larrieu, Isabelle; Brethes, Daniel; Paumard, Patrick] Univ Bordeaux Segalen, IBGC, UMR 5095, Lab Syst Transducteurs Energie & Morphol Mitochon, Bordeaux, France; [Habersetzer, Johann; Larrieu, Isabelle; Priault, Muriel; Salin, Benedicte; Brethes, Daniel; Paumard, Patrick] CNRS, IBGC, UMR 5095, Bordeaux, France; [Rossignol, Rodrigue] Univ Bordeaux Segalen, Lab Malad Rares Genet & Metab, MRGM, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Paumard, P (corresponding author), Univ Bordeaux Segalen, IBGC, UMR 5095, Lab Syst Transducteurs Energie & Morphol Mitochon, Bordeaux, France.	patrick.paumard@ibgc.cnrs.fr	Priault, Muriel/HHT-0658-2022; Rossignol, Rodrigue/K-7821-2014	Priault, Muriel/0000-0001-8193-0389; 	Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux Segalen; Ministere de la recherche et de l'education nationale; Region Aquitaine Limousin	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Bordeaux Segalen; Ministere de la recherche et de l'education nationale; Region Aquitaine Limousin	This work was supported by Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux Segalen; Ministere de la recherche et de l'education nationale; Region Aquitaine Limousin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen, 1995, PROTOPLASMA, V189, P1; ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 2004, J BIOL CHEM, V279, P40392, DOI 10.1074/jbc.M404316200; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Bustos DM, 2005, J BIOL CHEM, V280, P29004, DOI 10.1074/jbc.M502140200; Cabezon E, 2000, J BIOL CHEM, V275, P28353, DOI 10.1074/jbc.C000427200; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Devin A, 2001, EUR J BIOCHEM, V268, P3943, DOI 10.1046/j.1432-1327.2001.02306.x; Dienhart M, 2002, J BIOL CHEM, V277, P39289, DOI 10.1074/jbc.M205720200; Eskelinen Eeva-Liisa, 2008, V445, P11, DOI 10.1007/978-1-59745-157-4_2; Fronzes R, 2006, BIOCHEMISTRY-US, V45, P6715, DOI 10.1021/bi0601407; Garcia JJ, 2006, BIOCHEMISTRY-US, V45, P12695, DOI 10.1021/bi060339j; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Habersetzer J, 2013, INT J BIOCHEM CELL B, V45, P99, DOI 10.1016/j.biocel.2012.05.017; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Kao LP, 2012, TOXICOL APPL PHARM, V261, P42, DOI 10.1016/j.taap.2012.03.009; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Krause F, 2005, BIOCHEM BIOPH RES CO, V329, P583, DOI 10.1016/j.bbrc.2005.02.010; Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martin M, 1998, J BIOENERG BIOMEMBR, V30, P565, DOI 10.1023/A:1020584517588; Nath S, 2010, J BIOENERG BIOMEMBR, V42, P293, DOI 10.1007/s10863-010-9296-5; Nath S, 2010, J BIOENERG BIOMEMBR, V42, P301, DOI 10.1007/s10863-010-9295-6; Okabe Makoto, 2001, Journal of Cellular and Molecular Medicine, V5, P92, DOI 10.1111/j.1582-4934.2001.tb00142.x; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200; Rojo M, 2002, J CELL SCI, V115, P1663; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soubannier V, 2002, J BIOL CHEM, V277, P10739, DOI 10.1074/jbc.M111882200; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Suhai T, 2009, ELECTROPHORESIS, V30, P3622, DOI 10.1002/elps.200900114; Tomasetig L, 2002, BBA-BIOENERGETICS, V1556, P133, DOI 10.1016/S0005-2728(02)00344-4; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Velours J, 2009, INT J BIOCHEM CELL B, V41, P1783, DOI 10.1016/j.biocel.2009.01.011; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2010, BBA-BIOENERGETICS, V1797, P1004, DOI 10.1016/j.bbabio.2010.02.021; YOSHIDA M, 1975, J BIOL CHEM, V250, P7910	48	58	58	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75429	10.1371/journal.pone.0075429	http://dx.doi.org/10.1371/journal.pone.0075429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098383	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500031
J	Hoeks, JCJ; Stowe, LA; Hendriks, P; Brouwer, H				Hoeks, John C. J.; Stowe, Laurie A.; Hendriks, Petra; Brouwer, Harm			Questions Left Unanswered: How the Brain Responds to Missing Information	PLOS ONE			English	Article							LANGUAGE COMPREHENSION; NEURAL MECHANISMS; P600; PREDICTION; AMBIGUITY; SYNTAX	It sometimes happens that when someone asks a question, the addressee does not give an adequate answer, for instance by leaving out part of the required information. The person who posed the question may wonder why the information was omitted, and engage in extensive processing to find out what the partial answer actually means. The present study looks at the neural correlates of the pragmatic processes invoked by partial answers to questions. Two experiments are presented in which participants read mini-dialogues while their Event-Related brain Potentials (ERPs) are being measured. In both experiments, violating the dependency between questions and answers was found to lead to an increase in the amplitude of the P600 component. We interpret these P600-effects as reflecting the increased effort in creating a coherent representation of what is communicated. This effortful processing might include the computation of what the dialogue participant meant to communicate by withholding information. Our study is one of few investigating language processing in conversation, be it that our participants were 'eavesdroppers' instead of real interactants. Our results contribute to the as of yet small range of pragmatic phenomena that modulate the processes underlying the P600 component, and suggest that people immediately attempt to regain cohesion if a question-answer dependency is violated in an ongoing conversation.	[Hoeks, John C. J.; Stowe, Laurie A.; Hendriks, Petra; Brouwer, Harm] Univ Groningen, Ctr Language & Cognit Groningen, Groningen, Netherlands; [Hoeks, John C. J.; Stowe, Laurie A.; Hendriks, Petra; Brouwer, Harm] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen	Hoeks, JCJ (corresponding author), Univ Groningen, Ctr Language & Cognit Groningen, Groningen, Netherlands.	j.c.j.hoeks@rug.nl		Hendriks, Petra/0000-0002-7584-4078; Hoeks, John/0000-0002-6874-1126	NWO (The Netherlands Organization for Scientific Research) [10-26]; NWO Open Access Incentive Fund [036.002.407]	NWO (The Netherlands Organization for Scientific Research)(Netherlands Organization for Scientific Research (NWO)); NWO Open Access Incentive Fund	This research was funded by NWO (The Netherlands Organization for Scientific Research) PGW grant 10-26 awarded to John Hoeks and Harm Brouwer, and NWO Open Access Incentive Fund (036.002.407). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, INFORM STRUCTURE SEN, V71; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; Brouwer H, 2013, TIME PLACE LAN UNPUB; Brouwer H, 2012, BRAIN RES, V1446, P127, DOI 10.1016/j.brainres.2012.01.055; Burkhardt P, 2007, NEUROREPORT, V18, P1851, DOI 10.1097/WNR.0b013e3282f1a999; Burkhardt P, 2006, BRAIN LANG, V98, P159, DOI 10.1016/j.bandl.2006.04.005; Clark HH, 1977, ADV RES THEOR, V1, P1; FRIEDERICI AD, 1995, BRAIN LANG, V50, P259, DOI 10.1006/brln.1995.1048; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Geurts B., 2010, QUANTITY IMPLICATURE; Gouvea AC, 2010, LANG COGNITIVE PROC, V25, P149, DOI 10.1080/01690960902965951; Grice H, 1975, LOGIC CONVERSATION, V1975, P41; Hoeks J, 1999, THESIS U NIJMEGEN NI; Hoeks J. C. J., 2014, OXFORD HDB LANGUAGE; Hoeks JCJ, 2002, J MEM LANG, V46, P99, DOI 10.1006/jmla.2001.2800; Hoeks JCJ, 2006, Q J EXP PSYCHOL, V59, P1581, DOI 10.1080/17470210500268982; Horn L., 2004, HDB PRAGMATICS; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Lau E, 2006, BRAIN LANG, V98, P74, DOI 10.1016/j.bandl.2006.02.003; Levinson S. C., 2000, PRESUMPTIVE MEANINGS; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; Schumacher P. B., 2011, EXPT PRAGMATICS SEMA, P199, DOI DOI 10.1075/LA.175.10SCH; Sperber D., 1995, RELEVANCE COMMUNICAT, V2nd ed.; Sperber D, 1986, RELEVANCE COGNITION; Steinhauer K, 2012, BRAIN LANG, V120, P135, DOI 10.1016/j.bandl.2011.07.001; Van Berkum J.J., 2009, SEMANTICS PRAGMATICS, P276; Van Petten C, 2012, INT J PSYCHOPHYSIOL, V83, P176, DOI 10.1016/j.ijpsycho.2011.09.015; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036	29	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e73594	10.1371/journal.pone.0073594	http://dx.doi.org/10.1371/journal.pone.0073594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098327	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500005
J	Gioia, T; Logozzo, G; Attene, G; Bellucci, E; Benedettelli, S; Negri, V; Papa, R; Zeuli, PS				Gioia, Tania; Logozzo, Giuseppina; Attene, Giovanna; Bellucci, Elisa; Benedettelli, Stefano; Negri, Valeria; Papa, Roberto; Zeuli, Pierluigi Spagnoletti			Evidence for Introduction Bottleneck and Extensive Inter-Gene Pool (Mesoamerica x Andes) Hybridization in the European Common Bean (Phaseolus vulgaris L.) Germplasm	PLOS ONE			English	Article							MICROSATELLITE DIVERSITY; SECONDARY CENTER; SSR MARKERS; LANDRACES; NUCLEAR; WILD; ORIGIN; CHLOROPLAST; VARIABILITY; CENTERS	Common bean diversity within and between Mesoamerican and Andean gene pools was compared in 89 landraces from America and 256 landraces from Europe, to elucidate the effects of bottleneck of introduction and selection for adaptation during the expansion of common bean (Phaseolus vulgaris L.) in Europe. Thirteen highly polymorphic nuclear microsatellite markers (nuSSRs) were used to complement chloroplast microsatellite (cpSSRs) and nuclear markers (phaseolin and Pv-shatterproof1) data from previous studies. To verify the extent of the introduction bottleneck, inter-gene pool hybrids were distinguished from "pure" accessions. Hybrids were identified on the basis of recombination of gene pool specific cpSSR, phaseolin and Pv-shatterproof1 markers with a Bayesian assignments based on nuSSRs, and with STRUCTURE admixture analysis. More hybrids were detected than previously, and their frequency was almost four times larger in Europe (40.2%) than in America (12.3%). The genetic bottleneck following the introduction into Europe was not evidenced in the analysis including all the accessions, but it was significant when estimated only with "pure" accessions, and five times larger for Mesoamerican than for Andean germplasm. The extensive inter-gene pool hybridization generated a large amount of genotypic diversity that mitigated the effects of the bottleneck that occurred when common bean was introduced in Europe. The implication for evolution and the advantages for common bean breeding are discussed.	[Gioia, Tania; Logozzo, Giuseppina; Zeuli, Pierluigi Spagnoletti] Univ Basilicata, Scuola Sci Agr Forestali Alimentari & Ambientali, I-85100 Potenza, Italy; [Attene, Giovanna] Univ Sassari, Dipartimento Agr, Sez Agron Coltivaz Erbacee & Genet, I-07100 Sassari, Italy; [Bellucci, Elisa; Papa, Roberto] Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Ancona, Italy; [Benedettelli, Stefano] Univ Florence, Dipartimento Sci Prod Vegetali Suolo & Ambiente A, Florence, Italy; [Negri, Valeria] Univ Perugia, Dipartimento Biol Applicata, I-06100 Perugia, Italy; [Papa, Roberto] Cereal Res Ctr CRA CER, Consiglio Ric & Sperimentaz Agr, Foggia, Italy	University of Basilicata; University of Sassari; Marche Polytechnic University; University of Florence; University of Perugia; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Zeuli, PS (corresponding author), Univ Basilicata, Scuola Sci Agr Forestali Alimentari & Ambientali, I-85100 Potenza, Italy.	pierluigi.spagnoletti@unibas.it	Benedettelli, Stefano/M-9760-2015; Gioia, Tania/AAT-9961-2021; Bellucci, Elisa/AAS-9237-2021; papa, roberto/F-9510-2014	Benedettelli, Stefano/0000-0002-6035-1801; LOGOZZO, Giuseppina/0000-0002-7951-2425; Gioia, Tania/0000-0001-8980-3034; papa, roberto/0000-0001-9598-3131; Bellucci, Elisa/0000-0002-1636-0719; Negri, Valeria/0000-0003-2941-121X	Italian Government (MIUR) [2002075423]; Universita degli Studi della Basilicata (Potenza, Italy)	Italian Government (MIUR)(Ministry of Education, Universities and Research (MIUR)); Universita degli Studi della Basilicata (Potenza, Italy)	This study was supported by the Italian Government (MIUR) grant no. # 2002075423, Project COFIN 2002: "Beans in Europe: structure of genetic diversity under the effect of colonization and breeding system". TG was supported by a student research fellowship from the Universita degli Studi della Basilicata (Potenza, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rabah'ah MA, 2004, MOL ECOL, V13, P1075, DOI 10.1111/j.1365-294X.2004.02142.x; Angioi SA, 2010, THEOR APPL GENET, V121, P829, DOI 10.1007/s00122-010-1353-2; Angioi SA, 2009, MOL BREEDING, V23, P413, DOI 10.1007/s11032-008-9245-8; Asfaw A, 2009, THEOR APPL GENET, V120, P1, DOI 10.1007/s00122-009-1154-7; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Becerra Velasquez Viviana L., 1994, Genome, V37, P256, DOI 10.1139/g94-036; BERGLUNDBRUCHER O, 1976, ECON BOT, V30, P257, DOI 10.1007/BF02909734; Bitocchi E, 2013, NEW PHYTOL, V197, P300, DOI 10.1111/j.1469-8137.2012.04377.x; Blair MW, 2006, THEOR APPL GENET, V113, P100, DOI 10.1007/s00122-006-0276-4; Blair MW, 2010, THEOR APPL GENET, V121, P237, DOI 10.1007/s00122-010-1305-x; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Burle ML, 2010, THEOR APPL GENET, V121, P801, DOI 10.1007/s00122-010-1350-5; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Escribano MR, 1998, PLANT BREEDING, V117, P49, DOI 10.1111/j.1439-0523.1998.tb01447.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Freyre R, 1996, ECON BOT, V50, P195, DOI 10.1007/BF02861451; Gaitan-Solis E, 2002, CROP SCI, V42, P2128, DOI 10.2135/cropsci2002.2128; Gepts P., 1988, Genetic resources of Phaseolus beans., P375; Gepts P., 1991, Common beans: research for crop improvement., P7; GEPTS P, 1985, J HERED, V76, P447, DOI 10.1093/oxfordjournals.jhered.a110142; GEPTS P, 1988, ECON BOT, V42, P86, DOI 10.1007/BF02859038; GEPTS P, 1986, ECON BOT, V40, P469, DOI [10.1007/BF02859659, 10.1007/BF02859660]; Gepts P, 1998, HORTSCIENCE, V33, P1124, DOI 10.21273/HORTSCI.33.7.1124; Gepts P., 1999, BEAN BREEDING 21 CEN BEAN BREEDING 21 CEN, P389; Guerra-Sanz JM, 2004, PLANT BREEDING, V123, P87, DOI 10.1046/j.0179-9541.2003.00929.x; GUZMAN P, 1995, PHYTOPATHOLOGY, V85, P600, DOI 10.1094/Phyto-85-600; Johnson WC, 1999, EUPHYTICA, V106, P45, DOI 10.1023/A:1003541201923; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KOENIG R, 1989, THEOR APPL GENET, V78, P809, DOI 10.1007/BF00266663; KOINANGE EMK, 1992, J HERED, V83, P135, DOI 10.1093/oxfordjournals.jhered.a111173; Kwak M, 2009, THEOR APPL GENET, V118, P979, DOI 10.1007/s00122-008-0955-4; Limongelli G., 1996, PLANT BREEDING, V119, P513, DOI [10.1046/j.1439-0523.2000.00531.x, DOI 10.1046/J.1439-0523.2000.00531.X]; LIOI L, 1989, SEED SCI TECHNOL, V17, P317; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Logozzo G, 2007, GENET RESOUR CROP EV, V54, P1763, DOI 10.1007/s10722-006-9185-2; Masi P, 2009, CROP SCI, V49, P187, DOI 10.2135/cropsci2008.05.0265; Masi P, 2001, THESIS U STUDI BASIL; Mercati F, 2013, GENET RESOUR CROP EV, V60, P839, DOI 10.1007/s10722-012-9879-6; Metais I, 2002, THEOR APPL GENET, V104, P1346, DOI 10.1007/s00122-002-0901-9; NEI M, 1974, GENETICS, V76, P379; Ocampo CH, 2002, ANN REP BEAN IMPROV, V45, P236; Ortwin-Sauer C., 1966, EARLY SPANISH MAN, P51; Papa R, 2003, THEOR APPL GENET, V106, P239, DOI 10.1007/s00122-002-1085-z; Papa R, 2006, DARWINS HARVEST NEW, P121, DOI DOI 10.7312/MOTL13316-007; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PETIT RJ, 1993, HEREDITY, V71, P630, DOI 10.1038/hdy.1993.188; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Piergiovanni AR, 2000, GENET RESOUR CROP EV, V47, P489, DOI 10.1023/A:1008719105895; Pritchard JK, 2000, GENETICS, V155, P945; Rodino AP, 2006, CROP SCI, V46, P2540, DOI 10.2135/cropsci2006.02.0104; Rodino AP, 2003, EUPHYTICA, V131, P165, DOI 10.1023/A:1023973309788; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Roullier C, 2011, MOL ECOL, V20, P3963, DOI 10.1111/j.1365-294X.2011.05229.x; Salimas A. D., 1988, Genetic resources of Phaseolus beans., P163; Santalla M, 2002, THEOR APPL GENET, V104, P934, DOI 10.1007/s00122-001-0844-6; Santalla M, 2010, THEOR APPL GENET, V120, P1635, DOI 10.1007/s00122-010-1282-0; Semerikov VL, 2003, AM J BOT, V90, P1113, DOI 10.3732/ajb.90.8.1113; Sicard D, 2005, PLANT BREEDING, V124, P464, DOI 10.1111/j.1439-0523.2005.01137.x; Singh S. P, 1999, COMMON BEAN IMPROVEM; SINGH SP, 1991, CROP SCI, V31, P23, DOI 10.2135/cropsci1991.0011183X003100010005x; Tohme J, 1996, CROP SCI, V36, P1375, DOI 10.2135/cropsci1996.0011183X003600050048x; Vigouroux Y, 2002, P NATL ACAD SCI USA, V99, P9650, DOI 10.1073/pnas.112324299; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Yaish MWF, 2003, GENET MOL BIOL, V26, P337, DOI 10.1590/S1415-47572003000300019; Yu K, 2000, J HERED, V91, P429, DOI 10.1093/jhered/91.6.429; Zeven AC, 1997, EUPHYTICA, V94, P319, DOI 10.1023/A:1002940220241; Zhang XY, 2008, THEOR APPL GENET, V117, P629, DOI 10.1007/s00122-008-0807-2	70	39	40	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75974	10.1371/journal.pone.0075974	http://dx.doi.org/10.1371/journal.pone.0075974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098412	Green Published, gold			2022-12-25	WOS:000325427100030
J	Margaret, I; Lucas, MM; Acosta-Jurado, S; Buendia-Claveria, AM; Fedorova, E; Hidalgo, A; Rodriguez-Carvajal, MA; Rodriguez-Navarro, DN; Ruiz-Sainz, JE; Vinardell, JM				Margaret, Isabel; Lucas, M. Mercedes; Acosta-Jurado, Sebastian; Buendia-Claveria, Ana M.; Fedorova, Elena; Hidalgo, Angeles; Rodriguez-Carvajal, Miguel A.; Rodriguez-Navarro, Dulce N.; Ruiz-Sainz, Jose E.; Vinardell, Jose M.			The Sinorhizobium fredii HH103 Lipopolysaccharide Is Not Only Relevant at Early Soybean Nodulation Stages but Also for Symbiosome Stability in Mature Nodules	PLOS ONE			English	Article							BIOFILM FORMATION; BRADYRHIZOBIUM-JAPONICUM; RHIZOBIUM-LEGUMINOSARUM; SYMBIOTIC PROPERTIES; IN-VITRO; MUTANT; POLYSACCHARIDES; BIOSYNTHESIS; INFECTION; LEGUMES	In this work we have characterised the Sinorhizobium fredii HH103 greA lpsB lpsCDE genetic region and analysed for the first time the symbiotic performance of Sinorhizobium fredii lps mutants on soybean. The organization of the S. fredii HH103 greA, lpsB, and lpsCDE genes was equal to that of Sinorhizobium meliloti 1021. S. fredii HH103 greA, lpsB, and lpsE mutant derivatives produced altered LPS profiles that were characteristic of the gene mutated. In addition, S. fredii HH103 greA mutants showed a reduction in bacterial mobility and an increase of auto-agglutination in liquid cultures. RT-PCR and qPCR experiments demonstrated that the HH103 greA gene has a positive effect on the transcription of lpsB. Soybean plants inoculated with HH103 greA, lpsB or lpsE mutants formed numerous ineffective pseudonodules and showed severe symptoms of nitrogen starvation. However, HH103 greA and lps mutants were also able to induce the formation of a reduced number of soybean nodules of normal external morphology, allowing the possibility of studying the importance of bacterial LPS in later stages of the S. fredii HH103-soybean symbiosis. The infected cells of these nodules showed signs of early termination of symbiosis and lytical clearance of bacteroids. These cells also had very thick walls and accumulation of phenolic-like compounds, pointing to induced defense reactions. Our results show the importance of bacterial LPS in later stages of the S. fredii HH103-soybean symbiosis and their role in preventing host cell defense reactions. S. fredii HH103 lpsB mutants also showed reduced nodulation with Vigna unguiculata, although the symbiotic impairment was less pronounced than in soybean.	[Margaret, Isabel; Acosta-Jurado, Sebastian; Buendia-Claveria, Ana M.; Hidalgo, Angeles; Ruiz-Sainz, Jose E.; Vinardell, Jose M.] Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain; [Lucas, M. Mercedes; Fedorova, Elena] CSIC, Inst Ciencias Agr, Madrid, Spain; [Rodriguez-Carvajal, Miguel A.] Univ Seville, Fac Quim, Dept Quim Organ, E-41071 Seville, Spain; [Rodriguez-Navarro, Dulce N.] Ctr Torres Tomejil, IFAPA, Alcala Del Rio, Sevilla, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Agrarias (ICA); University of Sevilla	Vinardell, JM (corresponding author), Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain.	jvinar@us.es	Vinardell, José M/H-5355-2013; Lucas, M Mercedes/H-4529-2016; Oliver, Isabel Maria Margaret/J-8663-2016; Carvajal, Miguel Ángel Rodríguez/F-2577-2012; Fedorova, Elena Erika/U-1069-2017; Jurado, Sebastián Acosta/ABH-3676-2020	Vinardell, José M/0000-0002-7105-5389; Lucas, M Mercedes/0000-0002-3252-0145; Carvajal, Miguel Ángel Rodríguez/0000-0002-2131-6448; Ruiz Sainz, Jose Enrique/0000-0003-0106-3495; Fedorova, Elena/0000-0003-3953-1282; Acosta Jurado, Sebastian/0000-0002-5505-2508; Buendia Claveria, Ana Maria/0000-0002-7058-3497; Margaret Oliver, Isabel Maria/0000-0001-8770-1309	Andalusia Government [P07-CVI-02506]; Spanish Ministry of Science and Innovation [BIO2011-30229-C02-01]; Comunidad de Madrid [S2009/AMB-1511]	Andalusia Government; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by grants from the Andalusia Government (P07-CVI-02506), the Spanish Ministry of Science and Innovation (BIO2011-30229-C02-01), and the Comunidad de Madrid (Programa Microambiente S2009/AMB-1511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardissone S, 2011, MOL PLANT MICROBE IN, V24, P1513, DOI 10.1094/MPMI-05-11-0143; BECKER A, 1995, GENE, V162, P37, DOI 10.1016/0378-1119(95)00313-U; Becker A, 2005, MOL PLANT MICROBE IN, V18, P899, DOI 10.1094/MPMI-18-0899; Becker A, 1997, J BACTERIOL, V179, P1375, DOI 10.1128/jb.179.4.1375-1384.1997; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Borukhov S, 2005, MOL MICROBIOL, V55, P1315, DOI 10.1111/j.1365-2958.2004.04481.x; Brewin NJ, 1993, ADV MOL GENETICS PLA, V2, P369; Buendia-Claveria AM, 2003, MICROBIOL-SGM, V149, P1807, DOI 10.1099/mic.0.26099-0; Campbell GRO, 2003, J BACTERIOL, V185, P3853, DOI 10.1128/JB.185.13.3853-3862.2003; Campbell GRO, 2002, P NATL ACAD SCI USA, V99, P3938, DOI 10.1073/pnas.062425699; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; CARLSON RW, 1995, J BIOL CHEM, V270, P11783, DOI 10.1074/jbc.270.20.11783; Chataigne G, 2008, J CHROMATOGR A, V1185, P241, DOI 10.1016/j.chroma.2008.01.065; Collmer A., 1991, Advances in molecular genetics of plant-microbe interactions. Vol. 1. Proceedings of the 5th international symposium on the molecular genetics of plant-microbe interactions, Interlaken, Switzerland, September 9-14, 1990., P65; Crespo-Rivas JC, 2007, INT MICROBIOL, V10, P169, DOI 10.2436/20.1501.01.24; Crespo-Rivas JC, 2009, MOL PLANT MICROBE IN, V22, P575, DOI 10.1094/MPMI-22-5-0575; De Castro C, 2008, CARBOHYD RES, V343, P1924, DOI 10.1016/j.carres.2008.01.036; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Gil-Serrano AM, 1999, BIOCHEM J, V342, P527, DOI 10.1042/0264-6021:3420527; Hidalgo A, 2010, MICROBIOL-SGM, V156, P3398, DOI 10.1099/mic.0.042499-0; KANNENBERG EL, 1998, RHIZOBIACEAE, P119; Lagares A, 2001, J BACTERIOL, V183, P1248, DOI 10.1128/JB.183.4.1248-1258.2001; LAGARES A, 1992, J BACTERIOL, V174, P5941, DOI 10.1128/jb.174.18.5941-5952.1992; LeVier K, 2000, SCIENCE, V287, P2492, DOI 10.1126/science.287.5462.2492; Lopez-Lara IM, 2003, MOL PLANT MICROBE IN, V16, P567, DOI 10.1094/MPMI.2003.16.7.567; Madinabeitia N, 2002, MOL PLANT MICROBE IN, V15, P150, DOI 10.1094/MPMI.2002.15.2.150; Margaret I, 2012, MOL PLANT MICROBE IN, V25, P825, DOI 10.1094/MPMI-10-11-0262; Margaret I, 2011, J BIOTECHNOL, V155, P11, DOI 10.1016/j.jbiotec.2011.03.016; Margaret-Oliver I, 2012, ARCH MICROBIOL, V194, P87, DOI 10.1007/s00203-011-0729-2; Moran JF, 1997, FREE RADICAL BIO MED, V22, P861, DOI 10.1016/S0891-5849(96)00426-1; NOEL KD, 1986, J BACTERIOL, V168, P1392, DOI 10.1128/jb.168.3.1392-1401.1986; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Oliveira LR, 2013, FUNCT INTEGR GENOMIC, V13, P275, DOI 10.1007/s10142-013-0322-7; Parada M, 2006, MOL PLANT MICROBE IN, V19, P43, DOI 10.1094/MPMI-19-0043; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; PUVANESARAJAH V, 1987, J BACTERIOL, V169, P137, DOI 10.1128/jb.169.1.137-141.1987; REUHS BL, 1994, MOL PLANT MICROBE IN, V7, P240, DOI 10.1094/MPMI-7-0240; Rinaudi LV, 2010, FEMS MICROBIOL LETT, V304, P1, DOI 10.1111/j.1574-6968.2009.01840.x; Rinaudi LV, 2009, J BACTERIOL, V191, P7216, DOI 10.1128/JB.01063-09; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shvaleva A, 2010, PLANT SOIL, V326, P109, DOI 10.1007/s11104-009-9985-1; SIMON R, 1984, MOL GEN GENET, V196, P413, DOI 10.1007/BF00436188; STACEY G, 1991, MOL PLANT MICROBE IN, V4, P332, DOI 10.1094/MPMI-4-332; Stepanova E, 2007, J BACTERIOL, V189, P8772, DOI 10.1128/JB.00911-07; Vanderlinde EM, 2009, MICROBIOL-SGM, V155, P3055, DOI 10.1099/mic.0.025031-0; Vinardell JM, 2004, MOL PLANT MICROBE IN, V17, P676, DOI 10.1094/MPMI.2004.17.6.676; Vinardell JM, 2004, ARCH MICROBIOL, V181, P144, DOI 10.1007/s00203-003-0635-3; Vincent JM, 1970, MANUAL PRACTICAL STU, P144; Weidner S, 2012, J BACTERIOL, V194, P1617, DOI 10.1128/JB.06729-11	52	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74717	10.1371/journal.pone.0074717	http://dx.doi.org/10.1371/journal.pone.0074717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098345	Green Submitted, Green Published, gold			2022-12-25	WOS:000325427100007
J	Capderrey, C; Kaufmann, B; Jean, P; Malard, F; Konecny-Dupre, L; Lefebure, T; Douady, CJ				Capderrey, Cecile; Kaufmann, Bernard; Jean, Pauline; Malard, Florian; Konecny-Dupre, Lara; Lefebure, Tristan; Douady, Christophe J.			Microsatellite Development and First Population Size Estimates for the Groundwater Isopod Proasellus walteri	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; GENETIC-STRUCTURE; N-E; TEMPORAL-CHANGES; MIGRATION RATES; CONSERVATION; DIVERSITY; EVOLUTION; PHYLOGEOGRAPHY; FISHES	Effective population size (N-e) is one of the most important parameters in, ecology, evolutionary and conservation biology; however, few studies of N-e in surface freshwater organisms have been published to date. Even fewer studies have been carried out in groundwater organisms, although their evolution has long been considered to be particularly constrained by small N-e. In this study, we estimated the contemporary effective population size of the obligate groundwater isopod: Proasellus walteri (Chappuis, 1948). To this end, a genomic library was enriched for microsatellite motifs and sequenced using 454 GS-FLX technology. A total of 54,593 reads were assembled in 10,346 contigs or singlets, of which 245 contained candidate microsatellite sequences with suitable priming sites. Ninety-six loci were tested for amplification, polymorphism and multiplexing properties, of which seven were finally selected for N-e estimation. Linkage disequilibrium and approximate Bayesian computation methods revealed that N-e in this small interstitial groundwater isopod could reach large sizes (> 585 individuals). Our results suggest that environmental conditions in groundwater, while often referred to as extreme, are not necessarily associated with small N-e.	[Capderrey, Cecile; Kaufmann, Bernard; Jean, Pauline; Malard, Florian; Konecny-Dupre, Lara; Lefebure, Tristan; Douady, Christophe J.] Univ Lyon 1, CNRS, Ecol Hydrosyst Nat & Anthropises UMR5023, F-69622 Villeurbanne, France; [Douady, Christophe J.] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut Universitaire de France	Douady, CJ (corresponding author), Univ Lyon 1, CNRS, Ecol Hydrosyst Nat & Anthropises UMR5023, F-69622 Villeurbanne, France.	christophe.douady@univ-lyon1.fr	Douady, Christophe J/N-1357-2014; Lefebure, Tristan/A-6489-2009; Douady, Christophe/N-3069-2019; Capderrey, Cécile/ACB-8991-2022	Douady, Christophe J/0000-0002-4503-8040; Lefebure, Tristan/0000-0003-3923-8166; Douady, Christophe/0000-0002-4503-8040; Kaufmann, Bernard/0000-0001-9097-3452	French Water Agency Rhone-Mediterranee-Corse; Agence Nationale de la Recherche [ANR-08-JCJC-0120- 01]; Institut Universitaire de France; European Commission [226874]	French Water Agency Rhone-Mediterranee-Corse; Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut Universitaire de France; European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was funded by the French Water Agency Rhone-Mediterranee-Corse; the Agence Nationale de la Recherche (ANR-08-JCJC-0120- 01, "DEEP"); the Institut Universitaire de France; and the European Commission (7th EU Framework Programme, Contract No. 226874, BioFresh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araguas RM, 2012, FRESHWATER BIOL, V57, P143, DOI 10.1111/j.1365-2427.2011.02705.x; Ardren WR, 2003, MOL ECOL, V12, P35, DOI 10.1046/j.1365-294X.2003.01705.x; AVISE JC, 1972, EVOLUTION, V26, P1, DOI 10.1111/j.1558-5646.1972.tb00170.x; Beebee TJC, 2007, FRESHWATER BIOL, V52, P2101, DOI 10.1111/j.1365-2427.2007.01834.x; Belkhir K, 1996, 5171 CNRS UMR U MONT; Borowsky RL, 2001, MOL ECOL, V10, P2799, DOI 10.1046/j.0962-1083.2001.01409.x; BOU C, 1967, CR ACAD SCI D NAT, V265, P369; Buhay JE, 2005, MOL ECOL, V14, P4259, DOI 10.1111/j.1365-294X.2005.02755.x; Buhay JE, 2007, MOL PHYLOGENET EVOL, V42, P435, DOI 10.1016/j.ympev.2006.07.014; Calvignac S, 2011, MITOCHONDRION, V11, P246, DOI 10.1016/j.mito.2010.10.004; Carreras-Carbonell J, 2008, CONSERV GENET, V9, P181, DOI 10.1007/s10592-007-9322-2; Chapman DD, 2003, CONSERV GENET, V4, P415, DOI 10.1023/A:1024771215616; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Clemento AJ, 2009, CONSERV GENET, V10, P1321, DOI 10.1007/s10592-008-9712-0; Dawnay N, 2011, CONSERV GENET, V12, P731, DOI 10.1007/s10592-010-0179-4; Dillman CB, 2007, SYSTEMATICS SPECIES; Djuikwo-Teukeng FF, 2011, INFECT GENET EVOL, V11, P17, DOI 10.1016/j.meegid.2010.10.018; England PR, 2010, CONSERV GENET, V11, P2425, DOI 10.1007/s10592-010-0112-x; Ewing G, 2006, MOL BIOL EVOL, V23, P988, DOI 10.1093/molbev/msj111; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Ficetola GF, 2010, ANIM CONSERV, V13, P82, DOI 10.1111/j.1469-1795.2009.00306.x; Finlay JB, 2006, ANIM CONSERV, V9, P375, DOI 10.1111/j.1469-1795.2006.00046.x; Frankham R, 2009, INTRO CONSERVATION G; Gossmann TI, 2011, GENETICS, V189, P1389, DOI 10.1534/genetics.111.132654; Gow JL, 2011, EVOL APPL, V4, P763, DOI 10.1111/j.1752-4571.2011.00198.x; Guzik MT, 2009, MOL ECOL, V18, P3683, DOI 10.1111/j.1365-294X.2009.04296.x; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Hinaux H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053553; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jehle R, 2005, J EVOLUTION BIOL, V18, P619, DOI 10.1111/j.1420-9101.2004.00864.x; Jones JW, 2009, THESIS VIRGINIA STAT; Kane T.C., 1994, P245; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Lance SL, 2010, CONSERV GENET RESOUR, V2, P139, DOI 10.1007/s12686-010-9195-4; Leberg P, 2005, J WILDLIFE MANAGE, V69, P1385, DOI 10.2193/0022-541X(2005)69[1385:GAFETE]2.0.CO;2; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Massa-Gallucci A, 2010, CONSERV GENET, V11, P1689, DOI 10.1007/s10592-010-0061-4; Morvan C, 2013, SYST BIOL, V62, P512, DOI 10.1093/sysbio/syt015; NEI M, 1981, GENETICS, V98, P625; Osborne MJ, 2010, MOL ECOL, V19, P2832, DOI 10.1111/j.1365-294X.2010.04695.x; Ostergaard S, 2003, MOL ECOL, V12, P3123, DOI 10.1046/j.1365-294X.2003.01976.x; Palumbi Stephen R., 1996, P205; Phillipsen IC, 2011, EVOLUTION, V65, P2927, DOI 10.1111/j.1558-5646.2011.01356.x; Primmer CR, 2005, J AVIAN BIOL, V36, P348; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sbordoni MC, 1996, J ZOOL SYST EVOL RES, V34, P75; Sbordoni Valerio, 2005, P447; Schwartz M, 1999, J ADV MATER, V31, P2; Scribner KT, 1997, MOL ECOL, V6, P701, DOI 10.1046/j.1365-294X.1997.00238.x; Serbezov D, 2012, GENETICS, V191, P579, DOI 10.1534/genetics.111.136580; Shama LNS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-278; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Stoch F, 2010, HYDROBIOLOGIA, V653, P217, DOI 10.1007/s10750-010-0356-y; Tallmon DA, 2004, GENETICS, V167, P977, DOI 10.1534/genetics.103.026146; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Taylor EB, 2012, CAN J ZOOL, V90, P291, DOI 10.1139/Z11-135; Trouve S, 2005, J EVOLUTION BIOL, V18, P358, DOI 10.1111/j.1420-9101.2004.00831.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Wang JL, 2001, GENET RES, V78, P243, DOI 10.1017/S0016672301005286; Wang JL, 2003, GENETICS, V163, P429; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Waples RS, 2002, MOL ECOL, V11, P1029, DOI 10.1046/j.1365-294X.2002.01504.x; WAPLES RS, 1989, GENETICS, V121, P379; Watts PC, 2007, J ANIM ECOL, V76, P790, DOI 10.1111/j.1365-2656.2007.01249.x; Wright S, 1931, GENETICS, V16, P0097; Zeller M, 2008, J EVOLUTION BIOL, V21, P1755, DOI 10.1111/j.1420-9101.2008.01589.x	73	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76213	10.1371/journal.pone.0076213	http://dx.doi.org/10.1371/journal.pone.0076213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086709	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900085
J	Kubo, M; Imai, A; Nishiyama, T; Ishikawa, M; Sato, Y; Kurata, T; Hiwatashi, Y; Reski, R; Hasebe, M				Kubo, Minoru; Imai, Akihiro; Nishiyama, Tomoaki; Ishikawa, Masaki; Sato, Yoshikatsu; Kurata, Tetsuya; Hiwatashi, Yuji; Reski, Ralf; Hasebe, Mitsuyasu			System for Stable beta-Estradiol-Inducible Gene Expression in the Moss Physcomitrella patens	PLOS ONE			English	Article							SEVERE GROWTH DEFECTS; EVOLUTIONARY INSIGHTS; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; LEXA GENE; LAND; GENOME; TRANSCRIPTION; ARABIDOPSIS; INDUCTION	Inducible transgene expression provides a useful tool to analyze gene function. The moss Physcomitrella patens is a model basal land plant with well-developed research tools, including a high efficiency of gene targeting and substantial genomics resources. However, current systems for controlled transgene expression remain limited. Here we report the development of an estrogen receptor mediated inducible gene expression system, based on the system used in flowering plants. After identifying the appropriate promoters to drive the chimeric transducer, we succeeded in inducing transcription over 1,000-fold after 24 h incubation with beta-estradiol. The P. patens system was also effective for high-level long-term induction of gene expression; transcript levels of the activated gene were maintained for at least seven days on medium containing beta-estradiol. We also established two potentially neutral targeting sites and a set of vectors for reproducible expression of two transgenes. This beta-estradiol-dependent system will be useful to test genes individually or in combination, allowing stable, inducible transgenic expression in P. patens.	[Kubo, Minoru; Imai, Akihiro; Nishiyama, Tomoaki; Ishikawa, Masaki; Hiwatashi, Yuji; Hasebe, Mitsuyasu] Natl Inst Basic Biol, Okazaki, Aichi 444, Japan; [Kubo, Minoru; Imai, Akihiro; Nishiyama, Tomoaki; Ishikawa, Masaki; Sato, Yoshikatsu; Kurata, Tetsuya; Hasebe, Mitsuyasu] Japan Sci & Technol Agcy, ERATO, Okazaki, Aichi, Japan; [Kubo, Minoru; Reski, Ralf] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Kubo, Minoru; Reski, Ralf] FRIAS Freiburg Inst Adv Studies, Freiburg, Germany; [Imai, Akihiro] Duke Univ, Dept Biol, Durham, NC USA; [Nishiyama, Tomoaki] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Ishikawa, Masaki; Hiwatashi, Yuji; Hasebe, Mitsuyasu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi, Japan; [Reski, Ralf] BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); University of Freiburg; Duke University; Kanazawa University; Graduate University for Advanced Studies - Japan	Kubo, M (corresponding author), Natl Inst Basic Biol, Okazaki, Aichi 444, Japan.	minoru.kubo@biologie.uni-freiburg.de; mhasebe@nibb.ac.jp	Kubo, Minoru/AAH-1689-2019; Ishikawa, Masaki/Q-7598-2018; Sato, Yoshikatsu/I-6129-2014; Ishikawa, Masaki/AAC-8162-2022	Kubo, Minoru/0000-0001-8691-6252; Ishikawa, Masaki/0000-0002-6491-5539; Ishikawa, Masaki/0000-0002-6491-5539; Hasebe, Mitsuyasu/0000-0001-7425-8758; Reski, Ralf/0000-0002-5496-6711; HIWATASHI, YUJI/0000-0002-3996-0549	Japan Science and Technology Agency under the Exploratory Research for Advanced Technology program; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; Ministry of Education, Culture, Sports, Science and Technology	Japan Science and Technology Agency under the Exploratory Research for Advanced Technology program; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japan Science and Technology Agency under the Exploratory Research for Advanced Technology program to MH, the Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation to RR and MH, and the Ministry of Education, Culture, Sports, Science and Technology to TN and MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTINGMEES MA, 1989, NUCLEIC ACIDS RES, V17, P9494, DOI 10.1093/nar/17.22.9494; Amirsadeghi S, 2007, PLANTA, V226, P453, DOI 10.1007/s00425-007-0495-1; Andersen SU, 2003, MOL PLANT MICROBE IN, V16, P1069, DOI 10.1094/MPMI.2003.16.12.1069; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Brand L, 2006, PLANT PHYSIOL, V141, P1194, DOI 10.1104/pp.106.081299; Butaye KMJ, 2005, MOL BREEDING, V16, P79, DOI 10.1007/s11032-005-4929-9; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Core R Team, 2013, R LANG ENV STAT COMP; Corrado G, 2009, BIOTECHNOL ADV, V27, P733, DOI 10.1016/j.biotechadv.2009.05.006; CORUZZI G, 1984, EMBO J, V3, P1671, DOI 10.1002/j.1460-2075.1984.tb02031.x; Cove D, 2006, ANNU REV PLANT BIOL, V57, P497, DOI 10.1146/annurev.arplant.57.032905.105338; DALRYMPLE MA, 1985, NUCLEIC ACIDS RES, V13, P7865, DOI 10.1093/nar/13.21.7865; Decker EL, 2008, BIOPROC BIOSYST ENG, V31, P3, DOI 10.1007/s00449-007-0151-y; Decker EL, 2007, CURR OPIN BIOTECH, V18, P393, DOI 10.1016/j.copbio.2007.07.012; FLUHR R, 1986, EMBO J, V5, P2063, DOI 10.1002/j.1460-2075.1986.tb04467.x; Gitzinger M, 2009, PLANT BIOTECHNOL J, V7, P73, DOI 10.1111/j.1467-7652.2008.00376.x; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Hiwatashi Y, 2008, PLANT CELL, V20, P3094, DOI 10.1105/tpc.108.061705; HORII T, 1981, CELL, V23, P689, DOI 10.1016/0092-8674(81)90432-3; Ishige F, 1999, PLANT J, V18, P443, DOI 10.1046/j.1365-313X.1999.00456.x; Ishikawa M, 2011, PLANT CELL, V23, P2924, DOI 10.1105/tpc.111.088005; JEFFERSON RA, 1986, P NATL ACAD SCI USA, V83, P8447, DOI 10.1073/pnas.83.22.8447; Judd W. S., 2007, PLANT SYSTEMATICS PH; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kamisugi Y, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni172; Kang HG, 1999, PLANT J, V20, P127, DOI 10.1046/j.1365-313X.1999.00575.x; Khraiwesh B, 2008, PLANT PHYSIOL, V148, P684, DOI 10.1104/pp.108.128025; Konietschke F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031242; Lang D, 2008, TRENDS PLANT SCI, V13, P542, DOI 10.1016/j.tplants.2008.07.002; MIKI T, 1981, NUCLEIC ACIDS RES, V9, P529, DOI 10.1093/nar/9.3.529; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Moore I, 2006, PLANT J, V45, P651, DOI 10.1111/j.1365-313X.2006.02660.x; Nakaoka Y, 2012, PLANT CELL, V24, P1478, DOI 10.1105/tpc.112.098509; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Nishiyama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036471; ODELL J, 1990, MOL GEN GENET, V223, P369, DOI 10.1007/BF00264442; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Okano Y, 2009, P NATL ACAD SCI USA, V106, P16321, DOI 10.1073/pnas.0906997106; Padidam M, 2003, CURR OPIN PLANT BIOL, V6, P169, DOI 10.1016/S1369-5266(03)00005-0; Prigge MJ, 2010, DEVELOPMENT, V137, P3535, DOI 10.1242/dev.049023; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P115; Saidi Y, 2005, PLANT MOL BIOL, V59, P697, DOI 10.1007/s11103-005-0889-z; Saidi Y, 2009, PLANT SIGNAL BEHAV, V4, P457, DOI 10.4161/psb.4.5.8541; Sakakibara K, 2008, EVOL DEV, V10, P555, DOI 10.1111/j.1525-142X.2008.00271.x; Schaefer DG, 1997, PLANT J, V11, P1195, DOI 10.1046/j.1365-313X.1997.11061195.x; Shinmyo A, 1996, ANN NY ACAD SCI, V782, P97, DOI 10.1111/j.1749-6632.1996.tb40551.x; Srivastava V, 2010, IN VITRO CELL DEV-PL, V46, P219, DOI 10.1007/s11627-009-9274-y; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Zeidler M, 1996, PLANT MOL BIOL, V30, P199, DOI 10.1007/BF00017815; ZHANG WG, 1991, PLANT CELL, V3, P1155, DOI 10.1105/tpc.3.11.1155; Zimmer AD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-498; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	55	49	50	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e77356	10.1371/journal.pone.0077356	http://dx.doi.org/10.1371/journal.pone.0077356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086772	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900115
J	Mallela, J; Lewis, SE; Croke, B				Mallela, Jennie; Lewis, Stephen E.; Croke, Barry			Coral Skeletons Provide Historical Evidence of Phosphorus Runoff on the Great Barrier Reef	PLOS ONE			English	Article							INNER-SHELF; FLOOD PLUMES; SEDIMENT; GROWTH; NITROGEN; RECORDS; AUSTRALIA; PHOSPHATE; DECLINE; REGION	Recently, the inshore reefs of the Great Barrier Reef have declined rapidly because of deteriorating water quality. Increased catchment runoff is one potential culprit. The impacts of land-use on coral growth and reef health however are largely circumstantial due to limited long-term data on water quality and reef health. Here we use a 60 year coral core record to show that phosphorus contained in the skeletons (P/Ca) of long-lived, near-shore Porites corals on the Great Barrier Reef correlates with annual records of fertiliser application and particulate phosphorus loads in the adjacent catchment. Skeletal P/Ca also correlates with Ba/Ca, a proxy for fluvial sediment loading, again linking near-shore phosphorus records with river runoff. Coral core records suggest that phosphorus levels increased 8 fold between 1949 and 2008 with the greatest levels coinciding with periods of high fertiliser-phosphorus use. Periods of high P/Ca correspond with intense agricultural activity and increased fertiliser application in the river catchment following agricultural expansion and replanting after cyclone damage. Our results demonstrate how coral P/Ca records can be used to assess terrestrial nutrient loading of vulnerable near-shore reefs.	[Mallela, Jennie] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Mallela, Jennie] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Lewis, Stephen E.] James Cook Univ, TropWATER, Catchment Reef Res Grp, Townsville, Qld 4811, Australia; [Croke, Barry] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Croke, Barry] Australian Natl Univ, Dept Math, Canberra, ACT, Australia	Australian National University; Australian National University; James Cook University; Australian National University; Australian National University	Mallela, J (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia.	jennie.mallela@anu.edu.au	Lewis, Stephen E/P-7205-2016; Croke, Barry/A-2275-2008	Lewis, Stephen E/0000-0002-6929-6626; Croke, Barry/0000-0001-9216-1554; Mallela, Jennie/0000-0002-7811-6850	Marine and Tropical Science Facility (MTSRF) awarded; ARC DECRA awarded	Marine and Tropical Science Facility (MTSRF) awarded; ARC DECRA awarded(Australian Research Council)	Funding for this work was provided by: 1) The Marine and Tropical Science Facility (MTSRF) awarded to JM & SL:Project 3.7.2 Connectivity and risk: tracing materials from the upper catchment to the Reef, and 2) ARC DECRA awarded to JM: http://www.arc.gov.au/ncgp/decra.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibert C, 2003, GEOCHIM COSMOCHIM AC, V67, P231, DOI 10.1016/S0016-7037(02)01055-4; Alibert C, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004263; [Anonymous], 2010, HIST MON DAT TULL RI; Armour JD, 2009, MAR FRESHWATER RES, V60, P1091, DOI 10.1071/MF08345; BOM, 2010, CLIM DAT ONL BUR MET; Brodie J, 2007, 0607 ACTFR J COOK U; Brodie J, 2012, MAR POLLUT BULL, V65, P267, DOI 10.1016/j.marpolbul.2011.12.011; Burke L., 2011, REEFS RISK REVISITED; Chen TR, 2011, MAR POLLUT BULL, V62, P2114, DOI 10.1016/j.marpolbul.2011.07.014; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Devlin M, 2009, MAR FRESHWATER RES, V60, P1109, DOI 10.1071/MF08343; DODGE RE, 1984, MAR POLLUT BULL, V15, P178, DOI 10.1016/0025-326X(84)90317-5; Dunn JG, 2012, J EXP MAR BIOL ECOL, V411, P34, DOI 10.1016/j.jembe.2011.10.013; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Filippelli GM, 2008, ELEMENTS, V4, P89, DOI 10.2113/GSELEMENTS.4.2.89; Furnas M., 2003, CATCHMENTS CORALS TE; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; HUNTER CL, 1995, B MAR SCI, V57, P501; KINSEY DW, 1979, LIMNOL OCEANOGR, V24, P935, DOI 10.4319/lo.1979.24.5.0935; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Kumarsingh K, 1998, MAR POLLUT BULL, V36, P1012, DOI 10.1016/S0025-326X(98)00086-1; LaVigne M, 2010, GEOCHIM COSMOCHIM AC, V74, P1282, DOI 10.1016/j.gca.2009.11.002; LaVigne M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031926; Lewis SE, 2012, MAR POLLUT BULL, V65, P306, DOI 10.1016/j.marpolbul.2011.09.030; Lough JM, 2002, CORAL REEFS, V21, P333, DOI 10.1007/s00338-002-0253-6; Mallela J, 2011, CORAL REEFS, V30, P813, DOI 10.1007/s00338-011-0757-z; Mallela J, 2007, CORAL REEFS, V26, P53, DOI DOI 10.1007/S00338-006-0168-8; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Mitchell AW, 2001, WATER SCI TECHNOL, V43, P99, DOI 10.2166/wst.2001.0516; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Perry CT, 2011, MAR GEOL, V289, P60, DOI 10.1016/j.margeo.2011.09.012; PULS J, 1996, HEMICELLULOSES HEMIC, P1; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Roff G., 2013, P R SOC LOND B, V280; SHOTYK W, 1995, J CHROMATOGR A, V706, P209, DOI 10.1016/0021-9673(94)01153-6; Sweatman H. P. A., 2007, MARINE TROPICAL SCI; Thompson A, 2011, REEF RESCUE MARINE M, P128; Whinney JC, 2007, PHYS CONDITIONS MARG; Wolanski E, 2005, ESTUAR COAST SHELF S, V65, P153, DOI 10.1016/j.ecss.2005.06.003; Wolanski E, 2008, ESTUAR COAST SHELF S, V77, P755, DOI 10.1016/j.ecss.2007.10.014; Zhang FF, 2011, ANAL CHEM, V83, P7870, DOI 10.1021/ac2017663	44	20	22	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75663	10.1371/journal.pone.0075663	http://dx.doi.org/10.1371/journal.pone.0075663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086606	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000325223900056
J	Hoogeboom, TJ; van Meeteren, NLU; Kim, RH; Stevens-Lapsley, JE				Hoogeboom, Thomas J.; van Meeteren, Nico L. U.; Kim, Raymond H.; Stevens-Lapsley, Jennifer E.			Linear and Curvilinear Relationship between Knee Range of Motion and Physical Functioning in People with Knee Osteoarthritis: A Cross-Sectional Study	PLOS ONE			English	Article							HIP; ARTHROPLASTY; PERFORMANCE; LIMITATIONS; FLEXION; STRENGTH; OUTCOMES; GAIT; GO	Background: Knee range of motion (KROM) is associated with the ability to perform daily activities in people with knee OA. However, this association is weak, possibly through the use of linear analyses. Curvilinear associations appear much more relevant, as these allow the determination of relevant clinical thresholds in KROM. The goal of this study is to assess the curvilinear association between KROM and daily activities (self-reported and observed) in people with knee osteoarthritis (OA). Methods: Demographic, functional and KROM (flexion and extension) data were collected from a convenience sample of people with knee OA awaiting total knee arthroplasty. Self-reported functioning was measured by use of the Knee Osteoarthritis Outcomes Scale and observed functioning with the timed up and go and six-minute walk test. The presence of curvilinear relationships between KROM and measures of functioning were tested by generalized additive modeling, piecewise regression modeling and receiver operated curves. Results: Data from 110 participants (mean age +/- standard deviation: 65 +/- 9 and female: 54%) with knee OA were evaluated. Statistical modeling did not reveal linear nor curvilinear associations between KROM and self-reported or observed measures of functioning; except for statistical significant associations between reduced knee flexion and major difficulties standing (p<=0.01). However, further modeling did not provide convincing evidence for relevant clinical associations and thresholds. Conclusions: No clinically relevant relationship between KROM and self-reported or observed measures of physical functioning could be established, indicating that the limitations in range of motion in the affected knee OA alone do not contribute to poorer functional performance.	[Hoogeboom, Thomas J.; Stevens-Lapsley, Jennifer E.] Univ Colorado, Dept Phys Med & Rehabil, Phys Therapy Program, Denver, CO 80202 USA; [Hoogeboom, Thomas J.; van Meeteren, Nico L. U.] Maastricht Univ, Med Ctr, Caphri Res Sch, Maastricht, Netherlands; [Hoogeboom, Thomas J.; van Meeteren, Nico L. U.] Ctr Care Technol Res CCTR, Maastricht, Netherlands; [van Meeteren, Nico L. U.] TNO Hlth Living, Leiden, Netherlands; [Kim, Raymond H.] Porter Adventist Hosp, Dept Orthoped, Denver, CO USA	University of Colorado System; University of Colorado Denver; Maastricht University; Netherlands Organization Applied Science Research	Hoogeboom, TJ (corresponding author), Univ Colorado, Dept Phys Med & Rehabil, Phys Therapy Program, Denver, CO 80202 USA.	thomashoogeboom@gmail.com	Hoogeboom, Thomas J/G-8767-2015	Hoogeboom, Thomas J/0000-0003-2103-419X; Stevens-Lapsley, Jennifer/0000-0002-8118-378X				Bieleman HJ, 2010, INT ARCH OCC ENV HEA, V83, P913, DOI 10.1007/s00420-010-0541-3; Brown K, 2009, J STRENGTH COND RES, V23, P436, DOI 10.1519/JSC.0b013e318198fc13; Cook TM, 1997, J ORTHOP SPORT PHYS, V25, P236, DOI 10.2519/jospt.1997.25.4.236; Ferrucci L, 1997, J GERONTOL A-BIOL, V52, pM275, DOI 10.1093/gerona/52A.5.M275; Holla JFM, 2010, ARTHRIT CARE RES, V62, P1415, DOI 10.1002/acr.20263; JETTE AM, 1995, PHYS THER, V75, P965, DOI 10.1093/ptj/75.11.965; Jette AM, 2001, PHYS THER, V81; Jette AM, 2001, PHYS THER, V81, P3; Kennedy DM, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-3; Konrat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033559; Lenssen AF, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-83; Meneghini RM, 2007, J ARTHROPLASTY, V22, P47, DOI 10.1016/j.arth.2007.03.031; Miner AL, 2003, J ARTHROPLASTY, V18, P286, DOI 10.1054/arth.2003.50046; Norkin CC., 2003, MEASUREMENT JOINT MO; OBERG T, 1994, J REHABIL RES DEV, V31, P199; Park KK, 2007, J BONE JOINT SURG BR, V89B, P604, DOI 10.1302/0301-620X.89B5.18117; Pisters MF, 2012, OSTEOARTHR CARTILAGE, V20, P503, DOI 10.1016/j.joca.2012.02.002; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P17, DOI 10.1186/1477-7525-1-17; Royston P., 1998, STATA TECH B, V42, P38; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Steultjens MPM, 2000, RHEUMATOLOGY, V39, P955, DOI 10.1093/rheumatology/39.9.955; Stevens-Lapsley JE, 2012, J ARTHROPLASTY, V27, P1812, DOI 10.1016/j.arth.2012.02.016; Stevens-Lapsley JE, 2012, PHYS THER, V92, P210, DOI 10.2522/ptj.20110124; van Dijk GM, 2010, ARCH PHYS MED REHAB, V91, P58, DOI 10.1016/j.apmr.2009.08.147; van Dijk GM, 2009, DISABIL REHABIL, V31, P1685, DOI 10.1080/09638280902736809; WINTER DA, 1983, PHYS THER, V63, P331, DOI 10.1093/ptj/63.3.331; Zhang W, 2010, ANN RHEUM DIS, V69, P483, DOI 10.1136/ard.2009.113100	28	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76173	10.1371/journal.pone.0076173	http://dx.doi.org/10.1371/journal.pone.0076173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086704	Green Published, gold, Green Submitted			2022-12-25	WOS:000325220000062
J	Landesmann, JB; Gundel, PE; Martinez-Ghersa, MA; Ghersa, CM				Landesmann, Jennifer B.; Gundel, Pedro E.; Alejandra Martinez-Ghersa, M.; Ghersa, Claudio M.			Ozone Exposure of a Weed Community Produces Adaptive Changes in Seed Populations of Spergula arvensis	PLOS ONE			English	Article							(SEMI-)NATURAL VEGETATION; EVOLUTIONARY RESPONSES; CLIMATE-CHANGE; ELEVATED CO2; PLANT; DORMANCY; QUALITY; GERMINATION; IMPACT; YIELD	Tropospheric ozone is one of the major drivers of global change. This stress factor alters plant growth and development. Ozone could act as a selection pressure on species communities composition, but also on population genetic background, thus affecting life history traits. Our objective was to evaluate the consequences of prolonged ozone exposure of a weed community on phenotypic traits of Spergula arvensis linked to persistence. Specifically, we predicted that the selection pressure exerted by high ozone concentrations as well as the concomitant changes in the weed community would drive population adaptive changes which will be reflected on seed germination, dormancy and longevity. In order to test seed viability and dormancy level, we conducted germination experiments for which we used seeds produced by S. arvensis plants grown within a weed community exposed to three ozone treatments during four years (0, 90 and 120 ppb). We also performed a soil seed bank experiment to test seed longevity with seeds coming from both the four-year ozone exposure experiment and from a short-term treatment conducted at ambient and added ozone concentrations. We found that prolonged ozone exposure produced changes in seed germination, dormancy and longevity, resulting in three S. arvensis populations. Seeds from the 90 ppb ozone selection treatment had the highest level of germination when stored at 75% RH and 25 degrees C and then scarified. These seeds showed the lowest dormancy level when being subjected to 5 degrees C/5% RH and 25 degrees C/75% followed by 5% RH storage conditions. Furthermore, ozone exposure increased seed persistence in the soil through a maternal effect. Given that tropospheric ozone is an important pollutant in rural areas, changes in seed traits due to ozone exposure could increase weed persistence in fields, thus affecting weed-crop interactions, which could ultimately reduce crop production.	[Landesmann, Jennifer B.] Univ Nacl Comahue, INIBIOMA CONICET, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina; [Landesmann, Jennifer B.; Gundel, Pedro E.; Alejandra Martinez-Ghersa, M.; Ghersa, Claudio M.] IFEVA CONICET, Fac Agron UBA, Catedra Ecol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Landesmann, JB (corresponding author), Univ Nacl Comahue, INIBIOMA CONICET, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina.	jennifer.landesmann@gmail.com	Gundel, Pedro/A-5314-2013	Gundel, Pedro/0000-0003-3246-0282	UBACYT [G073]; FONCYT [PICT 2010 1573]	UBACYT; FONCYT(FONCyT)	This research was funded by UBACYT G073 and FONCYT PICT 2010 1573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anav A, 2011, GLOBAL CHANGE BIOL, V17, P2342, DOI 10.1111/j.1365-2486.2010.02387.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2008, INT RUL SEED TEST, P1; ASHMORE MR, 1991, ANN BOT-LONDON, V67, P39, DOI 10.1093/oxfordjournals.aob.a088207; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Barbo DN, 1998, NEW PHYTOL, V138, P653, DOI 10.1046/j.1469-8137.1998.00138.x; Baskin J.M., 1998, SEEDS ECOLOGY BIOGEO; Baskin Jerry M., 2000, Plant Species Biology, V15, P139, DOI 10.1046/j.1442-1984.2000.00034.x; Benech-Arnold RL, 2000, FIELD CROP RES, V67, P105, DOI 10.1016/S0378-4290(00)00087-3; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Black VJ, 2010, ENVIRON EXP BOT, V69, P121, DOI 10.1016/j.envexpbot.2010.04.006; Bogo H, 1999, ATMOS ENVIRON, V33, P2587, DOI 10.1016/S1352-2310(98)00270-2; Booker F, 2009, J INTEGR PLANT BIOL, V51, P337, DOI 10.1111/j.1744-7909.2008.00805.x; Bosac C, 1998, J PLANT PHYSIOL, V153, P127, DOI 10.1016/S0176-1617(98)80055-2; BOUWMEESTER HJ, 1993, CAN J BOT, V71, P64, DOI 10.1139/b93-008; Crawley MJ., 2007, R BOOK; Darbah JNT, 2008, ENVIRON POLLUT, V155, P446, DOI 10.1016/j.envpol.2008.01.033; Fenner M., 2005, ECOLOGY SEEDS; Galloway LF, 2001, AM J BOT, V88, P832, DOI 10.2307/2657035; Grantz DA, 2006, CROP SCI, V46, P1879, DOI 10.2135/cropsci2005.06.0167; Gundel PE, 2008, EUR J AGRON, V28, P606, DOI 10.1016/j.eja.2008.01.004; Hayes F, 2007, ENVIRON POLLUT, V146, P754, DOI 10.1016/j.envpol.2006.06.011; HOGSETT WE, 1985, ATMOS ENVIRON, V19, P1135, DOI 10.1016/0004-6981(85)90198-2; Iriti M, 2009, J AGR FOOD CHEM, V57, P201, DOI 10.1021/jf802819m; Kangasjarvi J, 2005, PLANT CELL ENVIRON, V28, P1021, DOI 10.1111/j.1365-3040.2005.01325.x; LEFOHN AS, 1986, ATMOS ENVIRON, V20, P361, DOI 10.1016/0004-6981(86)90039-9; Leisner CP, 2012, GLOBAL CHANGE BIOL, V18, P606, DOI 10.1111/j.1365-2486.2011.02535.x; Lyons TM, 1997, NEW PHYTOL, V136, P503, DOI 10.1046/j.1469-8137.1997.00773.x; Martinez-Ghersa Maria A., 2000, Plant Species Biology, V15, P127, DOI 10.1046/j.1442-1984.2000.00033.x; Mendoza R, 2008, THESIS BUENOS AIRES; Merritt DJ, 2003, AUST J BOT, V51, P85, DOI 10.1071/BT02040; Mills G, 2007, ENVIRON POLLUT, V146, P736, DOI 10.1016/j.envpol.2006.04.005; Mills G, 2011, GLOBAL CHANGE BIOL, V17, P592, DOI 10.1111/j.1365-2486.2010.02217.x; Mortimer AM, 1997, PESTIC SCI, V51, P299, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;299::AID-PS653&gt;3.0.CO;2-I; Ooi MKJ, 2009, GLOBAL CHANGE BIOL, V15, P2375, DOI 10.1111/j.1365-2486.2009.01887.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pfleeger TG, 2010, AGR ECOSYST ENVIRON, V138, P116, DOI 10.1016/j.agee.2010.04.009; ROBERTS HA, 1982, WEED RES, V22, P13, DOI 10.1111/j.1365-3180.1982.tb00137.x; Salamin N, 2010, TRENDS ECOL EVOL, V25, P692, DOI 10.1016/j.tree.2010.09.009; Schnell RC, 2009, NAT GEOSCI, V2, P120, DOI 10.1038/NGEO415; Skelly DK, 2007, CONSERV BIOL, V21, P1353, DOI 10.1111/j.1523-1739.2007.00764.x; TRAINER M, 1987, NATURE, V329, P705, DOI 10.1038/329705a0; VANSTADE.J, 1973, J EXP BOT, V24, P662, DOI 10.1093/jxb/24.4.662; Vingarzan R, 2004, ATMOS ENVIRON, V38, P3431, DOI 10.1016/j.atmosenv.2004.03.030; Voigt W, 2007, GLOBAL CHANGE BIOL, V13, P1710, DOI 10.1111/j.1365-2486.2007.01398.x; WAGNER LK, 1988, AM J BOT, V75, P465, DOI 10.2307/2444211; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; WARWICK MA, 1984, WEED RES, V24, P261, DOI 10.1111/j.1365-3180.1984.tb01563.x; Way DA, 2010, GLOBAL CHANGE BIOL, V16, P1046, DOI 10.1111/j.1365-2486.2009.02007.x; Zhaozhong F, 2008, GLOBAL CHANGE BIOL, V14, P2696	50	10	10	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75820	10.1371/journal.pone.0075820	http://dx.doi.org/10.1371/journal.pone.0075820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086640	Green Published, gold, Green Submitted			2022-12-25	WOS:000325220000045
J	Loop, MS; Kent, ST; Al-Hamdan, MZ; Crosson, WL; Estes, SM; Estes, MG; Quattrochi, DA; Hemmings, SN; Wadley, VG; McClure, LA				Loop, Matthew Shane; Kent, Shia T.; Al-Hamdan, Mohammad Z.; Crosson, William L.; Estes, Sue M.; Estes, Maurice G., Jr.; Quattrochi, Dale A.; Hemmings, Sarah N.; Wadley, Virginia G.; McClure, Leslie A.			Fine Particulate Matter and Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort	PLOS ONE			English	Article							AIR-POLLUTION EXPOSURE; VASCULAR RISK-FACTORS; UNITED-STATES; BRAIN INFLAMMATION; INDIVIDUALS; ASSOCIATION; AEROSOL; HEART; CHILDREN; DECLINE	Studies of the effect of air pollution on cognitive health are often limited to populations living near cities that have air monitoring stations. Little is known about whether the estimates from such studies can be generalized to the U.S. population, or whether the relationship differs between urban and rural areas. To address these questions, we used a satellite-derived estimate of fine particulate matter (PM2.5) concentration to determine whether PM2.5 was associated with incident cognitive impairment in a geographically diverse, biracial US cohort of men and women (n = 20,150). A 1-year mean baseline PM2.5 concentration was estimated for each participant, and cognitive status at the most recent follow-up was assessed over the telephone using the Six-Item Screener (SIS) in a subsample that was cognitively intact at baseline. Logistic regression was used to determine whether PM2.5 was related to the odds of incident cognitive impairment. A 10 mu g/m(3) increase in PM2.5 concentration was not reliably associated with an increased odds of incident impairment, after adjusting for temperature, season, incident stroke, and length of follow-up [OR (95% CI): 1.26 (0.97, 1.64)]. The odds ratio was attenuated towards 1 after adding demographic covariates, behavioral factors, and known comorbidities of cognitive impairment. A 10 mu g/m(3) increase in PM2.5 concentration was slightly associated with incident impairment in urban areas (1.40 [1.06-1.85]), but this relationship was also attenuated after including additional covariates in the model. Evidence is lacking that the effect of PM2.5 on incident cognitive impairment is robust in a heterogeneous US cohort, even in urban areas.	[Loop, Matthew Shane; McClure, Leslie A.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Kent, Shia T.] Univ Alabama Birmingham, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; [Al-Hamdan, Mohammad Z.; Crosson, William L.; Estes, Sue M.; Estes, Maurice G., Jr.; Hemmings, Sarah N.] NASA Marshall Space Flight Ctr, Univ Space Res Assoc, Huntsville, AL USA; [Quattrochi, Dale A.] NASA Marshall Space Flight Ctr, Earth Sci Off, Huntsville, AL USA; [Wadley, Virginia G.] Univ Alabama Birmingham, Sch Med, Div Gerontol Geriatr & Palliat Care, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Universities Space Research Association (USRA); National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University of Alabama System; University of Alabama Birmingham	Loop, MS (corresponding author), Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.	loop2@uab.edu	McClure, Leslie/P-2929-2015	Loop, Matthew/0000-0001-9442-4573	National Institute of Neurological Disorders and Stroke [U01NS41588]; National Institutes of Health Heart, Lung and Blood Institute [T32HL079888]; National Aeronautics and Space Administration [NNX09AV81G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL079888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by federal grants from National Institute of Neurological Disorders and Stroke (U01NS41588, http://www.ninds.nih.gov/), National Institutes of Health Heart, Lung and Blood Institute (T32HL079888, http://www.nhlbi.nih.gov/), and National Aeronautics and Space Administration (NNX09AV81G, http://www.nasa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hamdan MZ, 2014, GEOCARTO INT, V29, P85, DOI 10.1080/10106049.2012.715209; Al-Hamdan MZ, 2009, J AIR WASTE MANAGE, V59, P865, DOI 10.3155/1047-3289.59.7.865; Blacker D, 2007, ARCH NEUROL-CHICAGO, V64, P862, DOI 10.1001/archneur.64.6.862; Calderon-Garciduenas L, 2004, TOXICOL PATHOL, V32, P650, DOI 10.1080/01926230490520232; Calderon-Garciduenas L, 2003, TOXICOL PATHOL, V31, P524, DOI 10.1080/01926230390226645; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2007, TOXICOL PATHOL, V35, P154, DOI 10.1080/01926230601059985; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Campbell A, 2005, NEUROTOXICOLOGY, V26, P133, DOI 10.1016/j.neuro.2004.08.003; Chen JC, 2009, NEUROTOXICOLOGY, V30, P231, DOI 10.1016/j.neuro.2008.12.011; Cosgrove BA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003118; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Duron E, 2008, VASC HEALTH RISK MAN, V4, P363; Euser SM, 2008, EPIDEMIOLOGY, V19, P440, DOI 10.1097/EDE.0b013e31816a1d31; Freire C, 2010, J EPIDEMIOL COMMUN H, V64, P223, DOI 10.1136/jech.2008.084574; Gryparis A, 2009, BIOSTATISTICS, V10, P258, DOI 10.1093/biostatistics/kxn033; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Heal MR, 2012, CHEM SOC REV, V41, P6606, DOI 10.1039/c2cs35076a; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Hu ZY, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-26; Hu ZY, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-27; Kumar N, 2010, ENVIRON HEALTH PERSP, V118, pA109, DOI 10.1289/ehp.0901732; Liu W, 2005, ATMOS ENVIRON, V39, P4453, DOI 10.1016/j.atmosenv.2005.03.048; Martuzevicius D, 2004, ATMOS ENVIRON, V38, P1091, DOI 10.1016/j.atmosenv.2003.11.015; MELCHIOR LA, 1993, EDUC PSYCHOL MEAS, V53, P1117, DOI 10.1177/0013164493053004024; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Power MC, 2011, ENVIRON HEALTH PERSP, V119, P682, DOI 10.1289/ehp.1002767; Puett RC, 2009, ENVIRON HEALTH PERSP, V117, P1697, DOI 10.1289/ehp.0900572; Pullicino PM, 2008, J CARD FAIL, V14, P290, DOI 10.1016/j.cardfail.2008.01.003; Ranft U, 2009, ENVIRON RES, V109, P1004, DOI 10.1016/j.envres.2009.08.003; Steffens DC, 2006, AM J GERIAT PSYCHIAT, V14, P401, DOI 10.1097/01.JGP.0000194646.65031.3f; Suglia SF, 2008, AM J EPIDEMIOL, V167, P280, DOI 10.1093/aje/kwm308; Tamura MK, 2008, AM J KIDNEY DIS, V52, P227, DOI 10.1053/j.ajkd.2008.05.004; Tsivgoulis G, 2009, NEUROLOGY, V73, P589, DOI 10.1212/WNL.0b013e3181b38969; Unverzagt FW, 2011, NEUROLOGY, V77, P1729, DOI 10.1212/WNL.0b013e318236ef23; Wadley VG, 2007, STROKE, V38, P1143, DOI 10.1161/01.STR.0000259676.75552.38; Wadley VG, 2011, ANN NEUROL, V70, P229, DOI 10.1002/ana.22432; Wellenius GA, 2012, ARCH INTERN MED, V172, P229, DOI 10.1001/archinternmed.2011.732; Weuve J, 2012, ARCH INTERN MED, V172, P219, DOI 10.1001/archinternmed.2011.683; Wilber ST, 2005, ACAD EMERG MED, V12, P612, DOI 10.1111/j.1553-2712.2005.tb00915.x; Zhang H, 2009, J AIR WASTE MANAGE, V59, P1358, DOI 10.3155/1047-3289.59.11.1358	41	62	66	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75001	10.1371/journal.pone.0075001	http://dx.doi.org/10.1371/journal.pone.0075001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086422	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700049
J	Nair, M; Ariana, P; Ohuma, EO; Gray, R; De Stavola, B; Webster, P				Nair, Manisha; Ariana, Proochista; Ohuma, Eric O.; Gray, Ron; De Stavola, Bianca; Webster, Premila			Effect of the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA) on Malnutrition of Infants in Rajasthan, India: A Mixed Methods Study	PLOS ONE			English	Article							FOOD INSECURITY; DEFINITION; NUTRITION; MORTALITY; IMPACT	Objectives: Analyse the effect of the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA), a wage-for-employment policy of the Indian Government, on infant malnutrition and delineate the pathways through which MGNREGA affects infant malnutrition. Hypothesis: MGNREGA could reduce infant malnutrition through positive effects on household food security and infant feeding. Method: Mixed methods using cross-sectional study and focus group discussions conducted in Dungarpur district, Rajasthan, India. Participants: Infants aged 1 to <12 months and their mothers/caregivers. Final sample 528 households with 1056 participants, response rate 89.6%. Selected households were divided into MGNREGA-households and non-MGNREGA-households based on participation in MGNREGA between August-2010 and September-2011. Outcomes: Infant malnutrition measured using anthropometric indicators - underweight, stunting, and wasting (WHO criteria). Results: We included 528 households with 1,056 participants. Out of 528, 281 households took part in MGNREGA between August'10, and September'11. Prevalence of wasting was 39%, stunting 24%, and underweight 50%. Households participating in MGNREGA were less likely to have wasted infants (OR 0.57, 95% CI 0.37-0.89, p = 0.014) and less likely to have underweight infants (OR 0.48, 95% CI 0.30-0.76, p = 0.002) than non-participating households. Stunting did not differ significantly between groups. We did 11 focus group discussions with 62 mothers. Although MGNREGA reduced starvation, it did not provide the desired benefits because of lower than standard wages and delayed payments. Results from path analysis did not support existence of an effect through household food security and infant feeding, but suggested a pathway of effect through low birth-weight. Conclusion: Participation in MGNREGA was associated with reduced infant malnutrition possibly mediated indirectly via improved birth-weight rather than by improved infant feeding. Addressing factors such as lack of mothers' knowledge and inappropriate feeding practices, over and above the social and economic policies, is key in efforts to reduce infant malnutrition.	[Nair, Manisha; Gray, Ron] Univ Oxford, NPEU, Nuffield Dept Populat Hlth, Oxford, England; [Ariana, Proochista; Webster, Premila] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Ariana, Proochista] Univ Oxford, Dept Int Dev, Oxford, England; [Ohuma, Eric O.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England; [De Stavola, Bianca] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [De Stavola, Bianca] London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, London WC1, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Nair, M (corresponding author), Univ Oxford, NPEU, Nuffield Dept Populat Hlth, Oxford, England.	manisha.nair@npeu.ox.ac.uk		De Stavola, Bianca Lucia/0000-0001-7853-0528; Nair, Manisha/0000-0003-0660-5054	Weidenfeld Scholarship; Department of Public Health, University of Oxford, UK	Weidenfeld Scholarship; Department of Public Health, University of Oxford, UK	This paper is from the PhD thesis of MN funded by the Weidenfeld Scholarship and Leadership Programme and Department of Public Health, University of Oxford, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBI R, 1988, Food and Nutrition Bulletin, V10, P51; Asparouhov T., 2010, MPLUS TECHNICAL APPE; BAQUI AH, 1991, INT J EPIDEMIOL, V20, P1057, DOI 10.1093/ije/20.4.1057; Bawdekar M, 2008, J BIOSOC SCI, V40, P771, DOI 10.1017/S0021932008002757; Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Burchi F, 2010, ECON HUM BIOL, V8, P331, DOI 10.1016/j.ehb.2010.05.010; Charmarbagwala R, 2004, DETERMINANTS CHILD H; Chitnis S., 1997, POLITICS BACKWARDNES; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; DEONIS M, 1993, B WORLD HEALTH ORGAN, V71, P703; Dev SM, 2011, WP2011004 I GANDH I; Frongillo EA, 1997, J NUTR, V127, P2302, DOI 10.1093/jn/127.12.2302; Galanter Marc, 1984, COMPETING EQUALITIES; Government of Rajasthan and Planning Commission of India, 2009, DUNG DISTR HUM DEV R; Gulliford MC, 2005, J CLIN EPIDEMIOL, V58, P246, DOI 10.1016/j.jclinepi.2004.08.012; Hooper D, 2008, ELECT J BUSINESS RES, V6, P53, DOI DOI 10.21427/D7CF7R; International Institute for Population Sciences, 2011, DISTR LEV HOUS FAC S; International Institute for Population Sciences (IIPS), 2007, NAT FAM HLTH SURV NF; Jha R, 2011, J ASIAN ECON, V22, P189, DOI 10.1016/j.asieco.2010.11.004; Kenny DA, 2003, STRUCT EQU MODELING, V10, P333, DOI 10.1207/S15328007SEM1003_1; Khera R., 2011, BATTLE EMPLOYMENT GU; Mascie-Taylor CGN, 2010, B WORLD HEALTH ORGAN, V88, P854, DOI 10.2471/BLT.10.080994; Naandi Foundation, 2011, HUNGAMA FIGHT HUNG M; Nair M, 2011, B WORLD HEALTH ORGAN, V89, P778, DOI 10.2471/BLT.11.093799; Paul KH, 2011, FOOD NUTR BULL, V32, P244, DOI 10.1177/156482651103200308; PELLETIER DL, 1994, J NUTR, V124, pS2047; Planning Commission, 2002, 10 5 YEAR PLAN 2002; Senarath U, 2012, MATERN CHILD NUTR, V8, P5, DOI 10.1111/j.1740-8709.2011.00371.x; Swindale A., 2006, FHI 360FANTA; United Nations Children Fund (UNICEF), 2007, WAT ENV SAN CHILDR W; Uppal V., 2009, IS NREGS SAFETY NET; Vasconcelos AGG, 1998, ANN EPIDEMIOL, V8, P262, DOI 10.1016/S1047-2797(97)00213-5; Vesel L, 2010, B WORLD HEALTH ORGAN, V88, P39, DOI 10.2471/BLT.08.057901; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WATERLOW JC, 1972, BRIT MED J, V3, P566, DOI 10.1136/bmj.3.5826.566; Webb P, 1995, EMPLOYMENT POVERTY R; WHO, 2006, WHO CHILD GROWTH STA; WHO/ UNICEF, 2009, WHO CHILD GROWTH STA; World Health Organization, 2010, IND ASS INF YOUNG CH	39	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75089	10.1371/journal.pone.0075089	http://dx.doi.org/10.1371/journal.pone.0075089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086447	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700052
J	Panda, SP; Guntur, AR; Polusani, SR; Fajardo, RJ; Gakunga, PT; Roman, LJ; Masters, BS				Panda, Satya P.; Guntur, Anyonya R.; Polusani, Srikanth R.; Fajardo, Roberto J.; Gakunga, Peter T.; Roman, Linda J.; Masters, Bettie Sue			Conditional Deletion of Cytochrome P450 Reductase in Osteoprogenitor Cells Affects Long Bone and Skull Development in Mice Recapitulating Antley-Bixler Syndrome: Role of a Redox Enzyme in Development	PLOS ONE			English	Article							P450 OXIDOREDUCTASE; PKC-DELTA; MOUSE; GROWTH; EXPRESSION; OSTEOBLAST; GENE; DIFFERENTIATION; KNOCKOUT; DEFECTS	NADPH-cytochrome P450 oxidoreductase (POR) is the primary electron donor for cytochromes P450, dehydrocholesterol reductase, heme oxygenase, and squalene monooxygenase. Human patients with specific mutations in POR exhibit severe developmental malformations including disordered steroidogenesis, sexual ambiguities and various bone defects, similar to those seen in patients with Antley-Bixler syndrome (ABS). To probe the role of POR during bone development, we generated a conditional knockout mouse (CKO) by cross breeding Por(lox/lox) and Dermo1 Cre mice. CKO mice were smaller than their littermate controls and exhibited significant craniofacial and long bone abnormalities. Differential staining of the CKO mice skull bases shows premature fusion of the sphenooccipital and basioccipital-exoccipital synchondroses. Class III malocclusion was noted in adult knockout mice with an unusual overgrowth of the lower incisors. Shorter long bones were observed along with a reduction in the bone volume fraction, measured by microCT, in the Por-deleted mice compared to age-and sex-matched littermate controls. Concerted up-or down-regulation of proteins in the FGF signaling pathway observed by immunohistochemistry in the tibia samples of CKO mice compared to wild type controls shows a decrease in the FGF signaling pathway. To our knowledge, this is the first report of a mouse model that recapitulates both skull and long bone defects upon Por deletion, offering an approach to study the sequelae of POR mutations. This unique model demonstrates that P450 metabolism in bone itself is potentially important for proper bone development, and that an apparent link exists between the POR and FGF signaling pathways, begging the question of how an oxidation-reduction flavoprotein affects developmental and cellular signaling processes.	[Panda, Satya P.; Guntur, Anyonya R.; Polusani, Srikanth R.; Roman, Linda J.; Masters, Bettie Sue] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Fajardo, Roberto J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Orthoped, San Antonio, TX 78229 USA; [Gakunga, Peter T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Dev Dent, Div Orthodont, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Panda, SP (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	panda@uthscsa.edu; masters@uthscsa.edu	Polusani, Srikanth R/H-7318-2015	polusani, Srikanth/0000-0002-7186-0345	NIH [GM081568]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081568] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grant GM081568 to BSM and SPP and BSM is The Robert A. Welch Distinguished Professor in Chemistry (AQ-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2009, ENDOCRINOLOGY, V150, P2732, DOI 10.1210/en.2009-0043; Alam J, 2002, ANTIOXID REDOX SIGN, V4, P559, DOI 10.1089/15230860260220049; Antley R, 1975, Birth Defects Orig Artic Ser, V11, P397; Auchus RJ, 2001, ENDOCRIN METAB CLIN, V30, P101, DOI 10.1016/S0889-8529(08)70021-5; Cheng JB, 2003, J BIOL CHEM, V278, P38084, DOI 10.1074/jbc.M307028200; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dobrowolski R, 2009, HUM MOL GENET, V18, P2899, DOI 10.1093/hmg/ddp227; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Fang C, 2012, NEUROSCIENCE, V218, P170, DOI 10.1016/j.neuroscience.2012.05.027; Fang C, 2008, DRUG METAB DISPOS, V36, P1722, DOI 10.1124/dmd.108.021881; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Guntur AR, 2011, DEVELOPMENT, V138, P1433, DOI 10.1242/dev.058016; Horvat S, 2011, DRUG METAB REV, V43, P69, DOI 10.3109/03602532.2010.540580; Huang NW, 2005, AM J HUM GENET, V76, P729, DOI 10.1086/429417; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Keber R, 2011, J BIOL CHEM, V286, P29086, DOI 10.1074/jbc.M111.253245; Kolpakova-Hart E, 2008, DEV BIOL, V321, P407, DOI 10.1016/j.ydbio.2008.07.005; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Laurita J, 2011, DEV DYNAM, V240, P2584, DOI 10.1002/dvdy.22752; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Lee CH, 2011, EUR J PHARMACOL, V668, P383, DOI 10.1016/j.ejphar.2011.06.059; Liu ZH, 2007, DEV BIOL, V302, P80, DOI 10.1016/j.ydbio.2006.08.071; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Makarenkova H, 1999, DEV BIOL, V207, P380, DOI 10.1006/dbio.1998.9171; Masters BS, 2006, DRUG METAB REV, V38, P209, DOI 10.1080/03602530600570065; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Melville H, 2010, AM J MED GENET A, V152A, P3007, DOI 10.1002/ajmg.a.33703; Nagata M, 2011, BONE, V48, P847, DOI 10.1016/j.bone.2010.11.014; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Niger C, 2012, AM J PHYSIOL-CELL PH, V302, pC1035, DOI 10.1152/ajpcell.00262.2011; Opperman L.A., 2005, SEMIN ORTHOD, V11, P199, DOI [10.1053/j.sodo.2005.07.004, DOI 10.1053/J.SODO.2005.07.004, DOI 10.1053/J.S0D0.2005.07.004]; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; Polusani SR, 2011, BIOCHEM BIOPH RES CO, V411, P490, DOI 10.1016/j.bbrc.2011.06.132; Ribes V, 2007, DEV BIOL, V303, P66, DOI 10.1016/j.ydbio.2006.10.032; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Schmidt K, 2009, MOL CELL BIOL, V29, P2716, DOI 10.1128/MCB.01638-08; Seo HS, 2007, DEV BIOL, V310, P304, DOI 10.1016/j.ydbio.2007.07.040; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Stavridis MP, 2010, DEVELOPMENT, V137, P881, DOI 10.1242/dev.043117; Takahashi H, 1997, ENDOCR RES, V23, P95, DOI 10.1080/07435809709031845; Tou LQ, 2001, MOL CELL ENDOCRINOL, V183, P71, DOI 10.1016/S0303-7207(01)00594-9; Tsuchiya Yoshiko, 2004, Bull Tokyo Dent Coll, V45, P87, DOI 10.2209/tdcpublication.45.87; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Twigg SRF, 2009, DEV DYNAM, V238, P331, DOI 10.1002/dvdy.21790; Weng Y, 2007, CANCER RES, V67, P7825, DOI 10.1158/0008-5472.CAN-07-1006; Wu L, 2005, J PHARMACOL EXP THER, V312, P35, DOI 10.1124/jpet.104.073353; Wu L, 2003, GENESIS, V36, P177, DOI 10.1002/gene.10214; Yeh LCC, 1996, ENDOCRINOLOGY, V137, P1921, DOI 10.1210/en.137.5.1921; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang QY, 2009, DRUG METAB DISPOS, V37, P651, DOI 10.1124/dmd.108.025429	55	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75638	10.1371/journal.pone.0075638	http://dx.doi.org/10.1371/journal.pone.0075638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086598	Green Submitted, gold, Green Published			2022-12-25	WOS:000325218700106
J	Elustondo, PA; Angelova, PR; Kawalec, M; Michalak, M; Kurcok, P; Abramov, AY; Pavlov, EV				Elustondo, Pia A.; Angelova, Plamena R.; Kawalec, Michal; Michalak, Michal; Kurcok, Piotr; Abramov, Andrey Y.; Pavlov, Evgeny V.			Polyhydroxybutyrate Targets Mammalian Mitochondria and Increases Permeability of Plasmalemmal and Mitochondrial Membranes	PLOS ONE			English	Article							INORGANIC POLYPHOSPHATE; (R)-3-HYDROXYBUTANOIC ACID; ESCHERICHIA-COLI; LIPID-BILAYERS; CHANNEL; CELLS; IDENTIFICATION; METABOLISM; TRANSPORT; CA2+	Poly(3-hydroxybutyrate) (PHB) is a polyester of 3-hydroxybutyric acid (HB) that is ubiquitously present in all organisms. In higher eukaryotes PHB is found in the length of 10 to 100 HB units and can be present in free form as well as in association with proteins and inorganic polyphosphate. It has been proposed that PHB can mediate ion transport across lipid bilayer membranes. We investigated the ability of PHB to interact with living cells and isolated mitochondria and the effects of these interactions on membrane ion transport. We performed experiments using a fluorescein derivative of PHB (fluo-PHB). We found that fluo-PHB preferentially accumulated inside the mitochondria of HeLa cells. Accumulation of fluo-PHB induced mitochondrial membrane depolarization. This membrane depolarization was significantly delayed by the inhibitor of the mitochondrial permeability transition pore - Cyclosporin A. Further experiments using intact cells as well as isolated mitochondria confirmed that the effects of PHB directly linked to its ability to facilitate ion transport, including calcium, across the membranes. We conclude that PHB demonstrates ionophoretic properties in biological membranes and this effect is most profound in mitochondria due to the selective accumulation of the polymer in this organelle.	[Elustondo, Pia A.; Pavlov, Evgeny V.] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada; [Kawalec, Michal; Michalak, Michal; Kurcok, Piotr] Polish Acad Sci, Ctr Polymer & Carbon Mat, Zabrze, Poland; [Angelova, Plamena R.; Abramov, Andrey Y.] UCL Inst Neurol, London, England	Dalhousie University; Polish Academy of Sciences; Centre of Polymer & Carbon Materials of the Polish Academy of Sciences; University of London; University College London	Pavlov, EV (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada.	evgeny.pavlov@dal.ca	Kawalec, Michal/H-3918-2011; Michalak, Michal/O-4975-2019; Kurcok, Piotr/B-5773-2016; Michalak, Michał/D-4543-2016; Stroh, Plamena/K-4444-2013; Abramov, Andrey/AAC-6712-2019; Abramov, Andrey Y/H-9053-2012	Kawalec, Michal/0000-0002-5760-3756; Michalak, Michal/0000-0001-6306-3744; Kurcok, Piotr/0000-0002-8748-1649; Michalak, Michał/0000-0001-6306-3744; Stroh, Plamena/0000-0003-4596-9117; Abramov, Andrey/0000-0002-7646-7235; Abramov, Andrey Y/0000-0002-7646-7235	Heart and Stroke Foundation of Nova Scotia; Natural Sciences and Engineering Research Council of Canada	Heart and Stroke Foundation of Nova Scotia; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Heart and Stroke Foundation of Nova Scotia and Natural Sciences and Engineering Research Council of Canada (to EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2003, CELL CALCIUM, V33, P101, DOI 10.1016/S0143-4160(02)00203-8; Abramov AY, 2001, BBA-BIOMEMBRANES, V1512, P98, DOI 10.1016/S0005-2736(01)00307-8; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Cao CK, 2013, CELL REP, V4, P302, DOI 10.1016/j.celrep.2013.06.022; Das S, 1999, MACROMOLECULES, V32, P8781, DOI 10.1021/ma991105t; Das S, 1997, P NATL ACAD SCI USA, V94, P9075, DOI 10.1073/pnas.94.17.9075; Elustondo P, 2012, CHEM BIODIVERS, V9, P2597, DOI 10.1002/cbdv.201200294; Fritz MG, 1999, MACROMOLECULES, V32, P574, DOI 10.1021/ma981256g; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gee PJ, 2002, HELV CHIM ACTA, V85, P618, DOI 10.1002/1522-2675(200202)85:2<618::AID-HLCA618>3.0.CO;2-Q; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; Kawalec M, 2012, REACT FUNCT POLYM, V72, P509, DOI 10.1016/j.reactfunctpolym.2012.04.013; KESSLER RJ, 1977, P NATL ACAD SCI USA, V74, P2241, DOI 10.1073/pnas.74.6.2241; Pavlov E, 2005, BIOPHYS J, V88, P2614, DOI 10.1529/biophysj.104.057281; Pavlov E, 2010, J BIOL CHEM, V285, P9420, DOI 10.1074/jbc.M109.013011; Piddubnyak V, 2004, BIOMATERIALS, V25, P5271, DOI 10.1016/j.biomaterials.2003.12.029; Reusch RN, 2003, ACTA DIABETOL, V40, P91; REUSCH RN, 1989, P SOC EXP BIOL MED, V191, P377; REUSCH RN, 1988, P NATL ACAD SCI USA, V85, P4176, DOI 10.1073/pnas.85.12.4176; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Seebach D, 1999, INT J BIOL MACROMOL, V25, P217, DOI 10.1016/S0141-8130(99)00037-9; SEEBACH D, 1994, EUR J BIOCHEM, V224, P317, DOI 10.1111/j.1432-1033.1994.00317.x; Smithen M, 2013, CELL CALCIUM, V54, P86, DOI 10.1016/j.ceca.2013.04.006; Trainer MA, 2006, APPL MICROBIOL BIOT, V71, P377, DOI 10.1007/s00253-006-0354-1; Wood-Kaczmar A, 2013, ADV EXP MED BIOL, V961, P241, DOI 10.1007/978-1-4614-4756-6_20; Zakharian E, 2007, BIOPHYS J, V92, P588, DOI 10.1529/biophysj.106.095273; Zakharian E, 2004, BIOCHEM BIOPH RES CO, V322, P1059, DOI 10.1016/j.bbrc.2004.08.027; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zamaraeva MV, 1997, CELL CALCIUM, V22, P235, DOI 10.1016/S0143-4160(97)90062-2; Zawidlak-Wegrzynska B, 2010, EUR J MED CHEM, V45, P1833, DOI 10.1016/j.ejmech.2010.01.020	31	32	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75812	10.1371/journal.pone.0075812	http://dx.doi.org/10.1371/journal.pone.0075812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086638	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200121
J	Gulden, E; Ihira, M; Ohashi, A; Reinbeck, AL; Freudenberg, MA; Kolb, H; Burkart, V				Guelden, Elke; Ihira, Masaru; Ohashi, Atsushi; Reinbeck, Anna Lena; Freudenberg, Marina A.; Kolb, Hubert; Burkart, Volker			Toll-Like Receptor 4 Deficiency Accelerates the Development of Insulin-Deficient Diabetes in Non-Obese Diabetic Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; INNATE IMMUNITY; AUTOIMMUNE-THYROIDITIS; NITRIC-OXIDE; BETA-CELLS; TLR4; LPS; ACTIVATION; PROTEIN	Background/Objective: Toll-like receptors (TLR) mediate the recognition of microbial constituents and stress-induced endogenous ligands by the immune system. They may also be involved in the maintenance or break down of tolerance against autologous antigens. The aim of our investigation was to study the consequence of TLR4 deficiency on the development of insulin-deficient diabetes in the NOD mouse. Methods: The TLR4 defect of the C57BL/10ScN mouse was backcrossed onto the NOD background and the effect of TLR4 deficiency on diabetes development was analysed by in vivo and in vitro studies. Results: Compared to animals with wildtype TLR4 expression (TLR4(+/+)), female NOD mice carrying a homozygous TLR4 defect (TLR4(-/-)), showed significant acceleration of diabetes development, with a younger age at diabetes onset (TLR4(+/+) 177 +/- 22 d, TLR-/- : 118 +/- 21 d; p < 0.01). Pancreata of 120 d old TLR4(-/-) NOD mice revealed increased proportions of islets with advanced stages of immune cell infiltration compared to TLR4(+/+) mice (p < 0.05). TLR4 deficiency did not affect the susceptibility of islet cells to the beta cell damaging mediators nitric oxide or the inflammatory cytokines tumor necrosis factor alpha, interleukin-1 beta and interferon gamma. The lack of TLR4 further had no effect on the frequency of regulatory T-cells but reduced their capacity to inhibit T-cell proliferation. Conclusions: Our findings demonstrate that TLR4 deficiency results in an acceleration of diabetes development and immune cell infiltration of islets in NOD mice. We conclude that TLR4 is involved in the progression of the insulitis process thereby controlling the development of insulin-deficient diabetes in NOD mice.	[Guelden, Elke; Ihira, Masaru; Ohashi, Atsushi; Reinbeck, Anna Lena; Kolb, Hubert; Burkart, Volker] Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Freudenberg, Marina A.] Max Planck Inst Immunbiol & Epigenet, Dept Dev Immunol, Freiburg, Germany	Deutsches Diabetes-Zentrum (DDZ); Max Planck Society	Burkart, V (corresponding author), Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.	burkart@ddz.uni-duesseldorf.de		Freudenberg, Marina Alexandra/0000-0001-5894-1805	Deutsche Forschungsgemeinschaft; Deutsche Diabetes-Gesellschaft; Bundesministerium fur Bildung und Forschung to the Deutsches Zentrum fur Diabetesforschung (DZD e.V.)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Diabetes-Gesellschaft; Bundesministerium fur Bildung und Forschung to the Deutsches Zentrum fur Diabetesforschung (DZD e.V.)(Federal Ministry of Education & Research (BMBF))	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft, the Deutsche Diabetes-Gesellschaft, and from the Bundesministerium fur Bildung und Forschung to the Deutsches Zentrum fur Diabetesforschung (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848; Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Beutler B, 2001, DRUG METAB DISPOS, V29, P474; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Brandhorst D, 2003, CELL TRANSPLANT, V12, P859, DOI 10.3727/000000003771000200; Brusko T, 2009, CELL BIOCH BIOPHYS, V48, P165; Burkart V, 2000, J BIOL CHEM, V275, P19521, DOI 10.1074/jbc.M002265200; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Burkart V, 1996, IMMUNOBIOLOGY, V195, P601, DOI 10.1016/S0171-2985(96)80025-8; Buschard K, 2011, APMIS, V119, P1, DOI 10.1111/j.1600-0463.2011.02765.x; CAMPBELL IL, 1988, J IMMUNOL, V141, P2325; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Caramalho I, 2011, SCAND J IMMUNOL, V74, P585, DOI 10.1111/j.1365-3083.2011.02627.x; Caricilli AM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001212; Chan JY, 2011, DIABETOLOGIA, V54, P1766, DOI 10.1007/s00125-011-2139-z; Collison LW, 2011, METHODS MOL BIOL, V707, P21, DOI 10.1007/978-1-61737-979-6_2; Dai J, 2007, J IMMUNOL, V178, P3219, DOI 10.4049/jimmunol.178.5.3219; Devaraj Sridevi, 2010, Expert Rev Endocrinol Metab, V5, P19; Freudenberg MA, 2008, IMMUNOBIOLOGY, V213, P193, DOI 10.1016/j.imbio.2007.11.008; Garay-Malpartida HM, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-18; Habich C, 2002, J IMMUNOL, V168, P569, DOI 10.4049/jimmunol.168.2.569; Huurman VAL, 2008, CLIN EXP IMMUNOL, V152, P488, DOI 10.1111/j.1365-2249.2008.03656.x; Jahromi MM, 2007, CELL MOL LIFE SCI, V64, P865, DOI 10.1007/s00018-007-6469-4; Jiang DH, 2010, ANAT REC, V293, P982, DOI 10.1002/ar.21102; Kang YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049994; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Kim HS, 2009, CURR MOL MED, V9, P30, DOI 10.2174/156652409787314471; Kong YCM, 2009, AUTOIMMUN REV, V9, P28, DOI 10.1016/j.autrev.2009.02.034; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Marshak-Rothstein A, 2004, J ENDOTOXIN RES, V10, P247, DOI 10.1179/096805104225005850; Martin S, 1999, HORM METAB RES, V31, P636, DOI 10.1055/s-2007-978812; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018; Pasare C, 2003, CURR OPIN IMMUNOL, V15, P677, DOI 10.1016/j.coi.2003.09.002; Pavlovic D, 2000, EUR CYTOKINE NETW, V11, P267; Poltorak A, 2001, J IMMUNOL, V167, P2106, DOI 10.4049/jimmunol.167.4.2106; Poltorak A, 2000, J ENDOTOXIN RES, V6, P51, DOI 10.1177/09680519000060010701; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pozzilli P, 2009, ENDOCRINOL NUTR S4, V56, P50; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Saemann MD, 2005, J CLIN INVEST, V115, P468, DOI 10.1172/JCI200522720; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Tree TIM, 2006, ANN NY ACAD SCI, V1079, P9, DOI 10.1196/annals.1375.002; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Wagner H, 2006, ADV IMMUNOL, V91, P159, DOI 10.1016/S0065-2776(06)91004-9; Wei WZ, 2005, CANCER RES, V65, P8471, DOI 10.1158/0008-5472.CAN-05-0934; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wong FS, 2008, ANN NY ACAD SCI, V1150, P146, DOI 10.1196/annals.1447.039	60	41	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75385	10.1371/journal.pone.0075385	http://dx.doi.org/10.1371/journal.pone.0075385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086519	gold, Green Submitted, Green Published			2022-12-25	WOS:000326520200098
J	Wilson, IM; Vucic, EA; Enfield, KSS; Thu, KL; Zhang, YA; Chari, R; Lockwood, WW; Radulovich, N; Starczynowski, DT; Banath, JP; Zhang, M; Pusic, A; Fuller, M; Lonergan, KM; Rowbotham, D; Yee, J; English, JC; Buys, TPH; Selamat, SA; Laird-Offringa, IA; Liu, P; Anderson, M; You, M; Tsao, MS; Brown, CJ; Bennewith, KL; MacAulay, CE; Karsan, A; Gazdar, AF; Lam, S; Lam, WL				Wilson, I. M.; Vucic, E. A.; Enfield, K. S. S.; Thu, K. L.; Zhang, Y. A.; Chari, R.; Lockwood, W. W.; Radulovich, N.; Starczynowski, D. T.; Banath, J. P.; Zhang, M.; Pusic, A.; Fuller, M.; Lonergan, K. M.; Rowbotham, D.; Yee, J.; English, J. C.; Buys, T. P. H.; Selamat, S. A.; Laird-Offringa, I. A.; Liu, P.; Anderson, M.; You, M.; Tsao, M. S.; Brown, C. J.; Bennewith, K. L.; MacAulay, C. E.; Karsan, A.; Gazdar, A. F.; Lam, S.; Lam, W. L.			EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk	ONCOGENE			English	Article						EYA4; two hit; hypermethylation; tumor suppressor; TSG; non-small-cell lung cancer	GENE-EXPRESSION SIGNATURE; SUSCEPTIBILITY LOCUS; DNA METHYLATION; HISTONE H2AX; GENOME; SMOKING; ADENOCARCINOMA; DELETION; BRCA1	In an effort to identify novel biallelically inactivated tumor suppressor genes (TSGs) in sporadic invasive and preinvasive non-small-cell lung cancer (NSCLC) genomes, we applied a comprehensive integrated multiple 'omics' approach to investigate patient-matched, paired NSCLC tumor and non-malignant parenchymal tissues. By surveying lung tumor genomes for genes concomitantly inactivated within individual tumors by multiple mechanisms, and by the frequency of disruption in tumors across multiple cohorts, we have identified a putative lung cancer TSG, Eyes Absent 4 (EYA4). EYA4 is frequently and concomitantly deleted, hypermethylated and underexpressed in multiple independent lung tumor data sets, in both major NSCLC subtypes and in the earliest stages of lung cancer. We found that decreased EYA4 expression is not only associated with poor survival in sporadic lung cancers but also that EYA4 single-nucleotide polymorphisms are associated with increased familial cancer risk, consistent with EYA4s proximity to the previously reported lung cancer susceptibility locus on 6q. Functionally, we found that EYA4 displays TSG-like properties with a role in modulating apoptosis and DNA repair. Cross-examination of EYA4 expression across multiple tumor types suggests a cell-type-specific tumorigenic role for EYA4, consistent with a tumor suppressor function in cancers of epithelial origin. This work shows a clear role for EYA4 as a putative TSG in NSCLC.	[Wilson, I. M.; Vucic, E. A.; Enfield, K. S. S.; Thu, K. L.; Chari, R.; Lockwood, W. W.; Banath, J. P.; Zhang, M.; Pusic, A.; Fuller, M.; Lonergan, K. M.; Rowbotham, D.; Buys, T. P. H.; Bennewith, K. L.; MacAulay, C. E.; Karsan, A.; Lam, S.; Lam, W. L.] British Columbia Canc Res Ctr, Integrat Oncol Genet Unit, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Zhang, Y. A.; Gazdar, A. F.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Chari, R.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Lockwood, W. W.] NHGRI, Canc Genet Branch, Bethesda, MD 20892 USA; [Radulovich, N.; Tsao, M. S.] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Starczynowski, D. T.] Cincinnati Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH USA; [Yee, J.] Vancouver Gen Hosp, Dept Surg, Vancouver, BC, Canada; [English, J. C.] Vancouver Gen Hosp, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Selamat, S. A.; Laird-Offringa, I. A.] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Liu, P.; Anderson, M.; You, M.] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA; [Brown, C. J.] Univ British Columbia, Life Sci Ctr, Dept Med Genet, Vancouver, BC, Canada	British Columbia Cancer Agency; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of British Columbia; University of British Columbia; University of Southern California; Medical College of Wisconsin; University of British Columbia	Wilson, IM (corresponding author), British Columbia Canc Res Ctr, Integrat Oncol Genet Unit, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.	iwilson@bccrc.ca	Brown, Carolyn J/A-5159-2014; Chari, Raj/G-3285-2019; Offringa, Ite/R-4101-2019; Karsan, Aly/K-2067-2015; Tsao, Ming Sound/AFQ-7332-2022; Tsao, Ming-Sound/M-3503-2017; MacAulay, Calum/K-1795-2016	Brown, Carolyn J/0000-0002-8959-0101; Tsao, Ming Sound/0000-0002-9160-5405; Selamat, Suhaida/0000-0002-7185-6995; Thu, Kelsie/0000-0001-9262-7238; Vucic, Emily/0000-0002-2728-8708; Fuller, Megan/0000-0002-8752-8312; MacAulay, Calum/0000-0003-4440-2792	Canadian Institutes of Health Research (CIHR) [MOP86731, MOP77903, MOP94867]; Canadian Cancer Society [CCS017076, CCS20485]; Terry Fox Foundation [20395]; NCI Early Detection Research Network [5U01 CA84971-10]; Canary Foundation; NIH Genetic Epidemiology of Lung Cancer Consortium [U01CA76293]; CIHR, Canada; Vanier Canada; NATIONAL CANCER INSTITUTE [U01CA084971, P50CA070907, U01CA076293] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation; NCI Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canary Foundation; NIH Genetic Epidemiology of Lung Cancer Consortium; CIHR, Canada(Canadian Institutes of Health Research (CIHR)); Vanier Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank Miwa Suzuki, Denise McDougal, Chad Malloff and Bradley Coe for assistance. Grant supports were from Canadian Institutes of Health Research (CIHR MOP86731, MOP77903, MOP94867), Canadian Cancer Society (CCS017076, CCS20485); Terry Fox Foundation (20395); NCI Early Detection Research Network (5U01 CA84971-10), Canary Foundation, NIH Genetic Epidemiology of Lung Cancer Consortium (U01CA76293); and scholarships from CIHR (IMW, EAV, KSSE and WWL) and Vanier Canada (RC, KLT and NR).	Amos CI, 2010, CANCER RES, V70, P2359, DOI 10.1158/0008-5472.CAN-09-3096; Bailey-Wilson JE, 2004, AM J HUM GENET, V75, P460, DOI 10.1086/423857; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bell DW, 2002, CANCER RES, V62, P2741; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Bijron JG, 2012, ENDOCR-RELAT CANCER, V19, P69, DOI 10.1530/ERC-11-0338; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Birgisdottir V, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1522; Boelens MC, 2009, J PATHOL, V218, P182, DOI 10.1002/path.2520; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Clark SW, 2002, J BIOL CHEM, V277, P3560, DOI 10.1074/jbc.M108410200; Coe BP, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq548; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim YH, 2011, ANN SURG ONCOL, V18, P2338, DOI 10.1245/s10434-011-1573-y; Kisiel JB, 2013, ALIMENT PHARM THER, V37, P546, DOI 10.1111/apt.12218; Kisiel JB, 2012, CANCER-AM CANCER SOC, V118, P2623, DOI 10.1002/cncr.26558; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Liu PY, 2008, JNCI-J NATL CANCER I, V100, P1326, DOI 10.1093/jnci/djn268; Liu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042725; Lockwood WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037775; Lonergan KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009162; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Miller SJ, 2010, ONCOGENE, V29, P368, DOI 10.1038/onc.2009.360; Nagayama K, 2007, GENE CHROMOSOME CANC, V46, P1000, DOI 10.1002/gcc.20485; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Olive PL, 2004, INT J RADIAT ONCOL, V58, P331, DOI 10.1016/j.ijrobp.2003.09.028; Osborn NK, 2006, CLIN GASTROENTEROL H, V4, P212, DOI 10.1016/j.cgh.2005.11.009; Oster B, 2011, INT J CANCER, V129, P2855, DOI 10.1002/ijc.25951; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Sadatomi D, 2013, INT J MOL SCI, V14, P4596, DOI 10.3390/ijms14034596; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Selamat SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021443; SELLERS TA, 1990, J NATL CANCER I, V82, P1272, DOI 10.1093/jnci/82.15.1272; SELLERS TA, 1992, CANCER RES, V52, pS2694; Tessema M, 2008, CANCER RES, V68, P1707, DOI 10.1158/0008-5472.CAN-07-6325; Thu KL, 2014, ONCOGENE, V33, P279, DOI 10.1038/onc.2012.595; Thu KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033003; Thu KL, 2011, J THORAC ONCOL, V6, P1521, DOI 10.1097/JTO.0b013e3182289479; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; TOKUHATA GEORGE K., 1963, JOUR NATL CANCER INST, V30, P289; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; You M, 2009, CLIN CANCER RES, V15, P2666, DOI 10.1158/1078-0432.CCR-08-2335; Zhang X, 2002, J CLIN ENDOCR METAB, V87, P1262, DOI 10.1210/jc.87.3.1262; Zou HZ, 2005, CANCER EPIDEM BIOMAR, V14, P830, DOI 10.1158/1055-9965.EPI-04-0506	53	29	30	0	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 4	2014	33	36					4464	4473		10.1038/onc.2013.396	http://dx.doi.org/10.1038/onc.2013.396			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MY	24096489	Green Accepted, Green Submitted			2022-12-25	WOS:000341158800002
J	Abou-Saleh, H; Pathan, AR; Daalis, A; Hubrack, S; Abou-Jassoum, H; Al-Naeimi, H; Rusch, NJ; Machaca, K				Abou-Saleh, Haissam; Pathan, Asif R.; Daalis, Arwa; Hubrack, Satanay; Abou-Jassoum, Hamda; Al-Naeimi, Hamda; Rusch, Nancy J.; Machaca, Khaled			Inositol 1,4,5-Trisphosphate (IP3) Receptor Up-regulation in Hypertension Is Associated with Sensitization of Ca2+ Release and Vascular Smooth Muscle Contractility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Calcium Signaling; Hypertension; NFAT Transcription Factor; Vascular Smooth Muscle Cells; A7r5; IP3 Receptor	HIGH BLOOD-PRESSURE; CEREBRAL-ARTERIES; MYOGENIC RESPONSE; CALCIUM-CHANNELS; PHOSPHOLIPASE-C; ION CHANNELS; CELLS; ENTRY; TRISPHOSPHATE; EXPRESSION	Background: The role of the vascular IP3 receptor (IP3R) in hypertension is unknown. Results: IP3R are up-regulated in vascular smooth muscle (VSM) in hypertension through the calcineurin-NFAT pathway. Conclusion: Up-regulated IP3R in VSM sensitize Ca2+ release and enhance contraction. Significance: Up-regulated vascular IP3R may contribute to vascular resistance in hypertension. Resistance arteries show accentuated responsiveness to vasoconstrictor agonists in hypertension, and this abnormality relies partly on enhanced Ca2+ signaling in vascular smooth muscle (VSM). Although inositol 1,4,5-triphosphate receptors (IP(3)Rs) are abundant in VSM, their role in the molecular remodeling of the Ca2+ signaling machinery during hypertension has not been addressed. Therefore, we compared IP3R expression and function between mesenteric arteries of normotensive and hypertensive animals. Levels of IP3R transcript and protein were significantly increased in mesenteric arteries of hypertensive animals, and pharmacological inhibition of the IP3R revealed a higher contribution of IP3-dependent Ca2+ release to vascular contraction in these arteries. Subsequently, we established cultured aortic VSM A7r5 cells as a cellular model that replicates IP3R up-regulation during hypertension by depolarizing the VSM cell membrane. IP3R up-regulation requires Ca2+ influx through L-type Ca2+ channels, followed by activation of the calcineurin-NFAT axis, resulting in IP3R transcription. Functionally, IP3R up-regulation in VSM is associated with enhancement and sensitization of IP3-dependent Ca2+ release, resulting in increased VSM contraction in response to agonist stimulation.	[Abou-Saleh, Haissam; Daalis, Arwa; Hubrack, Satanay; Machaca, Khaled] Qatar Fdn, Dept Physiol & Biophys, Weill Cornell Med Coll Qatar, Doha 24144, Qatar; [Pathan, Asif R.; Rusch, Nancy J.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Abou-Jassoum, Hamda; Al-Naeimi, Hamda] Qatar Univ, Dept Biol & Environm Sci, Doha 2713, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Arkansas System; University of Arkansas Medical Sciences; Qatar University	Machaca, K (corresponding author), Qatar Fdn, Dept Physiol & Biophys, Weill Cornell Med Coll Qatar, Doha 24144, Qatar.	khm2002@qatar-med.cornell.edu	Machaca, Khaled/AAF-3579-2019	Hubrack, Satanay/0000-0003-1095-7386	Qatar National Research Fund, National Priority Research Program Grant [NPRP 08-392-3-087]; Biomedical Research Program at Weill Cornell Medical College in Qatar; Qatar Foundation	Qatar National Research Fund, National Priority Research Program Grant(Qatar National Research Fund (QNRF)); Biomedical Research Program at Weill Cornell Medical College in Qatar(Qatar National Research Fund (QNRF)); Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF))	This work was supported by a grant from the Qatar National Research Fund, National Priority Research Program Grant NPRP 08-392-3-087. The laboratory of K. M. is also supported by the Biomedical Research Program at Weill Cornell Medical College in Qatar, a program funded by Qatar Foundation.	Baek Eun Bok, 2011, Journal of Smooth Muscle Research, V47, P55; Bergdahl A, 2005, AM J PHYSIOL-CELL PH, V288, pC872, DOI 10.1152/ajpcell.00334.2004; Bergdahl A, 2003, CIRC RES, V93, P839, DOI 10.1161/01.RES.0000100367.45446.A3; BERNIER S, 1993, AM J HYPERTENS, V6, P217; BOSNJAK ZJ, 1993, ANESTHESIOLOGY, V79, P1392, DOI 10.1097/00000542-199312000-00031; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Chockalingam A, 2008, CAN J CARDIOL, V24, P441, DOI 10.1016/S0828-282X(08)70617-2; Cox RH, 2002, MICROCIRCULATION, V9, P243, DOI 10.1038/sj.mn.7800140; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Genazzani AA, 1999, P NATL ACAD SCI USA, V96, P5797, DOI 10.1073/pnas.96.10.5797; Grayson TH, 2004, CELL CALCIUM, V36, P447, DOI 10.1016/j.ceca.2004.04.005; HASHIMOTO T, 1986, J PHYSIOL-LONDON, V370, P605, DOI 10.1113/jphysiol.1986.sp015953; Hill MA, 2001, J APPL PHYSIOL, V91, P973, DOI 10.1152/jappl.2001.91.2.973; HIRST GDS, 1989, PHYSIOL REV, V69, P546, DOI 10.1152/physrev.1989.69.2.546; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Inscho EW, 1998, HYPERTENSION, V31, P421, DOI 10.1161/01.HYP.31.1.421; Jung S, 2002, AM J PHYSIOL-CELL PH, V282, pC347, DOI 10.1152/ajpcell.00283.2001; Kharade SV, 2013, HYPERTENSION, V61, P137, DOI 10.1161/HYPERTENSIONAHA.112.197863; KULIK TJ, 1991, BIOCHEM BIOPH RES CO, V180, P982, DOI 10.1016/S0006-291X(05)81162-3; Lee CH, 2001, J PHYSIOL-LONDON, V534, P641, DOI 10.1111/j.1469-7793.2001.t01-1-00641.x; Lemarie CA, 2010, J MOL CELL CARDIOL, V48, P433, DOI 10.1016/j.yjmcc.2009.09.018; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MATSUMOTO H, 1995, AM J PHYSIOL-CELL PH, V268, pC458, DOI 10.1152/ajpcell.1995.268.2.C458; Miriel VA, 1999, J PHYSIOL-LONDON, V518, P815, DOI 10.1111/j.1469-7793.1999.0815p.x; Monkawa T, 1998, KIDNEY INT, V53, P296, DOI 10.1046/j.1523-1755.1998.00763.x; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; NARAYANAN J, 1994, AM J PHYSIOL, V266, pH1840, DOI 10.1152/ajpheart.1994.266.5.H1840; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; Oparil S, 2003, ANN INTERN MED, V139, P761, DOI 10.7326/0003-4819-139-9-200311040-00011; OSOL G, 1993, AM J PHYSIOL, V265, pH415, DOI 10.1152/ajpheart.1993.265.1.H415; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Perez JF, 2005, J GEN PHYSIOL, V125, P555, DOI 10.1085/jgp.200409217; Pesic A, 2004, CIRC RES, V94, pE97, DOI 10.1161/01.RES.0000131495.93500.3c; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Pratt PF, 2002, HYPERTENSION, V40, P214, DOI 10.1161/01.HYP.0000025877.23309.36; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rizzoni D, 2012, INTERN EMERG MED, V7, P205, DOI 10.1007/s11739-011-0548-0; RUSCH NJ, 1991, ADV EXP MED BIOL, V308, P1; Schubert R, 2008, CARDIOVASC RES, V77, P8, DOI 10.1016/j.cardiores.2007.07.018; SMITH JB, 1986, AM J PHYSIOL, V250, pF759, DOI 10.1152/ajprenal.1986.250.5.F759; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; SOMLYO AV, 1985, P NATL ACAD SCI USA, V82, P5231, DOI 10.1073/pnas.82.15.5231; STEKIEL WJ, 1993, HYPERTENSION, V21, P1005, DOI 10.1161/01.HYP.21.6.1005; STEKIEL WJ, 1986, AM J PHYSIOL, V250, pC547, DOI 10.1152/ajpcell.1986.250.4.C547; STEKIEL WJ, 1991, HYPERTENSION, V17, P1185, DOI 10.1161/01.HYP.17.6.1185; TAKATA Y, 1983, CLIN EXP HYPERTENS A, V5, P827, DOI 10.3109/10641968309081811; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Wang YP, 2001, CIRC RES, V88, P202; WATANABE J, 1993, CIRC RES, V73, P465, DOI 10.1161/01.RES.73.3.465; Xi Q, 2008, CIRC RES, V102, P1118, DOI 10.1161/CIRCRESAHA.108.173948; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; ZIEGLER MG, 1991, AM J HYPERTENS, V4, P586, DOI 10.1093/ajh/4.7.586	55	38	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32941	32951		10.1074/jbc.M113.496802	http://dx.doi.org/10.1074/jbc.M113.496802			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097979	Green Published, hybrid			2022-12-25	WOS:000328841700012
J	Wu, ZQ; Zhang, XQ; Shen, L; Xiong, YY; Wu, X; Huo, R; Wei, ZY; Cai, L; Qi, GY; Xu, QQ; Cui, DX; Cui, DH; Zhao, GC; He, L; Qin, SY				Wu, Zhenqiang; Zhang, Xiaoqing; Shen, Lu; Xiong, Yuyu; Wu, Xi; Huo, Ran; Wei, Zhiyun; Cai, Lei; Qi, Guoyang; Xu, Qingqing; Cui, Daxiang; Cui, Donghong; Zhao, Gengchun; He, Lin; Qin, Shengying			A Systematically Combined Genotype and Functional Combination Analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in Different Geographic Areas of Mainland China - A Basis for Personalized Therapy	PLOS ONE			English	Article							GENETIC-POLYMORPHISM ANALYSIS; HAN POPULATIONS; DRUG-METABOLISM; CYTOCHROME-P450; PHARMACOGENETICS; MEDICINE; ENZYMES	The cytochrome P450 is the major enzyme involved in drug metabolism. Single CYP genotypes and metabolic phenotypes have been widely studied, but no combination analysis has been conducted in the context of specific populations and geographical areas. This study is the first to systematically analyze the combined genotypes and functional combinations of 400 samples of major CYP genes-CYP2E1, CYP2D6, CYP2C9, and CYP2C19 in four geographical areas of mainland China. 167 different genotype combinations were identified, of which 25 had a greater than 1% frequency in the Chinese Han population. In addition, phenotypes of the four genes for each sample were in line with the predictions of previous studies of the four geographical areas. On the basis of the genotype classification, we were able to produce a systemic functional combinations analysis for the population. 25 of the combinations detected had at least two non-wild phenotypes and four showed a frequency above 1%. A bioinformatics analysis of the relationship between particular drugs and multi-genes was conducted. This is the first systematic study to analyze genotype combinations and functional combinations across whole Chinese population and could make a significant contribution in the field of personalized medicine and therapy.	[Wu, Zhenqiang; Zhang, Xiaoqing; Shen, Lu; Xiong, Yuyu; Wu, Xi; Huo, Ran; Wei, Zhiyun; Cai, Lei; Xu, Qingqing; Cui, Daxiang; Cui, Donghong; He, Lin; Qin, Shengying] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Wu, Zhenqiang; Shen, Lu; Xiong, Yuyu; Wu, Xi; Huo, Ran; Wei, Zhiyun; Xu, Qingqing; He, Lin; Qin, Shengying] Shanghai Geno MePilot Inst Genom & Human Hlth, Shanghai, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zhang, Xiaoqing] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Pharm, Shanghai 200092, Peoples R China; [Qi, Guoyang] Wuxi Mental Hlth Ctr, Wuxi, Jiangsu, Peoples R China; [Cui, Daxiang] Shanghai Jiao Tong Univ, Res Inst Micro Nano Sci & Technol, Shanghai 200030, Peoples R China; [Cui, Donghong] Shanghai Inst Mental Hlth, Shanghai, Peoples R China; [Zhao, Gengchun] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Fudan University; Tongji University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Qin, SY (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	chinsir@sjtu.edu.cn	Wei, Zhiyun/E-2008-2016; Cai, Lei/H-3972-2017; Lu, Shen/B-2644-2008; cui, donghong/AAV-2619-2020	Wei, Zhiyun/0000-0002-3554-4142; Cai, Lei/0000-0002-5726-2971; Lu, Shen/0000-0002-0659-2399; 	863 Program [2012AA02A515]; 973 Program [2010CB529600]; National Key Technology RD Program [2012BAI01B09]; National Nature Science Foundation of China [81273596, 81121001, 30900799, 30972823]; Shanghai Jiao Tong University Med-X Fund [YG2010MS61]; Public Science and Technology Research Funds [201210056]; Shanghai Jiao Tong University Interdisciplinary Research fund; Major Program of Shanghai Committee of Science and Technology [11dz1950300]; Shanghai Leading Academic Discipline Project [B205]	863 Program(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University Med-X Fund; Public Science and Technology Research Funds; Shanghai Jiao Tong University Interdisciplinary Research fund; Major Program of Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the 863 Program (2012AA02A515), the 973 Program (2010CB529600), the National Key Technology R&D Program (2012BAI01B09), the National Nature Science Foundation of China (81273596, 81121001, 30900799, 30972823), the Shanghai Jiao Tong University Med-X Fund (YG2010MS61), the Public Science and Technology Research Funds(201210056), the Shanghai Jiao Tong University Interdisciplinary Research fund, the Major Program of Shanghai Committee of Science and Technology (11dz1950300) and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertilsson L, 2002, BRIT J CLIN PHARMACO, V53, P111, DOI 10.1046/j.0306-5251.2001.01548.x; BERTILSSON L, 1992, CLIN PHARMACOL THER, V51, P388, DOI 10.1038/clpt.1992.38; Chen LL, 2008, PHARMACOGENOMICS, V9, P691, DOI 10.2217/14622416.9.6.691; de Leon J, 2006, EXPERT REV MOL DIAGN, V6, P277, DOI 10.1586/14737159.6.3.277; Eichelbaum M, 2006, ANNU REV MED, V57, P119, DOI 10.1146/annurev.med.56.082103.104724; EVANS WE, 1993, J CLIN INVEST, V91, P2150, DOI 10.1172/JCI116441; Gardiner SJ, 2006, PHARMACOL REV, V58, P521, DOI 10.1124/pr.58.3.6; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; GUIYUN M, 2005, J CHENGDE MED COLL, V22; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; MADISEN L, 1987, AM J MED GENET, V27, P379, DOI 10.1002/ajmg.1320270216; Marshall A, 1997, NAT BIOTECHNOL, V15, P1249, DOI 10.1038/nbt1197-1249; McGraw J, 2012, EXPERT OPIN DRUG MET, V8, P371, DOI 10.1517/17425255.2012.657626; Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6; Qin SY, 2008, GENOMICS, V92, P152, DOI 10.1016/j.ygeno.2008.05.004; Rendic S, 1997, DRUG METAB REV, V29, P413, DOI 10.3109/03602539709037591; Tang KF, 2010, GENOMICS, V95, P224, DOI 10.1016/j.ygeno.2010.01.005; WATKINS PB, 1990, SEMIN LIVER DIS, V10, P235, DOI 10.1055/s-2008-1040480; Wolf CR, 2000, BRIT MED J, V320, P987, DOI 10.1136/bmj.320.7240.987; Xiong YY, 2011, GENOMICS, V97, P277, DOI 10.1016/j.ygeno.2010.11.004	20	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e71934	10.1371/journal.pone.0071934	http://dx.doi.org/10.1371/journal.pone.0071934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098323	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500002
J	Jongsma, MLA; Meulenbroek, RGJ; Okely, J; Baas, CM; van der Lubbe, RHJ; Steenbergen, B				Jongsma, Marijtje L. A.; Meulenbroek, Ruud G. J.; Okely, Judith; Baas, C. Marjolein; van der Lubbe, Rob H. J.; Steenbergen, Bert			Effects of Hand Orientation on Motor Imagery - Event Related Potentials Suggest Kinesthetic Motor Imagery to Solve the Hand Laterality Judgment Task	PLOS ONE			English	Article							MENTAL ROTATION; EMBODIED COGNITION; STROKE; VOLUNTARY	Motor imagery (MI) refers to the process of imagining the execution of a specific motor action without actually producing an overt movement. Two forms of MI have been distinguished: visual MI and kinesthetic MI. To distinguish between these forms of MI we employed an event related potential (ERP) study to measure interference effects induced by hand orientation manipulations in a hand laterality judgement task. We hypothesized that this manipulation should only affect kinesthetic MI but not visual MI. The ERPs elicited by rotated hand stimuli contained the classic rotation related negativity (RRN) with respect to palm view stimuli. We observed that laterally rotated stimuli led to a more marked RRN than medially rotated stimuli. This RRN effect was observed when participants had their hands positioned in either a straight (control) or an inward rotated posture, but not when their hands were positioned in an outward rotated posture. Posture effects on the ERP-RRN have not previously been studied. Apparently, a congruent hand posture (hands positioned in an outward rotated fashion) facilitates the judgement of the otherwise more demanding laterally rotated hand stimuli. These ERP findings support a kinesthetic interpretation of MI involved in solving the hand laterality judgement task. The RRN may be used as a non-invasive marker for kinesthetic MI and seems useful in revealing the covert behavior of MI in e. g. rehabilitation programs.	[Jongsma, Marijtje L. A.; Baas, C. Marjolein; Steenbergen, Bert] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [van der Lubbe, Rob H. J.] Univ Twente, NL-7500 AE Enschede, Netherlands; [Meulenbroek, Ruud G. J.; Okely, Judith] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Donders Ctr Cognit, NL-6525 ED Nijmegen, Netherlands; [van der Lubbe, Rob H. J.] Univ Finance & Management, Dept Cognit Psychol, Warsaw, Poland	Radboud University Nijmegen; University of Twente; Radboud University Nijmegen; University of Finance & Management Warsaw	Jongsma, MLA (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	m.jongsma@donders.ru.nl	Meulenbroek, Ruud/D-4781-2009; van+der+Lubbe, Rob/AAJ-8120-2020	Meulenbroek, Ruud/0000-0002-5099-3771; Steenbergen, Bert/0000-0001-8863-2624; van der Lubbe, Rob/0000-0003-3658-0345	Netherlands Scientific Research NWO Brain & Cognition program	Netherlands Scientific Research NWO Brain & Cognition program	The research was funded by the Netherlands Scientific Research NWO Brain & Cognition program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT J, 1995, NEUROPSYCHOLOGIA, V33, P1395, DOI 10.1016/0028-3932(95)00072-B; ASHTON R, 1978, ACTA PSYCHOL, V42, P253, DOI 10.1016/0001-6918(78)90001-X; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; de Lange FP, 2006, NEUROIMAGE, V33, P609, DOI 10.1016/j.neuroimage.2006.07.017; de Vries S, 2007, J REHABIL MED, V39, P5, DOI 10.2340/16501977-0020; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Dietrich A, 2008, METHODS, V45, P319, DOI 10.1016/j.ymeth.2008.04.004; Dijkerman HC, 2004, CLIN REHABIL, V18, P538, DOI 10.1191/0269215504cr769oa; Funk M, 2005, DEVELOPMENTAL SCI, V8, P402, DOI 10.1111/j.1467-7687.2005.00428.x; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Ionta S, 2009, EXP BRAIN RES, V195, P207, DOI 10.1007/s00221-009-1770-0; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Liu KP, 2004, ARCH PHYS MED REHAB, V85, P1403, DOI 10.1016/j.apmr.2003.12.035; Lust JM, 2006, CHILD CARE HLTH DEV, V32, P649, DOI 10.1111/j.1365-2214.2006.00683.x; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Nine G., 1994, J CLIN NEUROPHYSIOL, V11, P40, DOI DOI 10.1097/00004691-199401000-00010.PUBMED:8195426; Page SJ, 2005, ARCH PHYS MED REHAB, V86, P399, DOI 10.1016/j.apmr.2004.10.002; Page SJ, 2001, CLIN REHABIL, V15, P233, DOI 10.1191/026921501672063235; Page SJ, 2011, CLIN REHABIL, V25, P627, DOI 10.1177/0269215510395793; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Porro CA, 1996, J NEUROSCI, V16, P7688; ROLAND PE, 1982, J NEUROPHYSIOL, V48, P467, DOI 10.1152/jn.1982.48.2.467; Rugg M. D., 1995, OX PSYCH S, V25, P27; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Shenton JT, 2004, NEUROSCI LETT, V370, P19, DOI 10.1016/j.neulet.2004.07.053; Sirigu A, 2001, J COGNITIVE NEUROSCI, V13, P910, DOI 10.1162/089892901753165827; Steenbergen B, 2009, DEV MED CHILD NEUROL, V51, P690, DOI 10.1111/j.1469-8749.2009.03371.x; Stinear CM, 2006, EXP BRAIN RES, V168, P157, DOI 10.1007/s00221-005-0078-y; ter Horst AC, 2012, PSYCHOPHYSIOLOGY, V49, P566, DOI 10.1111/j.1469-8986.2011.01322.x; ter Horst AC, 2011, EXP BRAIN RES, V212, P635, DOI 10.1007/s00221-011-2748-2; ter Horst AC, 2010, EXP BRAIN RES, V203, P347, DOI 10.1007/s00221-010-2235-1; Thayer ZC, 2006, PSYCHOPHYSIOLOGY, V43, P401, DOI 10.1111/j.1469-8986.2006.00404.x; Vannuscorps G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00299; Vingerhoets G, 2002, NEUROIMAGE, V17, P1623, DOI 10.1006/nimg.2002.1290; YUE G, 1992, J NEUROPHYSIOL, V67, P1114, DOI 10.1152/jn.1992.67.5.1114; Zimmermann M, 2012, CEREB CORTEX, V22, P122, DOI 10.1093/cercor/bhr098; ZIMMERMANNSCHLA.A, 2008, J NEUROENG REHABIL, V5, P5, DOI DOI 10.1186/1743-0003-5-5	42	16	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76515	10.1371/journal.pone.0076515	http://dx.doi.org/10.1371/journal.pone.0076515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228WY	24086747	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900104
J	Osthoff, M; Yong, HMA; Dean, MM; Eisen, DP				Osthoff, Michael; Yong, Hue Mun Au; Dean, Melinda M.; Eisen, Damon P.			Significance of Mannose-Binding Lectin Deficiency and Nucleotide-Binding Oligomerization Domain 2 Polymorphisms in Staphylococcus aureus Bloodstream Infections: A Case-Control Study	PLOS ONE			English	Article							GENETIC-VARIANTS; CROHNS-DISEASE; BACTEREMIA; MORTALITY; SEPSIS; NOD2; OPSONOPHAGOCYTOSIS; ACTIVATION; PNEUMONIA; SEVERITY	Background: Pathways coordinated by innate pattern recognition receptors like mannose-binding lectin (MBL) and nucleotide-binding oligomerization domain 2 (NOD2) are among the first immune responses to Staphylococcus aureus (S. aureus) bloodstream infections (BSI) in animal models, but human data are limited. Here, we investigated the role of MBL deficiency and NOD2 mutations in the predisposition to and severity of S. aureus BSI. Patients and Methods: A matched case-control study was undertaken involving 70 patients with S. aureus BSI and 70 age-and sex-matched hospitalized controls. MBL levels, MBL2 and NOD2 polymorphisms were analyzed. Results: After adjusting for potential confounders, MBL deficiency (<0.5 mu g/ml) was found less frequently in cases than controls (26 vs. 41%, OR 0.4, 95% confidence interval (CI) 0.20-0.95, p=0.04) as were low producing MBL genotypes (11 vs. 23%, OR 0.2, 95% CI 0.08-0.75, p=0.01), whereas NOD2 polymorphisms were similarly distributed. Cases with NOD2 polymorphisms had less organ dysfunction as shown by a lower SOFA score (median 2.5 vs. 4.5, p=0.02), whereas only severe MBL deficiency (<0.1 mu g/ml) was associated with life-threatening S. aureus BSI (OR 5.6, 95% CI 1.25-24.85, p=0.02). Conclusions: Contrary to animal model data, our study suggests MBL deficiency may confer protection against acquiring S. aureus BSI. NOD2 mutations were less frequently associated with multi-organ dysfunction. Further human studies of the innate immune response in S. aureus BSI are needed to identify suitable host targets in sepsis treatment.	[Osthoff, Michael; Eisen, Damon P.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia; [Osthoff, Michael; Yong, Hue Mun Au; Eisen, Damon P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia; [Dean, Melinda M.] Australian Red Cross Blood Serv, Kelvin Grove, Qld, Australia	Royal Melbourne Hospital; Royal Melbourne Hospital; University of Melbourne; Australian Red Cross Blood Service	Eisen, DP (corresponding author), Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia.	Damon.Eisen@mh.org.au	eisen, damon/AAC-7433-2019	Eisen, Damon/0000-0002-8987-4358; Osthoff, Michael/0000-0001-5439-957X	University of Melbourne, Department of Medicine	University of Melbourne, Department of Medicine	This work was supported by the University of Melbourne, Department of Medicine funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blot SI, 2002, ARCH INTERN MED, V162, P2229, DOI 10.1001/archinte.162.19.2229; Brenmoehl J, 2007, INTENS CARE MED, V33, P1541, DOI 10.1007/s00134-007-0722-z; Brouwer N, 2008, J IMMUNOL, V180, P4124, DOI 10.4049/jimmunol.180.6.4124; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Cavanaugh JA, 2003, ANN HUM GENET, V67, P35, DOI 10.1046/j.1469-1809.2003.00006.x; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Eisen DP, 2008, CLIN INFECT DIS, V47, P510, DOI 10.1086/590006; Eisen DP, 2006, FEMS IMMUNOL MED MIC, V48, P274, DOI 10.1111/j.1574-695X.2006.00144.x; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; Elliott T, 2011, GUT, V60, pA61, DOI 10.1136/gut.2011.239301.121; Ferdinands JM, 2011, EMERG INFECT DIS, V17, P2294, DOI 10.3201/eid1712.111002; Fidler KJ, 2004, INTENS CARE MED, V30, P1438, DOI 10.1007/s00134-004-2303-8; Fode P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032315; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Gillrie MR, 2010, EUR J IMMUNOL, V40, P1639, DOI 10.1002/eji.200939929; Henckaerts L, 2009, CRIT CARE MED, V37, P192, DOI 10.1097/CCM.0b013e31819263d8; Herpers BL, 2009, CLIN EXP IMMUNOL, V156, P488, DOI 10.1111/j.1365-2249.2009.03929.x; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Kapetanovic R, 2010, MICROBES INFECT, V12, P759, DOI 10.1016/j.micinf.2010.05.003; Minchinton RM, 2002, SCAND J IMMUNOL, V56, P630, DOI 10.1046/j.1365-3083.2002.01167.x; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Naber CK, 2009, CLIN INFECT DIS, V48, pS231, DOI 10.1086/598189; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; Noskin GA, 2005, ARCH INTERN MED, V165, P1756, DOI 10.1001/archinte.165.15.1756; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Park KH, 2010, J BIOL CHEM, V285, P27167, DOI 10.1074/jbc.M110.141309; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rose WE, 2012, J INFECT DIS, V206, P1604, DOI 10.1093/infdis/jis552; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Smithson A, 2008, CLIN INFECT DIS, V47, P1492, DOI 10.1086/593106; Styers David, 2006, Ann Clin Microbiol Antimicrob, V5, P2; Sutherland AM, 2005, CRIT CARE MED, V33, P638, DOI [10.1097/01.CCM.0000156242.44356.C5, 10.1097/01.ccm.0000156242.44356.c5]; van Belkum A, 2007, MICROBES INFECT, V9, P1471, DOI 10.1016/j.micinf.2007.08.003; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vuononvirta J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026198; Wehrhahn MC, 2012, J INFECT DIS, V205, P1840, DOI 10.1093/infdis/jis279	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76218	10.1371/journal.pone.0076218	http://dx.doi.org/10.1371/journal.pone.0076218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086711	Green Published, Green Accepted, gold			2022-12-25	WOS:000325223900086
J	Rizvi, A; Hasan, SS; Naseem, I				Rizvi, Asim; Hasan, S. Saif; Naseem, Imrana			Selective Cytotoxic Action and DNA Damage by Calcitriol-Cu(II) Interaction: Putative Mechanism of Cancer Prevention	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; CELLULAR-DNA; COPPER; ACID; PROOXIDANT; BREAKAGE; BINDING	Background: Vitamin D is known to play an important role in cancer-prevention. One of the features associated with the onset of malignancy is the elevation of Cu (II) levels. The mode of cancer-prevention mediated by calcitriol, the biologically active form of vitamin D, remain largely unknown. Methods: Using exogenously added Cu (II) to stimulate a malignancy like condition in a novel cellular system of rabbit calcitriol overloaded lymphocytes, we assessed lipid peroxidation, protein carbonylation, DNA damage and consequent apoptosis. Free radical mediators were identified using free radical scavengers and the role of Cu (II) in the reaction was elucidated using chelators of redox active cellular metal ions. Results: Lipid peroxidation and protein carbonylation (markers of oxidative stress), consequent DNA fragmentation and apoptosis were observed due to calcitriol-Cu (II) interaction. Hydroxyl radicals, hydrogen peroxide and superoxide anions mediate oxidative stress produced during this interaction. Amongst cellular redox active metals, copper was found to be responsible for this reaction. Conclusion: This is the first report implicating Cu (II) and calcitriol interaction as the cause of selective cytotoxic action of calcitriol against malignant cells. We show that this interaction leads to the production of oxidative stress due to free radical production and consequent DNA fragmentation, which leads to apoptosis. A putative mechanism is presented to explain this biological effect.	[Rizvi, Asim; Naseem, Imrana] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh, Uttar Pradesh, India; [Hasan, S. Saif] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Aligarh Muslim University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rizvi, A (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh, Uttar Pradesh, India.	rizvirizviasim@gmail.com	Hasan, Syed Saif/A-3400-2015	Hasan, Syed Saif/0000-0002-0759-7511; Rizvi, Asim/0000-0003-0771-0227	UGC-CSIR Junior Research Fellowship from the Government of India	UGC-CSIR Junior Research Fellowship from the Government of India	AR received a UGC-CSIR Junior Research Fellowship from the Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEGRETTO EA, 1985, J BIOL CHEM, V260, P139; ALLEGRETTO EA, 1987, J BIOL CHEM, V262, P1312; Barsony J, 1997, J BIOL CHEM, V272, P5774, DOI 10.1074/jbc.272.9.5774; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Chibber S, 2012, MED CHEM RES, V21, P2379, DOI 10.1007/s00044-011-9758-2; Chibber S, 2011, TUMOR BIOL, V32, P881, DOI 10.1007/s13277-011-0189-y; Christakos S, 2010, ENDOCRIN METAB CLIN, V39, P243, DOI 10.1016/j.ecl.2010.02.002; Ebad E, 1998, PROG CLIN BIOL RES, V259, P167; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; Hadi SM, 2007, SEMIN CANCER BIOL, V17, P370, DOI 10.1016/j.semcancer.2007.04.002; Hadi SM, 2000, IUBMB LIFE, V50, P167, DOI 10.1080/152165400300001471; Hasan SS, 2013, IUBMB LIFE, V65, P787, DOI 10.1002/iub.1199; Hassan I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036273; KAGAWA TF, 1991, J BIOL CHEM, V266, P20175; Koren R, 2001, CANCER RES, V61, P1439; Lowndes SA, 2005, J MAMMARY GLAND BIOL, V10, P299, DOI 10.1007/s10911-006-9003-7; Moran PO, 2005, FRON BIO, V10, P2723, DOI DOI 10.2741/1731; Mukhopadhyay B, 2010, J BIOL CHEM, V285, P19002, DOI 10.1074/jbc.M109.068460; Nakagawa K, 2010, J HEALTH SCI, V53, P591, DOI [10.1248/jhs.53.591, DOI 10.1248/JHS.53.591]; Narvaez CJ, 2001, J BIOL CHEM, V276, P9101, DOI 10.1074/jbc.M006876200; Nasulewiez A, 2004, J TRACE ELEM MED BIO, V18, P1, DOI 10.1016/j.jtemb.2004.02.004; Orlov I, 2012, EMBO J, V31, P291, DOI 10.1038/emboj.2011.445; PIKE JW, 1984, J BIOL CHEM, V259, P1167; RAMANATHAN R, 1994, FREE RADICAL BIO MED, V16, P43, DOI 10.1016/0891-5849(94)90241-0; Shaffer PL, 2005, BIOCHEMISTRY-US, V44, P2678, DOI 10.1021/bi0477182; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; STUDZINSKI GP, 1995, CANCER RES, V55, P4014; Ting HJ, 2012, CANCER RES, V72, P958, DOI 10.1158/0008-5472.CAN-11-0042; Ullah MF, 2011, CANCER CHEMOTH PHARM, V67, P103, DOI 10.1007/s00280-010-1290-4; YOSHIDA D, 1993, J NEURO-ONCOL, V16, P109, DOI 10.1007/BF01324697; Zowczak M, 2001, BIOL TRACE ELEM RES, V82, P1, DOI 10.1385/BTER:82:1-3:001	32	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76191	10.1371/journal.pone.0076191	http://dx.doi.org/10.1371/journal.pone.0076191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086705	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900084
J	Jelen, S; Ulhoi, BP; Larsen, A; Frokiaer, J; Nielsen, S; Rutzler, M				Jelen, Sabina; Ulhoi, Benedicte Parm; Larsen, Agnete; Frokiaer, Jorgen; Nielsen, Soren; Rutzler, Michael			AQP9 Expression in Glioblastoma Multiforme Tumors Is Limited to a Small Population of Astrocytic Cells and CD15(+)/CalB(+) Leukocytes	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; MOLECULAR CHARACTERIZATION; GLIOMAS REVEALS; STEM-CELLS; AQUAPORIN-9; BRAIN; CD14; MARKER; WATER; DIFFERENTIATION	Aquaporin-9 (AQP9) is a membrane protein channel that is permeable to a range of small solutes, including glycerol, urea and nucleobases. Expression of AQP9 in normal brain is limited, while widespread AQP9 expression has previously been reported in human glioblastoma. However, the specific cellular expression of AQP9 in glioblastoma remains unclear. In this study, we have examined microarrays to corroborate AQP9 mRNA expression in glioma. These analyses suggested that AQP9 mRNA expression in glioblastoma is primarily explained by tumor infiltration with AQP9 expressing leukocytes. Immunolabeling confirmed that within tumor regions, AQP9 was expressed in CD15(+) and Calgranulin B+ leukocytes, but also in larger cells that morphologically resembled glioma cells. Specificity of immunoreagents was tested in recombinant cell lines, leukocyte preparations, and sections of normal human brain and liver tissue. Apparent AQP9(+) glioma cells were frequently observed in proximity to blood vessels, where brain tumor stem cells have been observed previously. A fraction of these larger AQP9 expressing cells co-expressed the differentiated astrocyte marker GFAP. AQP9 expressing glioma cells were negative for the brain tumor stem cell marker CD15, but were observed in proximity to CD15(+) glioma cells. AQP9 expression may therefore require signals of the perivascular tumor environment or alternatively it may be restricted to a population of glioma stem cell early progenitor cells.	[Jelen, Sabina; Nielsen, Soren; Rutzler, Michael] Aarhus Univ, Water & Salt Res Ctr, Dept Biomed, Aarhus, Denmark; [Ulhoi, Benedicte Parm] Aarhus Univ Hosp, Dept Pathol, DK-8000 Aarhus, Denmark; [Larsen, Agnete] Aarhus Univ, Dept Biomed Pharmacol, Aarhus, Denmark; [Frokiaer, Jorgen] Aarhus Univ, Inst Clin Med, Water & Salt Res Ctr, Aarhus, Denmark; [Rutzler, Michael] Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Lund, Sweden	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Lund University	Rutzler, M (corresponding author), Aarhus Univ, Water & Salt Res Ctr, Dept Biomed, Aarhus, Denmark.	michael.rutzler@biochemistry.lu.se	Rutzler, Michael/ABE-7914-2020	Rutzler, Michael/0000-0001-5597-8880; Frokiaer, Jorgen/0000-0002-6206-8065; Larsen, Agnete/0000-0001-8765-8443	Lundbeck Foundation [R17A1742]; Marie Curie Research Training Network; Nordic Research Grant for Water Imbalance Related Disorders; Danish National Research Foundation	Lundbeck Foundation(Lundbeckfonden); Marie Curie Research Training Network(European Commission); Nordic Research Grant for Water Imbalance Related Disorders; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by The Lundbeck Foundation Grant R17A1742 (http://lundbeckfonden.dk/), a Marie Curie Research Training Network grant (http://ec.europa.eu/research/fp6/index_en.cfm?p = 10_curie), a Nordic Research Grant for Water Imbalance Related Disorders (http://www.cmbn.no/wired/). The Water and Salt Research Center was established and funded by The Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado T, 2007, J BIOL CHEM, V282, P6854, DOI 10.1074/jbc.M608900200; Arcienega II, 2010, NEUROSCIENCE, V167, P1103, DOI 10.1016/j.neuroscience.2010.02.059; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Brescia P, 2012, J ONCOL, V2012, DOI 10.1155/2012/376894; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; FEARNS C, 1995, J EXP MED, V181, P857, DOI 10.1084/jem.181.3.857; Fossdal G, 2012, SCI WORLD J, DOI 10.1100/2012/915176; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; GRIFFIN JD, 1981, J CLIN INVEST, V68, P932, DOI 10.1172/JCI110348; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V244, P268, DOI 10.1006/bbrc.1998.8252; Jelen S, 2011, J BIOL CHEM, V286, P44319, DOI 10.1074/jbc.M111.297002; Jersmann HPA, 2001, INFECT IMMUN, V69, P479, DOI 10.1128/IAI.69.1.479-485.2001; Kitai R, 2010, BRAIN TUMOR PATHOL, V27, P17, DOI 10.1007/s10014-009-0261-0; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Mao XG, 2009, TRANSL ONCOL, V2, P247, DOI 10.1593/tlo.09136; Margareto J, 2007, J MOL NEUROSCI, V32, P53, DOI 10.1007/s12031-007-0008-5; Mylonakou MN, 2009, J NEUROSCI RES, V87, P1310, DOI 10.1002/jnr.21952; Nauseef William M., 2007, V412, P15, DOI 10.1007/978-1-59745-467-4_2; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Schittenhelm J, 2011, HISTOPATHOLOGY, V58, P739, DOI 10.1111/j.1365-2559.2011.03801.x; Shervington A, 2008, CANCER INVEST, V26, P535, DOI 10.1080/07357900801904140; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Sugawara K, 2002, LAB INVEST, V82, P345, DOI 10.1038/labinvest.3780428; Tan G, 2008, J INT MED RES, V36, P777, DOI 10.1177/147323000803600420; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; VANDERMEULEN JDM, 1978, NEUROPATH APPL NEURO, V4, P177; VELASCO ME, 1980, CANCER, V45, P484, DOI 10.1002/1097-0142(19800201)45:3<484::AID-CNCR2820450312>3.0.CO;2-9; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Warth A, 2007, APPL IMMUNOHISTO M M, V15, P193, DOI 10.1097/01.pai.0000213110.05108.e9; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	47	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75764	10.1371/journal.pone.0075764	http://dx.doi.org/10.1371/journal.pone.0075764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086629	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700111
J	Kelly, JF; Bridge, ES; Frick, WF; Chilson, PB				Kelly, Jeffrey F.; Bridge, Eli S.; Frick, Winifred F.; Chilson, Phillip B.			Ecological Energetics of an Abundant Aerial Insectivore, the Purple Martin	PLOS ONE			English	Article							PROGNE-SUBIS; SURVIVAL; DECLINES; BATS	The atmospheric boundary layer and lower free atmosphere, or aerosphere, is increasingly important for human transportation, communication, environmental monitoring, and energy production. The impacts of anthropogenic encroachment into aerial habitats are not well understood. Insectivorous birds and bats are inherently valuable components of biodiversity and play an integral role in aerial trophic dynamics. Many of these insectivores are experiencing range-wide population declines. As a first step toward gaging the potential impacts of these declines on the aerosphere's trophic system, estimates of the biomass and energy consumed by aerial insectivores are needed. We developed a suite of energetics models for one of the largest and most common avian aerial insectivores in North America, the Purple Martin (Progne subis). The base model estimated that Purple Martins consumed 412 (+/- 104) billion insects*y(-1) with a biomass of 115,860 (+/- 29,192) metric tonnes*y(-1). During the breeding season Purple Martins consume 10.3 (+/- 3.0) kg of prey biomass per km(3) of aerial habitat, equal to about 36,000 individual insects*km(-3). Based on these calculations, the cumulative seasonal consumption of insects*km(-3) is greater in North America during the breeding season than during other phases of the annual cycle, however the maximum daily insect consumption*km(-3) occurs during fall migration. This analysis provides the first range-wide quantitative estimate of the magnitude of the trophic impact of this large and common aerial insectivore. Future studies could use a similar modeling approach to estimate impacts of the entire guild of aerial insectivores at a variety of temporal and spatial scales. These analyses would inform our understanding of the impact of population declines among aerial insectivores on the aerosphere's trophic dynamics.	[Kelly, Jeffrey F.; Bridge, Eli S.] Univ Oklahoma, Oklahoma Biol Survey, Norman, OK 73019 USA; [Kelly, Jeffrey F.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Kelly, Jeffrey F.; Bridge, Eli S.; Chilson, Phillip B.] Univ Oklahoma, Ecol & Evolutionary Biol Program, Norman, OK 73019 USA; [Frick, Winifred F.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Chilson, Phillip B.] Univ Oklahoma, Sch Meteorol, Norman, OK 73019 USA; [Chilson, Phillip B.] Univ Oklahoma, Adv Radar Res Ctr, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of California System; University of California Santa Cruz; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Kelly, JF (corresponding author), Univ Oklahoma, Oklahoma Biol Survey, Norman, OK 73019 USA.	jkelly@ou.edu	Bridge, Eli/AAN-1928-2020; Chilson, Phillip B./C-8491-2012; Kelly, Jeffrey F/B-2029-2015; Frick, Winifred/ABA-3519-2020	Kelly, Jeffrey F/0000-0002-8255-7990; Frick, Winifred/0000-0002-9469-1839; Bridge, Eli/0000-0003-3453-2008	National Science Foundation [EPS-0919466]; Direct For Biological Sciences [1340921] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Jeff Kelly was supported by National Science Foundation Grant EPS-0919466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RW, 1952, AM MIDL NAT, V47, P606, DOI 10.2307/2422034; [Anonymous], 2017, BIRDS N AM, DOI 10.2173/bna.cliswa.03%3e; Beal FEL, 1918, USDA B, V619, P3; BOHNINGGAESE K, 1993, CONSERV BIOL, V7, P76, DOI 10.1046/j.1523-1739.1993.07010076.x; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Brooks SJ, 1996, ECOSCIENCE, V3, P247, DOI 10.1080/11956860.1996.11682338; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Dunn EH, 2002, CONSERV BIOL, V16, P1632, DOI 10.1046/j.1523-1739.2002.01250.x; Farber SC, 2002, ECOL ECON, V41, P375, DOI 10.1016/S0921-8009(02)00088-5; JOHNSTON RF, 1967, IBIS, V109, P8, DOI 10.1111/j.1474-919X.1967.tb00002.x; Johnston Richard F., 2001, P49; KALE HW, 1968, AUK, V85, P654, DOI 10.2307/4083372; Kunz TH, 2008, INTEGR COMP BIOL, V48, P1, DOI [10.1093/icb/icn030, 10.1093/icb/icn037]; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; MathWorks, 2012, MATL R2012A 7 14 0 7; Nebel S, 2010, AVIAN CONSERV ECOL, V5; Odum HT, 2000, ECOSYSTEMS, V3, P21, DOI 10.1007/s100210000005; Rees M, 2009, ECOL MONOGR, V79, P575, DOI 10.1890/08-1474.1; RICH TD, 2004, PARTNERS FLIGHT N AM; Robillard A, 2013, LANDSCAPE ECOL, V28, P201, DOI 10.1007/s10980-012-9828-y; ROHWER S, 1979, Z TIERPSYCHOL, V51, P282; SAGE RD, 1982, AM MIDL NAT, V108, P407, DOI 10.2307/2425505; Saha N, 2012, BIOL CONTROL, V63, P1, DOI 10.1016/j.biocontrol.2012.05.004; Sauer JR, 2012, N AM BREEDING BIRD S; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Stutchbury BJM, 2009, AUK, V126, P278, DOI 10.1525/auk.2009.08038; Tarof SA, 2011, AUK, V128, P716, DOI 10.1525/auk.2011.11087; UTTER JM, 1973, ECOLOGY, V54, P597, DOI 10.2307/1935345; Wagner RH, 1996, ANIM BEHAV, V52, P123, DOI 10.1006/anbe.1996.0158	30	19	19	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76616	10.1371/journal.pone.0076616	http://dx.doi.org/10.1371/journal.pone.0076616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086755	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700129
J	Nickels, S; Vrieling, A; Seibold, P; Heinz, J; Obi, N; Flesch-Janys, D; Chang-Claude, J				Nickels, Stefan; Vrieling, Alina; Seibold, Petra; Heinz, Judith; Obi, Nadia; Flesch-Janys, Dieter; Chang-Claude, Jenny			Mortality and Recurrence Risk in Relation to the Use of Lipid-Lowering Drugs in a Prospective Breast Cancer Patient Cohort	PLOS ONE			English	Article							STATIN USE; THERAPY	Lipid-lowering drugs are used for the prevention of cardiovascular diseases. Statins are the most commonly used lipid-lowering drugs. Evidence from preclinical and observational studies suggests that statins might improve the prognosis of breast cancer patients. We analyzed data from the German MARIEplus study, a large prospective population-based cohort of patients aged 50 and older, who were diagnosed with breast cancer between 2001 and 2005. For overall mortality, breast-cancer specific mortality, and non-breast-cancer mortality, we included 3189 patients with invasive breast cancer stage I-IV, and for recurrence risk 3024 patients with breast cancer stage I-III. We used Cox proportional hazards models to assess the association with self-reported lipid-lowering drug use at recruitment. We stratified by study region, tumor grade, and estrogen/progesterone receptor status, and adjusted for age, tumor size, nodal status, metastases (stage I-IV only), menopausal hormone treatment, mode of detection, radiotherapy, and smoking. Mortality analyses were additionally adjusted for cardiovascular disease, diabetes mellitus and body-mass index. During a median follow-up of 5.3 years, 404 of 3189 stage I-IV patients died, and 286 deaths were attributed to breast cancer. Self-reported use of lipid-lowering drugs was non-significantly associated with increased non-breast cancer mortality (Hazard ratio (HR) 1.49, 95% confidence interval (CI) 0.88-2.52) and increased overall mortality (HR 1.21, 95% CI 0.87-1.69) whereas no association with breast cancer-specific mortality was found (HR 1.04, 0.67-1.60). Restricted to stage I-III breast cancer patients, 387 recurrences occurred during a median follow-up of 5.4 years. We found lipid-lowering drug use to be non-significantly associated with a reduced risk of recurrence (HR 0.83, 95% CI 0.54-1.24) and of breast cancer-specific mortality (HR 0.89, 95% CI 0.52-1.49). Although compatible with previous findings of an improved prognosis associated with statin use, our results do not provide clear supportive evidence for an association with lipid-lowering drug use due to imprecise estimates.	[Nickels, Stefan; Vrieling, Alina; Seibold, Petra; Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Vrieling, Alina] Radboud Univ Nijmegen Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands; [Heinz, Judith; Obi, Nadia; Flesch-Janys, Dieter] Univ Med Ctr Hamburg Eppendorf, Dept Canc Epidemiol, Clin Canc Registry, Hamburg, Germany; [Flesch-Janys, Dieter] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometr & Epidemiol, Hamburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Radboud University Nijmegen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Chang-Claude, J (corresponding author), German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany.	j.chang-claude@dkfz.de	Vrieling, Alina/A-2725-2016	Vrieling, Alina/0000-0002-8178-2125	Deutsche Krebshilfe [108253/108419]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Krebshilfe, Project numbers 108253/108419. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TP, 2011, JNCI-J NATL CANCER I, V103, P1461, DOI 10.1093/jnci/djr291; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Bosco JLF, 2010, J CLIN EPIDEMIOL, V63, P64, DOI 10.1016/j.jclinepi.2009.03.001; Calip GS, 2013, BREAST CANC RES TREA; Chae YK, 2011, CANCER INVEST, V29, P585, DOI 10.3109/07357907.2011.616252; Ewertz M, 2011, J CLIN ONCOL, V29, P25, DOI 10.1200/JCO.2010.29.7614; Fiesch-Janys D, 2008, INT J CANCER, V123, P933, DOI 10.1002/ijc.23655; Gopalan A, 2013, CANCER LETT, V329, P9, DOI 10.1016/j.canlet.2012.08.031; Holmes MD, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3336; Jakobisiak M, 2003, INT J ONCOL, V23, P1055; Katz MS, 2005, NAT CLIN PRACT ONCOL, V2, P82, DOI 10.1038/ncponc0097; Kwan ML, 2008, BREAST CANCER RES TR, V109, P573, DOI 10.1007/s10549-007-9683-8; Latry P, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-46; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Ozdemir BH, 2004, AM J CLIN PATHOL, V122, P696, DOI 10.1309/HW2MYB5TVF4AMOY4; Protani M, 2010, BREAST CANCER RES TR, V123, P627, DOI 10.1007/s10549-010-0990-0; Schwabe U., 2010, ARZNEIVERORDNUNGS RE; Therneau TM, 2000, MODELING SURVIVAL DA; Undela K, 2012, BREAST CANCER RES TR, V135, P261, DOI 10.1007/s10549-012-2154-x; Vaklavas C, 2011, PHARMACOL THERAPEUT, V130, P177, DOI 10.1016/j.pharmthera.2011.01.009	21	42	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75088	10.1371/journal.pone.0075088	http://dx.doi.org/10.1371/journal.pone.0075088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086446	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700051
J	Tobar, A; Ori, Y; Benchetrit, S; Milo, G; Herman-Edelstein, M; Zingerman, B; Lev, N; Gafter, U; Chagnac, A				Tobar, Ana; Ori, Yaacov; Benchetrit, Sydney; Milo, Gai; Herman-Edelstein, Michal; Zingerman, Boris; Lev, Netta; Gafter, Uzi; Chagnac, Avry			Proximal Tubular Hypertrophy and Enlarged Glomerular and Proximal Tubular Urinary Space in Obese Subjects with Proteinuria	PLOS ONE			English	Article							INDEPENDENT RISK-FACTOR; BODY-MASS INDEX; METABOLIC SYNDROME; RENAL HEMODYNAMICS; STRUCTURAL-CHANGES; DIABETES-MELLITUS; MECHANICAL-STRESS; GROWTH-FACTORS; KIDNEY; HYPERFILTRATION	Background: Obesity is associated with glomerular hyperfiltration, increased proximal tubular sodium reabsorption, glomerular enlargement and renal hypertrophy. A single experimental study reported an increased glomerular urinary space in obese dogs. Whether proximal tubular volume is increased in obese subjects and whether their glomerular and tubular urinary spaces are enlarged is unknown. Objective: To determine whether proximal tubules and glomerular and tubular urinary space are enlarged in obese subjects with proteinuria and glomerular hyperfiltration. Methods: Kidney biopsies from 11 non-diabetic obese with proteinuria and 14 non-diabetic lean patients with a creatinine clearance above 50 ml/min and with mild or no interstitial fibrosis were retrospectively analyzed using morphometric methods. The cross-sectional area of the proximal tubular epithelium and lumen, the volume of the glomerular tuft and of Bowman's space and the nuclei number per tubular profile were estimated. Results: Creatinine clearance was higher in the obese than in the lean group (P=0.03). Proteinuria was similarly increased in both groups. Compared to the lean group, the obese group displayed a 104% higher glomerular tuft volume (P=0.001), a 94% higher Bowman's space volume (P=0.003), a 33% higher cross-sectional area of the proximal tubular epithelium (P=0.02) and a 54% higher cross-sectional area of the proximal tubular lumen (P=0.01). The nuclei number per proximal tubular profile was similar in both groups, suggesting that the increase in tubular volume is due to hypertrophy and not to hyperplasia. Conclusions: Obesity-related glomerular hyperfiltration is associated with proximal tubular epithelial hypertrophy and increased glomerular and tubular urinary space volume in subjects with proteinuria. The expanded glomerular and urinary space is probably a direct consequence of glomerular hyperfiltration. These effects may be involved in the pathogenesis of obesity-related renal disease.	[Tobar, Ana] Rabin Med Ctr, Dept Pathol, Petah Tiqwa, Israel; [Ori, Yaacov; Milo, Gai; Herman-Edelstein, Michal; Zingerman, Boris; Lev, Netta; Gafter, Uzi; Chagnac, Avry] Rabin Med Ctr, Dept Hypertens & Nephrol, Petah Tiqwa, Israel; [Benchetrit, Sydney] Meir Med Ctr, Dept Nephrol, Kefar Sava, Israel; [Tobar, Ana; Ori, Yaacov; Benchetrit, Sydney; Milo, Gai; Zingerman, Boris; Lev, Netta; Gafter, Uzi; Chagnac, Avry] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Chagnac, A (corresponding author), Rabin Med Ctr, Dept Hypertens & Nephrol, Petah Tiqwa, Israel.	Chagnac@clalit.org.il						Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; BANK N, 1990, J CLIN INVEST, V86, P309, DOI 10.1172/JCI114700; Baumgartl HJ, 1998, NEPHROL DIAL TRANSPL, V13, P630, DOI 10.1093/ndt/13.3.630; Bayliss G, 2012, CURR DIABETES REP, V12, P440, DOI 10.1007/s11892-012-0288-1; Bonnet F, 2001, AM J KIDNEY DIS, V37, P720, DOI 10.1016/S0272-6386(01)80120-7; Chagnac A, 2000, AM J PHYSIOL-RENAL, V278, pF817, DOI 10.1152/ajprenal.2000.278.5.F817; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Chagnac A, 2008, NEPHROL DIAL TRANSPL, V23, P3946, DOI 10.1093/ndt/gfn379; Chen HM, 2006, AM J KIDNEY DIS, V48, P772, DOI 10.1053/j.ajkd.2006.07.025; Chiarelli F, 2009, HORM METAB RES, V41, P585, DOI 10.1055/s-0029-1220752; COHEN AH, 1975, AM J PATHOL, V81, P117; D'Agati VD, 2008, KIDNEY INT, V73, P909, DOI 10.1038/ki.2008.42; Darouich S, 2011, ULTRASTRUCT PATHOL, V35, P176, DOI 10.3109/01913123.2011.584657; Du ZP, 2004, P NATL ACAD SCI USA, V101, P13068, DOI 10.1073/pnas.0405179101; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Gonzalez E, 2005, KIDNEY INT, V68, P263, DOI 10.1111/j.1523-1755.2005.00401.x; Goumenos DS, 2009, NEPHROL DIAL TRANSPL, V24, P3732, DOI 10.1093/ndt/gfp329; HANNEDOUCHE TP, 1990, KIDNEY INT, V37, P1126, DOI 10.1038/ki.1990.95; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; Hirschberg R, 2005, CURR OPIN NEPHROL HY, V14, P43, DOI 10.1097/00041552-200501000-00008; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; KASISKE BL, 1986, ARCH INTERN MED, V146, P1105, DOI 10.1001/archinte.146.6.1105; Kataoka H, 2012, CLIN EXP NEPHROL, V16, P706, DOI 10.1007/s10157-012-0613-7; Kato S, 2009, CLIN EXP NEPHROL, V13, P332, DOI 10.1007/s10157-009-0169-3; Krikken JA, 2007, KIDNEY INT, V71, P260, DOI 10.1038/sj.ki.5002011; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Lawson ML, 1996, DIABETES, V45, P51, DOI 10.2337/diabetes.45.1.51; Meier-Kriesche HU, 2002, TRANSPLANTATION, V73, P70, DOI 10.1097/00007890-200201150-00013; MORTENSEN JB, 1980, SCAND J CLIN LAB INV, V40, P695, DOI DOI 10.3109/00365518009095584.PUBMED:7280549; NAGATA M, 1992, KIDNEY INT, V42, P148, DOI 10.1038/ki.1992.272; OSTERBY R, 1986, CLIN ENDOCRINOL META, V15, P733, DOI 10.1016/S0300-595X(86)80072-X; Pecly IMD, 2006, INT J CLIN PRACT, V60, P1198, DOI 10.1111/j.1742-1241.2006.01037.x; Porter LE, 1998, HYPERTENSION, V32, P144, DOI 10.1161/01.HYP.32.1.144; Praga M, 2005, NEPHROL DIAL TRANSPL, V20, P2594, DOI 10.1093/ndt/gfi201; Rea DJ, 2006, KIDNEY INT, V70, P1636, DOI 10.1038/sj.ki.5001799; REISIN E, 1987, J HYPERTENS, V5, P397; RIBSTEIN J, 1995, HYPERTENSION, V26, P610, DOI 10.1161/01.HYP.26.4.610; Ritz E, 2011, CURR OPIN NEPHROL HY, V20, P44, DOI 10.1097/MNH.0b013e3283414ca1; Serra A, 2008, KIDNEY INT, V73, P947, DOI 10.1038/sj.ki.5002796; SEYERHANSEN K, 1980, DIABETOLOGIA, V18, P501; Sonomura K, 2012, KIDNEY INT, V81, P449, DOI 10.1038/ki.2011.403; Strazzullo P, 2006, J HYPERTENS, V24, P1633, DOI 10.1097/01.hjh.0000239300.48130.07; Thomson SC, 2001, J CLIN INVEST, V107, P217, DOI 10.1172/JCI10963; Tsuboi N, 2012, CLIN J AM SOC NEPHRO, V7, P735, DOI 10.2215/CJN.07270711; Vallon V, 1999, J AM SOC NEPHROL, V10, P2569; Vallon V, 2003, J AM SOC NEPHROL, V14, P530, DOI 10.1097/01.ASN.0000051700.07403.27; VERANI RR, 1992, AM J KIDNEY DIS, V20, P629, DOI 10.1016/S0272-6386(12)70230-5; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Weibel ER., 1979, STEREOLOGICAL METHOD, P44; Wuerzner G, 2010, AM J KIDNEY DIS, V56, P303, DOI 10.1053/j.ajkd.2010.03.017; Zerbini G, 2006, DIABETES, V55, P2620, DOI 10.2337/db06-0592	51	56	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75547	10.1371/journal.pone.0075547	http://dx.doi.org/10.1371/journal.pone.0075547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086563	gold, Green Submitted, Green Published			2022-12-25	WOS:000325218700098
J	Labonte, D; Thies, E; Pechmann, Y; Groffen, AJ; Verhage, M; Smit, AB; van Kesteren, RE; Kneussel, M				Labonte, Dorthe; Thies, Edda; Pechmann, Yvonne; Groffen, Alexander J.; Verhage, Matthijs; Smit, August B.; van Kesteren, Ronald E.; Kneussel, Matthias			TRIM3 Regulates the Motility of the Kinesin Motor Protein KIF21B	PLOS ONE			English	Article							RING FINGER PROTEIN; POSTTRANSLATIONAL MODIFICATIONS; E3 LIGASE; TRANSPORT; CARGO; PHOSPHORYLATION; SUSCEPTIBILITY; LOCALIZATION; MICROTUBULES; REPLICATION	Kinesin superfamily proteins (KIFs) are molecular motors that transport cellular cargo along the microtubule cytoskeleton. KIF21B is a neuronal kinesin that is highly enriched in dendrites. The regulation and specificity of microtubule transport involves the binding of motors to individual cargo adapters and accessory proteins. Moreover, posttranslational modifications of either the motor protein, their cargos or tubulin regulate motility, cargo recognition and the binding or unloading of cargos. Here we show that the ubiquitin E3 ligase TRIM3, also known as BERP, interacts with KIF21B via its RBCC domain. TRIM3 is found at intracellular and Golgi-derived vesicles and colocalizes with the KIF21B motor in neurons. Trim3 gene deletion in mice and TRIM3 overexpression in cultured neurons both suggested that the E3-ligase function of TRIM3 is not involved in KIF21B degradation, however TRIM3 depletion reduces the motility of the motor. Together, our data suggest that TRIM3 is a regulator in the modulation of KIF21B motor function.	[Labonte, Dorthe; Thies, Edda; Pechmann, Yvonne; Kneussel, Matthias] Univ Med Ctr Hamburg Eppendorf, ZMNH, Ctr Mol Neurobiol, Dept Mol Neurogenet, Hamburg, Germany; [Groffen, Alexander J.; Verhage, Matthijs; Smit, August B.; van Kesteren, Ronald E.] Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands	University of Hamburg; University Medical Center Hamburg-Eppendorf; Vrije Universiteit Amsterdam	Kneussel, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, ZMNH, Ctr Mol Neurobiol, Dept Mol Neurogenet, Hamburg, Germany.	matthias.kneussel@zmnh.uni-hamburg.de	van Kesteren, Ronald E/E-2505-2014; Groffen, A.J.A./C-1118-2009	Groffen, A.J.A./0000-0003-0046-4027; verhage, matthijs/0000-0002-6085-7503; Kneussel, Matthias/0000-0003-4900-366X; van Kesteren, Ronald/0000-0002-9592-3777	Deutsche Forschungsgemeinschaft DFG [KN556/4-2, DFG KN556/6-1, GRK1459]; EU-FP7 SYNSYS [HEALTH-2009-2.1.2-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); EU-FP7 SYNSYS	Supported by grants of the Deutsche Forschungsgemeinschaft DFG KN556/4-2, DFG KN556/6-1 and GRK1459 to MK and by HEALTH-2009-2.1.2-1 EU-FP7 SYNSYS to REvK and ABS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Cheung CC, 2010, P NATL ACAD SCI USA, V107, P11883, DOI 10.1073/pnas.1006529107; Cho KI, 2009, EMBO REP, V10, P480, DOI 10.1038/embor.2009.29; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; El-Husseini AE, 1999, J BIOL CHEM, V274, P19771, DOI 10.1074/jbc.274.28.19771; El-Husseini AED, 2000, BIOCHEM BIOPH RES CO, V267, P906, DOI 10.1006/bbrc.1999.2045; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Friedman DS, 1999, NAT CELL BIOL, V1, P293, DOI 10.1038/13008; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Goris A, 2010, J MED GENET, V47, P775, DOI 10.1136/jmg.2009.075911; Guillaud L, 2008, NAT CELL BIOL, V10, P19, DOI 10.1038/ncb1665; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Heisler FF, 2011, NEURON, V70, P66, DOI 10.1016/j.neuron.2011.03.008; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Huang CJ, 2012, MOL CELL BIOCHEM, V360, P121, DOI 10.1007/s11010-011-1050-8; Hung AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009842; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Loiseau P, 2010, DEVELOPMENT, V137, P2763, DOI 10.1242/dev.048108; Maas C, 2009, P NATL ACAD SCI USA, V106, P8731, DOI 10.1073/pnas.0812391106; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; McCauley JL, 2010, HUM MOL GENET, V19, P953, DOI 10.1093/hmg/ddp542; Mosesson Y, 2009, DEV CELL, V16, P687, DOI 10.1016/j.devcel.2009.03.015; Napolitano LM, 2012, IUBMB LIFE, V64, P64, DOI 10.1002/iub.580; Napolitano LM, 2011, BIOCHEM J, V434, P309, DOI 10.1042/BJ20101487; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133; Rieser E, 2013, TRENDS BIOCHEM SCI, V38, P94, DOI 10.1016/j.tibs.2012.11.007; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Shin SM, 2012, NAT NEUROSCI, V15, P1655, DOI 10.1038/nn.3259; Sun FN, 2011, EMBO J, V30, P3416, DOI 10.1038/emboj.2011.229; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Yan Q, 2005, MOL BIOL CELL, V16, P2470, DOI 10.1091/mbc.e04-11-1014; Ying HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009168	46	25	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75603	10.1371/journal.pone.0075603	http://dx.doi.org/10.1371/journal.pone.0075603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086586	Green Submitted, gold, Green Published			2022-12-25	WOS:000325025200054
J	Mudvari, P; Ohshiro, K; Nair, V; Horvath, A; Kumar, R				Mudvari, Prakriti; Ohshiro, Kazufumi; Nair, Vasudha; Horvath, Anelia; Kumar, Rakesh			Genomic Insights into Triple-Negative and HER2-Positive Breast Cancers Using Isogenic Model Systems	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; MOLECULAR PORTRAITS; CATHEPSIN-B; IDENTIFICATION; PROGRESSION; CARCINOMAS; PREDICTOR; PROFILES; PATTERNS; SUBTYPES	Introduction: In general, genomic signatures of breast cancer subtypes have little or no overlap owing to the heterogeneous genetic backgrounds of study samples. Thus, obtaining a reliable signature in the context of isogenic nature of the cells has been challenging and the precise contribution of isogenic triple negative breast cancer (TNBC) versus non-TNBC remains poorly defined. Methods: We established isogenic stable cell lines representing TNBC and Human Epidermal Growth Factor Receptor 2 positive (HER2+) breast cancers by introducing HER2 in TNBC cell lines MDA-MB-231 and MDA-MB-468. We examined protein level expression and functionality of the transfected receptor by treatment with an antagonist of HER2. Using microarray profiling, we obtained a comprehensive gene list of differentially expressed between TNBC and HER2+ clones. We identified and validated underlying isogenic components using qPCR and also compared results with expression data from patients with similar breast cancer subtypes. Results: We identified 544 and 1087 statistically significant differentially expressed genes between isogenic TNBC and HER2+ samples in MDA-MB-231 and MDA-MB-468 backgrounds respectively and a shared signature of 49 genes. By comparing results from MDA-MB-231 and MDA-MB-468 backgrounds with two patient microarray datasets, we identified 17 and 22 common genes with same expression trend respectively. Additionally, we identified 56 and 78 genes from MDA-MB-231 and MDA-MB-468 comparisons respectively present in our published RNA-seq data. Conclusions: Using our unique model system, we have identified an isogenic gene expression signature between TNBC and HER2+ breast cancer. A portion of our results was also verified in patient data samples, indicating an existence of isogenic element associated with HER2 status between genetically heterogeneous breast cancer samples. These findings may potentially contribute to the development of molecular platform that would be valuable for diagnostic and therapeutic decision for TNBC and in distinguishing it from HER2+ subtype.	[Mudvari, Prakriti; Horvath, Anelia; Kumar, Rakesh] George Washington Univ, Sch Med & Hlth Sci, McCormick Genom & Prote Ctr, Washington, DC 20052 USA; [Mudvari, Prakriti; Ohshiro, Kazufumi; Nair, Vasudha; Horvath, Anelia; Kumar, Rakesh] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA	George Washington University; George Washington University	Kumar, R (corresponding author), George Washington Univ, Sch Med & Hlth Sci, McCormick Genom & Prote Ctr, Washington, DC 20052 USA.	bcmrxk@gwu.edu	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803	McCormick Genomic and Proteomics Center	McCormick Genomic and Proteomics Center	This work is supported by the McCormick Genomic and Proteomics Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2011, BREAST CANC FACTS FI; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bertucci F, 2004, ONCOGENE, V23, P2564, DOI 10.1038/sj.onc.1207361; Boyle P, 2012, ANN ONCOL S, V23, P12, DOI [10.1093/annonc/mds187, DOI 10.1093/ANN0NC/MDS187.PUBMED:23012306]; Cadenas C, 2012, BBA-MOL CELL BIOL L, V1821, P1256, DOI 10.1016/j.bbalip.2011.11.008; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; CLARKE R, 1990, ANN ONCOL, V1, P401, DOI 10.1093/oxfordjournals.annonc.a057790; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Espinoza I, 2011, MOL CANCER THER, V10, P732, DOI 10.1158/1535-7163.MCT-10-0836; Eswaran J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00264; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; LEONESSA F, 1992, ACTA ONCOL, V31, P115, DOI 10.3109/02841869209088890; Leygue E, 1998, CANCER RES, V58, P1348; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nouh MA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-1; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vincent-Salomon A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1666; Watson CJ, 2009, J MAMMARY GLAND BIOL, V14, P171, DOI 10.1007/s10911-009-9126-8	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74993	10.1371/journal.pone.0074993	http://dx.doi.org/10.1371/journal.pone.0074993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086418	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200068
J	Takahashi, M; Hasegawa, Y; Ikeda, Y; Wada, Y; Tajiri, M; Ariki, S; Takamiya, R; Nishitani, C; Araki, M; Yamaguchi, Y; Taniguchi, N; Kuroki, Y				Takahashi, Motoko; Hasegawa, Yoshihiro; Ikeda, Yoshitaka; Wada, Yoshinao; Tajiri, Michiko; Ariki, Shigeru; Takamiya, Rina; Nishitani, Chiaki; Araki, Motoko; Yamaguchi, Yoshiki; Taniguchi, Naoyuki; Kuroki, Yoshio			Suppression of Heregulin beta Signaling by the Single N-Glycan Deletion Mutant of Soluble ErbB3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epidermal Growth Factor Receptor (EGFR); Glycosylation; Growth Factors; Mass Spectrometry (MS); Receptors	EPIDERMAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; NEU DIFFERENTIATION FACTOR; EXTRACELLULAR REGION; CORE FUCOSYLATION; BISECTING GLCNAC; TUMOR PROMOTION; CELL-ADHESION; UP-REGULATION; HELAS3 CELLS	Background: Extracellular domain of ErbBs (sErbBs) down-regulates growth factor signaling. Results: sErbB3 acts on ErbB3-containing heterodimers to suppress heregulin signaling, and the effects are enhanced by single N-glycan deletion. Conclusion:N-Glycan on Asn-418 controls the ability of sErbB3 to suppress heregulin signaling. Significance: Provides new insights toward understanding the mechanisms by which N-glycan regulates ErbB receptors. Heregulin signaling is involved in various tumor proliferations and invasions; thus, receptors of heregulin are targets for the cancer therapy. In this study we examined the suppressing effects of extracellular domains of ErbB2, ErbB3, and ErbB4 (soluble ErbB (sErbB)) on heregulin signaling in human breast cancer cell line MCF7. It was found that sErbB3 suppresses ligand-induced activation of ErbB receptors, PI3K/Akt and Ras/Erk pathways most effectively; sErbB2 scarcely suppresses ligand-induced signaling, and sErbB4 suppresses receptor activation at approximate to 10% efficiency of sErbB3. It was revealed that sErbB3 does not decrease the effective ligands but decreases the effective receptors. By using small interfering RNA (siRNA) for ErbB receptors, we determined that sErbB3 suppresses the heregulin signaling by interfering ErbB3-containing heterodimers including ErbB2/ErbB3. By introducing the mutation of N418Q to sErbB3, the signaling-inhibitory effects were increased by 2-3-fold. Moreover, the sErbB3 N418Q mutant enhanced anticancer effects of lapatinib more effectively than the wild type. We also determined the structures of N-glycan on Asn-418. Results suggested that the N-glycan-deleted mutant of sErbB3 suppresses heregulin signaling via ErbB3-containing heterodimers more effectively than the wild type. Thus, we demonstrated that the sErbB3 N418Q mutant is a potent inhibitor for heregulin signaling.	[Takahashi, Motoko; Hasegawa, Yoshihiro; Ariki, Shigeru; Takamiya, Rina; Nishitani, Chiaki; Araki, Motoko; Kuroki, Yoshio] Sapporo Med Univ, Sch Med, Dept Biochem, Sapporo, Hokkaido 0608556, Japan; [Ikeda, Yoshitaka] Saga Univ, Mol Cell Biol Div, Dept Biomol Sci, Fac Med, Saga 8498501, Japan; [Wada, Yoshinao; Tajiri, Michiko] Osaka Med Ctr, Dept Mol Med, Osaka 5941101, Japan; [Wada, Yoshinao; Tajiri, Michiko] Res Inst Maternal & Child Hlth, Osaka 5941101, Japan; [Yamaguchi, Yoshiki; Taniguchi, Naoyuki] RIKEN, Syst Glycobiol Res Grp, Max Planck Joint Res Ctr, Global Res Cluster, Wako, Saitama 3510198, Japan	Sapporo Medical University; Saga University; Osaka Medical Center for Cancer & Cardiovascular Diseases; RIKEN	Takahashi, M (corresponding author), Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, South 1 West 17, Sapporo, Hokkaido 0608556, Japan.	takam@sapmed.ac.jp	Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014; Ariki, Shigeru/E-3861-2014; Yamaguchi, Yoshiki/N-5246-2015; Takahashi, Motoko/I-3154-2013	Taniguchi, Naoyuki/0000-0001-5889-5968; Ariki, Shigeru/0000-0001-5838-499X; Yamaguchi, Yoshiki/0000-0003-0100-5439; Takahashi, Motoko/0000-0002-2112-6142	Japan Society for the Promotion of Science [21590342]; Takeda Science Foundation; Suhara Foundation; Grants-in-Aid for Scientific Research [24591173] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suhara Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for Science Research from the Japan Society for the Promotion of Science 21590342, the Takeda Science Foundation, and the Suhara Foundation.	Alvarado D, 2009, NATURE, V461, P287, DOI 10.1038/nature08297; Azios NG, 2001, ONCOGENE, V20, P5199, DOI 10.1038/sj.onc.1204555; Baselga J, 1998, CANCER RES, V58, P2825; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; Doherty JK, 1999, P NATL ACAD SCI USA, V96, P10869, DOI 10.1073/pnas.96.19.10869; Ferguson KM, 2000, EMBO J, V19, P4632, DOI 10.1093/emboj/19.17.4632; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; Hong YJ, 2003, J BIOL CHEM, V278, P53045, DOI 10.1074/jbc.M309967200; HORAN T, 1995, J BIOL CHEM, V270, P24604, DOI 10.1074/jbc.270.41.24604; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Lee H, 2001, CANCER RES, V61, P4467; Lee SH, 2006, J BIOCHEM, V139, P391, DOI 10.1093/jb/mvj039; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Li W, 2007, GLYCOBIOLOGY, V17, P655, DOI 10.1093/glycob/cwm022; Lindzen M, 2012, ONCOGENE, V31, P3505, DOI 10.1038/onc.2011.518; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Osumi D, 2009, CANCER SCI, V100, P888, DOI 10.1111/j.1349-7006.2009.01125.x; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Rusnak DW, 2001, CANCER RES, V61, P7196; Sato Y, 2001, J BIOL CHEM, V276, P11956, DOI 10.1074/jbc.M008551200; Shibukawa Y, 2003, J BIOL CHEM, V278, P3197, DOI 10.1074/jbc.M207870200; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Tajiri M, 2005, GLYCOBIOLOGY, V15, P1332, DOI 10.1093/glycob/cwj019; Takahashi M, 2003, GLYCOCONJUGATE J, V20, P207, DOI 10.1023/B:GLYC.0000024252.63695.5c; Takahashi M, 2008, BBA-GEN SUBJECTS, V1780, P520, DOI 10.1016/j.bbagen.2007.10.019; Takahashi M, 2009, CARBOHYD RES, V344, P1387, DOI 10.1016/j.carres.2009.04.031; Tsuda T, 2000, J BIOL CHEM, V275, P21988, DOI 10.1074/jbc.M003400200; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Wada Y, 2004, ANAL CHEM, V76, P6560, DOI 10.1021/ac049062o; Wada Y, 2010, J PROTEOME RES, V9, P1367, DOI 10.1021/pr900913k; WARD WHJ, 1994, BIOCHEM PHARMACOL, V48, P659, DOI 10.1016/0006-2952(94)90042-6; Watty A, 2002, J BIOL CHEM, V277, P50457, DOI 10.1074/jbc.M208664200; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Xu JG, 2003, J BIOL CHEM, V278, P10770, DOI 10.1074/jbc.M207968200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yokoe S, 2007, CANCER RES, V67, P1935, DOI 10.1158/0008-5472.CAN-06-3023; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Zhang Q, 2012, P NATL ACAD SCI USA, V109, P13237, DOI 10.1073/pnas.1200105109	51	15	15	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32910	32921		10.1074/jbc.M113.491902	http://dx.doi.org/10.1074/jbc.M113.491902			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097984	Green Published, hybrid			2022-12-25	WOS:000328841700009
J	Malenczyk, K; Jazurek, M; Keimpema, E; Silvestri, C; Janikiewicz, J; Mackie, K; Di Marzo, V; Redowicz, MJ; Harkany, T; Dobrzyn, A				Malenczyk, Katarzyna; Jazurek, Magdalena; Keimpema, Erik; Silvestri, Cristoforo; Janikiewicz, Justyna; Mackie, Ken; Di Marzo, Vincenzo; Redowicz, Maria J.; Harkany, Tibor; Dobrzyn, Agnieszka			CB1 Cannabinoid Receptors Couple to Focal Adhesion Kinase to Control Insulin Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cannabinoid Receptors; Cytoskeleton; Endocannabinoids; Exocytosis; Focal Adhesion Kinase; Insulin Release	DIACYLGLYCEROL LIPASE-ALPHA; BETA-CELL; MOLECULAR CHARACTERIZATION; ENDOCANNABINOID SYSTEM; INTRACELLULAR CALCIUM; CYTOSOLIC CA2+; SECRETION; ACTIN; ANANDAMIDE; MOBILIZATION	Background: Endocannabinoids can affect pancreatic cell physiology. Results: Anandamide and 2-arachidonoylglycerol binding to CB1 receptors induces focal adhesion kinase phosphorylation, which is a prerequisite of insulin release. Conclusion: Focal adhesion kinase activation downstream from CB1 receptors couples cytoskeletal reorganization to insulin release. Significance: Identifies the molecular blueprint of 2-arachidonoylglycerol signaling in the endocrine pancreas, and outlines a kinase activation cascade linking endocannabinoid signals to insulin release. Endocannabinoid signaling has been implicated in modulating insulin release from cells of the endocrine pancreas. Cells express CB1 cannabinoid receptors (CB(1)Rs), and the enzymatic machinery regulating anandamide and 2-arachidonoylglycerol bioavailability. However, the molecular cascade coupling agonist-induced cannabinoid receptor activation to insulin release remains unknown. By combining molecular pharmacology and genetic tools in INS-1E cells and in vivo, we show that CB1R activation by endocannabinoids (anandamide and 2-arachidonoylglycerol) or synthetic agonists acutely or after prolonged exposure induces insulin hypersecretion. In doing so, CB(1)Rs recruit Akt/PKB and extracellular signal-regulated kinases 1/2 to phosphorylate focal adhesion kinase (FAK). FAK activation induces the formation of focal adhesion plaques, multimolecular platforms for second-phase insulin release. Inhibition of endocannabinoid synthesis or FAK activity precluded insulin release. We conclude that FAK downstream from CB(1)Rs mediates endocannabinoid-induced insulin release by allowing cytoskeletal reorganization that is required for the exocytosis of secretory vesicles. These findings suggest a mechanistic link between increased circulating and tissue endocannabinoid levels and hyperinsulinemia in type 2 diabetes.	[Malenczyk, Katarzyna; Jazurek, Magdalena; Janikiewicz, Justyna; Redowicz, Maria J.; Dobrzyn, Agnieszka] M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; [Malenczyk, Katarzyna; Keimpema, Erik; Harkany, Tibor] Karolinska Inst, Div Mol Neurobiol, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Silvestri, Cristoforo; Di Marzo, Vincenzo] CNR, Endocannabinoid Res Grp, Ist Chim Biomol, I-80078 Naples, Italy; [Mackie, Ken] Indiana Univ, Gill Ctr Neurosci, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Harkany, Tibor] Univ Aberdeen, Sch Med Sci, Aberdeen AB25 2ZD, Scotland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Karolinska Institutet; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Indiana University System; Indiana University Bloomington; University of Aberdeen	Harkany, T (corresponding author), Karolinska Inst, Div Mol Neurobiol, Dept Med Biochem & Biophys, Scheeles Vag 1,A1,2nd Floor, SE-17177 Stockholm, Sweden.	Tibor.Harkany@ki.se; a.dobrzyn@nencki.gov.pl	Redowicz, Maria Jolanta/R-4083-2016; Dobrzyn, Agnieszka/R-4073-2016; Redowicz, Maria Jolanta/AAM-8020-2020; Silvestri, Cristoforo/Y-2504-2019; Di Marzo, Vincenzo/AAD-7742-2019	Redowicz, Maria Jolanta/0000-0001-5834-471X; Dobrzyn, Agnieszka/0000-0002-6331-9460; Silvestri, Cristoforo/0000-0001-5635-1545; Di Marzo, Vincenzo/0000-0002-1490-3070; Keimpema, Erik/0000-0002-7555-6762; Jazurek-Ciesiolka, Magdalena/0000-0001-7403-7218; Malenczyk, Katarzyna/0000-0002-4818-238X; Janikiewicz, Justyna/0000-0002-6484-9164	National Institutes of Health [DA023214, DA011322, DA021696]; Foundation for Polish Science [TEAM/2010-5/2, MPD/2009/4]; National Science Center (NCN) [UMO-2011/03/B/NZ4/03055]; Scottish Universities Life Science Alliance; Vetenskapsradet; Hjarnfonden; European Commission [HEALTH-F2-2007-201159]; Novo Nordisk Foundation; Visby international mobility scholarship; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA021696, R01DA011322, R01DA023214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); National Science Center (NCN)(National Science Centre, Poland); Scottish Universities Life Science Alliance; Vetenskapsradet(Swedish Research Council); Hjarnfonden; European Commission(European CommissionEuropean Commission Joint Research Centre); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Visby international mobility scholarship; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA023214 (to T. H.), DA011322 (to K. Mac.), and DA021696 (to K. Mac.), Foundation for Polish Science Grants TEAM/2010-5/2 (to A. D.) and MPD/2009/4 (to A. D.), National Science Center (NCN) Grant UMO-2011/03/B/NZ4/03055 (to A. D.), Scottish Universities Life Science Alliance (to T. H.), Vetenskapsradet (to T. H.), Hjarnfonden (to T. H.), European Commission Grant HEALTH-F2-2007-201159 (to T. H.), and the Novo Nordisk Foundation (to T. H.).; Recipient of a Visby international mobility scholarship to study in Sweden.	Arous C, 2013, DIABETOLOGIA, V56, P792, DOI 10.1007/s00125-012-2800-1; Begg M, 2005, PHARMACOL THERAPEUT, V106, P133, DOI 10.1016/j.pharmthera.2004.11.005; Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; Bermudez-Silva FJ, 2008, DIABETOLOGIA, V51, P476, DOI 10.1007/s00125-007-0890-y; Bermudez-Silva FJ, 2007, EUR J PHARMACOL, V565, P207, DOI 10.1016/j.ejphar.2007.02.066; Bisht B, 2008, J PHYSIOL-LONDON, V586, P3825, DOI 10.1113/jphysiol.2008.157107; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Cai EP, 2012, DIABETES, V61, P1708, DOI 10.2337/db11-1344; Cheung AT, 2000, DIABETES, V49, P810, DOI 10.2337/diabetes.49.5.810; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Dalton GD, 2013, CELL SIGNAL, V25, P1665, DOI 10.1016/j.cellsig.2013.03.020; Daval M, 2011, DIABETES, V60, P1186, DOI 10.2337/db10-1048; De Marchi Nicola, 2003, Lipids Health Dis, V2, P5, DOI 10.1186/1476-511X-2-5; De Petrocellis L, 1998, P NATL ACAD SCI USA, V95, P8375, DOI 10.1073/pnas.95.14.8375; De Petrocellis L, 2007, EXP CELL RES, V313, P2993, DOI 10.1016/j.yexcr.2007.05.012; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Derkinderen P, 1996, SCIENCE, V273, P1719, DOI 10.1126/science.273.5282.1719; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Di Marzo V, 2012, PHILOS T R SOC B, V367, P3216, DOI 10.1098/rstb.2011.0382; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Getty-Kaushik L, 2009, OBESITY, V17, P1856, DOI 10.1038/oby.2009.234; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; GOMEZ DP, 2000, BIOCHEM J, V347, P369; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; Henquin JC, 2012, FEBS LETT, V586, P89, DOI 10.1016/j.febslet.2011.11.030; Higuchi M, 2013, J CELL SCI, V126, P745, DOI 10.1242/jcs.112722; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Huang DS, 2006, ENDOCRINOLOGY, V147, P3333, DOI 10.1210/en.2005-0382; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Juan-Pico P, 2006, CELL CALCIUM, V39, P155, DOI 10.1016/j.ceca.2005.10.005; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Keimpema E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02093; Keimpema E, 2013, P NATL ACAD SCI USA, V110, P1935, DOI 10.1073/pnas.1212563110; Kim W, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002519; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Laezza C, 2008, ENDOCR-RELAT CANCER, V15, P965, DOI 10.1677/ERC-08-0030; Lauckner JE, 2005, P NATL ACAD SCI USA, V102, P19144, DOI 10.1073/pnas.0509588102; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Li C, 2010, CELL PHYSIOL BIOCHEM, V26, P187, DOI 10.1159/000320527; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Matias I, 2006, J Endocrinol Invest, V29, P15; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Matias I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042399; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Melck D, 1999, BIOCHEM BIOPH RES CO, V262, P275, DOI 10.1006/bbrc.1999.1105; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Mombouli JV, 1999, BRIT J PHARMACOL, V126, P1593, DOI 10.1038/sj.bjp.0702483; Muccioli GG, 2008, CHEMBIOCHEM, V9, P2704, DOI 10.1002/cbic.200800428; Mulder J, 2011, BRAIN, V134, P1041, DOI 10.1093/brain/awr046; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nakata M, 2008, REGUL PEPTIDES, V145, P49, DOI 10.1016/j.regpep.2007.08.009; Nithipatikom K, 2012, ENDOCRINOLOGY, V153, P29, DOI 10.1210/en.2011-1144; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Obara Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024284; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Ortar G, 2008, J MED CHEM, V51, P6970, DOI 10.1021/jm800978m; Rasmussen I, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-44; Ren XD, 2000, J CELL SCI, V113, P3673; Rondas D, 2012, J BIOL CHEM, V287, P2423, DOI 10.1074/jbc.M111.279885; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Saleem S, 2009, J PATHOL, V219, P182, DOI 10.1002/path.2577; Sato Y, 1998, FEBS LETT, V421, P115, DOI 10.1016/S0014-5793(97)01547-0; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Simon GM, 2008, J BIOL CHEM, V283, P9341, DOI 10.1074/jbc.M707807200; SLIPETZ DM, 1995, MOL PHARMACOL, V48, P352; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Vilches-Flores A, 2013, CLIN SCI, V124, P467, DOI 10.1042/CS20120447; Vilches-Flores A, 2010, REGUL PEPTIDES, V163, P81, DOI 10.1016/j.regpep.2010.04.013; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; Zhang W, 2000, J BIOL CHEM, V275, P41521, DOI 10.1074/jbc.M005479200; Zhou D, 2002, FEBS LETT, V525, P164, DOI 10.1016/S0014-5793(02)03091-0; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	84	53	55	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32685	32699		10.1074/jbc.M113.478354	http://dx.doi.org/10.1074/jbc.M113.478354			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24089517	hybrid, Green Published			2022-12-25	WOS:000328681700053
J	Shim, JY; Ahn, KH; Kendall, DA				Shim, Joong-Youn; Ahn, Kwang H.; Kendall, Debra A.			Molecular Basis of Cannabinoid CB1 Receptor Coupling to the G Protein Heterotrimer G alpha(i)beta gamma IDENTIFICATION OF KEY CB1 CONTACTS WITH THE C-TERMINAL HELIX alpha(5) OF G alpha(i)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cannabinoid Receptors; Computer Modeling; G Protein-coupled Receptors (GPCR); G Proteins; Molecular Dynamics; Mutagenesis; Protein-Protein Interactions; Signaling	BETA(2) ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; INTRACELLULAR LOOP; BETA(2)-ADRENERGIC RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; STRUCTURAL REQUIREMENTS; FORCE-FIELD; ACTIVATION; RHODOPSIN; DYNAMICS	The cannabinoid (CB1) receptor is a member of the rhodopsin-like G protein-coupled receptor superfamily. The human CB1 receptor, which is among the most expressed receptors in the brain, has been implicated in several disease states, including drug addiction, anxiety, depression, obesity, and chronic pain. Different classes of CB1 agonists evoke signaling pathways through the activation of specific subtypes of G proteins. The molecular basis of CB1 receptor coupling to its cognate G protein is unknown. As a first step toward understanding CB1 receptor-mediated G protein signaling, we have constructed a ternary complex structural model of the CB1 receptor and G(i) heterotrimer (CB1-G(i)), guided by the x-ray structure of (2)-adrenergic receptor ((2)AR) in complex with G(s) ((2)AR-G(s)), through 824-ns duration molecular dynamics simulations in a fully hydrated 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine bilayer environment. We identified a group of residues at the juxtamembrane regions of the intracellular loops 2 and 3 (IC2 and IC3) of the CB1 receptor, including Ile-218(3.54), Tyr-224(IC2), Asp-338(6.30), Arg-340(6.32), Leu-341(6.33), and Thr-344(6.36), as potential key contacts with the extreme C-terminal helix (5) of G(i). Ala mutations of these residues at the receptor-G(i) interface resulted in little G protein coupling activity, consistent with the present model of the CB1-G(i) complex, which suggests tight interactions between CB1 and the extreme C-terminal helix (5) of G(i). The model also suggests that unique conformational changes in the extreme C-terminal helix (5) of G play a crucial role in the receptor-mediated G protein activation.	[Shim, Joong-Youn] N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; [Ahn, Kwang H.; Kendall, Debra A.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA	University of North Carolina; North Carolina Central University; University of Connecticut	Shim, JY (corresponding author), N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA.	jyshim@nccu.edu			National Institutes of Health [DA020663, DA020763]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020763, K01DA020663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA020663 (to J.Y.S.) and DA020763 (to D.A.K.).	Abdulaev NG, 2006, BIOCHEMISTRY-US, V45, P12986, DOI 10.1021/bi061088h; Ahn KH, 2012, J BIOL CHEM, V287, P12070, DOI 10.1074/jbc.M111.316463; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Berg J. M., 2010, BIOCHEMISTRY-US, P7; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bockmann RA, 2003, BIOPHYS J, V85, P1647, DOI 10.1016/S0006-3495(03)74594-9; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen XP, 2010, BRIT J PHARMACOL, V161, P1817, DOI 10.1111/j.1476-5381.2010.01006.x; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; Costanzi S, 2009, CURR PHARM DESIGN, V15, P3994, DOI 10.2174/138161209789824795; D'Antona AM, 2006, BIOCHEMISTRY-US, V45, P5606, DOI 10.1021/bi060067k; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; GERARD CM, 1991, BIOCHEM J, V279, P129, DOI 10.1042/bj2790129; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Gurtovenko AA, 2008, J PHYS CHEM B, V112, P1953, DOI 10.1021/jp0750708; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2010, CURR MED CHEM, V17, P1382, DOI 10.2174/092986710790980023; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Kapur A, 2008, J PHARMACOL EXP THER, V325, P341, DOI 10.1124/jpet.107.133256; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lei S, 2002, J BIOL CHEM, V277, P40989, DOI 10.1074/jbc.M206801200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; McAllister SD, 2004, J BIOL CHEM, V279, P48024, DOI 10.1074/jbc.M406648200; Meschler JP, 2000, BIOCHEM PHARMACOL, V60, P1315, DOI 10.1016/S0006-2952(00)00447-0; MORO O, 1993, J BIOL CHEM, V268, P22273; Mukhopadhyay S, 1999, BIOCHEMISTRY-US, V38, P3447, DOI 10.1021/bi981767v; Nebane NM, 2006, FEBS LETT, V580, P5392, DOI 10.1016/j.febslet.2006.09.001; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Nordstrom KJV, 2011, MOL BIOL EVOL, V28, P2471, DOI 10.1093/molbev/msr061; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; PFEUFFER T, 1988, CURR TOP CELL REGUL, V29, P129; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Preininger AM, 2009, BIOCHEMISTRY-US, V48, P2630, DOI 10.1021/bi801853a; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Roche JP, 1999, MOL PHARMACOL, V56, P611, DOI 10.1124/mol.56.3.611; Saam J, 2002, BIOPHYS J, V83, P3097, DOI 10.1016/S0006-3495(02)75314-9; Sansuk K, 2011, MOL PHARMACOL, V79, P262, DOI 10.1124/mol.110.066068; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scott CE, 2013, PROTEIN SCI, V22, P101, DOI 10.1002/pro.2192; Shan JF, 2010, BIOCHEMISTRY-US, V49, P10691, DOI 10.1021/bi100580s; Shim JY, 2013, METHOD ENZYMOL, V520, P337, DOI 10.1016/B978-0-12-391861-1.00016-2; Shim JY, 2012, J BIOL CHEM, V287, P38741, DOI 10.1074/jbc.M112.390955; Shim JY, 2011, J BIOL CHEM, V286, P33422, DOI 10.1074/jbc.M111.261651; Shim JY, 2009, BIOPHYS J, V96, P3251, DOI 10.1016/j.bpj.2008.12.3934; Smaby JM, 1997, BIOPHYS J, V73, P1492, DOI 10.1016/S0006-3495(97)78181-5; Stadel R, 2011, J NEUROCHEM, V117, P1, DOI 10.1111/j.1471-4159.2011.07186.x; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tao Q, 1998, J PHARMACOL EXP THER, V285, P651; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Ulfers AL, 2002, BIOCHEMISTRY-US, V41, P11344, DOI 10.1021/bi0259610; Van Eps N, 2010, BIOCHEMISTRY-US, V49, P6877, DOI 10.1021/bi100846c; Vanni S, 2010, J MOL BIOL, V397, P1339, DOI 10.1016/j.jmb.2010.01.060; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; White S. H., 1996, MEMBRANE STRUCTURE D, P127	97	22	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32449	32465		10.1074/jbc.M113.489153	http://dx.doi.org/10.1074/jbc.M113.489153			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24092756	hybrid, Green Published			2022-12-25	WOS:000328681700030
J	Tkaczyk, C; Hamilton, MM; Datta, V; Yang, XP; Hilliard, JJ; Stephens, GL; Sadowska, A; Hua, L; O'Day, T; Suzich, J; Stover, CK; Sellman, BR				Tkaczyk, Christine; Hamilton, Melissa M.; Datta, Vivekananda; Yang, Xiang Ping; Hilliard, Jamese J.; Stephens, Geoffrey L.; Sadowska, Agnieszka; Hua, Lei; O'Day, Terrence; Suzich, Joann; Stover, Charles Kendall; Sellman, Bret R.			Staphylococcus aureus Alpha Toxin Suppresses Effective Innate and Adaptive Immune Responses in a Murine Dermonecrosis Model	PLOS ONE			English	Article							SOFT-TISSUE INFECTION; HYPER-IGE SYNDROME; NEUTROPHIL RECRUITMENT; SKIN INFECTION; HEMOLYSIN; ACTIVATION; BACTERIAL; CELLS; INFLAMMASOME; RECEPTOR	An optimal host response against Staphylococcus aureus skin and soft tissue infections (SSTI) is dependent on IL-1 beta and IL-17 mediated abscess formation. Alpha toxin (AT), an essential virulence factor for SSTI, has been reported to damage tissue integrity; however its effect on the immune response has not been investigated. Here, we demonstrate that infection with USA300 AT isogenic mutant (Delta hla), or passive immunization with an AT neutralizing mAb, 2A3, 24 h prior to infection with wild type USA300 (WT), resulted in dermonecrotic lesion size reduction, and robust neutrophil infiltration. Infiltration correlates with increase in proinflammatory cytokines and chemokines, as well as enhanced bacterial clearance relative to immunization with a negative control mAb. In addition, infection with Delta hla, or with WT +2A3, resulted in an early influx of innate IL-17(+)gamma delta T cells and a more rapid induction of an adaptive immune response as measured by Th1 and Th17 cell recruitment at the site of infection. These results are the first direct evidence of a role for AT in subverting the innate and adaptive immune responses during a S. aureus SSTI. Further, these effects of AT can be overcome with a high affinity anti-AT mAb resulting in a reduction in disease severity.	[Tkaczyk, Christine; Hamilton, Melissa M.; Hilliard, Jamese J.; Sadowska, Agnieszka; Hua, Lei; Suzich, Joann; Stover, Charles Kendall; Sellman, Bret R.] MedImmune LLC, Dept Infect Dis, Gaithersburg, MD USA; [Datta, Vivekananda] MedImmune LLC, Dept Pathol, Gaithersburg, MD USA; [Yang, Xiang Ping; Stephens, Geoffrey L.] MedImmune LLC, Dept Resp Inflammatory & Autoimmune Dis, Gaithersburg, MD USA; [O'Day, Terrence] MedImmune LLC, Dept Biostat, Gaithersburg, MD USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune	Sellman, BR (corresponding author), MedImmune LLC, Dept Infect Dis, Gaithersburg, MD USA.	sellmanb@medimmune.com		Stover, Charles/0000-0002-7406-1696	AstraZeneca Pharmaceuticals	AstraZeneca Pharmaceuticals(AstraZeneca)	All authors are employees of MedImmune, LLC, (a wholly owned subsidiary of AstraZeneca Pharmaceuticals) whose company funded this study. The monoclonal antibody described in this manuscript is included in a pending patent application. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Frank KM, 2012, INFECT IMMUN, V80, P3161, DOI 10.1128/IAI.00191-12; Gittler JK, 2012, J ALLERGY CLIN IMMUN; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Guttman-Yassky E, 2008, J IMMUNOL, V181, P7420, DOI 10.4049/jimmunol.181.10.7420; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Inoshima N, 2012, J INVEST DERMATOL, V132, P1513, DOI 10.1038/jid.2011.462; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kernodle DS, 1997, INFECT IMMUN, V65, P179, DOI 10.1128/IAI.65.1.179-184.1997; Kim MH, 2011, BLOOD, V117, P3343, DOI 10.1182/blood-2010-07-296970; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Manfredi R, 2002, J CUTAN PATHOL, V29, P168, DOI 10.1034/j.1600-0560.2002.290307.x; McLoughlin RM, 2008, J IMMUNOL, V181, P1323, DOI 10.4049/jimmunol.181.2.1323; McLoughlin RM, 2006, P NATL ACAD SCI USA, V103, P10408, DOI 10.1073/pnas.0508961103; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Milner JD, 2010, CURR OPIN HIV AIDS, V5, P179, DOI 10.1097/COH.0b013e328335ed3e; Minegishi Y, 2009, J EXP MED, V206, P1291, DOI 10.1084/jem.20082767; Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000; Molne L, 2003, CLIN EXP IMMUNOL, V132, P209, DOI 10.1046/j.1365-2249.2003.02151.x; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Narita K, 2010, INFECT IMMUN, V78, P4234, DOI 10.1128/IAI.00447-10; Nygaard TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036532; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Powers ME, 2012, J INFECT DIS, V206, P352, DOI 10.1093/infdis/jis192; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Soong G, 2012, J INFECT DIS, V205, P1571, DOI 10.1093/infdis/jis244; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tkaczyk C, 2012, CLIN VACCINE IMMUNOL, V19, P377, DOI 10.1128/CVI.05589-11; Ventura CL, 2008, INFECT IMMUN, V76, P5862, DOI 10.1128/IAI.00865-08; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107	51	54	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75103	10.1371/journal.pone.0075103	http://dx.doi.org/10.1371/journal.pone.0075103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098366	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500020
J	Bishop, T; Turchyn, AV; Sivan, O				Bishop, Tom; Turchyn, Alexandra V.; Sivan, Orit			Fire and Brimstone: The Microbially Mediated Formation of Elemental Sulfur Nodules from an Isotope and Major Element Study in the Paleo-Dead Sea	PLOS ONE			English	Article							DISSIMILATORY SULFATE REDUCTION; ORGANIC-MATTER; LAKE LISAN; REDUCING BACTERIUM; MARINE-SEDIMENTS; FRACTIONATION; CYCLE; IRON; DISPROPORTIONATION; THIOSULFATE	We present coupled sulfur and oxygen isotope data from sulfur nodules and surrounding gypsum, as well as iron and manganese concentration data, from the Lisan Formation near the Dead Sea (Israel). The sulfur isotope composition in the nodules ranges between -9 and -11 parts per thousand, 27 to 29 parts per thousand lighter than the surrounding gypsum, while the oxygen isotope composition of the gypsum is constant around 24 parts per thousand. The constant sulfur isotope composition of the nodule is consistent with formation in an 'open system'. Iron concentrations in the gypsum increase toward the nodule, while manganese concentrations decrease, suggesting a redox boundary at the nodule-gypsum interface during aqueous phase diagenesis. We propose that sulfur nodules in the Lisan Formation are generated through bacterial sulfate reduction, which terminates at elemental sulfur. We speculate that the sulfate-saturated pore fluids, coupled with the low availability of an electron donor, terminates the trithionate pathway before the final two-electron reduction, producing thionites, which then disproportionate to form abundant elemental sulfur.	[Bishop, Tom; Turchyn, Alexandra V.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Sivan, Orit] Ben Gurion Univ Negev, Beer Sheva, Israel	University of Cambridge; Ben Gurion University	Turchyn, AV (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	avt25@cam.ac.uk		Turchyn, Alexandra/0000-0002-9298-2173	British Council grant through BIRAX program [BY2/GEO/04]; NERC [NE/H011595/1]; Natural Environment Research Council [NE/H011595/1] Funding Source: researchfish	British Council grant through BIRAX program; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by a British Council grant through the BIRAX program, BY2/GEO/04, to AVT and OS and NERC, NE/H011595/1, to OS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Azcarate J, 2001, CHEM GEOL, V174, P389, DOI 10.1016/S0009-2541(00)00286-2; Avrahamov N, 2010, RADIOCARBON, V52, P1123, DOI 10.1017/S0033822200046208; Bradley AS, 2011, GEOBIOLOGY, V9, P446, DOI 10.1111/j.1472-4669.2011.00292.x; Brandt KK, 2001, MICROBIAL ECOL, V41, P1; Bruchert V, 2001, GEOCHIM COSMOCHIM AC, V65, P763, DOI 10.1016/S0016-7037(00)00557-3; Bruchert V., 2004, SULFUR BIOGEOCHEMIST, V379, P1, DOI [10.1130/0-8137-2379-5.1, DOI 10.1130/0-8137-2379-5.1]; Brunner B, 2005, GEOCHIM COSMOCHIM AC, V69, P4759, DOI 10.1016/j.gca.2005.04.015; Canfield DE, 2006, GEOCHIM COSMOCHIM AC, V70, P548, DOI 10.1016/j.gca.2005.10.028; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Cypionka H, 1998, FEMS MICROBIOL LETT, V166, P181, DOI 10.1111/j.1574-6968.1998.tb13888.x; Davidson MM, 2009, APPL ENVIRON MICROB, V75, P5621, DOI 10.1128/AEM.02948-08; Detmers J, 2001, APPL ENVIRON MICROB, V67, P888, DOI 10.1128/AEM.67.2.888-894.2001; Farquhar J, 2003, GEOBIOLOGY, V1, P27, DOI 10.1046/j.1472-4669.2003.00007.x; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; GAT JR, 1984, EARTH PLANET SC LETT, V71, P361, DOI 10.1016/0012-821X(84)90103-1; Gavrieli I, 2001, EARTH PLANET SC LETT, V186, P199, DOI 10.1016/S0012-821X(01)00247-3; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Habicht KS, 2001, GEOLOGY, V29, P555, DOI 10.1130/0091-7613(2001)029<0555:IFBSRN>2.0.CO;2; Hodell DA, 2008, QUATERNARY SCI REV, V27, P1152, DOI 10.1016/j.quascirev.2008.02.008; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Hunger S, 2007, GEOCHEM T, V8, DOI 10.1186/1467-4866-8-1; Jassim SZ, 1999, J GEOL SOC LONDON, V156, P25, DOI 10.1144/gsjgs.156.1.0025; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; JORGENSEN BB, 1990, LIMNOL OCEANOGR, V35, P1329, DOI 10.4319/lo.1990.35.6.1329; KAPLAN IR, 1964, J GEN MICROBIOL, V34, P195, DOI 10.1099/00221287-34-2-195; Kasten S., 2000, MARINE GEOCHEMISTRY, P263, DOI [10.1007/978-3-662-04242-7-8, DOI 10.1007/978-3-662-04242-7_8, DOI 10.1007/978-3-662-04242-7-8]; LEE JP, 1973, J BACTERIOL, V115, P453, DOI 10.1128/JB.115.1.453-455.1973; Lindtke J, 2011, GEOL MAG, V148, P655, DOI 10.1017/S0016756811000124; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; MACHEL HG, 1992, NATIVE SULFUR DEVELOPMENTS IN GEOLOGY AND EXPLORATION, P3; Milucka J, 2012, NATURE, V491, P541, DOI 10.1038/nature11656; NISSENBAUM A, 1972, GEOCHIM COSMOCHIM AC, V36, P1007, DOI 10.1016/0016-7037(72)90018-X; NRIAGU JO, 1968, LIMNOL OCEANOGR, V13, P430, DOI 10.4319/lo.1968.13.3.0430; Oren A, 2009, HYDROBIOLOGIA, V626, P15, DOI 10.1007/s10750-009-9734-8; REES CE, 1973, GEOCHIM COSMOCHIM AC, V37, P1141, DOI 10.1016/0016-7037(73)90052-5; Ron H, 2006, GEOL SOC AM SPEC PAP, V401, P171, DOI 10.1130/2006.2401(11); Schippers A, 1999, APPL ENVIRON MICROB, V65, P319; SCHREIBER BC, 1975, J SEDIMENT PETROL, V45, P469; Sim MS, 2011, SCIENCE, V333, P74, DOI 10.1126/science.1205103; Sivan O, 2011, LIMNOL OCEANOGR, V56, P1536, DOI 10.4319/lo.2011.56.4.1536; THAMDRUP B, 1993, APPL ENVIRON MICROB, V59, P101, DOI 10.1128/AEM.59.1.101-108.1993; Torfstein A, 2008, GEOCHIM COSMOCHIM AC, V72, P2491, DOI 10.1016/j.gca.2008.02.015; Torfstein A, 2005, EARTH PLANET SC LETT, V236, P61, DOI 10.1016/j.epsl.2005.04.026; TROELSEN H, 1982, ESTUAR COAST SHELF S, V15, P255, DOI 10.1016/0272-7714(82)90062-2; Vasconcelos C, 2006, GUAT AM GEOPH UN FAL, P1; Volkov I, 1972, LITOLOGIYA POLEZN IS, V4, P50; Worden RH, 1997, GEOLOGY, V25, P643, DOI 10.1130/0091-7613(1997)025<0643:SCIBE>2.3.CO;2; Wortmann UG, 2007, GEOCHIM COSMOCHIM AC, V71, P4221, DOI 10.1016/j.gca.2007.06.033; Zeng ZG, 2011, J ASIAN EARTH SCI, V40, P661, DOI 10.1016/j.jseaes.2010.10.019	50	14	14	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75883	10.1371/journal.pone.0075883	http://dx.doi.org/10.1371/journal.pone.0075883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098403	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100024
J	Laskus, T; Kibler, KV; Chmielewski, M; Wilkinson, J; Adair, D; Horban, A; Stanczak, G; Radkowski, M				Laskus, Tomasz; Kibler, Karen V.; Chmielewski, Marcin; Wilkinson, Jeffrey; Adair, Debra; Horban, Andrzej; Stanczak, Grzegorz; Radkowski, Marek			Effect of Hepatitis C Infection on HIV-Induced Apoptosis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; T-CELLS; COINFECTION; REPLICATION; PROGRESSION; SURVIVAL; INDIVIDUALS; INHIBITION; INTERACTS	Background: Hepatitis C virus (HCV) coinfection was reported to negatively affect HIV disease and HIV infection has a deleterious effect on HCV-related liver disease. However, despite common occurrence of HCV/HIV coinfection little is known about the mechanisms of interactions between the two viruses. Methods: We studied CD4+ and CD8+ T cell and CD19+ B cell apoptosis in 104 HIV-positive patients (56 were also HCV-positive) and in 22 HCV/HIV-coinfected patients treated for chronic hepatitis C with pegylated interferon and ribavirin. We also analyzed HCV/HIV coinfection in a Daudi B-cell line expressing CD4 and susceptible to both HCV and HIV infection. Apoptosis was measured by AnnexinV staining. Results: HCV/HIV coinfected patients had lower CD4+ and CD8+ T cell apoptosis and higher CD19+ B cell apoptosis than those with HIV monoinfection. Furthermore, anti-HCV treatment of HCV/HIV coinfected patients was followed by an increase of CD4+ and CD8+ T cell apoptosis and a decrease of CD19+ B cell apoptosis. In the Daudi CD4+ cell line, presence of HCV infection facilitated HIV replication, however, decreased the rate of HIV-related cell death. Conclusion: In HCV/HIV coinfected patients T-cells were found to be destroyed at a slower rate than in HIV monoinfected patients. These results suggest that HCV is a molecular-level determinant in HIV disease.	[Laskus, Tomasz; Chmielewski, Marcin; Radkowski, Marek] Med Univ Warsaw, Dept Immunopathol, Warsaw, Poland; [Kibler, Karen V.] Arizona State Univ, Biodesign Inst, Phoenix, AZ USA; [Wilkinson, Jeffrey; Adair, Debra] St Josephs Hosp, Phoenix, AZ USA; [Horban, Andrzej; Stanczak, Grzegorz] Municipal Hosp Infect Dis, Warsaw, Poland	Medical University of Warsaw; Arizona State University; Arizona State University-Downtown Phoenix; St. Joseph's Hospital and Medical Center	Radkowski, M (corresponding author), Med Univ Warsaw, Dept Immunopathol, Warsaw, Poland.	marek.radkowski@wum.edu.pl	Radkowski, Marek/V-3860-2018	Radkowski, Marek/0000-0003-1808-679X	MNiSW [NN401 646740, NN401 646940]	MNiSW(Ministry of Science and Higher Education, Poland)	This study was supported by MNiSW grant Nos. NN401 646740 and NN401 646940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONI BA, 1995, J VIROL, V69, P2384, DOI 10.1128/JVI.69.4.2384-2392.1995; Bantel H, 2003, CELL DEATH DIFFER, V10, pS48, DOI 10.1038/sj.cdd.4401119; Beld M, 1998, VIROLOGY, V244, P504, DOI 10.1006/viro.1998.9130; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; De Luca A, 2002, ARCH INTERN MED, V162, P2125, DOI 10.1001/archinte.162.18.2125; Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; FREED EO, 1994, J VIROL, V68, P2503, DOI 10.1128/JVI.68.4.2503-2512.1994; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; He YP, 2002, J VIROL, V76, P9207, DOI 10.1128/JVI.76.18.9207-9217.2002; Kamegaya Y, 2005, HEPATOLOGY, V41, P660, DOI 10.1002/hep.20621; Korner C, 2009, CLIN SCI, V116, P861, DOI 10.1042/CS20080532; KOVACS A, 2004, 15 INT AIDS C JUL 11; Lan KH, 2002, ONCOGENE, V21, P4801, DOI 10.1038/sj.onc.1205589; Laskus T, 2000, J INFECT DIS, V181, P442, DOI 10.1086/315283; Laskus T, 2004, BLOOD, V103, P3854, DOI 10.1182/blood-2003-08-2923; LeGall S, 1997, VIROLOGY, V229, P295; Machida K, 2001, J BIOL CHEM, V276, P12140, DOI 10.1074/jbc.M010137200; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; MOGENSEN SC, 1979, MICROBIOL REV, V43, P1; Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643; Nakajima N, 1996, J VIROL, V70, P3325, DOI 10.1128/JVI.70.5.3325-3329.1996; Nanda SK, 2006, GASTROENTEROLOGY, V130, P794, DOI 10.1053/j.gastro.2005.12.030; Naora H, 1999, IMMUNOLOGY, V97, P181, DOI 10.1046/j.1365-2567.1999.00807.x; Nunez M, 2006, CLIN INFECT DIS, V43, P1209, DOI 10.1086/508355; Pal S, 2006, GASTROENTEROLOGY, V130, P1107, DOI 10.1053/j.gastro.2005.12.039; Radkowski M, 2005, HEPATOLOGY, V41, P106, DOI 10.1002/hep.20518; Ross TM, 2001, LEUKEMIA, V15, P332, DOI 10.1038/sj.leu.2402028; Sansonno D, 1998, BLOOD, V92, P3328, DOI 10.1182/blood.V92.9.3328.421k04_3328_3337; Stebbing J, 2005, CLIN INFECT DIS, V41, P906, DOI 10.1086/432885; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Sulkowski MS, 2003, ANN INTERN MED, V138, P197, DOI 10.7326/0003-4819-138-3-200302040-00012; Thomas DL, 2001, J INFECT DIS, V183, P973, DOI 10.1086/319256; Toubi E, 2004, J VIROL, V78, P11379, DOI 10.1128/JVI.78.20.11379-11384.2004; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Yue FY, 2005, J IMMUNOL, V174, P2196, DOI 10.4049/jimmunol.174.4.2196	42	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75921	10.1371/journal.pone.0075921	http://dx.doi.org/10.1371/journal.pone.0075921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098405	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100026
J	Eisenreich, S; Abou-El-Ardat, K; Szafranski, K; Valenzuela, JAC; Rump, A; Nigro, JM; Bjerkvig, R; Gerlach, EM; Hackmann, K; Schrock, E; Krex, D; Kaderali, L; Schackert, G; Platzer, M; Klink, B				Eisenreich, Sophie; Abou-El-Ardat, Khalil; Szafranski, Karol; Valenzuela, Jaime A. Campos; Rump, Andreas; Nigro, Janice M.; Bjerkvig, Rolf; Gerlach, Eva-Maria; Hackmann, Karl; Schroeck, Evelin; Krex, Dietmar; Kaderali, Lars; Schackert, Gabriele; Platzer, Matthias; Klink, Barbara			Novel CIC Point Mutations and an Exon-Spanning, Homozygous Deletion Identified in Oligodendroglial Tumors by a Comprehensive Genomic Approach Including Transcriptome Sequencing	PLOS ONE			English	Article							BINDING-PROTEIN; IDH1 MUTATIONS; C-MYC; GLIOMAS; FUSE; CLASSIFICATION; SURVIVAL; CAPICUA; FUBP1; 19Q	Oligodendroglial tumors form a distinct subgroup of gliomas, characterized by a better response to treatment and prolonged overall survival. Most oligodendrogliomas and also some oligoastrocytomas are characterized by a unique and typical unbalanced translocation, der(1,19), resulting in a 1p/19q co-deletion. Candidate tumor suppressor genes targeted by these losses, CIC on 19q13.2 and FUBP1 on 1p31.1, were only recently discovered. We analyzed 17 oligodendrogliomas and oligoastrocytomas by applying a comprehensive approach consisting of RNA expression analysis, DNA sequencing of CIC, FUBP1, IDH1/2, and array CGH. We confirmed three different genetic subtypes in our samples: i) the "oligodendroglial" subtype with 1p/19q co-deletion in twelve out of 17 tumors; ii) the "astrocytic" subtype in three tumors; iii) the "other" subtype in two tumors. All twelve tumors with the 1p/19q co-deletion carried the most common IDH1 R132H mutation. In seven of these tumors, we found protein-disrupting point mutations in the remaining allele of CIC, four of which are novel. One of these tumors also had a deleterious mutation in FUBP1. Only by integrating RNA expression and array CGH data, were we able to discover an exon-spanning homozygous microdeletion within the remaining allele of CIC in an additional tumor with 1p/19q co-deletion. Therefore we propose that the mutation rate might be underestimated when looking at sequence variants alone. In conclusion, the high frequency and the spectrum of CIC mutations in our 1p/19q-codeleted tumor cohort support the hypothesis that CIC acts as a tumor suppressor in these tumors, whereas FUBP1 might play only a minor role.	[Eisenreich, Sophie; Abou-El-Ardat, Khalil; Rump, Andreas; Gerlach, Eva-Maria; Hackmann, Karl; Schroeck, Evelin; Klink, Barbara] Tech Univ Dresden, Inst Klin Genet, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany; [Szafranski, Karol; Platzer, Matthias] FLI, Leibniz Inst Age Res, Jena, Germany; [Valenzuela, Jaime A. Campos; Kaderali, Lars] Tech Univ Dresden, Inst Med Informat & Biometrie, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany; [Nigro, Janice M.; Bjerkvig, Rolf] Univ Bergen, Dept Biomed, Bergen, Norway; [Krex, Dietmar; Schackert, Gabriele] Tech Univ Dresden, Klin & Poliklin Neurochirurg, Univ Klinikum Carl Gustav Carus, D-01062 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Bergen; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Klink, B (corresponding author), Tech Univ Dresden, Inst Klin Genet, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany.	barbara.klink@tu-dresden.de	Krex, Dietmar/E-6833-2014	Kaderali, Lars/0000-0002-2359-2294; Klink, Barbara/0000-0002-8753-8238; Rump, Andreas/0000-0001-7116-6364	grant (MeDDrive programm) of the Medizinische Fakultat Carl Gustav Carus, TU Dresden; Bundesministerium fur Bildung und Forschung within the framework of the Nationales Genomforschungsnetzwerk [01GS08182]	grant (MeDDrive programm) of the Medizinische Fakultat Carl Gustav Carus, TU Dresden; Bundesministerium fur Bildung und Forschung within the framework of the Nationales Genomforschungsnetzwerk(Federal Ministry of Education & Research (BMBF))	Part of this work was supported by a grant (MeDDrive programm) of the Medizinische Fakultat Carl Gustav Carus, TU Dresden, awarded to BK, and by the Bundesministerium fur Bildung und Forschung within the framework of the Nationales Genomforschungsnetzwerk, grant 01GS08182, to KS and MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ajuria L, 2011, DEVELOPMENT, V138, P915, DOI 10.1242/dev.057729; Astigarraga S, 2007, EMBO J, V26, P668, DOI 10.1038/sj.emboj.7601532; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Bromberg JEC, 2009, ONCOLOGIST, V14, P155, DOI 10.1634/theoncologist.2008-0248; Cairncross G, 2008, CANCER J, V14, P352, DOI 10.1097/PPO.0b013e31818d8178; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chien HL, 2011, J VIROL, V85, P4698, DOI 10.1128/JVI.01950-10; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Griffin CA, 2006, J NEUROPATH EXP NEUR, V65, P988, DOI 10.1097/01.jnen.0000235122.98052.8f; Hsiao HH, 2010, BIOCHEMISTRY-US, V49, P4620, DOI 10.1021/bi9021445; Idbaih A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045950; Irwin N, 1997, NUCLEIC ACIDS RES, V25, P1281, DOI 10.1093/nar/25.6.1281; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Kim YH, 2010, AM J PATHOL, V177, P2708, DOI 10.2353/ajpath.2010.100680; Klink B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059773; Klink B, 2010, ANAL CELL PATHOL, V33, P37, DOI [10.1155/2010/279317, 10.3233/ACP-CLO-2010-0530]; Knudson AG, 2002, AM J MED GENET, V111, P96, DOI 10.1002/ajmg.10320; Labussiere M, 2010, NEUROLOGY, V74, P1886, DOI 10.1212/WNL.0b013e3181e1cf3a; Lee CJ, 2002, MOL BRAIN RES, V106, P151, DOI 10.1016/S0169-328X(02)00439-4; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicholson P, 2010, BIOCHEM SOC T, V38, P1615, DOI 10.1042/BST0381615; Ohgaki H, 2011, BRAIN TUMOR PATHOL, V28, P177, DOI 10.1007/s10014-011-0029-1; Olanich ME, 2011, ONCOGENE, V30, P77, DOI 10.1038/onc.2010.404; Ollila J, 1996, FEBS LETT, V396, P119, DOI 10.1016/0014-5793(96)01075-7; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Riemenschneider MJ, 2010, ACTA NEUROPATHOL, V120, P567, DOI 10.1007/s00401-010-0736-4; Roch F, 2002, DEVELOPMENT, V129, P993; Sahm F, 2012, ACTA NEUROPATHOL, V123, P853, DOI 10.1007/s00401-012-0993-5; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; The WHO, 2020, CLASSIFICATION TUMOU; van den Bent MJ, 2006, J CLIN ONCOL, V24, P2715, DOI 10.1200/JCO.2005.04.6078; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Weiler M, 2012, CURR OPIN NEUROL, V25, P767, DOI 10.1097/WCO.0b013e32835a0217; Williams BY, 2000, FEBS LETT, V470, P207, DOI 10.1016/S0014-5793(00)01320-X; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang D, 2010, BBA-GENE REGUL MECH, V1799, P157, DOI 10.1016/j.bbagrm.2009.11.002; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995; Zhang J, 2013, ONCOGENE, V32, P2907, DOI 10.1038/onc.2012.350	42	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76623	10.1371/journal.pone.0076623	http://dx.doi.org/10.1371/journal.pone.0076623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086756	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900107
J	Gaultney, RA; Gonzalez, T; Floden, AM; Brissette, CA				Gaultney, Robert A.; Gonzalez, Tammy; Floden, Angela M.; Brissette, Catherine A.			BB0347, from the Lyme Disease Spirochete Borrelia burgdorferi, Is Surface Exposed and Interacts with the CS1 Heparin-Binding Domain of Human Fibronectin	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ANAPLASMA-PHAGOCYTOPHILUM; SERUM ANTIBODIES; UNITED-STATES; HOST-CELLS; PROTEIN; EXPRESSION; ADHESIN; IDENTIFICATION; PLASMINOGEN	The causative agent of Lyme disease, Borrelia burgdorferi, codes for several known fibronectin-binding proteins. Fibronectin a common the target of diverse bacterial pathogens, and has been shown to be essential in allowing for the development of certain disease states. Another borrelial protein, BB0347, has sequence similarity with these other known fibronectin-binding proteins, and may be important in Lyme disease pathogenesis. Herein, we perform an initial characterization of BB0347 via the use of molecular and biochemical techniques. We found that BB0347 is expressed, produced, and presented on the outer surface of intact B. burgdorferi. We also demonstrate that BB0347 has the potential to be important in Lyme disease progression, and have begun to characterize the nature of the interaction between human fibronectin and this bacterial protein. Further work is needed to define the role of this protein in the borrelial infection process.	[Gaultney, Robert A.; Gonzalez, Tammy; Floden, Angela M.; Brissette, Catherine A.] Univ N Dakota, Sch Med & Hlth Sci, Edwin C James Med Res Facil, Dept Microbiol & Immunol, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks	Brissette, CA (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Edwin C James Med Res Facil, Dept Microbiol & Immunol, Grand Forks, ND 58201 USA.	catherine.brissette@med.und.edu		Brissette, Catherine/0000-0003-0792-1403	NIH/NIAID [1K22AI093671-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI093671] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID 1K22AI093671-01 to CAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2003, J PERIODONTOL, V74, P90, DOI 10.1902/jop.2003.74.1.90; Aquino RS, 2010, PROG MOL BIOL TRANSL, V93, P373, DOI 10.1016/S1877-1173(10)93016-0; Balzer S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-26; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Behera AK, 2008, CELL MICROBIOL, V10, P320, DOI 10.1111/j.1462-5822.2007.01043.x; Boone TJ, 2011, MICROB PATHOGENESIS, V51, P255, DOI 10.1016/j.micpath.2011.06.005; Brissette CA, 2008, INT J MED MICROBIOL, V298, P257, DOI 10.1016/j.ijmm.2007.09.004; Brissette CA, 2009, INFECT IMMUN, V77, P2802, DOI 10.1128/IAI.00227-09; Bunikis I, 2011, J MICROBIOL METH, V86, P243, DOI 10.1016/j.mimet.2011.05.004; Busscher HJ, 2008, LANGMUIR, V24, P10968, DOI 10.1021/la8016968; CARROLL JA, 2010, CURR PROTOC MICROBIO, V12; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chan KF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-157; Chenail AM, 2012, J BACTERIOL, V194, P4570, DOI 10.1128/JB.00661-12; Coburn J, 2005, MOL MICROBIOL, V57, P1182, DOI 10.1111/j.1365-2958.2005.04759.x; COUCHMAN JR, 1990, J INVEST DERMATOL, V94, pS7, DOI 10.1111/1523-1747.ep12874973; Dabo SM, 2006, INFECT IMMUN, V74, P2513, DOI 10.1128/IAI.74.5.2513-2521.2006; Dhanoa A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-270; Dickerson MT, 2012, BIOCONJUGATE CHEM, V23, P184, DOI 10.1021/bc200436x; Edwards AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018899; Floden AM, 2013, CLIN VACCINE IMMUNOL, V20, P892, DOI 10.1128/CVI.00758-12; Floden AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027502; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gilmore RD, 2000, INFECT IMMUN, V68, P411, DOI 10.1128/IAI.68.1.411-414.2000; Goldstein SF, 1996, J BACTERIOL, V178, P6539, DOI 10.1128/jb.178.22.6539-6545.1996; Hallstrom T, 2010, J INFECT DIS, V202, P490, DOI 10.1086/653825; Hamer-Barrera R, 2004, CAN J VET RES, V68, P33; Hauck CR, 2006, CURR OPIN MICROBIOL, V9, P5, DOI 10.1016/j.mib.2005.12.002; Hoen AG, 2009, P NATL ACAD SCI USA, V106, P15013, DOI 10.1073/pnas.0903810106; Hu LT, 2012, ANN INTERN MED, V157, DOI [10.7326/0003-4819-157-3-201208070-01002, 10.7326/0003-4819-157-3-20120807-01002]; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Jaenson TGT, 2011, TICKS TICK-BORNE DIS, V2, P44, DOI 10.1016/j.ttbdis.2010.10.006; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; Keller TE, 2012, GENOME BIOL EVOL, V4, P80, DOI 10.1093/gbe/evr129; KENEDY MR, 2012, FEMS IMMUNOL MED MIC; Kingsley RA, 2004, MOL MICROBIOL, V52, P345, DOI 10.1111/j.1365-2958.2004.03995.x; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Kumru OS, 2011, J BACTERIOL, V193, P5759, DOI 10.1128/JB.05622-11; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Liu CY, 2012, FEMS MICROBIOL LETT, V337, P104, DOI 10.1111/1574-6968.12013; Liu RM, 2005, ANTICANCER RES, V25, P2129; Livengood JA, 2006, MICROBES INFECT, V8, P2832, DOI 10.1016/j.micinf.2006.08.014; MA Y, 1991, INFECT IMMUN, V59, P671, DOI 10.1128/IAI.59.2.671-678.1991; Magnarelli LA, 2013, J WILDLIFE DIS, V49, P294, DOI 10.7589/2012-06-172; Magnarelli LA, 2012, J WILDLIFE DIS, V48, P12, DOI 10.7589/0090-3558-48.1.12; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Margos G, 2012, APPL ENVIRON MICROB, V78, P6059, DOI 10.1128/AEM.00231-12; McElroy MC, 2002, INFECT IMMUN, V70, P3865, DOI 10.1128/IAI.70.7.3865-3873.2002; McNabb Scott J. N., 2006, Morbidity and Mortality Weekly Report, V55, P1; Mendes-Giannini MJS, 2005, FEMS IMMUNOL MED MIC, V45, P383, DOI 10.1016/j.femsim.2005.05.014; Moreillon P, 2002, INFECT DIS CLIN N AM, V16, P297, DOI 10.1016/S0891-5520(01)00009-5; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; Moriarty TJ, 2012, MOL MICROBIOL, V86, P1116, DOI 10.1111/mmi.12045; Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797; Nogueira SV, 2012, INFECT IMMUN, V80, P82, DOI 10.1128/IAI.05671-11; Onder O, 2012, J BIOL CHEM, V287, P16860, DOI 10.1074/jbc.M111.290775; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Ouyang ZM, 2010, J BACTERIOL, V192, P1965, DOI 10.1128/JB.01616-09; Pinne M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006071; Probert WS, 1998, MOL MICROBIOL, V30, P1003, DOI 10.1046/j.1365-2958.1998.01127.x; Rejmanek D, 2012, MICROBIOL-SGM, V158, P2632, DOI 10.1099/mic.0.059808-0; Roger P, 1999, EUR RESPIR J, V13, P1301, DOI 10.1183/09031936.99.13613109; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Shinji H, 2011, INFECT IMMUN, V79, P2215, DOI 10.1128/IAI.00133-11; Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000; Sridhar S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-598; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2011, CLIN INFECT DIS, V52, pS259, DOI 10.1093/cid/ciq117; Stevenson B, 2006, WIEN KLIN WOCHENSCHR, V118, P643, DOI 10.1007/s00508-006-0690-2; Stewart PE, 2004, APPL ENVIRON MICROB, V70, P5973, DOI 10.1128/AEM.70.10.5973-5979.2004; Tegtmeyer N, 2010, J BIOL CHEM, V285, P23513, DOI 10.1074/jbc.M109.096214; Torelli R, 2012, J INFECT DIS, V206, P952, DOI 10.1093/infdis/jis440; Verma SK, 2012, WORLD J MICROB BIOT, V28, P2487, DOI 10.1007/s11274-012-1056-8; Wang HM, 2012, ASIAN PAC J CANCER P, V13, P613, DOI 10.7314/APJCP.2012.13.2.613; WILSKE B, 1993, INFECT IMMUN, V61, P2182, DOI 10.1128/IAI.61.5.2182-2191.1993; Wu J, 2011, INFECT IMMUN, V79, P1338, DOI 10.1128/IAI.01188-10; Xu HJ, 2010, INFECT IMMUN, V78, P2910, DOI 10.1128/IAI.00372-10	78	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75643	10.1371/journal.pone.0075643	http://dx.doi.org/10.1371/journal.pone.0075643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086600	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900053
J	Jin, QF; Wang, ZY; Yan, F; Deng, ZT; Ni, F; Wu, JR; Shandas, R; Liu, X; Zheng, HR				Jin, Qiaofeng; Wang, Zhiyong; Yan, Fei; Deng, Zhiting; Ni, Fei; Wu, Junru; Shandas, Robin; Liu, Xin; Zheng, Hairong			A Novel Cationic Microbubble Coated with Stearic Acid-Modified Polyethylenimine to Enhance DNA Loading and Gene Delivery by Ultrasound	PLOS ONE			English	Article							TRANSFECTION IN-VITRO; CONTRAST AGENTS; DESTRUCTION; PLASMID; CELLS; CAVITATION; EXPRESSION; THERAPY; DRUG; CANCER	A novel cationic microbubble (MB) for improvement of the DNA loading capacity and the ultrasound-mediated gene delivery efficiency has been developed; it has been prepared with commercial lipids and a stearic acid modified polyethylenimine 600 (Stearic-PEI600) polymer synthesized via acylation reaction of branched PEI600 and stearic acid mediated by N, N'-carbonyldiimidazole (CDI). The MBs' concentration, size distribution, stability and zeta potential (zeta-potential) were measured and the DNA loading capacity was examined as a function of the amount of Stearic-PEI600. The gene transfection efficiency and cytotoxicity were also examined using breast cancer MCF-7 cells via the reporter plasmid pCMV-Luc, encoding the firefly luciferase gene. The results showed that the Stearic-PEI600 polymer caused a significant increase in magnitude of zeta-potential of MBs. The addition of DNA into cationic MBs can shift zeta-potentials from positive to negative values. The DNA loading capacity of the MBs grew linearly from (5+/-0.2) x 10(-3) pg/mu m(2) to (20+/-1.8) x 10(-3) pg/mu m(2) when Stearic-PEI600 was increased from 5 mol% to 30 mol%. Transfection of MCF-7 cells using 5% PEI600 MBs plus ultrasound exposure yielded 5.76+/-2.58 x 10(3) p/s/cm(2)/sr average radiance intensity, was 8.97- and 7.53-fold higher than those treated with plain MBs plus ultrasound (6.41+/-5.82) x 10(2) p/s/cm(2)/sr, (P < 0.01) and PEI600 MBs without ultrasound (7.65+/-6.18) x 10(2) p/s/cm(2)/sr, (P < 0.01), respectively. However, the PEI600 MBs showed slightly higher cytotoxicity than plain MBs. The cells treated with PEI600-MBs and plain MBs plus ultrasound showed 59.5+/-6.1% and 71.4+/-7.1% cell viability, respectively. In conclusion, our study demonstrated that the novel cationic MBs were able to increase DNA loading capacity and gene transfection efficiency and could be potentially applied in targeted gene delivery and therapy.	[Jin, Qiaofeng; Wang, Zhiyong; Yan, Fei; Deng, Zhiting; Ni, Fei; Liu, Xin; Zheng, Hairong] Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Wu, Junru] Univ Vermont, Dept Phys, Burlington, VT 05405 USA; [Shandas, Robin] Univ Colorado Denver, Dept Bioengn, Aurora, CO USA; [Liu, Xin] Chinese Acad Sci, Shenzhen Key Lab MRI, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Vermont; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Yan, F (corresponding author), Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.	fei.yan@siat.ac.cn; hr.zheng@siat.ac.cn	Jin, Qiaofeng/GXH-7164-2022	Jin, Qiaofeng/0000-0002-6086-0630; Shandas, Robin/0000-0002-9473-7542	National Basic Research Program 973 from Ministry of Science and Technology, China [2012CB733800, 2011CB707903, 2010CB732604]; National Science Foundation [61020106008, 30900749]; HAS fund of the University of Vermont, USA	National Basic Research Program 973 from Ministry of Science and Technology, China; National Science Foundation(National Science Foundation (NSF)); HAS fund of the University of Vermont, USA	The work was supported by National Basic Research Program 973 (Grant Nos. 2012CB733800, 2011CB707903, and 2010CB732604) from Ministry of Science and Technology, China, National Science Foundation Grants (Grant Nos. 61020106008 and 30900749). The work of J. Wu was partially supported by HAS fund of the University of Vermont, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SP, 1997, ULTRASOUND MED BIOL, V23, P953, DOI 10.1016/S0301-5629(97)00025-2; Bekeredjian R, 2005, ULTRASOUND MED BIOL, V31, P687, DOI 10.1016/j.ultrasmedbio.2004.08.002; Bekeredjian R, 2003, CIRCULATION, V108, P1022, DOI 10.1161/01.CIR.0000084535.35435.AE; Borden MA, 2006, LANGMUIR, V22, P4291, DOI 10.1021/la052841v; Borden MA, 2005, IEEE T ULTRASON FERR, V52, P1992, DOI 10.1109/TUFFC.2005.1561668; Borden MA, 2007, LANGMUIR, V23, P9401, DOI 10.1021/la7009034; Chandrashekhar C, 2013, ACTA BIOMATER, V9, P4985, DOI 10.1016/j.actbio.2012.09.015; Chen SY, 2006, P NATL ACAD SCI USA, V103, P8469, DOI 10.1073/pnas.0602921103; Chen ZY, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-152; Christiansen JP, 2003, ULTRASOUND MED BIOL, V29, P1759, DOI 10.1016/S0301-5629(03)00976-1; Daigeler A, 2010, ULTRASOUND MED BIOL, V36, P1893, DOI 10.1016/j.ultrasmedbio.2010.08.009; De Temmerman ML, 2011, BIOMATERIALS, V32, P9128, DOI 10.1016/j.biomaterials.2011.08.024; Deshpande MC, 2007, J CONTROL RELEASE, V118, P126, DOI 10.1016/j.jconrel.2006.12.010; Feshitan JA, 2009, J COLLOID INTERF SCI, V329, P316, DOI 10.1016/j.jcis.2008.09.066; Frenkel PA, 2002, ULTRASOUND MED BIOL, V28, P817, DOI 10.1016/S0301-5629(02)00518-5; Godbey WT, 2000, J BIOMED MATER RES, V51, P321, DOI 10.1002/1097-4636(20000905)51:3<321::AID-JBM5>3.3.CO;2-I; Karshafian R, 2009, ULTRASOUND MED BIOL, V35, P847, DOI 10.1016/j.ultrasmedbio.2008.10.013; Kimmel Eitan, 2006, Critical Reviews in Biomedical Engineering, V34, P105, DOI 10.1615/CritRevBiomedEng.v34.i2.10; Lawrie A, 2000, GENE THER, V7, P2023, DOI 10.1038/sj.gt.3301339; Lentacker I, 2006, LANGMUIR, V22, P7273, DOI 10.1021/la0603828; Lentacker I, 2010, MOL THER, V18, P101, DOI 10.1038/mt.2009.160; Lum AFH, 2006, J CONTROL RELEASE, V111, P128, DOI 10.1016/j.jconrel.2005.11.006; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Min SH, 2006, J GENE MED, V8, P1425, DOI 10.1002/jgm.973; Morille M, 2008, BIOMATERIALS, V29, P3477, DOI 10.1016/j.biomaterials.2008.04.036; Nomikou N, 2012, ACTA BIOMATER, V8, P1273, DOI 10.1016/j.actbio.2011.09.010; Pollard H, 1998, J BIOL CHEM, V273, P7507, DOI 10.1074/jbc.273.13.7507; Qiu YY, 2010, J CONTROL RELEASE, V145, P40, DOI 10.1016/j.jconrel.2010.04.010; Sirsi SR, 2012, THERANOSTICS, V2, P1208, DOI 10.7150/thno.4306; Sirsi SR, 2012, J CONTROL RELEASE, V157, P224, DOI 10.1016/j.jconrel.2011.09.071; Sun L, 2013, BIOMATERIALS, V34, P2107, DOI 10.1016/j.biomaterials.2012.11.041; Suvasini R, 2008, CANCER BIOL THER, V7, P225, DOI 10.4161/cbt.7.2.5796; Suzuki J, 2010, J AM COLL CARDIOL, V55, P904, DOI 10.1016/j.jacc.2009.09.054; Tlaxca JL, 2010, ULTRASOUND MED BIOL, V36, P1907, DOI 10.1016/j.ultrasmedbio.2010.05.014; Tse MT, 2009, INT J PHARMACEUT, V370, P33, DOI 10.1016/j.ijpharm.2008.11.006; Ulasov I, 2013, PLOS ONE, V8; Unger EC, 2001, PROG CARDIOVASC DIS, V44, P45, DOI 10.1053/pcad.2001.26443; Wan Q, 2013, NANOSCALE, V5, P744, DOI 10.1039/c2nr32438e; Wang DS, 2012, RADIOLOGY, V264, P721, DOI 10.1148/radiol.12112368; Wu J, 2008, ADV DRUG DELIVER REV, V60, P1103, DOI 10.1016/j.addr.2008.03.009; Yan F, 2012, ULTRASOUND MED BIOL, V38, P670, DOI 10.1016/j.ultrasmedbio.2011.12.025; Zarnitsyn VG, 2004, ULTRASOUND MED BIOL, V30, P527, DOI 10.1016/j.ultrasmedbio.2004.01.008; Zhou Q, 2012, INT J NANOMED, V5819	45	28	28	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76544	10.1371/journal.pone.0076544	http://dx.doi.org/10.1371/journal.pone.0076544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086748	Green Submitted, Green Published, gold			2022-12-25	WOS:000325220000068
J	Kroon, J; Tol, S; van Amstel, S; Elias, JA; Fernandez-Borja, M				Kroon, Jeffrey; Tol, Simon; van Amstel, Sven; Elias, Judith A.; Fernandez-Borja, Mar			The Small GTPase RhoB Regulates TNF alpha Signaling in Endothelial Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; MESSENGER-RNA; TRANSCRIPTIONAL ACTIVATION; EARLY ENDOSOMES; KINASE PATHWAY; GENE RHOB; EXPRESSION; TRAFFICKING; BINDING	The inflammatory response of endothelial cells triggered by cytokines such as TNF alpha and IL1 beta plays a pivotal role in innate immunity. Upon pro-inflammatory cytokine stimulation, endothelial cells produce chemokines and cytokines that attract and activate leukocytes, and express high levels of leukocyte adhesion molecules. This process is mediated by intracellular signaling cascades triggered by activation of e. g. the TNF alpha receptor (TNFR) that lead to the activation of the NFkB transcription factor and of MAP kinases, which in turn activate inflammatory gene transcription. We found that the small GTPase RhoB was strongly and rapidly upregulated in primary human endothelial cells by TNF alpha, IL1 beta and LPS. We subsequently investigated the role of RhoB in the regulation of TNFR signaling in endothelial cells by silencing RhoB expression with siRNA. We provide evidence that the TNF alpha-induced activation of p38 MAP kinase is strongly dependent on RhoB, but not on RhoA, while JNK activation is regulated by both RhoB and RhoA. Consistent with the important role of p38 MAP kinase in inflammation, we demonstrate that loss of RhoB impairs TNF alpha-induced ICAM-1 expression and reduces cell production of IL6 and IL8. In addition, we show that RhoB silencing alters the intracellular traffic of TNF alpha after endocytosis. Since RhoB is a known regulator of the intracellular traffic of membrane receptors, our data suggest that RhoB controls TNF alpha signaling through the regulation of the TNFR traffic.	[Kroon, Jeffrey; Tol, Simon; van Amstel, Sven; Elias, Judith A.; Fernandez-Borja, Mar] Univ Amsterdam, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands	University of Amsterdam	Fernandez-Borja, M (corresponding author), Univ Amsterdam, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands.	m.fernandez@sanquin.nl	Kroon, Jeffrey/AAL-2588-2021; kim, hyangah/T-1669-2019	Kroon, Jeffrey/0000-0001-9983-6614; 	Landsteiner Foundation for Blood Transfusion [112]	Landsteiner Foundation for Blood Transfusion	M. Fernandez-Borja was funded by project 112 from the Landsteiner Foundation for Blood Transfusion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Dodeller F, 2008, J BIOL CHEM, V283, P21487, DOI 10.1074/jbc.M801908200; Engel ME, 1998, J BIOL CHEM, V273, P9921, DOI 10.1074/jbc.273.16.9921; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; Fritz G, 2001, NUCLEIC ACIDS RES, V29, P792, DOI 10.1093/nar/29.3.792; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Huang M, 2007, ARTERIOSCL THROM VAS, V27, P2597, DOI 10.1161/ATVBAHA.107.154211; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; Kajimoto H, 2007, CIRCULATION, V115, P1777, DOI 10.1161/CIRCULATIONAHA.106.649566; Kamon H, 2006, EMBO J, V25, P4108, DOI 10.1038/sj.emboj.7601286; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kim BK, 2011, CARCINOGENESIS, V32, P254, DOI 10.1093/carcin/bgq244; Kim DM, 2010, APOPTOSIS, V15, P1540, DOI 10.1007/s10495-010-0531-7; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kraan TCTMV, 1997, J IMMUNOL, V158, P5560; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lajoie-Mazenc I, 2008, J BIOL CHEM, V283, P4155, DOI 10.1074/jbc.M709639200; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Liao W, 2008, CURR BIOL, V18, P641, DOI 10.1016/j.cub.2008.04.017; Llado A, 2008, MOL BIOL CELL, V19, P17, DOI 10.1091/mbc.E07-05-0411; Mahul-Mellier AL, 2008, J BIOL CHEM, V283, P34954, DOI 10.1074/jbc.M803140200; Mannam P, 2013, J IMMUNOL, V190, P1264, DOI 10.4049/jimmunol.1202012; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Neel NF, 2007, J CELL SCI, V120, P1559, DOI 10.1242/jcs.03437; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Nwariaku FE, 2003, J APPL PHYSIOL, V95, P1889, DOI 10.1152/japplphysiol.00225.2003; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Rolfe BE, 2005, ATHEROSCLEROSIS, V183, P1, DOI 10.1016/j.atherosclerosis.2005.04.023; Rondanino C, 2007, TRAFFIC, V8, P932, DOI 10.1111/j.1600-0854.2007.00575.x; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Su X, 2008, BBA-MOL CELL RES, V1783, P1623, DOI 10.1016/j.bbamcr.2008.04.009; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; TSUJIMOTO M, 1985, P NATL ACAD SCI USA, V82, P7626, DOI 10.1073/pnas.82.22.7626; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Westmark CJ, 2005, ONCOGENE, V24, P502, DOI 10.1038/sj.onc.1208224; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Woo CH, 2006, BIOCHEM BIOPH RES CO, V351, P972, DOI 10.1016/j.bbrc.2006.10.154; Wysk M, 1999, P NATL ACAD SCI USA, V96, P3763, DOI 10.1073/pnas.96.7.3763	51	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75031	10.1371/journal.pone.0075031	http://dx.doi.org/10.1371/journal.pone.0075031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086429	gold, Green Published, Green Submitted			2022-12-25	WOS:000325220000014
J	Qian, H				Qian, Hong			Environmental Determinants of Woody Plant Diversity at a Regional Scale in China	PLOS ONE			English	Article							AVIAN SPECIES RICHNESS; GLOBAL PATTERNS; CLIMATIC GRADIENTS; SOUTHERN AFRICA; TREE; ENERGY; AVAILABILITY; MODELS; SPACE	Understanding what drives the geographic variation of species richness across the globe is a fundamental goal of ecology and biogeography. Environmental variables have been considered as drivers of global diversity patterns but there is no consensus among ecologists on what environmental variables are primary drivers of the geographic variation of species richness. Here, I examine the relationship of woody plant species richness at a regional scale in China with sixteen environmental variables representing energy availability, water availability, energy-water balance, seasonality, and habitat heterogeneity. I found that temperature seasonality is the best predictor of woody species richness in China. Other important environmental variables include annual precipitation, mean temperature of the coldest month, and potential evapotranspiration. The best model explains 85% of the variation in woody plant species richness at the regional scale in China.	Illinois State Museum, Res & Collect Ctr, Springfield, IL USA		Qian, H (corresponding author), Illinois State Museum, Res & Collect Ctr, Springfield, IL USA.	hqian@museum.state.il.us						Ahn C-H, 1994, PHOTOGRAMM REMOTE SE, V33, P12; Boucher-Lalonde V, 2012, GLOBAL ECOL BIOGEOGR, V21, P1157, DOI 10.1111/j.1466-8238.2012.00764.x; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; Cooperative Group of the Flora of Anhui, 1986, FLOR ANH, V1-5; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; Davies RG, 2007, GLOBAL ECOL BIOGEOGR, V16, P220, DOI 10.1111/j.1466-8238.2007.00282.x; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Evans KL, 2006, GLOBAL ECOL BIOGEOGR, V15, P372, DOI 10.1111/j.1466-822x.2006.00228.x; FANG JY, 2010, ATLAS WOODY PLANTS C; Flora Reipublicae Popularis Sinicae Editorial Committee, 1959, FLORA REIPUBLICAE PO, V1-80; Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Fu L. G, 1999, HIGHER PLANTS CHINA, V2-13; Giam X, 2010, BIOL CONSERV, V143, P1594, DOI 10.1016/j.biocon.2010.04.019; Hortal J, 2008, J BIOGEOGR, V35, P1202, DOI 10.1111/j.1365-2699.2007.01850.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Latham Roger Earl, 1993, P294; Montoya D, 2007, ECOGRAPHY, V30, P173, DOI 10.1111/j.0906-7590.2007.04873.x; Moore JL, 2002, P ROY SOC B-BIOL SCI, V269, P1645, DOI 10.1098/rspb.2002.2075; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Normand S, 2011, P ROY SOC B-BIOL SCI, V278, P3644, DOI 10.1098/rspb.2010.2769; O'Brien EM, 1998, ECOGRAPHY, V21, P495, DOI 10.1111/j.1600-0587.1998.tb00441.x; O'Brien EM, 2000, OIKOS, V89, P588, DOI 10.1034/j.1600-0706.2000.890319.x; OBRIEN EM, 1993, J BIOGEOGR, V20, P181, DOI 10.2307/2845670; PALMER MW, 1994, FOLIA GEOBOT PHYTOTX, V29, P511, DOI 10.1007/BF02883148; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qian H, 2008, J BIOGEOGR, V35, P1362, DOI 10.1111/j.1365-2699.2008.01901.x; Qian H, 2007, CONSERV BIOL, V21, P937, DOI 10.1111/j.1523-1739.2007.00692.x; Qian H, 2012, PLANT ECOL, V213, P749, DOI 10.1007/s11258-012-0038-0; Qian H, 2011, GLOBAL ECOL BIOGEOGR, V20, P362, DOI 10.1111/j.1466-8238.2010.00590.x; Qian H, 2010, ECOLOGY, V91, P1172, DOI 10.1890/09-0620.1; Raes N, 2009, ECOGRAPHY, V32, P180, DOI 10.1111/j.1600-0587.2009.05800.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; ROSENZWEIG ML, 1968, AM NAT, V102, P67, DOI 10.1086/282523; Shafer SL, 2001, ECOSYSTEMS, V4, P200, DOI 10.1007/s10021-001-0004-5; Wang ZH, 2011, P ROY SOC B-BIOL SCI, V278, P2122, DOI 10.1098/rspb.2010.1897; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882; Wright David H., 1993, P66; Wu C-Y, 1994, FLORA CHINA, V4-25; Zheng W., 1983, SYLVA SINICA	41	30	39	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75832	10.1371/journal.pone.0075832	http://dx.doi.org/10.1371/journal.pone.0075832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086642	gold, Green Submitted, Green Published			2022-12-25	WOS:000325220000047
J	Sharma, A; Prasongwattana, V; Cha'on, U; Selmi, C; Hipkaeo, W; Boonnate, P; Pethlert, S; Titipungul, T; Intarawichian, P; Waraasawapati, S; Puapiroj, A; Sitprija, V; Reungjui, S				Sharma, Amod; Prasongwattana, Vitoon; Cha'on, Ubon; Selmi, Carlo; Hipkaeo, Wiphawi; Boonnate, Piyanard; Pethlert, Supattra; Titipungul, Tanin; Intarawichian, Piyapharom; Waraasawapati, Sakda; Puapiroj, Anucha; Sitprija, Visith; Reungjui, Sirirat			Monosodium Glutamate (MSG) Consumption Is Associated with Urolithiasis and Urinary Tract Obstruction in Rats	PLOS ONE			English	Article							CHINESE ADULTS; KIDNEY; METABOLISM; CALCIUM; CITRATE; PH; OVERWEIGHT; NUTRITION; PHOSPHATE; EXCRETION	Background: The peritoneal injection of monosodium glutamate (MSG) can induce kidney injury in adult rats but the effects of long-term oral intake have not been determined. Methods: We investigated the kidney histology and function in adult male Wistar rats that were fed ad libitum with a standard rat chow pellet and water with or without the addition of 2 mg/g body weight MSG/day in drinking water (n=10 per group). Both MSG-treated and control animals were sacrificed after 9 months when renal function parameters, blood and urine electrolytes, and tissue histopathology were determined. Results: MSG-treated rats were more prone to kidney stone formation, as represented by the alkaline urine and significantly higher activity product of calcium phosphate. Accordingly, 3/10 MSG-treated rats developed kidney stones over 9 months versus none of the control animals. Further, 2/10 MSG-treated rats but none (0/10) of the controls manifested hydronephrosis. MSG-treated rats had significantly higher levels of serum creatinine and potassium including urine output volume, urinary excretion sodium and citrate compared to controls. In contrast, MSG-treated rats had significantly lower ammonium and magnesium urinary excretion. Conclusion: Oral MSG consumption appears to cause alkaline urine and may increase the risks of kidney stones with hydronephrosis in rats. Similar effects in humans must be verified by dedicated studies.	[Sharma, Amod; Prasongwattana, Vitoon; Cha'on, Ubon; Boonnate, Piyanard; Pethlert, Supattra] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand; [Selmi, Carlo] Humanitas Clin & Res Ctr, Milan, Italy; [Selmi, Carlo] Univ Milan, BIOMETRA Dept, Milan, Italy; [Hipkaeo, Wiphawi] Khon Kaen Univ, Fac Med, Dept Anat, Khon Kaen, Thailand; [Titipungul, Tanin] Mahasarakham Hosp, Dept Pathol, Maha Sarakham, Thailand; [Intarawichian, Piyapharom; Waraasawapati, Sakda; Puapiroj, Anucha] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen, Thailand; [Sitprija, Visith] Queen Saovabha Mem Inst, Bangkok, Thailand; [Reungjui, Sirirat] Khon Kaen Univ, Fac Med, Dept Internal Med, Khon Kaen, Thailand	Khon Kaen University; University of Milan; Khon Kaen University; Khon Kaen University; Khon Kaen University	Cha'on, U (corresponding author), Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand.	ubocha@kku.ac.th	sharma, amod/ABT-8672-2022; Selmi, Carlo/ABG-4899-2021; Sharma, Amod/AAA-3679-2022	Selmi, Carlo/0000-0002-0323-0376; Sharma, Amod/0000-0002-2860-7790	Research and Technology affairs division, Khon Kaen University; Faculty of Medicine [I54139, I56124]	Research and Technology affairs division, Khon Kaen University; Faculty of Medicine	UC received the grants from the Research and Technology affairs division, Khon Kaen University, under incubation research project and the invitation research fund from the Faculty of Medicine (I54139 and I56124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2004, SPECTROSC SPECT ANAL, V24, P1016; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bellisle F, 1999, NEUROSCI BIOBEHAV R, V23, P423, DOI 10.1016/S0149-7634(98)00043-8; BRENNAN S, 1988, AM J PHYSIOL, V255, pF301, DOI 10.1152/ajprenal.1988.255.2.F301; CHANEY AL, 1962, CLIN CHEM, V8, P130; Chauvin MF, 1997, J BIOL CHEM, V272, P4705, DOI 10.1074/jbc.272.8.4705; Cheema-Dhadli S, 2002, AM J PHYSIOL-RENAL, V282, pF1049, DOI 10.1152/ajprenal.00006.2001; Chevassus H, 2002, BRIT J CLIN PHARMACO, V53, P641, DOI 10.1046/j.1365-2125.2002.01596.x; Collison KS, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-58; Collison KS, 2010, PHYSIOL BEHAV, V99, P334, DOI 10.1016/j.physbeh.2009.11.010; DEGROOT AP, 1988, FOOD CHEM TOXICOL, V26, P425, DOI 10.1016/0278-6915(88)90053-1; GOLDENBERG H, 1966, CLIN CHEM, V12, P871; GRUNERT RR, 1950, J NUTR, V42, P609, DOI 10.1093/jn/42.4.609; Halpern BP, 2000, J NUTR, V130, p910S, DOI 10.1093/jn/130.4.910S; He K, 2008, OBESITY, V16, P1875, DOI 10.1038/oby.2008.274; He K, 2011, AM J CLIN NUTR, V93, P1328, DOI 10.3945/ajcn.110.008870; Hediger MA, 1999, AM J PHYSIOL-RENAL, V277, pF487, DOI 10.1152/ajprenal.1999.277.4.F487; Roson MI, 2011, J NEPHROL, V24, P119, DOI 10.5301/JN.2010.5824; Insawang T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-50; Kamel KS, 2007, NEPHROL DIAL TRANSPL, V22, P424, DOI 10.1093/ndt/gfl588; KAUFMAN AM, 1988, AM J PHYSIOL, V255, pF182, DOI 10.1152/ajprenal.1988.255.1.F182; LEVIN M, 1989, MINER ELECTROL METAB, V15, P214; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; OHARA I, 1977, PHYSIOL BEHAV, V19, P627, DOI 10.1016/0031-9384(77)90037-3; Ortiz GG, 2006, BIOMED PHARMACOTHER, V60, P86, DOI 10.1016/j.biopha.2005.07.012; Paul MVS, 2012, TOXICOL MECH METHOD, V22, P625, DOI 10.3109/15376516.2012.714008; PETRARULO M, 1995, CLIN CHEM, V41, P1518; PETTERSSON BA, 1984, KIDNEY INT, V26, P122, DOI 10.1038/ki.1984.145; Rao GN, 2002, TOXICOL PATHOL, V30, P651, DOI 10.1080/01926230290166733; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sampson N, 2011, MOL ENDOCRINOL, V25, P503, DOI 10.1210/me.2010-0340; Shi ZM, 2011, J HYPERTENS, V29, P846, DOI 10.1097/HJH.0b013e328344da8e; Shi ZM, 2010, BRIT J NUTR, V104, P457, DOI 10.1017/S0007114510000760; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; STEGINK LD, 1973, J NUTR, V103, P1146, DOI 10.1093/jn/103.8.1146; Thomas M, 2010, PHYSIOL BEHAV, V99, P334, DOI [10.1016/j.physbeh.2009.11.010, DOI 10.1016/J.PHYSBEH.2009.11.010.PUBMED:19945473]; Thu Hien VT, 2012, PUBLIC HEALTH NUTR, P1; TISELIUS HG, 1984, EUR UROL, V10, P191; Tucker MJ, 2003, DIS WISTAR RAT; Vercoutere B, 2004, BIOCHEM J, V378, P485, DOI 10.1042/BJ20031088; VINAY P, 1986, KIDNEY INT, V29, P68, DOI 10.1038/ki.1986.9; Wagner CA, 2010, J NEPHROL, V23, pS165; Walker R, 2000, J NUTR, V130, p1049S, DOI 10.1093/jn/130.4.1049S; WYBENGA DR, 1971, CLIN CHEM, V17, P891; Yatabe MS, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-160	46	20	20	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75546	10.1371/journal.pone.0075546	http://dx.doi.org/10.1371/journal.pone.0075546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086562	gold, Green Published, Green Submitted			2022-12-25	WOS:000325220000026
J	Choi, JS; Kim, YA; Kang, YU; Kim, CS; Bae, EH; Ma, SK; Ahn, YK; Jeong, MH; Kim, SW				Choi, Joon Seok; Kim, Young A.; Kang, Yong Un; Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Ahn, Young-Keun; Jeong, Myung Ho; Kim, Soo Wan			Clinical Impact of Hospital-Acquired Anemia in Association with Acute Kidney Injury and Chronic Kidney Disease in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							ERYTHROPOIETIN DEFICIENCY; CARDIOVASCULAR OUTCOMES; RENAL-FUNCTION; MORTALITY; RISK	Background: Hospital-acquired anemia (HAA) is common in patients with acute myocardial infarction (AMI) and is an independent indicator of long-term mortality in these patients. However, limited information exists regarding the development and prognostic impact of HAA associated with acute kidney injury (AKI) and chronic kidney disease (CKD) in AMI patients. Methods and Results: We retrospectively analyzed 2,289 patients with AMI, and excluded those with anemia at admission. The study population included 1,368 patients, of whom 800 (58.5%) developed HAA. Age, Hgb level at admission, Length of hospital stay, documented in-hospital bleeding and use of glycoprotein IIb/IIIa inhibitor, presence of CKD and occurrence of AKI were significantly associated with the development of HAA. HAA was significantly associated with higher 3-year mortality (4.8% and 11.4% for non-HAA and HAA patients, respectively; P < 0.001). After adjustment for multivariable confounders, the risk for long-term mortality was increased in HAA patients with AKI and/or CKD but not in HAA patients without AKI and/or CKD, compared to non-HAA patients (HAA patients without AKI and CKD, hazard ratio [HR]: 1.34, 95% confidence interval [CI]: 0.70-2.56; HAA patients with either AKI or CKD, HR: 2.80, 95% CI: 1.37-5.73; HAA patients with AKI and CKD, HR: 3.25, 95% CI: 1.28-8.24; compared with the non-HAA group). Conclusion: AKI and CKD were strongly associated with the development of HAA in AMI patients. HAA, when accompanied by AKI or CKD, is an independent risk predictor for long-term mortality in AMI patients.	[Choi, Joon Seok; Kim, Young A.; Kang, Yong Un; Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Sch Med, Dept Internal Med, Div Nephrol, Gwangju, South Korea; [Ahn, Young-Keun; Jeong, Myung Ho] Chonnam Natl Univ, Cardiovasc Res Inst, Gwangju, South Korea	Chonnam National University; Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Div Nephrol, Gwangju, South Korea.	skimw@chonnam.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0009743]; National Research Foundation of Korea (NRF) grant (MRC for Gene Regulation) [2011-0030132]; Korea government (MSIP)	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF) grant (MRC for Gene Regulation)(National Research Foundation of Korea); Korea government (MSIP)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0009743), and by the National Research Foundation of Korea (NRF) grant (MRC for Gene Regulation, 2011-0030132) funded by the Korea government (MSIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Falluji N, 2002, AM HEART J, V144, P636, DOI 10.1067/mhj.2002.124351; AlFaleh HF, 2013, INT J CARDIOL, V167, P866, DOI 10.1016/j.ijcard.2012.01.097; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Amin AP, 2010, AM HEART J, V160, P1065, DOI 10.1016/j.ahj.2010.08.007; Anand I, 2004, CIRCULATION, V110, P149, DOI 10.1161/01.CIR.0000134279.79571.73; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Babitt JL, 2012, J AM SOC NEPHROL, V23, P1631, DOI 10.1681/ASN.2011111078; Bae EH, 2012, AM J KIDNEY DIS, V59, P795, DOI 10.1053/j.ajkd.2012.01.016; COTES PM, 1982, BRIT J HAEMATOL, V50, P427, DOI 10.1111/j.1365-2141.1982.tb01938.x; Davies MJ, 1997, NEW ENGL J MED, V336, P1312, DOI 10.1056/NEJM199705013361809; DAVIES MJ, 1993, BRIT HEART J, V69, P377; du Cheyron D, 2005, INTENS CARE MED, V31, P1529, DOI 10.1007/s00134-005-2739-5; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Erslev AJ, 1997, KIDNEY INT, V51, P622, DOI 10.1038/ki.1997.91; GARCIA JF, 1982, J LAB CLIN MED, V99, P624; HALES M, 1994, RENAL FAILURE, V16, P125, DOI 10.3109/08860229409044854; Langston RD, 2003, KIDNEY INT, V64, P1398, DOI 10.1046/j.1523-1755.2003.00200.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LIPKIN GW, 1989, LANCET, V1, P1029; MCGONIGLE RJS, 1984, KIDNEY INT, V25, P437, DOI 10.1038/ki.1984.36; Montalescot G, 2007, EUR HEART J, V28, P1409, DOI 10.1093/eurheartj/ehm031; NIELSEN OJ, 1990, J INTERN MED, V227, P373, DOI 10.1111/j.1365-2796.1990.tb00175.x; NIELSEN OJ, 1989, LANCET, V1, P624; Nutritional Anaemias, 1968, WHO TECH REP SER, V405, P5; O'Riordan E, 2000, NEPHROL DIAL TRANSPL, V15, P19, DOI 10.1093/oxfordjournals.ndt.a027971; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Salisbury AC, 2011, AM J CARDIOL, V108, P949, DOI 10.1016/j.amjcard.2011.05.026; Salisbury AC, 2011, AM HEART J, V162, P300, DOI 10.1016/j.ahj.2011.05.021; Salisbury AC, 2010, CIRC-CARDIOVASC QUAL, V3, P337, DOI 10.1161/CIRCOUTCOMES.110.957050; TAHNKJOHNSON ME, 1993, AM J CARDIOL, V71, P869, DOI 10.1016/0002-9149(93)90842-Z; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; 2012, KIDNEY INT, pS1	32	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75583	10.1371/journal.pone.0075583	http://dx.doi.org/10.1371/journal.pone.0075583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086579	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200053
J	Lee, CH; Kim, TH; Lee, JH; Oh, SJ; Yoo, JY; Kwon, HS; Kim, YI; Ferguson, SD; Ahn, JY; Ku, BJ; Fazleabas, AT; Lim, JM; Jeong, JW				Lee, Chae Hyun; Kim, Tae Hoon; Lee, Jae Hee; Oh, Seo Jin; Yoo, Jung-Yoon; Kwon, Hyo Suk; Kim, Young Im; Ferguson, Susan D.; Ahn, Ji Yeon; Ku, Bon Jeong; Fazleabas, Asgerally T.; Lim, Jeong Mook; Jeong, Jae-Wook			Extracellular Signal-Regulated Kinase 1/2 Signaling Pathway Is Required for Endometrial Decidualization in Mice and Human	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; PROGESTERONE-RECEPTOR; STROMAL CELLS; C/EBP-BETA; C-FOS; IMPLANTATION; ACTIVATOR; DIFFERENTIATION; PROLIFERATION; ESTROGEN	Decidualization is a crucial change required for successful embryo implantation and the maintenance of pregnancy. During this process, endometrial stromal cells differentiate into decidual cells in response to the ovarian steroid hormones of early pregnancy. Extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) are known to regulate cell proliferation and apoptosis in multiple cell types, including uterine endometrial cells. Aberrant activation of ERK1/2 has recently been implicated in the pathological processes of endometriosis and endometrial cancer. However, the function of ERK1/2 signaling during implantation and decidualization is still unknown. To determine the role and regulation of ERK1/2 signaling during implantation and decidualization, we examine ERK1/2 signaling in the mouse uterus during early pregnancy using immunostaining and qPCR. Interestingly, levels of phospho-ERK1/2 were highest within decidual cells located at the implantation sites. Expression levels of ERK1/2 target genes were also significantly higher at implantation sites, when compared to either inter-implantation sites. To determine if ERK1/2 signaling is also important during human endometrial decidualization, we examined levels of phospho-ERK1/2 in cultured human endometrial stromal cells during in vitro decidualization. Following treatment with a well-established decidualization-inducing steroidogenic cocktail, levels of phospho-ERK1/2 were markedly increased. Treatment with the ERK1/2 inhibitor, U0126, significantly decreased the expression of the known decidualization marker genes, IGFBP1 and PRL as well as inhibited the induction of known ERK1/2 target genes; FOS, MSK1, STAT1, and STAT3. Interestingly, the phosphorylation level of CCAAT/enhancer binding protein beta(C/EBP beta), a protein previously shown to be critical for decidualization, was significantly reduced in this model. These results suggest that ERK1/2 signaling is required for successful decidualization in mice as well as human endometrial stromal cells and implicates C/EBP beta as a downstream target of ERK1/2.	[Lee, Chae Hyun; Kim, Tae Hoon; Lee, Jae Hee; Oh, Seo Jin; Yoo, Jung-Yoon; Ferguson, Susan D.; Fazleabas, Asgerally T.; Jeong, Jae-Wook] Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA; [Lee, Chae Hyun; Lim, Jeong Mook] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Oh, Seo Jin; Kwon, Hyo Suk; Kim, Young Im; Ahn, Ji Yeon; Fazleabas, Asgerally T.; Lim, Jeong Mook; Jeong, Jae-Wook] Seoul Natl Univ, WCU Biomodulat Program, Seoul, South Korea; [Ahn, Ji Yeon] Seoul Natl Univ Hosp, Canc Res Inst, Seoul 110744, South Korea; [Ku, Bon Jeong] Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon, South Korea	Michigan State University; Michigan State University College of Human Medicine; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Chungnam National University	Lim, JM (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	limjm@snu.ac.kr; JaeWook.Jeong@hc.msu.edu		Ku, Bon Jeong/0000-0002-3414-8949; Yoo, Jung-Yoon/0000-0001-9366-3863	National Institutes of Health [R01HD057873]; American Cancer Society Research Scholar Grant [RSG-12-084-01-TBG]; World Class University program [R31-10056]; National Research Foundation of Korea; Ministry of Education, Science and Technology; National Institute of Child Health cooperative agreement [U54HD40093]; Specialized Cooperative Centers Program in Reproduction and Infertility Research; Ministry of Education, Science and Technology, Republic of Korea [20120006091]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057873] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD040093] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P50CA098258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); World Class University program; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institute of Child Health cooperative agreement; Specialized Cooperative Centers Program in Reproduction and Infertility Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank the Human Female Reproductive Tract Biopository and the Spectrum Health Medical Group, Department of Obstetrics, Gynecology and Reproductive Biology and Women's Health (Elizabeth Leary M.D., Calvin Leazenby M.D. and Diana Bitner M.D.) for their help in obtaining human endometrial tissue samples. This work was supported by National Institutes of Health Grant R01HD057873, American Cancer Society Research Scholar Grant RSG-12-084-01-TBG and World Class University program (R31-10056) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (to JWJ), and the National Institute of Child Health cooperative agreement U54HD40093 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (to ATF) and this study was also supported by a grant from the Ministry of Education, Science and Technology, Republic of Korea No. 20120006091 (to JML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; BAKER DJ, 1992, BIOL REPROD, V47, P492, DOI 10.1095/biolreprod47.3.492; Banerjee P, 2009, ENDOCRINOLOGY, V150, P4326, DOI 10.1210/en.2009-0394; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Chalmers CJ, 2007, CELL SIGNAL, V19, P695, DOI 10.1016/j.cellsig.2006.09.001; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Christian M, 2002, MOL ENDOCRINOL, V16, P141, DOI 10.1210/me.16.1.141; Duncan SA, 1997, DEV DYNAM, V208, P190, DOI 10.1002/(SICI)1097-0177(199702)208:2<190::AID-AJA6>3.0.CO;2-D; Fan HY, 2011, MOL ENDOCRINOL, V25, P253, DOI 10.1210/me.2010-0318; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Fazleabas AT, 2002, MOL CELL ENDOCRINOL, V186, P143, DOI 10.1016/S0303-7207(01)00655-4; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Hsu YL, 2013, ONCOGENE, V32, P4436, DOI 10.1038/onc.2012.444; IRWIN JC, 1991, ENDOCRINOLOGY, V129, P2385, DOI 10.1210/endo-129-5-2385; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Kannan A, 2010, REPROD SCI, V17, P434, DOI 10.1177/1933719110361384; Karpovich N, 2005, J CLIN ENDOCR METAB, V90, P1607, DOI 10.1210/jc.2004-0868; Kim JJ, 1998, BIOL REPROD, V59, P160, DOI 10.1095/biolreprod59.1.160; Klemmt PAB, 2006, FERTIL STERIL, V85, P564, DOI 10.1016/j.fertnstert.2005.08.046; Laird S, 2006, REPROD BIOMED ONLINE, V13, P13, DOI 10.1016/S1472-6483(10)62011-1; Lee JH, 2013, FASEB J, V27, P2553, DOI 10.1096/fj.12-225664; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Liang XH, 2010, ENDOCRINOLOGY, V151, P5007, DOI 10.1210/en.2010-0170; Liu TY, 2002, BIOL REPROD, V67, P114, DOI 10.1095/biolreprod67.1.114; LOCKWOOD CJ, 1994, ANN NY ACAD SCI, V734, P57, DOI 10.1111/j.1749-6632.1994.tb21736.x; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Mormile R, 2013, ARCH GYNECOL OBSTET, V287, P837, DOI 10.1007/s00404-012-2587-9; Pohnke Y, 1999, J BIOL CHEM, V274, P24808, DOI 10.1074/jbc.274.35.24808; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Ryan I P, 1997, Obstet Gynecol Surv, V52, P365, DOI 10.1097/00006254-199706000-00021; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; SCHATZ F, 1993, J CLIN ENDOCR METAB, V77, P621, DOI 10.1210/jc.77.3.621; Tamm K, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-150; Velarde MC, 2009, ENDOCRINOLOGY, V150, P4701, DOI 10.1210/en.2009-0389; Wang W, 2012, MOL ENDOCRINOL, V26, P2016, DOI 10.1210/me.2012-1169; Wang W, 2010, ENDOCRINOLOGY, V151, P3929, DOI 10.1210/en.2009-1437; Wetendorf M, 2012, MOL CELL ENDOCRINOL, V357, P108, DOI 10.1016/j.mce.2011.10.028; Yotova IY, 2011, HUM REPROD, V26, P885, DOI 10.1093/humrep/der010; Zarich N, 2006, MOL BIOL CELL, V17, P3591, DOI 10.1091/mbc.E05-12-1104; Zhang L, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-75; Zhao YC, 2013, ENDOCRINOLOGY, V154, P1349, DOI 10.1210/en.2012-2026	47	25	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75282	10.1371/journal.pone.0075282	http://dx.doi.org/10.1371/journal.pone.0075282			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086495	Green Submitted, Green Published, gold			2022-12-25	WOS:000325025200037
J	Nghe, P; Boulineau, S; Gude, S; Recouvreux, P; van Zon, JS; Tans, SJ				Nghe, Philippe; Boulineau, Sarah; Gude, Sebastian; Recouvreux, Pierre; van Zon, Jeroen S.; Tans, Sander J.			Microfabricated Polyacrylamide Devices for the Controlled Culture of Growing Cells and Developing Organisms	PLOS ONE			English	Article							MICROFLUIDIC DEVICE; ESCHERICHIA-COLI; SINGLE-CELL; GENE-REGULATION; CHEMOSTAT; BACTERIAL; POLY(DIMETHYLSILOXANE); EXPRESSION; HYDROGELS; FRACTURE	The ability to spatially confine living cells or small organisms while dynamically controlling their aqueous environment is important for a host of microscopy applications. Here, we show how polyacrylamide layers can be patterned to construct simple microfluidic devices for this purpose. We find that polyacrylamide gels can be molded like PDMS into micron-scale structures that can enclose organisms, while being permeable to liquids, and transparent to allow for microscopic observation. We present a range of chemostat-like devices to observe bacterial and yeast growth, and C. elegans nematode development. The devices can integrate PDMS layers and allow for temporal control of nutrient conditions and the presence of drugs on a minute timescale. We show how spatial confinement of motile C. elegans enables for time-lapse microscopy in a parallel fashion.	[Nghe, Philippe; Boulineau, Sarah; Gude, Sebastian; Recouvreux, Pierre; van Zon, Jeroen S.; Tans, Sander J.] FOM Inst AMOLF, Amsterdam, Netherlands	AMOLF	Tans, SJ (corresponding author), FOM Inst AMOLF, Amsterdam, Netherlands.	tans@amolf.nl	Nghe, Philippe/AAB-3575-2019; Tans, Sander/AAS-2901-2020; Nghe, Philippe/M-3065-2015; van Zon, Jeroen/C-8313-2018	Nghe, Philippe/0000-0003-3690-4610; Nghe, Philippe/0000-0003-3690-4610; van Zon, Jeroen/0000-0002-6021-2924; Gude, Sebastian/0000-0003-0688-5025; Recouvreux, Pierre/0000-0002-0747-5821	Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO)	Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO))	This work is part of the research program of the Stichting voor Fundamenteel Onderzoek der Materie (FOM), which is financially supported by the Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2010, NANO LETT, V10, P3379, DOI 10.1021/nl101204e; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Bonn D, 1998, SCIENCE, V280, P265, DOI 10.1126/science.280.5361.265; Brahmasandra SN, 2001, ELECTROPHORESIS, V22, P300, DOI 10.1002/1522-2683(200101)22:2<300::AID-ELPS300>3.0.CO;2-F; Brenner S, 1974, AENORHABDITIS ELEGAN, P71; Breslauer DN, 2006, MOL BIOSYST, V2, P97, DOI 10.1039/b515632g; Bringmann H, 2011, J NEUROSCI METH, V201, P78, DOI 10.1016/j.jneumeth.2011.07.013; Burnham MR, 2006, BIOMATERIALS, V27, P5883, DOI 10.1016/j.biomaterials.2006.08.001; Caulfield MJ, 2003, POLYMER, V44, P1331, DOI 10.1016/S0032-3861(03)00003-X; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Cheng SY, 2007, LAB CHIP, V7, P763, DOI 10.1039/b618463d; Chi WJ, 2012, APPL MICROBIOL BIOT, V94, P917, DOI 10.1007/s00253-012-4023-2; Cho HJ, 2007, PLOS BIOL, V5, P2614, DOI 10.1371/journal.pbio.0050302; Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022; Crank J., 1956, MATH DIFFUSION; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Ducret A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007282; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Hoog JL, 2011, J CELL SCI, V124, P693, DOI 10.1242/jcs.072967; Hung PJ, 2005, BIOTECHNOL BIOENG, V89, P1, DOI 10.1002/bit.20289; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Kwon HJ, 2011, POLYM ENG SCI, V51, P1078, DOI 10.1002/pen.21923; Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Liu JK, 2008, ELECTROPHORESIS, V29, P2241, DOI 10.1002/elps.200700608; Long Z, 2013, LAB CHIP, V13, P947, DOI 10.1039/c2lc41196b; Mannik J, 2009, P NATL ACAD SCI USA, V106, P14861, DOI 10.1073/pnas.0907542106; Mather W, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.208101; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; Moorthy J, 2007, ANAL CHEM, V79, P5322, DOI 10.1021/ac070226l; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Podbilewicz B, 2006, COLD SPRING HARBOR P; Regehr KJ, 2009, LAB CHIP, V9, P2132, DOI 10.1039/b903043c; Robert L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.12; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Takeuchi S, 2005, NANO LETT, V5, P1819, DOI 10.1021/nl0507360; Tanaka Y, 2000, EUR PHYS J E, V3, P395, DOI 10.1007/s101890070010; Tran PT, 2004, METHODS, V33, P220, DOI 10.1016/j.ymeth.2003.11.017; Tse JR, 2010, CURR PROTOC CELL BIO, V47, DOI [10.1002/0471143030.cb1016-47, DOI 10.1002/0471143030.CB1016-47]; Tuson HH, 2012, CHEM COMMUN, V48, P1595, DOI 10.1039/c1cc14705f; Walker GM, 2004, LAB CHIP, V4, P91, DOI 10.1039/b311214d; Walters EM, 2004, METH MOL B, V254, P375; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wong I, 2010, LAB CHIP, V10, P2710, DOI 10.1039/c004719h; Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883	61	18	19	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75537	10.1371/journal.pone.0075537	http://dx.doi.org/10.1371/journal.pone.0075537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086559	Green Published, gold			2022-12-25	WOS:000325025200045
J	Xu, B; Chakraborty, R; Eilers, M; Dakshinamurti, S; O'Neil, JD; Smith, SO; Bhullar, RP; Chelikani, P				Xu, Bing; Chakraborty, Raja; Eilers, Markus; Dakshinamurti, Shyamala; O'Neil, Joe D.; Smith, Steven O.; Bhullar, Rajinder P.; Chelikani, Prashen			High-Level Expression, Purification and Characterization of a Constitutively Active Thromboxane A2 Receptor Polymorphic Variant	PLOS ONE			English	Article							A(2); GLYCOSYLATION; RHODOPSIN	G protein-coupled receptors (GPCRs) exhibit some level of basal signaling even in the absence of a bound agonist. This basal or constitutive signaling can have important pathophysiological roles. In the past few years, a number of high resolution crystal structures of GPCRs have been reported, including two crystal structures of constitutively active mutants (CAM) of the dim-light receptor, rhodopsin. The structural characterizations of CAMs are impeded by the lack of proper expression systems. The thromboxane A2 receptor (TP) is a GPCR that mediates vasoconstriction and promotes thrombosis in response to the binding of thromboxane. Here, we report on the expression and purification of a genetic variant and CAM in TP, namely A160T, using tetracycline-inducible HEK293S-TetR and HEK293S (GnTI(-))-TetR cell lines. Expression of the TP and the A160T genes in these mammalian cell lines resulted in a 4-fold increase in expression to a level of 15.8 +/- 0.3 pmol of receptor/mg of membrane protein. The receptors expressed in the HEK293S (GnTI(-))-TetR cell line showed homogeneous glycosylation. The functional yield of the receptors using a single step affinity purification was 45 mu g/10(6) cells. Temperature-dependent secondary structure changes of the purified TP and A160T receptors were characterized using circular dichroism (CD) spectropolarimetry. The CD spectra shows that the loss of activity or thermal sensitivity that was previously observed for the A160T mutant, is not owing to large unfolding of the protein but rather to a more subtle effect. This is the first study to report on the successful high-level expression, purification, and biophysical characterization of a naturally occurring, diffusible ligand activated GPCR CAM.	[Xu, Bing; Chakraborty, Raja; Bhullar, Rajinder P.; Chelikani, Prashen] Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada; [Eilers, Markus; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Dakshinamurti, Shyamala] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Dakshinamurti, Shyamala; Chelikani, Prashen] Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB, Canada; [O'Neil, Joe D.] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Manitoba; University of Manitoba; University of Manitoba	Chelikani, P (corresponding author), Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada.	chelikan@cc.umanitoba.ca	Xu, Bing/AAB-6608-2019; O'Neil, Joe/R-2356-2019; Smith, Steven/HDM-9496-2022; Chakraborty, Raja/L-6316-2017	O'Neil, Joe/0000-0002-5917-0392; Chelikani, Prashen/0000-0003-1129-7957	Natural Sciences and Engineering Research Council of Canada [RGPIN 356285]; Manitoba Health Research Coucnil; Heart and Stroke Foundation of Manitoba; National Institutes of Health [GM 41412]; Heart and Stroke Foundation of Canada; MICH/MHRC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041412] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Manitoba Health Research Coucnil; Heart and Stroke Foundation of Manitoba; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); MICH/MHRC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Discovery grant (RGPIN 356285) from the Natural Sciences and Engineering Research Council of Canada to PC, and an operating grants from the Manitoba Health Research Coucnil to PC, from the Heart and Stroke Foundation of Manitoba to RB and the National Institutes of Health (GM 41412) to SOS. An MMSF/MHRC Dr. F.W. DuVal Clinical Research Professorship to SD, a New Investigator Award from Heart and Stroke Foundation of Canada to PC, and a MICH/MHRC graduate studentship to RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capra V, 2004, MOL PHARMACOL, V66, P880, DOI 10.1124/mol.104.001487; Chakraborty R, 2013, MOL CELL BIOL, V33, P184, DOI 10.1128/MCB.00725-12; Chakraborty R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029996; Chelikani P, 2006, PROTEIN SCI, V15, P1433, DOI 10.1110/ps.062080006; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Kazius J, 2008, HUM MUTAT, V29, P39, DOI 10.1002/humu.20638; Kelley LP, 2003, BBA-GEN SUBJECTS, V1621, P192, DOI 10.1016/S0304-4165(03)00059-X; KINSELLA BT, 1994, J BIOL CHEM, V269, P29914; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Oates J, 2012, BBA-BIOMEMBRANES, V1818, P2228, DOI 10.1016/j.bbamem.2012.04.010; Pawate S, 1998, J BIOL CHEM, V273, P22753, DOI 10.1074/jbc.273.35.22753; RAYCHOWDHURY MK, 1994, J BIOL CHEM, V269, P19256; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ruan KH, 2008, BIOCHEMISTRY-US, V47, P6819, DOI 10.1021/bi702501g; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009	19	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76481	10.1371/journal.pone.0076481	http://dx.doi.org/10.1371/journal.pone.0076481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086743	Green Submitted, Green Published, gold			2022-12-25	WOS:000326520200137
J	Fiore, LS; Ganguly, SS; Sledziona, J; Cibull, ML; Wang, C; Richards, DL; Neltner, JM; Beach, C; McCorkle, JR; Kaetzel, DM; Plattner, R				Fiore, L. S.; Ganguly, S. S.; Sledziona, J.; Cibull, M. L.; Wang, C.; Richards, D. L.; Neltner, J. M.; Beach, C.; McCorkle, J. R.; Kaetzel, D. M.; Plattner, R.			c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer	ONCOGENE			English	Article						metastasis suppressor; c-Abl; Arg; NM23-H1; cathepsin	MESSENGER-RNA EXPRESSION; TUMOR-CELL MOTILITY; BREAST-CANCER; CYSTEINE CATHEPSINS; ADHERENS JUNCTIONS; TYROSINE KINASES; GENE-EXPRESSION; MELANOMA-CELLS; GROWTH; ENDOCYTOSIS	Metastasis suppressors comprise a growing class of genes whose downregulation triggers metastatic progression. In contrast to tumor suppressors, metastasis suppressors are rarely mutated or deleted, and little is known regarding the mechanisms by which their expression is downregulated. Here, we demonstrate that the metastasis suppressor, NM23-H1, is degraded by lysosomal cysteine cathepsins (L,B), which directly cleave NM23-H1. In addition, activation of c-Abl and Arg oncoproteins induces NM23-H1 degradation in invasive cancer cells by increasing cysteine cathepsin transcription and activation. Moreover, c-Abl activates cathepsins by promoting endosome maturation, which facilitates trafficking of NM23-H1 to the lysosome where it is degraded. Importantly, the invasion- and metastasis-promoting activity of c-Abl/Arg is dependent on their ability to induce NM23-H1 degradation, and the pathway is clinically relevant as c-Abl/Arg activity and NM23-H1 expression are inversely correlated in primary breast cancers and melanomas. Thus, we demonstrate a novel mechanism by which cathepsin expression is upregulated in cancer cells (via Abl kinases). We also identify a novel role for intracellular cathepsins in invasion and metastasis (degradation of a metastasis suppressor). Finally, we identify novel crosstalk between oncogenic and metastasis suppressor pathways, thereby providing mechanistic insight into the process of NM23-H1 loss, which may pave the way for new strategies to restore NM23-H1 expression and block metastatic progression.	[Fiore, L. S.; Ganguly, S. S.; Sledziona, J.; McCorkle, J. R.; Plattner, R.] Univ Kentucky, Sch Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; [Cibull, M. L.; Richards, D. L.; Neltner, J. M.] Univ Kentucky, Sch Med, Dept Pathol, Lexington, KY 40536 USA; [Wang, C.] Univ Kentucky, Sch Med, Dept Biostat, Lexington, KY 40536 USA; [Wang, C.] Univ Kentucky, Sch Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Beach, C.] Univ Kentucky, Sch Med, Dept Biochem, Lexington, KY 40536 USA; [Kaetzel, D. M.] Univ Maryland, Sch Med, Dept Mol & Cellular Biol, Baltimore, MD 21201 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University System of Maryland; University of Maryland Baltimore	Plattner, R (corresponding author), Univ Kentucky, Sch Med, Dept Mol & Biomed Pharmacol, Combs Res Bldg,Room 209,800 Rose St, Lexington, KY 40536 USA.	rplat2@uky.edu	McCorkle, Rob/AAH-3759-2019	McCorkle, Rob/0000-0002-5028-8853	NIH/NCI/R01 [CA116784, CA166499]; NIH/NCI; Office of the Vice President for Research; NATIONAL CANCER INSTITUTE [R01CA116784, R01CA159871, R01CA166499, P30CA177558] Funding Source: NIH RePORTER	NIH/NCI/R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of the Vice President for Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the following individuals for their assistance. Garretson Epperly and James Begley (confocal), Spear/Peterson Labs (qPCR), Jonathan Sims and Divya Srinivasan (cell lysates), Vivek Rangnekar, Suzanne Ridges, Aditi Jain (manuscript review) and Woodrow Friend (Figures 1a and 6d). Mass spectrometry was performed at the University of Kentucky Proteomics Core Facility, which is supported in part by the Office of the Vice President for Research. Edman Degradation was performed at the University of Nebraska Protein Structure Core Facility. This work was supported by NIH/NCI/R01 grants to RP (CA116784, CA166499). Dr Plattner is funded by NIH/NCI. DMK also is funded by NIH/NCI, but this work was not supported by his grants.	Allington TM, 2011, CELLS TISSUES ORGANS, V193, P98, DOI 10.1159/000320163; Allington TM, 2009, FASEB J, V23, P4231, DOI 10.1096/fj.09-138412; Annesley SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026024; Authier F, 1999, J BIOL CHEM, V274, P33723, DOI 10.1074/jbc.274.47.33723; Balaji K, 2012, J CELL SCI, V125, P5887, DOI 10.1242/jcs.113688; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Bauer B, 2009, CELL MICROBIOL, V11, P156, DOI 10.1111/j.1462-5822.2008.01246.x; Boissan M, 2010, CANCER RES, V70, P7710, DOI 10.1158/0008-5472.CAN-10-1887; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Curtis CD, 2007, CANCER RES, V67, P10600, DOI 10.1158/0008-5472.CAN-07-0055; De Braekeleer E, 2011, EUR J HAEMATOL, V86, P361, DOI 10.1111/j.1600-0609.2011.01586.x; De Wever O, 2010, INT J DEV BIOL, V54, P887, DOI 10.1387/ijdb.092948ow; Easty DJ, 1996, BRIT J CANCER, V74, P109, DOI 10.1038/bjc.1996.323; ENGEL M, 1993, INT J CANCER, V55, P375, DOI 10.1002/ijc.2910550306; Fenyo David, 2007, J Vis Exp, P192, DOI 10.3791/192; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Ganguly Sourik S, 2012, Genes Cancer, V3, P414, DOI 10.1177/1947601912458586; GOODALL RJ, 1994, PATHOLOGY, V26, P423, DOI 10.1080/00313029400169122; Horak CE, 2008, APMIS, V116, P586, DOI 10.1111/j.1600-0463.2008.01213.x; Horak CE, 2007, CANCER RES, V67, P7238, DOI 10.1158/0008-5472.CAN-07-0962; Hsu T, 2006, J BIOL CHEM, V281, P12069, DOI 10.1074/jbc.M511621200; Huang SY, 2000, CYTOKINES CELL MOL T, V6, P9, DOI 10.1080/13684730050515868; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hwang Byung-Gap, 1997, Journal of Korean Medical Science, V12, P514; IIZUKA N, 1995, CANCER RES, V55, P652; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jacob M, 2009, CELL SIGNAL, V21, P1308, DOI 10.1016/j.cellsig.2009.03.016; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Lin LI, 1998, ANTICANCER RES, V18, P541; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Ma D, 1996, INVEST OPHTH VIS SCI, V37, P2293; Ma DQ, 2004, J BIOL CHEM, V279, P18073, DOI 10.1074/jbc.M400185200; Marshall JC, 2010, EUR J CANCER, V46, P1278, DOI 10.1016/j.ejca.2010.02.042; McDermott WG, 2008, CLIN EXP METASTAS, V25, P131, DOI 10.1007/s10585-007-9128-0; Mesaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019764; MYEROFF LL, 1993, J NATL CANCER I, V85, P147, DOI 10.1093/jnci/85.2.147; Novak M, 2011, N-S ARCH PHARMACOL, V384, P433, DOI 10.1007/s00210-011-0621-2; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Rosenfeld JL, 2001, J CELL SCI, V114, P4499; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Saha A, 2011, FEBS LETT, V585, P3174, DOI 10.1016/j.febslet.2011.08.007; Sgouros J, 2007, IN VIVO, V21, P519; Sims JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055509; Smith SC, 2009, NAT REV CANCER, V9, P253, DOI 10.1038/nrc2594; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Srinivasan D, 2009, CELL SIGNAL, V21, P1143, DOI 10.1016/j.cellsig.2009.03.003; Steeg PS, 2008, CLIN CANCER RES, V14, P5006, DOI 10.1158/1078-0432.CCR-08-0238; Taha TA, 2006, FEBS LETT, V580, P6047, DOI 10.1016/j.febslet.2006.09.070; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Wetzel DM, 2012, MOL CELL BIOL, V32, P3176, DOI 10.1128/MCB.00086-12; Woolworth JA, 2009, MOL CELL BIOL, V29, P4679, DOI 10.1128/MCB.00297-09; Wright PK, 2008, RECENT PAT ANTI-CANC, V3, P137, DOI 10.2174/157489208784638730; Xiong WJ, 2013, DEVELOPMENT, V140, P176, DOI 10.1242/dev.088799; Yogalingam G, 2008, J BIOL CHEM, V283, P35941, DOI 10.1074/jbc.M804543200	65	32	34	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 4	2014	33	36					4508	4520		10.1038/onc.2013.399	http://dx.doi.org/10.1038/onc.2013.399			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MY	24096484	Green Accepted			2022-12-25	WOS:000341158800006
J	Tu, YF; Wan, L; Fan, YH; Wang, KZ; Bu, LH; Huang, T; Cheng, Z; Shen, BZ				Tu, Yingfeng; Wan, Lin; Fan, Yuhua; Wang, Kezheng; Bu, Lihong; Huang, Tao; Cheng, Zhen; Shen, Baozhong			Ischemic Postconditioning-Mediated miRNA-21 Protects against Cardiac ischemia/reperfusion Injury via PTEN/Akt Pathway	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ACUTE MYOCARDIAL-INFARCTION; NITRIC-OXIDE SYNTHASE; CARDIOMYOCYTE APOPTOSIS; HEART; MICRORNA; EXPRESSION; CARDIOPROTECTION; ATTENUATION; ACTIVATION	Background: Ischemic postconditioning (IPost) protects the reperfused heart from infarction which has drawn much attention recently. However, studies to date have rarely investigated the role of microRNAs (miRNAs) in IPost. The aims of this study were to investigate whether miR-21 is involved in the protective effect of IPost against myocardial ischemia-reperfusion (I/R) injury and disclose the potential molecular mechanisms involved. Methods and Results: We found that miR-21 was remarkably up-regulated in mouse hearts after IPost. To determine the protective role of IPost-induced miR-21 up-regulation, the mice were divided into the following four groups: I/R group; I/R+IPost group (I/R mice treated with IPost); Antagomir-21+IPost+I/R group (I/R mice treated with anagomir-21 and IPost); Scramble+IPost+I/R group (I/R mice treated with scramble and IPost). The results showed IPost could reduce I/R injury-induced infarct size of the left ventricle, improve cardiac function, and prevent myocardial apoptosis, while knockdown of miR-21 with antagomir-21 could reverse these protective effects of IPost against mouse I/R injury. Furthermore, we confirmed that miR-21 plays a protective role in myocardial apoptosis through PTEN/Akt signaling pathway, which was abrogated by the PI3K inhibitor LY294002. The protective effect of miR-21 on myocardial apoptosis was further revealed in mouse hearts after IPost treatment in vivo. Conclusions: Our data clearly demonstrate that miR-21 is involved in IPost-mediated cardiac protection against I/R injury and dysfunction through the PTEN/Akt signaling pathway in vivo. Identifying the beneficial roles of IPost-regulated miRNAs in cardiac protection, which may be a rational target selection for ischemic cardioprotection.	[Tu, Yingfeng; Wan, Lin; Wang, Kezheng; Bu, Lihong; Huang, Tao; Shen, Baozhong] Harbin Med Univ, Hosp 4, Dept Radiol, Harbin, Heilongjiang, Peoples R China; [Tu, Yingfeng; Wan, Lin; Wang, Kezheng; Bu, Lihong; Huang, Tao; Shen, Baozhong] Harbin Med Univ, Hosp 4, Key Lab Mol Imaging, Harbin, Heilongjiang, Peoples R China; [Tu, Yingfeng] Harbin Med Univ, Hosp 4, Dept Cardiol, Harbin, Heilongjiang, Peoples R China; [Fan, Yuhua] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Heilongjiang, Peoples R China; [Cheng, Zhen] Stanford Univ, Mol Imaging Program Stanford, Dept Radiol, Stanford, CA 94305 USA; [Cheng, Zhen] Stanford Univ, Biox Program, Stanford, CA 94305 USA	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Stanford University; Stanford University	Shen, BZ (corresponding author), Harbin Med Univ, Hosp 4, Dept Radiol, Harbin, Heilongjiang, Peoples R China.	shenbzh@vip.sina.com	Cheng, Zhen/K-2843-2012	Cheng, Zhen/0000-0001-8177-9463	National Natural Science Foundation of China [30970807, 31210103913]; Harbin Medical University [WLD-QN1120]; China Postdoctoral Science Foundation [2012M520765-119186]; Research Fund for the Doctoral Program of Higher Education of China [20112307120025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Medical University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China (30970807), National Natural Science Foundation of China (31210103913), "Liande Wu Funding" of Harbin Medical University (WLD-QN1120), China Postdoctoral Science Foundation (2012M520765-119186), Research Fund for the Doctoral Program of Higher Education of China (20112307120025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027923; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bai HT, 2011, FEBS LETT, V585, P402, DOI 10.1016/j.febslet.2010.12.027; Chen ZG, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-80; Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Duan X, 2012, CARDIOLOGY, V122, P36, DOI 10.1159/000338149; Forouzanfar MH, 2012, GLOB HEART, V7, P331, DOI 10.1016/j.gheart.2012.10.003; Frank D, 2012, J MOL CELL CARDIOL, V52, P711, DOI 10.1016/j.yjmcc.2011.12.001; Gross GJ, 2009, AM J PHYSIOL-HEART C, V297, pH47, DOI 10.1152/ajpheart.01084.2008; Guo YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041178; He B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-22; Jabs A, 2010, CLIN HEMORHEOL MICRO, V45, P185, DOI 10.3233/CH-2010-1297; Zhang J, 2010, MOL MED, V16, P307, DOI 10.2119/molmed.2009.00121; Jujo K, 2013, CIRCULATION, V127, P63, DOI 10.1161/CIRCULATIONAHA.112.099242; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lin XM, 2010, CHINESE MED J-PEKING, V123, P1833, DOI 10.3760/cma.j.issn.0366-6999.2010.14.002; Lonborg J, 2010, CIRC-CARDIOVASC INTE, V3, P34, DOI 10.1161/CIRCINTERVENTIONS.109.905521; Lu YJ, 2009, CARDIOVASC RES, V84, P434, DOI 10.1093/cvr/cvp232; Ma XJ, 2012, CORONARY ARTERY DIS, V23, P245, DOI 10.1097/MCA.0b013e3283526a7d; Mukhopadhyay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015705; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Pan ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050515; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Ruan HM, 2009, J MOL CELL CARDIOL, V46, P193, DOI 10.1016/j.yjmcc.2008.10.021; Selvamani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032662; Somers SJ, 2011, PHYSIOL RES, V60, P971, DOI 10.33549/physiolres.932129; Sumi S, 2010, AM J PHYSIOL-HEART C, V299, pH1174, DOI 10.1152/ajpheart.00116.2010; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; Sun HM, 2010, HEART SURG FORUM, V13, pE305, DOI 10.1532/HSF98.20101013; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Wu QL, 2012, SHOCK, V38, P165, DOI 10.1097/SHK.0b013e31825b5633; Xu XD, 2012, J CELL PHYSIOL, V227, P1391, DOI 10.1002/jcp.22852; Xue F, 2010, CLIN CARDIOL, V33, P439, DOI 10.1002/clc.20796; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yin C, 2009, CIRC RES, V104, P572, DOI 10.1161/CIRCRESAHA.108.193250; Zhuo CJ, 2011, MOL CELL BIOCHEM, V346, P39, DOI 10.1007/s11010-010-0589-0; Zu LY, 2011, AM J PHYSIOL-HEART C, V300, pH2177, DOI 10.1152/ajpheart.01138.2010	40	98	105	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75872	10.1371/journal.pone.0075872	http://dx.doi.org/10.1371/journal.pone.0075872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098402	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600025
J	Chambers, LE; Altwegg, R; Barbraud, C; Barnard, P; Beaumont, LJ; Crawford, RJM; Durant, JM; Hughes, L; Keatley, MR; Low, M; Morellato, PC; Poloczanska, ES; Ruoppolo, V; Vanstreels, RET; Woehler, EJ; Wolfaardt, AC				Chambers, Lynda E.; Altwegg, Res; Barbraud, Christophe; Barnard, Phoebe; Beaumont, Linda J.; Crawford, Robert J. M.; Durant, Joel M.; Hughes, Lesley; Keatley, Marie R.; Low, Matt; Morellato, Patricia C.; Poloczanska, Elvira S.; Ruoppolo, Valeria; Vanstreels, Ralph E. T.; Woehler, Eric J.; Wolfaardt, Anton C.			Phenological Changes in the Southern Hemisphere	PLOS ONE			English	Article							CLIMATE-CHANGE; BREEDING PHENOLOGY; REPRODUCTIVE SUCCESS; ECOLOGICAL RESEARCH; MIGRATION; MARINE; TERRESTRIAL; PENGUINS; BIRDS; OCEAN	Current evidence of phenological responses to recent climate change is substantially biased towards northern hemisphere temperate regions. Given regional differences in climate change, shifts in phenology will not be uniform across the globe, and conclusions drawn from temperate systems in the northern hemisphere might not be applicable to other regions on the planet. We conduct the largest meta-analysis to date of phenological drivers and trends among southern hemisphere species, assessing 1208 long-term datasets from 89 studies on 347 species. Data were mostly from Australasia (Australia and New Zealand), South America and the Antarctic/subantarctic, and focused primarily on plants and birds. This meta-analysis shows an advance in the timing of spring events (with a strong Australian data bias), although substantial differences in trends were apparent among taxonomic groups and regions. When only statistically significant trends were considered, 82% of terrestrial datasets and 42% of marine datasets demonstrated an advance in phenology. Temperature was most frequently identified as the primary driver of phenological changes; however, in many studies it was the only climate variable considered. When precipitation was examined, it often played a key role but, in contrast with temperature, the direction of phenological shifts in response to precipitation variation was difficult to predict a priori. We discuss how phenological information can inform the adaptive capacity of species, their resilience, and constraints on autonomous adaptation. We also highlight serious weaknesses in past and current data collection and analyses at large regional scales (with very few studies in the tropics or from Africa) and dramatic taxonomic biases. If accurate predictions regarding the general effects of climate change on the biology of organisms are to be made, data collection policies focussing on targeting data-deficient regions and taxa need to be financially and logistically supported.	[Chambers, Lynda E.] Ctr Australian Weather & Climate Res, Melbourne, Vic, Australia; [Altwegg, Res; Barnard, Phoebe] South African Natl Biodivers Inst, Kirstenbosch Res Ctr, Cape Town, South Africa; [Barbraud, Christophe] CNRS, CEBC, UPR 1934, Villiers En Bois, France; [Beaumont, Linda J.; Hughes, Lesley] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Crawford, Robert J. M.] Dept Environm Affairs & Tourism, Cape Town, South Africa; [Durant, Joel M.] Univ Oslo, Ctr Ecol & Evolutionary Synth, Dept Biosci, Oslo, Norway; [Keatley, Marie R.] Univ Melbourne, Dept Forest & Ecosyst Sci, Creswick, Vic, Australia; [Low, Matt] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Morellato, Patricia C.] UNESP Univ Estadual Paulista, Lab Fenol, Dept Bot, Inst Biociencias, Sao Paulo, Brazil; [Poloczanska, Elvira S.] CSIRO Marine & Atmospher Res, Climate Adaptat Flagship, Brisbane, Qld, Australia; [Ruoppolo, Valeria] Int Fund Anim Welf, Yarmouth Port, MA USA; [Ruoppolo, Valeria; Vanstreels, Ralph E. T.] Univ Sao Paulo, Lab Wildlife Comparat Pathol, Fac Vet Med, Sao Paulo, Brazil; [Woehler, Eric J.] Univ Tasmania, Inst Marine & Antarctic Studies, Sandy Bay, Tas, Australia; [Altwegg, Res] Univ Cape Town, Anim Demog Unit, ZA-7700 Rondebosch, South Africa; [Barnard, Phoebe] Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, DST NRF Ctr Excellence, ZA-7700 Rondebosch, South Africa	Commonwealth Scientific & Industrial Research Organisation (CSIRO); South African National Biodiversity Institute; Centre National de la Recherche Scientifique (CNRS); Macquarie University; University of Oslo; University of Melbourne; Swedish University of Agricultural Sciences; Universidade de Sao Paulo; Universidade Estadual Paulista; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidade de Sao Paulo; University of Tasmania; University of Cape Town; National Research Foundation - South Africa; University of Cape Town	Chambers, LE (corresponding author), Ctr Australian Weather & Climate Res, Melbourne, Vic, Australia.	L.Chambers@bom.gov.au	Poloczanska, Elvira/F-4366-2014; Morellato, Patricia/B-6026-2013; Barbraud, Christophe/A-5870-2012; Beaumont, Linda J/D-5499-2012; poloczanska, elvira/P-5356-2014; Durant, Joël/D-3821-2013; Vanstreels, Ralph/H-8029-2015	Morellato, Patricia/0000-0001-5265-8988; Barbraud, Christophe/0000-0003-0146-212X; Beaumont, Linda J/0000-0001-6307-1680; Durant, Joël/0000-0002-1129-525X; Low, Matthew/0000-0002-7345-6063; Hughes, Lesley/0000-0003-0313-9780; poloczanska, elvira/0000-0001-8470-0925; Keatley, Marie/0000-0001-5490-576X; Woehler, Eric/0000-0002-1125-0748	National Research Foundation of South Africa; Applied Centre for Climate and Earth System Science; FAPESP (Sao Paulo Research Foundation) [2010/50713-5, 2010/52113-5]; CNPq (National Council for Science); Swedish research council (FORMAS); Macquarie University	National Research Foundation of South Africa(National Research Foundation - South Africa); Applied Centre for Climate and Earth System Science; FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (National Council for Science)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Swedish research council (FORMAS)(Swedish Research CouncilSwedish Research Council Formas); Macquarie University	This work is based upon research supported by the National Research Foundation of South Africa to RA, PB, and RJMC, and by the Applied Centre for Climate and Earth System Science to RA. LPCM and the Phenology Laboratory at UNESP are supported by FAPESP (Sao Paulo Research Foundation grant # 2010/50713-5 and # 2010/52113-5); LPCM receives a Research Productivity Fellowship and grant from CNPq (National Council for Science). ML is supported by the Swedish research council (FORMAS). LJB was supported by a Macquarie University New Staff Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Aizen MA, 2006, ECOGRAPHY, V29, P357, DOI 10.1111/j.2006.0906-7590.04552.x; Altwegg R, 2012, P ROY SOC B-BIOL SCI, V279, P1485, DOI 10.1098/rspb.2011.1897; Barbraud C, 2006, P NATL ACAD SCI USA, V103, P6248, DOI 10.1073/pnas.0510397103; Barbraud C, 2012, MAR ECOL PROG SER, V454, P285, DOI 10.3354/meps09616; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Brown CJ, 2011, GLOBAL CHANGE BIOL, V17, P3697, DOI 10.1111/j.1365-2486.2011.02531.x; Brunel T, 2007, FISH OCEANOGR, V16, P336, DOI 10.1111/j.1365-2419.2007.00435.x; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Chambers LE, 2006, B AM METEOROL SOC, V87, P201, DOI 10.1175/BAMS-87-2-201; Chambers LE, INT J BIOMETEOROLOGY; Chambers LE, 2013, PHENOLOGY INTEGRATIV; Chambers LE, 2011, EMU, V111, P235, DOI 10.1071/MU10033; Chan K, 2001, EMU, V101, P281, DOI 10.1071/MU00034; Chou C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030327; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Davis CC, 2010, PHILOS T R SOC B, V365, P3201, DOI 10.1098/rstb.2010.0130; Day TA, 1999, OECOLOGIA, V119, P24, DOI 10.1007/s004420050757; de la Roque S, 2008, REV SCI TECH OIE, V27, P339, DOI 10.20506/rst.27.2.1807; Dickey MH, 2008, GLOBAL CHANGE BIOL, V14, P1973, DOI 10.1111/j.1365-2486.2008.01622.x; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Diffenbaugh NS, 2012, CLIMATIC CHANGE, V114, P813, DOI 10.1007/s10584-012-0570-x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Durant JM, 2010, MAR ECOL PROG SER, V420, P263, DOI 10.3354/meps08857; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Emslie SD, 2005, ANTARCT SCI, V17, P57, DOI 10.1017/S0954102005002427; Encinas-Viso F, 2012, ECOL LETT, V15, P198, DOI 10.1111/j.1461-0248.2011.01726.x; Forcada J, 2008, GLOBAL CHANGE BIOL, V14, P2473, DOI 10.1111/j.1365-2486.2008.01678.x; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Frederiksen M, 2004, GLOBAL CHANGE BIOL, V10, P1214, DOI 10.1111/j.1529-8817.2003.00794.x; Gallagher RV, 2009, AUST J BOT, V57, P1, DOI 10.1071/BT08051; Giorgi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025734; Green K, 2010, J MT SCI-ENGL, V7, P167, DOI 10.1007/s11629-010-1115-2; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hawkins E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050087; Hegerl G.C., 2009, P INT PAN CLIM CHANG; Hegerl GC, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P663; Henschel J, 2000, NAMIBIAN LONG TERM E; Hindell MA, 2012, ECOL EVOL, V2, P1563, DOI 10.1002/ece3.281; Hinke JT, 2012, MAR ECOL PROG SER, V454, P91, DOI 10.3354/meps09633; Holmgren M., 2006, ADV GEOSCIENCES, V6, P69, DOI [DOI 10.5194/ADGEO-6-69-2006, 10.5194/adgeo-6-69-2006]; Jahn AE, 2012, EMU, V112, P17, DOI 10.1071/MU10091; Keatley MR, 2013, PHENOLOGY INTEGRATIV; Kobori H, 2012, ECOL RES, V27, P173, DOI 10.1007/s11284-011-0891-7; KOCHMER JP, 1986, ECOL MONOGR, V56, P303, DOI 10.2307/1942549; Kopp M, 2011, MAR ECOL PROG SER, V435, P263, DOI 10.3354/meps09229; Koubbi P, 2011, POLAR SCI, V5, P225, DOI 10.1016/j.polar.2011.02.003; Latif M, 2009, P NATL ACAD SCI USA, V106, P20578, DOI 10.1073/pnas.0710860105; Lescroel A, 2009, POLAR BIOL, V32, P1495, DOI 10.1007/s00300-009-0647-9; Lewis S, 2012, OIKOS, V121, P2061, DOI 10.1111/j.1600-0706.2012.20293.x; Linden A, 2011, BOREAL ENVIRON RES, V16, P49; Lynch HJ, 2012, MAR ECOL PROG SER, V454, P135, DOI 10.3354/meps09252; MacNeil MA, 2010, PHILOS T R SOC B, V365, P3753, DOI 10.1098/rstb.2010.0289; Mair L, 2012, GLOBAL CHANGE BIOL, V18, P2439, DOI 10.1111/j.1365-2486.2012.02730.x; McCarthy MA, 2005, J APPL ECOL, V42, P1012, DOI 10.1111/j.1365-2664.2005.01101.x; McClellan K, 2011, THESIS MACQUARIE U; McKone MJ, 1998, GLOB CHANGE BIOL, V4, P591, DOI 10.1046/j.1365-2486.1998.00172.x; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Miller-Rushing A, 2012, FRONT ECOL ENVIRON, V10, P285, DOI 10.1890/110278; Miller-Rushing AJ, 2008, AUK, V125, P565, DOI 10.1525/auk.2008.07005; Mintenbeck K, 2012, ADV ECOL RES, V46, P351, DOI 10.1016/B978-0-12-396992-7.00006-X; Moe B, 2009, MAR ECOL PROG SER, V393, P235, DOI 10.3354/meps08222; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller AP, 2011, CLIM RES, V47, P201, DOI 10.3354/cr01005; Morellato L.P.C., 2013, PHENOLOGY INTEGRATIV, P91, DOI [DOI 10.1007/978-94-007-6925-0_6, 10.1007/978-94-007-6925-0_6]; Morellato LPC, 2000, BIOTROPICA, V32, P811, DOI 10.1111/j.1744-7429.2000.tb00620.x; Moussus JP, 2011, OIKOS, V120, P991, DOI 10.1111/j.1600-0706.2010.18955.x; Moussus JP, 2010, METHODS ECOL EVOL, V1, P140, DOI 10.1111/j.2041-210X.2010.00020.x; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; OLSEN PD, 1989, EMU, V89, P1, DOI 10.1071/MU9890001; Pakhomov EA, 1996, MAR ECOL PROG SER, V134, P1, DOI 10.3354/meps134001; Park IW, 2012, INT J BIOMETEOROL, V56, P1179, DOI 10.1007/s00484-012-0521-2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Parmesan C, 2011, NAT CLIM CHANGE, V1, P2, DOI 10.1038/nclimate1056; Parry ML, 2007, CLIMATE CHANGE 2007; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; Petry MV, 2013, POLAR BIOL, V36, P603, DOI 10.1007/s00300-012-1277-1; Poloczanska ES, NATURE CLIMATE CHANG; Potter C, 2008, CLIM DYNAM, V31, P67, DOI 10.1007/s00382-007-0339-5; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sadras VO, 2011, AUST J GRAPE WINE R, V17, P199, DOI 10.1111/j.1755-0238.2011.00138.x; Salido L, 2012, ECOGRAPHY, V35, P604, DOI 10.1111/j.1600-0587.2011.06797.x; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Schaper SV, 2012, AM NAT, V179, pE55, DOI 10.1086/663675; Scharlemann JPW, 2001, INT J BIOMETEOROL, V45, P208, DOI 10.1007/s004840100098; Schauber EM, 2002, ECOLOGY, V83, P1214, DOI 10.1890/0012-9658(2002)083[1214:MBENZP]2.0.CO;2; Schwartz M.D., 2003, PHENOLOGY INTEGRATIV; Senapathi D, 2011, P ROY SOC B-BIOL SCI, V278, P3184, DOI 10.1098/rspb.2011.0212; Siegal-Causey D., 1990, Current Ornithology, V7, P285; Siegel-Causey D, 1995, COLONIAL BREEDING WA; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Sokolov LV, 2008, RUSS J ECOL+, V39, P56, DOI 10.1134/S1067413608010098; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Southward AJ, 2005, ADV MAR BIOL, V47, P1; Sparks TH, 2007, J ORNITHOL, V148, P503, DOI 10.1007/s10336-007-0193-6; Sparks T, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P123, DOI 10.1007/978-90-481-3335-2_6; Staggemeier VG, 2011, INT J BIOMETEOROL, V55, P843, DOI 10.1007/s00484-011-0482-x; Staggemeier VG, 2010, J ECOL, V98, P1409, DOI 10.1111/j.1365-2745.2010.01717.x; Steffen, 2009, AUSTR BIODIVERSITY C; Stine AR, 2009, NATURE, V457, P435, DOI 10.1038/nature07675; Stokes C, 2010, NATURE CLIM IN PRESS; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Vegvari Z, 2010, GLOBAL CHANGE BIOL, V16, P1, DOI 10.1111/j.1365-2486.2009.01876.x; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Webb LB, 2012, NAT CLIM CHANGE, V2, P259, DOI [10.1038/nclimate1417, 10.1038/NCLIMATE1417]; Woehler EJ, 2012, PROTECTION 3 POLES, P218; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x; YODER JA, 1993, GLOBAL BIOGEOCHEM CY, V7, P181, DOI 10.1029/93GB02358; Ziello C, 2012, ECOGRAPHY, V35, P1017, DOI 10.1111/j.1600-0587.2012.07607.x	116	140	144	3	220	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75514	10.1371/journal.pone.0075514	http://dx.doi.org/10.1371/journal.pone.0075514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098389	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100019
J	Resende, FA; de Oliveira, APS; de Camargo, MS; Vilegas, W; Varanda, EA				Resende, Flavia A.; de Oliveira, Ana Paula S.; de Camargo, Mariana S.; Vilegas, Wagner; Varanda, Eliana A.			Evaluation of Estrogenic Potential of Flavonoids Using a Recombinant Yeast Strain and MCF7/BUS Cell Proliferation Assay	PLOS ONE			English	Article							ENDOCRINE DISRUPTORS; RECEPTOR; DERIVATIVES; ISOFLAVONES	Phytoestrogens are of interest because of their reported beneficial effects on many human maladies including cancer, neurodegeneration, cardiovascular disease and diabetes. Furthermore, there is a search for compounds with estrogenic activity that can replace estrogen in hormone replacement therapy during menopause, without the undesirable effects of estrogen, such as the elevation of breast cancer occurrence. Thus, the principal objective of this study was to assess the estrogenic activity of flavonoids with different hydroxylation patterns: quercetin, kaempferol, luteolin, fisetin, chrysin, galangin, flavone, 3-hydroxyflavone, 5-hydroxyflavone and 7-hydroxyflavone via two different in vitro assays, the recombinant yeast assay (RYA) and the MCF-7 proliferation assay (E-screen), since the most potent phytoestrogens are members of the flavonoid family. In these assays, kaempferol was the only compound that showed ER alpha-dependent transcriptional activation activity by RYA, showing 6.74 +/- 1.7 nM EEQ, besides acting as a full agonist for the stimulation of proliferation of MCF-7/BUS cells. The other compounds did not show detectable levels of interaction with ER under the conditions used in the RYA. However, in the E-screen assay, compounds such as galangin, luteolin and fisetin also stimulated the proliferation of MCF-7/BUS cells, acting as partial agonists. In the evaluation of antiestrogenicity, the compounds quercetin, chrysin and 3-hydroxyflavone significantly inhibited the cell proliferation induced by 17-beta-estradiol in the E-screen assay, indicating that these compounds may act as estrogen receptor antagonists. Overall, it became clear in the assay results that the estrogenic activity of flavonoids was affected by small structural differences such as the number of hydroxyl groups, especially those on the B ring of the flavonoid.	[Resende, Flavia A.; de Oliveira, Ana Paula S.; de Camargo, Mariana S.; Varanda, Eliana A.] Univ Estadual Paulista, Fac Pharmaceut Sci, Dept Biol Sci, Sao Paulo, Brazil; [Vilegas, Wagner] Univ Estadual Paulista, Campus Litoral Paulista Unidade Sao Vicente, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Resende, FA (corresponding author), Univ Estadual Paulista, Fac Pharmaceut Sci, Dept Biol Sci, Sao Paulo, Brazil.	flaviabiomed@yahoo.com.br	Vilegas, Wagner/D-3170-2012; Camargo, Mariana/A-9928-2015; Resende, Flávia Aparecida/J-4686-2012; Resende, Flávia/P-1580-2019; Vilegas, Wagner/S-3209-2019	Vilegas, Wagner/0000-0003-3032-2556; Camargo, Mariana/0000-0002-3791-4725; Resende, Flávia Aparecida/0000-0002-9432-5919; Resende, Flávia/0000-0002-9432-5919; Oliveira Hohne, Ana Paula/0000-0002-3260-7275	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)'', Brazilian state agency; "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)'', Brazilian federal agency	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)'', Brazilian state agency; "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)'', Brazilian federal agency	This work was supported by "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)'' and "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)'', Brazilian state and federal agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstead GM, 1997, STEROIDS, V62, P268, DOI 10.1016/S0039-128X(96)00242-5; Brix R, 2010, ENVIRON INT, V36, P361, DOI 10.1016/j.envint.2010.02.004; Cespedes R, 2005, CHEMOSPHERE, V61, P1710, DOI 10.1016/j.chemosphere.2005.03.082; Choi SY, 2008, PLANTA MED, V74, P25, DOI 10.1055/s-2007-993760; De Naeyer A, 2004, J NAT PROD, V67, P1829, DOI 10.1021/np040069a; De-Eknamkul W, 2011, J MOL GRAPH MODEL, V29, P784, DOI 10.1016/j.jmgm.2011.01.001; Fang H, 2001, CHEM RES TOXICOL, V14, P280, DOI 10.1021/tx000208y; Ferguson LR, 2001, MUTAT RES-FUND MOL M, V475, P89, DOI 10.1016/S0027-5107(01)00073-2; Garcia-Reyero N, 2004, ENVIRON TOXICOL CHEM, V23, P705, DOI 10.1897/03-141; Garcia-Reyero N, 2001, ENVIRON TOXICOL CHEM, V20, P1152, DOI 10.1002/etc.5620200603; GREEN S, 1991, NUCLEAR HORMONE RECE, P15; Hou DX, 2010, ANTIOXID REDOX SIGN, V13, P691, DOI 10.1089/ars.2009.2816; Kuch B, 2010, ENVIRON SCI POLLUT R, V17, P250, DOI 10.1007/s11356-009-0234-1; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Liu S, 2013, MOL PHARMACOL, V83, P1066, DOI 10.1124/mol.112.084228; Noguerol TN, 2006, TALANTA, V69, P351, DOI 10.1016/j.talanta.2005.09.044; Ogawa T, 2009, BIOORGAN MED CHEM, V17, P1109, DOI 10.1016/j.bmc.2008.12.044; Oh SM, 2009, TOXICOL IN VITRO, V23, P1242, DOI 10.1016/j.tiv.2009.07.032; Schiliro T, 2011, J STEROID BIOCHEM, V127, P139, DOI 10.1016/j.jsbmb.2011.03.002; SCHNEIDER JC, 1991, METHOD ENZYMOL, V194, P373; Sharan S, 2013, TOXICOL APPL PHARM, V269, P176, DOI 10.1016/j.taap.2013.03.009; Silva ID, 2000, CHEM-BIOL INTERACT, V124, P29; SOTO AM, 1992, ADV MOD ENV, V21, P295; Tarnow P, 2013, TOXICOL IN VITRO, V27, P1467, DOI 10.1016/j.tiv.2013.03.003; Tokarz J, 2013, J STEROID BIOCHEM, V137, P165, DOI 10.1016/j.jsbmb.2013.01.003; Vanparys C, 2010, SCI TOTAL ENVIRON, V408, P4451, DOI 10.1016/j.scitotenv.2010.06.049; VILLALOBOS M, 1995, ENVIRON HEALTH PERSP, V103, P844, DOI 10.2307/3432398; Wanda GJMK, 2006, PHYTOMEDICINE, V13, P139, DOI 10.1016/j.phymed.2005.06.003; Ward HA, 2010, ARCH BIOCHEM BIOPHYS, V501, P170, DOI 10.1016/j.abb.2010.05.018; Watanabe Chigusa, 2010, Environmental Health and Preventive Medicine, V15, P319, DOI 10.1007/s12199-010-0146-1; Zand RSR, 2000, BREAST CANCER RES TR, V62, P35, DOI 10.1023/A:1006422302173	31	64	69	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74881	10.1371/journal.pone.0074881	http://dx.doi.org/10.1371/journal.pone.0074881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098354	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100012
J	Xu, B; Chen, XJ; Mao, ZL; Chen, MJ; Han, XM; Du, GZ; Ji, XL; Chang, CX; Rehan, VK; Wang, XR; Xia, YK				Xu, Bo; Chen, Xiaojiao; Mao, Zhilei; Chen, Minjian; Han, Xiumei; Du, Guizhen; Ji, Xiaoli; Chang, Chunxin; Rehan, Virender K.; Wang, Xinru; Xia, Yankai			Perfluorooctane Sulfonate Disturbs Nanog Expression through miR-490-3p in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATORY CIRCUITRY; PERFLUORINATED ACIDS; MICRORNA REGULATION; EXPOSURE; PFOS; PLURIPOTENCY; ZEBRAFISH; SERUM; TOXICITY; DICER	Perfluorooctane sulfonate (PFOS) poses potential risks to reproduction and development. Mouse embryonic stem cells (mESCs) are ideal models for developmental toxicity testing of environmental contaminants in vitro. However, the mechanism by which PFOS affects early embryonic development is still unclear. In this study, mESCs were exposed to PFOS for 24 h, and then general cytotoxicity and pluripotency were evaluated. MTT assay showed that neither PFOS (0.2 mu M, 2 mu M, 20 mu M, and 200 mu M) nor control medium (0.1% DMSO) treatments affected cell viability. Furthermore, there were no significant differences in cell cycle and apoptosis between the PFOS treatment and control groups. However, we found that the mRNA and protein levels of pluripotency markers (Sox2, Nanog) in mESCs were significantly decreased following exposure to PFOS for 24 h, while there were no significant changes in the mRNA and protein levels of Oct4. Accordingly, the expression levels of miR-145 and miR-490-3p, which can regulate Sox2 and Nanog expressions were significantly increased. Chrm2, the host gene of miR-490-3p, was positively associated with miR-490-3p expression after PFOS exposure. Dual luciferase reporter assay suggests that miR-490-3p directly targets Nanog. These results suggest that PFOS can disturb the expression of pluripotency factors in mESCs, while miR-145 and miR-490-3p play key roles in modulating this effect.	[Xu, Bo; Chen, Xiaojiao; Mao, Zhilei; Chen, Minjian; Han, Xiumei; Du, Guizhen; Ji, Xiaoli; Chang, Chunxin; Wang, Xinru; Xia, Yankai] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Xu, Bo; Chen, Xiaojiao; Mao, Zhilei; Chen, Minjian; Han, Xiumei; Du, Guizhen; Ji, Xiaoli; Chang, Chunxin; Wang, Xinru; Xia, Yankai] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Chen, Xiaojiao] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing Matern & Child Hlth Hosp, Nanjing, Jiangsu, Peoples R China; [Rehan, Virender K.] Harbor UCLA Med Ctr, David Geffen Sch Med, Dept Pediat, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Lundquist Institute	Wang, XR (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	xrwang@njmu.edu.cn; yankaixia@njmu.edu.cn	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	National 973 Program [2012CBA01306]; National Natural Science Foundation of China [81072328]; Key Project of MOE [211063]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER	National 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of MOE; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by National 973 Program (2012CBA01306); National Natural Science Foundation of China (No. 81072328); The Key Project of MOE (No. 211063); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 2009, REPROD TOXICOL, V27, P258, DOI 10.1016/j.reprotox.2008.05.061; Apelberg BJ, 2007, ENVIRON HEALTH PERSP, V115, P1670, DOI 10.1289/ehp.10334; Arbuckle TE, 2013, INT J HYG ENVIR HEAL, V216, P184, DOI 10.1016/j.ijheh.2012.03.004; Arzumanyan A, 2009, ALCOHOL CLIN EXP RES, V33, P2172, DOI 10.1111/j.1530-0277.2009.01057.x; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cai MH, 2012, J HAZARD MATER, V209, P335, DOI 10.1016/j.jhazmat.2012.01.030; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Case MT, 2001, INT J TOXICOL, V20, P101; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen H, 2012, MAR POLLUT BULL, V64, P902, DOI 10.1016/j.marpolbul.2012.03.012; Chen JF, 2013, ENVIRON TOXICOL CHEM, V32, P201, DOI 10.1002/etc.2031; Cheng W, 2013, TOXICOL IN VITRO, V27, P1503, DOI 10.1016/j.tiv.2013.03.014; Croes K, 2012, CHEMOSPHERE, V89, P988, DOI 10.1016/j.chemosphere.2012.06.058; Ehresman DJ, 2007, ENVIRON RES, V103, P176, DOI 10.1016/j.envres.2006.06.008; Fei CY, 2008, ENVIRON HEALTH PERSP, V116, P1391, DOI 10.1289/ehp.11277; Fuentes S, 2007, TOXICOL SCI, V98, P589, DOI 10.1093/toxsci/kfm121; Goosey E, 2012, ENVIRON INT, V45, P86, DOI 10.1016/j.envint.2012.04.007; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Heinrich EM, 2012, CIRC RES, V110, P1014, DOI 10.1161/CIRCRESAHA.111.243394; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huang HH, 2010, AQUAT TOXICOL, V98, P139, DOI 10.1016/j.aquatox.2010.02.003; Huang QS, 2011, AQUAT TOXICOL, V105, P71, DOI 10.1016/j.aquatox.2011.05.012; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Ibrahim WNW, 2013, TOXICOL APPL PHARM, V269, P51, DOI 10.1016/j.taap.2013.03.003; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jones PD, 2003, ENVIRON TOXICOL CHEM, V22, P2639, DOI 10.1897/02-553; Jung EM, 2010, TOXICOL IN VITRO, V24, P1538, DOI 10.1016/j.tiv.2010.06.019; Key BD, 1997, ENVIRON SCI TECHNOL, V31, P2445, DOI 10.1021/es961007c; Kraugerud M, 2011, TOXICOL LETT, V205, P62, DOI 10.1016/j.toxlet.2011.05.230; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lau C, 2003, TOXICOL SCI, V74, P382, DOI 10.1093/toxsci/kfg122; Lee HG, 2012, NEUROTOXICOLOGY, V33, P314, DOI 10.1016/j.neuro.2012.01.017; Li JG, 2013, ENVIRON INT, V53, P47, DOI 10.1016/j.envint.2012.12.002; Liao TT, 2010, J HAZARD MATER, V179, P1055, DOI 10.1016/j.jhazmat.2010.03.113; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martin JW, 2003, ENVIRON TOXICOL CHEM, V22, P189, DOI [10.1002/etc.5620220125, 10.1897/1551-5028(2003)022&lt;0189:DAOPAI&gt;2.0.CO;2]; Martin JW, 2003, ENVIRON TOXICOL CHEM, V22, P196, DOI 10.1897/1551-5028(2003)022&lt;0196:BATDOP&gt;2.0.CO;2; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; O'Loghlen A, 2012, CELL STEM CELL, V10, P33, DOI 10.1016/j.stem.2011.12.004; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Seacat AM, 2002, TOXICOL SCI, V68, P249, DOI 10.1093/toxsci/68.1.249; Shi XJ, 2008, TOXICOL APPL PHARM, V230, P23, DOI 10.1016/j.taap.2008.01.043; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Stein CR, 2012, REPROD TOXICOL, V34, P312, DOI 10.1016/j.reprotox.2012.05.039; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Toft G, 2012, HUM REPROD, V27, P2532, DOI 10.1093/humrep/des185; Wang MY, 2011, ENVIRON TOXICOL CHEM, V30, P2073, DOI 10.1002/etc.594; Washino N, 2009, ENVIRON HEALTH PERSP, V117, P660, DOI 10.1289/ehp.11681; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yahia D, 2008, J TOXICOL SCI, V33, P219, DOI 10.2131/jts.33.219; Yan H, 2012, CHEMOSPHERE, V88, P1300, DOI 10.1016/j.chemosphere.2012.03.105; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhang J, 2013, ENVIRON TOXICOL, V28, P322, DOI 10.1002/tox.20723	60	14	15	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74968	10.1371/journal.pone.0074968	http://dx.doi.org/10.1371/journal.pone.0074968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098361	gold, Green Published, Green Submitted			2022-12-25	WOS:000325427100013
J	Mazzola, V; Vuilleumier, P; Latorre, V; Petito, A; Gallese, V; Popolizio, T; Arciero, G; Bondolfi, G				Mazzola, Viridiana; Vuilleumier, Patrik; Latorre, Valeria; Petito, Annamaria; Gallese, Vittorio; Popolizio, Teresa; Arciero, Giampiero; Bondolfi, Guido			Effects of Emotional Contexts on Cerebello-Thalamo-Cortical Activity during Action Observation	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; MEDIAL TEMPORAL-LOBE; FUNCTIONAL TOPOGRAPHY; PREFRONTAL CORTEX; SUPPLEMENTARY; CONNECTIVITY; METAANALYSIS; INHIBITION; RESPONSES	Several studies investigated the neural and functional mechanisms underlying action observation in contexts with objects. However, actions seen in everyday life are often embedded in emotional contexts. The neural systems integrating emotion cues in action observation are still poorly understood. Previous findings suggest that the processing of both action and emotion information recruits motor control areas within the cerebello-thalamo-cortical pathways. It is therefore hard to determine whether social emotional contexts influence action processing via a direct modulation of motor representations coding for the observed action or via the affective state and implicit motor preparedness elicited in observers in response to emotional contexts. Here we designed a novel fMRI task to identify neural networks engaged by the affective appraisal of a grasping action seen in two different emotional contexts, while keeping the action kinematics constant. Results confirmed that observing the same acts of grasping but in different emotional contexts modulated activity in supplementary motor area, ventrolateral thalamus, anterior cerebellum. Moreover, changes in functional connectivity between left supplementary motor area and parahippocampus in different emotional contexts suggested a direct neural pathway through which emotional contexts may drive the neural motor system. Taken together, these findings shed new light on the malleability of motor system as a function of emotional contexts.	[Mazzola, Viridiana] Univ Geneva, Swiss Ctr Affect Sci CISA, Geneva, Switzerland; [Vuilleumier, Patrik] Univ Geneva, Dept Neurol, Univ Hosp, Lab Behav Neurol & Imaging Cognit, Geneva, Switzerland; [Vuilleumier, Patrik] Univ Geneva, Sch Med, Dept Neurosci, CH-1211 Geneva, Switzerland; [Latorre, Valeria; Arciero, Giampiero] Inst Postrationalist Psychol IPRA, Rome, Italy; [Petito, Annamaria; Arciero, Giampiero] Univ Foggia, Dept Med Sci, Inst Psychiat & Clin Psychol, Foggia, Italy; [Gallese, Vittorio; Arciero, Giampiero] Univ Parma, Dept Neurosci, Physiol Sect, I-43100 Parma, Italy; [Gallese, Vittorio; Arciero, Giampiero] Italian Inst Technol IIT, Brain Ctr Social & Motor Cognit, Parma, Italy; [Popolizio, Teresa; Arciero, Giampiero] Casa Sollievo Sofferenza IRCCSS, Dept Neuroradiol, Foggia, Italy; [Arciero, Giampiero; Bondolfi, Guido] Univ Hosp Geneva, Dept Mental Hlth & Psychiat, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Foggia; University of Parma; Istituto Italiano di Tecnologia - IIT; IRCCS Casa Sollievo Della Sofferenza; University of Geneva	Mazzola, V (corresponding author), Univ Geneva, Swiss Ctr Affect Sci CISA, Geneva, Switzerland.	Viridiana.Mazzola@unige.ch	Vuilleumier, Patrik/AAJ-1839-2021; Gallese, Vittorio/ABD-5097-2021	Vuilleumier, Patrik/0000-0002-8198-9214; Gallese, Vittorio/0000-0003-4815-3607				Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Arciero G, 1989, EVOLUTIONARY EPISTEM; Arciero G., 2009, SELFHOOD IDENTITY PE; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Baumann O, 2012, NEUROIMAGE, V61, P805, DOI 10.1016/j.neuroimage.2012.03.044; Bermejo-Pareja F, 2011, NAT REV NEUROL, V7, P273, DOI 10.1038/nrneurol.2011.44; Boy F, 2010, CURR BIOL, V20, P1779, DOI 10.1016/j.cub.2010.09.003; Boy F, 2010, EXP BRAIN RES, V206, P441, DOI 10.1007/s00221-010-2417-x; Carbon M, 2011, BRAIN, V134, P1416, DOI 10.1093/brain/awr060; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Chang SE, 2011, CEREB CORTEX, V21, P2507, DOI 10.1093/cercor/bhr028; Coelho CM, 2010, NEUROSCI LETT, V481, P135, DOI 10.1016/j.neulet.2010.03.027; Cojan Y, 2009, NEUROIMAGE, V47, P1026, DOI 10.1016/j.neuroimage.2009.05.023; Coombes SA, 2009, COGN AFFECT BEHAV NE, V9, P380, DOI 10.3758/CABN.9.4.380; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Dinomais M, 2009, NEUROREPORT, V20, P1351, DOI 10.1097/WNR.0b013e328330cd43; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Edwards MJ, 2012, BRAIN, V135, P3495, DOI 10.1093/brain/aws129; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ekman P., 1976, PICTURES FACIAL AFFE; Ekman P., 1999, HDB COGN EMOT, V98, P16; Ferri F, 2013, PONE, V8, P54091, DOI [10.1371/journal.pone.0054091, DOI 10.1371/J0URNAL.P0NE.0054091.PUBMED:23349792]; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Frijda N.H.., 1986, REV PHILOS LOUVAIN; Frijda NH, 1995, PSYCHOL FACIAL EXPRE; Frith C, 2010, NEURON, V65, P739, DOI 10.1016/j.neuron.2010.03.015; Gallese V, 2011, TRENDS COGN SCI, V15, P512, DOI 10.1016/j.tics.2011.09.003; Griffiths PE, 2008, CAMBRIDGE HDB SITUAT; Grosbras MH, 2006, CEREB CORTEX, V16, P1087; Grosbras MH, 2012, HUM BRAIN MAPP, V33, P431, DOI 10.1002/hbm.21222; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; Hinde R. A., 1985, DEV EXPRESSIVE BEHAV, P103; HINDE RA, 1985, ANIM BEHAV, V33, P985, DOI 10.1016/S0003-3472(85)80032-4; HORNE MK, 1995, PROG NEUROBIOL, V46, P199, DOI 10.1016/0301-0082(95)00002-D; Howard LR, 2011, J NEUROSCI, V31, P5253, DOI 10.1523/JNEUROSCI.6055-10.2011; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kelly RM, 2003, J NEUROSCI, V23, P8432; Keysers C, 2009, CURR OPIN NEUROBIOL, V19, P666, DOI 10.1016/j.conb.2009.10.006; Kveraga K, 2011, P NATL ACAD SCI USA, V108, P3389, DOI 10.1073/pnas.1013760108; Lench HC, 2011, PSYCHOL BULL, V137, P834, DOI 10.1037/a0024244; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Mullally SL, 2011, J NEUROSCI, V31, P7441, DOI 10.1523/JNEUROSCI.0267-11.2011; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Neef NE, 2011, CORTEX, V47, P945, DOI 10.1016/j.cortex.2010.06.007; Oliveri M, 2003, EXP BRAIN RES, V149, P214, DOI 10.1007/s00221-002-1346-8; Paulhus D. L., 2007, HDB RES METHODS PERS; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Pichon S, 2012, CEREB CORTEX, V22, P274, DOI 10.1093/cercor/bhr060; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Sagaspe P, 2011, NEUROIMAGE, V55, P1825, DOI 10.1016/j.neuroimage.2011.01.027; Schutter DJLG, 2008, PSYCHOPHYSIOLOGY, V45, P345, DOI 10.1111/j.1469-8986.2007.00635.x; Shmuelof L, 2006, J NEUROSCI, V26, P9736, DOI 10.1523/JNEUROSCI.1836-06.2006; Singer T, 2012, NEUROIMAGE, V61, P437, DOI 10.1016/j.neuroimage.2012.01.109; Smith SD, 2011, NEUROIMAGE, V58, P269, DOI 10.1016/j.neuroimage.2011.06.004; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spraker MB, 2007, J NEUROPHYSIOL, V98, P821, DOI 10.1152/jn.00239.2007; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Sumner P, 2008, NEUROSCIENTIST, V14, P474, DOI 10.1177/1073858408314435; Sumner P, 2007, NEURON, V54, P697, DOI 10.1016/j.neuron.2007.05.016; Talairach J., 1998, COPLANAR STEREOTAXIC; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Torriero S, 2011, J COGNITIVE NEUROSCI, V23, P338, DOI 10.1162/jocn.2010.21471; van Loon AM, 2010, COGN AFFECT BEHAV NE, V10, P174, DOI 10.3758/CABN.10.2.174; Voon V, 2010, BRAIN, V133, P1526, DOI 10.1093/brain/awq054; Vuilleumier P, 2001, BRAIN, V124, P1077, DOI 10.1093/brain/124.6.1077; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Wardak C, 2011, J NEUROSCI, V31, P5181, DOI 10.1523/JNEUROSCI.0006-11.2011; Wolbers T, 2011, CURR BIOL, V21, P984, DOI 10.1016/j.cub.2011.04.038	78	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75912	10.1371/journal.pone.0075912	http://dx.doi.org/10.1371/journal.pone.0075912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086664	Green Published, gold			2022-12-25	WOS:000325220000053
J	Sinha, D; Gupta, MK; Patel, HK; Ranjan, A; Sonti, RV				Sinha, Dipanwita; Gupta, Mahesh Kumar; Patel, Hitendra Kumar; Ranjan, Ashish; Sonti, Ramesh V.			Cell Wall Degrading Enzyme Induced Rice Innate Immune Responses Are Suppressed by the Type 3 Secretion System Effectors XopN, XopQ, XopX and XopZ of Xanthomonas oryzae pv. oryzae	PLOS ONE			English	Article							GENOME SEQUENCE; III EFFECTOR; PSEUDOMONAS-SYRINGAE; TRIGGERED IMMUNITY; PLANT IMMUNITY; DANGER SIGNALS; VIRULENCE; CAMPESTRIS; ARABIDOPSIS; DEFENSE	Innate immune responses are induced in plants and animals through perception of Damage Associated Molecular Patterns. These immune responses are suppressed by pathogens during infection. A number of studies have focussed on identifying functions of plant pathogenic bacteria that are involved in suppression of Pathogen Associated Molecular Pattern induced immune responses. In comparison, there is very little information on functions used by plant pathogens to suppress Damage Associated Molecular Pattern induced immune responses. Xanthomonas oryzae pv. oryzae, a gram negative bacterial pathogen of rice, secretes hydrolytic enzymes such as LipA (Lipase/Esterase) that damage rice cell walls and induce innate immune responses. Here, we show that Agrobacterium mediated transient transfer of the gene for XopN, a X. oryzae pv. oryzae type 3 secretion (T3S) system effector, results in suppression of rice innate immune responses induced by LipA. A xopN(-) mutant of X. oryzae pv. oryzae retains the ability to suppress these innate immune responses indicating the presence of other functionally redundant proteins. In transient transfer assays, we have assessed the ability of 15 other X. oryzae pv. oryzae T3S secreted effectors to suppress rice innate immune responses. Amongst these proteins, XopQ, XopX and XopZ are suppressors of LipA induced innate immune responses. A mutation in any one of the xopN, xopQ, xopX or xopZ genes causes partial virulence deficiency while a xopN(-) xopX(-) double mutant exhibits a greater virulence deficiency. A xopN(-) xopQ(-) xopX(-) xopZ(-) quadruple mutant of X. oryzae pv. oryzae induces callose deposition, an innate immune response, similar to a X. oryzae pv. oryzae T3S(-) mutant in rice leaves. Overall, these results indicate that multiple T3S secreted proteins of X. oryzae pv. oryzae can suppress cell wall damage induced rice innate immune responses.	[Sinha, Dipanwita; Gupta, Mahesh Kumar; Patel, Hitendra Kumar; Ranjan, Ashish; Sonti, Ramesh V.] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sonti, RV (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	sonti@ccmb.res.in	Ranjan, Ashish/I-5058-2019	Ranjan, Ashish/0000-0002-6711-2088	Department of Biotechnology (DBT), Government of India; Council of Scientific and Industrial Research (CSIR); DBT; CSIR	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); DBT(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants to RVS from the Department of Biotechnology (DBT), Government of India and the Plant-Microbe and Soil Interactions project of the Council of Scientific and Industrial Research (CSIR). DS and MKG were supported by doctoral and post-doctoral fellowships, respectively, from the DBT. AR was supported by a doctoral fellowship from CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto-Tomiyama C, 2012, MOL PLANT MICROBE IN, V25, P505, DOI 10.1094/MPMI-06-11-0167; ALBERSHEIM P, 1969, ANNU REV PHYTOPATHOL, V7, P171, DOI 10.1146/annurev.py.07.090169.001131; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aparna G, 2009, PLANT CELL, V21, P1860, DOI 10.1105/tpc.109.066886; Bartetzko V, 2009, MOL PLANT MICROBE IN, V22, P655, DOI 10.1094/MPMI-22-6-0655; BESTWICK CS, 1995, PLANT PHYSIOL, V108, P503, DOI 10.1104/pp.108.2.503; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Cheng YF, 2004, PLANT PHYSIOL, V135, P1020, DOI 10.1104/pp.104.044495; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cunha C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00286; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DARVILL AG, 1984, ANNU REV PLANT PHYS, V35, P243, DOI 10.1146/annurev.pp.35.060184.001331; Furutani A, 2009, MOL PLANT MICROBE IN, V22, P96, DOI 10.1094/MPMI-22-1-0096; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Giska F, 2013, PLANT PHYSIOL, V161, P2049, DOI 10.1104/pp.112.209023; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; HOOD EE, 1986, J BACTERIOL, V168, P1291, DOI 10.1128/jb.168.3.1291-1301.1986; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; INNES RW, 1988, J BACTERIOL, V170, P3793, DOI 10.1128/jb.170.9.3793-3802.1988; Jha G, 2007, MOL PLANT MICROBE IN, V20, P31, DOI 10.1094/MPMI-20-0031; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Kim JG, 2003, J BACTERIOL, V185, P3155, DOI 10.1128/JB.185.10.3155-3166.2003; Kim JG, 2008, PLANT CELL, V20, P1915, DOI 10.1105/tpc.108.058529; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; LEACH JE, 1990, MOL PLANT MICROBE IN, V3, P238, DOI 10.1094/MPMI-3-238; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059684; Metz M, 2005, PLANT J, V41, P801, DOI 10.1111/j.1365-313X.2005.02338.x; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Ochiai H, 2005, JARQ-JPN AGR RES Q, V39, P275, DOI 10.6090/jarq.39.275; Pandey A, 2010, J BACTERIOL, V192, P3187, DOI 10.1128/JB.01558-09; Pennell RI, 1997, PLANT CELL, V9, P1157, DOI 10.1105/tpc.9.7.1157; Pieretti I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-616; Rajeshwari R, 2005, MOL PLANT MICROBE IN, V18, P830, DOI 10.1094/MPMI-18-0830; Ray SK, 2000, MOL PLANT MICROBE IN, V13, P394, DOI 10.1094/MPMI.2000.13.4.394; Roden J, 2004, MOL PLANT MICROBE IN, V17, P633, DOI 10.1094/MPMI.2004.17.6.633; Roden JA, 2004, P NATL ACAD SCI USA, V101, P16624, DOI 10.1073/pnas.0407383101; RYAN CA, 1991, ANNU REV PLANT PHYS, V42, P651, DOI 10.1146/annurev.pp.42.060191.003251; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schulze S, 2012, NEW PHYTOL, V195, P894, DOI 10.1111/j.1469-8137.2012.04210.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Song CF, 2010, MOL PLANT MICROBE IN, V23, P893, DOI 10.1094/MPMI-23-7-0893; Swords KMM, 1996, J BACTERIOL, V178, P4661, DOI 10.1128/jb.178.15.4661-4669.1996; Taylor KW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002768; Wang LF, 2007, MOL PLANT PATHOL, V8, P491, DOI 10.1111/J.1364-3703.2007.00409.X; Windgassen M, 2000, FEMS MICROBIOL LETT, V193, P201, DOI 10.1016/S0378-1097(00)00476-6; Zhao S, 2013, WORLD J MICROB BIOT, V29, P733, DOI 10.1007/s11274-012-1229-5	54	48	49	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75867	10.1371/journal.pone.0075867	http://dx.doi.org/10.1371/journal.pone.0075867			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086651	gold, Green Published, Green Submitted			2022-12-25	WOS:000325220000049
J	Andriantahina, F; Liu, XL; Huang, H				Andriantahina, Farafidy; Liu, Xiaolin; Huang, Hao			Genetic Map Construction and Quantitative Trait Locus (QTL) Detection of Growth-Related Traits in Litopenaeus vannamei for Selective Breeding Applications	PLOS ONE			English	Article							PACIFIC WHITE SHRIMP; LINKAGE MAP; AFLP; MICROSATELLITES; GENOME; PERFORMANCE; SOFTWARE; MARKERS; SSR	Growth is a priority trait from the point of view of genetic improvement. Molecular markers linked to quantitative trait loci (QTL) have been regarded as useful for marker-assisted selection (MAS) in complex traits as growth. Using an intermediate F-2 cross of slow and fast growth parents, a genetic linkage map of Pacific whiteleg shrimp, Litopenaeus vannamei, based on amplified fragment length polymorphisms (AFLP) and simple sequence repeats (SSR) markers was constructed. Meanwhile, QTL analysis was performed for growth-related traits. The linkage map consisted of 451 marker loci (429 AFLPs and 22 SSRs) which formed 49 linkage groups with an average marker space of 7.6 cM; they spanned a total length of 3627.6 cM, covering 79.50% of estimated genome size. 14 QTLs were identified for growth-related traits, including three QTLs for body weight (BW), total length (TL) and partial carapace length (PCL), two QTLs for body length (BL), one QTL for first abdominal segment depth (FASD), third abdominal segment depth (TASD) and first abdominal segment width (FASW), which explained 2.62 to 61.42% of phenotypic variation. Moreover, comparison of linkage maps between L. vannamei and Penaeus japonicus was applied, providing a new insight into the genetic base of QTL affecting the growth-related traits. The new results will be useful for conducting MAS breeding schemes in L. vannamei.	[Andriantahina, Farafidy; Liu, Xiaolin] Northwest A&F Univ, Shaanxi Key Lab Mol Biol Agr, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Huang, Hao] Hainan Guangtai Ocean Breeding Co Ltd, Haikou, Peoples R China	Northwest A&F University - China	Liu, XL (corresponding author), Northwest A&F Univ, Shaanxi Key Lab Mol Biol Agr, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	liuxiaolin@nwsuaf.edu.cn			Northwest A&F University, China [XNY2013-4]; National Ministry of Agricultural Science and Technology, China [2012GB2E200361]; National Fundamental Research Program, China [2006AA10A406]	Northwest A&F University, China; National Ministry of Agricultural Science and Technology, China; National Fundamental Research Program, China	This research work was supported by the collaborative project of Northwest A&F University, China (XNY2013-4), National Ministry of Agricultural Science and Technology, China (2012GB2E200361), and National Fundamental Research Program, China (2006AA10A406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriantahina F, 2013, MAR BIOTECHNOL, V15, P399, DOI 10.1007/s10126-013-9500-9; Andriantahina F, 2013, CHIN J OCEANOL LIMN, V31, P534, DOI 10.1007/s00343-013-2220-1; Andriantahina F, 2012, CHIN J OCEANOL LIMN, V30, P200, DOI 10.1007/s00343-012-1066-2; Andriantahina F, 2012, AQUACULTURE, V324, P194, DOI 10.1016/j.aquaculture.2011.10.026; ARMSTRONG KC, 1982, CAN J GENET CYTOL, V24, P735, DOI 10.1139/g82-079; Ball AO, 1998, MOL ECOL, V7, P1251; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Du ZQ, 2010, ANIM GENET, V41, P286, DOI 10.1111/j.1365-2052.2009.02002.x; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Kasha K J, 1970, Nature, V225, P874, DOI 10.1038/225874a0; Kiani SP, 2009, PLANT BREEDING, V128, P363, DOI 10.1111/j.1439-0523.2009.01628.x; Kocher TD, 1998, GENETICS, V148, P1225; Li L, 2005, AQUACULTURE, V245, P63, DOI 10.1016/j.aquaculture.2004.12.015; Li YT, 2006, AQUACULTURE, V258, P198, DOI 10.1016/j.aquaculture.2006.04.027; Liu B, 2010, CHIN J OCEANOL LIMN, V28, P815, DOI 10.1007/s00343-010-9915-3; [刘萍 Liu Ping], 2004, [海洋水产研究, Marine Fisheries Research], V25, P80; Liu ZJ, 2003, GENETICS, V165, P687; [罗云 Luo Yun], 2010, [渔业科学进展, Progress in Fishery Sciences], V31, P56; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Maneeruttanarungroj C, 2006, ANIM GENET, V37, P363, DOI 10.1111/j.1365-2052.2006.01493.x; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Meehan D, 2003, MAR BIOTECHNOL, V5, P311, DOI 10.1007/s10126-002-0092-z; NAG DK, 1989, NATURE, V340, P318, DOI 10.1038/340318a0; Ng SHS, 2005, GENOMICS, V86, P396, DOI 10.1016/j.ygeno.2005.06.001; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez-Ramos I, 2012, SCI WORLD J, DOI 10.1100/2012/369802; Sekino M, 2007, GENETICS, V175, P945, DOI 10.1534/genetics.106.065839; Upadyayula N, 2006, THEOR APPL GENET, V112, P592, DOI 10.1007/s00122-005-0133-x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang J., 2012, AFR J BIOTECHNOL, V11, P7874; Wang S., 2007, WINDOWS QTL CARTOGRA; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0; Woram RA, 2003, GENOME RES, V13, P272, DOI 10.1101/gr.578503; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-135; Yu ZN, 2003, BIOL BULL-US, V204, P327, DOI 10.2307/1543603; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang LS, 2007, GENETICA, V131, P37, DOI 10.1007/s10709-006-9111-8; [张天时 ZHANG Tianshi], 2006, [海洋水产研究, Marine Fisheries Research], V27, P34	39	42	44	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75206	10.1371/journal.pone.0075206	http://dx.doi.org/10.1371/journal.pone.0075206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086466	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700057
J	Beer, B; Erb, R; Pavlic, M; Ulmer, H; Giacomuzzi, S; Riemer, Y; Oberacher, H				Beer, Beate; Erb, Robert; Pavlic, Marion; Ulmer, Hanno; Giacomuzzi, Salvatore; Riemer, Yvonne; Oberacher, Herbert			Association of Polymorphisms in Pharmacogenetic Candidate Genes (OPRD1, GAL, ABCB1, OPRM1) with Opioid Dependence in European Population: A Case-Control Study	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE GENE; P-GLYCOPROTEIN; SEQUENCE VARIATIONS; HEROIN-ADDICTION; GALANIN; VARIANTS; ALLELE; OPIATE; ABUSE	It is becoming increasingly evident that genetic variants contribute to the development of opioid addiction. An elucidation of these genetic factors is crucial for a better understanding of this chronic disease and may help to develop novel therapeutic strategies. In recent years, several candidate genes were implicated in opioid dependence. However, most study findings have not been replicated and additional studies are required before reported associations can be considered robust. Thus, the major objective of this study was to replicate earlier findings and to identify new genetic polymorphisms contributing to the individual susceptibility to opioid addiction, respectively. Therefore, a candidate gene association study was conducted including 142 well-phenotyped long-term opioid addicts undergoing opioid maintenance therapy and 142 well-matched healthy controls. In both study groups, 24 single nucleotide polymorphisms predominantly located in pharmacogenetic candidate genes have been genotyped using an accurate mass spectrometry based method. The most significant associations with opioid addiction (remaining significant after adjustment for multiple testing) were observed for the rs948854 SNP in the galanin gene (GAL, p = 0.001) and the rs2236861 SNP in the delta opioid receptor gene (OPRD1, p = 0.001). Moreover, an association of the ATP binding cassette transporter 1 (ABCB1) variant rs1045642 and the Mu Opioid receptor (OPRM1) variant rs9479757 with opioid addiction was observed. The present study provides further support for a contribution of GAL and OPRD1 variants to the development of opioid addiction. Furthermore, our results indicate a potential contribution of OPRM1 and ABCB1 SNPs to the development of this chronic relapsing disease. Therefore it seems important that these genes are addressed in further addiction related studies.	[Beer, Beate; Erb, Robert; Pavlic, Marion; Oberacher, Herbert] Med Univ Innsbruck, Inst Legal Med, A-6020 Innsbruck, Austria; [Ulmer, Hanno] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria; [Giacomuzzi, Salvatore; Riemer, Yvonne] Med Univ Innsbruck, Dept Gen Psychiat, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Oberacher, H (corresponding author), Med Univ Innsbruck, Inst Legal Med, A-6020 Innsbruck, Austria.	herbert.oberacher@i-med.ac.at	Ulmer, Hanno/S-6615-2019; Parson, Walther/AAD-6845-2020	Ulmer, Hanno/0000-0001-5911-1002; Oberacher, Herbert/0000-0002-0963-8268	Anniversary Fund of the Oesterreichische Nationalbank [13253]	Anniversary Fund of the Oesterreichische Nationalbank	This study was funded by the Anniversary Fund of the Oesterreichische Nationalbank (http://www.oenb.at/de/ueber_die_oenb/foerderung/jubilaeumsfonds/jubilaeumsfonds.jsp; grant number: 13253). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Carrion Oscar, 2012, Curr Drug Abuse Rev, V5, P178; Bart G, 2004, MOL PSYCHIATR, V9, P547, DOI 10.1038/sj.mp.4001504; Beer B, 2012, ANALYST, V137, P5325, DOI 10.1039/c2an35440c; Beer B, 2011, ANAL BIOANAL CHEM, V400, P2361, DOI 10.1007/s00216-010-4597-4; Brandstatter A, 2007, FORENSIC SCI INT, V166, P164, DOI 10.1016/j.forsciint.2006.05.006; Cascorbi I, 2011, HANDB EXP PHARMACOL, V201, P261, DOI 10.1007/978-3-642-14541-4_6; Coller JK, 2006, CLIN PHARMACOL THER, V80, P682, DOI 10.1016/j.clpt.2006.09.011; Crettol S, 2006, CLIN PHARMACOL THER, V80, P668, DOI 10.1016/j.clpt.2006.09.012; de Klerk Onno L., 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P197; Farre M, 2002, DRUG ALCOHOL DEPEN, V65, P283, DOI 10.1016/S0376-8716(01)00171-5; Fonseca F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019527; Fujii T, 2012, J PSYCHIATR RES, V46, P555, DOI 10.1016/j.jpsychires.2012.01.012; Gelernter Joel, 2010, Dialogues Clin Neurosci, V12, P77; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Ho MK, 2010, CLIN PHARMACOL THER, V88, P779, DOI 10.1038/clpt.2010.175; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Huang CJ, 2008, ANAESTHESIA, V63, P1288, DOI 10.1111/j.1365-2044.2008.05760.x; Hung CC, 2011, PHARMACOGENOMICS, V12, P1525, DOI [10.2217/PGS.11.96, 10.2217/pgs.11.96]; Kadiev E, 2008, EXPERT OPIN DRUG MET, V4, P77, DOI 10.1517/17425255.4.1.77 ; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Kreek MJ, 2005, PHARMACOL REV, V57, P1, DOI 10.1124/pr.57.1.1; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Levran O, 2008, GENES BRAIN BEHAV, V7, P720, DOI 10.1111/j.1601-183X.2008.00410.x; Levran O, 2008, HUM MOL GENET, V17, P2219, DOI 10.1093/hmg/ddn122; Levran O, 2012, HUM GENET, V131, P823, DOI 10.1007/s00439-012-1172-4; Li MD, 2009, NAT REV GENET, V10, P225, DOI 10.1038/nrg2536; Li T, 2002, AM J MED GENET, V114, P329, DOI 10.1002/ajmg.10200; Lotsch J, 2009, PHARMACOL THERAPEUT, V124, P168, DOI 10.1016/j.pharmthera.2009.06.010; Mroziewicz Margaret, 2010, Addict Sci Clin Pract, V5, P17; Nelson EC, 2014, ADDICT BIOL, V19, P111, DOI 10.1111/j.1369-1600.2012.00445.x; Oberacher H, 2005, ANAL CHEM, V77, P4999, DOI 10.1021/ac050399f; Picciotto MR, 2010, EXPERIENTIA SUPPL, V102, P195, DOI 10.1007/978-3-0346-0228-0_14; Terman GW, 2004, BRIT J PHARMACOL, V141, P55, DOI 10.1038/sj.bjp.0705595; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Unschuld PG, 2008, J AFFECT DISORDERS, V105, P177, DOI 10.1016/j.jad.2007.05.006; Unschuld PG, 2010, NEUROPSYCHOPHARMACOL, V35, P1583, DOI 10.1038/npp.2010.30; Vandenbergh DJ, 1997, AM J MED GENET, V74, P439, DOI 10.1002/(SICI)1096-8628(19970725)74:4<439::AID-AJMG16>3.0.CO;2-J; Yuferov V, 2010, ANN NY ACAD SCI, V1187, P184, DOI 10.1111/j.1749-6632.2009.05275.x; Zhang H, 2008, MOL PSYCHIATR, V13, P531, DOI 10.1038/sj.mp.4002035; ZHANG L, 2008, BEHAV BRAIN FUNCT, V2, P28; Zheng HX, 2002, HUM IMMUNOL, V63, P765, DOI 10.1016/S0198-8859(02)00426-3; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	44	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75359	10.1371/journal.pone.0075359	http://dx.doi.org/10.1371/journal.pone.0075359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086514	gold, Green Published, Green Submitted			2022-12-25	WOS:000325218700080
J	Kim, SH; Kim, JY; Choi, Y; Nguyen, HH; Song, MK; Chang, J				Kim, So-Hee; Kim, Joo Young; Choi, Youngjoo; Nguyen, Huan H.; Song, Man Ki; Chang, Jun			Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection	PLOS ONE			English	Article							A VIRUS; SINGLE MUCOSAL; IMMUNITY; IMMUNIZATION; MICE; ANTIBODIES; RESPONSES; VACCINES; PROTEIN; NASAL	Influenza vaccines that target the highly variable surface glycoproteins hemagglutinin and neuraminidase cause inconvenience of having vaccination every year. For this reason, development of universal vaccines targeting conserved viral components is needed. In this study, we generated recombinant adenovirus (rAd) vaccine encoding nucleoprotein (NP) of A/PR/8/34 influenza virus, designated rAd/NP BALB/c mice were immunized intranasally or sublingually with rAd/NP vaccine and subsequently challenged with lethal doses of heterologous as well as homologous influenza viruses. We found that intranasal immunization of rAd/NP elicited strong mucosal IgA responses as well as stronger CD8 T-cell responses toward immunodominant K-d-restricted NP147-155 epitope than sublingual immunization. Importantly, only single intranasal but not sublingual immunization of rAd/NP provides potent protection against both homologous and heterologous influenza virus challenges. These results suggest that recombinant rAd/ NP could be a universal vaccine candidate for mucosal administration against influenza virus.	[Kim, So-Hee; Kim, Joo Young; Choi, Youngjoo; Chang, Jun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Nguyen, Huan H.; Song, Man Ki] Int Vaccine Inst, Div Sci Lab, Seoul, South Korea	Ewha Womans University; International Vaccine Institute	Chang, J (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea.	tcell@ewha.ac.kr	Kim, Jooyoung/R-5839-2018	Kim, Jooyoung/0000-0003-4846-6259; CHANG, JUN/0000-0002-8423-5987	TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea) which part of Korea Healthcare technology R&D Project by Ministry of Health & Welfare, Republic of Korea [A103001]	TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea) which part of Korea Healthcare technology R&D Project by Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea) which part of Korea Healthcare technology R&D Project by Ministry of Health & Welfare, Republic of Korea (Grant No. : A103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2001, J CLIN IMMUNOL, V21, P227, DOI 10.1023/A:1011087132180; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Crowe SR, 2003, J EXP MED, V198, P399, DOI 10.1084/jem.20022151; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Dai C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2755; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hillaire MLB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939860; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032226; Kim S, 2010, VACCINE, V28, P3801, DOI 10.1016/j.vaccine.2010.03.032; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Kurono Y, 1999, J INFECT DIS, V180, P122, DOI 10.1086/314827; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Lemiale F, 2003, J VIROL, V77, P10078, DOI 10.1128/JVI.77.18.10078-10087.2003; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; MOLDOVEANU Z, 1995, VACCINE, V13, P1006, DOI 10.1016/0264-410X(95)00016-T; Pabst R, 2008, TRENDS IMMUNOL, V29, P206, DOI 10.1016/j.it.2008.02.006; Park Min-Hee, 2012, Immune Netw, V12, P261, DOI 10.4110/in.2012.12.6.261; Pedersen GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026973; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Shim BS, 2013, J MICROBIOL, V51, P130, DOI 10.1007/s12275-013-2399-z; Shim BS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-215; Soboleski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021937; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Tretyakova I, 2013, VIROLOGY, V442, P67, DOI 10.1016/j.virol.2013.03.027; Tutykhina IL, 2011, J MOL MED, V89, P331, DOI 10.1007/s00109-010-0696-0; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Van Kampen KR, 2005, VACCINE, V23, P1029, DOI 10.1016/j.vaccine.2004.07.043; van Riet E, 2012, VACCINE, V30, P5893, DOI 10.1016/j.vaccine.2012.04.109; WALKER RI, 1994, VACCINE, V12, P387, DOI 10.1016/0264-410X(94)90112-0; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; YEWDELL JW, 1981, J IMMUNOL, V126, P1814; Zhang JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022605; Zhou DM, 2010, MOL THER, V18, P2182, DOI 10.1038/mt.2010.202	44	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75460	10.1371/journal.pone.0075460	http://dx.doi.org/10.1371/journal.pone.0075460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086536	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700088
J	Tang, FM; Sally, B; Ciszewski, C; Abadie, V; Curran, SA; Groh, V; FitzGerald, O; Winchester, RJ; Jabri, B				Tang, Fangming; Sally, Benjamin; Ciszewski, Cezary; Abadie, Valerie; Curran, Shane A.; Groh, Veronika; FitzGerald, Oliver; Winchester, Robert J.; Jabri, Bana			Interleukin 15 Primes Natural Killer Cells to Kill via NKG2D and cPLA2 and This Pathway Is Active in Psoriatic Arthritis	PLOS ONE			English	Article							CELIAC-DISEASE; NK CELLS; T-CELLS; CYTOKINE SECRETION; MAST-CELLS; RECEPTORS; TISSUE; IL-15; CTL; IMMUNOPATHOLOGY	NK cells are large granular lymphocytes that form a critical component of the innate immune system, whose functions include the killing of cells expressing stress-induced molecules. It is increasingly accepted that despite being considered prototypical effector cells, NK cells require signals to reach their full cytotoxic potential. We previously showed that IL-15 is capable of arming CD8 effector T cells to kill independently of their TCR via NKG2D in a cPLA2-dependent process. As NK cells also express NKG2D, we wanted to investigate whether this pathway functioned in an analogous manner and if resting NK cells could be primed to the effector phase by IL-15. Furthermore, to establish relevance to human disease we studied a possible role for this pathway in the pathogenesis of psoriatic arthritis, since there are aspects of this disease that suggest a potential effector role for the innate immune system. We found that PsA patients had upregulated IL-15 and MIC in their affected synovial tissues, and that this unique inflammatory environment enabled NK cell activation and killing via NKG2D and cPLA2. Moreover, we were able to reproduce the phenotype of joint NK cells from blood NK cells by incubating them with IL-15. Altogether, these findings suggest a destructive role for NK cells when activated by environmental stress signals during the pathogenesis of PsA and demonstrate that IL-15 is capable of priming resting NK cells in tissues to the effector phase.	[Tang, Fangming; Sally, Benjamin; Ciszewski, Cezary; Abadie, Valerie; Curran, Shane A.; Jabri, Bana] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Sally, Benjamin] Columbia Univ, Dept Microbiol & Immunol, New York, NY USA; [Curran, Shane A.; Winchester, Robert J.] Columbia Univ, Dept Med, New York, NY USA; [Groh, Veronika] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [FitzGerald, Oliver] Univ Coll Dublin, Dept Rheumatol, St Vincents Univ Hosp, Dublin 2, Ireland; [FitzGerald, Oliver] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland	University of Chicago; Columbia University; Columbia University; Fred Hutchinson Cancer Center; University College Dublin; Saint Vincent's University Hospital; University College Dublin	Jabri, B (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bjabri@bsd.uchicago.edu		FitzGerald, Oliver/0000-0002-6607-6070	 [R01 DK067180];  [R01 DK058727]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058727, R01DK067180] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01 DK067180 and R01 DK058727. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allez M, 2007, GASTROENTEROLOGY, V132, P2346, DOI 10.1053/j.gastro.2007.03.025; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Costello PJ, 2001, J IMMUNOL, V166, P2878, DOI 10.4049/jimmunol.166.4.2878; Curran SA, 2004, J IMMUNOL, V172, P1935, DOI 10.4049/jimmunol.172.3.1935; Dai ZP, 2009, J EXP MED, V206, P793, DOI 10.1084/jem.20081648; de Matos CT, 2007, IMMUNOLOGY, V122, P291, DOI 10.1111/j.1365-2567.2007.02638.x; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; FitzGerald O, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2580; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; McGonagle D, 2009, CURR OPIN RHEUMATOL, V21, P340, DOI 10.1097/BOR.0b013e32832c6ab9; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; Perricone R, 2008, AUTOIMMUN REV, V7, P384, DOI 10.1016/j.autrev.2008.03.002; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Tang FM, 2009, J EXP MED, V206, P707, DOI 10.1084/jem.20071887; Ueno N, 2011, J BIOL CHEM, V286, P37249, DOI 10.1074/jbc.M111.290312; Villadsen LS, 2003, J CLIN INVEST, V112, P1571, DOI 10.1172/JCI200318986; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Winchester R, 2012, ARTHRITIS RHEUM-US, V64, P1134, DOI 10.1002/art.33415; Yokomizo T, 2011, ADV ENZYME REGUL, V51, P59, DOI 10.1016/j.advenzreg.2010.08.002	29	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76292	10.1371/journal.pone.0076292	http://dx.doi.org/10.1371/journal.pone.0076292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086722	Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700123
J	Zhu, JN; Chen, R; Fu, YH; Lin, QX; Huang, S; Guo, LL; Zhang, MZ; Deng, CY; Zou, X; Zhong, SL; Yang, M; Zhuang, J; Yu, XY; Shan, ZX				Zhu, Jie-Ning; Chen, Ren; Fu, Yong-Heng; Lin, Qiu-Xiong; Huang, Shuai; Guo, Lin-Lin; Zhang, Meng-Zhen; Deng, Chun-Yu; Zou, Xiao; Zhong, Shi-Long; Yang, Min; Zhuang, Jian; Yu, Xi-Yong; Shan, Zhi-Xin			Smad3 Inactivation and MiR-29b Upregulation Mediate the Effect of Carvedilol on Attenuating the Acute Myocardium Infarction-Induced Myocardial Fibrosis in Rat	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; CARDIAC FIBROBLASTS; PULMONARY-FIBROSIS; OXIDATIVE STRESS; MICRORNAS; EXPRESSION; DISEASE; MODEL; ANTIOXIDANT; MORBIDITY	Carvedilol, a nonselective beta-adrenoreceptor antagonist, protects against myocardial injury induced by acute myocardium infarction (AMI). The mechanisms underlying the anti-fibrotic effects of carvedilol are unknown. Recent studies have revealed the critical role of microRNAs (miRNAs) in a variety of cardiovascular diseases. This study investigated whether miR-29b is involved in the cardioprotective effect of carvedilol against AMI-induced myocardial fibrosis. Male SD rats were randomized into several groups: the sham surgery control, left anterior descending (LAD) surgery-AMI model, AMI plus low-dose carvedilol treatment (1 mg/kg per day, CAR-L), AMI plus medium-dose carvedilol treatment (5 mg/kg per day, CAR-M) and AMI plus high-dose carvedilol treatment (10 mg/kg per day, CAR-H). Cardiac remodeling and impaired heart function were observed 4 weeks after LAD surgery treatment; the observed cardiac remodeling, decreased ejection fraction, and fractional shortening were rescued in the CAR-M and CAR-H groups. The upregulated expression of Col1a1, Col3a1, and alpha-SMA mRNA was significantly reduced in the CAR-M and CAR-H groups. Moreover, the downregulated miR-29b was elevated in the CAR-M and CAR-H groups. The in vitro study showed that Col1a1, Col3a1, and alpha-SMA were downregulated and miR-29b was upregulated by carvedilol in a dose-dependent manner in rat cardiac fibroblasts. Inhibition of ROS-induced Smad3 activation by carvedilol resulted in downregulation of Col1a1, Col3a1, and alpha-SMA and upregulation of miR-29b derived from the miR-29b-2 precursor. Enforced expression of miR-29b significantly suppressed Col1a1, Col3a1, and alpha-SMA expression. Taken together, we found that smad3 inactivation and miR-29b upregulation contributed to the cardioprotective activity of carvedilol against AMI-induced myocardial fibrosis.	[Zhu, Jie-Ning; Chen, Ren; Fu, Yong-Heng; Lin, Qiu-Xiong; Huang, Shuai; Guo, Lin-Lin; Zhang, Meng-Zhen; Deng, Chun-Yu; Zou, Xiao; Zhong, Shi-Long; Yang, Min; Zhuang, Jian; Yu, Xi-Yong; Shan, Zhi-Xin] Guangdong Acad Med Sci, Guangdong Prov Cardiovasc Inst, Guangdong Gen Hosp, Dept Med Res, Guangzhou, Guangdong, Peoples R China; [Shan, Zhi-Xin] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China	Yu, XY (corresponding author), Guangdong Acad Med Sci, Guangdong Prov Cardiovasc Inst, Guangdong Gen Hosp, Dept Med Res, Guangzhou, Guangdong, Peoples R China.	yuxycn@hotmail.com; zhixinshan@aliyun.com	Guo, Linlin/AAA-6196-2022	Guo, Linlin/0000-0001-5529-0971; Shan, zhi xin/0000-0001-6086-5565	National Natural Science Foundation of China [81070102, 81071635, 81120108003, 81270222, 81273516]; Natural Science Foundation of Guangdong Province [S2011020005911, S2012010009453]; National Key Basic Research Program (NKBRP) of China [2012CB526602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Key Basic Research Program (NKBRP) of China(National Basic Research Program of China)	This research was supported by the National Natural Science Foundation of China (No. 81070102, 81071635, 81120108003, 81270222, 81273516). This work was also supported by Natural Science Foundation of Guangdong Province (No. S2011020005911, S2012010009453) and the National Key Basic Research Program (NKBRP) of China (No. 2012CB526602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen-Scarabelli C, 2012, AM J CARDIOVASC DRUG, V12, P391, DOI 10.2165/11636090-000000000-00000; Colucci WS, 1996, CIRCULATION, V94, P2800, DOI 10.1161/01.CIR.94.11.2800; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Feng YL, 2011, SCI CHINA LIFE SCI, V54, P1113, DOI 10.1007/s11427-011-4257-8; FEUERSTEIN GZ, 1995, EUR HEART J, V16, P38, DOI 10.1093/eurheartj/16.suppl_F.38; Fu YH, 2009, METHOD FIND EXP CLIN, V31, P367, DOI 10.1358/mf.2009.31.6.1393631; Gao F, 2008, ANTIOXID REDOX SIGN, V10, P343, DOI 10.1089/ars.2007.1908; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Li B, 2006, INT J CARDIOL, V111, P247, DOI 10.1016/j.ijcard.2005.08.065; Lijnen PJ, 2012, CARDIOVASC THER, V30, pe1, DOI 10.1111/j.1755-5922.2010.00205.x; Lotze U, 2002, J CARDIOVASC PHARM, V39, P576, DOI 10.1097/00005344-200204000-00014; Lowes BD, 1999, AM J CARDIOL, V83, P1201, DOI 10.1016/S0002-9149(99)00059-4; Nanjo S, 2006, INT HEART J, V47, P607, DOI 10.1536/ihj.47.607; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Senior R, 1999, AM HEART J, V137, P646, DOI 10.1016/S0002-8703(99)70217-6; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Shi B, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-11; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vaughan DE, 1995, EUR HEART J, V16, P31, DOI 10.1093/eurheartj/16.suppl_K.31; Wang RJ, 2006, J PHARMACOL EXP THER, V318, P45, DOI 10.1124/jpet.105.099903; Wei S, 2000, J AM COLL CARDIOL, V36, P276, DOI 10.1016/S0735-1097(00)00671-9; Wong VY, 2001, BRIT J PHARMACOL, V134, P977, DOI 10.1038/sj.bjp.0704329; Xiao J, 2012, MOL THER, V20, P1251, DOI 10.1038/mt.2012.36; YUE TL, 1992, J PHARMACOL EXP THER, V263, P92; Zhang JL, 2009, CHINESE MED J-PEKING, V122, P2372, DOI 10.3760/cma.j.issn.0366-6999.2009.19.033; Zhu HY, 2012, CARDIOVASC RES, V94, P284, DOI 10.1093/cvr/cvr291; Zhuang XF, 2009, J INT MED RES, V37, P1354, DOI 10.1177/147323000903700510; Zmijewski JW, 2005, AM J PHYSIOL-HEART C, V289, pH852, DOI 10.1152/ajpheart.00015.2005	37	49	51	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75557	10.1371/journal.pone.0075557	http://dx.doi.org/10.1371/journal.pone.0075557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086569	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700101
J	Jansen, D; Zerbi, V; Arnoldussen, IAC; Wiesmann, M; Rijpma, A; Fang, XTT; Dederen, PJ; Mutsaers, MPC; Broersen, LM; Lutjohann, D; Miller, M; Joosten, LAB; Heerschap, A; Kiliaan, AJ				Jansen, Diane; Zerbi, Valerio; Arnoldussen, Ilse A. C.; Wiesmann, Maximilian; Rijpma, Anne; Fang, Xiaotian T.; Dederen, Pieter J.; Mutsaers, Martina P. C.; Broersen, Laus M.; Luetjohann, Dieter; Miller, Malgorzata; Joosten, Leo A. B.; Heerschap, Arend; Kiliaan, Amanda J.			Effects of Specific Multi-Nutrient Enriched Diets on Cerebral Metabolism, Cognition and Neuropathology in A beta PPswe-PS1dE9 Mice	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACID; MAGNETIC-RESONANCE-SPECTROSCOPY; MORRIS WATER MAZE; APP/PS1 TRANSGENIC MICE; MICROTUBULE-ASSOCIATED PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; BRAIN CHOLESTEROL-SYNTHESIS; SPATIAL MEMORY DEFICIT; NERVE GROWTH-FACTOR; AGE-RELATED-CHANGES	Recent studies have focused on the use of multi-nutrient dietary interventions in search of alternatives for the treatment and prevention of Alzheimer's disease (AD). In this study we investigated to which extent long-term consumption of two specific multi-nutrient diets can modulate AD-related etiopathogenic mechanisms and behavior in 11-12-month-old A beta PPswe-PS1dE9 mice. Starting from 2 months of age, male A beta PP-PS1 mice and wild-type littermates were fed either a control diet, the DHA+EPA+UMP (DEU) diet enriched with uridine monophosphate (UMP) and the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), or the Fortasyn (R) Connect (FC) diet enriched with the DEU diet plus phospholipids, choline, folic acid, vitamins and antioxidants. We performed behavioral testing, proton magnetic resonance spectroscopy, immunohistochemistry, biochemical analyses and quantitative real-time PCR to gain a better understanding of the potential mechanisms by which these multi-nutrient diets exert protective properties against AD. Our results show that both diets were equally effective in changing brain fatty acid and cholesterol profiles. However, the diets differentially affected AD-related pathologies and behavioral measures, suggesting that the effectiveness of specific nutrients may depend on the dietary context in which they are provided. The FC diet was more effective than the DEU diet in counteracting neurodegenerative aspects of AD and enhancing processes involved in neuronal maintenance and repair. Both diets elevated interleukin-1 beta mRNA levels in A beta PP-PS1 and wild-type mice. The FC diet additionally restored neurogenesis in A beta PP-PS1 mice, decreased hippocampal levels of unbound choline-containing compounds in wild-type and A beta PP-PS1 animals, suggesting diminished membrane turnover, and decreased anxiety-related behavior in the open field behavior. In conclusion, the current data indicate that specific multi-nutrient diets can influence AD-related etiopathogenic processes. Intervention with the FC diet might be of interest for several other neurodegenerative and neurological disorders.	[Jansen, Diane; Zerbi, Valerio; Arnoldussen, Ilse A. C.; Wiesmann, Maximilian; Rijpma, Anne; Fang, Xiaotian T.; Dederen, Pieter J.; Mutsaers, Martina P. C.; Kiliaan, Amanda J.] Radboud Univ Nijmegen, Med Ctr, Dept Anat, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Broersen, Laus M.] Danone Res, Ctr Specialised Nutr, Nutricia Adv Med Nutr, Wageningen, Netherlands; [Luetjohann, Dieter] Univ Clin Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Miller, Malgorzata; Joosten, Leo A. B.] Radboud Univ Nijmegen, Dept Gen Internal Med, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6525 ED Nijmegen, Netherlands; [Heerschap, Arend] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Danone Nutricia; University of Bonn; Radboud University Nijmegen; Radboud University Nijmegen	Kiliaan, AJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Anat, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	A.Kiliaan@anat.umcn.nl	Fang, Xiaotian/AAV-9272-2021; Joosten, Leo AB/H-3138-2015; Wiesmann, Maximilian/C-5482-2012; Heerschap, Arend/G-5228-2010; Kiliaan, Amanda J/D-8778-2012; Zerbi, Valerio/K-3405-2018; Arnoldussen, Ilse A.C./H-4421-2015; Wiesmann, Maximilian/AAW-1627-2021; Rijpma, Anne/P-8251-2015; Rijpma, Anne/ABA-7746-2021; Dederen, Pieter.J.W.C/E-1899-2016	Fang, Xiaotian/0000-0001-9706-1122; Joosten, Leo AB/0000-0001-6166-9830; Wiesmann, Maximilian/0000-0002-1412-398X; Arnoldussen, Ilse A.C./0000-0002-7395-5284; Wiesmann, Maximilian/0000-0002-1412-398X; Rijpma, Anne/0000-0001-9411-5404; Zerbi, Valerio/0000-0001-7984-9565	European Community's Seventh Framework Programme (FP7) [211696]	European Community's Seventh Framework Programme (FP7)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no211696 (LipiDiDiet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackl N, 2005, NEUROSCI LETT, V384, P23, DOI 10.1016/j.neulet.2005.04.035; Arendash GW, 2007, NEUROSCIENCE, V149, P286, DOI 10.1016/j.neuroscience.2007.08.018; Barberger-Gateau P, 2002, BRIT MED J, V325, P932, DOI 10.1136/bmj.325.7370.932; Barcelo-Coblijn G, 2003, P NATL ACAD SCI USA, V100, P11321, DOI 10.1073/pnas.1734008100; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Bjorkhem I, 2006, J INTERN MED, V260, P493, DOI 10.1111/j.1365-2796.2006.01725.x; Block W, 2002, AMINO ACIDS, V23, P317, DOI 10.1007/s00726-001-0144-0; Boekhoorn K, 2006, NEUROBIOL DIS, V24, P1, DOI 10.1016/j.nbd.2006.04.017; Bonnet E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003487; BOURRE JM, 1989, J NUTR, V119, P1880, DOI 10.1093/jn/119.12.1880; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Broersen LM, 2013, J ALZHEIMERS DIS, V33, P177, DOI 10.3233/JAD-2012-112039; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; Carrie I, 2002, NUTR NEUROSCI, V5, P43, DOI 10.1080/10284150290007074; Cavassila S, 2001, NMR BIOMED, V14, P278, DOI 10.1002/nbm.701; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Chen SQ, 2012, BEHAV BRAIN RES, V235, P1, DOI 10.1016/j.bbr.2012.07.016; Chen SQ, 2009, DEMENT GERIATR COGN, V28, P558, DOI 10.1159/000261646; Chiu CC, 2008, PROG NEURO-PSYCHOPH, V32, P1538, DOI 10.1016/j.pnpbp.2008.05.015; Choi IY, 2003, NEUROCHEM RES, V28, P987, DOI 10.1023/A:1023370104289; Conte V, 2004, J NEUROCHEM, V90, P758, DOI 10.1111/j.1471-4159.2004.02560.x; Cuppini R, 2002, INT J VITAM NUTR RES, V72, P170, DOI 10.1024/0300-9831.72.3.170; Dangour AD, 2010, AM J CLIN NUTR, V91, P1725, DOI 10.3945/ajcn.2009.29121; Das UN, 2008, PROSTAG LEUKOTR ESS, V78, P11, DOI 10.1016/j.plefa.2007.10.006; De Bruin NMWJ, 2003, NEUROBIOL LEARN MEM, V80, P63, DOI 10.1016/S1074-7427(03)00024-8; De La Torre JC, 2002, ANN NY ACAD SCI, V977, P196; DEBRUIN JPC, 1994, BRAIN RES, V652, P323, DOI 10.1016/0006-8993(94)90243-7; Dedeoglu A, 2004, BRAIN RES, V1012, P60, DOI 10.1016/j.brainres.2004.02.079; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; Depino A, 2005, J NEUROIMMUNOL, V168, P96, DOI 10.1016/j.jneuroim.2005.07.009; Doody RS, 2003, J CLIN PSYCHIAT, V64, P11; Dyall SC, 2010, J NEUROSCI RES, V88, P2091, DOI 10.1002/jnr.22390; Enciu AM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-75; Eriksson C, 1999, NEUROSCIENCE, V93, P915, DOI 10.1016/S0306-4522(99)00178-5; Farina N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002854.pub3; Farkas T, 2000, P NATL ACAD SCI USA, V97, P6362, DOI 10.1073/pnas.120157297; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Ferretti L, 2001, J GERIATR PSYCH NEUR, V14, P52, DOI 10.1177/089198870101400111; Figueiredo CP, 2011, J ALZHEIMERS DIS, V24, P61, DOI 10.3233/JAD-2010-101320; Fontani G, 2005, EUR J CLIN INVEST, V35, P691, DOI 10.1111/j.1365-2362.2005.01570.x; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Frederick BD, 2004, PROG NEURO-PSYCHOPH, V28, P1313, DOI 10.1016/j.pnpbp.2004.08.013; Freund-Levi Y, 2008, INT J GERIATR PSYCH, V23, P161, DOI 10.1002/gps.1857; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Fujii A, 1996, GEN PHARMACOL, V27, P995, DOI 10.1016/0306-3623(95)02072-1; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010; GINSBERG L, 1993, BRAIN RES, V615, P355, DOI 10.1016/0006-8993(93)90050-W; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Goodfellow J, 2000, J AM COLL CARDIOL, V35, P265, DOI 10.1016/S0735-1097(99)00548-3; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Griffith HR, 2008, ALZHEIMERS DEMENT, V4, P421, DOI 10.1016/j.jalz.2008.04.008; Grossberg GT, 2003, J CLIN PSYCHIAT, V64, P3; Guerrero AL, 1999, NEUROREPORT, V10, P1689, DOI 10.1097/00001756-199906030-00012; Hamilton A, 2012, BRAIN RES, V1449, P83, DOI 10.1016/j.brainres.2012.02.015; Harris WS, 1997, AM J CLIN NUTR, V65, P1611; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; Heverin M, 2005, J LIPID RES, V46, P1047, DOI 10.1194/jlr.M500024-JLR200; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; HIGGINS GA, 1991, MOL BRAIN RES, V9, P143, DOI 10.1016/0169-328X(91)90139-O; Holguin S, 2008, FASEB J, V22, P3938, DOI 10.1096/fj.08-112425; Holguin S, 2008, BEHAV BRAIN RES, V191, P11, DOI 10.1016/j.bbr.2008.02.042; Hooijmans CR, 2009, NEUROBIOL DIS, V33, P482, DOI 10.1016/j.nbd.2008.12.002; Horrocks LA, 2004, PROSTAG LEUKOTR ESS, V70, P361, DOI 10.1016/j.plefa.2003.12.011; Huang W, 2001, NEUROLOGY, V57, P626, DOI 10.1212/WNL.57.4.626; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jansen D, 2014, BRAIN STRUCT FUNCT, V219, P1841, DOI 10.1007/s00429-013-0606-7; Jansen D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063643; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Joseph JA, 1998, J NEUROSCI, V18, P8047; Juric DM, 2001, INT J DEV NEUROSCI, V19, P675, DOI 10.1016/S0736-5748(01)00044-2; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Kamphuis PJGH, 2011, J NUTR HEALTH AGING, V15, P720, DOI 10.1007/s12603-011-0105-6; Kantarci K, 2007, BRIT J RADIOL, V80, pS146, DOI 10.1259/bjr/60346217; Kantarci K, 2004, NEUROLOGY, V63, P1393; Kavanagh T, 2004, PROSTAG LEUKOTR ESS, V70, P391, DOI 10.1016/j.plefa.2003.12.014; Kawakita E, 2006, NEUROSCIENCE, V139, P991, DOI 10.1016/j.neuroscience.2006.01.021; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kitajka K, 2002, P NATL ACAD SCI USA, V99, P2619, DOI 10.1073/pnas.042698699; Kotani S, 2006, NEUROSCI RES, V56, P159, DOI 10.1016/j.neures.2006.06.010; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lalonde R, 2012, NEUROSCI BIOBEHAV R, V36, P1357, DOI 10.1016/j.neubiorev.2012.02.011; Lalonde R, 2004, NEUROSCI LETT, V369, P156, DOI 10.1016/j.neulet.2004.07.069; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Lee JH, 2008, MAYO CLIN PROC, V83, P324, DOI 10.4065/83.3.324; LOCASCIO JJ, 1995, ARCH NEUROL-CHICAGO, V52, P1087, DOI 10.1001/archneur.1995.00540350081020; Lovasic L, 2005, GENES BRAIN BEHAV, V4, P197, DOI 10.1111/j.1601-183X.2004.00104.x; Lutjohann D, 2004, STEROIDS, V69, P431, DOI 10.1016/j.steroids.2004.03.012; Lutjohann D, 2002, J LIPID RES, V43, P1078, DOI 10.1194/jlr.M200071-JLR200; MacKay S, 1996, ARCH NEUROL-CHICAGO, V53, P167, DOI 10.1001/archneur.1996.00550020079018; MALOUF M, 2003, COCHRANE DB SYST REV; Malouf R, 2003, Cochrane Database Syst Rev, pCD004393, DOI 10.1002/14651858.CD004393; Malouf R, 2003, COCHRANE DB SYST REV, V2003; Marjanska M, 2005, P NATL ACAD SCI USA, V102, P11906, DOI 10.1073/pnas.0505513102; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; Matousek SB, 2012, J NEUROIMMUNE PHARM, V7, P156, DOI 10.1007/s11481-011-9331-2; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MEYERHOFF DJ, 1994, ANN NEUROL, V36, P40; Mlynarik V, 2012, J ALZHEIMERS DIS, V31, pS87, DOI 10.3233/JAD-2012-112072; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Naliwaiko K, 2004, NUTR NEUROSCI, V7, P91, DOI 10.1080/10284150410001704525; Niidome T, 2008, NEUROREPORT, V19, P1361, DOI 10.1097/WNR.0b013e32830e6dd6; O'Leary TP, 2009, BEHAV BRAIN RES, V201, P120, DOI 10.1016/j.bbr.2009.01.039; Oberg J, 2008, NEUROBIOL AGING, V29, P1423, DOI 10.1016/j.neurobiolaging.2007.03.002; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Okuda N, 2005, ATHEROSCLEROSIS, V178, P371, DOI 10.1016/j.atherosclerosis.2004.09.007; Pfefferbaum A, 1999, MAGNET RESON MED, V41, P276, DOI 10.1002/(SICI)1522-2594(199902)41:2<276::AID-MRM10>3.0.CO;2-8; Proescholdt MG, 2002, NEUROSCIENCE, V112, P731, DOI 10.1016/S0306-4522(02)00048-9; Pugh PL, 2007, BEHAV BRAIN RES, V178, P18, DOI 10.1016/j.bbr.2006.11.044; Puolivali J, 2002, NEUROBIOL DIS, V9, P339, DOI 10.1006/nbdi.2002.0481; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rogers PJ, 2008, BRIT J NUTR, V99, P421, DOI 10.1017/S0007114507801097; Rose SE, 1999, MAGN RESON IMAGING, V17, P291, DOI 10.1016/S0730-725X(98)00168-4; Rusanen M, 2011, ARCH INTERN MED, V171, P333, DOI 10.1001/archinternmed.2010.393; Sacks FM, 2002, AM J MED, V113, P13, DOI 10.1016/S0002-9343(01)00987-1; Savelkoul PJM, 2012, J NEUROCHEM, V120, P631, DOI 10.1111/j.1471-4159.2011.07616.x; Scheltens P, 2012, J ALZHEIMERS DIS, V31, P225, DOI 10.3233/JAD-2012-121189; Scheltens P, 2010, ALZHEIMERS DEMENT, V6, P1, DOI 10.1016/j.jalz.2009.10.003; Schipper P, 2011, BEHAV PHARMACOL, V22, P324, DOI 10.1097/FBP.0b013e328347881b; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuff N, 1997, NEUROLOGY, V49, P1513, DOI 10.1212/WNL.49.6.1513; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Shrivastava R, 2005, NUTR NEUROSCI, V8, P317, DOI 10.1080/10284150500510242; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Skoog I, 2006, NEUROL RES, V28, P605, DOI 10.1179/016164106X130506; Small BJ, 2003, ACTA NEUROL SCAND, V107, P29, DOI 10.1034/j.1600-0404.107.s179.6.x; Solomon A, 2009, DEMENT GERIATR COGN, V28, P75, DOI 10.1159/000231980; Song C, 2004, J LIPID RES, V45, P1112, DOI [10.1194/jlr.M300526-JLR200, 10.1194/jlr.M300526-JLr200]; Song C, 2008, J NUTR, V138, P954, DOI 10.1093/jn/138.5.954; Streijger F, 2005, BEHAV BRAIN RES, V157, P219, DOI 10.1016/j.bbr.2004.07.002; STRIJBOS PJLM, 1995, J NEUROSCI, V15, P3468; Takeuchi T, 2003, BRAIN RES, V964, P136, DOI 10.1016/S0006-8993(02)04113-6; Tanabe Y, 2004, CLIN EXP PHARMACOL P, V31, P700, DOI 10.1111/j.1440-1681.2004.04068.x; Taniuchi N, 2007, NEUROREPORT, V18, P1801, DOI 10.1097/WNR.0b013e3282f1c9e9; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Teather LA, 2003, PROG NEURO-PSYCHOPH, V27, P711, DOI 10.1016/S0278-5846(03)00086-1; Teri L, 1999, J GERONTOL A-BIOL, V54, pM348, DOI 10.1093/gerona/54.7.M348; Thelen KM, 2006, J PHARMACOL EXP THER, V316, P1146, DOI 10.1124/jpet.105.094136; Van Dam D, 2006, NEUROBIOL LEARN MEM, V85, P164, DOI 10.1016/j.nlm.2005.09.006; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86; van Gelder BM, 2007, AM J CLIN NUTR, V85, P1142, DOI 10.1093/ajcn/85.4.1142; Vela JM, 2002, MOL CELL NEUROSCI, V20, P489, DOI 10.1006/mcne.2002.1127; von Arnim CAF, 2010, NUTRITION, V26, P694, DOI 10.1016/j.nut.2009.11.009; von Kienlin M, 2005, NEUROBIOL DIS, V18, P32, DOI 10.1016/j.nbd.2004.09.005; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Watanabe T, 2012, NEUROBIOL LEARN MEM, V97, P289, DOI 10.1016/j.nlm.2012.01.006; WELSH K, 1991, ARCH NEUROL-CHICAGO, V48, P278, DOI 10.1001/archneur.1991.00530150046016; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Wiesmann M, 2013, J ALZHEIMERS DIS, DOI [10.3223/JAD-130179, DOI 10.3223/JAD-130179]; Wu LY, 2012, CAN J NEUROL SCI, V39, P436, DOI 10.1017/S0317167100013949; Wurtman RJ, 2008, METABOLISM, V57, pS6, DOI 10.1016/j.metabol.2008.07.007; Wurtman RJ, 2006, BRAIN RES, V1088, P83, DOI 10.1016/j.brainres.2006.03.019; WURTMAN RJ, 1985, NEUROCHEM INT, V7, P369, DOI 10.1016/0197-0186(85)90127-5; Xu W, 2010, J NEUROSCI RES, V88, P3155, DOI 10.1002/jnr.22479; Yaffe K, 2007, CURR ALZHEIMER RES, V4, P123, DOI 10.2174/156720507780362191; Yamada K, 1999, EUR J NEUROSCI, V11, P83, DOI 10.1046/j.1460-9568.1999.00408.x; Zhang XM, 2012, NUTR NEUROSCI, V15, P55, DOI 10.1179/1476830511Y.0000000025	172	34	34	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75393	10.1371/journal.pone.0075393	http://dx.doi.org/10.1371/journal.pone.0075393			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086523	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200041
J	Valvo, G; Baldini, S; Brachini, F; Apicella, F; Cosenza, A; Ferrari, AR; Guerrini, R; Muratori, F; Romano, MF; Santorelli, FM; Tancredi, R; Sicca, F				Valvo, Giulia; Baldini, Sara; Brachini, Francesca; Apicella, Fabio; Cosenza, Angela; Ferrari, Anna Rita; Guerrini, Renzo; Muratori, Filippo; Romano, Maria Francesca; Santorelli, Filippo M.; Tancredi, Raffaella; Sicca, Federico			Somatic Overgrowth Predisposes to Seizures in Autism Spectrum Disorders	PLOS ONE			English	Article							HEAD CIRCUMFERENCE; INTELLECTUAL DISABILITY; EEG ABNORMALITIES; 1ST YEAR; EPILEPSY; CHILDREN; GROWTH; REGRESSION; LIFE; METAANALYSIS	Background: Comorbidity of Autism Spectrum Disorders with seizures or abnormal EEG (Autism-Epilepsy Phenotype) suggests shared pathomechanisms, and might be a starting point to identify distinct populations within the clinical complexity of the autistic spectrum. In this study, we tried to assess whether distinct subgroups, having distinctive clinical hallmarks, emerge from this comorbid condition. Methods: Two-hundred and six individuals with idiopathic Autism Spectrum Disorders were subgrouped into three experimental classes depending on the presence of seizures and EEG abnormalities. Neurobehavioral, electroclinical and auxological parameters were investigated to identify differences among groups and features which increase the risk of seizures. Our statistical analyses used ANOVA, post-hoc multiple comparisons, and the Chi-squared test to analyze continuous and categorical variables. A correspondence analysis was also used to decompose significant Chi-squared and reduce variables dimensions. Results: The high percentage of children with seizures (28.2% of our whole cohort) and EEG abnormalities (64.1%) confirmed that the prevalence of epilepsy in Autism Spectrum Disorders exceeds that of the general population. Seizures were associated with severe intellectual disability, and not with autism severity. Interestingly, tall stature (without macrocephaly) was significantly associated with EEG abnormalities or later onset seizures. However, isolated macrocephaly was equally distributed among groups or associated with early onset seizures when accompanied by tall stature. Conclusions: Tall stature seems to be a phenotypic "biomarker" of susceptibility to EEG abnormalities or late epilepsy in Autism Spectrum Disorders and, when concurring with macrocephaly, predisposes to early onset seizures. Growth pattern might act as an endophenotypic marker in Autism-Epilepsy comorbidity, delineating distinct pathophysiological subtypes and addressing personalized diagnostic work-up and therapeutic approaches.	[Valvo, Giulia; Baldini, Sara; Brachini, Francesca; Ferrari, Anna Rita; Guerrini, Renzo; Sicca, Federico] IRCCS Stella Maris Fdn, Epilepsy Neurophysiol & Neurogenet Unit, Pisa, Italy; [Apicella, Fabio; Cosenza, Angela; Muratori, Filippo; Tancredi, Raffaella] IRCCS Stella Maris Fdn, Dev Psychiat Unit, Pisa, Italy; [Guerrini, Renzo] Univ Florence, A Meyer Pediat Hosp, Child Neurol Unit, Florence, Italy; [Romano, Maria Francesca] St Anna Sch Adv Studies, Inst Econ, Pisa, Italy; [Santorelli, Filippo M.] IRCCS Stella Maris Fdn, Mol Med Unit, Pisa, Italy	IRCCS Fondazione Stella Maris; IRCCS Fondazione Stella Maris; University of Florence; Scuola Superiore Sant'Anna; IRCCS Fondazione Stella Maris	Sicca, F (corresponding author), IRCCS Stella Maris Fdn, Epilepsy Neurophysiol & Neurogenet Unit, Pisa, Italy.	federico.sicca@inpe.unipi.it	Sicca, Federico/J-7768-2016; Baldini, Sara/J-6456-2016; Santorelli, Filippo M/ABE-5124-2020; Bargagna, Stefania/AAB-7603-2019; Muratori, Filippo/K-3187-2018; Ferrari, Anna Rita/AAB-9899-2019; Cosenza, Angela/ABI-6504-2020; Tancredi, Raffaella/C-3868-2018; Apicella, Fabio/ABF-4304-2020; Romano, Maria Francesca/G-7717-2011	Sicca, Federico/0000-0002-4917-5253; Baldini, Sara/0000-0001-8330-0452; Santorelli, Filippo M/0000-0002-1359-9062; Bargagna, Stefania/0000-0001-6430-9494; Muratori, Filippo/0000-0001-9598-0096; Ferrari, Anna Rita/0000-0002-5397-6184; Cosenza, Angela/0000-0001-7971-5735; Tancredi, Raffaella/0000-0003-3517-4919; Apicella, Fabio/0000-0001-7390-3241; Romano, Maria Francesca/0000-0001-8933-125X; Guerrini, Renzo/0000-0002-7272-7079	Telethon - Italy [GGP11188]	Telethon - Italy(Fondazione Telethon)	The financial support of Telethon - Italy (http://www.telethon.it/en; Grant no. GGP11188) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiet C, 2008, BIOL PSYCHIAT, V64, P577, DOI 10.1016/j.biopsych.2008.04.030; Baird G, 2008, J AUTISM DEV DISORD, V38, P1827, DOI 10.1007/s10803-008-0571-9; Barnard-Brak L, 2011, PEDIATR NEUROL, V44, P97, DOI 10.1016/j.pediatrneurol.2010.09.011; Berg AT, 2012, EPILEPSY BEHAV, V23, P193, DOI 10.1016/j.yebeh.2012.01.015; Berg AT, 2011, J CHILD NEUROL, V26, P540, DOI 10.1177/0883073810384869; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Brooks-Kayal A, 2010, BRAIN DEV-JPN, V32, P731, DOI 10.1016/j.braindev.2010.04.010; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Canitano R, 2005, J CHILD NEUROL, V20, P27, DOI 10.1177/08830738050200010401; Chawarska K, 2011, ARCH GEN PSYCHIAT, V68, P1021, DOI 10.1001/archgenpsychiatry.2011.106; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Cuccaro ML, 2012, J AUTISM DEV DISORD, V42, P1630, DOI 10.1007/s10803-011-1402-y; Dementieva YA, 2005, PEDIATR NEUROL, V32, P102, DOI 10.1016/j.pediatrneurol.2004.08.005; Deonna T, 2006, EPILEPSIA, V47, P79, DOI 10.1111/j.1528-1167.2006.00697.x; Dissanayake C, 2006, DEV PSYCHOPATHOL, V18, P381, DOI 10.1017/S0954579406060202; Giannotti F, 2008, J AUTISM DEV DISORD, V38, P1888, DOI 10.1007/s10803-008-0584-4; Hara H, 2007, BRAIN DEV-JPN, V29, P486, DOI 10.1016/j.braindev.2006.12.012; Hrdlicka M, 2004, EUR CHILD ADOLES PSY, V13, P209, DOI 10.1007/s00787-004-0353-7; Hua X, 2013, HUM BRAIN MAPP, V34, P425, DOI 10.1002/hbm.21441; Lainhart JE, 2006, AM J MED GENET A, V140A, P2257, DOI 10.1002/ajmg.a.31465; Muratori F, 2012, RES AUTISM SPECT DIS, V6, P442, DOI 10.1016/j.rasd.2011.07.004; NELLHAUS G, 1968, PEDIATRICS, V41, P106; Parmeggiani A, 2002, BRAIN DEV-JPN, V24, P296, DOI 10.1016/S0387-7604(02)00063-3; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Sicca F, 2011, NEUROBIOL DIS, V43, P239, DOI 10.1016/j.nbd.2011.03.016; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Torrey EF, 2004, BIOL PSYCHIAT, V56, P892, DOI 10.1016/j.biopsych.2004.09.014; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Tuchman RF, 1997, PEDIATRICS, V99, P560, DOI 10.1542/peds.99.4.560; Tuchman R, 2011, CURR NEUROL NEUROSCI, V11, P428, DOI 10.1007/s11910-011-0195-x; Tuchman R, 2010, BRAIN DEV-JPN, V32, P709, DOI 10.1016/j.braindev.2010.04.008; Tuchman R, 2009, BRAIN DEV-JPN, V31, P95, DOI 10.1016/j.braindev.2008.09.009; Turk J, 2009, ACTA PAEDIATR, V98, P675, DOI 10.1111/j.1651-2227.2008.01184.x; van Daalen E, 2007, PEDIATR NEUROL, V37, P324, DOI 10.1016/j.pediatrneurol.2007.06.006; WONG V, 1993, J CHILD NEUROL, V8, P316, DOI 10.1177/088307389300800405; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002	37	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75015	10.1371/journal.pone.0075015	http://dx.doi.org/10.1371/journal.pone.0075015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086423	gold, Green Published, Green Submitted			2022-12-25	WOS:000326520200070
J	Quazi, F; Molday, RS				Quazi, Faraz; Molday, Robert S.			Differential Phospholipid Substrates and Directional Transport by ATP-binding Cassette Proteins ABCA1, ABCA7, and ABCA4 and Disease-causing Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Cholesterol Metabolism; High Density Lipoprotein (HDL); Lipid Transport; Membrane Reconstitution; Phospholipid; ABCA1; ABCA4; Stargardt Disease; Tangier Disease	APOLIPOPROTEIN-A-I; N-RETINYLIDENE-PHOSPHATIDYLETHANOLAMINE; CELLULAR LIPID EFFLUX; CHOLESTEROL EFFLUX; TANGIER-DISEASE; RIM PROTEIN; APOA-I; MUTATIONS; IDENTIFICATION; PURIFICATION	Background: Lipid transport by the A-subfamily of ATP-binding cassette (ABC) transporters implicated in human disorders is poorly understood. Results: ABCA1 and ABCA7 export phosphatidylcholine and phosphatidylserine across membranes, whereas ABCA4 imports phosphatidylethanolamine. Conclusion: ABCA transporters actively flip phospholipids across membranes, a function severely reduced for disease-causing mutants. Significance: ABCA-dependent phospholipid transport plays a crucial role in cellular lipid homeostasis. ABCA1, ABCA7, and ABCA4 are members of the ABCA subfamily of ATP-binding cassette transporters that share extensive sequence and structural similarity. Mutations in ABCA1 cause Tangier disease characterized by defective cholesterol homeostasis and high density lipoprotein (HDL) deficiency. Mutations in ABCA4 are responsible for Stargardt disease, a degenerative disorder associated with severe loss in central vision. Although cell-based studies have implicated ABCA proteins in lipid transport, the substrates and direction of transport have not been firmly established. We have purified and reconstituted ABCA1, ABCA7, and ABCA4 into liposomes for fluorescent-lipid transport studies. ABCA1 actively exported or flipped phosphatidylcholine, phosphatidylserine, and sphingomyelin from the cytoplasmic to the exocytoplasmic leaflet of membranes, whereas ABCA7 preferentially exported phosphatidylserine. In contrast, ABCA4 transported phosphatidylethanolamine in the reverse direction. The same phospholipids stimulated the ATPase activity of these ABCA transporters. The transport and ATPase activities of ABCA1 and ABCA4 were reduced by 25% in the presence of 20% cholesterol. Nine ABCA1 Tangier mutants and the corresponding ABCA4 Stargardt mutants showed significantly reduced phospholipid transport activity and subcellular mislocalization. These studies provide the first direct evidence for ABCA1 and ABCA7 functioning as phospholipid transporters and suggest that this activity is an essential step in the loading of apoA-1 with phospholipids for HDL formation.	[Quazi, Faraz; Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Ctr Macular Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Molday, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	molday@mail.ubc.ca			National Institutes of Health [EY002422]; Natural Sciences and Engineering Research Council of Canada; NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY002422.; Supported by a predoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada.	Abe-Dohmae S, 2006, FEBS LETT, V580, P1178, DOI 10.1016/j.febslet.2005.12.029; Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Ahn J, 2000, J BIOL CHEM, V275, P20399, DOI 10.1074/jbc.M000555200; Ahn JH, 2003, J BIOL CHEM, V278, P39600, DOI 10.1074/jbc.M304236200; Alder-Baerens N, 2005, J BIOL CHEM, V280, P26321, DOI 10.1074/jbc.M413993200; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; Chroni A, 2004, BIOCHEMISTRY-US, V43, P2126, DOI 10.1021/bi035813p; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; Fitzgerald ML, 2004, J LIPID RES, V45, P287, DOI 10.1194/jlr.M300355-JLR200; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Hassan HH, 2007, J LIPID RES, V48, P2428, DOI 10.1194/jlr.M700206-JLR200; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hozoji M, 2009, J BIOL CHEM, V284, P11293, DOI 10.1074/jbc.M900580200; Iatan I, 2011, J LIPID RES, V52, P2043, DOI 10.1194/jlr.M016196; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Kim WS, 2006, NEUROREPORT, V17, P891, DOI 10.1097/01.wnr.0000221833.41340.cd; LAKOWICZ JR, 1980, J BIOCHEM BIOPH METH, V2, P91, DOI 10.1016/0165-022X(80)90077-9; Linsel-Nitschke P, 2005, J LIPID RES, V46, P86, DOI 10.1194/jlr.M400247-JLR200; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Molday RS, 2009, BBA-MOL CELL BIOL L, V1791, P573, DOI 10.1016/j.bbalip.2009.02.004; Nagao K, 2012, BBA-MOL CELL BIOL L, V1821, P530, DOI 10.1016/j.bbalip.2011.06.024; Nagao K, 2011, FEBS J, V278, P3190, DOI 10.1111/j.1742-4658.2011.08170.x; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; Nasonkin I, 1998, HUM GENET, V102, P21, DOI 10.1007/s004390050649; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Piehler Armin P, 2012, Front Psychiatry, V3, P17, DOI 10.3389/fpsyt.2012.00017; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Quazi F, 2011, ESSAYS BIOCHEM, V50, P265, DOI [10.1042/BSE0500265, 10.1042/bse0500265]; Rajasekharan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028401; Reboul E, 2013, BIOCHIMIE, V95, P957, DOI 10.1016/j.biochi.2012.11.009; Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Singaraja RR, 2006, CIRC RES, V99, P389, DOI 10.1161/01.RES.0000237920.70451.ad; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Smith JD, 2004, J LIPID RES, V45, P635, DOI 10.1194/jlr.M300336-JLR200; Szakacs G, 2001, BIOCHEM BIOPH RES CO, V288, P1258, DOI 10.1006/bbrc.2001.5905; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Tsybovsky Y, 2013, STRUCTURE, V21, P854, DOI 10.1016/j.str.2013.03.001; Tsybovsky Y, 2011, BIOCHEMISTRY-US, V50, P6855, DOI 10.1021/bi200774w; Urbatsch IL, 2001, ARCH BIOCHEM BIOPHYS, V388, P171, DOI 10.1006/abbi.2001.2299; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel JJ, 2007, FRONT BIOSCI-LANDMRK, V12, P3177, DOI 10.2741/2305; Wong JP, 2009, J PROTEOME RES, V8, P2388, DOI 10.1021/pr801008c; Zhong M, 2009, J BIOL CHEM, V284, P3640, DOI 10.1074/jbc.M806580200	59	129	133	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34414	34426		10.1074/jbc.M113.508812	http://dx.doi.org/10.1074/jbc.M113.508812			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24097981	Green Published, hybrid			2022-12-25	WOS:000329812800013
J	Zhang, YJ; Zhang, LY; Wu, JH; Di, CX; Xia, ZW				Zhang, Yanjie; Zhang, Liya; Wu, Jinhong; Di, Caixia; Xia, Zhenwei			Heme Oxygenase-1 Exerts a Protective Role in Ovalbumin-induced Neutrophilic Airway Inflammation by Inhibiting Th17 Cell-mediated Immune Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Asthma; Heme Oxygenase; Immunology; Inflammation; T Cell; Th17; Treg	REGULATORY T-CELLS; RECEPTOR TRANSGENIC MICE; OXIDATIVE STRESS; UP-REGULATION; T(H)17 CELLS; IN-VIVO; ASTHMA; STAT3; HYPERREACTIVITY; PROLIFERATION	Background: Heme oxygenase-1 (HO-1) is an inducible enzyme that exerts multiple physiological functions. Results: Induction of HO-1 inhibits Th17-mediated neutrophilic airway inflammation in vivo and suppresses Th17 cell differentiation in vitro. Conclusion: HO-1 exhibits anti-inflammatory activity in non-eosinophilic asthma (NEA) by inhibiting Th17 responses. Significance: HO-1 may become a novel therapeutic target in NEA. Allergic asthma is conventionally considered as a Th2 immune response characterized by eosinophilic inflammation. Recent investigations revealed that Th17 cells play an important role in the pathogenesis of non-eosinophilic asthma (NEA), resulting in steroid-resistant neutrophilic airway inflammation. Heme oxygenase-1 (HO-1) has anti-inflammation, anti-oxidation, and anti-apoptosis functions. However, its role in NEA is still unclear. Here, we explore the role of HO-1 in a mouse model of NEA. HO-1 inducer hemin or HO-1 inhibitor tin protoporphyrin IX was injected intraperitoneally into ovalbumin-challenged DO11.10 mice. Small interfering RNA (siRNA) was delivered into mice to knock down HO-1 expression. The results show that induction of HO-1 by hemin attenuated airway inflammation and decreased neutrophil infiltration in bronchial alveolar lavage fluid and was accompanied by a lower proportion of Th17 cells in mediastinal lymph nodes and spleen. More importantly, induction of HO-1 down-regulated Th17-related transcription factor retinoic acid-related orphan receptor t (RORt) expression and decreased IL-17A levels, all of which correlated with a decrease in phosphorylated STAT3 (p-STAT3) level and inhibition of Th17 cell differentiation. Consistently, the above events could be reversed by tin protoporphyrin IX. Also, HO-1 siRNA transfection abolished the effect of hemin induced HO-1 in vivo. Meanwhile, the hemin treatment promoted the level of Foxp3 expression and enhanced the proportion of regulatory T cells (Tregs). Collectively, our findings indicate that HO-1 exhibits anti-inflammatory activity in the mouse model of NEA via inhibition of the p-STAT3-RORt pathway, regulating kinetics of RORt and Foxp3 expression, thus providing a possible novel therapeutic target in asthmatic patients.	[Zhang, Yanjie; Zhang, Liya; Wu, Jinhong; Di, Caixia; Xia, Zhenwei] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Pediat, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University	Xia, ZW (corresponding author), Ruijin Hosp, Dept Pediat, Ruijin 2nd Rd 197, Shanghai 200025, Peoples R China.	xzw63@hotmail.com			National Natural Science Foundation of China [81070022, 81128001, 81270084]; Shanghai Municipal Science and Technology Commission Foundation [13XD1402800, 10410701000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission Foundation	This work was supported by National Natural Science Foundation of China Grants 81070022, 81128001, and 81270084 and Shanghai Municipal Science and Technology Commission Foundation Grants 13XD1402800 and 10410701000.	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Almolki A, 2004, AM J PHYSIOL-LUNG C, V287, pL26, DOI 10.1152/ajplung.00237.2003; Almolki A, 2008, AM J PATHOL, V173, P981, DOI 10.2353/ajpath.2008.070863; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Chang TJ, 2008, AM J PHYSIOL-HEART C, V295, pH999, DOI 10.1152/ajpheart.01289.2007; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Chen HL, 2012, INFLAMMATION, V35, P1087, DOI 10.1007/s10753-011-9415-4; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; Desbuards N, 2007, THROMB HAEMOSTASIS, V98, P614, DOI 10.1160/TH06-12-0717; Devey L, 2009, MOL THER, V17, P65, DOI 10.1038/mt.2008.237; Douwes J, 2002, THORAX, V57, P643, DOI 10.1136/thorax.57.7.643; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Elguero B, 2012, NEOPLASIA, V14, P1043, DOI 10.1593/neo.121358; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gao HW, 2007, EXPERT OPIN THER TAR, V11, P869, DOI 10.1517/14728222.11.7.869; Grochot-Przeczek A, 2012, CLIN SCI, V122, P93, DOI 10.1042/CS20110147; Haines DD, 2012, ACTA PHYSIOL, V204, P487, DOI 10.1111/j.1748-1716.2011.02387.x; Hori R, 2002, J BIOL CHEM, V277, P10712, DOI 10.1074/jbc.M107749200; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jia YX, 1999, INT ARCH ALLERGY IMM, V120, P141, DOI 10.1159/000024232; Kikuchi S, 2005, INT ARCH ALLERGY IMM, V137, P7, DOI 10.1159/000085425; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Knott PG, 2000, AM J RESP CRIT CARE, V161, P1340, DOI 10.1164/ajrccm.161.4.9906078; Kobayashi H, 2006, ARTHRITIS RHEUM-US, V54, P1132, DOI 10.1002/art.21754; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lin TH, 2010, J CELL PHYSIOL, V222, P757, DOI 10.1002/jcp.22008; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Nakae S, 2007, BLOOD, V109, P3640, DOI 10.1182/blood-2006-09-046128; Nakagome K, 2011, J IMMUNOL, V186, P5975, DOI 10.4049/jimmunol.1001274; Oboki Keisuke, 2008, Allergol Int, V57, P121, DOI 10.2332/allergolint.R-07-160; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pae HO, 2004, J IMMUNOL, V172, P4744, DOI 10.4049/jimmunol.172.8.4744; Presser K, 2008, J IMMUNOL, V181, P7751, DOI 10.4049/jimmunol.181.11.7751; Robinson DS, 2009, CLIN EXP ALLERGY, V39, P1314, DOI 10.1111/j.1365-2222.2009.03301.x; Scott MJ, 2002, CLIN DIAGN LAB IMMUN, V9, P1153, DOI 10.1128/CDLI.9.6.1153-1159.2002; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Song RP, 2004, J IMMUNOL, V172, P1220, DOI 10.4049/jimmunol.172.2.1220; Tae YM, 2012, J IMMUNOL, V188, P1799, DOI 10.4049/jimmunol.1102481; Takeda Y, 2004, CLIN EXP IMMUNOL, V138, P237, DOI 10.1111/j.1365-2249.2004.02594.x; Tanaka S, 2009, J IMMUNOL, V183, P7523, DOI 10.4049/jimmunol.0803828; Vanella L, 2010, BONE, V46, P236, DOI 10.1016/j.bone.2009.10.012; Varga C, 2007, EUR J PHARMACOL, V561, P164, DOI 10.1016/j.ejphar.2006.12.022; Wilder JA, 2001, J LEUKOCYTE BIOL, V69, P538; Wong CK, 2009, IMMUNOL INVEST, V38, P652, DOI 10.1080/08820130903062756; Wu JY, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-77; Xia ZW, 2007, AM J PATHOL, V171, P1904, DOI 10.2353/ajpath.2007.070096; Xia ZW, 2006, J IMMUNOL, V177, P5936, DOI 10.4049/jimmunol.177.9.5936; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Ye JA, 2011, EUR J IMMUNOL, V41, P936, DOI 10.1002/eji.201040682; Yoriki H, 2013, J GASTROEN HEPATOL, V28, P632, DOI 10.1111/jgh.12074; Zhong WW, 2010, J PEDIATR GASTR NUTR, V50, P132, DOI 10.1097/MPG.0b013e3181c61591; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	59	51	56	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34612	34626		10.1074/jbc.M113.494369	http://dx.doi.org/10.1074/jbc.M113.494369			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24097973	Green Published, hybrid			2022-12-25	WOS:000329812800029
J	Ghorpade, DS; Sinha, AY; Holla, S; Singh, V; Balaji, KN				Ghorpade, Devram Sampat; Sinha, Akhuri Yash; Holla, Sahana; Singh, Vikas; Balaji, Kithiganahalli Narayanaswamy			NOD2-Nitric Oxide-responsive MicroRNA-146a Activates Sonic Hedgehog Signaling to Orchestrate Inflammatory Responses in Murine Model of Inflammatory Bowel Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Inflammatory Bowel Disease; Innate Immunity; Macrophages; MicroRNA; Nitric Oxide; NOD-like Receptors (NLR); Signal Transduction; Signaling	NITRIC-OXIDE; CROHNS-DISEASE; INTESTINAL EPITHELIUM; UP-REGULATION; BOVIS BCG; NOD2; EXPRESSION; SYNTHASE; DIFFERENTIATION; MACROPHAGES	Background: Genetic variants of NOD2 are linked to inflammatory bowel disease (IBD) etiology. Results: DSS model of colitis in wild-type and inducible nitric-oxide synthase (iNOS) null mice revealed that NOD2-iNOS/NO-responsive microRNA-146a targets NUMB gene facilitating Sonic hedgehog (SHH) signaling. Conclusion: miR-146a-mediated NOD2-SHH signaling regulates gut inflammation. Significance: Identification of novel regulators of IBD provides new insights into pathophysiology and development of new therapy concepts. Inflammatory bowel disease (IBD) is a debilitating chronic inflammatory disorder of the intestine. The interactions between enteric bacteria and genetic susceptibilities are major contributors of IBD etiology. Although genetic variants with loss or gain of NOD2 functions have been linked to IBD susceptibility, the mechanisms coordinating NOD2 downstream signaling, especially in macrophages, during IBD pathogenesis are not precisely identified. Here, studies utilizing the murine dextran sodium sulfate model of colitis revealed the crucial roles for inducible nitric-oxide synthase (iNOS) in regulating pathophysiology of IBDs. Importantly, stimulation of NOD2 failed to activate Sonic hedgehog (SHH) signaling in iNOS null macrophages, implicating NO mediated cross-talk between NOD2 and SHH signaling. NOD2 signaling up-regulated the expression of a NO-responsive microRNA, miR-146a, that targeted NUMB gene and alleviated the suppression of SHH signaling. In vivo and ex vivo studies confirmed the important roles for miR-146a in amplifying inflammatory responses. Collectively, we have identified new roles for miR-146a that established novel cross-talk between NOD2-SHH signaling during gut inflammation. Potential implications of these observations in therapeutics could increase the possibility of defining and developing better regimes to treat IBD pathophysiology.	[Ghorpade, Devram Sampat; Sinha, Akhuri Yash; Holla, Sahana; Singh, Vikas; Balaji, Kithiganahalli Narayanaswamy] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Balaji, KN (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in	Singh, Vikas/AAQ-2841-2021	Singh, Vikas/0000-0003-3102-4286; Holla, Sahana/0000-0001-5186-0180	Department of Biotechnology (DBT); Department of Science and Technology (DST); Council for Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR), Government of India; Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA); Indian Institute of Science (IISc)	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR)); Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA); Indian Institute of Science (IISc)(Indian Institute of Science (IISC) - Bangalore)	This study was supported by funds from the Department of Biotechnology (DBT), Department of Science and Technology (DST), Council for Scientific and Industrial Research (CSIR), Indian Council of Medical Research (ICMR), Government of India, and the Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA) and by infrastructure support from the ICMR (Center for advanced study in Molecular Medicine), DST (FIST), and UGC (special assistance) (to K. N. B.).; Supported by a fellowship from the Indian Institute of Science (IISc).	Bansal K, 2011, J BIOL CHEM, V286, P37032, DOI 10.1074/jbc.M111.260414; Bansal K, 2011, J BIOL CHEM, V286, P5823, DOI 10.1074/jbc.M110.192393; Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Bauersachs J, 2011, CIRC RES, V109, P334, DOI 10.1161/CIRCRESAHA.110.228676; Beck PL, 2007, GASTROENTEROLOGY, V132, P1778, DOI 10.1053/j.gastro.2007.01.032; Blantz RC, 2002, NEPHRON, V90, P373, DOI 10.1159/000054723; Brooks MN, 2011, CELL MICROBIOL, V13, P402, DOI 10.1111/j.1462-5822.2010.01544.x; Cho JH, 2007, ANNU REV MED, V58, P401, DOI 10.1146/annurev.med.58.061705.145024; Cooke JP, 1997, ANNU REV MED, V48, P489, DOI 10.1146/annurev.med.48.1.489; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; El-Zaatari M, 2009, CURR OPIN ENDOCRINOL, V16, P60, DOI 10.1097/MED.0b013e328320a821; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Ghorpade DS, 2013, MOL CELL BIOL, V33, P543, DOI 10.1128/MCB.01108-12; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Hehlio T, 2003, GUT, V52, P558, DOI 10.1136/gut.52.4.558; Iborra M, 2012, AUTOIMMUN REV, V11, P305, DOI 10.1016/j.autrev.2010.07.002; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; Kufer TA, 2008, MOL BIOSYST, V4, P380, DOI 10.1039/b718948f; Kufer TA, 2006, ANN NY ACAD SCI, V1072, P19, DOI 10.1196/annals.1326.020; Laroux FS, 2000, ANTIOXID REDOX SIGN, V2, P391, DOI 10.1089/15230860050192161; Lees CW, 2008, PLOS MED, V5, P1761, DOI 10.1371/journal.pmed.0050239; Mathe E, 2012, INT J CANCER, V131, P760, DOI 10.1002/ijc.26403; Netea MG, 2004, EUR J IMMUNOL, V34, P2052, DOI 10.1002/eji.200425229; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Nielsen CM, 2004, LAB INVEST, V84, P1631, DOI 10.1038/labinvest.3700197; Ozturk H, 2007, RENAL FAILURE, V29, P249, DOI 10.1080/08860220601166289; Pan QL, 2006, INFECT IMMUN, V74, P2121, DOI 10.1128/IAI.74.4.2121-2127.2006; Pere M., 2012, J BIOMED BIOTECHNOL, V2012; Pilichos CJ, 2004, IN VIVO, V18, P513; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Reiter CD, 2003, CURR OPIN HEMATOL, V10, P99, DOI 10.1097/00062752-200303000-00001; Richardson WM, 2010, GASTROENTEROLOGY, V139, P904, DOI 10.1053/j.gastro.2010.05.038; Rumbo M, 2005, FEBS J, V272, P444, DOI 10.1111/j.1742-4658.2004.04484.x; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Sohn JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044156; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Thoreson R, 2007, SURG CLIN N AM, V87, P575, DOI 10.1016/j.suc.2007.03.001; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Waldner Maximilian J, 2009, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0555s46; Wang ZW, 2011, WORLD J GASTROENTERO, V17, P118, DOI 10.3748/wjg.v17.i1.118; Zhou XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048889	45	68	73	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33037	33048		10.1074/jbc.M113.492496	http://dx.doi.org/10.1074/jbc.M113.492496			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24092752	Green Published, hybrid			2022-12-25	WOS:000328841700020
J	Wientjes, E; Drop, B; Kouril, R; Boekema, EJ; Croce, R				Wientjes, Emilie; Drop, Bartlomiej; Kouril, Roman; Boekema, Egbert J.; Croce, Roberta			During State 1 to State 2 Transition in Arabidopsis thaliana, the Photosystem II Supercomplex Gets Phosphorylated but Does Not Disassemble	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Photosynthesis; Photosystem II; Plant; Plant Biochemistry; Protein Phosphorylation; State Transitions; Supramolecular Organization	LIGHT-HARVESTING COMPLEX; EXCITATION-ENERGY DISTRIBUTION; PROTEIN-PHOSPHORYLATION; MEMBRANE ORGANIZATION; CHARGE SEPARATION; QUANTUM YIELD; ANTENNA; PHOTOSYNTHESIS; FLUORESCENCE; DYNAMICS	Background: State transition balances the excitation pressure between the two photosystems of plants. Results: The organization of photosystem II supercomplexes and megacomplexes is the same in state 1 and state 2. Conclusion: Phosphorylation is not sufficient to induce the disassembly of the supercomplexes. Significance: This work helps to understand how plants optimize light harvesting under ever changing light conditions. Plants are exposed to continuous changes in light quality and quantity that challenge the performance of the photosynthetic apparatus and have evolved a series of mechanisms to face this challenge. In this work, we have studied state transitions, the process that redistributes the excitation pressure between photosystems I and II (PSI/PSII) by the reversible association of LHCII, the major antenna complex of higher plants, with either one of them upon phosphorylation/dephosphorylation. By combining biochemical analysis and electron microscopy, we have studied the effect of state transitions on the composition and organization of photosystem II in Arabidopsis thaliana. Two LHCII trimers (called trimers M and S) are part of the PSII supercomplex, whereas up to two more are loosely associated with PSII in state 1 in higher plants (called extra trimers). Here, we show that the LHCII from the extra pool migrates to PSI in state 2, thus leaving the PSII supercomplex and the semicrystalline PSII arrays intact. In state 2, not only is the mobile LHCII phosphorylated, but also the LHCII in the PSII supercomplexes. This demonstrates that PSII phosphorylation is not sufficient for disconnecting LHCII trimers S and M from PSII and for their migration to PSI.	[Wientjes, Emilie; Drop, Bartlomiej; Croce, Roberta] Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands; [Kouril, Roman; Boekema, Egbert J.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Fac Math & Nat Sci, NL-9747 AG Groningen, Netherlands; [Kouril, Roman] Palacky Univ, Dept Biophys, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Olomouc 78371, Czech Republic	Vrije Universiteit Amsterdam; University of Groningen; Palacky University Olomouc	Croce, R (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands.	r.croce@vu.nl	Croce, Roberta/ABG-3595-2021; Croce, Roberta/F-1174-2014; Wientjes, Emilie/AAC-8491-2019; KOUŘIL, Roman/A-9587-2018; Croce, Roberta/N-4067-2014; Croce, Roberta/HGU-9554-2022; Wientjes, Emilie/M-6387-2014	Croce, Roberta/0000-0003-3469-834X; Wientjes, Emilie/0000-0003-2625-8045; KOUŘIL, Roman/0000-0001-8211-3348; Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Wientjes, Emilie/0000-0003-2625-8045	Netherlands Organization for Scientific Research (NWO), Earth and Life Sciences; Vici grant; European Research Council (ERC) [281341, ED0007/01/01]	Netherlands Organization for Scientific Research (NWO), Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO)); Vici grant; European Research Council (ERC)(European Research Council (ERC))	This work was supported by the Netherlands Organization for Scientific Research (NWO), Earth and Life Sciences (ALW), through a Vici grant and the European Research Council (ERC) starting/consolidator Grant 281341 (to R. C.), and Grant ED0007/01/01 Centre of the Region Hana for Biotechnological and Agricultural Research (to R. K.).	Allen JF, 2000, PHILOS T R SOC B, V355, P1351, DOI 10.1098/rstb.2000.0697; ALLEN JF, 1992, TRENDS BIOCHEM SCI, V17, P12, DOI 10.1016/0968-0004(92)90418-9; ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; Allen JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026372; BASSI R, 1988, BIOCHIM BIOPHYS ACTA, V935, P152, DOI 10.1016/0005-2728(88)90212-5; BASSI R, 1992, EUR J BIOCHEM, V204, P317, DOI 10.1111/j.1432-1033.1992.tb16640.x; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; BENNETT J, 1991, ANNU REV PLANT PHYS, V42, P281, DOI 10.1146/annurev.pp.42.060191.001433; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Broess K, 2008, BBA-BIOENERGETICS, V1777, P404, DOI 10.1016/j.bbabio.2008.02.003; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; CHOW WS, 1990, P NATL ACAD SCI USA, V87, P7502, DOI 10.1073/pnas.87.19.7502; Croce R, 1996, BIOCHEMISTRY-US, V35, P8572, DOI 10.1021/bi960214m; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Damkjaer JT, 2009, PLANT CELL, V21, P3245, DOI 10.1105/tpc.108.064006; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; Dietzel L, 2011, PLANT CELL, V23, P2964, DOI 10.1105/tpc.111.087049; Galka P, 2012, PLANT CELL, V24, P2963, DOI 10.1105/tpc.112.100339; Grieco M, 2012, PLANT PHYSIOL, V160, P1896, DOI 10.1104/pp.112.206466; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; Hogewoning SW, 2012, PLANT CELL, V24, P1921, DOI 10.1105/tpc.112.097972; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jarvi S, 2011, BIOCHEM J, V439, P207, DOI 10.1042/BJ20102155; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; Kouril R, 2013, BBA-BIOENERGETICS, V1827, P411, DOI 10.1016/j.bbabio.2012.12.003; Kouril R, 2011, BBA-BIOENERGETICS, V1807, P368, DOI 10.1016/j.bbabio.2010.11.007; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; KYLE DJ, 1983, ARCH BIOCHEM BIOPHYS, V222, P527, DOI 10.1016/0003-9861(83)90551-9; LARSSON UK, 1987, BIOCHIM BIOPHYS ACTA, V894, P59, DOI 10.1016/0005-2728(87)90212-X; LARSSON UK, 1983, EUR J BIOCHEM, V136, P25, DOI 10.1111/j.1432-1033.1983.tb07700.x; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; MELIS A, 1991, BIOCHIM BIOPHYS ACTA, V1058, P87, DOI 10.1016/S0005-2728(05)80225-7; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Oostergetel GT, 1998, ULTRAMICROSCOPY, V74, P47, DOI 10.1016/S0304-3991(98)00022-9; PETER GF, 1991, J BIOL CHEM, V266, P16745; Pribil M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000288; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shapiguzov A, 2010, P NATL ACAD SCI USA, V107, P4782, DOI 10.1073/pnas.0913810107; TELFER A, 1983, BIOCHIM BIOPHYS ACTA, V722, P176, DOI 10.1016/0005-2728(83)90171-8; Tikkanen M, 2008, BBA-BIOENERGETICS, V1777, P425, DOI 10.1016/j.bbabio.2008.02.001; Wientjes E, 2013, J PHYS CHEM B, V117, P11200, DOI 10.1021/jp401663w; Wientjes E, 2013, BBA-BIOENERGETICS, V1827, P420, DOI 10.1016/j.bbabio.2012.12.009	48	57	59	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32821	32826		10.1074/jbc.M113.511691	http://dx.doi.org/10.1074/jbc.M113.511691			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097972	hybrid, Green Published			2022-12-25	WOS:000328841700001
J	Chockalingam, K; Vedhachalam, C; Rangasamy, S; Sekar, G; Adinarayanan, S; Swaminathan, S; Menon, PA				Chockalingam, Kolappan; Vedhachalam, Chandrasekaran; Rangasamy, Subramani; Sekar, Gomathi; Adinarayanan, Srividya; Swaminathan, Soumya; Menon, Pradeep Aravindan			Prevalence of Tobacco Use in Urban, Semi Urban and Rural Areas in and around Chennai City, India	PLOS ONE			English	Article								Background: Tobacco use leads to many health complications and is a risk factor for the occurrence of cardio vascular diseases, lung and oral cancers, chronic bronchitis etc. Almost 6 million people die from tobacco-related causes every year. This study was conducted to measure the prevalence of tobacco use in three different areas around Chennai city, south India. Methods: A survey of 7510 individuals aged > = 15 years was undertaken covering Chennai city (urban), Ambattur (semi-urban) and Sriperumbudur (rural) taluk. Details on tobacco use were collected using a questionnaire adapted from both Global Youth Tobacco Survey and Global Adults Tobacco Survey. Results: The overall prevalence of tobacco use was significantly higher in the rural (23.7%) compared to semi-urban (20.9%) and urban (19.4%) areas (P value < 0.001) Tobacco smoking prevalence was 14.3%, 13.9% and 12.4% in rural, semi-urban and urban areas respectively. The corresponding values for smokeless tobacco use were 9.5%, 7.0% and 7.0% respectively. Logistic regression analysis showed that the odds of using tobacco (with smoke or smokeless forms) was significantly higher among males, older individuals, alcoholics, in rural areas and slum localities. Behavioural pattern analysis of current tobacco users led to three groups (1) those who were not reached by family or friends to advice on harmful effects (2) those who were well aware of harmful effects of tobacco and even want to quit and (3) those are exposed to second hand/passive smoking at home and outside. Conclusions: Tobacco use prevalence was significantly higher in rural areas, slum dwellers, males and older age groups in this region of south India. Women used mainly smokeless tobacco. Tobacco control programmes need to develop strategies to address the different subgroups among tobacco users. Public health facilities need to expand smoking cessation counseling services as well as provide pharmacotherapy where necessary.	[Chockalingam, Kolappan; Vedhachalam, Chandrasekaran; Rangasamy, Subramani; Sekar, Gomathi; Adinarayanan, Srividya; Swaminathan, Soumya; Menon, Pradeep Aravindan] Natl Inst Res TB, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Menon, PA (corresponding author), Natl Inst Res TB, Madras, Tamil Nadu, India.	docpradeep@yahoo.com			United States Agency for International Development (USAID) under the Model DOTS Project [MDP TSA-2010/103409]	United States Agency for International Development (USAID) under the Model DOTS Project(United States Agency for International Development (USAID))	The analysis and presentation of the data was supported in part by the World Health Organization with financial assistance provided by the United States Agency for International Development (USAID) under the Model DOTS Project (Grant no: MDP TSA-2010/103409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejuwon G A, 2009, Afr J Med Med Sci, V38 Suppl 2, P21; Chaly Preetha Elizabeth, 2007, Indian J Dent Res, V18, P2; Critchley JA, 2003, THORAX, V58, P435, DOI 10.1136/thorax.58.5.435; Gajalakshmi V, 2010, TOB USE INSIGHTS, V3, P23; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; GIOVINO GA, 1995, EPIDEMIOL REV, V17, P48, DOI 10.1093/oxfordjournals.epirev.a036185; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Gupta PC, INDIAN J CANC, V49, P393; International Institute for Population Sciences (IIPS), 2007, NAT FAM HLTH SURV NF; Kolappan C, 2007, INT J TUBERC LUNG D, V11, P999; MOHFW, 2010, GLOB AD TOB SURV FAC; Neufeld KJ, 2005, DRUG ALCOHOL DEPEN, V77, P283, DOI 10.1016/j.drugalcdep.2004.08.022; NFHS-2, 1998, IND NAT FAM HLTH SUR, P1; Rani M, 2003, Tob Control, V12, pe4, DOI 10.1136/tc.12.4.e4; Rooban T, 2010, Indian J Cancer, V47 Suppl 1, P53, DOI 10.4103/0019-509X.63869; Subramanian SV, 2004, BMJ-BRIT MED J, V328, P801, DOI 10.1136/bmj.328.7443.801; WHO, 1997, TOB HLTH GLOB STAT R; WHO, 2006, IND GLOB YOUTH TOB S; WHO, 2011, WHO REP GLOB TOB EP	19	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76005	10.1371/journal.pone.0076005	http://dx.doi.org/10.1371/journal.pone.0076005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098418	Green Submitted, Green Published, gold			2022-12-25	WOS:000325427100035
J	Cheng, G; Palanisamy, AP; Evans, ZP; Sutter, AG; Jin, L; Singh, I; May, H; Schmidt, MG; Chavin, KD				Cheng, Gang; Palanisamy, Arun P.; Evans, Zachary P.; Sutter, Alton G.; Jin, Lan; Singh, Inderjit; May, Harold; Schmidt, Michael G.; Chavin, Kenneth D.			Cerulenin Blockade of Fatty Acid Synthase Reverses Hepatic Steatosis in ob/ob Mice	PLOS ONE			English	Article							UNCOUPLING PROTEIN-2 EXPRESSION; BREAST-CANCER CELLS; PPAR-GAMMA; MESSENGER-RNA; FOOD-INTAKE; MOUSE HEPATOCYTES; UP-REGULATION; BODY-WEIGHT; LIVER; INHIBITION	Fatty liver or hepatic steatosis is a common health problem associated with abnormal liver function and increased susceptibility to ischemia/reperfusion injury. The objective of this study was to investigate the effect of the fatty acid synthase inhibitor cerulenin on hepatic function in steatotic ob/ob mice. Different dosages of cerulenin were administered intraperitoneally to ob/ob mice for 2 to 7 days. Body weight, serum AST/ALT, hepatic energy state, and gene expression patterns in ob/ob mice were examined. We found that cerulenin treatment markedly improved hepatic function in ob/ob mice. Serum AST/ALT levels were significantly decreased and hepatic ATP levels increased in treated obese mice compared to obese controls, accompanied by fat depletion in the hepatocyte. Expression of peroxisome proliferator-activated receptors alpha and gamma and uncoupling protein 2 were suppressed with cerulenin treatment and paralleled changes in AST/ALT levels. Hepatic glutathione content were increased in some cases and apoptotic activity in the steatotic livers was minimally changed with cerulenin treatment. In conclusion, these results demonstrate that fatty acid synthase blockade constitutes a novel therapeutic strategy for altering hepatic steatosis at non-stressed states in obese livers.	[Cheng, Gang; Palanisamy, Arun P.; Evans, Zachary P.; Sutter, Alton G.; Jin, Lan; Chavin, Kenneth D.] Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA; [Singh, Inderjit] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [May, Harold; Schmidt, Michael G.] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Palanisamy, AP (corresponding author), Med Univ S Carolina, Dept Surg, Div Transplant Surg, Charleston, SC 29425 USA.	arunp@musc.edu	Sutter, Alton/GWV-3369-2022; Palanisamy, Arun/I-7712-2019; Palanisamy, Arun/L-2019-2014	Palanisamy, Arun/0000-0002-7793-0682; Palanisamy, Arun/0000-0002-7793-0682; Schmidt, Michael G/0000-0002-7794-7265	National Institutes of Health [DK069369]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS022576, R01NS022576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a grant from the National Institutes of Health, number DK069369. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Angulo Paul, 2005, Rev Gastroenterol Mex, V70 Suppl 3, P52; Armeni T, 2000, J SURG RES, V88, P207, DOI 10.1006/jsre.1999.5781; Asselah T, 2006, GUT, V55, P123, DOI 10.1136/gut.2005.069757; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1158, DOI 10.3748/wjg.v19.i8.1158; Begriche K, 2013, HEPATOLOGY; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Boelsterli UA, 2002, BIOCHEM PHARMACOL, V63, P1, DOI 10.1016/S0006-2952(01)00817-6; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Chavin KD, 2004, AM J TRANSPLANT, V4, P1440, DOI 10.1111/j.1600-6143.2004.00546.x; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Cheng G, 2003, BIOCHEM BIOPH RES CO, V308, P573, DOI 10.1016/S0006-291X(03)01409-8; Cho WS, 2009, TOXICOL APPL PHARM, V236, P16, DOI 10.1016/j.taap.2008.12.023; Cortez-Pinto H, 1999, GASTROENTEROLOGY, V116, P1184, DOI 10.1016/S0016-5085(99)70022-3; DAGNOLO G, 1973, BIOCHIM BIOPHYS ACTA, V326, P155, DOI 10.1016/0005-2760(73)90241-5; de Las Heras N, 2013, NUTR METAB CARDIOVAS; Deepa PR, 2013, NUTR CANCER, V65, P311, DOI 10.1080/01635581.2013.748923; Della Corte C, 2012, J ADOLESCENT HEALTH, V51, P305, DOI 10.1016/j.jadohealth.2012.01.010; Dongiovanni P, 2013, PPAR RES, V2013, DOI 10.1155/2013/452061; Dridi S, 2006, AM J PHYSIOL-REG I, V291, pR138, DOI 10.1152/ajpregu.00899.2005; Evans ZP, 2009, TRANSPL P, V41, P4094, DOI 10.1016/j.transproceed.2009.09.055; Evans ZP, 2012, AM J PHYSIOL-GASTR L, V302, pG336, DOI 10.1152/ajpgi.00049.2011; Falck-Ytter Y, 2001, SEMIN LIVER DIS, V21, P17, DOI 10.1055/s-2001-12926; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fink BD, 2005, AM J PHYSIOL-ENDOC M, V288, pE71, DOI 10.1152/ajpendo.00332.2004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gres S, 2013, MOL NUTR FOOD RES; Guan LL, 2012, ZHONGHUA GAN ZANG BI, V20, P131; Kimura K, 1999, FEBS LETT, V457, P75, DOI 10.1016/S0014-5793(99)00987-4; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Makimura H, 2001, DIABETES, V50, P733, DOI 10.2337/diabetes.50.4.733; Malnick SDH, 2003, QJM-INT J MED, V96, P699, DOI 10.1093/qjmed/hcg120; Tirado-Velez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046484; Marques AR, 2004, BRIT J CANCER, V91, P732, DOI 10.1038/sj.bjc.6601989; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Menendez JA, 2004, P NATL ACAD SCI USA, V101, P10715, DOI 10.1073/pnas.0403390101; Nadig SN, 2004, J GASTROINTEST SURG, V8, P695, DOI 10.1016/j.gassur.2004.04.002; Nakatani T, 2002, J BIOL CHEM, V277, P9562, DOI 10.1074/jbc.M110132200; Nardo B, 2001, TRANSPLANTATION, V71, P1816, DOI 10.1097/00007890-200106270-00018; NOMURA S, 1972, J ANTIBIOT, V25, P365, DOI 10.7164/antibiotics.25.365; Pizer ES, 1996, CANCER RES, V56, P2745; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563; Rashid A, 1999, HEPATOLOGY, V29, P1131, DOI 10.1002/hep.510290428; Ronnett GV, 2006, OBESITY, V14, P201; Shimokawa T, 1998, BIOCHEM BIOPH RES CO, V251, P374, DOI 10.1006/bbrc.1998.9479; Spiegelman BM, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801492; Suzuki S, 2013, BIOCHEM BIOPH RES CO, V432, P92, DOI 10.1016/j.bbrc.2013.01.080; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Thupari JN, 2001, BIOCHEM BIOPH RES CO, V285, P217, DOI 10.1006/bbrc.2001.5146; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Van der Lee KAJM, 2000, FASEB J, V14, P495, DOI 10.1096/fasebj.14.3.495; Viguerie-Bascands N, 1999, BIOCHEM BIOPH RES CO, V256, P138, DOI 10.1006/bbrc.1999.0303	59	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75980	10.1371/journal.pone.0075980	http://dx.doi.org/10.1371/journal.pone.0075980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086674	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900069
J	Manni, S; Brancalion, A; Mandato, E; Tubi, LQ; Colpo, A; Pizzi, M; Cappellesso, R; Zaffino, F; Di Maggio, SA; Cabrelle, A; Marino, F; Zambello, R; Trentin, L; Adami, F; Gurrieri, C; Semenzato, G; Piazza, F				Manni, Sabrina; Brancalion, Alessandra; Mandato, Elisa; Tubi, Laura Quotti; Colpo, Anna; Pizzi, Marco; Cappellesso, Rocco; Zaffino, Fortunato; Di Maggio, Speranza Antonia; Cabrelle, Anna; Marino, Filippo; Zambello, Renato; Trentin, Livio; Adami, Fausto; Gurrieri, Carmela; Semenzato, Gianpietro; Piazza, Francesco			Protein Kinase CK2 Inhibition Down Modulates the NF-kappa B and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells	PLOS ONE			English	Article							PROTEASOME INHIBITORS; THERAPEUTIC TARGET; SIGNALING PATHWAY; INDUCED APOPTOSIS; CANCER-CELLS; ACTIVATION; PHOSPHORYLATION; EXPRESSION; PROLIFERATION; TRANSCRIPTION	CK2 is a pivotal pro-survival protein kinase in multiple myeloma that may likely impinge on bortezomib-regulated cellular pathways. In the present study, we investigated CK2 expression in multiple myeloma and mantle cell lymphoma, two bortezomib-responsive B cell tumors, as well as its involvement in bortezomib-induced cytotoxicity and signaling cascades potentially mediating bortezomib resistance. In both tumors, CK2 expression correlated with that of its activated targets NF-kappa B and STAT3 transcription factors. Bortezomib-induced proliferation arrest and apoptosis were significantly amplified by the simultaneous inhibition of CK2 with two inhibitors (CX-4945 and K27) in multiple myeloma and mantle cell lymphoma cell lines, in a model of multiple myeloma bone marrow microenvironment and in cells isolated from patients. CK2 inhibition empowered bortezomib-triggered mitochondrial-dependent cell death. Phosphorylation of NF-kappa B p65 on Ser529 (a CK2 target site) and rise of the levels of the endoplasmic reticulum stress kinase/endoribonuclease Ire1 alpha were markedly reduced upon CK2 inhibition, as were STAT3 phospho Ser727 levels. On the contrary, CK2 inhibition increased phospho Ser51 eIF2 alpha levels and enhanced the bortezomib-dependent accumulation of poly-ubiquitylated proteins and of the proteotoxic stress-associated chaperone Hsp70. Our data suggest that CK2 over expression in multiple myeloma and mantle cell lymphoma cells might sustain survival signaling cascades and can antagonize bortezomib-induced apoptosis at different levels. CK2 inhibitors could be useful in bortezomib-based combination therapies.	[Manni, Sabrina; Brancalion, Alessandra; Mandato, Elisa; Tubi, Laura Quotti; Colpo, Anna; Zaffino, Fortunato; Di Maggio, Speranza Antonia; Zambello, Renato; Trentin, Livio; Adami, Fausto; Gurrieri, Carmela; Semenzato, Gianpietro; Piazza, Francesco] Univ Padua, Dept Med, Hematol & Clin Immunol Branch, Padua, Italy; [Manni, Sabrina; Brancalion, Alessandra; Mandato, Elisa; Tubi, Laura Quotti; Colpo, Anna; Zaffino, Fortunato; Cabrelle, Anna; Zambello, Renato; Trentin, Livio; Gurrieri, Carmela; Semenzato, Gianpietro; Piazza, Francesco] Venetian Inst Mol Med, Hematol Malignancies Unit, Myeloma & Lymphoma Pathobiol Lab, Padua, Italy; [Pizzi, Marco; Cappellesso, Rocco; Marino, Filippo] Univ Padua, Dept Med, Gen Pathol & Cytopathol Unit, Padua, Italy	University of Padua; Veneto Institute Molecular Medicine; University of Padua	Semenzato, G (corresponding author), Univ Padua, Dept Med, Hematol & Clin Immunol Branch, Padua, Italy.	g.semenzato@unipd.it; francesco.piazza@unipd.it	SEMENZATO, GIANPIETRO C/J-7727-2016; gurrieri, carmela/AAA-5365-2022; Cappellesso, Rocco/L-5463-2016; mandato, elisa/AGI-6364-2022; TRENTIN, LIVIO/L-6678-2019; TRENTIN, LIVIO/J-7676-2016; Piazza, Francesco/K-6695-2016; Manni, Sabrina/AAE-9182-2021; Piazza, Francesco/AAD-1600-2019; Zambello, Renato/AAB-5280-2022; Adami, Fernando/D-3855-2012; Pizzi, Marco/H-6273-2016	SEMENZATO, GIANPIETRO C/0000-0002-6061-4595; Cappellesso, Rocco/0000-0002-0480-3412; mandato, elisa/0000-0002-7443-2821; TRENTIN, LIVIO/0000-0003-1222-6149; TRENTIN, LIVIO/0000-0003-1222-6149; Piazza, Francesco/0000-0002-2831-623X; Piazza, Francesco/0000-0002-2831-623X; Zambello, Renato/0000-0002-8799-5324; Adami, Fernando/0000-0003-1918-3364; COLPO, ANNA/0000-0001-8286-4336; MANNI, SABRINA/0000-0001-6804-0680; Pizzi, Marco/0000-0003-4006-7317; gurrieri, carmela/0000-0001-8233-6007	Ministero dell'Istruzione, dell' Universita e della Ricerca Scientifica (MIUR) [RBFR086EW9]; University of Padova [CPDA114940/11]; Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.)	Ministero dell'Istruzione, dell' Universita e della Ricerca Scientifica (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Padova; Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.)(Fondazione AIRC per la ricerca sul cancro)	This study was supported by a grant from the Ministero dell'Istruzione, dell' Universita e della Ricerca Scientifica (MIUR; www.miur.it) no RBFR086EW9 (FIRB "Futuro in Ricerca") and from a University of Padova (www.unipd.it) grant no CPDA114940/11 "Progetti di Ricerca di Ateneo" to Francesco Piazza and from the Associazione Italiana per la Ricerca sul Cancro (A.I.R.C., Milan; www.airc.it) to Gianpietro Semenzato. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird TA, 1997, J BIOL CHEM, V272, P32606, DOI 10.1074/jbc.272.51.32606; Bjorling-Poulsen M, 2005, ONCOGENE, V24, P6194, DOI 10.1038/sj.onc.1208762; Buac D, 2013, CURR PHARM DESIGN, V19, P4025, DOI 10.2174/1381612811319220012; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Cenci S, 2007, FEBS LETT, V581, P3652, DOI 10.1016/j.febslet.2007.04.031; Cortelazzo S, 2012, CRIT REV ONCOL HEMAT, V82, P78, DOI 10.1016/j.critrevonc.2011.05.001; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Fassan M, 2010, J CLIN PATHOL, V63, P692, DOI 10.1136/jcp.2010.078253; Fassina A, 2012, LAB INVEST, V92, P1574, DOI 10.1038/labinvest.2012.129; Ferguson AD, 2010, FEBS LETT; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Harvey EJ, 2007, ARTERIOSCL THROM VAS, V27, P806, DOI 10.1161/01.ATV.0000258867.79411.96; Hessenauer A, 2011, CELL SIGNAL, V23, P145, DOI 10.1016/j.cellsig.2010.08.014; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Holkova B, 2012, BEST PRACT RES CL HA, V25, P133, DOI 10.1016/j.beha.2012.04.007; Hosoi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040144; Hoster E, 2008, BLOOD, V111, P558, DOI 10.1182/blood-2007-06-095331; Ishikawa H, 2003, LEUKEMIA LYMPHOMA, V44, P1477, DOI 10.1080/1042819031000097339; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Koprivnikar JL, 2012, FUTURE ONCOL, V8, P359, DOI [10.2217/FON.12.23, 10.2217/fon.12.23]; Lai R, 2003, J PATHOL, V199, P84, DOI 10.1002/path.1253; Lawasut P, 2012, CURR HEMATOL MALIG R, V7, P258, DOI 10.1007/s11899-012-0141-2; Manni S, 2012, CLIN CANCER RES, V18, P1888, DOI 10.1158/1078-0432.CCR-11-1789; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Mitsiades CS, 2009, SEMIN HEMATOL, V46, P166, DOI 10.1053/j.seminhematol.2009.02.003; Miyata Y, 2004, ANN NY ACAD SCI, V1030, P150, DOI 10.1196/annals.1329.019; Miyata Y, 2009, CELL MOL LIFE SCI, V66, P1840, DOI 10.1007/s00018-009-9152-0; Mujtaba T, 2011, DISCOV MED, V12, P471; Navas TA, 2006, LEUKEMIA, V20, P1017, DOI 10.1038/sj.leu.2404200; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Padgett CS, 2010, EJC SUPPL, V8, P131, DOI 10.1016/S1359-6349(10)72121-2; Piazza F, 2012, LEUKEMIA, V26, P1174, DOI 10.1038/leu.2011.385; Piazza F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-526; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Prowald A, 1997, FEBS LETT, V408, P99, DOI 10.1016/S0014-5793(97)00399-2; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Romieu-Mourez R, 2002, CANCER RES, V62, P6770; Roue G, 2011, BLOOD, V117, P1270, DOI 10.1182/blood-2010-04-278853; Ruzzene M, 2009, BIOCH BIOPHYS ACTA; Ruzzene M, 2010, BBA-PROTEINS PROTEOM, V1804, P499, DOI 10.1016/j.bbapap.2009.07.018; Sarno S, 2011, CURR TOP MED CHEM, V11, P1340, DOI 10.2174/156802611795589638; Schewe DM, 2009, CANCER RES, V69, P1545, DOI 10.1158/0008-5472.CAN-08-3858; Schneider CC, 2012, CELL SIGNAL, V24, P1797, DOI 10.1016/j.cellsig.2012.05.006; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Timofeeva OA, 2006, ONCOGENE, V25, P7555, DOI 10.1038/sj.onc.1209742; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Wang H, 2010, CELL SIGNAL, V22, P1717, DOI 10.1016/j.cellsig.2010.06.012; Yared MA, 2005, ARCH PATHOL LAB MED, V129, P990; Zhang L, 2012, BLOOD, V120, P3783, DOI 10.1182/blood-2012-04-424630; Zheng Y, 2011, BLOOD, V118, P156, DOI 10.1182/blood-2010-01-266320	55	61	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75280	10.1371/journal.pone.0075280	http://dx.doi.org/10.1371/journal.pone.0075280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086494	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900041
J	Pelisson, PF; Bel-Venner, MC; Giron, D; Menu, F; Venner, S				Pelisson, Pierre-Francois; Bel-Venner, Marie-Claude; Giron, David; Menu, Frederic; Venner, Samuel			From Income to Capital Breeding: When Diversified Strategies Sustain Species Coexistence	PLOS ONE			English	Article							ALLOCATION; ENERGY; ACQUISITION; PHYSIOLOGY; DICHOTOMY; EVOLUTION; CURCULIO; BREEDERS	There is empirical evidence of many diversified ways for energy to be acquired and allocated to reproduction, notably with strategies ranging from strict income breeding (females fueling their gametes with energy gained concomitantly during reproduction) to strict capital breeding (females storing nutrients prior reproduction). Until now, the question of whether diversification of these strategies might impact the way communities are organized has not been considered. Here, we suggest that diversified resource allocation strategies among competing species may contribute to their coexistence. We examined this hypothesis by focusing on communities composed of four phytophagous insect species that coexist and compete for egg-laying sites. From wild-caught females, we determined precisely the breeding period of each species and we described their resource acquisition and allocation to reproduction dynamics. We quantified in each species the total amount of larval energy stored by newly-emerging females and then monitored the total energy budget of females caught in the field before and throughout their breeding period. We found that the four sibling weevil species are markedly segregated along the income-capital-breeding continuum, which is correlated with clear time partitioning in their laying activity. Our results suggest that diversified resource allocation strategies might contribute to time partitioning of plant resources exploitation and thus indirectly to their coexistence. This work should further encourage studies examining the extent to which competitive coexistence might be affected by diversification of income-capital breeding strategies together with the intensity of interspecific competition, and considering the divergent evolution of these strategies.	[Pelisson, Pierre-Francois; Bel-Venner, Marie-Claude; Menu, Frederic; Venner, Samuel] Univ Lyon, Lyon, France; [Pelisson, Pierre-Francois; Bel-Venner, Marie-Claude; Menu, Frederic; Venner, Samuel] Univ Lyon, CNRS, UMR5558, Lab Biometrie & Biol Evolut, Villeurbanne, France; [Pelisson, Pierre-Francois] Univ Libre Bruxelles, Biol Control & Spatial Ecol Lab LUBIES, Brussels, Belgium; [Giron, David] Univ Tours, CNRS, UMR 7261, Inst Rech Biol Insecte, Tours, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Tours	Pelisson, PF (corresponding author), Univ Lyon, Lyon, France.	pfpelisson@gmail.com; Samuel.Venner@univ-lyon1.fr	MENU, Frédéric/C-3107-2016; Venner, Samuel/ABC-7739-2020; Giron, David/B-9108-2013	Venner, Samuel/0000-0001-7127-3733; Giron, David/0000-0001-8356-0983	French National Research Agency (ANR: CoCoReCo project) [JC09_470585]; CNRS	French National Research Agency (ANR: CoCoReCo project)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the French National Research Agency (ANR: CoCoReCo project JC09_470585) and by the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; BOGGS CL, 1992, FUNCT ECOL, V6, P508, DOI 10.2307/2390047; Bonnet X, 1998, OIKOS, V83, P333, DOI 10.2307/3546846; Bonnet-Masimbert M., 1984, Pollinisation et productions vegetales, P219; Boyd IL, 2000, FUNCT ECOL, V14, P623, DOI 10.1046/j.1365-2435.2000.t01-1-00463.x; Casas J, 2005, ECOLOGY, V86, P545, DOI 10.1890/04-0812; Cecich RA, 1999, CAN J FOREST RES, V29, P1817, DOI 10.1139/cjfr-29-12-1817; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Coutin R., 1992, Memoires de la Societe Royale Belge d'Entomologie, V35, P259; Giron D, 2003, ECOL LETT, V6, P273, DOI 10.1046/j.1461-0248.2003.00429.x; Hoffmann A, 1986, F D FRAN SOC SCI NAT, V59, P1090; Houston AI, 2007, BEHAV ECOL, V18, P241, DOI 10.1093/beheco/arl080; Hughes J, 2004, MOL PHYLOGENET EVOL, V32, P601, DOI 10.1016/j.ympev.2004.02.007; Jervis MA, 2001, J ANIM ECOL, V70, P442, DOI 10.1046/j.1365-2656.2001.00507.x; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; Johnson RA, 2006, INSECT SOC, V53, P316, DOI 10.1007/s00040-006-0874-9; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; KARASOV WH, 1986, TRENDS ECOL EVOL, V1, P101, DOI 10.1016/0169-5347(86)90034-0; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Kemp DJ, 2003, AM NAT, V162, P290, DOI 10.1086/376890; Klaassen M, 2006, ARDEA, V94, P371; Mathias A, 2013, THEOR POPUL BIOL, V84, P56, DOI 10.1016/j.tpb.2012.11.009; Meijer T, 1999, IBIS, V141, P399, DOI 10.1111/j.1474-919X.1999.tb04409.x; Pelisson PF, 2011, ENTOMOL EXP APPL, V138, P77, DOI 10.1111/j.1570-7458.2010.01077.x; PELISSON PF, 2011, THESIS, P260; Pelisson PF, 2012, FUNCT ECOL, V26, P198, DOI 10.1111/j.1365-2435.2011.01925.x; PERRIN N, 1993, ANNU REV ECOL SYST, V24, P379, DOI 10.1146/annurev.es.24.110193.002115; SORK VL, 1993, ECOLOGY, V74, P528, DOI 10.2307/1939313; Stearns S.C., 1992, pi; Stephens PA, 2009, ECOLOGY, V90, P2057, DOI 10.1890/08-1369.1; Tammaru T, 1996, OIKOS, V77, P561, DOI 10.2307/3545946; Thoren LM, 1998, J ECOL, V86, P501, DOI 10.1046/j.1365-2745.1998.00276.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Varpe O, 2009, OIKOS, V118, P363, DOI 10.1111/j.1600-0706.2008.17036.x; Venner S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018039; Warner DA, 2008, J ANIM ECOL, V77, P1242, DOI 10.1111/j.1365-2656.2008.01442.x; Wessels FJ, 2010, J INSECT PHYSIOL, V56, P1269, DOI 10.1016/j.jinsphys.2010.03.033; WILLIAMSON MJ, 1966, FOREST SCI, V12, P19	39	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76086	10.1371/journal.pone.0076086	http://dx.doi.org/10.1371/journal.pone.0076086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086694	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900080
J	Zhang, DJ; Wang, XM; Wang, M; Li, JH; Guo, XY; Chong, K; Xu, YY				Zhang, Dajian; Wang, Xiaomin; Wang, Min; Li, Junhua; Guo, Xiaoyu; Chong, Kang; Xu, Yunyuan			Ectopic Expression of WUS in Hypocotyl Promotes Cell Division via GRP23 in Arabidopsis	PLOS ONE			English	Article							WUSCHEL GENE; SHOOT; CYTOKININ; PROTEIN; GROWTH; AUXIN; CYCLE; FATE; GIBBERELLINS; TOLERANCE	WUSCHEL (WUS) is essential for preventing stem cell differentiation in Arabidopsis. Here we report that in addition to its functions in meristematic stem cell maintenance, WUS is involved in the regulation of cell division. The WUS gain-of-function mutant, stem ectopic flowers (sef), displayed elongated hypocotyls, whereas the loss-of-function wus-1 mutant had shortened hypocotyls. The long hypocotyl in sef was due to the presence of more cells, rather than increased cell elongation. Microscopic observation, flow cytometry assays, quantitative RT-PCR (qRT-PCR), and histochemical staining of CycB1;1::GUS supported the hypothesis that ectopic cell division occurred in the sef hypocotyls after germination. Both immunoblot and qRT-PCR results showed that WUS was ectopically expressed in sef hypocotyls. Luciferase activity, chromatin immunoprecipitation (ChIP) and electrophoretic mobility shift assay (EMSA) showed that GLUTAMINE-RICH PROTEIN 23 (GRP23) expression can be activated by WUS and that GRP23 is a direct target gene of WUS. The phenotypes of 35S::GRP23 plants and GRP23 knockdown lines supported the notion that GRP23 mediates the effects of WUS on hypocotyl length. Together, our data suggest that ectopic expression of WUS in hypocotyl controls cell division through its target gene GRP23.	[Zhang, Dajian; Wang, Xiaomin; Wang, Min; Li, Junhua; Guo, Xiaoyu; Chong, Kang; Xu, Yunyuan] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China; [Zhang, Dajian] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, YY (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China.	xuyy@ibcas.ac.cn			National Science Foundation of China for Innovative Research Groups [31121065]	National Science Foundation of China for Innovative Research Groups(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the National Science Foundation of China for Innovative Research Groups (31121065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Buechel S, 2010, EUR J CELL BIOL, V89, P279, DOI 10.1016/j.ejcb.2009.11.016; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; Cheng ZJ, 2013, PLANT PHYSIOL, V161, P240, DOI 10.1104/pp.112.203166; Chickarmane VS, 2012, P NATL ACAD SCI USA, V109, P4002, DOI 10.1073/pnas.1200636109; Clouse SD, 1996, PLANT J, V10, P1, DOI 10.1046/j.1365-313X.1996.10010001.x; Collett CE, 2000, PLANT PHYSIOL, V124, P553, DOI 10.1104/pp.124.2.553; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Cowling RJ, 1999, J EXP BOT, V50, P1351, DOI 10.1093/jexbot/50.337.1351; Dewitte W, 2003, ANNU REV PLANT BIOL, V54, P235, DOI 10.1146/annurev.arplant.54.031902.134836; Ding YH, 2006, PLANT CELL, V18, P815, DOI 10.1105/tpc.105.039495; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Gutierrez C, 2005, NAT CELL BIOL, V7, P535, DOI 10.1038/ncb0605-535; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Jing YJ, 2013, PLANT CELL, V25, P242, DOI 10.1105/tpc.112.105742; Laux T, 1996, DEVELOPMENT, V122, P87; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Li JJ, 2011, PLANT CELL, V23, P4411, DOI 10.1105/tpc.111.092684; Lin RC, 2007, SCIENCE, V318, P1302, DOI 10.1126/science.1146281; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; MCNELLIS TW, 1995, PLANT CELL, V7, P1749, DOI 10.1105/tpc.7.11.1749; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sablowski R, 2009, P NATL ACAD SCI USA, V106, P16016, DOI 10.1073/pnas.0909300106; Saibo NJM, 2003, PLANT J, V33, P989, DOI 10.1046/j.1365-313X.2003.01684.x; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Sosso D, 2012, PLANT CELL, V24, P676, DOI 10.1105/tpc.111.091074; Xu YY, 2005, PLANT MOL BIOL, V57, P773, DOI 10.1007/s11103-005-0952-9; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	40	2	3	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75773	10.1371/journal.pone.0075773	http://dx.doi.org/10.1371/journal.pone.0075773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086632	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000043
J	Basile, AJ; Horiuchi, K; Panella, AJ; Laven, J; Kosoy, O; Lanciotti, RS; Venkateswaran, N; Biggerstaff, BJ				Basile, Alison J.; Horiuchi, Kalanthe; Panella, Amanda J.; Laven, Janeen; Kosoy, Olga; Lanciotti, Robert S.; Venkateswaran, Neeraja; Biggerstaff, Brad J.			Multiplex Microsphere Immunoassays for the Detection of IgM and IgG to Arboviral Diseases	PLOS ONE			English	Article							WEST-NILE-VIRUS; MONOCLONAL-ANTIBODIES; ENCEPHALITIS; IDENTIFICATION; FLAVIVIRUS; INFECTIONS; ANTIGEN	Serodiagnosis of arthropod-borne viruses (arboviruses) at the Division of Vector-Borne Diseases, CDC, employs a combination of individual enzyme-linked immunosorbent assays and microsphere immunoassays (MIAs) to test for IgM and IgG, followed by confirmatory plaque-reduction neutralization tests. Based upon the geographic origin of a sample, it may be tested concurrently for multiple arboviruses, which can be a cumbersome task. The advent of multiplexing represents an opportunity to streamline these types of assays; however, because serologic cross-reactivity of the arboviral antigens often confounds results, it is of interest to employ data analysis methods that address this issue. Here, we constructed 13-virus multiplexed IgM and IgG MIAs that included internal and external controls, based upon the Luminex platform. Results from samples tested using these methods were analyzed using 8 different statistical schemes to identify the best way to classify the data. Geographic batteries were also devised to serve as a more practical diagnostic format, and further samples were tested using the abbreviated multiplexes. Comparative error rates for the classification schemes identified a specific boosting method based on logistic regression "Logitboost" as the classification method of choice. When the data from all samples tested were combined into one set, error rates from the multiplex IgM and IgG MIAs were <5% for all geographic batteries. This work represents both the most comprehensive, validated multiplexing method for arboviruses to date, and also the most systematic attempt to determine the most useful classification method for use with these types of serologic tests.	[Basile, Alison J.; Horiuchi, Kalanthe; Panella, Amanda J.; Laven, Janeen; Kosoy, Olga; Lanciotti, Robert S.; Biggerstaff, Brad J.] Ctr Dis Control, Div Vector Borne Dis, Ft Collins, CO 80521 USA; [Venkateswaran, Neeraja] Radix Biosolut, Georgetown, TX USA		Basile, AJ (corresponding author), Ctr Dis Control, Div Vector Borne Dis, Ft Collins, CO 80521 USA.	Ajj1@cdc.gov		Basile, Alison Jane/0000-0002-5646-1557	CDC, DVBD	CDC, DVBD	CDC, DVBD is a federally funded national public health Lab (USCDC) and the work presented was supported by this federal funding. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.	Adjemian J, 2012, VECTOR-BORNE ZOONOT, V12, P922, DOI 10.1089/vbz.2011.0917; Beaty BC., 1995, VIRAL RICKETTSIAL CH, P189; Briese T, 1999, LANCET, V354, P1261, DOI 10.1016/S0140-6736(99)04576-6; Centers for Disease Control and Prevention, 2012, NAT NOT DIS COND CUR; Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4; Core R Team, 2012, R LANG ENV STAT COMP; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Hastie T., 2008, ELEMENTS STAT LEARNI; Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Hunt AR, 2001, J VIROL METHODS, V97, P133, DOI 10.1016/S0166-0934(01)00346-9; Johnson AJ, 2005, CLIN DIAGN LAB IMMUN, V12, P566, DOI 10.1128/CDLI.12.5.566-574.2005; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; Johnson AJ, 2007, CLIN VACCINE IMMUNOL, V14, P1084, DOI 10.1128/CVI.00115-07; Jokela P, 2012, J VIROL METHODS, V182, P82, DOI 10.1016/j.jviromet.2012.03.015; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Lammie PJ, 2012, INT J PARASITOL, V42, P797, DOI 10.1016/j.ijpara.2012.07.002; LUDWIG GV, 1991, MICROB PATHOGENESIS, V11, P411, DOI 10.1016/0882-4010(91)90037-B; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Martins TB, 2008, AM J CLIN PATHOL, V129, P34, DOI 10.1309/65VKWVNAQ38PHMGQ; Monath TP, 2008, ANTIVIR RES, V78, P116, DOI 10.1016/j.antiviral.2007.10.009; Prince HE, 2013, J CLIN LAB ANAL, V27, P27, DOI 10.1002/jcla.21557; Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130; Roberson JA, 2007, J CLIN MICROBIOL, V45, P3167, DOI 10.1128/JCM.01143-07; ROEHRIG JT, 1983, VIROLOGY, V128, P118, DOI 10.1016/0042-6822(83)90323-9; ROEHRIG JT, 1990, AM J TROP MED HYG, V42, P394, DOI 10.4269/ajtmh.1990.42.394; Roehrig JT, 1986, TOGAVIRIDAE FLAVIVIR, P251; van der Wal FJ, 2012, J VIROL METHODS, V183, P99, DOI 10.1016/j.jviromet.2012.03.008; Zubach V, 2012, J CLIN MICROBIOL, V50, P460, DOI 10.1128/JCM.06090-11	29	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75670	10.1371/journal.pone.0075670	http://dx.doi.org/10.1371/journal.pone.0075670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086608	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700107
J	Abdelmoaty, S; Wigerblad, G; Bas, DB; Codeluppi, S; Fernandez-Zafra, T; El-Awady, ES; Moustafa, Y; Abdelhamid, AES; Brodin, E; Svensson, CI				Abdelmoaty, Sally; Wigerblad, Gustaf; Bas, Duygu B.; Codeluppi, Simone; Fernandez-Zafra, Teresa; El-Awady, El-Sayed; Moustafa, Yasser; Abdelhamid, Alaa El-din S.; Brodin, Ernst; Svensson, Camilla I.			Spinal Actions of Lipoxin A(4) and 17(R)-Resolvin D1 Attenuate Inflammation-Induced Mechanical Hypersensitivity and Spinal TNF Release	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; RESOLVIN D1; FACTOR-ALPHA; CYTOKINE PRODUCTION; INDUCED ARTHRITIS; GLIAL ACTIVATION; GENE-EXPRESSION; PAIN BEHAVIOR; CORD-INJURY	Lipoxins and resolvins have anti-inflammatory and pro-resolving actions and accumulating evidence indicates that these lipid mediators also attenuate pain-like behavior in a number of experimental models of inflammation and tissue injury-induced pain. The present study was undertaken to assess if spinal administration of lipoxin A(4) (LXA4) or 17 (R)-resolvin D1 (17(R)-RvD1) attenuates mechanical hypersensitivity in the carrageenan model of peripheral inflammation in the rat. Given the emerging role of spinal cytokines in the generation and maintenance of inflammatory pain we measured cytokine levels in the cerebrospinal fluid (CSF) after LXA4 or 17(R)-RvD1 administration, and the ability of these lipid metabolites to prevent stimuli-induced release of cytokines from cultured primary spinal astrocytes. We found that intrathecal bolus injection of LXA4 and17(R)-RvD1 attenuated inflammation-induced mechanical hypersensitivity without reducing the local inflammation. Furthermore, both LXA4 and 17(R)-RvD1 reduced carrageenan-induced tumor necrosis factor (TNF) release in the CSF, while only 17(R)-RvD1attenuated LPS and IFN-gamma-induced TNF release in astrocyte cell culture. In conclusion, this study demonstrates that lipoxins and resolvins potently suppress inflammation-induced mechanical hypersensitivity, possibly by attenuating cytokine release from spinal astrocytes. The inhibitory effect of lipoxins and resolvins on spinal nociceptive processing puts them in an intriguing position in the search for novel pain therapeutics.	[Abdelmoaty, Sally; Wigerblad, Gustaf; Bas, Duygu B.; Brodin, Ernst; Svensson, Camilla I.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Codeluppi, Simone; Fernandez-Zafra, Teresa] Karolinska Inst, Dept Mol Biochem & Biophys, Stockholm, Sweden; [Abdelmoaty, Sally; El-Awady, El-Sayed; Moustafa, Yasser] Suez Canal Univ, Fac Pharm, Dept Pharmacol & Toxicol, Ismailia, Egypt; [Abdelhamid, Alaa El-din S.] Suez Canal Univ, Fac Med, Dept Clin Pathol, Ismailia, Egypt	Karolinska Institutet; Karolinska Institutet; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Suez Canal University	Svensson, CI (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	camilla.svensson@ki.se	Svensson, Camilla/C-9511-2014; Moustafa, Yasser/AAS-1212-2021; codeluppi, simone/I-4143-2012	Svensson, Camilla/0000-0001-7980-4631; Moustafa, Yasser/0000-0001-5394-5559; codeluppi, simone/0000-0002-7053-0520; abdelhamid, alaa eldin/0000-0002-4764-5573	EU [224882]; Swedish Research Council [2007-5750]; Swedish Association for Strategic Research; Egyptian Ministry of Higher Education	EU(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Association for Strategic Research; Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF))	This work was supported by: EU (Marie Curie International Reintergration grants-No.224882) to CIS, Swedish Research Council(No.2007-5750) to CIS, Swedish Association for Strategic Research (CIS) and the Egyptian Ministry of Higher Education (PhD scholarship to SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2003, J IMMUNOL, V170, P6266, DOI 10.4049/jimmunol.170.12.6266; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Bang S, 2012, BRIT J PHARMACOL, V165, P683, DOI 10.1111/j.1476-5381.2011.01568.x; Bang S, 2010, BRIT J PHARMACOL, V161, P707, DOI 10.1111/j.1476-5381.2010.00909.x; Boyle DL, 2003, ARTHRITIS RES THER, V5, pR352, DOI 10.1186/ar1004; Brandenburg LO, 2007, J NEUROCHEM, V101, P718, DOI 10.1111/j.1471-4159.2006.04351.x; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Choi JI, 2010, PAIN, V149, P243, DOI 10.1016/j.pain.2010.02.008; CHUNG IY, 1990, J IMMUNOL, V144, P2999; Codeluppi S, 2011, J NEUROSCI METH, V197, P118, DOI 10.1016/j.jneumeth.2011.02.011; Conte FP, 2010, BRIT J PHARMACOL, V161, P911, DOI 10.1111/j.1476-5381.2010.00950.x; Decker Y, 2009, AM J PHYSIOL-CELL PH, V296, pC1420, DOI 10.1152/ajpcell.00380.2008; Feng QX, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-148; Filep JG, 2005, PROSTAG LEUKOTR ESS, V73, P257, DOI 10.1016/j.plefa.2005.05.014; GARRISON CJ, 1991, BRAIN RES, V565, P1, DOI 10.1016/0006-8993(91)91729-K; Gwak YS, 2008, PAIN, V138, P410, DOI 10.1016/j.pain.2008.01.021; Halonen SK, 2006, J NEUROIMMUNOL, V175, P19, DOI 10.1016/j.jneuroim.2006.02.015; Hashimoto A, 2007, J RHEUMATOL, V34, P2144; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Hu S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-278; Huang LA, 2011, PAIN, V152, P557, DOI 10.1016/j.pain.2010.11.021; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jozsef L, 2002, P NATL ACAD SCI USA, V99, P13266, DOI 10.1073/pnas.202296999; Koistinaho M, 2002, GLIA, V40, P175, DOI 10.1002/glia.10151; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lafortune L, 1996, J NEUROPATH EXP NEUR, V55, P515, DOI 10.1097/00005072-199605000-00003; Le YY, 2000, J NEUROIMMUNOL, V111, P102, DOI 10.1016/S0165-5728(00)00373-8; LEE SC, 1993, J IMMUNOL, V150, P2659; LI D, 2013, MUCOSAL IMMUNOL, P62912; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Lima-Garcia JF, 2011, BRIT J PHARMACOL, V164, P278, DOI 10.1111/j.1476-5381.2011.01345.x; MALIPIERO UV, 1990, J IMMUNOL, V144, P3816; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Menezes-de-Lima O, 2006, PROSTAG OTH LIPID M, V80, P123, DOI 10.1016/j.prostaglandins.2006.05.016; Milligan ED, 2005, EUR J NEUROSCI, V21, P2136, DOI 10.1111/j.1460-9568.2005.04057.x; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Niederberger E, 2008, FASEB J, V22, P3432, DOI 10.1096/fj.08-109355; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Ohira T, 2010, J BIOL CHEM, V285, P3451, DOI 10.1074/jbc.M109.044131; Park CK, 2011, J NEUROSCI, V31, P18433, DOI 10.1523/JNEUROSCI.4192-11.2011; Pollock J, 2002, NEUROPHARMACOLOGY, V42, P93, DOI 10.1016/S0028-3908(01)00163-0; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Saito O, 2010, BRIT J PHARMACOL, V160, P1754, DOI 10.1111/j.1476-5381.2010.00811.x; Saklatvala J, 1999, BIOCHEM SOC SYMP, P63; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; Schafers M, 2008, NEUROSCI LETT, V437, P188, DOI 10.1016/j.neulet.2008.03.052; Schafers Maria, 2007, Expert Rev Neurother, V7, P1613, DOI 10.1586/14737175.7.11.1613; Semple BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-67; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Sun T, 2012, EUR J PAIN, V16, P18, DOI 10.1016/j.ejpain.2011.05.005; Svensson CI, 2007, J EXP MED, V204, P245, DOI 10.1084/jem.20061826; Sweitzer SM, 1999, BRAIN RES, V829, P209, DOI 10.1016/S0006-8993(99)01326-8; Tawfik VL, 2007, BRAIN BEHAV IMMUN, V21, P238, DOI 10.1016/j.bbi.2006.07.001; Vale ML, 2003, J PHARMACOL EXP THER, V304, P102, DOI 10.1124/jpet.102.038703; Wang YP, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-95; Wu SH, 2008, INFLAMM RES, V57, P430, DOI 10.1007/s00011-008-7147-1; Xu MX, 2013, CNS NEUROSCI THER, V19, P235, DOI 10.1111/cns.12069; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yu CG, 2003, J PAIN, V4, P129, DOI 10.1054/jpai.2003.11; Zhang RX, 2008, PAIN, V135, P232, DOI 10.1016/j.pain.2007.05.023	68	57	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75543	10.1371/journal.pone.0075543	http://dx.doi.org/10.1371/journal.pone.0075543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086560	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200046
J	Scheepers, C; Mohr, S; Fischer, MH; Roberts, AM				Scheepers, Christoph; Mohr, Sibylle; Fischer, Martin H.; Roberts, Andrew M.			Listening to Limericks: A Pupillometry Investigation of Perceivers' Expectancy	PLOS ONE			English	Article							PROCESSING LOAD; RESPONSES	What features of a poem make it captivating, and which cognitive mechanisms are sensitive to these features? We addressed these questions experimentally by measuring pupillary responses of 40 participants who listened to a series of Limericks. The Limericks ended with either a semantic, syntactic, rhyme or metric violation. Compared to a control condition without violations, only the rhyme violation condition induced a reliable pupillary response. An anomaly-rating study on the same stimuli showed that all violations were reliably detectable relative to the control condition, but the anomaly induced by rhyme violations was perceived as most severe. Together, our data suggest that rhyme violations in Limericks may induce an emotional response beyond mere anomaly detection.	[Scheepers, Christoph; Mohr, Sibylle] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Fischer, Martin H.] Univ Potsdam, Dept Psychol, Potsdam, Germany; [Roberts, Andrew M.] Univ Dundee, Sch Humanities, Dundee, Scotland	University of Glasgow; University of Potsdam; University of Dundee	Scheepers, C (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	Christoph.Scheepers@glasgow.ac.uk	Fischer, Martin H./D-9965-2017; Mohr, Sibylle/AAG-6191-2021	Fischer, Martin H./0000-0003-3818-7272; Mohr, Sibylle/0000-0002-9089-6327	School of Humanities at the University of Dundee; AHRC [AH/G013721/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/G013721/1] Funding Source: researchfish	School of Humanities at the University of Dundee; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	This research was part funded by a small grant from the School of Humanities at the University of Dundee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ashby J, 2005, COGNITION, V96, pB89, DOI 10.1016/j.cognition.2004.12.006; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Carminati MN, 2006, POETICS, V34, P204, DOI 10.1016/j.poetic.2006.05.001; Engelhardt PE, 2010, Q J EXP PSYCHOL, V63, P639, DOI 10.1080/17470210903469864; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Gray T, 1965, POEMS GRAY COLLINS G; Hanauer D., 2001, PSYCHOL SOCIOLOGY LI, P107, DOI DOI 10.1075/UPAL.35.08HAN; Hoorn J. F., 1996, ADV DISC PROCESS, P339; Janisse M.P., 1977, PUPILLOMETRY PSYCHOL; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Lea RB, 2008, PSYCHOL SCI, V19, P709, DOI 10.1111/j.1467-9280.2008.02146.x; Legman Gershon, 1988, LIMERICK; McGann Jerome, 1980, BYRON COMPLETE POETI, VI, P320; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Scheepers C, 2004, ON-LINE STUDY OF SENTENCE COMPREHENSION, P167; Schrott R, 2011, GEHIRN GEDICHT; Short Mick, 1996, EXPLORING LANGUAGE P	17	22	22	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74986	10.1371/journal.pone.0074986	http://dx.doi.org/10.1371/journal.pone.0074986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	246EK	24086417	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200067
J	Chen, SF; Wu, CH; Lee, YM; Tam, K; Tsai, YC; Liou, JY; Shyue, SK				Chen, Shu-Fen; Wu, Chun-Hu; Lee, Yen-Ming; Tam, Kabik; Tsai, Yi-Chen; Liou, Jun-Yang; Shyue, Song-Kun			Caveolin-1 Interacts with Derlin-1 and Promotes Ubiquitination and Degradation of Cyclooxygenase-2 via Collaboration with p97 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caveolin; Cyclooxygenase (COX) Pathway; ER-associated Degradation; Protein Degradation; Ubiquitination; Derlin-1; Caveolin-1; Cyclooxygenase-2; p97	RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; PROTEIN-DEGRADATION; AAA-ATPASE; MEMBRANE; PATHWAY; ACTIVATION; EXPRESSION; DISEASE; VCP	Caveolin-1 (Cav-1) interacts with and mediates protein trafficking and various cellular functions. Derlin-1 is a candidate for the retrotranslocation channel of endoplasmic reticulum proteins. However, little is known about how Derlin-1 mediates glycosylated protein degradation. Here, we identified Cav-1 as a key player in Derlin-1- and p97-mediated cyclooxygenase 2 (COX-2) ubiquitination and degradation. Derlin-1 augmented the interaction of Cav-1 and COX-2 and mediated the degradation of COX-2 in a COX-2 C terminus-dependent manner. Suppression of Cav-1 decreased the ubiquitination of COX-2, and mutation of Asn-594 to Ala to disrupt N-glycosylation at the C terminus of COX-2 reduced the interaction of COX-2 with Cav-1 but not Derlin-1. Moreover, suppression of p97 increased the ubiquitination of COX-2 and up-regulated COX-2 but not COX-1. Cav-1 enhanced the interaction of p97 with Ufd1 and Derlin-1 and collaborated with p97 to interact with COX-2. Cav-1 may be a cofactor in the interaction of Derlin-1 and N-glycosylated COX-2 and may facilitate Derlin-1- and p97 complex-mediated COX-2 ubiquitination, retrotranslocation, and degradation.	[Chen, Shu-Fen; Wu, Chun-Hu; Lee, Yen-Ming; Tam, Kabik; Tsai, Yi-Chen; Shyue, Song-Kun] Acad Sinica, Inst Biomed Sci, Cardiovasc Div, Taipei 11529, Taiwan; [Liou, Jun-Yang] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Taiwan; [Shyue, Song-Kun] China Med Univ, Sch Chinese Med, Taichung 40402, Taiwan	Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan	Shyue, SK (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sec 2, Taipei 11529, Taiwan.	skshyue@ibms.sinica.edu.tw	Liou, Jun-Yang/B-1065-2010; Shyue, Song-Kun/Q-2583-2018; WU, CHUN-HU/P-3958-2018	Shyue, Song-Kun/0000-0002-1057-8696; WU, CHUN-HU/0000-0001-6851-7936	National Science Council, Taiwan [NSC 94-2320-B-001-038, NSC 99-2628-B-001-013-MY3]; Institute of Biomedical Sciences, Academia Sinica	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Institute of Biomedical Sciences, Academia Sinica(Academia Sinica - Taiwan)	This study was supported by National Science Council, Taiwan, Grants NSC 94-2320-B-001-038 and NSC 99-2628-B-001-013-MY3 and by the Institute of Biomedical Sciences, Academia Sinica.	Al-Hourani BJ, 2011, EXPERT OPIN THER PAT, V21, P1339, DOI 10.1517/13543776.2011.593510; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bonuccelli G, 2009, AM J PATHOL, V174, P1650, DOI 10.2353/ajpath.2009.080648; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chang TC, 2005, J BIOL CHEM, V280, P36567, DOI 10.1074/jbc.M504280200; Chen SF, 2010, J CELL BIOCHEM, V109, P356, DOI 10.1002/jcb.22407; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Gaudreault SB, 2004, NEUROBIOL AGING, V25, P753, DOI 10.1016/j.neurobiolaging.2003.07.004; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Isakov E, 2011, J BIOL CHEM, V286, P30274, DOI 10.1074/jbc.M111.240309; Kirchner P, 2013, J BIOL CHEM, V288, P7363, DOI 10.1074/jbc.M112.429076; Lass A, 2007, ARCH BIOCHEM BIOPHYS, V462, P62, DOI 10.1016/j.abb.2007.04.010; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Sato M, 2012, J BIOL CHEM, V287, P20674, DOI 10.1074/jbc.M111.280651; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; Sugiyama T, 2011, BIOCHEM BIOPH RES CO, V404, P853, DOI 10.1016/j.bbrc.2010.12.074; Tsai TH, 2011, SHOCK, V35, P92, DOI 10.1097/SHK.0b013e3181ea45ca; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang F, 2012, J BIOL CHEM, V287, P10482, DOI 10.1074/jbc.M111.312223; Wu KK, 2005, PROSTAG LEUKOTR ESS, V72, P89, DOI 10.1016/j.plefa.2004.11.001; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	42	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33462	33469		10.1074/jbc.M113.521799	http://dx.doi.org/10.1074/jbc.M113.521799			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089527	hybrid, Green Published			2022-12-25	WOS:000328841700058
J	Leiszter, K; Galamb, O; Sipos, F; Krenacs, T; Veres, G; Wichmann, B; Kalmar, A; Patai, AV; Toth, K; Valcz, G; Molnar, B; Tulassay, Z				Leiszter, Katalin; Galamb, Orsolya; Sipos, Ferenc; Krenacs, Tibor; Veres, Gabor; Wichmann, Barnabas; Kalmar, Alexandra; Patai, Arpad V.; Toth, Kinga; Valcz, Gabor; Molnar, Bela; Tulassay, Zsolt			Sporadic Colorectal Cancer Development Shows Rejuvenescence Regarding Epithelial Proliferation and Apoptosis	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; INTESTINAL EPITHELIUM; INVITRO SENESCENCE; HUMAN-FIBROBLASTS; PERIPHERAL-BLOOD; SELF-RENEWAL; COLON-CANCER; EXPRESSION; AGE; P53	Background and Aims: Sporadic colorectal cancer (CRC) development is a sequential process showing age-dependency, uncontrolled epithelial proliferation and decreased apoptosis. During juvenile growth cellular proliferation and apoptosis are well balanced, which may be perturbed upon aging. Our aim was to correlate proliferative and apoptotic activities in aging human colonic epithelium and colorectal cancer. We also tested the underlying molecular biology concerning the proliferation- and apoptosis-regulating gene expression alterations. Materials and Methods: Colorectal biopsies from healthy children (n(1) = 14), healthy adults (n(2) = 10), adult adenomas (n(3) = 10) and CRCs (n(4) = 10) in adults were tested for Ki-67 immunohistochemistry and TUNEL apoptosis assay. Mitosis- and apoptosis-related gene expression was also studied in healthy children (n1 = 6), adult (n2 = 41) samples and in CRC (n3 = 34) in HGU133plus2.0 microarray platform. Measured alterations were confirmed with RT-PCR both on dependent and independent sample sets (n(1)= 6, n(2)= 6, n(3) = 6). Results: Mitotic index (MI) was significantly higher (p<0.05) in intact juvenile (MI = 0.33 +/- 0.06) and CRC samples (MI = 0.42 +/- 0.10) compared to healthy adult samples (MI = 0.15 +/- 0.06). In contrast, apoptotic index (AI) was decreased in children (0.13 +/- 0.06) and significantly lower in cancer (0.06 +/- 0.03) compared to healthy adult samples (0.17 +/- 0.05). Eight proliferation- (e.g. MKI67, CCNE1) and 11 apoptosis-associated genes (e.g. TNFSF10, IFI6) had altered mRNA expression both in the course of normal aging and carcinogenesis, mainly inducing proliferation and reducing apoptosis compared to healthy adults. Eight proliferation- associated genes including CCND1, CDK1, CDK6 and 26 apoptosis- regulating genes (e.g. SOCS3) were differently expressed between juvenile and cancer groups mostly supporting the pronounced cell growth in CRC. Conclusion: Colorectal samples from children and CRC patients can be characterized by similarly increased proliferative and decreased apoptotic activities compared to healthy colonic samples from adults. Therefore, cell kinetic alterations during colorectal cancer development show uncontrolled rejuvenescence as opposed to the controlled cell growth in juvenile colonic epithelium.	[Leiszter, Katalin; Galamb, Orsolya; Sipos, Ferenc; Wichmann, Barnabas; Kalmar, Alexandra; Patai, Arpad V.; Toth, Kinga; Valcz, Gabor; Molnar, Bela; Tulassay, Zsolt] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Galamb, Orsolya; Molnar, Bela; Tulassay, Zsolt] Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary; [Krenacs, Tibor] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Veres, Gabor] Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Semmelweis University	Leiszter, K (corresponding author), Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary.	leiszterkata@gmail.com	Sipos, Ferenc/GYV-6182-2022	Valcz, Gabor/0000-0002-7109-3529	Hungarian Scientific Research Fund (Orszagos Tudomanyos Kutatasi Alapprogram/OTKA-K/) [105530]	Hungarian Scientific Research Fund (Orszagos Tudomanyos Kutatasi Alapprogram/OTKA-K/)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by Hungarian Scientific Research Fund (Orszagos Tudomanyos Kutatasi Alapprogram/OTKA-K/) 105530. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 1998, J IMMUNOL, V160, P1627; Arai T, 2007, PATHOL INT, V57, P303, DOI 10.1111/j.1440-1827.2007.02101.x; Bingham S, 2004, NAT REV CANCER, V4, P206, DOI 10.1038/nrc1298; Carvalho B, 2012, CELL ONCOL, V35, P53, DOI 10.1007/s13402-011-0065-1; DEAN R, 1986, BIOCHEM BIOPH RES CO, V135, P105, DOI 10.1016/0006-291X(86)90948-4; DELGADO D, 1986, BIOCHEM BIOPH RES CO, V137, P917, DOI 10.1016/0006-291X(86)90312-8; Diamond SJ, 2011, GASTROINTEST ENDOSC, V74, P135, DOI 10.1016/j.gie.2011.03.1178; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Galamb O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048547; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Grimberg A, 2004, CANCER BIOL THER, V3, P731, DOI 10.4161/cbt.3.8.1030; HALL PA, 1994, J CELL SCI, V107, P3569; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Herman JG, 1996, CANCER RES, V56, P722; Kikuchi Y, 1997, VIRCHOWS ARCH, V431, P111, DOI 10.1007/s004280050076; Kim HJ, 2008, BMB REP, V41, P685, DOI 10.5483/BMBRep.2008.41.10.685; Kolligs FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020076; Koornstra JJ, 2003, CRIT REV ONCOL HEMAT, V45, P37, DOI 10.1016/S1040-8428(01)00228-1; KULJU KS, 1995, EXP CELL RES, V217, P336, DOI 10.1006/excr.1995.1095; Lee HM, 2000, MECH AGEING DEV, V115, P139, DOI 10.1016/S0047-6374(00)00120-2; Leiszter K, 2010, MAGYAR BELORVOSI ARC, V63, P19; Leiszter Katalin, 2010, Orvosi Hetilap, V151, P885, DOI 10.1556/OH.2010.28882; LIPKIN M, 1963, J CLIN INVEST, V42, P767, DOI 10.1172/JCI104769; Mandir N, 2005, INT J EXP PATHOL, V86, P125, DOI 10.1111/j.0959-9673.2005.00422.x; MIYAWAKI T, 1992, J IMMUNOL, V149, P3753; Moss SF, 1996, DIGEST DIS SCI, V41, P2238, DOI 10.1007/BF02071407; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Peter ME, 2005, BBA-REV CANCER, V1755, P25, DOI 10.1016/j.bbcan.2005.01.001; PINES J, 1995, BIOCHEM J, V308, P697, DOI 10.1042/bj3080697; Reenstra WR, 1996, EXP CELL RES, V227, P252, DOI 10.1006/excr.1996.0274; Salh B, 1999, ANTICANCER RES, V19, P741; Soussi T, 2000, CANCER RES, V60, P1777; Takano Y, 1996, J CANCER RES CLIN, V122, P166, DOI 10.1007/BF01366957; Theodosiou NA, 2003, DEV BIOL, V259, P258, DOI 10.1016/S0012-1606(03)00185-4; Ukraintseva SV, 2004, ANN NY ACAD SCI, V1019, P200, DOI 10.1196/annals.1297.032; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Xiao ZQ, 2001, MECH AGEING DEV, V122, P1849, DOI 10.1016/S0047-6374(01)00323-2; Zhang T, 1997, CANCER RES, V57, P169	42	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74140	10.1371/journal.pone.0074140	http://dx.doi.org/10.1371/journal.pone.0074140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098334	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000325483600003
J	Won, EY; Yoon, MK; Kim, SW; Jung, Y; Bae, HW; Lee, D; Park, SG; Lee, CH; Hwang, GS; Chi, SW				Won, Eun-Young; Yoon, Mi-Kyung; Kim, Sang-Woo; Jung, Youngae; Bae, Hyun-Whee; Lee, Daeyoup; Park, Sung Goo; Lee, Chul-Ho; Hwang, Geum-Sook; Chi, Seung-Wook			Gender-Specific Metabolomic Profiling of Obesity in Leptin-Deficient ob/ob Mice by H-1 NMR Spectroscopy	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; DIET-INDUCED OBESITY; FATTY-ACID; L-ARGININE; LIQUID-CHROMATOGRAPHY; INSULIN-RESISTANCE; MISSENSE MUTATION; SYSTEMS BIOLOGY; SKELETAL-MUSCLE; GUT MICROBIOTA	Despite the numerous metabolic studies on obesity, gender bias in obesity has rarely been investigated. Here, we report the metabolomic analysis of obesity by using leptin-deficient ob/ob mice based on the gender. Metabolomic analyses of urine and serum from ob/ob mice compared with those from C57BL/6J lean mice, based on the H-1 NMR spectroscopy in combination with multivariate statistical analysis, revealed clear metabolic differences between obese and lean mice. We also identified 48 urine and 22 serum metabolites that were statistically significantly altered in obese mice compared to lean controls. These metabolites are involved in amino acid metabolism (leucine, alanine, ariginine, lysine, and methionine), tricarbocylic acid cycle and glucose metabolism (pyruvate, citrate, glycolate, acetoacetate, and acetone), lipid metabolism (cholesterol and carnitine), creatine metabolism (creatine and creatinine), and gut-microbiome-derived metabolism (choline, TMAO, hippurate, p-cresol, isobutyrate, 2-hydroxyisobutyrate, methylamine, and trigonelline). Notably, our metabolomic studies showed distinct gender variations. The obese male mice metabolism was specifically associated with insulin signaling, whereas the obese female mice metabolism was associated with lipid metabolism. Taken together, our study identifies the biomarker signature for obesity in ob/ob mice and provides biochemical insights into the metabolic alteration in obesity based on gender.	[Won, Eun-Young; Yoon, Mi-Kyung; Park, Sung Goo; Chi, Seung-Wook] KRIBB, Med Prote Res Ctr, Taejon, South Korea; [Kim, Sang-Woo; Lee, Chul-Ho] KRIBB, Lab Anim Ctr, Taejon, South Korea; [Won, Eun-Young; Lee, Daeyoup] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Jung, Youngae; Bae, Hyun-Whee; Hwang, Geum-Sook] Korea Basic Sci Inst, Integrated Metabol Res Grp, Seoul, South Korea; [Bae, Hyun-Whee; Hwang, Geum-Sook] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Korea Basic Science Institute (KBSI); Chungnam National University	Lee, CH (corresponding author), KRIBB, Lab Anim Ctr, Taejon, South Korea.	chullee@kribb.re.kr; gshwang@kbsi.re.kr; swchi@kribb.re.kr	Lee, Daeyoup/C-1653-2011	Lee, Daeyoup/0000-0003-2006-1823	National Research Foundation of Korea (NRF); Korea government (MSIP) [NRF-2011-0016011, NRF-2012M3C1A3671508, NRF-2013M3A9B6046418]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIP) (No. NRF-2011-0016011, No. NRF-2012M3C1A3671508, and No. NRF-2013M3A9B6046418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], 2012, J BIOMED BIOTECHNOL; [Anonymous], 2009, AMINO ACIDS, DOI DOI 10.1007/s00726-008-0210-y; BACKMAN L, 1975, SCAND J GASTROENTERO, V10, P811; Bae KH, 2012, BMB REP, V45, P700, DOI 10.5483/BMBRep.2012.45.12.235; Brosnan JT, 2010, MOL GENET METAB, V100, pS49, DOI 10.1016/j.ymgme.2010.02.020; CALLESESCANDON J, 1984, METABOLISM, V33, P364, DOI 10.1016/0026-0495(84)90200-2; Calvani R, 2010, INT J OBESITY, V34, P1095, DOI 10.1038/ijo.2010.44; Cao J, 2012, AGING MALE, V15, P85, DOI 10.3109/13685538.2012.666585; Cha YS, 2008, ASIA PAC J CLIN NUTR, V17, P306; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; Conway B, 2004, Obes Rev, V5, P145, DOI 10.1111/j.1467-789X.2004.00144.x; D'Eon T, 2002, J WOMEN HEALTH GEN-B, V11, P225, DOI 10.1089/152460902753668439; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; DEVILLIERS DC, 1966, METABOLIS, V15, P458, DOI 10.1016/0026-0495(66)90088-6; Dey J, 2002, J UROLOGY, V167, P169, DOI 10.1016/S0022-5347(05)65405-5; Duggan GE, 2011, J APPL PHYSIOL, V110, P1311, DOI 10.1152/japplphysiol.00701.2010; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fischer-Posovszky P, 2010, J CLIN ENDOCR METAB, V95, P2836, DOI 10.1210/jc.2009-2466; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fu WJJ, 2005, J NUTR, V135, P714, DOI 10.1093/jn/135.4.714; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Garlick PJ, 2005, J NUTR, V135, p1553S, DOI 10.1093/jn/135.6.1553S; Gipson GT, 2008, MOL BIOSYST, V4, P1015, DOI 10.1039/b807332e; GOLAY A, 1986, J CLIN ENDOCR METAB, V63, P481, DOI 10.1210/jcem-63-2-481; Grossmann M, 2008, J CLIN ENDOCR METAB, V93, P1834, DOI 10.1210/jc.2007-2177; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hinault C, 2004, FASEB J, V18, P1894, DOI 10.1096/fj.03-1409fje; Holecek M, 2001, NUTRITION, V17, P70, DOI 10.1016/S0899-9007(00)00483-4; Jobgen WJ, 2009, J NUTR, V139, P230, DOI 10.3945/jn.108.096362; Jung JY, 2012, BMB REP, V45, P419, DOI 10.5483/BMBRep.2012.45.7.248; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p; Kimball SR, 2001, CURR OPIN CLIN NUTR, V4, P39, DOI 10.1097/00075197-200101000-00008; Kochhar S, 2006, ANAL BIOCHEM, V352, P274, DOI 10.1016/j.ab.2006.02.033; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337/diacare.27.5.1036; Larsen FH, 2006, J CHEMOMETR, V20, P198, DOI 10.1002/cem.991; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Lees HJ, 2013, J PROTEOME RES, V12, P1527, DOI 10.1021/pr300900b; Li HK, 2008, J PROTEOME RES, V7, P4775, DOI 10.1021/pr800352k; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lynch CJ, 2001, J NUTR, V131, p861S, DOI 10.1093/jn/131.3.861S; MACFARLANE GT, 1992, FEMS MICROBIOL ECOL, V101, P81, DOI 10.1111/j.1574-6968.1992.tb05764.x; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; McKnight JR, 2010, AMINO ACIDS, V39, P349, DOI 10.1007/s00726-010-0598-z; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Piloquet H, 2003, AM J PHYSIOL-ENDOC M, V285, pE561, DOI 10.1152/ajpendo.00042.2003; Plumb R, 2003, ANALYST, V128, P819, DOI 10.1039/b304296k; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; RUDERMAN NB, 1975, ANNU REV MED, V26, P245, DOI 10.1146/annurev.me.26.020175.001333; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; SATOH H, 1994, ADV EXP MED BIOL, V359, P181; Schirra HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002764; Serkova NJ, 2006, J HEPATOL, V44, P956, DOI 10.1016/j.jhep.2005.07.009; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Sishi B, 2011, EXP PHYSIOL, V96, P179, DOI 10.1113/expphysiol.2010.054189; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Smith EA, 1996, J APPL BACTERIOL, V81, P288, DOI 10.1111/j.1365-2672.1996.tb04331.x; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Sun J, 2008, J CHROMATOGR B, V871, P328, DOI 10.1016/j.jchromb.2008.04.008; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Doorn M, 2007, BRIT J CLIN PHARMACO, V63, P562, DOI 10.1111/j.1365-2125.2006.02816.x; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; WALKER JB, 1961, J BIOL CHEM, V236, P493; Williams RE, 2005, J PHARMACEUT BIOMED, V38, P465, DOI 10.1016/j.jpba.2005.01.013; Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; Zhang M, 2004, AMINO ACIDS, V26, P267, DOI 10.1007/s00726-003-0059-z; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao LC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/431894; Zyromski NJ, 2009, PANCREATOLOGY, V9, P410, DOI 10.1159/000199436	81	45	47	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75998	10.1371/journal.pone.0075998	http://dx.doi.org/10.1371/journal.pone.0075998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098417	gold, Green Submitted, Green Published			2022-12-25	WOS:000325483600026
J	Dunner, N; Quezada, C; Berndt, FA; Canovas, J; Rojas, CV				Duenner, Natalia; Quezada, Carolina; Andres Berndt, F.; Canovas, Jose; Rojas, Cecilia V.			Angiotensin II Signaling in Human Preadipose Cells: Participation of ERK1,2-Dependent Modulation of Akt	PLOS ONE			English	Article							PROTEIN-KINASE KINASE; DIET-INDUCED OBESITY; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; IN-VITRO; GENE-EXPRESSION; SMOOTH-MUSCLE; PHOSPHORYLATION; RECEPTORS; SYSTEM	The renin-angiotensin system expressed in adipose tissue has been implicated in the modulation of adipocyte formation, glucose metabolism, triglyceride accumulation, lipolysis, and the onset of the adverse metabolic consequences of obesity. As we investigated angiotensin II signal transduction mechanisms in human preadipose cells, an interplay of extracellular-signal-regulated kinases 1 and 2 (ERK1,2) and Akt/PKB became evident. Angiotensin II caused attenuation of phosphorylated Akt (p-Akt), at serine 473; the p-Akt/Akt ratio decreased to 0.5 +/- 0.2-fold the control value without angiotensin II (p<0.001). Here we report that the reduction of phosphorylated Akt associates with ERK1,2 activities. In the absence of angiotensin II, inhibition of ERK1,2 activation with U0126 or PD98059 resulted in a 2.1 +/- 0.5 (p < 0.001) and 1.4 +/- 0.2-fold (p<0.05) increase in the p-Akt/Akt ratio, respectively. In addition, partial knockdown of ERK1 protein expression by the short hairpin RNA technique also raised phosphorylated Akt in these cells (the p-Akt/Akt ratio was 1.5 +/- 0.1-fold the corresponding control; p<0.05). Furthermore, inhibition of ERK1,2 activation with U0126 prevented the reduction of p-Akt/Akt by angiotensin II. An analogous effect was found on the phosphorylation status of Akt downstream effectors, the forkhead box (Fox) proteins O1 and O4. Altogether, these results indicate that angiotensin II signaling in human preadipose cells involves an ERK1,2-dependent attenuation of Akt activity, whose impact on the biological functions under its regulation is not fully understood.	[Duenner, Natalia; Quezada, Carolina; Andres Berndt, F.; Canovas, Jose; Rojas, Cecilia V.] Univ Chile, Fac Med, Inst Biomed Sci, Santiago 7, Chile; [Rojas, Cecilia V.] Univ Chile, Inst Nutr & Food Technol, Santiago 7, Chile	Universidad de Chile; Universidad de Chile	Rojas, CV (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Santiago 7, Chile.	crojas@inta.uchile.cl	Quezada, Carolina Paz/AAG-1981-2019	Quezada, Carolina Paz/0000-0002-0260-5754	CONICYT; FONDECYT/Regular [1100126]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT/Regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was supported by CONICYT, FONDECYT/Regular 1100126. http://www.conicyt.cl/fondecyt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2007, AM J PHYSIOL-CELL PH, V293, pC772, DOI 10.1152/ajpcell.00622.2006; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Andreozzi F, 2004, CIRC RES, V94, P1211, DOI 10.1161/01.RES.0000126501.34994.96; Arellano-Plancarte A, 2010, BIOCHEM PHARMACOL, V79, P733, DOI 10.1016/j.bcp.2009.10.014; Aurelie NDC, 2011, CURR HYPERTENS REP, V13, P122, DOI 10.1007/s11906-011-0187-x; Bhattacharya I, 2006, FEBS LETT, V580, P5765, DOI 10.1016/j.febslet.2006.09.032; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Brucher R, 2007, OBESITY, V15, P1643, DOI 10.1038/oby.2007.196; Carvalho E, 2000, DIABETOLOGIA, V43, P1107, DOI 10.1007/s001250051501; Chai WD, 2011, DIABETES, V60, P2939, DOI 10.2337/db10-1691; Chuang CC, 2007, ENDOCRINOLOGY, V148, P4267, DOI 10.1210/en.2007-0179; Cook JL, 2012, AM J PHYSIOL-REG I, V302, pR482, DOI 10.1152/ajpregu.00493.2011; Crandall DL, 1999, ENDOCRINOLOGY, V140, P154, DOI 10.1210/en.140.1.154; CRANDALL DL, 1994, J LIPID RES, V35, P1378; Csibi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010070; Diamond-Stanic Maggie K., 2010, Archives of Physiology and Biochemistry, V116, P88, DOI 10.3109/13813451003758703; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Fritsche L, 2011, AM J PHYSIOL-ENDOC M, V300, pE824, DOI 10.1152/ajpendo.00409.2010; Fuentes P, 2010, J ENDOCRINOL, V206, P75, DOI 10.1677/JOE-10-0049; Giacchetti G, 2002, AM J HYPERTENS, V15, P381, DOI 10.1016/S0895-7061(02)02257-4; Gwathmey TM, 2012, AM J PHYSIOL-REG I, V302, pR518, DOI 10.1152/ajpregu.00525.2011; Hashikawa-Hobara N, 2012, DIABETES, V61, P925, DOI 10.2337/db11-1468; Hay N, 2011, BBA-MOL CELL RES, V1813, P1965, DOI 10.1016/j.bbamcr.2011.03.013; Iwai M, 2009, AM J HYPERTENS, V22, P784, DOI 10.1038/ajh.2009.85; Janke J, 2002, DIABETES, V51, P1699, DOI 10.2337/diabetes.51.6.1699; Kalupahana NS, 2012, CRIT REV BIOCHEM MOL, V47, P379, DOI 10.3109/10409238.2012.694843; Karlsson C, 1998, J CLIN ENDOCR METAB, V83, P3925, DOI 10.1210/jc.83.11.3925; Khundmiri SJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1171, DOI 10.1152/ajpcell.00535.2006; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Lardizabal Joel A, 2010, Curr Cardiol Rep, V12, P464, DOI 10.1007/s11886-010-0138-1; Leal-Ortiz S, 2008, J CELL BIOL, V181, P831, DOI 10.1083/jcb.200711167; Magun R, 1996, ENDOCRINOLOGY, V137, P3590, DOI 10.1210/en.137.8.3590; Massiera F, 2001, FASEB J, V15, P2727, DOI 10.1096/fj.01-0457fje; Matsushita K, 2006, HYPERTENSION, V48, P1095, DOI 10.1161/01.HYP.0000248211.82232.a7; Merighi Stefania, 2006, Purinergic Signal, V2, P627, DOI 10.1007/s11302-006-9020-4; Nazarewicz Rafal Robert, 2011, J Biol Chem, V286, P2886, DOI 10.1074/jbc.M110.141499; Patel CB, 2010, MOL PHARMACOL, V78, P983, DOI 10.1124/mol.110.067066; Punn A, 2006, MOL ENDOCRINOL, V20, P3179, DOI 10.1210/me.2006-0255; Rahmouni K, 2004, AM J PHYSIOL-ENDOC M, V286, pE891, DOI 10.1152/ajpendo.00551.2003; Salmon Patrick, 2006, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0421s37; Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341; Schling P, 2002, J BIOL CHEM, V277, P48066, DOI 10.1074/jbc.M204058200; Schling P, 2001, HORM METAB RES, V33, P189, DOI 10.1055/s-2001-14951; Schling P, 1999, INT J OBESITY, V23, P336, DOI 10.1038/sj.ijo.0800821; Shah BH, 2002, TRENDS ENDOCRIN MET, V13, P1, DOI 10.1016/S1043-2760(01)00539-2; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; Tanski W, 2002, J SURG RES, V108, P98, DOI 10.1006/jsre.2002.6529; Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004; Tchkonia T, 2002, AM J PHYSIOL-REG I, V282, pR1286, DOI 10.1152/ajpregu.00653.2001; Tomono Y, 2008, AM J HYPERTENS, V21, P206, DOI 10.1038/ajh.2007.50; van Harmelen V, 2000, OBES RES, V8, P337, DOI 10.1038/oby.2000.40; van Harmelen V, 2000, INT J OBESITY, V24, P673, DOI 10.1038/sj.ijo.0801217; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wang T, 2008, ENDOCRINOLOGY, V149, P358, DOI 10.1210/en.2007-0467; Yang SJ, 2010, EUR J PHARMACOL, V638, P21, DOI 10.1016/j.ejphar.2010.04.016; Yasue S, 2010, AM J HYPERTENS, V23, P425, DOI 10.1038/ajh.2009.263; Ye ZW, 2009, METABOLISM, V58, P1288, DOI 10.1016/j.metabol.2009.04.014; Yoshiga D, 2007, MOL ENDOCRINOL, V21, P1120, DOI 10.1210/me.2006-0413; Yun SJ, 2008, BIOCHEM BIOPH RES CO, V371, P138, DOI 10.1016/j.bbrc.2008.04.029; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	64	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75440	10.1371/journal.pone.0075440	http://dx.doi.org/10.1371/journal.pone.0075440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098385	Green Submitted, Green Published, gold			2022-12-25	WOS:000325434500033
J	Guo, YF; Lee, CL; So, KH; Gao, J; Yeung, WSB; Yao, YQ; Lee, KF				Guo, YiFan; Lee, Cheuk-Lun; So, Kam-Hei; Gao, Jing; Yeung, William S. B.; Yao, YuanQing; Lee, Kai-Fai			Soluble Human Leukocyte Antigen-G5 Activates Extracellular Signal-Regulated Protein Kinase Signaling and Stimulates Trophoblast Invasion	PLOS ONE			English	Article							HLA-G; GLYCODELIN-A; EXPRESSION; KIR2DL4; CELLS; PREECLAMPSIA; MACROPHAGES; SECRETION; MIGRATION; RECEPTOR	Soluble human leukocyte antigen-G (HLA-G) is a non-classical class Ib HLA molecule that is secreted from blastocysts. Soluble HLA-G modulates the immune tolerance of the mother and can be used as a prognostic factor for the clinical pregnancy rate. However, the underlying mechanism of how soluble HLA-G5 affects pregnancy remains largely unknown. We hypothesized that soluble HLA-G5 promotes successful implantation and pregnancy by modulating trophoblast invasion through receptor binding and activation of extracellular signal-regulated protein kinase (ERK) signaling pathway. Recombinant HLA-G5 protein over-expressed in E. coli BL21 was purified to near homogeneity. We studied the expression of HLA-G5 and its receptors, the leukocyte immunoglobulin-like receptor subfamily B1 (LILRB1) and killer cell immunoglobulin-like receptor 2DL4 (KIR2DL4), in primary trophoblasts and trophoblastic (JAr and JEG-3) cell lines by florescence-labeled HLA-G5. HLA-G5 was detected in the primary trophoblasts and JEG-3 cells. The LILRB1 and KIR2DL4 receptors were expressed in both primary trophoblasts and trophoblastic cell lines. HLA-G5 stimulated cell invasion (p<0.05) and increased urokinase (uPA) and matrix metalloproteinases (MMPs) transcripts and their activity (p<0.05) in trophoblastic cells. HLA-G5 activated the ERK signaling pathway and induced ERK1/2 phosphorylation in the trophoblastic cell lines. Addition of ERK inhibitors (U0126 and PD98059) nullified the stimulatory effect of HLA-G5 on trophoblastic cell invasion. Taken together, HLA-G5 induced trophoblast invasion by binding to KIR2DL4 and LILRB1, by increasing uPA and MMPs expressions and by activating the ERK signaling pathway.	[Guo, YiFan; Yao, YuanQing] Chinese Peoples Liberat Army Gen Hosp, Dept Obstet & Gynaecol, Beijing, Peoples R China; [Guo, YiFan; Lee, Cheuk-Lun; So, Kam-Hei; Gao, Jing; Yeung, William S. B.; Lee, Kai-Fai] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Lee, Cheuk-Lun; Yeung, William S. B.; Lee, Kai-Fai] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China	Chinese People's Liberation Army General Hospital; University of Hong Kong; University of Hong Kong	Yao, YQ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Obstet & Gynaecol, Beijing, Peoples R China.	yqyao@126.com; ckflee@hku.hk	Lee, Cheuk Lun/AGX-5720-2022; Lee, Calvin Kai Fai/C-4328-2009	Lee, Cheuk Lun/0000-0003-1553-3478; So, Karl Kam Hei/0000-0002-3154-2940; Lee, Calvin Kai Fai/0000-0001-5957-439X; Yeung, Shu Biu William/0000-0003-0670-0879; YAO, YUANQING/0000-0001-5942-4121				[Anonymous], [No title captured]; Apps R, 2011, MOL HUM REPROD, V17, P577, DOI 10.1093/molehr/gar022; Bai SX, 2005, REPRODUCTION, V129, P103, DOI 10.1530/rep.1.00283; Biyik I, 2013, J MATERN FETAL NEONA; Blanco O, 2008, HUM REPROD, V23, P144, DOI 10.1093/humrep/dem326; Carosella ED, 2011, IMMUNOL LETT, V138, P22, DOI 10.1016/j.imlet.2011.02.011; Cartwright JE, 2005, EXP CELL RES, V304, P328, DOI 10.1016/j.yexcr.2004.11.013; Das C, 2002, J REPROD IMMUNOL, V53, P257, DOI 10.1016/S0165-0378(01)00099-7; Du MR, 2007, HUM REPROD, V22, P2528, DOI 10.1093/humrep/dem222; ELLIS SA, 1986, IMMUNOLOGY, V59, P595; Fitzgerald JS, 2005, CHEM IMMUNOL ALLERGY, V88, P181, DOI 10.1159/000087834; Fons P, 2006, BLOOD, V108, P2608, DOI 10.1182/blood-2005-12-019919; Forbes K, 2013, PLACENTA, V34, pS27, DOI 10.1016/j.placenta.2012.12.011; Goldman-Wohl D, 2009, J REPROD IMMUNOL, V82, P96, DOI 10.1016/j.jri.2009.05.002; Holling TM, 2009, ANN NY ACAD SCI, V1173, P538, DOI 10.1111/j.1749-6632.2009.04660.x; Hunt JS, 2009, CURR OPIN PHARMACOL, V9, P462, DOI 10.1016/j.coph.2009.05.007; Kawashima M, 2009, FERTIL STERIL, V91, P343, DOI 10.1016/j.fertnstert.2007.12.005; Lam KKW, 2011, J BIOL CHEM, V286, P37118, DOI 10.1074/jbc.M111.233841; Lam KKW, 2009, HUM REPROD, V24, P2093, DOI 10.1093/humrep/dep205; Le Bouteiller P, 2003, J REPROD IMMUNOL, V59, P219, DOI 10.1016/S0165-0378(03)00049-4; Lee CL, 2012, J BIOL CHEM, V287, P36999, DOI 10.1074/jbc.M112.385336; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; Li CL, 2009, P NATL ACAD SCI USA, V106, P5767, DOI 10.1073/pnas.0901173106; Male Victoria, 2012, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0740s97; Marlin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030017; McCormick J, 2009, HUM REPROD, V24, P1339, DOI 10.1093/humrep/dep026; Morandi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011763; Naruse K, 2009, PLACENTA, V30, P398, DOI 10.1016/j.placenta.2009.02.002; Pearson H, 2002, NATURE, V420, P265, DOI 10.1038/420265a; Rajagopalan S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00258; Rebmann V, 2007, TISSUE ANTIGENS, V69, P143, DOI 10.1111/j.1399-0039.2006.763_5.x; Rebmann V, 1999, TISSUE ANTIGENS, V53, P14, DOI 10.1034/j.1399-0039.1999.530102.x; Rebmann V, 2010, HUM REPROD, V25, P1691, DOI 10.1093/humrep/deq120; Rizzo R, 2007, HUM IMMUNOL, V68, P244, DOI 10.1016/j.humimm.2006.10.012; Roussev RG, 2007, J ASSIST REPROD GEN, V24, P288, DOI 10.1007/s10815-007-9148-3; Sargent IL, 2006, REPROD BIOMED ONLINE, V13, P680, DOI 10.1016/S1472-6483(10)60659-1; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; So KH, 2012, REPROD BIOMED ONLINE, V24, P639, DOI 10.1016/j.rbmo.2012.03.004; Tang CL, 2012, PLACENTA, V33, P704, DOI 10.1016/j.placenta.2012.06.007; van der Meer A, 2007, MOL HUM REPROD, V13, P123, DOI 10.1093/molehr/gal100; Wong BST, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103903; Yao YQ, 2005, J IMMUNOL, V175, P8379, DOI 10.4049/jimmunol.175.12.8379	42	22	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76023	10.1371/journal.pone.0076023	http://dx.doi.org/10.1371/journal.pone.0076023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098421	gold, Green Submitted, Green Published			2022-12-25	WOS:000325427100037
J	Rossetti, V; Ammann, TW; Thurnheer, T; Bagheri, HC; Belibasakis, GN				Rossetti, Valentina; Ammann, Thomas W.; Thurnheer, Thomas; Bagheri, Homayoun C.; Belibasakis, Georgios N.			Phenotypic Diversity of Multicellular Filamentation in Oral Streptococci	PLOS ONE			English	Article							SULFUR BACTERIA; COMMUNITIES; SURVIVAL; GROWTH	Filamentous multicellular bacteria are among the most ancient multicellular organisms. They inhabit a great variety of environments and are present in the human body, including the oral cavity. Beside the selective advantages related to the larger size achieved through filamentation, the development of multicellular bacteria can be also driven by simple ecological factors such as birth and death rates at the cellular level. In order to extend earlier results obtained in aquatic species, we investigate the filamentation process of four different strains of oral streptococci, namely S. mutans, S. salivarius, S. oralis and S. anginosus. The results indicate differences in the capacities of different streptococcus species to form filaments, manifested in terms of length and the time-scale of filament elongation. The filamentation pattern of these oral streptococci resembles that of aquatic bacteria, whereby filaments reach a peak length during exponential growth and become short when the population reaches a steady state. Hence, this study validates that multicellularity can be an emergent property of filamentous bacteria of different ecological niches, and that phenotypic differences in filamentation can occur within species of the same genus, in this case oral streptococci. Moreover, given the role that specific oral streptococci can play in the etiology of oral diseases, these results can possibly open new perspectives in the study of the virulence properties of these species.	[Rossetti, Valentina; Bagheri, Homayoun C.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Ammann, Thomas W.; Thurnheer, Thomas; Belibasakis, Georgios N.] Univ Zurich, Inst Oral Biol, Sect Oral Microbiol & Immunol, Zurich, Switzerland; [Rossetti, Valentina] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich	Rossetti, V (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	valentina.rossetti@uzh.ch	Belibasakis, Georgios/AAL-3159-2020	Belibasakis, Georgios/0000-0002-8164-0653; Bagheri, Homayoun/0000-0002-2495-7785; Thurnheer, Thomas/0000-0002-8615-8209	University of Zurich	University of Zurich	This work has been supported by the University of Zurich (www.uzh.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DG, 2000, CURR OPIN MICROBIOL, V3, P618, DOI 10.1016/S1369-5274(00)00150-8; Berman-Frank I, 2003, RES MICROBIOL, V154, P157, DOI 10.1016/S0923-2508(03)00029-9; Bibby BG, 1939, J BACTERIOL, V38, P263, DOI 10.1128/JB.38.3.263-274.1939; Bonner John Tyler, 1998, Integrative Biology, V1, P27; BURTON JP, 2013, J MED MICROBIOL; Carlsson J, 1968, Odontol Revy, V19, P137; Carlsson J, 1967, Odontol Revy, V18, P55; FISHER LE, 1993, J DENT RES, V72, P1191, DOI 10.1177/00220345930720080501; Gallardo VA, 2007, INT MICROBIOL, V10, P97, DOI 10.2436/20.1501.01.14; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Ishijima SA, 2012, APPL ENVIRON MICROB, V78, P2190, DOI 10.1128/AEM.07055-11; Jorgensen BB, 1999, FEMS MICROBIOL ECOL, V28, P301, DOI 10.1016/S0168-6496(98)00122-6; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Kaiser D, 2001, ANNU REV GENET, V35, P103, DOI 10.1146/annurev.genet.35.102401.090145; KAUFMAN J, 1989, INFECT IMMUN, V57, P331, DOI 10.1128/IAI.57.2.331-337.1989; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; KOMAREK J, 2005, SUSSWASSERFLORA MITT, V2; LANCY P, 1980, INFECT IMMUN, V29, P663; LANCY P, 1983, INFECT IMMUN, V40, P303, DOI 10.1128/IAI.40.1.303-309.1983; LISTGARTEN MA, 1976, J PERIODONTOL, V47, P139, DOI 10.1902/jop.1976.47.3.139; Paerl HW, 2000, ENVIRON MICROBIOL, V2, P11, DOI 10.1046/j.1462-2920.2000.00071.x; Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329; Rossetti V, 2011, J R SOC INTERFACE, V8, P1772, DOI 10.1098/rsif.2011.0102; Rossetti V, 2010, J THEOR BIOL, V262, P23, DOI 10.1016/j.jtbi.2009.09.009; Schaudinn C, 2009, J AM DENT ASSOC, V140, P978, DOI 10.14219/jada.archive.2009.0307; Schopf JW, 2006, PHILOS T R SOC B, V361, P869, DOI 10.1098/rstb.2006.1834; Smith EG, 2012, J DENT RES, V91, P133, DOI 10.1177/0022034511415415; Stinson MW, 2003, INFECT IMMUN, V71, P2365, DOI 10.1128/IAI.71.5.2365-2372.2003; TAKAZOE I, 1963, J DENT RES, V42, P681, DOI 10.1177/00220345630420021601; Tannock GW, 1999, ANTON LEEUW INT J G, V76, P265, DOI 10.1023/A:1002038308506; Wescombe PA, 2012, FUTURE MICROBIOL, V7, P1355, DOI [10.2217/FMB.12.113, 10.2217/fmb.12.113]; Whiley RA, 1998, ORAL MICROBIOL IMMUN, V13, P195, DOI 10.1111/j.1399-302X.1998.tb00698.x; Whitton B.A., 2000, ECOLOGY CYANOBACTERI	33	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76221	10.1371/journal.pone.0076221	http://dx.doi.org/10.1371/journal.pone.0076221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086713	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000325223900088
J	Yu-Wai-Man, C; Smith, FE; Firbank, MJ; Guthrie, G; Guthrie, S; Gorman, GS; Taylor, RW; Turnbull, DM; Griffiths, PG; Blamire, AM; Chinnery, PF; Yu-Wai-Man, P				Yu-Wai-Man, Cynthia; Smith, Fiona E.; Firbank, Michael J.; Guthrie, Grant; Guthrie, Stuart; Gorman, Grainne S.; Taylor, Robert W.; Turnbull, Douglass M.; Griffiths, Philip G.; Blamire, Andrew M.; Chinnery, Patrick F.; Yu-Wai-Man, Patrick			Extraocular Muscle Atrophy and Central Nervous System Involvement in Chronic Progressive External Ophthalmoplegia	PLOS ONE			English	Article							MITOCHONDRIAL DISEASE; MR; MUTATIONS; MYOPATHY; SPECTRUM; BRAIN	Background: Chronic progressive external ophthalmoplegia (CPEO) is a classical mitochondrial ocular disorder characterised by bilateral progressive ptosis and ophthalmoplegia. These ocular features can develop either in isolation or in association with other prominent neurological deficits (CPEO+). Molecularly, CPEO can be classified into two distinct genetic subgroups depending on whether patients harbour single, large-scale mitochondrial DNA (mtDNA) deletions or multiple mtDNA deletions secondary to a nuclear mutation disrupting mtDNA replication or repair. The aim of this magnetic resonance imaging (MRI) study was to investigate whether the ophthalmoplegia in CPEO is primarily myopathic in origin or whether there is evidence of contributory supranuclear pathway dysfunction. Methods: Ten age-matched normal controls and twenty patients with CPEO were recruited nine patients with single, large-scale mtDNA deletions and eleven patients with multiple mtDNA deletions secondary to mutations in POLG, PEO1, OPA1, and RRM2B. All subjects underwent a standardised brain and orbital MRI protocol, together with proton magnetic resonance spectroscopy in two voxels located within the parietal white matter and the brainstem. Results: There was evidence of significant extraocular muscle atrophy in patients with single or multiple mtDNA deletions compared with controls. There was no significant difference in metabolite concentrations between the patient and control groups in both the parietal white matter and brainstem voxels. Volumetric brain measurements revealed marked cortical and cerebellar atrophy among patients with CPEO+ phenotypes. Conclusion: The results of this study support a primary myopathic aetiology for the progressive limitation of eye movements that develops in CPEO.	[Yu-Wai-Man, Cynthia; Guthrie, Grant; Guthrie, Stuart; Griffiths, Philip G.; Yu-Wai-Man, Patrick] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Smith, Fiona E.; Blamire, Andrew M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Smith, Fiona E.; Blamire, Andrew M.] Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Firbank, Michael J.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gorman, Grainne S.; Turnbull, Douglass M.; Chinnery, Patrick F.] Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Gorman, Grainne S.; Taylor, Robert W.; Turnbull, Douglass M.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Chinnery, Patrick F.; Yu-Wai-Man, Patrick] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Yu-Wai-Man, P (corresponding author), Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	Patrick.Yu-Wai-Man@ncl.ac.uk	Blamire, Andrew/AAU-6100-2021; Firbank, Michael J/K-3335-2012	Firbank, Michael J/0000-0002-9536-0185; Chinnery, Patrick/0000-0002-7065-6617; Blamire, Andrew/0000-0002-8749-1257; Yu-Wai-Man, Cynthia/0000-0003-4868-5187; Gorman, Grainne/0000-0002-7585-3409; Turnbull, Doug/0000-0002-8878-9901	Newcastle Joint Research Executive Scientific Committee (JRESC); Medical Research Council (MRC, UK); Wellcome Trust; Medical Research Council [G0700718, MR/K000608/1, G0701386, G1002570] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish; MRC [MR/K000608/1, G0701386, G1002570, G0700718] Funding Source: UKRI	Newcastle Joint Research Executive Scientific Committee (JRESC); Medical Research Council (MRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by research grants from the Newcastle Joint Research Executive Scientific Committee (JRESC), the Medical Research Council (MRC, UK), and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlow TJ, 1998, AM J NEURORADIOL, V19, P95; DAROFF RB, 1966, NEUROLOGY, V16, P161, DOI 10.1212/WNL.16.2_Part_1.161; Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002; Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b; Fratter C, 2010, NEUROLOGY, V74, P1619, DOI 10.1212/WNL.0b013e3181df099f; Greaves LC, 2010, INVEST OPHTH VIS SCI, V51, P3340, DOI 10.1167/iovs.09-4659; Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088; Kapeller P, 1996, J NEUROL SCI, V135, P126, DOI 10.1016/0022-510X(95)00290-I; Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d; Man CYW, 2006, EYE, V20, P564, DOI 10.1038/sj.eye.6701924; MATTHEWS PM, 1993, NEUROLOGY, V43, P2484, DOI 10.1212/WNL.43.12.2484; McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2; Ortube MC, 2006, J AAPOS, V10, P414, DOI 10.1016/j.jaapos.2006.04.012; Palin EJH, 2013, BRAIN, V136, P2379, DOI 10.1093/brain/awt160; Richardson C, 2005, EYE, V19, P258, DOI 10.1038/sj.eye.6701488; Taherian K, 2007, EYE, V21, P639, DOI 10.1038/sj.eye.6702296; VIVIAN AJ, 1993, EYE, V7, P565, DOI 10.1038/eye.1993.123; WRAY SH, 1995, AM J NEURORADIOL, V16, P1167; Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007; Yu-Wai-Man P, 2012, BRIT J OPHTHALMOL, V96, P1536, DOI 10.1136/bjophthalmol-2012-302566	20	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75048	10.1371/journal.pone.0075048	http://dx.doi.org/10.1371/journal.pone.0075048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086434	Green Submitted, gold, Green Published			2022-12-25	WOS:000325223900035
J	Eguchi, H; Wada, K				Eguchi, Hisashi; Wada, Koji			Knowledge of HBV and HCV and Individuals' Attitudes Toward HBV- and HCV-Infected Colleagues: A National Cross-Sectional Study among a Working Population in Japan	PLOS ONE			English	Article							HEPATITIS-C; HEALTH-PROFESSIONALS; HIV/AIDS STIGMA; AWARENESS; WORKPLACE; PAKISTAN; VIETNAM; PEOPLE; HIV	Prejudice and discrimination in the workplace regarding the risk of transmission of Hepatitis B virus (HBV) and Hepatitis C virus (HCV) are increased by excess concerns due to a lack of relevant knowledge. Education to increase knowledge about HBV and HCV and their prevention could be the first step to reduce prejudice and discrimination. This study aimed to determine the association between the level of knowledge and negative attitudes toward HBV- and HCV-infected colleagues among the Japanese working population. An online anonymous nationwide survey involving about 3,000 individuals was conducted in Japan. The questionnaire consisted of knowledge of HBV and HCV, and attitudes toward HBV- and HCV-infected colleagues in the workplace. Knowledge was divided into three categories: "ensuring daily activities not to be infected"; "risk of infection"; and "characteristics of HBV/HCV hepatitis", based on the result of factor analysis. Multiple logistic regression analysis was applied. A total of 3,129 persons responded to the survey: 36.0% reported they worried about the possibility of transmission of HBV and HCV from infected colleagues; 32.1% avoided contact with infected colleagues; and 23.7% had prejudiced opinions about HBV and HCV infection. The participants were classified into tertiles. A higher level of knowledge of HBV and HCV was significantly associated with these three negative attitudes (P for trend < 0.005). This study suggests that increasing knowledge may decrease individuals' negative attitudes towards HBV- and HCV-infected colleagues. Thus, we should promote increased knowledge of HBV and HCV in stages to reduce negative attitudes toward HBV- and HCV-infected colleagues.	[Eguchi, Hisashi] Kyocera Corp Shiga Gamou Plant, Environm & Safety Div, Higashiomi, Shiga, Japan; [Wada, Koji] Natl Inst Global Hlth & Med, Shinjuku Ku, Tokyo, Japan	Kyocera	Wada, K (corresponding author), Natl Inst Global Hlth & Med, Shinjuku Ku, Tokyo, Japan.	kwada-sgy@umin.ac.jp			Health Labour Sciences Research Grant from The Ministry of Health, Labour, and Welfare [H23-Hepatitis-general-001]	Health Labour Sciences Research Grant from The Ministry of Health, Labour, and Welfare	This study was funded by a Health Labour Sciences Research Grant from The Ministry of Health, Labour, and Welfare (H23-Hepatitis-general-001). The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Arikan K, 1999, ISRAEL J PSYCHIAT, V36, P95; Balfour L, 2009, SCAND J CARING SCI, V23, P801, DOI 10.1111/j.1471-6712.2008.00668.x; Bashir S, 2011, SAHARA J-J SOC ASP H, V8, P156, DOI 10.1080/17290376.2011.9724998; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Chao J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-98; Corrigan PW, 2004, PSYCHIAT SERV, V55, P577, DOI 10.1176/appi.ps.55.5.577; Heijnders Miriam, 2006, Psychol Health Med, V11, P353, DOI 10.1080/13548500600595327; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Hoa NR, 2004, INT J TUBERC LUNG D, V8, P603; Janke EA, 2008, PSYCHOSOMATICS, V49, P494, DOI 10.1176/appi.psy.49.6.494; Kontos EZ, 2012, AM J PUBLIC HEALTH, V102, P1911, DOI 10.2105/AJPH.2011.300435; Krauskopf K, 2011, J VIRAL HEPATITIS, V18, P785, DOI 10.1111/j.1365-2893.2010.01383.x; Lee S, 2005, SOC SCI MED, V61, P2038, DOI 10.1016/j.socscimed.2005.04.010; Lim V. K. G., 1999, SMJ, V40, P410; Minuk GY, 2005, J VIRAL HEPATITIS, V12, P51, DOI 10.1111/j.1365-2893.2005.00553.x; Narai R, 2007, J OCCUP HEALTH, V49, P9, DOI 10.1539/joh.49.9; Richmond JA, 2007, J VIRAL HEPATITIS, V14, P624, DOI 10.1111/j.1365-2893.2007.00849.x; Sastre MTM, 2002, PREV MED, V34, P596, DOI 10.1006/pmed.2002.1023; Thi MDA, 2008, AIDS BEHAV, V12, pS63, DOI 10.1007/s10461-008-9374-4; ul Haq N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-692; van der Veen YJJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-512; Zacks S, 2006, J CLIN GASTROENTEROL, V40, P220, DOI 10.1097/00004836-200603000-00009; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	23	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76921	10.1371/journal.pone.0076921	http://dx.doi.org/10.1371/journal.pone.0076921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VP	24086765	gold, Green Published, Green Submitted			2022-12-25	WOS:000325220000074
J	Li, G; Shu, ZH; Wang, YQ				Li, Guang; Shu, ZongHuang; Wang, Yiquan			Year-Round Reproduction and Induced Spawning of Chinese Amphioxus, Branchiostoma belcheri, in Laboratory	PLOS ONE			English	Article							DEUTEROSTOME PHYLOGENY; DEVELOPMENTAL BIOLOGY; CHORDATE AMPHIOXUS; 2 LANCELETS; EVOLUTION; VERTEBRATES; GENOME; LANCEOLATUM; DIVERSITY; INSIGHTS	Amphioxus is a best candidate for studying the evolutionary and developmental mechanisms of vertebrates, because of its vertebrate-like but much simpler morphology, embryonic development and genome structure. Producing live amphioxus embryos throughout the year is an ideal for comparative evolution and developmental studies. However, all amphioxus species have distinct breeding seasons in the wild and laboratory. We recently found that Chinese amphioxus B. belcheri could reproduce repeatedly beyond its natural breeding season when reared under proper conditions. In this study, we were able to extend further and produce embryos throughout the year from October 2011 to October 2012. We found all examined animals had spawned repeatedly during the examined period. In addition, both lancelets B. belcheri and B. japonicum could be induced to spawn by heat-shock method, although the induced spawning efficiency was not as high as that observed in the European lancelet. In general, we have succeeded in producing B. belcheri embryos almost daily throughout the year. This advancement will provide essential embryonic material for evolutionary and developmental studies, and have great implications for the cultivation and spawning induction of other amphioxus species.	[Li, Guang; Shu, ZongHuang; Wang, Yiquan] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China; [Li, Guang; Wang, Yiquan] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Peoples R China	Xiamen University; Xiamen University	Wang, YQ (corresponding author), Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China.	wangyq@xmu.edu.cn			Natural Science Foundation of Fujian Province of China [2011J05097]; National High Technology Research and Development Program of China [2008AA092602]; National Natural Science Foundation of China [30830023, 31101631]; Social Development and Technological Project by Department of Science and Technology of Shenzhen [JSF201006290026A]	Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development and Technological Project by Department of Science and Technology of Shenzhen	This work was supported by the Natural Science Foundation of Fujian Province of China (No. 2011J05097), the National High Technology Research and Development Program of China (No. 2008AA092602), the National Natural Science Foundation of China (No. 30830023 and No. 31101631) and Social Development and Technological Project by the Department of Science and Technology of Shenzhen (No. JSF201006290026A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaster-Jones L, 2012, BRIEF FUNCT GENOMICS, V11, P118, DOI 10.1093/bfgp/els006; Bertrand S, 2011, DEVELOPMENT, V138, P4819, DOI 10.1242/dev.066720; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Candiani S, 2012, BRIEF FUNCT GENOMICS, V11, P107, DOI 10.1093/bfgp/els004; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; Fuentes M, 2007, J EXP ZOOL PART B, V308B, P484, DOI 10.1002/jez.b.21179; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Gee H, 2001, SYST ASSOC SPEC VOL, V61, P1; Holland LZ, 2004, CELL MOL LIFE SCI, V61, P2290, DOI 10.1007/s00018-004-4075-2; HOLLAND ND, 1989, BIOL BULL-US, V176, P111, DOI 10.2307/1541578; Koop Demian, 2008, Birth Defects Research, V84, P175, DOI 10.1002/bdrc.20128; Li G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050838; Li WY, 2013, ZOOL SCI, V30, P83, DOI 10.2108/zsj.30.83; Paps J, 2012, BRIEF FUNCT GENOMICS, V11, P177, DOI 10.1093/bfgp/els012; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Stokes D, 1991, INVERTEBRA BIOL, V115, P349; Theodosiou M, 2011, J EXP ZOOL PART B, V316B, P263, DOI 10.1002/jez.b.21397; TURBEVILLE JM, 1994, MOL BIOL EVOL, V11, P648; Wang Yi-quan, 2006, Zoological Research, V27, P631; Wang Yi-quan, 2005, Zoological Research, V26, P666; Wu SC, 1986, ADV SCI CHINA BIOL, P231; Xu QS, 2005, J EXP ZOOL PART B, V304B, P259, DOI 10.1002/jez.b.21036; Yu JK, 2009, COLD SPRING HARB PRO, V2009; Zhang QJ, 2007, J EXP ZOOL PART B, V308B, P464, DOI 10.1002/jez.b.21172; Zhang QJ, 2006, ZOOL SCI, V23, P573, DOI 10.2108/zsj.23.573	29	27	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75461	10.1371/journal.pone.0075461	http://dx.doi.org/10.1371/journal.pone.0075461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086537	Green Published, gold			2022-12-25	WOS:000325220000022
J	Chen, J; Lee, EJ; Jing, LF; Christoforou, N; Leong, KW; Setton, LA				Chen, Jun; Lee, Esther J.; Jing, Liufang; Christoforou, Nicolas; Leong, Kam W.; Setton, Lori A.			Differentiation of Mouse Induced Pluripotent Stem Cells (iPSCs) into Nucleus Pulposus-Like Cells In Vitro	PLOS ONE			English	Article							HUMAN INTERVERTEBRAL-DISK; PROTEIN GENE-EXPRESSION; NEURAL GANGLIOSIDE GD2; MATRIX INTERACTIONS; CHONDROCYTE TRANSPLANTATION; NOTOCHORDAL CELLS; END-PLATE; DEGENERATION; PHENOTYPE; GROWTH	A large percentage of the population may be expected to experience painful symptoms or disability associated with intervertebral disc (IVD) degeneration - a condition characterized by diminished integrity of tissue components. Great interest exists in the use of autologous or allogeneic cells delivered to the degenerated IVD to promote matrix regeneration. Induced pluripotent stem cells (iPSCs), derived from a patient's own somatic cells, have demonstrated their capacity to differentiate into various cell types although their potential to differentiate into an IVD cell has not yet been demonstrated. The overall objective of this study was to assess the possibility of generating iPSC-derived nucleus pulposus (NP) cells in a mouse model, a cell population that is entirely derived from notochord. This study employed magnetic activated cell sorting (MACS) to isolate a CD24(+) iPSC subpopulation. Notochordal cell-related gene expression was analyzed in this CD24(+) cell fraction via real time RT-PCR. CD24(+) iPSCs were then cultured in a laminin-rich culture system for up to 28 days, and the mouse NP phenotype was assessed by immunostaining. This study also focused on producing a more conducive environment for NP differentiation of mouse iPSCs with addition of low oxygen tension and notochordal cell conditioned medium (NCCM) to the culture platform. iPSCs were evaluated for an ability to adopt an NP-like phenotype through a combination of immunostaining and biochemical assays. Results demonstrated that a CD24(+) fraction of mouse iPSCs could be retrieved and differentiated into a population that could synthesize matrix components similar to that in native NP. Likewise, the addition of a hypoxic environment and NCCM induced a similar phenotypic result. In conclusion, this study suggests that mouse iPSCs have the potential to differentiate into NP-like cells and suggests the possibility that they may be used as a novel cell source for cellular therapy in the IVD.	[Chen, Jun; Setton, Lori A.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27705 USA; [Lee, Esther J.; Jing, Liufang; Christoforou, Nicolas; Leong, Kam W.; Setton, Lori A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University; Duke University	Chen, J (corresponding author), Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27705 USA.	junchen@duke.edu	Leong, Kam/O-9302-2019; Leong, Kam W/A-7270-2009	Leong, Kam/0000-0002-8133-4955; Leong, Kam W/0000-0002-8133-4955; Setton, Lori/0000-0001-5992-4206	NIH [R01AR057410, R01EB002263, R01AR047442, R01HL083008]; AOSpine Foundation; FAMRI Young Clinical Scientist Award; Pratt Undergraduate Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057410, R01AR047442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002263] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AOSpine Foundation; FAMRI Young Clinical Scientist Award; Pratt Undergraduate Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by NIH under grants R01AR057410, R01EB002263, R01AR047442, R01HL083008, AOSpine Foundation, FAMRI Young Clinical Scientist Award (NC), and a Pratt Undergraduate Research Fellowship (EJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2012, J ORTHOP RES, V30, P482, DOI 10.1002/jor.21534; Allon Aliza A, 2009, SAS J, V3, P41, DOI 10.1016/SASJ-2009-0005-NT; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Boyd LM, 2008, ARTHRITIS RHEUM, V58, P164, DOI 10.1002/art.23231; Boyd LM, 2004, SPINE, V29, P2217, DOI 10.1097/01.brs.0000142747.90488.1d; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Chen J, 2002, BIOCHEM BIOPH RES CO, V293, P932, DOI 10.1016/S0006-291X(02)00314-5; Chen J, 2009, CONNECT TISSUE RES, V50, P294, DOI 10.3109/03008200802714925; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Christoforou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065963; Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c; Dahia CL, 2009, SPINE, V34, P447, DOI 10.1097/BRS.0b013e3181990c64; Dahia CL, 2009, SPINE, V34, P456, DOI 10.1097/BRS.0b013e3181913e98; Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109; Erwin WM, 2006, ARTHRITIS RHEUM-US, V54, P3859, DOI 10.1002/art.22258; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Fujita N, 2005, BIOCHEM BIOPH RES CO, V338, P1890, DOI 10.1016/j.bbrc.2005.10.166; Gai H, 2009, CELL BIOL INT, V33, P1184, DOI 10.1016/j.cellbi.2009.08.008; Ganey T, 2003, SPINE, V28, P2609, DOI 10.1097/01.BRS.0000097891.63063.78; Gilchrist CL, 2011, EUR CELLS MATER, V21, P523, DOI 10.22203/eCM.v021a39; Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343; Gilchrist CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027170; Gilson A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2931; GOTZ W, 1995, CELL TISSUE RES, V280, P455; Gruber HE, 2002, SPINE, V27, P1626, DOI 10.1097/00007632-200208010-00007; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; hon BH, 2011, HUMAN UMBILICAL CORD, P36; HUMZAH MD, 1988, ANAT RECORD, V220, P337, DOI 10.1002/ar.1092200402; Jiang W, 2011, STEM CELLS, V29, P609, DOI 10.1002/stem.608; Kandel R, 2008, EUR SPINE J, V17, pS480, DOI 10.1007/s00586-008-0746-2; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kim MJ, 2011, ARTHRITIS RHEUM-US, V63, P3010, DOI 10.1002/art.30488; Korecki CL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt18; Li XD, 2005, CONNECT TISSUE RES, V46, P75, DOI 10.1080/03008200590954104; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Longo U. G., 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/921053-921057; Luo X, 2004, SPINE; Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90; Maier JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055528; Martinez C, 2007, BLOOD, V109, P4245, DOI 10.1182/blood-2006-08-039347; Masuda Koichi, 2004, Spine J, V4, p330S, DOI 10.1016/j.spinee.2004.07.028; McCann MR, 2012, DIS MODEL MECH, V5, P73, DOI 10.1242/dmm.008128; Meisel HJ, 2007, BIOMOL ENG, V24, P5, DOI 10.1016/j.bioeng.2006.07.002; Nishimura K, 1998, SPINE, V23, P1531, DOI 10.1097/00007632-199807150-00006; Nomura T, 2001, CLIN ORTHOP RELAT R, P94; OEGEMA TR, 1993, CLIN SPORT MED, V12, P419; Pattappa G, 2012, J ANAT, V221, P480, DOI 10.1111/j.1469-7580.2012.01521.x; Purmessur D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3344; Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018; Risbud MV, 2010, DEV DYNAM, V239, P2141, DOI 10.1002/dvdy.22350; Risbud MV, 2004, SPINE, V29, P2627, DOI 10.1097/01.brs.0000146462.92171.7f; ROBERTS S, 1991, SPINE, V16, P1030, DOI 10.1097/00007632-199109000-00003; Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9; Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226; Sakai D, 2008, EUR SPINE J, V17, pS452, DOI 10.1007/s00586-008-0743-5; Setton LA, 2007, REGENERATION REPLACE; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052020; TROUT JJ, 1982, TISSUE CELL, V14, P359, DOI 10.1016/0040-8166(82)90033-7; von Furstenberg RJ, 2011, AM J PHYSIOL-GASTR L, V300, pG409, DOI 10.1152/ajpgi.00453.2010; Wei YY, 2012, EUR CELLS MATER, V23, P1; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Xu J, 2009, CELL PHYSIOL BIOCHEM, V23, P415, DOI 10.1159/000218188; Yu J, 2002, BIOCHEM SOC T, V30, P848, DOI 10.1042/bst0300848	70	41	43	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75548	10.1371/journal.pone.0075548	http://dx.doi.org/10.1371/journal.pone.0075548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086564	gold, Green Published, Green Submitted			2022-12-25	WOS:000325218700099
J	Jalbert, E; Crawford, TQ; D'Antoni, ML; Keating, SM; Norris, PJ; Nakamoto, BK; Seto, T; Parikh, NI; Shikuma, CM; Ndhlovu, LC; Barbour, JD				Jalbert, Emilie; Crawford, Timothy Q.; D'Antoni, Michelle L.; Keating, Sheila M.; Norris, Philip J.; Nakamoto, Beau K.; Seto, Todd; Parikh, Nisha I.; Shikuma, Cecilia M.; Ndhlovu, Lishomwa C.; Barbour, Jason D.			IL-1B Enriched Monocytes Mount Massive IL-6 Responses to Common Inflammatory Triggers among Chronically HIV-1 Infected Adults on Stable Anti-Retroviral Therapy at Risk for Cardiovascular Disease	PLOS ONE			English	Article							FLOW-CYTOMETRY; HIV; INFECTION; EXPRESSION; TNF; INTERLEUKIN-1; MACROPHAGES; ACTIVATION; INITIATION; IL-1-BETA	Chronic infection by HIV increases the risk of cardiovascular disease (CVD) despite effective antiretroviral therapy (ART). The mechanisms linking HIV to CVD have yet to be fully elucidated. High plasma levels of the pro-inflammatory cytokine IL-6, which may be triggered by IL-1 beta, is a biomarker of CVD risk in HIV-negative adults, and of all-cause mortality in HIV disease. Monocytes play a pivotal role in atherosclerosis, and may be major mediators of HIV-associated inflammation. We therefore hypothesized that monocytes from HIV-infected adults would display high inflammatory responses. Employing a 10-color flow cytometry intracellular cytokine staining assay, we directly assessed cytokine and chemokine responses of monocytes from the cryopreserved peripheral blood of 33 chronically HIV-1 infected subjects. Participants were 45 years or older, on virologically suppressive ART and at risk for CVD. This group was compared to 14 HIV-negative subjects matched for age and gender, with similar CVD risk. We simultaneously detected intracellular expression of IL-1 beta, IL-6, IL-8 and TNF in blood monocytes in the basal state and after stimulation by triggers commonly found in the blood of treated, chronically HIV-infected subjects: lipopolysaccharide (LPS) and oxidized low-density lipoprotein (oxLDL). In the absence of stimulation, monocytes from treated HIV-infected subjects displayed a high frequency of cells producing IL-1 beta (median 19.5%), compared to low levels in HIV-uninfected persons (0.9% p<0.0001). IL-8, which is induced by IL-1 beta, was also highly expressed in the HIV-infected group in the absence of stimulation, 43.7% compared to 1.9% in HIV-uninfected subjects, p<0.0001. Strikingly, high basal expression of IL-1 beta by monocytes predicted high IL-6 levels in the plasma, and high monocyte IL-6 responses in HIV-infected subjects. Hyper-inflammatory IL-1 beta enriched monocytes may be a major source of IL-6 production and systemic inflammation in HIV-infected adults, and may contribute to the risk for all-cause mortality and cardiovascular disease in treated HIV infection.	[Jalbert, Emilie; Crawford, Timothy Q.; D'Antoni, Michelle L.; Seto, Todd; Parikh, Nisha I.; Shikuma, Cecilia M.; Ndhlovu, Lishomwa C.; Barbour, Jason D.] Hawaii Ctr HIV AIDS, Honolulu, HI 96813 USA; [Jalbert, Emilie; Crawford, Timothy Q.; D'Antoni, Michelle L.; Ndhlovu, Lishomwa C.; Barbour, Jason D.] Univ Hawaii, John A Burns Sch Med, Dept Trop Med, Honolulu, HI 96822 USA; [Keating, Sheila M.; Norris, Philip J.] Blood Syst Res Inst, San Francisco, CA USA; [Keating, Sheila M.; Norris, Philip J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Norris, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Nakamoto, Beau K.; Shikuma, Cecilia M.] Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA; [Nakamoto, Beau K.] Straub Clin & Hosp, Honolulu, HI USA; [Seto, Todd; Parikh, Nisha I.] Queens Med Ctr, Honolulu, HI USA	University of Hawaii System; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Hawaii System; The Queen's Medical Center	Barbour, JD (corresponding author), Hawaii Ctr HIV AIDS, Honolulu, HI 96813 USA.	jbarbour@hawaii.edu	n, l/AAX-3992-2020	Keating, Sheila/0000-0002-8324-3694; Ndhlovu, Lishomwa/0000-0001-5427-4187; Jalbert, Emilie/0000-0001-7056-5275	NIH [R01HL095135]; Dean's Office of the John A. Burns School of Medicine; Vice Chancellor's Office for Research and Graduate Education of the University of Hawaii Manoa; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dean's Office of the John A. Burns School of Medicine; Vice Chancellor's Office for Research and Graduate Education of the University of Hawaii Manoa; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The authors thank the NIH R01HL095135 for funding support to C. S. and support from the Dean's Office of the John A. Burns School of Medicine, and the Vice Chancellor's Office for Research and Graduate Education of the University of Hawaii Manoa, to J.D.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autissier P, 2010, CYTOM PART A, V77A, P410, DOI 10.1002/cyto.a.20859; Baker J, 2013, 20 C RETR OPP INF 3; Baker JV, 2011, AIDS, V25, P2133, DOI 10.1097/QAD.0b013e32834be088; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Berg KE, 2012, CIRC-CARDIOVASC GENE, V5, P122, DOI 10.1161/CIRCGENETICS.111.960385; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; CalzadaWack JC, 1996, J INFLAMM, V46, P78; DINARELLO CA, 1984, NEW ENGL J MED, V311, P1413; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dutertre CA, 2012, BLOOD, V120, P2259, DOI 10.1182/blood-2012-03-418681; Esser S, 2013, CLIN RES CARDIOL, V102, P203, DOI 10.1007/s00392-012-0519-0; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Jalbert E, 2013, CYTOM PART A, V83A, P280, DOI 10.1002/cyto.a.22257; Longenecker C, 2013, HIV MED; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Ratto-Kim S, 2008, J NEUROIMMUNOL, V195, P100, DOI 10.1016/j.jneuroim.2007.11.021; Robbins CS, 2010, CELL MOL LIFE SCI, V67, P2685, DOI 10.1007/s00018-010-0375-x; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shikuma CM, 2012, AIDS RES HUM RETROV, V28, P793, DOI [10.1089/aid.2011.0086, 10.1089/AID.2011.0086]; Shive CL, 2012, JAIDS-J ACQ IMM DEF, V61, P145, DOI 10.1097/QAI.0b013e31825ddbbf; Siedlar M, 2000, IMMUNOBIOLOGY, V202, P11, DOI 10.1016/S0171-2985(00)80047-9; TOSATO G, 1990, BLOOD, V75, P1305, DOI 10.1182/blood.V75.6.1305.1305; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605	33	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75500	10.1371/journal.pone.0075500	http://dx.doi.org/10.1371/journal.pone.0075500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086545	Green Submitted, gold, Green Published			2022-12-25	WOS:000325218700091
J	Ma, JX; Trop, S; Baer, S; Rakhmanaliev, E; Arany, Z; Dumoulin, P; Zhang, H; Romano, J; Coppens, I; Levitsky, V; Levitskaya, J				Ma, Jinxia; Trop, Stefanie; Baer, Samantha; Rakhmanaliev, Elian; Arany, Zita; Dumoulin, Peter; Zhang, Hao; Romano, Julia; Coppens, Isabelle; Levitsky, Victor; Levitskaya, Jelena			Dynamics of the Major Histocompatibility Complex Class I Processing and Presentation Pathway in the Course of Malaria Parasite Development in Human Hepatocytes: Implications for Vaccine Development	PLOS ONE			English	Article							CD8(+) T-CELLS; PLASMODIUM CIRCUMSPOROZOITE PROTEIN; VIRAL IMMUNE EVASION; BERGHEI LIVER STAGES; ENDOPLASMIC-RETICULUM; MEMORY; STAGE; STRATEGIES; EFFECTOR; ESCAPE	Control of parasite replication exerted by MHC class I restricted CD8+ T-cells in the liver is critical for vaccination-induced protection against malaria. While many intracellular pathogens subvert the MHC class I presentation machinery, its functionality in the course of malaria replication in hepatocytes has not been characterized. Using experimental systems based on specific identification, isolation and analysis of human hepatocytes infected with P. berghei ANKA GFP or P. falciparum 3D7 GFP sporozoites we demonstrated that molecular components of the MHC class I pathway exhibit largely unaltered expression in malaria-infected hepatocytes until very late stages of parasite development. Furthermore, infected cells showed no obvious defects in their capacity to upregulate expression of different molecular components of the MHC class I machinery in response to pro-inflammatory lymphokines or trigger direct activation of allo-specific or peptide-specific human CD8+ T-cells. We further demonstrate that ectopic expression of circumsporozoite protein does not alter expression of critical genes of the MHC class I pathway and its response to pro-inflammatory cytokines. In addition, we identified supra-cellular structures, which arose at late stages of parasite replication, possessed the characteristic morphology of merosomes and exhibited nearly complete loss of surface MHC class I expression. These data have multiple implications for our understanding of natural T-cell immunity against malaria and may promote development of novel, efficient anti-malaria vaccines overcoming immune escape of the parasite in the liver.	[Ma, Jinxia; Trop, Stefanie; Baer, Samantha; Rakhmanaliev, Elian; Arany, Zita; Dumoulin, Peter; Zhang, Hao; Romano, Julia; Coppens, Isabelle; Levitskaya, Jelena] Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Levitsky, Victor] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Levitskaya, J (corresponding author), Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	jelevits@jhsph.edu		Romano, Julia/0000-0001-8956-7377	JHMRI pilot grant "Alterations of the MHC class I processing and presentation pathway at the liver stage of malaria infection"; JHMRI postdoctoral fellowship	JHMRI pilot grant "Alterations of the MHC class I processing and presentation pathway at the liver stage of malaria infection"; JHMRI postdoctoral fellowship	This work was supported by the JHMRI pilot grant "Alterations of the MHC class I processing and presentation pathway at the liver stage of malaria infection" and JHMRI postdoctoral fellowship awarded to Jinxia Ma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Abele R, 2011, ESSAYS BIOCHEM, V50, P249, DOI [10.1042/BSE0500249, 10.1042/bse0500249]; Lin AF, 2007, CELL MOL IMMUNOL, V4, P91; Alto NM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006114; Balam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051875; Basta S, 2003, VIRAL IMMUNOL, V16, P231, DOI 10.1089/088282403322396064; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Berridge MJ, 1997, CRIT REV IMMUNOL, V17, P155, DOI 10.1615/CritRevImmunol.v17.i2.30; Bongfen SE, 2007, J IMMUNOL, V178, P7054, DOI 10.4049/jimmunol.178.11.7054; Butler NS, 2012, TRENDS IMMUNOL, V33, P247, DOI 10.1016/j.it.2012.02.001; Chakravarty S, 2008, INFECT IMMUN, V76, P3628, DOI 10.1128/IAI.00471-08; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Chinnaiyan A M, 1997, Semin Immunol, V9, P69, DOI 10.1006/smim.1996.0055; Cockburn IA, 2007, CURR OPIN IMMUNOL, V19, P424, DOI 10.1016/j.coi.2007.05.008; Cockburn IA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001318; Cockburn IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000877; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Ewen CL, 2012, CELL DEATH DIFFER, V19, P28, DOI 10.1038/cdd.2011.153; Frevert U, 1998, EMBO J, V17, P3816, DOI 10.1093/emboj/17.14.3816; Fruh K, 1999, IMMUNOL REV, V168, P157, DOI 10.1111/j.1600-065X.1999.tb01290.x; Fruh K, 2002, VIRUS RES, V88, P55, DOI 10.1016/S0168-1702(02)00120-X; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Graewe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002224; Greenwood B, 2011, PHILOS T R SOC B, V366, P2733, DOI 10.1098/rstb.2011.0076; Gruhler A, 2000, TRAFFIC, V1, P306, DOI 10.1034/j.1600-0854.2000.010403.x; Hafalla JCR, 2007, J INFECT DIS, V196, P1827, DOI 10.1086/522965; Hafalla JC, 2011, IMMUNOL REV, V240, P297, DOI 10.1111/j.1600-065X.2010.00988.x; Hoves S, 2010, J LEUKOCYTE BIOL, V87, P237, DOI 10.1189/jlb.0909608; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Johnston JB, 2003, J VIROL, V77, P6093, DOI 10.1128/JVI.77.11.6093-6100.2003; Kamp W, 2000, EUR J CLIN INVEST, V30, P740; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levitsky V, 1997, J IMMUNOL, V159, P5383; Levitsky V, 1996, J EXP MED, V183, P915, DOI 10.1084/jem.183.3.915; Levitsky V, 2002, VIRUS RES, V88, P71, DOI 10.1016/S0168-1702(02)00121-1; Lopez JA, 2012, TRENDS IMMUNOL, V33, P406, DOI 10.1016/j.it.2012.04.001; Lorenzo ME, 2001, SEMIN IMMUNOL, V13, P1, DOI 10.1006/smim.2000.0290; Morrot A, 2004, IMMUNOL REV, V201, P291, DOI 10.1111/j.0105-2896.2004.00175.x; Nagata S, 1996, Prog Mol Subcell Biol, V16, P87; Renggli J, 1997, PARASITE IMMUNOL, V19, P145, DOI 10.1046/j.1365-3024.1997.d01-190.x; Ressing ME, 2005, J IMMUNOL, V174, P6829, DOI 10.4049/jimmunol.174.11.6829; Reyes-Sandoval A, 2011, J IMMUNOL, V187, P1347, DOI 10.4049/jimmunol.1100302; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Rock KL, 1996, IMMUNOL TODAY, V17, P131, DOI 10.1016/0167-5699(96)80605-0; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Sayers TJ, 2011, CANCER IMMUNOL IMMUN, V60, P1173, DOI 10.1007/s00262-011-1008-4; Schwenk RJ, 2011, TRENDS PARASITOL, V27, P306, DOI 10.1016/j.pt.2011.02.002; Sijts A., 2001, Current Molecular Medicine (Hilversum), V1, P665, DOI 10.2174/1566524013363230; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Sinnis P, 2007, PARASITOL INT, V56, P171, DOI 10.1016/j.parint.2007.04.002; Talman AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009156; Trimnell A, 2009, J IMMUNOL, V183, P5870, DOI 10.4049/jimmunol.0900302; Tse SW, 2011, MEM I OSWALDO CRUZ, V106, P172, DOI 10.1590/S0074-02762011000900022; van Endert PM, 1999, CURR OPIN IMMUNOL, V11, P82, DOI 10.1016/S0952-7915(99)80015-6; vanParijs L, 1996, CURR OPIN IMMUNOL, V8, P355, DOI 10.1016/S0952-7915(96)80125-7; Vitoria M, 2009, AM J CLIN PATHOL, V131, P844, DOI 10.1309/AJCP5XHDB1PNAEYT; Voskoboinik I, 2010, IMMUNOL REV, V235, P35, DOI 10.1111/j.0105-2896.2010.00896.x; Vossen MTM, 2002, IMMUNOGENETICS, V54, P527, DOI 10.1007/s00251-002-0493-1; WHO Malaria Policy Advisory Committee and Secretariat, 2012, Malar J, V11, P424, DOI 10.1186/1475-2875-11-424; Wiertz E, 1997, IMMUNOL LETT, V57, P213, DOI 10.1016/S0165-2478(97)00073-4; Yewdell JW, 1998, J IMMUNOTHER, V21, P127, DOI 10.1097/00002371-199803000-00006	62	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75321	10.1371/journal.pone.0075321	http://dx.doi.org/10.1371/journal.pone.0075321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086507	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700075
J	Silveira, CB; Cardoso, AM; Coutinho, FH; Lima, JL; Pinto, LH; Albano, RM; Clementino, MM; Martins, OB; Vieira, RP				Silveira, Cynthia B.; Cardoso, Alexander M.; Coutinho, Felipe H.; Lima, Joyce L.; Pinto, Leonardo H.; Albano, Rodolpho M.; Clementino, Maysa M.; Martins, Orlando B.; Vieira, Ricardo P.			Tropical Aquatic Archaea Show Environment-Specific Community Composition	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; MICROBIAL ECOLOGY; LAKE; ATLANTIC; SEDIMENT; GENOME; SEA; CRENARCHAEOTA; WIDESPREAD; EVOLUTION	The Archaea domain is ubiquitously distributed and extremely diverse, however, environmental factors that shape archaeal community structure are not well known. Aquatic environments, including the water column and sediments harbor many new uncultured archaeal species from which metabolic and ecological roles remain elusive. Some environments are especially neglected in terms of archaeal diversity, as is the case of pristine tropical areas. Here we investigate the archaeal composition in marine and freshwater systems from IIha Grande, a South Atlantic tropical environment. All sampled habitats showed high archaeal diversity. No OTUs were shared between freshwater, marine and mangrove sediment samples, yet these environments are interconnected and geographically close, indicating environment-specific community structuring. Group II Euryarchaeota was the main clade in marine samples, while the new putative phylum Thaumarchaeota and LDS/RCV Euryarchaeota dominated freshwaters. Group III Euryarchaeota, a rare clade, was also retrieved in reasonable abundance in marine samples. The archaeal community from mangrove sediments was composed mainly by members of mesophilic Crenarchaeota and by a distinct clade forming a sister-group to Crenarchaeota and Thaumarchaeota. Our results show strong environment-specific community structuring in tropical aquatic Archaea, as previously seen for Bacteria.	[Silveira, Cynthia B.; Coutinho, Felipe H.; Lima, Joyce L.; Pinto, Leonardo H.; Martins, Orlando B.; Vieira, Ricardo P.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio de Janeiro, Brazil; [Silveira, Cynthia B.; Coutinho, Felipe H.] Univ Fed Rio de Janeiro, Dept Genet, Rio de Janeiro, Brazil; [Cardoso, Alexander M.] Ctr Univ Estadual Zona Oeste UEZO, Rio De Janeiro, Brazil; [Cardoso, Alexander M.] INMETRO, Inst Nacl Metrol Qualidade & Tecnol, Rio De Janeiro, Brazil; [Albano, Rodolpho M.] Univ Estado Rio De Janeiro, Dept Bioquim, Rio De Janeiro, Brazil; [Clementino, Maysa M.] Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Controle Qualidade Saude, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Centro Universitario Estadual da Zona Oeste; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz	Silveira, CB (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio de Janeiro, Brazil.	cynthiabsilveira@gmail.com; alexandercardoso@uezo.rj.gov.br	Cardoso, Alexander/S-6687-2017; Clementino, Maysa/C-1944-2009; Cardoso, Alexander/AAX-2505-2021; Coutinho, Felipe Hernandes/R-3714-2019	Cardoso, Alexander/0000-0003-2974-0232; Coutinho, Felipe Hernandes/0000-0001-6430-7069; Silveira, Cynthia/0000-0002-9533-5588; Albano, Rodolpho/0000-0002-0643-901X	FAPERJ; FIOCRUZ; CNPq	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FIOCRUZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by FAPERJ, FIOCRUZ and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Barberan A, 2011, MOL ECOL, V20, P1988, DOI 10.1111/j.1365-294X.2011.05057.x; Bergauer K, 2013, FEMS MICROBIOL ECOL, V84, P461, DOI 10.1111/1574-6941.12073; Bernardes MC, 2012, BRAZ J BIOL, V72, P761, DOI 10.1590/S1519-69842012000400011; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Bowman JP, 2003, APPL ENVIRON MICROB, V69, P2463, DOI 10.1128/AEM.69.5.2463-2483.2003; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Bruce T, 2010, MICROB ECOL, V60, P840, DOI 10.1007/s00248-010-9750-2; BUCKLES L, 2013, ENV MICROBIOL; Cao HP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076946, 10.1371/journal.pone.0052853]; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Crump BC, 2000, FEMS MICROBIOL ECOL, V31, P231, DOI 10.1016/S0168-6496(99)00102-6; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dorador C, 2010, FEMS MICROBIOL ECOL, V73, P291, DOI 10.1111/j.1574-6941.2010.00891.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fuhrman JA, 2002, ANTON LEEUW INT J G, V81, P521, DOI 10.1023/A:1020513506777; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Galand PE, 2006, AQUAT MICROB ECOL, V44, P115, DOI 10.3354/ame044115; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Glissmann K, 2004, MICROB ECOL, V48, P389, DOI 10.1007/s00248-003-2027-2; Gupta RS, 2011, ANTON LEEUW INT J G, V99, P133, DOI 10.1007/s10482-010-9488-3; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Jurgens G, 2000, FEMS MICROBIOL ECOL, V34, P45, DOI 10.1111/j.1574-6941.2000.tb00753.x; Karl DM, 2002, NATURE, V415, P590, DOI 10.1038/415590b; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Lliros M, 2008, FEMS MICROBIOL ECOL, V66, P331, DOI 10.1111/j.1574-6941.2008.00583.x; Lliros M, 2010, APPL ENVIRON MICROB, V76, P6853, DOI 10.1128/AEM.02864-09; Lopez-Garcia P, 2001, ENVIRON MICROBIOL, V3, P72, DOI 10.1046/j.1462-2920.2001.00162.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Mendes LW, 2012, RES MICROBIOL, V163, P366, DOI 10.1016/j.resmic.2012.05.005; MN H, 2013, P NATL ACAD SCI USA, V110, P6004, DOI DOI 10.1073/PNAS.1216863110.PUBMED:23536290; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Nusslein B, 2001, ENVIRON MICROBIOL, V3, P460, DOI 10.1046/j.1462-2920.2001.00215.x; Offre P, 2013, ANNU REV MICROBIOL, V67, P437, DOI 10.1146/annurev-micro-092412-155614; OGRAM A, 1987, J MICROBIOL METH, V7, P57, DOI 10.1016/0167-7012(87)90025-X; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Ravenschlag K, 1999, APPL ENVIRON MICROB, V65, P3982; Robertson CE, 2005, CURR OPIN MICROBIOL, V8, P638, DOI 10.1016/j.mib.2005.10.003; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Siboni N, 2008, ENVIRON MICROBIOL, V10, P2979, DOI 10.1111/j.1462-2920.2008.01718.x; Silveira CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017789; Somboonna N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S29; Taib N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058950; Tamames J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-85; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turque AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015774; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vieira RP, 2007, MICROB ECOL, V54, P460, DOI 10.1007/s00248-007-9261-y; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wang YF, 2013, APPL MICROBIOL BIOT, V97, P7015, DOI 10.1007/s00253-012-4430-4; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	69	10	10	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76321	10.1371/journal.pone.0076321	http://dx.doi.org/10.1371/journal.pone.0076321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086729	Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700126
J	Xu, GH; Yang, JJ; Li, GQ				Xu, Guanghua; Yang, Junjie; Li, Guoqing			Simulating Society Transitions: Standstill, Collapse and Growth in an Evolving Network Model	PLOS ONE			English	Article							EVOLUTIONARY MODEL; MAYA CIVILIZATION; DYNASTIC CYCLE; COMPLEXITY; SYSTEMS	We developed a model society composed of various occupations that interact with each other and the environment, with the capability of simulating three widely recognized societal transition patterns: standstill, collapse and growth, which are important compositions of society evolving dynamics. Each occupation is equipped with a number of inhabitants that may randomly flow to other occupations, during which process new occupations may be created and then interact with existing ones. Total population of society is associated with productivity, which is determined by the structure and volume of the society. We ran the model under scenarios such as parasitism, environment fluctuation and invasion, which correspond to different driving forces of societal transition, and obtained reasonable simulation results. This work adds to our understanding of societal evolving dynamics as well as provides theoretical clues to sustainable development.	[Xu, Guanghua; Yang, Junjie] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Xu, Guanghua; Yang, Junjie] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Guoqing] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China	Li, GQ (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China.	liguoqing@nwsuaf.edu.cn						[Anonymous], 2001, PANARCHY UNDERSTANDI; [Anonymous], 2001, TIME GOES IND REVOLU; Bak P., 1996, NATURE WORKS SCI SEL; Berman A., 1979, NONNEGATIVE MATRICES; Buchanan M., 2000, UBIQUITY SCI HIST WH; Curry A, 2010, J FUTURES STUD, V14, P75; Danilevsky N. Ya., 1895, RUSSIA EUROPE LOOK C; De Carolis E, 2003, VESUVIUS A D 79 DEST; DIAMOND JM, 2005, COLLAPSE SOC CHOOSE; Dittrich P, 2001, ARTIF LIFE, V7, P225, DOI 10.1162/106454601753238636; Feichtinger G, 1996, CHAOS SOLITON FRACT, V7, P257, DOI 10.1016/0960-0779(95)00011-9; Gotts NM, 2007, ECOL SOC, V12; Green DG, 2009, UNIFYING THEMES COMP; Grimm V, 2006, CONTRIB ECON, P139, DOI 10.1007/3-7908-1721-X_7; Hanel R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036110; Haug GH, 2003, SCIENCE, V299, P1731, DOI 10.1126/science.1080444; Holling CS, 2001, ECOSYSTEMS, V4, P390, DOI 10.1007/s10021-001-0101-5; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jain S, 2002, P NATL ACAD SCI USA, V99, P2055, DOI 10.1073/pnas.032618499; Jain S, 1998, PHYS REV LETT, V81, P5684, DOI 10.1103/PhysRevLett.81.5684; Jin Guantao, 1992, XINGSHENG YU WEIJI L; Levin S., 1999, FRAGILE DOMINION; Levin SA, 2005, BIOSCIENCE, V55, P1075, DOI 10.1641/0006-3568(2005)055[1075:SATEOC]2.0.CO;2; Liu C, 1981, REASONS PERPETUATING; LOVELOCK J E, 1991, P3; Medina-Elizalde M, 2012, SCIENCE, V335, P956, DOI 10.1126/science.1216629; Nefedov S. A., 2004, SOCIAL EVOLUTION HIS, V3, P69; Paperin G, 2011, J ROYAL SOC INTERFAC; Railsback S.F., 2011, AGENT BASED INDIVIDU; Saeed K, 2007, J OPERATIONAL RES SO, V59, P1289; Schultz TW., 1993, ORIGINS INCREASING R; Schumpeter, 2006, HIST EC ANAL; SCHUSTER P, 1983, J THEOR BIOL, V100, P533, DOI 10.1016/0022-5193(83)90445-9; Smith Adam, 1776, INQUIRY NATURE CAUSE; Tainter J., 1990, COLLAPSE COMPLEX SOC; Thurner S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/075029; Thurner S, 2010, PHYSICA A, V389, P747, DOI 10.1016/j.physa.2009.10.030; TURCHIN P, 2008, SECULAR CYCLES; Turchin P, 2006, SOC EVOL HIST, V5, P112; Turchin P, 2009, ANN NY ACAD SCI, V1162, P1, DOI 10.1111/j.1749-6632.2009.04447.x; USHER D, 1989, AM ECON REV, V79, P1031; Weeks B, 2004, P COMPL SYST SUMM SC	42	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75433	10.1371/journal.pone.0075433	http://dx.doi.org/10.1371/journal.pone.0075433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086530	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700086
J	Morris, VA; Zhang, AL; Yang, TM; Stirewalt, DL; Ramamurthy, R; Meshinchi, S; Oehler, VG				Morris, Valerie A.; Zhang, Ailin; Yang, Taimei; Stirewalt, Derek L.; Ramamurthy, Ranjani; Meshinchi, Soheil; Oehler, Vivian G.			MicroRNA-150 Expression Induces Myeloid Differentiation of Human Acute Leukemia Cells and Normal Hematopoietic Progenitors	PLOS ONE			English	Article							C-MYB; GRANULOCYTIC DIFFERENTIATION; TRANSCRIPTION FACTORS; MYELOGENOUS LEUKEMIA; GENE-EXPRESSION; DOWN-REGULATION; LINE; MIR-150; ESTABLISHMENT; ALPHA	In acute myeloid leukemia (AML) and blast crisis (BC) chronic myeloid leukemia (CML) normal differentiation is impaired. Differentiation of immature stem/progenitor cells is critical for normal blood cell function. MicroRNAs (miRNAs or miRs) are small non-coding RNAs that interfere with gene expression by degrading messenger RNAs (mRNAs) or blocking protein translation. Aberrant miRNA expression is a feature of leukemia and miRNAs also play a significant role in normal hematopoiesis and differentiation. We have identified miRNAs differentially expressed in AML and BC CML and identified a new role for miR-150 in myeloid differentiation. Expression of miR-150 is low or absent in BC CML and AML patient samples and cell lines. We have found that expression of miR-150 in AML cell lines, CD34+ progenitor cells from healthy individuals, and primary BC CML and AML patient samples at levels similar to miR-150 expression in normal bone marrow promotes myeloid differentiation of these cells. MYB is a direct target of miR-150, and we have identified that the observed phenotype is partially mediated by MYB. In AML cell lines, differentiation of miR-150 expressing cells occurs independently of retinoic acid receptor a (RARA) signaling. High-throughput gene expression profiling (GEP) studies of the AML cell lines HL60, PL21, and THP-1 suggest that activation of CEPBA, CEBPE, and cytokines associated with myeloid differentiation in miR-150 expressing cells as compared to control cells contributes to myeloid differentiation. These data suggest that miR-150 promotes myeloid differentiation, a previously uncharacterized role for this miRNA, and that absent or low miR-150 expression contributes to blocked myeloid differentiation in acute leukemia cells.	[Morris, Valerie A.; Zhang, Ailin; Yang, Taimei; Stirewalt, Derek L.; Meshinchi, Soheil; Oehler, Vivian G.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Morris, Valerie A.; Oehler, Vivian G.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Ramamurthy, Ranjani] Univ Washington, Dept Med, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Oehler, VG (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	voehler@u.washington.edu		zhang, ailin/0000-0001-9598-3772; Morris, Valerie/0000-0002-0355-7379	National Institute of Health [R01 CA140371]; American Society of Hematology (Scholar Award); Institute of Translational Health Sciences, University of Washington [2UL1TR000423]; Hope Foundation (SWOG Development Award) [T32 HL 7093-36)]; NATIONAL CANCER INSTITUTE [R01CA140371] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000423] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology (Scholar Award); Institute of Translational Health Sciences, University of Washington; Hope Foundation (SWOG Development Award); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by grants from the National Institute of Health (R01 CA140371), the American Society of Hematology (Scholar Award (www. ash. org)), the Institute of Translational Health Sciences, University of Washington (2UL1TR000423), and the Hope Foundation (SWOG Development Award) [VGO]; a NIH Hematology Training Grant (2 T32 HL 7093-36) [VAM]; and by resources from and use of facilities at the Fred Hutchinson Cancer Research Center, Seattle, Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Alemdehy MF, 2012, BLOOD, V119, P4723, DOI 10.1182/blood-2011-10-386359; APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; Bedi R, 2009, BLOOD, V113, P317, DOI 10.1182/blood-2008-02-139741; Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Bianchi E, 2010, BLOOD, V116, pE99, DOI 10.1182/blood-2009-08-238311; Bissels U., 2011, HAEMATOLOGICA, V97, P160, DOI [DOI 10.3324/HAEMAT0L.2011.051730.PUBMED:22058204, 10.3324/haematol.2011.051730]; Breccia M, 2012, EXPERT OPIN PHARMACO, V13, P1031, DOI 10.1517/14656566.2012.677436; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; De Marchis ML, 2009, LEUKEMIA, V23, P856, DOI 10.1038/leu.2008.372; Delgado MD, 2013, CLIN TRANSL ONCOL, V15, P87, DOI 10.1007/s12094-012-0926-8; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; El Gazzar M, 2012, IMMUNOL CELL BIOL, V90, P587, DOI 10.1038/icb.2011.74; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; FERRARI S, 1990, CELL GROWTH DIFFER, V1, P543; Gao SM, 2011, LEUKEMIA LYMPHOMA, V52, P2365, DOI 10.3109/10428194.2011.601476; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Ghani S, 2011, BLOOD, V118, P2275, DOI 10.1182/blood-2011-02-335141; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Halene S, 2010, EXP HEMATOL, V38, P90, DOI 10.1016/j.exphem.2009.11.004; Huang XQ, 2011, BLOOD, V117, P2157, DOI 10.1182/blood-2010-08-302711; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kaplan IM, 2011, J IMMUNOL, V186, P2826, DOI 10.4049/jimmunol.1002806; KOEFFLER HP, 1978, SCIENCE, V200, P1153, DOI 10.1126/science.306682; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105; KUBONISHI I, 1984, BLOOD, V63, P254; Kuchenbauer F, 2011, BLOOD, V118, P3350, DOI 10.1182/blood-2010-10-312454; LANGE B, 1987, BLOOD, V70, P192; LANOTTE M, 1991, BLOOD, V77, P1080; Laslo P, 2008, SEMIN IMMUNOL, V20, P228, DOI 10.1016/j.smim.2008.08.003; Li YH, 2013, BLOOD, V121, P499, DOI 10.1182/blood-2012-07-444729; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Li ZJ, 2012, BLOOD, V119, P2314, DOI 10.1182/blood-2011-10-386235; Lidonnici MR, 2008, BLOOD, V111, P4771, DOI 10.1182/blood-2007-08-105072; LIEBERMANN DA, 1994, STEM CELLS, V12, P352, DOI 10.1002/stem.5530120402; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Machova Polakova K, 2011, MOL CANCER, V10, P41, DOI DOI 10.1186/1476-4598-10-41; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; Oehler VG, 2009, BLOOD, V114, P3299, DOI 10.1182/blood-2008-07-170282; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Petriv OI, 2010, P NATL ACAD SCI USA, V107, P15443, DOI 10.1073/pnas.1009320107; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Sanz MA, 2011, J CLIN ONCOL, V29, P495, DOI 10.1200/JCO.2010.32.1067; SEIGNEURIN D, 1987, EXP HEMATOL, V15, P822; Senyuk V, 2013, P NATL ACAD SCI USA, V110, P5594, DOI 10.1073/pnas.1302645110; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Tabe Y, 2012, PPAR RES, V2012, DOI 10.1155/2012/483656; Tano N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023114; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Walz C, 2012, BLOOD, V119, P3550, DOI 10.1182/blood-2011-12-397554; Wang XS, 2012, BLOOD, V119, P4992, DOI 10.1182/blood-2011-10-385716; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104; Zuber J, 2011, GENE DEV, V25, P1628, DOI 10.1101/gad.17269211	73	47	50	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75815	10.1371/journal.pone.0075815	http://dx.doi.org/10.1371/journal.pone.0075815			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086639	Green Submitted, gold, Green Published			2022-12-25	WOS:000325025200064
J	Avanzino, L; Pelosin, E; Martino, D; Abbruzzese, G				Avanzino, Laura; Pelosin, Elisa; Martino, Davide; Abbruzzese, Giovanni			Motor Timing Deficits in Sequential Movements in Parkinson Disease Are Related to Action Planning: A Motor Imagery Study	PLOS ONE			English	Article							MENTAL REPRESENTATION; TIME REPRODUCTION; NEURAL-NETWORKS; MODULATION; FACILITATION; DISSOCIATION; CEREBELLUM; INTERVALS; ROTATION; DECLINE	Timing of sequential movements is altered in Parkinson disease (PD). Whether timing deficits in internally generated sequential movements in PD depends also on difficulties in motor planning, rather than merely on a defective ability to materially perform the planned movement is still undefined. To unveil this issue, we adopted a modified version of an established test for motor timing, i.e. the synchronization-continuation paradigm, by introducing a motor imagery task. Motor imagery is thought to involve mainly processes of movement preparation, with reduced involvement of end-stage movement execution-related processes. Fourteen patients with PD and twelve matched healthy volunteers were asked to tap in synchrony with a metronome cue (SYNC) and then, when the tone stopped, to keep tapping, trying to maintain the same rhythm (CONT-EXE) or to imagine tapping at the same rhythm, rather than actually performing it (CONT-MI). We tested both a sub-second and a supra-second inter-stimulus interval between the cues. Performance was recorded using a sensor-engineered glove and analyzed measuring the temporal error and the interval reproduction accuracy index. PD patients were less accurate than healthy subjects in the supra-second time reproduction task when performing both continuation tasks (CONT-MI and CONT-EXE), whereas no difference was detected in the synchronization task and on all tasks involving a sub-second interval. Our findings suggest that PD patients exhibit a selective deficit in motor timing for sequential movements that are separated by a supra-second interval and that this deficit may be explained by a defect of motor planning. Further, we propose that difficulties in motor planning are of a sufficient degree of severity in PD to affect also the motor performance in the supra-second time reproduction task.	[Avanzino, Laura] Univ Genoa, Dept Expt Med, Sect Human Physiol, Genoa, Italy; [Avanzino, Laura] Univ Genoa, Ctr Polifunz Sci Motorie, Genoa, Italy; [Pelosin, Elisa; Abbruzzese, Giovanni] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy; [Martino, Davide] South London NHS Trust, Queen Elizabeth Hosp, London, England; [Martino, Davide] Kings Coll Hosp London, London, England; [Martino, Davide] Queen Mary Univ London, Ctr Neurosci & Trauma, London, England	University of Genoa; University of Genoa; University of Genoa; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; Queen Mary University London	Avanzino, L (corresponding author), Univ Genoa, Dept Expt Med, Sect Human Physiol, Genoa, Italy.	lavanzino76@gmail.com	Avanzino, Laura/K-6623-2016; Pelosin, Elisa/AAA-9637-2019	Pelosin, Elisa/0000-0002-9880-2241; AVANZINO, LAURA/0000-0001-6286-1509				Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; Battaglia F, 2006, CLIN NEUROPHYSIOL, V117, P1009, DOI 10.1016/j.clinph.2006.01.008; Buch ER, 2012, BRAIN, V135, P596, DOI 10.1093/brain/awr331; Crammond DJ, 1997, TRENDS NEUROSCI, V20, P54, DOI 10.1016/S0166-2236(96)30019-2; Cunnington R, 1997, BRAIN, V120, P1339, DOI 10.1093/brain/120.8.1339; Decety J, 1996, BEHAV BRAIN RES, V72, P127; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Deiber MP, 1998, NEUROIMAGE, V7, P73, DOI 10.1006/nimg.1997.0314; Elsinger CL, 2003, J INT NEUROPSYCH SOC, V9, P1088, DOI 10.1017/S1355617703970123; Fourkas AD, 2008, CEREB CORTEX, V18, P2382, DOI 10.1093/cercor/bhn005; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Gonzalez B, 2005, BEHAV NEUROSCI, V119, P622, DOI 10.1037/0735-7044.119.2.622; Harrington DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017461; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Helmich RC, 2007, NEUROPSYCHOLOGIA, V45, P2201, DOI 10.1016/j.neuropsychologia.2007.02.024; Helmich RC, 2012, HUM BRAIN MAPP, V33, P1763, DOI 10.1002/hbm.21318; Heremans E, 2012, NEUROREHAB NEURAL RE, V26, P27, DOI 10.1177/1545968311411055; Heremans E, 2009, BRAIN RES, V1278, P50, DOI 10.1016/j.brainres.2009.04.041; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; HUSAROVA I, J NEUROIMAGING; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; Jahanshahi M, 2010, BRAIN, V133, P727, DOI 10.1093/brain/awq012; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P51, DOI 10.1016/S0926-6410(00)00022-7; Jones CRG, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00081; Kasess CH, 2008, NEUROIMAGE, V40, P828, DOI 10.1016/j.neuroimage.2007.11.040; Koch G, 2008, NEUROPSYCHOLOGIA, V46, P1305, DOI 10.1016/j.neuropsychologia.2007.12.005; Koch G, 2009, PHILOS T R SOC B, V364, P1907, DOI 10.1098/rstb.2009.0018; Konczak J, 2012, BRAIN, V135, P3371, DOI 10.1093/brain/aws265; Kuhn AA, 2006, BRAIN, V129, P695, DOI 10.1093/brain/awh715; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Madan CR, 2012, COGN PROCESS, V13, P211, DOI 10.1007/s10339-012-0438-z; McAuley JD, 2006, J EXP PSYCHOL GEN, V135, P348, DOI 10.1037/0096-3445.135.3.348; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Michelon P, 2006, J NEUROPHYSIOL, V95, P811, DOI 10.1152/jn.00488.2005; Nair DG, 2003, COGNITIVE BRAIN RES, V15, P250, DOI 10.1016/S0926-6410(02)00197-0; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parsons LM, 2001, ACTA PSYCHOL, V107, P155, DOI 10.1016/S0001-6918(01)00023-3; PASTOR MA, 1992, BRAIN, V115, P211, DOI 10.1093/brain/115.1.211; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; Personnier P, 2010, NEUROSCI LETT, V476, P146, DOI 10.1016/j.neulet.2010.04.017; Petit LS, 2003, BRAIN COGNITION, V51, P95, DOI 10.1016/S0278-2626(02)00526-2; Rochester L, 2009, MOVEMENT DISORD, V24, P839, DOI 10.1002/mds.22400; ROSENBAUM DA, 1993, J MOTOR BEHAV, V25, P217, DOI 10.1080/00222895.1993.9942051; Saimpont A, 2013, J MOTOR BEHAV, V45, P21, DOI 10.1080/00222895.2012.740098; Samuel M, 2001, NEUROREPORT, V12, P821, DOI 10.1097/00001756-200103260-00040; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Skoura X, 2008, CORTEX, V44, P1271, DOI 10.1016/j.cortex.2007.07.008; Spencer RMC, 2005, BRAIN COGNITION, V58, P84, DOI 10.1016/j.bandc.2004.09.010; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Szameitat AJ, 2007, NEUROIMAGE, V34, P702, DOI 10.1016/j.neuroimage.2006.09.033; Thobois S, 2000, NEUROLOGY, V55, P996, DOI 10.1212/WNL.55.7.996; Torta DME, 2010, J NEUROL, V257, P1356, DOI 10.1007/s00415-010-5532-5; Tremblay F, 2008, EXP BRAIN RES, V185, P249, DOI 10.1007/s00221-007-1150-6; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3	63	19	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75454	10.1371/journal.pone.0075454	http://dx.doi.org/10.1371/journal.pone.0075454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086534	Green Submitted, Green Published, gold			2022-12-25	WOS:000326520200102
J	Hayoz, S; Cubano, L; Maldonado, H; Bychkov, R				Hayoz, Sebastien; Cubano, Luis; Maldonado, Hector; Bychkov, Rostislav			Protein Kinase A and C Regulate Leak Potassium Currents in Freshly Isolated Vascular Myocytes from the Aorta	PLOS ONE			English	Article							SMOOTH-MUSCLE; ARTERIAL STIFFNESS; CHANNEL DIVERSITY; K+ CURRENT; FUNCTIONAL-CHARACTERISTICS; DEPENDENT ACTIVATION; INDUCED VASODILATION; PULSE PRESSURE; CAMP ANALOGS; INHIBITION	We tested the hypothesis that protein kinase A (PKA) inhibits K2P currents activated by protein kinase C (PKC) in freshly isolated aortic myocytes. PDBu, the PKC agonist, applied extracellularly, increased the amplitude of the K2P currents in the presence of the "cocktail'' of K+ channel blockers. Go 6976 significantly reduced the increase of the K2P currents by PDBu suggesting the involvement of either alpha or beta isoenzymes of PKC. We found that forskolin, or membrane permeable cAMP, did not inhibit K2P currents activated by the PKC. However, when PKA agonists were added prior to PDBu, they produced a strong decrease in the K2P current amplitudes activated by PKC. Inhibition of PDBu-elicited K2P currents by cAMP agonists was not prevented by the treatment of vascular smooth muscle cells with PKA antagonists (H-89 and Rp-cAMPs). Zn2+ and Hg2+ inhibited K2P currents in one population of cells, produced biphasic responses in another population, and increased the amplitude of the PDBu-elicited K+ currents in a third population of myocytes, suggesting expression of several K2P channel types. We found that cAMP agonists inhibited biphasic responses and increase of amplitude of the PDBu-elicited K2P currents produced by Zn2+ and Hg-2. 6-Bnz-cAMp produced a significantly altered pH sensitivity of PDBu-elicited K2P-currents, suggesting the inhibition of alkaline-activated K2P-currents. These results indicate that 6-Bnz-cAMP and other cAMP analogs may inhibit K2P currents through a PKA-independent mechanism. cAMP analogs may interact with unidentified proteins involved in K2P channel regulation. This novel cellular mechanism could provide insights into the interplay between PKC and PKA pathways that regulate vascular tone.	[Hayoz, Sebastien] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; [Hayoz, Sebastien; Cubano, Luis; Maldonado, Hector; Bychkov, Rostislav] Univ Cent Caribe, Dept Pharmacol, Bayamon, PR USA	Michigan State University	Bychkov, R (corresponding author), Univ Cent Caribe, Dept Pharmacol, Bayamon, PR USA.	rostislav.bychkov@uccaribe.edu		Maldonado, Hector/0000-0003-4585-3165	National Institutes of Health [SC2 NHLBI (HL107237)]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC2HL107237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the grant SC2 NHLBI (HL107237) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello EA, 1996, AM J PHYSIOL-HEART C, V271, pH109, DOI 10.1152/ajpheart.1996.271.1.H109; Barman SA, 2004, AM J PHYSIOL-LUNG C, V286, pL149, DOI 10.1152/ajplung.00207.2003; Berg AP, 2007, J NEUROPHYSIOL, V97, P1546, DOI 10.1152/jn.01090.2006; Besana A, 2004, J BIOL CHEM, V279, P33154, DOI 10.1074/jbc.M403525200; Blondeau N, 2007, CIRC RES, V101, P176, DOI 10.1161/CIRCRESAHA.107.154443; Bockenhauer D, 2001, NAT NEUROSCI, V4, P486, DOI 10.1038/87434; Boland LM, 1999, AM J PHYSIOL-CELL PH, V277, pC100, DOI 10.1152/ajpcell.1999.277.1.C100; Bonnet S, 2007, PHARMACOL THERAPEUT, V115, P56, DOI 10.1016/j.pharmthera.2007.03.014; Buckler KJ, 2010, ADV EXP MED BIOL, V661, P15, DOI 10.1007/978-1-60761-500-2_2; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Bychkov R, 1998, J PHARMACOL EXP THER, V285, P293; Chae YJ, 2010, ANESTHESIOLOGY, V113, P1326, DOI 10.1097/ALN.0b013e3181f90ca5; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; CLARK JM, 1985, ARTERIOSCLEROSIS, V5, P19, DOI 10.1161/01.ATV.5.1.19; Clarke CE, 2008, J BIOL CHEM, V283, P16985, DOI 10.1074/jbc.M801368200; Czirjak G, 2006, MOL PHARMACOL, V69, P1024, DOI 10.1124/mol.105.018556; Czirjak G, 2001, AM J PHYSIOL-CELL PH, V281, pC700, DOI 10.1152/ajpcell.2001.281.2.C700; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; Dingemans KP, 2000, ANAT REC, V258, P1; Enyeart JA, 2010, MOL PHARMACOL, V77, P469, DOI 10.1124/mol.109.061861; Enyedi P, 2012, MOL CELL ENDOCRINOL, V353, P75, DOI 10.1016/j.mce.2011.11.009; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Fanchaouy M, 2007, CELL CALCIUM, V41, P41, DOI 10.1016/j.ceca.2006.04.030; Fanchaouy M, 2005, CELL CALCIUM, V37, P25, DOI 10.1016/j.ceca.2004.06.008; Farand P, 2007, MICROVASC RES, V73, P95, DOI 10.1016/j.mvr.2006.10.005; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Fujita T, 2002, J BIOL CHEM, V277, P22191, DOI 10.1074/jbc.M110364200; Garry A, 2007, EMBO REP, V8, P354, DOI 10.1038/sj.embor.7400916; GLASS DB, 1989, J BIOL CHEM, V264, P14579; Gu WL, 2002, J PHYSIOL-LONDON, V539, P657, DOI 10.1113/jphysiol.2001.013432; Gurney A, 2009, EUR BIOPHYS J BIOPHY, V38, P305, DOI 10.1007/s00249-008-0326-8; Hayoz S, 2009, ACTA PHYSIOL, V195, P247, DOI 10.1111/j.1748-1716.2008.01884.x; Hayoz S, 2007, AM J PHYSIOL-CELL PH, V292, pC1502, DOI 10.1152/ajpcell.00522.2006; HIDAKA H, 1991, METHOD ENZYMOL, V201, P328; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Hwang SJ, 2008, J PHYSIOL-LONDON, V586, P1169, DOI 10.1113/jphysiol.2007.148718; Iacovelli L, 2001, MOL PHARMACOL, V60, P924, DOI 10.1124/mol.60.5.924; Ivins JK, 2004, J NEUROSCI, V24, P1212, DOI 10.1523/JNEUROSCI.4689-03.2004; Kang DW, 2006, AM J PHYSIOL-CELL PH, V291, pC649, DOI 10.1152/ajpcell.00047.2006; Keshavaprasad B, 2005, ANESTH ANALG, V101, P1042, DOI 10.1213/01.ane.0000168447.87557.5a; Kim JS, 2005, J PHARMACOL EXP THER, V314, P618, DOI 10.1124/jpet.105.084418; Lindner M, 2011, J PHYSIOL-LONDON, V589, P3149, DOI 10.1113/jphysiol.2011.208983; Liu HY, 2008, J GEN PHYSIOL, V132, P279, DOI 10.1085/jgp.200810003; Lloyd EE, 2009, EXP BIOL MED, V234, P1493, DOI 10.3181/0903-RM-110; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; Michelakis ED, 1997, CAN J PHYSIOL PHARM, V75, P889, DOI 10.1139/cjpp-75-7-889; Murbartian J, 2005, J BIOL CHEM, V280, P30175, DOI 10.1074/jbc.M503862200; Namiranian K, 2010, AM J PHYSIOL-REG I, V299, pR461, DOI 10.1152/ajpregu.00057.2010; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Nilius B, 2012, TRENDS NEUROSCI, V35, P477, DOI 10.1016/j.tins.2012.04.002; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Olschewski A, 2006, CIRC RES, V98, P1072, DOI 10.1161/01.RES.0000219677.12988.e9; Poels MMF, 2012, STROKE, V43, P2637, DOI 10.1161/STROKEAHA.111.642264; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Purves GI, 2009, J PHYSIOL-LONDON, V587, P3639, DOI 10.1113/jphysiol.2009.173534; Rabkin SW, 2012, J ALZHEIMERS DIS, V32, P541, DOI 10.3233/JAD-2012-120757; Rahm AK, 2012, BRIT J PHARMACOL, V166, P764, DOI 10.1111/j.1476-5381.2011.01813.x; Sabbadini M, 2009, J MOL BIOL, V385, P1331, DOI 10.1016/j.jmb.2008.11.048; Safar ME, 2012, CURR HYPERTENS REP, V14, P339, DOI 10.1007/s11906-012-0272-9; Salamanca DA, 2005, BIOCHEM PHARMACOL, V70, P1537, DOI 10.1016/j.bcp.2005.07.017; Schubert R, 1999, AM J PHYSIOL-CELL PH, V276, pC648, DOI 10.1152/ajpcell.1999.276.3.C648; Serir K, 2006, BRIT J PHARMACOL, V147, P45, DOI 10.1038/sj.bjp.0706432; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Veale EL, 2007, MOL PHARMACOL, V71, P1666, DOI 10.1124/mol.106.033241; Vega-Saenz de Miera E, 2001, J NEUROPHYSIOL, V86, P130, DOI 10.1152/jn.2001.86.1.130; Xu FL, 2007, J NEUROCHEM, V101, P1284, DOI 10.1111/j.1471-4159.2007.04468.x	70	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75077	10.1371/journal.pone.0075077	http://dx.doi.org/10.1371/journal.pone.0075077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086441	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200079
J	Im-Aram, A; Farrand, L; Bae, SM; Song, G; Song, YS; Han, JY; Tsang, BK				Im-aram, Akechai; Farrand, Lee; Bae, Seung-Min; Song, Gwonhwa; Song, Yong Sang; Han, Jae Yong; Tsang, Benjamin K.			The mTORC2 Component Rictor Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells	PLOS ONE			English	Article							X-LINKED INHIBITOR; AKT PHOSPHORYLATION; DOWN-REGULATION; COMPLEX 2; P53; APOPTOSIS; PATHWAY; CHEMORESISTANCE; UBIQUITINATION; PKC	Resistance to cisplatin-based therapy is a major cause of treatment failure in human ovarian cancer. A better understanding of the mechanisms of cisplatin resistance will offer new insights for novel therapeutic strategies for this deadly disease. Akt and p53 are determinants of cisplatin sensitivity. Rictor is a component of mTOR protein kinase complex 2, which is required for Akt phosphorylation (Ser473) and full activation. However, the precise role of rictor and the relationship between rictor and p53 in cisplatin resistance remains poorly understood. Here, using sensitive wild-type p53 (OV2008 and A2780s), resistant wild-type p53 (C13* and OVCAR433), and p53 compromised (A2780cp, OCC1, and SKOV-3) ovarian cancer cells, we have demonstrated that (i) rictor is a determinant of cisplatin resistance in chemosensitive human ovarian cancer cells; (ii) cisplatin down-regulates rictor content by caspase-3 cleavage and proteasomal degradation; (iii) rictor down-regulation sensitizes chemo-resistant ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner; (iv) rictor suppresses cisplatin-induced apoptosis and confers resistance by activating and stabilizing Akt. These findings extend current knowledge on the molecular and cellular basis of cisplatin resistance and provide a rationale basis for rictor as a potential therapeutic target for chemo-resistant ovarian cancer.	[Im-aram, Akechai; Farrand, Lee; Bae, Seung-Min; Song, Gwonhwa; Song, Yong Sang; Han, Jae Yong; Tsang, Benjamin K.] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, World Class Univ Biomodulat Major, Seoul, South Korea; [Tsang, Benjamin K.] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada; [Tsang, Benjamin K.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Tsang, Benjamin K.] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Tsang, Benjamin K.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON, Canada	Seoul National University (SNU); University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Tsang, BK (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, World Class Univ Biomodulat Major, Seoul, South Korea.	btsang@ohri.ca	Song, Gwonhwa/H-3647-2015; gwonhwa, song/H-3208-2015	Tsang, Benjamin K./0000-0003-1213-3946; SONG, YONGSANG/0000-0001-7115-4021	World Class University (WCU) program through the Ministry of Education, Science and Technology; National Research Foundation of Korea [R31-10056]; Canadian Institutes of Health Research [M0P-126144]	World Class University (WCU) program through the Ministry of Education, Science and Technology; National Research Foundation of Korea(National Research Foundation of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the World Class University (WCU) program through the Ministry of Education, Science and Technology and funded by the National Research Foundation of Korea (R31-10056) and by the Canadian Institutes of Health Research (M0P-126144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2008, CANCER RES, V68, P4511, DOI 10.1158/0008-5472.CAN-08-0673; Abedini MR, 2004, ONCOGENE, V23, P6997, DOI 10.1038/sj.onc.1207925; Ali AY, 2011, ONCOGENE, V29, P1; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Back JH, 2012, PHOTOCHEM PHOTOBIOL, V88, P1165, DOI 10.1111/j.1751-1097.2012.01097.x; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Fraser M, 2006, ONCOGENE, V25, P2203, DOI 10.1038/sj.onc.1209251; Fraser M, 2003, CANCER RES, V63, P7081; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Fu L, 2009, CANCER RES, V69, P8967, DOI 10.1158/0008-5472.CAN-09-2190; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Guppy AE, 2005, CLIN ONCOL-UK, V17, P399, DOI 10.1016/j.clon.2005.05.009; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hietakangas V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-282; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Kmet LM, 2003, CANCER, V97, P389, DOI 10.1002/cncr.11064; Li H, 2012, BREAST CANC RES TR, V2, P1; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Moll UM, 2003, MOL CANCER RES, V1, P1001; No JH, 2011, GYNECOL ONCOL, V121, P8, DOI 10.1016/j.ygyno.2010.12.364; Peng DJ, 2010, BIOCHEM BIOPH RES CO, V394, P600, DOI 10.1016/j.bbrc.2010.03.029; Perego P, 2003, INT J CANCER, V105, P617, DOI 10.1002/ijc.11140; Roulin D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-57; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sasaki H, 2000, CANCER RES, V60, P5659; Schuijer M, 2003, HUM MUTAT, V21, P285, DOI 10.1002/humu.10181; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Woo MG, 2012, J BIOL CHEM, V287, P3963, DOI 10.1074/jbc.M111.314765; Wu YT, 2011, J BIOL CHEM, V286, P14190, DOI 10.1074/jbc.M111.219923; Yang X, 2008, BRIT J CANCER, V98, P803, DOI 10.1038/sj.bjc.6604223; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Zhang F, 2010, CANCER RES, V70, P9360, DOI 10.1158/0008-5472.CAN-10-0207; Zhang HY, 2009, EUR J OBSTET GYN R B, V146, P81, DOI 10.1016/j.ejogrb.2009.04.035	44	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75455	10.1371/journal.pone.0075455	http://dx.doi.org/10.1371/journal.pone.0075455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086535	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200103
J	Mi, RS; Wang, XJ; Li, CH; Huang, Y; Zhou, P; Li, ZF; Lei, MT; Cai, JZ; Chen, ZG				Mi, Rongsheng; Wang, Xiaojuan; Li, Chunhua; Huang, Yan; Zhou, Peng; Li, Zhengfeng; Lei, Mengtong; Cai, Jinzhong; Chen, Zhaoguo			Prevalence and Genetic Characterization of Cryptosporidium in Yaks in Qinghai Province of China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; DAIRY CALVES; SUBTYPE ANALYSIS; SUBGENOTYPE ANALYSIS; CATTLE; HUMANS; PARVUM; GIARDIA; SPP.; GENOTYPES	The objective of this study was to determine the prevalence, species and subtypes of Cryptosporidium infecting yaks in the Qinghai Province of Northwestern China. The prevalence of Cryptosporidium spp. was detected by microscopy and nested-PCR. A total of 586 fecal samples were collected from yaks in 6 counties, of which 142 (24.2%) samples tested positive for Cryptosporidium. The small subunit (SSU) rRNA gene of fifty-five samples were amplified and sequenced successfully and demonstrated that Cryptosporidium bovis (31/55, 56.4%) was the most common species, followed by C. parvum (16/55, 29.1%) and C. ryanae (5/55, 9.0%). Mixed infections of C. parvum and C. bovis (n = 2), C. ryanae and C. bovis (n = 1) were also detected. All three species were found in yaks ranging in age from <1 year, 1-2 years, to >2 years. Cryptosporidium was most commonly detected in spring (28.4%), followed by summer (20.9%), then winter (17.5%). Cryptosporidium parvum positive samples were subtyped using the 60 kDa glycoprotein (gp60) gene. Subtypes IIaA15G2R1 (n = 8), IIaA16G2R1 (n = 2), IIaA14G1R1 (n = 1), IIaA14G2R1 (n = 1) and IIaA16G3R1 (n = 1) were detected. All of these subtypes are zoonotic, and may pose a potential threat to human health.	[Mi, Rongsheng; Wang, Xiaojuan; Huang, Yan; Zhou, Peng; Li, Zhengfeng; Chen, Zhaoguo] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Minist Agr, Key Lab Anim Parasitol, Shanghai, Peoples R China; [Li, Chunhua; Lei, Mengtong; Cai, Jinzhong] Qinghai Acad Anim & Vet Sci, Vet Res Inst, Lab Plateau Vet Parasitol, Xining, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Qinghai University	Cai, JZ (corresponding author), Qinghai Acad Anim & Vet Sci, Vet Res Inst, Lab Plateau Vet Parasitol, Xining, Peoples R China.	caijinz@vip.sina.com; zhaoguochen@shvri.ac.cn			National S & T Major Program [2012ZX10004220-008]; Shanghai Municipal Agriculture Commission [2005-3-4]; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China [2012JB16, 2013JB13]	National S & T Major Program; Shanghai Municipal Agriculture Commission; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China	This study was supported in part by National S & T Major Program (Grant No. 2012ZX10004220-008), Shanghai Municipal Agriculture Commission (Grant No. 2005-3-4) and Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China (Grant Nos. 2012JB16 and 2013JB13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2006, PARASITOL RES, V99, P303, DOI 10.1007/s00436-006-0140-0; Almawly J, 2013, VET PARASITOL; Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; Amer S, 2013, VET PARASITOL, V191, P123, DOI 10.1016/j.vetpar.2012.08.015; Bornay-Llinares FJ, 1999, APPL ENVIRON MICROB, V65, P1455; Brook EJ, 2009, VET J, V179, P378, DOI 10.1016/j.tvjl.2007.10.023; Budu-Amoako E, 2012, VET PARASITOL, V184, P1, DOI 10.1016/j.vetpar.2011.10.027; Chen ZG, 2011, VET PARASITOL, V181, P113, DOI 10.1016/j.vetpar.2011.04.037; Dou C, 2007, ANIM HUSBANDRY FEED, P14; Fayer R, 2006, VET PARASITOL, V135, P105, DOI 10.1016/j.vetpar.2005.08.003; Fayer R, 2007, VET PARASITOL, V145, P260, DOI 10.1016/j.vetpar.2006.12.009; Fayer R, 2010, VET PARASITOL, V170, P187, DOI 10.1016/j.vetpar.2010.02.040; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; Feng YY, 2012, VET PARASITOL, V185, P309, DOI 10.1016/j.vetpar.2011.09.025; Follet J, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-116; Geurden T, 2007, PARASITOLOGY, V134, P1981, DOI 10.1017/S0031182007003460; Hamnes IS, 2006, VET PARASITOL, V140, P204, DOI 10.1016/j.vetpar.2006.03.024; Helmy YA, 2013, VET PARASITOL, V193, P15, DOI 10.1016/j.vetpar.2012.12.015; Herges GR, 2012, APPL ENVIRON MICROB, V78, P8096, DOI 10.1128/AEM.02105-12; Ikarashi M, 2013, VET PARASITOL; Imre K, 2011, VET PARASITOL, V181, P321, DOI 10.1016/j.vetpar.2011.04.042; Jex AR, 2008, ELECTROPHORESIS, V29, P4119, DOI 10.1002/elps.200800422; Kang'ethe EK, 2012, TROP ANIM HEALTH PRO, V44, pS25, DOI 10.1007/s11250-012-0202-5; Karanis P, 2007, PARASITOL RES, V101, P1575, DOI 10.1007/s00436-007-0681-x; King BJ, 2007, PARASITOLOGY, V134, P309, DOI 10.1017/S0031182006001491; Kvac M, 2011, VET PARASITOL, V177, P378, DOI 10.1016/j.vetpar.2010.11.048; Langkjaer RB, 2007, PARASITOLOGY, V134, P339, DOI 10.1017/S0031182006001533; Learmonth JJ, 2003, WATER SCI TECHNOL, V47, P21, DOI 10.2166/wst.2003.0150; Liu AQ, 2009, PARASITOL RES, V105, P797, DOI 10.1007/s00436-009-1457-2; Long RJ, 1999, PREV VET MED, V38, P195, DOI 10.1016/S0167-5877(98)00125-1; Ma L, 2011, ACTA ECOL ANIM DOMAS, V32, P47; Maikai BV, 2011, VET PARASITOL, V178, P241, DOI 10.1016/j.vetpar.2010.12.048; Murakoshi F, 2013, J VET MED SCI; Murakoshi F, 2012, VET PARASITOL, V187, P123, DOI 10.1016/j.vetpar.2011.12.011; Nazemalhosseini-Mojarad E, 2011, VET PARASITOL, V179, P250, DOI 10.1016/j.vetpar.2011.01.051; Nydam DV, 2002, PARASITOL RES, V88, P797, DOI 10.1007/s00436-002-0665-9; Peng MM, 2003, PARASITOL RES, V90, P175, DOI 10.1007/s00436-003-0834-5; Quilez J, 2008, PARASITOLOGY, V135, P1613, DOI 10.1017/S0031182008005088; Rieux A, 2012, VET PARASITOL; Rossignol JF, 2010, EXP PARASITOL, V124, P45, DOI 10.1016/j.exppara.2009.07.005; Nguyen ST, 2012, PARASITOL RES, V111, P1817, DOI 10.1007/s00436-012-3038-z; Santin M, 2004, VET PARASITOL, V122, P103, DOI 10.1016/j.vetpar.2004.03.020; Silva C. A. T., 2012, EPIDEMIOL INFECT, P1; Silverlas C, 2013, INT J PARASITOL, V43, P155, DOI 10.1016/j.ijpara.2012.10.009; Silverlas C, 2010, VET PARASITOL, V169, P289, DOI 10.1016/j.vetpar.2010.01.003; Smith HV, 2005, VET REC, V156, P710, DOI 10.1136/vr.156.22.710; Soba B, 2008, PARASITOLOGY, V135, P1263, DOI 10.1017/S0031182008004800; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Sun WC, 2011, B ENVIRON CONTAM TOX, V86, P653, DOI 10.1007/s00128-011-0282-3; Szonyi B, 2010, PARASITOL RES, V107, P317, DOI 10.1007/s00436-010-1864-4; Trotz-Williams LA, 2006, PARASITOL RES, V99, P346, DOI 10.1007/s00436-006-0157-4; Wang RJ, 2011, PARASITOL INT, V60, P1, DOI 10.1016/j.parint.2010.09.002; Wang RJ, 2011, J CLIN MICROBIOL, V49, P1077, DOI 10.1128/JCM.02194-10; Wielinga PR, 2008, INT J PARASITOL, V38, P809, DOI 10.1016/j.ijpara.2007.10.014; Xiao LH, 2001, J INFECT DIS, V183, P492, DOI 10.1086/318090; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; Xiao LH, 2007, PARASITOL RES, V100, P701, DOI 10.1007/s00436-006-0337-2; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Xiao LH, 2009, EUKARYOT CELL, V8, P429, DOI 10.1128/EC.00295-08; ZHANG J, 2006, CHIN QINGHAI J ANIM, V36, P16; Zhang WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054857; Zhao GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060112; Zhou Chun-xiang, 2009, Chinese Journal of Zoonoses, V25, P389	64	44	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74985	10.1371/journal.pone.0074985	http://dx.doi.org/10.1371/journal.pone.0074985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086416	gold, Green Published			2022-12-25	WOS:000326520200066
J	Park, JW; Shin, MK; Pitot, HC; Lambert, PF				Park, Jung Wook; Shin, Myeong-Kyun; Pitot, Henry C.; Lambert, Paul F.			High Incidence of HPV-Associated Head and Neck Cancers in FA Deficient Mice Is Associated with E7's Induction of DNA Damage through Its Inactivation of Pocket Proteins	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 E6; SQUAMOUS-CELL CARCINOMAS; FANCONI-ANEMIA; S-PHASE; PATHWAY; GENE; LINK; RB; ONCOPROTEIN; SUPPRESSOR	Fanconi anemia (FA) patients are highly susceptible to solid tumors at multiple anatomical sites including head and neck region. A subset of head and neck cancers (HNCs) is associated with 'high-risk' HPVs, particularly HPV16. However, the correlation between HPV oncogenes and cancers in FA patients is still unclear. We previously learned that FA deficiency in mice predisposes HPV16 E7 transgenic mice to HNCs. To address HPV16 E6's oncogenic potential under FA deficiency in HNCs, we utilized HPV16 E6-transgenic mice (K14E6) and HPV16 E6/E7-bi-transgenic mice (K14E6E7) on genetic backgrounds sufficient or deficient for one of the fanc genes, fancD2 and monitored their susceptibility to HNCs. K14E6 mice failed to develop tumor. However, E6 and fancD2-deficiency accelerated E7-driven tumor development in K14E6E7 mice. The increased tumor incidence was more correlated with E7-driven DNA damage than proliferation. We also found that deficiency of pocket proteins, pRb, p107, and p130 that are well-established targets of E7, could recapitulate E7's induction of DNA damage. Our findings support the hypothesis that E7 induces HPV-associated HNCs by promoting DNA damage through the inactivation of pocket proteins, which explains why a deficiency in DNA damage repair would increase susceptibility to E7-driven cancer. Our results further demonstrate the unexpected finding that FA deficiency does not predispose E6 transgenic mice to HNCs, indicating a specificity in the synergy between FA deficiency and HPV oncogenes in causing HNCs.	[Park, Jung Wook; Shin, Myeong-Kyun; Pitot, Henry C.; Lambert, Paul F.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Lambert, PF (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA.	lambert@oncology.wisc.edu		Park, Jung Wook/0000-0003-4798-9621	National Institutes of Health (NIH) [CA098428, CA022443]; NATIONAL CANCER INSTITUTE [P01CA022443, P30CA014520, R01CA098428] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The source of funding for this work was National Institutes of Health (NIH) (CA098428, CA022443). NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter BP, 2013, INT J CANCER, V133, P1513, DOI 10.1002/ijc.28157; Begum S, 2005, CLIN CANCER RES, V11, P5694, DOI 10.1158/1078-0432.CCR-05-0587; Birkeland AC, 2011, ARCH OTOLARYNGOL, V137, P930, DOI 10.1001/archoto.2011.154; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Duensing S, 2002, CANCER RES, V62, P7075; Duensing S, 2002, ONCOGENE, V21, P6241, DOI 10.1038/sj.onc.1205709; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fernandez-Capetillo O, 2003, CELL CYCLE, V2, P426, DOI 10.4161/cc.2.5.509; Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Hoskins EE, 2008, ONCOGENE, V27, P4798, DOI 10.1038/onc.2008.121; Hoskins EE, 2009, ONCOGENE, V28, P674, DOI 10.1038/onc.2008.416; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Jabbar S, 2010, VIROLOGY, V407, P60, DOI 10.1016/j.virol.2010.08.003; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kutler DI, 2003, J NATL CANCER I, V95, P1718, DOI 10.1093/jnci/djg091; Kutler DI, 2003, ARCH OTOLARYNGOL, V129, P106, DOI 10.1001/archotol.129.1.106; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Lowy DR, 2003, JNCI-J NATL CANCER I, V95, P1648, DOI 10.1093/jnci/djg125; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; Park JW, 2010, CANCER RES, V70, P9959, DOI 10.1158/0008-5472.CAN-10-1291; Pichierri P, 2004, CELL CYCLE, V3, P698; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Riley RR, 2003, CANCER RES, V63, P4862; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Rosenberg PS, 2003, BLOOD, V101, P822, DOI 10.1182/blood-2002-05-1498; Rosenberg PS, 2005, BLOOD, V105, P67, DOI 10.1182/blood-2004-04-1652; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Shai A, 2010, CANCER RES, V70, P5064, DOI 10.1158/0008-5472.CAN-09-3307; Shin MK, 2012, CANCER RES, V72, P5418, DOI 10.1158/0008-5472.CAN-12-2083; Shin MK, 2012, CANCER RES, V72, P1280, DOI 10.1158/0008-5472.CAN-11-2833; Simpson DS, 2009, CANCER RES, V69, P8733, DOI 10.1158/0008-5472.CAN-09-1359; Song SY, 1999, J VIROL, V73, P5887, DOI 10.1128/JVI.73.7.5887-5893.1999; Spardy N, 2007, J VIROL, V81, P13265, DOI 10.1128/JVI.01121-07; Strati K, 2007, CANCER RES, V67, P11585, DOI 10.1158/0008-5472.CAN-07-3007; Strati K, 2006, P NATL ACAD SCI USA, V103, P14152, DOI 10.1073/pnas.0606698103; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Tribius S, 2011, CANCER LETT, V304, P71, DOI 10.1016/j.canlet.2011.02.002; van Zeeburg HJT, 2008, J NATL CANCER I, V100, P1649, DOI 10.1093/jnci/djn366	52	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75056	10.1371/journal.pone.0075056	http://dx.doi.org/10.1371/journal.pone.0075056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086435	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200077
J	Ross, OA; Soto-Ortolaza, AI; Heckman, MG; Verbeeck, C; Serie, DJ; Rayaprolu, S; Rich, SS; Nalls, MA; Singleton, A; Guerreiro, R; Kinsella, E; Wszolek, ZK; Brott, TG; Brown, RD; Worrall, BB; Meschia, JF				Ross, Owen A.; Soto-Ortolaza, Alexandra I.; Heckman, Michael G.; Verbeeck, Christophe; Serie, Daniel J.; Rayaprolu, Sruti; Rich, Stephen S.; Nalls, Michael A.; Singleton, Andrew; Guerreiro, Rita; Kinsella, Emma; Wszolek, Zbigniew K.; Brott, Thomas G.; Brown, Robert D., Jr.; Worrall, Bradford B.; Meschia, James F.			NOTCH3 Variants and Risk of Ischemic Stroke	PLOS ONE			English	Article							CADASIL; MUTATION; ARTERIOPATHY; INFARCTS; GENE	Background: Mutations within the NOTCH3 gene cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). CADASIL mutations appear to be restricted to the first twenty-four exons, resulting in the gain or loss of a cysteine amino acid. The role of other exonic NOTCH3 variation not involving cysteine residues and mutations in exons 25-33 in ischemic stroke remains unresolved. Methods: All 33 exons of NOTCH3 were sequenced in 269 Caucasian probands from the Siblings With Ischemic Stroke Study (SWISS), a 70-center North American affected sibling pair study and 95 healthy Caucasian control subjects. Variants identified by sequencing in the SWISS probands were then tested for association with ischemic stroke using US Caucasian controls collected at the Mayo Clinic (n=654), and further assessed in a Caucasian (n=802) and African American (n=298) patient-control series collected through the Ischemic Stroke Genetics Study (ISGS). Results: Sequencing of the 269 SWISS probands identified one (0.4%) with small vessel type stroke carrying a known CADASIL mutation (p. R558C; Exon 11). Of the 19 common NOTCH3 variants identified, the only variant significantly associated with ischemic stroke after multiple testing adjustment was p. R1560P (rs78501403; Exon 25) in the combined SWISS and ISGS Caucasian series (Odds Ratio [OR] 0.50, P=0.0022) where presence of the minor allele was protective against ischemic stroke. Although only significant prior to adjustment for multiple testing, p.T101T (rs3815188; Exon 3) was associated with an increased risk of small-vessel stroke (OR: 1.56, P=0.008) and p.P380P (rs61749020; Exon 7) was associated with decreased risk of large-vessel stroke (OR: 0.35, P=0.047) in Caucasians. No significant associations were observed in the small African American series. Conclusion: Cysteine-affecting NOTCH3 mutations are rare in patients with typical ischemic stroke, however our observation that common NOTCH3 variants may be associated with risk of ischemic stroke warrants further study.	[Ross, Owen A.; Soto-Ortolaza, Alexandra I.; Verbeeck, Christophe; Rayaprolu, Sruti] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Heckman, Michael G.; Serie, Daniel J.] Mayo Clin, Biostat Sect, Jacksonville, FL 32224 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Gen, Charlottesville, VA USA; [Nalls, Michael A.; Singleton, Andrew; Guerreiro, Rita; Kinsella, Emma] Natl Inst Hlth, Natl Inst Aging, Neurogenet Lab, Bethesda, MD USA; [Guerreiro, Rita] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Guerreiro, Rita] Inst Neurol, Reta Lilla Weston Labs, London WC1N 3BG, England; [Guerreiro, Rita] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Kinsella, Emma] Cardiff Univ, Sch Med, Cardiff, Wales; [Wszolek, Zbigniew K.; Brott, Thomas G.; Meschia, James F.] Mayo Clin, Coll Med, Dept Neurol, Jacksonville, FL 32224 USA; [Brown, Robert D., Jr.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Worrall, Bradford B.] Univ Virginia, Dept Neurol, Charlottesville, VA USA	Mayo Clinic; Mayo Clinic; University of Virginia; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; Universidade de Coimbra; Cardiff University; Mayo Clinic; Mayo Clinic; University of Virginia	Ross, OA (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	ross.owen@mayo.edu	Sander-Effron, Samuel/AAX-2231-2020; Wszolek, Zbigniew K./AAB-1431-2019; Resource Center, NINDS Human Genetics/AGF-2474-2022; Singleton, Andrew B/C-3010-2009; Meschia, James/GPP-1636-2022; Guerreiro, Rita J L/A-1327-2011	Meschia, James/0000-0002-4475-8142; Guerreiro, Rita/0000-0001-5879-3486; Ross, Owen/0000-0003-4813-756X; Rich, Stephen/0000-0003-3872-7793; Rayaprolu, Sruti/0000-0002-5212-3745	James and Ester King Foundation New Investigator Award from the Department of Health, Florida State; American Heart Association (AHA); Myron and Jane Hanley Award in Stroke Research; National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS39987]; Marriott Disease Risk and Regenerative Medicine Initiative Award in Individualized Medicine; NINDS [R01 NS42733]; National Institutes of Health (NIH) /NINDS [P50 NS072187]; Mayo Clinic Center for Regenerative Medicine; Dystonia Medical Research Foundation; Intramural Research Program of the National Institute on Aging, NIH, Department of Health and Human Services [Z01 AG000950-06]; UK Motor Neurone Disease Association [6057]; Wellcome Trust/MRC Joint Call in Neurodegeneration award [WT089698]; UCL/Institute of Neurology; University of Sheffield; MRC Protein Phosphorylation Unit at the University of Dundee; Alzheimer's Research UK; MRC [MC_G1000735] Funding Source: UKRI; Medical Research Council [MC_G1000735] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187, R01NS042733, R01NS039987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000950] Funding Source: NIH RePORTER	James and Ester King Foundation New Investigator Award from the Department of Health, Florida State; American Heart Association (AHA)(American Heart Association); Myron and Jane Hanley Award in Stroke Research; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Marriott Disease Risk and Regenerative Medicine Initiative Award in Individualized Medicine; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NIH) /NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayo Clinic Center for Regenerative Medicine; Dystonia Medical Research Foundation; Intramural Research Program of the National Institute on Aging, NIH, Department of Health and Human Services; UK Motor Neurone Disease Association; Wellcome Trust/MRC Joint Call in Neurodegeneration award(Wellcome TrustUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCL/Institute of Neurology; University of Sheffield; MRC Protein Phosphorylation Unit at the University of Dundee(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	OAR is a recipient of a James and Ester King Foundation New Investigator Award from the Department of Health, Florida State. OAR is also funded by the American Heart Association (AHA) and the Myron and Jane Hanley Award in Stroke Research. The Siblings with Ischemic Stroke Study was funded by a grant from the National Institute of Neurological Disorders and Stroke (NINDS) (R01 NS39987; JFM, PI) and by a Marriott Disease Risk and Regenerative Medicine Initiative Award in Individualized Medicine. The Ischemic Stroke Genetics Study (ISGS) was funded by a grant from the NINDS (R01 NS42733). ZKW is partially supported by the National Institutes of Health (NIH) /NINDS P50 NS072187, Mayo Clinic Center for Regenerative Medicine, and Dystonia Medical Research Foundation. This work was supported in part by the Intramural Research Program of the National Institute on Aging, NIH, Department of Health and Human Services, project number Z01 AG000950-06; the UK Motor Neurone Disease Association grant 6057 to John Hardy and Richard Orrell and Alzheimer's Research UK funding to John Hardy. This work was supported in part by the Wellcome Trust/MRC Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium (UKPDC) whose members are from the UCL/Institute of Neurology, the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee and a fellowship from Alzheimer's Research UK to Dr. Guerreiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Arboleda-Velasquez JF, 2008, P NATL ACAD SCI USA, V105, P4856, DOI 10.1073/pnas.0709867105; BARRETT JC, 2009, COLD SPRING HARB PRO, P71; DICHGANS M, 2003, STROKE GENETICS, P165; DUDOIT S, 2004, STAT APPL GENET 0614, P3; Federico A, 2005, NEUROL SCI, V26, P117, DOI 10.1007/s10072-005-0444-3; Fouillade C, 2008, HUM MUTAT, V29, P452, DOI 10.1002/humu.9527; Guerreiro RJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.009; Guidetti D, 2006, CLIN EXP HYPERTENS, V28, P271, DOI 10.1080/10641960600549223; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kalimo H, 2002, BRAIN PATHOL, V12, P371; Meschia JF, 2011, NAT REV NEUROL, V7, P369, DOI 10.1038/nrneurol.2011.80; Pescini F, 2008, J NEUROL SCI, V267, P170, DOI 10.1016/j.jns.2007.10.017; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ross OA, 2007, CURR DRUG TARGETS, V8, P850; Schmidt H, 2011, BRAIN, V134, P3384, DOI 10.1093/brain/awr252; Vikelis M, 2007, SWISS MED WKLY, V137, P323	19	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75035	10.1371/journal.pone.0075035	http://dx.doi.org/10.1371/journal.pone.0075035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086431	gold, Green Published, Green Submitted			2022-12-25	WOS:000326520200074
J	Chen, Z; Zhang, Y; Jia, C; Wang, Y; Lai, P; Zhou, X; Wang, Y; Song, Q; Lin, J; Ren, Z; Gao, Q; Zhao, Z; Zheng, H; Wan, Z; Gao, T; Zhao, A; Dai, Y; Bai, X				Chen, Z.; Zhang, Y.; Jia, C.; Wang, Y.; Lai, P.; Zhou, X.; Wang, Y.; Song, Q.; Lin, Jun; Ren, Z.; Gao, Q.; Zhao, Z.; Zheng, H.; Wan, Z.; Gao, T.; Zhao, A.; Dai, Y.; Bai, X.			mTORC1/2 targeted by n-3 polyunsaturated fatty acids in the prevention of mammary tumorigenesis and tumor progression	ONCOGENE			English	Article						mTORC1; mTORC2; breast cancer; n-3 polyunsaturated fatty acids (n-3 PUFAs); fat-1	BREAST-CANCER; DOCOSAHEXAENOIC ACID; MAMMALIAN TARGET; DIETARY-FAT; GROWTH; OMEGA-3-FATTY-ACIDS; COMPLEX; LONG; OIL; METASTASIS	Although epidemiological and preclinical studies have shown the preventative effects of n-3 polyunsaturated fatty acids (PUFAs) on breast cancer, inconsistencies still remain in the data and the underlying mechanisms remain unclear. In this study, we identified mammalian target of rapamycin (mTOR) signaling, which plays an essential role in cell proliferation and breast tumorigenesis, as a target of n-3 PUFAs. In breast cancer cell lines, n-3 PUFAs rapidly and efficiently suppress both mTOR complex 1 (mTORC1) and mTORC2 and their downstream signaling, and subsequently inhibit cell proliferation and angiogenesis while promoting apoptosis. Further study indicates that stabilization of the mTOR-raptor complex by n-3 PUFAs may contribute to their inhibitory effect on mTORC1. Importantly, four complementary and well-controlled animal models were utilized to identify the role and molecular target of n-3 PUFAs in the prevention of breast carcinogenesis and progression, namely: (1) chemically induced mammary tumor rats with a high dietary intake of n-3 PUFAs; (2) nude mice implanted with mammary tumor cell lines stably expressing fat-1, a desaturase that catalyzes the conversion of n-6 to n-3 PUFAs and produces n-3 PUFAs endogenously; (3) fat-1 transgenic severe combined immune deficiency mice implanted with breast tumor cells; and (4) the fat-1 transgenic mouse mammary tumor virus-polyoma virus middle T oncogene double-hybrid mice, a model of aggressive breast cancer. In summary, dietary and endogenous n-3 PUFAs abrogate the activity of mTORC1/2 pathways in vitro and in vivo and prevent breast carcinogenesis, tumor growth and metastasis. Taken together, our findings convincingly clarify the causal relationship between n-3 PUFAs and breast cancer prevention and establish mTORC1/2 as a target of n-3 PUFAs.	[Chen, Z.; Zhang, Y.; Jia, C.; Lai, P.; Zhou, X.; Song, Q.; Lin, Jun; Bai, X.] Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Y.; Wang, Y.; Ren, Z.; Gao, Q.; Wan, Z.; Zhao, A.; Dai, Y.] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wang, Y.; Wang, Y.; Ren, Z.; Gao, Q.; Wan, Z.; Zhao, A.; Dai, Y.] Nanjing Med Univ, Jiangsu Key Lab Xenotransplantat, Nanjing, Jiangsu, Peoples R China; [Zhao, Z.] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Zheng, H.] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Gao, T.] Southern Med Univ, Dept Anat & Neurobiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Nanjing Medical University; Nanjing Medical University; Nankai University; Southern Medical University - China; Southern Medical University - China	Dai, Y (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	yifandai08@gmail.com; baixc15@smu.edu.cn	qiancheng, song/C-4159-2014	zhang, yue/0000-0002-6612-8002; Chen, Zhenguo/0000-0003-3280-5201; Song, Qiancheng/0000-0002-9335-5147; Bai, Xiaochun/0000-0001-9631-4781	State Key Development Program for Basic Research of China [2009CB918904, 2013CB945203]; National Natural Sciences Foundation of China [91029727]; Guangdong Natural Science Foundation [s2012010008209]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1142]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	We greatly appreciate the gift of TSC2<SUP>+/+</SUP> and TSC2<SUP>-/-</SUP> MEFs from Dr David J Kwiatkowski (Brigham and Women's Hospital, Boston, MA, USA). This work was supported by the State Key Development Program for Basic Research of China (2009CB918904, 2013CB945203), National Natural Sciences Foundation of China (91029727), Guangdong Natural Science Foundation (s2012010008209) and Program for Changjiang Scholars and Innovative Research Team in University (IRT1142). TSC2<SUP>+/+</SUP>P53<SUP>-/-</SUP> and TSC2<SUP>-/-</SUP>P53<SUP>-/-</SUP> mouse embryonic fibroblasts (MEF) were provided by Dr David J Kwiatkowski (Brigham and Women's Hospital, Boston, MA, USA).	Bai XC, 2010, CELL MOL LIFE SCI, V67, P239, DOI 10.1007/s00018-009-0163-7; Berquin IM, 2008, CANCER LETT, V269, P363, DOI 10.1016/j.canlet.2008.03.044; BRADEN LM, 1986, LIPIDS, V21, P285, DOI 10.1007/BF02536414; COHEN LA, 1993, LIPIDS, V28, P449, DOI 10.1007/BF02535944; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Engeset D, 2006, INT J CANCER, V119, P175, DOI 10.1002/ijc.21819; GABOR H, 1985, J NATL CANCER I, V74, P1299; Gerber M, 2012, BRIT J NUTR, V107, pS228, DOI 10.1017/S0007114512001614; Gingras AA, 2007, J PHYSIOL-LONDON, V579, P269, DOI 10.1113/jphysiol.2006.121079; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Jiang WQ, 2012, CANCER RES, V72, P3795, DOI 10.1158/0008-5472.CAN-12-1047; Jing K, 2011, AUTOPHAGY, V7, P1348, DOI 10.4161/auto.7.11.16658; JURKOWSKI JJ, 1985, J NATL CANCER I, V74, P1145; Kang JX, 2008, J NUTRIGENET NUTRIGE, V1, P172, DOI 10.1159/000119714; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MacLean CH, 2006, JAMA-J AM MED ASSOC, V295, P403, DOI 10.1001/jama.295.4.403; MacLennan MB, 2013, J NUTR BIOCHEM, V24, P388, DOI 10.1016/j.jnutbio.2012.08.002; Manni A, 2010, CANCER PREV RES, V3, P322, DOI 10.1158/1940-6207.CAPR-09-0173; O'Regan R, 2011, EXPERT OPIN THER TAR, V15, P859, DOI 10.1517/14728222.2011.575362; Olivo SE, 2005, CARCINOGENESIS, V26, P1563, DOI 10.1093/carcin/bgi118; ROSE DP, 1995, JNCI-J NATL CANCER I, V87, P587, DOI 10.1093/jnci/87.8.587; ROSE DP, 1993, JNCI-J NATL CANCER I, V85, P1743, DOI 10.1093/jnci/85.21.1743; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; SCHATZKIN A, 1989, JAMA-J AM MED ASSOC, V261, P3284, DOI 10.1001/jama.261.22.3284; Signori C, 2011, CANCER RES, V71, P6091, DOI 10.1158/0008-5472.CAN-11-0977; van Veelen W, 2011, ONCOGENE, V30, P2289, DOI 10.1038/onc.2010.630; Warner E, 2011, NEW ENGL J MED, V365, P1025, DOI 10.1056/NEJMcp1101540; Wei D, 2010, DIABETES, V59, P471, DOI 10.2337/db09-0284; Wen ZH, 2013, ONCOGENE, V32, P160, DOI 10.1038/onc.2012.47; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xia SH, 2006, P NATL ACAD SCI USA, V103, P12499, DOI 10.1073/pnas.0605394103; Yoshida S, 2011, J BIOL CHEM, V286, P32651, DOI 10.1074/jbc.M111.238014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	39	47	51	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 11	2014	33	37					4548	4557		10.1038/onc.2013.402	http://dx.doi.org/10.1038/onc.2013.402			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AP3UZ	24096482				2022-12-25	WOS:000342004800002
J	Delaine-Smith, RM; Sittichokechaiwut, A; Reilly, GC				Delaine-Smith, Robin M.; Sittichokechaiwut, Anuphan; Reilly, Gwendolen C.			Primary cilia respond to fluid shear stress and mediate flow-induced calcium deposition in osteoblasts	FASEB JOURNAL			English	Article						mechanotransduction; oscillatory fluid flow; osteogenesis; extracellular matrix	STEM-CELL DIFFERENTIATION; BONE-CELLS; MATRIX PRODUCTION; OSTEOCYTES; MECHANOTRANSDUCTION; POLYCYSTIN-1; POLARIS	Bone turnover in vivo is regulated by mechanical forces such as shear stress originating from interstitial oscillatory fluid flow (OFF), and bone cells in vitro respond to mechanical loading. However, the mechanisms by which bone cells sense mechanical forces, resulting in increased mineral deposition, are not well understood. The aim of this study was to investigate the role of the primary cilium in mechanosensing by osteoblasts. MLO-A5 murine osteoblasts were cultured in monolayer and subjected to two different OFF regimens: 5 short (2 h daily) bouts of OFF followed by morphological analysis of primary cilia; or exposure to chloral hydrate to damage or remove primary cilia and 2 short bouts (2 h on consecutive days) of OFF. Primary cilia were shorter and there were fewer cilia per cell after exposure to periods of OFF compared with static controls. Damage or removal of primary cilia inhibited OFF-induced PGE(2) release into the medium and mineral deposition, assayed by Alizarin red staining. We conclude that primary cilia are important mediators of OFF-induced mineral deposition, which has relevance for the design of bone tissue engineering strategies and may inform clinical treatments of bone disorders causes by load-deficiency.Delaine-Smith, R. M., Sittichokechaiwut, A., Reilly, G. C. Primary cilia respond to fluid shear stress and mediate flow-induced calcium deposition in osteoblasts.	[Delaine-Smith, Robin M.; Reilly, Gwendolen C.] Univ Sheffield, Dept Mat Sci & Engn, Kroto Res Inst, Sheffield, S Yorkshire, England; [Sittichokechaiwut, Anuphan] Naresuan Univ, Periodontol Sect, Dept Prevent Dent, Phitsanulok, Thailand	University of Sheffield; Naresuan University	Delaine-Smith, RM (corresponding author), Queen Mary Univ London, Sch Engn & Mat Sci, Mile End Rd, London E1 4NS, England.	r.delaine-smith@qmul.ac.uk	Sittichokechaiwut, Anuphan/GRS-0477-2022; Reilly, Gwendolen C./C-3456-2009	Reilly, Gwendolen C./0000-0003-1456-1071	Engineering and Physical Sciences Research Council (EPSRC); University of Sheffield Women Academic Returners Programme; University of Sheffield Excellence Exchange Scheme; Royal Thai Government	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Sheffield Women Academic Returners Programme; University of Sheffield Excellence Exchange Scheme; Royal Thai Government	The authors thank the Engineering and Physical Sciences Research Council (EPSRC) and the University of Sheffield Women Academic Returners Programme for funding provided to G. R. for R.M.D.-S. Part of the imaging was performed at the Kroto Research Institute Confocal Imaging Facility. Prof. Lynda Bonewald (University of Missouri, Kansas City, MO, USA) kindly provided the MLO-A5 cells. Preliminary data (not shown) were gathered and technical training was undertaken by A. S. at Stanford University (Stanford, CA, USA) in the laboratory of Dr. Christopher Jacobs with funding from the University of Sheffield Excellence Exchange Scheme and the Royal Thai Government. The authors also thank Dr. Jacobs (currently at Columbia University, New York, NY, USA) for helpful discussions. G. R. is currently a member of the Insigneo Institute for In Silico Medicine (University of Sheffield). The authors declare no conflicts of interest.	Abdul-Majeed S, 2012, CELL MOL LIFE SCI, V69, P165, DOI 10.1007/s00018-011-0744-0; Abdul-Majeed S, 2011, HYPERTENSION, V58, P325, DOI 10.1161/HYPERTENSIONAHA.111.172080; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Blackwell KA, 2010, TRENDS ENDOCRIN MET, V21, P294, DOI 10.1016/j.tem.2009.12.004; Delaine-Smith RM, 2012, EUR CELLS MATER, V24, P162, DOI 10.22203/eCM.v024a12; Delaine-Smith Robin M, 2012, Muscles Ligaments Tendons J, V2, P169; Delaine-Smith RM, 2011, VITAM HORM, V87, P417, DOI 10.1016/B978-0-12-386015-6.00039-1; Donahue TLH, 2003, J BIOMECH, V36, P1363, DOI 10.1016/S0021-9290(03)00118-0; Donnelly E, 2010, J ORTHOP RES, V28, P77, DOI 10.1002/jor.20946; Farnum CE, 2009, METHOD CELL BIOL, V94, P117, DOI 10.1016/S0091-679X(08)94006-1; Felgner H, 1996, J CELL SCI, V109, P509; Gardner K, 2011, J ORTHOP RES, V29, P582, DOI 10.1002/jor.21271; Geiger RC, 2009, AM J RESP CELL MOL, V40, P76, DOI 10.1165/rcmb.2007-0307OC; Hoey DA, 2012, STEM CELLS, V30, P2561, DOI 10.1002/stem.1235; Hoey DA, 2012, J BIOMECH, V45, P17, DOI 10.1016/j.jbiomech.2011.08.008; Hoey DA, 2011, BIOCHEM BIOPH RES CO, V412, P182, DOI 10.1016/j.bbrc.2011.07.072; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Jensen CG, 2004, CELL BIOL INT, V28, P101, DOI 10.1016/j.cellbi.2003.11.007; Kato Y, 2001, J BONE MINER RES, V16, P1622, DOI 10.1359/jbmr.2001.16.9.1622; Kwon RY, 2010, FASEB J, V24, P2859, DOI 10.1096/fj.09-148007; Lee KL, 2010, CLIN REV BONE MINER, V8, P201, DOI 10.1007/s12018-010-9078-y; Leucht P, 2013, MED ENG PHYS, V35, P392, DOI 10.1016/j.medengphy.2012.06.005; Liedert Astrid, 2008, V1, P253; Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Malone AMD, 2007, AM J PHYSIOL-CELL PH, V292, pC1830, DOI 10.1152/ajpcell.00352.2005; Masyuk AI, 2008, AM J PHYSIOL-GASTR L, V295, pG725, DOI 10.1152/ajpgi.90265.2008; McGlashan SR, 2006, J HISTOCHEM CYTOCHEM, V54, P1005, DOI 10.1369/jhc.5A6866.2006; McGlashan SR, 2010, CELL BIOL INT, V34, P441, DOI 10.1042/CBI20090094; MikuniTakagaki Y, 1996, ENDOCRINOLOGY, V137, P2028, DOI 10.1210/en.137.5.2028; Morris HL, 2010, P I MECH ENG H, V224, P1509, DOI 10.1243/09544119JEIM751; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Pitaval A, 2010, J CELL BIOL, V191, P303, DOI 10.1083/jcb.201004003; Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089; Potter DR, 2008, CIRC RES, V102, P770, DOI 10.1161/CIRCRESAHA.107.160226; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P69, DOI 10.1007/s00232-002-1042-4; Prodromou NV, 2012, J CELL SCI, V125, P4297, DOI 10.1242/jcs.100545; Qiu N, 2012, J CELL SCI, V125, P1945, DOI 10.1242/jcs.095893; Reilly GC, 2003, BIORHEOLOGY, V40, P591; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Rydholm S, 2010, AM J PHYSIOL-RENAL, V298, pF1096, DOI 10.1152/ajprenal.00657.2009; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Sittichockechaiwut A, 2009, BONE, V44, P822, DOI 10.1016/j.bone.2008.12.027; Sittichokechaiwut A, 2010, EUR CELLS MATER, V20, P45; Temiyasathit S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033368; Tummala P, 2010, CELL MOL BIOENG, V3, P207, DOI 10.1007/s12195-010-0127-x; Wann AKT, 2012, CELL MOL LIFE SCI, V69, P2967, DOI 10.1007/s00018-012-0980-y; Wann AKT, 2012, FASEB J, V26, P1663, DOI 10.1096/fj.11-193649; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200	59	57	63	0	33	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					430	439		10.1096/fj.13-231894	http://dx.doi.org/10.1096/fj.13-231894			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24097311	Green Published, Green Accepted			2022-12-25	WOS:000333526100040
J	Gamsjaeger, R; O'Connell, MR; Cubeddu, L; Shepherd, NE; Lowry, JA; Kwan, AH; Vandevenne, M; Swanton, MK; Matthews, JM; Mackay, JP				Gamsjaeger, Roland; O'Connell, Mitchell R.; Cubeddu, Liza; Shepherd, Nicholas E.; Lowry, Jason A.; Kwan, Ann H.; Vandevenne, Marylene; Swanton, Michael K.; Matthews, Jacqueline M.; Mackay, Joel P.			A Structural Analysis of DNA Binding by Myelin Transcription Factor 1 Double Zinc Fingers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Myelin; Nuclear Magnetic Resonance; Protein Structure; Zinc Finger	NUCLEIC-ACID STRUCTURES; CENTRAL-NERVOUS-SYSTEM; NEURONAL DIFFERENTIATION; OLIGODENDROCYTE LINEAGE; DIRECT CONVERSION; PROTEIN; GENE; FAMILY; CELLS; FIBROBLASTS	Background: Myelin transcription factor 1 (MyT1) contains seven similar zinc finger domains that bind DNA specifically. Results: A three-dimensional structural model explains how a double zinc finger unit is able to recognize DNA. Conclusion: DNA-binding residues are conserved among all MyT1 zinc fingers, suggesting an identical DNA binding mode. Significance: Determination of the molecular details of DNA interaction will be crucial in understanding MyT1 function. Myelin transcription factor 1 (MyT1/NZF2), a member of the neural zinc-finger (NZF) protein family, is a transcription factor that plays a central role in the developing central nervous system. It has also recently been shown that, in combination with two other transcription factors, the highly similar paralog MyT1L is able to direct the differentiation of murine and human stem cells into functional neurons. MyT1 contains seven zinc fingers (ZFs) that are highly conserved throughout the protein and throughout the NZF family. We recently presented a model for the interaction of the fifth ZF of MyT1 with a DNA sequence derived from the promoter of the retinoic acid receptor (RARE) gene. Here, we have used NMR spectroscopy, in combination with surface plasmon resonance and data-driven molecular docking, to delineate the mechanism of DNA binding for double ZF polypeptides derived from MyT1. Our data indicate that a two-ZF unit interacts with the major groove of the entire RARE motif and that both fingers bind in an identical manner and with overall two-fold rotational symmetry, consistent with the palindromic nature of the target DNA. Several key residues located in one of the irregular loops of the ZFs are utilized to achieve specific binding. Analysis of the human and mouse genomes based on our structural data reveals three putative MyT1 target genes involved in neuronal development.	[Gamsjaeger, Roland; O'Connell, Mitchell R.; Cubeddu, Liza; Shepherd, Nicholas E.; Kwan, Ann H.; Vandevenne, Marylene; Matthews, Jacqueline M.; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Gamsjaeger, Roland; Cubeddu, Liza] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 2751, Australia; [Swanton, Michael K.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia	University of Sydney; Western Sydney University; Victor Chang Cardiac Research Institute	Gamsjaeger, R (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Locked Bag 1797, Penrith, NSW 2751, Australia.	r.gamsjaeger@uws.edu.au; joel.mackay@sydney.edu.au	Shepherd, Nicholas/H-6781-2016; Mackay, Joel/D-6834-2011	Shepherd, Nicholas/0000-0001-6234-4456; Mackay, Joel/0000-0001-7508-8033; O'Connell, Mitchell/0000-0002-8642-3973; Kwan, Ann/0000-0002-1506-2226; Vandevenne, Marylene/0000-0002-4492-2635; Matthews, Jacqueline/0000-0001-8518-3472; Gamsjaeger, Roland/0000-0003-1095-2569	National Health and Medical Council of Australia (NHMRC); Australian Research Council (ARC); NHMRC	National Health and Medical Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Council of Australia (NHMRC) and the Australian Research Council (ARC).; Recipients of Senior Research Fellowships from the NHMRC.	Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; Berkovits HJ, 1999, BIOCHEMISTRY-US, V38, P16826, DOI 10.1021/bi991433l; Berkovits-Cymet HJ, 2004, BIOCHEMISTRY-US, V43, P898, DOI 10.1021/bi035159d; Besold AN, 2010, J BIOL INORG CHEM, V15, P583, DOI 10.1007/s00775-010-0626-1; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gamsjaeger R, 2008, J BIOL CHEM, V283, P5158, DOI 10.1074/jbc.M703772200; Goddard T. D, 2007, SPARKY 3; Hagiwara T, 1996, GENOMICS, V33, P508, DOI 10.1006/geno.1996.0226; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Jiang YH, 1996, J BIOL CHEM, V271, P10723, DOI 10.1074/jbc.271.18.10723; Kameyama T, 2011, NEUROSCI LETT, V497, P74, DOI 10.1016/j.neulet.2011.04.033; Kim EJ, 2011, J COMP NEUROL, V519, P1355, DOI 10.1002/cne.22574; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; KIM JG, 1992, MOL CELL BIOL, V12, P5632, DOI 10.1128/MCB.12.12.5632; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Macke TJ, 1998, ACS SYM SER, V682, P379; MACKLIN WB, 1987, J NEUROSCI RES, V18, P383, DOI 10.1002/jnr.490180302; Murray RC, 2000, DEV DYNAM, V218, P189, DOI 10.1002/(SICI)1097-0177(200005)218:1<189::AID-DVDY16>3.0.CO;2-4; Nielsen JA, 2004, MOL CELL NEUROSCI, V25, P111, DOI 10.1016/j.mcn.2003.10.001; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Von Wilmsdorff M, 2013, WORLD J BIOL PSYCHIA, V14, P490, DOI 10.3109/15622975.2011.645877; WOLF P, 1983, ANAL BIOCHEM, V129, P145, DOI 10.1016/0003-2697(83)90062-3; Yang JL, 2008, FASEB J, V22, P3956, DOI 10.1096/fj.08-111013; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366; Zweckstetter M, 2004, BIOPHYS J, V86, P3444, DOI 10.1529/biophysj.103.035790	37	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35180	35191		10.1074/jbc.M113.482075	http://dx.doi.org/10.1074/jbc.M113.482075			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24097990	Green Published, hybrid			2022-12-25	WOS:000329867600019
J	van Straaten, KE; Ko, JB; Jagdhane, R; Anjum, S; Palmer, DRJ; Sanders, DAR				van Straaten, Karin E.; Ko, Jong Bum; Jagdhane, Rajendra; Anjum, Shazia; Palmer, David R. J.; Sanders, David A. R.			The Structure of NtdA, a Sugar Aminotransferase Involved in the Kanosamine Biosynthetic Pathway in Bacillus subtilis, Reveals a New Subclass of Aminotransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Carbohydrate; Cell Wall; Crystal Structure; Enzymes; X-ray Crystallography; Kanosamine; Transaminase	3,3'-NEOTREHALOSADIAMINE BMY-28251; 3-AMINO-3-DEOXY-D-GLUCOSE; MECHANISM; ALIGNMENT; SYSTEM	Background: NtdA represents a novel aminotransferase recognizing a sugar 6-phosphate. Results: We have determined the structure of NtdA with pyridoxamine phosphate (the internal and external aldimines), identifying determinants of substrate specificity. Conclusion: The structures suggest a canonical aminotransferase chemical mechanism, but features exclude the binding of sugar nucleotides. Significance: A new subfamily of sugar aminotransferases is revealed, enhancing our understanding of antibiotic biosynthesis. NtdA from Bacillus subtilis is a sugar aminotransferase that catalyzes the pyridoxal phosphate-dependent equatorial transamination of 3-oxo-alpha-D-glucose 6-phosphate to form alpha-D-kanosamine 6-phosphate. The crystal structure of NtdA shows that NtdA shares the common aspartate aminotransferase fold (Type 1) with residues from both monomers forming the active site. The crystal structures of NtdA alone, co-crystallized with the product alpha-D-kanosamine 6-phosphate, and incubated with the amine donor glutamate reveal three key structures in the mechanistic pathway of NtdA. The structure of NtdA alone reveals the internal aldimine form of NtdA with the cofactor pyridoxal phosphate covalently attached to Lys-247. The addition of glutamate results in formation of pyridoxamine phosphate. Co-crystallization with kanosamine 6-phosphate results in the formation of the external aldimine. Only alpha-D-kanosamine 6-phosphate is observed in the active site of NtdA, not the beta-anomer. Acomparison of the structure and sequence of NtdA with other sugar aminotransferases enables us to propose that the VI beta family of aminotransferases should be divided into subfamilies based on the catalytic lysine motif.	[van Straaten, Karin E.; Ko, Jong Bum; Jagdhane, Rajendra; Anjum, Shazia; Palmer, David R. J.; Sanders, David A. R.] Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 5C9, Canada	University of Saskatchewan	Sanders, DAR (corresponding author), Univ Saskatchewan, Dept Chem, 110 Sci Pl, Saskatoon, SK S7N 5C9, Canada.	david.sanders@usask.ca	Sanders, David A.R./I-5668-2016; Palmer, David R J/F-1934-2010	Palmer, David R J/0000-0001-9300-7460	Saskatchewan Health Research Foundation Team grant; University of Saskatchewan	Saskatchewan Health Research Foundation Team grant; University of Saskatchewan	This work was supported by a Saskatchewan Health Research Foundation Team grant to the Molecular Design Research Group and by the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakawa K, 2002, J AM CHEM SOC, V124, P10644, DOI 10.1021/ja0206339; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Burgie ES, 2007, PROTEIN SCI, V16, P887, DOI 10.1110/ps.062711007; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DOLAK LA, 1980, J ANTIBIOT, V33, P900, DOI 10.7164/antibiotics.33.900; Floss HG, 2011, J ANTIBIOT, V64, P35, DOI 10.1038/ja.2010.139; Fodje M. N., 2010, P 8 INT WORKSH PERS, P130; FUSETANI N, 1987, EXPERIENTIA, V43, P464, DOI 10.1007/BF01940457; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guo JT, 2002, J AM CHEM SOC, V124, P10642, DOI 10.1021/ja026628m; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hwang BY, 2005, J MOL CATAL B-ENZYM, V37, P47, DOI 10.1016/j.molcatb.2005.09.004; Hwang BY, 2004, CHEM BIOL, V11, P915, DOI 10.1016/j.chembiol.2004.04.015; Inaoka T, 2004, J BIOL CHEM, V279, P3885, DOI 10.1074/jbc.M309925200; Inaoka T, 2007, J BACTERIOL, V189, P65, DOI 10.1128/JB.01478-06; Janiak AM, 2001, MED MYCOL, V39, P401, DOI 10.1080/mmy.39.5.401.408; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P67; Larkin A, 2010, BIOCHEMISTRY-US, V49, P7227, DOI 10.1021/bi100805b; Milner JL, 1996, APPL ENVIRON MICROB, V62, P3061, DOI 10.1128/AEM.62.8.3061-3065.1996; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NUMATA KI, 1986, J ANTIBIOT, V39, P1346, DOI 10.7164/antibiotics.39.1346; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shang HZ, 1999, CURR MICROBIOL, V38, P199, DOI 10.1007/PL00006787; Thoden JB, 2009, BIOCHEMISTRY-US, V48, P1553, DOI 10.1021/bi8022015; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSUNO T, 1986, J ANTIBIOT, V39, P1001, DOI 10.7164/antibiotics.39.1001; UMEZAWA S, 1967, B CHEM SOC JPN, V40, P2419, DOI 10.1246/bcsj.40.2419; UMEZAWA S, 1968, J ANTIBIOT, V21, P485, DOI 10.7164/antibiotics.21.485; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Straaten KE, 2009, ACTA CRYSTALLOGR F, V65, P426, DOI 10.1107/S1744309109009038; Vetter ND, 2013, J AM CHEM SOC, V135, P5970, DOI 10.1021/ja4010255	36	19	20	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34121	34130		10.1074/jbc.M113.500637	http://dx.doi.org/10.1074/jbc.M113.500637			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24097983	Green Published, hybrid			2022-12-25	WOS:000327250200056
J	Marimuthu, K; Muthu, N; Xavier, R; Arockiaraj, J; Rahman, MA; Subramaniam, S				Marimuthu, Kasi; Muthu, Narmataa; Xavier, Rathinam; Arockiaraj, Jesu; Rahman, M. Aminur; Subramaniam, Sreeramanan			Toxicity of Buprofezin on the Survival of Embryo and Larvae of African Catfish, Clarias gariepinus (Bloch)	PLOS ONE			English	Article							INSECT GROWTH-REGULATORS; ORYZIAS-LATIPES; LIFE STAGES; PYRIPROXYFEN; PARAMETERS; MECHANISM	Buprofezin is an insect growth regulator and widely used insecticide in Malaysia. The present study evaluated the toxic effects of buprofezin on the embryo and larvae of African catfish (Clarias gariepinus) as a model organism. The embryos and larvae were exposed to 7 different concentrations (0, 0.05, 0.5, 5, 25, 50 and 100 mg/L) of buprofezin. Each concentration was assessed in five replicates. Eggs were artificially fertilized and 200 eggs and larvae were subjected to a static bath treatment for all the concentrations. The mortality of embryos was significantly increased with increasing buprofezin concentrations from 5 to 100 mg/L (p< 0.05). However, the mortality was not significantly different (p< 0.05) among the following concentrations: 0 (control), 0.05, 0.5 and 5 mg/L. Data obtained from the buprofezin acute toxicity tests were evaluated using probit analysis. The 24 h LC50 value (with 95% confidence limits) of buprofezin for embryos was estimated to be 6.725 (3.167-15.017) mg/L. The hatching of fish embryos was recorded as 68.8, 68.9, 66.9, 66.4, 26.9, 25.1 and 0.12% in response to 7 different concentrations of buprofezin, respectively. The mortality rate of larvae significantly (p< 0.05) increased with increasing buprofezin concentrations exposed to 24-48 h. The 24 and 48 h LC50 values (with 95% confidence limits) of buprofezin for the larvae was estimated to be 5.702 (3.198-8.898) and 4.642 (3.264-6.287) mg/L respectively. There were no significant differences (p>0.05) in the LC50 values obtained at 24 and 48 h exposure times. Malformations were observed when the embryos and larvae exposed to more than 5 mg/L. The results emerged from the study suggest that even the low concentration (5 mg/L) of buprofezin in the aquatic environment may have adverse effect on the early embryonic and larval development of African catfish.	[Marimuthu, Kasi; Muthu, Narmataa; Xavier, Rathinam] AIMST Univ, Fac Sci Appl, Dept Biotechnol, Bedong, Kedah Darul Ama, Malaysia; [Arockiaraj, Jesu] SRM Univ, Fac Sci & Humanities, Dept Biotechnol, Div Fisheries Biotechnol & Mol Biol, Madras 603203, Tamil Nadu, India; [Rahman, M. Aminur] Univ Putra Malaysia, Inst Biosci, Lab Marine Biotechnol, Upm Serdang 43400, Selangor, Malaysia; [Subramaniam, Sreeramanan] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia	AIMST University; SRM Institute of Science & Technology Chennai; Universiti Putra Malaysia; Universiti Sains Malaysia	Marimuthu, K (corresponding author), AIMST Univ, Fac Sci Appl, Dept Biotechnol, Bedong, Kedah Darul Ama, Malaysia.	aquamuthu2k@yahoo.com	Subramaniam, Sreeramanan Sree/I-1130-2012; Arockiaraj, Jesu/A-6227-2013; Subramaniam, Sreeramanan/AAA-5094-2022	Subramaniam, Sreeramanan Sree/0000-0003-4392-285X; Arockiaraj, Jesu/0000-0002-0240-7141; 	University (AIMST University, Malaysia)	University (AIMST University, Malaysia)	The authors received internal funds from the University (AIMST University, Malaysia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilash PC, 2009, J HAZARD MATER, V165, P1, DOI 10.1016/j.jhazmat.2008.10.061; Adhikari S, 2004, ECOTOX ENVIRON SAFE, V58, P220, DOI 10.1016/j.ecoenv.2003.12.003; American Public Health Association (APHA), 1985, STANDARD METHODS EXA, V16th ed., P1268; [Anonymous], 2010, EFSA J, V8, P1624; [Anonymous], 2007, EFSA J, V620, P1; Aydin R, 2005, PESTIC BIOCHEM PHYS, V82, P220, DOI 10.1016/j.pestbp.2005.03.001; Cajaraville MP, 2000, SCI TOTAL ENVIRON, V247, P295, DOI 10.1016/S0048-9697(99)00499-4; CRANE M, 1991, ENVIRON TOXICOL CHEM, V10, P1331, DOI 10.1002/etc.5620101012; DIMICHELE L, 1981, J EXP ZOOL, V217, P73, DOI 10.1002/jez.1402170108; FENT K, 1994, ARCH ENVIRON CON TOX, V27, P224; Gaikowski MP, 1996, ECOTOX ENVIRON SAFE, V34, P252, DOI 10.1006/eesa.1996.0070; Guideline for Testing of Chemicals, 1998, DAPHN MAGN REPR TEST, V211; Haniffa M.A., 2003, Indian Journal of Fisheries, V50, P355; Haniffa MA, 2004, CURR SCI INDIA, V86, P1375; HATAKOSHI M, 1992, J INSECT PHYSIOL, V38, P793, DOI 10.1016/0022-1910(92)90032-9; Ishaaya I, 1998, APPL AGR, P1; John PJ, 2003, B ENVIRON CONTAM TOX, V70, P1013, DOI 10.1007/s00128-003-0083-4; Kanno H. K., 1981, P BRIGHT CROP PROT C, P56; Katzung BG, 1992, BASIC CLIN PHARM, P1017; Marimuthu K., 2001, Naga, V24, P21; Marimuthu K, 2012, INFOFISH INT, V4, P28; Marimuthu K., 2000, FISHING CHIMES, V19, P105; MARTY GD, 1990, AQUAT TOXICOL, V17, P45, DOI 10.1016/0166-445X(90)90011-D; Nasr HM, 2010, PESTIC BIOCHEM PHYS, V98, P198, DOI 10.1016/j.pestbp.2010.06.007; NRA, 2001, EV NEW ACT BUPR PROD; OH HS, 1991, AM SOC TEST MATER, V1124, P343, DOI 10.1520/STP23584S; Rendon-von Osten, 2005, CHEMOSPHERE, V58, P627, DOI 10.1016/j.chemosphere.2004.08.065; SCHOOTS AFM, 1983, DEV BIOL, V100, P59, DOI 10.1016/0012-1606(83)90200-2; SVENSSON BG, 1994, INT ARCH OCC ENV HEA, V65, P351, DOI 10.1007/BF00383243; TAKIMOTO Y, 1984, J PESTIC SCI, V9, P463; Toscano NC, 2001, J ECON ENTOMOL, V94, P1538, DOI 10.1603/0022-0493-94.6.1538; Zhu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046286	32	34	34	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75545	10.1371/journal.pone.0075545	http://dx.doi.org/10.1371/journal.pone.0075545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098390	Green Submitted, Green Published, gold			2022-12-25	WOS:000325483600020
J	Lin, H; Liu, XB; Yu, JJ; Hua, F; Hu, ZW				Lin, Heng; Liu, Xiao-bo; Yu, Jiao-jiao; Hua, Fang; Hu, Zhuo-wei			Antioxidant N-Acetylcysteine Attenuates Hepatocarcinogenesis by Inhibiting ROS/ER Stress in TLR2 Deficient Mouse	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TOLL-LIKE RECEPTORS; HEPATOCELLULAR-CARCINOMA; COMPENSATORY PROLIFERATION; ADENOMATOUS HYPERPLASIA; OXIDATIVE STRESS; AUTOPHAGIC FLUX; LIVER; CANCER; TUMORIGENESIS	Hepatocellular carcinoma (HCC) remains one of the most deadly solid tumor malignancies worldwide. We recently find that the loss of toll-like receptor 2 (TLR2) activities promotes the diethylnitrosamine (DEN) induced hepatocellular carcinogenesis and tumor progression, which associates with an abundant accumulation of reactive oxygen species (ROS) and endoplasmic reticulum (ER) stress. This finding suggests that the ROS/ER stress plays a role in TLR2 modulated carcinogenesis of HCC. To investigate the mechanism of TLR2 activity defending against hepatocarcinogenesis, the TLR2-deficient mice were treated with or without antioxidant N-acetylcysteine (NAC) before DEN administration. We found that pretreatment of these animals with NAC attenuated carcinogenesis and progression of HCC in the TLR2-deficient mice, declined ROS/ER stress, and alleviated the unfold protein response and inflammatory response in TLR2-deficient liver tissue. Moreover, the NAC treatment significantly reduced the enhanced aggregation of p62 and Mallory-Denk bodies in the DEN-induced HCC liver tissue, suggesting that NAC treatment improves the suppressive autophagic flux in the TLR2-deficient liver. These findings indicate that TLR2 activity defends against hepatocarcinogenesis through diminishing the accumulation of ROS and alleviating ER stress and unfold protein response mediated inflammatory response in the liver.	[Hu, Zhuo-wei] Peking Union Med Coll, Beijing Key Lab New Drug Mech & Pharmacol Evaluat, State Key Lab Bioact Subst & Funct Nat Med, Mol Immunol & Pharmacol Grp,Inst Mat Med, Beijing 100021, Peoples R China; Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Hu, ZW (corresponding author), Peking Union Med Coll, Beijing Key Lab New Drug Mech & Pharmacol Evaluat, State Key Lab Bioact Subst & Funct Nat Med, Mol Immunol & Pharmacol Grp,Inst Mat Med, Beijing 100021, Peoples R China.	huzhuowei@imm.ac.cn		Liu, Xiaobo/0000-0002-8256-6002	National Natural Science Foundation of China [30973557, 81101595]; National Natural Science Foundation [81030056]; International Corporation Project; Ministry of Science and Technology [2010DFB32900]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1007]; Institute of Materia Medica [2013CHX17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); International Corporation Project; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Institute of Materia Medica	This work was supported by grants from the National Natural Science Foundation of China (30973557), the Major Program of the National Natural Science Foundation (81030056), the International Corporation Project supported by the Ministry of Science and Technology (2010DFB32900), and the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, No. IRT1007). Dr. Fang Hua is supported by a grant from the National Natural Science Foundation of China (81101595). Dr. Heng Lin is supported by a grant from the Basic Research Program of the Institute of Materia Medica (2013CHX17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardag-Gorce F, 2010, EXP MOL PATHOL, V88, P376, DOI 10.1016/j.yexmp.2010.02.004; Clarke R, 2012, CANCER RES, V72, P1321, DOI 10.1158/0008-5472.CAN-11-3213; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI [10.1002/0471142727.mb2303s51, 10.1002/0471142727.mb2302s51]; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Junjie Xie, 2012, BMC Cancer, V12, P57, DOI 10.1186/1471-2407-12-57; Kimbro K, 2009, RECENT PAT ANTI-CANC, V4, P189, DOI 10.2174/157489209789206904; Kudo M, 2009, J GASTROENTEROL, V44, P112, DOI 10.1007/s00535-008-2274-6; Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010; Lin H, 2013, HEPATOLOGY, V57, P171, DOI 10.1002/hep.25991; Lin H, 2012, AUTOPHAGY, V8, P1859, DOI 10.4161/auto.22094; Liu SB, 2002, INFECT IMMUN, V70, P3433, DOI 10.1128/IAI.70.7.3433-3442.2002; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marra M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-171; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsumura T, 2003, IMMUNOLOGY, V109, P127, DOI 10.1046/j.1365-2567.2003.01627.x; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nischalke HD, 2012, INT J CANCER, V130, P1470, DOI 10.1002/ijc.26143; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; SAKAMOTO M, 1991, HUM PATHOL, V22, P172, DOI 10.1016/0046-8177(91)90039-R; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Schneider C, 2004, GUT, V53, P355, DOI 10.1136/gut.2003.026005; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Shingu K, 2003, AM J RESP CELL MOL, V28, P316, DOI 10.1165/rcmb.2002-0106OC; Sia D, 2011, ONCOLOGY-BASEL, V81, P18, DOI 10.1159/000333254; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213; Szabo G, 2006, HEPATOLOGY, V44, P287, DOI 10.1002/hep.21308; TAKAYAMA T, 1990, LANCET, V336, P1150, DOI 10.1016/0140-6736(90)92768-D; Wang ZY, 2013, AUTOPHAGY, V9, P925, DOI 10.4161/auto.24229; Wang ZY, 2013, HEPATOLOGY, V57, P1869, DOI 10.1002/hep.26234; Yan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024705; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	41	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74130	10.1371/journal.pone.0074130	http://dx.doi.org/10.1371/journal.pone.0074130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098333	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500011
J	Sun, M; Gao, ZQ; Zhao, WF; Deng, LF; Deng, Y; Zhao, HM; Ren, AX; Li, G; Yang, ZP				Sun, Min; Gao, ZhiQiang; Zhao, WeiFeng; Deng, LianFeng; Deng, Yan; Zhao, HongMei; Ren, AiXia; Li, Gang; Yang, ZhenPing			Effect of Subsoiling in Fallow Period on Soil Water Storage and Grain Protein Accumulation of Dryland Wheat and Its Regulatory Effect by Nitrogen Application	PLOS ONE			English	Article							CONSERVATION TILLAGE; RESIDUE MANAGEMENT; USE EFFICIENCY; LONG-TERM; LOESS PLATEAU; PROLINE ACCUMULATION; YIELD; FERTILIZATION; STRESS; CHINA	To provide a new way to increase water storage and retention of dryland wheat, a field study was conducted at Wenxi experimental site of Shanxi Agricultural University. The effect of subsoiling in fallow period on soil water storage, accumulation of proline, and formation of grain protein after anthesis were determined. Our results showed that subsoiling in fallow period could increase water storage in the 0-300 cm soil at pre-sowing stage and at anthesis stage with low or medium N application, especially for the 60-160 cm soil. However, the proline content, glutamine synthetase (GS) activity, glutamate dehydrogenase (GDH) activity in flag leaves and grains were all decreased by subsoiling in fallow period. In addition, the content of albumin, gliadin, and total protein in grains were also decreased while globulin content, Glu/Gli, protein yield, and glutelin content were increased. With N application increasing, water storage of soil layers from 20 to 200 cm was decreased at anthesis stage. High N application resulted in the increment of proline content and GS activity in grains. Besides, correlation analysis showed that soil storage in 40-160 cm soil was negatively correlated with proline content in grains; proline content in grains was positively correlated with GS and GDH activity in flag leaves. Contents of albumin, globulin and total protein in grains were positively correlated with proline content in grains and GDH activity in flag leaves. In conclusion, subsoiling in fallow period, together with N application at 150 kg.hm(-2), was beneficial to increase the protein yield and Glu/Gli in grains which improve the quality of wheat.	[Sun, Min; Gao, ZhiQiang; Zhao, WeiFeng; Deng, LianFeng; Deng, Yan; Zhao, HongMei; Ren, AiXia; Li, Gang; Yang, ZhenPing] Shanxi Agr Univ, Coll Crop Sci, Taigu, Shanxi Province, Peoples R China	Shanxi Agricultural University	Gao, ZQ (corresponding author), Shanxi Agr Univ, Coll Crop Sci, Taigu, Shanxi Province, Peoples R China.	sm_sunmin@126.com			Modern Agriculture Industry Technology System Construction [CARS-03-01-24]; NSFC (Natural Science Foundation of China) [31101112]; Scientific Research Project of Shanxi Province for Returned Oversea Students [2009037]; Youth Fund of Shanxi Province [2010021028-3]; Shanxi Province for Scientific and Technical Key Projects [20110311001-4]	Modern Agriculture Industry Technology System Construction; NSFC (Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Scientific Research Project of Shanxi Province for Returned Oversea Students; Youth Fund of Shanxi Province; Shanxi Province for Scientific and Technical Key Projects	This work was supported by Modern Agriculture Industry Technology System Construction [CARS-03-01-24]; NSFC (Natural Science Foundation of China) [31101112]; Scientific Research Project of Shanxi Province for Returned Oversea Students [2009037]; Youth Fund of Shanxi Province [2010021028-3]; and the assistance from Shanxi Province for Scientific and Technical Key Projects [20110311001-4]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Baumhardt RL, 2002, SOIL TILL RES, V68, P71, DOI 10.1016/S0167-1987(02)00097-1; Baumhardt RL, 2002, SOIL TILL RES, V65, P19, DOI 10.1016/S0167-1987(01)00273-2; BHAGAT RM, 1994, SOIL TILL RES, V29, P323, DOI 10.1016/0167-1987(94)90106-6; BLEVINS RL, 1993, ADV AGRON, V51, P33, DOI 10.1016/S0065-2113(08)60590-8; BLUM A, 1983, AGR WATER MANAGE, V7, P195, DOI 10.1016/0378-3774(83)90083-5; DAY AD, 1971, AGRON J, V63, P115, DOI 10.2134/agronj1971.00021962006300010035x; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; [邓志英 DENG ZhiYing], 2006, [生态学报, Acta Ecologica Sinica], V26, P2757; Fan TL, 2005, AGR ECOSYST ENVIRON, V106, P313, DOI 10.1016/j.agee.2004.09.003; Fan XueMei, 2004, Acta Phytoecologica Sinica, V28, P680; Fu Xue-li, 2008, Yingyong Shengtai Xuebao, V19, P317; Halvorson AD, 2004, AGRON J, V96, P1196, DOI 10.2134/agronj2004.1196; Huang MB, 2003, SOIL TILL RES, V72, P95, DOI 10.1016/S0167-1987(03)00065-5; Huang YL, 2005, AGR WATER MANAGE, V72, P209, DOI 10.1016/j.agwat.2004.09.012; Ireland R. J, 1999, ENZYMES GLUTAMINE GL; Jiang Dong, 2004, Acta Agronomica Sinica, V30, P175; Johansson E, 2001, CEREAL CHEM, V78, P19, DOI 10.1094/CCHEM.2001.78.1.19; LAL R, 1989, SOIL TILL RES, V14, P359, DOI 10.1016/0167-1987(89)90055-X; Lu BB, 2005, PLANT SCI, V169, P295, DOI 10.1016/j.plantsci.2004.09.031; Maiorana M, 2001, J AGR ENG RES, V79, P231, DOI 10.1006/jaer.2000.0693; MORIN J, 1984, SOIL TILL RES, V4, P215, DOI 10.1016/0167-1987(84)90021-7; Reynolds M, 2005, AGRON J, V97, P1062; Shipitalo MJ, 2000, SOIL TILL RES, V53, P167, DOI 10.1016/S0167-1987(99)00104-X; Sijtsma CH, 1998, SOIL TILL RES, V49, P223, DOI 10.1016/S0167-1987(98)00175-5; Skopelitis DS, 2006, PLANT CELL, V18, P2767, DOI 10.1105/tpc.105.038323; Sun Min, 2010, Acta Agronomica Sinica, V36, P486, DOI 10.3724/SP.J.1006.2010.00486; Verslues PE, 2006, J EXP BOT, V57, P201, DOI 10.1093/jxb/erj026; Wang XB, 2006, PEDOSPHERE, V16, P587, DOI 10.1016/S1002-0160(06)60092-1; Wang ZQ, 2007, J PLANT PHYSIOL, V164, P695, DOI 10.1016/j.jplph.2006.05.001; Xu D., 2000, J SOIL WATER CONSERV, V14, P64; Zhao BQL, 1997, ACTA AGRONOMICA SINI, V5; Zhao Hui, 2007, Acta Agronomica Sinica, V33, P2021; Zhu J, 1999, CEREAL CHEM, V76, P915, DOI 10.1094/CCHEM.1999.76.6.915; Zhu W, 1997, MAICHA FIELD CROPS, V4, P26	35	19	22	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75191	10.1371/journal.pone.0075191	http://dx.doi.org/10.1371/journal.pone.0075191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098371	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500024
J	Byrne, LC; Khalid, F; Lee, T; Zin, EA; Greenberg, KP; Visel, M; Schaffer, DV; Flannery, JG				Byrne, Leah C.; Khalid, Fakhra; Lee, Trevor; Zin, Emilia A.; Greenberg, Kenneth P.; Visel, Meike; Schaffer, David V.; Flannery, John G.			AAV-Mediated, Optogenetic Ablation of Muller Glia Leads to Structural and Functional Changes in the Mouse Retina	PLOS ONE			English	Article							TYPE-2; TRANSDUCTION; CELLS	Muller glia, the primary glial cell in the retina, provide structural and metabolic support for neurons and are essential for retinal integrity. Muller cells are closely involved in many retinal degenerative diseases, including macular telangiectasia type 2, in which impairment of central vision may be linked to a primary defect in Muller glia. Here, we used an engineered, Muller-specific variant of AAV, called ShH10, to deliver a photo-inducibly toxic protein, KillerRed, to Muller cells in the mouse retina. We characterized the results of specific ablation of these cells on visual function and retinal structure. ShH10-KillerRed expression was obtained following intravitreal injection and eyes were then irradiated with green light to induce toxicity. Induction of KillerRed led to loss of Muller cells and a concomitant decrease of Muller cell markers glutamine synthetase and cellular retinaldehyde-binding protein, reduction of rhodopsin and cone opsin, and upregulation of glial fibrillary acidic protein. Loss of Muller cells also resulted in retinal disorganization, including thinning of the outer nuclear layer and the photoreceptor inner and outer segments. High resolution imaging of thin sections revealed displacement of photoreceptors from the ONL, formation of rosette-like structures and the presence of phagocytic cells. Furthermore, Muller cell ablation resulted in increased area and volume of retinal blood vessels, as well as the formation of tortuous blood vessels and vascular leakage. Electrophysiologic measures demonstrated reduced retinal function, evident in decreased photopic and scotopic electroretinogram amplitudes. These results show that loss of Muller cells can cause progressive retinal degenerative disease, and suggest that AAV delivery of an inducibly toxic protein in Muller cells may be useful to create large animal models of retinal dystrophies.	[Byrne, Leah C.; Khalid, Fakhra; Lee, Trevor; Zin, Emilia A.; Visel, Meike; Flannery, John G.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Byrne, Leah C.; Khalid, Fakhra; Lee, Trevor; Zin, Emilia A.; Visel, Meike; Schaffer, David V.; Flannery, John G.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Greenberg, Kenneth P.] Spiral Devices LLC, Berkeley, CA USA; [Schaffer, David V.] Univ Calif Berkeley, Dept Chem Engn, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Flannery, JG (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	flannery@berkeley.edu		Flannery, John/0000-0002-0720-8897; Araujo Zin, Emilia/0000-0002-1275-3697; Byrne, Leah/0000-0002-3229-4993	NIH; Foundation Fighting Blindness; MacTel Project; Howard Hughes Medical Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); MacTel Project; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was funded by the following agencies: the NIH, the Foundation Fighting Blindness (http://www.blindness.org/), the MacTel Project (https://web.emmes.com/study/mactel/index.htm), and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Del Bene F, 2010, SCIENCE, V330, P669, DOI 10.1126/science.1192949; Dubois-Dauphin M, 2000, NEUROSCIENCE, V95, P9; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Klein R, 2010, AM J OPHTHALMOL, V150, P55, DOI 10.1016/j.ajo.2010.02.013; Klimczak RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007467; Koerber JT, 2009, MOL THER, V17, P2088, DOI 10.1038/mt.2009.184; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Len ACL, 2012, J PROTEOME RES, V11, P537, DOI 10.1021/pr200889t; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Li YJ, 2007, DIABETES, V56, P656, DOI 10.2337/db06-0999; Narayanan R, 2013, GRAEF ARCH CLIN EXP, V251, P1311, DOI 10.1007/s00417-012-2191-5; Nishikiori N, 2007, DIABETES, V56, P1333, DOI 10.2337/db06-1431; Otteson DC, 2010, INVEST OPHTH VIS SCI, V51, P5991, DOI 10.1167/iovs.10-5395; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Powner MB, 2013, OPHTHALMOLOGY, DOI [10.1016/j.ophtha.2013.04.013, DOI 10.1016/J.0PHTHA.2013.04.013.PUBMED:23769334]; Powner MB, 2011, BRIT J OPHTHALMOL, V95, P1316, DOI 10.1136/bjo.2011.204222; Powner MB, 2010, OPHTHALMOLOGY, V117, P2407, DOI 10.1016/j.ophtha.2010.04.001; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Sallo FB, 2012, INVEST OPHTH VIS SCI, V53, P7889, DOI 10.1167/iovs.12-10765; Shen WY, 2012, J NEUROSCI, V32, P15715, DOI 10.1523/JNEUROSCI.2841-12.2012; Shen WY, 2011, INVEST OPHTH VIS SCI, V52, P119, DOI 10.1167/iovs.10-6033; Shen WY, 2010, J NEUROSCI RES, V88, P1485, DOI 10.1002/jnr.22317; Shibuya T, 2012, J PHOTOCH PHOTOBIO B, V117, P1, DOI 10.1016/j.jphotobiol.2012.08.005; Shirmanova MV, 2013, J BIOPHOTONICS, V6, P283, DOI 10.1002/jbio.201200056; TOUT S, 1993, NEUROSCIENCE, V55, P291, DOI 10.1016/0306-4522(93)90473-S; Yin L, 2011, INVEST OPHTH VIS SCI, V52, P2775, DOI 10.1167/iovs.10-6250	28	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76075	10.1371/journal.pone.0076075	http://dx.doi.org/10.1371/journal.pone.0076075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086689	gold, Green Submitted, Green Published			2022-12-25	WOS:000325223900076
J	Gupta, A; Shrivastava, N; Grover, P; Singh, A; Mathur, K; Verma, V; Kaur, C; Chaudhary, VK				Gupta, Amita; Shrivastava, Nimisha; Grover, Payal; Singh, Ajay; Mathur, Kapil; Verma, Vaishali; Kaur, Charanpreet; Chaudhary, Vijay K.			A Novel Helper Phage Enabling Construction of Genome-Scale ORF-Enriched Phage Display Libraries	PLOS ONE			English	Article							OPEN READING FRAMES; FILAMENTOUS PHAGE; SURFACE EXPRESSION; CDNA LIBRARIES; GENE; ANTIBODIES; SELECTION; PROTEINS; ASSAY; M13	Phagemid-based expression of cloned genes fused to the gIIIP coding sequence and rescue using helper phages, such as VCSM13, has been used extensively for constructing large antibody phage display libraries. However, for randomly primed cDNA and gene fragment libraries, this system encounters reading frame problems wherein only one of 18 phages display the translated foreign peptide/protein fused to phagemid-encoded gIIIP. The elimination of phages carrying out-of-frame inserts is vital in order to improve the quality of phage display libraries. In this study, we designed a novel helper phage, AGM13, which carries trypsin-sensitive sites within the linker regions of gIIIP. This renders the phage highly sensitive to trypsin digestion, which abolishes its infectivity. For open reading frame (ORF) selection, the phagemid-borne phages are rescued using AGM13, so that clones with in-frame inserts express fusion proteins with phagemid-encoded trypsin-resistant gIIIP, which becomes incorporated into the phages along with a few copies of AGM13-encoded trypsin-sensitive gIIIP. In contrast, clones with out-of-frame inserts produce phages carrying only AGM13-encoded trypsin-sensitive gIIIP. Trypsin treatment of the phage population renders the phages with out-of-frame inserts non-infectious, whereas phages carrying in-frame inserts remain fully infectious and can hence be enriched by infection. This strategy was applied efficiently at a genome scale to generate an ORF-enriched whole genome fragment library from Mycobacterium tuberculosis, in which nearly 100% of the clones carried in-frame inserts after selection. The ORF-enriched libraries were successfully used for identification of linear and conformational epitopes for monoclonal antibodies specific to mycobacterial proteins.	[Gupta, Amita] Univ Delhi South Campus, Dept Microbiol, New Delhi, India; [Shrivastava, Nimisha; Grover, Payal; Singh, Ajay; Mathur, Kapil; Verma, Vaishali; Kaur, Charanpreet; Chaudhary, Vijay K.] Univ Delhi South Campus, Dept Biochem, New Delhi, India	University of Delhi; University of Delhi	Gupta, A (corresponding author), Univ Delhi South Campus, Dept Microbiol, Benito Juarez Rd, New Delhi, India.	amitagupta@south.du.ac.in; vkchaudhary@south.du.ac.in	Verma, Vaishali/ABH-2408-2021	Verma, Vaishali/0000-0001-5076-7435	Department of Science and Technology; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, India	Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Science and Technology to AG and Department of Biotechnology, Government of India to VKC. NS, VV are recipient of Research Fellowship from Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN Y, J STRUCT BIOL, V175, P189; ARMSTRONG J, 1981, FEBS LETT, V135, P167, DOI 10.1016/0014-5793(81)80969-6; BHARDWAJ D, 1995, J IMMUNOL METHODS, V179, P165, DOI 10.1016/0022-1759(94)00280-A; BREITLING F, 1991, GENE, V104, P147, DOI 10.1016/0378-1119(91)90244-6; Caberoy NB, 2010, J MOL RECOGNIT, V23, P74, DOI 10.1002/jmr.983; CRAMERI R, 1994, EUR J BIOCHEM, V226, P53, DOI 10.1111/j.1432-1033.1994.tb20025.x; D'Angelo S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S5; DINIRO R, NUCL ACIDS RES, V38, pE110; Fack F, 1997, J IMMUNOL METHODS, V206, P43, DOI 10.1016/S0022-1759(97)00083-5; Faix PH, 2004, BIOTECHNIQUES, V36, P1018, DOI 10.2144/04366RR03; Goletz S, 2002, J MOL BIOL, V315, P1087, DOI 10.1006/jmbi.2001.5314; Gupta A, 2009, MABS, V1, P268, DOI 10.4161/mabs.1.3.8231; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Hust M, 2006, BIOTECHNIQUES, V41, P335, DOI 10.2144/000112225; JESPERS LS, 1995, BIO-TECHNOL, V13, P378, DOI 10.1038/nbt0495-378; Johnston SA, 1997, VACCINE, V15, P808, DOI 10.1016/S0264-410X(96)00276-9; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Kudva IT, 2006, MOL CELL PROTEOMICS, V5, P1514, DOI 10.1074/mcp.T600013-MCP200; Kugler J, 2008, APPL MICROBIOL BIOT, V80, P447, DOI 10.1007/s00253-008-1576-1; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Liu JW, 2006, PROTEIN EXPRES PURIF, V47, P258, DOI 10.1016/j.pep.2005.11.019; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Maxwell KL, 1999, PROTEIN SCI, V8, P1908, DOI 10.1110/ps.8.9.1908; Rollins SM, 2005, CELL MICROBIOL, V7, P1, DOI 10.1111/j.1462-5822.2004.00477.x; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Zacchi P, 2003, GENOME RES, V13, P980, DOI 10.1101/gr.861503	28	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75212	10.1371/journal.pone.0075212	http://dx.doi.org/10.1371/journal.pone.0075212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086469	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900039
J	Gurha, P; Wang, TN; Larimore, AH; Sassi, Y; Abreu-Goodger, C; Ramirez, MO; Reddy, AK; Engelhardt, S; Taffet, GE; Wehrens, XHT; Entman, ML; Rodriguez, A				Gurha, Priyatansh; Wang, Tiannan; Larimore, Ashley H.; Sassi, Yassine; Abreu-Goodger, Cei; Ramirez, Maricela O.; Reddy, Anilkumar K.; Engelhardt, Stefan; Taffet, George E.; Wehrens, Xander H. T.; Entman, Mark L.; Rodriguez, Antony			microRNA-22 Promotes Heart Failure through Coordinate Suppression of PPAR/ERR-Nuclear Hormone Receptor Transcription	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; MESSENGER-RNA; ERR-ALPHA; GAMMA; GENE; DISEASE; STRESS; MUSCLE; METABOLISM; MECHANISMS	Increasing evidence suggests that microRNAs are intimately involved in the pathophysiology of heart failure. MicroRNA-22 (miR-22) is a muscle-enriched miRNA required for optimum cardiac gene transcription and adaptation to hemodynamic stress by pressure overload in mice. Recent evidence also suggests that miR-22 induces hypertrophic growth and it is oftentimes upregulated in end stage heart failure. However the scope of mRNA targets and networks of miR-22 in the heart failure remained unclear. We analyzed transgenic mice with enhanced levels of miR-22 expression in adult cardiomyocytes to identify important pathophysiologic targets of miR-22. Our data shows that forced expression of miR-22 induces a pro-hypertrophic gene expression program, and it elicits contractile dysfunction leading to cardiac dilation and heart failure. Increased expression of miR-22 impairs the Ca2+ transient, Ca2+ loading into the sarcoplasmic reticulum plus it interferes with transcription of estrogen related receptor (ERR) and PPAR downstream genes. Mechanistically, miR-22 postranscriptionally inhibits peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha), PPAR alpha and sirtuin 1 (SIRT1) expression via a synergistic circuit, which may account for deleterious actions of unchecked miR-22 expression on the heart.	[Gurha, Priyatansh; Larimore, Ashley H.; Ramirez, Maricela O.; Rodriguez, Antony] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Wang, Tiannan; Wehrens, Xander H. T.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Sassi, Yassine; Engelhardt, Stefan] Tech Univ Munich, Inst Pharmacol & Toxicol, D-80290 Munich, Germany; [Sassi, Yassine; Engelhardt, Stefan] Munich Heart Alliance, Munich, Germany; [Abreu-Goodger, Cei] CINVESTAV, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Ramirez, Maricela O.; Rodriguez, Antony] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Reddy, Anilkumar K.; Taffet, George E.; Entman, Mark L.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Technical University of Munich; Munich Heart Alliance; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Baylor College of Medicine; Baylor College of Medicine	Rodriguez, A (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	micromax@gmail.com	Wehrens, Xander/AAQ-9574-2020; Engelhardt, Stefan/AAA-9329-2019; Reddy, Anilkumar/GLS-1391-2022; Abreu-Goodger, Cei/A-1268-2010	Wehrens, Xander/0000-0001-5044-672X; Engelhardt, Stefan/0000-0001-5378-8661; Abreu-Goodger, Cei/0000-0001-8302-9893; Gurha, Priyatansh/0000-0003-4867-7785; Sassi, Yassine/0000-0002-7807-1728	American Heart Association, National and a Gillson-Longenbaugh Foundation award; National Institutes of Health (NIH) [HL089792]; Hankamer Foundation; NIH [K25 HL73041, R01 HL22512, HL089598, HL091947]; Fondation Leducq (Alliance for CaMKII Signaling in Heart); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011795] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089598, R01HL091947, R01HL089792, K25HL073041, R01HL022512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002182] Funding Source: NIH RePORTER	American Heart Association, National and a Gillson-Longenbaugh Foundation award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hankamer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq (Alliance for CaMKII Signaling in Heart); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	A.R. was supported by the American Heart Association, National and a Gillson-Longenbaugh Foundation award. M.L.E. was supported by National Institutes of Health (NIH) grant HL089792 and also by the Hankamer Foundation; A.K.R. was supported by NIH grants, K25 HL73041 and R01 HL22512; X.W. was supported by NIH grants HL089598 and HL091947 and the Fondation Leducq (Alliance for CaMKII Signaling in Heart). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Crawford PA, 2013, J MOL CELL CARDIOL, V55, P130, DOI 10.1016/j.yjmcc.2012.06.008; Diwan A, 2007, PHYSIOLOGY, V22, P56, DOI 10.1152/physiol.00033.2006; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jentzsch C, 2012, J MOL CELL CARDIOL, V52, P13, DOI 10.1016/j.yjmcc.2011.07.010; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100	28	65	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75882	10.1371/journal.pone.0075882	http://dx.doi.org/10.1371/journal.pone.0075882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086656	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900067
J	Lee, YJ; Kim, NK; Yang, JY; Noh, JH; Lee, SS; Ko, KS; Rhee, BD; Kim, DJ				Lee, Yun Jeong; Kim, Na Kyung; Yang, Ju Yean; Noh, Jung Hyun; Lee, Sung-Soon; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Dong-Jun			Low Pulmonary Function in Individuals with Impaired Fasting Glucose: The 2007-2009 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							RESTRICTIVE VENTILATORY DYSFUNCTION; LUNG-FUNCTION; INSULIN-RESISTANCE; METABOLIC SYNDROME; ASSOCIATION; HEART; HYPERGLYCEMIA; DIAGNOSIS; DISEASE	Objective: To investigate the association between fasting plasma glucose level and pulmonary function. Research Design and Methods: Nutritional information, pulmonary function data, and laboratory test data from 9,223 subjects from the fourth Korea National Health and Nutrition Examination Survey were examined. The participants were divided into five groups according to fasting plasma glucose (FPG) level: normal fasting glucose (NFG) 1, FPG <90 mg/dl; NFG2, FPG 90-99 mg/dl; impaired fasting glucose (IFG) 1: FPG 100-109 mg/dl; IFG2, FPG 110-125 mg/dl; and diabetes, FPG >= 126 mg/dl and/or current anti-diabetes medications. Results: After adjustment for several variables, the percentage of predicted forced vital capacity(FVC%) decreased with increasing fasting plasma glucose level in both sexes[men: (mean +/- SEM) 92.0 +/- 0.3 in NFG1; 91.9 +/- 0.3 in NFG2; 92.0 +/- 0.4 in IFG1; 90.2 +/- 0.7 in IFG2; and 89.9 +/- 0.5 in diabetes, P = 0.004; women: 93.7 +/- 0.3 in NFG1; 93.7 +/- 0.3 in NFG2; 93.1 +/- 0.5 in IFG1; 91.1 +/- 0.9 in IFG2; and 90.7 +/- 0.6 in diabetes, P<0.001]. A logistic regression analysis found that IFG2 and diabetes were independently associated with the lowest quintile of predicted FVC% (IFG2: odds ratio [95% CI], 1.50 [1.18-1.89], P = 0.001; diabetes: 1.56 [1.30-1.88], P<0.001) using NFG1 as a control. Conclusions: The current data suggest that forced vital capacity may begin to decrease in the higher range of IFG.	[Lee, Yun Jeong; Yang, Ju Yean; Noh, Jung Hyun; Lee, Sung-Soon; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Dong-Jun] Inje Univ, Coll Med, Dept Internal Med, Busan, South Korea; [Kim, Na Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea	Inje University; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, DJ (corresponding author), Inje Univ, Coll Med, Dept Internal Med, Busan, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/AAU-8113-2020	Noh, Junghyun/0000-0002-7964-0515	Inje University	Inje University	This work was supported by a 2012 Inje University research grant. The relevant grant number is one. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bongaerts BWC, 2012, DIABETES CARE, V35, P1891, DOI 10.2337/dc11-2028; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Davis TME, 2000, DIABETES RES CLIN PR, V50, P153, DOI 10.1016/S0168-8227(00)00166-2; Davis WA, 2004, DIABETES CARE, V27, P752, DOI 10.2337/diacare.27.3.752; Fimognari FL, 2007, J GERONTOL A-BIOL, V62, P760, DOI 10.1093/gerona/62.7.760; Ford ES, 2004, DIABETES CARE, V27, P2966, DOI 10.2337/diacare.27.12.2966; Fox CS, 2005, DIABETES CARE, V28, P2436, DOI 10.2337/diacare.28.10.2436; Gabir MM, 2000, DIABETES CARE, V23, P1113, DOI 10.2337/diacare.23.8.1113; Hickson DA, 2011, LUNG, V189, P311, DOI 10.1007/s00408-011-9296-1; Kim HK, 2011, EXP CLIN ENDOCR DIAB, V119, P47, DOI 10.1055/s-0030-1268467; Klein OL, 2010, DIABETIC MED, V27, P977, DOI 10.1111/j.1464-5491.2010.03073.x; Ko SH, 2011, DIABETES METAB J, V35, P431, DOI 10.4093/dmj.2011.35.5.431; Lawlor DA, 2004, DIABETOLOGIA, V47, P195, DOI 10.1007/s00125-003-1310-6; Lazarus R, 1998, EUR RESPIR J, V12, P641, DOI 10.1183/09031936.98.12030641; Lin WY, 2006, OBESITY, V14, P1654, DOI 10.1038/oby.2006.190; Litonjua AA, 2005, RESP MED, V99, P1583, DOI 10.1016/j.rmed.2005.03.023; McKeever TM, 2005, AM J EPIDEMIOL, V161, P546, DOI 10.1093/aje/kwi076; Nakajima K, 2008, CHEST, V134, P712, DOI 10.1378/chest.07-3003; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Oda Eiji, 2009, Environmental Health and Preventive Medicine, V14, P284, DOI 10.1007/s12199-009-0098-5; Oda E, 2009, DIABETES RES CLIN PR, V85, P111, DOI 10.1016/j.diabres.2009.04.011; Oh JY, 2008, DIABETES RES CLIN PR, V80, P463, DOI 10.1016/j.diabres.2008.01.022; SANDLER M, 1990, ARCH INTERN MED, V150, P1385, DOI 10.1001/archinte.150.7.1385; Thyagarajan B, 2006, INT J EPIDEMIOL, V35, P1001, DOI 10.1093/ije/dyl049; Walter RE, 2003, AM J RESP CRIT CARE, V167, P911, DOI 10.1164/rccm.2203022; Yeh HC, 2008, DIABETES CARE, V31, P741, DOI 10.2337/dc07-1464	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76244	10.1371/journal.pone.0076244	http://dx.doi.org/10.1371/journal.pone.0076244			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086719	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900091
J	Yang, WH; Liu, SC; Tsai, CH; Fong, YC; Wang, SJ; Chang, YS; Tang, CH				Yang, Wei-Hung; Liu, Shan-Chi; Tsai, Chun-Hao; Fong, Yi-Chin; Wang, Shoou-Jyi; Chang, Yung-Sen; Tang, Chih-Hsin			Leptin Induces IL-6 Expression through OBRl Receptor Signaling Pathway in Human Synovial Fibroblasts	PLOS ONE			English	Article							NF-KAPPA-B; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; ARTICULAR-CARTILAGE; INTERLEUKIN-6; OSTEOARTHRITIS; AKT; BINDING; CELLS; FLUID	Background: Leptin, an adipocyte-secreted hormone that centrally regulates weight control, may exert proinflammatory effects in the joint, depending on the immune response. Leptin is abundantly expressed in osteoarthritis (OA) cartilage and synovium. However, the relationship between leptin and interleukin-6 (IL-6) in OA synovial fibroblasts (OASFs) remains obscure. Methodology/Principal Findings: Stimulation of OASFs with leptin induced IL-6 expression in a concentration-and time-dependent manner. OASFs expressed the long (OBRl) and short (OBRs) isoforms of the leptin receptor. However, OBRl, but not OBRs, antisense oligonucleotide (AS-ODN) abolished the leptin-mediated increase of IL-6 expression. Transfection with insulin receptor substrate (IRS)-1 siRNA decreased leptin-induced IL-6 production. In addition, pretreatment of cells with PI3K, Akt, or AP-1 inhibitor also inhibited the potentiating action of leptin. Leptin-induced AP-1 activation was inhibited by OBRl, IRS-1, PI3K, or Akt inhibitors and siRNAs. Conclusions/Significance: Our results showed that leptin activates the OBRl receptor, which in turn activates IRS-1, PI3K, Akt, and AP-1 pathway, leading to up-regulation of IL-6 expression.	[Yang, Wei-Hung; Chang, Yung-Sen] Taichung Hosp, Dept Orthoped Surg, Dept Hlth Execut Yuan, Taichung, Taiwan; [Yang, Wei-Hung] Natl Taichung Univ Sci & Technol, Dept Nursing, Taichung, Taiwan; [Yang, Wei-Hung; Fong, Yi-Chin] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Yang, Wei-Hung] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Liu, Shan-Chi] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Tsai, Chun-Hao] China Med Univ, Dept Med, Taichung, Taiwan; [Tsai, Chun-Hao] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Tsai, Chun-Hao; Fong, Yi-Chin] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Wang, Shoou-Jyi] Chang Hua Hosp, Dept Orthoped Surg, Dept Hlth Execut Yuan, Puhsin, Changhua County, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan	National Taichung University of Science & Technology; China Medical University Taiwan; National Chung Hsing University; National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Tang, CH (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.	chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015; Tsai, Chun-Hao/H-3140-2013	Tang, Chih Hsin/0000-0002-7113-8352; Tsai, Chun-Hao/0000-0002-4428-3132	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3, 100-2320-B-039-028-MY3]; Department of Health Executive Yuan [DOH10220]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health Executive Yuan	This study was supported by grants from the National Science Council of Taiwan (NSC99-2320-B-039-003-MY3; 100-2320-B-039-028-MY3) and Department of Health Executive Yuan (DOH10220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Attoub S, 2000, FASEB J, V14, P2329, DOI 10.1096/fj.00-0162; Attur M, 2013, CURR OPIN RHEUMATOL, V25, P136, DOI 10.1097/BOR.0b013e32835a9381; Bao JP, 2010, MOL BIOL REP, V37, P3265, DOI 10.1007/s11033-009-9911-x; Busso N, 2002, J IMMUNOL, V168, P875, DOI 10.4049/jimmunol.168.2.875; Cawston TE, 1998, ARTHRITIS RHEUM-US, V41, P1760, DOI 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M; Chattopadhyay M, 2011, DIABETES, V60, P1483, DOI 10.2337/db10-0869; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Del Rey MJ, 2010, ARTHRITIS RHEUM-US, V62, P3584, DOI 10.1002/art.27750; Dumond H, 2003, ARTHRITIS RHEUM, V48, P3118, DOI 10.1002/art.11303; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Gkretsi V, 2011, PROG LIPID RES, V50, P133, DOI 10.1016/j.plipres.2010.11.001; GRAEVE L, 1993, CLIN INVESTIGATOR, V71, P664; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; Grimble RF, 1998, NUTRITION, V14, P634, DOI 10.1016/S0899-9007(98)00010-0; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Huang CY, 2012, ARTHRITIS RHEUM-US, V64, P3344, DOI 10.1002/art.34557; Kaneko S, 2000, CYTOKINES CELL MOL T, V6, P71, DOI 10.1080/13684730050515796; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Ku JH, 2009, CLIN RHEUMATOL, V28, P1431, DOI 10.1007/s10067-009-1242-8; Liu JF, 2013, BBA-MOL CELL RES, V1833, P966, DOI 10.1016/j.bbamcr.2012.12.023; Livshits G, 2009, ARTHRITIS RHEUM-US, V60, P2037, DOI 10.1002/art.24598; Marks R, 2002, ARTHRITIS RES, V4, P112, DOI 10.1186/ar387; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Metlakunta AS, 2011, AM J PHYSIOL-REG I, V300, pR1185, DOI 10.1152/ajpregu.00794.2010; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Palmer G, 2003, ANN RHEUM DIS, V62, P913, DOI 10.1136/ard.62.10.913; Pelletier JP, 2010, ANN RHEUM DIS, V69, P2095, DOI 10.1136/ard.2009.122002; Persson E, 2005, BONE, V37, P513, DOI 10.1016/j.bone.2005.04.043; Poree B, 2008, J BIOL CHEM, V283, P4850, DOI 10.1074/jbc.M706387200; Presle N, 2006, OSTEOARTHR CARTILAGE, V14, P690, DOI 10.1016/j.joca.2006.01.009; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767; Samuels J, 2008, BULL HOSP JT DIS, V66, P244; Schaffler A, 2003, JAMA-J AM MED ASSOC, V290, P1709, DOI 10.1001/jama.290.13.1709-c; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Simopoulou T, 2007, OSTEOARTHR CARTILAGE, V15, P872, DOI 10.1016/j.joca.2007.01.018; Sui YH, 2009, ARTHRITIS RHEUM-US, V60, P2985, DOI 10.1002/art.24857; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Tang CH, 2007, J IMMUNOL, V179, P1292, DOI 10.4049/jimmunol.179.2.1292; Tang CH, 2010, ARTHRITIS RHEUM-US, V62, P3615, DOI 10.1002/art.27755; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tong KM, 2008, CELL SIGNAL, V20, P1478, DOI 10.1016/j.cellsig.2008.04.003; Vecchione C, 2002, DIABETES, V51, P168, DOI 10.2337/diabetes.51.1.168; Zarkesh-Esfahani H, 2001, J IMMUNOL, V167, P4593, DOI 10.4049/jimmunol.167.8.4593; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	48	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75551	10.1371/journal.pone.0075551	http://dx.doi.org/10.1371/journal.pone.0075551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086566	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900046
J	Yeh, HH; Chang, WT; Lu, KC; Lai, WW; Liu, HS; Su, WC				Yeh, Hsuan-Heng; Chang, Wen-Tsan; Lu, Kuang-Chu; Lai, Wu-Wei; Liu, Hsiao-Sheng; Su, Wu-Chou			Upregulation of Tissue Factor by Activated Stat3 Contributes to Malignant Pleural Effusion Generation via Enhancing Tumor Metastasis and Vascular Permeability in Lung Adenocarcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR EXPRESSION; PULMONARY METASTASIS; CANCER; COAGULATION; ANGIOGENESIS; PROGRESSION; SURVIVAL; CELLS; GLIOBLASTOMA	Malignant pleural effusion (MPE) is a poor prognostic sign for patients with lung cancer. Tissue factor (TF) is a coagulation factor that participates in angiogenesis and vascular permeability and is abundant in MPE. We previously demonstrated that autocrine IL-6-activated Stat3 contributes to tumor metastasis and upregulation of VEGF, resulting in the generation of MPE in lung adenocarcinoma. In this study, we found IL-6-triggered Stat3 activation also induces TF expression. By using pharmacologic inhibitors, it was shown that JAK2 kinase, but not Src kinase, contributed to autocrine IL-6-induced TF expression. Inhibition of Stat3 activation by dominant negative Stat3 (S3D) in lung adenocarcinoma suppressed TF-induced coagulation, anchorage-independent growth in vitro, and tumor growth in vivo. Consistently, knockdown of TF expression by siRNA resulted in a reduction of anchorage-independent growth of lung adenocarcinoma cells. Inhibition of TF expression also decreased the adhesion ability of cancer cells in normal lung tissues. In the nude mouse model, both lung metastasis and MPE generation were decreased when PC14PE6/AS2-siTF cells (TF expression was silenced) were intravenously injected. PC14PE6/AS2-siTF cells also produced less malignant ascites through inhibition of vascular permeability. In summary, we showed that TF expression plays a pivotal role in the pathogenesis of MPE generation via regulating of tumor metastasis and vascular permeability in lung adenocarcinoma bearing activated Stat3.	[Yeh, Hsuan-Heng; Chang, Wen-Tsan; Lu, Kuang-Chu; Liu, Hsiao-Sheng; Su, Wu-Chou] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Yeh, Hsuan-Heng; Su, Wu-Chou] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Ctr Canc, Tainan 70101, Taiwan; [Chang, Wen-Tsan; Lu, Kuang-Chu] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Lai, Wu-Wei] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70101, Taiwan; [Liu, Hsiao-Sheng] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Su, Wu-Chou] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70101, Taiwan; [Liu, Hsiao-Sheng] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Liu, HS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.	a713@mail.ncku.edu.tw; sunnysu@mail.ncku.edu.tw	, 賴吾為/T-8615-2019	, 賴吾為/0000-0001-9174-8310; Su, Wu-Chou/0000-0003-2953-4105; Liu, Hsiao-Sheng/0000-0003-0576-7203	Department of Health, Taiwan, R.O.C. [DOH102-TD-C-111-003, DOH102-TD-B-111-002, DOH101-TD-PB-111-TM024]	Department of Health, Taiwan, R.O.C.	This work was supported by the grants DOH102-TD-C-111-003, DOH102-TD-B-111-002 and DOH101-TD-PB-111-TM024 from Department of Health, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1999, P NATL ACAD SCI USA, V96, P8663, DOI 10.1073/pnas.96.15.8663; Alexandrakis MG, 2000, ONCOL REP, V7, P1327; Amarzguioui M, 2006, CLIN CANCER RES, V12, P4055, DOI 10.1158/1078-0432.CCR-05-2482; ANDERSON CB, 1974, CANCER-AM CANCER SOC, V33, P916, DOI 10.1002/1097-0142(197404)33:4<916::AID-CNCR2820330405>3.0.CO;2-U; Antony VB, 2001, EUR RESPIR J, V18, P402, DOI 10.1183/09031936.01.00225601; Belting M, 2005, ARTERIOSCL THROM VAS, V25, P1545, DOI 10.1161/01.ATV.0000171155.05809.bf; Belting M, 2004, NAT MED, V10, P502, DOI 10.1038/nm1037; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; BROMBERG ME, 1995, P NATL ACAD SCI USA, V92, P8205, DOI 10.1073/pnas.92.18.8205; Buettner R, 2002, CLIN CANCER RES, V8, P945; Camerer E, 1996, THROMB RES, V81, P1, DOI 10.1016/0049-3848(95)00209-X; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Dorfleutner A, 2004, MOL BIOL CELL, V15, P4416, DOI 10.1091/mbc.E03-09-0640; Friedl J, 2002, BLOOD, V100, P1334, DOI 10.1182/blood.V100.4.1334.h81602001334_1334_1339; Gieseler F, 2007, THROMB HAEMOSTASIS, V97, P1023, DOI 10.1160/TH06-12-0712; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Hsu IL, 2009, LUNG CANCER, V65, P371, DOI 10.1016/j.lungcan.2008.12.007; Im JH, 2004, CANCER RES, V64, P8613, DOI 10.1158/0008-5472.CAN-04-2078; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; Krikun G, 2000, MOL ENDOCRINOL, V14, P393, DOI 10.1210/me.14.3.393; Liu HS, 2008, NEOPLASIA, V10, P52, DOI 10.1593/neo.07691; Liu Y, 2011, CANCER RES, V71, P6492, DOI 10.1158/0008-5472.CAN-11-1145; MACKMAN N, 1990, P NATL ACAD SCI USA, V87, P2254, DOI 10.1073/pnas.87.6.2254; MACKMAN N, 1995, FASEB J, V9, P883, DOI 10.1096/fasebj.9.10.7615158; MEMON A, 1981, Current Problems in Cancer, V5, P1, DOI 10.1016/S0147-0272(81)80012-8; Milsom CC, 2008, CANCER RES, V68, P10068, DOI 10.1158/0008-5472.CAN-08-2067; Moschos C, 2009, NEOPLASIA, V11, P298, DOI 10.1593/neo.81480; Mueller BM, 1998, J CLIN INVEST, V101, P1372, DOI 10.1172/JCI930; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Provencal M, 2009, CARCINOGENESIS, V30, P1089, DOI 10.1093/carcin/bgp085; Regina S, 2009, CLIN CHEM, V55, P1834, DOI 10.1373/clinchem.2009.123695; Rickles FR, 2003, CHEST, V124, p58S, DOI 10.1378/chest.124.3_suppl.58S; Rong Y, 2006, CANCER RES, V66, P7067, DOI 10.1158/0008-5472.CAN-06-0346; Rong Y, 2009, CANCER RES, V69, P2540, DOI 10.1158/0008-5472.CAN-08-1547; Sawada M, 1999, BRIT J CANCER, V79, P472, DOI 10.1038/sj.bjc.6690073; Shigemori C, 1998, THROMB HAEMOSTASIS, V80, P894; Stathopoulos GT, 2008, JNCI-J NATL CANCER I, V100, P1464, DOI 10.1093/jnci/djn325; Stathopoulos GT, 2007, CANCER RES, V67, P9825, DOI 10.1158/0008-5472.CAN-07-1064; Stathopoulos GT, 2006, AM J RESP CELL MOL, V34, P142, DOI 10.1165/rcmb.2005-0130OC; Ueno T, 2000, BRIT J CANCER, V83, P164; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Versteeg HH, 2006, SEMIN THROMB HEMOST, V32, P24, DOI 10.1055/s-2006-933337; Wang XL, 2004, INT J CANCER, V112, P994, DOI 10.1002/ijc.20527; Yano S, 2000, AM J PATHOL, V157, P1893, DOI 10.1016/S0002-9440(10)64828-6; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Yu JL, 2005, BLOOD, V105, P1734, DOI 10.1182/blood-2004-05-2042; ZHANG YM, 1994, J CLIN INVEST, V94, P1320, DOI 10.1172/JCI117451	47	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75287	10.1371/journal.pone.0075287	http://dx.doi.org/10.1371/journal.pone.0075287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086497	Green Submitted, gold, Green Published			2022-12-25	WOS:000325223900042
J	Odaka, C; Loranger, A; Takizawa, K; Ouellet, M; Tremblay, MJ; Murata, S; Inoko, A; Inagaki, M; Marceau, N				Odaka, Chikako; Loranger, Anne; Takizawa, Kazuya; Ouellet, Michel; Tremblay, Michel J.; Murata, Shigeo; Inoko, Akihito; Inagaki, Masaki; Marceau, Normand			Keratin 8 Is Required for the Maintenance of Architectural Structure in Thymus Epithelium	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; MEDULLARY EPITHELIUM; MONOCLONAL-ANTIBODIES; DESMOSOMAL ADHESION; APOPTOTIC CELLS; MURINE THYMUS; MOUSE; EXPRESSION; PROTEIN; DESMOPLAKIN	Keratins (Ks), the intermediate filament (IF) proteins of epithelia, are coordinately expressed as pairs in a cell-lineage and differentiation manner. Cortical thymic epithelial cells (cTECs) predominantly express the simple epithelium keratin 8/18 (K8/K18) pair, whereas medullary thymic epithelial cells (mTECs) express the stratified epithelium K5/K14 pair, with TECs exhibiting K5 and K8 at the cortico-medullary junction in mature thymus. In the work reported here, we used wild-type (WT) and K8-knockout (K8-null) mice to address the contribution of K8/K18 IFs in the maintenance of the thymic epithelial structure. K8-null thymus maintained the differential cell segregation at the cortex versus the medulla observed in WT thymus, and the distribution of immature thymocytes at the cortex. The K8/K18 loss did not affect thymocyte development. However, it massively perturbed the TEC morphology both at the cortex and the medulla, along with a prominent depletion of cTECs. Such tissue alterations coincided with an increase in apoptosis and a reduced expression of Albatross (Fas-binding factor-1), also known for its capacity to bind K8/18 IFs. In addition, the K8/K18 loss affected the distribution of K5/K14-positive mTECs, but not their differentiation status. Together, the results indicate that K8/K18 IFs constitute key promoters of the thymic epithelium integrity.	[Odaka, Chikako; Takizawa, Kazuya] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan; [Loranger, Anne; Marceau, Normand] Univ Laval, Ctr Rech Canc, Quebec City, PQ, Canada; [Loranger, Anne; Ouellet, Michel; Tremblay, Michel J.; Marceau, Normand] CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Ouellet, Michel; Tremblay, Michel J.] Univ Laval, Ctr Rech Infectiol, Quebec City, PQ, Canada; [Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Tokyo, Japan; [Inoko, Akihito; Inagaki, Masaki] Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 464, Japan	National Institute of Infectious Diseases (NIID); Laval University; Laval University; Laval University; University of Tokyo; Aichi Cancer Center	Odaka, C (corresponding author), Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan.	odaka@nih.go.jp	Ouellet, Michel/C-9942-2015; Inagaki, Masaki/B-9920-2016; Murata, Shigeo/A-1426-2010; Ouellet, Michel/ABC-3759-2020	Ouellet, Michel/0000-0002-2353-7535; Murata, Shigeo/0000-0002-3177-3503; Ouellet, Michel/0000-0002-2353-7535; Inoko, Akihito/0000-0002-6739-2948	National Sciences and Engineering Council of Canada [312270]; Canadian Institutes of Health Research [MOP15529]; Grants-in-Aid for Scientific Research [23247035] Funding Source: KAKEN	National Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the National Sciences and Engineering Council of Canada (312270) and the Canadian Institutes of Health Research (MOP15529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Baribault H, 1992, GENE DEV, V7, P1991; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Bravo-Nuevo A, 2011, INT IMMUNOL, V23, P593, DOI 10.1093/intimm/dxr064; BRULET P, 1980, P NATL ACAD SCI-BIOL, V77, P4113, DOI 10.1073/pnas.77.7.4113; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; DEGERMANN S, 1994, J IMMUNOL, V152, P3254; FARR AG, 1985, J IMMUNOL, V134, P2971; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; GARROD DR, 1999, ADV MOL CEL, V28, P165; Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130; Godsel LM, 2005, J CELL BIOL, V171, P1045, DOI 10.1083/jcb.200510038; Habtezion A, 2011, P NATL ACAD SCI USA, V108, P1445, DOI 10.1073/pnas.1010833108; Irla M, 2010, TRENDS IMMUNOL, V31, P71, DOI 10.1016/j.it.2009.11.002; JACKSON BW, 1980, DIFFERENTIATION, V17, P161, DOI 10.1111/j.1432-0436.1980.tb01093.x; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; LANE EB, 1982, EMBO J, V1, P1365, DOI 10.1002/j.1460-2075.1982.tb01324.x; LEE MG, 1994, J IMMUNOL, V152, P5653; Loranger A, 1997, AM J PATHOL, V151, P1673; Loranger A, 2006, EXP CELL RES, V312, P4108, DOI 10.1016/j.yexcr.2006.09.031; Marceau N, 2004, METHOD CELL BIOL, V78, P95; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Odaka C, 2006, CELL TISSUE RES, V325, P13, DOI 10.1007/s00441-005-0139-3; Odaka C, 1999, J IMMUNOL, V163, P5346; Odaka C, 2002, CELL DEATH DIFFER, V9, P104, DOI 10.1038/sj/cdd/4400941; Odaka C, 2009, J HISTOCHEM CYTOCHEM, V57, P373, DOI 10.1369/jhc.2008.952895; Oriolo AS, 2007, EXP CELL RES, V313, P2255, DOI 10.1016/j.yexcr.2007.02.030; Oshima RG, 1996, CANCER METAST REV, V15, P445, DOI 10.1007/BF00054012; REISNER Y, 1976, CELL IMMUNOL, V25, P129, DOI 10.1016/0008-8749(76)90103-9; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; ROUSE RV, 1988, J HISTOCHEM CYTOCHEM, V36, P1511, DOI 10.1177/36.12.2461413; Runswick SK, 2001, NAT CELL BIOL, V3, P823, DOI 10.1038/ncb0901-823; Schmidt T, 2000, BBA-GENE STRUCT EXPR, V1493, P249, DOI 10.1016/S0167-4781(00)00163-9; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sugimoto M, 2008, J CELL BIOL, V183, P19, DOI 10.1083/jcb.200803133; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076	44	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75101	10.1371/journal.pone.0075101	http://dx.doi.org/10.1371/journal.pone.0075101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086449	gold, Green Submitted, Green Published			2022-12-25	WOS:000325025200025
J	Quinlan, ME; Hirasawa, M				Quinlan, Michelle E.; Hirasawa, Michiru			Multivesicular Release Underlies Short Term Synaptic Potentiation Independent of Release Probability Change in the Supraoptic Nucleus	PLOS ONE			English	Article							OXYTOCIN NEURONS; IN-VITRO; VASOPRESSIN NEURONS; RAT HYPOTHALAMUS; RIBBON SYNAPSE; MAGNOCELLULAR NEURONS; HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; LAMINA TERMINALIS; BURSTING ACTIVITY	Magnocellular neurons of the supraoptic nucleus receive glutamatergic excitatory inputs that regulate the firing activity and hormone release from these neurons. A strong, brief activation of these excitatory inputs induces a lingering barrage of tetrodotoxin-resistant miniature EPSCs (mEPSCs) that lasts for tens of minutes. This is known to accompany an immediate increase in large amplitude mEPSCs. However, it remains unknown how long this amplitude increase can last and whether it is simply a byproduct of greater release probability. Using in vitro patch clamp recording on acute rat brain slices, we found that a brief, high frequency stimulation (HFS) of afferents induced a potentiation of mEPSC amplitude lasting up to 20 min. This amplitude potentiation did not correlate with changes in mEPSC frequency, suggesting that it does not reflect changes in presynaptic release probability. Nonetheless, neither postsynaptic calcium chelator nor the NMDA receptor antagonist blocked the potentiation. Together with the known calcium dependency of HFS-induced potentiation of mEPSCs, our results imply that mEPSC amplitude increase requires presynaptic calcium. Further analysis showed multimodal distribution of mEPSC amplitude, suggesting that large mEPSCs were due to multivesicular glutamate release, even at late post-HFS when the frequency is no longer elevated. In conclusion, high frequency activation of excitatory synapses induces lasting multivesicular release in the SON, which is independent of changes in release probability. This represents a novel form of synaptic plasticity that may contribute to prolonged excitatory tone necessary for generation of burst firing of magnocellular neurons.	[Quinlan, Michelle E.; Hirasawa, Michiru] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, St John, NF, Canada	Memorial University Newfoundland	Hirasawa, M (corresponding author), Mem Univ Newfoundland, Fac Med, Div Biomed Sci, St John, NF, Canada.	michiru@mun.ca			Natural Sciences and Engineering Research Council of Canada [298916-2011]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant 298916-2011). (http://www.nserc-crsng.gc.ca/index_eng.asp) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong WE, 1995, PROG NEUROBIOL, V47, P291, DOI 10.1016/0301-0082(95)00025-9; Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; Boudaba C, 1997, J NEUROPHYSIOL, V77, P3396, DOI 10.1152/jn.1997.77.6.3396; Boudaba C, 2006, AM J PHYSIOL-REG I, V291, pR102, DOI 10.1152/ajpregu.00795.2005; Brown CH, 2006, TRENDS NEUROSCI, V29, P108, DOI 10.1016/j.tins.2005.11.005; Brown CH, 2004, EUR J NEUROSCI, V19, P2977, DOI 10.1111/j.0953-816X.2004.03408.x; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Csaki A, 2002, EUR J NEUROSCI, V16, P55, DOI 10.1046/j.1460-9568.2002.02059.x; DUDEK FE, 1987, J PHYSIOL-LONDON, V387, P273, DOI 10.1113/jphysiol.1987.sp016573; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Gordon GRJ, 2005, J NEUROSCI, V25, P11385, DOI 10.1523/JNEUROSCI.2378-05.2005; Goutman JD, 2007, P NATL ACAD SCI USA, V104, P16341, DOI 10.1073/pnas.0705756104; Hirasawa M, 2003, P NATL ACAD SCI USA, V100, P6139, DOI 10.1073/pnas.0936131100; Hirasawa M, 2003, J NEUROSCI, V23, P4270; HU B, 1992, J PHYSIOL-LONDON, V458, P667, DOI 10.1113/jphysiol.1992.sp019440; Inenaga K, 1998, J NEUROENDOCRINOL, V10, P1, DOI 10.1046/j.1365-2826.1998.00662.x; Iremonger KJ, 2008, PROG BRAIN RES, V170, P119, DOI 10.1016/S0079-6123(08)00411-1; Israel JM, 2003, EUR J NEUROSCI, V17, P2619, DOI 10.1046/j.1460-9568.2003.02705.x; Jourdain P, 1998, J NEUROSCI, V18, P6641; Kabashima N, 1997, J PHYSIOL-LONDON, V504, P113, DOI 10.1111/j.1469-7793.1997.113bf.x; Kombian SB, 2000, J NEUROPHYSIOL, V83, P2542, DOI 10.1152/jn.2000.83.5.2542; Moos F, 2004, NEUROSCIENCE, V125, P391, DOI 10.1016/j.neuroscience.2004.01.033; NISSEN R, 1995, J PHYSIOL-LONDON, V484, P415, DOI 10.1113/jphysiol.1995.sp020674; Panatier A, 2006, J PHYSIOL-LONDON, V573, P711, DOI 10.1113/jphysiol.2006.109447; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; Quinlan ME, 2008, J PHYSIOL-LONDON, V586, P3147, DOI 10.1113/jphysiol.2007.148957; RENAUD LP, 1993, ANN NY ACAD SCI, V689, P122, DOI 10.1111/j.1749-6632.1993.tb55542.x; Richard D, 1995, J PHYSIOL-LONDON, V489, P567, DOI 10.1113/jphysiol.1995.sp021073; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; STERN JE, 1995, J PHYSIOL-LONDON, V488, P701, DOI 10.1113/jphysiol.1995.sp021001; VANDENPOL AN, 1982, J COMP NEUROL, V206, P317, DOI 10.1002/cne.902060402	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e77402	10.1371/journal.pone.0077402	http://dx.doi.org/10.1371/journal.pone.0077402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086774	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200080
J	Zhao, LX; Huang, YL; Zheng, JL				Zhao, Lixia; Huang, Yunlong; Zheng, Jialin			STAT1 Regulates Human Glutaminase 1 Promoter Activity through Multiple Binding Sites in HIV-1 Infected Macrophages	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYROSINE PHOSPHORYLATION; NEUROCOGNITIVE DISORDER; UNPHOSPHORYLATED STAT1; GLUTAMATE PRODUCTION; IFN-GAMMA; GENE; NEUROTOXICITY; EXPRESSION; PROTEIN	Mononuclear phagocytes (MP, macrophages and microglia), the main targets of HIV-1 infection in the brain, play a pathogenic role in HIV-associated neurocognitive disorders (HAND) through the production and release of various soluble neurotoxic factors including glutamate. We have previously reported that glutaminase (GLS), the glutamate-generating enzyme, is upregulated in HIV-1 infected MP and in the brain tissues of HIV dementia individuals, and that HIV-1 or interferon-alpha (IFN-alpha) regulates human glutaminase 1 (GLS1) promoter through signal transducer and activator of transcription 1 (STAT1) phosphorylation in macrophages. However, there are multiple putative STAT1 binding sites in human GLS1 promoter, the exact molecular mechanism of how HIV-1 or IFN-alpha regulates human GLS1 promoter remains unclear. To further study the function of the putative STAT1 binding sites, we mutated the sequence of each binding site to ACTAGTCTC and found that six mutants (mut 1,3,4,5,7,8) had significantly higher promoter activity and two mutants (mut 2 and mut 6) completely lost the promoter activity compared with the wild type. To determine whether sites 2 and 6 could interfere with other inhibitory sites, particularly the nearby inhibitory sites 3 and 5, we made double mutants dmut 2/3 and dmut 5/6, and found that both the double mutants had significantly higher activity than the wild type, indicating that sites 3 and 5 are critical inhibitory elements, while sites 2 and 6 are excitatory elements. ChIP assay verified that STAT1 could bind with sites 2/3 and 5/6 within human GLS1 promoter in IFN-alpha stimulated or HIV-1-infected monocyte-derived macrophages. Interestingly, we found that rat Gls1 promoter was regulated through a similar way as human GLS1 promoter. Together, our data identified critical elements that regulate GLS1 promoter activity.	[Zhao, Lixia; Zheng, Jialin] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Ctr Translat Neurodegenerat & Regenerat Therapy, Shanghai 200092, Peoples R China; [Zhao, Lixia; Huang, Yunlong; Zheng, Jialin] Univ Nebraska Med Ctr, Lab Neuroimmunol & Regenerat Therapy, Omaha, NE 68198 USA; [Zhao, Lixia; Huang, Yunlong; Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	Tongji University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Huang, YL (corresponding author), Univ Nebraska Med Ctr, Lab Neuroimmunol & Regenerat Therapy, Omaha, NE 68198 USA.	yhuan1@unmc.edu; jzheng@unmc.edu	Huang, Yunlong/J-6554-2015	Huang, Yunlong/0000-0002-3328-1924	National Institute of Health [R01 NS 041858, R01 NS 061642, P01 NS 043985]; China National Science and Technology major project [2014CB965001]; National Natural Science Foundation of China (NSFC) [81028007, 81329002, 81301468]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061642, R01NS041858, P01NS043985] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China National Science and Technology major project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by research grants by the National Institute of Health: R01 NS 041858, R01 NS 061642, P01 NS 043985, the China National Science and Technology major project (2014CB965001), and the National Natural Science Foundation of China (NSFC) # 81028007 and # 81329002 to JCZ, and NSFC # 81301468 to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOVICH C, 1994, EMBO J, V13, P5871, DOI 10.1002/j.1460-2075.1994.tb06932.x; Andratsch M, 2007, AM J PHYSIOL-RENAL, V293, pF846, DOI 10.1152/ajprenal.00139.2007; Barber SA, 2004, J NEUROVIROL, V10, P15, DOI 10.1080/13550280490268179; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Constantino AA, 2011, NEUROTOX RES, V20, P277, DOI 10.1007/s12640-011-9241-3; Cui M, 2009, ADV EXP MED BIOL, V665, P143; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Erdmann N, 2007, J NEUROCHEM, V102, P539, DOI 10.1111/j.1471-4159.2007.04594.x; Erdmann N, 2009, J NEUROCHEM, V109, P551, DOI 10.1111/j.1471-4159.2009.05989.x; Erickson JW, 2010, ONCOTARGET, V1, P734, DOI 10.18632/oncotarget.208; Ferrando S J, 2000, New Dir Ment Health Serv, P25; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Ghazawi I, 2005, J INTERF CYTOK RES, V25, P92, DOI 10.1089/jir.2005.25.92; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Huang YL, 2011, J NEUROSCI, V31, P15195, DOI 10.1523/JNEUROSCI.2051-11.2011; Huang YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005397; Jiang ZG, 2001, J NEUROIMMUNOL, V117, P97, DOI 10.1016/S0165-5728(01)00315-0; Kim DY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-25; Kraft-Terry SD, 2009, NEURON, V64, P133, DOI 10.1016/j.neuron.2009.09.042; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lindl KA, 2010, J NEUROIMMUNE PHARM, V5, P294, DOI 10.1007/s11481-010-9205-z; LIPTON SA, 1994, DEV NEUROSCI-BASEL, V16, P145, DOI 10.1159/000112101; Marquez J, 2006, NEUROCHEM INT, V48, P465, DOI 10.1016/j.neuint.2005.10.015; Mizuno T, 2008, FASEB J, V22, P1797, DOI 10.1096/fj.07-099499; MOCK B, 1989, GENOMICS, V5, P291, DOI 10.1016/0888-7543(89)90060-8; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Perez-Gomez C, 2003, BIOCHEM J, V370, P771, DOI 10.1042/BJ20021445; Phipps T, 2008, NATURE ED, V1; Ricciarelli R, 2004, IUBMB LIFE, V56, P349, DOI 10.1080/15216540412331286002; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; Saransaari P, 1998, NEUROCHEM RES, V23, P563, DOI 10.1023/A:1022494921018; Taylor L, 2001, BBA-GENE STRUCT EXPR, V1518, P132, DOI 10.1016/S0167-4781(01)00183-X; Yadav A, 2009, J NEUROIMMUNE PHARM, V4, P430, DOI 10.1007/s11481-009-9174-2; Yuasa K, 2012, FEBS LETT, V586, P3464, DOI 10.1016/j.febslet.2012.07.074; Zhao JX, 2004, J NEUROCHEM, V88, P169, DOI 10.1046/j.1471-4159.2003.02146.x; Zhao LX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032995	38	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e76581	10.1371/journal.pone.0076581	http://dx.doi.org/10.1371/journal.pone.0076581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086752	gold, Green Published, Green Submitted			2022-12-25	WOS:000325025200077
J	Takahashi, T; Takigami, S; Sunada, H; Lukowiak, K; Sakakibara, M				Takahashi, Tomoyo; Takigami, Satoshi; Sunada, Hiroshi; Lukowiak, Ken; Sakakibara, Manabu			Critical Period of Memory Enhancement during Taste Avoidance Conditioning in Lymnaea stagnalis	PLOS ONE			English	Article							LONG-TERM-MEMORY; INDUCED RETROGRADE-AMNESIA; PROTEIN-KINASE-C; INTERMEDIATE-TERM; BEHAVIORAL SENSITIZATION; SYNAPTIC FACILITATION; MOLECULAR-MECHANISMS; RESPIRATORY BEHAVIOR; WITHDRAWAL REFLEX; GILL-WITHDRAWAL	The present study investigated the optimal training procedure leading to long-lasting taste avoidance behavior in Lymnaea. A training procedure comprising 5 repeated pairings of a conditional stimulus (CS, sucrose), with an unconditional stimulus (US, a tactile stimulation to the animal's head), over a 4-day period resulted in an enhanced memory formation than 10 CS-US repeated pairings over a 2-day period or 20 CS-US repeated pairings on a single day. Backward conditioning (US-CS) pairings did not result in conditioning. Thus, this taste avoidance conditioning was CS-US pairing specific. Food avoidance behavior was not observed following training, however, if snails were immediately subjected to a cold-block (4 degrees C for 10 min). It was critical that the cold-block be applied within 10 min to block long-term memory (LTM) formation. Further, exposure to the cold-block 180 min after training also blocked both STM and LTM formation. The effects of the cold-block on subsequent learning and memory formation were also examined. We found no long lasting effects of the cold-block on subsequent memory formation. If protein kinase C was activated before the conditioning paradigm, snails could still acquire STM despite exposure to the cold-block.	[Takahashi, Tomoyo; Sakakibara, Manabu] Tokai Univ, Sch High Technol Human Welf, Shizuoka, Japan; [Takigami, Satoshi; Sakakibara, Manabu] Tokai Univ, Grad Sch High Technol Human Welf, Shizuoka, Japan; [Takigami, Satoshi; Sakakibara, Manabu] Tokai Univ, Grad Sch Biosci, Shizuoka, Japan; [Sunada, Hiroshi; Lukowiak, Ken] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Calgary, AB, Canada	Tokai University; Tokai University; Tokai University; University of Calgary	Sakakibara, M (corresponding author), Tokai Univ, Sch High Technol Human Welf, Shizuoka, Japan.	manabu@tokai.ac.jp						Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Alberini CM, 2012, TRENDS NEUROSCI, V35, P274, DOI 10.1016/j.tins.2011.12.007; Alkon D. L., 1987, MEMORY TRACES BRAIN; ALKON DL, 1985, BEHAV NEURAL BIOL, V44, P278, DOI 10.1016/S0163-1047(85)90296-1; ALKON DL, 1988, SCIENCE, V239, P998, DOI 10.1126/science.2830669; Alkon DL, 2005, P NATL ACAD SCI USA, V102, P16432, DOI 10.1073/pnas.0508001102; Alkon DL, 1998, ADV EXP MED BIOL, V446, P1; ANOKHIN KV, 1991, EUR J NEUROSCI, V3, P162, DOI 10.1111/j.1460-9568.1991.tb00076.x; Azami S, 2006, J NEUROSCI RES, V84, P1610, DOI 10.1002/jnr.21045; BANK B, 1988, P NATL ACAD SCI USA, V85, P1988, DOI 10.1073/pnas.85.6.1988; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Botzer D, 1998, LEARN MEMORY, V5, P204; Braun MH, 2011, NEUROBIOL LEARN MEM, V96, P403, DOI 10.1016/j.nlm.2011.06.016; Browning K, 2008, NEUROSCIENCE, V155, P613, DOI 10.1016/j.neuroscience.2008.06.012; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Commins S, 2003, BEHAV BRAIN RES, V139, P215, DOI 10.1016/S0166-4328(02)00270-X; Crow T, 2011, NEUROSCIENCE, V192, P102, DOI 10.1016/j.neuroscience.2011.06.063; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; Epstein HT, 2004, NEUROBIOL LEARN MEM, V81, P12, DOI 10.1016/S1074-7427(03)00074-1; Epstein HT, 2003, NEUROBIOL LEARN MEM, V79, P127, DOI 10.1016/S1074-7427(02)00020-5; FLEXNER LB, 1966, P NATL ACAD SCI USA, V55, P369, DOI 10.1073/pnas.55.2.369; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; Fulton D, 2005, EUR J NEUROSCI, V21, P1347, DOI 10.1111/j.1460-9568.2005.03970.x; Fulton D, 2008, J NEUROPHYSIOL, V100, P108, DOI 10.1152/jn.90389.2008; Fulton D, 2008, NEUROBIOL LEARN MEM, V90, P651, DOI 10.1016/j.nlm.2008.08.006; GARCIA J, 1974, SCIENCE, V185, P824, DOI 10.1126/science.185.4154.824; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Hawkins RD, 2006, BIOL BULL-US, V210, P174, DOI 10.2307/4134556; Hintzman D. L., 1974, THEORIES COGNITIVE P, P77; Hovland CI, 1940, J EXP PSYCHOL, V26, P568, DOI 10.1037/h0055061; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kawai R, 2004, NEUROBIOL LEARN MEM, V82, P164, DOI 10.1016/j.nlm.2004.06.003; Kawai R, 2004, J NEUROPHYSIOL, V91, P728, DOI 10.1152/jn.00757.2003; Kawai R, 2002, NEUROSCI RES, V43, P363, DOI 10.1016/S0168-0102(02)00061-5; Kuzirian AM, 2006, BIOL BULL-US, V210, P201, DOI 10.2307/4134558; Lukowiak K, 1998, J EXP BIOL, V201, P877; Lukowiak K, 2000, LEARN MEMORY, V7, P140, DOI 10.1101/lm.7.3.140; Marra V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2591; Martens K, 2007, NEUROBIOL LEARN MEM, V88, P232, DOI 10.1016/j.nlm.2007.04.009; Michel M, 2012, J NEUROSCI, V32, P4581, DOI 10.1523/JNEUROSCI.6264-11.2012; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Mozzachiodi R, 2008, NAT NEUROSCI, V11, P1146, DOI 10.1038/nn.2184; Murakami J, 2013, J NEUROSCI, V33, P371, DOI 10.1523/JNEUROSCI.0679-12.2013; Nelson TJ, 1996, P NATL ACAD SCI USA, V93, P13808, DOI 10.1073/pnas.93.24.13808; NELSON TJ, 1990, P NATL ACAD SCI USA, V87, P269, DOI 10.1073/pnas.87.1.269; OLDS JL, 1989, SCIENCE, V245, P866, DOI 10.1126/science.2772638; Ono M, 2002, NEUROBIOL LEARN MEM, V78, P53, DOI 10.1006/nlme.2001.4066; Parvez K, 2005, J EXP BIOL, V208, P1525, DOI 10.1242/jeb.01545; Pascale A, 2005, P NATL ACAD SCI USA, V102, P12065, DOI 10.1073/pnas.0504702102; Quattrone A, 2001, P NATL ACAD SCI USA, V98, P11668, DOI 10.1073/pnas.191388398; Ramirez RR, 1998, LEARN MEMORY, V4, P462, DOI 10.1101/lm.4.6.462; Rosenegger D, 2008, NEUROBIOL LEARN MEM, V90, P544, DOI 10.1016/j.nlm.2008.06.005; ROSENZWEIG MR, 1993, BEHAV BRAIN RES, V57, P193, DOI 10.1016/0166-4328(93)90135-D; Sakakibara M, 1998, NEUROBIOL LEARN MEM, V69, P1, DOI 10.1006/nlme.1997.3805; Sakakibara M, 2006, BIOL BULL-US, V210, P298, DOI 10.2307/4134566; Sakakibara Manabu, 2008, P131; Sangha S, 2003, NEUROBIOL LEARN MEM, V80, P130, DOI 10.1016/S1074-7427(03)00065-0; Sangha S, 2003, J NEUROSCI, V23, P9842; Sangha S, 2003, J NEUROSCI, V23, P8034; Sangha S, 2003, J EXP BIOL, V206, P71, DOI 10.1242/jeb.00061; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; SEKIGUCHI T, 1994, NEUROSCI RES, V18, P267, DOI 10.1016/0168-0102(94)90162-7; Sherff CM, 2004, P NATL ACAD SCI USA, V101, P7463, DOI 10.1073/pnas.0402163101; Sommerville J, 1999, BIOESSAYS, V21, P319, DOI 10.1002/(SICI)1521-1878(199904)21:4<319::AID-BIES8>3.3.CO;2-V; Staras K, 1998, J NEUROPHYSIOL, V79, P3030, DOI 10.1152/jn.1998.79.6.3030; Stough S, 2006, CURR OPIN NEUROBIOL, V16, P672, DOI 10.1016/j.conb.2006.10.009; Sunada H, 2012, ACTA BIOL HUNG, V63, P190, DOI 10.1556/ABiol.63.2012.Suppl.2.24; Sunada H, 2010, J EXP BIOL, V213, P3409, DOI 10.1242/jeb.043521; Sunada H, 2010, NEUROBIOL LEARN MEM, V94, P269, DOI 10.1016/j.nlm.2010.06.005; Sutton MA, 2001, NEURON, V31, P143, DOI 10.1016/S0896-6273(01)00342-7; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Timbers TA, 2011, BEHAV NEUROSCI, V125, P560, DOI 10.1037/a0024370; Wustenberg D, 1998, EUR J NEUROSCI, V10, P2742, DOI 10.1046/j.1460-9568.1998.t01-1-00319.x; Xia SZ, 1999, PHYSIOL BEHAV, V65, P617; YAMADA A, 1992, J NEUROSCI, V12, P729	80	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75276	10.1371/journal.pone.0075276	http://dx.doi.org/10.1371/journal.pone.0075276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098373	gold, Green Published, Green Submitted			2022-12-25	WOS:000325483600015
J	Maiga, B; Dolo, A; Toure, O; Dara, V; Tapily, A; Campino, S; Sepulveda, N; Risley, P; Silva, N; Corran, P; Rockett, KA; Kwiatkowski, D; Clark, TG; Troye-Blomberg, M; Doumbo, OK				Maiga, Bakary; Dolo, Amagana; Toure, Ousmane; Dara, Victor; Tapily, Amadou; Campino, Susana; Sepulveda, Nuno; Risley, Paul; Silva, Nipula; Corran, Patrick; Rockett, Kirk A.; Kwiatkowski, Dominic; Clark, Taane G.; Troye-Blomberg, Marita; Doumbo, Ogobara K.		MalariaGEN Consortium	Human Candidate Polymorphisms in Sympatric Ethnic Groups Differing in Malaria Susceptibility in Mali	PLOS ONE			English	Article							HUMORAL RESPONSE; FATAL MALARIA; CYTOKINES; CYTOADHERENCE; ASSOCIATIONS; INFECTIONS; PREVALENCE; PROTECTION; RESISTANCE; GENETICS	Malaria still remains a major public health problem in Mali, although disease susceptibility varies between ethnic groups, particularly between the Fulani and Dogon. These two sympatric groups share similar socio-cultural factors and malaria transmission rates, but Fulani individuals tend to show significantly higher spleen enlargement scores, lower parasite prevalence, and seem less affected by the disease than their Dogon neighbours. We have used genetic polymorphisms from malaria-associated genes to investigate associations with various malaria metrics between the Fulanai and Dogon groups. Two cross sectional surveys (transmission season 2006, dry season 2007) were performed. Healthy volunteers from the both ethnic groups (n=939) were recruited in a rural setting. In each survey, clinical (spleen enlargement, axillary temperature, weight) and parasitological data (malaria parasite densities and species) were collected, as well as blood samples. One hundred and sixty six SNPs were genotyped and 5 immunoassays (AMA1, CSP, MSP1, MSP2, total IgE) were performed on the DNA and serum samples respectively. The data confirm the reduced malaria susceptibility in the Fulani, with a higher level of the protective O-blood group, and increased circulating antibody levels to several malaria antigens (p<10(-15)). We identified SNP allele frequency differences between the 2 ethnic groups in CD36, IL4, RTN3 and ADCY9. Moreover, polymorphisms in FCER1A, RAD50, TNF, SLC22A4, and IL13 genes were correlated with antibody production (p-value<0.003). Further work is required to understand the mechanisms underpinning these genetic factors.	[Maiga, Bakary; Dolo, Amagana; Toure, Ousmane; Dara, Victor; Tapily, Amadou; Doumbo, Ogobara K.] Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Fac Med Pharm & Odonto Stomatol, Bamako, USTTB, Mali; [Campino, Susana; Rockett, Kirk A.; Kwiatkowski, Dominic] Wellcome Trust Sanger Inst, Hinxton, England; [Sepulveda, Nuno; Corran, Patrick; Clark, Taane G.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England; [Sepulveda, Nuno] Univ Lisbon, Ctr Stat & Applicat, P-1699 Lisbon, Portugal; [Risley, Paul; Silva, Nipula; Corran, Patrick] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Rockett, Kirk A.; Kwiatkowski, Dominic; MalariaGEN Consortium] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Clark, Taane G.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Troye-Blomberg, Marita] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	University of Science & Technology of Bamako; Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; Universidade de Lisboa; National Institute for Biological Standards & Control; University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine; Stockholm University	Maiga, B (corresponding author), Malaria Res & Training Ctr, Dept Epidemiol Parasit Dis, Fac Med Pharm & Odonto Stomatol, BP 1805, Bamako, USTTB, Mali.	bmaiga@icermali.org; adolo@icermali.org	Campino, Susana/AAM-2577-2020; Clark, Taane G./AAM-2570-2020; Sepulveda, Nuno/AAA-5544-2021; Sepulveda, Nuno/S-9936-2019; Risley, Paul/E-2489-2013; Troye-Blomberg, Marita/B-9210-2016	Campino, Susana/0000-0003-1403-6138; Clark, Taane G./0000-0001-8985-9265; Troye-Blomberg, Marita/0000-0002-2804-0325; Kwiatkowski, Dominic/0000-0002-5023-0176; Sepulveda, Nuno/0000-0002-8542-1706	Wellcome Trust [WT077383/Z/05/Z, 090770/Z/09/Z, 075491/Z/04, 090532/Z/09/Z, 098051]; Foundation of the National Institutes of Health, Bill & Melinda Gates' Grand Challenges in Global Health Initiative [566]; Medical Research Council [G0600718, G0600230]; Fundacao para Ciencia e Tecnologia, Portugal [Pest-OE/MAT/UI0006/2011]; MRC [G0600230, G0600718] Funding Source: UKRI; Medical Research Council [G0600718B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Foundation of the National Institutes of Health, Bill & Melinda Gates' Grand Challenges in Global Health Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The MalariaGEN Project is supported by the Wellcome Trust (WT077383/Z/05/Z), and by the Foundation of the National Institutes of Health (566), as part of the Bill & Melinda Gates' Grand Challenges in Global Health Initiative. The Resource Centre for Genomic Epidemiology of Malaria is supported by the Wellcome Trust (090770/Z/09/Z). This research was supported by the Medical Research Council (G0600718; G0600230). The Wellcome Trust provides core awards to Wellcome Trust Centre for Human Genetics (075491/Z/04; 090532/Z/09/Z) and the Wellcome Trust Sanger Institute (098051). TGC is funded by the Medical Research Council and the Wellcome Trust. Sepulveda Nuno acknowledges partial funding from Fundacao para Ciencia e Tecnologia, Portugal, through the project Pest-OE/MAT/UI0006/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Al-Sherbiny M, 2003, ACTA TROP, V88, P117, DOI 10.1016/S0001-706X(03)00195-5; [Anonymous], 2008, WORLD MAL REP 2008; Armah H, 2005, ANN TROP MED PARASIT, V99, P629, DOI 10.1179/136485905X51508; Bryceson ADM, 1976, ACTA TROP, V33, P424; Campino S, 2006, SEMIN IMMUNOL, V18, P411, DOI 10.1016/j.smim.2006.07.011; Clark TG, 2009, J INFECT DIS, V199, P569, DOI 10.1086/596320; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Cserti-Gazdewich CM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-233; Diakite M, 2009, HUM GENET, V125, P105, DOI 10.1007/s00439-008-0597-2; Diallo D, 2005, CLIN INFECT DIS, V41, P920; Dolo A, 2005, AM J TROP MED HYG, V72, P243, DOI 10.4269/ajtmh.2005.72.243; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Eid NA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-119; Fry AE, 2009, HUM MOL GENET, V18, P2683, DOI 10.1093/hmg/ddp192; Gazzinelli RT, 2006, NAT REV IMMUNOL, V12, P2006, DOI [10.1038/nm1469, DOI 10.1038/NM1469]; GREENWOOD BM, 1987, ANN TROP MED PARASIT, V81, P345, DOI 10.1080/00034983.1987.11812130; Hackett LW, 1944, J NAT MAL SOC, V3, P11; HASLER T, 1990, BLOOD, V76, P1845; Ho M, 1999, AM J PHYSIOL-CELL PH, V276, pC1231, DOI 10.1152/ajpcell.1999.276.6.C1231; Kouriba B, 2005, J IMMUNOL, V174, P6274, DOI 10.4049/jimmunol.174.10.6274; Kwiatkowski D, 2000, CURR OPIN GENET DEV, V10, P320, DOI 10.1016/S0959-437X(00)00087-3; Leenstra T, 2006, INFECT IMMUN, V74, P370, DOI 10.1128/IAI.74.1.370-381.2006; LOPEZ AF, 1988, BLOOD, V72, P1797; Loso JB, 2000, P NATL ACAD SCI USA, V97, P5693, DOI 10.1073/pnas.97.11.5693; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Manjurano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047463; Meyer CG, 2011, HUM MOL GENET, V20, P1173, DOI 10.1093/hmg/ddq562; Modiano D, 1998, AM J TROP MED HYG, V58, P220, DOI 10.4269/ajtmh.1998.58.220; Modiano D, 1999, AM J TROP MED HYG, V61, P663, DOI 10.4269/ajtmh.1999.61.663; Modiano D, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P193; Ohashi J, 2003, GENES IMMUN, V4, P528, DOI 10.1038/sj.gene.6364010; Patel SN, 2007, J IMMUNOL, V178, P3954, DOI 10.4049/jimmunol.178.6.3954; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; SCHLEIMER RP, 1989, J IMMUNOL, V143, P1310; SNYDER DB, 1983, AVIAN DIS, V27, P161, DOI 10.2307/1590381; Toure O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043987; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Vafa M, 2007, MICROBES INFECT, V9, P1043, DOI 10.1016/j.micinf.2007.04.011; Vafa M, 2009, MICROBES INFECT, V11, P779, DOI 10.1016/j.micinf.2009.04.017; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	46	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75675	10.1371/journal.pone.0075675	http://dx.doi.org/10.1371/journal.pone.0075675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098393	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000325434500036
J	Ferri, F; Ardizzi, M; Ambrosecchia, M; Gallese, V				Ferri, Francesca; Ardizzi, Martina; Ambrosecchia, Marianna; Gallese, Vittorio			Closing the Gap between the Inside and the Outside: Interoceptive Sensitivity and Social Distances	PLOS ONE			English	Article							RESPIRATORY SINUS ARRHYTHMIA; CARDIAC VAGAL TONE; HEART-RATE-VARIABILITY; PERIPERSONAL SPACE; PERIARCUATE NEURONS; AFFERENT PROPERTIES; MACAQUE MONKEYS; BEAT PERCEPTION; PANIC DISORDER; SHORT-TERM	Humans' ability to represent their body state from within through interoception has been proposed to predict different aspects of human cognition and behaviour. We focused on the possible contribution of interoceptive sensitivity to social behaviour as mediated by adaptive modulation of autonomic response. We, thus, investigated whether interoceptive sensitivity to one's heartbeat predicts participants' autonomic response at different social distances. We measured respiratory sinus arrhythmia (RSA) during either a Social or a Non-social task. In the Social task each participant viewed an experimenter performing a caress-like movement at different distances from their hand. In the Non-social task a metal stick was moved at the same distances from the participant's hand. We found a positive association between interoceptive sensitivity and autonomic response only for the social setting. Moreover, only good heartbeat perceivers showed higher autonomic response 1) in the social compared to the non-social setting, 2) specifically, when the experimenter's hand was moving at boundary of their peripersonal space (20 cm from the participant's hand). Our findings suggest that interoceptive sensitivity might contribute to interindividual differences concerning social attitudes and interpersonal space representation via recruitment of different adaptive autonomic response strategies.	[Ferri, Francesca; Ardizzi, Martina; Ambrosecchia, Marianna; Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Gallese, Vittorio] IIT, Brain Ctr Social & Motor Cognit, Parma, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT	Ferri, F (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	francesca.ferri@nemo.unipr.it; vittorio.gallese@unipr.it	Gallese, Vittorio/ABD-5097-2021; Ghiami, Zeinab/G-5492-2016; Ferri, Francesca/AAC-2527-2022	Gallese, Vittorio/0000-0003-4815-3607; Ferri, Francesca/0000-0003-1821-5870; Ardizzi, Martina/0000-0001-9185-6784	EU grant TESIS	EU grant TESIS	This work was supported by the EU grant TESIS to VG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley V, 2012, PSYCHOPHYSIOLOGY, V49, P1672, DOI 10.1111/j.1469-8986.2012.01468.x; Allen JJB, 2007, BIOL PSYCHOL, V74, P243, DOI 10.1016/j.biopsycho.2006.08.005; Bar KJ, 2010, SCHIZOPHRENIA BULL, V36, P1050, DOI 10.1093/schbul/sbp024; Bal E, 2010, J AUTISM DEV DISORD, V40, P358, DOI 10.1007/s10803-009-0884-3; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bassolino M, 2010, NEUROPSYCHOLOGIA, V48, P803, DOI 10.1016/j.neuropsychologia.2009.11.009; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; BESTLER M, 1990, Z EXP ANGEW PSYCHOL, V37, P361; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P759, DOI 10.1016/0028-3932(86)90075-8; Carlsson K, 2000, J COGNITIVE NEUROSCI, V12, P691, DOI 10.1162/089892900562318; Centomo C, PADUA INVENTORY BECK; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; DAMASIO AR, 1994, SCI AM, V271, P144, DOI 10.1038/scientificamerican1094-144; DEGEUS EJC, 1990, PSYCHOPHYSIOLOGY, V27, P457; Domschke K, 2010, CLIN PSYCHOL REV, V30, P1, DOI 10.1016/j.cpr.2009.08.008; DOSEY MA, 1969, J PERS SOC PSYCHOL, V11, P93, DOI 10.1037/h0027040; Dunn BD, 2010, PSYCHOL SCI, V21, P1835, DOI 10.1177/0956797610389191; Ehlers A, 1996, BIOL PSYCHOL, V42, P165, DOI 10.1016/0301-0511(95)05153-8; Ferri F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1140; Fogassi L, 1999, EXP BRAIN RES, V128, P194, DOI 10.1007/s002210050835; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Fustos J, 2013, SOC COGN AFFECT NEUR, V8, P911, DOI 10.1093/scan/nss089; Gorka SM, 2013, J PSYCHOPHYSIOL, V27, P95, DOI 10.1027/0269-8803/a000091; Gorka SM, 2013, BIOL PSYCHOL, V93, P334, DOI 10.1016/j.biopsycho.2013.03.003; Graziano MSA, 2001, NEURON, V29, P4, DOI 10.1016/S0896-6273(01)00174-X; Graziano PA, 2007, CHILD DEV, V78, P264, DOI 10.1111/j.1467-8624.2007.00996.x; Grossman P, 2001, RESPIRATION AND EMOTION, P43; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; HALLIGAN PW, 1991, NATURE, V350, P498, DOI 10.1038/350498a0; HAYANO J, 1990, AM J CARDIOL, V65, P84, DOI 10.1016/0002-9149(90)90030-5; Herbert BM, 2007, INT J PSYCHOPHYSIOL, V65, P214, DOI 10.1016/j.ijpsycho.2007.04.007; Herbert BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036646; Herbert BM, 2012, BIOL PSYCHOL, V89, P71, DOI 10.1016/j.biopsycho.2011.09.004; Herbert BM, 2010, PSYCHOPHYSIOLOGY, V47, P342, DOI 10.1111/j.1469-8986.2009.00931.x; Herbert BM, 2012, TOP COGN SCI; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; HOROWITZ MJ, 1964, ARCH GEN PSYCHIAT, V11, P651; Jones G. E., 1994, ADV PSYCHOP, V5, P55; Jurca R, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.10.024; KNOLL JF, 1992, PSYCHOPHYSIOLOGY, V29, P218, DOI 10.1111/j.1469-8986.1992.tb01689.x; Lloyd DM, 2009, NEUROSCI BIOBEHAV R, V33, P297, DOI 10.1016/j.neubiorev.2008.09.007; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Mathewson KJ, 2013, INT J PSYCHOPHYSIOL, V88, P171, DOI 10.1016/j.ijpsycho.2013.03.016; Matthias E, 2009, INT J PSYCHOPHYSIOL, V72, P154, DOI 10.1016/j.ijpsycho.2008.12.001; MONTGOMERY WA, 1984, PSYCHOPHYSIOLOGY, V21, P459, DOI 10.1111/j.1469-8986.1984.tb00227.x; Mussgay L, 1999, J PSYCHOPHYSIOL, V13, P27, DOI 10.1027//0269-8803.13.1.27; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panksepp J, 1997, ANN NY ACAD SCI, V807, P78, DOI 10.1111/j.1749-6632.1997.tb51914.x; Patriquin MA, 2011, DEV PSYCHOBIOL; Pedrabissi L, 1989, INVENTARIO ANSIA STA; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Pollatos Olga, 2008, Eat Behav, V9, P381, DOI 10.1016/j.eatbeh.2008.02.001; Pollatos O, 2007, J ANXIETY DISORD, V21, P931, DOI 10.1016/j.janxdis.2006.12.004; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V65, P167, DOI 10.1016/j.ijpsycho.2007.03.005; Pollatos O, 2009, DEPRESS ANXIETY, V26, P167, DOI 10.1002/da.20504; Porges S W, 1994, Monogr Soc Res Child Dev, V59, P167, DOI 10.2307/1166144; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Porges Stephen W, 2009, Cleve Clin J Med, V76 Suppl 2, pS86, DOI 10.3949/ccjm.76.s2.17; PORGES SW, 1995, NEUROSCI BIOBEHAV R, V19, P225, DOI 10.1016/0149-7634(94)00066-A; PORGES SW, 1995, PSYCHOPHYSIOLOGY, V32, P301, DOI 10.1111/j.1469-8986.1995.tb01213.x; Porges SW, 2003, ANN NY ACAD SCI, V1008, P31, DOI 10.1196/annals.1301.004; Porges SW, 2001, INT J PSYCHOPHYSIOL, V42, P123, DOI 10.1016/S0167-8760(01)00162-3; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Ruta L, 2012, J AUTISM DEV DISORD, V42, P625, DOI 10.1007/s10803-011-1290-1; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Stevens S, 2011, BEHAV RES THER, V49, P138, DOI 10.1016/j.brat.2010.11.009; SUESS PE, 1994, PSYCHOPHYSIOLOGY, V31, P17, DOI 10.1111/j.1469-8986.1994.tb01020.x; Tajadura-Jimenez A, 2013, J EXPT PSYCHOL GEN; Teneggi C, 2013, CURR BIOL, V23, P406, DOI 10.1016/j.cub.2013.01.043; Terasawa Y, 2013, SOC COGN AFFECT NEUR, V8, P259, DOI 10.1093/scan/nss108; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Van der Does AJW, 2000, BEHAV RES THER, V38, P47, DOI 10.1016/S0005-7967(98)00184-3; van Ede F, 2011, J NEUROSCI, V31, P2016, DOI 10.1523/JNEUROSCI.5630-10.2011; WHITEHEAD WE, 1980, PSYCHOPHYSIOLOGY, V17, P552, DOI 10.1111/j.1469-8986.1980.tb02296.x; World Health Organization web site, BMI CLASS TABL 1 INT; Yaroslavsky I, 2013, BIOL PSYCHOL, V94, P272, DOI 10.1016/j.biopsycho.2013.06.008; Yaroslavsky I, 2013, J ABNORM PSYCHOL, V122, P314, DOI 10.1037/a0032385; Zaki J, 2012, NEUROIMAGE, V62, P493, DOI 10.1016/j.neuroimage.2012.05.012	84	42	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75758	10.1371/journal.pone.0075758	http://dx.doi.org/10.1371/journal.pone.0075758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231OR	24098397	gold, Green Submitted, Green Published			2022-12-25	WOS:000325427100021
J	Fonville, JM; Burke, DF; Lewis, NS; Katzelnick, LC; Russell, CA				Fonville, Judith M.; Burke, David F.; Lewis, Nicola S.; Katzelnick, Leah C.; Russell, Colin A.			Quantifying the Fitness Advantage of Polymerase Substitutions in Influenza A/H7N9 Viruses during Adaptation to Humans	PLOS ONE			English	Article							A H7N9 VIRUS; HOST-RANGE DETERMINANTS; MOLECULAR-BASIS; AMINO-ACID; VIRAL POLYMERASE; PB2 PROTEIN; REPLICATION; INFECTION; CHINA	Adaptation of zoonotic influenza viruses towards efficient human-to-human transmissibility is a substantial public health concern. The recently emerged A/H7N9 influenza viruses in China provide an opportunity for quantitative studies of host-adaptation, as human-adaptive substitutions in the PB2 gene of the virus have been found in all sequenced human strains, while these substitutions have not been detected in any non-human A/H7N9 sequences. Given the currently available information, this observation suggests that the human-adaptive PB2 substitution might confer a fitness advantage to the virus in these human hosts that allows it to rise to proportions detectable by consensus sequencing over the course of a single human infection. We use a mathematical model of within-host virus evolution to estimate the fitness advantage required for a substitution to reach predominance in a single infection as a function of the duration of infection and the fraction of mutant present in the virus population that initially infects a human. The modeling results provide an estimate of the lower bound for the fitness advantage of this adaptive substitution in the currently sequenced A/H7N9 viruses. This framework can be more generally used to quantitatively estimate fitness advantages of adaptive substitutions based on the within-host prevalence of mutations. Such estimates are critical for models of cross-species transmission and host-adaptation of influenza virus infections.	[Fonville, Judith M.; Burke, David F.; Lewis, Nicola S.; Katzelnick, Leah C.; Russell, Colin A.] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Russell, CA (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	car44@cam.ac.uk	Russell, Colin/ABE-7106-2020; Burke, David F/C-2091-2013	Burke, David F/0000-0001-8830-3951; Russell, Colin/0000-0002-2113-162X	NIAID Centers of Excellence for Influenza Research and Surveillance; United States Department of Agriculture [58-3625-2-103F]; ESNIP3 - European Surveillance Network for Influenza in Pigs EC [259949]; Gates Cambridge Trust; Royal Society; Medical Research Council [MR/K021885/1] Funding Source: researchfish; MRC [MR/K021885/1] Funding Source: UKRI	NIAID Centers of Excellence for Influenza Research and Surveillance; United States Department of Agriculture(United States Department of Agriculture (USDA)); ESNIP3 - European Surveillance Network for Influenza in Pigs EC; Gates Cambridge Trust; Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JMF, DFB, and NSL acknowledge funding from the NIAID Centers of Excellence for Influenza Research and Surveillance. NSL was additionally supported by United States Department of Agriculture grant 58-3625-2-103F and by ESNIP3 - European Surveillance Network for Influenza in Pigs EC FP7 259949. LCK was supported by the Gates Cambridge Trust. CAR was supported by a University Research Fellowship from the Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOND JW, 1977, NATURE, V270, P617, DOI 10.1038/270617a0; Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Chang SY, 2013, LANCET, V381, P1621, DOI 10.1016/S0140-6736(13)60943-5; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen Y, 2013, LANCET; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Foeglein A, 2011, J GEN VIROL, V92, P1650, DOI 10.1099/vir.0.031492-0; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; GILLESPIE JH, 1984, SCIENCE, V224, P732, DOI 10.1126/science.224.4650.732; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; JONGES M, 2013, EURO SURVEILL, V18; Jonges M, 2011, J VIROL, V85, P10598, DOI 10.1128/JVI.05369-11; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; LI J, 2013, SCI CHINA LIFE SCI; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; LIU Q, 2013, MICROBES INFECT; LIUD SW, 2013, LANCET; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Mok CKP, 2011, J VIROL, V85, P9641, DOI 10.1128/JVI.00702-11; Munster VJ, 2007, J INFECT DIS, V196, P258, DOI 10.1086/518792; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Park M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0333; Perelson AS, 2012, J INFECT DIS, V205, P1642, DOI 10.1093/infdis/jis265; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Ribeiro RM, 2000, P NATL ACAD SCI USA, V97, P7681, DOI 10.1073/pnas.97.14.7681; Ribeiro RM, 1999, AIDS, V13, P351, DOI 10.1097/00002030-199902250-00007; RICHARD M, 2013, NATURE; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Watanabe T, 2013, NATURE; Wu H, 2013, N ENGL J MED; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Zhang QY, 2013, INT J PLANT PROD, V7, P341; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; ZHU H, 2013, SCIENCE	46	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76047	10.1371/journal.pone.0076047	http://dx.doi.org/10.1371/journal.pone.0076047			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086684	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900073
J	Hadaegh, F; Hasheminia, M; Lotfaliany, M; Mohebi, R; Azizi, F; Tohidi, M				Hadaegh, Farzad; Hasheminia, Mitra; Lotfaliany, Mojtaba; Mohebi, Reza; Azizi, Fereidoun; Tohidi, Maryam			Incidence of Metabolic Syndrome over 9 Years Follow-Up; the Importance of Sex Differences in the Role of Insulin Resistance and Other Risk Factors	PLOS ONE			English	Article							NUTRITION TRANSITION; SERUM CREATININE; IRANIAN ADULTS; MIDDLE-EAST; PREVALENCE; POPULATION; COMPONENTS; DISEASE; HEALTH; ASSOCIATION	To determine, the predictors of incident metabolic syndrome (MetS) in a community-based cohort of West Asians, during a mean follow-up of 9.3 years, a sample of 2858 non-MetS Iranian adults aged >= 20 years were examined at baseline and followed at three year intervals during three consecutive phases. The MetS was defined using the joint interim statement. Cox proportional hazard regression was used to determine the independent variables associated with incident MetS. Overall, 1117 new cases MetS were identified resulting in an incidence rate of 550.9/10000 person years (95% CI: 519.5-584.2). The corresponding incidence rates among women and men were 433.5/10000 person years (95% CI: 398.8-471.2) and 749.2/10000 person years (95% CI: 689.9-813.5), respectively. Baseline-adjusted predictors of developing MetS included all of the MetS components, being overweight or obese in both gender, and family history of diabetes and age only in women. There were significant effect modifications of gender on age (P<0.001), high blood pressure (0.026), high waist circumference (P<0001) and obesity categories (all P <= 0.01) in multivariate analysis. After considering HOMA-IR in the model, among women, all of the MetS predictors as well as those with HOMA-IR >= 2.23 showed a significant risk for incident MetS [HR: 1.63 (1.16-2.28)]; however, among men all the MetS components (WC was marginally significant) as well as the fourth quartile of HOMA-IR [HR: 1.50 (1.03-2.17)] and being overweight showed a significant risk. Finally, in the pooled analysis, we showed that female gender had lower risk for incident MetS than male [HR: 0.58 (0.47-0.70)]. In the Iranian population, high incidence of MetS, especially among men, was shown. Our findings confirmed that sex-specific risk predictors should be considered in primary prevention for incident MetS.	[Hadaegh, Farzad; Hasheminia, Mitra; Lotfaliany, Mojtaba; Mohebi, Reza; Tohidi, Maryam] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Tohidi, M (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran.	tohidi@endocrine.ac.ir	Azizi, Fereidoun/ABD-4136-2021; hadaegh, farzad/K-2460-2017; Lotfaliany, Mojtaba/ABB-6325-2020; Tohidi, Maryam/V-2261-2019; Mohebi, Reza/AAB-7178-2022; Mohebi, Reza/U-2192-2019	Azizi, Fereidoun/0000-0002-6470-2517; hadaegh, farzad/0000-0002-0352-8666; Mohebi, Reza/0000-0002-6744-3119; Lotfaliany Abrand Abadi, Mojtaba/0000-0001-6594-9004; Hadaegh, Farzad/0000-0002-8935-2744	National Research Council of the Islamic Republic of Iran [121]	National Research Council of the Islamic Republic of Iran	This study was supported by grant No. 121 from the National Research Council of the Islamic Republic of Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2002, METABOLISM, V51, P235, DOI 10.1053/meta.2002.28970; Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Agirbasli M, 2009, METABOLISM, V58, P1256, DOI 10.1016/j.metabol.2009.03.024; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Azizi F, 2010, ARCH IRAN MED, V13, P243; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Bahreynian M, 2012, ARCH IRAN MED, V15, P648; Bozorgmanesh M, 2011, J HYPERTENS, V29, P1486, DOI 10.1097/HJH.0b013e328348fdb2; Cheung BMY, 2008, CLIN ENDOCRINOL, V68, P730, DOI 10.1111/j.1365-2265.2007.03110.x; Delavar MA, 2009, SE ASIAN J TROP MED, V40, P612; Erem C, 2008, ENDOCRINE, V33, P9, DOI 10.1007/s12020-008-9044-3; Esteghamati A, 2009, DIABETIC MED, V26, P745, DOI 10.1111/j.1464-5491.2009.02756.x; Ghassemi H, 2002, PUBLIC HEALTH NUTR, V5, P149, DOI 10.1079/PHN2001287; Guerrero-Romero F, 2005, DIABETES CARE, V28, P2588; Hadaegh F, 2012, J EPIDEMIOL COMMUN H, V66, P427, DOI 10.1136/jech.2010.117697; Hadaegh F, 2008, DIABETES RES CLIN PR, V80, P328, DOI 10.1016/j.diabres.2008.01.003; Harita N, 2009, DIABETES CARE, V32, P424, DOI 10.2337/dc08-1265; Hosseinpanah F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-44; Hosseinpanah F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-426; Kim HA, 2013, DIABETES RES CLIN PR, V99, P54, DOI 10.1016/j.diabres.2012.10.011; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Mommersteeg PMC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1109; Motlagh B, 2009, EUR J CARDIOV PREV R, V16, P268, DOI 10.1097/HJR.0b013e328322ca1b; Onat A, 2002, ATHEROSCLEROSIS, V165, P285, DOI 10.1016/S0021-9150(02)00236-8; ONAT A, 2013, CURR PHARM DESIGN, P65630; Onat A, 2007, KIDNEY BLOOD PRESS R, V30, P88, DOI 10.1159/000100487; Onat A, 2013, J INVEST MED, V61, P27, DOI 10.2310/JIM.0b013e318276de59; Palaniappan L, 2004, DIABETES CARE, V27, P788, DOI 10.2337/diacare.27.3.788; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Ryu S, 2007, ANN EPIDEMIOL, V17, P245, DOI 10.1016/j.annepidem.2006.10.001; Santos AC, 2010, PREV MED, V50, P99, DOI 10.1016/j.ypmed.2009.11.011; Sheu WHH, 2006, DIABETES RES CLIN PR, V74, P162, DOI 10.1016/j.diabres.2006.03.011; Sirdah MM, 2011, DIABETES METAB SYND, V5, P93, DOI 10.1016/j.dsx.2012.02.024; Sung KCC, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-108; Tomaszewski M, 2007, KIDNEY INT, V71, P816, DOI 10.1038/sj.ki.5002160; Tong J, 2007, DIABETOLOGIA, V50, P1156, DOI 10.1007/s00125-007-0651-y; von Loeffelholz C, 2010, EUR J ENDOCRINOL, V162, P507, DOI 10.1530/EJE-09-0737; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wilsgaard T, 2007, DIABETES RES CLIN PR, V78, P217, DOI 10.1016/j.diabres.2007.03.006; WU HY, 2012, INT J CARDIOL; Zabetian A, 2007, DIABETES RES CLIN PR, V77, P251, DOI 10.1016/j.diabres.2006.12.001; Zabetian A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-138; Zarkesh M, 2012, GENET RES, V94, P331, DOI 10.1017/S001667231200050X; ZAVARONI I, 1992, J INTERN MED, V231, P235, DOI 10.1111/j.1365-2796.1992.tb00529.x	45	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76304	10.1371/journal.pone.0076304	http://dx.doi.org/10.1371/journal.pone.0076304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086723	Green Published, gold			2022-12-25	WOS:000325223900094
J	Kruk, JS; Vasefi, MS; Heikkila, JJ; Beazely, MA				Kruk, Jeff S.; Vasefi, Maryam S.; Heikkila, John J.; Beazely, Michael A.			Reactive Oxygen Species Are Required for 5-HT-Induced Transactivation of Neuronal Platelet-Derived Growth Factor and TrkB Receptors, but Not for ERK1/2 Activation	PLOS ONE			English	Article							FACTOR-BETA RECEPTOR; NEUTROPHIL NADPH OXIDASE; PROTEIN-KINASE; HYDROGEN-PEROXIDE; PHOSPHORYLATION; SEROTONIN; STIMULATION; EXPRESSION; DOPAMINE; PATHWAY	High concentrations of reactive oxygen species (ROS) induce cellular damage, however at lower concentrations ROS act as intracellular second messengers. In this study, we demonstrate that serotonin (5-HT) transactivates the platelet-derived growth factor (PDGF) type beta receptor as well as the TrkB receptor in neuronal cultures and SH-SY5Y cells, and that the transactivation of both receptors is ROS-dependent. Exogenous application of H2O2 induced the phosphorylation of these receptors in a dose-dependent fashion, similar to that observed with 5-HT. However the same concentrations of H2O2 failed to increase ERK1/2 phosphorylation. Yet, the NADPH oxidase inhibitors diphenyleneiodonium chloride and apocynin blocked both 5-HT-induced PDGF beta receptor phosphorylation and ERK1/2 phosphorylation. The increases in PDGF beta receptor and ERK1/2 phosphorylation were also dependent on protein kinase C activity, likely acting upstream of NADPH oxidase. Additionally, although the ROS scavenger N-acetyl-L-cysteine abrogated 5-HT-induced PDGF beta and TrkB receptor transactivation, it was unable to prevent 5-HT-induced ERK1/2 phosphorylation. Thus, the divergence point for 5-HT-induced receptor tyrosine kinase (RTK) transactivation and ERK1/2 phosphorylation occurs at the level of NADPH oxidase in this system. The ability of 5-HT to induce the production of ROS resulting in transactivation of both PDGF beta and TrkB receptors may suggest that instead of a single GPCR to single RTK pathway, a less selective, more global RTK response to GPCR activation is occurring.	[Kruk, Jeff S.; Vasefi, Maryam S.; Heikkila, John J.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Beazely, Michael A.] Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Beazely, MA (corresponding author), Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada.	mbeazely@uwaterloo.ca		Beazely, Michael/0000-0002-8722-460X	University of Waterloo, Faculty of Science; National Science and Engineering Research Council of Canada; Queen Elizabeth II Graduate Scholarship in Science and Technology	University of Waterloo, Faculty of Science; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen Elizabeth II Graduate Scholarship in Science and Technology	This research was funded through generous start-up funding from the University of Waterloo, Faculty of Science, by the National Science and Engineering Research Council of Canada, and by the Queen Elizabeth II Graduate Scholarship in Science and Technology awarded to JSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; Alvarez RH, 2006, MAYO CLIN PROC, V81, P1241, DOI 10.4065/81.9.1241; Bayraktutan U, 2000, ARTERIOSCL THROM VAS, V20, P1903, DOI 10.1161/01.ATV.20.8.1903; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Callsen D, 1999, FREE RADICAL BIO MED, V26, P1544, DOI 10.1016/S0891-5849(99)00015-5; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Catarzi S, 2007, BBA-GEN SUBJECTS, V1770, P872, DOI 10.1016/j.bbagen.2007.01.008; Chen CH, 2006, MOL PHARMACOL, V69, P1347, DOI 10.1124/mol.105.017558; Chen K, 2004, J BIOL CHEM, V279, P35079, DOI 10.1074/jbc.M404859200; Clark MA, 2007, REGUL PEPTIDES, V144, P115, DOI 10.1016/j.regpep.2007.07.001; Dusting GJ, 2005, MEM I OSWALDO CRUZ, V100, P97, DOI 10.1590/S0074-02762005000900016; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; Filip M, 2009, PHARMACOL REP, V61, P761, DOI 10.1016/S1734-1140(09)70132-X; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Geldenhuys WJ, 2009, EXPERT REV NEUROTHER, V9, P1073, DOI 10.1586/ERN.09.51; George A, 2010, BLOOD CELL MOL DIS, V45, P41, DOI 10.1016/j.bcmd.2010.02.006; Gill RS, 2010, CELL SIGNAL, V22, P285, DOI 10.1016/j.cellsig.2009.09.031; Goppelt-Struebe M, 2000, BIOCHEM J, V345, P217, DOI 10.1042/0264-6021:3450217; Guo DG, 2010, MOL CELL BIOCHEM, V334, P99, DOI 10.1007/s11010-009-0327-7; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P4; Hu YY, 2007, CELL SIGNAL, V19, P410, DOI 10.1016/j.cellsig.2006.07.017; Huang YZ, 2012, J NEUROSCI, V32, P15521, DOI 10.1523/JNEUROSCI.0755-12.2012; Kim YK, 2006, CELL SIGNAL, V18, P236, DOI 10.1016/j.cellsig.2005.04.008; Kleniewska P, 2012, ARCH IMMUNOL THER EX, V60, P277, DOI 10.1007/s00005-012-0176-z; Kruk JS, 2013, CELL SIGNAL, V25, P133, DOI 10.1016/j.cellsig.2012.09.021; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Li BM, 2008, PSYCHOPHARMACOLOGY, V201, P443, DOI 10.1007/s00213-008-1306-5; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; Liu Bo, 2003, V237, P99; Liu YL, 2007, FASEB J, V21, P2725, DOI 10.1096/fj.06-8058com; Mbong N, 2012, AM J PHYSIOL-HEART C, V302, pH1591, DOI 10.1152/ajpheart.00627.2011; McMahon B, 2002, FASEB J, V16, P1817, DOI 10.1096/fj.02-0416fje; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Moldovan L, 2000, CIRC RES, V86, P549, DOI 10.1161/01.RES.86.5.549; Monti JM, 2008, PROG BRAIN RES, V172, P625, DOI 10.1016/S0079-6123(08)00929-1; Moody TW, 2012, J PHARMACOL EXP THER, V341, P873, DOI 10.1124/jpet.111.190033; Oak JN, 2001, MOL PHARMACOL, V60, P92, DOI 10.1124/mol.60.1.92; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; OHNO Y, 1985, J BIOL CHEM, V260, P8438; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Rantamaki T, 2008, EXPERT OPIN THER TAR, V12, P705, DOI [10.1517/14728222.12.6.705 , 10.1517/14728220802121472]; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Sandoval YHG, 2011, CELL SIGNAL, V23, P354, DOI 10.1016/j.cellsig.2010.10.005; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Stefanska J, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/106507; Steiner JA, 2008, TRAFFIC, V9, P1393, DOI 10.1111/j.1600-0854.2008.00757.x; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Tseng HY, 2012, ARCH TOXICOL, V86, P935, DOI 10.1007/s00204-012-0856-9; Tsuchioka M, 2008, J NEUROCHEM, V106, P244, DOI 10.1111/j.1471-4159.2008.05357.x; Vasefi MS, 2013, J NEUROCHEM, V125, P26, DOI 10.1111/jnc.12157; Vasefi MS, 2012, NEUROSCI LETT, V511, P65, DOI 10.1016/j.neulet.2012.01.016; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Wiese S, 2007, P NATL ACAD SCI USA, V104, P17210, DOI 10.1073/pnas.0705267104; Zhang J, 2004, J BIOL CHEM, V279, P22118, DOI 10.1074/jbc.M400774200	61	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e77027	10.1371/journal.pone.0077027	http://dx.doi.org/10.1371/journal.pone.0077027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086766	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900110
J	Liu, T; Liu, YY; Bao, XX; Tian, JG; Liu, Y; Yang, XS				Liu, Ting; Liu, Yueyang; Bao, Xiangxiang; Tian, Jiguang; Liu, Yang; Yang, Xingsheng			Overexpression of TROP2 Predicts Poor Prognosis of Patients with Cervical Cancer and Promotes the Proliferation and Invasion of Cervical Cancer Cells by Regulating ERK Signaling Pathway	PLOS ONE			English	Article							EXPRESSION; CARCINOMA; MARKER	Overwhelming evidence has demonstrated that the aberrant expression of the human trophoblast cell-surface antigen (TROP2) was associated with tumor aggressiveness and poor prognosis in a variety of human cancers, however the roles of TROP2 in cervical cancer have not been investigated. The purpose of our study was to elucidate the prognostic significance of TROP2 expression in patients with cervical cancer and determine its effect on tumor progression. Immunohistochemistry assay showed that 88.7% (94/106 cases) of cervical cancer specimens were positively stained with TROP2, and the overexpression of TROP2 was closely related with FIGO stage, histological grades, lymphatic metastasis, invasive interstitial depth and high expression of Ki-67. Patients with TROP2-positive staining exhibited a significantly decreased overall survival and progression free survival; it was also an independent predictor for prognosis according to multivariate analysis. Moreover, down-regulation of TROP2 mediated by siRNA in Siha and CaSki cells resulted in a strong inhibition of proliferation and invasion, TROP2 abrogation also elevated the apoptotic ratio and caused G1 arrest. Conversely, enforced expression of TROP2 in HeLa and C33A cells remarkably promoted cell growth, migration and invasion. In addition, the tumorigenic function of TROP2 was associated with the increased expressions of cyclin D1, cyclin E, CDK2 and CDK4 but reduced expression of p27 and E-cadherin via the activation of Erk1/2 signaling pathway. Furthermore, the inhibition of TROP2 expression in cervical cancer cell lines enhances sensitivity to cisplatin. The present study suggest that overexpression of TROP2 may play crucial roles in the development and pathogenesis of human cervical cancer, therefore, TROP2 may represent a prospective prognostic indicator and a potential therapeutic target of cervical cancer.	[Liu, Ting; Liu, Yueyang; Bao, Xiangxiang; Liu, Yang; Yang, Xingsheng] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Tian, Jiguang] Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Yang, XS (corresponding author), Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China.	xingshengyang@sdu.edu.cn			National Natural Science Foundation of China and Science [81372809]; Technology Development Planning of Shandong Province [2011GSF12121]	National Natural Science Foundation of China and Science; Technology Development Planning of Shandong Province	The project was supported by National Natural Science Foundation of China and Science (No. 81372809) and Technology Development Planning of Shandong Province (No. 2011GSF12121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSALEH W, 1995, AM J CLIN PATHOL, V104, P154; Beloueche-Babari M, 2005, CANCER RES, V65, P3356, DOI 10.1158/0008-5472.CAN-03-2981; Bignotti E, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-22; Bignotti E, 2010, EUR J CANCER, V46, P944, DOI 10.1016/j.ejca.2009.12.019; Bizari L, 2006, CANCER GENET CYTOGEN, V165, P41, DOI 10.1016/j.cancergencyto.2005.08.031; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen CR, 2012, PHARMAZIE, V67, P351, DOI 10.1691/ph.2012.1634; Cubas R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-253; Farivar TN, 2012, N AM J MED SCI, V4, P582, DOI 10.4103/1947-2714.103319; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fong D, 2008, MODERN PATHOL, V21, P186, DOI 10.1038/modpathol.3801001; Govindan SV, 2004, BREAST CANCER RES TR, V84, P173, DOI 10.1023/B:BREA.0000018417.02580.ef; Guerra E, 2013, ONCOGENE, V32, P1594, DOI 10.1038/onc.2012.151; Guerra E, 2008, CANCER RES, V68, P8113, DOI 10.1158/0008-5472.CAN-07-6135; Hubalek MM, 2004, ONCOGENE, V23, P4187, DOI 10.1038/sj.onc.1207560; Lilic V, 2009, J BUON, V14, P587; Ning SL, 2013, J GASTROINTEST SURG, V17, P360, DOI 10.1007/s11605-012-2105-1; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Reuschenbach M, 2012, INT J CANCER, V130, P388, DOI 10.1002/ijc.26017; Ripani E, 1998, INT J CANCER, V76, P671; Villalba SR, 2011, CLIN TRANSL ONCOL, V13, P378, DOI 10.1007/s12094-011-0671-4; SZALA S, 1990, P NATL ACAD SCI USA, V87, P3542, DOI 10.1073/pnas.87.9.3542; Tang B, 2011, MED ONCOL, V28, P502, DOI 10.1007/s12032-010-9492-5; Trerotola M, 2013, ONCOGENE, V32, P222, DOI 10.1038/onc.2012.36; Varughese J, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.093; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Wang JB, 2008, MOL CANCER THER, V7, P280, DOI 10.1158/1535-7163.MCT-07-2003	27	58	75	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75864	10.1371/journal.pone.0075864	http://dx.doi.org/10.1371/journal.pone.0075864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086649	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900065
J	Stern, A; Wold, AE; Ostman, S				Stern, Anna; Wold, Agnes E.; Ostman, Sofia			Neonatal Mucosal Immune Stimulation by Microbial Superantigen Improves the Tolerogenic Capacity of CD103(+) Dendritic Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; STAPHYLOCOCCAL-ENTEROTOXIN-B; ORAL TOLERANCE; COSTIMULATORY MOLECULES; CLONAL DELETION; INDUCTION; ANTIGEN; ANERGY; DIFFERENTIATION; OVALBUMIN	Food allergy represents failure to develop tolerance to dietary proteins. Food allergy has increased in prevalence in parallel with decreased exposure to microbes during infancy. In mice, neonatal peroral exposure to the strongly T cell stimulating superantigen staphylococcal enterotoxin A (SEA), enhances the capacity to develop oral tolerance to a novel antigen encountered in adult life. A population of antigen-presenting cells in the gut, the CD103(+) dendritic cells (DCs), is thought to be involved in oral tolerance development, as they convert naive T cells into FoxP3(+) regulatory T cells (Treg). This function depends on their capacity to convert vitamin A to retinoic acid, carried out by the retinal aldehyde dehydrogenase (RALDH) enzyme. Here, newborn mice were treated with superantigen and DC function and tolerogenic capacity was examined at six weeks of age. We observed that, in mice fed superantigen neonatally, the CD11c(+) DCs had increased expression of RALDH and in vitro more efficiently induced expression Foxp3 expression to stimulated T cells. Further, these mice showed an accumulation of FoxP3(+) T cells in the small intestinal lamina propria and had a more Ag-specific FoxP3(+) T cells after oral tolerance induction in vivo. Moreover, the improved oral tolerance, as shown by increased protection from food allergy, was eradicated if the Vitamin A metabolism was inhibited. These observations contribute to the understanding of how a strong immune stimulation during the neonatal period influences the maturation of the immune system and suggests that such stimulation may reduce the risk of later allergy development.	[Stern, Anna; Wold, Agnes E.; Ostman, Sofia] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Med, Gothenburg, Sweden	University of Gothenburg	Ostman, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Med, Gothenburg, Sweden.	sofia.ostman@microbio.gu.se	Wold, Agnes/M-6310-2013	Wold, Agnes/0000-0001-9196-5040	Swedish Research Council [K2007-58X-08298-20-3]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was founded by the Swedish Research Council (grant K2007-58X-08298-20-3), The Medical Faculty of Gothenburg (LUA), The Torsten and Ragnar Soderberg Foundation and IngaBritt and Arne Lundbergs foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bilsborough J, 2003, IMMUNOLOGY, V108, P481, DOI 10.1046/j.1365-2567.2003.01606.x; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; CALLAHAN JE, 1990, J IMMUNOL, V144, P2473; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Garside P, 2004, ANN NY ACAD SCI, V1029, P9, DOI 10.1196/annals.1309.002; GONZALO JA, 1992, EUR J IMMUNOL, V22, P1007, DOI 10.1002/eji.1830220420; Grundstrom S, 2003, J IMMUNOL, V170, P5008, DOI 10.4049/jimmunol.170.10.5008; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; Lonnqvist A, 2009, EUR J IMMUNOL, V39, P447, DOI 10.1002/eji.200838418; Lundell AC, 2007, CLIN EXP ALLERGY, V37, P62, DOI 10.1111/j.1365-2222.2006.02625.x; Lundell AC, 2009, CLIN EXP ALLERGY, V39, P662, DOI 10.1111/j.1365-2222.2008.03176.x; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; MCCORMACK JE, 1993, J IMMUNOL, V150, P3785; Misra N, 2004, J IMMUNOL, V172, P4676, DOI 10.4049/jimmunol.172.8.4676; MOREAU MC, 1988, INFECT IMMUN, V56, P2766, DOI 10.1128/IAI.56.10.2766-2768.1988; Moreau MC, 1996, RES IMMUNOL, V147, P49, DOI 10.1016/0923-2494(96)81548-3; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Oderup C, 2006, IMMUNOLOGY, V118, P240, DOI 10.1111/j.1365-2567.2006.02362.x; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; RELLAHAN BL, 1990, J EXP MED, V172, P1091, DOI 10.1084/jem.172.4.1091; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Sudo N, 1997, J IMMUNOL, V159, P1739; SUNDSTEDT A, 1994, IMMUNOLOGY, V82, P117; Turnbull EL, 2005, J IMMUNOL, V174, P1374, DOI 10.4049/jimmunol.174.3.1374; Viney JL, 1998, J IMMUNOL, V160, P5815; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Wang M, 2007, J ALLERGY CLIN IMMUN; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	36	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75594	10.1371/journal.pone.0075594	http://dx.doi.org/10.1371/journal.pone.0075594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086582	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900048
J	Wang, K; Zhang, WP; Jiang, YQ; Zhang, TZ				Wang, Kai; Zhang, Wenpan; Jiang, Yanqin; Zhang, Tianzhen			Systematic Application of DNA Fiber-FISH Technique in Cotton	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; GOSSYPIUM-HIRSUTUM L.; ARABIDOPSIS-THALIANA; CYTOSINE METHYLATION; REPETITIVE DNA; TELOMERIC DNA; RIBOSOMAL DNA; CHROMOSOMES; RESOLUTION; ORGANIZATION	Fluorescence in situ hybridization on extended DNA (fiber-FISH) is a powerful tool in high-resolution physical mapping. To introduce this technique into cotton, we developed the technique and tested it by deliberately mapping of telomere and 5S rDNA. Results showed that telomere-length ranged from 0.80 kb to 37.86 kb in three species, G. hirsutum, G. herbaceum and G. arboreum. However, most of the telomeres (>91.0%) were below 10 kb. The length of 5S rDNA was revealed as 964 kb in G. herbaceum whereas, in G. arboreum, it was approximately three times longer (3.1 Mb). A fiber-FISH based immunofluorescence method was also described to assay the DNA methylation. Using this technique, we revealed that both telomere and 5S rDNA were methylated at different levels. In addition, we developed a BAC molecule-based fiber-FISH technique. Using this technique, we can precisely map BAC clones on each other and evaluated the size and location of overlapped regions. The development and application of fiber-FISH technique will facilitate high-resolution physical mapping and further directed sequencing projects for cotton.	[Wang, Kai; Zhang, Wenpan; Zhang, Tianzhen] Nanjing Agr Univ, Cotton Res Inst, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Jiang, Yanqin] Inst Bot, Nanjing, Jiangsu, Peoples R China; [Jiang, Yanqin] Chinese Acad Sci, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Nanjing Agricultural University; Chinese Academy of Sciences	Wang, K (corresponding author), Nanjing Agr Univ, Cotton Res Inst, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	kaiwang@njau.edu.cn; cotton@njau.edu.cn	Wang, Kai/A-2143-2011	Wang, Kai/0000-0002-1074-0438	National Natural Science Foundation of China [31071460]; New Century Excellent Talents in University [NCET-10-0496]; Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Priority Academic Program Development of Jiangsu Higher Education Institutions; 111 Program(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (31071460) and New Century Excellent Talents in University (NCET-10-0496). This work was also supported partly by The Priority Academic Program Development of Jiangsu Higher Education Institutions and 111 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Cheng ZK, 2002, CHROMOSOME RES, V10, P379, DOI 10.1023/A:1016849618707; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Cronn RC, 1996, J MOL EVOL, V42, P685, DOI 10.1007/BF02338802; de Jong JH, 1999, TRENDS PLANT SCI, V4, P258; Di Giulio M, 2010, J MOL EVOL, V71, P1, DOI 10.1007/s00239-010-9358-7; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; Fransz PF, 1996, PLANT J, V9, P421, DOI 10.1046/j.1365-313X.1996.09030421.x; Gong ZY, 2012, PLANT CELL, V24, P3559, DOI 10.1105/tpc.112.100511; Hanson RE, 1996, CHROMOSOMA, V105, P55, DOI 10.1007/BF02510039; HEISKANEN M, 1995, GENOMICS, V30, P31, DOI 10.1006/geno.1995.0005; Henegariu O, 2001, BIOTECHNIQUES, V31, P246, DOI 10.2144/01312bm01; Jackson SA, 1999, PLANT J, V17, P581, DOI 10.1046/j.1365-313X.1999.00398.x; Jackson SA, 1998, GENOME, V41, P566, DOI 10.1139/gen-41-4-566; Ji YF, 2007, GENETICS, V176, P115, DOI 10.1534/genetics.107.071738; Jiang JM, 2006, GENOME, V49, P1057, DOI 10.1139/G06-076; Jin WW, 2004, PLANT CELL, V16, P571, DOI 10.1105/tpc.018937; Koo DH, 2011, GENOME RES, V21, P908, DOI 10.1101/gr.116202.110; Kuznetsova I, 2006, CYTOGENET GENOME RES, V112, P248, DOI 10.1159/000089878; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Majerova E, 2011, PLANT MOL BIOL, V77, P533, DOI 10.1007/s11103-011-9834-5; Majerova E, 2011, PLANT MOL BIOL, V77, P371, DOI 10.1007/s11103-011-9816-7; Mathieu O, 2002, PLANT J, V29, P313, DOI 10.1046/j.0960-7412.2001.01212.x; McKnight TD, 2002, PLANT MOL BIOL, V48, P331, DOI 10.1023/A:1014091032750; MEYER P, 1994, EMBO J, V13, P2084, DOI 10.1002/j.1460-2075.1994.tb06483.x; Mizuno H, 2006, PLANT J, V46, P206, DOI 10.1111/j.1365-313X.2006.02684.X; O'Callaghan NJ, 2008, BIOTECHNIQUES, V44, P807, DOI 10.2144/000112761; Ohmido N, 2001, PLANT MOL BIOL, V47, P413, DOI 10.1023/A:1011632111845; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Saldanha SN, 2003, EUR J BIOCHEM, V270, P389, DOI 10.1046/j.1432-1033.2003.03410.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schwarzacher T, 2003, GENOME, V46, P953, DOI 10.1139/G03-119; Shiels C, 1997, CYTOGENET CELL GENET, V76, P20, DOI 10.1159/000134504; Sjoberg A, 1997, CHROMOSOME RES, V5, P247, DOI 10.1023/A:1018419619634; Sun FJ, 2009, J MOL EVOL, V69, P430, DOI 10.1007/s00239-009-9264-z; Uchida W, 2002, GENES GENET SYST, V77, P63, DOI 10.1266/ggs.77.63; Vaquero-Sedas MI, 2011, PLANT MOL BIOL, V77, P529, DOI 10.1007/s11103-011-9833-6; Vaquero-Sedas MI, 2011, NUCLEIC ACIDS RES, V39, P2007, DOI 10.1093/nar/gkq1119; Wang K, 2008, GENETICS, V178, P1117, DOI 10.1534/genetics.107.083576; Wang K, 2006, THEOR APPL GENET, V113, P73, DOI 10.1007/s00122-006-0273-7; Wang K, 2010, CHROMOSOMA, V119, P255, DOI 10.1007/s00412-009-0254-0; Wang K, 2009, CHROMOSOME RES, V17, P1041, DOI 10.1007/s10577-009-9085-3; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Watson JM, 2010, FEBS LETT, V584, P3752, DOI 10.1016/j.febslet.2010.06.017; WEIER HUG, 1995, HUM MOL GENET, V4, P1903; WENDEL JF, 1995, MOL PHYLOGENET EVOL, V4, P298, DOI 10.1006/mpev.1995.1027; Zhang H, 2012, PLANT J, V70, P357, DOI 10.1111/j.1365-313X.2011.04867.x; Zhao XP, 1998, GENOME RES, V8, P479, DOI 10.1101/gr.8.5.479; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462; Zhong XB, 1998, PLANT J, V13, P507, DOI 10.1046/j.1365-313X.1998.00055.x	53	13	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75674	10.1371/journal.pone.0075674	http://dx.doi.org/10.1371/journal.pone.0075674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086609	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900057
J	Abdulghani, J; Allen, JE; Dicker, DT; Liu, YY; Goldenberg, D; Smith, CD; Humphreys, R; El-Deiry, WS				Abdulghani, Junaid; Allen, Joshua E.; Dicker, David T.; Liu, Yingqiu Yvette; Goldenberg, David; Smith, Charles D.; Humphreys, Robin; El-Deiry, Wafik S.			Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; RAF/MEK/ERK PATHWAY; SELECTIVE MUTANTS; TRAIL RESISTANCE; CANCER-CELLS; IN-VITRO; C-MYC; APOPTOSIS; MCL-1; STAT3	Background: Approximately half of tumor cell lines are resistant to the tumor-selective apoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand (Apo22L/TRAIL). Previously, we showed that combining Apo2L/TRAIL with sorafenib, a multikinase inhibitor, results in dramatic efficacy in Apo2L/TRAIL-resistant tumor xenografts via inhibition of Mcl-1. Soluble Apo2L/TRAIL is capable of binding to several surface receptors, including the proapoptotic death receptors, DR4 and DR5, and decoy receptors, DcR1 and DcR2. Monoclonal antibodies targeting either of these death receptors are being investigated as antitumor agents in clinical trials. We hypothesized that sorafenib and Apo2L/TRAIL or Apo2L/TRAIL death receptor agonist (TRA) antibodies against DR4 (mapatumumab) and DR5 (lexatumumab) will overcome resistance to Apo2L/TRAIL-mediated apoptosis and as increase antitumor efficacy in Apo2L/TRAIL-sensitive solid tumors. Methodology/Principal Findings: We found that Apo2L/TRAIL or TRA antibodies combined with sorafenib synergistically reduce cell growth and increase cell death across a panel of solid tumor cell lines in vitro. This panel included human breast, prostate, colon, liver and thyroid cancers. The cooperativity of these combinations was also observed in vivo, as measured by tumor volume and TUNEL staining as a measure of apoptosis. We found that sorafenib inhibits Jak/Stat3 signaling and downregulates their target genes, including cyclin D1, cyclin D2 and Mcl-1, in a dose-dependent manner. Conclusions/Significance: The combination of sorafenib with Apo2L/TRAIL or Apo2L/TRAIL receptor agonist antibodies sensitizes Apo2L/TRAIL-resistant cells and increases the sensitivity of Apo2L/TRAIL-sensitive cells. Our findings demonstrate the involvement of the Jak2-Stat3-Mcl1 axis in response to sorafenib treatment, which may play a key role in sorafenib-mediated sensitization to Apo2L/TRAIL.	[El-Deiry, Wafik S.] Penn State Coll Med, Penn State Hershey Canc Inst, Lab Translat Oncol & Expt Canc Therapeut, Dept Med Hematol Oncol, Hershey, PA USA; Penn State Coll Med, Penn State Hershey Canc Inst, Dept Surg, Hershey, PA USA; Med Univ S Carolina, Coll Pharm, Pharmaceut & Biomed Sci Dept, Charleston, SC 29425 USA; Oncol Res Dept, Rockville, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Medical University of South Carolina	El-Deiry, WS (corresponding author), Penn State Coll Med, Penn State Hershey Canc Inst, Lab Translat Oncol & Expt Canc Therapeut, Dept Med Hematol Oncol, Hershey, PA USA.	wafik.eldeiry@gmail.com	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266	Penn State Hershey Cancer Institutional start-up fund; American Cancer Society	Penn State Hershey Cancer Institutional start-up fund; American Cancer Society(American Cancer Society)	This work was supported in part by Penn State Hershey Cancer Institutional start-up fund and the American Cancer Society Research Professorship received to Dr. WSED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Allen JE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004828; Allen JE, 2012, MOL CANCER THER, V11, P2087, DOI 10.1158/1535-7163.MCT-12-0366; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Burns TF, 2001, J BIOL CHEM, V276, P37879; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Erovic BM, 2005, CLIN CANCER RES, V11, P8632, DOI 10.1158/1078-0432.CCR-05-1170; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Greco FA, 2008, LUNG CANCER, V61, P82, DOI 10.1016/j.lungcan.2007.12.011; Hall MA, 2007, CANCER CELL, V12, P4, DOI 10.1016/j.ccr.2007.06.011; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; ITO T, 1994, INT J ONCOL, V4, P583; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Kane RC, 2009, ONCOLOGIST, V14, P95, DOI 10.1634/theoncologist.2008-0185; Kelley RF, 2005, J BIOL CHEM, V280, P2205, DOI 10.1074/jbc.M410660200; Kim SH, 2004, J BIOL CHEM, V279, P40044, DOI 10.1074/jbc.M404541200; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; MacFarlane M, 2005, CANCER RES, V65, P11265, DOI 10.1158/0008-5472.CAN-05-2801; Malin D, 2011, CLIN CANCER RES, V17, P5005, DOI 10.1158/1078-0432.CCR-11-0099; Masuda M, 2002, CANCER RES, V62, P3351; Nagane M, 2010, NEURO-ONCOLOGY, V12, P687, DOI 10.1093/neuonc/nop069; Park C, 2008, ACTA PHARMACOL SIN, V29, P341, DOI 10.1111/j.1745-7254.2008.00761.x; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Swers JS, 2013, MOL CANCER THER, V12, P1235, DOI 10.1158/1535-7163.MCT-12-1107; Wakelee HA, 2010, ANN ONCOL, V21, P376, DOI 10.1093/annonc/mdp292; Wang GL, 2013, NAT CHEM BIOL, V9, P84, DOI [10.1038/NCHEMBIO.1153, 10.1038/nchembio.1153]; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wang WG, 2003, CANCER BIOL THER, V2, P196, DOI 10.4161/cbt.2.2.347; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Younes A, 2010, BRIT J CANCER, V103, P1783, DOI 10.1038/sj.bjc.6605987; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	41	37	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75414	10.1371/journal.pone.0075414	http://dx.doi.org/10.1371/journal.pone.0075414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086526	Green Submitted, gold, Green Published			2022-12-25	WOS:000325220000020
J	Kopf, J; Dresler, T; Reicherts, P; Herrmann, MJ; Reif, A				Kopf, Juliane; Dresler, Thomas; Reicherts, Philipp; Herrmann, Martin J.; Reif, Andreas			The Effect of Emotional Content on Brain Activation and the Late Positive Potential in a Word n-back Task	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; WORKING-MEMORY; TIME-COURSE; INTERFERENCE RESOLUTION; CORTEX; ATTENTION; PICTURES; STIMULI; AROUSAL	Introduction: There is mounting evidence for the influence of emotional content on working memory performance. This is particularly important in light of the emotion processing that needs to take place when emotional content interferes with executive functions. In this study, we used emotional words of different valence but with similar arousal levels in an n-back task. Methods: We examined the effects on activation in the prefrontal cortex by means of functional near-infrared spectroscopy (fNIRS) and on the late positive potential (LPP). FNIRS and LPP data were examined in 30 healthy subjects. Results: Behavioral results show an influence of valence on the error rate depending on the difficulty of the task: more errors were made when the valence was negative and the task difficult. Brain activation was dependent both on the difficulty of the task and on the valence: negative valence of a word diminished the increase in activation, whereas positive valence did not influence the increase in activation, while difficulty levels increased. The LPP also differentiated between the different valences, and in addition was influenced by the task difficulty, the more difficult the task, the less differentiation could be observed. Conclusions: Summarized, this study shows the influence of valence on a verbal working memory task. When a word contained a negative valence, the emotional content seemed to take precedence in contrast to words containing a positive valence. Working memory and emotion processing sites seemed to overlap and compete for resources even when words are carriers of the emotional content.	[Kopf, Juliane; Dresler, Thomas; Herrmann, Martin J.; Reif, Andreas] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany; [Dresler, Thomas] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Reicherts, Philipp] Univ Wurzburg, Dept Psychol, D-97070 Wurzburg, Germany	University of Wurzburg; Eberhard Karls University of Tubingen; University of Wurzburg	Kopf, J (corresponding author), Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany.	Kopf_J1@klinik.uni-wuerzburg.de	herrmann, martin/AAT-9836-2020; Herrmann, Martin J./C-9904-2009	Herrmann, Martin J./0000-0001-9970-2122	German Research Foundation; University of Wuerzburg; DFG [RE1632/5-1, He45411-1, KFO 125, SFB TRR 58 Z02, C04, RTG 1253]	German Research Foundation(German Research Foundation (DFG)); University of Wuerzburg; DFG(German Research Foundation (DFG))	This publication was funded by the German Research Foundation and the University of Wuerzburg in the funding programme Open Access Publishing. The study was supported by the DFG (URL: http://www.dfg.de/en/) (Grant RE1632/5-1 to AR, He45411-1 to MJH, KFO 125 to AR; SFB TRR 58 Z02 to AR, C04 to MJH, RTG 1253 to AR, MJH and JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A., 1986, WORKING MEMORY, P289; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Dresler T, 2009, PSYCHOL RES-PSYCH FO, V73, P364, DOI 10.1007/s00426-008-0154-6; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Fruhholz S, 2011, BIOL PSYCHOL, V87, P265, DOI 10.1016/j.biopsycho.2011.03.008; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gray JR, 2001, J EXP PSYCHOL GEN, V130, P436, DOI 10.1037//0096-3445.130.3.436; Hajcak G, 2007, BEHAV NEUROSCI, V121, P1156, DOI 10.1037/0735-7044.121.6.1156; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Herrmann MJ, 2008, HUM BRAIN MAPP, V29, P28, DOI 10.1002/hbm.20368; Hofmann MJ, 2009, COGN AFFECT BEHAV NE, V9, P389, DOI 10.3758/9.4.389; Horn W, 1983, LPS LEISTUNGSPRUFSYS; Hoshi Y, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804911; Hoshi Y, 2011, J NEUROIMAGING, V21, pe94, DOI 10.1111/j.1552-6569.2009.00454.x; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Keil A, 2004, EMOTION, V4, P23, DOI 10.1037/1528-3542.4.1.23; Kensinger EA, 2003, EMOTION, V3, P378, DOI 10.1037/1528-3542.3.4.378; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kopf J, 2011, NEUROIMAGE, V57, P1617, DOI 10.1016/j.neuroimage.2011.05.034; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Lehrl S, 2005, MWT B MEHRFACHWAHL W; Leon-Carrion J, 2006, NEUROSCI LETT, V403, P90, DOI 10.1016/j.neulet.2006.04.050; Levens SA, 2008, EMOTION, V8, P267, DOI 10.1037/1528-3542.8.2.267; Levens SM, 2010, J COGNITIVE NEUROSCI, V22, P2790, DOI 10.1162/jocn.2010.21428; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; MacNamara A, 2011, COGN AFFECT BEHAV NE, V11, P321, DOI 10.3758/s13415-011-0036-z; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Perlstein WM, 2002, P NATL ACAD SCI USA, V99, P1736, DOI 10.1073/pnas.241650598; Pessoa L, 2003, PROG BRAIN RES, V144, P171, DOI 10.1016/S0079-6123(03)14401-2; Plichta MM, 2011, NEUROIMAGE, V55, P1200, DOI 10.1016/j.neuroimage.2011.01.011; Plichta MM, 2006, NEUROIMAGE, V31, P116, DOI 10.1016/j.neuroimage.2005.12.008; Plichta MM, 2006, NEUROPSYCHOBIOLOGY, V53, P77, DOI 10.1159/000091723; Schecklmann M, 2010, J PSYCHIATR RES, V44, P621, DOI 10.1016/j.jpsychires.2009.11.018; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Townsend JD, 2013, J AFFECT DISORDERS, V147, P389, DOI 10.1016/j.jad.2012.08.019; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242	44	26	28	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75598	10.1371/journal.pone.0075598	http://dx.doi.org/10.1371/journal.pone.0075598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VP	24086584	gold, Green Submitted, Green Published			2022-12-25	WOS:000325220000031
J	Schmitt, P; Santini, A; Vergnes, A; Degremont, L; de Lorgeril, J				Schmitt, Paulina; Santini, Adrien; Vergnes, Agnes; Degremont, Lionel; de Lorgeril, Julien			Sequence Polymorphism and Expression Variability of Crassostrea gigas Immune Related Genes Discriminate Two Oyster Lines Contrasted in Term of Resistance to Summer Mortalities	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PACIFIC OYSTER; SURVIVAL; PROTEIN; TRANSGLUTAMINASE; SUSCEPTIBILITY; IDENTIFICATION; ASSOCIATION; HEMOCYTES; SELECTION	Summer mortalities of Crassostrea gigas are a major concern in oyster aquaculture. They are the result of a complex interaction between the host, pathogens and environmental factors. Oyster genetics have been identified as an essential determinant of oyster susceptibility to summer mortalities. As the capability of oysters to circumvent diseases depends in part on their immune defenses, we aimed to analyze the gene expression and sequence polymorphism of 42 immune related genes in two oyster lines selected for their "High" (H) and "Low" (L) survival to summer mortalities. Results showed that the variability of gene expression and the sequence polymorphism acting on particular genes could enable the discrimination between H and L oyster lines. Besides, a higher sequence polymorphism was observed on the L line affecting 11 of the 42 analyzed genes. By analyzing gene expression, sequence polymorphism and gene copy number of two antimicrobial peptide families (Cg-Defs and Cg-Prp), and an antimicrobial protein (Cg-BPI) on individual oysters, we showed that gene expression and/or sequence polymorphism could also discriminate H and L oyster lines. Finally, we observed a positive correlation between the gene expression and the gene copy number of antimicrobials and that sequence polymorphism could be encoded in the genome. Overall, this study gives new insights in the relationship between oyster immunity and divergent phenotypes, and discusses the potential implication of antimicrobial diversity in oyster survival to summer mortalities.	[Schmitt, Paulina; Santini, Adrien; Vergnes, Agnes] Univ Montpellier I, Univ Montpellier 2, IFREMER, Ctr Natl Rech Sci,Inst Rech Dev,UMR Ecol Syst Mar, Montpellier, France; [Degremont, Lionel; de Lorgeril, Julien] IFREMER, Lab Genet & Pathol Mollusques Marins, La Tremblade, France	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Ifremer	Schmitt, P (corresponding author), Univ Montpellier I, Univ Montpellier 2, IFREMER, Ctr Natl Rech Sci,Inst Rech Dev,UMR Ecol Syst Mar, Montpellier, France.	julien.de.lorgeril@ifremer.fr	de Lorgeril, Julien/O-7488-2014; VERGNES, Agnès/O-3659-2014; degremont, lionel/A-4163-2011	de Lorgeril, Julien/0000-0002-6400-5455; degremont, lionel/0000-0001-6759-6791; Schmitt, Paulina/0000-0001-6598-837X	Institut Francais de Recherche et d'Exploitation de la Mer (Ifremer); Centre National de la Recherche Scientifique (CNRS) grant from EC2CO (Ecosphere Continentale et Cotiere) MicrobiEn; PNEC project MicroGigas [0405/1B1INEE]	Institut Francais de Recherche et d'Exploitation de la Mer (Ifremer); Centre National de la Recherche Scientifique (CNRS) grant from EC2CO (Ecosphere Continentale et Cotiere) MicrobiEn; PNEC project MicroGigas	Funding was received from the Institut Francais de Recherche et d'Exploitation de la Mer (Ifremer) and the Centre National de la Recherche Scientifique (CNRS) grant from EC2CO (Ecosphere Continentale et Cotiere) MicrobiEn and PNEC project MicroGigas (0405/1B1INEE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Chen B, 2009, EUR J CANCER, V45, P2598, DOI 10.1016/j.ejca.2009.06.023; Combie H., 2008, SUMMER MORTALITY PAC; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; David E, 2007, AQUAT TOXICOL, V84, P389, DOI 10.1016/j.aquatox.2007.06.017; David E, 2012, BIOMARKERS, V17, P85, DOI 10.3109/1354750X.2011.639464; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; Degenhardt JD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000346; Degremont L, 2005, AQUACULTURE, V249, P213, DOI 10.1016/j.aquaculture.2005.03.046; Degremont L, 2007, AQUACULTURE, V262, P41, DOI 10.1016/j.aquaculture.2006.10.025; Degremont L, 2011, AQUACULTURE, V317, P94, DOI 10.1016/j.aquaculture.2011.04.029; Degremont L, 2010, J SHELLFISH RES, V29, P847, DOI 10.2983/035.029.0419; Degremont L, 2010, AQUACULTURE, V299, P21, DOI 10.1016/j.aquaculture.2009.11.017; Derache C, 2009, DEV COMP IMMUNOL, V33, P959, DOI 10.1016/j.dci.2009.03.005; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; Fagutao FE, 2012, FISH SHELLFISH IMMUN, V32, P711, DOI 10.1016/j.fsi.2012.01.018; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Fleury E, 2012, MAR BIOTECHNOL, V14, P203, DOI 10.1007/s10126-011-9403-6; Fleury E, 2010, MAR BIOTECHNOL, V12, P326, DOI 10.1007/s10126-009-9227-9; Garnier M, 2008, SYST APPL MICROBIOL, V31, P358, DOI 10.1016/j.syapm.2008.06.003; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gonzalez M, 2007, DEV COMP IMMUNOL, V31, P332, DOI 10.1016/j.dci.2006.07.006; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Gueguen Y, 2009, MOL IMMUNOL, V46, P516, DOI 10.1016/j.molimm.2008.07.021; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hedgecock D, 2005, J SHELLFISH RES, V24, P429, DOI 10.2983/0730-8000(2005)24[429:TCFSTP]2.0.CO;2; Hou YL, 2012, FUNCT INTEGR GENOMIC, V12, P81, DOI 10.1007/s10142-011-0252-1; Huvet A, 2004, GENE, V343, P211, DOI 10.1016/j.gene.2004.09.008; Kamerbeek NM, 2007, BLOOD, V109, P3560, DOI 10.1182/blood-2006-08-042531; Kikuchi S, 2005, J NEUROIMMUNOL, V167, P170, DOI 10.1016/j.jneuroim.2005.06.021; Le Roux F, 2002, AQUAT LIVING RESOUR, V15, P251, DOI 10.1016/S0990-7440(02)01176-2; Li YH, 2010, J INVEST DERMATOL, V130, P2768, DOI 10.1038/jid.2010.214; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Lin ZY, 2012, DEV COMP IMMUNOL, V37, P164, DOI 10.1016/j.dci.2011.09.003; Loof TG, 2011, BLOOD, V118, P2589, DOI 10.1182/blood-2011-02-337568; Lopez-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021766; Maningas MBB, 2008, MOL IMMUNOL, V45, P1269, DOI 10.1016/j.molimm.2007.09.016; Otvos L, 2002, CELL MOL LIFE SCI, V59, P1138, DOI 10.1007/s00018-002-8493-8; Pazgier M, 2007, J BIOL CHEM, V282, P1819, DOI 10.1074/jbc.M607210200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rosa RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025594; Rosa RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-252; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sauvage C, 2007, GENE, V406, P13, DOI 10.1016/j.gene.2007.05.011; Sauvage C, 2009, MOL ECOL RESOUR, V9, P853, DOI 10.1111/j.1755-0998.2009.02525.x; Schmitt P, 2012, DEV COMP IMMUNOL, V37, P363, DOI 10.1016/j.dci.2012.01.004; Schmitt P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-23; Scocchi M, 2011, CELL MOL LIFE SCI, V68, P2317, DOI 10.1007/s00018-011-0721-7; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Tanne A, 2009, J EXP MED, V206, P2205, DOI 10.1084/jem.20090188; Taris N, 2009, ANIM GENET, V40, P663, DOI 10.1111/j.1365-2052.2009.01894.x; Taris N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-234; Tennessen JA, 2009, DEV COMP IMMUNOL, V33, P1247, DOI 10.1016/j.dci.2009.07.004; Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2; Yang H, 2012, AUTOIMMUNITY, V45, P226, DOI 10.3109/08916934.2011.633134; Yildiz Y, 2010, ARCH MED SCI, V6, P932, DOI 10.5114/aoms.2010.19304; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zervou MI, 2011, HUM IMMUNOL, V72, P1210, DOI 10.1016/j.humimm.2011.09.003; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang Y, 2011, FISH SHELLFISH IMMUN, V30, P1354, DOI 10.1016/j.fsi.2011.03.008	61	28	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75900	10.1371/journal.pone.0075900	http://dx.doi.org/10.1371/journal.pone.0075900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086661	Green Published, gold			2022-12-25	WOS:000325220000051
J	Turner, HC; Baussano, I; Garnett, GP				Turner, Hugo C.; Baussano, Iacopo; Garnett, Geoff P.			Vaccinating Women Previously Exposed to Human Papillomavirus: A Cost-Effectiveness Analysis of the Bivalent Vaccine	PLOS ONE			English	Article							HPV-16/18 AS04-ADJUVANTED VACCINE; TRANSMISSION DYNAMIC-MODEL; BLIND PATRICIA TRIAL; OF-STUDY ANALYSIS; CERVICAL-CANCER; UNITED-KINGDOM; ECONOMIC-EVALUATION; HPV VACCINATION; ADULT WOMEN; INFECTION	Recent trials have indicated that women with prior exposure to Human papillomavirus (HPV) subtypes 16/18 receive protection against reinfection from the HPV vaccines. However, many of the original models investigating the cost effectiveness of different vaccination strategies for the protection of cervical cancer assumed, based on the trial results at that time, that these women received no protection. We developed a deterministic, dynamic transmission model that incorporates the vaccine-induced protection of women with prior exposure to HPV. The model was used to estimate the cost effectiveness of progressively extending a vaccination programme using the bivalent vaccine to older age groups both with and without protection of women with prior exposure. We did this under a range of assumptions on the level of natural immunity. Our modelling projections indicate that including the protection of women with prior HPV exposure can have a profound effect on the cost effectiveness of vaccinating adults. The impact of this protection is inversely related to the level of natural immunity. Our results indicate that adult vaccination strategies should potentially be reassessed, and that it is important to include the protection of non-naive women previously infected with HPV in future studies. Furthermore, they also highlight the need for a more thorough investigation of this protection.	[Turner, Hugo C.; Garnett, Geoff P.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Baussano, Iacopo] Int Agcy Res Canc, F-69372 Lyon, France	Imperial College London; World Health Organization; International Agency for Research on Cancer (IARC)	Turner, HC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	hugo.turner06@imperial.ac.uk	Garnett, Geoffrey P/A-9312-2008	Turner, Hugo/0000-0002-8428-3874	European Community [242061]; Bill & Melinda Gates Foundation [OPP1053353]; Wellcome Trust [090285/Z/09/Z]	European Community(European Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Wellcome Trust(Wellcome TrustEuropean Commission)	Dr. Iacopo Baussano is supported by the following grant sponsors: European Community's Seventh Framework Programme (FP7/2007-2013; acronym PREHDICT), grant number: 242061; and the Bill & Melinda Gates Foundation, grant number: OPP1053353. Geoff P. Garnett acknowledges support from the Wellcome Trust, grant number: 090285/Z/09/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, HDB CANC PREV IARC; [Anonymous], 2010, CERV SCREEN PROGR EN; Bogaards JA, 2011, VACCINE, V29, P8929, DOI 10.1016/j.vaccine.2011.09.055; British Medical Association the Royal Pharmaceutical Society of Great Britain, 2010, 59 BMA ROYAL PHARM S, V59; Brown RE, 2006, CURR MED RES OPIN, V22, P663, DOI 10.1185/030079906X99972; Castellsague X, 2011, BRIT J CANCER, V105, P28, DOI 10.1038/bjc.2011.185; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Curtis L, 2005, NIT COSTS HLTH SOCIA; Curtis L, 2007, NIT COSTS HLTH SOCIA; Department of Health, 2011, NNUAL HPV VACC COV E; Elbasha EH, 2009, VALUE HEALTH, V12, P697, DOI 10.1111/j.1524-4733.2009.00512.x; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Health Protection Agency, 2012, HUM PAP HPV CERV CAN; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Insinga RP, 2007, VACCINE, V26, P128, DOI 10.1016/j.vaccine.2007.10.056; JCVI, 2008, STAT HPV VACC; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Jit M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5775; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; Kim JJ, 2009, ANN INTERN MED, V151, P538, DOI 10.7326/0003-4819-151-8-200910200-00007; Kitchener HC, 2006, BRIT J CANCER, V95, P56, DOI 10.1038/sj.bjc.6603210; Kreimer AR, 2011, JNCI-J NATL CANCER I, V103, P1444, DOI 10.1093/jnci/djr319; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Levy-Bruhl D, 2009, EUR J CANCER, V45, P2709, DOI 10.1016/j.ejca.2009.07.023; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Myers E, 2004, P 21 INT PAP C MEX M; National Institute for Health and Clinical Excellence, 2013, MEAS EFF COST EFF QA; National Institute for Health Clinical Excellence, 2004, N0515 NAT I HLTH CLI; NHS, 2013, HPV VACC GIV; Office for National Statistics, 2008, POP EST UK ENGL WAL; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Rondy M, 2010, VACCINE, V28, P2070, DOI 10.1016/j.vaccine.2009.12.042; Salisbury DM, 2012, LANCET INFECT DIS, V12, P582, DOI 10.1016/S1473-3099(12)70082-8; Szarewski A, 2012, INT J CANCER, V131, P106, DOI 10.1002/ijc.26362; Usher C, 2008, VACCINE, V26, P5654, DOI 10.1016/j.vaccine.2008.07.098; Wallace LA, 2005, VACCINE, V23, P5624, DOI 10.1016/j.vaccine.2005.06.034; Westra TA, 2011, J INFECT DIS, V204, P377, DOI 10.1093/infdis/jir281; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; Wolstenholme JL, 1998, EUR J CANCER, V34, P1889, DOI 10.1016/S0959-8049(98)00232-9; World Health Organization, 2010, UK HUM PAP REL CANC	42	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75552	10.1371/journal.pone.0075552	http://dx.doi.org/10.1371/journal.pone.0075552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086567	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000027
J	van der Spek, N; Vos, J; van Uden-Kraan, CF; Breitbart, W; Tollenaar, RAEM; Cuijpers, P; Verdonck-de Leeuw, IM				van der Spek, Nadia; Vos, Joel; van Uden-Kraan, Cornelia F.; Breitbart, William; Tollenaar, Rob A. E. M.; Cuijpers, Pim; Verdonck-de Leeuw, Irma M.			Meaning Making in Cancer Survivors: A Focus Group Study	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; RANDOMIZED CONTROLLED-TRIAL; EXPRESSIVE GROUP-THERAPY; QUALITY-OF-LIFE; INTERVENTION; DISTRESS; GROWTH; WOMEN; EXPERIENCE; SENSE	Background: Confrontation with a life-threatening disease like cancer can evoke existential distress, which can trigger a search for meaning in people after having survived this disease. Methods: In an effort to gain more insight in the meaning making process, we conducted four focus groups with 23 cancer survivors on this topic. Participants responded to questions about experienced meaning making, perceived changes in meaning making after cancer and the perceived need for help in this area. Results: Most frequently mentioned meaning making themes were relationships and experiences. We found that, in general, cancer survivors experienced enhanced meaning after cancer through relationships, experiences, resilience, goal-orientation and leaving a legacy. Some participants, however, also said to have (also) experienced a loss of meaning in their lives through experiences, social roles, relationships and uncertainties about the future. Conclusions: The results indicated that there is a group of cancer survivors that has succeeded in meaning making efforts, and experienced sometimes even more meaning in life than before diagnosis, while there is also a considerable group of survivors that struggled with meaning making and has an unmet need for help with that. The results of this study contribute to develop a meaning centered intervention for cancer survivors.	[van der Spek, Nadia; van Uden-Kraan, Cornelia F.; Cuijpers, Pim; Verdonck-de Leeuw, Irma M.] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Vos, Joel] Leiden Univ, Dept Clin Genet, Med Ctr, Leiden, Netherlands; [Breitbart, William] Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, New York, NY 10021 USA; [Tollenaar, Rob A. E. M.] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands; [Verdonck-de Leeuw, Irma M.] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Memorial Sloan Kettering Cancer Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	van der Spek, N (corresponding author), Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	n.vander.spek@vu.nl	Vos, Joel/T-4567-2019; Cuijpers, Pim/G-1703-2013; van Uden-Kraan, Cornelia/AAH-4093-2021	Verdonck-de Leeuw, Irma/0000-0002-4507-4607; Cuijpers, Pim/0000-0001-5497-2743; Vos, Joel/0000-0002-7961-2354	Dutch Cancer Society/Alpe d'HuZes/KWF Fund [4864]	Dutch Cancer Society/Alpe d'HuZes/KWF Fund	The study is funded by the Dutch Cancer Society/Alpe d'HuZes/KWF Fund, grant-number 4864. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordeleau L, 2003, J CLIN ONCOL, V21, P1944, DOI 10.1200/JCO.2003.04.080; Breitbart W, 2010, PSYCHO-ONCOLOGY, V19, P21, DOI 10.1002/pon.1556; Brenner H, 2002, LANCET, V360, P1131, DOI 10.1016/S0140-6736(02)11199-8; Carlson LE, 2010, J CLIN ONCOL, V28, P4884, DOI 10.1200/JCO.2009.27.3698; Chochinov HM, 2005, J CLIN ONCOL, V23, P5520, DOI 10.1200/JCO.2005.08.391; Classen C, 2001, ARCH GEN PSYCHIAT, V58, P494, DOI 10.1001/archpsyc.58.5.494; Coward Doris Dickerson, 2003, Oncol Nurs Forum, V30, P291, DOI 10.1188/03.ONF.291-300; Davis CG, 2000, DEATH STUD, V24, P497; Davis CG, 1998, J PERS SOC PSYCHOL, V75, P561, DOI 10.1037/0022-3514.75.2.561; Debats DL, 1996, BRIT J CLIN PSYCHOL, V35, P503, DOI 10.1111/j.2044-8260.1996.tb01207.x; Dutch Comprehensive Cancer Centres, 2011, KANK NED; Ferrell B, 2003, CANCER, V98, P1061, DOI 10.1002/cncr.11291; Frankl V., 1989, WILL MEANING FDN APP; Frankl V, 1986, PSYCHOTHERAPY LOGOTH; Frankl V.E., 1998, MANS SEARCH MEANING; Giese-Davis J, 2002, J CONSULT CLIN PSYCH, V70, P916, DOI 10.1037//0022-006X.70.4.916; Henoch I, 2009, PSYCHO-ONCOLOGY, V18, P225, DOI 10.1002/pon.1424; Hodgkinson K, 2007, SUPPORT CARE CANCER, V15, P515, DOI 10.1007/s00520-006-0170-2; Hoffman KE, 2009, ARCH INTERN MED, V169, P1274, DOI 10.1001/archinternmed.2009.179; Howlader N, 2012, SEER CANC STAT REV 1; Jaarsma TA, 2007, PSYCHO-ONCOL, V16, P241, DOI 10.1002/pon.1056; Kissane DW, 2003, PSYCHO-ONCOLOGY, V12, P532, DOI 10.1002/pon.683; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lee Chun Hee, 2006, Taehan Kanho Hakhoe Chi, V36, P701; Lee V, 2006, SOC SCI MED, V62, P3133, DOI 10.1016/j.socscimed.2005.11.041; Lee V, 2008, SUPPORT CARE CANCER, V16, P779, DOI 10.1007/s00520-007-0396-7; Lee Virginia, 2004, Palliat Support Care, V2, P291; Litosseliti L., 2007, USING FOCUS GROUPS R; Park CL, 2008, J CONSULT CLIN PSYCH, V76, P863, DOI 10.1037/a0013348; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rabiee F, 2004, P NUTR SOC, V63, P655, DOI 10.1079/PNS2004399; Richards MA, 2000, BRIT MED J, V320, P895, DOI 10.1136/bmj.320.7239.895; Ryff CD, 1998, PSYCHOL INQ, V9, P1, DOI 10.1207/s15327965pli0901_1; SILVER RL, 1983, J SOC ISSUES, V39, P81, DOI 10.1111/j.1540-4560.1983.tb00142.x; Spiegel D., 1991, SUPPORTIVE EXPRESSIV; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Thewes B, 2004, J PSYCHOSOC ONCOL, V22, P51, DOI 10.1300/J077v22n01_04; Thompson S. C, 1994, J PSYCHOSOC ONCOL, V11, P1, DOI [DOI 10.1300/J077V11N03_01, 10.1300/j077v11n03_01]; Thornton AA, 2002, J CLIN PSYCHOL MED S, V9, P153, DOI 10.1023/A:1014996127535; Tomich PL, 2005, PSYCHO-ONCOL, V14, P1018, DOI 10.1002/pon.914; Tomich PL, 2002, PSYCHO-ONCOLOGY, V11, P154, DOI 10.1002/pon.570; Yalom I.D., 1980, EXISTENTIAL PSYCHOTH, V1; ZIKA S, 1992, BRIT J PSYCHOL, V83, P133, DOI 10.1111/j.2044-8295.1992.tb02429.x	43	38	38	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76089	10.1371/journal.pone.0076089	http://dx.doi.org/10.1371/journal.pone.0076089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VP	24086695	Green Published, gold, Green Submitted			2022-12-25	WOS:000325220000058
J	Anderson, NM; Javadi, M; Berndl, E; Berberovic, Z; Bailey, ML; Huang, K; Flenniken, AM; Osborne, LR; Adamson, SL; Rossant, J; Carter-Su, C; Wang, C; McNagny, KM; Paulson, RF; Minden, MD; Stanford, WL; Barber, DL				Anderson, Nicole M.; Javadi, Mojib; Berndl, Elizabeth; Berberovic, Zorana; Bailey, Monica L.; Huang, Kai; Flenniken, Ann M.; Osborne, Lucy R.; Adamson, S. Lee; Rossant, Janet; Carter-Su, Christin; Wang, Chen; McNagny, Kelly M.; Paulson, Robert F.; Minden, Mark D.; Stanford, William L.; Barber, Dwayne L.			Enu Mutagenesis Identifies a Novel Platelet Phenotype in a Loss-Of-Function Jak2 Allele	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TYROSINE-PHOSPHORYLATION; PSEUDOKINASE DOMAIN; ACTIVATING MUTATION; MYELOID-LEUKEMIA; PCM1-JAK2 FUSION; PROTEIN-KINASE; GENE; RECEPTOR; CRLF2	Utilizing ENU mutagenesis, we identified a mutant mouse with elevated platelets. Genetic mapping localized the mutation to an interval on chromosome 19 that encodes the Jak2 tyrosine kinase. We identified a A3056T mutation resulting in a premature stop codon within exon 19 of Jak2 (Jak2(K915X)), resulting in a protein truncation and functionally inactive enzyme. This novel platelet phenotype was also observed in mice bearing a hemizygous targeted disruption of the Jak2 locus (Jak2(+/-)). Timed pregnancy experiments revealed that Jak2(K915X/K915X) and Jak2(-/-) displayed embryonic lethality; however, Jak2(K915X/K915X) embryos were viable an additional two days compared to Jak2(-/-) embryos. Our data suggest that perturbing JAK2 activation may have unexpected consequences in elevation of platelet number and correspondingly, important implications for treatment of hematological disorders with constitutive Jak2 activity.	[Anderson, Nicole M.; Stanford, William L.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Javadi, Mojib; Minden, Mark D.; Barber, Dwayne L.] Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON, Canada; [Berndl, Elizabeth; Stanford, William L.] Univ Toronto, Fac Med, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Adamson, S. Lee] Univ Toronto, Fac Med, Dept Obstet & Gynecol, Toronto, ON, Canada; [Osborne, Lucy R.] Univ Toronto, Dept Med, Fac Med, Toronto, ON, Canada; [Osborne, Lucy R.; Rossant, Janet] Univ Toronto, Fac Med, Dept Mol Genet, Toronto, ON, Canada; [Adamson, S. Lee] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Wang, Chen] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Berberovic, Zorana; Flenniken, Ann M.] Toronto Ctr Phenogen, Toronto, ON, Canada; [Rossant, Janet] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Carter-Su, Christin] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [McNagny, Kelly M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Bailey, Monica L.; Huang, Kai; Paulson, Robert F.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Minden, Mark D.; Barber, Dwayne L.] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Stanford, William L.] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada; [Stanford, William L.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Michigan System; University of Michigan; University of British Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Barber, DL (corresponding author), Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON, Canada.	dbarber@uhnres.utoronto.ca	Wang, Chen/J-2346-2016; McNagny, Kelly/P-5239-2014; Adamson, S. Lee/E-4581-2013	McNagny, Kelly/0000-0003-4737-3499; Adamson, S. Lee/0000-0002-7340-3041; Rossant, Janet/0000-0002-3731-5466; Barber, Dwayne/0000-0001-5528-8150; Stanford, William/0000-0002-5813-8016	Dina Gordon Malkin Ontario Graduate Scholarship in Science and Technology; Heart and Stroke/Richard Lewar Centre of Ecellence Scholarship; NSERC Canada; Canadian Institutes of Health Research [FRN 74611]; Heart and Stroke Foundation of Ontario [NA-6363]; Canada Research Chair; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034171] Funding Source: NIH RePORTER	Dina Gordon Malkin Ontario Graduate Scholarship in Science and Technology; Heart and Stroke/Richard Lewar Centre of Ecellence Scholarship; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NA was supported by the Dina Gordon Malkin Ontario Graduate Scholarship in Science and Technology and a Heart and Stroke/Richard Lewar Centre of Ecellence Scholarship. EB was supported by a NSERC Canada Graduate Scholarship award. This sutdy was funded by a group operatiing grant form the Canadian Institutes of Health Research (FRN 74611) to DLB, RP, CW, MDM, KMM and WLS and a grant from the Heart and Stroke Foundation of Ontario (NA-6363) to WLS. WLS is supported by a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NM, 2012, EXP HEMATOL, V40, P48, DOI 10.1016/j.exphem.2011.09.007; Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; BACON CM, 1995, FEBS LETT, V370, P63, DOI 10.1016/0014-5793(95)00796-C; Ballmaier M, 2001, BLOOD, V97, P139, DOI 10.1182/blood.V97.1.139; Bandaranayake RM, 2012, NAT STRUCT MOL BIOL, V19, P754, DOI 10.1038/nsmb.2348; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Bousquet M, 2005, ONCOGENE, V24, P7248, DOI 10.1038/sj.onc.1208850; Deshpande A, 2012, LEUKEMIA, V26, P708, DOI 10.1038/leu.2011.255; Griesinger F, 2005, GENE CHROMOSOME CANC, V44, P329, DOI 10.1002/gcc.20235; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Hertzberg L, 2010, BLOOD, V115, P1006, DOI 10.1182/blood-2009-08-235408; Ho JMY, 1999, BLOOD, V93, P4354, DOI 10.1182/blood.V93.12.4354.412k30_4354_4364; Hughes MR, 2011, EXP HEMATOL, V39, P305, DOI 10.1016/j.exphem.2010.12.009; Ihara K, 1999, P NATL ACAD SCI USA, V96, P3132, DOI 10.1073/pnas.96.6.3132; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Ishida-Takahashi R, 2006, MOL CELL BIOL, V26, P4063, DOI 10.1128/MCB.01589-05; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Javadi M, 2012, J BIOL CHEM, V287, P26223, DOI 10.1074/jbc.M112.382721; Kearney L, 2009, BLOOD, V113, P646, DOI 10.1182/blood-2008-08-170928; Koppikar P, 2012, NATURE, V489, P155, DOI 10.1038/nature11303; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Marit MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043437; Mazurkiewicz-Munoz AM, 2006, MOL CELL BIOL, V26, P4052, DOI 10.1128/MCB.01591-05; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Morita H, 1996, FEBS LETT, V395, P228, DOI 10.1016/0014-5793(96)01047-2; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Murati A, 2005, LEUKEMIA, V19, P1692, DOI 10.1038/sj.leu.2403879; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nebral K, 2009, LEUKEMIA, V23, P134, DOI 10.1038/leu.2008.306; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; PALLARD C, 1995, EMBO J, V14, P2847, DOI 10.1002/j.1460-2075.1995.tb07284.x; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Poitras JL, 2008, GENE CHROMOSOME CANC, V47, P884, DOI 10.1002/gcc.20585; Reiter A, 2005, CANCER RES, V65, P2662, DOI 10.1158/0008-5472.CAN-04-4263; Rouyez MC, 1997, MOL CELL BIOL, V17, P4991, DOI 10.1128/MCB.17.9.4991; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; TORTOLANI PJ, 1995, BLOOD, V85, P3444, DOI 10.1182/blood.V85.12.3444.bloodjournal85123444; Tyner JW, 2010, BLOOD, V115, P5232, DOI 10.1182/blood-2009-05-223727; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; Van Roosbroeck K, 2011, BLOOD, V117, P4056, DOI 10.1182/blood-2010-06-291310; Verstovsek S, 2012, BLOOD, V120, P1202, DOI 10.1182/blood-2012-02-414631; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Weigert O, 2012, J EXP MED, V209, P259, DOI 10.1084/jem.20111694; Wiestner A, 1998, NAT GENET, V18, P49, DOI 10.1038/ng0198-49; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107	54	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75472	10.1371/journal.pone.0075472	http://dx.doi.org/10.1371/journal.pone.0075472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086539	gold, Green Submitted, Green Published			2022-12-25	WOS:000325218700089
J	Dunlop, RA; Cox, PA; Banack, SA; Rodgers, KJ				Dunlop, Rachael Anne; Cox, Paul Alan; Banack, Sandra Anne; Rodgers, Kenneth John			The Non-Protein Amino Acid BMAA Is Misincorporated into Human Proteins in Place of L-Serine Causing Protein Misfolding and Aggregation	PLOS ONE			English	Article							METHYLAMINO-L-ALANINE; AMYOTROPHIC-LATERAL-SCLEROSIS; CYANOBACTERIAL NEUROTOXINS; NEURODEGENERATIVE DISEASE; POSSIBLE LINK; EXPOSURE; ALS; BIOMAGNIFICATION; SYNTHETASE; TOXICITY	Mechanisms of protein misfolding are of increasing interest in the aetiology of neurodegenerative diseases characterized by protein aggregation and tangles including Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease (AD), Parkinson's disease (PD), Lewy Body Dementia (LBD), and Progressive Supranuclear Palsy (PSP). Some forms of neurodegenerative illness are associated with mutations in genes which control assembly of disease related proteins. For example, the mouse sticky mutation sti, which results in undetected mischarging of tRNA Ala with serine resulting in the substitution of serine for alanine in proteins causes cerebellar Purkinje cell loss and ataxia in laboratory animals. Replacement of serine 422 with glutamic acid in tau increases the propensity of tau aggregation associated with neurodegeneration. However, the possibility that environmental factors can trigger abnormal folding in proteins remains relatively unexplored. We here report that a non-protein amino acid, b-N-methylamino-L-alanine (BMAA), can be misincorporated in place of L-serine into human proteins. We also report that this misincorporation can be inhibited by L-serine. Misincorporation of BMAA into human neuroproteins may shed light on putative associations between human exposure to BMAA produced by cyanobacteria and an increased incidence of ALS.	[Dunlop, Rachael Anne; Rodgers, Kenneth John] Univ Technol Sydney, Cell Biol Grp, Sch Med & Mol Biosci, Ultimo, NSW, Australia; [Cox, Paul Alan; Banack, Sandra Anne] Inst Ethnomed, Jackson Hole, WY USA	University of Technology Sydney	Rodgers, KJ (corresponding author), Univ Technol Sydney, Cell Biol Grp, Sch Med & Mol Biosci, Ultimo, NSW, Australia.	kenneth.rodgers@uts.edu.au	Rodgers, Kenneth J./AGM-3353-2022; Rodgers, Kenneth/R-9196-2019	Rodgers, Kenneth J./0000-0002-3627-9651; Cox, Paul/0000-0001-6401-2981; Dunlop, Rachael/0000-0002-7816-3251	Deerbrook Charitable Trust (Institute for Ethnomedicine, Wyoming); University of Technology, New South Wales	Deerbrook Charitable Trust (Institute for Ethnomedicine, Wyoming); University of Technology, New South Wales	This work was funded by D. M. Kinney and the Deerbrook Charitable Trust (Institute for Ethnomedicine, Wyoming) and University of Technology, New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDE CC, 1964, J BIOL CHEM, V239, P1102; Banack SA, 2011, TOXICON, V57, P730, DOI 10.1016/j.toxicon.2011.02.005; Banack SA, 2007, MAR DRUGS, V5, P180, DOI 10.3390/md20070014; Bell EA, 2009, AMYOTROPH LATERAL SC, V10, P21, DOI 10.3109/17482960903268700; Bell EA, 2003, J AGR FOOD CHEM, V51, P2854, DOI 10.1021/jf020880w; Bradley WG, 2013, AMYOTROPH LAT SCL FR, V14, P325, DOI 10.3109/21678421.2012.750364; Caller TA, 2009, AMYOTROPH LATERAL SC, V10, P101, DOI 10.3109/17482960903278485; Chan SW, 2012, EXP NEUROL, V238, P29, DOI 10.1016/j.expneurol.2011.09.029; Cheng R, 2009, AMYOTROPH LATERAL SC, V10, P41, DOI 10.3109/17482960903273528; Chiu AS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01482; Chiu AS, 2011, INT J ENV RES PUB HE, V8, P3728, DOI 10.3390/ijerph8093728; Costanzo M, 2013, BIOCHEM J, V452, P1, DOI 10.1042/BJ20121898; Cox PA, 2003, P NATL ACAD SCI USA, V100, P13380, DOI 10.1073/pnas.2235808100; Cox PA, 2005, P NATL ACAD SCI USA, V102, P5074, DOI 10.1073/pnas.0501526102; Cox PA, 2009, AMYOTROPH LATERAL SC, V10, P109, DOI 10.3109/17482960903286066; de Munck E, 2013, ENVIRON TOXICOL PHAR, V36, P243, DOI 10.1016/j.etap.2013.04.007; Dunlop RA, 2008, BIOCHEM J, V410, P131, DOI 10.1042/BJ20070161; Dunlop RA, 2011, BIOCHEM J, V435, P207, DOI 10.1042/BJ20100682; Field NC, 2013, TOXICON, V70, P179, DOI 10.1016/j.toxicon.2013.04.010; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Karlsson O, 2013, J PROTEOME RES, V12, P1678, DOI 10.1021/pr3010265; Karlsson O, 2009, PIGM CELL MELANOMA R, V22, P120, DOI 10.1111/j.1755-148X.2008.00508.x; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lobner D, 2007, NEUROBIOL DIS, V25, P360, DOI 10.1016/j.nbd.2006.10.002; MINTER AJ, 1992, THROMB HAEMOSTASIS, V67, P718; Mondo K, 2012, MAR DRUGS, V10, P509, DOI 10.3390/md10020509; Murch SJ, 2004, P NATL ACAD SCI USA, V101, P12228, DOI 10.1073/pnas.0404926101; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Okle O, 2013, TOXICOL APPL PHARM, V270, P9, DOI 10.1016/j.taap.2013.04.003; Okle O, 2013, TOXICOL SCI, V131, P217, DOI 10.1093/toxsci/kfs291; Pablo J, 2009, ACTA NEUROL SCAND, V120, P216, DOI 10.1111/j.1600-0404.2008.01150.x; POLSKY FI, 1972, FED PROC, V31, P1473; Rodgers KJ, 2008, INT J BIOCHEM CELL B, V40, P1452, DOI 10.1016/j.biocel.2008.01.009; Rodgers KJ, 2004, FREE RADICAL BIO MED, V37, P1756, DOI 10.1016/j.freeradbiomed.2004.08.009; Rodgers KJ, 2002, FREE RADICAL BIO MED, V32, P766, DOI 10.1016/S0891-5849(02)00768-2; ROSENTHAL GA, 1977, SCIENCE, V196, P658, DOI 10.1126/science.854740; Rubenstein E, 2000, MEDICINE, V79, P80, DOI 10.1097/00005792-200003000-00002; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tang J, 2011, PHYTOTHER RES, V25, P417, DOI 10.1002/ptr.3283; Tso C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037091; Xie XB, 2013, NEUROREPORT, V24, P779, DOI 10.1097/WNR.0b013e328363fd89; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036	44	204	211	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75376	10.1371/journal.pone.0075376	http://dx.doi.org/10.1371/journal.pone.0075376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086518	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700082
J	Muszewska, A; Steczkiewicz, K; Ginalski, K				Muszewska, Anna; Steczkiewicz, Kamil; Ginalski, Krzysztof			DIRS and Ngaro Retrotransposons in Fungi	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; SEQUENCE; GENOME; FAMILIES; ACCURATE; DATABASE; ORIGINS; TOOL	Retrotransposons with a tyrosine recombinase (YR) have been discovered recently and lack thorough annotation in fungi. YR retrotransposons are divided into 3 groups: DIRS, Ngaro and VIPER (known only from kinetoplastida). We used comparative genomics to investigate the evolutionary patterns of retrotransposons in the fungal kingdom. The identification of both functional and remnant elements provides a unique view on both recent and past transposition activity. Our searches covering a wide range of fungal genomes allowed us to identify 2241 YR retrotransposons. Based on CLANS clustering of concatenated sequences of the reverse transcriptase (RT), RNase H (RH), DNA N-6-adenine-methyltransferase (MT) and YR protein domains we propose a revised classification of YR elements expanded by two new categories of Ngaro elements. A phylogenetic analysis of 477 representatives supports this observation and additionally demonstrates that DIRS and Ngaro abundance changed independently in Basidiomycota and Blastocladiomycota/Mucoromycotina/Kixellomycotina. Interestingly, a single remnant Ngaro element could be identified in an Ascomycota genome. Our analysis revealed also that 3 Pucciniomycotina taxa, known for their overall mobile element abundance and big genome size, encode an elevated number of Ngaro retrotransposons. Considering the presence of DIRS elements in all analyzed Mucoromycotina, Kickxellomycotina and Blastocladiomycota genomes one might assume a common origin of fungal DIRS retrotransposons with a loss in Dicarya. Ngaro elements described to date from Opisthokonta, seem to have invaded the common ancestor of Agaricomycotina and Pucciniomycotina after Ustilagomycotina divergence. Yet, most of analyzed genomes are devoid of YR elements and most identified retrotransposons are incomplete.	[Muszewska, Anna; Steczkiewicz, Kamil; Ginalski, Krzysztof] Univ Warsaw, CeNT, Lab Bioinformat & Syst Biol, Warsaw, Poland	University of Warsaw	Muszewska, A (corresponding author), Univ Warsaw, CeNT, Lab Bioinformat & Syst Biol, Warsaw, Poland.	musze@ibb.waw.pl	Muszewska, Anna/S-9406-2019; Steczkiewicz, Kamil/ABB-2260-2021	Muszewska, Anna/0000-0002-4578-844X; Steczkiewicz, Kamil/0000-0002-6223-1694	Ministry of Science and Higher Education [0376/IP1/2011/71]; Foundation for Polish Science [TEAM/2010-6/5]; European Social Fund [UDA-POKL.04.01.01-00-072/09-00]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Social Fund(European Social Fund (ESF))	This work was supported by Ministry of Science and Higher Education (0376/IP1/2011/71), Foundation for Polish Science (TEAM/2010-6/5) and European Social Fund (UDA-POKL.04.01.01-00-072/09-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chicas A, 2004, NUCLEIC ACIDS RES, V32, P4237, DOI 10.1093/nar/gkh764; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Eddy Sean R, 2009, Genome Inform, V23, P205; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Goodwin TJD, 2004, MOL BIOL EVOL, V21, P746, DOI 10.1093/molbev/msh072; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hua-Van A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-19; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-44; Kapitonov VV, 2007, TRENDS GENET, V23, P521, DOI 10.1016/j.tig.2007.08.004; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kojima KK, 2011, REPBASE REPORTS; Kwon-Chung KJ, 2012, CLIN INFECT DIS, V54, pS8, DOI 10.1093/cid/cir864; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-272; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; Lorenzi HA, 2006, MOL BIOCHEM PARASIT, V145, P184, DOI 10.1016/j.molbiopara.2005.10.002; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Malik HS, 2005, CYTOGENET GENOME RES, V110, P392, DOI 10.1159/000084971; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Muszewska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029425; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; Piednoel M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-621; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; Rachidi N, 1999, MOL GEN GENET, V261, P841, DOI 10.1007/s004380050028; RuizPerez VL, 1996, MOL GEN GENET, V253, P324, DOI 10.1007/s004380050328; Smit AFA, 2008, REPEATMODELER OPEN 1; Wang XY, 2010, GENE DEV, V24, P2566, DOI 10.1101/gad.1970910; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Windhofer F, 2000, CURR GENET, V37, P194, DOI 10.1007/s002940050519; Zemojtel T, 2009, TRENDS GENET, V25, P63, DOI 10.1016/j.tig.2008.11.005	41	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76319	10.1371/journal.pone.0076319	http://dx.doi.org/10.1371/journal.pone.0076319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086727	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700125
J	Yu, S; Tajiri, N; Franzese, N; Franzblau, M; Bae, E; Platt, S; Kaneko, Y; Borlongan, CV				Yu, SeongJin; Tajiri, Naoki; Franzese, Nick; Franzblau, Max; Bae, EunKyung; Platt, Simon; Kaneko, Yuji; Borlongan, Cesar V.			Stem Cell-Like Dog Placenta Cells Afford Neuroprotection against Ischemic Stroke Model via Heat Shock Protein Upregulation	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; HUMAN TERM PLACENTA; MESENCHYMAL STEM; DEMYELINATING DISORDERS; UMBILICAL-CORD; BRAIN-INJURY; RAT; TRANSPLANTATION; THERAPY	In this study, we investigated the dog placenta as a viable source of stem cells for stroke therapy. Immunocytochemical evaluation of phenotypic markers of dog placenta cells (DPCs) cultured in proliferation and differentiation medium revealed that DPCs expressed both stem cell and neural cell markers, respectively. Co-culture with DPCs afforded neuroprotection of rat primary neural cells in a dose-dependent manner against oxygen-glucose deprivation. Subsequent in vivo experiments showed that transplantation of DPCs, in particular intravenous and intracerebral cell delivery, produced significant behavioral recovery and reduced histological deficits in ischemic stroke animals compared to those that received intra-arterial delivery of DPCs or control stroke animals. Furthermore, both in vitro and in vivo studies implicated elevated expression of heat shock protein 27 (Hsp27) as a potential mechanism of action underlying the observed therapeutic benefits of DPCs in stroke. This study supports the use of stem cells for stroke therapy and implicates a key role of Hsp27 signaling pathway in neuroprotection.	[Yu, SeongJin; Tajiri, Naoki; Franzese, Nick; Franzblau, Max; Bae, EunKyung; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA; [Platt, Simon] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Atlanta, GA USA	State University System of Florida; University of South Florida; University System of Georgia; University of Georgia	Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Tajiri, Naoki/K-1230-2012; Kaneko, Yuji/J-6447-2012; Borlongan, Cesar/I-5696-2012	Tajiri, Naoki/0000-0003-2189-662X; Borlongan, Cesar/0000-0002-2966-9782; Platt, Simon/0000-0002-7818-1011	National Institutes of Health, National Institute of Neurological Disorders and Stroke [1R01NS071956-01]; James and Esther King Foundation for Biomedical Research Program; SanBio Inc.; Celgene Cellular Therapeutics; KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); James and Esther King Foundation for Biomedical Research Program; SanBio Inc.; Celgene Cellular Therapeutics(Bristol-Myers SquibbCelgene Corporation); KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CVB is supported by National Institutes of Health, National Institute of Neurological Disorders and Stroke 1R01NS071956-01, James and Esther King Foundation for Biomedical Research Program, SanBio Inc., Celgene Cellular Therapeutics, KMPHC and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JJ, 2008, FEBS J, V275, P1296, DOI 10.1111/j.1742-4658.2008.06291.x; Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Barcena A, 2009, REPROD SCI, V16, P178, DOI 10.1177/1933719108327621; Barlow S, 2008, STEM CELLS DEV, V17, P1095, DOI 10.1089/scd.2007.0154; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Black L, 2008, VET THER, V9; Black LL, 2007, VET THER, V8, P272; Bliss TM, 2010, NEUROBIOL DIS, V37, P275, DOI 10.1016/j.nbd.2009.10.003; Borlongan CV, 2009, STROKE, V40, pS146, DOI 10.1161/STROKEAHA.108.533091; Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730; Borlongan CV, 2000, FASEB J, V14, P1307, DOI 10.1096/fj.14.10.1307; Brambilla R, 2001, ANN NY ACAD SCI, V939, P54; Chen J, 2012, CELL TRANSPLANT; Dawson DA, 1996, J CEREBR BLOOD F MET, V16, P170, DOI 10.1097/00004647-199601000-00020; El-Badri NS, 2004, STEM CELLS DEV, V13, P463, DOI 10.1089/scd.2004.13.463; Franklin TB, 2005, INT J HYPERTHER, V21, P379, DOI 10.1080/02656730500069955; Gredal H, 2013, VET J, V196, P408, DOI 10.1016/j.tvjl.2012.10.018; Heneidi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064752; Ilancheran S, 2009, PLACENTA, V30, P2, DOI 10.1016/j.placenta.2008.09.009; Imura T, 1999, J NEUROSCI, V19, P9768; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; KATO H, 1995, BRAIN RES, V679, P1, DOI 10.1016/0006-8993(95)00198-Y; Kholodenko IV, 2012, B EXP BIOL MED+, V154, P118, DOI 10.1007/s10517-012-1890-6; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Kranz A, 2010, BRAIN RES, V1315, P128, DOI 10.1016/j.brainres.2009.12.001; Krueger-Naug AMR, 2000, J COMP NEUROL, V428, P495, DOI 10.1002/1096-9861(20001218)428:3<495::AID-CNE7>3.0.CO;2-4; Liu SP, 2010, CELL TRANSPLANT, V19, P1261, DOI 10.3727/096368910X507204; Luyten FP, 2004, CURR OPIN RHEUMATOL, V16, P599, DOI 10.1097/01.bor.0000130284.64686.63; Meamar R, 2013, INT J PREVENTIVE MED, V4, pS139; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Noto T, 2007, BIOL PHARM BULL, V30, P313, DOI 10.1248/bpb.30.313; Onteniente B, 2013, CURR MOL MED, V13, P821, DOI 10.2174/1566524011313050013; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pluchino S, 2005, J NEUROL SCI, V233, P117, DOI 10.1016/j.jns.2005.03.026; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Revencu T, 2013, ROM J MORPHOL EMBRYO, V54, P291; Reynolds LPR, 2003, CEREBELLUM, V2, P171, DOI 10.1080/14734220310016114; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Rosado-de-Castro PH, 2013, STEM CELLS DEV; Sanberg PR, 1997, NAT MED, V3, P1129, DOI 10.1038/nm1097-1129; Shen CC, 2010, CURR NEUROVASC RES, V7, P167, DOI 10.2174/156720210792231822; Stetler RA, 2012, J NEUROSCI, V32, P2667, DOI 10.1523/JNEUROSCI.5169-11.2012; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Teramoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066001; Thirumala S, 2013, EXPERT OPIN BIOL TH, V13, P673, DOI 10.1517/14712598.2013.763925; Timmins NE, 2012, BIOTECHNOL BIOENG, V109, P1817, DOI 10.1002/bit.24425; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Uccelli A, 2006, EXPERT OPIN BIOL TH, V6, P17, DOI 10.1517/14712598.6.1.17; Wang LQ, 2013, NEUROL RES, V35, P470, DOI 10.1179/1743132813Y.0000000210; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863; Yarygin KN, 2009, B EXP BIOL MED+, V148, P862, DOI 10.1007/s10517-010-0837-z; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098	55	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76329	10.1371/journal.pone.0076329	http://dx.doi.org/10.1371/journal.pone.0076329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086730	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700127
J	Guo, Y; Liu, LJ; Xu, L; Tang, P; Lv, YY; Feng, Y; Meng, M; Jonas, JB				Guo, Yin; Liu, Li Juan; Xu, Liang; Tang, Ping; Lv, Yan Yun; Feng, Yi; Meng, Meng; Jonas, Jost B.			Myopic Shift and Outdoor Activity among Primary School Children: One-Year Follow-Up Study in Beijing	PLOS ONE			English	Article							PROGRESSIVE-ADDITION LENSES; SINGLE-VISION LENSES; RANDOMIZED-TRIAL; FORM-DEPRIVATION; CHINESE CHILDREN; OCULAR COMPONENTS; JAPANESE CHILDREN; REFRACTIVE ERRORS; VISUAL ACTIVITY; CONTACT-LENSES	Purpose: To assess whether a change in myopia related oculometric parameters of primary school children in Beijing was associated with indoors and outdoors activity. Methods: The longitudinal school-based study included school children who were examined in 2011 and who were re-examined in 2012. The children underwent a comprehensive eye examination including ocular biometry by optical low-coherence reflectometry and non-cycloplegic refractometry. Parents and children had a detailed interview including questions on time spent indoors and outdoors. Results: Out of 681 students examined at baseline, 643 (94.4%) returned for follow-up examination. Within the one-year period, mean time spent daily outdoors increased by 0.4 +/- 0.9 hours, mean axial length by 0.26 +/- 0.49 mm, the ratio of axial length divided by anterior corneal curvature (AL/CC) by 0.03 +/- 0.06, and myopic refractive error by -0.06 +/- 0.89 diopters. In multivariate analysis, elongation of axial length was significantly associated with less total time spent outdoors (P = 0.02; standardized coefficient beta -0.12) and more time spent indoors with studying (P = 0.007; beta: 0.14) after adjustment for maternal myopia (P = 0.02; beta: 0.12). An increase in AL/CC was significantly associated with less time spent outdoors (P = 0.01; beta: -0.12) after adjustment for paternal myopia (P = 0.003; beta: 0.15) and if region of habitation was excludedors for leisure (P = 0.006; beta: -0.13), with less total time spent outdoors (P = 0.04; beta: -0.10), or with more time spent i. An increase in myopic refractive error, after adjustment for age, was significantly associated with less time spent outdo ndoors with studying (P = 0.005; beta: 0.13). Conclusions: A change in oculometric parameters indicating an increase in myopia was significantly associated with less time spent outdoors and more time spent indoors in school children in Greater Beijing within a study period of one year. Our study provides additional information on the potentially helpful role of outdoors activity in the prevention of myopia. Public health care measures such as school agendas may potentially take it into account.	[Guo, Yin; Tang, Ping; Lv, Yan Yun; Feng, Yi; Meng, Meng] Capital Med Univ, Beijing Tongren Hosp, Tongren Eye Care Ctr, Beijing, Peoples R China; [Liu, Li Juan; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@163.com	Guo, Yin/ABC-2134-2020	Guo, Yin/0000-0003-3806-3771	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby RS, 2010, INVEST OPHTH VIS SCI, V51, P5247, DOI 10.1167/iovs.09-4689; Berntsen DA, 2012, INVEST OPHTH VIS SCI, V53, P640, DOI 10.1167/iovs.11-7769; Breslin KMM, 2013, INVEST OPHTH VIS SCI, V54, P4843, DOI 10.1167/iovs.13-11813; Cheng D, 2010, ARCH OPHTHALMOL-CHIC, V128, P12, DOI 10.1001/archophthalmol.2009.332; Cui DM, 2013, OPHTHALMOLOGY, V120, P1074, DOI 10.1016/j.ophtha.2012.10.022; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Donovan L, 2012, OPTOMETRY VISION SCI, V89, P1196, DOI 10.1097/OPX.0b013e3182640996; Fan DSP, 2004, ANN ACAD MED SINGAP, V33, P39; Feldkaemper M, 2013, EXP EYE RES, DOI [10.1016/j.exer.2013.02.007, DOI 10.1016/J.EXER.2013.02.007.[]; Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004; French AN, 2012, INVEST OPHTH VIS SCI, V53, P4021, DOI 10.1167/iovs.12-9556; French AN, 2013, OPHTHALMOLOGY; French AN, 2013, EXP EYE RES, V2013; Fujiwara M, 2012, JPN J OPHTHALMOL, V56, P401, DOI 10.1007/s10384-012-0148-1; GROSVENOR T, 1994, OPTOMETRY VISION SCI, V71, P573, DOI 10.1097/00006324-199409000-00005; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; Gwiazda J, 2003, INVEST OPHTH VIS SCI, V44, P1492, DOI 10.1167/iovs.02-0816; Gwiazda J, 2011, INVEST OPHTH VIS SCI, V52, P2749, DOI 10.1167/iovs.10-6631; Hasebe S, 2008, INVEST OPHTH VIS SCI, V49, P2781, DOI 10.1167/iovs.07-0385; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Jones-Jordan LA, 2012, INVEST OPHTH VIS SCI, V53, P7169, DOI 10.1167/iovs.11-8336; Jones-Jordan LA, 2011, INVEST OPHTH VIS SCI, V52, P1841, DOI 10.1167/iovs.09-4997; Katz J, 2003, AM J OPHTHALMOL, V136, P82, DOI 10.1016/S0002-9394(03)00106-5; Lam CSY, 1999, OPTOMETRY VISION SCI, V76, P370, DOI 10.1097/00006324-199906000-00016; Li SM, 2011, SURV OPHTHALMOL, V56, P451, DOI 10.1016/j.survophthal.2011.06.002; Liang YB, 2013, BRIT J OPHTHALMOL, V97, P765, DOI 10.1136/bjophthalmol-2012-302468; Low W, 2010, BRIT J OPHTHALMOL, V94, P1012, DOI 10.1136/bjo.2009.173187; Lu B, 2009, ARCH OPHTHALMOL-CHIC, V127, P769, DOI 10.1001/archophthalmol.2009.105; McCarthy CS, 2007, EXP EYE RES, V84, P100, DOI 10.1016/j.exer.2006.09.018; Megaw PL, 1997, AUST NZ J OPHTHALMOL, V25, pS76; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Nickla DL, 2011, EXP EYE RES, V93, P782, DOI 10.1016/j.exer.2011.08.001; Onal S, 2007, OPTOMETRY VISION SCI, V84, P175, DOI 10.1097/OPX.0b013e3180335c52; PARSSINEN O, 1993, INVEST OPHTH VIS SCI, V34, P2794; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2005, BRIT J OPHTHALMOL, V89, P1489, DOI 10.1136/bjo.2005.071118; Sherwin JC, 2012, INVEST OPHTH VIS SCI, V53, P4363, DOI 10.1167/iovs.11-8677; Smith EL, 2013, INVEST OPHTH VIS SCI, V54, P2959, DOI 10.1167/iovs.13-11713; Tong L, 2009, OPHTHALMOLOGY, V116, P572, DOI 10.1016/j.ophtha.2008.10.020; Walline JJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P1760, DOI 10.1001/archopht.122.12.1760; Wang YX, 2006, AM J OPHTHALMOL, V141, P1078, DOI 10.1016/j.ajo.2006.01.023; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Xiang F, 2012, OPHTHALMOLOGY, V119, P1478, DOI 10.1016/j.ophtha.2012.01.017; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035	45	67	71	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75260	10.1371/journal.pone.0075260	http://dx.doi.org/10.1371/journal.pone.0075260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086484	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200033
J	Hirano, M; Kato, S; Kobayashi, K; Okada, T; Yaginuma, H; Kobayashi, K				Hirano, Miyabi; Kato, Shigeki; Kobayashi, Kenta; Okada, Tomoaki; Yaginuma, Hiroyuki; Kobayashi, Kazuto			Highly Efficient Retrograde Gene Transfer into Motor Neurons by a Lentiviral Vector Pseudotyped with Fusion Glycoprotein	PLOS ONE			English	Article							NERVOUS-SYSTEM; ACETYLCHOLINE-RECEPTOR; ADENOASSOCIATED VIRUS; RABIES; TRANSDUCTION; DELIVERY; MOTONEURONS; CELLS; EXPRESSION; MUTATIONS	The development of gene therapy techniques to introduce transgenes that promote neuronal survival and protection provides effective therapeutic approaches for neurological and neurodegenerative diseases. Intramuscular injection of adenoviral and adeno-associated viral vectors, as well as lentiviral vectors pseudotyped with rabies virus glycoprotein (RV-G), permits gene delivery into motor neurons in animal models for motor neuron diseases. Recently, we developed a vector with highly efficient retrograde gene transfer (HiRet) by pseudotyping a human immunodeficiency virus type 1 (HIV-1)-based vector with fusion glycoprotein B type (FuG-B) or a variant of FuG-B (FuG-B2), in which the cytoplasmic domain of RV-G was replaced by the corresponding part of vesicular stomatitis virus glycoprotein (VSV-G). We have also developed another vector showing neuron-specific retrograde gene transfer (NeuRet) with fusion glycoprotein C type, in which the short C-terminal segment of the extracellular domain and transmembrane/cytoplasmic domains of RV-G was substituted with the corresponding regions of VSV-G. These two vectors afford the high efficiency of retrograde gene transfer into different neuronal populations in the brain. Here we investigated the efficiency of the HiRet (with FuG-B2) and NeuRet vectors for retrograde gene transfer into motor neurons in the spinal cord and hindbrain in mice after intramuscular injection and compared it with the efficiency of the RV-G pseudotype of the HIV-1-based vector. The main highlight of our results is that the HiRet vector shows the most efficient retrograde gene transfer into both spinal cord and hindbrain motor neurons, offering its promising use as a gene therapeutic approach for the treatment of motor neuron diseases.	[Hirano, Miyabi; Kato, Shigeki; Kobayashi, Kazuto] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Mol Genet, Fukushima, Japan; [Kobayashi, Kenta] Natl Inst Physiol Sci, Sect Viral Vector Dev, Okazaki, Aichi 444, Japan; [Okada, Tomoaki] Fukushima Med Univ, Sch Med, Dept Neuroanat & Embryol, Fukushima, Japan; [Yaginuma, Hiroyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Japan	Fukushima Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Fukushima Medical University; Japan Science & Technology Agency (JST)	Kobayashi, K (corresponding author), Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Mol Genet, Fukushima, Japan.	kazuto@fmu.ac.jp	Kato, Shigeki/S-8016-2018	Kato, Shigeki/0000-0002-8792-7591	Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan	Core Research for Evolutional Science and Technology of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid from Core Research for Evolutional Science and Technology of Japan Science and Technology Agency. Part of this work was supported by "Highly Creative Animal Model Development for Brain Sciences" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Azzouz M, 2004, J CLIN INVEST, V114, P1726, DOI 10.1172/JCI200422922; Azzouz M, 2004, J GENE MED, V6, P951, DOI 10.1002/jgm.600; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Baumgartner BJ, 1998, EXP NEUROL, V153, P102, DOI 10.1006/exnr.1998.6878; de Carvalho M, 2011, CURR OPIN NEUROL, V24, P497, DOI 10.1097/WCO.0b013e32834916a9; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; ElMallah MK, 2012, HUM GENE THER METHOD, V23, P148, DOI 10.1089/hgtb.2012.009; Federici Thais, 2009, Genet Vaccines Ther, V7, P1, DOI 10.1186/1479-0556-7-1; Finiels F, 1995, NEUROREPORT, V7, P373, DOI 10.1097/00001756-199512000-00088; Gastka M, 1996, J GEN VIROL, V77, P2437, DOI 10.1099/0022-1317-77-10-2437; Gravel C, 1997, NAT MED, V3, P765, DOI 10.1038/nm0797-765; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; HANHAM CA, 1993, J VIROL, V67, P530, DOI 10.1128/JVI.67.1.530-542.1993; Kato S, 2007, HUM GENE THER, V18, P1141, DOI 10.1089/hum.2007.082; Kato S, 2013, REV NEUROSCIENCE, V24, P1, DOI 10.1515/revneuro-2012-0043; Kato S, 2011, HUM GENE THER, V22, P1511, DOI 10.1089/hum.2011.111; Kato S, 2011, J NEUROSCI, V31, P17169, DOI 10.1523/JNEUROSCI.4005-11.2011; Kato S, 2011, HUM GENE THER, V22, P197, DOI 10.1089/hum.2009.179; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Lentz T L, 1990, J Mol Recognit, V3, P82, DOI 10.1002/jmr.300030205; LENTZ TL, 1987, PROTEINS, V2, P298, DOI 10.1002/prot.340020406; Lundberg C, 2008, CURR GENE THER, V8, P461, DOI 10.2174/156652308786847996; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; Mentis GZ, 2006, J NEUROSCI METH, V157, P208, DOI 10.1016/j.jneumeth.2006.04.011; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Owens Roland A., 2002, Current Gene Therapy, V2, P145, DOI 10.2174/1566523024605627; Perrelet D, 2000, EUR J NEUROSCI, V12, P2059, DOI 10.1046/j.1460-9568.2000.00098.x; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Ribotta MGY, 1997, J NEUROSCI RES, V48, P281; Sakamoto T, 2003, J NEUROSCI RES, V72, P54, DOI 10.1002/jnr.10558; Thoulouze MI, 1998, J VIROL, V72, P7181, DOI 10.1128/JVI.72.9.7181-7190.1998; Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119; Towne C, 2011, MOL THER, V19, P274, DOI 10.1038/mt.2010.260; Tuffereau C, 1998, EMBO J, V17, P7250, DOI 10.1093/emboj/17.24.7250; Wee CD, 2010, CURR OPIN NEUROL, V23, P450, DOI 10.1097/WCO.0b013e32833e1765; Wong LF, 2006, HUM GENE THER, V17, P1, DOI 10.1089/hum.2006.17.1; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Yan ZY, 2000, P NATL ACAD SCI USA, V97, P6716, DOI 10.1073/pnas.97.12.6716	46	35	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75896	10.1371/journal.pone.0075896	http://dx.doi.org/10.1371/journal.pone.0075896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086660	gold, Green Published, Green Submitted			2022-12-25	WOS:000325025200070
J	Mahani, A; Henriksson, J; Wright, APH				Mahani, Amir; Henriksson, Johan; Wright, Anthony P. H.			Origins of Myc Proteins - Using Intrinsic Protein Disorder to Trace Distant Relatives	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RNA-POLYMERASE-I; C-MYC; TRANSACTIVATION DOMAIN; TRANSCRIPTION FACTORS; ENERGY CONTENT; RIBOSOMAL DNA; MAX NETWORK; WEB SERVER; CELL-SIZE	Mammalian Myc proteins are important determinants of cell proliferation as well as the undifferentiated state of stem cells and their activity is frequently deregulated in cancer. Based mainly on conservation in the C-terminal DNA-binding and dimerization domain, Myc-like proteins have been reported in many simpler organisms within and outside the Metazoa but they have not been found in fungi or plants. Several important signature motifs defining mammalian Myc proteins are found in the N-terminal domain but the extent to which these are found in the Myc-like proteins from simpler organisms is not well established. The extent of N-terminal signature sequence conservation would give important insights about the evolution of Myc proteins and their current function in mammalian physiology and disease. In a systematic study of Myc-like proteins we show that N-terminal signature motifs are not readily detectable in individual Myc-like proteins from invertebrates but that weak similarities to Myc boxes 1 and 2 can be found in the N-termini of the simplest Metazoa as well as the unicellular choanoflagellate, Monosiga brevicollis, using multiple protein alignments. Phylogenetic support for the connections of these proteins to established Myc proteins is however poor. We show that the pattern of predicted protein disorder along the length of Myc proteins can be used as a complementary approach to making dendrograms of Myc proteins that aids the classification of Myc proteins. This suggests that the pattern of disorder within Myc proteins is more conserved through evolution than their amino acid sequence. In the disorder-based dendrograms the Myc-like proteins from simpler organisms, including M. brevicollis, are connected to established Myc proteins with a higher degree of certainty. Our results suggest that protein disorder based dendrograms may be of general significance for studying distant relationships between proteins, such as transcription factors, that have high levels of intrinsic disorder.	[Wright, Anthony P. H.] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; Karolinska Inst, Ctr Biosci, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet	Wright, APH (corresponding author), Karolinska Inst, Dept Lab Med, Huddinge, Sweden.	anthony.wright@ki.se	Henriksson, Johan/ABD-2430-2021; Wright, Anthony/J-8187-2015	Henriksson, Johan/0000-0002-7745-2844; Wright, Anthony/0000-0003-1029-9969	Swedish Research Council; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	The work was financed by the Swedish Research Council (www.vr.se) and the Swedish Cancer Society (www.cancerfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andresen C, 2012, NUCLEIC ACIDS RES, V40, P6353, DOI 10.1093/nar/gks263; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bordoli L, 2007, PROTEINS, V69, P129, DOI 10.1002/prot.21671; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Brown CJ, 2010, MOL BIOL EVOL, V27, P609, DOI 10.1093/molbev/msp277; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Daughdrill GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029207; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Ferreira ME, 2005, J BIOL CHEM, V280, P21779, DOI 10.1074/jbc.M502627200; Flinn EM, 1998, MOL CELL BIOL, V18, P5961, DOI 10.1128/MCB.18.10.5961; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Gallant P, 2006, CURR TOP MICROBIOL, V302, P235; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grothendieck G., 2012, SQLDF PERFORM SQL SE; Hartl M, 2010, P NATL ACAD SCI USA, V107, P4051, DOI 10.1073/pnas.0911060107; Hermann S, 2001, J BIOL CHEM, V276, P40127, DOI 10.1074/jbc.M103793200; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Hydbring P, 2010, AGING-US, V2, P244, DOI 10.18632/aging.100140; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Luscher B, 2012, GENE, V494, P145, DOI 10.1016/j.gene.2011.12.027; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; Marandel L, 2012, MOL REPROD DEV, V79, P85, DOI 10.1002/mrd.22004; McEwan IJ, 1996, BIOCHEMISTRY-US, V35, P9584, DOI 10.1021/bi960793v; McFerrin LG, 2011, GENOME BIOL EVOL, V3, P915, DOI 10.1093/gbe/evr082; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; MORTON CC, 1989, GENOMICS, V4, P367, DOI 10.1016/0888-7543(89)90344-3; Mulder Nicola, 2007, V396, P59; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Nilsson J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r65; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Obradovic Romero, 1997, GENOME INFORM SER WO, V8, P110; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Radivojac Predrag, 2003, Pac Symp Biocomput, P216; ROBERTSON NG, 1991, NUCLEIC ACIDS RES, V19, P3129, DOI 10.1093/nar/19.11.3129; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Skinner MK, 2010, DIFFERENTIATION, V80, P1, DOI 10.1016/j.diff.2010.02.003; Smith K, 2010, REGEN MED, V5, P947, DOI 10.2217/RME.10.79; SmithSorensen B, 1996, J BIOL CHEM, V271, P5513, DOI 10.1074/jbc.271.10.5513; Sodir NM, 2011, FINDING CANC WEAKEST; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toth-Petroczy A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000243; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xue B, 2012, MOL BIOSYST, V8, P134, DOI 10.1039/c1mb05163f; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Young SL, 2011, MOL BIOL EVOL, V28, P2961, DOI 10.1093/molbev/msr132	69	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75057	10.1371/journal.pone.0075057	http://dx.doi.org/10.1371/journal.pone.0075057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086436	gold, Green Submitted, Green Published			2022-12-25	WOS:000325025200020
J	Short, MA; Gradisar, M; Gill, J; Camfferman, D				Short, Michelle A.; Gradisar, Michael; Gill, Jason; Camfferman, Danny			Identifying Adolescent Sleep Problems	PLOS ONE			English	Article							DAYTIME SLEEPINESS; CIRCADIAN PHASE; SCHOOL CHILDREN; WAKE PATTERNS; DEPRESSION; DISORDERS; INSOMNIA; BEHAVIOR; ASSOCIATIONS; RESTRICTION	Objectives: To examine the efficacy of self-report and parental report of adolescent sleep problems and compare these findings to the incidence of adolescents who fulfill clinical criteria for a sleep problem. Sleep and daytime functioning factors that predict adolescents' self-identification of a sleep problem will also be examined. Method: 308 adolescents (aged 13-17 years) from eight socioeconomically diverse South Australian high schools participated in this study. Participants completed a survey battery during class time, followed by a 7-day Sleep Diary and the Flinders Fatigue Scale completed on the final day of the study. Parents completed a Sleep, Medical, Education and Family History Survey. Results: The percentage of adolescents fulfilling one or more of the criteria for a sleep problem was inordinately high at 66%. Adolescent self-reporting a sleep problem was significantly lower than the adolescents who had one or more of the clinical criteria for a sleep problem (23.1% vs. 66.6%; chi(2) = 17.46, p<. 001). Parental report of their adolescent having a sleep problem was significantly lower than adolescent self-report (14.3% vs. 21.1%, p<. 001). Adolescents who reported unrefreshing sleep were 4.81 times more likely to report a sleep problem. For every hour that bedtime was delayed, the odds of self-reporting a sleep problem increased by 1.91 times, while each additional 10 minutes taken to fall asleep increased the odds 1.40 times. Conclusion: While many adolescents were found to have sleep patterns indicative of a sleep problem, only a third of this number self-identify having a sleep problem, while only a sixth of this number are indicated by parental report. This study highlights important features to target in future sleep education and intervention strategies for both adolescents and parents.	[Short, Michelle A.; Gradisar, Michael; Gill, Jason] Flinders Univ South Australia, Sch Psychol, Adelaide, SA, Australia; [Short, Michelle A.] Univ S Australia, Ctr Sleep Res, Adelaide, SA 5001, Australia; [Camfferman, Danny] Univ S Australia, Samson Inst, Sch Hlth Sci, Adelaide, SA 5001, Australia	Flinders University South Australia; University of South Australia; University of South Australia	Short, MA (corresponding author), Flinders Univ South Australia, Sch Psychol, Adelaide, SA, Australia.	michelle.short@unisa.edu.au		Camfferman, Danny/0000-0002-4108-7099; , Michael/0000-0002-5146-2657	Australian Research Council [DP0881261]	Australian Research Council(Australian Research Council)	This study was funded by Australian Research Council grant #DP0881261 (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AASM, 2005, INT CLASS SLEEP DIS; Alexandru G, 2006, J SLEEP RES, V15, P266, DOI 10.1111/j.1365-2869.2006.00530.x; Blunden S, 2000, J CLIN EXP NEUROPSYC, V22, P554, DOI 10.1076/1380-3395(200010)22:5;1-9;FT554; Buysse DJ, 2006, SLEEP, V29, P1155, DOI 10.1093/sleep/29.9.1155; Cain N, 2011, SLEEP MED, V12, P246, DOI 10.1016/j.sleep.2010.06.008; CARSKADON M A, 1990, Pediatrician, V17, P5; CARSKADON MA, 1981, PSYCHOPHYSIOLOGY, V18, P107, DOI 10.1111/j.1469-8986.1981.tb02921.x; Carskadon MA, 1998, SLEEP, V21, P871, DOI 10.1093/sleep/21.8.871; CARSKADON MA, 1979, PERCEPT MOTOR SKILL, V48, P495, DOI 10.2466/pms.1979.48.2.495; CARSKADON MA, 1981, SLEEP, V4, P299; CARSKADON MA, 1981, PERCEPT MOTOR SKILL, V53, P103, DOI 10.2466/pms.1981.53.1.103; Carskadon MA, 2013, SLEEP MED ED FAMILY; Chung KF, 2008, SLEEP, V31, P185, DOI 10.1093/sleep/31.2.185; Crowley SJ, 2007, SLEEP MED, V8, P602, DOI 10.1016/j.sleep.2006.12.002; Crowley SJ, 2010, CHRONOBIOL INT, V27, P1469, DOI 10.3109/07420528.2010.503293; Dahl RE, 2002, J ADOLESCENT HEALTH, V31, P175, DOI 10.1016/S1054-139X(02)00506-2; Drake C, 2003, SLEEP, V26, P455; Gangwisch JE, 2010, SLEEP, V33, P97, DOI 10.1093/sleep/33.1.97; GARRISON CZ, 1991, J AM ACAD CHILD PSY, V30, P636, DOI 10.1097/00004583-199107000-00017; Gradisar M, 2008, SLEEP BIOL RHYTHMS, V6, P146, DOI 10.1111/j.1479-8425.2008.00353.x; Gradisar M, 2007, J CLIN SLEEP MED, V3, P722; Gradisar M, 2011, SLEEP, V34, P1671, DOI 10.5665/sleep.1432; Gradisar M, 2011, SLEEP MED, V12, P110, DOI 10.1016/j.sleep.2010.11.008; Gregory AM, 2005, J ABNORM CHILD PSYCH, V33, P157, DOI 10.1007/s10802-005-1824-0; Henshel A, 1987, SLEEP RES, V16, P354; Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008; KAHN A, 1989, PEDIATRICS, V84, P542; Leger D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045204; Lichstein KL, 2003, BEHAV RES THER, V41, P427, DOI 10.1016/S0005-7967(02)00023-2; Link S, 1995, SLEEP RES, V24, P184; Liu XC, 2005, PEDIATRICS, V115, P241, DOI 10.1542/peds.2004-0815F; Martin J, 2007, PEDIATRICS, V119, P947, DOI 10.1542/peds.2006-2569; Mindell JA, 2009, SLEEP MED, V10, P771, DOI 10.1016/j.sleep.2008.07.016; Mottl RW, 2005, EDUC PSYCHOL MEAS, V65, P190; NSF (National Sleep Foundation), 2006, SLEEP AM POLL; O'Brien Erin M, 2005, Behav Sleep Med, V3, P113, DOI 10.1207/s15402010bsm0303_1; Ohida T, 2004, SLEEP, V27, P978, DOI 10.1093/sleep/27.5.978; Pizza F, 2010, J CLIN SLEEP MED, V6, P41; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROGERS AE, 1993, NURS RES, V42, P368; Russo PM, 2007, J SLEEP RES, V16, P163, DOI 10.1111/j.1365-2869.2007.00584.x; Scholle S, 2011, SLEEP MED, V12, P542, DOI 10.1016/j.sleep.2010.11.011; Short MA, 2011, SLEEP, V34, P797, DOI 10.5665/SLEEP.1052; SMITH CS, 1989, J APPL PSYCHOL, V74, P728, DOI 10.1037/0021-9010.74.5.728; STRAUCH I, 1988, SLEEP, V11, P378, DOI 10.1093/sleep/11.4.378; Taylor A, 2008, SLEEP BIOL RHYTHMS, V6, P172, DOI 10.1111/j.1479-8425.2008.00356.x; White L, 1980, SLEEP RES, V9, P108; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G	49	38	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75301	10.1371/journal.pone.0075301	http://dx.doi.org/10.1371/journal.pone.0075301			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	226HG	24086501	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000325025200038
J	Marconi, G; Pace, R; Traini, A; Raggi, L; Lutts, S; Chiusano, M; Guiducci, M; Falcinelli, M; Benincasa, P; Albertini, E				Marconi, Gianpiero; Pace, Roberta; Traini, Alessandra; Raggi, Lorenzo; Lutts, Stanley; Chiusano, Marialuisa; Guiducci, Marcello; Falcinelli, Mario; Benincasa, Paolo; Albertini, Emidio			Use of MSAP Markers to Analyse the Effects of Salt Stress on DNA Methylation in Rapeseed (Brassica napus var. oleifera)	PLOS ONE			English	Article							SALINITY STRESS; GENOMIC DNA; RICE; TOLERANCE; PLANTS; ACCUMULATION; EXPRESSION; LEAVES; DEMETHYLATION; PROTEIN	Excessive soil salinity is a major ecological and agronomical problem, the adverse effects of which are becoming a serious issue in regions where saline water is used for irrigation. Plants can employ regulatory strategies, such as DNA methylation, to enable relatively rapid adaptation to new conditions. In this regard, cytosine methylation might play an integral role in the regulation of gene expression at both the transcriptional and post-transcriptional levels. Rapeseed, which is the most important oilseed crop in Europe, is classified as being tolerant of salinity, although cultivars can vary substantially in their levels of tolerance. In this study, the Methylation Sensitive Amplified Polymorphism (MSAP) approach was used to assess the extent of cytosine methylation under salinity stress in salinity-tolerant (Exagone) and salinity-sensitive (Toccata) rapeseed cultivars. Our data show that salinity affected the level of DNA methylation. In particular methylation decreased in Exagone and increased in Toccata. Nineteen DNA fragments showing polymorphisms related to differences in methylation were sequenced. In particular, two of these were highly similar to genes involved in stress responses (Lacerata and trehalose-6-phosphatase synthase S4) and were chosen to further characterization. Bisulfite sequencing and quantitative RT-PCR analysis of selected MSAP loci showed that cytosine methylation changes under salinity as well as gene expression varied. In particular, our data show that salinity stress influences the expression of the two stress-related genes. Moreover, we quantified the level of trehalose in Exagone shoots and found that it was correlated to TPS4 expression and, therefore, to DNA methylation. In conclusion, we found that salinity could induce genome-wide changes in DNA methylation status, and that these changes, when averaged across different genotypes and developmental stages, accounted for 16.8% of the total site-specific methylation differences in the rapeseed genome, as detected by MSAP analysis.	[Marconi, Gianpiero; Raggi, Lorenzo; Falcinelli, Mario; Albertini, Emidio] Univ Perugia, Dept Appl Biol, I-06100 Perugia, Italy; [Pace, Roberta; Guiducci, Marcello; Benincasa, Paolo] Univ Perugia, Dept Agr & Environm Sci, I-06100 Perugia, Italy; [Traini, Alessandra; Chiusano, Marialuisa] Univ Naples Federico II, Dept Soil Plant Environm & Anim Prod Sci, Naples, Italy; [Lutts, Stanley] Catholic Univ Louvain, Earth & Life Inst Agron, Grp Rech Physiol Vegetale, B-1348 Louvain, Belgium	University of Perugia; University of Perugia; University of Naples Federico II; Universite Catholique Louvain	Albertini, E (corresponding author), Univ Perugia, Dept Appl Biol, I-06100 Perugia, Italy.	emidio.albertini@unipg.it	Raggi, Lorenzo/G-5645-2013; Guiducci, Marcello/N-6002-2015; Albertini, Emidio/F-7393-2014; luisa, chiusano maria/AAQ-3064-2021	Raggi, Lorenzo/0000-0003-0484-8669; Guiducci, Marcello/0000-0003-1888-4732; luisa, chiusano maria/0000-0002-6296-7132; BENINCASA, Paolo/0000-0001-8502-8026; Albertini, Emidio/0000-0003-2585-5649; MARCONI, GIANPIERO/0000-0003-2669-0399	University of Perugia - Department of Applied Biology projects - Molecular characterization of agronomically important species	University of Perugia - Department of Applied Biology projects - Molecular characterization of agronomically important species	This study was supported by the University of Perugia - Department of Applied Biology projects - Molecular characterization of agronomically important species (project code ALBERPREST) Associazione Produttori Olivicoli (A.PR.OL) (http://www.aprolperugia.it/aprol/index.php) Molecular characterization of oil crops (project code APRO09ALB and APRO10ALB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2013, MOL BIOTECHNOL, V54, P102, DOI 10.1007/s12033-012-9538-3; Aina R, 2004, PHYSIOL PLANTARUM, V121, P472, DOI 10.1111/j.1399-3054.2004.00343.x; ALBERTINI E, 2013, DIAGNOSTICS PLANT BR, DOI DOI 10.1007/978-94-007-5687-8.P.12; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angers B, 2010, MOL ECOL, V19, P1283, DOI 10.1111/j.1365-294X.2010.04580.x; Baurens FC, 2003, PLANT MOL BIOL REP, V21, P339, DOI 10.1007/BF02772583; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Cameron KD, 2006, PLANT PHYSIOL, V140, P176, DOI 10.1104/pp.105.069724; Cao DH, 2012, PLANT MOL BIOL REP, V30, P1102, DOI 10.1007/s11105-012-0420-z; Capomaccio Stefano, 2011, BMC Physiology, V11, P3, DOI 10.1186/1472-6793-11-3; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carillo P, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, P21; Causevic A, 2005, PLANT PHYSIOL BIOCH, V43, P681, DOI 10.1016/j.plaphy.2005.05.011; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; CRAMER GR, 1992, PHYSIOL PLANTARUM, V84, P600, DOI 10.1111/j.1399-3054.1992.tb04710.x; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Duan H, 2005, PLANT PHYSIOL, V137, P1067, DOI 10.1104/pp.104.055715; Fernandez O, 2010, TRENDS PLANT SCI, V15, P409, DOI 10.1016/j.tplants.2010.04.004; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hasbun R, 2008, PLANT PHYSIOL BIOCH, V46, P815, DOI 10.1016/j.plaphy.2008.04.009; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; Johnston JW, 2009, PLANT PHYSIOL BIOCH, V47, P123, DOI 10.1016/j.plaphy.2008.10.008; JONES MM, 1980, AUST J PLANT PHYSIOL, V7, P181, DOI 10.1071/PP9800181; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Kosma DK., 2007, ADV MOL BREEDING DRO, P91, DOI DOI 10.1007/978-1-4020-5578-2_5; Kosma DK, 2009, PLANT PHYSIOL, V151, P1918, DOI 10.1104/pp.109.141911; Kovarik A, 1997, THEOR APPL GENET, V95, P301, DOI 10.1007/s001220050563; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kumar R, 2012, PLANT MOL BIOL, V79, P555, DOI 10.1007/s11103-012-9928-8; Labra M, 2002, PLANT BIOSYST, V136, P269, DOI 10.1080/11263500212331351179; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li XueLin, 2009, Acta Agronomica Sinica, V35, P588, DOI 10.3724/SP.J.1006.2009.00588; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lizal P, 2001, PHYSIOL PLANTARUM, V113, P121, DOI 10.1034/j.1399-3054.2001.1130116.x; Lu GY, 2007, J INTEGR PLANT BIOL, V49, P1599, DOI 10.1111/j.1774-7909.2007.00566.x; Lu YL, 2008, J GENET GENOMICS, V35, P41, DOI 10.1016/S1673-8527(08)60006-5; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; Manjunath S, 1997, PLANT MOL BIOL, V33, P97, DOI 10.1023/A:1005729112038; Ruiz-Lozano JM, 2012, J EXP BOT, V63, P4033, DOI 10.1093/jxb/ers126; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Muller T, 2012, J AGRON CROP SCI, V198, P207, DOI 10.1111/j.1439-037X.2011.00502.x; MUNNS R, 1986, AUST J PLANT PHYSIOL, V13, P143, DOI 10.1071/PP9860143; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nemati I, 2011, PLANT SOIL ENVIRON, V57, P26, DOI 10.17221/71/2010-PSE; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Pace R., 2010, Italian Journal of Agronomy, V5, P69; Pace R, 2012, EXP AGR, V48, P238, DOI 10.1017/S0014479711001189; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Paszkowski J, 2001, CURR OPIN PLANT BIOL, V4, P123, DOI 10.1016/S1369-5266(00)00147-3; Peleg Z, 2011, ADV BOT RES, V57, P405, DOI 10.1016/B978-0-12-387692-8.00012-6; Peng H, 2009, PROG NAT SCI-MATER, V19, P1037, DOI 10.1016/j.pnsc.2008.10.014; Portis E, 2004, PLANT SCI, V166, P169, DOI 10.1016/j.plantsci.2003.09.004; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Redillas MCFR, 2012, PLANT BIOTECHNOL REP, V6, P89, DOI 10.1007/s11816-011-0210-3; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rozen S, 2000, Methods Mol Biol, V132, P365; Salmon A, 2008, PLANT SCI, V174, P61, DOI 10.1016/j.plantsci.2007.09.012; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Tan MP, 2010, PLANT PHYSIOL BIOCH, V48, P21, DOI 10.1016/j.plaphy.2009.10.005; Turkan I, 2009, ENVIRON EXP BOT, V67, P2, DOI 10.1016/j.envexpbot.2009.05.008; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Voisin D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000703; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036663, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0040084, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045380]; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wu RH, 2011, PLANT CELL, V23, P3392, DOI 10.1105/tpc.111.088625; WURR DCE, 1985, SEED SCI TECHNOL, V13, P11; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064; Yi CX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-259; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang N, 2011, MOL BIOL REP, V38, P2241, DOI 10.1007/s11033-010-0354-1; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhong L, 2009, AFR J BIOTECHNOL, V8, P6201; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	83	63	65	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75597	10.1371/journal.pone.0075597	http://dx.doi.org/10.1371/journal.pone.0075597			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086583	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200114
J	Han, L; Wu, CJ; Riaz, H; Bai, LY; Chen, JG; Zhen, YH; Guo, AZ; Yang, LG				Han, Li; Wu, Canjie; Riaz, Hasan; Bai, Liya; Chen, Jianguo; Zhen, Yanhong; Guo, Aizhen; Yang, Liguo			Characterization of the Mechanism of Inhibin alpha-Subunit Gene in Mouse Anterior Pituitary Cells by RNA Interference	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; RAT PITUITARY; FSH-BETA; BINDING-SITES; EXPRESSION; ACTIVIN; TRANSCRIPTION; FOLLISTATIN; BETAGLYCAN; SECRETION	Inhibin, a member of the transforming growth factor-beta [TGF-beta] superfamily, is a suppressor of follicle-stimulating hormone [FSH] release through pituitary-gonadal negative feedback loop to regulate follicular development. In this study, Inhibin alpha-subunit [Inha] gene was knocked down successfully in mice primary anterior pituitary cells at both transcriptional and translational levels by RNAi-Ready pSIREN-RetroQ-ZsGreen Vector mediated recombinant pshRNA vectors. The results indicated that inhibin silencing significantly promoted apoptosis by up-regulating Caspase-3, Bax and Bcl-2 genes without affecting p53 both at transcriptional and translational levels. Furthermore, it markedly impaired the progression of G1 phase of cell cycle and decreased the amount of cells in S phase [as detected by flow cytometry]. Inhibin silencing resulted in significant up-regulation of mRNA and protein expressions of Gondotropin releasing hormone receptors [GnRHR] and down-regulated mRNA levels of beta-glycans with parellel change in the amount of its protein expression. Silencing of inhibin-a significantly increased [P<0.05] activin-beta concentration without affecting FSH and LH levels in anterior pituitary cells. These findings revealed that up regulation of GnRH receptors by silencing inhibin a-subunit gene might increase the concentration of activin-b in the culture medium. Inhibin a silencing resulted in increased mRNA and protein expressions of inhibin beta which may demonstrate that both inhibin subunits co-participate in the regulation of reproductive events in anterior pituitary cells. This study concludes that inhibin is a broad regulatory marker in anterior pituitary cells by regulating apoptosis, cellular progression and simultaneously by vital fluctuations in the hormonal signaling.	[Han, Li; Guo, Aizhen] Huazhong Agr Univ, Coll Anim Sci & Vet Med, Lab Anim Infect Dis, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Han, Li; Wu, Canjie; Riaz, Hasan; Bai, Liya; Chen, Jianguo; Zhen, Yanhong; Yang, Liguo] Huazhong Agr Univ, Coll Anim Sci & Vet Med, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Guo, AZ (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Vet Med, Lab Anim Infect Dis, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	aizhen@mail.hzau.edu.cn; yangliguo2006@yahoo.com.cn	Riaz, Hasan/AAE-5698-2019; Riaz, Hasan/D-2940-2014		National Natural Science Foundation of China [30972099]; China Postdoctoral Science Foundation [20100471194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (30972099) and the China Postdoctoral Science Foundation (20100471194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADEN TD, 1990, ENDOCRINOLOGY, V127, P2387, DOI 10.1210/endo-127-5-2387; Burger LL, 2004, ENDOCRINOLOGY, V145, P71, DOI 10.1210/en.2003-1047; Cai KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025585; Chapman SC, 2003, ENDOCRINOLOGY, V144, P5640, DOI 10.1210/en.2003-0670; Chen Fengjian, 2007, Journal of Genetics and Genomics, V34, P1106, DOI 10.1016/S1673-8527(07)60126-X; Childs GV, 1997, ENDOCRINOLOGY, V138, P1577, DOI 10.1210/en.138.4.1577; CHILDS GV, 1994, ENDOCRINOLOGY, V134, P990, DOI 10.1210/en.134.2.990; Ciccone NA, 2004, J NEUROENDOCRINOL, V16, P999, DOI 10.1111/j.1365-2826.2005.01260.x; Clarke IJ, 2008, ENDOCRINOLOGY, V149, P5811, DOI 10.1210/en.2008-0575; de Kretser DM, 2002, HUM REPROD UPDATE, V8, P529, DOI 10.1093/humupd/8.6.529; Demura R, 1996, ENDOCR J, V43, P403, DOI 10.1507/endocrj.43.403; Denkova R, 2004, Endocr Regul, V38, P51; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; FORAGE RG, 1986, P NATL ACAD SCI USA, V83, P3091, DOI 10.1073/pnas.83.10.3091; Gray PC, 2005, RES PERSPECT END INT, P1, DOI 10.1007/3-540-26940-1_1; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han L, 2008, ANIM REPROD SCI, V109, P251, DOI 10.1016/j.anireprosci.2007.12.012; Kananen K, 1996, MOL CELL ENDOCRINOL, V119, P135, DOI 10.1016/0303-7207(96)03802-6; Klockel BJ, 2002, CELL DEATH DIFFER, V9, P1063, DOI 10.1038/sj.cdd.4401067; KOTSUJI F, 1988, ENDOCRINOLOGY, V123, P2683, DOI 10.1210/endo-123-6-2683; Kumar TR, 2003, MOL CELL ENDOCRINOL, V212, P19, DOI 10.1016/j.mce.2003.09.019; Makanji Y, 2008, J BIOL CHEM, V283, P16743, DOI 10.1074/jbc.M801045200; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Pierson TM, 2000, MOL ENDOCRINOL, V14, P1075, DOI 10.1210/me.14.7.1075; Sari IP, 2009, ENDOCRINOLOGY, V150, P5549, DOI 10.1210/en.2009-0775; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Vitale AM, 2002, BIOL REPROD, V67, P1989, DOI 10.1095/biolreprod.102.003673; WANG QF, 1989, ENDOCRINOLOGY, V124, P363, DOI 10.1210/endo-124-1-363; Wang SL, 2012, THERIOGENOLOGY, V78, P393, DOI 10.1016/j.theriogenology.2012.02.019; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Wiater E, 2006, J BIOL CHEM, V281, P17011, DOI 10.1074/jbc.M601459200; WOODRUFF TK, 1993, ENDOCRINOLOGY, V132, P2332, DOI 10.1210/en.132.6.2332; WOODRUFF TK, 1987, MOL ENDOCRINOL, V1, P561, DOI 10.1210/mend-1-8-561; WOODRUFF TK, 1995, ANNU REV PHYSIOL, V57, P219; ZATZ M, 1985, P NATL ACAD SCI USA, V82, P1286, DOI 10.1073/pnas.82.4.1286	38	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74596	10.1371/journal.pone.0074596	http://dx.doi.org/10.1371/journal.pone.0074596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098340	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600007
J	Lee, CH; Sugiyama, T; Kataoka, A; Kudo, A; Fujino, F; Chen, YW; Mitsuyama, Y; Nomura, S; Yoshioka, T				Lee, Chih-Hung; Sugiyama, Takashi; Kataoka, Aiko; Kudo, Ayako; Fujino, Fukue; Chen, Yu-Wen; Mitsuyama, Yuki; Nomura, Shinobu; Yoshioka, Tohru			Analysis for Distinctive Activation Patterns of Pain and Itchy in the Human Brain Cortex Measured Using Near Infrared Spectroscopy (NIRS)	PLOS ONE			English	Article							HISTAMINE-INDUCED ITCH; POSITRON-EMISSION-TOMOGRAPHY; CROSS-CORRELATION; CEREBRAL HEMODYNAMICS; MUSCLE OXYGENATION; PERCEPTION; FMRI; CONNECTIVITY; OSCILLATIONS; MODULATION	Pain and itch are closely related sensations, yet qualitatively quite distinct. Despite recent advances in brain imaging techniques, identifying the differences between pain and itch signals in the brain cortex is difficult due to continuous temporal and spatial changes in the signals. The high spatial resolution of positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) has substantially advanced research of pain and itch, but these are uncomfortable because of expensiveness, importability and the limited operation in the shielded room. Here, we used near infrared spectroscopy (NIRS), which has more conventional usability. NIRS can be used to visualize dynamic changes in oxygenated hemoglobin and deoxyhemoglobin concentrations in the capillary networks near activated neural circuits in real-time as well as fMRI. We observed distinct activation patterns in the frontal cortex for acute pain and histamine-induced itch. The prefrontal cortex exhibited a pain-related and itch-related activation pattern of blood flow in each subject. Although it looked as though that activation pattern for pain and itching was different in each subject, further cross correlation analysis of NIRS signals between each channels showed an overall agreement with regard to prefrontal area involvement. As a result, pain-related and itch-related blood flow responses (delayed responses in prefrontal area) were found to be clearly different between pain (tau = +18.7 sec) and itch (tau = +0.63 sec) stimulation. This is the first pilot study to demonstrate the temporal and spatial separation of a pain-induced blood flow and an itch-induced blood flow in human cortex during information processing.	[Lee, Chih-Hung] Kaohsiung Chang Gung Mem Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Lee, Chih-Hung] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Sugiyama, Takashi] Waseda Univ, Adv Res Inst Biosci, Tokyo, Japan; [Kataoka, Aiko; Kudo, Ayako; Fujino, Fukue] Kanagawa Dent Univ, Jr Coll, Dept Dent Hyg, Yokosuka, Kanagawa, Japan; [Chen, Yu-Wen] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Mitsuyama, Yuki] Waseda Univ, Grad Sch Human Sci, Saitama, Japan; [Nomura, Shinobu] Waseda Univ, Fac Human Sci, Saitama, Japan; [Yoshioka, Tohru] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Waseda University; Kanagawa Dental College; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Waseda University; Waseda University; Kaohsiung Medical University	Yoshioka, T (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.	yoshioka@kmu.edu.tw	Lee, Chih-Hung/AAJ-5551-2020	Lee, Chih-Hung/0000-0001-9804-3874	National Science Council [NSC95-2314-B-037-024, NSC96-2314-B-037-043, NSC97-2320-B-010-013-MY3]; National Health Research Institute [NHRI-EO-096-PP-11, NHRI CN-PD-9611P]; Kaohsiung Medical University (KMU) [KMU-QA096005]; KMU Center of Excellence for Environmental Medicine [98.2b]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); Kaohsiung Medical University (KMU); KMU Center of Excellence for Environmental Medicine	This work was supported by grants from the National Science Council (NSC95-2314-B-037-024, NSC96-2314-B-037-043 and NSC97-2320-B-010-013-MY3); National Health Research Institute (NHRI-EO-096-PP-11; NHRI CN-PD-9611P); Kaohsiung Medical University (KMU)(KMU-QA096005); and KMU Center of Excellence for Environmental Medicine (98.2b). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2008, CURR OPIN NEUROBIOL, V18, P464, DOI 10.1016/j.conb.2008.09.012; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Darsow U, 2000, J INVEST DERMATOL, V115, P1029, DOI 10.1046/j.1523-1747.2000.00193.x; Drzezga A, 2001, PAIN, V92, P295, DOI 10.1016/S0304-3959(01)00271-8; Duncan JS, 1999, REV NEUROL, V155, P482; Durkin JL, 2006, ERGONOMICS, V49, P28, DOI 10.1080/00140130500356882; Elwell CE, 1999, ADV EXP MED BIOL, V471, P57; Ganong WF, 2005, REV MED PHYSL, Vxii; Hamill TG, 2009, SYNAPSE, V63, P1122, DOI 10.1002/syn.20689; Herde L, 2007, J NEUROPHYSIOL, V98, P2347, DOI 10.1152/jn.00475.2007; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Kell RT, 2006, EUR J APPL PHYSIOL, V96, P241, DOI 10.1007/s00421-005-0072-x; Klede M, 2003, J NEUROPHYSIOL, V90, P353, DOI 10.1152/jn.01136.2002; KOLTZENBURG M, 1993, NEUROSCI LETT, V150, P219, DOI 10.1016/0304-3940(93)90540-2; Kulkarni B, 2007, ARTHRITIS RHEUM, V56, P1345, DOI 10.1002/art.22460; Leknes SG, 2007, J NEUROPHYSIOL, V97, P415, DOI 10.1152/jn.00070.2006; Mehagnoul-Schipper DJ, 2002, HUM BRAIN MAPP, V16, P14, DOI 10.1002/hbm.10026; Mochizuki H, 2003, PAIN, V105, P339, DOI 10.1016/S0304-3959(03)00249-5; Mochizuki H, 2007, NEUROIMAGE, V36, P706, DOI 10.1016/j.neuroimage.2007.04.003; Mochizuki H, 2009, J NEUROPHYSIOL, V102, P2657, DOI 10.1152/jn.00460.2009; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Ostojic S, 2009, J NEUROSCI, V29, P10234, DOI 10.1523/JNEUROSCI.1275-09.2009; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Peyron R, 2011, M S-MED SCI, V27, P82, DOI 10.1051/medsci/201127182; Rowley AB, 2007, PHYSIOL MEAS, V28, P161, DOI 10.1088/0967-3334/28/2/005; Schmelz M, 2003, NEUROLOGY, V61, P564, DOI 10.1212/01.WNL.0000078193.64949.08; Sprenger T, 2005, EUR J PAIN, V9, P117, DOI 10.1016/j.ejpain.2004.07.010; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P191, DOI 10.1152/jn.1981.46.2.191; Valet M, 2008, J INVEST DERMATOL, V128, P426, DOI 10.1038/sj.jid.5701002; Walter B, 2005, J INVEST DERMATOL, V125, P380, DOI 10.1111/j.0022-202X.2005.23817.x; Yosipovitch G, 2005, J INVEST DERMATOL, V125, P1268, DOI 10.1111/j.0022-202X.2005.23942.x; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	36	25	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75360	10.1371/journal.pone.0075360	http://dx.doi.org/10.1371/journal.pone.0075360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098378	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600016
J	Shaw, J; Izu, L; Chen-Izu, Y				Shaw, John; Izu, Leighton; Chen-Izu, Ye			Mechanical Analysis of Single Myocyte Contraction in a 3-D Elastic Matrix	PLOS ONE			English	Article							ELLIPSOIDAL INCLUSION; SARCOMERE LENGTH; HEART; STRESS; MUSCLE; FIELD	Background: Cardiac myocytes experience mechanical stress during each heartbeat. Excessive mechanical stresses under pathological conditions cause functional and structural remodeling that lead to heart diseases, yet the precise mechanisms are still incompletely understood. To study the cellular and molecular level mechanotransduction mechanisms, we developed a new 'cell-in-gel' experimental system to exert multiaxial (3-D) stresses on a single myocyte during active contraction. Methods: Isolated myocytes are embedded in an elastic hydrogel to simulate the mechanical environment in myocardium (afterload). When electrically stimulated, the in-gel myocyte contracts while the matrix resists shortening and broadening of the cell, exerting normal and shear stresses on the cell. Here we provide a mechanical analysis, based on the Eshelby inclusion problem, of the 3-D strain and stress inside and outside the single myocyte during contraction in an elastic matrix. Results: (1) The fractional shortening of the myocyte depends on the cell's geometric dimensions and the relative stiffness of the cell to the gel. A slender or softer cell has less fractional shortening. A myocyte of typical dimensions embedded in a gel of similar elastic stiffness can contract only 20% of its load-free value. (2) The longitudinal stress inside the cell is about 15 times the transverse stress level. (3) The traction on the cell surface is highly non-uniform, with a maximum near its ends, showing 'hot spots' at the location of intercalated disks. (4) The mechanical energy expenditure of the myocyte increases with the matrix stiffness in a monotonic and nonlinear manner. Conclusion: Our mechanical analyses provide analytic solutions that readily lend themselves to parametric studies. The resulting 3-D mapping of the strain and stress states serve to analyze and interpret ongoing cell-in-gel experiments, and the mathematical model provides an essential tool to decipher and quantify mechanotransduction mechanisms in cardiac myocytes.	[Shaw, John] Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA; [Izu, Leighton] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Chen-Izu, Ye] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of Michigan System; University of Michigan; University of California System; University of California Davis; University of California System; University of California Davis	Shaw, J (corresponding author), Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA.	jashaw@umich.edu	Izu, Leighton/C-4066-2015	Chen-Izu, Ye/0000-0003-4818-9570	University of Michigan; National Institutes of Health (NIH) [R01 HL90880]; University of California; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090880] Funding Source: NIH RePORTER	University of Michigan(University of Michigan System); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the University of Michigan sabbatical funding to JS; the National Institutes of Health (NIH) R01 HL90880 to LI and YC; and the University of California startup funds to YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DG, 1982, J PHYSIOL-LONDON, V327, P79, DOI 10.1113/jphysiol.1982.sp014221; Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Bollensdorff C, 2011, PFLUG ARCH EUR J PHY, V462, P39, DOI 10.1007/s00424-011-0964-z; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; De Jong AM, 2011, CARDIOVASC RES, V89, P754, DOI 10.1093/cvr/cvq357; ESHELBY JD, 1959, PROC R SOC LON SER-A, V252, P561, DOI 10.1098/rspa.1959.0173; ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133; EVANS SJ, 1995, CARDIOVASC RES, V29, P555, DOI 10.1016/S0008-6363(96)88534-8; GAUTEL M, 2011, J PHYSL, V462, P119, DOI DOI 10.1007/S00424-011-0946-1; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; Hannigan GE, 2007, CIRC RES, V100, P1408, DOI 10.1161/01.RES.0000265233.40455.62; HASHIN Z, 1963, J MECH PHYS SOLIDS, V11, P127, DOI 10.1016/0022-5096(63)90060-7; HILL R, 1965, J MECH PHYS SOLIDS, V13, P213, DOI 10.1016/0022-5096(65)90010-4; Hill R, 1961, PROGR SOLID MECHANIC, V2, P89; KENTISH JC, 1986, CIRC RES, V58, P755, DOI 10.1161/01.RES.58.6.755; Luo JT, 2009, ADV EXP MED BIOL, V611, P19, DOI 10.1007/978-0-387-73657-0_9; MORI T, 1973, ACTA METALL MATER, V21, P571, DOI 10.1016/0001-6160(73)90064-3; Mura T., 1991, MICROMECHANICS DEFEC; Petroff MGV, 2001, NAT CELL BIOL, V3, P867, DOI 10.1038/ncb1001-867; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Prosser BL, 2012, J MOL CELLU IN PRESS; Rodin GJ, 1996, J MECH PHYS SOLIDS, V44, P1977, DOI 10.1016/S0022-5096(96)00066-X; SONNENBLICK EH, 1967, CIRC RES, V21, P423, DOI 10.1161/01.RES.21.4.423; von Anrep G, 1912, J PHYSIOL-LONDON, V45, P307; Wineman A.S., 2000, MECH RESPONSE POLYM	25	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e75492	10.1371/journal.pone.0075492	http://dx.doi.org/10.1371/journal.pone.0075492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098388	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600019
J	Wansink, B; Just, DR; Patterson, RW; Smith, LE				Wansink, Brian; Just, David R.; Patterson, Richard W.; Smith, Laura E.			Nutrition Report Cards: An Opportunity to Improve School Lunch Selection	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OBESITY; PREVENTION; PREVALENCE; HEALTH	Objective: To explore the feasibility and implementation efficiency of Nutritional Report Cards(NRCs) in helping children make healthier food choices at school. Methods: Pilot testing was conducted in a rural New York school district (K-12). Over a five-week period, 27 parents received a weekly e-mail containing a NRC listing how many meal components (fruits, vegetables, starches, milk), snacks, and a-la-carte foods their child selected. We analyzed choices of students in the NRC group vs. the control group, both prior to and during the intervention period. Point-of-sale system data for a-la-carte items was analyzed using Generalized Least Squares regressions with clustered standard errors. Results: NRCs encouraged more home conversations about nutrition and more awareness of food selections. Despite the small sample, the NRC was associated with reduced selection of some items, such as the percentage of those selecting cookies which decreased from 14.3 to 6.5 percent. Additionally, despite requiring new keys on the check-out registers to generate the NRC, checkout times increased by only 0.16 seconds per transaction, and compiling and sending the NRCs required a total weekly investment of 30 minutes of staff time. Conclusions: This test of concept suggests that NRCs are a feasible and inexpensive tool to guide children towards healthier choices.	[Wansink, Brian; Just, David R.] Cornell Univ, Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA; [Patterson, Richard W.; Smith, Laura E.] Cornell Univ, Ithaca, NY USA	Cornell University; Cornell University	Wansink, B (corresponding author), Cornell Univ, Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA.	foodandbrandlab@cornell.edu	Just, David/K-7302-2012; Smith, Laura/R-4615-2018	Just, David/0000-0002-7471-5178; Smith, Laura/0000-0002-4793-2791				Ackard DM, 2003, PEDIATRICS, V111, P67, DOI 10.1542/peds.111.1.67; Blaylock J, 1999, FOOD POLICY, V24, P269, DOI 10.1016/S0306-9192(99)00029-9; Colavito EA, 1996, J NUTR EDUC, V28, P321, DOI 10.1016/S0022-3182(96)70121-8; Contento IR, 2002, J NUTR EDUC BEHAV, V34, P2, DOI 10.1016/S1499-4046(06)60220-0; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; Gross SM, 2010, J NUTR EDUC BEHAV, V42, P235, DOI 10.1016/j.jneb.2009.05.007; Kaplan M, 2006, J NUTR EDUC BEHAV, V38, P298, DOI 10.1016/j.jneb.2006.02.010; KLESGES RC, 1991, AM J CLIN NUTR, V54, pR4; Moshfegh A, 2005, WHAT WE EAT AM NHANE, P1; Nihiser AJ, 2009, PEDIATRICS, V124, pS89, DOI 10.1542/peds.2008-3586L; PERRI MG, 1984, J CONSULT CLIN PSYCH, V52, P404, DOI 10.1037/0022-006X.52.3.404; Portilla MG, 2011, J AM DIET ASSOC, V111, P442, DOI 10.1016/j.jada.2010.11.018; Raczynski JM, 2009, J PUBLIC HEALTH POL, V30, pS124, DOI 10.1057/jphp.2008.54; Roseman MG, 2011, J NUTR EDUC BEHAV, V43, P2, DOI 10.1016/j.jneb.2010.07.009	14	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e72008	10.1371/journal.pone.0072008	http://dx.doi.org/10.1371/journal.pone.0072008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24098324	Green Published, gold			2022-12-25	WOS:000325434500003
J	Scorza, R; Kriss, AB; Callahan, AM; Webb, K; Demuth, M; Gottwald, T				Scorza, Ralph; Kriss, Alissa B.; Callahan, Ann M.; Webb, Kevin; Demuth, Mark; Gottwald, Tim			Spatial and Temporal Assessment of Pollen- and Seed-Mediated Gene Flow from Genetically Engineered Plum Prunus domestica	PLOS ONE			English	Article							POX-VIRUS; RISK-ASSESSMENT; MODIFIED CROPS; RESISTANCE; RELEASE; PLANTS; BEES	Pollen flow from a 0.46 ha plot of genetically engineered (GE) Prunus domestica located in West Virginia, USA was evaluated from 2000-2010. Sentinel plum trees were planted at distances ranging from 132 to 854 m from the center of the GE orchard. Plots of mixed plum varieties and seedlings were located at 384, 484 and 998 m from the GE plot. Bee hives (Apis mellifera) were dispersed between the GE plum plot and the pollen flow monitoring sites. Pollen-mediated gene flow from out of the GE plum plot to non-GE plums under the study conditions was low, only occurring at all in 4 of 11 years and then in only 0.31% of the 12,116 seeds analyzed. When it occurred, gene flow, calculated as the number of GUS positive embryos/total embryos sampled, ranged from 0.215% at 132 m from the center of the GE plum plot (28 m from the nearest GE plum tree) to 0.033-0.017% at longer distances (384-998 m). Based on the percentage of GUS positive seeds per individual sampled tree the range was 0.4% to 12%. Within the GE field plot, gene flow ranged from 4.9 to 39%. Gene flow was related to distance and environmental conditions. A single year sample from a sentinel plot 132 m from the center of the GE plot accounted for 65% of the total 11-year gene flow. Spatial modeling indicated that gene flow dramatically decreased at distances over 400 m from the GE plot. Air temperature and rainfall were, respectively, positively and negatively correlated with gene flow, reflecting the effects of weather conditions on insect pollinator activity. Seed-mediated gene flow was not detected. These results support the feasibility of coexistence of GE and non-GE plum orchards.	[Scorza, Ralph; Callahan, Ann M.; Webb, Kevin; Demuth, Mark] ARS, USDA, Kearneysville, WV USA; [Kriss, Alissa B.; Gottwald, Tim] ARS, USDA, US Hort Res Lab, Ft Pierce, FL USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Scorza, R (corresponding author), ARS, USDA, Kearneysville, WV USA.	Ralph.Scorza@ars.usda.gov			USDA-ARS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	USDA-ARS funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, CROP POLLINATION BEE; Armstrong TT, 2005, MOL ECOL, V14, P2111, DOI 10.1111/j.1365-294X.2005.02572.x; Benedek P, 1996, FLORAL BIOL TEMPERAT, P287; Biddinger D, 2011, PENNSYLVANIA ST 0927; BURRILL RM, 1981, APIDOLOGIE, V12, P319, DOI 10.1051/apido:19810402; Calzoni GL, 1998, SCI HORTIC-AMSTERDAM, V72, P227, DOI 10.1016/S0304-4238(97)00132-5; Cambra M., 2006, Bulletin OEPP, V36, P202; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; Chandler S, 2008, CRIT REV PLANT SCI, V27, P25, DOI 10.1080/07352680802053916; DARLINGTON C. D., 1927, NATURE [LONDON], V119, P390, DOI 10.1038/119390a0; Deckers B, 2008, BIOL INVASIONS, V10, P717, DOI 10.1007/s10530-007-9164-3; Di Nicola-Negri E, 2005, TRANSGENIC RES, V14, P989, DOI 10.1007/s11248-005-1773-y; DiFazio SP, 2004, PLANTATION FOREST BIOTECHNOLOGY FOR THE 21ST CENTURY 2004, P405; DOLGOV S, 2010, JULIUS KUHN ARCH, V427, P133; EASTMAN K, 2002, 28 EUR ENV AG; Ellstrand NC, 2003, PHILOS T R SOC B, V358, P1163, DOI 10.1098/rstb.2003.1299; ENIKEEV H. K., 1957, Agrobiologija (Agrobiology), P139; Enikeev HK, 1962, ABSTRACT BIBLIO FRUI, P81; Enikeyev, 1963, Genetics today. Proceedings of the XI International Congress of Genetics, The Hague, The Netherlands, September 1963., V1, pp; FISCHER A., 1938, ZUCHTER, V10, P157, DOI 10.1007/BF01812347; Ford CS, 2006, P R SOC B, V273, P3111, DOI 10.1098/rspb.2006.3686; Fuchs Marc, 2004, Environmental Biosafety Research, V3, P5, DOI 10.1051/ebr:2004003; Gonsalves D, 2012, TROP PLANT BIOL, V5, P153, DOI 10.1007/s12042-011-9090-5; Hails RS, 2005, TRENDS ECOL EVOL, V20, P245, DOI 10.1016/j.tree.2005.02.006; Hegedus A., 2006, J HORTIC SCI, V12, P137; Henry M, 2012, ECOL MODEL, V225, P103, DOI 10.1016/j.ecolmodel.2011.11.015; Heuberger S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014128; JACKSON JF, 1991, THEOR APPL GENET, V82, P169, DOI 10.1007/BF00226208; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kobayashi N., 1998, PLANT TISSUE CULT BI, V4, P76; Larsen AS, 2009, CONSERV GENET, V10, P1637, DOI 10.1007/s10592-008-9713-z; Macoun WT, 1925, ABSTRACT BIBLIO FRUI; Mallory-Smith C, 2008, PEST MANAG SCI, V64, P428, DOI 10.1002/ps.1517; Marshall RE, 1919, P AM SOC HORTIC SCI, V16, P42; Muhammad N, 2010, J AGR SCI TECHNOL, V4, P1; Okie WR, 1996, FRUIT BREEDING, VI, P559; OLDEN E. J., 1955, Sveriges Pomologiska Forenings Arsskrift, P155; Olden EJ, 1965, 1 BALSG FRUIT BREED, V1; Peat J, 2005, BEHAV ECOL SOCIOBIOL, V58, P152, DOI 10.1007/s00265-005-0916-8; Pfeiffer DG, 2012, JULIUS KUHN ARCH; Pons E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025810; Poppy GM, 2005, BIOL SCI SER, P1, DOI 10.1002/9780470988497; RAYBOULD AF, 1993, J APPL ECOL, V30, P199, DOI 10.2307/2404623; Reim Stefanie, 2006, Environmental Biosafety Research, V5, P89, DOI 10.1051/ebr:2006016; Schulze J, 2012, FLORA, V207, P762, DOI 10.1016/j.flora.2012.07.007; SCORZA R, 1994, PLANT CELL REP, V14, P18, DOI 10.1007/BF00233291; SCORZA R, 1995, J AM SOC HORTIC SCI, V120, P943, DOI 10.21273/JASHS.120.6.943; Scorza R., 2013, REGULATION AGR BIOTE, P269, DOI 10.1007/1978-1094-1007-2156-1002_1012.; Smouse PE, 2007, TREE GENET GENOMES, V3, P141, DOI 10.1007/s11295-006-0075-8; Soejima J, 2007, ACTA HORTIC, P341, DOI 10.17660/ActaHortic.2007.738.40; Somerville D, 1999, DAI126 NEW S WAL AGR, V126; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; Szabo Z, 1996, ACTA HORTIC, P23, DOI 10.17660/ActaHortic.1996.423.2; Tyson RC, 2011, ECOL MODEL, V222, P2084, DOI 10.1016/j.ecolmodel.2011.03.039; Viljoen Chris, 2011, Environmental Sciences Europe, V23, P8, DOI 10.1186/2190-4715-23-8; Waugh FA, 1898, B VT AGR EXP STN, V67; Wellington R, 1927, TECH B NY ST AGR EXP, V127; Williams NM, 2007, ECOL APPL, V17, P910, DOI 10.1890/06-0269; Yoshimura Yasuyuki, 2006, Environmental Biosafety Research, V5, P169, DOI 10.1051/ebr:2007003; Zahra S., 2010, Environmental Biosafety Research, V9, P75, DOI 10.1051/ebr/2010011; Zhang SC, 2006, CAN J PLANT PATHOL, V28, P263, DOI 10.1080/07060660609507295	61	20	21	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75291	10.1371/journal.pone.0075291	http://dx.doi.org/10.1371/journal.pone.0075291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098374	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100017
J	Murai, M; Ruffler, H; Berlemont, A; Campbell, G; Esono, F; Agbor, A; Mbomio, D; Ebana, A; Nze, A; Kuhl, HS				Murai, Mizuki; Ruffler, Heidi; Berlemont, Antoine; Campbell, Genevieve; Esono, Fidel; Agbor, Anthony; Mbomio, Domingo; Ebana, Agustin; Nze, Antonio; Kuehl, Hjalmar S.			Priority Areas for Large Mammal Conservation in Equatorial Guinea	PLOS ONE			English	Article							GORILLA-GORILLA; PROTECTED AREAS; NATIONAL-PARK; RAIN-FORESTS; CONGO BASIN; RIO-MUNI; BUSHMEAT; ABUNDANCE; PRIMATE; CENSUS	Hunting is one of the main driving forces behind large mammal density distribution in many regions of the world. In tropical Africa, urban demand for bushmeat has been shown to dominate over subsistence hunting and its impact often overrides spatial-ecological species characteristics. To effectively protect remaining mammal populations the main factors that influence their distribution need to be integrated into conservation area prioritisation and management plans. This information has been lacking for Rio Muni, Equatorial Guinea, as prior studies have been outdated or have not systematically covered the continental region of the country. In this study we evaluated: 1) the relative importance of local vs. commercial hunting; 2) wildlife density of protected vs. non-protected areas; and 3) the importance of ecological factors vs. human influence in driving mammal density distribution in Rio Muni. We adopted a systematic countrywide line transect approach with particular focus on apes and elephants, but also including other mammal species. For analysis of field data we used generalised linear models with a set of predictor variables representing ecological conditions, anthropogenic pressure and protected areas. We estimate that there are currently 884 (437-1,789) elephants and 11,097 (8,719-13,592) chimpanzees and gorillas remaining in Rio Muni. The results indicate strong hunting pressures on both local and commercial levels, with roads demonstrating a negative impact on elephants and overall mammal body mass. Protected areas played no role in determining any of the mammal species distributions and significant human hunting signs were found inside these protected areas, illustrating the lack of environmental law enforcement throughout the country. Rio Muni is currently under-represented in conservation efforts in Western Equatorial Africa, and we recommend a focus on cross-boundary conservation, in particular in the Monte Alen-Monts de Cristal and Rio Campo Ma'an conservation landscapes, where the highest densities and diversity of large mammals remain.	[Murai, Mizuki; Campbell, Genevieve; Kuehl, Hjalmar S.] Max Planck Inst Evolutionary Anthropol MPI EVA, Leipzig, Germany; [Murai, Mizuki; Ruffler, Heidi; Berlemont, Antoine; Agbor, Anthony; Mbomio, Domingo] CI, Arlington, VA USA; [Esono, Fidel] Natl Inst Forestry Dev & Protected Area Managemen, Bata, Equat Guinea; [Ebana, Agustin; Nze, Antonio] Natl Univ Equatorial Guinea UNGE, Malabo, Equat Guinea	Max Planck Society	Murai, M (corresponding author), Max Planck Inst Evolutionary Anthropol MPI EVA, Leipzig, Germany.	m.murai@hotmail.co.uk			United States Fish and Wildlife Service; Margot Marsh Biodiversity Foundation; USAID/CARPE (United States Agency for International Development's Central African Regional Program for the Environment)	United States Fish and Wildlife Service(US Fish & Wildlife Service); Margot Marsh Biodiversity Foundation; USAID/CARPE (United States Agency for International Development's Central African Regional Program for the Environment)(United States Agency for International Development (USAID))	This project was funded by the United States Fish and Wildlife Service, the Margot Marsh Biodiversity Foundation, and the USAID/CARPE (United States Agency for International Development's Central African Regional Program for the Environment). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allebone-Webb SM, 2011, CONSERV BIOL, V25, P597, DOI 10.1111/j.1523-1739.2011.01681.x; [Anonymous], 2012, BBC; BARNES REW, 1989, IVORY TRADE FUTURE A; BARNES RFW, 1991, AFR J ECOL, V29, P54, DOI 10.1111/j.1365-2028.1991.tb00820.x; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Blanc Julian J., 2007, AFRICAN ELEPHANT STA; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Buckland S.T., 2001, pi; Campbell G., 2008, CURR BIOL, V18, P904; *CARPE, 2006, FOR CONG BAS STAT FO; CARROLL RW, 1986, PRIM CONSERV, V7, P38; CASTROVIEJO J, 1994, BIODIVERS CONSERV, V3, P951, DOI 10.1007/BF00129669; *CI, 2012, REP CHIN URB RES CON; *CITES, 2011, STAT EL POP LEV ILL; Cowlishaw G, 2005, J APPL ECOL, V42, P460, DOI 10.1111/j.1365-2664.2005.01046.x; Dupain J, 2004, ORYX, V38, P209, DOI 10.1017/S0030605304000365; East T, 2005, BIOL CONSERV, V126, P206, DOI 10.1016/j.biocon.2005.05.012; Fa J.E., 1992, Oryx, V26, P87; Fa JE, 2005, BIOL CONSERV, V121, P167, DOI 10.1016/j.biocon.2004.04.016; FA JE, 1995, CONSERV BIOL, V9, P1107, DOI 10.1046/j.1523-1739.1995.951107.x; Fa JE, 1997, J ANIM ECOL, V66, P98, DOI 10.2307/5968; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; FAY JM, 1992, AM J PRIMATOL, V27, P275, DOI 10.1002/ajp.1350270405; Garcia JE, 1997, ORYX, V31, P67, DOI 10.1046/j.1365-3008.1997.d01-5.x; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; GonzalezKirchner JP, 1997, FOLIA ZOOL, V46, P15; Hart JA, 1996, CONSERV BIOL, V10, P316, DOI 10.1046/j.1523-1739.1996.10020316.x; Hedges S., 2006, DUNG SURVEY STANDARD; Hedley SL, 2004, J AGR BIOL ENVIR ST, V9, P181, DOI 10.1198/1085711043578; Inogwabini BI, 2012, AFR J ECOL, V50, P285, DOI 10.1111/j.1365-2028.2012.01323.x; ISSAC NJB, 2004, P ROY SOC LOND B BIO, V271, P1135; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Jones C, 1971, Biblthca primatol, V13, P1; Junker J, 2012, DIVERS DISTRIB, V18, P1077, DOI 10.1111/ddi.12005; K?hl H., 2008, BEST PRACTICE GUIDEL; Kaplinsky R., 2007, 291 IDS; Karsenty A., 2007, OVERVIEW IND FOREST; Khl H., 2007, GORILLA J, V34, P20; Kingdon J, 1997, KINGDON FIELD GUIDE; Koops K, 2012, INT J PRIMATOL, V33, P356, DOI 10.1007/s10764-012-9585-4; Kouakou CY, 2009, AM J PRIMATOL, V71, P447, DOI 10.1002/ajp.20673; Kuehl HS, 2007, ECOL APPL, V17, P2403, DOI 10.1890/06-0934.1; Kuehl HS, 2009, BIOL CONSERV, V142, P1500, DOI 10.1016/j.biocon.2009.02.032; Kumpel NF, 2010, HUM ECOL, V38, P251, DOI 10.1007/s10745-010-9316-4; Laing SE, 2003, J APPL ECOL, V40, P1102, DOI 10.1111/j.1365-2664.2003.00861.x; LARISON B, 1999, BIOTIC SURVEYS BIOKO; Lee MC, 2006, J CONTEMP AFR STUD, V24, P303, DOI 10.1080/02589000600976570; Matthews A, 2004, PRIMATES, V45, P15, DOI 10.1007/s10329-003-0058-4; McCullagh P, 1989, GEN LINEAR MODELS; McNeilage A, 2006, ORYX, V40, P419, DOI 10.1017/S0030605306001311; Morgan D, 2006, INT J PRIMATOL, V27, P147, DOI 10.1007/s10764-005-9013-0; N'Goran PK, 2012, CONSERV BIOL, V26, P565, DOI 10.1111/j.1523-1739.2012.01821.x; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; NCHANJI AC, 2005, BIODIVERSITY ASSESSM, P70; Norris K, 2010, BIOL CONSERV, V143, P2341, DOI 10.1016/j.biocon.2009.12.032; PI JS, 1972, MAN, V7, P239; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Plumptre AJ, 2006, PRIMATES, V47, P65, DOI 10.1007/s10329-005-0146-8; Puit Marielle, 2006, Pachyderm, V41, P44; R Development Core Team, 2012, R LANG ENV STAT COMP; Remis MJ, 2012, AM J PRIMATOL, V74, P602, DOI 10.1002/ajp.22012; Remis MJ, 2011, AFR J ECOL, V49, P70, DOI 10.1111/j.1365-2028.2010.01229.x; Sanz C, 2007, J APPL ECOL, V44, P263, DOI 10.1111/j.1365-2664.2007.01278.x; Stokes EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010294; Struhsaker TT, 2005, BIOL CONSERV, V123, P45, DOI 10.1016/j.biocon.2004.10.007; SUNDERLAND TCH, 2005, BIODIVERSITY ASSESSM; TCHAMBA MN, 1991, NATURE FAUNE, V7, P27; Thomas L., 2009, DISTANCE 6 0 RELEASE; THOMAS S, 2012, HUMAN ELEPHANT CONFL; Tranquilli S, 2012, CONSERV LETT, V5, P48, DOI 10.1111/j.1755-263X.2011.00211.x; TUTIN CEG, 1984, AM J PRIMATOL, V6, P313, DOI 10.1002/ajp.1350060403; Walsh PD, 2005, ECOL APPL, V15, P1342, DOI 10.1890/03-5283; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Walsh PD, 2001, J APPL ECOL, V38, P217, DOI 10.1046/j.1365-2664.2001.00578.x; Wich SA, 2012, BIOL CONSERV, V146, P163, DOI 10.1016/j.biocon.2011.12.006; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; *WORLD BANK, 2011, SUB SAH AFR; YAMAGIWA J, 2008, AFRICAN STUDY MONO S, V29, P3	78	21	21	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75024	10.1371/journal.pone.0075024	http://dx.doi.org/10.1371/journal.pone.0075024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086426	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900034
J	Shore, DA; Yang, H; Balish, AL; Shepard, SS; Carney, PJ; Chang, JC; Davis, CT; Donis, RO; Villanueva, JM; Klimov, AI; Stevens, J				Shore, David A.; Yang, Hua; Balish, Amanda L.; Shepard, Samuel S.; Carney, Paul J.; Chang, Jessie C.; Davis, Charles T.; Donis, Ruben O.; Villanueva, Julie M.; Klimov, Alexander I.; Stevens, James			Structural and Antigenic Variation among Diverse Clade 2 H5N1 Viruses	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RECEPTOR-BINDING SPECIFICITY; AVIAN INFLUENZA-VIRUSES; TO-PERSON TRANSMISSION; A VIRUSES; HEMAGGLUTININ; VACCINE; EVOLUTION; SELECTION; IMMUNOGENICITY	Antigenic variation among circulating H5N1 highly pathogenic avian influenza A viruses mandates the continuous production of strain-specific pre-pandemic vaccine candidates and represents a significant challenge for pandemic preparedness. Here we assessed the structural, antigenic and receptor-binding properties of three H5N1 HPAI virus hemagglutinins, which were recently selected by the WHO as vaccine candidates [A/Egypt/N03072/2010 (Egypt10, clade 2.2.1), A/Hubei/1/2010 (Hubei10, clade 2.3.2.1) and A/Anhui/1/2005 (Anhui05, clade 2.3.4)]. These analyses revealed that antigenic diversity among these three isolates was restricted to changes in the size and charge of amino acid side chains at a handful of positions, spatially equivalent to the antigenic sites identified in H1 subtype viruses circulating among humans. All three of the H5N1 viruses analyzed in this study were responsible for fatal human infections, with the most recently-isolated strains, Hubei10 and Egypt10, containing multiple residues in the receptor-binding site of the HA, which were suspected to enhance mammalian transmission. However, glycan-binding analyses demonstrated a lack of binding to human alpha 2-6-linked sialic acid receptor analogs for all three HAs, reinforcing the notion that receptor-binding specificity contributes only partially to transmissibility and pathogenesis of HPAI viruses and suggesting that changes in host specificity must be interpreted in the context of the host and environmental factors, as well as the virus as a whole. Together, our data reveal structural linkages with phylogenetic and antigenic analyses of recently emerged H5N1 virus clades and should assist in interpreting the significance of future changes in antigenic and receptor-binding properties.	[Shore, David A.; Yang, Hua; Balish, Amanda L.; Shepard, Samuel S.; Carney, Paul J.; Chang, Jessie C.; Davis, Charles T.; Donis, Ruben O.; Villanueva, Julie M.; Klimov, Alexander I.; Stevens, James] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Stevens, J (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30329 USA.	fwb4@cdc.gov	Stevens, James/GQH-1081-2022		Centers for Disease Control and Prevention; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Centers for Disease Control by the Consortium for Functional Glycomics (CFG); National Institute of General Medical Sciences [GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Centers for Disease Control by the Consortium for Functional Glycomics (CFG); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Centers for Disease Control and Prevention. This research was supported in part by an appointment to the Research Participation Program at the Centers for Disease Control and Prevention administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and CDC. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Glycan microarrays were produced under contract for the Centers for Disease Control by the Consortium for Functional Glycomics (CFG) funded by National Institute of General Medical Sciences Grant GM62116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P418; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P97; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P93; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P359; Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrera-Badillo Gisela, 2012, Morbidity and Mortality Weekly Report, V61, P726; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Blixt O, 2008, GLYCOCONJUGATE J, V25, P27, DOI 10.1007/s10719-007-9045-0; Brown IH, 2009, INFLUENZA OTHER RESP, V3, P59, DOI 10.1111/j.1750-2659.2009.00078.x; Cai ZP, 2012, J MOL BIOL, V422, P145, DOI 10.1016/j.jmb.2012.05.011; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; *CDC, 2012, H5N1 GEN CHANG INV T; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; CHAYEN NE, 1992, J CRYST GROWTH, V122, P176, DOI 10.1016/0022-0248(92)90241-A; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Vries RP, 2010, VIROLOGY, V403, P17, DOI 10.1016/j.virol.2010.03.047; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fauci AS, 2006, J INFECT DIS, V194, pS73, DOI 10.1086/507550; FITCH WM, 1991, P NATL ACAD SCI USA, V88, P4270, DOI 10.1073/pnas.88.10.4270; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Ilyushina NA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000043; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Jia N, 2009, J CLIN VIROL, V44, P225, DOI 10.1016/j.jcv.2008.12.014; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Klimov Alexander, 2012, Methods Mol Biol, V865, P25, DOI 10.1007/978-1-61779-621-0_3; Kongchanagul A, 2008, J GEN VIROL, V89, P1805, DOI 10.1099/vir.0.2008/002469-0; Lee MS, 2003, J INFECT DIS, V188, P1362, DOI 10.1086/379045; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Naughtin M, 2011, ANTIMICROB AGENTS CH, V55, P2004, DOI 10.1128/AAC.01773-10; O'Neill E, 2009, CURR TOP MICROBIOL, V333, P83, DOI 10.1007/978-3-540-92165-3_4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peiris JSM, 2012, SCIENCE, V335, P1173, DOI 10.1126/science.1219936; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Russell RJ, 2006, GLYCOCONJUGATE J, V23, P85, DOI 10.1007/s10719-006-5440-1; SHEPARD SS, 2013, LABEL FAST ACCURATE; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Su Y, 2008, ARCH VIROL, V153, P2253, DOI 10.1007/s00705-008-0255-y; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Tang JW, 2008, J MED VIROL, V80, P1992, DOI 10.1002/jmv.21321; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Wan XF, 2011, J VIROL, V85, P13432, DOI 10.1128/JVI.05266-11; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHO, 2013, CAND VACC VIR POT TE; *WHO, 2006, AV INFL SIT IND UPD; *WHO, 2011, MAN LAB DIAGN VIR SU, P48; WHO, 2012, CUM NUMB CONF HUM CA; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; YANG H, 2010, PLOS CURR; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081; Yang Ji-xing, 2009, Zhonghua Yufang Yixue Zazhi, V43, P305, DOI 10.3760/cma.j.issn.0253-9624.2009.04.009; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yen HL, 2009, P NATL ACAD SCI USA, V106, P286, DOI 10.1073/pnas.0811052106; Younan M, 2013, EMERG INFECT DIS, V19, P43, DOI 10.3201/eid1901.121080	84	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75209	10.1371/journal.pone.0075209	http://dx.doi.org/10.1371/journal.pone.0075209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086467	gold, Green Published, Green Submitted			2022-12-25	WOS:000325223900038
J	Yan, J; Seibenhener, ML; Calderilla-Barbosa, L; Diaz-Meco, MT; Moscat, J; Jiang, JX; Wooten, MW; Wooten, MC				Yan, Jin; Seibenhener, Michael Lamar; Calderilla-Barbosa, Luis; Diaz-Meco, Maria-Theresa; Moscat, Jorge; Jiang, Jianxiong; Wooten, Marie W.; Wooten, Michael C.			SQSTM1/p62 Interacts with HDAC6 and Regulates Deacetylase Activity	PLOS ONE			English	Article							SEQUESTOSOME 1/P62; PROTEIN; TUBULIN; ACETYLATION; BINDING; P62; MICROTUBULES; P62/SQSTM1; AGGRESOMES; DEGRADATION	Protein aggregates can form in the cytoplasm of the cell and are accumulated at aggresomes localized to the microtubule organizing center (MTOC) where they are subsequently degraded by autophagy. In this process, aggregates are engulfed into autophagosomes which subsequently fuse with lysosomes for protein degradation. A member of the class II histone deacetylase family, histone deacetylase 6(HDAC6) has been shown to be involved in both aggresome formation and the fusion of autophagosomes with lysosomes making it an attractive target to regulate protein aggregation. The scaffolding protein sequestosome 1(SQSTM1)/p62 has also been shown to regulate accumulation and autophagic clearance of protein aggregates. Recent studies have revealed colocalization of HDAC6 and p62 to ubiquitinated mitochondria, as well as, ubiquitinated protein aggregates associated with the E3 ubiquitin ligase TRIM50. HDAC6 deacetylase activity is required for aggresome formation and can be regulated by protein interaction with HDAC6. Due to their colocalization at ubiquitinated protein aggregates, we sought to examine if p62 specifically interacted with HDAC6 and if so, if this interaction had any effect on HDAC6 activity and/or the physiological function of cortactin-F-actin assembly. We succeeded in identifying and mapping the direct interaction between HDAC6 and p62. We further show that this interaction regulates HDAC6 deacetylase activity. Data are presented demonstrating that the absence of p62 results in hyperactivation of HDAC6 and deacetylation of alpha-tubulin and cortactin. Further, upon induction of protein misfolding we show that p62 is required for perinuclear co-localization of cortactin-F-actin assemblies. Thus, our findings indicate that p62 plays a key role in regulating the recruitment of F-actin network assemblies to the MTOC, a critical cellular function that is required for successful autophagic clearance of protein aggregates.	[Yan, Jin; Seibenhener, Michael Lamar; Calderilla-Barbosa, Luis; Wooten, Marie W.; Wooten, Michael C.] Auburn Univ, Dept Biol Sci, Cellular & Mol Biosci Program, Auburn, AL 36849 USA; [Diaz-Meco, Maria-Theresa; Moscat, Jorge] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Jiang, Jianxiong] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Auburn University System; Auburn University; Sanford Burnham Prebys Medical Discovery Institute; Emory University	Wooten, MC (corresponding author), Auburn Univ, Dept Biol Sci, Cellular & Mol Biosci Program, Auburn, AL 36849 USA.	wootemc@auburn.edu	Jiang, Jianxiong/A-1987-2010	Jiang, Jianxiong/0000-0003-3955-8928; Diaz-Meco, Maria/0000-0003-0147-0998	National Institute of Health [NIH-2RO1NS033661]; NATIONAL CANCER INSTITUTE [R01CA172025, R01CA132847, R01CA134530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033661] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Institute of Health (Grant number NIH-2RO1NS033661 (MCW)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu JR, 2008, J NEUROCHEM, V106, P107, DOI 10.1111/j.1471-4159.2008.05340.x; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Di Fulvio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028563; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Fusco C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040440; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kirkin V, 2009, AUTOPHAGY, V5, P732, DOI 10.4161/auto.5.5.8566; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; LEE G, 1992, J CELL SCI, V102, P227; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Li GY, 2011, J NEUROL SCI, V304, P1, DOI 10.1016/j.jns.2011.02.017; MACRAE TH, 1992, BIOCHEM CELL BIOL, V70, P835, DOI 10.1139/o92-131; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rosenbaum J, 2000, CURR BIOL, V10, pR801, DOI 10.1016/S0960-9822(00)00767-3; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Seibenhener ML, 2013, BBA-MOL CELL RES, V1833, P452, DOI 10.1016/j.bbamcr.2012.11.004; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Sokal R. R., 2012, BIOMETRY; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Watabe M, 2011, J CELL SCI, V124, P1519, DOI 10.1242/jcs.081778; Watanabe Y, 2011, J CELL SCI, V124, P2692, DOI 10.1242/jcs.081232; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wickstrom SA, 2010, EMBO J, V29, P131, DOI 10.1038/emboj.2009.317; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Yao Tso-Pang, 2010, Genes Cancer, V1, P779; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zhou J, 2004, BIOCHEM PHARMACOL, V68, P2435, DOI 10.1016/j.bcp.2004.08.032; Zhou J, 2009, J BIOL CHEM, V284, P9648, DOI 10.1074/jbc.M808708200; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	58	77	79	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76016	10.1371/journal.pone.0076016	http://dx.doi.org/10.1371/journal.pone.0076016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086678	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900070
J	Honea, RA; Cruchaga, C; Perea, RD; Saykin, AJ; Burns, JM; Weinberger, DR; Goate, AM				Honea, Robyn A.; Cruchaga, Carlos; Perea, Rodrigo D.; Saykin, Andrew J.; Burns, Jeffrey M.; Weinberger, Daniel R.; Goate, Alison M.		Alzheimer's Dis Neuroimaging Initi	Characterizing the Role of Brain Derived Neurotrophic Factor Genetic Variation in Alzheimer's Disease Neurodegeneration	PLOS ONE			English	Article							BDNF VAL66MET POLYMORPHISM; GENOME-WIDE ASSOCIATION; PARKINSONS-DISEASE; VAL(66)MET POLYMORPHISM; HIPPOCAMPAL VOLUME; EXECUTIVE FUNCTION; MESSENGER-RNA; HUMAN-MEMORY; ONSET; SUSCEPTIBILITY	There is accumulating evidence that neurotrophins, like brain-derived neurotrophic factor (BDNF), may impact aging and Alzheimer's Disease. However, traditional genetic association studies have not found a clear relationship between BDNF and AD. Our goal was to test whether BDNF single nucleotide polymorphisms (SNPs) impact Alzheimer's Disease-related brain imaging and cognitive markers of disease. We completed an imaging genetics study on 645 Alzheimer's Disease Neuroimaging Initiative participants (ND=175, MCI=316, AD=154) who had cognitive, brain imaging, and genetics data at baseline and a subset of those with brain imaging data at two years. Samples were genotyped using the Illumina Human610-Quad BeadChip. 13 SNPs in BDNF were identified in the dataset following quality control measures (rs6265(Val66Met), rs12273363, rs11030094, rs925946, rs1050187, rs2203877, rs11030104, rs11030108, rs10835211, rs7934165, rs908867, rs1491850, rs1157459). We analyzed a subgroup of 8 SNPs that were in low linkage disequilibrium with each other. Automated brain morphometric measures were available through ADNI investigators, and we analyzed baseline cognitive scores, hippocampal and whole brain volumes, and rates of hippocampal and whole brain atrophy and rates of change in the ADAS-Cog over one and two years. Three out of eight BDNF SNPs analyzed were significantly associated with measures of cognitive decline (rs1157659, rs11030094, rs11030108). No SNPs were significantly associated with baseline brain volume measures, however six SNPs were significantly associated with hippocampal and/or whole brain atrophy over two years (rs908867, rs11030094, rs6265, rs10501087, rs1157659, rs1491850). We also found an interaction between the BDNF Val66Met SNP and age with whole brain volume. Our imaging-genetics analysis in a large dataset suggests that while BDNF genetic variation is not specifically associated with a diagnosis of AD, it appears to play a role in AD-related brain neurodegeneration.	[Honea, Robyn A.; Perea, Rodrigo D.; Burns, Jeffrey M.] Univ Kansas, Med Ctr, Dept Neurol, Alzheimers Dis Ctr, Kansas City, KS 66103 USA; [Cruchaga, Carlos; Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat & Neurol, St Louis, MO USA; [Saykin, Andrew J.] Indiana Univ Sch Med, Dept Radiol, Ctr Computat Biol & Bioinformat, Ctr Neuroimaging,Div Imaging Sci, Indianapolis, IN 46202 USA; [Saykin, Andrew J.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Weinberger, Daniel R.] Lieber Inst Brain Dev, Baltimore, MD USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	University of Kansas; University of Kansas Medical Center; Washington University (WUSTL); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Honea, RA (corresponding author), Univ Kansas, Med Ctr, Dept Neurol, Alzheimers Dis Ctr, Kansas City, KS 66103 USA.	rhonea@kumc.edu	Cruchaga, Carlos/ABF-4065-2020; Saykin, Andrew/A-1318-2007	Cruchaga, Carlos/0000-0002-0276-2899; Goate, Alison/0000-0002-0576-2472; Burns, Jeffrey/0000-0001-7609-8954; Saykin, Andrew/0000-0002-1376-8532	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Alzheimer's Disease Genetics Consortium [U01AG032984]; NIA [R01AG19771, P30AG010133]; NCRAD [U24AG021886]; NIH [K01 AG035042, P30 AG010129]; Alzheimer's Disease Neuroimaging Initiative (ADNI); NATIONAL INSTITUTE ON AGING [U01AG024904, R01AG019771, P30AG010133, P30AG035982, U24AG021886, P30AG010129, U01AG032984, K01AG035042] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Disease Genetics Consortium; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRAD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Disease Neuroimaging Initiative (ADNI); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. Additional support was provided by U01AG032984 (Alzheimer's Disease Genetics Consortium), NIA R01AG19771 and P30AG010133. Samples from the NCRAD, which receives government support under a cooperative agreement (U24AG021886) awarded by the NIA were used in this study. RAH is supported by NIH grants K01 AG035042 and P30 AG010129. RAH had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, all commercial funding was made through the Alzheimer's Disease Neuroimaging Initiative (ADNI) and no direct commercial funding was received.	Arancibia S, 2008, NEUROBIOL DIS, V31, P316, DOI 10.1016/j.nbd.2008.05.012; Bertram Anthony, 2010, N Z Med J, V123, P122; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Fukumoto N, 2010, AM J MED GENET B, V153B, P235, DOI 10.1002/ajmg.b.30986; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Harris SE, 2006, MOL PSYCHIATR, V11, P505, DOI 10.1038/sj.mp.4001799; Hashimoto R, 2008, GENES BRAIN BEHAV; Ho AJ, 2011, HUM BRAIN MAPP, V32, P1371, DOI 10.1002/hbm.21113; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Holland D, 2009, P NATL ACAD SCI USA, V106, P20954, DOI 10.1073/pnas.0906053106; Huang R, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044883; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; KNUSEL B, 1992, J NEUROSCI, V12, P4391; Kocabas NA, 2011, INT CLIN PSYCHOPHARM, V26, P1, DOI 10.1097/YIC.0b013e32833d18f8; Kunugi H, 2001, MOL PSYCHIATR, V6, P83, DOI 10.1038/sj.mp.4000792; Laumet G, 2010, J ALZHEIMERS DIS, V20, P1181, DOI 10.3233/JAD-2010-100126; Lim YY, 2013, NEUROBIOL AGING; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nagata T, 2012, DEMENT GERIATR COGN, V33, P266, DOI 10.1159/000339358; Nagata T, 2011, PSYCHOGERIATRICS, V11, P141, DOI 10.1111/j.1479-8301.2011.00364.x; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Real E, 2009, BIOL PSYCHIAT, V66, P674, DOI 10.1016/j.biopsych.2009.05.017; Reiman EM, 2007, ANN NY ACAD SCI, V1097, P94, DOI 10.1196/annals.1379.011; Saarela MS, 2006, FOLIA NEUROPATHOL, V44, P12; Sambataro F, 2010, MOL PSYCHIATR, V15, P116, DOI 10.1038/mp.2009.64; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Tost H, 2013, NEUROPSYCHOPHARMACOL, V38, P525, DOI 10.1038/npp.2012.214; Tsai SJ, 2004, NEUROPSYCHOBIOLOGY, V49, P10, DOI 10.1159/000075332; Tsai SJ, 2006, DEMENT GERIATR COGN, V21, P139, DOI 10.1159/000090673; Tseng KY, 2001, J NEUROSCI, V21, P6430, DOI 10.1523/JNEUROSCI.21-16-06430.2001; Ventriglia M, 2002, MOL PSYCHIATR, V7, P136, DOI 10.1038/sj.mp.4000952; Voineskos AN, 2011, ARCH GEN PSYCHIAT, V68, P198, DOI 10.1001/archgenpsychiatry.2010.194; Xu CL, 2010, NEUROREPORT, V21, P802, DOI 10.1097/WNR.0b013e32833ccaf4; Zdanys KF, 2009, J ALZHEIMERS DIS, V17, P887, DOI 10.3233/JAD-2009-1106; Ziegenhorn AA, 2007, NEUROBIOL AGING, V28, P1436, DOI 10.1016/j.neurobiolaging.2006.06.011	45	39	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76001	10.1371/journal.pone.0076001	http://dx.doi.org/10.1371/journal.pone.0076001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086677	gold, Green Published			2022-12-25	WOS:000325220000056
J	Shi, SL; Yu, LP; Zhang, TR; Qi, HY; Xavier, S; Ju, WJ; Bottinger, E				Shi, Shaolin; Yu, Liping; Zhang, Taoran; Qi, Haiying; Xavier, Sandhya; Ju, Wenjun; Bottinger, Erwin			Smad2-Dependent Downregulation of miR-30 Is Required for TGF-beta-Induced Apoptosis in Podocytes	PLOS ONE			English	Article							INDUCED COLLAGEN EXPRESSION; GROWTH-FACTOR-BETA; MIR-200 FAMILY; DELETION; MICRORNA-155; TARGETS; SMAD2; CELLS; ZEB1	Transforming growth factors beta (TGF-beta) are multi-functional cytokines capable of inducing apoptosis in epithelial cells, including glomerular podocytes. We and others have previously shown that podocyte-selective genetic deletion of the microRNA (miR)-processing enzyme, Dicer, caused glomerulosclerosis that was associated with podocyte apoptosis, and the miR-30 family was implicated in the process. Here, we report that apoptosis-associated genes were highly enriched among the predicted targets of miR-30 when compared with randomly selected miRs (26% vs. 4.5 +/- 2.1%) or with the known TGF-beta-regulated miR-192 (6%), miR-216a (5.1%), and miR-217 (0%). miR-30 family members were abundantly expressed in podocytes in normal mice but were downregulated in albumin/TGF-beta transgenic mice with podocyte apoptosis and glomerulosclerosis. In vitro, TGF-beta downregulated miR-30s in wildtype and Smad3-deficient, but not Smad2- or Smad2/Smad3-deficient, podocytes. The TGF-beta-induced activation of caspase 3 and an increase in TUNEL-positive nuclei were significantly inhibited by the lentivirus-mediated overexpression of miR-30d, but not by a scrambled control miR, in podocytes. TGF-beta stimulated the phosphorylation of pro-apoptotic p53 in podocytes with lentiviral expression of a scrambled miR, but not in podocytes expressing miR-30d. In contrast, miR-30d had no effect on the phosphorylation of pro-apoptotic p38 MAP kinase induced by TGF-beta. Thus, we report that Smad2-dependent inhibition of miR-30s in podocytes is required for the activation of p53 and the induction of apoptosis by TGF-beta. These results demonstrate a novel functional role for miR-30 in podocyte survival and indicate that the loss of miR-30 survival signaling is a novel and specific mechanism of TGF-beta-induced podocyte apoptosis during glomerulosclerosis. We propose the therapeutic replacement of miR-30 as a novel strategy to prevent the podocyte apoptosis that is characteristic of progressive glomerular diseases.	[Shi, Shaolin; Yu, Liping; Zhang, Taoran; Qi, Haiying; Xavier, Sandhya; Ju, Wenjun; Bottinger, Erwin] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Shi, SL (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	shaolinshi1001@yahoo.com; erwin.bottinger@mssm.edu		Ju, Wenjun/0000-0002-9136-8454; Shi, Shaolin/0000-0003-2297-6496	National Institute of Health [R01- DK60043, R01-DK073960, R01-DK056077, U01-DK060995, R01-DK097253]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097253, R01DK056077, R01DK073960, R01DK060043, U01DK060995] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institute of Health grants R01- DK60043, R01-DK073960, R01-DK056077, U01-DK060995, and R01-DK097253 to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; Ho J, 2008, J AM SOC NEPHROL, V19, P2069, DOI 10.1681/ASN.2008020162; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kriz W, 1998, NEPHROL DIAL TRANSPL, V13, P2781, DOI 10.1093/ndt/13.11.2781; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; ROBERTS AB, 1990, PHILOS T R SOC B, V327, P145, DOI 10.1098/rstb.1990.0050; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Sequeira-Lopez MLS, 2010, J AM SOC NEPHROL, V21, P460, DOI 10.1681/ASN.2009090964; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; TAKEUCHI A, 1992, AM J PATHOL, V141, P107; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wu DT, 2005, J AM SOC NEPHROL, V16, P3211, DOI 10.1681/ASN.2004121055; Xavier S, 2009, J AM SOC NEPHROL, V20, P2127, DOI 10.1681/ASN.2008070806; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	39	44	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75572	10.1371/journal.pone.0075572	http://dx.doi.org/10.1371/journal.pone.0075572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086574	Green Submitted, Green Published, gold			2022-12-25	WOS:000325220000029
J	Ye, H; Deng, G; Mauger, SJ; Hersbach, AA; Dawson, PW; Heasman, JM				Ye, Hua; Deng, Guang; Mauger, Stefan J.; Hersbach, Adam A.; Dawson, Pam W.; Heasman, John M.			A Wavelet-Based Noise Reduction Algorithm and Its Clinical Evaluation in Cochlear Implants	PLOS ONE			English	Article							SPEECH ENHANCEMENT; INTELLIGIBILITY; SIMULATIONS; SUPPRESSION; TRANSFORM; USERS	Noise reduction is often essential for cochlear implant (CI) recipients to achieve acceptable speech perception in noisy environments. Most noise reduction algorithms applied to audio signals are based on time-frequency representations of the input, such as the Fourier transform. Algorithms based on other representations may also be able to provide comparable or improved speech perception and listening quality improvements. In this paper, a noise reduction algorithm for CI sound processing is proposed based on the wavelet transform. The algorithm uses a dual-tree complex discrete wavelet transform followed by shrinkage of the wavelet coefficients based on a statistical estimation of the variance of the noise. The proposed noise reduction algorithm was evaluated by comparing its performance to those of many existing wavelet-based algorithms. The speech transmission index (STI) of the proposed algorithm is significantly better than other tested algorithms for the speech-weighted noise of different levels of signal to noise ratio. The effectiveness of the proposed system was clinically evaluated with CI recipients. A significant improvement in speech perception of 1.9 dB was found on average in speech weighted noise.	[Ye, Hua; Deng, Guang] La Trobe Univ, Dept Elect Engn, Melbourne, Vic, Australia; [Mauger, Stefan J.; Hersbach, Adam A.; Dawson, Pam W.; Heasman, John M.] Cochlear Ltd, Melbourne, Vic, Australia; [Dawson, Pam W.] HEARing CRC, Melbourne, Vic, Australia	La Trobe University; Cochlear	Deng, G (corresponding author), La Trobe Univ, Dept Elect Engn, Melbourne, Vic, Australia.	d.deng@latrobe.edu.au			HEARing CRC; Cochlear Limited	HEARing CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Cochlear Limited	In-kind audiological funding was provided by the HEARing CRC. In-kind engineering funding was provided by Cochlear Limited. Clinical testing was carried out at Cochlear, Melbourne, Research & Applications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boll S., 1979, ACOUSTICS SPEECH SIG, V27, P113, DOI DOI 10.1109/TASSP.1979.1163209; Boothroyd A, 1968, INT J AUDIOL, V7, P368; Buechner A, 2010, OTOL NEUROTOL, V31, P1386, DOI 10.1097/MAO.0b013e3181f1cdc6; Cameron S, 2007, EAR HEARING, V28, P196, DOI 10.1097/AUD.0b013e318031267f; Chung King, 2004, Cochlear Implants Int, V5 Suppl 1, P192, DOI 10.1179/cim.2004.5.Supplement-1.192; COIFMAN R, 1995, 475 STANF U DEP STAT; Dawson PW, 2011, EAR HEARING, V32, P382, DOI 10.1097/AUD.0b013e318201c200; Dawson PW, 2013, EAR HEAR, V34; EPHRAIM Y, 1984, IEEE T ACOUST SPEECH, V32, P1109, DOI 10.1109/TASSP.1984.1164453; Goldsworthy RL, 2004, J ACOUST SOC AM, V116, P3679, DOI 10.1121/1.1804628; Gopalakrishna V, 2010, IEEE T BIO-MED ENG, V57, P2053, DOI 10.1109/TBME.2010.2047644; Hagerman B., 1976, SCAND AUDIOL, V5, P219, DOI [10.3109/01050397609044991, DOI 10.3109/01050397609044991]; Hersbach AA, 2012, EAR HEARING, V33, pE13, DOI 10.1097/AUD.0b013e31824b9e21; HOCHBERG I, 1992, EAR HEARING, V13, P263, DOI 10.1097/00003446-199208000-00008; Hu Y, 2007, J ACOUST SOC AM, V122, pEL128, DOI 10.1121/1.2772401; Hu Y, 2007, SPEECH COMMUN, V49, P588, DOI 10.1016/j.specom.2006.12.006; Hu Y, 2010, J ACOUST SOC AM, V127, P3689, DOI 10.1121/1.3365256; Lei SF, 2008, IEICE T FUND ELECTR, VE91A, P2555, DOI 10.1093/ietfec/e91-a.9.2555; LIM JS, 1979, P IEEE, V67, P1586, DOI 10.1109/PROC.1979.11540; Loizou Philipos C, 2006, Adv Otorhinolaryngol, V64, P109, DOI 10.1159/000094648; Mauger SJ, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/065007; Mauger SJ, 2012, J ACOUST SOC AM, V131, P327, DOI 10.1121/1.3665990; MCAULAY RJ, 1980, IEEE T ACOUST SPEECH, V28, P137, DOI 10.1109/TASSP.1980.1163394; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; NOGUEIRA W, 2006, INT CONF ACOUST SPEE, P121; Patrick James F, 2006, Trends Amplif, V10, P175, DOI 10.1177/1084713806296386; Pesquet JC, 1996, IEEE T SIGNAL PROCES, V44, P1964, DOI 10.1109/78.533717; Poissant SF, 2006, J ACOUST SOC AM, V119, P1606, DOI 10.1121/1.2168428; Seligman P., 1995, Annals of Otology Rhinology and Laryngology, V104, P139; Sendur L, 2002, IEEE T SIGNAL PROCES, V50, P2744, DOI 10.1109/TSP.2002.804091; Wouters J, 2001, EAR HEARING, V22, P420, DOI 10.1097/00003446-200110000-00006; Yang LP, 2005, J ACOUST SOC AM, V117, P1001, DOI 10.1121/1.1852873; Yao J, 2002, IEEE T BIO-MED ENG, V49, P1299, DOI 10.1109/TBME.2002.804590; Yao J, 2001, IEEE T BIO-MED ENG, V48, P856, DOI 10.1109/10.936362	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75662	10.1371/journal.pone.0075662	http://dx.doi.org/10.1371/journal.pone.0075662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086605	Green Submitted, gold, Green Published			2022-12-25	WOS:000325220000033
J	Sakai, K; Imamura, M; Tanaka, Y; Iwata, M; Hirose, H; Kaku, K; Maegawa, H; Watada, H; Tobe, K; Kashiwagi, A; Kawamori, R; Maeda, S				Sakai, Kensuke; Imamura, Minako; Tanaka, Yasushi; Iwata, Minoru; Hirose, Hiroshi; Kaku, Kohei; Maegawa, Hiroshi; Watada, Hirotaka; Tobe, Kazuyuki; Kashiwagi, Atsunori; Kawamori, Ryuzo; Maeda, Shiro			Replication Study for the Association of 9 East Asian GWAS-Derived Loci with Susceptibility to Type 2 Diabetes in a Japanese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FASTING PLASMA-GLUCOSE; INSULIN-RESISTANCE; RISK LOCI; VARIANTS; POLYMORPHISM; GENE; HOMEOSTASIS; MTNR1B; HMGA1	Aims: East Asian genome-wide association studies (GWAS) for type 2 diabetes identified 8 loci with genome-wide significance, and 2 loci with a borderline association. However, the associations of these loci except MAEA locus with type 2 diabetes have not been evaluated in independent East Asian cohorts. We performed a replication study to investigate the association of these susceptibility loci with type 2 diabetes in an independent Japanese population. Methods: We genotyped 7,379 Japanese participants (5,315 type 2 diabetes and 2,064 controls) for each of the 9 single nucleotide polymorphisms (SNPs), rs7041847 in GLIS3, rs6017317 in FITM2-R3HDML-HNF4A, rs6467136 near GCCI-PAX4, rs831571 near PSMD6, rs9470794 in ZFAND3, rs3786897 in PEPD, rs1535500 in KCNK16, rs16955379 in CMIP, and rs17797882 near WWOX. Because the sample size in this study was not sufficient to replicate single SNP associations, we constructed a genetic risk score (GRS) by summing a number of risk alleles of the 9 SNPs, and examined the association of the GRS with type 2 diabetes using logistic regression analysis. Results: With the exception of rs1535500 in KCNK16, all SNPs had the same direction of effect (odds ratio [OR]>1.0) as in the original reports. The GRS constructed from the 9 SNPs was significantly associated with type 2 diabetes in the Japanese population (p = 4.0 x 10(-4), OR = 1.05, 95% confidence interval: 1.02-1.09). In quantitative trait analyses, rs16955379 in CMIP was nominally associated with a decreased homeostasis model assessment of beta-cell function and with increased fasting plasma glucose, but neither the individual SNPs nor the GRS showed a significant association with the glycemic traits. Conclusions: These results indicate that 9 loci that were identified in the East Asian GWAS meta-analysis have a significant effect on the susceptibility to type 2 diabetes in the Japanese population.	[Sakai, Kensuke; Imamura, Minako; Maeda, Shiro] RIKEN Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan; [Sakai, Kensuke; Tanaka, Yasushi] St Marianna Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Kawasaki, Kanagawa, Japan; [Iwata, Minoru; Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Toyama 930, Japan; [Hirose, Hiroshi] Keio Univ, Sch Med, Ctr Hlth, Tokyo, Japan; [Kaku, Kohei] Kawasaki Med Sch, Dept Internal Med, Div Diabet Endocrinol & Metab, Kurashiki, Okayama, Japan; [Maegawa, Hiroshi; Kashiwagi, Atsunori] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Dept Endocrinol & Metab, Tokyo, Japan; [Watada, Hirotaka; Kawamori, Ryuzo] Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo, Japan	RIKEN; Saint Marianna University; University of Toyama; Keio University; Kawasaki Medical School; Shiga University of Medical Science; Juntendo University; Juntendo University	Maeda, S (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Endocrinol Metab & Kidney Dis, Yokohama, Kanagawa, Japan.	smaeda@src.riken.jp	Kashiwagi, Atsunori/H-8712-2019; Hirose, Hiroshi/F-8556-2014	Watada, Hirotaka/0000-0001-5961-1816; Maegawa, Hiroshi/0000-0002-4611-8149	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Chiefari E, 2011, JAMA-J AM MED ASSOC, V305, P903, DOI 10.1001/jama.2011.207; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fukuda H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046263; Hayashi T, 2007, DIABETOLOGIA, V50, P980, DOI 10.1007/s00125-007-0618-z; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Imamura M, 2011, DIABETOLOGIA, V54, P3071, DOI 10.1007/s00125-011-2293-3; Imamura M, 2013, J DIABETES INVEST, V4, P168, DOI 10.1111/jdi.12017; Imamura M, 2012, HUM MOL GENET, V21, P3042, DOI 10.1093/hmg/dds113; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; International Diabetes Federation, 2012, DIABETES ATLAS, P2012; Iwata M, 2012, DIABETES CARE, V35, P1763, DOI 10.2337/dc11-2006; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Liu L, 2012, DIABETOLOGIA, V55, P1685, DOI 10.1007/s00125-012-2518-0; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; Onuma H, 2010, J HUM GENET, V55, P600, DOI 10.1038/jhg.2010.75; Peterson RE, 2011, HUM GENET, V129, P221, DOI 10.1007/s00439-010-0917-1; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	42	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76317	10.1371/journal.pone.0076317	http://dx.doi.org/10.1371/journal.pone.0076317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086726	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000325218700124
J	Scortichini, M; Marcelletti, S; Ferrante, P; Firrao, G				Scortichini, Marco; Marcelletti, Simone; Ferrante, Patrizia; Firrao, Giuseppe			A Genomic Redefinition of Pseudomonas avellanae species	PLOS ONE			English	Article							SYRINGAE PV AVELLANAE; BACTERIUM CAUSING CANKER; AD-HOC-COMMITTEE; GENETIC DIVERSITY; CORYLUS-AVELLANA; SEQUENCE; DNA; DEFINITION; HAZELNUT; IDENTIFICATION	The circumscription of bacterial species is a complex task. So far, DNA-DNA hybridization (DDH), 16S rRNA gene sequencing, and multiocus sequence typing analysis (MLSA) are currently the preferred techniques for their genetic determination. However, the average nucleotide identity (ANI) analysis of conserved and shared genes between two bacterial strains based on the pair-wise genome comparisons, with support of the tetranucleotide frequency correlation coefficients (TETRA) value, has recently been proposed as a reliable substitute for DDH. The species demarcation boundary has been set to a value of 95-96% of the ANI identity, with further confirmation through the assessment of the corresponding TETRA value. In this study, we performed a genome-wide MLSA of 14 phytopathogenic pseudomonads genomes, and assessed the ANI and TETRA values of 27 genomes, representing seven out of the nine genomospecies of Pseudomonas spp. sensu Gardan et alii, and their phylogenetic relationships using maximum likelihood and Bayesian approaches. The results demonstrate the existence of a well demarcated genomic cluster that includes strains classified as P. avellanae, P. syringae pv. theae, P. s. pv. actinidiae and one P. s. pv. morsprunorum strain all belonging to the single species P. avellanae. In addition, when compared with P. avellanae, five strains of P. s. pv. tomato, including the model strain DC3000, and one P. s. pv. lachrymans strain, appear as very closely related to P. avellanae, with ANI values of nearly 96% as confirmed by the TETRA analysis. Conversely, one representative strain, previously classified as P. avellanae and isolated in central Italy, is a genuine member of the P. syringae species complex and can be defined as P. s. pv. avellanae. Currently. The core and pan genomes of P. avellanae species consist of 3,995 and 5,410 putative protein-coding genes, respectively.	[Scortichini, Marco; Marcelletti, Simone; Ferrante, Patrizia] Ctr Ric Frutticoltura, Consiglio Ric & Sperimentaz Agr, Rome, Italy; [Scortichini, Marco] Consiglio Ric & Sperimentaz Agr, Unita Ric Frutticoltura, Rome, Italy; [Firrao, Giuseppe] Univ Udine, Dipartimento Sci Agr & Ambientali, I-33100 Udine, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Udine	Scortichini, M (corresponding author), Ctr Ric Frutticoltura, Consiglio Ric & Sperimentaz Agr, Rome, Italy.	marco.scortichini@entecra.it		FIRRAO, Giuseppe/0000-0002-7890-0899; Scortichini, Marco/0000-0003-1565-9097; FERRANTE, PATRIZIA/0000-0001-7577-9096	Italian Ministry of Agriculture, Food and Forestry	Italian Ministry of Agriculture, Food and Forestry	The work was funded by the Italian Ministry of Agriculture, Food and Forestry in the framework of the project ARDICA: "Azioni di ricerca e difesa al cancro batterico dell'Actinidia (Psa)". No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bull CT, 2008, J PLANT PATHOL, V90, P403; Bull CT, 2011, PHYTOPATHOLOGY, V101, P847, DOI 10.1094/PHYTO-11-10-0318; Butler MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057464; Carrion VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036709; Chan JZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-302; Coenye T, 2005, FEMS MICROBIOL REV, V29, P147, DOI 10.1016/j.femsre.2004.11.004; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dellaglio F, 2004, INT J SYST EVOL MICR, V54, P279, DOI 10.1099/ijs.0.02782-0; Dress AWM, 2004, IEEE ACM T COMPUT BI, V1, P109, DOI 10.1109/TCBB.2004.27; Ferrante P, 2011, J PLANT PATHOL, V93, P659; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gilbert V, 2009, EUR J PLANT PATHOL, V124, P199, DOI 10.1007/s10658-008-9406-y; Godreuil Sylvain, 2005, Infection Genetics and Evolution, V5, P375, DOI 10.1016/j.meegid.2004.03.004; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hofte M, 2006, PLANT-ASSOCIATED BACTERIA, P507; Holland BR, 2004, MOL BIOL EVOL, V21, P1459, DOI 10.1093/molbev/msh145; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Janse JD, 1996, SYST APPL MICROBIOL, V19, P589, DOI 10.1016/S0723-2020(96)80030-0; Kaluzna M, 2010, J PLANT PATHOL, V92, P781; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kuo CH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-108; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lapage SP, 1992, INT CODE NOMENCLATUR; Marcelletti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027297; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; MOORE ERB, 2006, PROKARYOTES, V0006, P00021; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Murillo J, 2011, RES MICROBIOL, V162, P253, DOI 10.1016/j.resmic.2010.10.011; Parkinson N, 2011, PLANT PATHOL, V60, P338, DOI 10.1111/j.1365-3059.2010.02366.x; Poptsova MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-120; PSALLIDAS PG, 1979, PHYTOPATHOL Z, V94, P103; PSALLIDAS PG, 1993, PLANT PATHOL, V42, P358, DOI 10.1111/j.1365-3059.1993.tb01512.x; R Core Team, 2022, R LANG ENV STAT COMP; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Sarris PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059366; Scortichini M, 2006, PLANT PATHOL, V55, P451, DOI 10.1111/j.1365-3059.2006.01352.x; Scortichini M, 2003, PLANT PATHOL, V52, P277, DOI 10.1046/j.1365-3059.2003.00860.x; Scortichini M., 1999, Journal of Plant Pathology, V81, P55; Scortichini M, 1998, J PHYTOPATHOL, V146, P417, DOI 10.1111/j.1439-0434.1998.tb04774.x; SCORTICHINI M, 1994, J PHYTOPATHOL, V140, P65, DOI 10.1111/j.1439-0434.1994.tb00177.x; Scortichini M, 2002, EUR J PLANT PATHOL, V108, P269, DOI 10.1023/A:1015178104513; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI 10.1099/00207713-52-3-1043; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vicente JG, 2007, EUR J PLANT PATHOL, V117, P383, DOI 10.1007/s10658-007-9107-y; Vinatzer Boris A., 2009, P37; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Wang PW, 2007, MICROBIOL-SGM, V153, P2067, DOI 10.1099/mic.0.2006/001545-0; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463	63	32	34	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75794	10.1371/journal.pone.0075794	http://dx.doi.org/10.1371/journal.pone.0075794			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086635	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700112
J	Kamaraj, B; Kumar, A; Purohit, R				Kamaraj, Balu; Kumar, Ambuj; Purohit, Rituraj			Evolutionary Reconstruction and Population Genetics Analysis of Aurora Kinases	PLOS ONE			English	Article							SYNONYMOUS CODON USAGE; INFERENCE; SELECTION; SEQUENCE; IDENTIFICATION; MRBAYES; BIAS	Background: Aurora kinases belong to the highly conserved kinase family and play a vital role in cell cycle regulation. The structure and function of these kinases are inter-related and sometimes they also act as substitutes in case of knockdown of other aurora kinases. Method: In this work we carried out the evolutionary reconstruction and population genetic studies of aurora kinase proteins. Substitution saturation test, CAI (Codon adaptation index), gene expression and RSCU (Relative synonymous codon usage) values were computed for all the three aurora kinases. Linear regression method was used to check the dependency of gene expression on their CAI values. Results: The results suggested that aurora-B and aurora-C has shown convergence in their evolutionary pathway. Moreover, the aurora-A I57V mutation showed high penetrance in human population and exist at very high frequency (84.4%) when compared to the native residue (15.6%). The mutation showed notable range of functional gain and seemed to be promising for the evolution of aurora-A function. Mutant allele might also become a challenging prospect for understanding the pattern of evolution followed by cell cycle kinases. Conclusion: The overall result suggested that the aurora-A is currently under the evolutionary transition and to determine the functional significance of the mutation further investigation are required.	[Kamaraj, Balu; Kumar, Ambuj; Purohit, Rituraj] Vellore Inst Technol Univ, Bioinformat Div, Sch Bio Sci & Technol, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Purohit, R (corresponding author), Vellore Inst Technol Univ, Bioinformat Div, Sch Bio Sci & Technol, Vellore, Tamil Nadu, India.	riturajpurohit@gmail.com	Kumar, Ambuj/E-4649-2012; Purohit, Rituraj/I-8856-2012; Kamaraj, Balu/AAE-2852-2019; Purohit, Rituraj/AAF-6257-2021; Kumar, Ambuj/U-5268-2019	Kumar, Ambuj/0000-0003-3692-3694; Purohit, Rituraj/0000-0002-2101-9398; Kamaraj, Balu/0000-0002-9747-3984; Purohit, Rituraj/0000-0002-2101-9398; 				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Bazykin GA, 2011, GENOME BIOL EVOL, V3, P1006, DOI 10.1093/gbe/evr086; Bolanos-Garcia VM, 2005, INT J BIOCHEM CELL B, V37, P1572, DOI 10.1016/j.biocel.2005.02.021; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Brown JR, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-39; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Castro A, 2002, EMBO REP, V3, P457, DOI 10.1093/embo-reports/kvf095; Castro A, 2002, EMBO REP, V3, P1209, DOI 10.1093/embo-reports/kvf241; Chen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019996; Crane R, 2004, J CELL SCI, V117, P5975, DOI 10.1242/jcs.01418; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Eyers PA, 2005, CELL CYCLE, V4, P784, DOI 10.4161/cc.4.6.1693; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Gabillard JC, 2011, BIOCHEM BIOPH RES CO, V408, P647, DOI 10.1016/j.bbrc.2011.04.078; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Gupta SK, 2004, J BIOMOL STRUCT DYN, V21, P527, DOI 10.1080/07391102.2004.10506946; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Loewe L, 2008, NATURE, V1; Macarulla T, 2008, RECENT PAT ANTI-CANC, V3, P114, DOI 10.2174/157489208784638785; Machado JP, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-342; Naya H, 2001, FEBS LETT, V501, P127, DOI 10.1016/S0014-5793(01)02644-8; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santos MA, 2011, HUM REPROD, V26, P1868, DOI 10.1093/humrep/der111; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Swpfford DL, 1999, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wolf JBW, 2009, GENOME BIOL EVOL, V1, P308, DOI 10.1093/gbe/evp030; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yan XM, 2005, GENES CELLS, V10, P617, DOI 10.1111/j.1365-2443.2005.00863.x; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	42	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75763	10.1371/journal.pone.0075763	http://dx.doi.org/10.1371/journal.pone.0075763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086628	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200061
J	Xue, Y; Shen, L; Cui, Y; Zhang, HB; Chen, Q; Cui, AF; Fang, FD; Chang, YS				Xue, Yuan; Shen, Lian; Cui, Ying; Zhang, Huabing; Chen, Qi; Cui, Anfang; Fang, Fude; Chang, Yongsheng			Tff3, as a Novel Peptide, Regulates Hepatic Glucose Metabolism	PLOS ONE			English	Article							INTESTINAL TREFOIL FACTOR; GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; GAMMA COACTIVATOR-1-ALPHA; INSULIN-RESISTANCE; GLUCONEOGENESIS; RECEPTOR; CELLS; PGC-1; IDENTIFICATION	Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder strongly associated with hepatic glucose intolerance and insulin resistance. The trefoil peptides are a family of small regulatory proteins and Tff3 is widely expressed in multiple tissues including liver. But the roles of Tff3 in regulation of glucose metabolism and insulin sensitivity in liver remain unclear. Here we show that the hepatic Tff3 expression levels were decreased in ob/ob and high-fat diet-induced obese mice. Overexpression of Tff3 in primary mouse hepatocytes inhibited the expression of gluconeogenic genes, including G6pc, PEPCK and PGC-1 alpha, subsequently decreasing cellular glucose output. GTT and ITT experiments revealed that adenovirus-mediated overexpression of Tff3 in diabetic or obese mice improved glucose tolerance and insulin sensitivity. Collectively, our results indicated that Tff3 peptides are involved in glucose homeostasis and insulin sensitivity, providing a promising peptide on new therapies against the metabolic disorders associated with T2DM.	[Xue, Yuan; Shen, Lian; Cui, Ying; Zhang, Huabing; Chen, Qi; Cui, Anfang; Fang, Fude; Chang, Yongsheng] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Xue, Yuan; Shen, Lian; Cui, Ying; Zhang, Huabing; Chen, Qi; Cui, Anfang; Fang, Fude; Chang, Yongsheng] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Fang, FD (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	fangfd@vip.sina.com; changy@ibms.pumc.edu.cn		zhang, huabing/0000-0001-8402-7830	National Natural Science Foundation of China [81170763]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81170763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera Roa GJ, 2013, J HEALTH SCI, V3, P1, DOI DOI 10.17532/JHSCI.2013.26; Fernandez-Estivariz C, 2003, AM J PHYSIOL-REG I, V284, pR564, DOI 10.1152/ajpregu.00428.2002; Fueger PT, 2008, MOL ENDOCRINOL, V22, P1251, DOI 10.1210/me.2007-0500; Guillen N, 2009, PHYSIOL GENOMICS, V37, P187, DOI 10.1152/physiolgenomics.90339.2008; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HAUSER F, 1993, P NATL ACAD SCI USA, V90, P6961, DOI 10.1073/pnas.90.15.6961; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Higginbotham JN, 2002, HUM GENE THER, V13, P129, DOI 10.1089/10430340152712683; KHAN A, 1995, ENDOCRINOLOGY, V136, P1934, DOI 10.1210/en.136.5.1934; Kinoshita K, 2000, MOL CELL BIOL, V20, P4680, DOI 10.1128/MCB.20.13.4680-4690.2000; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Ludeking A, 1998, FEBS LETT, V439, P180, DOI 10.1016/S0014-5793(98)01368-4; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Ogata H, 1997, AM J PHYSIOL-GASTR L, V273, pG348, DOI 10.1152/ajpgi.1997.273.2.G348; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; SUEMORI S, 1991, P NATL ACAD SCI USA, V88, P11017, DOI 10.1073/pnas.88.24.11017; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taupin D, 1999, J CLIN INVEST, V103, pR31, DOI 10.1172/JCI3304; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Thim L, 2005, CELL MOL LIFE SCI, V62, P2956, DOI 10.1007/s00018-005-5484-6; Thim L, 1997, CELL MOL LIFE SCI, V53, P888, DOI 10.1007/s000180050108; THIM L, 1995, BIOCHEMISTRY-US, V34, P4757, DOI 10.1021/bi00014a033; Tran CP, 1998, AM J PHYSIOL-GASTR L, V275, pG85, DOI 10.1152/ajpgi.1998.275.1.G85; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wiernsperger NF, 1999, DRUGS, V58, P31, DOI 10.2165/00003495-199958001-00009; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026; Zsengeller Z, 2000, J VIROL, V74, P9655, DOI 10.1128/JVI.74.20.9655-9667.2000	41	19	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75240	10.1371/journal.pone.0075240	http://dx.doi.org/10.1371/journal.pone.0075240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086476	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200092
J	Kim, YR; Kim, IJ; Kang, TW; Choi, C; Kim, KK; Kim, MS; Nam, KI; Jung, C				Kim, Y-R; Kim, I-J; Kang, T. W.; Choi, C.; Kim, K. K.; Kim, M. S.; Nam, K. I.; Jung, C.			HOXB13 downregulates intracellular zinc and increases NF-kappa B signaling to promote prostate cancer metastasis	ONCOGENE			English	Article						HOXB13; metastasis; prostate cancer; zinc; ZnT4	ANDROGEN RECEPTOR GENE; UPTAKE TRANSPORTER; IN-VITRO; EXPRESSION; CELLS; ACTIVATION; SUPPRESSION; ADENOCARCINOMA; PROGRESSION; GROWTH	Characteristically, prostate cancer (PCa) cells exhibit marked decrease in intracellular zinc; however, the mechanism responsible is not clearly understood. HOXB13 is involved in PCa progression and is overexpressed in castration-resistant PCa. DNA microarray analysis of LNCaP Pca cells showed that ZnT zinc output transporters were strikingly upregulated among androgen-independent HOXB13 target genes. Furthermore, exogenous HOXB13 caused intracellular zinc concentrations to fall in PCa cells, stimulated NF-kappa B-mediated signaling by reducing inhibitor of NF-kappa B alpha (I kappa B alpha) and enhanced the nuclear translocation of RelA/p65. Human prostate tumors also exhibited strong inverse correlation between the protein expressions of HOXB13 and I kappa B alpha. Consequently, HOXB13 stimulated PCa cell invasion, and this was inhibited by the suppression of ZnT4. In addition, studies in a PC3 orthotopic mouse model of PCa metastasis showed that HOXB13 is a strong metastatic stimulator. Taken together, these results show that HOXB13 promotes PCa invasion and metastasis by decreasing intracellular zinc levels, thus stimulating NF-kappa B signals, and suggest that HOXB13 acts as a modulator of intracellular zinc levels that promotes the malignant characteristics of PCa.	[Kim, Y-R; Kim, I-J; Nam, K. I.; Jung, C.] Chonnam Natl Univ, Sch Med, Dept Anat, Kwangju 501190, South Korea; [Kang, T. W.] Chonnam Natl Univ, Sch Med, Dept Urol, Kwangju 501190, South Korea; [Choi, C.] Chonnam Natl Univ, Sch Med, Dept Pathol, Kwangju 501190, South Korea; [Kim, K. K.] Chonnam Natl Univ, Sch Med, Dept Pharmacol, Kwangju 501190, South Korea; [Kim, M. S.] Chonnam Natl Univ, Coll Nat Sci, Dept Stat, Kwangju 501190, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University	Jung, C (corresponding author), Chonnam Natl Univ, Sch Med, Dept Anat, 5 Hak Dong, Kwangju 501190, South Korea.	chjung@chonnam.ac.kr	Jung, Chaeyong/AAD-8357-2021; Nam, Kwang Il/C-4580-2019	Jung, Chaeyong/0000-0002-5557-4576; Nam, Kwang Il/0000-0001-5380-6815	Korea Science and Engineering Foundation through the Medical Research Center for Gene Regulation [2012-0009445]; Basic Science Research Program of the National Research Foundation of Korea (NRF) grant - Korea Government [2010-0003838]; Chonnam National University Research Institute of Medical Sciences [2010-CURIMS-DR011]	Korea Science and Engineering Foundation through the Medical Research Center for Gene Regulation(Korea Science and Engineering Foundation); Basic Science Research Program of the National Research Foundation of Korea (NRF) grant - Korea Government; Chonnam National University Research Institute of Medical Sciences	This work was supported by the Korea Science and Engineering Foundation through the Medical Research Center for Gene Regulation (2012-0009445), by the Basic Science Research Program of the National Research Foundation of Korea (NRF) grant funded by the Korea Government (2010-0003838), and by a grant from the Chonnam National University Research Institute of Medical Sciences ((2010-CURIMS-DR011).	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Beck FWJ, 2004, PROSTATE, V58, P374, DOI 10.1002/pros.10344; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen CD, 2002, MOL CELL BIOL, V22, P2862, DOI 10.1128/MCB.22.8.2862-2870.2002; Costello LC, 1999, J BIOL CHEM, V274, P17499, DOI 10.1074/jbc.274.25.17499; Costello LC, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-17; Economides KD, 2003, DEVELOPMENT, V130, P2061, DOI 10.1242/dev.00432; Edwards J, 2003, BRIT J CANCER, V89, P552, DOI 10.1038/sj.bjc.6601127; Franklin RB, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-32; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Golovine K, 2008, CLIN CANCER RES, V14, P5376, DOI 10.1158/1078-0432.CCR-08-0455; Golovine K, 2008, PROSTATE, V68, P1443, DOI 10.1002/pros.20810; Henshall SM, 2003, ONCOGENE, V22, P6005, DOI 10.1038/sj.onc.1206797; Ho LH, 2004, J IMMUNOL, V172, P7750, DOI 10.4049/jimmunol.172.12.7750; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Jeon KI, 2000, J IMMUNOL, V164, P5981, DOI 10.4049/jimmunol.164.11.5981; Jung C, 2005, BRIT J CANCER, V92, P2233, DOI 10.1038/sj.bjc.6602631; Jung C, 2004, CANCER RES, V64, P9185, DOI 10.1158/0008-5472.CAN-04-1330; Jung CY, 2001, GENE, V271, P143, DOI 10.1016/S0378-1119(01)00513-3; Kim SD, 2010, ANAT CELL BIOL, V43, P284, DOI 10.5115/acb.2010.43.4.284; Kim YR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-124; Linja MJ, 2001, CANCER RES, V61, P3550; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; McMahon RJ, 1998, J NUTR, V128, P667, DOI 10.1093/jn/128.4.667; Michalczyk AA, 2002, BIOCHEM J, V364, P105, DOI 10.1042/bj3640105; Muenchen HJ, 2000, CLIN CANCER RES, V6, P1969; Murgia C, 1999, AM J PHYSIOL-GASTR L, V277, pG1231, DOI 10.1152/ajpgi.1999.277.6.G1231; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Rosoff B, 1981, Prog Clin Biol Res, V75A, P447; Salsi V, 2006, J BIOL CHEM, V281, P1992, DOI 10.1074/jbc.M510900200; Shaut CA, 2007, DEV DYNAM, V236, P951, DOI 10.1002/dvdy.21077; Shukla S, 2004, NEOPLASIA, V6, P390, DOI 10.1593/neo.04112; Shukla S, 2004, CLIN CANCER RES, V10, P3169, DOI 10.1158/1078-0432.CCR-03-0586; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sreenath T, 1999, PROSTATE, V41, P203, DOI 10.1002/(SICI)1097-0045(19991101)41:3<203::AID-PROS8>3.0.CO;2-J; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Suh JH, 2002, PROSTATE, V52, P183, DOI 10.1002/pros.10082; Sweeney C, 2004, CLIN CANCER RES, V10, P5501, DOI 10.1158/1078-0432.CCR-0571-03; Tricoli JV, 1996, GENE CHROMOSOME CANC, V15, P108, DOI 10.1002/(SICI)1098-2264(199602)15:2<108::AID-GCC5>3.0.CO;2-7; Uzzo RG, 2002, CLIN CANCER RES, V8, P3579; Uzzo RG, 2006, CARCINOGENESIS, V27, P1980, DOI 10.1093/carcin/bgl034; Yamashita A, 1996, PROSTATE, V29, P1; Zaichick V. Ye., 1997, International Urology and Nephrology, V29, P565, DOI 10.1007/BF02552202; Zhang LY, 2009, AM J PATHOL, V175, P489, DOI 10.2353/ajpath.2009.080727; Zou J, 2011, PROSTATE, V71, P1518, DOI 10.1002/pros.21368	46	46	50	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 11	2014	33	37					4558	4567		10.1038/onc.2013.404	http://dx.doi.org/10.1038/onc.2013.404			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AP3UZ	24096478				2022-12-25	WOS:000342004800003
J	Wu, DW; Wu, TC; Wu, JY; Cheng, YW; Chen, YC; Lee, MC; Chen, CY; Lee, H				Wu, D-W; Wu, T-C; Wu, J-Y; Cheng, Y-W; Chen, Y-C; Lee, M-C; Chen, C-Y; Lee, H.			Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression	ONCOGENE			English	Article						PXN; Bcl-2; cisplatin-based chemotherapy; NSCLC	OVARIAN-CANCER; REGULATES ADHESION; PREDICTS SURVIVAL; GROWTH; INVASION; PROLIFERATION; SENSITIVITY; CARCINOMA; APOPTOSIS; RELAPSE	Paxillin (PXN) is required for receptor tyrosine kinase-mediated ERK activation, and the activation of the Raf/MEK/ERK cascade has been linked with Bcl-2 expression. We hypothesized that phosphorylation of PXN by the EGFR/Src pathway might contribute to cisplatin resistance via increased Bcl-2 expression. We show that cisplatin resistance was dependent on PXN expression, as evidenced by PXN overexpression in TL-13 and TL-10 cells and PXN knockdown in H23 and CL1-5 cells. Specific inhibitors of signaling pathways indicated that the phosphorylation of PXN at Y118 and Y31 via the Src pathway was responsible for cisplatin resistance. We further demonstrated that ERK activation was also dependent on this PXN phosphorylation. Bcl-2 transcription was upregulated by phosphorylated PXN-mediated ERK activation via increased binding of phosphorylated CREB to the Bcl-2 promoter. A subsequent increase in Bcl-2 levels by a PXN/ERK axis was responsible for the resistance to cisplatin. Animal models further confirmed the findings of in vitro cells indicating that xenograft tumors induced by TL-13-overexpressing cells were successfully suppressed by cisplatin combined with Src or ERK inhibitor compared with treatment of cisplatin, Src inhibitor or ERK inhibitor alone. A positive correlation of phosphorylated PXN with phosphorylated ERK and Bcl-2 was observed in lung tumors from NSCLC patients. Patients with tumors positive for PXN, phosphorylated PXN, phosphorylated ERK and Bcl-2 more commonly showed a poorer response to cisplatin-based chemotherapy than did patients with negative tumors. Collectively, PXN phosphorylation might contribute to cisplatin resistance via activating ERK-mediated Bcl-2 transcription. Therefore, we suggest that Src or ERK inhibitor might be helpful to improve the sensitivity for cisplatin-based chemotherapy in NSCLC patients with PXN-positive tumors.	[Wu, D-W; Cheng, Y-W; Lee, H.] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Wu, T-C] Chung Shan Med Univ, Dept Internal Med, Taichung, Taiwan; [Wu, J-Y] Buddhist Tzu Chi Taichung Gen Hosp, Div Thorac Surg, Taichung, Taiwan; [Wu, J-Y] Tzu Chi Univ, Coll Med, Hualien, Taiwan; [Chen, Y-C] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taichung, Taiwan; [Lee, M-C] Taichung Vet Gen Hosp, Dept Thorac Surg, Taichung, Taiwan; [Chen, C-Y] China Med Univ Hosp, Dept Surg, Taichung, Taiwan	Taipei Medical University; Chung Shan Medical University; Buddhist Tzu Chi General Hospital; Tzu Chi University; Taipei Medical University; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lee, H (corresponding author), Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Room 5,12F,3,Pk St, Taipei, Taiwan.	hl@tmu.edu.tw			National Health Research Institute [NHRI96-TD-G-111-006, NHRI97-TD-G-111-006]; National Science Council of Taiwan, ROC [NSC-100-2314-B-038-043-MY3]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was jointly supported by grants from the National Health Research Institute (NHRI96-TD-G-111-006; NHRI97-TD-G-111-006) and the National Science Council (NSC-100-2314-B-038-043-MY3) of Taiwan, ROC.	Aponte M, 2008, CANCER RES, V68, P5839, DOI 10.1158/0008-5472.CAN-07-5771; Arany I, 2005, KIDNEY INT, V68, P1573, DOI 10.1111/j.1523-1755.2005.00569.x; Bai LF, 2012, INT J CANCER, V130, P2693, DOI 10.1002/ijc.26303; Bendardaf R, 2008, ONCOL REP, V20, P999, DOI 10.3892/or_00000101; Bertotti A, 2010, CLIN CANCER RES, V16, P3933, DOI 10.1158/1078-0432.CCR-10-0106; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Bray K, 2009, MOL CANCER RES, V7, P1487, DOI 10.1158/1541-7786.MCR-09-0166; Creson TK, 2009, J MOL NEUROSCI, V37, P123, DOI 10.1007/s12031-008-9122-2; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Hiscox S, 2006, BREAST CANCER RES TR, V97, P263, DOI 10.1007/s10549-005-9120-9; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Lee JH, 2013, MOL CELL, V49, P668, DOI 10.1016/j.molcel.2012.12.004; Li J, 2008, CANCER CHEMOTH PHARM, V61, P525, DOI 10.1007/s00280-007-0499-3; Low SY, 2012, CANCER LETT, V314, P166, DOI 10.1016/j.canlet.2011.09.025; Mano Y, 1999, EUR J CANCER, V35, P1214, DOI 10.1016/S0959-8049(99)00124-0; Meller R, 2005, J CEREBR BLOOD F MET, V25, P234, DOI 10.1038/sj.jcbfm.9600024; Miyake H, 1998, ONCOGENE, V16, P933, DOI 10.1038/sj.onc.1201602; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Sachdev S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-12; Sakata H, 1996, CELL GROWTH DIFFER, V7, P1513; Sen A, 2012, J CLIN INVEST, V122, P2469, DOI 10.1172/JCI62044; Sen A, 2010, J BIOL CHEM, V285, P28787, DOI 10.1074/jbc.M110.134064; Sheibani N, 2008, J CELL PHYSIOL, V214, P655, DOI 10.1002/jcp.21256; Shintani Y, 2011, ANN THORAC SURG, V92, P1794, DOI 10.1016/j.athoracsur.2011.07.032; Sorenson CM, 2004, J BIOL CHEM, V279, P11368, DOI 10.1074/jbc.M310079200; Subramanian M, 2007, J IMMUNOL, V179, P2330, DOI 10.4049/jimmunol.179.4.2330; Sung WW, 2011, CLIN CANCER RES, V17, P5991, DOI 10.1158/1078-0432.CCR-11-0227; Tabassam FH, 2011, AM J PHYSIOL-GASTR L, V301, pG601, DOI 10.1152/ajpgi.00375.2010; Turner CE, 2000, J CELL SCI, V113, P4139; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wu DW, 2014, ONCOGENE, V33, P1515, DOI 10.1038/onc.2013.107; Wu DW, 2012, AM J PATHOL, V181, P1796, DOI 10.1016/j.ajpath.2012.07.032; Wu DW, 2011, CLIN CANCER RES, V17, P1895, DOI 10.1158/1078-0432.CCR-10-2316; Wu DW, 2010, CANCER RES, V70, P10392, DOI 10.1158/0008-5472.CAN-10-2341; Yang TM, 2009, AM J RESP CELL MOL, V41, P14, DOI 10.1165/rcmb.2008-0320OC; Yoon H, 2011, BIOCHEM BIOPH RES CO, V405, P333, DOI 10.1016/j.bbrc.2010.11.130; Zhuo WL, 2008, BIOCHEM BIOPH RES CO, V369, P1098, DOI 10.1016/j.bbrc.2008.02.143; Zou W, 2012, J BONE MINER RES, V27, P2490, DOI 10.1002/jbmr.1706	43	51	52	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 28	2014	33	35					4385	4395		10.1038/onc.2013.389	http://dx.doi.org/10.1038/onc.2013.389			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MR	24096476	Bronze			2022-12-25	WOS:000341157800003
J	Ridlon, L; Skodova, I; Pan, SQ; Lukes, J; Maslov, DA				Ridlon, Lucie; Skodova, Ingrid; Pan, Songqin; Lukes, Julius; Maslov, Dmitri A.			The Importance of the 45 S Ribosomal Small Subunit-related Complex for Mitochondrial Translation in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Protein Synthesis; Ribonuclear Protein (RNP); Trypanosoma brucei; Trypanosome; Leish	PENTATRICOPEPTIDE REPEAT PROTEINS; INDUCIBLE EXPRESSION SYSTEM; RNA INTERFERENCE; KINETOPLAST DNA; LEISHMANIA; IDENTIFICATION; MECHANISM	Background: Trypanosome mitochondria contain a 45 S ribosomal SSU-related complex with no precedence in other systems. Results: A selective ablation of the 45 S complex was associated with synthesis inhibition of some mitochondrial polypeptides. Conclusion: The 45 S complex is a factor required for mitochondrial translation that may have selective effects on different mRNAs. Significance: The mechanisms of mitochondrial translation in trypanosomes have no counterparts in other eukaryotes. The mitochondrial 45 S SSU* complex in Trypanosoma brucei contains the 9 S SSU ribosomal RNA, a set of SSU ribosomal proteins, several pentatricopeptide repeat (PPR) proteins, and proteins not typically found in ribosomes, including rhodanese domain protein (Rhod) and a 200-kDa coiled-coil protein. To investigate the function of this complex, PPR29, Rhod, 200-kDa protein, and mitochondrial ribosomal protein S17 were knocked down by RNAi in procyclic T. brucei. A growth retardation phenotype, a reduction in the amount of the 45 S SSU* complexes, and the preferential inhibition of synthesis of the cytochrome c oxidase subunit I over apocytochrome b were observed as early as day 2 postinduction of RNAi. On the contrary, the down-regulation of mitochondrial ribosomal protein L3 drastically reduced the amount of the large subunit and indiscriminately inhibited mitochondrial translation. The relative amounts of translation-competent, long poly(AU)-tailed cytochrome c oxidase subunit I and edited apocytochrome b mRNAs were selectively reduced by ablation of the 45 S SSU* complex. The formation of the 80 S translation complexes, identified by association of the long-tailed mRNAs with the mitoribosomes, was also disrupted. On the other hand, the relative amount of long-tailed edited RPS12 mRNA was not substantially affected, and there was no noticeable effect on the RPS12 translation complexes. In bloodstream trypanosomes, the amount of the 45 S complexes was drastically reduced compared with procyclics. We propose that the 45 S SSU* complex represents a factor required for normal mitochondrial translation that may have selective effects on different mRNAs.	[Ridlon, Lucie; Skodova, Ingrid; Maslov, Dmitri A.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Ridlon, Lucie; Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Budweis, Czech Republic; [Skodova, Ingrid] Comenius Univ, Fac Nat Sci, Bratislava 84215, Slovakia; [Pan, Songqin] Univ Calif Riverside, WM Keck Prote Lab, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Lukes, Julius] Ctr Biol, Inst Parasitol, Ceske Budejovice 37005, Budweis, Czech Republic	University of California System; University of California Riverside; University of South Bohemia Ceske Budejovice; Comenius University Bratislava; University of California System; University of California Riverside; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Maslov, DA (corresponding author), Univ Calif Riverside, Dept Biol, 900 Univ Ave, Riverside, CA 92531 USA.	maslov@ucr.edu	Lukes, Julius/H-6760-2012; Sveráková, Ingrid/AAE-2756-2019	Lukes, Julius/0000-0002-0578-6618; Sveráková, Ingrid/0000-0002-4004-3377	National Institutes of Health [AI088292]; Grant Agency of the Czech Republic [P305/11/2179]; Ministry of Education of the Czech Republic [AMVIS LH12104]; Praemium Academiae award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Praemium Academiae award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI088292 (to D. M.). This work was also supported by Grant Agency of the Czech Republic Grant P305/11/2179, Ministry of Education of the Czech Republic Grant AMVIS LH12104, and the Praemium Academiae award (to J. L.).	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Alfonzo JD, 1997, NUCLEIC ACIDS RES, V25, P3751, DOI 10.1093/nar/25.19.3751; Alfonzo JD, 2009, BIOL CHEM, V390, P717, DOI 10.1515/BC.2009.101; Ammerman ML, 2012, NUCLEIC ACIDS RES, V40, P5637, DOI 10.1093/nar/gks211; Aphasizhev R, 2011, WIRES RNA, V2, P669, DOI 10.1002/wrna.82; Aphasizhev R, 2011, RES MICROBIOL, V162, P655, DOI 10.1016/j.resmic.2011.04.015; Aphasizheva I, 2011, MOL CELL, V42, P106, DOI 10.1016/j.molcel.2011.02.021; BENNE R, 1994, EUR J BIOCHEM, V221, P9, DOI 10.1111/j.1432-1033.1994.tb18710.x; BORST P, 1979, PLASMID, V2, P20, DOI 10.1016/0147-619X(79)90003-9; BRALY P, 1974, J PROTOZOOL, V21, P782, DOI 10.1111/j.1550-7408.1974.tb03752.x; BRUN R, 1979, ACTA TROP, V36, P289; CHEN JH, 1995, CELL, V80, P61, DOI 10.1016/0092-8674(95)90451-4; Christian BE, 2012, BBA-GENE REGUL MECH, V1819, P1035, DOI 10.1016/j.bbagrm.2011.11.009; Etheridge RD, 2008, EMBO J, V27, P1596, DOI 10.1038/emboj.2008.87; Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267; HAJDUK SL, 1993, FASEB J, V7, P54, DOI 10.1096/fasebj.7.1.8422975; Hannaert Veronique, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated; Hashimi H, 2013, TRENDS PARASITOL, V29, P91, DOI 10.1016/j.pt.2012.11.005; Herrmann JM, 2013, BBA-MOL CELL RES, V1833, P286, DOI 10.1016/j.bbamcr.2012.03.007; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Horvath A, 2002, J BIOL CHEM, V277, P7222, DOI 10.1074/jbc.M109715200; Kable ML, 1997, TRENDS BIOCHEM SCI, V22, P162, DOI 10.1016/S0968-0004(97)01041-4; Kolev NG, 2011, EUKARYOT CELL, V10, P1156, DOI 10.1128/EC.05114-11; Koslowsky Donna J, 2004, Methods Mol Biol, V265, P161; Koslowsky DJ, 2009, TRENDS PARASITOL, V25, P252, DOI 10.1016/j.pt.2009.03.008; Lipinski KA, 2011, MOL BIOL EVOL, V28, P2935, DOI 10.1093/molbev/msr120; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Lye LF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001161; Maslov D. A., 2013, TRANSLATION MITOCHON, P133; Maslov DA, 2007, MOL BIOCHEM PARASIT, V152, P203, DOI 10.1016/j.molbiopara.2007.01.012; Maslov DA, 2006, MOL BIOCHEM PARASIT, V148, P69, DOI 10.1016/j.molbiopara.2006.02.021; Maslov Dmitri A., 2012, P215; Maslov DA, 2013, TRENDS PARASITOL, V29, P43, DOI 10.1016/j.pt.2012.11.001; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Mingler MK, 2006, MOL BIOCHEM PARASIT, V150, P37, DOI 10.1016/j.molbiopara.2006.06.006; Nebohacova M, 2004, J BIOL CHEM, V279, P7819, DOI 10.1074/jbc.M311360200; Pusnik M, 2007, MOL CELL BIOL, V27, P6876, DOI 10.1128/MCB.00708-07; Pusnik M, 2012, EUKARYOT CELL, V11, P79, DOI 10.1128/EC.05213-11; Rackham O, 2012, BBA-GENE REGUL MECH, V1819, P1008, DOI 10.1016/j.bbagrm.2011.10.007; Sambrook J, 2001, MOL CLONING LAB MANU; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Sharma MR, 2009, P NATL ACAD SCI USA, V106, P9637, DOI 10.1073/pnas.0901631106; SIMPSON L, 1986, INT REV CYTOL, V99, P119; SIMPSON L, 1995, CELL, V81, P837, DOI 10.1016/0092-8674(95)90003-9; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Simpson L, 1993, RNA EDITING ALTERATI, P53; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Vickerman K., 1976, P35; Vickerman K., 1976, P1; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zikova A, 2008, MOL CELL PROTEOMICS, V7, P1286, DOI 10.1074/mcp.M700490-MCP200	55	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32963	32978		10.1074/jbc.M113.501874	http://dx.doi.org/10.1074/jbc.M113.501874			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089529	Green Published, hybrid			2022-12-25	WOS:000328841700014
J	Hales, PW; Phipps, KP; Kaur, R; Clark, CA				Hales, Patrick W.; Phipps, Kim P.; Kaur, Ramneek; Clark, Christopher A.			A Two-Stage Model for In Vivo Assessment of Brain Tumor Perfusion and Abnormal Vascular Structure Using Arterial Spin Labeling	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ROUTINE CLINICAL-PRACTICE; IMAGING TECHNIQUES; VESSEL TORTUOSITY; VOLUME; MRI; PERMEABILITY; WATER; QUANTIFICATION; INVERSION	The ability to assess brain tumor perfusion and abnormalities in the vascular structure in vivo could provide significant benefits in terms of lesion diagnosis and assessment of treatment response. Arterial spin labeling (ASL) has emerged as an increasingly viable methodology for non-invasive assessment of perfusion. Although kinetic models have been developed to describe perfusion in healthy tissue, the dynamic behaviour of the ASL signal in the brain tumor environment has not been extensively studied. We show here that dynamic ASL data acquired in brain tumors displays an increased level of 'biphasic' behaviour, compared to that seen in healthy tissue. A new two-stage model is presented which more accurately describes this behaviour, and provides measurements of perfusion, pre-capillary blood volume fraction and transit time, and capillary bolus arrival time. These biomarkers offer a novel contrast in the tumor and surrounding tissue, and provide a means for measuring tumor perfusion and vascular structural abnormalities in a fully non-invasive manner.	[Hales, Patrick W.; Kaur, Ramneek; Clark, Christopher A.] UCL, Inst Child Hlth, Imaging & Biophys Unit, London, England; [Phipps, Kim P.] Great Ormond St Hosp Sick Children, Dept Neurooncol, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Hales, PW (corresponding author), UCL, Inst Child Hlth, Imaging & Biophys Unit, London, England.	p.hales@ucl.ac.uk		Hales, Patrick/0000-0002-4269-0252	Cancer Research UK [C7809/A10342]; Cancer Research UK [10342] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK (http://www.cancerresearchuk.org/home/), Grant Number C7809/A10342. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broome DR, 2008, EUR J RADIOL, V66, P230, DOI 10.1016/j.ejrad.2008.02.011; Bullitt E, 2005, ACAD RADIOL, V12, P1232, DOI 10.1016/j.acra.2005.05.027; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Chappell MA, 2010, MAGN RESON MED, V63, P1357, DOI 10.1002/mrm.22320; Chappell MA, 2009, IEEE T SIGNAL PROCES, V57, P223, DOI 10.1109/TSP.2008.2005752; Chen TY, 2012, CLIN IMAG, V36, P345, DOI 10.1016/j.clinimag.2011.11.003; Deibler AR, 2008, AM J NEURORADIOL, V29, P1228, DOI 10.3174/ajnr.A1030; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Fidler IJ, 2002, LANCET ONCOL, V3, P53, DOI 10.1016/S1470-2045(01)00622-2; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Golay X, 2012, MAGN RESON MATER PHY, V25, P79, DOI 10.1007/s10334-012-0308-9; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; Hales PW, 2013, J CEREBR BLOOD F MET, V33, P67, DOI 10.1038/jcbfm.2012.125; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hendrikse J, 2008, RADIOLOGY, V246, P572, DOI 10.1148/radiol.2461062100; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778; Kim HS, 2007, AM J NEURORADIOL, V28, P1693, DOI 10.3174/ajnr.A0674; Knopp EA, 1999, RADIOLOGY, V211, P791, DOI 10.1148/radiology.211.3.r99jn46791; Kremer S, 2002, J NEURORADIOLOGY, V29, P105; Law M, 2004, AM J NEURORADIOL, V25, P746; Law M, 2004, MAGN RESON IMAGING, V22, P599, DOI 10.1016/j.mri.2004.01.031; Li CY, 2000, JNCI-J NATL CANCER I, V92, P143, DOI 10.1093/jnci/92.2.143; Li KL, 2005, MAGN RESON MED, V53, P511, DOI 10.1002/mrm.20390; MacIntosh BJ, 2008, J CEREBR BLOOD F MET, V28, P1514, DOI 10.1038/jcbfm.2008.46; MacIntosh BJ, 2010, MAGN RESON MED, V63, P641, DOI 10.1002/mrm.22256; Noguchi T, 2008, AM J NEURORADIOL, V29, P688, DOI 10.3174/ajnr.A0903; Parikh AH, 2004, TECHNOL CANCER RES T, V3, P585, DOI 10.1177/153303460400300608; Parkes LM, 2002, MAGN RESON MED, V48, P27, DOI 10.1002/mrm.10180; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Shin JH, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790783; St Lawrence KS, 2000, MAGN RESON MED, V44, P440, DOI 10.1002/1522-2594(200009)44:3<440::AID-MRM15>3.0.CO;2-6; Stewart G N, 1893, J Physiol, V15, P1; STILLER C, 2007, CHILDHOOD CANC BRIT; Warmuth C, 2003, RADIOLOGY, V228, P523, DOI 10.1148/radiol.2282020409; Wetzel SG, 2002, RADIOLOGY, V224, P797, DOI 10.1148/radiol.2243011014; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Ye FQ, 1997, MAGN RESON MED, V37, P226, DOI 10.1002/mrm.1910370215; Zhou JY, 2001, J CEREBR BLOOD F MET, V21, P440, DOI 10.1097/00004647-200104000-00013	41	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75717	10.1371/journal.pone.0075717	http://dx.doi.org/10.1371/journal.pone.0075717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098395	Green Published, Green Submitted, gold			2022-12-25	WOS:000325434500037
J	Ogiso-Tanaka, E; Matsubara, K; Yamamoto, S; Nonoue, Y; Wu, JZ; Fujisawa, H; Ishikubo, H; Tanaka, T; Ando, T; Matsumoto, T; Yano, M				Ogiso-Tanaka, Eri; Matsubara, Kazuki; Yamamoto, Shin-ichi; Nonoue, Yasunori; Wu, Jianzhong; Fujisawa, Hiroko; Ishikubo, Harumi; Tanaka, Tsuyoshi; Ando, Tsuyu; Matsumoto, Takashi; Yano, Masahiro			Natural Variation of the RICE FLOWERING LOCUS T 1 Contributes to Flowering Time Divergence in Rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; CONTROLLING HEADING DATE; PHOTOPERIOD SENSITIVITY; GENE; FT; HD3A; ARABIDOPSIS; PROTEIN; HD1; DIVERSIFICATION	In rice (Oryza sativa L.), there is a diversity in flowering time that is strictly genetically regulated. Some indica cultivars show extremely late flowering under long-day conditions, but little is known about the gene(s) involved. Here, we demonstrate that functional defects in the florigen gene RFT1 are the main cause of late flowering in an indica cultivar, Nona Bokra. Mapping and complementation studies revealed that sequence polymorphisms in the RFT1 regulatory and coding regions are likely to cause late flowering under long-day conditions. We detected polymorphisms in the promoter region that lead to reduced expression levels of RFT1. We also identified an amino acid substitution (E105K) that leads to a functional defect in Nona Bokra RFT1. Sequencing of the RFT1 region in rice accessions from a global collection showed that the E105K mutation is found only in indica, and indicated a strong association between the RFT1 haplotype and extremely late flowering in a functional Hd1 background. Furthermore, SNPs in the regulatory region of RFT1 and the E105K substitution in 1,397 accessions show strong linkage disequilibrium with a flowering time-associated SNP. Although the defective E105K allele of RFT1 (but not of another florigen gene, Hd3a) is found in many cultivars, relative rate tests revealed no evidence for differential rate of evolution of these genes. The ratios of nonsynonymous to synonymous substitutions suggest that the E105K mutation resulting in the defect in RFT1 occurred relatively recently. These findings indicate that natural mutations in RFT1 provide flowering time divergence under long-day conditions.	[Ogiso-Tanaka, Eri; Matsubara, Kazuki; Yamamoto, Shin-ichi; Nonoue, Yasunori; Wu, Jianzhong; Fujisawa, Hiroko; Ishikubo, Harumi; Tanaka, Tsuyoshi; Ando, Tsuyu; Matsumoto, Takashi; Yano, Masahiro] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Kannondai Tsukuba, Ibaraki, Japan		Yano, M (corresponding author), Natl Inst Agrobiol Sci, Agrogen Res Ctr, Kannondai Tsukuba, Ibaraki, Japan.	myano@affrc.go.jp	Matsubara, Kazuki/S-9378-2019; Ogiso-Tanaka, Eri/GWR-3103-2022; Yano, Masahiro/AAC-5441-2019; Ogiso-Tanaka, Eri/P-3518-2019	Matsubara, Kazuki/0000-0002-2084-8362; Ogiso-Tanaka, Eri/0000-0002-7655-3408; Wu, Jianzhong/0000-0002-4033-852X	Ministry of Agriculture, Forestry and Fishery [IP1001]; Genomics for Agricultural Innovation [GPN0001, QTL5003]	Ministry of Agriculture, Forestry and Fishery; Genomics for Agricultural Innovation	This work was supported by the Ministry of Agriculture, Forestry and Fishery (Integrated Research Project for Plant, Insect, and Animal using Genome Technology, IP1001); and Genomics for Agricultural Innovation (GPN0001 and QTL5003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Best R., 1959, Field Crop Abstracts, V12, P85; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Bonnin I, 2008, THEOR APPL GENET, V116, P383, DOI 10.1007/s00122-007-0676-0; Catalan P, 1997, MOL PHYLOGENET EVOL, V8, P150, DOI 10.1006/mpev.1997.0416; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Coustham V, 2012, SCIENCE, V337, P584, DOI 10.1126/science.1221881; Dai XD, 2012, J INTEGR PLANT BIOL, V54, P790, DOI 10.1111/j.1744-7909.2012.01166.x; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Dung LV, 1998, THEOR APPL GENET, V97, P714, DOI 10.1007/s001220050947; Duvick J, 2008, NUCLEIC ACIDS RES, V36, pD959, DOI 10.1093/nar/gkm1041; Ebana K, 2011, THEOR APPL GENET, V122, P1199, DOI 10.1007/s00122-010-1524-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fujino K, 2013, THEOR APPL GENET, V126, P611, DOI 10.1007/s00122-012-2005-5; Fujino K, 2010, MOL GENET GENOMICS, V284, P137, DOI 10.1007/s00438-010-0555-2; Fuse T., 2001, PLANT BIOTECHNOL, V18, P219, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.18.219; Garner WW, 1919, J AGRIC RES, V18, P0553; Hagiwara WE, 2009, MOL ECOL, V18, P1537, DOI 10.1111/j.1365-294X.2009.04119.x; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Holden J., 1993, GENES CROPS ENV; Hori K, 2013, PLANT J, V76, P36, DOI 10.1111/tpj.12268; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Inoue H, 1998, BREEDING SCI, V48, P103; Ishikawa R, 2011, MOL GENET GENOMICS, V285, P461, DOI 10.1007/s00438-011-0621-4; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Izawa T, 2007, J EXP BOT, V58, P3091, DOI 10.1093/jxb/erm159; Jing L, 2011, POLYMORPHISM ANAL RI; Karlgren A, 2011, PLANT PHYSIOL, V156, P1967, DOI 10.1104/pp.111.176206; Kikuchi R, 2009, PLANT PHYSIOL, V149, P1341, DOI 10.1104/pp.108.132134; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Lu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034021; Matsubara K, 2008, THEOR APPL GENET, V117, P935, DOI 10.1007/s00122-008-0833-0; Matsubara K, 2012, PLANT CELL PHYSIOL, V53, P709, DOI 10.1093/pcp/pcs028; Minobe Y, 2004, Japan Patent Kokai, Patent No. [2004-003122 (2004-09-23), 2004003122]; Monna L, 2002, THEOR APPL GENET, V104, P772, DOI 10.1007/s00122-001-0813-0; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nonoue Y, 2008, THEOR APPL GENET, V116, P715, DOI 10.1007/s00122-007-0704-0; Ogiso E, 2010, PLANT PHYSIOL, V152, P808, DOI 10.1104/pp.109.148908; OKUMOTO Y, 1991, JPN J BREED, V41, P135; Okumoto Y, 2000, BREED RES, V2, P2000; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Saito H, 2012, PLANT CELL PHYSIOL, V53, P717, DOI 10.1093/pcp/pcs029; Saito H, 2009, THEOR APPL GENET, V119, P315, DOI 10.1007/s00122-009-1040-3; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; SANO Y, 1992, JPN J BREED, V42, P561; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1206, DOI 10.1093/nar/gks1125; Schwartz C, 2009, GENETICS, V183, P723, DOI 10.1534/genetics.109.104984; Seshu D. V., 1976, International Rice Research Newsletter, P5; Sobrizal P.L. Sanchez, 2000, RICE GENET NEWSLETT, V17, P46; Subedi M, 2013, RES DEV, V22, P54; Sun CH, 2012, PLANT CELL, V24, P3235, DOI 10.1105/tpc.112.101436; TAJIMA F, 1993, GENETICS, V135, P599; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Takahashi Y, 2011, GENES GENET SYST, V86, P175, DOI 10.1266/ggs.86.175; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Takai T, 2007, BREEDING SCI, V57, P257, DOI 10.1270/jsbbs.57.257; Takeuchi Y, 2006, BREEDING SCI, V56, P405, DOI 10.1270/jsbbs.56.405; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; The International Rice Research Institute, 1985, FLOW RESP RIC PLANT; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Uga Y, 2007, THEOR APPL GENET, V114, P1457, DOI 10.1007/s00122-007-0534-0; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Yano M, 2001, PLANT PHYSIOL, V127, P1425, DOI 10.1104/pp.010710; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yokoo M., 1980, B NATL I AGR SCI D, V31, P95	82	69	75	5	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75959	10.1371/journal.pone.0075959	http://dx.doi.org/10.1371/journal.pone.0075959			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098411	Green Published, gold, Green Submitted			2022-12-25	WOS:000325427100029
J	Rodrigues, TB; Ceballos, A; Grijota-Martinez, C; Nunez, B; Refetoff, S; Cerdan, S; Morte, B; Bernal, J				Rodrigues, Tiago B.; Ceballos, Ainhoa; Grijota-Martinez, Carmen; Nunez, Barbara; Refetoff, Samuel; Cerdan, Sebastian; Morte, Beatriz; Bernal, Juan			Increased Oxidative Metabolism and Neurotransmitter Cycling in the Brain of Mice Lacking the Thyroid Hormone Transporter Slc16a2 (Mct8)	PLOS ONE			English	Article							C6 GLIOMA-CELLS; MONOCARBOXYLATE TRANSPORTER-8; CEREBRAL METABOLISM; CLINICAL PHENOTYPE; GENE-EXPRESSION; DEFICIENCY; MUTATIONS; C-13; HYPOTHYROIDISM; LACTATE	Mutations of the monocarboxylate transporter 8 (MCT8) cause a severe X-linked intellectual deficit and neurological impairment. MCT8 is a specific thyroid hormone (T-4 and T-3) transporter and the patients also present unusual abnormalities in the serum profile of thyroid hormone concentrations due to altered secretion and metabolism of T-4 and T-3. Given the role of thyroid hormones in brain development, it is thought that the neurological impairment is due to restricted transport of thyroid hormones to the target neurons. In this work we have investigated cerebral metabolism in mice with Mct8 deficiency. Adult male mice were infused for 30 minutes with (1-C-13) glucose and brain extracts prepared and analyzed by C-13 nuclear magnetic resonance spectroscopy. Genetic inactivation of Mct8 resulted in increased oxidative metabolism as reflected by increased glutamate C4 enrichment, and of glutamatergic and GABAergic neurotransmissions as observed by the increases in glutamine C4 and GABA C2 enrichments, respectively. These changes were distinct to those produced by hypothyroidism or hyperthyroidism. Similar increments in glutamate C4 enrichment and GABAergic neurotransmission were observed in the combined inactivation of Mct8 and D2, indicating that the increased neurotransmission and metabolic activity were not due to increased production of cerebral T-3 by the D2-encoded type 2 deiodinase. In conclusion, Mct8 deficiency has important metabolic consequences in the brain that could not be correlated with deficiency or excess of thyroid hormone supply to the brain during adulthood.	[Rodrigues, Tiago B.; Ceballos, Ainhoa; Grijota-Martinez, Carmen; Nunez, Barbara; Cerdan, Sebastian; Morte, Beatriz; Bernal, Juan] CSIC, Inst Invest Biomed, Madrid, Spain; [Rodrigues, Tiago B.; Ceballos, Ainhoa; Grijota-Martinez, Carmen; Nunez, Barbara; Cerdan, Sebastian; Morte, Beatriz; Bernal, Juan] Univ Autonoma Madrid, Madrid, Spain; [Rodrigues, Tiago B.] Univ Cambridge, CRUK, Cambridge Inst, Cambridge, England; [Rodrigues, Tiago B.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Grijota-Martinez, Carmen; Morte, Beatriz; Bernal, Juan] Ctr Biomed Res Rare Dis, Madrid, Spain; [Refetoff, Samuel] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Refetoff, Samuel] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Refetoff, Samuel] Univ Chicago, Dept Genet, Chicago, IL 60637 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Chicago; University of Chicago; University of Chicago	Morte, B (corresponding author), CSIC, Inst Invest Biomed, Madrid, Spain.	bmorte@iib.uam.es; jbernal@iib.uam.es	Refetoff, Samuel/ABB-1263-2021; Bernal, Juan/J-6086-2014; Grijota-Martinez, Carmen/P-5093-2017	Refetoff, Samuel/0000-0003-0164-8231; Bernal, Juan/0000-0002-5867-4951; Grijota-Martinez, Carmen/0000-0003-2656-9062; Morte, Beatriz/0000-0003-0702-7815; Rodrigues, Tiago/0000-0002-4474-0639	Plan Nacional de I+D [SAF2008-01168, SAF2011-25608, SAF2011-23622]; Ramon Areces Foundation; Center for Biomedical Research on Rare Diseases (CIBERER), Instituto Carlos III, Spain; Community of Madrid [S2010/BMD-2349]; National Institutes of Health, USA [DK15070]; EMBO fellowship [EMBO-ALT-1145-2009]; Intra-European Marie Curie Fellowship [FP7-PEOPLE-2009-IEF]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015070, R37DK015070] Funding Source: NIH RePORTER	Plan Nacional de I+D; Ramon Areces Foundation; Center for Biomedical Research on Rare Diseases (CIBERER), Instituto Carlos III, Spain; Community of Madrid(Comunidad de Madrid); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO fellowship(European Molecular Biology Organization (EMBO)); Intra-European Marie Curie Fellowship(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported with grants from Plan Nacional de I+D SAF2008-01168 and SAF2011-25608 (BM and JB) and SAF2011-23622 (SC), the Ramon Areces Foundation (BM and JB), the Center for Biomedical Research on Rare Diseases (CIBERER), Instituto Carlos III, Spain (BM and JB), S2010/BMD-2349 from the Community of Madrid (SC), grant DK15070 (SR) from the National Institutes of Health, USA, an Intra-European Marie Curie (FP7-PEOPLE-2009-IEF, Imaging Lymphoma) and a Long-term EMBO (EMBO-ALT-1145-2009) fellowships (TBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan W, 1944, AM J MENT DEF, V48, P325; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Biebermann H, 2005, EUR J ENDOCRINOL, V153, P359, DOI 10.1530/eje.1.01980; Bouzier AK, 1998, J BIOL CHEM, V273, P27162, DOI 10.1074/jbc.273.42.27162; Bouzier AK, 1998, DEV NEUROSCI-BASEL, V20, P331, DOI 10.1159/000017328; Boyages SC, 2000, WERNER INGBARS THYRO, V8th, P803; Brockmann K, 2005, J NEUROL, V252, P663, DOI 10.1007/s00415-005-0713-3; CERDAN S, 1990, J BIOL CHEM, V265, P12916; CHAPA F, 1995, ENDOCRINOLOGY, V136, P296, DOI 10.1210/en.136.1.296; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; DEESCOBAR GM, 1985, ENDOCRINOLOGY, V117, P1890, DOI 10.1210/endo-117-5-1890; DELONG GR, 1985, DEV MED CHILD NEUROL, V27, P317; Di Cosmo C, 2010, J CLIN INVEST, V120, P3377, DOI 10.1172/JCI42113; Di Cosmo C, 2009, ENDOCRINOLOGY, V150, P4450, DOI 10.1210/en.2009-0209; Diez D, 2008, ENDOCRINOLOGY, V149, P3989, DOI 10.1210/en.2008-0350; Dumitrescu AM, 2006, ENDOCRINOLOGY, V147, P4036, DOI 10.1210/en.2006-0390; Dumitrescu Alexandra M., 2007, V10, P127, DOI 10.1159/000106824; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; Ferrara AM, 2013, ENDOCRINOLO IN PRESS; Friesema ECH, 2005, VITAM HORM, V70, P137, DOI 10.1016/S0083-6729(05)70005-4; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Friesema ECH, 2006, NAT CLIN PRACT ENDOC, V2, P512, DOI 10.1038/ncpendmet0262; Fuchs O, 2008, DEV MED CHILD NEUROL, V50, P1; Galton VA, 2007, ENDOCRINOLOGY, V148, P3080, DOI 10.1210/en.2006-1727; Gika AD, 2009, DEV MED CHILD NEUROL; Grueters Annette, 2007, V10, P118, DOI 10.1159/000106823; Hernandez A, 2012, ENDOCRINOLOGY, V153, P2919, DOI 10.1210/en.2011-1905; Heuer H, 2013, BBA-GEN SUBJECTS, V1830, P3974, DOI 10.1016/j.bbagen.2012.04.009; Holden KR, 2005, J CHILD NEUROL, V20, P852, DOI 10.1177/08830738050200101601; Ito K, 2011, J PHARM SCI-US, V100, P3939, DOI 10.1002/jps.22487; James SR, 2009, ENDOCRINOLOGY, V150, P1961, DOI 10.1210/en.2008-1031; Kinne A, 2010, J BIOL CHEM, V285, P28054, DOI 10.1074/jbc.M110.129577; Knerr I, 2007, J INHERIT METAB DIS, V30, P279, DOI 10.1007/s10545-007-0574-2; Legrand J, 1984, NEUROBEHAVIORAL TERA, P331; Martinez B, 2009, ENDOCRINOLOGY, V150, P3953, DOI 10.1210/en.2008-1755; Mayerl S, 2012, ENDOCRINOLOGY, V153, P1528, DOI 10.1210/en.2011-1633; MOORE S, 1958, FED PROC, V17, P1107; Morte B, 2010, ENDOCRINOLOGY, V151, P2381, DOI 10.1210/en.2009-0944; Namba N, 2008, EUR J PEDIATR, V167, P785, DOI 10.1007/s00431-007-0589-6; Palha JA, 2000, ENDOCRINOLOGY, V141, P3267; Roberts LM, 2008, ENDOCRINOLOGY, V149, P6251, DOI 10.1210/en.2008-0378; Rodrigues TB, 2005, MAGN RESON MED, V54, P1014, DOI 10.1002/mrm.20620; Rodrigues TB, 2005, J NEUROSCI RES, V79, P119, DOI 10.1002/jnr.20308; Rodrigues TB, 2009, J NEUROCHEM, V109, P237, DOI 10.1111/j.1471-4159.2009.05935.x; Schwartz CE, 2007, BEST PRACT RES CL EN, V21, P307, DOI 10.1016/j.beem.2007.03.009; Sijens PE, 2008, J CLIN ENDOCR METAB, V93, P1854, DOI 10.1210/jc.2007-2441; SRIVASTAVA LK, 1985, BIOCHEM INT, V11, P491; Trajkovic M, 2007, J CLIN INVEST, V117, P627, DOI 10.1172/JCI28253; Trajkovic-Arsic M, 2010, ENDOCRINOLOGY, V151, P5053, DOI 10.1210/en.2010-0593; Wirth EK, 2009, J NEUROSCI, V29, P9439, DOI 10.1523/JNEUROSCI.6055-08.2009	52	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e74621	10.1371/journal.pone.0074621	http://dx.doi.org/10.1371/journal.pone.0074621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098341	Green Submitted, Green Published, gold			2022-12-25	WOS:000325427100005
J	Ishida, T; Alexandrov, M; Nishimura, T; Hirota, R; Ikeda, T; Kuroda, A				Ishida, Takenori; Alexandrov, Maxym; Nishimura, Tomoki; Hirota, Ryuichi; Ikeda, Takeshi; Kuroda, Akio			Molecular Engineering of a Fluorescent Bioprobe for Sensitive and Selective Detection of Amphibole Asbestos	PLOS ONE			English	Article							PROTEIN; FIBERS; IDENTIFICATION	Fluorescence microscopy-based affinity assay could enable highly sensitive and selective detection of airborne asbestos, an inorganic environmental pollutant that can cause mesothelioma and lung cancer. We have selected an Escherichia coli histone-like nucleoid structuring protein, H-NS, as a promising candidate for an amphibole asbestos bioprobe. H-NS has high affinity to amphibole asbestos, but also binds to an increasingly common asbestos substitute, wollastonite. To develop a highly specific Bioprobe for amphibole asbestos, we first identified a specific but low-affinity amosite-binding sequence by slicing H-NS into several fragments. Second, we constructed a streptavidin tetramer complex displaying four amosite-binding fragments, resulting in the 250-fold increase in the probe affinity as compared to the single fragment. The tetramer probe had sufficient affinity and specificity for detecting all the five types of asbestos in the amphibole group, and could be used to distinguish them from wollastonite. In order to clarify the binding mechanism and identify the amino acid residues contributing to the probe's affinity to amosite fibers, we constructed a number of shorter and substituted peptides. We found that the probable binding mechanism is electrostatic interaction, with positively charged side chains of lysine residues being primarily responsible for the probe's affinity to asbestos.	[Ishida, Takenori; Alexandrov, Maxym; Nishimura, Tomoki; Hirota, Ryuichi; Ikeda, Takeshi; Kuroda, Akio] Dept Mol Biotechnol, Higashihiroshima, Hiroshima, Japan		Kuroda, A (corresponding author), Dept Mol Biotechnol, Higashihiroshima, Hiroshima, Japan.	akuroda@hiroshima-u.ac.jp	Ikeda, Takeshi/B-4792-2008; Hirota, Ryuichi/Q-3138-2016	Ikeda, Takeshi/0000-0001-7159-5660; Hirota, Ryuichi/0000-0003-3959-5892; Ishida, Takenori/0000-0002-6705-915X	Ministry of the Environment, Japan [C-1101]; Japan Science and Technology Agency; JSPS KAKENHI [25249117]	Ministry of the Environment, Japan(Ministry of the Environment, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Environment Research and Technology Development Fund (C-1101) of the Ministry of the Environment, Japan, the Development of Systems and Technology for Advanced Measurement and Analysis Program of the Japan Science and Technology Agency, and the Grant-in-Aid for Scientific Research (A) from JSPS KAKENHI (grant number 25249117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DAVIS JMG, 1978, BRIT J CANCER, V37, P673, DOI 10.1038/bjc.1978.105; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Ishida T, 2012, J FLUORESC, V22, P357, DOI 10.1007/s10895-011-0967-3; Ishida T, 2010, ENVIRON SCI TECHNOL, V44, P755, DOI 10.1021/es902395h; Kohyama N, 1997, IND HEALTH, V35, P415, DOI 10.2486/indhealth.35.415; Kuroda A, 2008, BIOTECHNOL BIOENG, V99, P285, DOI 10.1002/bit.21588; National Institute of Occupational Safety and Health (NIOSH), 2011, NAT I OCC SAF HLTH N; National Institute of Occupational Safety and Health (NIOSH), 1994, BIOSH MAN AN METH; Sano K, 2005, SMALL, V1, P826, DOI 10.1002/smll.200500010; Seker UOS, 2011, MOLECULES, V16, P1426, DOI 10.3390/molecules16021426; Shindo H, 1999, FEBS LETT, V455, P63, DOI 10.1016/S0014-5793(99)00862-5; TAYLOR DG, 1984, AM IND HYG ASSOC J, V45, P84, DOI 10.1080/15298668491399415; World Health Organisation, 2000, AIR QUAL GUID EUR, P273	13	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76231	10.1371/journal.pone.0076231	http://dx.doi.org/10.1371/journal.pone.0076231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086716	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900089
J	He, WF; Tong, YF; Wang, Y; Liu, JJ; Luo, GX; Wu, J; Zhang, J				He, Weifeng; Tong, Yifan; Wang, Ying; Liu, Jingjing; Luo, Gaoxing; Wu, Jun; Zhang, Jin			Serum Soluble CD14 Is a Potential Prognostic Indicator of Recurrence of Human Breast Invasive Ductal Carcinoma with Her2-Enriched Subtype	PLOS ONE			English	Article							CANCER; RECEPTOR; HER2	In clinical practice, breast cancers with lymph node positive, ER/PR-negative and overexpressed human epidermal growth factor receptor 2 (LN+ER/PR-Her2+) have high risk of recurrence, but the effective biomarkers of prognostic for this type tumor are still lacking. Since breast cancers with LN+ER/PR-Her2+ is at higher risk of recurrence than those with LN-ER/PR+Her2-. The differential proteins between those two groups could be related to the risk of recurrence. Herein, we report that serum soluble CD14 (sCD14) was revealed as the stable differential protein between LN+ER/PR-Her2+ (n=50) and LN-ER/PR+Her2-(n=50) breast cancer patients by proteomics analysis. To validate sCD14 as a biomarker for predicting recurrence of breast cancer, 90 breast cancer patients with LN+ER/PR-Her2+ and 93 patients with LN-ER/PR+Her2-were recruited. The patients with higher level of serum sCD14 at primary surgery showed to be at significantly lower risk of relapse in 3 years follow-up than those with lower level of serum sCD14 at primary surgery. The levels of serum sCD14 at primary surgery were significantly correlated to the risk of 3-year recurrence of LN+ER/PR-Her2+ breast cancer and the corresponding AUC of the ROC curve was 0.833 (95% CI, and 0.742 to 0.920). Therefore, we surmise that serum sCD14 could be a potential biomarker for predicting the prognosis of breast invasive ductal carcinoma with LN+ER/PR-Her2+.	[He, Weifeng; Wang, Ying; Luo, Gaoxing; Wu, Jun] Third Mil Med Univ, Chongqing Key Lab Dis Prote, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res,Southwest Hosp, Chongqing, Peoples R China; [Liu, Jingjing; Zhang, Jin] Tianjin Med Univ, Canc Inst & Hosp, Dept Breast Canc 3, China Tianjin Breast Canc Prevent Treatment & Res, Tianjin, Peoples R China	Army Medical University; Tianjin Medical University	Luo, GX (corresponding author), Third Mil Med Univ, Chongqing Key Lab Dis Prote, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res,Southwest Hosp, Chongqing, Peoples R China.	logxw@hotmail.com; junwupro1@yahoo.com.cn; davidz9132002@yahoo.com	Gaoxing, LUO/AAE-4505-2020	LUO, Gaoxing/0000-0003-4764-3209	Chongqing Key Laboratory	Chongqing Key Laboratory	This work was supported by the special fund of Chongqing Key Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub N, 2011, ASIAN PAC J CANCER P, V12, P1127; Carlsson A, 2011, P NATL ACAD SCI USA, V108, P14252, DOI 10.1073/pnas.1103125108; GADDUCCI A, 1995, GYNECOL ONCOL, V58, P184, DOI 10.1006/gyno.1995.1207; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; He WF, 2012, PROTEOMICS, V12, P1059, DOI 10.1002/pmic.201100400; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lundell AC, 2007, INFECT IMMUN, V75, P4097, DOI 10.1128/IAI.01744-06; Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Standish Leanna J, 2008, J Soc Integr Oncol, V6, P158; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Zdolsek HA, 2004, CLIN EXP ALLERGY, V34, P532, DOI 10.1111/j.1365-2222.2004.1921.x; Zhou M, 2010, CANCER RES, V70, P7534, DOI 10.1158/0008-5472.CAN-10-0815; ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4	18	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75366	10.1371/journal.pone.0075366	http://dx.doi.org/10.1371/journal.pone.0075366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086515	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700081
J	Smith, RKW; Werling, NJ; Dakin, SG; Alam, R; Goodship, AE; Dudhia, J				Smith, Roger Kenneth Whealands; Werling, Natalie Jayne; Dakin, Stephanie Georgina; Alam, Rafiqul; Goodship, Allen E.; Dudhia, Jayesh			Beneficial Effects of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Naturally Occurring Tendinopathy	PLOS ONE			English	Article							PLATELET-RICH PLASMA; DIGITAL FLEXOR TENDINITIS; GENE-EXPRESSION PATTERNS; STROMAL CELLS; SULFATED GLYCOSAMINOGLYCANS; ADIPOSE-TISSUE; MESSENGER-RNA; TENDON REPAIR; EQUINE FLEXOR; HORSES	Tendon injuries are a common age-related degenerative condition where current treatment strategies fail to restore functionality and normal quality of life. This disease also occurs naturally in horses, with many similarities to human tendinopathy making it an ideal large animal model for human disease. Regenerative approaches are increasingly used to improve outcome involving mesenchymal stem cells (MSCs), supported by clinical data where injection of autologous bone marrow derived MSCs (BM-MSCs) suspended in marrow supernatant into injured tendons has halved the re-injury rate in racehorses. We hypothesized that stem cell therapy induces a matrix more closely resembling normal tendon than the fibrous scar tissue formed by natural repair. Twelve horses with career-ending naturally-occurring superficial digital flexor tendon injury were allocated randomly to treatment and control groups. 1x10(7) autologous BM-MSCs suspended in 2 ml of marrow supernatant were implanted into the damaged tendon of the treated group. The control group received the same volume of saline. Following a 6 month exercise programme horses were euthanized and tendons assessed for structural stiffness by non-destructive mechanical testing and for morphological and molecular composition. BM-MSC treated tendons exhibited statistically significant improvements in key parameters compared to saline-injected control tendons towards that of normal tendons and those in the contralateral limbs. Specifically, treated tendons had lower structural stiffness (p<0.05) although no significant difference in calculated modulus of elasticity, lower (improved) histological scoring of organisation (p<0.003) and crimp pattern (p<0.05), lower cellularity (p<0.007), DNA content (p<0.05), vascularity (p<0.03), water content (p<0.05), GAG content (p<0.05), and MMP-13 activity (p<0.02). Treatment with autologous MSCs in marrow supernatant therefore provides significant benefits compared to untreated tendon repair in enhancing normalisation of biomechanical, morphological, and compositional parameters. These data in natural disease, with no adverse findings, support the use of this treatment for human tendon injuries.	[Smith, Roger Kenneth Whealands; Dakin, Stephanie Georgina; Alam, Rafiqul; Dudhia, Jayesh] Univ London, Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England; [Werling, Natalie Jayne] Natl Inst Biol Stand & Controls, Dept Biotherapeut, S Mimms, Herts, England; [Goodship, Allen E.] Univ Coll London, Inst Orthopaed & Musculoskeletal Sci, Stanmore, Middx, England	University of London; University of London Royal Veterinary College; National Institute for Biological Standards & Control; University of London; University College London	Dudhia, J (corresponding author), Univ London, Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England.	jdudhia@rvc.ac.uk		Dakin, Stephanie Georgina/0000-0003-2470-1031; Werling, Natalie/0000-0001-5813-6128; Dudhia, Jayesh/0000-0002-2503-697X	Horserace Betting Levy Board, UK; Royal Veterinary College, UK; VetCell Bioscience Ltd, UK; Biotechnology and Biological Sciences Research Council	Horserace Betting Levy Board, UK; Royal Veterinary College, UK; VetCell Bioscience Ltd, UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Horserace Betting Levy Board, UK, the Royal Veterinary College, UK (http://www.hblb.org.uk) and VetCell Bioscience Ltd, UK (http://www.vetcell.com). SGD was funded by a Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves AGL, 2011, VET CLIN N AM-EQUINE, V27, P315, DOI 10.1016/j.cveq.2011.06.001; Avella CS, 2009, EQUINE VET J, V41, P449, DOI 10.2746/042516409X391042; Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267; Awad HA, 2003, J ORTHOP RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8; Bancroft J., 2007, THEORY PRACTICE HIST, V6 ed; Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950; Batson EL, 2003, EQUINE VET J, V35, P314, DOI 10.2746/042516403776148327; Becerra P, 2013, J ORTHOP RES, V31, P1096, DOI 10.1002/jor.22338; Birch HL, 1999, EQUINE VET J, V31, P391, DOI 10.1111/j.2042-3306.1999.tb03838.x; Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456; Cadby JA, 2013, EQUINE VET J, V45, P642, DOI 10.1111/evj.12035; Caniglia CJ, 2012, EQUINE VET J, V44, P587, DOI 10.1111/j.2042-3306.2011.00514.x; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Corps AN, 2006, RHEUMATOLOGY, V45, P291, DOI 10.1093/rheumatology/kei152; Corps AN, 2012, ANN RHEUM DIS, V71, P746, DOI 10.1136/annrheumdis-2011-200391; Crevier-Denoix N, 1997, Equine Vet J Suppl, P23; Crovace A, 2007, VET RES COMMUN, V31, P281, DOI 10.1007/s11259-007-0047-y; Crovace Antonio, 2010, Vet Med Int, V2010, P250978, DOI 10.4061/2010/250978; Dahlgren LA, 2005, J ORTHOP RES, V23, P84, DOI 10.1016/j.orthres.2004.05.007; Dakin SG, 2011, EQUINE VET J, V43, P418, DOI 10.1111/j.2042-3306.2010.00303.x; Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048978; Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032333; Duffy MM, 2011, EUR J IMMUNOL, V41, P2840, DOI 10.1002/eji.201141499; Dyson SJ, 2004, EQUINE VET J, V36, P415, DOI 10.2746/0425164044868422; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fortier LA, 1998, AM J VET RES, V59, P1182; Fu SC, 2007, CLIN J SPORT MED, V17, P129, DOI 10.1097/JSM.0b013e318037998f; Godwin EE, 2012, EQUINE VET J, V44, P25, DOI 10.1111/j.2042-3306.2011.00363.x; Guest DJ, 2008, EQUINE VET J, V40, P178, DOI 10.2746/042516408X276942; Guest DJ, 2010, EQUINE VET J, V42, P636, DOI 10.1111/j.2042-3306.2010.00112.x; Herthel D., 2001, P AM ASS EQ PRACT, V47, P319; Hildebrand KA, 2002, MICROSC RES TECHNIQ, V58, P34, DOI 10.1002/jemt.10114; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Maffulli N, 2008, CLIN ORTHOP RELAT R, V466, P1605, DOI 10.1007/s11999-008-0261-0; Magnussen RA, 2009, CLIN J SPORT MED, V19, P54, DOI 10.1097/JSM.0b013e31818ef090; McCarrel T, 2009, J ORTHOP RES, V27, P1033, DOI 10.1002/jor.20853; Movin T, 1997, ACTA ORTHOP SCAND, V68, P170, DOI 10.3109/17453679709004002; O'Meara B, 2010, EQUINE VET J, V42, P322, DOI 10.1111/j.2042-3306.2009.00021.x; Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615; Plaas A, 2011, J ORTHOP RES, V29, P900, DOI 10.1002/jor.21332; RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367; Samiric T, 2009, MATRIX BIOL, V28, P230, DOI 10.1016/j.matbio.2009.04.001; Schnabel LV, 2008, EQUINE VET J, V40, P260, DOI 10.2746/042516408X278030; Schnabel LV, 2007, J ORTHOP RES, V25, P230, DOI 10.1002/jor.20278; Schnabel LV, 2009, J ORTHOP RES, V27, P1392, DOI 10.1002/jor.20887; Schramme M, 2010, VET COMP ORTHOPAED, V23, P231, DOI 10.3415/VCOT-09-10-0106; Schu S, 2012, J CELL MOL MED, V16, P2094, DOI 10.1111/j.1582-4934.2011.01509.x; Smith JJ, 2006, VET COMP ORTHOPAED, V19, P43; Smith MM, 2008, ARTHRITIS RHEUM-US, V58, P1055, DOI 10.1002/art.23388; Smith RKW, 2003, EQUINE VET J, V35, P99, DOI 10.2746/042516403775467388; SMITH RKW, 1994, EQUINE VET J, V26, P460, DOI 10.1111/j.2042-3306.1994.tb04050.x; Smith RWK, 2010, DIAGNOSIS MANAGEMENT; STRASSBURG S, 2006, T ORTH RES SOC ANN M, V31, P1113; Vidal MA, 2007, VET SURG, V36, P613, DOI 10.1111/j.1532-950X.2007.00313.x; Vidal MA, 2006, VET SURG, V35, P601, DOI 10.1111/j.1532-950X.2006.00197.x; Vidal MA, 2008, VET SURG, V37, P713, DOI 10.1111/j.1532-950X.2008.00462.x; Wang VM, 2012, J ORTHOP RES, V30, P620, DOI 10.1002/jor.21558; Williams RB, 2001, EQUINE VET J, V33, P478, DOI 10.2746/042516401776254808; Wilson AM, 2001, NATURE, V414, P895, DOI 10.1038/414895a; Young NJ, 2009, MATRIX BIOL, V28, P311, DOI 10.1016/j.matbio.2009.05.002; Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403	63	112	115	5	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75697	10.1371/journal.pone.0075697	http://dx.doi.org/10.1371/journal.pone.0075697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086616	gold, Green Published			2022-12-25	WOS:000325218700110
J	Lai, D; Tan, CL; Gunaratne, J; Quek, LS; Nei, WL; Thierry, F; Bellanger, S				Lai, Deborah; Tan, Chye Ling; Gunaratne, Jayantha; Quek, Ling Shih; Nei, Wenlong; Thierry, Francoise; Bellanger, Sophie			Localization of HPV-18 E2 at Mitochondrial Membranes Induces ROS Release and Modulates Host Cell Metabolism	PLOS ONE			English	Article							HIGH-RISK; ELECTRON-TRANSPORT; TUMOR-SUPPRESSOR; PROTEIN; EXPRESSION; CANCER; TRANSCRIPTION; GENERATION; APOPTOSIS; PATHWAY	Papillomavirus E2 proteins are predominantly retained in the nuclei of infected cells, but oncogenic (high-risk) HPV-18 and 16 E2 can shuttle between the host nucleus and cytoplasm. We show here that cytoplasmic HPV-18 E2 localizes to mitochondrial membranes, and independent mass spectrometry analyses of the E2 interactome revealed association to the inner mitochondrial membrane including components of the respiratory chain. Mitochondrial E2 association modifies the cristae morphology when analyzed by electron microscopy and increases production of mitochondrial ROS. This ROS release does not induce apoptosis, but instead correlates with stabilization of HIF-1 alpha and increased glycolysis. These mitochondrial functions are not shared by the non-oncogenic (low-risk) HPV-6 E2 protein, suggesting that modification of cellular metabolism by high-risk HPV E2 proteins could play a role in carcinogenesis by inducing the Warburg effect.	[Lai, Deborah; Tan, Chye Ling; Quek, Ling Shih; Nei, Wenlong; Thierry, Francoise; Bellanger, Sophie] ASTAR, Inst Med Biol, Singapore, Singapore; [Gunaratne, Jayantha] ASTAR, Inst Mol & Cell Biol, Quantitat Prote Grp, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Bellanger, S (corresponding author), ASTAR, Inst Med Biol, Singapore, Singapore.	sophie.bellanger@imb.a-star.edu.sg		nei, wen long/0000-0001-6027-1652	Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Aguirre L, 2009, J IMMUNOL, V183, P5379, DOI 10.4049/jimmunol.0900228; Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Ando M, 2008, LIVER INT, V28, P1158, DOI 10.1111/j.1478-3231.2008.01720.x; Bellanger S, 2005, CELL CYCLE, V4, P1608, DOI 10.4161/cc.4.11.2123; Bellanger S, 2011, AM J CANCER RES, V1, P373; Bellanger S, 2010, J VIROL, V84, P437, DOI 10.1128/JVI.01162-09; Blachon S, 2005, J BIOL CHEM, V280, P36088, DOI 10.1074/jbc.M505138200; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Demeret C, 2003, ONCOGENE, V22, P168, DOI 10.1038/sj.onc.1206108; Desaintes C, 1997, EMBO J, V16, P504, DOI 10.1093/emboj/16.3.504; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Lee YI, 2004, J BIOL CHEM, V279, P15460, DOI 10.1074/jbc.M309280200; Maehama T, 1998, INT J CANCER, V76, P639, DOI 10.1002/(SICI)1097-0215(19980529)76:5<639::AID-IJC5>3.0.CO;2-R; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nohl H, 2005, BIOCHEM PHARMACOL, V69, P719, DOI 10.1016/j.bcp.2004.12.002; Ohta A, 2011, MITOCHONDRION, V11, P1, DOI 10.1016/j.mito.2010.08.006; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Pfefferle R, 2008, J INVEST DERMATOL, V128, P2310, DOI 10.1038/jid.2008.73; Raj K, 2004, J VIROL, V78, P7199, DOI 10.1128/JVI.78.13.7199-7207.2004; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Silic-Benussi M, 2010, FEBS LETT, V584, P2070, DOI 10.1016/j.febslet.2010.02.030; Thierry F, 2004, CANCER RES, V64, P895, DOI 10.1158/0008-5472.CAN-03-2349; THIERRY F, 1987, EMBO J, V6, P3391, DOI 10.1002/j.1460-2075.1987.tb02662.x; Villota C, 2012, J BIOL CHEM, V287, P21303, DOI 10.1074/jbc.M111.326694; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xue YZ, 2010, CANCER RES, V70, P5316, DOI 10.1158/0008-5472.CAN-09-3789	32	50	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75625	10.1371/journal.pone.0075625	http://dx.doi.org/10.1371/journal.pone.0075625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086592	gold, Green Published, Green Submitted			2022-12-25	WOS:000325025200056
J	Parkhouse, R; Ebong, IO; Robinson, CV; Monie, TP				Parkhouse, Rhiannon; Ebong, Ima-Obong; Robinson, Carol V.; Monie, Tom P.			The N-Terminal Region of the Human Autophagy Protein ATG16L1 Contains a Domain That Folds into a Helical Structure Consistent with Formation of a Coiled-Coil	PLOS ONE			English	Article							MASS-SPECTROMETRY; ISOLATION MEMBRANE; CONJUGATE; PATHWAY; COMPLEX; FIP200; ASSEMBLIES; CELLS; YEAST; LC3	Autophagy is a fundamental cellular process required for organelle degradation and removal of invasive pathogens. Autophagosome formation involves the recruitment of, and interaction between, multiple proteins produced from autophagy-related (ATG) genes. One of the key complexes in autophagosome formation is the ATG12-ATG5-ATG16L1 complex. ATG16L1 functions as a molecular scaffold mediating protein-protein interactions necessary for formation of the autophagosome in response to both classical and pathogen-related autophagy stimuli. The coiled-coil domain of the yeast ortholog, ATG16, exists as a homodimer both in solution and in the crystal form. The yeast and human orthologs show poor sequence identity. Here we have sought to determine the minimal boundaries of the human ATG16L1 coiled-coil domain and ascertain its oligomeric status in solution. Using a range of biochemical and biophysical techniques we show that the secondary structure of the human ATG16L1 coiled-coil has the expected helical composition and that the domain forms a homodimer in solution. We also observe extensive sequence conservation across vertebrates providing strong support for the crucial functional role of the ATG16L1 coiled-coil.	[Parkhouse, Rhiannon; Monie, Tom P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Ebong, Ima-Obong; Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford OX1 3QZ, England	University of Cambridge; University of Oxford	Monie, TP (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	tpm22@cam.ac.uk	Monie, Tom/H-4662-2019	Monie, Tom/0000-0003-4097-1680; robinson, carol/0000-0001-7829-5505	Wellcome Trust [WT085090MA]; BBSRC Doctoral Training Grant; Biotechnology and Biological Sciences Research Council [979868] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC Doctoral Training Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a Wellcome Trust Career Development Fellowship to TPM (WT085090MA; www.wellcome.ac.uk) and a BBSRC Doctoral Training Grant for RP (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boada-Romero E, 2013, EMBO J, V32, P566, DOI 10.1038/emboj.2013.8; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Fujioka Y, 2008, ACTA CRYSTALLOGR F, V64, P1046, DOI 10.1107/S1744309108031898; Fujioka Y, 2010, J BIOL CHEM, V285, P1508, DOI 10.1074/jbc.M109.053520; Gammoh N, 2013, NAT STRUCT MOL BIOL, V20, P144, DOI 10.1038/nsmb.2475; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hernandez H, 2001, J BIOL CHEM, V276, P46685, DOI 10.1074/jbc.R100024200; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Heul AMV, 2013, J BIOL CHEM, V288, P6890, DOI 10.1074/jbc.M112.413781; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Monie TP, 2005, RNA, V11, P1803, DOI 10.1261/rna.2214405; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Nishimura T, 2013, EMBO REP, V14, P284, DOI 10.1038/embor.2013.6; Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431; Ruotolo BT, 2006, CURR OPIN CHEM BIOL, V10, P402, DOI 10.1016/j.cbpa.2006.08.020; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; van den Heuvel RH, 2004, CURR OPIN CHEM BIOL, V8, P519, DOI 10.1016/j.cbpa.2004.08.006; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Woolfson DN, 2012, CURR OPIN STRUC BIOL, V22, P432, DOI 10.1016/j.sbi.2012.03.002; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035	30	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e76237	10.1371/journal.pone.0076237	http://dx.doi.org/10.1371/journal.pone.0076237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086718	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200075
J	Thureborn, P; Lundin, D; Plathan, J; Poole, AM; Sjoberg, BM; Sjoling, S				Thureborn, Petter; Lundin, Daniel; Plathan, Josefin; Poole, Anthony M.; Sjoberg, Britt-Marie; Sjoling, Sara			A Metagenomics Transect into the Deepest Point of the Baltic Sea Reveals Clear Stratification of Microbial Functional Capacities	PLOS ONE			English	Article							COMMUNITY STRUCTURE; CLIMATE VARIABILITY; GENOME ANNOTATION; NITROGEN-FIXATION; GOTLAND BASIN; WATER COLUMN; SEDIMENT; HYPOXIA; DENITRIFICATION; EUTROPHICATION	The Baltic Sea is characterized by hyposaline surface waters, hypoxic and anoxic deep waters and sediments. These conditions, which in turn lead to a steep oxygen gradient, are particularly evident at Landsort Deep in the Baltic Proper. Given these substantial differences in environmental parameters at Landsort Deep, we performed a metagenomic census spanning surface to sediment to establish whether the microbial communities at this site are as stratified as the physical environment. We report strong stratification across a depth transect for both functional capacity and taxonomic affiliation, with functional capacity corresponding most closely to key environmental parameters of oxygen, salinity and temperature. We report similarities in functional capacity between the hypoxic community and hadal zone communities, underscoring the substantial degree of eutrophication in the Baltic Proper. Reconstruction of the nitrogen cycle at Landsort deep shows potential for syntrophy between archaeal ammonium oxidizers and bacterial denitrification at anoxic depths, while anaerobic ammonium oxidation genes are absent, despite substantial ammonium levels below the chemocline. Our census also reveals enrichment in genetic prerequisites for a copiotrophic lifestyle and resistance mechanisms reflecting adaptation to prevalent eutrophic conditions and the accumulation of environmental pollutants resulting from ongoing anthropogenic pressures in the Baltic Sea.	[Thureborn, Petter; Lundin, Daniel; Sjoling, Sara] Sodertorn Univ, Sch Nat Sci & Environm Studies, Huddinge, Sweden; [Thureborn, Petter; Plathan, Josefin; Poole, Anthony M.; Sjoberg, Britt-Marie] Stockholm Univ, Dept Mol Biol & Funct Genom, S-10691 Stockholm, Sweden; [Lundin, Daniel] Royal Inst Technol, Sci Life Labs, Solna, Sweden; [Lundin, Daniel; Sjoberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Poole, Anthony M.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand	Sodertorn University; Stockholm University; Royal Institute of Technology; Stockholm University; University of Canterbury	Thureborn, P (corresponding author), Sodertorn Univ, Sch Nat Sci & Environm Studies, Huddinge, Sweden.	petter.thureborn@sh.se		Lundin, Daniel/0000-0002-8779-6464; Poole, Anthony/0000-0001-9940-2824; Sjoberg, Britt-Marie/0000-0001-5953-3360	Foundation for Baltic and East European Studies [1169/42/2007:17]; Helge Ax:son Johnson foundation; Science for Life Laboratories in Stockholm; Swedish Research Council; Rutherford Discovery Fellowship; Royal Swedish Academy of Sciences Research Fellowship from the Knut and Alice Wallenberg Foundation	Foundation for Baltic and East European Studies; Helge Ax:son Johnson foundation; Science for Life Laboratories in Stockholm; Swedish Research Council(Swedish Research CouncilEuropean Commission); Rutherford Discovery Fellowship; Royal Swedish Academy of Sciences Research Fellowship from the Knut and Alice Wallenberg Foundation	The work was funded by the Foundation for Baltic and East European Studies 1169/42/2007:17 (www.ostersjostiftelsen.se). Sequence analyses were co-funded by the Helge Ax:son Johnson foundation (http://www.haxsonj.se), the Science for Life Laboratories in Stockholm, and the Swedish Research Council (to BMS). AMP is supported by a Rutherford Discovery Fellowship, administered by the Royal Society of New Zealand, and acknowledges past receipt of a Royal Swedish Academy of Sciences Research Fellowship from the Knut and Alice Wallenberg Foundation (www.kva.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; Barz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013846; Brettar I, 2006, APPL ENVIRON MICROB, V72, P1364, DOI 10.1128/AEM.72.2.1364-1372.2006; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; CEDERWALL H, 1990, AMBIO, V19, P109; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3412, DOI 10.1021/es802762a; DeBruyn JM, 2009, ENVIRON SCI TECHNOL, V43, P3467, DOI 10.1021/es803348g; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dos Santos PC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-162; Edlund A, 2006, ENVIRON MICROBIOL, V8, P223, DOI 10.1111/j.1462-2920.2005.00887.x; Edlund A, 2008, ENVIRON MICROBIOL, V10, P2051, DOI 10.1111/j.1462-2920.2008.01624.x; Eloe EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020388; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Falk S, 2007, BIOGEOSCIENCES, V4, P255, DOI 10.5194/bg-4-255-2007; Farnelid H, 2013, ISME J, V7, P1413, DOI 10.1038/ismej.2013.26; Feike J, 2012, ISME J, V6, P461, DOI 10.1038/ismej.2011.94; Galushko A, 1999, ENVIRON MICROBIOL, V1, P415; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P183, DOI 10.4056/sigs.1202536; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Glaubitz S, 2009, ENVIRON MICROBIOL, V11, P326, DOI 10.1111/j.1462-2920.2008.01770.x; Grote J, 2012, P NATL ACAD SCI USA, V109, P506, DOI 10.1073/pnas.1111262109; Grote J, 2008, APPL ENVIRON MICROB, V74, P7546, DOI 10.1128/AEM.01186-08; Hakansson L., 2008, EUTROPHICATION BALTI; Hannig M, 2007, LIMNOL OCEANOGR, V52, P1336, DOI 10.4319/lo.2007.52.4.1336; Hannig M, 2006, FEMS MICROBIOL ECOL, V57, P260, DOI 10.1111/j.1574-6941.2006.00116.x; Hansson M. P., 2009, EXTENT ANOXIA HYPOXI; Havelsrud OE, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-221; HELCOM, 2018, BALTIC SEA ENV P, V162; HELCOM, 2003, BALT SEA ENV P; HELCOM, 2009, BALT SEA ENV P B; Hietanen S, 2008, HYDROBIOLOGIA, V596, P67, DOI 10.1007/s10750-007-9058-5; Hietanen S, 2012, LIMNOL OCEANOGR, V57, P325, DOI 10.4319/lo.2012.57.1.0325; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jantti H, 2012, AMBIO, V41, P161, DOI 10.1007/s13280-011-0233-6; Johnston AWB, 2005, TRENDS MICROBIOL, V13, P416, DOI 10.1016/j.tim.2005.07.002; Jost G, 2010, FEMS MICROBIOL ECOL, V71, P226, DOI 10.1111/j.1574-6941.2009.00798.x; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Knapp AN, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00374; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Koskinen K, 2011, FEMS MICROBIOL ECOL, V75, P99, DOI 10.1111/j.1574-6941.2010.00987.x; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Kuparinen J, 2001, AMBIO, V30, P190, DOI 10.1639/0044-7447(2001)030[0190:EASPCF]2.0.CO;2; Labrenz M, 2007, AQUAT MICROB ECOL, V46, P177, DOI 10.3354/ame046177; Labrenz M, 2010, ISME J, V4, P1496, DOI 10.1038/ismej.2010.78; Lacroix G, 2007, CONT SHELF RES, V27, P1422, DOI 10.1016/j.csr.2007.01.013; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Lu XY, 2011, APPL MICROBIOL BIOT, V89, P1357, DOI 10.1007/s00253-010-3072-7; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21; Mitra S, 2010, ISME J, V4, P1236, DOI 10.1038/ismej.2010.51; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pinhassi J, 2000, AQUAT MICROB ECOL, V21, P245, DOI 10.3354/ame021245; Pohl C, 2004, MAR CHEM, V84, P143, DOI 10.1016/j.marchem.2003.07.002; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; R Development Core Team, 2009, R FDN STAT COMP; Raes J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.6; Rensing C, 2002, SOIL BIOL BIOCHEM, V34, P285, DOI 10.1016/S0038-0717(01)00183-3; Riemann L, 2008, APPL ENVIRON MICROB, V74, P503, DOI 10.1128/AEM.01983-07; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Savage C, 2010, LIMNOL OCEANOGR, V55, P1033, DOI 10.4319/lo.2010.55.3.1033; Schinke H, 1998, CONT SHELF RES, V18, P67, DOI 10.1016/S0278-4343(97)00071-X; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; SOMERVILLE CC, 1989, APPL ENVIRON MICROB, V55, P548, DOI 10.1128/AEM.55.3.548-554.1989; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Tamminen T, 2007, MAR ECOL PROG SER, V340, P121, DOI 10.3354/meps340121; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; Wright MS, 2008, ISME J, V2, P417, DOI 10.1038/ismej.2008.8; Wulff F, 1989, GLOBAL BIOGEOCHEM CY, V3, P63, DOI 10.1029/GB003i001p00063; Zillen L, 2008, EARTH-SCI REV, V91, P77, DOI 10.1016/j.earscirev.2008.10.001; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	83	35	35	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e74983	10.1371/journal.pone.0074983	http://dx.doi.org/10.1371/journal.pone.0074983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086414	gold, Green Published, Green Submitted			2022-12-25	WOS:000326520200065
J	Bessede, E; Staedel, C; Amador, LAA; Nguyen, PH; Chambonnier, L; Hatakeyama, M; Belleannee, G; Megraud, F; Varon, C				Bessede, E.; Staedel, C.; Amador, L. A. Acuna; Nguyen, P. H.; Chambonnier, L.; Hatakeyama, M.; Belleannee, G.; Megraud, F.; Varon, C.			Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes	ONCOGENE			English	Article						gastric cancer; infection; CD44	GASTRIC-CANCER; INCREASED RISK; CAGA PROTEIN; IDENTIFICATION; EXPRESSION; INFECTION; CD44	Helicobacter pylori infection is the major risk factor for gastric adenocarcinoma. The link with gastric adenocarcinoma is partly due to the H. pylori CagA oncoprotein. CagA is responsible for a particular cell phenotype in vitro, the 'hummingbird' phenotype, that corresponds to an elongation of the cells, mimicking an epithelial-mesenchymal transition (EMT). EMT participates in the carcinogenesis process, and is involved in the generation of cancer stem cells (CSCs). However, its involvement in gastric carcinogenesis has yet not been studied. Therefore, the aim of this study was to determine the role of H. pylori in EMT and in the emergence of gastric CSCs. For this purpose, gastric epithelial cells were cocultured with a cagA-positive H. pylori strain or its isogenic-deleted mutants or were transfected with CagA expression vectors. Study of the expression of epithelial and mesenchymal markers showed that H. pylori, via CagA, is responsible for an EMT phenotype associated with an increase in mesenchymal markers as well as CD44 expression, a known gastric CSC marker. Moreover, infection led to an increased ability to migrate, to invade and to form tumorspheres. Cell sorting experiments showed that only the CD44(high) cells induced by H. pylori infection displayed the mesenchymal phenotype and CSC properties in vitro, and had higher tumorigenic properties than CD44(low) cells in xenografted mice. Immunohistochemistry analyses on human and mouse gastric mucosa tissue samples confirmed a high expression of CD44 and mesenchymal markers in H. pylori-infected cases, and in gastric dysplasia and carcinoma. All of these data suggest that H. pylori, via CagA, unveils CSC-like properties by induction of EMT-like changes in gastric epithelial cells.	[Bessede, E.; Amador, L. A. Acuna; Nguyen, P. H.; Chambonnier, L.; Megraud, F.; Varon, C.] Univ Bordeaux, Bacteriol Lab, F-33000 Bordeaux, France; [Bessede, E.; Amador, L. A. Acuna; Nguyen, P. H.; Chambonnier, L.; Megraud, F.; Varon, C.] INSERM, U853, Bordeaux, France; [Staedel, C.] Univ Bordeaux, RNA Nat & Artificial Regulat ARNA Lab, F-33000 Bordeaux, France; [Staedel, C.] INSERM, U869, Bordeaux, France; [Hatakeyama, M.] Univ Tokyo, Grad Sch Med, Div Microbiol, Tokyo, Japan; [Belleannee, G.] Univ Hosp Ctr, Haut Leveque Hosp, Dept Pathol, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Tokyo; CHU Bordeaux	Bessede, E (corresponding author), Univ Bordeaux, INSERM, Bacteriol Lab, U853, F-33000 Bordeaux, France.	emilie.bessede@chu-bordeaux.fr	STAEDEL, Cathy/M-7284-2014	Varon, Christine/0000-0003-4026-2016; Acuna-Amador, Luis/0000-0003-1009-3020; Staedel, Cathy/0000-0003-0488-0239	French 'Association pour la Recherche contre le Cancer' [8412]; Institut du Cancer [07/3D1616/IABC-23-12/NC-NG]; Conseil Regional d'Aquitaine [20071301017, 20081302203]	French 'Association pour la Recherche contre le Cancer'(Fondation ARC pour la Recherche sur le Cancer); Institut du Cancer(Institut National du Cancer (INCA) France); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	This project was supported by the French 'Association pour la Recherche contre le Cancer' (grant number 8412), 'Institut du Cancer' (grant number 07/3D1616/IABC-23-12/NC-NG), 'Conseil Regional d'Aquitaine' (grant number 20071301017 and 20081302203). We thank D Collet (Digestive Surgery of Hospital Haut-Leveque, University Hospital Center of Bordeaux, France) and Professor JP Merlio (Tumor Bank of University Hospital Center of Bordeaux, France) for providing human gastric tissue samples from consenting patients. We thank A Giese (EA2406, Bordeaux, France), B Rousseau (level 2 animal facilities, Universite de Bordeaux), V Pitard and S Gonzalez (cytometry platform, Universite de Bordeaux), A Menard, M Alibert, E Siffre and L Biguet for technical support.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Baud J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060315; Bellizzi A, 2013, J CELL PHYSIOL, V228, P408, DOI 10.1002/jcp.24145; BLASER MJ, 1995, CANCER RES, V55, P2111; Ferrand J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029007; Franco AT, 2008, CANCER RES, V68, P379, DOI 10.1158/0008-5472.CAN-07-0824; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Gwack J, 2006, BRIT J CANCER, V95, P639, DOI 10.1038/sj.bjc.6603309; Hao JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040716; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; IARC, 1994, IARC MON EV CARC RIS, V61, P177; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kure S, 2012, INT J ONCOL, V41, P1314, DOI 10.3892/ijo.2012.1565; Li CW, 2009, METHODS MOL BIOL, V568, P161, DOI 10.1007/978-1-59745-280-9_10; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meng EH, 2012, CLIN EXP METASTAS, V29, P939, DOI 10.1007/s10585-012-9482-4; Mitsuno Y, 2001, GUT, V49, P18, DOI 10.1136/gut.49.1.18; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Saito Y, 2010, J EXP MED, V207, P2157, DOI 10.1084/jem.20100602; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Varon C, 2009, GUT, V58, P629, DOI 10.1136/gut.2007.144501; Varon C, 2012, GASTROENTEROLOGY, V142, P281, DOI 10.1053/j.gastro.2011.10.036; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yin YF, 2010, GUT, V59, P1037, DOI 10.1136/gut.2009.199794	33	116	125	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 7	2014	33	32					4123	4131		10.1038/onc.2013.380	http://dx.doi.org/10.1038/onc.2013.380			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YK	24096479				2022-12-25	WOS:000340595700003
J	Seung, D; Thalmann, M; Sparla, F; Hachem, M; Lee, SK; Issakidis-Bourguet, E; Svensson, B; Zeeman, SC; Santelia, D				Seung, David; Thalmann, Matthias; Sparla, Francesca; Abou Hachem, Maher; Lee, Sang Kyu; Issakidis-Bourguet, Emmanuelle; Svensson, Birte; Zeeman, Samuel C.; Santelia, Diana			Arabidopsis thaliana AMY3 Is a Unique Redox- regulated Chloroplastic alpha-Amylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Carbohydrate Metabolism; Plant Biochemistry; Redox Regulation; Thioredoxin; -Amylase; Amylopectin; Starch	STARCH DEGRADATION; BETA-AMYLASE; PLASTIDIAL THIOREDOXINS; BINDING MODES; BREAKDOWN; PHOSPHOGLUCAN; METABOLISM; ENZYMES; SPECIFICITY; SENSITIVITY	alpha-Amylases are glucan hydrolases that cleave -1,4-glucosidic bonds in starch. In vascular plants, -amylases can be classified into three subfamilies. Arabidopsis has one member of each subfamily. Among them, only AtAMY3 is localized in the chloroplast. We expressed and purified AtAMY3 from Escherichia coli and carried out a biochemical characterization of the protein to find factors that regulate its activity. Recombinant AtAMY3 was active toward both insoluble starch granules and soluble substrates, with a strong preference for -limit dextrin over amylopectin. Activity was shown to be dependent on a conserved aspartic acid residue (Asp(666)), identified as the catalytic nucleophile in other plant -amylases such as the barley AMY1. AtAMY3 released small linear and branched glucans from Arabidopsis starch granules, and the proportion of branched glucans increased after the predigestion of starch with a -amylase. Optimal rates of starch digestion in vitro was achieved when both AtAMY3 and -amylase activities were present, suggesting that the two enzymes work synergistically at the granule surface. We also found that AtAMY3 has unique properties among other characterized plant -amylases, with a pH optimum of 7.5-8, appropriate for activity in the chloroplast stroma. AtAMY3 is also redox-regulated, and the inactive oxidized form of AtAMY3 could be reactivated by reduced thioredoxins. Site-directed mutagenesis combined with mass spectrometry analysis showed that a disulfide bridge between Cys(499) and Cys(587) is central to this regulation. This work provides new insights into how -amylase activity may be regulated in the chloroplast.	[Seung, David; Thalmann, Matthias; Lee, Sang Kyu; Zeeman, Samuel C.; Santelia, Diana] ETH, Inst Agr Sci, CH-8092 Zurich, Switzerland; [Sparla, Francesca] Univ Bologna, Dept Expt Evolutionary Biol, I-40126 Bologna, Italy; [Abou Hachem, Maher; Svensson, Birte] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Issakidis-Bourguet, Emmanuelle] Univ Paris 11, CNRS, UMR 8618, Inst Biol Plantes, F-91405 Orsay, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bologna; Technical University of Denmark; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Santelia, D (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	dsantelia@botinst.uzh.ch	Santelia, Diana/AAQ-3967-2020; Abou Hachem, Maher/M-4772-2019; Seung, David/D-8811-2013	Abou Hachem, Maher/0000-0001-8250-1842; Seung, David/0000-0003-3905-3647; Issakidis-Bourguet, Emmanuelle/0000-0002-6144-4364; Sparla, Francesca/0000-0002-2103-4870; Zeeman, Samuel/0000-0002-2791-0915; Svensson, Birte/0000-0002-2993-8196; Thalmann, Matthias/0000-0002-6260-1448	Swiss-South African Joint Research Program [IZ LS Z3122916]; SNSF Marie Heim-Vogtlin [PMPDP3_139645]; Novartis-ETH Zurich Excellence Scholarship	Swiss-South African Joint Research Program; SNSF Marie Heim-Vogtlin; Novartis-ETH Zurich Excellence Scholarship	This work was supported by the Swiss-South African Joint Research Program Grant IZ LS Z3122916 (to D. Santelia and S. C. Z.), SNSF Marie Heim-Vogtlin Grant PMPDP3_139645 (to D. Santelia), and a Novartis-ETH Zurich Excellence Scholarship (to D. Seung).	Anthon GE, 2002, ANAL BIOCHEM, V305, P287, DOI 10.1006/abio.2002.5644; Asatsuma S, 2005, PLANT CELL PHYSIOL, V46, P858, DOI 10.1093/pcp/pci091; Bak-Jensen KS, 2004, J BIOL CHEM, V279, P10093, DOI 10.1074/jbc.M312825200; Brandes HK, 1996, J BIOL CHEM, V271, P3333; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; Delatte T, 2006, J BIOL CHEM, V281, P12050, DOI 10.1074/jbc.M513661200; Ficarra R, 2002, J PHARMACEUT BIOMED, V29, P989, DOI 10.1016/S0731-7085(02)00139-5; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; Glaring MA, 2012, PLANT PHYSIOL BIOCH, V58, P89, DOI 10.1016/j.plaphy.2012.06.017; Glaring MA, 2011, FEBS J, V278, P1175, DOI 10.1111/j.1742-4658.2011.08043.x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; HELDT HW, 1973, BIOCHIM BIOPHYS ACTA, V314, P224, DOI 10.1016/0005-2728(73)90137-0; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v; Kaplan F, 2006, PHYSIOL PLANTARUM, V126, P120, DOI [10.1111/j.1399-3054.2006.00604.x, 10.1111/j.1399-3054.2005.00604.x]; Kaplan F, 2005, PLANT J, V44, P730, DOI 10.1111/j.1365-313X.2005.02565.x; Kitajima A, 2009, PLANT CELL, V21, P2844, DOI 10.1105/tpc.109.068288; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; Kuriki T, 1999, J BIOSCI BIOENG, V87, P557, DOI 10.1016/S1389-1723(99)80114-5; Lemaire SD, 2007, CURR GENET, V51, P343, DOI 10.1007/s00294-007-0128-z; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; MCCLEARY BV, 1987, J CEREAL SCI, V6, P237, DOI 10.1016/S0733-5210(87)80061-9; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Mikkelsen R, 2005, P NATL ACAD SCI USA, V102, P1785, DOI 10.1073/pnas.0406674102; Mikkelsen R, 2006, BIOCHEMISTRY-US, V45, P4674, DOI 10.1021/bi051712a; Mori H, 2001, EUR J BIOCHEM, V268, P6545, DOI 10.1046/j.0014-2956.2001.02609.x; Nielsen JW, 2012, ARCH BIOCHEM BIOPHYS, V528, P1, DOI 10.1016/j.abb.2012.08.005; OKITA TW, 1979, PLANT PHYSIOL, V64, P187, DOI 10.1104/pp.64.2.187; Robert X, 2003, STRUCTURE, V11, P973, DOI 10.1016/S0969-2126(03)00151-5; Santelia D, 2011, PLANT CELL, V23, P4096, DOI 10.1105/tpc.111.092155; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Scialdone A, 2013, ELIFE, V2, DOI 10.7554/eLife.00669; Serrato AJ, 2004, J BIOL CHEM, V279, P43821, DOI 10.1074/jbc.M404696200; Silver DM, 2013, FEBS J, V280, P538, DOI 10.1111/j.1742-4658.2012.08546.x; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; SOGAARD M, 1993, J BIOL CHEM, V268, P22480; SOGAARD M, 1993, CARBOHYD POLYM, V21, P137, DOI 10.1016/0144-8617(93)90008-R; Sokolov LN, 2006, P NATL ACAD SCI USA, V103, P9732, DOI 10.1073/pnas.0603329103; Sparla F, 2006, PLANT PHYSIOL, V141, P840, DOI 10.1104/pp.106.079186; Stanley D, 2002, BIOLOGIA, V57, P137; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Streb S, 2012, J BIOL CHEM, V287, P41745, DOI 10.1074/jbc.M112.395244; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valerio C, 2011, J EXP BOT, V62, P545, DOI 10.1093/jxb/erq288; Weise SE, 2006, PLANT PHYSIOL, V141, P879, DOI 10.1104/pp.106.081174; WILLIAMS JF, 1973, CROP SCI, V13, P612, DOI 10.2135/cropsci1973.0011183X001300060008x; Wong JH, 2002, P NATL ACAD SCI USA, V99, P16325, DOI 10.1073/pnas.212641999; Yu TS, 2005, J BIOL CHEM, V280, P9773, DOI 10.1074/jbc.M413638200; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; ZIEGLER P, 1988, PLANT PHYSIOL, V86, P659, DOI 10.1104/pp.86.3.659; Ziegler P, 1999, J CEREAL SCI, V29, P195, DOI 10.1006/jcrs.1998.0238	57	68	72	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33620	33633		10.1074/jbc.M113.514794	http://dx.doi.org/10.1074/jbc.M113.514794			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24089528	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000327250200011
J	Wang, JY; Zhang, Y; Weng, WH; Qiao, YX; Ma, LF; Xiao, WF; Yu, YC; Pan, QH; Sun, FY				Wang, Jiayi; Zhang, Yue; Weng, Wenhao; Qiao, Yongxia; Ma, Lifang; Xiao, Weifan; Yu, Yongchun; Pan, Qiuhui; Sun, Fenyong			Impaired Phosphorylation and Ubiquitination by p70 S6 Kinase (p70S6K) and Smad Ubiquitination Regulatory Factor 1 (Smurf1) Promote Tribbles Homolog 2 (TRIB2) Stability and Carcinogenic Property in Liver Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Gene Regulation; Hepatocellular Carcinoma; Phosphorylation; Post-translational Modification	LIGASE SMURF1; C/EBP-ALPHA; DEGRADATION; ACTIVATION; RAPAMYCIN; DOMAIN; TUMORIGENESIS; LOCALIZATION; CONTRIBUTES; RESISTANCE	Tribbles homolog 2 (TRIB2) is critical for both solid and non-solid malignancies. Recently, TRIB2 was identified as a liver cancer-specific Wnt/-catenin signaling downstream target and is functionally important for liver cancer cell survival and transformation. TRIB2 functions as a protein that interacts with E3 ubiquitin ligases and thereby modulates protein stability of downstream effectors. However, the regulation underlying TRIB2 protein stability per se has not yet been reported. In this study, we found that TRIB2 was up-regulated and exhibited high stability in liver cancer cells compared with other cells. We performed a structure-function analysis of TRIB2 and identified a domain (amino acids 1-5) at the N terminus that interacted with the E3 ubiquitin ligase Smurf1 and was critical for protein stability. Deletion of this domain extended TRIB2 half-life time accompanied with a more significant malignant property compared with wild type TRIB2. Furthermore, Smurf1-mediated ubiquitination required phosphorylation of TRIB2 by p70 S6 kinase (p70S6K) via another domain (amino acids 69-85) that is also essential for correct TRIB2 subcellular localization. Mutation of Ser-83 diminished p70S6K-induced phosphorylation of TRIB2. Moreover, the high stability of TRIB2 may be due to the fact that both p70S6K and Smurf1 were down-regulated and negatively correlated with TRIB2 expression in both liver cancer tissues and established liver cancer cell lines. Taken together, impaired phosphorylation and ubiquitination by p70S6K and Smurf1 increase the protein stability of TRIB2 in liver cancer and thus may be helpful in the development of diagnosis and treatment strategies against this malignant disease.	[Wang, Jiayi; Weng, Wenhao; Ma, Lifang; Sun, Fenyong] Tongji Univ, Dept Clin Lab Med, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China; [Zhang, Yue; Xiao, Weifan; Yu, Yongchun; Pan, Qiuhui] Tongji Univ, Dept Cent Lab, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China; [Qiao, Yongxia] Shanghai Jiao Tong Univ, Sch Publ Hlth, Sch Med, Shanghai 200025, Peoples R China	Tongji University; Tongji University; Shanghai Jiao Tong University	Pan, QH (corresponding author), Tongji Univ, Dept Cent Lab, Shanghai Peoples Hosp 10, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.	panqiuhui@263.net; sunfenyong@126.com		Wang, Jiayi/0000-0003-1688-2864	973 Program [2011CBA01100, 2012CB966900]; Natural Science Foundation of China [81272292, 81071524, 81201884]; 5810 Training Program from Shanghai Tenth People's Hospital	973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 5810 Training Program from Shanghai Tenth People's Hospital	This work was supported by 973 Program Grants 2011CBA01100 and 2012CB966900; Natural Science Foundation of China Grants 81272292, 81071524, and 81201884; and the 5810 Training Program (to J. W.) from Shanghai Tenth People's Hospital.	Chen YL, 2013, J PATHOL, V229, P486, DOI 10.1002/path.4130; COFFER PJ, 1994, BIOCHEM BIOPH RES CO, V198, P780, DOI 10.1006/bbrc.1994.1112; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Grandinetti KB, 2011, ONCOGENE, V30, P3328, DOI 10.1038/onc.2011.57; Guo X, 2011, J BIOL CHEM, V286, P18037, DOI 10.1074/jbc.M111.225615; Hannon MM, 2012, BRIT J HAEMATOL, V158, P626, DOI 10.1111/j.1365-2141.2012.09222.x; Iwanami A, 2013, P NATL ACAD SCI USA, V110, P4339, DOI 10.1073/pnas.1217602110; Jimenez RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007373; Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012; Keeshan K, 2010, BLOOD, V116, P4948, DOI 10.1182/blood-2009-10-247361; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Nie J, 2010, J BIOL CHEM, V285, P22816, DOI 10.1074/jbc.M110.126920; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Soond SM, 2011, ONCOGENE, V30, P2451, DOI 10.1038/onc.2010.617; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Totary-Jain H, 2013, J BIOL CHEM, V288, P6034, DOI 10.1074/jbc.M112.416446; Wang JY, 2013, HEPATOLOGY, V58, P1011, DOI 10.1002/hep.26420; Wang JY, 2013, MOL CELL, V51, P211, DOI 10.1016/j.molcel.2013.05.013; Xie P, 2011, BIOCHEM BIOPH RES CO, V407, P254, DOI 10.1016/j.bbrc.2011.03.016; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zanella F, 2010, ONCOGENE, V29, P2973, DOI 10.1038/onc.2010.58; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	29	30	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33667	33681		10.1074/jbc.M113.503292	http://dx.doi.org/10.1074/jbc.M113.503292			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24089522	Green Published, hybrid			2022-12-25	WOS:000327250200015
J	Alfred, RL; Palombo, EA; Panozzo, JF; Bhave, M				Alfred, Rebecca L.; Palombo, Enzo A.; Panozzo, Joseph F.; Bhave, Mrinal			The Antimicrobial Domains of Wheat Puroindolines Are Cell-Penetrating Peptides with Possible Intracellular Mechanisms of Action	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; FORM ION CHANNELS; GRAIN HARDNESS; SACCHAROMYCES-CEREVISIAE; MOLECULAR-GENETICS; TRYPTOPHAN-RICH; MEMBRANES; INDOLICIDIN; EXPRESSION; RESISTANCE	The puroindoline proteins (PINA and PINB) of wheat display lipid-binding properties which affect the grain texture, a critical parameter for wheat quality. Interestingly, the same proteins also display antibacterial and antifungal properties, attributed mainly to their Tryptophan-rich domain (TRD). Synthetic peptides based on this domain also display selectivity towards bacterial and fungal cells and do not cause haemolysis of mammalian cells. However, the mechanisms of these activities are unclear, thus limiting our understanding of the in vivo roles of PINs and development of novel applications. This study investigated the mechanisms of antimicrobial activities of synthetic peptides based on the TRD of the PINA and PINB proteins. Calcein dye leakage tests and transmission electron microscopy showed that the peptides PuroA, Pina-M and Pina-W -> F selectively permeabilised the large unilamellar vesicles (LUVs) made with negatively charged phospholipids mimicking bacterial membranes, but were ineffective against LUVs made with zwitterionic phospholipids mimicking eukaryotic membranes. Propidium iodide fluorescence tests of yeast (Saccharomyces cerevisiae) cells showed the peptides were able to cause loss of membrane integrity, PuroA and Pina-M being more efficient. Scanning electron micrographs of PINA-based peptide treated yeast cells showed the formation of pits or pores in cell membranes and release of cellular contents. Gel retardation assays indicated the peptides were able to bind to DNA in vitro, and the induction of filamental growth of E. coli cells indicated in vivo inhibition of DNA synthesis. Together, the results strongly suggest that the PIN-based peptides exert their antimicrobial effects by pore formation in the cell membrane, likely by a carpet-like mechanism, followed by intracellular mechanisms of activity.	[Alfred, Rebecca L.; Palombo, Enzo A.; Bhave, Mrinal] Swinburne Univ Technol, Fac Life & Social Sci, Environm & Biotechnol Ctr, Melbourne, Vic, Australia; [Panozzo, Joseph F.] Dept Environm & Primary Ind, Horsham, Vic, Australia	Swinburne University of Technology	Bhave, M (corresponding author), Swinburne Univ Technol, Fac Life & Social Sci, Environm & Biotechnol Ctr, Melbourne, Vic, Australia.	mbhave@swin.edu.au	Palombo, Enzo/AAV-8632-2021	Palombo, Enzo/0000-0001-5889-1393; /0000-0003-3011-9953	Australian Research Council (ARC) Linkage Grant [LP0989191]	Australian Research Council (ARC) Linkage Grant(Australian Research Council)	This research was supported by the Australian Research Council (ARC) Linkage Grant LP0989191. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfred RL, 2013, WORLD J MICROB BIOT, P1; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; Bhave M, 2008, PLANT MOL BIOL, V66, P221, DOI 10.1007/s11103-007-9264-6; Bhave M, 2008, PLANT MOL BIOL, V66, P205, DOI 10.1007/s11103-007-9263-7; Capparelli R, 2005, PLANT MOL BIOL, V58, P857, DOI 10.1007/s11103-005-8270-9; Capparelli R, 2007, J BIOTECHNOL, V128, P606, DOI 10.1016/j.jbiotec.2006.11.004; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Charnet P, 2003, BIOPHYS J, V84, P2416, DOI 10.1016/S0006-3495(03)75046-2; Chen F, 2006, THEOR APPL GENET, V112, P400, DOI 10.1007/s00122-005-0095-z; Chen F, 2005, J CEREAL SCI, V42, P267, DOI 10.1016/j.jcs.2005.03.004; Chen P, 2008, TALANTA, V77, P262, DOI 10.1016/j.talanta.2008.06.018; Chou HT, 2010, PEPTIDES, V31, P1811, DOI 10.1016/j.peptides.2010.06.021; Davey HM, 2011, ENVIRON MICROBIOL, V13, P163, DOI 10.1111/j.1462-2920.2010.02317.x; Donachie W. D., 1987, ESCHERICHIA COLI SAL, P1578; Dubreil L, 1998, PLANT SCI, V138, P121, DOI 10.1016/S0168-9452(98)00121-6; Espinel-Ingroff A, 2007, ANTIMICROBIAL SUSCEP, P173; Evrard A, 2008, J CEREAL SCI, V48, P379, DOI 10.1016/j.jcs.2007.11.001; Faize M, 2004, PLANT SCI, V167, P347, DOI 10.1016/j.plantsci.2004.04.003; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Fang B, 2013, FEBS J, V280, P1007, DOI 10.1111/febs.12093; GAUTIER MF, 1994, PLANT MOL BIOL, V25, P43, DOI 10.1007/BF00024197; Giroux MJ, 1997, THEOR APPL GENET, V95, P857, DOI 10.1007/s001220050636; Giroux MJ, 1998, P NATL ACAD SCI USA, V95, P6262, DOI 10.1073/pnas.95.11.6262; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Gonzalez CF, 2002, PHYTOPATHOLOGY, V92, P917, DOI 10.1094/PHYTO.2002.92.8.917; Gunderson CW, 2006, MOL MICROBIOL, V59, P1129, DOI 10.1111/j.1365-2958.2005.05009.x; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hsu CH, 2005, NUCLEIC ACIDS RES, V33, P4053, DOI 10.1093/nar/gki725; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jing W, 2003, J PEPT RES, V61, P219, DOI 10.1034/j.1399-3011.2003.00050.x; Jing WG, 2003, J BACTERIOL, V185, P4938, DOI 10.1128/JB.185.16.4938-4947.2003; Kim KH, 2012, J PHYTOPATHOL, V160, P243, DOI 10.1111/j.1439-0434.2012.01881.x; Kooijman M, 1998, J CEREAL SCI, V28, P43, DOI 10.1006/jcrs.1998.0193; Krishnamurthy K, 2001, MOL PLANT MICROBE IN, V14, P1255, DOI 10.1094/MPMI.2001.14.10.1255; Le Guerneve C, 1998, ARCH BIOCHEM BIOPHYS, V360, P179, DOI 10.1006/abbi.1998.0931; Lillemo M, 2000, THEOR APPL GENET, V100, P1100, DOI 10.1007/s001220051392; Llanos P, 2006, FEBS J, V273, P1710, DOI 10.1111/j.1742-4658.2006.05185.x; Lundblad V, 2008, CURRENT PROTOCOLS MO; Luo L, 2008, MOL BIOL REP, V35, P195, DOI 10.1007/s11033-007-9070-x; LUTKENHAUS J, 1990, TRENDS GENET, V6, P22, DOI 10.1016/0168-9525(90)90045-8; Marion D, 1994, WHEAT KERNEL PROTEIN, P175; Miao Y, 2012, AMINO ACIDS, P1; Morris CF, 2002, PLANT MOL BIOL, V48, P633, DOI 10.1023/A:1014837431178; Nan YH, 2009, FEMS MICROBIOL LETT, V292, P134, DOI 10.1111/j.1574-6968.2008.01484.x; Pan Z, 2004, CEREAL CHEM, V81, P287, DOI 10.1094/CCHEM.2004.81.2.287; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Pauly A, 2013, COMPR REV FOOD SCI F, V12, P413, DOI 10.1111/1541-4337.12019; Pauly A, 2013, COMPR REV FOOD SCI F, V12, P427, DOI 10.1111/1541-4337.12018; Phillips RL, 2011, J CEREAL SCI, V53, P112, DOI 10.1016/j.jcs.2010.10.005; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; Schibli DJ, 2006, BIOPHYS J, V91, P4413, DOI 10.1529/biophysj.106.085837; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; Subbalakshmi C, 1998, FEMS MICROBIOL LETT, V160, P91, DOI 10.1016/S0378-1097(98)00008-1; Teixeira V, 2012, PROG LIPID RES, V51, P149, DOI 10.1016/j.plipres.2011.12.005; Yu LL, 2012, CHEM J CHINESE U, V33, P2681, DOI 10.7503/cjcu20120476	56	38	39	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75488	10.1371/journal.pone.0075488	http://dx.doi.org/10.1371/journal.pone.0075488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098387	Green Published, gold			2022-12-25	WOS:000325434500034
J	Woo, CC; Hsu, A; Kumar, AP; Sethi, G; Tan, KHB				Woo, Chern Chiuh; Hsu, Annie; Kumar, Alan Prem; Sethi, Gautam; Tan, Kwong Huat Benny			Thymoquinone Inhibits Tumor Growth and Induces Apoptosis in a Breast Cancer Xenograft Mouse Model: The Role of p38 MAPK and ROS	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTIONAL REPRESSOR; CELL-DEATH; IN-VITRO; PATHWAY; CISPLATIN; PROLIFERATION; SUPPRESSION; MECHANISM; PRODUCTS	Due to narrow therapeutic window of cancer therapeutic agents and the development of resistance against these agents, there is a need to discover novel agents to treat breast cancer. The antitumor activities of thymoquinone (TQ), a compound isolated from Nigella sativa oil, were investigated in breast carcinoma in vitro and in vivo. Cell responses after TQ treatment were assessed by using different assays including MTT assay, annexin V-propidium iodide staining, Mitosox staining and Western blot. The antitumor effect was studied by breast tumor xenograft mouse model, and the tumor tissues were examined by histology and immunohistochemistry. The level of antioxidant enzymes/molecules in mouse liver tissues was measured by commercial kits. Here, we show that TQ induced p38 phosphorylation and ROS production in breast cancer cells. These inductions were found to be responsible for TQ's anti-proliferative and pro-apoptotic effects. Moreover, TQ-induced ROS production regulated p38 phosphorylation but not vice versa. TQ treatment was found to suppress the tumor growth and this effect was further enhanced by combination with doxorubicin. TQ also inhibited the protein expression of anti-apoptotic genes, such as XIAP, survivin, Bcl-xL and Bcl-2, in breast cancer cells and breast tumor xenograft. Reduced Ki67 and increased TUNEL staining were observed in TQ-treated tumors. TQ was also found to increase the level of catalase, superoxide dismutase and glutathione in mouse liver tissues. Overall, our results demonstrated that the anti-proliferative and pro-apoptotic effects of TQ in breast cancer are mediated through p38 phosphorylation via ROS generation.	[Woo, Chern Chiuh; Hsu, Annie; Kumar, Alan Prem; Sethi, Gautam; Tan, Kwong Huat Benny] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Kumar, Alan Prem; Sethi, Gautam] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117595, Singapore; [Kumar, Alan Prem] Curtin Univ, Fac Hlth Sci, Sch Biomed Sci, Perth, WA 6845, Australia; [Kumar, Alan Prem] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	National University of Singapore; National University of Singapore; Curtin University; University of North Texas System; University of North Texas Denton	Sethi, G (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore.	phcgs@nus.edu.sg; benny_tan@nuhs.edu.sg	Sethi, Gautam/F-2372-2011; Kumar, Alan Prem/ABE-7492-2020	Sethi, Gautam/0000-0002-8677-8475; Kumar, Alan Prem/0000-0002-3754-5712	NUS Academic Research Fund [R-184-000-207-112]; National Medical Research Council of Singapore [R-184-000-211-213]	NUS Academic Research Fund; National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by grants from NUS Academic Research Fund (R-184-000-207-112) and National Medical Research Council of Singapore (R-184-000-211-213) to GS. (http://www.nuhs.edu.sg/research/funding/funding-opportunities/individual-research-grants/academic-research-fund-tier-1-university-research-committee.html) (http://www.nmrc.gov.sg/content/nmrc_internet/home.html) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe JI, 2000, J BIOL CHEM, V275, P1739, DOI 10.1074/jbc.275.3.1739; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Al-Shabanah OA, 1998, J EXP CLIN CANC RES, V17, P193; Alhosin M, 2010, BIOCHEM PHARMACOL, V79, P1251, DOI 10.1016/j.bcp.2009.12.015; Attoub S, 2013, FUND CLIN PHARMACOL, V27, P557, DOI 10.1111/j.1472-8206.2012.01056.x; Badary OA, 1997, CAN J PHYSIOL PHARM, V75, P1356, DOI 10.1139/cjpp-75-12-1356; Banerjee S, 2009, CANCER RES, V69, P5575, DOI 10.1158/0008-5472.CAN-08-4235; Behr Thomas M, 2003, Curr Opin Investig Drugs, V4, P1059; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Choi SY, 2012, INFLAMM RES, V61, P493, DOI 10.1007/s00011-012-0437-7; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; El-Najjar N, 2010, APOPTOSIS, V15, P183, DOI 10.1007/s10495-009-0421-z; Gali-Muhtasib H, 2004, INT J ONCOL, V25, P857; Gali-Muhtasib H, 2008, CANCER RES, V68, P5609, DOI 10.1158/0008-5472.CAN-08-0884; Gali-Muhtasib H, 2008, J CELL MOL MED, V12, P330, DOI 10.1111/j.1582-4934.2007.00095.x; Hussain AR, 2011, FREE RADICAL BIO MED, V50, P978, DOI 10.1016/j.freeradbiomed.2010.12.034; Jafri SH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-87; Kang YH, 2008, J CELL PHYSIOL, V217, P23, DOI 10.1002/jcp.21470; Kaseb AO, 2007, CANCER RES, V67, P7782, DOI 10.1158/0008-5472.CAN-07-1483; Koka PS, 2010, EXP BIOL MED, V235, P751, DOI 10.1258/ebm.2010.009369; Lei XF, 2012, BIOCHEM BIOPH RES CO, V417, P864, DOI 10.1016/j.bbrc.2011.12.063; Li F, 2010, BRIT J PHARMACOL, V161, P541, DOI 10.1111/j.1476-5381.2010.00874.x; Liao Y, 2003, MOL CELL BIOL, V23, P6836, DOI 10.1128/MCB.23.19.6836-6848.2003; Maillet A, 2012, ANTIOXID REDOX SIGN, V16, P1285, DOI 10.1089/ars.2011.4434; Mansour MA, 2002, CELL BIOCHEM FUNCT, V20, P143, DOI 10.1002/cbf.968; Martin-Cordero C, 2012, CURR DRUG TARGETS, V13, P1006, DOI 10.2174/138945012802009044; Mohamed A, 2003, BIOMED SCI INSTRUM, V39, P440; Molnar A, 1997, J BIOL CHEM, V272, P13229, DOI 10.1074/jbc.272.20.13229; Nadeau PJ, 2012, MOL IMMUNOL, V49, P582, DOI 10.1016/j.molimm.2011.10.007; Naviaux RK, 2012, J PHARMACOL EXP THER, V342, P608, DOI 10.1124/jpet.112.192120; Pan JS, 2009, WORLD J GASTROENTERO, V15, P1702, DOI 10.3748/wjg.15.1702; Pargellis Christopher, 2003, Curr Opin Investig Drugs, V4, P566; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Sankaranarayanan C, 2011, CHEM-BIOL INTERACT, V190, P148, DOI 10.1016/j.cbi.2011.02.029; Sethi G, 2008, MOL CANCER RES, V6, P1059, DOI 10.1158/1541-7786.MCR-07-2088; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje; Woo CC, 2012, BIOCHEM PHARMACOL, V83, P443, DOI 10.1016/j.bcp.2011.09.029; Woo CC, 2011, BIOCHEM PHARMACOL, V82, P464, DOI 10.1016/j.bcp.2011.05.030; Xiu M, 2003, MOL CELL BIOL, V23, P8890, DOI 10.1128/MCB.23.23.8890-8901.2003	43	118	120	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75356	10.1371/journal.pone.0075356	http://dx.doi.org/10.1371/journal.pone.0075356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098377	Green Published, gold			2022-12-25	WOS:000325434500027
J	Brennan, LD; Roland, T; Morton, DG; Fellman, SM; Chung, SY; Soltani, M; Kevek, JW; McEuen, PM; Kemphues, KJ; Wang, MD				Brennan, Lucy D.; Roland, Thibault; Morton, Diane G.; Fellman, Shanna M.; Chung, SueYeon; Soltani, Mohammad; Kevek, Joshua W.; McEuen, Paul M.; Kemphues, Kenneth J.; Wang, Michelle D.			Small Molecule Injection into Single-Cell C. elegans Embryos via Carbon-Reinforced Nanopipettes	PLOS ONE			English	Article							ANTERIOR-POSTERIOR AXIS; PAR PROTEINS; POLARITY; MYOSIN; POLARIZATION; ESTABLISHMENT; REORGANIZATION; MICROINJECTION; MICROFILAMENTS; COMMUNICATION	The introduction of chemical inhibitors into living cells at specific times in development is a useful method for investigating the roles of specific proteins or cytoskeletal components in developmental processes. Some embryos, such as those of Caenorhabditis elegans, however, possess a tough eggshell that makes introducing drugs and other molecules into embryonic cells challenging. We have developed a procedure using carbon-reinforced nanopipettes (CRNPs) to deliver molecules into C. elegans embryos with high temporal control. The use of CRNPs allows for cellular manipulation to occur just subsequent to meiosis II with minimal damage to the embryo. We have used our technique to replicate classical experiments using latrunculin A to inhibit microfilaments and assess its effects on early polarity establishment. Our injections of latrunculin A confirm the necessity of microfilaments in establishing anterior-posterior polarity at this early stage, even when microtubules remain intact. Further, we find that latrunculin A treatment does not prevent association of PAR-2 or PAR-6 with the cell cortex. Our experiments demonstrate the application of carbon-reinforced nanopipettes to the study of one temporally-confined developmental event. The use of CRNPs to introduce molecules into the embryo should be applicable to investigations at later developmental stages as well as other cells with tough outer coverings.	[Brennan, Lucy D.; Roland, Thibault; Fellman, Shanna M.; Chung, SueYeon; Soltani, Mohammad; Kevek, Joshua W.; McEuen, Paul M.; Wang, Michelle D.] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Roland, Thibault; Fellman, Shanna M.; Chung, SueYeon; Soltani, Mohammad; Wang, Michelle D.] Cornell Univ, Howard Hughes Med Inst, Ithaca, NY USA; [Morton, Diane G.; Kemphues, Kenneth J.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; Cornell University; Howard Hughes Medical Institute; Cornell University	Kemphues, KJ (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	kjk1@cornell.edu; mdw17@cornell.edu	Chung, SueYeon/ABI-7940-2020	Brennan, Lucy/0000-0002-4019-6904; Chung, SueYeon/0000-0001-5726-4865	NSF MRSEC program [DMR-1120296]; NIH [GM059849, GM79112, T32GM008267]; NSF [MCB-0820293]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008267, R01GM079112, R01GM059849] Funding Source: NIH RePORTER	NSF MRSEC program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work made use of the Cornell Center for Materials Research Shared Facilities which are supported through the NSF MRSEC program (DMR-1120296). We wish to acknowledge support from NIH grants (GM059849 to M.D.W; GM79112 to KJK), an NIH Molecular Biophysics Training grant (T32GM008267, traineeship for LB), and an NSF grant (MCB-0820293 to M.D.W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono S, 2004, DEVELOPMENT, V131, P2865, DOI 10.1242/dev.01146; BOSSINGER O, 1992, DEV BIOL, V151, P401, DOI 10.1016/0012-1606(92)90180-O; Bossinger O, 1996, DEV GENES EVOL, V206, P25, DOI 10.1007/s004270050027; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRENNER S, 1974, GENETICS, V77, P71; Carvalho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024656; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Chitwood BG, 1974, INTRO NEMATOADE; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Cowan CR, 2007, DEVELOPMENT, V134, P1035, DOI 10.1242/dev.000513; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Goehring NW, 2011, SCIENCE, V334, P1137, DOI 10.1126/science.1208619; Goehring NW, 2011, J CELL BIOL, V193, P583, DOI 10.1083/jcb.201011094; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gonczy P., 2005, ASYMMETRIC CELL DIVI; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; HILL DP, 1990, DEVELOPMENT, V108, P159; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Hung TJ, 1999, DEVELOPMENT, V126, P127; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Johnston WL, 2012, GENESIS, V50, P333, DOI 10.1002/dvg.20823; Johnston WL, 2006, BIOMED CENTRAL BIOL, V4; KIRBY C, 1990, DEV BIOL, V142, P203, DOI 10.1016/0012-1606(90)90164-E; Laffafian I, 1998, BIOPHYS J, V75, P2558, DOI 10.1016/S0006-3495(98)77700-8; Lee JY, 2003, DEVELOPMENT, V130, P307, DOI 10.1242/dev.00211; Motegi F, 2011, NAT CELL BIOL, V13, P1361, DOI 10.1038/ncb2354; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Munro E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003400; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Noatynska A, 2012, ESSAYS BIOCHEM, V53, P1, DOI [10.1042/BSE0530001, 10.1042/bse0530001]; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; Olson SK, 2012, J CELL BIOL, V198, P731, DOI 10.1083/jcb.201206008; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Schonegg S, 2006, DEVELOPMENT, V133, P3507, DOI 10.1242/dev.02527; Schrlau MG, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/01/015101; Schrlau MG, 2009, ACS NANO, V3, P563, DOI 10.1021/nn800851d; Schrlau MG, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/32/325102; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Stone TW, 1985, MICROIONTOPHORESIS P; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Tagawa A, 2001, DEV BIOL, V233, P412, DOI 10.1006/dbio.2001.0234; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tsai MC, 2007, J CELL BIOL, V179, P397, DOI 10.1083/jcb.200708101; Velarde N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-142; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Wang XY, 2013, CHEM SOC REV, V42, P202, DOI 10.1039/c2cs35259a; Watts JL, 1996, DEVELOPMENT, V122, P3133; Wood E., 1994, BIOCHEM EDUC, V22, P83, DOI [10.1016/0307-4412(94)90083-3, DOI 10.1016/0307-4412(94)90083-3]; Zhang Y, 2007, MICROINJECTION TECHN; Zhang Y, 2008, BIOESSAYS, V30, P606, DOI 10.1002/bies.20759; Zonies S, 2010, DEVELOPMENT, V137, P1669, DOI 10.1242/dev.045823	59	9	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75712	10.1371/journal.pone.0075712	http://dx.doi.org/10.1371/journal.pone.0075712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086620	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000036
J	Buggele, WA; Krause, KE; Horvath, CM				Buggele, William A.; Krause, Katherine E.; Horvath, Curt M.			Small RNA Profiling of Influenza A Virus-Infected Cells Identifies miR-449b as a Regulator of Histone Deacetylase 1 and Interferon Beta	PLOS ONE			English	Article							MICRORNA EXPRESSION; CELLULAR MICRORNAS; GENE-EXPRESSION; INNATE IMMUNITY; RIG-I; PROTEIN; TRANSCRIPTION; OLIGONUCLEOTIDE; DEADENYLATION; REQUIREMENT	The mammalian antiviral response relies on the alteration of cellular gene expression, to induce the production of antiviral effectors and regulate their activities. Recent research has indicated that virus infections can induce the accumulation of cellular microRNA (miRNA) species that influence the stability of host mRNAs and their protein products. To determine the potential for miRNA regulation of cellular responses to influenza A virus infection, small RNA profiling was carried out using next generation sequencing. Comparison of miRNA expression profiles in uninfected human A549 cells to cells infected with influenza A virus strains A/Udorn/72 and A/WSN/33, revealed virus-induced changes in miRNA abundance. Gene expression analysis identified mRNA targets for a cohort of highly inducible miRNAs linked to diverse cellular functions. Experiments demonstrate that the histone deacetylase, HDAC1, can be regulated by influenza-inducible miR-449b, resulting in altered mRNA and protein levels. Expression of miR-449b enhances virus and poly(I: C) activation of the IFN beta promoter, a process known to be negatively regulated by HDAC1. These findings demonstrate miRNA induction by influenza A virus infection and elucidate an example of miRNA control of antiviral gene expression in human cells, defining a role for miR-449b in regulation of HDAC1 and antiviral cytokine signaling.	[Buggele, William A.; Krause, Katherine E.; Horvath, Curt M.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Horvath, CM (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	horvath@northwestern.edu		Horvath, Curt/0000-0003-2449-225X	NIH from the NIAID IMVC program [U01AI082984]; NIH from the Malkin Scholars Award; NIH from the Cell and Molecular Basis of Disease Pre-doctoral training grant [T32 GM008061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	NIH from the NIAID IMVC program; NIH from the Malkin Scholars Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from the Cell and Molecular Basis of Disease Pre-doctoral training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH Grant U01AI082984 from the NIAID IMVC program to CMH and a the Malkin Scholars Award and the Cell and Molecular Basis of Disease Pre-doctoral training grant (T32 GM008061) to WAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Buggele WA, 2013, J VIROL, V87, P9260, DOI 10.1128/JVI.01064-13; Buggele WA, 2012, J BIOL CHEM, V287, P31027, DOI 10.1074/jbc.M112.387670; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Control CfD, 2010, MMWR-MORBID MORTAL W, V59, P1057; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Ford E, 2010, BBA-GENE REGUL MECH, V1799, P328, DOI 10.1016/j.bbagrm.2010.01.010; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Icardi L, 2012, FASEB J, V26, P240, DOI 10.1096/fj.11-191122; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Klampfer L, 2004, J BIOL CHEM, V279, P30358, DOI 10.1074/jbc.M401359200; KRUG RM, 1979, CELL, V18, P329, DOI 10.1016/0092-8674(79)90052-7; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2011, VIROLOGY, V421, P105, DOI 10.1016/j.virol.2011.09.011; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Lize M, 2010, CELL CYCLE, V9, P4579, DOI 10.4161/cc.9.22.13870; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Miyoshi Keita, 2008, V442, P29, DOI 10.1007/978-1-59745-191-8_3; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Nusinzon Inna, 2005, Sci STKE, V2005, pre11, DOI 10.1126/stke.2962005re11; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Peng X, 2011, MBIO, V2; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Primo MN, 2012, CYTOKINE, V60, P741, DOI 10.1016/j.cyto.2012.07.031; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Terrier O, 2013, J GEN VIROL, V94, P985, DOI 10.1099/vir.0.049528-0; Thornburg NJ, 2012, MBIO, V3, DOI 10.1128/mBio.00220-12; Umbach JL, 2010, MBIO, V1, DOI 10.1128/mBio.00204-10; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhao H, 2012, J HEPATOL, V56, P326, DOI 10.1016/j.jhep.2011.07.026; Zhao PS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-159; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	59	34	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76560	10.1371/journal.pone.0076560	http://dx.doi.org/10.1371/journal.pone.0076560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086750	gold, Green Published, Green Submitted			2022-12-25	WOS:000325220000069
J	Granato, M; Santarelli, R; Lotti, LV; Di Renzo, L; Gonnella, R; Garufi, A; Trivedi, P; Frati, L; D'Orazi, G; Faggioni, A; Cirone, M				Granato, Marisa; Santarelli, Roberta; Lotti, Lavinia V.; Di Renzo, Livia; Gonnella, Roberta; Garufi, Alessia; Trivedi, Pankaj; Frati, Luigi; D'Orazi, Gabriella; Faggioni, Alberto; Cirone, Mara			JNK and Macroautophagy Activation by Bortezomib Has a Pro-Survival Effect in Primary Effusion Lymphoma Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; LUNG-CANCER CELLS; PROTEASOME INHIBITOR; CELLULAR-RESPONSE; INDUCED AUTOPHAGY; MYELOMA CELLS; APOPTOSIS; DEATH; P62/SQSTM1	Understanding the mechanisms of autophagy induction and its role during chemotherapeutic treatments is of fundamental importance in order to manipulate it to improve the outcome of chemotherapy. In particular whether the bortezomib-induced autophagy plays a pro-survival or pro-death role is still controversial. In this study we investigated if bortezomib induced endoplasmic reticulum (ER) stress and activated autophagy in Primary Effusion Lymphoma (PEL) cells and how they influenced cell survival. We found that bortezomib induced up-regulation of the pro-survival and pro-death ER stress molecules BIP and CHOP and activated c-Jun NH2-terminal kinase (JNK), resulting in Bcl-2 phosphorylation and induction of autophagy. JNK and autophagy activation played a pro-survival role in this setting, thus their inhibition increased the bortezomib cytotoxic effect and PARP cleavage in PEL cells. Based on our results we suggest that the combination of bortezomib with JNK or autophagy inhibitors could be exploited to improve the outcome of therapy of this aggressive B cell lymphoma.	[Granato, Marisa; Santarelli, Roberta; Lotti, Lavinia V.; Di Renzo, Livia; Gonnella, Roberta; Trivedi, Pankaj; Frati, Luigi; Faggioni, Alberto; Cirone, Mara] Univ Roma La Sapienza, Dept Expt Med, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Garufi, Alessia; D'Orazi, Gabriella] Regina Elena Inst Canc Res, Dept Expt Oncol, Mol Oncogenesis Lab, Rome, Italy; [D'Orazi, Gabriella] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; G d'Annunzio University of Chieti-Pescara	Faggioni, A (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy.	alberto.faggioni@uniroma1.it; mara.cirone@uniroma1.it	Gonnella, Roberta/Y-5564-2019; Di Renzo, Livia/D-1143-2013; Granato, Marisa/K-6203-2014; Gonnella, Roberta/R-2028-2016; Garufi, Alessia/AAT-3363-2020; Santarelli, Roberta/K-5434-2015; D'Orazi, Gabriella/T-2792-2019; Frati, Luigi/ABI-7437-2020	Gonnella, Roberta/0000-0003-4894-4986; Di Renzo, Livia/0000-0003-3807-0760; Gonnella, Roberta/0000-0003-4894-4986; Santarelli, Roberta/0000-0002-9416-7594; D'Orazi, Gabriella/0000-0001-6876-9105; Garufi, Alessia/0000-0001-9354-993X; , Marisa/0000-0002-2758-5120	MIUR; Associazione Italiana per la Ricerca (AIRC) [Nu 10265]; Patseur Cenci-Bolognetti Foundation	MIUR(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca (AIRC)(Fondazione AIRC per la ricerca sul cancro); Patseur Cenci-Bolognetti Foundation	This work was supported by MIUR, Associazione Italiana per la Ricerca (AIRC) Nu 10265 and Patseur Cenci-Bolognetti Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Benoit M, 2011, J SURG RES, V167, pE193, DOI 10.1016/j.jss.2011.01.015; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Butterfield L, 1997, J BIOL CHEM, V272, P10110; Chari A, 2010, BIOL-TARGETS THER, V4, P273, DOI 10.2147/BTT.S3419; Cirone M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031732; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Hoang B, 2009, MOL CANCER THER, V8, P1974, DOI 10.1158/1535-7163.MCT-08-1177; Hui B, 2012, CANCER-AM CANCER SOC, V118, P5560, DOI 10.1002/cncr.27586; Jager R, 2012, BIOL CELL, V104, P259, DOI 10.1111/boc.201100055; Jenner RG, 2003, P NATL ACAD SCI USA, V100, P10399, DOI 10.1073/pnas.1630810100; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kawaguchi T, 2011, INT J ONCOL, V38, P643, DOI 10.3892/ijo.2010.882; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li CY, 2012, CANCER LETT, V314, P102, DOI 10.1016/j.canlet.2011.09.020; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Matta H, 2005, CANCER BIOL THER, V4, P77, DOI 10.4161/cbt.4.1.1379; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Puca R, 2010, FREE RADICAL BIO MED, V48, P1338, DOI 10.1016/j.freeradbiomed.2010.02.015; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Trusina A, 2010, DIABETES OBES METAB, V12, P27, DOI 10.1111/j.1463-1326.2010.01274.x; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Verfaillie T, 2010, INT J CELL BIOL, V2010; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wu WKK, 2010, DRUG RESIST UPDATE, V13, P87, DOI 10.1016/j.drup.2010.04.003; Wu WKK, 2010, AUTOPHAGY, V6, P228, DOI 10.4161/auto.6.2.11042; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang Y, 2004, CANCER SCI, V95, P176, DOI 10.1111/j.1349-7006.2004.tb03200.x	42	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75965	10.1371/journal.pone.0075965	http://dx.doi.org/10.1371/journal.pone.0075965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086672	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000054
J	Sun, KY; Yang, W; Huang, YN; Wang, YZ; Xiang, L; Qi, JH				Sun, Kaiyue; Yang, Wei; Huang, Yanna; Wang, Yizhen; Xiang, Lan; Qi, Jianhua			Leu452His Mutation in Lipoprotein Lipase Gene Transfer Associated with Hypertriglyceridemia in Mice in vivo	PLOS ONE			English	Article							SKELETAL-MUSCLE; INSULIN SENSITIVITY; CHOLESTEROL LEVELS; HEPARIN-BINDING; TRANSGENIC MICE; PLASMID DNA; OVEREXPRESSION; ELECTROPORATION; HYPERLIPIDEMIA; RESISTANCE	Mutated mouse lipoprotein lipase (LPL) containing a leucine (L) to histidine (H) substitution at position 452 was transferred into mouse liver by hydrodynamics-based gene delivery (HD). Mutated-LPL (MLPL) gene transfer significantly increased the concentrations of plasma MLPL and triglyceride (TG) but significantly decreased the activity of plasma LPL. Moreover, the gene transfer caused adiposis hepatica and significantly increased TG content in mouse liver. To understand the effects of MLPL gene transfer on energy metabolism, we investigated the expression of key functional genes related to energy metabolism in the liver, epididymal fat, and leg muscles. The mRNA contents of hormone-sensitive lipase (HSL), adipose triglyceride lipase (ATGL), fatty acid-binding protein (FABP), and uncoupling protein (UCP) were found to be significantly reduced. Furthermore, we investigated the mechanism by which MLPL gene transfer affected fat deposition in the liver, fat tissue, and muscle. The gene expression and protein levels of forkhead Box O3 (FOXO3), AMP-activated protein kinase (AMPK), and peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha) were found to be remarkably decreased in the liver, fat and muscle. These results suggest that the Leu452His mutation caused LPL dysfunction and gene transfer of MLPL in vivo produced resistance to the AMPK/PGC-1 alpha signaling pathway in mice.	[Sun, Kaiyue; Yang, Wei; Xiang, Lan; Qi, Jianhua] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Yanna; Wang, Yizhen] Zhejiang Univ, Key Lab Feed & Anim Nutr Zhejiang Prov, Key Lab Mol Anim Nutr, Inst Feed Sci,Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Xiang, L (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China.	lxiang@zju.edu.cn	Yang, Wei/GWV-4107-2022; Yang, Wei/HIA-0360-2022	wang, yizhen/0000-0002-3908-7102	Special Fund for Cultivation and Breeding of New Transgenic Organism [2009ZX08009-144B]	Special Fund for Cultivation and Breeding of New Transgenic Organism	This study was supported financially by the Special Fund for Cultivation and Breeding of New Transgenic Organism (Grand No. 2009ZX08009-144B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBATE SL, 1990, J CARDIOVASC PHARM, V16, pS1, DOI 10.1097/00005344-199000169-00002; Arndt Claudia, 2012, Methods Mol Biol, V869, P49, DOI 10.1007/978-1-61779-821-4_5; Benlian P, 1996, AM J HUM GENET, V59, P431; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; Ferreira LDMCB, 2001, DIABETES, V50, P1064, DOI 10.2337/diabetes.50.5.1064; Hanyu O, 2004, ATHEROSCLEROSIS, V174, P385, DOI 10.1016/j.atherosclerosis.2004.01.034; Hanyu O, 2007, CLIN CHIM ACTA, V384, P118, DOI 10.1016/j.cca.2007.06.015; HIDE WA, 1992, J LIPID RES, V33, P167; Hill JS, 1998, J BIOL CHEM, V273, P30979, DOI 10.1074/jbc.273.47.30979; Hu Y, 2007, J LIPID RES, V48, P1681, DOI 10.1194/jlr.M600382-JLR200; Huang YN, 2012, GENE, V502, P87, DOI 10.1016/j.gene.2012.04.052; Jap TS, 2003, PANCREAS, V27, P122, DOI 10.1097/00006676-200308000-00003; Jensen DR, 1997, AM J PHYSIOL-REG I, V273, pR683, DOI 10.1152/ajpregu.1997.273.2.R683; Johansen CT, 2011, CURR OPIN LIPIDOL, V22, P247, DOI 10.1097/MOL.0b013e3283471972; Keiper T, 2001, J LIPID RES, V42, P1180; Kobayashi Y, 2002, EUR J BIOCHEM, V269, P4701, DOI 10.1046/j.1432-1033.2002.03179.x; Koike T, 2004, J BIOL CHEM, V279, P7521, DOI 10.1074/jbc.M311514200; LevakFrank S, 1997, J BIOL CHEM, V272, P17182, DOI 10.1074/jbc.272.27.17182; Liu EQ, 2005, METABOLISM, V54, P132, DOI 10.1016/j.metabol.2004.07.021; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lookene A, 2004, J BIOL CHEM, V279, P49964, DOI 10.1074/jbc.M407419200; Lutz EP, 2004, J BIOL CHEM, V279, P238, DOI 10.1074/jbc.M310559200; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Razzaghi H, 2000, HUM GENET, V107, P257, DOI 10.1007/s004390000367; Seip RL, 1998, EXERCISE SPORT SCI R, V26, P191; SHIMADA M, 1995, ARTERIOSCL THROM VAS, V15, P1688, DOI 10.1161/01.ATV.15.10.1688; VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626; Wang YZ, 2011, INT J MOL MED, V28, P617, DOI 10.3892/ijmm.2011.711; Xiang L, 2005, INT J MOL MED, V16, P1015; Xiang L, 2003, BIOCHEM BIOPH RES CO, V307, P440, DOI 10.1016/S0006-291X(03)01172-0; Yang T, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9134; Yang Yuhong, 2007, Journal of Genetics and Genomics, V34, P381, DOI 10.1016/S1673-8527(07)60041-1; Zsigmond E, 1997, HUM GENE THER, V8, P1921, DOI 10.1089/hum.1997.8.16-1921	33	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75462	10.1371/journal.pone.0075462	http://dx.doi.org/10.1371/journal.pone.0075462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086538	gold, Green Submitted, Green Published			2022-12-25	WOS:000325220000023
J	Hazai, D; Szudoczki, R; Ding, JD; Soderling, SH; Weinberg, RJ; Stonyi, P; Racz, B				Hazai, Diana; Szudoczki, Robert; Ding, Jindong; Soderling, Scott H.; Weinberg, Richard J.; Stonyi, Peter; Racz, Bence			Ultrastructural Abnormalities in CA1 Hippocampus Caused by Deletion of the Actin Regulator WAVE-1	PLOS ONE			English	Article							DENDRITIC SPINE MORPHOGENESIS; SYNAPTIC PLASTICITY; ARP2/3 COMPLEX; CENTRAL SYNAPSES; AMPA RECEPTORS; SMALL GTPASES; RHO-GTPASES; IN-VIVO; CYTOSKELETON; MEMORY	By conveying signals from the small GTPase family of proteins to the Arp2/3 complex, proteins of the WAVE family facilitate actin remodeling. The WAVE-1 isoform is expressed at high levels in brain, where it plays a role in normal synaptic processing, and is implicated in hippocampus-dependent memory retention. We used electron microscopy to determine whether synaptic structure is modified in the hippocampus of WAVE-1 knockout mice, focusing on the neuropil of CA1 stratum radiatum. Mice lacking WAVE-1 exhibited alterations in the morphology of both axon terminals and dendritic spines; the relationship between the synaptic partners was also modified. The abnormal synaptic morphology we observed suggests that signaling through WAVE-1 plays a critical role in establishing normal synaptic architecture in the rodent hippocampus.	[Hazai, Diana; Szudoczki, Robert; Stonyi, Peter; Racz, Bence] Szent Istvan Univ, Fac Vet Sci, Dept Anat & Histol, Budapest, Hungary; [Ding, Jindong] Duke Univ, Dept Ophthalmol, Duke Eye Ctr, Durham, NC USA; [Soderling, Scott H.] Duke Univ, Dept Cell Biol, Durham, NC USA; [Soderling, Scott H.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Weinberg, Richard J.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Weinberg, Richard J.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC USA	Hungarian University of Agriculture & Life Sciences; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Racz, B (corresponding author), Szent Istvan Univ, Fac Vet Sci, Dept Anat & Histol, Budapest, Hungary.	racz.bence@aotk.szie.hu	Weinberg, Richard/AAC-1898-2020; Rácz, Bence/J-4220-2019; Ding, Jindong/B-3324-2008	Rácz, Bence/0000-0002-1933-5332; Ding, Jindong/0000-0003-0427-0369; Weinberg, Richard/0000-0001-9689-7278	Hungarian Scientific Research Fund (OTKA) [K83830]; National Institutes of Health [NS-39444, NS-35527, 2R56-NS059957]; Hungarian Academy of Sciences;  [TAMOP-4.2.2.B-10/1];  [TAMOP-4.2.1.B-11/2/KMR-2011-0003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035527, R01NS039444, R56NS059957] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian Academy of Sciences(Hungarian Academy of Sciences); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge grants from the Hungarian Scientific Research Fund (OTKA, grant number K83830 to BR) and from the National Institutes of Health (NS-39444 and NS-35527 to RJW, and 2R56-NS059957 to SHS). The study was also sponsored by the TAMOP-4.2.2.B-10/1 and TAMOP-4.2.1.B-11/2/KMR-2011-0003 projects. BR is supported by the Janos Bolyai Research Fellowship from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Brunig I, 2004, NEUROPHARMACOLOGY, V47, P669, DOI 10.1016/j.neuropharm.2004.07.038; Ceglia I, 2010, J NEUROCHEM, V114, P182, DOI 10.1111/j.1471-4159.2010.06743.x; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fortin DA, 2012, NEUROSCIENTIST, V18, P326, DOI 10.1177/1073858411407206; Gonzalez-Billault C, 2012, CYTOSKELETON, V69, P464, DOI 10.1002/cm.21034; GOTOW T, 1991, NEUROSCIENCE, V40, P587, DOI 10.1016/0306-4522(91)90143-C; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Haditsch U, 2009, MOL CELL NEUROSCI, V41, P409, DOI 10.1016/j.mcn.2009.04.005; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Harris KM, 2012, COLD SPRING HARB PER; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Jensen V, 2007, J PHYSIOL-LONDON, V583, P129, DOI 10.1113/jphysiol.2007.131300; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim IH, 2013, J NEUROSCI, V33, P6081, DOI 10.1523/JNEUROSCI.0035-13.2013; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Lippman J, 2005, J NEUROBIOL, V64, P47, DOI 10.1002/neu.20149; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Marra V, 2012, NEURON, V76, P579, DOI 10.1016/j.neuron.2012.08.042; Sanchez AM, 2013, MOL ENDOCRINOL, V27, P693, DOI 10.1210/me.2012-1278; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Murakoshi H, 2012, TRENDS NEUROSCI, V35, P135, DOI 10.1016/j.tins.2011.12.002; Nakagawa T, 2004, NEUROPHARMACOLOGY, V47, P734, DOI 10.1016/j.neuropharm.2004.07.022; Nakamura Y, 2011, EMBO J, V30, P719, DOI 10.1038/emboj.2010.357; Nozumi M, 2003, J CELL SCI, V116, P239, DOI 10.1242/jcs.00233; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Penzes P, 2012, ADV EXP MED BIOL, V970, P81, DOI 10.1007/978-3-7091-0932-8_4; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Proepper C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027045; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Schenck A, 2004, DEV BIOL, V274, P260, DOI 10.1016/j.ydbio.2004.07.009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2006, BIOCHEM SOC T, V34, P73, DOI 10.1042/BST0340073; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Spillane M, 2011, DEV NEUROBIOL, V71, P747, DOI 10.1002/dneu.20907; Stavoe AKH, 2012, GENE DEV, V26, P2206, DOI 10.1101/gad.193409.112; Tahirovic S, 2010, J NEUROSCI, V30, P6930, DOI 10.1523/JNEUROSCI.5395-09.2010; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200	54	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75248	10.1371/journal.pone.0075248	http://dx.doi.org/10.1371/journal.pone.0075248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086480	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700061
J	Mazumdar, T; Sandhu, R; Qadan, M; DeVecchio, J; Magloire, V; Agyeman, A; Li, BB; Houghton, JA				Mazumdar, Tapati; Sandhu, Ranjodh; Qadan, Maha; DeVecchio, Jennifer; Magloire, Victoria; Agyeman, Akwasi; Li, Bibo; Houghton, Janet A.			Hedgehog Signaling Regulates Telomerase Reverse Transcriptase in Human Cancer Cells	PLOS ONE			English	Article							SONIC HEDGEHOG; HTERT GENE; STEM-CELL; GLI GENES; TARGET; ACTIVATION; PATHWAY; CATENIN; EXPRESSION; MECHANISM	The Hedgehog (HH) signaling pathway is critical for normal embryonic development, tissue patterning and cell differentiation. Aberrant HH signaling is involved in multiple human cancers. HH signaling involves a multi-protein cascade activating the GLI proteins that transcriptionally regulate HH target genes. We have previously reported that HH signaling is essential for human colon cancer cell survival and inhibition of this signal induces DNA damage and extensive cell death. Here we report that the HH/GLI axis regulates human telomerase reverse transcriptase (hTERT), which determines the replication potential of cancer cells. Suppression of GLI1/GLI2 functions by a C-terminus truncated GLI3 repressor mutant (GLI3R), or by GANT61, a pharmacological inhibitor of GLI1/GLI2, reduced hTERT protein expression in human colon cancer, prostate cancer and Glioblastoma multiforme (GBM) cell lines. Expression of an N-terminus deleted constitutively active mutant of GLI2 (GLI2DN) increased hTERT mRNA and protein expression and hTERT promoter driven luciferase activity in human colon cancer cells while GANT61 inhibited hTERT mRNA expression and hTERT promoter driven luciferase activity. Chromatin immunoprecipitation with GLI1 or GLI2 antibodies precipitated fragments of the hTERT promoter in human colon cancer cells, which was reduced upon exposure to GANT61. In contrast, expression of GLI1 or GLI2DN in nonmalignant 293T cells failed to alter the levels of hTERT mRNA and protein, or hTERT promoter driven luciferase activity. Further, expression of GLI2DN increased the telomerase enzyme activity, which was reduced by GANT61 administration in human colon cancer, prostate cancer, and GBM cells. These results identify hTERT as a direct target of the HH signaling pathway, and reveal a previously unknown role of the HH/GLI axis in regulating the replication potential of cancer cells. These findings are of significance in understanding the important regulatory mechanisms that determine the functions of HH/GLI signaling in cancer cells.	[Mazumdar, Tapati; Qadan, Maha; DeVecchio, Jennifer; Magloire, Victoria; Agyeman, Akwasi; Houghton, Janet A.] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA; [Sandhu, Ranjodh; Li, Bibo] Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Mazumdar, T (corresponding author), Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA.	mazumdt@ccf.org	Sandhu, Ranjodh/AAN-5645-2020	Sandhu, Ranjodh/0000-0002-6459-7542	NCI [RO1 CA 87952]; Cleveland Clinic; NATIONAL CANCER INSTITUTE [R01CA087952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066095] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cleveland Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to acknowledge financial support from NCI award RO1 CA 87952 (JAH), and from the Cleveland Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Avilion AA, 1996, CANCER RES, V56, P645; Bai CB, 2002, DEVELOPMENT, V129, P4753; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Chun SG, 2009, CANCER BIOL THER, V8, P1328, DOI 10.4161/cbt.8.14.8633; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; Dosch JS, 2010, PANCREATOLOGY, V10, P151, DOI 10.1159/000225923; Ecke I, 2008, MOL CARCINOGEN, V47, P361, DOI 10.1002/mc.20394; Fan HR, 1999, J CELL BIOL, V147, P71, DOI 10.1083/jcb.147.1.71; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Greider CW, 2012, SCIENCE, V336, P1519, DOI 10.1126/science.1223785; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hodes RJ, 1999, J EXP MED, V190, P153, DOI 10.1084/jem.190.2.153; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Horikawa I, 2003, CARCINOGENESIS, V24, P1167, DOI 10.1093/carcin/bgg085; Jaitner S, 2012, CELL CYCLE, V11, P3331, DOI 10.4161/cc.21790; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katoh Y, 2008, INT J ONCOL, V33, P881, DOI 10.3892/ijo_00000076; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Lee J, 1997, DEVELOPMENT, V124, P2537; Liu C, 2007, CANCER RES, V67, P2626, DOI 10.1158/0008-5472.CAN-06-4126; Liu JL, 2006, WORLD J GASTROENTERO, V12, P465, DOI 10.3748/wjg.v12.i3.465; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Mazumdar T, 2011, ONCOTARGET, V2, P638; Mazumdar T, 2011, CANCER RES, V71, P5904, DOI 10.1158/0008-5472.CAN-10-4173; Mazumdar T, 2011, CANCER RES, V71, P1092, DOI 10.1158/0008-5472.CAN-10-2315; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Neidle S, 2003, CURR OPIN STRUC BIOL, V13, P275, DOI 10.1016/S0959-440X(03)00072-1; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Park HL, 2000, DEVELOPMENT, V127, P1593; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Shi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013054; Singh RR, 2011, ONCOGENE, V30, P4874, DOI 10.1038/onc.2011.195; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Xu FG, 2009, CANCER LETT, V283, P119, DOI 10.1016/j.canlet.2009.01.014; Zhang Y, 2012, J BIOL CHEM, V287, P32494, DOI 10.1074/jbc.M112.368282	50	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75253	10.1371/journal.pone.0075253	http://dx.doi.org/10.1371/journal.pone.0075253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086482	gold, Green Submitted, Green Published			2022-12-25	WOS:000325218700063
J	Banai, K; Ahissar, M				Banai, Karen; Ahissar, Merav			Musical Experience, Auditory Perception and Reading-Related Skills in Children	PLOS ONE			English	Article							SPEECH-PERCEPTION; FREQUENCY DISCRIMINATION; CORTICAL REPRESENTATION; DEVELOPMENTAL DYSLEXIA; PROCESSING DEFICITS; BRAIN PLASTICITY; VISUAL MEMORY; LANGUAGE; MUSICIANS; ABILITY	Background: The relationships between auditory processing and reading-related skills remain poorly understood despite intensive research. Here we focus on the potential role of musical experience as a confounding factor. Specifically we ask whether the pattern of correlations between auditory and reading related skills differ between children with different amounts of musical experience. Methodology/Principal Findings: Third grade children with various degrees of musical experience were tested on a battery of auditory processing and reading related tasks. Very poor auditory thresholds and poor memory skills were abundant only among children with no musical education. In this population, indices of auditory processing (frequency and interval discrimination thresholds) were significantly correlated with and accounted for up to 13% of the variance in reading related skills. Among children with more than one year of musical training, auditory processing indices were better, yet reading related skills were not correlated with them. A potential interpretation for the reduction in the correlations might be that auditory and reading-related skills improve at different rates as a function of musical training. Conclusions/Significance: Participants' previous musical training, which is typically ignored in studies assessing the relations between auditory and reading related skills, should be considered. Very poor auditory and memory skills are rare among children with even a short period of musical training, suggesting musical training could have an impact on both. The lack of correlation in the musically trained population suggests that a short period of musical training does not enhance reading related skills of individuals with within-normal auditory processing skills. Further studies are required to determine whether the associations between musical training, auditory processing and memory are indeed causal or whether children with poor auditory and memory skills are less likely to study music and if so, why this is the case.	[Banai, Karen] Univ Haifa, Dept Commun Sci & Disorders, IL-31999 Haifa, Israel; [Ahissar, Merav] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel; [Ahissar, Merav] Hebrew Univ Jerusalem, Dept Cognit Sci, Jerusalem, Israel	University of Haifa; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Banai, K (corresponding author), Univ Haifa, Dept Commun Sci & Disorders, IL-31999 Haifa, Israel.	kbanai@research.haifa.ac.il	Banai, Karen/J-1448-2019	Banai, Karen/0000-0002-2990-0470; Ahissar, Merav/0000-0001-7694-8111	Israeli Science Foundation	Israeli Science Foundation(Israel Science Foundation)	The study was supported by the Israeli Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 2000, P NATL ACAD SCI USA, V97, P6832, DOI 10.1073/pnas.97.12.6832; Ahissar M, 2007, TRENDS COGN SCI, V11, P458, DOI 10.1016/j.tics.2007.08.015; Ahissar M, 2006, NAT NEUROSCI, V9, P1558, DOI 10.1038/nn1800; Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; Banai K, 2004, AUDIOL NEURO-OTOL, V9, P328, DOI 10.1159/000081282; Banai K, 2006, CEREB CORTEX, V16, P1718, DOI 10.1093/cercor/bhj107; Banai K, 2013, COGNITIVE DEV, V28, P300, DOI 10.1016/j.cogdev.2013.05.002; Banai K, 2012, HEARING RES, V284, P59, DOI 10.1016/j.heares.2011.12.002; Banai K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019769; Banai K, 2009, CEREB CORTEX, V19, P2699, DOI 10.1093/cercor/bhp024; Bialystok E, 2009, J EXP PSYCHOL HUMAN, V35, P565, DOI 10.1037/a0012735; Bidelman GM, 2011, BRAIN COGNITION, V77, P1, DOI 10.1016/j.bandc.2011.07.006; Bidelman GM, 2011, EUR J NEUROSCI, V33, P530, DOI 10.1111/j.1460-9568.2010.07527.x; Bishop DVM, 1999, J SPEECH LANG HEAR R, V42, P155, DOI 10.1044/jslhr.4201.155; Boets B, 2008, BRAIN LANG, V106, P29, DOI 10.1016/j.bandl.2007.12.004; Butzlaff R, 2000, J AESTHET EDUC, V34, P167, DOI 10.2307/3333642; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; Crncec R, 2006, MUSIC PERCEPT, V23, P305, DOI 10.1525/mp.2006.23.4.305; Deutsch A, 1996, J EXP CHILD PSYCHOL, V63, P386, DOI 10.1006/jecp.1996.0055; DEWEIRDT W, 1988, APPL PSYCHOLINGUIST, V9, P163, DOI 10.1017/S0142716400006792; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Forgeard M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003566; Foxton JM, 2003, NAT NEUROSCI, V6, P343, DOI 10.1038/nn1035; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Georgiou GK, 2010, CORTEX, V46, P1330, DOI 10.1016/j.cortex.2010.06.006; Goswami U, 2011, J COGNITIVE NEUROSCI, V23, P325, DOI 10.1162/jocn.2010.21453; Grube M, 2012, P ROY SOC B-BIOL SCI, V279, P4496, DOI 10.1098/rspb.2012.1817; Heath SM, 1999, J CHILD PSYCHOL PSYC, V40, P637, DOI 10.1111/1469-7610.00480; Herholz SC, 2012, NEURON, V76, P486, DOI 10.1016/j.neuron.2012.10.011; Ho YC, 2003, NEUROPSYCHOLOGY, V17, P439, DOI 10.1037/0894-4105.17.3.439; Hughes CML, 2007, J MOTOR BEHAV, V39, P3, DOI 10.3200/JMBR.39.1.3-8; Hulslander J, 2004, J EXP CHILD PSYCHOL, V88, P274, DOI 10.1016/j.jecp.2004.03.006; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; Jakobson LS, 2008, MUSIC PERCEPT, V26, P41, DOI 10.1525/MP.2008.26.1.41; Kishon-Rabin Liat, 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P125; Kraus N, 2012, ANN NY ACAD SCI, V1252, P100, DOI 10.1111/j.1749-6632.2012.06463.x; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Magne C, 2006, J COGNITIVE NEUROSCI, V18, P199, DOI 10.1162/089892906775783660; McArthur GM, 2008, COGNITION, V107, P946, DOI 10.1016/j.cognition.2007.12.005; Meyer M, 2011, EUR J NEUROSCI, V34, P755, DOI 10.1111/j.1460-9568.2011.07795.x; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Mody M, 1997, J EXP CHILD PSYCHOL, V64, P199, DOI 10.1006/jecp.1996.2343; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; MORRONGIELLO BA, 1990, DEV PSYCHOL, V26, P814, DOI 10.1037/0012-1649.26.5.814; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Papadopoulos TC, 2012, RES DEV DISABIL, V33, P1841, DOI 10.1016/j.ridd.2012.04.009; Parbery-Clark A, 2011, NEUROPSYCHOLOGIA, V49, P3338, DOI 10.1016/j.neuropsychologia.2011.08.007; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; Penhune V, 2005, ANN NY ACAD SCI, V1060, P265, DOI 10.1196/annals.1360.049; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Rammsayer T, 2006, MUSIC PERCEPT, V24, P37, DOI 10.1525/mp.2006.24.1.37; Raven J., 2000, MANUAL RAVENS PROGR; REED MA, 1989, J EXP CHILD PSYCHOL, V48, P270, DOI 10.1016/0022-0965(89)90006-4; Roden I, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00572; Rosen S, 2001, J SPEECH LANG HEAR R, V44, P720, DOI 10.1044/1092-4388(2001/057); Rosen S, 1999, CURR BIOL, V9, pR698, DOI 10.1016/S0960-9822(99)80443-6; Shahin AJ, 2008, NEUROIMAGE, V41, P113, DOI 10.1016/j.neuroimage.2008.01.067; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Talcott JB, 2000, P NATL ACAD SCI USA, V97, P2952, DOI 10.1073/pnas.040546597; Talcott Joel B, 2002, Dyslexia, V8, P204, DOI 10.1002/dys.224; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Tsang CD, 2011, MUSIC PERCEPT, V29, P157, DOI 10.1525/MP.2011.29.2.157; Virtala P, 2012, PSYCHOPHYSIOLOGY, V49, P1125, DOI 10.1111/j.1469-8986.2012.01386.x; Walker KMM, 2006, BRAIN RES, V1124, P126, DOI 10.1016/j.brainres.2006.09.080; Wan CY, 2010, NEUROSCIENTIST, V16, P566, DOI 10.1177/1073858410377805; Wechsler David, 1998, WECHSLER INTELLIGENC; WEISS MW, 2011, AUGMENTING COGNITION, P103; White S, 2006, DEVELOPMENTAL SCI, V9, P237, DOI 10.1111/j.1467-7687.2006.00483.x; Witton C, 1998, CURR BIOL, V8, P791, DOI 10.1016/S0960-9822(98)70320-3; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	73	29	29	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75876	10.1371/journal.pone.0075876	http://dx.doi.org/10.1371/journal.pone.0075876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	226HG	24086654	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200066
J	Hayes, AJ; Reynolds, S; Nowell, MA; Meakin, LB; Habicher, J; Ledin, J; Bashford, A; Caterson, B; Hammond, CL				Hayes, Anthony J.; Reynolds, Scott; Nowell, Mari A.; Meakin, Lee B.; Habicher, Judith; Ledin, Johan; Bashford, Andrew; Caterson, Bruce; Hammond, Chrissy L.			Spinal Deformity in Aged Zebrafish Is Accompanied by Degenerative Changes to Their Vertebrae that Resemble Osteoarthritis	PLOS ONE			English	Article							CHONDROITIN SULFATE STRUCTURE; FACET JOINT OSTEOARTHRITIS; KERATAN SULFATE; ARTICULAR-CARTILAGE; MONOCLONAL-ANTIBODIES; HEPARAN-SULFATE; GLYCOSAMINOGLYCANS; EXPRESSION; GENETICS; MODEL	Age-related degenerative changes within the vertebral column are a significant cause of morbidity with considerable socio-economic impact worldwide. An improved understanding of these changes through the development of experimental models may lead to improvements in existing clinical treatment options. The zebrafish is a well-established model for the study of skeletogenesis with significant potential in gerontological research. With advancing age, zebrafish frequently develop gross deformities of their vertebral column, previously ascribed to reduced trunk muscle tone. In this study, we assess degenerative changes specifically within the bone and cartilage of the vertebral column of zebrafish at 1, 2 and 3-years of age. We show increased frequency and severity of spinal deformities/curvatures with age. Underlying the most severe phenotypes are partial or complete vertebral dislocations and focal thickening of the vertebral bone at the joint margins. MicroCT examination demonstrates small defects, fractures and morphological evidence suggestive of bone erosion and remodeling (i.e. osteophytes) within the vertebrae during aging, but no significant change in bone density. Light and electron microscopic examination reveal striking agerelated changes in cell morphology, suggestive of chondroptosis, and tissue remodelling of the vertebral cartilage, particularly within the pericellular micro-environment. Glycosaminoglycan analysis of the vertebral column by HPLC demonstrates a consistent, age-related increase in the yield of total chondroitin sulfate disaccharide, but no change in sulfation pattern, supported by immunohistochemical analysis. Immunohistochemistry strongly identifies all three chondroitin/dermatan sulphate isoforms (C-0-S, C-4-S/DS and C-6-S) within the vertebral cartilage, particularly within the pericellular micro-environment. In contrast, keratan sulfate immunolocalises specifically with the notochordal tissue of the intervertebral disc, and its labelling diminishes with age. In summary, these observations raise the prospect that zebrafish, in addition to modelling skeletal development, may have utility in modelling age-related degenerative changes that affect the skeleton during senescence.	[Hayes, Anthony J.; Bashford, Andrew; Caterson, Bruce] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Reynolds, Scott; Hammond, Chrissy L.] Univ Bristol, Dept Biochem & Physiol, Bristol, Avon, England; [Reynolds, Scott; Hammond, Chrissy L.] Univ Bristol, Dept Pharmacol, Bristol BS8 1TD, Avon, England; [Nowell, Mari A.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales; [Meakin, Lee B.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Habicher, Judith; Ledin, Johan] Uppsala Univ, Evolutionary Biol Ctr, Uppsala, Sweden	Cardiff University; University of Bristol; University of Bristol; Cardiff University; University of Bristol; Uppsala University	Hayes, AJ (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	hayesaj@cf.ac.uk	Meakin, Lee/H-7726-2019; Bashford, Andrew/G-9302-2014; Hammond, Chrissy/D-6568-2013	Meakin, Lee/0000-0002-2161-9414; Bashford, Andrew/0000-0003-1628-0898; Ledin, Johan/0000-0002-7319-7735; Hayes, Anthony/0000-0002-2918-3723; Nowell, Mari/0000-0003-0053-0127; Hammond, Chrissy/0000-0002-4935-6724; Caterson, Bruce/0000-0001-6016-0661	Arthritis Research UK grants [18331, 19858, 17654, 19476]; Arthritis Research UK PhD studentship [19986]; Wellcome Trust; MRC [G0800248] Funding Source: UKRI; Medical Research Council [G0800248] Funding Source: researchfish; Versus Arthritis [19476, 17654, 19858] Funding Source: researchfish; Healthway [19986] Funding Source: researchfish	Arthritis Research UK grants(Versus Arthritis); Arthritis Research UK PhD studentship(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); Healthway	AJH and BC received financial support from Arthritis Research UK grants 18331 and 19858. MAN and CL were funded by Arthritis Research UK career development grants 17654 and 19476 respectively. SR was funded by Arthritis Research UK PhD studentship 19986. LM was funded by an integrated Training Fellowship from the Wellcome Trust. The funder's had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2000, SPINE, V25, P1625, DOI 10.1097/00007632-200007010-00005; Bayliss MT, 1999, J BIOL CHEM, V274, P15892, DOI 10.1074/jbc.274.22.15892; Bendele A. M., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P501; Bensimon-Brito A, 2010, J APPL ICHTHYOL, V26, P235, DOI 10.1111/j.1439-0426.2010.01412.x; Bouvier DJ, 2000, DOUBLE TIME CU UNPUB, P313; CARNEY SL, 1992, MATRIX, V12, P137, DOI 10.1016/S0934-8832(11)80055-7; CATERSON B, 1985, FED PROC, V44, P386; CATERSON B, 1990, J CELL SCI, V97, P411; CATERSON B, 1983, J BIOL CHEM, V258, P8848; Christiansen HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008481; COUCHMAN JR, 1984, NATURE, V307, P650, DOI 10.1038/307650a0; Ellis K, 2013, J CELL BIOL, V200, P667, DOI 10.1083/jcb.201212095; Erwin WM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3548; Erwin WM, 2006, SPINE, V31, P1094, DOI 10.1097/01.brs.0000216593.97157.dd; Feitsma H, 2008, MOL CANCER RES, V6, P685, DOI 10.1158/1541-7786.MCR-07-2167; Fiaz AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034072; Filipek-Gorniok B, 2013, DEV DYNAM, V242, P964, DOI 10.1002/dvdy.23981; Frobin W, 2001, EUR RADIOL, V11, P263, DOI 10.1007/s003300000556; Fujiwara A, 2000, SPINE, V25, P3036, DOI 10.1097/00007632-200012010-00011; Gerhard GS, 2002, AGING CELL, V1, P104, DOI 10.1046/j.1474-9728.2002.00012.x; Gerhard GS, 2002, EXP GERONTOL, V37, P1055, DOI 10.1016/S0531-5565(02)00088-8; Gorman KF, 2007, COMP BIOCHEM PHYS C, V145, P28, DOI 10.1016/j.cbpc.2006.10.004; Haga Y, 2009, TRANSGENIC RES, V18, P669, DOI 10.1007/s11248-009-9259-y; Hammond Chrissy L, 2012, Front Endocrinol (Lausanne), V3, P91, DOI 10.3389/fendo.2012.00091; Hardingham T, 1995, ACTA ORTHOP SCAND, V66, P107, DOI 10.3109/17453679509157663; Hayes AJ, 2013, DEV DYNAM, V242, P778, DOI 10.1002/dvdy.23970; Holmborn K, 2012, J BIOL CHEM, V287, P33905, DOI 10.1074/jbc.M112.401646; Kalb S, 2012, WORLD NEUROSURG, V77, P491, DOI 10.1016/j.wneu.2011.07.014; Kalichman L, 2007, SEMIN ARTHRITIS RHEU, V37, P69, DOI 10.1016/j.semarthrit.2007.01.007; Kanuga MK, 2011, J EXP ZOOL PART A, V315A, P156, DOI 10.1002/jez.661; Kapitonova M Yu, 2003, Malays J Pathol, V25, P15; Kishi S, 2009, GERONTOLOGY, V55, P430, DOI 10.1159/000228892; Kuiper JI, 1998, SPINE, V23, P657, DOI 10.1097/00007632-199803150-00003; Lall SP, 2007, AQUACULTURE, V267, P3, DOI 10.1016/j.aquaculture.2007.02.053; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Leone A, 2007, RADIOLOGY, V245, P62, DOI 10.1148/radiol.2451051359; Lotz MK, 2010, ARTHRITIS RHEUM-US, V62, P2206, DOI 10.1002/art.27528; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; Meakin LB, 2013, BONE, V54, P113, DOI 10.1016/j.bone.2013.01.029; MILLER JM, 1988, SYST BOT, V13, P173, DOI 10.1097/00007632-198802000-00008; Mistry D, 2004, OSTEOARTHR CARTILAGE, V12, P131, DOI 10.1016/j.joca.2003.10.006; Mitchell RE, 2013, OSTEOARTHR CARTILAGE, V21, P269, DOI 10.1016/j.joca.2012.11.004; Morin-Kensicki EM, 2002, DEVELOPMENT, V129, P3851; Muller UK, 2000, J EXP BIOL, V203, P193; Papadakis Michael, 2011, Open Orthop J, V5, P335, DOI 10.2174/1874325001105010335; Poole CA, 1997, J ANAT, V191, P1, DOI 10.1046/j.1469-7580.1997.19110001.x; POOLE CA, 1991, ARTHRITIS RHEUM-US, V34, P22, DOI 10.1002/art.1780340105; Prescher A, 1998, EUR J RADIOL, V27, P181, DOI 10.1016/S0720-048X(97)00165-4; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Roach HI, 2004, APOPTOSIS, V9, P265, DOI 10.1023/B:APPT.0000025803.17498.26; SHINMEI M, 1992, ARTHRITIS RHEUM, V35, P1304, DOI 10.1002/art.1780351110; Souza ARC, 2007, GLYCOCONJUGATE J, V24, P521, DOI 10.1007/s10719-007-9046-z; Spoorendonk KM, 2010, J APPL ICHTHYOL, V26, P219, DOI 10.1111/j.1439-0426.2010.01409.x; Tallroth K, 1998, EUR J RADIOL, V27, P206, DOI 10.1016/S0720-048X(97)00168-X; THONAR EJMA, 1987, J RHEUMATOL, V14, P23; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; van der Meulen T, 2006, AM J PHYSIOL-REG I, V291, pR1040, DOI 10.1152/ajpregu.00116.2006; VISCO DM, 1993, ARTHRITIS RHEUM, V36, P1718, DOI 10.1002/art.1780361211; Wang XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048069, 10.1371/journal.pone.0051667, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0032405, 10.1371/journal.pone.0036274]; Westerfield M, 2012, ZEBRAFISH BOOK GUIDE; Williams FMK, 2011, BEST PRACT RES CL RH, V25, P69, DOI 10.1016/j.berh.2011.01.007; Yelick PC, 2002, CRIT REV ORAL BIOL M, V13, P308, DOI 10.1177/154411130201300402; Zamli Z, 2011, INT J RHEUM DIS, V14, P159, DOI 10.1111/j.1756-185X.2011.01618.x; Zhang FM, 2009, GLYCOCONJUGATE J, V26, P211, DOI 10.1007/s10719-008-9177-x	64	49	49	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75787	10.1371/journal.pone.0075787	http://dx.doi.org/10.1371/journal.pone.0075787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086633	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000325025200062
J	Sonmez, M; Ince, HY; Yalcin, O; Ajdzanovic, V; Spasojevic, I; Meiselman, HJ; Baskurt, OK				Sonmez, Melda; Ince, Huseyin Yavuz; Yalcin, Ozlem; Ajdzanovic, Vladimir; Spasojevic, Ivan; Meiselman, Herbert J.; Baskurt, Oguz K.			The Effect of Alcohols on Red Blood Cell Mechanical Properties and Membrane Fluidity Depends on Their Molecular Size	PLOS ONE			English	Article							DIFFUSIONAL WATER PERMEABILITY; SPONTANEOUSLY HYPERTENSIVE RATS; ERYTHROCYTE-MEMBRANE; LIPID-BILAYER; ALIPHATIC-ALCOHOLS; BENZYL ALCOHOL; IN-VITRO; ETHANOL; DEFORMABILITY; RELEVANCE	The role of membrane fluidity in determining red blood cell (RBC) deformability has been suggested by a number of studies. The present investigation evaluated alterations of RBC membrane fluidity, deformability and stability in the presence of four linear alcohols (methanol, ethanol, propanol and butanol) using ektacytometry and electron paramagnetic resonance (EPR) spectroscopy. All alcohols had a biphasic effect on deformability such that it increased then decreased with increasing concentration; the critical concentration for reversal was an inverse function of molecular size. EPR results showed biphasic changes of near-surface fluidity (i.e., increase then decrease) and a decreased fluidity of the lipid core; rank order of effectiveness was butanol > propanol > ethanol > methanol, with a significant correlation between near-surface fluidity and deformability (r = 0.697; p<0.01). The presence of alcohol enhanced the impairment of RBC deformability caused by subjecting cells to 100 Pa shear stress for 300 s, with significant differences from control being observed at higher concentrations of all four alcohols. The level of hemolysis was dependent on molecular size and concentration, whereas echinocytic shape transformation (i.e., biconcave disc to crenated morphology) was observed only for ethanol and propanol. These results are in accordance with available data obtained on model membranes. They document the presence of mechanical links between RBC deformability and near-surface membrane fluidity, chain length-dependence of the ability of alcohols to alter RBC mechanical behavior, and the biphasic response of RBC deformability and near-surface membrane fluidity to increasing alcohol concentrations.	[Sonmez, Melda; Ince, Huseyin Yavuz; Yalcin, Ozlem; Baskurt, Oguz K.] Koc Univ, Sch Med, Istanbul, Turkey; [Ajdzanovic, Vladimir] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Belgrade, Serbia; [Spasojevic, Ivan] Univ Belgrade, Inst Multidisciplinary Res, Belgrade, Serbia; [Meiselman, Herbert J.] Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA USA	Koc University; University of Belgrade; University of Belgrade	Meiselman, HJ (corresponding author), Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA USA.	meiselma@usc.edu	Ince, Yavuz/AFX-0433-2022; Yalcin, Ozlem/AAF-4036-2019	Spasojevic, Ivan/0000-0002-3150-3087; Yalcin, Ozlem/0000-0001-5547-6653; Ajdzanovic, Vladimir/0000-0002-6540-9603	Turkish Academy of Sciences, NIH [HL015722, HL090511]; Ministry of Science, Education and Technological Development of the Republic of Serbia [173009, 173014]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL090511, R01HL015722, R37HL015722] Funding Source: NIH RePORTER	Turkish Academy of Sciences, NIH(Turkish Academy of Sciences); Ministry of Science, Education and Technological Development of the Republic of Serbia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Turkish Academy of Sciences, NIH research Grants HL015722 and HL090511 and Ministry of Science, Education and Technological Development of the Republic of Serbia, Grant numbers 173009 and 173014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdzanovic V, 2011, J MEMBRANE BIOL, V239, P131, DOI 10.1007/s00232-010-9332-8; Ajdzanovic V, 2010, CAN J PHYSIOL PHARM, V88, P497, DOI [10.1139/y10-020, 10.1139/Y10-020]; ALMEIDA LM, 1986, BIOCHEMISTRY-US, V25, P4832, DOI 10.1021/bi00365a017; BARRY JA, 1994, BIOCHEMISTRY-US, V33, P8082, DOI 10.1021/bi00192a013; Baskurt OK, 2013, CLIN HEMORHEOL MICRO, V54, P99, DOI 10.3233/CH-2012-1616; Baskurt OK, 2012, SEMIN THROMB HEMOST, V38, P854, DOI 10.1055/s-0032-1325616; Baskurt OK, 2009, SCAND J CLIN LAB INV, V69, P777, DOI 10.3109/00365510903266069; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Baskurt OK, 2013, ENDOTHELIUM MOL ASPE, P72; BEAUGE F, 1994, ALCOHOL ALCOHOLISM, V29, P59; Benga G, 1995, COMP BIOCHEM PHYS B, V112, P653, DOI 10.1016/0305-0491(95)00116-6; Blanc L, 2010, BIOCHEMISTRY-US, V49, P4516, DOI 10.1021/bi1003684; BOIGEGRAIN RA, 1984, CHEM PHYS LIPIDS, V35, P321, DOI 10.1016/0009-3084(84)90075-6; BRAHM J, 1983, J GEN PHYSIOL, V81, P283, DOI 10.1085/jgp.81.2.283; CHABANEL A, 1985, BIOCHIM BIOPHYS ACTA, V816, P142, DOI 10.1016/0005-2736(85)90402-X; CHASIS JA, 1986, J CELL BIOL, V103, P343, DOI 10.1083/jcb.103.2.343; CHIEN DY, 1977, BIOCHIM BIOPHYS ACTA, V464, P45, DOI 10.1016/0005-2736(77)90369-8; CHIEN S, 1987, ANNU REV PHYSIOL, V49, P177, DOI 10.1146/annurev.ph.49.030187.001141; Chmiel B, 1999, CLIN HEMORHEOL MICRO, V21, P325; Cicco G, 1999, CLIN HEMORHEOL MICRO, V21, P169; COLLANDER R, 1954, PHYSIOL PLANTARUM, V7, P420, DOI 10.1111/j.1399-3054.1954.tb07589.x; Dickey AN, 2007, BIOPHYS J, V92, P2366, DOI 10.1529/biophysj.106.097022; Fehr M, 2008, CLIN HEMORHEOL MICRO, V39, P351, DOI 10.3233/CH-2008-1102; Gurtovenko AA, 2009, J PHYS CHEM B, V113, P1983, DOI 10.1021/jp808041z; Ingolfsson HI, 2011, BIOPHYS J, V101, P847, DOI 10.1016/j.bpj.2011.07.013; Johnson RM, 1989, METHOD ENZYMOL, V173, P35, DOI [10.1016/S0076-6879(89)73004-4, DOI 10.1016/S0076-6879(89)73004-4, 10.1016/s0076-6879(89)73004-4]; Kaye MD, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.050907; Kleszczynska H, 2005, J FLUORESC, V15, P137, DOI 10.1007/s10895-005-2521-7; Koter M, 2004, INT J BIOCHEM CELL B, V36, P205, DOI 10.1016/S1357-2725(03)00195-X; Lahajnar G, 2000, BIOELECTROCHEMISTRY, V52, P179, DOI 10.1016/S0302-4598(00)00100-8; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; Ly HV, 2004, BIOPHYS J, V87, P1013, DOI 10.1529/biophysj.103.034280; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; Mesquita R, 1999, CLIN HEMORHEOL MICRO, V21, P95; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; MOHANDAS N, 1982, BLOOD, V59, P768; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Nagai Y, 2001, CLIN HEMORHEOL MICRO, V25, P135; Oonishi T, 2000, ALCOHOL CLIN EXP RES, V24, P352, DOI 10.1097/00000374-200003000-00017; ORLOV SN, 1982, CLIN SCI, V63, P43, DOI 10.1042/cs0630043; Patra M, 2006, BIOPHYS J, V90, P1121, DOI 10.1529/biophysj.105.062364; Rabai M, 2014, CLIN HEMORHEOL MICRO, V56, P87, DOI 10.3233/CH-2012-1632; Rabai M, 2010, CLIN HEMORHEOL MICRO, V44, P227, DOI 10.3233/CH-2010-1267; REED K W, 1987, Journal of Parenteral Science and Technology, V41, P37; Reinhart WH, 2011, CLIN HEMORHEOL MICRO, V49, P11, DOI 10.3233/CH-2011-1453; SCHREIER S, 1978, BIOCHIM BIOPHYS ACTA, V515, P395, DOI DOI 10.1016/0304-4157(78)90011-4; Spasojevic I, 2011, CRIT REV CL LAB SCI, V48, P114, DOI 10.3109/10408363.2011.591772; Subczynski WK, 2000, ACTA BIOCHIM POL, V47, P613, DOI 10.18388/abp.2000_3983; TSUDA K, 1987, HYPERTENSION, V9, P19; Uyuklu M, 2007, CLIN HEMORHEOL MICRO, V36, P25; VERTESSY BG, 1989, BIOPHYS J, V55, P255, DOI 10.1016/S0006-3495(89)82800-0; WIDMER J, 1987, NEUROPSYCHOBIOLOGY, V18, P60, DOI 10.1159/000118394; Zicha J, 1999, AM J HYPERTENS, V12, P315, DOI 10.1016/S0895-7061(98)00178-2	54	36	37	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76579	10.1371/journal.pone.0076579	http://dx.doi.org/10.1371/journal.pone.0076579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086751	Green Published, gold			2022-12-25	WOS:000326520200139
J	Gu, JP; Congdon, EE; Sigurdsson, EM				Gu, Jiaping; Congdon, Erin E.; Sigurdsson, Einar M.			Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Endosomes; Immunotherapy; Lysosomes; Phosphorylation; Tau; Alzheimer Disease; Autophagosomes	CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA 25-35; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; MOUSE MODEL; TRANSGENIC MICE; PASSIVE-IMMUNIZATION; CEREBROSPINAL-FLUID; IMMUNOTHERAPY; PROPAGATION	Background: Tau immunotherapy is an emerging approach to treat Alzheimer disease. Results: Two novel Tau antibodies targeting the 396/404 region are primarily taken up by neurons and reduce Tau pathology. Conclusion: Receptor-mediated endocytosis and the intracellular endosome/autophagosome/lysosome system are likely involved in antibody-mediated clearance of pathological Tau. Significance: This study provides valuable insight into development of Tau immunotherapy. Aggregated Tau proteins are hallmarks of Alzheimer disease and other tauopathies. Recent studies from our group and others have demonstrated that both active and passive immunizations reduce Tau pathology and prevent cognitive decline in transgenic mice. To determine the efficacy and safety of targeting the prominent 396/404 region, we developed two novel monoclonal antibodies (mAbs) with distinct binding profiles for phospho and non-phospho epitopes. The two mAbs significantly reduced hyperphosphorylated soluble Tau in long term brain slice cultures without apparent toxicity, suggesting the therapeutic importance of targeting the 396/404 region. In mechanistic studies, we found that neurons were the primary cell type that internalized the mAbs, whereas a small amount of mAbs was taken up by microglia cells. Within neurons, the two mAbs were highly colocalized with distinct pathological Tau markers, indicating their affinity toward different stages or forms of pathological Tau. Moreover, the mAbs were largely co-localized with endosomal/lysosomal markers, and partially co-localized with autophagy pathway markers. Additionally, the Fab fragments of the mAbs were able to enter neurons, but unlike the whole antibodies, the fragments were not specifically localized in pathological neurons. In summary, our Tau mAbs were safe and efficient to clear pathological Tau in a brain slice model. Fc-receptor-mediated endocytosis and the endosome/autophagosome/lysosome system are likely to have a critical role in antibody-mediated clearance of Tau pathology.	[Gu, Jiaping; Congdon, Erin E.; Sigurdsson, Einar M.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY 10016 USA; [Sigurdsson, Einar M.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA	New York University; New York University	Sigurdsson, EM (corresponding author), 550 1st Ave MSB 459, New York, NY 10016 USA.	einar.sigurdsson@nyumc.org		Congdon, Erin/0000-0001-8322-6176; Sigurdsson, Einar/0000-0003-1451-0952	National Institutes of Health [NS077239, AG032611, AG020197]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032611, R01AG020197, P30AG008051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS077239, AG032611, and AG020197. E. M. Sigurdsson is an inventor on New York University patents on Tau immunotherapy. New York University technology on Tau immunotherapy is licensed to and is being co-developed with H. Lundbeck A/S.	Adhami F, 2007, AUTOPHAGY, V3, P42, DOI 10.4161/auto.3412; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; d'Abramo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062402; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Delacourte A, 2002, NEUROLOGY, V59, P398, DOI 10.1212/WNL.59.3.398; DIETZSCHOLD B, 1992, P NATL ACAD SCI USA, V89, P7252, DOI 10.1073/pnas.89.15.7252; Donovan LE, 2012, PROTEOM CLIN APPL, V6, P201, DOI 10.1002/prca.201100068; Duff K, 2002, J MOL NEUROSCI, V19, P317, DOI 10.1385/JMN:19:3:317; FABIAN RH, 1987, NEUROLOGY, V37, P1780, DOI 10.1212/WNL.37.11.1780; Farlow M, 2012, ALZHEIMERS DEMENT, V8, P261, DOI 10.1016/j.jalz.2011.09.224; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gong CX, 2001, BRAIN RES PROTOC, V6, P134, DOI 10.1016/S1385-299X(00)00046-5; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kerchner GA, 2010, EXPERT OPIN BIOL TH, V10, P1121, DOI 10.1517/14712598.2010.493872; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Krishnamurthy Pavan K, 2011, Front Psychiatry, V2, P59, DOI 10.3389/fpsyt.2011.00059; Kuusisto E, 2002, NEUROPATH APPL NEURO, V28, P228, DOI 10.1046/j.1365-2990.2002.00394.x; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Liu L, 2012, PLOS ONE, V7; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nixon RA, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P277; Okun E, 2010, NEUROMOL MED, V12, P164, DOI 10.1007/s12017-009-8099-5; Panza F, 2011, CURR ALZHEIMER RES, V8, P808, DOI 10.2174/156720511798192718; Pearson R C, 1989, Rev Neurosci, V2, P101, DOI 10.1515/REVNEURO.1989.2.2.101; Ribe EM, 2005, NEUROBIOL DIS, V20, P814, DOI 10.1016/j.nbd.2005.05.027; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Santa-Maria I, 2012, J BIOL CHEM, V287, P20522, DOI 10.1074/jbc.M111.323279; Siemers ER, 2010, CLIN NEUROPHARMACOL, V33, P67, DOI 10.1097/WNF.0b013e3181cb577a; Sigurdsson EM, 2009, CURR ALZHEIMER RES, V6, P446, DOI 10.2174/156720509789207930; Sigurdsson EM, 1996, NEUROBIOL AGING, V17, P893, DOI 10.1016/S0197-4580(96)00169-8; Sigurdsson EM, 1997, NEUROBIOL AGING, V18, P591, DOI 10.1016/S0197-4580(97)00154-1; Tampellini D, 2007, J BIOL CHEM, V282, P18895, DOI 10.1074/jbc.M700373200; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1	57	113	125	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33081	33095		10.1074/jbc.M113.494922	http://dx.doi.org/10.1074/jbc.M113.494922			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089520	Green Published, hybrid			2022-12-25	WOS:000328841700024
J	Pocewicz, A; Estes-Zumpf, WA; Andersen, MD; Copeland, HE; Keinath, DA; Griscom, HR				Pocewicz, Amy; Estes-Zumpf, Wendy A.; Andersen, Mark D.; Copeland, Holly E.; Keinath, Douglas A.; Griscom, Hannah R.			Modeling the Distribution of Migratory Bird Stopovers to Inform Landscape-Scale Siting of Wind Development	PLOS ONE			English	Article							SEASONAL MOVEMENTS; SPRING-MIGRATION; SANDHILL CRANES; AVIAN USE; MORTALITY; CONSERVATION; ECOLOGY; SITES; AREA	Conservation of migratory birds requires understanding the distribution of and potential threats to their migratory habitats. However, although migratory birds are protected under international treaties, few maps have been available to represent migration at a landscape scale useful to target conservation efforts or inform the siting of wind energy developments that may affect migratory birds. To fill this gap, we developed models that predict where four groups of birds concentrate or stopover during their migration through the state of Wyoming, USA: raptors, wetland, riparian and sparse grassland birds. The models were based on existing literature and expert knowledge concerning bird migration behavior and ecology and validated using expert ratings and known occurrences. There was significant agreement between migratory occurrence data and migration models for all groups except raptors, and all models ranked well with experts. We measured the overlap between the migration concentration models and a predictive model of wind energy development to assess the potential exposure of migratory birds to wind development and illustrate the utility of migratory concentration models for landscape-scale planning. Wind development potential is high across 15% of Wyoming, and 73% of this high potential area intersects important migration concentration areas. From 5.2% to 18.8% of each group's important migration areas was represented within this high wind potential area, with the highest exposures for sparse grassland birds and the lowest for riparian birds. Our approach could be replicated elsewhere to fill critical data gaps and better inform conservation priorities and landscape-scale planning for migratory birds.	[Pocewicz, Amy; Copeland, Holly E.] Nature Conservancy, Wyoming Chapter, Lander, WY USA; [Estes-Zumpf, Wendy A.; Andersen, Mark D.; Keinath, Douglas A.; Griscom, Hannah R.] Univ Wyoming, Wyoming Nat Div Database, Laramie, WY 82071 USA	Nature Conservancy; University of Wyoming	Pocewicz, A (corresponding author), Nature Conservancy, Wyoming Chapter, Lander, WY USA.	apocewicz@tnc.org			Mayer and Morris Kaplan Family Foundation	Mayer and Morris Kaplan Family Foundation	This study was funded by a grant from the Mayer and Morris Kaplan Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration U.E.I., 2011, ANN ENERGY OUTLOOK 2; Alexander SA, 1997, SHOREBIRD MIGRATION; American Wind Energy Association, 2012, WIND EN FACTS WYOMIN; Arnett EB, 2007, WILDLIFE SOC TECHNIC, P49; Beason RC, 1995, BIRDS N AM ONLINE; Bechard M. J., 2010, BIRDS N AM ONLINE, DOI [10.2173/bow.swahaw.01, DOI 10.2173/BOW.SWAHAW.01]; Bechard MJ, 1995, BIRDS N AM ONLINE; Beier P., 2007, CONCEPTUAL STEPS DES; Bellrose F, 1980, DUCKS GEESE SWANS N; BINGMAN VP, 1982, ANIM BEHAV, V30, P49, DOI 10.1016/S0003-3472(82)80236-4; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Carlisle JD, 2009, CONDOR, V111, P211, DOI 10.1525/cond.2009.080096; Comer P., 2003, ECOLOGICAL SYSTEMS U; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Copeland H, 2011, ENERGY DEV WILDLIFE; Copeland HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067261; Copeland HE, 2010, ECOL INDIC, V10, P869, DOI 10.1016/j.ecolind.2010.01.011; Cottam Clarence, 1944, CONDOR, V46, P127; Davidson A, 2009, DIGITAL LAND COVER M; DeLong JP, 2005, J FIELD ORNITHOL, V76, P326, DOI 10.1648/0273-8570-76.4.326; Department of Energy, 2008, 20 WIND EN 2030 INCR; Desholm M, 2009, J ENVIRON MANAGE, V90, P2672, DOI 10.1016/j.jenvman.2009.02.005; Dinsmore SJ, 2005, J WILDLIFE MANAGE, V69, P1546, DOI 10.2193/0022-541X(2005)69[1546:MPPRTB]2.0.CO;2; Dinsmore SJ, 2003, ECOL APPL, V13, P1013, DOI 10.1890/01-5311; Downs JA, 2008, INT J GEOGR INF SCI, V22, P687, DOI 10.1080/13658810701674962; Drewien RC, 1999, J WILDLIFE MANAGE, V63, P126, DOI 10.2307/3802493; Drewitt AL, 2008, ANN NY ACAD SCI, V1134, P233, DOI 10.1196/annals.1439.015; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Energy Information Administration, 2011, ANN EN REV 2010; Erickson WP, 2001, AVIAN COLLISIONS WIN; Faaborg J, 2010, ECOL APPL, V20, P398, DOI 10.1890/09-0397.1; Fargione J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041468; Faulkner D. W., 2010, BIRDS WYOMING; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; Fink D., 2010, ECOL APPL, V20, P2131, DOI 10.1890/09-1340.1.; Franklin J, 2009, MAPPING SPECIES DIST; Galle AM, 2009, WEST N AM NATURALIST, V69, P491, DOI 10.3398/064.069.0409; Gammonley JH, 1996, BIRDS N AM ONLINE; Goodrich LJ, 2008, STATE N AM BIRDS PRE; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Heintzelman DS, 1986, MIGRATION HAWKS; Hijmans RJ, 2013, RASTER GEOGRAPHIC DA; Hill D. P., 1997, BIRDS N AM ONLINE; HOPKINS LD, 1977, J AM I PLANNERS, V43, P386, DOI 10.1080/01944367708977903; Hothem RL, 2010, BIRDS N AM ONLINE; Hutto RL, 2000, STUD AVIAN BIOL-SER, P109; Jenness J., 2006, TOPOGRAPHIC POSITION; Keinath D. A., 2010, RANGE MODELED DISTRI; Kerlinger P., 1989, FLIGHT STRATEGIES MI; Kiesecker JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017566; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Kingsley A, 2003, WIND TURBIN IN PRESS, P79; Knopf FL, 2006, BIRDS N AM ONLINE; Knopf FL, 2004, BIRDS N AM ONLINE; Krueper D, 2003, CONSERV BIOL, V17, P607, DOI 10.1046/j.1523-1739.2003.01546.x; Kuvlesky WP, 2007, J WILDLIFE MANAGE, V71, P2487, DOI 10.2193/2007-248; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; McClelland BR, 1994, WILDLIFE MONOGR, V125, P3; Mitchell CD, 2010, BIRDS N AM ONLINE; Munson M Arthur, 2011, EBIRD REFERENCE DATA; National Renewable Energy Laboratory, 2008, ANN AV WIND RES POT; Neal M. C., 2009, FALL 2009 RAPTOR MIG; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; O'Donnell MS, 2010, SPATIAL MAPPING ATTR; Obermeyer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026698; Ott, 2012, MONITORING LEMMING A; Parrish JD, 2000, STUD AVIAN BIOL-SER, P53; Pearse AT, 2011, WATERBIRDS, V34, P10, DOI 10.1675/063.034.0102; Petit DR, 2000, STUD AVIAN BIOL-SER, P15; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Piorkowski MD, 2012, J WILDLIFE MANAGE, V76, P451, DOI 10.1002/jwmg.327; Poulin R, 2011, BIRDS N AM ONLINE; Pugesek BH, 1999, WATERBIRDS, V22, P29, DOI 10.2307/1521990; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reed JM, 2013, BIRDS N AM ONLINE; REINECKE KJ, 1986, J WILDLIFE MANAGE, V50, P71, DOI 10.2307/3801490; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Rubega M. A., 2000, BIRDS N AM ONLINE; Ryder R. A., 1994, BIRDS N AM ONLINE; RYDER RA, 1967, BIRD BANDING, V38, P257, DOI 10.2307/4511410; SKAGEN SK, 1993, CONSERV BIOL, V7, P533, DOI 10.1046/j.1523-1739.1993.07030533.x; Skagen SK, 1998, CONSERV BIOL, V12, P896, DOI 10.1046/j.1523-1739.1998.96384.x; Skamarock W.C., 2008, NCARTN475STR, DOI [10.5065/D68S4MVH, DOI 10.5065/D68S4MVH]; Smallwood KS, 2008, J WILDLIFE MANAGE, V72, P215, DOI 10.2193/2007-032; Smallwood KS, 2009, J WILDLIFE MANAGE, V73, P1082, DOI 10.2193/2008-555; Smith JP, 2001, FALL 2000 EXPLORATOR; Steenhof K, 2005, CONDOR, V107, P481, DOI 10.1650/0010-5422(2005)107[0481:LMABDO]2.0.CO;2; Steenhof K, 1998, BIRDS N AM ONLINE; Stevens LE, 1977, IMPORTANCE PRESERVAT, P156; Tankersley R, 2003, ECOL SOC, V7; The White House, 2011, BLUEPR SEC EN FUT; U. S. Environmental Protection Agency, 2010, LEV 3 EC CONT US REV; van Riper CI, 2008, PROTECTED AREAS PARK, P312; Vickery PD, 1996, BIRDS N AM ONLINE; Wethington Susan M., 2005, U S Forest Service General Technical Report PSW, V191, P646; White C.M., 2020, BIRDS OF THE WORLD; Williams C. S., 1944, AUK, V61, P251; Yong W, 1997, SOUTHWEST NAT, V42, P137	99	10	12	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75363	10.1371/journal.pone.0075363	http://dx.doi.org/10.1371/journal.pone.0075363			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098379	gold, Green Published, Green Submitted			2022-12-25	WOS:000325434500028
J	Zhai, CZ; Zhao, L; Yin, LJ; Chen, M; Wang, QY; Li, LC; Xu, ZS; Ma, YZ				Zhai, Chao-Zeng; Zhao, Lei; Yin, Li-Juan; Chen, Ming; Wang, Qing-Yu; Li, Lian-Cheng; Xu, Zhao-Shi; Ma, You-Zhi			Two Wheat Glutathione Peroxidase Genes Whose Products Are Located in Chloroplasts Improve Salt and H2O2 Tolerances in Arabidopsis	PLOS ONE			English	Article							ABSCISIC-ACID; HYDROGEN-PEROXIDE; MOLECULAR CHARACTERIZATION; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; FREE-RADICALS; DROUGHT; EXPRESSION; PROMOTER; PLANTS	Oxidative stress caused by accumulation of reactive oxygen species (ROS) is capable of damaging effects on numerous cellular components. Glutathione peroxidases (GPXs, EC 1.11.1.9) are key enzymes of the antioxidant network in plants. In this study, W69 and W106, two putative GPX genes, were obtained by de novo transcriptome sequencing of salt-treated wheat (Triticum aestivum) seedlings. The purified His-tag fusion proteins of W69 and W106 reduced H2O2 and t-butyl hydroperoxide (t-BHP) using glutathione (GSH) or thioredoxin (Trx) as an electron donor in vitro, showing their peroxidase activity toward H2O2 and toxic organic hydroperoxide. GFP fluorescence assays revealed that W69 and W106 are localized in chloroplasts. Quantitative real-time PCR (Q-RT-PCR) analysis showed that two GPXs were differentially responsive to salt, drought, H2O2, or ABA. Isolation of the W69 and W106 promoters revealed some cis-acting elements responding to abiotic stresses. Overexpression of W69 and W106 conferred strong tolerance to salt, H2O2, and ABA treatment in Arabidopsis. Moreover, the expression levels of key regulator genes (SOS1, RbohD and ABI1/ABI2) involved in salt, H2O2 and ABA signaling were altered in the transgenic plants. These findings suggest that W69 and W106 not only act as scavengers of H2O2 in controlling abiotic stress responses, but also play important roles in salt and ABA signaling.	[Zhai, Chao-Zeng; Yin, Li-Juan; Chen, Ming; Li, Lian-Cheng; Xu, Zhao-Shi; Ma, You-Zhi] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Key Lab Biol & Genet Improvement Triticeae Crops, Inst Crop Sci,Minist Agr, Beijing 100193, Peoples R China; [Zhao, Lei; Wang, Qing-Yu] Jilin Univ, Coll Plant Sci, Changchun 130023, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Jilin University	Xu, ZS (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Key Lab Biol & Genet Improvement Triticeae Crops, Inst Crop Sci,Minist Agr, Beijing 100193, Peoples R China.	xuzhaoshi@caas.cn; mayouzhi@caas.cn			Natural Science Foundation of China [31171546]; National 863 High-tech Project [2012AA10A309]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 High-tech Project(National High Technology Research and Development Program of China)	This research was financially supported by the Natural Science Foundation of China (31171546) and the National 863 High-tech Project (2012AA10A309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Ahmad P, 2010, CRIT REV BIOTECHNOL, V30, P161, DOI 10.3109/07388550903524243; Aitken RJ, 2009, J CLIN INVEST, V119, P1849, DOI 10.1172/JCI39688; Avsian-Kretchmer O, 2004, PLANT PHYSIOL, V135, P1685, DOI 10.1104/pp.104.041921; Bae YA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-72; Baek IJ, 2011, IN VITRO CELL DEV-AN, V47, P535, DOI 10.1007/s11626-011-9438-z; Bartoli CG, 1999, J EXP BOT, V50, P375, DOI 10.1093/jexbot/50.332.373; Bhattacharjee S, 2005, CURR SCI INDIA, V89, P1113; Bonetta D, 1998, TRENDS PLANT SCI, V3, P231, DOI 10.1016/S1360-1385(98)01241-2; Chang CCC, 2009, PLANT PHYSIOL, V150, P670, DOI 10.1104/pp.109.135566; Chen SR, 2004, PLANT PHYSIOL, V135, P1630, DOI 10.1104/pp.103.038091; Churin Y, 1999, FEBS LETT, V459, P33, DOI 10.1016/S0014-5793(99)01208-9; CRIQUI MC, 1992, PLANT MOL BIOL, V18, P623, DOI 10.1007/BF00040684; Cummins I, 1999, PLANT J, V18, P285, DOI 10.1046/j.1365-313X.1999.00452.x; Depege N, 2000, PHYSIOL PLANTARUM, V110, P209, DOI 10.1034/j.1399-3054.2000.110210.x; Depege N, 1998, EUR J BIOCHEM, V253, P445, DOI 10.1046/j.1432-1327.1998.2530445.x; Desikan R, 1998, HARPIN HYDROGEN PERO; El-Shabrawi H, 2010, PROTOPLASMA, V245, P85, DOI 10.1007/s00709-010-0144-6; Eshdat Y, 1997, PHYSIOL PLANTARUM, V100, P234, DOI 10.1034/j.1399-3054.1997.1000204.x; Faltin Z, 2010, PLANT CELL PHYSIOL, V51, P1151, DOI 10.1093/pcp/pcq082; Gaber A, 2012, PLANT CELL PHYSIOL, V53, P1596, DOI 10.1093/pcp/pcs100; George S, 2010, J PLANT PHYSIOL, V167, P311, DOI 10.1016/j.jplph.2009.09.004; GURLEY WB, 1991, BIOCHEMISTRY-US, V30, P1, DOI 10.1021/bi00215a001; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Haluskova L, 2009, PLANT PHYSIOL BIOCH, V47, P1069, DOI 10.1016/j.plaphy.2009.08.003; Herbette S, 2005, BBA-GEN SUBJECTS, V1724, P108, DOI 10.1016/j.bbagen.2005.04.018; Herbette S, 2007, FEBS J, V274, P2163, DOI 10.1111/j.1742-4658.2007.05774.x; Herbette S, 2011, PLANT SCI, V180, P548, DOI 10.1016/j.plantsci.2010.12.002; Himmelbach A, 1998, PHILOS T R SOC B, V353, P1439, DOI 10.1098/rstb.1998.0299; HOLLAND D, 1993, PLANT MOL BIOL, V21, P923, DOI 10.1007/BF00027124; Hu XL, 2006, PLANT CELL PHYSIOL, V47, P1484, DOI 10.1093/pcp/pcl014; Imai H, 1998, J BIOL CHEM, V273, P1990, DOI 10.1074/jbc.273.4.1990; Iqbal A, 2006, FEBS J, V273, P5589, DOI 10.1111/j.1742-4658.2006.05548.x; ITZHAKI H, 1993, PLANT MOL BIOL, V22, P43, DOI 10.1007/BF00038994; Jannat R, 2011, J PLANT PHYSIOL, V168, P1919, DOI 10.1016/j.jplph.2011.05.006; Kim SY, 1997, PLANT J, V11, P1237, DOI 10.1046/j.1365-313X.1997.11061237.x; Kuhn H, 2002, FREE RADICAL BIO MED, V33, P154, DOI 10.1016/S0891-5849(02)00855-9; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Li SW, 2007, PLANT GROWTH REGUL, V52, P173, DOI 10.1007/s10725-007-9188-9; Li WJ, 2000, BBA-GENE STRUCT EXPR, V1493, P225, DOI 10.1016/S0167-4781(00)00152-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAIORINO M, 1990, METHOD ENZYMOL, V186, P448; MAIORINO M, 1995, BIOL CHEM H-S, V376, P651, DOI 10.1515/bchm3.1995.376.11.651; Margis R, 2008, FEBS J, V275, P3959, DOI 10.1111/j.1742-4658.2008.06542.x; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; Miao YC, 2006, PLANT CELL, V18, P2749, DOI 10.1105/tpc.106.044230; Milla MAR, 2003, PLANT J, V36, P602, DOI 10.1046/j.1365-313X.2003.01901.x; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Qi YC, 2010, RUSS J PLANT PHYSL+, V57, P233, DOI 10.1134/S102144371002010X; Ramos J, 2009, NEW PHYTOL, V181, P103, DOI 10.1111/j.1469-8137.2008.02629.x; Roeckel-Drevet P, 1998, PHYSIOL PLANTARUM, V103, P385, DOI 10.1034/j.1399-3054.1998.1030312.x; Rouhier N, 2004, PLANT PHYSIOL, V134, P1027, DOI 10.1104/pp.103.035865; Rouster J, 1997, PLANT J, V11, P513, DOI 10.1046/j.1365-313X.1997.11030513.x; Roxas VP, 2000, PLANT CELL PHYSIOL, V41, P1229, DOI 10.1093/pcp/pcd051; Sakai T, 1996, PLANT CELL PHYSIOL, V37, P906, DOI 10.1093/oxfordjournals.pcp.a029038; Scandalios J.G., 1997, OXIDATIVE STRESS MOL, V34, P343, DOI [DOI 10.1101/087969502.34.343, 10.1101/0.343-406, DOI 10.1101/0.343-406]; Schneider M, 2006, GENE EXPR PATTERNS, V6, P489, DOI 10.1016/j.modgep.2005.11.002; Sheen J., 2002, TRANSIENT EXPRESSION; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Slesak I, 2007, ACTA BIOCHIM POL, V54, P39, DOI 10.18388/abp.2007_3267; Sugimoto M, 1997, GENES GENET SYST, V72, P311, DOI 10.1266/ggs.72.311; SUTLIFF TD, 1993, PLANT CELL, V5, P1681, DOI 10.1105/tpc.5.11.1681; Toppo S, 2008, ANTIOXID REDOX SIGN, V10, P1501, DOI 10.1089/ars.2008.2057; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; URSINI F, 1995, METHOD ENZYMOL, V252, P38; Vernet P, 2004, MOL CELL ENDOCRINOL, V216, P31, DOI 10.1016/j.mce.2003.10.069; Victor VM, 2004, INT IMMUNOPHARMACOL, V4, P327, DOI 10.1016/j.intimp.2004.01.020; Wang MA, 2010, COMP BIOCHEM PHYS C, V152, P75, DOI 10.1016/j.cbpc.2010.03.003; Wang X, 2011, J PLANT PHYSIOL, V168, P585, DOI 10.1016/j.jplph.2010.09.016; Xu ZS, 2008, MOL GENET GENOMICS, V280, P497, DOI 10.1007/s00438-008-0382-x; Xu ZS, 2007, PLANT MOL BIOL, V65, P719, DOI 10.1007/s11103-007-9237-9; Xue ZY, 2004, PLANT SCI, V167, P849, DOI 10.1016/j.plantsci.2004.05.034; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yang XD, 2006, PLANT MOL BIOL, V62, P951, DOI 10.1007/s11103-006-9068-0; Ye NH, 2011, PLANT CELL PHYSIOL, V52, P689, DOI 10.1093/pcp/pcr028; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Zorb C, 2013, J PLANT PHYSIOL, V170, P220, DOI 10.1016/j.jplph.2012.09.012	86	48	55	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e73989	10.1371/journal.pone.0073989	http://dx.doi.org/10.1371/journal.pone.0073989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098330	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500007
J	Boudil, A; Skhiri, L; Candeias, S; Pasqualetto, V; Legrand, A; Bedora-Faure, M; Gautreau-Rolland, L; Rocha, B; Ezine, S				Boudil, Amine; Skhiri, Lamia; Candeias, Serge; Pasqualetto, Valerie; Legrand, Agnes; Bedora-Faure, Marie; Gautreau-Rolland, Laetitia; Rocha, Benedita; Ezine, Sophie			Single-Cell Analysis of Thymocyte Differentiation: Identification of Transcription Factor Interactions and a Major Stochastic Component in alpha beta-Lineage Commitment	PLOS ONE			English	Article							ADULT-MOUSE THYMUS; T-CELL; GAMMA-DELTA; IMMUNE-SYSTEM; FATE; GENE; TCR; BCL11B; SPECIFICATION; CHECKPOINT	T cell commitment and alpha beta/gamma delta lineage specification in the thymus involves interactions between many different genes. Characterization of these interactions thus requires a multiparameter analysis of individual thymocytes. We developed two efficient single-cell methods: (i) the quantitative evaluation of the co-expression levels of nine different genes, with a plating efficiency of 99-100% and a detection limit of 2 mRNA molecules/cell; and (ii) single-cell differentiation cultures, in the presence of OP9 cells transfected with the thymus Notch1 ligand DeltaL4. We show that during T cell commitment, Gata3 has a fundamental, dose-dependent role in maintaining Notch1 expression, with thymocytes becoming T-cell-committed when they co-express Notch1, Gata3 and Bc11b. Of the transcription factor expression patterns studied here, only that of Bcl11b was suggestive of a role in Pu1 down-regulation. Individual thymocytes became alpha beta/gamma delta lineage-committed at very different stages (from the TN2a stage onwards). However, 20% of TN3 cells are not alpha beta/gamma delta-lineage committed and TN4 cells comprise two main subpopulations with different degrees of maturity. The existence of a correlation between differentiation potential and expression of the pre-TCR showed that 83% of alpha beta-committed cells do not express the pre-TCR and revealed a major stochastic component in alpha beta-lineage specification.	[Boudil, Amine; Skhiri, Lamia; Pasqualetto, Valerie; Legrand, Agnes; Bedora-Faure, Marie; Gautreau-Rolland, Laetitia; Rocha, Benedita; Ezine, Sophie] Inst Natl Sante & Rech Med, Unite 1020, Paris, France; [Boudil, Amine; Skhiri, Lamia; Pasqualetto, Valerie; Legrand, Agnes; Bedora-Faure, Marie; Gautreau-Rolland, Laetitia; Rocha, Benedita; Ezine, Sophie] Univ Paris 05, Unite Mixte Rech, Paris, France; [Candeias, Serge] Univ Grenoble 1, Inst Rech Technol & Sci Vivant, Lab Chim & Biol Met, Ctr Natl Rech Sci,UMR 549, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Ezine, S (corresponding author), Inst Natl Sante & Rech Med, Unite 1020, Paris, France.	sophie.ezine@inserm.fr	Ricoux, Valerie/X-1921-2019; Gautreau-Rolland, Laetitia/AAC-8059-2019; Rolland, Laetitia Gautreau/L-3081-2015	Ricoux, Valerie/0000-0002-9812-8701; Gautreau-Rolland, Laetitia/0000-0003-0113-488X; Candeias, Serge/0000-0003-2257-5529; Marie, BEDORA-FAURE/0000-0002-4350-7683	Institut National de la Sante et de la Recherche Medicale; La Ligue Contre le Cancer; European Research Council (ERC); Societe Francaise d'Hematologie; Fondation pour la Recherche Medicale (FRM); Ministere de la Recherche et de la Technologie; Association de la Recherche sur le Cancer (ARC); ERC; ARC; FRM; Association Francaise contre les Myopathies; Agence de la BioMedecine	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); La Ligue Contre le Cancer(Ligue nationale contre le cancer); European Research Council (ERC)(European Research Council (ERC)European Commission); Societe Francaise d'Hematologie; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Ministere de la Recherche et de la Technologie; Association de la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); ERC(European Research Council (ERC)European Commission); ARC(Australian Research Council); FRM(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence de la BioMedecine	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Unit 1020 receives basic funding from the Institut National de la Sante et de la Recherche Medicale. AB was funded by La Ligue Contre le Cancer, the European Research Council (ERC), and the Societe Francaise d'Hematologie. LS was funded by the Fondation pour la Recherche Medicale (FRM). LGR was funded by the Ministere de la Recherche et de la Technologie and the Association de la Recherche sur le Cancer (ARC). This project was funded by grants from the ERC, ARC, FRM, Association Francaise contre les Myopathies and Agence de la BioMedecine.	Aifantis L, 1998, IMMUNITY, V9, P649, DOI 10.1016/S1074-7613(00)80662-7; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Gautreau L, 2007, J IMMUNOL, V179, P2925, DOI 10.4049/jimmunol.179.5.2925; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Hayday AC, 2007, NAT IMMUNOL, V8, P137, DOI 10.1038/ni1436; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Hozumi K, 2008, EUR J IMMUNOL, V38, P977, DOI 10.1002/eji.200737688; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Kreslavsky T, 2010, IMMUNOL REV, V238, P169, DOI 10.1111/j.1600-065X.2010.00947.x; Lambolez F, 2002, J EXP MED, V195, P437, DOI 10.1084/jem.20010798; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Mancini SJC, 2001, J IMMUNOL, V167, P4485, DOI 10.4049/jimmunol.167.8.4485; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Narayan K, 2010, SEMIN IMMUNOL, V22, P222, DOI 10.1016/j.smim.2010.04.003; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; PENIT C, 1995, J IMMUNOL, V154, P5103; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rothenberg EV, 2010, IMMUNOL REV, V238, P5, DOI 10.1111/j.1600-065X.2010.00965.x; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wilson A, 1999, INT IMMUNOL, V11, P1641, DOI 10.1093/intimm/11.10.1641; Xu W, 2007, BLOOD, V109, P4406, DOI 10.1182/blood-2006-08-043331; Yui MA, 2010, J IMMUNOL, V185, P284, DOI 10.4049/jimmunol.1000679	35	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e73098	10.1371/journal.pone.0073098	http://dx.doi.org/10.1371/journal.pone.0073098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098325	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100003
J	Lachance, PA; Hazen, A; Sevick-Muraca, EM				Lachance, Pier-Anne; Hazen, Amy; Sevick-Muraca, Eva M.			Lymphatic Vascular Response to Acute Inflammation	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; SKIN INFLAMMATION; GROWTH-FACTOR; HYPERSENSITIVITY REACTIONS; ANGIOGENESIS; LYMPHANGIOGENESIS; INDUCTION; BLOOD; BASAL	During acute inflammation, functioning lymphatics are believed to reduce edema and to provide a transiting route for immune cells, but the extent at which the dermal lymphatic remodeling impacts lymphatic transport or the factors regulating these changes remains unclear. Herein we quantify the increase in lymphatic endothelial cells (LECs) and examine the expression of pro-angiogenenic and lymphangiogenic factors during acute cutaneous hypersensitivity (CHS). We found that LECs actively proliferate during CHS but that this proliferation does not affect the lymphatic vessel density. Instead, lymphatic remodeling is accompanied by lymphatic vessel leakiness and lower ejection of lymph fluid, which is observed only in the proximal lymphatic vessel draining the inflamed area. LECs and the immune cells release growth factors and cytokines during inflammation, which impact the lymphatic microenvironment and function. We identified that FGF-2, PLGF-2, HGF, EGF, and KC/CXCL17 are differentially expressed within tissues during acute CHS, but both VEGF-C and VEGF-D levels do not significantly change. Our results indicate that VEGF-C and VEGF-D are not the only players and other factors may be responsible for the LECs proliferation and altered lymphatic function in acute CHS.	[Lachance, Pier-Anne; Sevick-Muraca, Eva M.] Univ Texas Hlth Sci Ctr Houston, Ctr Mol Imaging, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Lachance, Pier-Anne] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Hazen, Amy] Univ Texas Hlth Sci Ctr Houston, IMM Flow Cytometry Ctr, Brown Fdn Inst Mol Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Sevick-Muraca, EM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Mol Imaging, Brown Fdn Inst Mol Med, Houston, TX 77030 USA.	Eva.sevick@uth.tmc.edu	Sevick-Muraca, Eva M/A-4152-2017	Sevick-Muraca, Eva M/0000-0002-8152-4847	National Institutes of Health [R01 CA128919]; Canadian Institutes of Health Research Doctoral Research Award; Cancer Prevention and Research Institute of Texas (CPRIT) [RP 110776]; NATIONAL CANCER INSTITUTE [R01CA128919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health (R01 CA128919), the Canadian Institutes of Health Research Doctoral Research Award and in part by the shared instrumentation grant (RP 110776) from the Cancer Prevention and Research Institute of Texas (CPRIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Bohlen HG, 2009, AM J PHYSIOL-HEART C, V297, pH1319, DOI 10.1152/ajpheart.00039.2009; Bracher A, 2013, J INVEST DERMATOL, V133, P230, DOI 10.1038/jid.2012.272; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Capla JM, 2006, PLAST RECONSTR SURG, V117, P836, DOI 10.1097/01.prs.0000201459.91559.7f; Cappella P, 2008, CYTOM PART A, V73A, P626, DOI 10.1002/cyto.a.20582; Chang LK, 2004, P NATL ACAD SCI USA, V101, P11658, DOI 10.1073/pnas.0404272101; Dimmeler S, 2000, CIRC RES, V87, P434; Dixon JB, 2006, MICROCIRCULATION, V13, P597, DOI 10.1080/10739680600893909; Goldman J, 2005, CIRC RES, V96, P1193, DOI 10.1161/01.RES.0000168918.27576.78; Halin C, 2008, AM J PATHOL, V173, P265, DOI 10.2353/ajpath.2008.071074; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Huggenberger R, 2011, J INVEST DERM SYMP P, V15, P24, DOI 10.1038/jidsymp.2011.5; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Im E, 2006, CELL CYCLE, V5, P2057, DOI 10.4161/cc.5.18.3210; Kajiya K, 2005, EMBO J, V24, P2885, DOI 10.1038/sj.emboj.7600763; Kajiya K, 2009, J INVEST DERMATOL, V129, P1292, DOI 10.1038/jid.2008.351; Kim Y, 2011, MOL IMMUNOL, V48, P1035, DOI 10.1016/j.molimm.2011.01.013; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Kwon Sunkuk, 2007, Lymphatic Research and Biology, V5, P219, DOI 10.1089/lrb.2007.1013; Lange-Asschenfeldt B, 2002, BLOOD, V99, P538, DOI 10.1182/blood.V99.2.538; Lee WY, 2013, AM J PHYSIOL-ENDOC M, V304, pE32, DOI 10.1152/ajpendo.00083.2012; Liao S, 2011, P NATL ACAD SCI USA, V108, P18784, DOI 10.1073/pnas.1116152108; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Mendez U, 2012, AM J PHYSIOL-HEART C, V303, pH1107, DOI 10.1152/ajpheart.00522.2012; Oura H, 2003, BLOOD, V101, P560, DOI 10.1182/blood-2002-05-1516; Rasmussen JC, 2010, TRANSL ONCOL, V3, P362, DOI 10.1593/tlo.10190; Robinson HA, 2013, JOVE-J VIS EXP, DOI 10.3791/4326; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Scallan JP, 2013, J PHYSIOL-LONDON, V591, P2139, DOI 10.1113/jphysiol.2012.250662; Team RDC, 2019, R LANG ENV STAT COMP; Unno N, 2010, J VASC SURG, V52, P946, DOI 10.1016/j.jvs.2010.04.067; Velasco P, 2009, J INVEST DERMATOL, V129, P2022, DOI 10.1038/jid.2008.447; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447	36	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76078	10.1371/journal.pone.0076078	http://dx.doi.org/10.1371/journal.pone.0076078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086691	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900078
J	Misund, K; Selvik, LKM; Rao, S; Norsett, K; Bakke, I; Sandvik, AK; Laegreid, A; Bruland, T; Prestvik, WS; Thommesen, L				Misund, Kristine; Selvik, Linn-Karina Myrland; Rao, Shalini; Norsett, Kristin; Bakke, Ingunn; Sandvik, Arne K.; Laegreid, Astrid; Bruland, Torunn; Prestvik, Wenche S.; Thommesen, Liv			NR4A2 Is Regulated by Gastrin and Influences Cellular Responses of Gastric Adenocarcinoma Cells	PLOS ONE			English	Article							NUCLEAR RECEPTOR NURR1; GENE-EXPRESSION DATA; MOLECULAR MECHANISMS; C-FOS; IDENTIFICATION; PROMOTER; PROTEIN; CHOLECYSTOKININ; TRANSCRIPTION; SUPPRESSES	The peptide hormone gastrin is known to play a role in differentiation, growth and apoptosis of cells in the gastric mucosa. In this study we demonstrate that gastrin induces Nuclear Receptor 4A2 (NR4A2) expression in the adenocarcinoma cell lines AR42J and AGS-G(R), which both possess the gastrin/CCK2 receptor. In vivo, NR4A2 is strongly expressed in the gastrin responsive neuroendocrine ECL cells in normal mucosa, whereas gastric adenocarcinoma tissue reveals a more diffuse and variable expression in tumor cells. We show that NR4A2 is a primary early transient gastrin induced gene in adenocarcinoma cell lines, and that NR4A2 expression is negatively regulated by inducible cAMP early repressor (ICER) and zinc finger protein 36, C3H1 type-like 1 (Zfp36l1), suggesting that these gastrin regulated proteins exert a negative feedback control of NR4A2 activated responses. FRAP analyses indicate that gastrin also modifies the nucleus-cytosol shuttling of NR4A2, with more NR4A2 localized to cytoplasm upon gastrin treatment. Knock-down experiments with siRNA targeting NR4A2 increase migration of gastrin treated adenocarcinoma AGS-G(R) cells, while ectopically expressed NR4A2 increases apoptosis and hampers gastrin induced invasion, indicating a tumor suppressor function of NR4A2. Collectively, our results uncover a role of NR4A2 in gastric adenocarcinoma cells, and suggest that both the level and the localization of NR4A2 protein are of importance regarding the cellular responses of these cells.	[Misund, Kristine; Selvik, Linn-Karina Myrland; Rao, Shalini; Norsett, Kristin; Bakke, Ingunn; Sandvik, Arne K.; Laegreid, Astrid; Bruland, Torunn; Thommesen, Liv] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Selvik, Linn-Karina Myrland; Rao, Shalini; Prestvik, Wenche S.; Thommesen, Liv] Sor Trondelag Univ Coll, Fac Technol, Trondheim, Norway; [Sandvik, Arne K.] St Olavs Univ Hosp, Med Clin, Dept Gastroenterol & Hepatol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Thommesen, L (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway.	Liv.Thommesen@ntnu.no	Bluland, Torunn/AAT-5730-2021	Bakke, Ingunn/0000-0003-0356-6184; Bruland, Torunn/0000-0002-1568-2476	Norwegian Cancer Association; St. Olavs Hospital, Trondheim, Norway	Norwegian Cancer Association; St. Olavs Hospital, Trondheim, Norway	This work was supported by the Norwegian Cancer Association and the Cancer Fund at St. Olavs Hospital, Trondheim, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne CM, 2009, MOL IMMUNOL, V46, P3345, DOI 10.1016/j.molimm.2009.07.019; Bakke I, 2001, SCAND J GASTROENTERO, V36, P1128; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Burkitt MD, 2009, WORLD J GASTROENTERO, V15, P1, DOI 10.3748/wjg.15.1; Caplin M, 2000, BRIT J SURG, V87, P1035, DOI 10.1046/j.1365-2168.2000.01488.x; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Cardarelli F, 2012, J BIOL CHEM, V287, P5554, DOI 10.1074/jbc.M111.304899; Chang WJ, 2009, INT J CANCER, V125, P2844, DOI 10.1002/ijc.24699; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Dabrowski A, 1997, DIGESTION, V58, P361, DOI 10.1159/000201466; Dabrowski A, 1997, AM J PHYSIOL-CELL PH, V273, pC1472, DOI 10.1152/ajpcell.1997.273.5.C1472; Dockray GJ, 2001, ANNU REV PHYSIOL, V63, P119, DOI 10.1146/annurev.physiol.63.1.119; Edkins JS, 1906, J PHYSIOL-LONDON, V34, P133; Goetze JP, 2000, CANCER, V88, P2487, DOI 10.1002/1097-0142(20000601)88:11<2487::AID-CNCR9>3.0.CO;2-E; Han YF, 2012, WORLD J GASTROENTERO, V18, P6865, DOI 10.3748/wjg.v18.i47.6865; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Ichinose H, 1999, GENE, V230, P233, DOI 10.1016/S0378-1119(99)00065-7; Inamoto T, 2008, MOL CANCER THER, V7, P3825, DOI 10.1158/1535-7163.MCT-08-0730; ISHIZUKA J, 1992, ANN SURG, V215, P528, DOI 10.1097/00000658-199205000-00016; Garcia-Yague AJ, 2013, J BIOL CHEM, V288, P5506, DOI 10.1074/jbc.M112.439190; Kitagawa H, 2007, MOL CELL BIOL, V27, P7486, DOI 10.1128/MCB.00409-07; Koh TJ, 1997, GASTROENTEROLOGY, V113, P1015, DOI 10.1016/S0016-5085(97)70199-9; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llopis S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-139; Lodige I, 2005, J BIOL CHEM, V280, P43087, DOI 10.1074/jbc.M509180200; Luciano F, 2007, BLOOD, V109, P3849, DOI 10.1182/blood-2006-11-056879; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Mishra Prajna, 2010, J Mol Signal, V5, P9, DOI 10.1186/1750-2187-5-9; Misund K, 2007, J CELL BIOCHEM, V101, P1532, DOI 10.1002/jcb.21267; Mix KS, 2007, J BIOL CHEM, V282, P9492, DOI 10.1074/jbc.M608327200; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Norsett KG, 2005, PHYSIOL GENOMICS, V22, P24, DOI 10.1152/physiolgenomics.00245.2004; Norsett KG, 2011, AM J PHYSIOL-GASTR L, V301, pG446, DOI 10.1152/ajpgi.00527.2010; Norsetta KG, 2008, EUR J GASTROEN HEPAT, V20, P613, DOI 10.1097/MEG.0b013e3282f5dc19; OHMICHI M, 1994, J BIOL CHEM, V269, P3783; Parkinson H, 2005, NUCLEIC ACIDS RES, V33, pD553; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramirez-Herrick AM, 2011, BLOOD, V117, P2681, DOI 10.1182/blood-2010-02-267906; Selvik LKM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-429; SEVA C, 1990, DIGESTION, V46, P166, DOI 10.1159/000200381; SMITH JP, 1994, AM J PHYSIOL, V266, pR277, DOI 10.1152/ajpregu.1994.266.1.R277; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Steigedal TS, 2007, AM J PHYSIOL-GASTR L, V292, pG1062, DOI 10.1152/ajpgi.00287.2006; Steigedal TS, 2013, IN VITRO CELL DEV-AN, V49, P162, DOI 10.1007/s11626-013-9588-2; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Thommesen L, 2000, J BIOL CHEM, V275, P4244, DOI 10.1074/jbc.275.6.4244; Thommesen L, 2001, AM J PHYSIOL-ENDOC M, V281, pE1316, DOI 10.1152/ajpendo.2001.281.6.E1316; Todisco A, 2001, AM J PHYSIOL-GASTR L, V280, pG298, DOI 10.1152/ajpgi.2001.280.2.G298; Torii T, 1999, GENE, V230, P225, DOI 10.1016/S0378-1119(99)00064-5; Watson F, 2001, J BIOL CHEM, V276, P7661, DOI 10.1074/jbc.M006697200; Willard MD, 2012, MOL CANCER RES, V10, P739, DOI 10.1158/1541-7786.MCR-11-0483; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Zhang T, 2009, MOL CANCER RES, V7, P1408, DOI 10.1158/1541-7786.MCR-08-0533	59	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76234	10.1371/journal.pone.0076234	http://dx.doi.org/10.1371/journal.pone.0076234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086717	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900090
J	Geraghty, PT; Williamson, JE; Macbeth, WG; Wintner, SP; Harry, AV; Ovenden, JR; Gillings, MR				Geraghty, Pascal T.; Williamson, Jane E.; Macbeth, William G.; Wintner, Sabine P.; Harry, Alastair V.; Ovenden, Jennifer R.; Gillings, Michael R.			Population Expansion and Genetic Structure in Carcharhinus brevipinna in the Southern Indo-Pacific	PLOS ONE			English	Article							GULF-OF-MEXICO; HUMAN MITOCHONDRIAL-DNA; SPINNER SHARK; BLACKTIP SHARK; CONTROL REGION; GLOBAL PHYLOGEOGRAPHY; REPRODUCTIVE-BIOLOGY; RELATIVE ABUNDANCE; NEUTRALITY TESTS; NURSERY GROUNDS	Background: Quantifying genetic diversity and metapopulation structure provides insights into the evolutionary history of a species and helps develop appropriate management strategies. We provide the first assessment of genetic structure in spinner sharks (Carcharhinus brevipinna), a large cosmopolitan carcharhinid, sampled from eastern and northern Australia and South Africa. Methods and Findings: Sequencing of the mitochondrial DNA NADH dehydrogenase subunit 4 gene for 430 individuals revealed 37 haplotypes and moderately high haplotype diversity (h = 0.6770 +/- 0.025). While two metrics of genetic divergence (Phi(ST) and F-ST) revealed somewhat different results, subdivision was detected between South Africa and all Australian locations (pairwise Phi(ST), range 0.02717-0.03508, p values <= 0.0013; pairwise F-ST South Africa vs New South Wales = 0.04056, p = 0.0008). Evidence for fine-scale genetic structuring was also detected along Australia's east coast (pairwise Phi(ST) = 0.01328, p < 0.015), and between south-eastern and northern locations (pairwise Phi(ST) = 0.00669, p < 0.04). Conclusions: The Indian Ocean represents a robust barrier to contemporary gene flow in C. brevipinna between Australia and South Africa. Gene flow also appears restricted along a continuous continental margin in this species, with data tentatively suggesting the delineation of two management units within Australian waters. Further sampling, however, is required for a more robust evaluation of the latter finding. Evidence indicates that all sampled populations were shaped by a substantial demographic expansion event, with the resultant high genetic diversity being cause for optimism when considering conservation of this commercially-targeted species in the southern Indo-Pacific.	[Geraghty, Pascal T.; Williamson, Jane E.; Gillings, Michael R.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Geraghty, Pascal T.; Macbeth, William G.] Cronulla Fisheries Res Ctr Excellence, New South Wales Dept Primary Ind, Sydney, NSW, Australia; [Wintner, Sabine P.] KwaZulu Natal Sharks Board, Umhlanga Rocks, Kwazulu Natal, South Africa; [Harry, Alastair V.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Ovenden, Jennifer R.] Univ Queensland, Mol Fisheries Lab, St Lucia, Qld, Australia	Macquarie University; NSW Department of Primary Industries; James Cook University; University of Queensland	Geraghty, PT (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	pascal.geraghty@mq.edu.au	Gillings, Michael/AAF-5772-2020; Harry, Alastair V/A-3370-2011; Gillings, Michael R/C-6553-2008; Ovenden, Jennifer/A-3717-2010; Williamson, Jane E/G-9871-2011	Gillings, Michael/0000-0002-4043-4351; Harry, Alastair V/0000-0002-9905-7909; Gillings, Michael R/0000-0002-4043-4351; Ovenden, Jennifer/0000-0001-7538-1504; Williamson, Jane E/0000-0003-3627-4508	Northern Rivers Catchment Management Authority (NRCMA); Wild Fisheries Division of the New South Wales Department of Primary Industries (NSW DPI); Department of Biological Sciences at Macquarie University (MQ); Queensland Government; Australian Postgraduate Award scholarship	Northern Rivers Catchment Management Authority (NRCMA); Wild Fisheries Division of the New South Wales Department of Primary Industries (NSW DPI); Department of Biological Sciences at Macquarie University (MQ); Queensland Government; Australian Postgraduate Award scholarship	Funding was provided by the Northern Rivers Catchment Management Authority (NRCMA), the Wild Fisheries Division of the New South Wales Department of Primary Industries (NSW DPI), the Department of Biological Sciences at Macquarie University (MQ), the Queensland Government, and an Australian Postgraduate Award scholarship awarded to PTG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen H, 2009, MOL ECOL, V18, P4409, DOI 10.1111/j.1365-294X.2009.04377.x; Allen BR, 2002, S AFR J MARINE SCI, V24, P1, DOI 10.2989/025776102784528484; Allen BR, 2000, S AFR J MARINE SCI, V22, P199, DOI 10.2989/025776100784125654; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Arnaud-Haond S, 2006, MOL ECOL, V15, P3515, DOI 10.1111/j.1365-294X.2006.02997.x; Beheregaray LB, 2004, P NATL ACAD SCI USA, V101, P6514, DOI 10.1073/pnas.0400393101; Benavides MT, 2011, MAR FRESHWATER RES, V62, P861, DOI 10.1071/MF10236; Benavides Martin T., 2011, Endangered Species Research, V14, P13, DOI 10.3354/esr00337; Bird CE, 2011, CRUSTACEAN ISS, V19, P31; Blower DC, 2012, MAR ECOL PROG SER, V455, P229, DOI 10.3354/meps09659; BRANSTETTER S, 1987, COPEIA, P964; Broderick D, 2011, J FISH BIOL, V79, P633, DOI 10.1111/j.1095-8649.2011.03055.x; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; BURGESS GH, 2009, CARCHARHINUS BREVIPI; Capape C, 2003, ISR J ZOOL, V49, P269, DOI 10.1560/DHHM-A68M-VKQH-CY9F; Carlson JK, 2012, J FISH BIOL, V80, P1749, DOI 10.1111/j.1095-8649.2011.03193.x; Carlson JK, 2005, FISH B-NOAA, V103, P280; Carlson JK, 1999, MAR FISH REV, V61, P37; Castillo-Geniz JL, 1998, MAR FRESHWATER RES, V49, P611, DOI 10.1071/MF97120; CASTRO JI, 1993, ENVIRON BIOL FISH, V38, P37, DOI 10.1007/BF00842902; Chabot CL, 2009, MOL ECOL, V18, P545, DOI 10.1111/j.1365-294X.2008.04047.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Conrath CL, 2007, T AM FISH SOC, V136, P999, DOI 10.1577/T06-107.1; Cortes E, 2006, PANAMA CITY LAB CONT; Daly-Engel TS, 2012, PLOS ONE, V7, P279, DOI 10.1371/journal.pone.0029986; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diaz-Jaimes P, 2006, FISH RES, V80, P333, DOI 10.1016/j.fishres.2006.04.015; Dudgeon CL, 2012, J FISH BIOL, V80, P1789, DOI 10.1111/j.1095-8649.2012.03265.x; Dudgeon CL, 2009, MOL ECOL, V18, P248, DOI 10.1111/j.1365-294X.2008.04025.x; Dudley SFJ, 2006, MAR FRESHWATER RES, V57, P225, DOI 10.1071/MF05156; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; EXCOFFIER L, 1990, J MOL EVOL, V30, P125, DOI 10.1007/BF02099939; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Field IC, 2009, ADV MAR BIOL, V56, P275, DOI 10.1016/S0065-2881(09)56004-X; Fu YX, 1997, GENETICS, V147, P915; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Grubbs R. Dean, 2007, V50, P87; Hale L. F., 2011, NMFSSEFSC611 NOAA; HARPENDING HC, 1994, HUM BIOL, V66, P591; Harry AV, 2011, MAR FRESHWATER RES, V62, P710, DOI 10.1071/MF10155; Heist, 2005, BIOL STOCK ASSESSMEN; Henderson AC, 2007, FISH RES, V86, P159, DOI 10.1016/j.fishres.2007.05.012; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Hoelzel AR, 2002, P ROY SOC B-BIOL SCI, V269, P1467, DOI 10.1098/rspb.2002.2033; HOLM S, 1979, SCAND J STAT, V6, P65; HUETER R, 2007, 1241 MOT MAR LAB; Hueter R. E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P239; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Hussey NE, 2009, MAR FRESHWATER RES, V60, P571, DOI 10.1071/MF08280; Inoue JG, 2001, MOL PHYLOGENET EVOL, V20, P275, DOI 10.1006/mpev.2001.0970; Joung SJ, 2005, ZOOL STUD, V44, P102; Karl SA, 2011, CONSERV GENET, V12, P371, DOI 10.1007/s10592-010-0145-1; Karl SA, 2012, MAR BIOL, V159, P489, DOI 10.1007/s00227-011-1828-y; Keeney DB, 2006, MOL ECOL, V15, P3669, DOI 10.1111/j.1365-294X.2006.03036.x; Keeney DB, 2003, MAR BIOL, V143, P1039, DOI 10.1007/s00227-003-1166-9; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Last PR, 2009, SHARKS RAYS AUSTR; Lind CE, 2007, MOL ECOL, V16, P5193, DOI 10.1111/j.1365-294X.2007.03598.x; Lyrholm T, 1996, MOL BIOL EVOL, V13, P1318, DOI 10.1093/oxfordjournals.molbev.a025578; Macbeth W. G., 2009, IND INVESTMENT NSW F, V114; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; McVean AR, 2006, FISH RES, V82, P280, DOI 10.1016/j.fishres.2006.06.016; Merson RR, 2001, ENVIRON BIOL FISH, V61, P13, DOI 10.1023/A:1011017109776; MORGAN J, 2011, STOCK STRUCTURE EXPL; NAYLOR GJP, 2012, B AM MUS NAT HIST, V367, P262; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Ovenden JR, 2010, MAR FRESHWATER RES, V61, P253, DOI 10.1071/MF09151; Ovenden JR, 2011, MAR BIOL, V158, P1497, DOI 10.1007/s00227-011-1666-y; Ovenden JR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-40; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Pardini AT, 2001, NATURE, V412, P139, DOI 10.1038/35084125; Peakall R, 2003, MOL ECOL, V12, P2331, DOI 10.1046/j.1365-294X.2003.01926.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pereyra S, 2010, FISH RES, V106, P468, DOI 10.1016/j.fishres.2010.09.022; Pope LC, 1996, MOL ECOL, V5, P629, DOI 10.1111/j.1365-294X.1996.tb00358.x; Portnoy DS, 2012, J FISH BIOL, V80, P1120, DOI 10.1111/j.1095-8649.2011.03206.x; Portnoy DS, 2010, MOL ECOL, V19, P1994, DOI 10.1111/j.1365-294X.2010.04626.x; *QUEENSL GOV DEP A, 2006, REP QUEENSL SHARK SA; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Reid DD, 2011, MAR FRESHWATER RES, V62, P676, DOI 10.1071/MF10162; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rogers PJ, 2013, FISH OCEANOGR, V22, P102, DOI 10.1111/fog.12009; ROSE C, 2003, QLD DEP PRIM IND QI; Hoelzel AR, 2006, BIOL LETTERS, V2, P639, DOI 10.1098/rsbl.2006.0513; Schultz JK, 2008, MOL ECOL, V17, P5336, DOI 10.1111/j.1365-294X.2008.04000.x; Simpfendorfer C, 1998, MAR FRESHWATER RES, V49, P593, DOI 10.1071/MF97043; Sivasundar A, 2001, MOL ECOL, V10, P407, DOI 10.1046/j.1365-294x.2001.01194.x; Steeves TE, 2005, MOL ECOL, V14, P3877, DOI 10.1111/j.1365-294X.2005.02713.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor SM, 2013, J FISH BIOL, V82, P228, DOI 10.1111/jfb.12003; Thacker CE, 2004, CORAL REEFS, V23, P357, DOI 10.1007/s00338-004-0391-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorpe T, 2004, B MAR SCI, V74, P3; Tillett BJ, 2012, CONSERV GENET, V13, P99, DOI 10.1007/s10592-011-0268-z; Tillett BJ, 2012, FISH RES, V127, P109, DOI 10.1016/j.fishres.2012.04.007; Tillett J, 2012, J FISH BIOL, V80, P2140, DOI 10.1111/j.1095-8649.2012.03228.x; Verissimo A, 2010, MOL ECOL, V19, P1651, DOI 10.1111/j.1365-294X.2010.04598.x; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; White WT, 2007, J FISH BIOL, V71, P1512, DOI 10.1111/j.1095-8649.2007.01623.x; White WT, 2004, MAR BIOL, V145, P1023, DOI 10.1007/s00227-004-1386-7; Whitney NM, 2012, J BIOGEOGR, V39, P1144, DOI 10.1111/j.1365-2699.2011.02660.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zhang YP, 2002, PURE APPL CHEM, V74, P575, DOI 10.1351/pac200274040575; 2011, SEDAR 21 STOCK ASS R	114	19	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75169	10.1371/journal.pone.0075169	http://dx.doi.org/10.1371/journal.pone.0075169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086462	Green Published, gold, Green Accepted			2022-12-25	WOS:000325218700056
J	Liu, G; Cao, P; Chen, HJ; Yuan, W; Wang, JX; Tang, XY				Liu, Gang; Cao, Peng; Chen, Huajiang; Yuan, Wen; Wang, Jianxi; Tang, Xianye			MiR-27a Regulates Apoptosis in Nucleus Pulposus Cells by Targeting PI3K	PLOS ONE			English	Article							INTERVERTEBRAL DISC DEGENERATION; GENE-EXPRESSION; DIFFERENTIATION; MICRORNAS; NETWORK; PATHWAY	The precise role of apoptosis in the pathogenesis of intervertebral disc degeneration (IDD) remains to be elucidated. We analyzed degenerative nucleus pulposus (NP) cells and found that the expression of miR-27a was increased. The overexpression of miR-27a was further verified using real-time RT-PCR. Bioinformatics target prediction identified phosphoinositide-3 kinases (PI3K) as putative targets of miR-27a. Furthermore, miR-27a inhibited PI3K expression by directly targeting their 3'-UTRs, and this inhibition was abolished by mutation of the miR-27a binding sites. Various cellular processes including cell growth, proliferation, migration and adhesion are regulated by activation of the PI3K/AKT signaling pathway, and nucleus pulposus cells are known to strongly express the phosphorylated survival protein AKT. Our results identify PI3K as a novel target of miR-27a. Upregulation of miR-27a thus targets PI3K, initiating apoptosis of nucleus pulposus cells. This present study revealed that downregulated miR-27a might develop a novel intervention for IDD treatment through the prevention of apoptosis in Nucleus pulposus Cells.	[Liu, Gang; Cao, Peng; Chen, Huajiang; Yuan, Wen; Wang, Jianxi; Tang, Xianye] Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China	Naval Medical University	Chen, HJ (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China.	spine.chen@163.com; yuanwenspine@163.com						Aguiar DJ, 1999, EXP CELL RES, V246, P129, DOI 10.1006/excr.1998.4287; Aladin DMK, 2007, SPINE, V32, P2820, DOI 10.1097/BRS.0b013e31815b75c5; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cheng CC, 2009, J CELL PHYSIOL, V221, P668, DOI 10.1002/jcp.21904; Feng J, 2009, BRIT J HAEMATOL, V145, P412, DOI 10.1111/j.1365-2141.2009.07632.x; Guehring T, 2005, SPINE, V30, P2510, DOI 10.1097/01.brs.0000186591.17114.e9; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hidaka K, 2001, INT J BIOCHEM CELL B, V33, P1094, DOI 10.1016/S1357-2725(01)00067-X; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hsieh AH, 2010, J BIOMECH, V43, P137, DOI 10.1016/j.jbiomech.2009.09.019; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Rannou F, 2004, AM J PATHOL, V164, P915, DOI 10.1016/S0002-9440(10)63179-3; Reza AT, 2008, ANN BIOMED ENG, V36, P204, DOI 10.1007/s10439-007-9407-6; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Solovieva S, 2006, EUR SPINE J, V15, P613, DOI 10.1007/s00586-005-0988-1; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Stokes IAF, 2004, SPINE, V29, P2724, DOI 10.1097/01.brs.0000146049.52152.da; Tschoeke SK, 2008, J ORTHOP RES, V26, P999, DOI 10.1002/jor.20601; Vonk LA, 2010, MATRIX BIOL, V29, P209, DOI 10.1016/j.matbio.2009.12.001; Waddell G, 1996, SPINE, V21, P2820, DOI 10.1097/00007632-199612150-00002; Wang DL, 2007, SPINE, V32, P2521, DOI 10.1097/BRS.0b013e318158cb61; Yang SX, 2012, ONCOL REP, V28, P1249, DOI 10.3892/or.2012.1955; Zhao CQ, 2007, APOPTOSIS, V12, P2155, DOI 10.1007/s10495-007-0137-x; Zhao XH, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-55	32	75	86	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75251	10.1371/journal.pone.0075251	http://dx.doi.org/10.1371/journal.pone.0075251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086481	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700062
J	Phillips, M; Cataneo, RN; Chaturvedi, A; Kaplan, PD; Libardoni, M; Mundada, M; Patel, U; Zhang, X				Phillips, Michael; Cataneo, Renee N.; Chaturvedi, Anirudh; Kaplan, Peter D.; Libardoni, Mark; Mundada, Mayur; Patel, Urvish; Zhang, Xiang			Detection of an Extended Human Volatome with Comprehensive Two-Dimensional Gas Chromatography Time-of-Flight Mass Spectrometry	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; LUNG-CANCER; EXHALED BREATH; METABOLOME; BIOMARKERS	Background: Comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry (GCxGC-TOF MS) has been proposed as a powerful new tool for multidimensional analysis of complex chemical mixtures. We investigated GCxGC-TOF MS as a new method for identifying volatile organic compounds (VOCs) in normal human breath. Methods: Samples of alveolar breath VOCs and ambient room air VOC were collected with a breath collection apparatus (BCA) onto separate sorbent traps from 34 normal healthy volunteers (mean age = 40 yr, SD = 17 yr, male/female = 19/15). VOCs were separated on two serial capillary columns separated by a cryogenic modulator, and detected with TOF MS. The first and second dimension columns were non-polar and polar respectively. Results: BCA collection combined with GCxGC-TOF MS analysis identified approximately 2000 different VOCs in samples of human breath, many of which have not been previously reported. The 50 VOCs with the highest alveolar gradients (abundance in breath minus abundance in ambient room air) mostly comprised benzene derivatives, acetone, methylated derivatives of alkanes, and isoprene. Conclusions: Collection and analysis of breath VOCs with the BCA-GCxGC-TOF MS system extended the size of the detectable human volatile metabolome, the volatome, by an order of magnitude compared to previous reports employing one-dimensional GC-MS. The size of the human volatome has been under-estimated in the past due to coelution of VOCs in one-dimensional GC analytical systems.	[Phillips, Michael; Cataneo, Renee N.; Chaturvedi, Anirudh; Kaplan, Peter D.; Mundada, Mayur; Patel, Urvish] Menssana Res Inc, Breath Res Lab, Newark, NJ 07103 USA; [Phillips, Michael] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Libardoni, Mark] Southwest Res Inst, San Antonio, TX USA; [Zhang, Xiang] Univ Louisville, Dept Chem, Louisville, KY 40292 USA	New York Medical College; Southwest Research Institute; University of Louisville	Phillips, M (corresponding author), Menssana Res Inc, Breath Res Lab, Newark, NJ 07103 USA.	mphillips@menssanaresearch.com	Chaturvedi, Anirudh/M-1373-2016	Chaturvedi, Anirudh/0000-0001-7477-2300; Kaplan, Peter/0000-0002-2292-6862	Menssana Research, Inc.; LECO Corporation	Menssana Research, Inc.; LECO Corporation	This research was funded internally and performed by Menssana Research, Inc. The lease of the analytical system was subsidized by LECO Corporation, who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdassi E, 2000, FREE RADICAL BIO MED, V28, P880, DOI 10.1016/S0891-5849(00)00189-1; Amann A, 2007, MINI-REV MED CHEM, V7, P115, DOI 10.2174/138955707779802606; Amann A, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/1/010201; BATTEN JH, 1995, PHYTOCHEMISTRY, V39, P1351, DOI 10.1016/0031-9422(95)00126-R; Caldeira M, 2012, J CHROMATOGR A, V1254, P87, DOI 10.1016/j.chroma.2012.07.023; DAlessandro M., 2006, ASSESSING IMPORTANCE; Kim S, 2012, BIOINFORMATICS, V28, P1158, DOI 10.1093/bioinformatics/bts083; Libardoni M, 2006, J CHROMATOGR B, V842, P13, DOI 10.1016/j.jchromb.2006.05.008; Ligor M, 2009, CLIN CHEM LAB MED, V47, P550, DOI 10.1515/CCLM.2009.133; Pagonas N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046258; PAULING L, 1971, P NATL ACAD SCI USA, V68, P2374, DOI 10.1073/pnas.68.10.2374; Phillips M, 1999, J CHROMATOGR B, V729, P75, DOI 10.1016/S0378-4347(99)00127-9; Phillips M, 1997, ANAL BIOCHEM, V247, P272, DOI 10.1006/abio.1997.2069; PHILLIPS M, 1992, SCI AM, V267, P74, DOI 10.1038/scientificamerican0792-74; Phillips M, 2003, CHEST, V123, P2115, DOI 10.1378/chest.123.6.2115; PHILLIPS M, 1994, FREE RADICAL RES, V20, P333, DOI 10.3109/10715769409145633; Phillips Michael, 2007, Cancer Biomarkers, V3, P95; Phillips M, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/2/026003; Phillips M, 2010, TUBERCULOSIS, V90, P145, DOI 10.1016/j.tube.2010.01.003; Pierce KM, 2008, J CHROMATOGR A, V1184, P341, DOI 10.1016/j.chroma.2007.07.059; Scholler C, 1997, CHEMOSPHERE, V35, P1487, DOI 10.1016/S0045-6535(97)00209-9; Sinues PML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059909; Vautz W, 2010, J APPL PHYSIOL, V108, P697, DOI 10.1152/japplphysiol.00658.2009; Wallace L, 1996, ENVIRON HEALTH PERSP, V104, P861, DOI 10.2307/3433003; Wang B, 2010, ANAL CHEM, V82, P5069, DOI 10.1021/ac100064b; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xu ZQ, 2013, BRIT J CANCER, V108, P941, DOI 10.1038/bjc.2013.44; Zhang J, 2011, J CHROMATOGR A, V1218, P6522, DOI 10.1016/j.chroma.2011.07.039	28	57	59	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75274	10.1371/journal.pone.0075274	http://dx.doi.org/10.1371/journal.pone.0075274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086492	Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700068
J	Tirapelle, EF; Muller-Santos, M; Tadra-Sfeir, MZ; Kadowaki, MAS; Steffens, MBR; Monteiro, RA; Souza, EM; Pedrosa, FO; Chubatsu, LS				Tirapelle, Evandro F.; Mueller-Santos, Marcelo; Tadra-Sfeir, Michelle Z.; Kadowaki, Marco A. S.; Steffens, Maria B. R.; Monteiro, Rose A.; Souza, Emanuel M.; Pedrosa, Fabio O.; Chubatsu, Leda S.			Identification of Proteins Associated with Polyhydroxybutyrate Granules from Herbaspirillum seropedicae SmR1-Old Partners, New Players	PLOS ONE			English	Article							POLYHYDROXYALKANOATE GRANULES; AZOSPIRILLUM-BRASILENSE; PSEUDOMONAS-PUTIDA; NITROGEN-FIXATION; PHB; POLY(3-HYDROXYBUTYRATE); LOCALIZATION; PHASINS; BINDING; ACCUMULATION	Herbaspirillum seropedicae is a diazotrophic beta-Proteobacterium found associated with important agricultural crops. This bacterium produces polyhydroxybutyrate (PHB), an aliphatic polyester, as a carbon storage and/or source of reducing equivalents. The PHB polymer is stored as intracellular insoluble granules coated mainly with proteins, some of which are directly involved in PHB synthesis, degradation and granule biogenesis. In this work, we have extracted the PHB granules from H. seropedicae and identified their associated-proteins by mass spectrometry. This analysis allowed us to identify the main phasin (PhaP1) coating the PHB granule as well as the PHB synthase (PhbC1) responsible for its synthesis. A phbC1 mutant is impaired in PHB synthesis, confirming its role in H. seropedicae. On the other hand, a phaP1 mutant produces PHB granules but coated mainly with the secondary phasin (PhaP2). Furthermore, some novel proteins not previously described to be involved with PHB metabolism were also identified, bringing new possibilities to PHB function in H. seropedicae.	[Tirapelle, Evandro F.; Mueller-Santos, Marcelo; Tadra-Sfeir, Michelle Z.; Kadowaki, Marco A. S.; Steffens, Maria B. R.; Monteiro, Rose A.; Souza, Emanuel M.; Pedrosa, Fabio O.; Chubatsu, Leda S.] Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Parana	Chubatsu, LS (corresponding author), Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil.	chubatsu@ufpr.br	Pedrosa, Fabio 0/C-1938-2013; Chubatsu, Leda S./H-2603-2012; Müller-Santos, Marcelo/D-7272-2013; Kadowaki, Marco/AAA-9024-2021	Chubatsu, Leda S./0000-0002-8687-2816; Müller-Santos, Marcelo/0000-0001-9615-6007; Kadowaki, Marco/0000-0003-0188-2079; Monteiro, Rose Adele/0000-0001-8226-0700; Muller-Santos, Marcelo/0000-0001-9524-9084	INCT - Fixacao Biologica de Nitrogenio; CNPq; CAPES; Institutos do Milenio; PRONEX; Fundacao Araucaria	INCT - Fixacao Biologica de Nitrogenio; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Institutos do Milenio; PRONEX; Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	This research was financially supported by INCT - Fixacao Biologica de Nitrogenio, CNPq, CAPES, Institutos do Milenio, PRONEX and Fundacao Araucaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babel W, 2001, ADV BIOCHEM ENG BIOT, V71, P125; BALDANI JI, 1986, INT J SYST BACTERIOL, V36, P86, DOI 10.1099/00207713-36-1-86; Beeby M, 2012, J BACTERIOL, V194, P1092, DOI 10.1128/JB.06125-11; BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; Catalan AI, 2007, ENZYME MICROB TECH, V40, P1352, DOI 10.1016/j.enzmictec.2006.10.008; Chaves DFS, 2007, PROTEOMICS, V7, P3759, DOI 10.1002/pmic.200600859; Galan B, 2011, MOL MICROBIOL, V79, P402, DOI 10.1111/j.1365-2958.2010.07450.x; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; Grage K, 2009, BIOMACROMOLECULES, V10, P660, DOI 10.1021/bm801394s; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Gupta P, 2010, INT J BIOCHEM CELL B, V42, P683, DOI 10.1016/j.biocel.2010.01.002; Hervas AB, 2008, J BACTERIOL, V190, P416, DOI 10.1128/JB.01230-07; Huergo LF, 2010, FEMS MICROBIOL LETT, V308, P40, DOI 10.1111/j.1574-6968.2010.01986.x; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Jendrossek D, 2009, J BACTERIOL, V191, P3195, DOI 10.1128/JB.01723-08; Jurasek L, 2002, BIOMACROMOLECULES, V3, P256, DOI 10.1021/bm010145d; Kadouri D, 2003, APPL ENVIRON MICROB, V69, P3244, DOI 10.1128/AEM.69.6.3244-3250.2003; Kadowaki MAS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-230; Klint M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-81; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neumann L, 2008, J BACTERIOL, V190, P2911, DOI 10.1128/JB.01486-07; Pedersen LB, 1996, MOL MICROBIOL, V20, P295, DOI 10.1111/j.1365-2958.1996.tb02618.x; Pedrosa FO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002064; PEDROSA FO, 1984, FEMS MICROBIOL LETT, V23, P95, DOI 10.1016/0378-1097(84)90080-6; Pfeiffer D, 2012, J BACTERIOL, V194, P5909, DOI 10.1128/JB.00779-12; Pfeiffer D, 2011, MOL MICROBIOL, V82, P936, DOI 10.1111/j.1365-2958.2011.07869.x; Poehlein A, 2011, J BACTERIOL, V193, P5017, DOI 10.1128/JB.05660-11; Potter M, 2005, BIOMACROMOLECULES, V6, P552, DOI 10.1021/bm049401n; Potter M, 2004, MICROBIOL-SGM, V150, P2301, DOI 10.1099/mic.0.26970-0; Ratcliff WC, 2008, FEMS MICROBIOL ECOL, V65, P391, DOI 10.1111/j.1574-6941.2008.00544.x; Ren Q, 2009, BIOMACROMOLECULES, V10, P916, DOI 10.1021/bm801431c; Reusch RN, 2013, INT J MOL SCI, V14, P10727, DOI 10.3390/ijms140610727; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Souza EM, 2000, MICROBIOL-UK, V146, P1407, DOI 10.1099/00221287-146-6-1407; Wang CX, 2007, J BACTERIOL, V189, P9050, DOI 10.1128/JB.01190-07	40	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75066	10.1371/journal.pone.0075066	http://dx.doi.org/10.1371/journal.pone.0075066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086439	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700050
J	Barks, PM; Godin, JGJ				Barks, Patrick M.; Godin, Jean-Guy J.			Can Convict Cichlids (Amatitlania siquia) Socially Learn the Degree of Predation Risk Associated with Novel Visual Cues in Their Environment?	PLOS ONE			English	Article							MINNOWS PIMEPHALES-PROMELAS; CHEMICAL ALARM CUES; FATHEAD MINNOWS; ANTIPREDATOR BEHAVIOR; INFORMATION-TRANSFER; RECOGNITION; PREY; RESPONSES; SIZE; SPECIFICITY	For many animals, the ability to distinguish cues indicative of predation risk from cues unrelated to predation risk is not entirely innate, but rather is learned and improved with experience. Two pathways to such learning are possible. First, an animal could initially express antipredator behaviour toward a wide range of cues and subsequently learn which of those cues are non-threatening. Alternatively, it could initially express no antipredator behaviour toward a wide range of cues and subsequently learn which of them are threatening. While the learned recognition of threatening cues may occur either through personal interaction with a cue (asocial learning) or through observation of the behaviour of social companions toward a cue (social learning), the learned recognition of non-threatening cues seems to occur exclusively through habituation, a form of asocial learning. Here, we tested whether convict cichlid fish (Amatitlania siquia) can socially learn to recognize visual cues in their environment as either threatening or nonthreatening. We exposed juvenile convict cichlids simultaneously to a novel visual cue and one of three (visual) social cues: a social cue indicative of non-risk (the sight of conspecifics that had previously been habituated to the novel cue), a social cue indicative of predation risk (the sight of conspecifics trained to fear the novel cue), or a control treatment with no social cue. The subsequent response of focal fish, when presented with the novel cue alone, was not influenced by the social cue that they had previously witnessed. We therefore did not find evidence that convict cichlids in our study could use social learning to recognize novel visual cues as either threatening or non-threatening. We consider alternative explanations for our findings.	[Barks, Patrick M.; Godin, Jean-Guy J.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Barks, Patrick M.] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	Carleton University; University of Lethbridge	Godin, JGJ (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	jgodin@carleton.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 8074-2010]; Ontario Government	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Government	This research was supported by a Discovery research grant (RGPIN 8074-2010) from the Natural Sciences and Engineering Research Council of Canada (NSERC) to J-GJG and post-graduate scholarships from NSERC and the Ontario Government to PMB. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo Jamie J., 2001, Journal of Aquariculture & Aquatic Sciences, V9, P208; Barrera JP, 2011, ANIM BEHAV, V81, P779, DOI 10.1016/j.anbehav.2011.01.010; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Brown GE, 2006, CAN J ZOOL, V84, P1, DOI 10.1139/Z05-166; Brown GE, 2003, FISH FISH, V4, P227, DOI 10.1046/j.1467-2979.2003.00132.x; Brown GE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2712; CHIVERS DP, 1995, CAN J ZOOL, V73, P955, DOI 10.1139/z95-111; CHIVERS DP, 1994, ANIM BEHAV, V48, P597, DOI 10.1006/anbe.1994.1279; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; CSANYI V, 1985, BEHAVIOUR, V92, P227; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Deecke VB, 2002, NATURE, V420, P171, DOI 10.1038/nature01030; DILL LM, 1974, ANIM BEHAV, V22, P723, DOI 10.1016/S0003-3472(74)80023-0; Dowling LM, 2002, CAN J ZOOL, V80, P782, DOI 10.1139/Z02-036; DUGATKIN LA, 1992, ANN ZOOL FENN, V29, P233; Epp KJ, 2008, ETHOLOGY, V114, P607, DOI 10.1111/j.1439-0310.2008.01494.x; Evans JP, 2000, P NATL ACAD SCI USA, V97, P10074, DOI 10.1073/pnas.180207297; Ferrari MCO, 2008, ETHOLOGY, V114, P238, DOI 10.1111/j.1439-0310.2007.01468.x; Ferrari MCO, 2007, CHEMOECOLOGY, V17, P223, DOI 10.1007/s00049-007-0380-1; Ferrari MCO, 2006, BEHAV ECOL SOCIOBIOL, V60, P522, DOI 10.1007/s00265-006-0195-z; Ferrari MCO, 2011, ANIM COGN, V14, P309, DOI 10.1007/s10071-010-0363-4; Ferrari MCO, 2005, ANIM BEHAV, V70, P777, DOI 10.1016/j.anbehav.2005.01.009; Foam PE, 2005, BEHAVIOUR, V142, P129, DOI 10.1163/1568539053627631; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Godin Jean-Guy J., 1997, P191; Greenberg R.S., 1990, STUD AVIAN BIOL, V13, P431; Griffin AS, 2008, ANIM BEHAV, V75, P79, DOI 10.1016/j.anbehav.2007.04.008; Griffin AS, 2005, ANIM BEHAV, V69, P669, DOI 10.1016/j.anbehav.2004.05.020; Griffin AS, 2002, ETHOLOGY, V108, P1103, DOI 10.1046/j.1439-0310.2002.00840.x; Griffin AS, 2001, ANIM BEHAV, V62, P577, DOI 10.1006/anbe.2001.1781; Griffin AS, 2004, LEARN BEHAV, V32, P131; Hemmi JM, 2009, P R SOC B, V276, P4381, DOI 10.1098/rspb.2009.1452; KLOPFER PETER H., 1959, BEHAVIOUR, V14, P282, DOI 10.1163/156853959X00117; Krause J, 2002, LIVING GROUPS; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MAGURRAN AE, 1988, ETHOLOGY, V78, P153; Mirza RS, 2006, BEHAVIOUR, V143, P877, DOI 10.1163/156853906778017926; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reader SM, 2001, BEHAV BRAIN SCI, V24, P353, DOI 10.1017/S0140525X01543964; RYER CH, 1991, ENVIRON BIOL FISH, V30, P317, DOI 10.1007/BF02028847; Shier DM, 2007, ANIM BEHAV, V73, P567, DOI 10.1016/j.anbehav.2006.09.009; SIH A, 1992, AM NAT, V139, P1052, DOI 10.1086/285372; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; SUBOSKI MD, 1990, J COMP PSYCHOL, V104, P101, DOI 10.1037/0735-7036.104.1.101; Veen T, 2000, P ROY SOC B-BIOL SCI, V267, P2253, DOI 10.1098/rspb.2000.1276; Vennesland RG, 2010, CAN J ZOOL, V88, P81, DOI 10.1139/Z09-118; Ward AJW, 2003, FISH FISH, V4, P348, DOI 10.1046/j.1467-2979.2003.00135.x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wilkinson A, 2010, BIOL LETTERS, V6, P614, DOI 10.1098/rsbl.2010.0092; Wisenden BD, 1997, J CHEM ECOL, V23, P137, DOI 10.1023/B:JOEC.0000006350.66424.3d; Wisenden BD, 1997, ETHOLOGY, V103, P283; WISENDEN BD, 1994, CAN J ZOOL, V72, P2177, DOI 10.1139/z94-291; Wisenden BD, 2001, ETHOLOGY, V107, P357, DOI 10.1046/j.1439-0310.2001.00667.x; Wisenden BD, 2008, ENVIRON BIOL FISH, V81, P141, DOI 10.1007/s10641-006-9181-6; Yunker WK, 1999, J CHEM ECOL, V25, P2677, DOI 10.1023/A:1020843322518	57	2	2	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75858	10.1371/journal.pone.0075858	http://dx.doi.org/10.1371/journal.pone.0075858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086648	Green Published, gold			2022-12-25	WOS:000325025200065
J	Chow, KT; Schulz, D; McWhirter, SM; Schlissel, MS				Chow, Kwan T.; Schulz, Danae; McWhirter, Sarah M.; Schlissel, Mark S.			Gfi1 and Gfi1b Repress Rag Transcription in Plasmacytoid Dendritic Cells In Vitro	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; FACTOR E2-2; EXPRESSION; GFI-1B; PROGENITORS; GENE; DIFFERENTIATION; HEMATOPOIESIS; REGULATOR; PU.1	Growth factor independence genes (Gfi1 and Gfi1b) repress recombination activating genes (Rag) transcription in developing B lymphocytes. Because all blood lineages originate from hematopoietic stem cells (HSCs) and different lineage progenitors have been shown to share transcription factor networks prior to cell fate commitment, we hypothesized that GFI family proteins may also play a role in repressing Rag transcription or a global lymphoid transcriptional program in other blood lineages. We tested the level of Rag transcription in various blood cells when Gfi1 and Gfi1b were deleted, and observed an upregulation of Rag expression in plasmacytoid dendritic cells (pDCs). Using microarray analysis, we observed that Gfi1 and Gfi1b do not regulate a lymphoid or pDC-specific transcriptional program. This study establishes a role for Gfi1 and Gfi1b in Rag regulation in a non-B lineage cell type.	[Chow, Kwan T.; Schulz, Danae; McWhirter, Sarah M.; Schlissel, Mark S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Schlissel, Mark S.] Brown Univ, Off Provost, Providence, RI 02912 USA	University of California System; University of California Berkeley; Brown University	Schlissel, MS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mark_schlissel@brown.edu	Chow, Kwan/AAH-6782-2019	Chow, Kwan/0000-0003-1012-0797; Schulz, Danae/0000-0002-0392-7245	NIH [RO1 HL48702, R37 AI40227]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040227] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants to MS from NIH (RO1 HL48702 and R37 AI40227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2006, BLOOD, V108, P4025, DOI 10.1182/blood-2006-03-007757; Borghesi L, 2004, J EXP MED, V199, P491, DOI 10.1084/jem.20031800; Borghesi L, 2004, J EXP MED, V199, P483, DOI 10.1084/jem.20031802; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Dahl R, 2007, J BIOL CHEM, V282, P6473, DOI 10.1074/jbc.M607613200; Fiolka K, 2006, EMBO REP, V7, P326, DOI 10.1038/sj.embor.7400618; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hock H, 2006, CURR OPIN HEMATOL, V13, P1, DOI 10.1097/01.moh.0000190111.85284.8f; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Horman SR, 2009, BLOOD, V113, P5466, DOI 10.1182/blood-2008-09-179747; INABA K, 2009, CURR PROTOC IMMUNOL, V3, P32791; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; Khandanpour C, 2010, BLOOD, V116, P5149, DOI 10.1182/blood-2010-04-280305; KOURO T, 2005, CURR PROTOC IMMUNOL, V22, P32949; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Mak Ka Sin, 2011, Int J Cell Biol, V2011, P808524, DOI 10.1155/2011/808524; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Osawa M, 2002, BLOOD, V100, P2769, DOI 10.1182/blood-2002-01-0182; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Rathinam C, 2005, IMMUNITY, V22, P717, DOI 10.1016/j.immuni.2005.04.007; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Rock J, 2007, EUR J IMMUNOL, V37, P3564, DOI 10.1002/eji.200737711; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; Schulz D, 2012, J EXP MED, V209, P187, DOI 10.1084/jem.20110645; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; SHIVDASANI RA, 2005, CURR PROTOC IMMUNOL, V22, P32953; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tong B, 1998, MOL CELL BIOL, V18, P2462, DOI 10.1128/MCB.18.5.2462; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Vassen L, 2007, BLOOD, V109, P2356, DOI 10.1182/blood-2006-06-030031; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Welner RS, 2009, J IMMUNOL, V183, P7768, DOI 10.4049/jimmunol.0902333; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Yoshida T, 2010, CURR OPIN IMMUNOL, V22, P154, DOI 10.1016/j.coi.2010.02.011; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhu JF, 2006, P NATL ACAD SCI USA, V103, P18214, DOI 10.1073/pnas.0608981103; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	56	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75891	10.1371/journal.pone.0075891	http://dx.doi.org/10.1371/journal.pone.0075891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086657	Green Submitted, Green Published, gold			2022-12-25	WOS:000325025200067
J	Leroy, F; Meziane, T; Riera, P; Comtet, T				Leroy, Fanny; Meziane, Tarik; Riera, Pascal; Comtet, Thierry			Seasonal Variations in Maternal Provisioning of Crepidula fornicata (Gastropoda): Fatty Acid Composition of Females, Embryos and Larvae	PLOS ONE			English	Article							INTRODUCED SUSPENSION-FEEDERS; ARBACIA-LIXULA ECHINODERMATA; SEA-URCHIN LARVAE; COD GADUS-MORHUA; PECTEN-MAXIMUS L; EGG QUALITY; BIOCHEMICAL-COMPOSITION; PHENOTYPIC PLASTICITY; REPRODUCTIVE OUTPUT; NUTRITIONAL-VALUE	Recruitment success of marine invertebrate populations not only depends on the number of recruits but also on their quality which affects their survival. In species characterized by a mixed development (encapsulated embryonic development and release of planktotrophic larvae), the offspring quality depends on both maternal provisioning and larval feeding. Here, we investigated potential changes of maternal provisioning over the whole reproductive period in a gastropod with a mixed development: Crepidula fornicata. In its introduction area, C. fornicata reproduces from February to October, which implies that both adults and larvae are exposed to different food availabilities. Maternal provisioning was assessed by measuring the fatty acid (FA) composition of females, encapsulated embryos and larvae, in February, May, July and September 2009. FA are essential resources for the development of embryos and larvae, and are key biomarkers of offspring quality. Our results showed differences in FA composition between muscles, visceral masses, and encapsulated embryos. In particular, FA composition of embryos was similar to that of the visceral mass. Seasonal variations in FA composition were observed: in the middle of the reproductive season (May and July), female tissues and embryos showed a higher proportion of polyunsaturated fatty acids and especially.3, as compared to the beginning and end of the reproductive season (February and September). This showed that through maternal provisioning the quality of C. fornicata offspring was higher in the middle of the reproductive season. Whether this would result in an increase of recruitment success and juvenile performance would require further investigations.	[Leroy, Fanny; Riera, Pascal; Comtet, Thierry] Univ Paris 06, UPMC, UMR 7144, Biol Stn, Roscoff, France; [Leroy, Fanny; Riera, Pascal; Comtet, Thierry] CNRS, Biol Stn, UMR 7144, Roscoff, France; [Meziane, Tarik] Museum Natl Hist Nat, UMR BOREA 7208, Comm Programme & Coordinat 53, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Leroy, F (corresponding author), Univ Paris 06, UPMC, UMR 7144, Biol Stn, Roscoff, France.	Fanny.Leroy@obs-vlfr.fr	Meziane, Tarik/AAF-7906-2020; Comtet, Thierry/ABE-3212-2021; Meziane, Tarik/A-5465-2009	Meziane, Tarik/0000-0003-2142-6441; Meziane, Tarik/0000-0003-2142-6441	Ministere de la Recherche et de l'Enseignement Superieur; INSU [2009/10371755]	Ministere de la Recherche et de l'Enseignement Superieur; INSU(Centre National de la Recherche Scientifique (CNRS))	FL acknowledges a PhD fellowship from the Ministere de la Recherche et de l'Enseignement Superieur. This work was supported by INSU and IFREMER in the framework of the EC2CO program (project CRENULA, contract n 2009/10371755). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKMAN RG, 1968, J FISH RES BOARD CAN, V25, P1603, DOI 10.1139/f68-145; Bachan MM, 2012, MAR BIOL, V159, P2281, DOI 10.1007/s00227-012-2014-6; Bautista-Teruel MN, 2001, AQUAC RES, V32, P249, DOI 10.1046/j.1355-557x.2001.00022.x; Becker C, 2005, LIMNOL OCEANOGR, V50, P388, DOI 10.4319/lo.2005.50.1.0388; Beninger PG, 2007, MAR ECOL PROG SER, V334, P165, DOI 10.3354/meps334165; Berntsson KM, 1997, AQUACULTURE, V154, P139, DOI 10.1016/S0044-8486(97)00041-0; Bertram DF, 1998, ECOLOGY, V79, P315, DOI 10.2307/176885; Blanchard Michel, 1997, Scientia Marina, V61, P109; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brante A, 2009, J EXP BIOL, V212, P2287, DOI 10.1242/jeb.016329; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Byrne M, 2008, FUNCT ECOL, V22, P643, DOI 10.1111/j.1365-2435.2008.01427.x; Caers M, 2002, MAR BIOL, V140, P1157, DOI 10.1007/s00227-002-0798-5; Carboni S, 2012, AQUACULTURE, V324, P250, DOI 10.1016/j.aquaculture.2011.10.037; Chaparro OR, 2002, NEW ZEAL J MAR FRESH, V36, P661, DOI 10.1080/00288330.2002.9517122; Chaparro OR, 1999, J EXP MAR BIOL ECOL, V232, P261, DOI 10.1016/S0022-0981(98)00115-4; CHIPPERFIELD PNJ, 1951, J MAR BIOL ASSOC UK, V30, P49, DOI 10.1017/S0025315400012571; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Collin R, 2003, MAR ECOL PROG SER, V247, P103, DOI 10.3354/meps247103; Collin R, 2010, MAR ECOL PROG SER, V410, P89, DOI 10.3354/meps08638; Collin R, 2010, BIOL J LINN SOC, V99, P489, DOI 10.1111/j.1095-8312.2009.01388.x; Conklin E. G., 1897, Journal of Morphology Boston, Vxiii, P1; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Decottignies P, 2007, J EXP MAR BIOL ECOL, V342, P231, DOI 10.1016/j.jembe.2006.10.005; deJongWestman M, 1995, CAN J ZOOL, V73, P2080, DOI 10.1139/z95-245; DELAUNAY F, 1993, J EXP MAR BIOL ECOL, V173, P163, DOI 10.1016/0022-0981(93)90051-O; Desvilettes C, 1997, FRESHWATER BIOL, V38, P629, DOI 10.1046/j.1365-2427.1997.00241.x; DUNSTAN GA, 1994, PHYTOCHEMISTRY, V35, P155, DOI 10.1016/S0031-9422(00)90525-9; Faleiro F, 2010, AQUACULTURE, V307, P56, DOI 10.1016/j.aquaculture.2010.07.005; GALLAGER SM, 1986, AQUACULTURE, V56, P81, DOI 10.1016/0044-8486(86)90020-7; GARDNER D, 1972, J MAR BIOL ASSOC UK, V52, P827, DOI 10.1017/S0025315400040571; Gehman ALM, 2010, J EXP MAR BIOL ECOL, V386, P86, DOI 10.1016/j.jembe.2010.01.017; GEORGE SB, 1990, J EXP MAR BIOL ECOL, V141, P107, DOI 10.1016/0022-0981(90)90217-Z; George SB, 1999, J EXP MAR BIOL ECOL, V237, P203, DOI 10.1016/S0022-0981(98)00205-6; GEORGE SB, 1990, INVERTEBR REPROD DEV, V17, P111, DOI 10.1080/07924259.1990.9672098; HELM MM, 1987, AQUACULTURE, V62, P281, DOI 10.1016/0044-8486(87)90170-0; HELM MM, 1991, J MAR BIOL ASSOC UK, V71, P691, DOI 10.1017/S0025315400053248; Hendriks IE, 2003, J EXP MAR BIOL ECOL, V296, P199, DOI 10.1016/S0022-0981(03)00323-X; HOAGLAND KE, 1979, NAUTILUS, V93, P143; HOAGLAND KE, 1986, AM MALACOL BULL, V4, P173; Ito K, 1997, MAR ECOL PROG SER, V152, P187, DOI 10.3354/meps152187; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Jaeckle William B., 1995, P49; Jarrett JN, 2003, ECOLOGY, V84, P384, DOI 10.1890/0012-9658(2003)084[0384:SVILCA]2.0.CO;2; JORGENSEN CB, 1984, MAR ECOL PROG SER, V15, P283, DOI 10.3354/meps015283; Kach DJ, 2008, MAR BIOL, V153, P797, DOI 10.1007/s00227-007-0852-4; Kelly JR, 2008, MAR ECOL PROG SER, V373, P1, DOI 10.3354/meps07746; Labarta U, 1999, COMP BIOCHEM PHYS A, V123, P249, DOI 10.1016/S1095-6433(99)00054-9; LAING I, 1990, J MAR BIOL ASSOC UK, V70, P1, DOI 10.1017/S0025315400034147; Lanes CFC, 2012, AQUACULTURE, V324, P267, DOI 10.1016/j.aquaculture.2011.10.036; Leonardos N, 2000, AQUACULTURE, V184, P155, DOI 10.1016/S0044-8486(99)00320-8; Leroy F, 2011, THESIS U P M CURIE P; Leroy F, 2012, J SEA RES, V70, P23, DOI 10.1016/j.seares.2012.02.006; Leroy F, 2012, J MOLLUS STUD, V78, P100, DOI 10.1093/mollus/eyr044; LESSER MP, 1992, J EXP MAR BIOL ECOL, V165, P91, DOI 10.1016/0022-0981(92)90291-H; Lin H, 2007, AQUACULTURE, V264, P247, DOI 10.1016/j.aquaculture.2006.12.021; Liu H, 2007, AQUACULTURE, V264, P263, DOI 10.1016/j.aquaculture.2006.12.022; Marshall DJ, 2003, ECOLOGY, V84, P3131, DOI 10.1890/02-0311; Marshall DJ, 2008, AM NAT, V171, P214, DOI 10.1086/524954; Martin-Creuzburg D, 2009, AQUAT ECOL, V43, P943, DOI 10.1007/s10452-009-9239-6; Martinez-Pita I, 2005, J SHELLFISH RES, V24, P1209; MARTY Y, 1992, J EXP MAR BIOL ECOL, V163, P221, DOI 10.1016/0022-0981(92)90051-B; Mateos HT, 2010, FOOD CHEM, V123, P436, DOI 10.1016/j.foodchem.2010.04.062; Meziane T, 1997, J SEA RES, V38, P47, DOI 10.1016/S1385-1101(97)00035-X; Meziane T, 2002, J SEA RES, V47, P1, DOI 10.1016/S1385-1101(01)00092-2; Miloslavich P, 1996, J MOLLUS STUD, V62, P133, DOI 10.1093/mollus/62.1.133; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Nelson MM, 2002, COMP BIOCHEM PHYS B, V131, P695, DOI 10.1016/S1096-4959(02)00042-8; Nevejan N, 2003, AQUACULTURE, V217, P613, DOI 10.1016/S0044-8486(02)00585-9; NEWELL RC, 1977, J MAR BIOL ASSOC UK, V57, P161, DOI 10.1017/S0025315400021317; Ojeda JA, 2004, MAR BIOL, V144, P263, DOI 10.1007/s00227-003-1194-5; OLSON RR, 1989, ANNU REV ECOL SYST, V20, P225; ORTON J.H., 1912, J MAR BIOL ASSOC UK, V9, P437, DOI DOI 10.1017/S0025315400048372; PANDIAN TJ, 1967, HELGOLAND WISS MEER, V16, P216, DOI 10.1007/BF01611705; PANDIAN TJ, 1970, MAR BIOL, V5, P154, DOI 10.1007/BF00352599; PANDIAN TJ, 1967, HELGOLAND WISS MEER, V16, P225, DOI 10.1007/BF01611706; PANDIAN TJ, 1969, MAR BIOL, V3, P117, DOI 10.1007/BF00353430; Patil V, 2007, AQUACULT INT, V15, P1, DOI 10.1007/s10499-006-9060-3; Pechenik JA, 2004, J EXP MAR BIOL ECOL, V306, P75, DOI 10.1016/j.jembe.2004.01.004; Pernet F, 2005, J EXP MAR BIOL ECOL, V327, P115, DOI 10.1016/j.jembe.2005.06.008; Pernet F, 2004, J EXP MAR BIOL ECOL, V310, P73, DOI 10.1016/j.jembe.2004.04.001; Pettersen AK, 2010, AQUACULTURE, V309, P115, DOI 10.1016/j.aquaculture.2010.09.024; Poorbagher H, 2010, J MAR BIOL ASSOC UK, V90, P527, DOI 10.1017/S0025315409990907; Richard J, 2006, MAR BIOL, V149, P789, DOI 10.1007/s00227-005-0157-4; RIGAL F, 2009, THESIS U P M CURIE P; Rosa R, 2005, COMP BIOCHEM PHYS B, V140, P241, DOI 10.1016/j.cbpc.2004.10.009; SCHERRER B, 1984, BIOSTATISTIQUE; Schomburg G, 1987, GASCHROMATOGRAPHIE G; Sewell MA, 2005, MAR ECOL PROG SER, V304, P133, DOI 10.3354/meps304133; Smith BL, 2007, MAR FRESHWATER RES, V58, P1002, DOI 10.1071/MF06103; Soudant P, 1996, AQUACULT INT, V4, P191, DOI 10.1007/BF00117381; Soudant P, 1998, COMP BIOCHEM PHYS A, V121, P279, DOI 10.1016/S1095-6433(98)10130-7; Soudant P, 1996, AQUACULTURE, V143, P361, DOI 10.1016/0044-8486(96)01276-8; SULLIVAN CH, 1984, BIOL BULL-US, V167, P378, DOI 10.2307/1541284; THIRIOTQUIEVREUX C, 1982, MALACOLOGIA, V23, P37; THOMPSON PA, 1993, MAR BIOL, V117, P259, DOI 10.1007/BF00345671; Torres P, 2008, ESTUAR COAST SHELF S, V80, P307, DOI 10.1016/j.ecss.2008.07.018; Tremblay R, 2007, MAR ECOL PROG SER, V340, P1, DOI 10.3354/meps340001; UNESCO, 1968, ZOOPL SAMPL, P174; Utting SD, 1997, AQUACULTURE, V155, P45, DOI 10.1016/S0044-8486(97)00108-7; Vanderploeg HA, 1996, J GREAT LAKES RES, V22, P36, DOI 10.1016/S0380-1330(96)70932-2; WALDOCK MJ, 1984, LIPIDS, V19, P332, DOI 10.1007/BF02534783; Werner B., 1955, Helgolander Wissenschaftliche Meeresuntersuchungen, V5, P169, DOI 10.1007/BF01610508; WHYTE JNC, 1991, J EXP MAR BIOL ECOL, V149, P67, DOI 10.1016/0022-0981(91)90117-F; WHYTE JNC, 1989, AQUACULTURE, V78, P333, DOI 10.1016/0044-8486(89)90110-5; WHYTE JNC, 1990, MAR BIOL, V106, P239, DOI 10.1007/BF01314806; Yanes-Roca C, 2009, AQUACULTURE, V287, P335, DOI 10.1016/j.aquaculture.2008.10.043	108	7	8	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75316	10.1371/journal.pone.0075316	http://dx.doi.org/10.1371/journal.pone.0075316			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086505	Green Submitted, gold, Green Published			2022-12-25	WOS:000325025200039
J	Shepherd, AJ; Loo, L; Mohapatra, DP				Shepherd, Andrew J.; Loo, Lipin; Mohapatra, Durga P.			Chemokine Co-Receptor CCR5/CXCR4-Dependent Modulation of Kv2.1 Channel Confers Acute Neuroprotection to HIV-1 Glycoprotein gp120 Exposure	PLOS ONE			English	Article							DEPENDENT MODULATION; K+ CHANNEL; NEURONAL APOPTOSIS; POTASSIUM CHANNEL; CELL-DEATH; MECHANISMS; LOCALIZATION; CXCR4; EXCITABILITY; PHOSPHORYLATION	Infection with human immunodeficiency virus-1 (HIV-1) within the brain has long been known to be associated with neurodegeneration and neurocognitive disorder (referred as HAND), a condition characterized in its early stages by declining cognitive function and behavioral disturbances. Mechanistically, the HIV-1 coat glycoprotein 120 (gp120) has been suggested to be a critical factor inducing apoptotic cell death in neurons via the activation of p38 mitogenactivated protein kinase (MAPK), upon chronic exposure to the virus. Here we show that acute exposure of neurons to HIV-1 gp120 elicits a homeostatic response, which provides protection against non-apoptotic cell death, involving the major somatodendritic voltage-gated K+ (Kv) channel Kv2.1 as the key mediator. The Kv2.1 channel has recently been shown to provide homeostatic control of neuronal excitability under conditions of seizures, ischemia and neuromodulation/neuroinflammation. Following acute exposure to gp120, cultured rat hippocampal neurons show rapid dephosphorylation of the Kv2.1 protein, which ultimately leads to changes in specific sub-cellular localization and voltage-dependent channel activation properties of Kv2.1. Such modifications in Kv2.1 are dependent on the activation of the chemokine co-receptors CCR5 and CXCR4, and subsequent activation of the protein phosphatase calcineurin. This leads to the overall suppression of neuronal excitability and provides neurons with a homeostatic protective mechanism. Specific blockade of calcineurin and Kv2.1 channel activity led to significant enhancement of non-apoptotic neuronal death upon acute gp120 treatment. These observations shed new light on the intrinsic homeostatic mechanisms of neuronal resilience during the acute stages of neuro-HIV infections.	[Shepherd, Andrew J.; Loo, Lipin; Mohapatra, Durga P.] Univ Iowa, Dept Pharmacol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Mohapatra, Durga P.] Univ Iowa, Dept Anesthesia, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Mohapatra, DP (corresponding author), Univ Iowa, Dept Pharmacol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	dp-mohapatra@uiowa.edu	Mohapatra, Durga/M-2133-2017	Mohapatra, Durga/0000-0001-5016-1281; Loo, Lipin/0000-0002-4112-1816; Shepherd, Andrew/0000-0002-8440-6192	University of Iowa Office of the Vice President of Research; Department of Pharmacology, Roy J. Lucille A. Carver College of Medicine; Epilepsy Foundation; American Epilepsy Society [Pc-190423]; NIH/NINDS [NS069898]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069898] Funding Source: NIH RePORTER	University of Iowa Office of the Vice President of Research; Department of Pharmacology, Roy J. Lucille A. Carver College of Medicine; Epilepsy Foundation; American Epilepsy Society; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by start-up funds from the University of Iowa Office of the Vice President of Research, and the Department of Pharmacology, Roy J. Lucille A. Carver College of Medicine; and partly by research grants from the Epilepsy Foundation and American Epilepsy Society (Pc-190423), and NIH/NINDS (NS069898) to DPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banisadr G, 2002, EUR J NEUROSCI, V16, P1661, DOI 10.1046/j.1460-9568.2002.02237.x; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Chen LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025994; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; Grovit-Ferbas K, 2010, IMMUNOL RES, V48, P40, DOI 10.1007/s12026-010-8166-x; Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454; Guyon A, 2007, J MOL ENDOCRINOL, V38, P365, DOI 10.1677/JME-06-0013; Hesselgesser J, 1998, CURR BIOL, V8, P595, DOI 10.1016/S0960-9822(98)70230-1; Kaul M, 2007, CELL DEATH DIFFER, V14, P296, DOI 10.1038/sj.cdd.4402006; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Li W, 2005, NEUROTOX RES, V8, P119, DOI 10.1007/BF03033824; Liner Kevin J 2nd, 2008, Curr HIV/AIDS Rep, V5, P64, DOI 10.1007/s11904-008-0011-7; Lipton SA, 1991, BRAIN PATHOL, V1, P193, DOI 10.1111/j.1750-3639.1991.tb00659.x; LO TM, 1992, BRAIN RES, V594, P189, DOI 10.1016/0006-8993(92)91125-X; Loo L, 2012, J NEUROSCI, V32, P11942, DOI 10.1523/JNEUROSCI.1330-12.2012; Malin SA, 2002, J NEUROSCI, V22, P10094; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Maxwell CJ, 2013, DRUG AGING, V30, P569, DOI 10.1007/s40266-013-0083-y; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Mohapatra DP, 2007, BIOCHEM SOC T, V35, P1064, DOI 10.1042/BST0351064; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Mohapatra DP, 2009, CHANNELS, V3, P46, DOI 10.4161/chan.3.1.7655; Murakoshi H, 1999, J NEUROSCI, V19, P1728; NOTTET HSLM, 1995, IMMUNOL TODAY, V16, P441, DOI 10.1016/0167-5699(95)80022-0; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Potter MC, 2013, J NEUROIMMUNE PHARM, V8, P594, DOI 10.1007/s11481-013-9442-z; Pujol F, 2005, J CELL SCI, V118, P1071, DOI 10.1242/jcs.01694; RICHARDSON C, 2013, INT J GERIATR PSYCH, DOI DOI 10.1002/GPS.3966.PUBMED:23585364; Shepherd AJ, 2012, J NEUROSCI, V32, P17725, DOI 10.1523/JNEUROSCI.3029-12.2012; Shiau YS, 2003, CHEM RES TOXICOL, V16, P1217, DOI 10.1021/tx0341097; Shin AH, 2012, BRIT J PHARMACOL, V166, P1002, DOI 10.1111/j.1476-5381.2011.01805.x; Shin AH, 2013, MOL CELL NEUROSCI, V54, P22, DOI 10.1016/j.mcn.2012.12.005; Song XY, 2013, EUR J PHARMACOL, V710, P29, DOI 10.1016/j.ejphar.2013.03.051; Turchan J, 2003, CURR HIV RES, V1, P373, DOI 10.2174/1570162033485113; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Xu CS, 2011, GLIA, V59, P997, DOI 10.1002/glia.21171; Zheng JL, 1999, J NEUROIMMUNOL, V98, P185, DOI 10.1016/S0165-5728(99)00049-1	47	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e76698	10.1371/journal.pone.0076698	http://dx.doi.org/10.1371/journal.pone.0076698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086760	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200078
J	Zarelli, VE; Dawid, IB				Zarelli, Valeria E.; Dawid, Igor B.			The BTB-Containing Protein Kctd15 Is SUMOylated In Vivo	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AP-2; NEURAL CREST FORMATION; SUMO MODIFICATION; MOTIF; REPRESSION; MODIFIER; GENE; PHOSPHORYLATION; DIFFERENTIATION; DESUMOYLATION	Potassium Channel Tetramerization Domain containing 15 (Kctd15) has a role in regulating the neural crest (NC) domain in the embryo. Kctd15 inhibits NC induction by antagonizing Wnt signaling and by interaction with the transcription factor AP2a activation domain blocking its activity. Here we demonstrate that Kctd15 is SUMOylated by SUMO1 and SUMO2/3. Kctd15 contains a classical SUMO interacting motif, psi KxE, at the C-terminal end, and variants of the motif within the molecule. Kctd15 SUMOylation occurs exclusively in the C-terminal motif. Inability to be SUMOylated did not affect Kctd15's subcellular localization, or its ability to repress AP-2 transcriptional activity and to inhibit NC formation in zebrafish embryos. In contrast, a fusion of Kctd15 and SUMO had little effectiveness in AP-2 inhibition and in blocking of NC formation. These data suggest that the non-SUMOylated form of Kctd15 functions in NC development.	[Zarelli, Valeria E.; Dawid, Igor B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dawid, IB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD USA.	idawid@nih.gov			Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008809] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JW, 2009, BIOCHEM BIOPH RES CO, V379, P160, DOI 10.1016/j.bbrc.2008.12.043; Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x; Belaguli NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048019; Berlato C, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2838; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Chang TH, 2012, J IMMUNOL, V189, P3548, DOI 10.4049/jimmunol.1201104; Correale S, 2011, BIOCHIMIE, V93, P715, DOI 10.1016/j.biochi.2010.12.014; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Ding XF, 2009, J CELL BIOCHEM, V106, P285, DOI 10.1002/jcb.22002; Dutta S, 2010, DEVELOPMENT, V137, P3013, DOI 10.1242/dev.047548; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Eloranta JJ, 2002, J BIOL CHEM, V277, P30798, DOI 10.1074/jbc.M202780200; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Garee JP, 2011, BIOCHEM BIOPH RES CO, V408, P516, DOI 10.1016/j.bbrc.2011.04.040; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Holt EH, 2001, BIOCHEM BIOPH RES CO, V288, P752, DOI 10.1006/bbrc.2001.5846; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Jiang MS, 2000, P NATL ACAD SCI USA, V97, P12519, DOI 10.1073/pnas.220426097; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Lee CD, 2008, PROTEIN SCI, V17, P1241, DOI 10.1110/ps.035188.108; Li W, 2007, DEV BIOL, V304, P338, DOI 10.1016/j.ydbio.2006.12.042; Lomeli H, 2011, CELL MOL LIFE SCI, V68, P4045, DOI 10.1007/s00018-011-0792-5; Luo T, 2003, P NATL ACAD SCI USA, V100, P532, DOI 10.1073/pnas.0237226100; Meng XN, 2010, BIOCHEM BIOPH RES CO, V392, P526, DOI 10.1016/j.bbrc.2010.01.056; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Perdomo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050637; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rouviere JO, 2013, CHROMOSOMA; Skoblov M, 2013, BIOESSAYS, V35, P586, DOI 10.1002/bies.201300002; Snow JW, 2010, J BIOL CHEM, V285, P28064, DOI 10.1074/jbc.M109.096909; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; TOYAMA R, 1995, DEVELOPMENT, V121, P383; Van Rechem C, 2010, MOL CELL BIOL, V30, P4045, DOI 10.1128/MCB.00582-09; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; Wei WZ, 2008, BIOCHEM BIOPH RES CO, V375, P454, DOI 10.1016/j.bbrc.2008.08.028; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Williams MJ, 2012, CELL MOL LIFE SCI, V69, P3819, DOI 10.1007/s00018-012-1022-5; Wilson VG, 2005, SCI STKE, V2005, ppe32; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yu LY, 2010, J EXP MED, V207, P1183, DOI 10.1084/jem.20092215; Zarelli VE, 2013, P NATL ACAD SCI USA, V110, P2870, DOI 10.1073/pnas.1300203110	57	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75016	10.1371/journal.pone.0075016	http://dx.doi.org/10.1371/journal.pone.0075016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086424	Green Submitted, Green Published, gold			2022-12-25	WOS:000325025200019
J	Brozovic, A; Vukovic, L; Polancac, DS; Arany, I; Koberle, B; Fritz, G; Fiket, Z; Majhen, D; Ambriovic-Ristov, A; Osmak, M				Brozovic, Anamaria; Vukovic, Lidija; Polancac, Darija Stupin; Arany, Istvan; Koeberle, Beate; Fritz, Gerhard; Fiket, Zeljka; Majhen, Dragomira; Ambriovic-Ristov, Andreja; Osmak, Maja			Endoplasmic Reticulum Stress Is Involved in the Response of Human Laryngeal Carcinoma Cells to Carboplatin but Is Absent in Carboplatin-Resistant Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; CANCER-CELLS; CELLULAR PHARMACOLOGY; CISPLATIN RESISTANCE; MEDIATED APOPTOSIS; DRUG-RESISTANCE; DNA-ADDUCTS; COPPER; INHIBITION; ACCUMULATION	The major obstacle of successful tumor treatment with carboplatin (CBP) is the development of drug resistance. In the present study, we found that following treatment with CBP the amount of platinum which enters the human laryngeal carcinoma (HEp2)-derived CBP-resistant (7T) cells is reduced relative to the parental HEp2. As a consequence, the formation of reactive oxidative species (ROS) is reduced, the induction of endoplasmic reticulum (ER) stress is diminished, the amount of inter-and intrastrand cross-links is lower, and the induction of apoptosis is depressed. In HEp2 cells, ROS scavenger tempol, inhibitor of ER stress salubrinal, as well as gene silencing of ER stress marker CCAAT/enhancer-binding protein (CHOP) increases their survival and renders them as resistant to CBP as 7T cell subline but did not influence the survival of 7T cells. Our results suggest that in HEp2 cells CBP-induced ROS is a stimulus for ER stress. To the contrary, despite the ability of CBP to induce formation of ROS and activate ER stress in 7T cells, the cell death mechanism in 7T cells is independent of ROS induction and activation of ER stress. The novel signaling pathway of CBP-driven toxicity that was found in the HEp2 cell line, i.e. increased ROS formation and induction of ER stress, may be predictive for therapeutic response of epithelial cancer cells to CBP-based therapy.	[Brozovic, Anamaria; Vukovic, Lidija; Majhen, Dragomira; Ambriovic-Ristov, Andreja; Osmak, Maja] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia; [Polancac, Darija Stupin] Galapagos Res Ctr Ltd, Zagreb, Croatia; [Arany, Istvan] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA; [Koeberle, Beate] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Toxicol, D-55122 Mainz, Germany; [Fritz, Gerhard] Univ Dusseldorf, Inst Toxicol, Dusseldorf, Germany; [Fiket, Zeljka] Rudjer Boskovic Inst, Div Marine & Environm Res, Zagreb, Croatia	Rudjer Boskovic Institute; University of Mississippi; University of Mississippi Medical Center; Johannes Gutenberg University of Mainz; Heinrich Heine University Dusseldorf; Rudjer Boskovic Institute	Brozovic, A (corresponding author), Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia.	Brozovic@lrb.Hr	Fiket, Zeljka/J-4985-2019; Brozovic, Anamaria/D-5270-2016	Fiket, Zeljka/0000-0002-7628-9045; Brozovic, Anamaria/0000-0002-6820-2173; Majhen, Dragomira/0000-0003-0385-0900	Ministry of Science, Education and Sport of the Republic of Croatia [098-0982913-2748, 098-0982913-2850, 098-0982934-2715]; Deutsche Forschungsgemeinschaft [DFG-KO 1732/1-1]; Deutscher Akademischer Austauschdienst of the Federal Republic of Germany [DAAD D07/00066]	Ministry of Science, Education and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst of the Federal Republic of Germany	This study was supported by funds of the Ministry of Science, Education and Sport of the Republic of Croatia (Projects No. 098-0982913-2748, No. 098-0982913-2850, and No. 098-0982934-2715) and by funds of Deutsche Forschungsgemeinschaft (DFG-KO 1732/1-1) and Deutscher Akademischer Austauschdienst (DAAD D07/00066) of the Federal Republic of Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutani Manisha, 2006, Indian J Chest Dis Allied Sci, V48, P49; BLOMMAERT FA, 1995, BIOCHEMISTRY-US, V34, P8474, DOI 10.1021/bi00026a031; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brozovic A, 2004, INT J CANCER, V112, P974, DOI 10.1002/ijc.20522; Brozovic A, 2008, MOL PHARMACOL, V74, P298, DOI 10.1124/mol.107.043836; Brozovic A, 2010, CRIT REV TOXICOL, V40, P347, DOI 10.3109/10408441003601836; Brozovic A, 2009, MUTAT RES-FUND MOL M, V670, P32, DOI 10.1016/j.mrfmmm.2009.07.002; Carozzi VA, 2010, CURR CANCER DRUG TAR, V10, P670; Cheng CF, 2008, APOPTOSIS, V13, P883, DOI 10.1007/s10495-008-0214-9; Di Felice V, 1998, INT J ONCOL, V13, P225; England K, 2006, FREE RADICAL RES, V40, P1124, DOI 10.1080/10715760600838209; FICHTINGERSCHEPMAN AMJ, 1995, CARCINOGENESIS, V16, P2447, DOI 10.1093/carcin/16.10.2447; Gallerne C, 2013, BBA-MOL CELL RES, V1833, P1356, DOI 10.1016/j.bbamcr.2013.02.014; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; Hall MD, 2008, ANNU REV PHARMACOL, V48, P495, DOI 10.1146/annurev.pharmtox.48.080907.180426; Heffeter P, 2008, DRUG RESIST UPDATE, V11, P1, DOI 10.1016/j.drup.2008.02.002; Herraiz C, 2011, MOL ENDOCRINOL, V25, P138, DOI 10.1210/me.2010-0217; Hiss DC, 2009, EXPERT OPIN DRUG DIS, V4, P799, DOI 10.1517/17460440903052559; Holzer AK, 2006, MOL PHARMACOL, V70, P1390, DOI 10.1124/mol.106.022624; Husain K, 2003, INT J TOXICOL, V22, P335, DOI 10.1080/10915810390233357; Husain K, 2001, HEARING RES, V159, P14, DOI 10.1016/S0378-5955(01)00306-9; Katano K, 2002, CANCER RES, V62, P6559; Katano K, 2003, MOL PHARMACOL, V64, P466, DOI 10.1124/mol.64.2.466; Kloft C, 1999, THER DRUG MONIT, V21, P631, DOI 10.1097/00007691-199912000-00009; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Kubicek GJ, 2011, AM J CLIN ONCOL-CANC, V34, P380, DOI 10.1097/COC.0b013e3181e9c0a2; Liedert B, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl051; Liu H, 2005, J AM SOC NEPHROL, V16, P1985, DOI 10.1681/ASN.2004090768; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Materna V, 2005, INT J CANCER, V115, P393, DOI 10.1002/ijc.20899; MICKISCH G, 1990, UROL RES, V18, P131, DOI 10.1007/BF00302474; Moon IJ, 2011, CLIN EXP OTORHINOLAR, V4, P11, DOI 10.3342/ceo.2011.4.1.11; OSMAK M, 1995, MUTAT RES LETT, V347, P141, DOI 10.1016/0165-7992(95)00033-X; Park GB, 2010, J IMMUNOL, V185, P7274, DOI 10.4049/jimmunol.1001547; Pectasides D, 2007, CANCER TREAT REV, V33, P177, DOI 10.1016/j.ctrv.2006.10.007; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Reed E, 2010, CLIN CANCER RES, V16, P4511, DOI 10.1158/1078-0432.CCR-10-0528; Roos WP, 2012, CANC LETT; Safaei R, 2006, CANCER LETT, V234, P34, DOI 10.1016/j.canlet.2005.07.046; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Sue YM, 2011, BRIT J PHARMACOL, V162, P1716, DOI 10.1111/j.1476-5381.2010.01189.x; Todd RC, 2009, METALLOMICS, V1, P280, DOI 10.1039/b907567d; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Yu F, 2008, AM J PHYSIOL-RENAL, V295, pF44, DOI 10.1152/ajprenal.00593.2007; ZWELLING LA, 1979, CANCER TREAT REP, V63, P1439	51	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76397	10.1371/journal.pone.0076397	http://dx.doi.org/10.1371/journal.pone.0076397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086737	Green Submitted, Green Published, gold			2022-12-25	WOS:000326520200135
J	Ellison, ML; Farrow, JM; Parrish, W; Danell, AS; Pesci, EC				Ellison, Matthew L.; Farrow, John Matthew; Parrish, Whitney; Danell, Allison S.; Pesci, Everett C.			The Transcriptional Regulator Np20 Is the Zinc Uptake Regulator in Pseudomonas aeruginosa	PLOS ONE			English	Article							ESCHERICHIA-COLI; UPTAKE SYSTEM; MYCOBACTERIUM-TUBERCULOSIS; XANTHOMONAS-CAMPESTRIS; CAENORHABDITIS-ELEGANS; SALMONELLA-ENTERICA; YERSINIA-PESTIS; IN-VITRO; ZUR; VIRULENCE	Zinc is essential for all bacteria, but excess amounts of the metal can have toxic effects. To address this, bacteria have developed tightly regulated zinc uptake systems, such as the ZnuABC zinc transporter which is regulated by the Fur-like zinc uptake regulator (Zur). In Pseudomonas aeruginosa, a Zur protein has yet to be identified experimentally, however, sequence alignment revealed that the zinc-responsive transcriptional regulator Np20, encoded by np20 (PA5499), shares high sequence identity with Zur found in other bacteria. In this study, we set out to determine whether Np20 was functioning as Zur in P. aeruginosa. Using RT-PCR, we determined that np20 (hereafter known as zur) formed a polycistronic operon with znuC and znuB. Mutant strains, lacking the putative znuA, znuB, or znuC genes were found to grow poorly in zinc deplete conditions as compared to wild-type strain PAO1. Intracellular zinc concentrations in strain PAO-Zur (Delta zur) were found to be higher than those for strain PAO1, further implicating the zur as the zinc uptake regulator. Reporter gene fusions and real time RT-PCR revealed that transcription of znuA was repressed in a zinc-dependent manner in strain PAO1, however zinc-dependent transcriptional repression was alleviated in strain PAO-Zur, suggesting that the P. aeruginosa Zur homolog (ZurPA) directly regulates expression of znuA. Electrophoretic mobility shift assays also revealed that recombinant ZurPA specifically binds to the promoter region of znuA and does not bind in the presence of the zinc chelator N,N',N-tetrakis(2-pyridylmethyl) ethylenediamine (TPEN). Taken together, these data support the notion that Np20 is the P. aeruginosa Zur, which regulates the transcription of the genes encoding the high affinity ZnuABC zinc transport system.	[Ellison, Matthew L.; Farrow, John Matthew; Pesci, Everett C.] E Carolina Univ, Dept Microbiol & Immunol, Greenville, NC 27858 USA; [Ellison, Matthew L.] Morehead State Univ, Dept Biol & Chem, Morehead, KY 40351 USA; [Parrish, Whitney; Danell, Allison S.] E Carolina Univ, Dept Chem, Greenville, NC 27858 USA	University of North Carolina; East Carolina University; Morehead State University; University of North Carolina; East Carolina University	Ellison, ML (corresponding author), E Carolina Univ, Dept Microbiol & Immunol, Greenville, NC 27858 USA.	M.Ellison@moreheadstate.edu		Pesci, Everett/0000-0002-7490-7591; Farrow, John/0000-0003-1619-2388	National Institute of Allergy and Infectious Disease [AI076272]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076272, R01AI076272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103436] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a research grant from the National Institute of Allergy and Infectious Disease to ECP (grant AI076272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammendola S, 2007, INFECT IMMUN, V75, P5867, DOI 10.1128/IAI.00559-07; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; [Anonymous], 2010, HDB MICROBIOLOGICAL, DOI DOI 10.1201/EBK1439804063; Blaby-Haas CE, 2011, MOL MICROBIOL, V79, P700, DOI 10.1111/j.1365-2958.2010.07475.x; BRAY TM, 1990, FREE RADICAL BIO MED, V8, P281, DOI 10.1016/0891-5849(90)90076-U; Bremer H, 1996, ESCHERICHIA COLI SAL; Campoy S, 2002, INFECT IMMUN, V70, P4721, DOI 10.1128/IAI.70.8.4721-4725.2002; Cao H, 2001, ANNU REV PHYTOPATHOL, V39, P259, DOI 10.1146/annurev.phyto.39.1.259; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; COUDRAY C, 1993, BIOL TRACE ELEM RES, V38, P273, DOI 10.1007/BF02785311; Davis LM, 2009, J BACTERIOL, V191, P1631, DOI 10.1128/JB.01394-08; Desrosiers DC, 2010, INFECT IMMUN, V78, P5163, DOI 10.1128/IAI.00732-10; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Farrow JM, 2008, J BACTERIOL, V190, P7043, DOI 10.1128/JB.00753-08; Gabriel SE, 2008, J BACTERIOL, V190, P3482, DOI 10.1128/JB.01978-07; Gabriel SE, 2009, J BACTERIOL, V191, P6116, DOI 10.1128/JB.00802-09; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Hassan MET, 1999, GENE, V238, P417, DOI 10.1016/S0378-1119(99)00349-2; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Huang DL, 2008, NUCLEIC ACIDS RES, V36, P4295, DOI 10.1093/nar/gkn328; Huang DL, 2009, MOL PLANT MICROBE IN, V22, P321, DOI 10.1094/MPMI-22-3-0321; Kallifidas D, 2010, J BACTERIOL, V192, P608, DOI 10.1128/JB.01022-09; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kim S, 2004, J VET MED SCI, V66, P1059, DOI 10.1292/jvms.66.1059; Knoten CA, 2011, J BACTERIOL, V193, P6567, DOI 10.1128/JB.05803-11; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Lewinson O, 2009, P NATL ACAD SCI USA, V106, P4677, DOI 10.1073/pnas.0900666106; Lewis DA, 1999, INFECT IMMUN, V67, P5060, DOI 10.1128/IAI.67.10.5060-5068.1999; Li YL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-128; Lucarelli D, 2007, J BIOL CHEM, V282, P9914, DOI 10.1074/jbc.M609974200; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Makarova K.S., 2001, GENOME BIOL, V2; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Mellies JL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-123; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Outten CE, 2001, BIOCHEMISTRY-US, V40, P10417, DOI 10.1021/bi0155448; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Petrarca P, 2010, J BACTERIOL, V192, P1553, DOI 10.1128/JB.01310-09; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Sabri M, 2009, INFECT IMMUN, V77, P1155, DOI 10.1128/IAI.01082-08; Sambrook J., 2001, MOL CLONGING LAB MAN, V3rd ed.; Shin JH, 2011, P NATL ACAD SCI USA, V108, P5045, DOI 10.1073/pnas.1017744108; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; Smith KF, 2009, J BACTERIOL, V191, P1595, DOI 10.1128/JB.01392-08; Stork M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000969; Weston BF, 2009, INFECT IMMUN, V77, P2840, DOI 10.1128/IAI.01299-08; Yamamoto K, 2005, J BACTERIOL, V187, P6333, DOI 10.1128/JB.187.18.6333-6340.2005	53	37	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75389	10.1371/journal.pone.0075389	http://dx.doi.org/10.1371/journal.pone.0075389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086521	Green Published, gold			2022-12-25	WOS:000326520200099
J	Ghosh, M; van den Akker, NMS; Wijnands, KAP; Poeze, M; Weber, C; McQuade, LE; Pluth, MD; Lippard, SJ; Post, MJ; Molin, DGM; van Zandvoort, MAMJ				Ghosh, Mitrajit; van den Akker, Nynke M. S.; Wijnands, Karolina A. P.; Poeze, Martijn; Weber, Christian; McQuade, Lindsey E.; Pluth, Michael D.; Lippard, Stephen J.; Post, Mark J.; Molin, Daniel G. M.; van Zandvoort, Marc A. M. J.			Specific Visualization of Nitric Oxide in the Vasculature with Two-Photon Microscopy Using a Copper Based Fluorescent Probe	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; IN-VITRO; SYNTHASE; ARTERIES; CELLS; FLOW	To study the role and (sub) cellular nitric oxide (NO) constitution in various disease processes, its direct and specific detection in living cells and tissues is a major requirement. Several methods are available to measure the oxidation products of NO, but the detection of NO itself has proved challenging. We visualized NO production using a NO-sensitive copper-based fluorescent probe (Cu (2)FL2E) and two-photon laser scanning microscopy (TPLSM). Cu (2)FL2E demonstrated high sensitivity and specificity for NO synthesis, combined with low cytotoxicity. Furthermore, Cu (2)FL2E showed superior sensitivity over the conventionally used Griess assay. NO specificity of Cu (2)FL2E was confirmed in vitro in human coronary arterial endothelial cells and porcine aortic endothelial cells using various triggers for NO production. Using TPLSM on ex vivo mounted murine carotid artery and aorta, the applicability of the probe to image NO production in both endothelial cells and smooth muscle cells was shown. NO-production and time course was detected for multiple stimuli such as flow, acetylcholine and hydrogen peroxide and its correlation with vasodilation was demonstrated. NO-specific fluorescence and vasodilation was abrogated in the presence of NO-synthesis blocker L-NAME. Finally, the influence of carotid precontraction and vasorelaxation validated the functional properties of vessels. Specific visualization of NO production in vessels with Cu (2)FL2E-TPLSM provides a valid method for studying spatial-temporal synthesis of NO in vascular biology at an unprecedented level. This approach enables investigation of the pathways involved in the complex interplay between NO and vascular (dys) function.	[Ghosh, Mitrajit; van Zandvoort, Marc A. M. J.] Maastricht Univ, Dept Genet & Cell Biol Mol Biol, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [van den Akker, Nynke M. S.; Post, Mark J.; Molin, Daniel G. M.] Maastricht Univ, Dept Physiol, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Weber, Christian] Maastricht Univ, Dept Pathol, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Wijnands, Karolina A. P.; Poeze, Martijn] Maastricht Univ, Dept Surg, Nutr & Toxicol Res Inst Maastricht NUTRIM, Maastricht, Netherlands; [Ghosh, Mitrajit; van Zandvoort, Marc A. M. J.] Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res IMCAR, Aachen, Germany; [van den Akker, Nynke M. S.] Univ Munster, Fak Med, Dept Cardiol & Angiol, D-48149 Munster, Germany; [Weber, Christian] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [McQuade, Lindsey E.; Pluth, Michael D.; Lippard, Stephen J.] MIT, Dept Chem, Cambridge, MA 02139 USA	Maastricht University; Maastricht University; Maastricht University; Maastricht University; RWTH Aachen University; University of Munster; University of Munich; Massachusetts Institute of Technology (MIT)	Ghosh, M (corresponding author), Maastricht Univ, Dept Genet & Cell Biol Mol Biol, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands.	mitrajit.ghosh@maastrichtuniversity.nl	Weber, Christian/AAW-2153-2020; Pluth, Michael/A-7222-2012	Weber, Christian/0000-0003-4610-8714; Pluth, Michael/0000-0003-3604-653X	DFG (German Scientific Organization) [EuCAR GRK 1508/1]; NWO (Dutch Scientific Organization); STW/NWO smartmix for TeRM; Interreg Euregio Meuse-Rhine IVa grant BioMIMedics; Interreg IVa Flanders-The Netherlands grant VaRiA; medical section of NWO [902-16-276]; National Science Foundation [CHE-0907905]; National Institute of Health [K99GM092970]; Direct For Mathematical & Physical Scien [1265770, 0907905] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM092970] Funding Source: NIH RePORTER	DFG (German Scientific Organization)(German Research Foundation (DFG)); NWO (Dutch Scientific Organization)(Netherlands Organization for Scientific Research (NWO)); STW/NWO smartmix for TeRM; Interreg Euregio Meuse-Rhine IVa grant BioMIMedics; Interreg IVa Flanders-The Netherlands grant VaRiA; medical section of NWO; National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the DFG (German Scientific Organization) Grant for EuCAR GRK 1508/1 to IMCAR and by NWO (Dutch Scientific Organization) to CARIM, grant for MJP from STW/NWO smartmix for TeRM and for DGMM is supported by the Interreg Euregio Meuse-Rhine IVa grant BioMIMedics. NMSvdA and DGMM are support by the Interreg IVa Flanders-The Netherlands grant VaRiA. The Leica TPLSM was obtained via a grant (No. 902-16-276) from the medical section of NWO. This research was performed within the Vital Imaging Unit CARIM. Work at MIT is supported by the National Science Foundation (grant CHE-0907905 to SJL) and the National Institute of Health (grant K99GM092970 to MDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003; Buchwalow IB, 2002, FASEB J, V16, P500, DOI 10.1096/fj.01-0842com; Cai H, 2002, J BIOL CHEM, V277, P48311, DOI 10.1074/jbc.M208884200; Carrillo A, 2002, VET IMMUNOL IMMUNOP, V89, P91, DOI 10.1016/S0165-2427(02)00170-8; FEELISCH M, 1991, J CARDIOVASC PHARM, V17, pS25, DOI 10.1097/00005344-199117003-00006; Hong H, 2009, FREE RADICAL BIO MED, V47, P684, DOI 10.1016/j.freeradbiomed.2009.06.011; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; JAY BF, 1979, ANAL CHEM, V51, P1493, DOI DOI 10.1021/AC50045A032; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; Lu X, 2004, J PHYSIOL-LONDON, V561, P575, DOI 10.1113/jphysiol.2004.075218; McQuade LE, 2010, P NATL ACAD SCI USA, V107, P8525, DOI 10.1073/pnas.0914794107; Megens RTA, 2007, J VASC RES, V44, P87, DOI 10.1159/000098259; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; Nagano T, 2002, CHEM REV, V102, P1235, DOI 10.1021/cr010152s; Ouyang J, 2008, FREE RADICAL BIO MED, V45, P1426, DOI 10.1016/j.freeradbiomed.2008.08.016; Pluth MD, 2010, ORG LETT, V12, P2318, DOI 10.1021/ol1006289; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Sato M, 2005, P NATL ACAD SCI USA, V102, P14515, DOI 10.1073/pnas.0505136102; Singh RJ, 1996, J BIOL CHEM, V271, P18596, DOI 10.1074/jbc.271.31.18596; Thomas SR, 2002, J BIOL CHEM, V277, P6017, DOI 10.1074/jbc.M109107200; Tian J, 2010, FREE RADICAL BIO MED, V49, P159, DOI 10.1016/j.freeradbiomed.2010.03.023; van Zandvoort M, 2004, J VASC RES, V41, P54, DOI 10.1159/000076246; Wiklund NP, 1999, ACTA PHYSIOL SCAND, V167, P161; Yamada M, 2001, P NATL ACAD SCI USA, V98, P14096, DOI 10.1073/pnas.251542998; Yuan SY, 2006, AM J PHYSIOL-HEART C, V291, pH1029, DOI 10.1152/ajpheart.00509.2006; Zadeh MS, 2000, J LEUKOCYTE BIOL, V67, P327, DOI 10.1002/jlb.67.3.327	27	15	15	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75331	10.1371/journal.pone.0075331	http://dx.doi.org/10.1371/journal.pone.0075331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086509	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200097
J	Wang, L; He, YR; Zhang, G; Ma, J; Liu, CZ; He, W; Wang, W; Han, HM; Boruah, BM; Gao, B				Wang, Lei; He, Yanran; Zhang, Ge; Ma, Juan; Liu, Changzhen; He, Wen; Wang, Wei; Han, Huamin; Boruah, Bhargavi M.; Gao, Bin			Retargeting T Cells for HER2-Positive Tumor Killing by a Bispecific Fv-Fc Antibody	PLOS ONE			English	Article							BREAST-CANCER; RECEPTOR; GROWTH; ERTUMAXOMAB; FRAGMENTS; TRIAL; HER2	To exploit the biological and pharmacological properties of immunoglobulin constant domain Fc fragment and increase the killing efficacy of T cells, a single chain variable fragment specific to CD3 was fused with Fcab (Fc antigen binding), a mutant Fc fragment with specificity against Human epidermal growth factor receptor 2 (HER2) developed by F-star. The bispecific fusion named as FcabCD3 was expressed by transient transfection in HEK-293T cells and purified by affinity chromatography. Specific cytolytic activity of retargeted T cells to kill HER2 positive SKBR3 cell line was evaluated in vitro. FcabCD3 was able to retarget T cells to kill both Herceptin insensitive Colo205-luc cell line and HER2 low expression MDA-MB-231-luc cell line. Furthermore, FcabCD3 was effective in eliminating the Colo205 tumor established on BALB/c nu/nu mice.	[Wang, Lei; Zhang, Ge; Ma, Juan; Liu, Changzhen; He, Wen; Wang, Wei; Han, Huamin; Boruah, Bhargavi M.; Gao, Bin] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol CASPMI, Beijing, Peoples R China; [Wang, Lei; Zhang, Ge; He, Wen; Boruah, Bhargavi M.] Univ Chinese Acad Sci, Beijing, Peoples R China; [He, Yanran] Univ Chinese Agr, Beijing, Peoples R China; [He, Wen] Hebei Med Univ, Hebei Key Lab Med Biotechnol, Shijiazhuang, Peoples R China; [Gao, Bin] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hebei Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Gao, B (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol CASPMI, Beijing, Peoples R China.	bgao2004@gmail.com		Boruah, Bhargavi/0000-0002-3645-785X	Ministry of Science and Technology of China [2012ZX10004701-001-002]; 973 program [2013CB531502]; National Natural Science Foundation of China [30771953, 31070783, 31170829, 81021003]; Beijing Natural Science Foundation [5112022]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was funded by research grants from the Ministry of Science and Technology of China (S & T Major Program: number 2012ZX10004701-001-002), 973 program (2013CB531502) and the National Natural Science Foundation of China (number 30771953, 31070783, 31170829, 81021003), Beijing Natural Science Foundation (5112022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22; Camp RL, 2003, CANCER RES, V63, P1445; Cao Y, 2003, ADV DRUG DELIVER REV, V55, P171, DOI 10.1016/S0169-409X(02)00178-3; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Carter PJ, 2011, EXP CELL RES, V317, P1261, DOI 10.1016/j.yexcr.2011.02.013; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Choi BD, 2011, EXPERT OPIN BIOL TH, V11, P843, DOI 10.1517/14712598.2011.572874; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Fu XP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011867; Grosse-Hovest L, 1999, INT J CANCER, V80, P138, DOI 10.1002/(SICI)1097-0215(19990105)80:1<138::AID-IJC25>3.0.CO;2-J; Jager M, 2009, CANCER RES, V69, P4270, DOI 10.1158/0008-5472.CAN-08-2861; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Kellner C, 2011, BISPECIFIC ANTIBODIES, P217, DOI 10.1007/978-3-642-20910-9_13; Kiewe P, 2006, CLIN CANCER RES, V12, P3085, DOI 10.1158/1078-0432.CCR-05-2436; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; LUTTERBUESE R, 2008, AACR M, P2402; May C, 2012, BIOCHEM PHARMACOL, V84, P1105, DOI 10.1016/j.bcp.2012.07.011; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Muller D, 2010, BIODRUGS, V24, P89, DOI 10.2165/11530960-000000000-00000; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Repp R, 2003, BRIT J CANCER, V89, P2234, DOI 10.1038/sj.bjc.6601367; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Scholl S, 2001, ANN ONCOL, V12, P81, DOI 10.1023/A:1011192622688; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Weiner LM, 2005, NAT BIOTECHNOL, V23, P556, DOI 10.1038/nbt0505-556; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wozniak-Knopp G, 2010, PROTEIN ENG DES SEL, V23, P289, DOI 10.1093/protein/gzq005	29	7	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75589	10.1371/journal.pone.0075589	http://dx.doi.org/10.1371/journal.pone.0075589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086580	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200113
J	Iliou, MS; da Silva-Diz, V; Carmona, FJ; Ramalho-Carvalho, J; Heyn, H; Villanueva, A; Munoz, P; Esteller, M				Iliou, M. S.; da Silva-Diz, V.; Carmona, F. J.; Ramalho-Carvalho, J.; Heyn, H.; Villanueva, A.; Munoz, P.; Esteller, M.			Impaired DICER1 function promotes stemness and metastasis in colon cancer	ONCOGENE			English	Article						DICER1; miRNA; colon cancer; stemness; metastasis	EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN COLORECTAL-CANCER; TUMOR-SUPPRESSOR MICRORNAS; MIR-200 FAMILY; BREAST-CANCER; CELL-LINES; PANCREATIC-CANCER; PROSTATE-CANCER; INVASIVE STATES; REPRESSORS ZEB1	Disruption of microRNA (miRNA) expression patterns is now being recognized as a hallmark of human cancer. The causes of these altered profiles are diverse, and, among them, we found the existence of defects in the miRNA processing machinery. However, little is known about how these alterations affect the biology of the underlying tumors. Herein, we show that colorectal cancer cells with an impairment in DICER1, a major miRNA biogenesis gene, undergo enrichment of tumor stemness features and an epithelialto- mesenchymal transition. These phenotypes are associated with the downregulation of miRNAs, such as miR-34a, miR-126 and those of the miR-200 family, that target critical coding genes in these pathways. Most importantly, DICER1 impairment also induces the acquisition of a greater capacity for tumor initiation and metastasis, two properties associated with cancer stem cells.	[Iliou, M. S.; da Silva-Diz, V.; Carmona, F. J.; Ramalho-Carvalho, J.; Heyn, H.; Munoz, P.; Esteller, M.] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Villanueva, A.] Bellvitge Biomed Res Inst IDIBELL, Catalan Inst Oncol ICO, Lab Translat Res, Barcelona, Spain; [Esteller, M.] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Spain; [Esteller, M.] IDIBELL, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Munoz, P (corresponding author), Hosp Duran I Reynals, Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, 3rd Floor,Avda Gran Via Km 2-7, Barcelona 08908, Catalonia, Spain.	p.munoz@idibell.cat; mesteller@idibell.cat	Ramalho-Carvalho, João/U-2356-2017; Esteller, Manel/L-5956-2014	Ramalho-Carvalho, João/0000-0001-6140-7363; Esteller, Manel/0000-0003-4490-6093; Carmona Sanz, F Javier/0000-0001-7904-8493; Heyn, Holger/0000-0002-3276-1889	Spanish Ministry of Science and Innovation [SAF200801173, SAF2011-22803]; European Research Council Advanced Grant EPINORC [268626]; European Community's Seventh Framework Programme (FP7) [HEALTH-F2-2011-259015-COLTHERES, HEALTH-F5-2010-258236-SYSCOL]; Cellex Foundation; Botin Foundation; Health and Science Departments of the Catalan Government (Generalitat de Catalunya); Spanish Ministry of Science and Innovation fellowship	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Council Advanced Grant EPINORC; European Community's Seventh Framework Programme (FP7)(European Commission); Cellex Foundation(Foundation CELLEX); Botin Foundation; Health and Science Departments of the Catalan Government (Generalitat de Catalunya); Spanish Ministry of Science and Innovation fellowship(Ministry of Science and Innovation, Spain (MICINN))	We thank Dr Bert Vogelstein (Johns Hopkins Kimmel Comprehensive Cancer Center) for the generous gift of the parental and Dicerex5 isogenic cell lines; R Alvarez, J Comas and E Castanco (Universitat de Barcelona-SCT) for technical support with flow cytometry; and the staff of the IDIBELL animal facility for mouse care. This work was supported by grants from the Spanish Ministry of Science and Innovation (SAF200801173 and SAF2011-22803), the European Research Council Advanced Grant EPINORC no. 268626, the European Community's Seventh Framework Programme (FP7/ 2007-2013) under grant agreements no. HEALTH-F2-2011-259015-COLTHERES project and HEALTH-F5-2010-258236-SYSCOL project, Cellex Foundation, Botin Foundation, and the Health and Science Departments of the Catalan Government (Generalitat de Catalunya). MSI was an ESTOOLS Postdoctoral Research Fellow. VdS-D was funded by a Spanish Ministry of Science and Innovation fellowship. ME is an ICREA Research Professor.	Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anton R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026257; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cho SH, 2012, INT J ONCOL, V41, P211, DOI 10.3892/ijo.2012.1453; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Faber C, 2011, EUR J CANCER, V47, P1414, DOI 10.1016/j.ejca.2011.01.006; Faggad A, 2012, HISTOPATHOLOGY, V61, P552, DOI 10.1111/j.1365-2559.2011.04110.x; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Ghislin S, 2012, CELL CYCLE, V11, P1634, DOI 10.4161/cc.20095; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Gosens MJEM, 2007, MODERN PATHOL, V20, P221, DOI 10.1038/modpathol.3800733; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Guo XF, 2012, J CANCER RES CLIN, V138, P49, DOI 10.1007/s00432-011-1058-1; Hamada S, 2012, MOL CANCER RES, V10, P3, DOI 10.1158/1541-7786.MCR-11-0272; Henry JC, 2010, BIOCHEM BIOPH RES CO, V403, P120, DOI 10.1016/j.bbrc.2010.10.130; Heravi-Moussavi A, 2012, NEW ENGL J MED, V366, P234, DOI 10.1056/NEJMoa1102903; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iliou MS, 2011, EPIGENETICS-US, V6, P1344, DOI 10.4161/epi.6.11.18021; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kemper K, 2012, STEM CELLS, V30, P2378, DOI 10.1002/stem.1233; Khoshnaw SM, 2012, BREAST CANCER RES TR, V135, P403, DOI 10.1007/s10549-012-2169-3; Kim NH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001744; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Lopez-Serra P, 2012, ONCOGENE, V31, P1609, DOI 10.1038/onc.2011.354; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Luo ZH, 2013, CARCINOGENESIS, V34, P415, DOI 10.1093/carcin/bgs329; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Munoz P, 2012, MOL ONCOL, V6, P620, DOI 10.1016/j.molonc.2012.10.006; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Sasahira T, 2012, BRIT J CANCER, V107, P700, DOI 10.1038/bjc.2012.330; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Shu GS, 2012, PATHOL RES PRACT, V208, P392, DOI 10.1016/j.prp.2012.05.001; Sparks AB, 1998, CANCER RES, V58, P1130; Stratmann J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-345; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Tome M, 2011, CELL DEATH DIFFER, V18, P985, DOI 10.1038/cdd.2010.167; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu DY, 2012, MOL MED REP, V5, P695, DOI 10.3892/mmr.2011.711; Yu Zuoren, 2012, Frontiers in Genetics, V3, P191, DOI 10.3389/fgene.2012.00191; Zhu DX, 2012, CANCER SCI, V103, P875, DOI 10.1111/j.1349-7006.2012.02234.x	88	55	56	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 24	2014	33	30					4003	4015		10.1038/onc.2013.398	http://dx.doi.org/10.1038/onc.2013.398			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AL8NA	24096488	Green Published, hybrid			2022-12-25	WOS:000339394700012
J	Spadaro, M; Montone, M; Arigoni, M; Cantarella, D; Forni, G; Pericle, F; Pascolo, S; Calogero, RA; Cavallo, F				Spadaro, Michela; Montone, Monica; Arigoni, Maddalena; Cantarella, Daniela; Forni, Guido; Pericle, Federica; Pascolo, Steve; Calogero, Raffaele A.; Cavallo, Federica			Recombinant human lactoferrin induces human and mouse dendritic cell maturation via Toll-like receptors 2 and 4	FASEB JOURNAL			English	Article						alarmins; pattern recognition receptors	TALACTOFERRIN ALPHA; CYTOKINE PRODUCTION; ORAL TALACTOFERRIN; GENE-EXPRESSION; NATURAL-KILLER; MESSENGER-RNA; BIOCONDUCTOR; INDUCTION; IMMUNITY; PROTEIN	Lactoferrin, a key component of innate immunity, is a cationic monomeric 80-kDa glycoprotein of the transferrin superfamily. Recombinant human lactoferrin, known as talactoferrin (TLF), induces a distinct functional maturation program in human dendritic cells (DCs) derived from peripheral blood monocytes. However, the receptors and molecular mechanisms involved in this induction have not been fully determined. By exploiting genome-wide transcription profiling of immature DCs, TNF-- and IL-1-matured DCs (m-DCs), and TLF-matured DCs (TLF-DCs), we have detected a set of transcripts specific for m-DCs and one specific for TLF-DCs. Functional network reconstruction highlighted, as expected, the association of m-DC maturation with IL-1, TNF-, and NF-B, whereas TLF-DC maturation was associated with ERK and NF-B. This involvement of ERK and NF-B transduction factors suggests direct involvement of Toll-like receptors (TLRs) in TLF-induced maturation. We have used MyD88 inhibition and siRNA silencing TLRs on human DCs and mouse TLR-2-knockout cells, to show that TLF triggers the maturation of both human and mouse DCs through TLR-2 and TLR-4.Spadaro, M., Montone, M., Arigoni, M., Cantarella, D., Forni, G., Pericle, F., Pascolo, S., Calogero, R. A., Cavallo, F. Recombinant human lactoferrin induces human and mouse dendritic cell maturation via Toll-like receptors 2 and 4.	[Spadaro, Michela; Montone, Monica; Arigoni, Maddalena; Forni, Guido; Calogero, Raffaele A.; Cavallo, Federica] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, I-10126 Turin, Italy; [Cantarella, Daniela] Univ Turin, Lab Funct Genom, Oncogen Ctr, Inst Canc Res & Treatment,Sch Med, I-10126 Turin, Italy; [Pericle, Federica] Univ Texas El Paso, Ctr Res Entrepreneurship & Innovat Enterprise, El Paso, TX 79968 USA; [Pascolo, Steve] Univ Zurich Hosp, Dept Oncol, CH-8091 Zurich, Switzerland	University of Turin; University of Turin; University of Texas System; University of Texas El Paso; University of Zurich; University Zurich Hospital	Cavallo, F (corresponding author), Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, Via Nizza 52, I-10126 Turin, Italy.	federica.cavallo@unito.it	Spadaro, Michela/F-1399-2016; Calogero, Raffaele/K-9428-2019; Cavallo, Federica/C-5666-2011	Calogero, Raffaele/0000-0002-2848-628X; Arigoni, Maddalena/0000-0003-4629-3841; Spadaro, Michela/0000-0001-7544-8879; CANTARELLA, DANIELA/0000-0001-6135-2032; MONTONE, MONICA/0000-0001-7907-4333; Cavallo, Federica/0000-0003-4571-1060	Italian Association for Cancer Research (AIRC) [IG 5377]; Fondazione Ricerca Molinette (FRM) Onlus; University of Torino; Regione Piemonte; Agennix, Inc. (Houston, TX, USA)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Ricerca Molinette (FRM) Onlus; University of Torino; Regione Piemonte(Regione Piemonte); Agennix, Inc. (Houston, TX, USA)	This study was supported by grants from the Italian Association for Cancer Research (AIRC; IG 5377), the Fondazione Ricerca Molinette (FRM) Onlus, the University of Torino, the Regione Piemonte, and by research funding from Agennix, Inc. (Houston, TX, USA).	Actor JK, 2009, CURR PHARM DESIGN, V15, P1956, DOI 10.2174/138161209788453202; Aerts-Toegaert C, 2007, EUR J IMMUNOL, V37, P686, DOI 10.1002/eji.200636535; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Ando K, 2010, FEBS J, V277, P2051, DOI 10.1111/j.1742-4658.2010.07620.x; Baker EN, 2009, BIOCHIMIE, V91, P3, DOI 10.1016/j.biochi.2008.05.006; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Castiello L, 2011, CANCER IMMUNOL IMMUN, V60, P457, DOI 10.1007/s00262-010-0954-6; Collins CA, 2008, DEV BIOL, V324, P55, DOI 10.1016/j.ydbio.2008.08.034; Cumberbatch M, 2003, CLIN EXP IMMUNOL, V132, P352, DOI 10.1046/j.1365-2249.2003.02146.x; Curran CS, 2006, CELL IMMUNOL, V242, P23, DOI 10.1016/j.cellimm.2006.08.006; De la Rosa G, 2008, J IMMUNOL, V180, P6868, DOI 10.4049/jimmunol.180.10.6868; Dietz AB, 2000, BIOCHEM BIOPH RES CO, V275, P731, DOI 10.1006/bbrc.2000.3372; Fan Jie, 2010, Open Crit Care Med J, V2, P1; GAHR M, 1991, J LEUKOCYTE BIOL, V49, P427, DOI 10.1002/jlb.49.5.427; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giermasz AS, 2009, CANCER IMMUNOL IMMUN, V58, P1329, DOI 10.1007/s00262-008-0648-5; Gonzalez-Chavez SA, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.020; Haversen L, 2002, CELL IMMUNOL, V220, P83, DOI 10.1016/S0008-8749(03)00006-6; Hayes TG, 2010, INVEST NEW DRUG, V28, P156, DOI 10.1007/s10637-009-9233-9; Hayes TG, 2006, INVEST NEW DRUG, V24, P233, DOI 10.1007/s10637-005-3690-6; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jagannathan M, 2009, J IMMUNOL, V183, P7461, DOI 10.4049/jimmunol.0901517; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Jonasch E, 2008, CANCER-AM CANCER SOC, V113, P72, DOI 10.1002/cncr.23519; Kalinski P, 2009, FUTURE ONCOL, V5, P379, DOI [10.2217/fon.09.6, 10.2217/FON.09.6]; Kelly RJ, 2010, EXPERT OPIN BIOL TH, V10, P1379, DOI 10.1517/14712598.2010.512914; Legrand D, 2010, BIOMETALS, V23, P365, DOI 10.1007/s10534-010-9297-1; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Mehra A, 2003, BIOTECHNOL BIOENG, V84, P822, DOI 10.1002/bit.10860; Morris A, 2001, BREAST CANCER RES TR, V67, P71, DOI 10.1023/A:1010649303056; NISHIYA K, 1982, J IMMUNOL, V129, P2519; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Puddu P, 2010, BIOMETALS, V23, P387, DOI 10.1007/s10534-010-9307-3; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; SHAU HY, 1992, J LEUKOCYTE BIOL, V51, P343, DOI 10.1002/jlb.51.4.343; Shebl FM, 2010, CANCER EPIDEM BIOMAR, V19, P978, DOI 10.1158/1055-9965.EPI-10-0064; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Spadaro M, 2008, FASEB J, V22, P2747, DOI 10.1096/fj.07-098038; Spadaro M, 2007, CANCER RES, V67, P6425, DOI 10.1158/0008-5472.CAN-06-4080; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Varadhachary A, 2004, INT J CANCER, V111, P398, DOI 10.1002/ijc.20271; Vesela R, 2011, CELL IMMUNOL, V271, P78, DOI 10.1016/j.cellimm.2011.06.006; Von Heydebreck A., 2004, COLLECTION BIOSTAT R; Watts C, 2010, CURR OPIN IMMUNOL, V22, P124, DOI 10.1016/j.coi.2009.12.005; Yang D, 2009, TRENDS IMMUNOL, V30, P531, DOI 10.1016/j.it.2009.07.004	51	27	27	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2014	28	1					416	429		10.1096/fj.13-229591	http://dx.doi.org/10.1096/fj.13-229591			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AD8OS	24088817				2022-12-25	WOS:000333526100039
J	Chattopadhyay, MK; Tabor, H				Chattopadhyay, Manas K.; Tabor, Herbert			Polyamines Are Critical for the Induction of the Glutamate Decarboxylase-dependent Acid Resistance System in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Cyclic AMP (cAMP); Decarboxylase; Gene Expression; Glutamate; Microarray; Polyamines; Putrescine; Spermidine	SMALL-RNA; GADE YHIE; GENES; RPOS; EXPRESSION; PROTEIN; STRESS; REGULATORS; ACTIVATOR; GROWTH	As part of our studies on the biological functions of polyamines, we have used a mutant of Escherichia coli that lacks all the genes for polyamine biosynthesis for a global transcriptional analysis on the effect of added polyamines. The most striking early response to the polyamine addition is the increased expression of the genes for the glutamate-dependent acid resistance system (GDAR) that is important for the survival of the bacteria when passing through the acid environment of the stomach. Not only were the two genes for glutamate decarboxylases (gadA and gadB) and the gene for glutamate--aminobutyrate antiporter (gadC) induced by the polyamine addition, but the various genes involved in the regulation of this system were also induced. We confirmed the importance of polyamines for the induction of the GDAR system by direct measurement of glutamate decarboxylase activity and acid survival. The effect of deletions of the regulatory genes on the GDAR system and the effects of overproduction of two of these genes were also studied. Strikingly, overproduction of the alternative sigma factor rpoS and of the regulatory gene gadE resulted in very high levels of glutamate decarboxylase and almost complete protection against acid stress even in the absence of any polyamines. Thus, these data show that a major function of polyamines in E. coli is protection against acid stress by increasing the synthesis of glutamate decarboxylase, presumably by increasing the levels of the rpoS and gadE regulators.	[Chattopadhyay, Manas K.; Tabor, Herbert] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Chattopadhyay, MK (corresponding author), NIDDK, NIH, 8 Ctr Dr,Bldg 8,Rm 219, Bethesda, MD 20892 USA.	manasc@intra.niddk.nih.gov			National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024709] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NIDDK.	ALEXANDER DM, 1994, MOL MICROBIOL, V11, P1059, DOI 10.1111/j.1365-2958.1994.tb00383.x; Atlung T, 2002, MOL GENET GENOMICS, V266, P873, DOI 10.1007/s00438-001-0610-0; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castanie-Cornet MP, 2010, NUCLEIC ACIDS RES, V38, P3546, DOI 10.1093/nar/gkq097; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Castanie-Cornet MP, 2001, MICROBIOL-UK, V147, P709, DOI 10.1099/00221287-147-3-709; Chattopadhyay MK, 2013, FEMS MICROBIOL LETT, V338, P132, DOI 10.1111/1574-6968.12035; Chattopadhyay MK, 2009, J BACTERIOL, V191, P5549, DOI 10.1128/JB.00381-09; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Cohen S A, 1998, Guttmacher Rep Public Policy, V1, P1; Cotter PD, 2001, MOL MICROBIOL, V40, P465, DOI 10.1046/j.1365-2958.2001.02398.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; De Biase D, 2012, MOL MICROBIOL, V86, P770, DOI 10.1111/mmi.12020; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; Gale EF, 1940, BIOCHEM J, V34, P846, DOI 10.1042/bj0340846; Giangrossi M, 2005, J BIOL CHEM, V280, P21498, DOI 10.1074/jbc.M413255200; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; HENGGEARONIS R, 1993, CELL, V72, P165, DOI 10.1016/0092-8674(93)90655-A; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Hommais F, 2004, MICROBIOL-SGM, V150, P61, DOI 10.1099/mic.0.26659-0; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Jung IL, 2003, J BIOL CHEM, V278, P22846, DOI 10.1074/jbc.M212055200; Kanjee U, 2013, ANNU REV MICROBIOL, V67, P65, DOI 10.1146/annurev-micro-092412-155708; Kanjee U, 2011, EMBO J, V30, P931, DOI 10.1038/emboj.2011.5; KASHIWAGI K, 1991, J BIOL CHEM, V266, P20922; Kurihara S, 2009, FEMS MICROBIOL LETT, V294, P97, DOI 10.1111/j.1574-6968.2009.01552.x; Lease RA, 2004, J BACTERIOL, V186, P6179, DOI 10.1128/JB.186.18.6179-6185.2004; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Lu PL, 2013, CELL RES, V23, P635, DOI 10.1038/cr.2013.13; Ma Z, 2003, MOL MICROBIOL, V49, P1309, DOI 10.1046/j.1365-2958.2003.03633.x; Ma Z, 2002, J BACTERIOL, V184, P7001, DOI 10.1128/JB.184.24.7001-7012.2002; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; MILLER JH, 1992, SHORT COURSE BACTERI, P268; Opdyke JA, 2004, J BACTERIOL, V186, P6698, DOI 10.1128/JB.186.20.6698-6705.2004; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; Richard H, 2007, MICROBIOL-SGM, V153, P3154, DOI 10.1099/mic.0.2007/007575-0; Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4; Sanders JW, 1998, MOL MICROBIOL, V27, P299, DOI 10.1046/j.1365-2958.1998.00676.x; Sayed AK, 2007, MICROBIOL-SGM, V153, P2584, DOI 10.1099/mic.0.2007/007005-0; Sayed AK, 2009, MOL MICROBIOL, V71, P1435, DOI 10.1111/j.1365-2958.2009.06614.x; Sledjeski DD, 1996, EMBO J, V15, P3993, DOI 10.1002/j.1460-2075.1996.tb00773.x; SMITH DK, 1992, J BACTERIOL, V174, P5820, DOI 10.1128/jb.174.18.5820-5826.1992; StimHerndon KP, 1996, MICROBIOL-UK, V142, P1311, DOI 10.1099/13500872-142-5-1311; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TABOR H, 1982, P NATL ACAD SCI-BIOL, V79, P7087, DOI 10.1073/pnas.79.23.7087; Tkachenko AG, 2006, BIOCHEMISTRY-MOSCOW+, V71, P185, DOI 10.1134/S0006297906020118; Tramonti A, 2002, J BACTERIOL, V184, P2603, DOI 10.1128/JB.184.10.2603-2613.2002; Tramonti A, 2008, MOL MICROBIOL, V70, P965, DOI 10.1111/j.1365-2958.2008.06458.x; Tucker DL, 2003, J BACTERIOL, V185, P3190, DOI 10.1128/JB.185.10.3190-3201.2003; Vecerek B, 2010, NUCLEIC ACIDS RES, V38, P1284, DOI 10.1093/nar/gkp1125; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Waterman SR, 1996, INFECT IMMUN, V64, P2808, DOI 10.1128/IAI.64.7.2808-2811.1996; Waterman SR, 2003, J BACTERIOL, V185, P4644, DOI 10.1128/JB.185.15.4644-4647.2003; Yoshida M, 2004, J BIOL CHEM, V279, P46008, DOI 10.1074/jbc.M404393200; Yoshida M, 2002, J BIOL CHEM, V277, P37139, DOI 10.1074/jbc.M206668200; Yoshida M, 2001, J BIOL CHEM, V276, P16289, DOI 10.1074/jbc.M011059200	63	26	29	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33559	33570		10.1074/jbc.M113.510552	http://dx.doi.org/10.1074/jbc.M113.510552			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24097985	hybrid, Green Published			2022-12-25	WOS:000327250200006
J	Nascimento, AFZ; Trindade, DM; Tonoli, CCC; de Giuseppe, PO; Assis, LHP; Honorato, RV; de Oliveira, PSL; Mahajan, P; Burgess-Brown, NA; von Delft, F; Larson, RE; Murakami, MT				Nascimento, Andrey F. Z.; Trindade, Daniel M.; Tonoli, Celisa C. C.; de Giuseppe, Priscila O.; Assis, Leandro H. P.; Honorato, Rodrigo V.; de Oliveira, Paulo S. L.; Mahajan, Pravin; Burgess-Brown, Nicola A.; von Delft, Frank; Larson, Roy E.; Murakami, Mario T.			Structural Insights into Functional Overlapping and Differentiation among Myosin V Motors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Crystal Structure; Intracellular Trafficking; Molecular Motors; Myosin; Myosin V; Cargo-binding Domain; Molecular Plasticity; Redox Dimerization	GLOBULAR TAIL DOMAIN; PROTEIN-STRUCTURE; BIOLOGICAL MACROMOLECULES; MOLECULAR REPLACEMENT; MODEL; RESOLUTION; REFINEMENT; MUTATIONS; DISEASE; RILPL2	Background: MyoVs are molecular motors widely distributed in eukaryotic cells responsible for membrane trafficking and intracellular transport. Results: The cargo-binding domain from human MyoV paralogs was structurally and biophysically characterized. Conclusion: We identified singular structural changes and molecular events conferring functional differentiation and modulating cargo binding. Significance: This work provides structural insights into cargo recognition and regulatory mechanisms in MyoVs. Myosin V (MyoV) motors have been implicated in the intracellular transport of diverse cargoes including vesicles, organelles, RNA-protein complexes, and regulatory proteins. Here, we have solved the cargo-binding domain (CBD) structures of the three human MyoV paralogs (Va, Vb, and Vc), revealing subtle structural changes that drive functional differentiation and a novel redox mechanism controlling the CBD dimerization process, which is unique for the MyoVc subclass. Moreover, the cargo- and motor-binding sites were structurally assigned, indicating the conservation of residues involved in the recognition of adaptors for peroxisome transport and providing high resolution insights into motor domain inhibition by CBD. These results contribute to understanding the structural requirements for cargo transport, autoinhibition, and regulatory mechanisms in myosin V motors.	[Nascimento, Andrey F. Z.; Trindade, Daniel M.; Tonoli, Celisa C. C.; de Giuseppe, Priscila O.; Assis, Leandro H. P.; Honorato, Rodrigo V.; de Oliveira, Paulo S. L.; Murakami, Mario T.] Natl Ctr Res Energy & Mat, Brazilian Biosci Natl Lab, BR-13083970 Campinas, SP, Brazil; [Mahajan, Pravin; Burgess-Brown, Nicola A.; von Delft, Frank] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Larson, Roy E.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cellular & Mol Biol, BR-14049900 Sao Paulo, Brazil	University of Oxford; Universidade de Sao Paulo	Murakami, MT (corresponding author), Natl Ctr Res Energy & Mat, Brazilian Biosci Natl Lab, Giuseppe Maximo Scolfaro St 10000, BR-13083970 Campinas, SP, Brazil.	mario.murakami@lnbio.cnpem.br	Murakami, Mario T/C-2087-2012; Trindade, Daniel Maragno/J-6085-2012; Oliveira, Paulo S/K-5588-2013; Honorato, Rodrigo/H-9773-2013; Murakami, Mario T/F-5640-2016; Nascimento, Andrey Fabricio Ziem/M-1740-2016; Honorato, Rodrigo Vargas/AAY-9375-2020; Oliveira de Giuseppe, Priscila/GLR-1319-2022; Paula Assis, Leandro Henrique/Q-6823-2016	Trindade, Daniel Maragno/0000-0002-8005-8784; Honorato, Rodrigo/0000-0001-5267-3002; Murakami, Mario T/0000-0002-0405-8010; Nascimento, Andrey Fabricio Ziem/0000-0003-4692-5263; Honorato, Rodrigo Vargas/0000-0001-5267-3002; Oliveira de Giuseppe, Priscila/0000-0003-2094-7325; Paula Assis, Leandro Henrique/0000-0002-0610-9483; Tonoli, Celisa/0000-0003-2580-5588; Mahajan, Pravin/0000-0002-6073-9363; von Delft, Frank/0000-0003-0378-0017	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [09/08312-6, 07/59939-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [478059/2009-4, 486841/2012-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants 09/08312-6 (to M.T.M.) and 07/59939-3 (to R.E.L.), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grants 478059/2009-4 and 486841/2012-0, and grants from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BEMENT WM, 1994, P NATL ACAD SCI USA, V91, P11767; Chen YF, 2009, CANCER RES, V69, P8585, DOI 10.1158/0008-5472.CAN-09-2284; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Dong WJ, 2013, DIGEST DIS SCI, V58, P2038, DOI 10.1007/s10620-013-2600-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGLE LJ, 1994, GENOMICS, V19, P407, DOI 10.1006/geno.1994.1088; Eves PT, 2012, J CELL BIOL, V198, P69, DOI 10.1083/jcb.201201024; Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Hammersley AP, 1997, J SYNCHROTRON RADIAT, V4, P67, DOI 10.1107/S0909049596015087; Heuck A, 2010, J CELL BIOL, V189, P497, DOI 10.1083/jcb.201002076; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lan LX, 2010, INT J CANCER, V126, P53, DOI 10.1002/ijc.24641; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Lise MF, 2009, J CELL SCI, V122, P3810, DOI 10.1242/jcs.050344; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller T, 2008, NAT GENET, V40, P1163, DOI 10.1038/ng.225; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Olkkonen VM, 2006, J CELL SCI, V119, P5031, DOI 10.1242/jcs.03303; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Pashkova N, 2005, J CELL BIOL, V168, P359, DOI 10.1083/jcb.200407146; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Pranchevicius MCS, 2008, CELL MOTIL CYTOSKEL, V65, P441, DOI 10.1002/cm.20269; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rodriguez OC, 2002, J CELL SCI, V115, P991; Roder IV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003871; Rudolf R, 2011, J NEUROCHEM, V116, P177, DOI 10.1111/j.1471-4159.2010.07110.x; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schaub JR, 2013, MOL BIOL CELL, V24, P453, DOI 10.1091/mbc.E12-08-0598; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sellers JR, 2008, BIOCHEM BIOPH RES CO, V369, P176, DOI 10.1016/j.bbrc.2007.11.109; Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taylor KA, 2007, CURR OPIN CELL BIOL, V19, P67, DOI 10.1016/j.ceb.2006.12.014; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; van Diepen MT, 2009, NAT CELL BIOL, V11, P1191, DOI 10.1038/ncb1961; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wang TL, 2004, MOL BIOL CELL, V15, P815, DOI 10.1091/mbc.E03-06-0413; Wei ZY, 2013, P NATL ACAD SCI USA, V110, P11314, DOI 10.1073/pnas.1306768110; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3	66	24	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34131	34145		10.1074/jbc.M113.507202	http://dx.doi.org/10.1074/jbc.M113.507202			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24097982	Green Published, hybrid			2022-12-25	WOS:000327250200057
J	Fujiwara, N; Tateishi, R; Akahane, M; Taguri, M; Minami, T; Mikami, S; Sato, M; Uchino, K; Enooku, K; Kondo, Y; Asaoka, Y; Yamashiki, N; Goto, T; Shiina, S; Yoshida, H; Ohtomo, K; Koike, K				Fujiwara, Naoto; Tateishi, Ryosuke; Akahane, Masaaki; Taguri, Masataka; Minami, Tatsuya; Mikami, Shintaro; Sato, Masaya; Uchino, Kouji; Enooku, Kenichiro; Kondo, Yuji; Asaoka, Yoshinari; Yamashiki, Noriyo; Goto, Tadashi; Shiina, Shuichiro; Yoshida, Haruhiko; Ohtomo, Kuni; Koike, Kazuhiko			Changes in Risk of Immediate Adverse Reactions to Iodinated Contrast Media by Repeated Administrations in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; ANAPHYLACTOID REACTION; HIGH-OSMOLALITY; EXPERIENCE; COMMITTEE; DISEASE; SAFETY; AGENTS	Background: To elucidate whether repeated exposures to iodinated contrast media increase the risk of adverse reaction. Materials and Methods: We retrospectively reviewed 1,861 patients with hepatocellular carcinoma who visited authors' institution, a tertiary referral center, between 2004 and 2008. We analyzed cumulative probability of adverse reactions and risk factors. We categorized all symptoms into hypersensitivity reactions, physiologic reactions, and other reactions, according to the American College of Radiology guidelines, and evaluated each category as an event. We estimated the association between hazard for adverse reactions and the number of cumulative exposures to contrast media. We also evaluated subsequent contrast media injections and adverse reactions. Results: There were 23,684 contrast media injections in 1,729 patients. One hundred and thirty-two patients were excluded because they were given no contrast media during the study period. Adverse reactions occurred in 196 (0.83%) patients. The cumulative incidence at 10th, 20th, and 30th examination was 7.9%, 15.2%, and 24.1%, respectively. Presence of renal impairment was found to be one of risk factors for adverse reactions. The estimated hazard of overall adverse reaction gradually decreased until around 10th exposure and rose with subsequent exposures. The estimated hazard of hypersensitivity showed V-shaped change with cumulative number of exposures. The estimated hazard of physiologic reaction had a tendency toward decreasing and that of other reaction had a tendency toward increasing. Second adverse reaction was more severe than the initial in only one among 130 patients receiving subsequent injections. Conclusion: Repeated exposures to iodinated contrast media increase the risk of adverse reaction.	[Fujiwara, Naoto; Tateishi, Ryosuke; Minami, Tatsuya; Mikami, Shintaro; Sato, Masaya; Uchino, Kouji; Enooku, Kenichiro; Kondo, Yuji; Asaoka, Yoshinari; Yamashiki, Noriyo; Goto, Tadashi; Shiina, Shuichiro; Yoshida, Haruhiko; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo, Japan; [Akahane, Masaaki; Ohtomo, Kuni] Univ Tokyo, Dept Radiol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Taguri, Masataka] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan	University of Tokyo; University of Tokyo; Yokohama City University	Tateishi, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo, Japan.	tateishi-tky@umin.ac.jp	Tateishi, Ryosuke/G-7758-2014; Asaoka, Yoshinari/ABC-5412-2021; Fujiwara, Naoto/Y-5938-2019	Tateishi, Ryosuke/0000-0003-3021-2517; Asaoka, Yoshinari/0000-0002-2805-8226; Fujiwara, Naoto/0000-0002-4109-3421; YAMASHIKI, Noriyo/0000-0002-9274-0000	Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis); Grants-in-Aid for Scientific Research [23590962] Funding Source: KAKEN	Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Health Sciences Research Grants of The Ministry of Health, Labour and Welfare of Japan (Research on Hepatitis). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; American Civil Liberties Union, 2012, ADV EV INTR IOD CONT, P21; Andrew E, 2004, J TOXICOL-CLIN TOXIC, V42, P325, DOI 10.1081/CLT-120037430; BARRETT BJ, 1992, RADIOLOGY, V183, P105, DOI 10.1148/radiology.183.1.1549654; Bettmann MA, 1997, RADIOLOGY, V203, P611, DOI 10.1148/radiology.203.3.9169677; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; CARO JJ, 1991, AM J ROENTGENOL, V156, P825, DOI 10.2214/ajr.156.4.1825900; DAHLSTROM K, 1985, INVEST RADIOL, V20, pS117, DOI 10.1097/00004424-198501002-00028; Davenport MS, 2009, RADIOLOGY, V253, P372, DOI 10.1148/radiol.2532090465; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Freed KS, 2001, AM J ROENTGENOL, V176, P1389, DOI 10.2214/ajr.176.6.1761389; GREENBERGER PA, 1985, ARCH INTERN MED, V145, P2197, DOI 10.1001/archinte.145.12.2197; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Hagan JB, 2004, IMMUNOL ALLERGY CLIN, V24, P507, DOI 10.1016/j.iac.2004.03.005; Hwang J, 2012, BRIT J RADIOL, V85, pE314, DOI 10.1259/bjr/27727228; Ichikawa T, 2010, INVEST RADIOL, V45, P133, DOI 10.1097/RLI.0b013e3181caea5b; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; KATAYAMA H, 1990, RADIOLOGY, V175, P621, DOI 10.1148/radiology.175.3.2343107; Khalili K, 2011, J HEPATOL, V54, P723, DOI 10.1016/j.jhep.2010.07.025; Kopp AF, 2008, ACTA RADIOL, V49, P902, DOI 10.1080/02841850802282811; LANG DM, 1991, ANN INTERN MED, V115, P270, DOI 10.7326/0003-4819-115-4-270; LANG DM, 1993, ARCH INTERN MED, V153, P2033, DOI 10.1001/archinte.153.17.2033; LASSER EC, 1987, NEW ENGL J MED, V317, P845, DOI 10.1056/NEJM198710013171401; Lencioni R, 2008, J HEPATOL, V48, P848, DOI 10.1016/j.jhep.2008.02.005; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Mikami S, 2012, J VASC INTERV RADIOL, V23, P1269, DOI 10.1016/j.jvir.2012.06.032; Morcos SK, 2001, EUR RADIOL, V11, P1267, DOI 10.1007/s003300000729; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Sano K, 2011, RADIOLOGY, V261, P834, DOI 10.1148/radiol.11101840; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Thomsen HS, 2006, ABDOM IMAGING, V31, P131, DOI 10.1007/s00261-005-0380-y; Tramer MR, 2006, BRIT MED J, V333, P675, DOI 10.1136/bmj.38905.634132.AE; WOLF GL, 1991, INVEST RADIOL, V26, P404, DOI 10.1097/00004424-199105000-00003	35	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e76018	10.1371/journal.pone.0076018	http://dx.doi.org/10.1371/journal.pone.0076018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098420	Green Published, gold, Green Submitted			2022-12-25	WOS:000325434500041
J	Pellegrino, AC; Penaflor, MFGV; Nardi, C; Bezner-Kerr, W; Guglielmo, CG; Bento, JMS; McNeil, JN				Pellegrino, Ana Cristina; Gomes Villalba Penaflor, Maria Fernanda; Nardi, Cristiane; Bezner-Kerr, Wayne; Guglielmo, Christopher G.; Simoes Bento, Jose Mauricio; McNeil, Jeremy N.			Weather Forecasting by Insects: Modified Sexual Behaviour in Response to Atmospheric Pressure Changes	PLOS ONE			English	Article							VIRGIFERA-VIRGIFERA COLEOPTERA; CORN-ROOTWORM COLEOPTERA; BAROMETRIC-PRESSURE; POTATO APHID; CALLING BEHAVIOR; MATING-BEHAVIOR; FLIGHT ACTIVITY; WIND-SPEED; PHEROMONE; ECOLOGY	Prevailing abiotic conditions may positively or negatively impact insects at both the individual and population levels. For example while moderate rainfall and wind velocity may provide conditions that favour development, as well as movement within and between habitats, high winds and heavy rains can significantly decrease life expectancy. There is some evidence that insects adjust their behaviours associated with flight, mating and foraging in response to changes in barometric pressure. We studied changes in different mating behaviours of three taxonomically unrelated insects, the curcurbit beetle, Diabrotica speciosa (Coleoptera), the true armyworm moth, Pseudaletia unipuncta (Lepidoptera) and the potato aphid, Macrosiphum euphorbiae (Hemiptera), when subjected to natural or experimentally manipulated changes in atmospheric pressure. In response to decreasing barometric pressure, male beetles exhibited decreased locomotory activity in a Y-tube olfactometer with female pheromone extracts. However, when placed in close proximity to females, they exhibited reduced courtship sequences and the precopulatory period. Under the same situations, females of the true armyworm and the potato aphid exhibited significantly reduced calling behaviour. Neither the movement of male beetles nor the calling of armyworm females differed between stable and increasing atmospheric pressure conditions. However, in the case of the armyworm there was a significant decrease in the incidence of mating under rising atmospheric conditions, suggesting an effect on male behaviour. When atmospheric pressure rose, very few M. euphorbiae oviparae called. This was similar to the situation observed under decreasing conditions, and consequently very little mating was observed in this species except under stable conditions. All species exhibited behavioural modifications, but there were interspecific differences related to size-related flight ability and the diel periodicity of mating activity. We postulate that the observed behavioral modifications, especially under decreasing barometric pressure would reduce the probability of injury or death under adverse weather conditions.	[Pellegrino, Ana Cristina; Gomes Villalba Penaflor, Maria Fernanda; Simoes Bento, Jose Mauricio] Univ Sao Paulo, ESALQ, Dept Entomol & Acarol, Piracicaba, SP, Brazil; [Nardi, Cristiane] Univ Estadual Ctr Oeste UNICTR, Dept Agron, Guarapuava, PR, Brazil; [Bezner-Kerr, Wayne; Guglielmo, Christopher G.; McNeil, Jeremy N.] Univ Western Ontario, Dept Biol, London, ON, Canada	Universidade de Sao Paulo; Western University (University of Western Ontario)	Bento, JMS (corresponding author), Univ Sao Paulo, ESALQ, Dept Entomol & Acarol, Piracicaba, SP, Brazil.	jmsbento@usp.br	Pellegrino, Ana Cristina/AAO-4737-2020; Peñaflor, Maria Fernanda G.V./F-7591-2013; Nardi, Cristiane/J-8158-2014; Bento, José Maurício Simões/A-9759-2008; Morbey, Yolanda/F-9035-2013	Peñaflor, Maria Fernanda G.V./0000-0001-8240-8840; Bento, José Maurício Simões/0000-0001-8655-5178; Nardi, Cristiane/0000-0003-4264-5379	INCT Semioquimicos na Agricultura; FAPESP; CNPq; NSERC; CFI	INCT Semioquimicos na Agricultura; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFI(Canada Foundation for Innovation)	Funders: INCT Semioquimicos na Agricultura, FAPESP, CNPq, NSERC and CFI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAMENT JW, 1961, BIOL REV, V36, P281, DOI 10.1111/j.1469-185X.1961.tb01291.x; Breuner CW, 2013, J EXP BIOL, V216, P1982, DOI 10.1242/jeb.081067; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; CONNER WE, 1988, PHYSIOL ENTOMOL, V13, P15, DOI 10.1111/j.1365-3032.1988.tb00904.x; Crespo JE, 2012, J INSECT PHYSIOL, V58, P1562, DOI 10.1016/j.jinsphys.2012.09.010; Dickerson AK, 2012, P NATL ACAD SCI USA, V109, P9822, DOI 10.1073/pnas.1205446109; Didham RK, 2003, ARTHROPODS OF TROPICAL FORESTS, P28; Fournier F, 2005, ENVIRON ENTOMOL, V34, P1534, DOI 10.1603/0046-225X-34.6.1534; Goldansaz SH, 2006, J CHEM ECOL, V32, P1719, DOI 10.1007/s10886-006-9104-1; Goldansaz SH, 2003, ECOL ENTOMOL, V28, P291, DOI 10.1046/j.1365-2311.2003.00515.x; Heupel MR, 2003, J FISH BIOL, V63, P1357, DOI 10.1046/j.1095-8649.2003.00250.x; Isard SA, 2000, ENVIRON ENTOMOL, V29, P226, DOI 10.1603/0046-225X(2000)029[0226:AMOWCR]2.0.CO;2; Isard SA, 2004, ENVIRON ENTOMOL, V33, P650, DOI 10.1603/0046-225X-33.3.650; Isard SA, 1999, AEROBIOLOGIA, V15, P95; JANZEN DH, 1968, ECOLOGY, V49, P96, DOI 10.2307/1933565; KAAE RS, 1972, ANN ENTOMOL SOC AM, V65, P436, DOI 10.1093/aesa/65.2.436; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; LANIER GN, 1978, J CHEM ECOL, V4, P139, DOI 10.1007/BF00988050; Liu YL, 2010, MAR BIOL, V157, P2369, DOI 10.1007/s00227-010-1501-x; Marchand D, 2000, J INSECT BEHAV, V13, P187, DOI 10.1023/A:1007732113390; Marquardt PT, 2009, ENVIRON ENTOMOL, V38, P176, DOI 10.1603/022.038.0122; McIver SB, 1984, COMPREHENSIVE INSECT, V6, P71; MCNEIL JN, 1991, ANNU REV ENTOMOL, V36, P407, DOI 10.1146/annurev.en.36.010191.002203; Nardi C, 2012, ENVIRON ENTOMOL, V41, P562, DOI 10.1603/EN10284; PAIGE KN, 1995, FUNCT ECOL, V9, P463, DOI 10.2307/2390010; QUIRING DT, 1990, J APPL ECOL, V27, P965, DOI 10.2307/2404390; ROITBERG BD, 1993, NATURE, V364, P108, DOI 10.1038/364108a0; ROITBERG BD, 1978, CAN J ZOOL, V56, P103, DOI 10.1139/z78-014; Rousse P, 2009, ENVIRON ENTOMOL, V38, P896, DOI 10.1603/022.038.0344; Shaman J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000331; Spencer JL, 2005, WESTERN CORN ROOTWORM: ECOLOGY AND MANAGEMENT, P121, DOI 10.1079/9780851998176.0121; Spencer JL, 2009, AGR FOREST ENTOMOL, V11, P9, DOI 10.1111/j.1461-9563.2008.00399.x; TANAKA LK, 1982, BIOTROPICA, V14, P114, DOI 10.2307/2387740; TANNER EVJ, 1991, BIOTROPICA, V23, P513, DOI 10.2307/2388274; Tichy H, 2010, J NEUROPHYSIOL, V103, P3274, DOI 10.1152/jn.01043.2009; TURGEON J, 1982, ENTOMOL EXP APPL, V31, P402, DOI 10.1111/j.1570-7458.1982.tb03168.x; VANROERMUND HJW, 1995, J APPL ENTOMOL, V119, P465, DOI 10.1111/j.1439-0418.1995.tb01319.x; WALKER GP, 1984, ENVIRON ENTOMOL, V13, P724, DOI 10.1093/ee/13.3.724; Walsh GC, 2008, J APPL ENTOMOL, V132, P205, DOI 10.1111/j.1439-0418.2008.01272.x; WEAVER RJ, 1984, J INSECT PHYSIOL, V30, P831, DOI 10.1016/0022-1910(84)90020-9; Weisser WW, 1997, J ANIM ECOL, V66, P386, DOI 10.2307/5984; Wellington W. G., 1946, CANADIAN JOUR RES SECT D ZOOL SCI, V24, P51; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789	44	52	55	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75004	10.1371/journal.pone.0075004	http://dx.doi.org/10.1371/journal.pone.0075004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098362	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000325434500018
J	Boyer, S; Wratten, SD; Holyoake, A; Abdelkrim, J; Cruickshank, RH				Boyer, Stephane; Wratten, Stephen D.; Holyoake, Andrew; Abdelkrim, Jawad; Cruickshank, Robert H.			Using Next-Generation Sequencing to Analyse the Diet of a Highly Endangered Land Snail (Powelliphanta augusta) Feeding on Endemic Earthworms	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PREY DNA; INVERTEBRATE PREDATION; INSECT PREDATORS; GUT; FECES; PCR; IDENTIFICATION; LUMBRICIDAE; OLIGOCHAETA	Predation is often difficult to observe or quantify for species that are rare, very small, aquatic or nocturnal. The assessment of such species' diet can be conducted using molecular methods that target prey DNA remaining in predators' guts and faeces. These techniques do not require high taxonomic expertise, are applicable to soft-bodied prey and allow for identification at the species level. However, for generalist predators, the presence of mixed prey DNA in guts and faeces can be a major impediment as it requires development of specific primers for each potential prey species for standard (Sanger) sequencing. Therefore, next generation sequencing methods have recently been applied to such situations. In this study, we used 454-pyrosequencing to analyse the diet of Powelliphanta augusta, a carnivorous landsnail endemic to New Zealand and critically endangered after most of its natural habitat has been lost to opencast mining. This species was suspected to feed mainly on earthworms. Although earthworm tissue was not detectable in snail faeces, earthworm DNA was still present in sufficient quantity to conduct molecular analyses. Based on faecal samples collected from 46 landsnails, our analysis provided a complete map of the earthworm-based diet of P. augusta. Predated species appear to be earthworms that live in the leaf litter or earthworms that come to the soil surface at night to feed on the leaf litter. This indicates that P. augusta may not be selective and probably predates any earthworm encountered in the leaf litter. These findings are crucial for selecting future translocation areas for this highly endangered species. The molecular diet analysis protocol used here is particularly appropriate to study the diet of generalist predators that feed on liquid or soft-bodied prey. Because it is non-harmful and non-disturbing for the studied animals, it is also applicable to any species of conservation interest.	[Boyer, Stephane; Wratten, Stephen D.; Holyoake, Andrew] Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand; [Boyer, Stephane; Cruickshank, Robert H.] Lincoln Univ, Fac Agr & Life Sci, Dept Ecol, Lincoln, New Zealand; [Abdelkrim, Jawad] Univ Otago, Dept Anat & Struct Biol, Ctr Reprod & Genom, Dunedin, New Zealand; [Abdelkrim, Jawad] Museum Natl Hist Nat, Unite Conservat Especes Restaurat & Suivi Populat, UMR 7204, F-75231 Paris, France	Lincoln University - New Zealand; Lincoln University - New Zealand; University of Otago; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Boyer, S (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand.	Stephane.Boyer@lincoln.ac.nz	Boyer, Stéphane/H-8624-2013; Wratten, Steve D/J-3467-2013	Boyer, Stéphane/0000-0002-0750-4864; Wratten, Steve D/0000-0002-5168-8277	Solid Energy New Zealand Limited; Department of Ecology at Lincoln University; Bio-Protection Research Centre at Lincoln University	Solid Energy New Zealand Limited; Department of Ecology at Lincoln University; Bio-Protection Research Centre at Lincoln University	This work was funded by Solid Energy New Zealand Limited and supported by the Department of Ecology at Lincoln University and the Bio-Protection Research Centre at Lincoln University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti N, 1999, MOL ECOL, V8, P1467, DOI 10.1046/j.1365-294x.1999.00717.x; Ahmadian A, 2006, CLIN CHIM ACTA, V363, P83, DOI 10.1016/j.cccn.2005.04.038; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; BOORE JL, 1995, GENETICS, V141, P305; Bouche MB, 1972, ANN ZOOLOGIE ECOLOGI; Bowles E, 2011, MOL ECOL RESOUR, V11, P530, DOI 10.1111/j.1755-0998.2010.02974.x; Boyer S, 2011, ZOOTAXA, P21; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038215; Boyer S, 2011, PEDOBIOLOGIA, V54, pS99, DOI 10.1016/j.pedobi.2011.09.006; Boyer S, 2011, PEDOBIOLOGIA, V54, pS153, DOI 10.1016/j.pedobi.2011.08.002; Boyer S, 2010, ZOOL MIDDLE EAST, P31; Brown DS, 2012, MOL ECOL RESOUR, V12, P259, DOI 10.1111/j.1755-0998.2011.03098.x; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Budarf AC, 2011, J FISH BIOL, V79, P112, DOI 10.1111/j.1095-8649.2011.02999.x; Chen Y, 2000, MOL ECOL, V9, P1887, DOI 10.1046/j.1365-294x.2000.01100.x; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; Deagle BE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000831; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FRYXELL JM, 1994, EVOL ECOL, V8, P407, DOI 10.1007/BF01238191; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hibert F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025850; Hoogendoorn M, 2001, MOL ECOL, V10, P2059, DOI 10.1046/j.1365-294X.2001.01316.x; Jarman SN, 2004, MOL ECOL, V13, P1313, DOI 10.1111/j.1365-294X.2004.02109.x; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; King RA, 2011, MOL ECOL RESOUR, V11, P370, DOI 10.1111/j.1755-0998.2010.02913.x; King RA, 2010, MOL ECOL, V19, P1721, DOI 10.1111/j.1365-294X.2010.04602.x; Lavandero B, 2004, INT J PEST MANAGE, V50, P147, DOI 10.1080/09670870410001731853; LEE KE, 1959, EARTHWORM FAUNA NZ D; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Merfield CN, 2004, BIOL CONTROL, V29, P5, DOI 10.1016/S1049-9644(03)00095-1; Murray DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025776; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Pop AA, 2003, PEDOBIOLOGIA, V47, P428, DOI 10.1016/S0031-4056(04)70217-6; Pop AA, 2007, EUR J SOIL BIOL, V43, pS43, DOI 10.1016/j.ejsobi.2007.08.007; REID B, 1982, NEW ZEAL J ECOL, V5, P76; Riemann L, 2010, BIOL LETTERS, V6, P819, DOI 10.1098/rsbl.2010.0411; Simenc J, 2011, APPL BIOCHEM MICRO+, V47, P256, DOI 10.1134/S0003683811030136; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SOPP PI, 1992, J APPL ECOL, V29, P295, DOI 10.2307/2404498; SUNDERLAND KD, 1987, ACTA PHYTOPATHOL HUN, V22, P13; Suzuki N, 2006, FISHERIES SCI, V72, P342, DOI 10.1111/j.1444-2906.2006.01155.x; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Team RDC, 2009, R LANG ENV STAT COMP; Trewick SA, 2008, CONSERV GENET, V9, P1563, DOI 10.1007/s10592-007-9495-8; Turner AM, 2008, ANIM BEHAV, V76, P1211, DOI 10.1016/j.anbehav.2008.06.005; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Walker KJ, 2008, J ROY SOC NEW ZEAL, V38, P163, DOI 10.1080/03014220809510553; Zaidi RH, 1999, MOL ECOL, V8, P2081, DOI 10.1046/j.1365-294x.1999.00823.x; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	54	40	42	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75962	10.1371/journal.pone.0075962	http://dx.doi.org/10.1371/journal.pone.0075962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086671	gold, Green Submitted, Green Published			2022-12-25	WOS:000325223900068
J	Lefebvre, M; Tetaud, E; Thonnus, M; Salin, B; Boissier, F; Blancard, C; Sauvanet, C; Metzler, C; Espiau, B; Sahin, A; Merlin, G				Lefebvre, Michele; Tetaud, Emmanuel; Thonnus, Magali; Salin, Benedicte; Boissier, Fanny; Blancard, Corinne; Sauvanet, Cecile; Metzler, Christelle; Espiau, Benoit; Sahin, Annelise; Merlin, Gilles			LdFlabarin, a New BAR Domain Membrane Protein of Leishmania Flagellum	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; PARAFLAGELLAR ROD; RAC1-INTERACTING PROTEIN; ACTIN CYTOSKELETON; TRYPANOSOMA-BRUCEI; STRUCTURAL BASIS; EXPRESSION; AMPHIPHYSIN; BIOGENESIS; PARASITES	During the Leishmania life cycle, the flagellum undergoes successive assembly and disassembly of hundreds of proteins. Understanding these processes necessitates the study of individual components. Here, we investigated LdFlabarin, an uncharacterized L. donovani flagellar protein. The gene is conserved within the Leishmania genus and orthologous genes only exist in the Trypanosoma genus. LdFlabarin associates with the flagellar plasma membrane, extending from the base to the tip of the flagellum as a helicoidal structure. Site-directed mutagenesis, deletions and chimera constructs showed that LdFlabarin flagellar addressing necessitates three determinants: an N-terminal potential acylation site and a central BAR domain for membrane targeting and the C-terminal domain for flagellar specificity. In vitro, the protein spontaneously associates with liposomes, triggering tubule formation, which suggests a structural/morphogenetic function. LdFlabarin is the first characterized Leishmania BAR domain protein, and the first flagellum-specific BAR domain protein.	[Lefebvre, Michele; Merlin, Gilles] CNRS, UMR 5290, Montpellier, France; [Lefebvre, Michele; Merlin, Gilles] Univ Montpellier I, Montpellier, France; [Lefebvre, Michele; Merlin, Gilles] Ctr Hosp Univ Colombiere, Montpellier, France; [Lefebvre, Michele; Merlin, Gilles] IRD 224, Montpellier, France; [Tetaud, Emmanuel; Salin, Benedicte; Boissier, Fanny; Blancard, Corinne; Sauvanet, Cecile] CNRS, Inst Biochim Genet & Cellulaire, UMR 5095, Bordeaux, France; [Thonnus, Magali; Sahin, Annelise] CNRS, UMR 5234, Bordeaux, France; [Tetaud, Emmanuel; Thonnus, Magali; Salin, Benedicte; Boissier, Fanny; Blancard, Corinne; Sauvanet, Cecile; Metzler, Christelle; Sahin, Annelise] Univ Bordeaux Segalen, Bordeaux, France; [Espiau, Benoit] CNRS, EPHE, USR 3278, Papetoai, Moorea, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Merlin, G (corresponding author), CNRS, UMR 5290, Montpellier, France.	gmerlin@univ-montp1.fr			CNRS (Centre National de la Recherche Scientifique); Universite Bordeaux Segalen; IRD (Institut de Recherche pour le Developpement); Universite Montpellier I; CHU (Centre Hospitalier Universitaire) La Colombiere (Montpellier)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Universite Bordeaux Segalen; IRD (Institut de Recherche pour le Developpement); Universite Montpellier I; CHU (Centre Hospitalier Universitaire) La Colombiere (Montpellier)	The project was funded by the CNRS (Centre National de la Recherche Scientifique), the Universite Bordeaux Segalen, the IRD (Institut de Recherche pour le Developpement), the Universite Montpellier I and the CHU (Centre Hospitalier Universitaire) La Colombiere (Montpellier). A. Sahin and C. Sauvanet were MENRT (Ministere de l'Education Nationale, de la Recherche et de la Technologie) PhD fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTOINE JC, 1999, LEISHMANIOSES, P41; Bastin P, 1999, MOL CELL BIOL, V19, P8191; Boman AL, 1999, CELL MOTIL CYTOSKEL, V44, P119, DOI 10.1002/(SICI)1097-0169(199910)44:2<119::AID-CM4>3.3.CO;2-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Buchanan KT, 2005, J BIOL CHEM, V280, P40104, DOI 10.1074/jbc.M505777200; CACHON J, 1988, BIOL CELL, V63, P169, DOI 10.1016/0248-4900(88)90056-1; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Cuvillier A, 2003, CELL MICROBIOL, V5, P717, DOI 10.1046/j.1462-5822.2003.00316.x; Cuvillier A, 2000, J CELL SCI, V113, P2065; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; DELAFAILLE MAC, 1992, P NATL ACAD SCI USA, V89, P2703, DOI 10.1073/pnas.89.7.2703; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; DUTCHER SK, 1995, TRENDS GENET, V11, P398, DOI 10.1016/S0168-9525(00)89123-4; Emmer BT, 2009, J CELL SCI, V122, P867, DOI 10.1242/jcs.041764; Ersfeld K, 2001, J CELL SCI, V114, P141; Forestier CL, 2011, CELL HOST MICROBE, V9, P319, DOI 10.1016/j.chom.2011.03.011; Fridberg A, 2007, PARASITOL RES, V100, P205, DOI 10.1007/s00436-006-0329-2; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; Gluenz E, 2010, CURR OPIN MICROBIOL, V13, P473, DOI 10.1016/j.mib.2010.05.008; Godsel LM, 1999, EMBO J, V18, P2057, DOI 10.1093/emboj/18.8.2057; Ilg T, 2000, PARASITOL TODAY, V16, P489, DOI 10.1016/S0169-4758(00)01791-9; Ilgoutz SC, 2001, INT J PARASITOL, V31, P899, DOI 10.1016/S0020-7519(01)00197-7; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; Kjaerulff O, 2011, CELL BIOCHEM BIOPHYS, V60, P137, DOI 10.1007/s12013-010-9137-5; Koumandou VL, 2011, J CELL SCI, V124, P1496, DOI 10.1242/jcs.081596; Kunz S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000455; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lee L, 2011, GENE, V473, P57, DOI 10.1016/j.gene.2010.11.006; LICHTE B, 1992, EMBO J, V11, P2521, DOI 10.1002/j.1460-2075.1992.tb05317.x; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; LODES MJ, 1995, MOL CELL BIOL, V15, P6845; MacLean LM, 2012, CELL MICROBIOL, V14, P740, DOI 10.1111/j.1462-5822.2012.01756.x; Maga JA, 1999, TRENDS CELL BIOL, V9, P409, DOI 10.1016/S0962-8924(99)01635-9; Man ZQ, 2011, J BIOL CHEM, V286, P11569, DOI 10.1074/jbc.M110.201442; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Masuda M, 2010, SEMIN CELL DEV BIOL, V21, P391, DOI 10.1016/j.semcdb.2010.01.010; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Moore LL, 1996, MOL BIOCHEM PARASIT, V80, P125, DOI 10.1016/0166-6851(96)02688-6; Nakamura K, 2012, J BIOL CHEM, V287, P25478, DOI 10.1074/jbc.M112.365783; Nasser MIA, 2004, MOL BIOCHEM PARASIT, V135, P89, DOI 10.1016/j.molbiopara.2004.01.009; Overath P, 1997, TRENDS CELL BIOL, V7, P27, DOI 10.1016/S0962-8924(97)10046-0; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pullen TJ, 2004, MOL BIOL CELL, V15, P3257, DOI 10.1091/mbc.E04-03-0217; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sahin A, 2004, EXP PARASITOL, V108, P126, DOI 10.1016/j.exppara.2004.07.010; Sahin A, 2008, MOL BIOCHEM PARASIT, V157, P83, DOI 10.1016/j.molbiopara.2007.08.003; Sahin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001620; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHLAEPPI K, 1989, J CELL BIOL, V109, P1695, DOI 10.1083/jcb.109.4.1695; Selvapandiyan A, 2001, J BIOL CHEM, V276, P43253, DOI 10.1074/jbc.M106806200; Silflow CD, 2001, PLANT PHYSIOL, V127, P1500, DOI 10.1104/pp.127.4.1500; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; Tetaud E, 2002, MOL BIOCHEM PARASIT, V120, P195, DOI 10.1016/S0166-6851(02)00002-6; TETAUD E, 2011, PNUS SITE; Tran KD, 2012, J CELL SCI, V125, P3293, DOI 10.1242/jcs.103028; Tull D, 2004, MOL BIOL CELL, V15, P4775, DOI 10.1091/mbc.E04-06-0457; Tull D, 2010, J CELL SCI, V123, P544, DOI 10.1242/jcs.059097; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; Vincensini L, 2011, BIOL CELL, V103, P109, DOI 10.1042/BC20100104; 2013, GENEDB L MAJOR	76	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76380	10.1371/journal.pone.0076380	http://dx.doi.org/10.1371/journal.pone.0076380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086735	Green Submitted, gold, Green Published			2022-12-25	WOS:000325223900099
J	Tortosa, P; Dsouli, N; Gomard, Y; Ramasindrazana, B; Dick, CW; Goodman, SM				Tortosa, Pablo; Dsouli, Najla; Gomard, Yann; Ramasindrazana, Beza; Dick, Carl W.; Goodman, Steven M.			Evolutionary History of Indian Ocean Nycteribiid Bat Flies Mirroring the Ecology of Their Hosts	PLOS ONE			English	Article							CHIROPTERA MINIOPTERIDAE; MITOCHONDRIAL-DNA; COMORES ARCHIPELAGO; PHYLOGENY; IDENTIFICATION; BIOGEOGRAPHY; SPECIFICITY; MADAGASCAR; PATTERNS; DIPTERA	Bats and their parasites are increasingly investigated for their role in maintenance and transmission of potentially emerging pathogens. The islands of the western Indian Ocean hold nearly 50 bat species, mostly endemic and taxonomically well studied. However, investigation of associated viral, bacterial, and external parasites has lagged behind. In the case of their ectoparasites, more detailed information should provide insights into the evolutionary history of their hosts, as well as pathogen cycles in these wild animals. Here we investigate species of Nycteribiidae, a family of obligate hematophagous wingless flies parasitizing bats. Using morphological and molecular approaches, we describe fly species diversity sampled on Madagascar and the Comoros for two cave-roosting bat genera with contrasting ecologies: Miniopterus and Rousettus. Within the sampling area, 11 endemic species of insect-feeding Miniopterus occur, two of which are common to Madagascar and Comoros, while fruit-consuming Rousettus are represented by one species endemic to each of these zones. Morphological and molecular characterization of flies reveals that nycteribiids associated with Miniopterus bats comprise three species largely shared by most host species. Flies of M. griveaudi, one of the two bats found on Madagascar and certain islands in the Comoros, belong to the same taxon, which accords with continued over-water population exchange of this bat species and the lack of inter-island genetic structuring. Flies parasitizing Rousettus belong to two distinct species, each associated with a single host species, again in accordance with the distribution of each endemic bat species.	[Tortosa, Pablo; Dsouli, Najla; Gomard, Yann; Ramasindrazana, Beza] Plateforme Rech CYROI, Ctr Rech & Veille Malad Emergentes Ocean Indien, Ste Clotilde, Reunion, France; [Tortosa, Pablo; Gomard, Yann; Ramasindrazana, Beza] Univ La Reunion, Ste Clotilde, Reunion, France; [Dsouli, Najla; Gomard, Yann; Ramasindrazana, Beza] Inst Rech Dev, St Clotilde, Reunion, France; [Dick, Carl W.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA; [Dick, Carl W.; Goodman, Steven M.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Goodman, Steven M.] Assoc Vahatra, Antananarivo, Madagascar	University of La Reunion; Institut de Recherche pour le Developpement (IRD); Western Kentucky University; Field Museum of Natural History (Chicago)	Tortosa, P (corresponding author), Plateforme Rech CYROI, Ctr Rech & Veille Malad Emergentes Ocean Indien, Ste Clotilde, Reunion, France.	pablo.tortosa@univ-reunion.fr	RAMASINDRAZANA, Beza/AGY-9255-2022; Dick, Carl/AAE-7154-2022	Tortosa, Pablo/0000-0002-7928-7264; RAMASINDRAZANA, Beza/0000-0002-8838-949X	European Regional Development Fund/Programme Operationnel de Cooperation Territoriale Reunion; Pathogenes associes a la Faune Sauvage Ocean Indien [31189]; National Science Foundation/Division of Environmental Biology [1003459]; Research AMP; Creative Activity Program from Western Kentucky University [11-8020]	European Regional Development Fund/Programme Operationnel de Cooperation Territoriale Reunion; Pathogenes associes a la Faune Sauvage Ocean Indien; National Science Foundation/Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Research AMP; Creative Activity Program from Western Kentucky University	Funding comes from the European Regional Development Fund/Programme Operationnel de Cooperation Territoriale Reunion, Pathogenes associes a la Faune Sauvage Ocean Indien #31189, National Science Foundation/Division of Environmental Biology-1003459, and the Research & Creative Activity Program 11-8020 from Western Kentucky University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Ching L., 1968, MALAY NAT J, V21, P171; Dick CW, 2007, ECOL ENTOMOL, V32, P446, DOI 10.1111/j.1365-2311.2007.00836.x; Dick CW, 2007, INT J PARASITOL, V37, P871, DOI 10.1016/j.ijpara.2007.02.004; Dick CW, 2006, MICROMAMMALS AND MACROPARASITES: FROM EVOLUTIONARY ECOLOGY TO MANAGEMENT, P179, DOI 10.1007/978-4-431-36025-4_11; Drummond A., 2009, GENEIOUS V5 3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EMERICK CM, 1982, EARTH PLANET SC LETT, V60, P415, DOI 10.1016/0012-821X(82)90077-2; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goodman SM, 2010, J ZOOL SYST EVOL RES, V48, P75, DOI 10.1111/j.1439-0469.2009.00524.x; Goodman SM, 2012, J MAMMAL, V93, P1440, DOI 10.1644/11-MAMM-A-271.1; Goodman SM, 2010, J MAMMAL, V91, P593, DOI 10.1644/09-MAMM-A-283.1; Goodman SM, 2009, ZOOL SCR, V38, P339, DOI 10.1111/j.1463-6409.2008.00377.x; Hastriter MW, 2007, ZOOTAXA, P1; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Johnstone RA, 1996, BIOL J LINN SOC, V58, P453, DOI 10.1111/j.1095-8312.1996.tb01446.x; Lagadec E, 2012, EMERG INFECT DIS, V18, P1696, DOI 10.3201/eid1810.111898; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Marshall A.G., 1980, Proceedings International Bat Research Conference, V5, P135; MARSHALL AG, 1970, PARASITOLOGY, V61, P1, DOI 10.1017/S0031182000040798; Monadjem A, ZOOTAXA IN PRESS; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nougier J., 1986, Journal of African Earth Sciences, V5, P135, DOI 10.1016/0899-5362(86)90003-5; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson BD, 2007, J TROP ECOL, V23, P177, DOI 10.1017/S0266467406003816; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2021, R LANG ENV STAT COMP; Ramasindrazana B, 2011, BIOL J LINN SOC, V104, P284, DOI 10.1111/j.1095-8312.2011.01740.x; Swofford D. L., 2002, PHYLOGENETIC ANAL US, V42, P294, DOI DOI 10.1007/BF02198856; Theodor O, 1967, BRIT MUSEUM NATURAL, V665, P1; Tortosa P, 2012, INFECT GENET EVOL, V12, P1333, DOI 10.1016/j.meegid.2012.03.024; Wenzel R. L., 1966, P405; Weyeneth N, 2011, J EVOLUTION BIOL, V24, P1298, DOI 10.1111/j.1420-9101.2011.02262.x; Weyeneth N, 2008, MOL ECOL, V17, P5205, DOI 10.1111/j.1365-294X.2008.03994.x; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; Wilkinson DA, 2012, VIRUS RES, V170, P159, DOI 10.1016/j.virusres.2012.08.022	40	22	23	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75215	10.1371/journal.pone.0075215	http://dx.doi.org/10.1371/journal.pone.0075215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086470	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900040
J	Wang, LP; Fobert, PR				Wang, Lipu; Fobert, Pierre R.			Arabidopsis Clade I TGA Factors Regulate Apoplastic Defences against the Bacterial Pathogen Pseudomonas syringae through Endoplasmic Reticulum-Based Processes	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; UNFOLDED PROTEIN RESPONSE; DNA-BINDING ACTIVITY; SALICYLIC-ACID INDUCTION; TRANSCRIPTION FACTOR; NONHOST RESISTANCE; DISEASE RESISTANCE; SECRETORY PATHWAY; CALLOSE SYNTHASE; QUALITY-CONTROL	During the plant immune response, large-scale transcriptional reprogramming is modulated by numerous transcription (co) factors. The Arabidopsis basic leucine zipper transcription factors TGA1 and TGA4, which comprise the clade I TGA factors, have been shown to positively contribute to disease resistance against virulent strains of the bacterial pathogen Pseudomonas syringae. Despite physically interacting with the key immune regulator, NON-EXPRESSOR OF PATHOGENESIS-RELATED GENES 1 (NPR1), following elicitation with salicylic acid (SA), clade I function was shown to be largely independent of NPR1. Unlike mutants in NPR1, tga1-1 tga4-1 plants do not display reductions in steady-state levels of SA-pathway marker genes following treatment with this phenolic signaling metabolite or after challenge with virulent or avirulent P. syringae. By exploiting bacterial strains that have limited capacity to suppress Arabidopsis defence responses, the present study demonstrates that tga1-1 tga4-1 plants are compromised in basal resistance and defective in several apoplastic defence responses, including the oxidative burst of reactive oxygen species, callose deposition, as well as total and apoplastic PATHOGENESIS-RELATED 1 (PR-1) protein accumulation. Furthermore, analysis of npr1-1 and the tga1-1 tga4-1 npr1-1 triple mutant indicates that clade I TGA factors act substantially independent of NPR1 in mediating disease resistance against these strains of P. syringae. Increased sensitivity to the N-glycosylation inhibitor tunicamycin and elevated levels of endoplasmic reticulum (ER) stress marker genes encoding ER-resident chaperones in mutant seedlings suggest that loss of apoplastic defence responses is associated with aberrant protein secretion and implicate clade I TGA factors as positive regulators of one or more ER-related secretion pathways.	[Wang, Lipu] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Wang, Lipu; Fobert, Pierre R.] Natl Res Council Canada, Saskatoon, SK, Canada	University of Saskatchewan; National Research Council Canada	Fobert, PR (corresponding author), Natl Res Council Canada, Saskatoon, SK, Canada.	Pierre.Fobert@nrc-cnrc.gc.ca			National Science and Engineering Research Council of Canada (NSERC); NRC; University of Saskatchewan	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NRC(National Research Centre (NRC)); University of Saskatchewan	This research was supported by funding from the National Science and Engineering Research Council of Canada (NSERC) Discovery Grants program and NRC to PRF, and Graduate scholarships from the University of Saskatchewan to LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P., 1971, STAT METHODS MED RES, V1; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chen YN, 2012, PLANT J, V69, P266, DOI 10.1111/j.1365-313X.2011.04788.x; Choi J, 2010, DEV CELL, V19, P284, DOI 10.1016/j.devcel.2010.07.011; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Dempsey DA, 2012, TRENDS PLANT SCI, V17, P538, DOI 10.1016/j.tplants.2012.05.011; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; Dong XY, 2008, PLANTA, V229, P87, DOI 10.1007/s00425-008-0812-3; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Forsyth A, 2010, MOL PLANT MICROBE IN, V23, P1545, DOI 10.1094/MPMI-02-10-0047; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Ham JH, 2007, PLANT J, V51, P604, DOI 10.1111/j.1365-313X.2007.03165.x; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; HIRANO SS, 1990, ANNU REV PHYTOPATHOL, V28, P155, DOI 10.1146/annurev.py.28.090190.001103; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Iwata Y, 2012, TRENDS PLANT SCI, V17, P720, DOI 10.1016/j.tplants.2012.06.014; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; Jelitto-Van Dooren EPWM, 1999, PLANT CELL, V11, P1935, DOI 10.2307/3871088; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kalde M, 2007, P NATL ACAD SCI USA, V104, P11850, DOI 10.1073/pnas.0701083104; Kang L, 2003, P NATL ACAD SCI USA, V100, P3519, DOI 10.1073/pnas.0637377100; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kliebenstein DJ, 1999, MOL PLANT MICROBE IN, V12, P1022, DOI 10.1094/MPMI.1999.12.11.1022; Koizumi N, 1999, PLANT PHYSIOL, V121, P353, DOI 10.1104/pp.121.2.353; Kwon C, 2008, PLANT PHYSIOL, V147, P1575, DOI 10.1104/pp.108.121566; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Lu M, 2001, PLANT CELL, V13, P437, DOI 10.1105/tpc.13.2.437; Lu X, 2009, P NATL ACAD SCI USA, V106, P22522, DOI 10.1073/pnas.0907711106; Mishina TE, 2007, PHYSIOL PLANTARUM, V131, P448, DOI 10.1111/j.1399-3054.2007.00977.x; Moreno AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031944; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Nagashima Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00029; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Nomura K, 2011, P NATL ACAD SCI USA, V108, P10774, DOI 10.1073/pnas.1103338108; Pajerowska-Mukhtar KM, 2012, CURR BIOL, V22, P103, DOI 10.1016/j.cub.2011.12.015; Rochon A, 2006, PLANT CELL, V18, P3670, DOI 10.1105/tpc.106.046953; Rodriguez-Herva JJ, 2012, CELL MICROBIOL, V14, P669, DOI 10.1111/j.1462-5822.2012.01749.x; Rohde A, 2004, PLANT CELL, V16, P2749, DOI 10.1105/tpc.104.023705; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shearer HL, 2012, MOL PLANT MICROBE IN, V25, P1459, DOI 10.1094/MPMI-09-11-0256; Shearer HL, 2009, BOTANY, V87, P561, DOI 10.1139/B08-143; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van Wees SCM, 2003, PLANT J, V33, P733, DOI 10.1046/j.1365-313X.2003.01665.x; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang D, 2011, MOL PLANT, V4, P581, DOI 10.1093/mp/ssr053; Williams B, 2010, P NATL ACAD SCI USA, V107, P6088, DOI 10.1073/pnas.0912670107; Wu Y, 2012, CELL REPORTS, V1, P639, DOI 10.1016/j.celrep.2012.05.008; Zhang HR, 2008, PLANT CELL, V20, P1879, DOI 10.1105/tpc.108.061150; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	76	24	25	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e77378	10.1371/journal.pone.0077378	http://dx.doi.org/10.1371/journal.pone.0077378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086773	Green Published, gold			2022-12-25	WOS:000325223900116
J	Alvarado-Martinez, R; Salgado-Puga, K; Pena-Ortega, F				Alvarado-Martinez, Reynaldo; Salgado-Puga, Karla; Pena-Ortega, Fernando			Amyloid Beta Inhibits Olfactory Bulb Activity and the Ability to Smell	PLOS ONE			English	Article							DEPENDENT LEARNING-DEFICITS; ALZHEIMERS-DISEASE; A-BETA; GAMMA-OSCILLATIONS; MOUSE MODEL; RAT HIPPOCAMPUS; IN-VIVO; GABAERGIC INTERNEURONS; ODOR DISCRIMINATION; NETWORK ACTIVITY	Early olfactory dysfunction has been consistently reported in both Alzheimer's disease (AD) and in transgenic mice that reproduce some features of this disease. In AD transgenic mice, alteration in olfaction has been associated with increased levels of soluble amyloid beta protein (A beta) as well as with alterations in the oscillatory network activity recorded in the olfactory bulb (OB) and in the piriform cortex. However, since AD is a multifactorial disease and transgenic mice suffer a variety of adaptive changes, it is still unknown if soluble A beta, by itself, is responsible for OB dysfunction both at electrophysiological and behavioral levels. Thus, here we tested whether or not A beta directly affects OB network activity in vitro in slices obtained from mice and rats and if it affects olfactory ability in these rodents. Our results show that A beta decreases, in a concentration- and time-dependent manner, the network activity of OB slices at clinically relevant concentrations (low nM) and in a reversible manner. Moreover, we found that intrabulbar injection of A beta decreases the olfactory ability of rodents two weeks after application, an effect that is not related to alterations in motor performance or motivation to seek food and that correlates with the presence of A beta deposits. Our results indicate that A beta disrupts, at clinically relevant concentrations, the network activity of the OB in vitro and can trigger a disruption in olfaction. These findings open the possibility of exploring the cellular mechanisms involved in early pathological AD as an approach to reduce or halt its progress.	[Alvarado-Martinez, Reynaldo; Salgado-Puga, Karla; Pena-Ortega, Fernando] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Pena-Ortega, F (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Campus Juriquilla, Queretaro, Mexico.	jfpena@unam.mx		Salgado-Puga, Karla/0000-0002-5215-4760; Pena-Ortega, Fernando/0000-0002-0348-4392	Consejo Nacional de Ciencia y Tecnologia [151261, 181323]; Direccion General de Asuntos del Personal Academico-UNAM [IACODI1201511, IB200212]; Alzheimer's Association [NIRG-11-205443]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico-UNAM(Universidad Nacional Autonoma de Mexico); Alzheimer's Association(Alzheimer's Association)	This work was funded by Consejo Nacional de Ciencia y Tecnologia: Grants 151261 and 181323 (to FPO) and a scholarships to KSP and RAM, by Direccion General de Asuntos del Personal Academico-UNAM: Grants IACODI1201511 and IB200212 (to FPO), and by Alzheimer's Association Grant NIRG-11-205443. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaya-Villanueva A, 2010, PEPTIDES, V31, P1761, DOI 10.1016/j.peptides.2010.06.003; ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Araki T, 1997, J PHARM PHARMACOL, V49, P310, DOI 10.1111/j.2042-7158.1997.tb06802.x; Arnold SE, 2010, ANN NEUROL, V67, P462, DOI 10.1002/ana.21910; Attems J, 2005, J ALZHEIMERS DIS, V7, P149; Bacskai BJ, 2003, P NATL ACAD SCI USA, V100, P12462, DOI 10.1073/pnas.2034101100; Badonnel K, 2012, HORM BEHAV, V62, P120, DOI 10.1016/j.yhbeh.2012.05.010; Balleza-Tapia H, 2010, CURR ALZHEIMER RES, V7, P453, DOI 10.2174/156720510791383859; Barnes C. A., 2000, Neural Plasticity, V7, P167, DOI 10.1155/NP.2000.167; Baunez C, 2002, J NEUROSCI, V22, P562, DOI 10.1523/JNEUROSCI.22-02-00562.2002; Beshel J, 2007, J NEUROSCI, V27, P8358, DOI 10.1523/JNEUROSCI.1199-07.2007; Busciglio J, 1998, ANN NY ACAD SCI, V851, P429, DOI 10.1111/j.1749-6632.1998.tb09021.x; Calderon-Garciduenas L, 2007, TOXICOL PATHOL, V35, P154, DOI 10.1080/01926230601059985; Calderon-Garciduenas L, 2010, EXP TOXICOL PATHOL, V62, P91, DOI 10.1016/j.etp.2009.02.117; Cao LX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2013; Chapman CA, 1998, NEUROSCIENCE, V86, P1307, DOI 10.1016/S0306-4522(98)00092-X; Cheng N, 2011, J NEUROSCI, V31, P13699, DOI 10.1523/JNEUROSCI.1714-11.2011; CLEARY J, 1995, BRAIN RES, V682, P69, DOI 10.1016/0006-8993(95)00323-I; Colom LV, 2010, NEUROBIOL AGING, V31, P46, DOI 10.1016/j.neurobiolaging.2008.05.006; Condello C, 2011, SCI REP-UK, V1, DOI 10.1038/srep00019; Coronas-Samano G, 2011, REV DIG U, V12, P1067; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Didier A, 2001, P NATL ACAD SCI USA, V98, P6441, DOI 10.1073/pnas.101126398; Edwards DA, 1996, PHYSIOL BEHAV, V60, P1347, DOI 10.1016/S0031-9384(96)00260-0; EECKMAN FH, 1990, BRAIN RES, V528, P238, DOI 10.1016/0006-8993(90)91663-2; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Fourcaud-Trocme N, 2011, J PHYSIOL-PARIS, V105, P59, DOI 10.1016/j.jphysparis.2011.07.009; Frautschy SA, 1996, NEUROBIOL AGING, V17, P311, DOI 10.1016/0197-4580(95)02073-X; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; Friedman D, 2003, J NEUROPHYSIOL, V89, P2601, DOI 10.1152/jn.00887.2002; Gervais R, 2007, J PHYSIOL-PARIS, V101, P40, DOI 10.1016/j.jphysparis.2007.10.006; GIOVANNELLI L, 1995, NEUROSCIENCE, V66, P781, DOI 10.1016/0306-4522(94)00610-H; GRAY CM, 1988, EXP BRAIN RES, V69, P378; Guerin D, 2009, NEUROBIOL AGING, V30, P272, DOI 10.1016/j.neurobiolaging.2007.05.020; Gutierrez-Lerma Armando I, 2013, Int J Pept, V2013, P328140, DOI 10.1155/2013/328140; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HUGHES JR, 1989, CLIN ELECTROENCEPHAL, V20, P77, DOI 10.1177/155005948902000204; Igelstrom KM, 2011, J NEUROPHYSIOL, V106, P2593, DOI 10.1152/jn.00601.2011; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Kameshima N, 2012, NEUROSCI LETT, V513, P166, DOI 10.1016/j.neulet.2012.02.026; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kay LM, 2010, J NEUROPHYSIOL, V104, P829, DOI 10.1152/jn.00166.2010; Kay LM, 2009, TRENDS NEUROSCI, V32, P207, DOI 10.1016/j.tins.2008.11.008; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Kovacs T, 2004, AGEING RES REV, V3, P215, DOI 10.1016/j.arr.2003.10.003; Kovacs T, 1999, NEUROPATH APPL NEURO, V25, P481; Lagier S, 2004, J NEUROSCI, V24, P4382, DOI 10.1523/JNEUROSCI.5570-03.2004; Lagier S, 2007, P NATL ACAD SCI USA, V104, P7259, DOI 10.1073/pnas.0701846104; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Larriva-Sahd J, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00023; Le Pichon CE, 2009, NAT NEUROSCI, V12, P60, DOI 10.1038/nn.2238; Lehman EJH, 2003, NEUROBIOL AGING, V24, P645, DOI 10.1016/S0197-4580(02)00153-7; Lepousez G, 2010, J NEUROSCI, V30, P870, DOI 10.1523/JNEUROSCI.4958-09.2010; Li AA, 2011, P NATL ACAD SCI USA, V108, P5087, DOI 10.1073/pnas.1013814108; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Luna-Munoz J, 2008, ACTA NEUROPATHOL, V116, P507, DOI 10.1007/s00401-008-0431-x; Malm T, 2006, P NATL ACAD SCI USA, V103, P8852, DOI 10.1073/pnas.0602896103; Martin C, 2004, J PHYSIOLOGY-PARIS, V98, P467, DOI 10.1016/j.jphysparis.2005.09.003; Martin C, 2006, EUR J NEUROSCI, V23, P1801, DOI 10.1111/j.1460-9568.2006.04711.x; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Montgomery KS, 2011, NEUROBIOL AGING, V32, P1273, DOI 10.1016/j.neurobiolaging.2009.08.003; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; MORI K, 1978, J PHYSIOL-LONDON, V279, P569, DOI 10.1113/jphysiol.1978.sp012362; Mostany R, 2013, J NEUROSCI, V33, P4094, DOI 10.1523/JNEUROSCI.4825-12.2013; Mucignat-Caretta C, 2009, AM J PHYSIOL-LUNG C, V297, pL1073, DOI 10.1152/ajplung.00014.2009; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; MURPHY C, 1990, NEUROBIOL AGING, V11, P465, DOI 10.1016/0197-4580(90)90014-Q; Nakamura S, 2001, BRAIN RES, V912, P128, DOI 10.1016/S0006-8993(01)02704-4; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nieuwenhuys R, 1967, Prog Brain Res, V23, P1; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Nobakht Maliheh, 2011, Iranian Biomedical Journal, V15, P51; Nusser Z, 2001, J NEUROPHYSIOL, V86, P2823, DOI 10.1152/jn.2001.86.6.2823; O'Hare E, 1999, BRAIN RES, V815, P1, DOI 10.1016/S0006-8993(98)01002-6; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th, P456; Pena F, 1999, J NEUROCHEM, V72, P2006, DOI 10.1046/j.1471-4159.1999.0722006.x; Pena F, 2006, CURR NEUROPHARMACOL, V4, P149, DOI 10.2174/157015906776359531; Pena F, 2000, NEUROSCIENCE, V101, P547, DOI 10.1016/S0306-4522(00)00400-0; Pena F, 2010, HIPPOCAMPUS, V20, P78, DOI 10.1002/hipo.20592; Pena-Ortega F, 2013, NEURODEGENER DIS, V2013; Pena-Ortega Fernando, 2012, Int J Pept, V2012, P236289, DOI 10.1155/2012/236289; Pena-Ortega F, 2012, CURR ALZHEIMER RES, V9, P857, DOI 10.2174/156720512802455403; Portillo W, 2004, HORM BEHAV, V46, P330, DOI 10.1016/j.yhbeh.2004.03.001; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Ramirez JM, 2004, CURR OPIN NEUROBIOL, V14, P665, DOI 10.1016/j.conb.2004.10.011; Ramirez-Jarquin JO, 2012, PEPTIDES, V34, P360, DOI 10.1016/j.peptides.2012.02.011; Rey NL, 2012, NEUROBIOL AGING, V33; Richardson RL, 2002, BRAIN RES, V954, P1, DOI 10.1016/S0006-8993(02)03006-8; Rojas-Libano D, 2008, COGN NEURODYNAMICS, V2, P179, DOI 10.1007/s11571-008-9053-1; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Sassoe-Pognetto M, 2009, ANN NY ACAD SCI, V1170, P259, DOI 10.1111/j.1749-6632.2009.03882.x; Schofield PW, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-24; SCHREITERGASSER U, 1994, ELECTROEN CLIN NEURO, V90, P267, DOI 10.1016/0013-4694(94)90144-9; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; SERBY M, 1991, AM J PSYCHIAT, V148, P357; SHEPHERD GM, 1972, PHYSIOL REV, V52, P864, DOI 10.1152/physrev.1972.52.4.864; Sigurdsson EM, 1996, NEUROBIOL AGING, V17, P893, DOI 10.1016/S0197-4580(96)00169-8; Stakic J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023990; Stephan A, 2001, J NEUROSCI, V21, P5703, DOI 10.1523/JNEUROSCI.21-15-05703.2001; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thompson MD, 1998, NEUROPSYCHOL REV, V8, P11, DOI 10.1023/A:1025627106073; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Villette V, 2010, J NEUROSCI, V30, P10991, DOI 10.1523/JNEUROSCI.6284-09.2010; Vreugdenhil M, 2005, NEUROSCIENCE, V132, P1151, DOI 10.1016/j.neuroscience.2005.01.025; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; WARNER MD, 1986, BIOL PSYCHIAT, V21, P116, DOI 10.1016/0006-3223(86)90013-2; Watts JC, 2011, P NATL ACAD SCI USA, V108, P2528, DOI 10.1073/pnas.1019034108; Wesson DW, 2013, BEHAV BRAIN RES, V237, P96, DOI 10.1016/j.bbr.2012.09.019; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Xing CH, 2005, NEUROSCI LETT, V384, P93, DOI 10.1016/j.neulet.2005.04.063; Yamada K, 2005, BEHAV BRAIN RES, V162, P191, DOI 10.1016/j.bbr.2005.02.036; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Young JW, 2009, NEUROBIOL AGING, V30, P1430, DOI 10.1016/j.neurobiolaging.2007.11.018; Zussy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053117; Zussy C, 2011, AM J PATHOL, V179, P315, DOI 10.1016/j.ajpath.2011.03.021	121	37	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75745	10.1371/journal.pone.0075745	http://dx.doi.org/10.1371/journal.pone.0075745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086624	Green Published, gold, Green Submitted			2022-12-25	WOS:000325220000038
J	Ye, DM; Xu, YM; Zhang, H; Fu, TF; Jiang, L; Bai, YH				Ye, Dongmei; Xu, Yiming; Zhang, Han; Fu, Tengfei; Jiang, Lan; Bai, Yuehong			Effects of Low-Dose Microwave on Healing of Fractures with Titanium Alloy Internal Fixation: An Experimental Study in a Rabbit Model	PLOS ONE			English	Article							PULSED SHORTWAVE DIATHERMY; NONIONIZING RADIATION; SAR DISTRIBUTION; THERMAL-DAMAGE; TUMOR ABLATION; IN-VIVO; HYPERTHERMIA; TEMPERATURE; BONE; ULTRASOUND	Background: Microwave is a method for improving fracture repair. However, one of the contraindications for microwave treatment listed in the literature is surgically implanted metal plates in the treatment field. The reason is that the reflection of electromagnetic waves and the eddy current stimulated by microwave would increase the temperature of magnetic implants and cause heat damage in tissues. Comparing with traditional medical stainless steel, titanium alloy is a kind of medical implants with low magnetic permeability and electric conductivity. But the effects of microwave treatment on fracture with titanium alloy internal fixation in vivo were not reported. The aim of this article was to evaluate the security and effects of microwave on healing of a fracture with titanium alloy internal fixation. Methods: Titanium alloy internal fixation systems were implanted in New Zealand rabbits with a 3.0 mm bone defect in the middle of femur. We applied a 30-day microwave treatment (2,450MHz, 25W, 10 min per day) to the fracture 3 days after operation. Temperature changes of muscle tissues around implants were measured during the irradiation. Normalized radiographic density of the fracture gap was measured on the 10th day and 30th day of the microwave treatment. All of the animals were killed after 10 and 30 days microwave treatment with histologic and histomorphometric examinations performed on the harvested tissues. Findings: The temperatures did not increase significantly in animals with titanium alloy implants. The security of microwave treatment was also supported by histology of muscles, nerve and bone around the implants. Radiographic assessment, histologic and histomorphometric examinations revealed significant improvement in the healing bone. Conclusion: Our results suggest that, in the healing of fracture with titanium alloy internal fixation, a low dose of microwave treatment may be a promising method.	[Ye, Dongmei; Xu, Yiming; Zhang, Han; Fu, Tengfei; Jiang, Lan; Bai, Yuehong] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Rehabil, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Bai, YH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Rehabil, Shanghai 200030, Peoples R China.	aibyhw@126.com	Xu, yiming/E-5687-2012	Xu, yiming/0000-0002-7123-5793				Akyol Y, 2012, RHEUMATOL INT, V32, P3007, DOI 10.1007/s00296-011-2097-2; BERNHARDT JH, 1992, PHYS MED BIOL, V37, P807, DOI 10.1088/0031-9155/37/4/001; Campbell RSD., 2013, IMAGING POSTOPERATIV, P365; Chang WHS, 2002, BIOELECTROMAGNETICS, V23, P256, DOI 10.1002/bem.10009; Cooper J, 1996, ELECTRON LETT, V32, P2217, DOI 10.1049/el:19961507; Dewhirst MW, 2003, INT J HYPERTHER, V19, P267, DOI 10.1080/0265673031000119006; Draper DO, 2004, ATHLET THER TODAY, V9, P28; Eggers G, 2005, MAGN RESON MATER PHY, V18, P103, DOI 10.1007/s10334-005-0101-0; ERIKSSON AR, 1983, J PROSTHET DENT, V50, P101, DOI 10.1016/0022-3913(83)90174-9; Funk RHW, 1999, ANAT REC, V255, P458; Ganapathi M, 2002, J HAND SURG-BRIT EUR, V27B, P165, DOI 10.1054/jhsb.2001.0717; GINZBURG EL, 1976, TSITOLOGIYA+, V18, P600; Giombini A, 2007, BRIT MED BULL, V83, P379, DOI 10.1093/bmb/ldm020; Giombini A, 2001, J SPORT MED PHYS FIT, V41, P521; Giombini A, 2006, AM J SPORT MED, V34, P1247, DOI 10.1177/0363546506287827; Goats G C, 1990, Br J Sports Med, V24, P212; GRANT EH, 1981, IEE PROC-A, V128, P602, DOI 10.1049/ip-a-1.1981.0091; GUY AW, 1987, HEALTH PHYS, V53, P569, DOI 10.1097/00004032-198712000-00001; HARRIS ED, 1974, NEW ENGL J MED, V290, P1, DOI 10.1056/NEJM197401032900101; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; Huidobro C, 2009, THESCIENTIFICWORLDJO, V9, P10, DOI 10.1100/tsw.2009.4; Ji ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030505; Kaasik A, 2010, CARDIOVASC RES, V87, P83, DOI 10.1093/cvr/cvq039; KENNEDY WF, 1993, CLIN ORTHOP RELAT R, P198; LATEUR BJD, 1978, ARCH PHYS MED REHAB, V59, P488; LEHMANN JF, 1975, ARCH PHYS MED REHAB, V56, P145; LEHMANN JF, 1983, ARCH PHYS MED REHAB, V64, P127; LEON SA, 1993, INT J HYPERTHER, V9, P69, DOI 10.3109/02656739309061479; LEON SA, 1993, INT J HYPERTHER, V9, P77, DOI 10.3109/02656739309061480; Li J, 2005, CLIN GUIDELINES PHYS, P54; Liebergall M, 2000, CLIN ORTHOP RELAT R, P272; Lubner MG, 2010, J VASC INTERV RADIOL, V21, pS192, DOI 10.1016/j.jvir.2010.04.007; McIntosh RL, 2005, BIOELECTROMAGNETICS, V26, P377, DOI 10.1002/bem.20112; MESHORER A, 1983, ARCH PATHOL LAB MED, V107, P328; Mougenot C, 2009, MAGN RESON MED, V61, P603, DOI 10.1002/mrm.21887; Muranaka H, 2011, MAGN RESON MED SCI, V10, P11, DOI 10.2463/mrms.10.11; Muranaka Hiroyuki, 2010, Nihon Hoshasen Gijutsu Gakkai Zasshi, V66, P725; Olchowik G, 1992, Chir Narzadow Ruchu Ortop Pol, V57, P297; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Perren SM, 2008, ACTA CHIR ORTHOP TR, V75, P241; Perry AC, 2003, CLIN ORTHOP RELAT R, P95, DOI 10.1097/01.blo.0000087322.60612.14; Pope GD, 1995, PHYSIOTHERAPY, V81, P82, DOI DOI 10.1016/S0031-9406(05)67050-2; Rabini A, 2012, EUR J PHYS REHAB MED, V48, P549; Ruggera PS, 2003, PHYS MED BIOL, V48, P2919, DOI 10.1088/0031-9155/48/17/312; SAPARETO SA, 1984, INT J RADIAT ONCOL, V10, P787, DOI 10.1016/0360-3016(84)90379-1; Seiger C, 2006, J ORTHOP SPORT PHYS, V36, P669, DOI 10.2519/jospt.2006.2198; SEKINS KM, 1984, ARCH PHYS MED REHAB, V65, P1; SEYEDIN SM, 1987, J BIOL CHEM, V262, P1946; Shields Nora, 2002, Physiother Res Int, V7, P191, DOI 10.1002/pri.259; Skonieczki BD, 2011, EUR J RADIOL, V79, P343, DOI 10.1016/j.ejrad.2010.04.004; Sokka SD, 2003, PHYS MED BIOL, V48, P223, DOI 10.1088/0031-9155/48/2/306; Virtanen H, 2007, PHYS MED BIOL, V52, P1221, DOI 10.1088/0031-9155/52/5/001; Virtanen H, 2005, PHYS MED BIOL, V50, P2689, DOI 10.1088/0031-9155/50/11/017; WELGUS HG, 1981, J BIOL CHEM, V256, P9516; Wyper D J, 1976, Br J Sports Med, V10, P19; Yarmolenko PS, 2011, INT J HYPERTHER, V27, P320, DOI 10.3109/02656736.2010.534527; YATVIN MB, 1977, INT J RADIAT BIOL, V32, P513, DOI 10.1080/09553007714551301; Yue ZX, 2003, J EUR CERAM SOC, V23, P189, DOI 10.1016/S0955-2219(02)00082-1; Zderic V, 2008, MED PHYS, V35, P4292, DOI 10.1118/1.2975149	59	9	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75756	10.1371/journal.pone.0075756	http://dx.doi.org/10.1371/journal.pone.0075756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086626	Green Submitted, Green Published, gold			2022-12-25	WOS:000325220000040
J	Palanca, L; Gaskett, AC; Gunther, CS; Newcomb, RD; Goddard, MR				Palanca, Loida; Gaskett, Anne C.; Guenther, Catrin S.; Newcomb, Richard D.; Goddard, Matthew R.			Quantifying Variation in the Ability of Yeasts to Attract Drosophila melanogaster	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; POPULATION; DISPERSAL; ESTERS; OVIPOSITION; MODULATION; PREFERENCE; AVOIDANCE; INCREASES; EVOLUTION	Yeasts that invade and colonise fruit significantly enhance the volatile chemical diversity of this ecosystem. These modified bouquets are thought to be more attractive to Drosophila flies than the fruit alone, but the variance of attraction in natural yeast populations is uncharacterised. Here we investigate how a range of yeast isolates affect the attraction of female D. melanogaster to fruit in a simple two choice assay comparing yeast to sterile fruit. Of the 43 yeast isolates examined, 33 were attractive and seven repellent to the flies. The results of isolate-versus-isolate comparisons provided the same relative rankings. Attractiveness varied significantly by yeast, with the strongly fermenting Saccharomyces species generally being more attractive than the mostly respiring non-Saccharomyces species (P = 0.0035). Overall the habitat (fruit or other) from which the isolates were directly sampled did not explain attraction (P = 0.2352). However, yeasts isolated from fruit associated niches were more attractive than those from non-fruit associated niches (P = 0.0188) regardless of taxonomic positioning. These data suggest that while attractiveness is primarily correlated with phylogenetic status, the ability to attract Drosophila is a labile trait among yeasts that is potentially associated with those inhabiting fruit ecosystems. Preliminary analysis of the volatiles emitted by four yeast isolates in grape juice show the presence/absence of ethanol and acetic acid were not likely explanations for the observed variation in attraction. These data demonstrate variation among yeasts for their ability to attract Drosophila in a pattern that is consistent with the hypothesis that certain yeasts are manipulating fruit odours to mediate interactions with their Drosophila dispersal agent.	[Palanca, Loida; Gaskett, Anne C.; Guenther, Catrin S.; Newcomb, Richard D.; Goddard, Matthew R.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Newcomb, Richard D.] New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand	University of Auckland; New Zealand Institute for Plant & Food Research Ltd	Goddard, MR (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	m.goddard@auckland.ac.nz	Newcomb, Richard/C-2067-2009; Goddard, Matthew/C-7462-2014	Newcomb, Richard/0000-0002-7307-9755; Goddard, Matthew/0000-0002-7482-4438; Gaskett, Anne/0000-0002-7659-9537; Gunther, Catrin S/0000-0002-9712-0169	Faculty of Science, University of Auckland; Marsden Fund [PAF-09-01]	Faculty of Science, University of Auckland; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	Funding was provided by the Faculty of Science, University of Auckland to MG, and the Marsden Fund (PAF-09-01) to RDN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou C, 2010, ENTOMOL EXP APPL, V136, P1, DOI 10.1111/j.1570-7458.2010.00997.x; Anfang N, 2009, AUST J GRAPE WINE R, V15, P1, DOI 10.1111/j.1755-0238.2008.00031.x; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; BEGG M, 1946, PROC R SOC SER B-BIO, V133, P1, DOI 10.1098/rspb.1946.0001; Chandler JA, 2012, APPL ENVIRON MICROB, V78, P7327, DOI 10.1128/AEM.01741-12; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; Costa A, 2008, FOOD MICROBIOL, V25, P422, DOI 10.1016/j.fm.2007.10.003; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; FUYAMA Y, 1976, BEHAV GENET, V6, P407, DOI 10.1007/BF01065698; Ganter A, 2006, BIODIVERSITY ECOPHYS; Giglioli J., 1897, Nature, Vlvi, P575; GILBERT DG, 1980, OECOLOGIA, V46, P135, DOI 10.1007/BF00346979; Goddard MR, 2008, ECOLOGY, V89, P2077, DOI 10.1890/07-2060.1; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Gray JC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-43; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Howell KS, 2004, FEMS MICROBIOL LETT, V240, P125, DOI 10.1016/j.femsle.2004.09.022; Johnson LJ, 2004, GENETICS, V166, P43, DOI 10.1534/genetics.166.1.43; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Joseph RM, 2009, P NATL ACAD SCI USA, V106, P11352, DOI 10.1073/pnas.0901419106; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; Lebreton S, 2012, J INSECT PHYSIOL, V58, P125, DOI 10.1016/j.jinsphys.2011.10.009; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Moreira N, 2005, INT J FOOD MICROBIOL, V103, P285, DOI 10.1016/j.ijfoodmicro.2004.12.029; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Ogueta M, 2010, CHEM SENSES, V35, P813, DOI 10.1093/chemse/bjq084; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; Reuter M, 2007, CURR BIOL, V17, pR81, DOI 10.1016/j.cub.2006.11.059; Romano P, 2003, INT J FOOD MICROBIOL, V86, P169, DOI 10.1016/S0168-1605(03)00290-3; Saerens SMG, 2010, MICROB BIOTECHNOL, V3, P165, DOI 10.1111/j.1751-7915.2009.00106.x; Simmons FH, 1997, J INSECT PHYSIOL, V43, P779, DOI 10.1016/S0022-1910(97)00037-1; Stamps JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042238; STARMER WT, 1988, ANIM BEHAV, V36, P1691, DOI 10.1016/S0003-3472(88)80109-X; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Stensmyr MC, 2003, P ROY SOC B-BIOL SCI, V270, P2333, DOI 10.1098/rspb.2003.2512; Stokl J, 2010, CURR BIOL, V20, P1846, DOI 10.1016/j.cub.2010.09.033; Styger G, 2011, APPL MICROBIOL BIOT, V91, P713, DOI 10.1007/s00253-011-3237-z; Sumby KM, 2010, FOOD CHEM, V121, P1, DOI 10.1016/j.foodchem.2009.12.004; Swiegers JH, 2005, ADV APPL MICROBIOL, V57, P131, DOI 10.1016/S0065-2164(05)57005-9; THOMPSON J N JR, 1979, Southwestern Naturalist, V24, P204, DOI 10.2307/3670647; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Vianna E, 2001, J AGR FOOD CHEM, V49, P589, DOI 10.1021/jf000907g; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351	54	72	73	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75332	10.1371/journal.pone.0075332	http://dx.doi.org/10.1371/journal.pone.0075332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086510	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000325218700077
J	Wu, CY; Young, L; Young, D; Martel, J; Young, JD				Wu, Cheng-Yeu; Young, Lena; Young, David; Martel, Jan; Young, John D.			Bions: A Family of Biomimetic Mineralo-Organic Complexes Derived from Biological Fluids	PLOS ONE			English	Article							AMORPHOUS CALCIUM-CARBONATE; NANOBACTERIA-LIKE PARTICLES; POLYCYSTIC KIDNEY-DISEASE; FETAL BOVINE SERUM; CALCIFYING NANOPARTICLES; FETUIN-A; STONE FORMATION; CALCIPROTEIN PARTICLES; OXIDATIVE STRESS; RANDALLS PLAQUE	Mineralo-organic nanoparticles form spontaneously in human body fluids when the concentrations of calcium and phosphate ions exceed saturation. We have shown previously that these mineralo-organic nanoparticles possess biomimetic properties and can reproduce the whole phenomenology of the so-called nanobacteria-mineralized entities initially described as the smallest microorganisms on earth. Here, we examine the possibility that various charged elements and ions may form mineral nanoparticles with similar properties in biological fluids. Remarkably, all the elements tested, including sodium, magnesium, aluminum, calcium, manganese, iron, cobalt, nickel, copper, zinc, strontium, and barium form mineralo-organic particles with bacteria-like morphologies and other complex shapes following precipitation with phosphate in body fluids. Upon formation, these mineralo-organic particles, which we term bions, invariably accumulate carbonate apatite during incubation in biological fluids; yet, the particles also incorporate additional elements and thus reflect the ionic milieu in which they form. Bions initially harbor an amorphous mineral phase that gradually converts to crystals in culture. Our results show that serum produces a dual inhibition-seeding effect on bion formation. Using a comprehensive proteomic analysis, we identify a wide range of proteins that bind to these mineral particles during incubation in medium containing serum. The two main binding proteins identified, albumin and fetuin-A, act as both inhibitors and seeders of bions in culture. Notably, bions possess several biomimetic properties, including the possibility to increase in size and number and to be sub-cultured in fresh culture medium. Based on these results, we propose that bions represent biological, mineralo-organic particles that may form in the body under both physiological and pathological homeostasis conditions. These mineralo-organic particles may be part of a physiological cycle that regulates the function, transport and disposal of elements and minerals in the human body.	[Wu, Cheng-Yeu; Young, Lena; Young, David; Martel, Jan; Young, John D.] Chang Gung Univ, Lab Nanomat, Tao Yuan, Taiwan; [Wu, Cheng-Yeu; Martel, Jan; Young, John D.] Chang Gung Univ, Ctr Mol & Clin Immunol, Tao Yuan, Taiwan; [Wu, Cheng-Yeu] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Tao Yuan, Taiwan; [Young, Lena] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Young, David] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Young, John D.] Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA; [Young, John D.] Ming Chi Univ Technol, Biochem Engn Res Ctr, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Harvard University; Massachusetts Institute of Technology (MIT); Rockefeller University; Ming Chi University of Technology	Young, JD (corresponding author), Chang Gung Univ, Lab Nanomat, Tao Yuan, Taiwan.	dingeyoung@hotmail.com		Young, David/0000-0002-8290-5561; Martel, Jan/0000-0003-0879-109X	Primordia Institute of New Sciences and Medicine; Chang Gung University [CLRPD1A0011, QZRPD88E]; Ming Chi University of Technology [0XB0]; Ministry of Education of Taiwan [EMRPD1B047]; National Science Council of Taiwan [101-2632-B-182-001-MY3]	Primordia Institute of New Sciences and Medicine; Chang Gung University; Ming Chi University of Technology; Ministry of Education of Taiwan(Ministry of Education, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Primordia Institute of New Sciences and Medicine; by grants from Chang Gung University (CLRPD1A0011 and QZRPD88E), Ming Chi University of Technology (0XB0), the Ministry of Education of Taiwan (EMRPD1B047), and the National Science Council of Taiwan (101-2632-B-182-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-El-Sooud K, 2011, INSIGHT NANOTECHNOL, V1, P15; Aggarwal P, 2009, ADV DRUG DELIVER REV, V61, P428, DOI 10.1016/j.addr.2009.03.009; Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Aguzzi A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002651; Aizenberg J, 1996, ADV MATER, V8, P222, DOI 10.1002/adma.19960080307; Akerman KK, 1997, P SOC PHOTO-OPT INS, V3111, P436, DOI 10.1117/12.278798; [Anonymous], 2010, SCI AM, V302, P28; Ayman A, 2008, EUR PHYS J-SPEC TOP, V153, P497, DOI 10.1140/epjst/e2008-00493-5; Barr SC, 2003, AM J VET RES, V64, P176, DOI 10.2460/ajvr.2003.64.176; Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C; Barrere F, 2006, INT J NANOMED, V1, P317; Benzerara K, 2003, P NATL ACAD SCI USA, V100, P7438, DOI 10.1073/pnas.0832464100; Bonucci E, 2005, EUR J HISTOCHEM, V49, P1; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Bratos-Perez MA, 2008, EUR HEART J, V29, P371, DOI 10.1093/eurheartj/ehm592; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; Ciftcioglu N, 2005, KIDNEY INT, V67, P483, DOI 10.1111/j.1523-1755.2005.67105.x; Ciftcioglu N, 1999, KIDNEY INT, V56, P1893, DOI 10.1046/j.1523-1755.1999.00755.x; Ciftcioglu N, 1997, VACCINES, P99; Ciftcioglu N, 1998, PATHOPHYSIOLOGY, V4, P259, DOI DOI 10.1016/S0928-4680(97)10001-3; Ciftcioglu N, 2006, J INVEST MED, V54, P385, DOI 10.2310/6650.2006.06018; Ciftcioglu N, 2007, LANCET, V369, P2078, DOI 10.1016/S0140-6736(07)60977-5; Ciftcioglu N, 2008, INT J NANOMED, V3, P105; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496; Dell'Orco D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010949; Drancourt M, 2003, J CLIN MICROBIOL, V41, P368, DOI 10.1128/JCM.41.1.368-372.2003; EANES ED, 1973, CALC TISS RES, V12, P143, DOI 10.1007/BF02013730; Evan AP, 2010, PEDIATR NEPHROL, V25, P831, DOI 10.1007/s00467-009-1116-y; Evan AP, 2005, KIDNEY INT, V68, P145, DOI 10.1111/j.1523-1755.2005.00388.x; FOGHANDERSEN N, 1977, CLIN CHEM, V23, P2122; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Garcia-Ruiz JM, 2009, SCIENCE, V323, P362, DOI 10.1126/science.1165349; GARNETT J, 1990, BIOCHEM J, V266, P863; Gatti AM, 2005, J MATER SCI-MATER M, V16, P1213, DOI 10.1007/s10856-005-4731-6; Gatti AM, 2008, NANOPATHOLOGY: THE HEALTH IMPACT OF NANOPARTICLES, P1; Gatti AM, 2002, BIOMATERIALS, V23, P2381, DOI 10.1016/S0142-9612(01)00374-X; Ghadially FN, 2001, ULTRASTRUCT PATHOL, V25, P243; GILMAN H, 1994, J INORG BIOCHEM, V55, P31, DOI 10.1016/0162-0134(94)85130-1; Gross M, 2012, CURR BIOL, V22, pR207, DOI 10.1016/j.cub.2012.03.040; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Hendig D, 2006, CLIN CHEM, V52, P227, DOI 10.1373/clinchem.2005.059253; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Hjelle JT, 2000, KIDNEY INT, V57, P2360, DOI 10.1046/j.1523-1755.2000.00096.x; Hohling H J, 1997, Adv Dent Res, V11, P462; Hudelist G, 2004, HISTOPATHOLOGY, V45, P633, DOI 10.1111/j.1365-2559.2004.02030.x; Hyde ST, 2003, PHYSICA A, V339, P24; Iannitti T, 2010, INT J NANOMED, V5, P955, DOI 10.2147/IJN.S14363; Jahnen-Dechent W, 2001, Z Kardiol, V90 Suppl 3, P47; Jahnen-Dechent W., 2005, BIOMINERALISATION, P243; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; Jelic TM, 2004, SOUTH MED J, V97, P194, DOI 10.1097/01.SMJ.0000077067.44311.F0; Jersmann HPA, 2003, CLIN SCI, V105, P273, DOI 10.1042/CS20030126; Johansson L, 2003, CYTOTECHNOLOGY, V42, P67, DOI 10.1023/B:CYTO.0000009820.72920.cf; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Kajander EO, 2006, LETT APPL MICROBIOL, V42, P549, DOI 10.1111/j.1472-765X.2006.01945.x; Kajander EO, 1997, P SOC PHOTO-OPT INS, V3111, P420, DOI 10.1117/12.278796; Kajander EO, 2003, UROL RES, V31, P47, DOI 10.1007/s002440-003-0304-7; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Kajander EO, 2001, CURR OPIN NEPHROL HY, V10, P445, DOI 10.1097/00041552-200105000-00023; Kajander EO, 1993, VIRUS VIRUS LIKE AGE, P41; Ketteler M, 2005, PEDIATR NEPHROL, V20, P383, DOI 10.1007/s00467-004-1614-x; Ketteler M, 2003, KIDNEY INT, V63, pS84, DOI 10.1046/j.1523-1755.63.s84.21.x; Khullar M, 2004, UROL RES, V32, P190, DOI 10.1007/s00240-004-0400-3; Knoll A, 1999, SIZ LIM VER SMALL MI; Komaba H, 2009, KIDNEY INT, V75, P874, DOI 10.1038/ki.2009.52; Kumar V, 2006, J INVEST MED, V54, P412, DOI 10.2310/6650.2006.06021; Kutikhin AG, 2012, INT J NANOMED, V7, P339, DOI 10.2147/IJN.S28069; LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1; Lieske JC, 2008, NAT CLIN PRACT NEPHR, V4, P308, DOI 10.1038/ncpneph0794; Loohuis KMO, 2010, KIDNEY INT, V77, P77, DOI 10.1038/ki.2009.407; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I., 2006, DETECTING CRYPTIC EP, V2006, DOI [10.1126/stke.3272006pe14, DOI 10.1126/STKE.3272006PE14]; Lynch I, 2007, PHYSICA A, V373, P511, DOI 10.1016/j.physa.2006.06.008; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Mahamid J, 2010, P NATL ACAD SCI USA, V107, P6316, DOI 10.1073/pnas.0914218107; Mann S., 2001, BIOMINERALIZATION PR; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; Martel J, 2012, ANNU REV EARTH PL SC, V40, P167, DOI 10.1146/annurev-earth-042711-105401; Martel J, 2011, ANAL BIOCHEM, V418, P111, DOI 10.1016/j.ab.2011.06.018; Martel J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010343; Miller VM, 2009, NANOMEDICINE-UK, V4, P725, DOI [10.2217/nnm.09.61, 10.2217/NNM.09.61]; Nadra I, 2008, ATHEROSCLEROSIS, V196, P98, DOI 10.1016/j.atherosclerosis.2007.02.005; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; NYLEN MU, 1972, CALC TISS RES, V9, P95, DOI 10.1007/BF02061948; Park MVDZ, 2009, NANOMEDICINE-UK, V4, P669, DOI 10.2217/nnm.09.40; Peng HH, 2013, SMALL, V9, P2297, DOI 10.1002/smll.201202270; Peng HH, 2011, NANOMEDICINE-UK, V6, P643, DOI [10.2217/nnm.11.24, 10.2217/NNM.11.24]; POSNER AS, 1969, PHYSIOL REV, V49, P760, DOI 10.1152/physrev.1969.49.4.760; Price PA, 2004, J BIOL CHEM, V279, P1594, DOI 10.1074/jbc.M305199200; Puskas LG, 2005, ACTA BIOL HUNG, V56, P233, DOI 10.1556/ABiol.56.2005.3-4.7; Raz S, 2002, BIOL BULL-US, V203, P269, DOI 10.2307/1543569; Robinson C, 2004, J MATER CHEM, V14, P2242, DOI 10.1039/b401154f; Rochette CN, 2009, CHEMBIOCHEM, V10, P735, DOI 10.1002/cbic.200800719; Ruiz JMG, 2002, ASTROBIOLOGY, V2, P353, DOI 10.1089/153110702762027925; Ryall RL, 2008, UROL RES, V36, P77, DOI 10.1007/s00240-007-0131-3; Schlieper G, 2010, J AM SOC NEPHROL, V21, P689, DOI 10.1681/ASN.2009080829; Schwartz MAK, 2008, INT J NANOMED, V3, P243; Schwartz MK, 2010, SURGERY, V147, P181, DOI 10.1016/j.surg.2009.07.009; Schwartz MK, 2009, NANOMEDICINE-UK, V4, P931, DOI 10.2217/NNM.09.72; Schwartz MK, 2009, AM J PHYSIOL-HEART C, V296, pH1434, DOI 10.1152/ajpheart.00993.2008; Sedivy R, 2003, APMIS, V111, P951, DOI 10.1034/j.1600-0463.2003.1111006.x; Shiekh FA, 2009, CLIN NEPHROL, V71, P1; Shiekh FA, 2006, UROL RES, V34, P53, DOI 10.1007/s00240-005-0034-0; Shiekh FA, 2010, ACTA BIOMATER, V6, P4065, DOI 10.1016/j.actbio.2010.05.004; Shoskes DA, 2005, J UROLOGY, V173, P474, DOI 10.1097/01.ju.0000150062.60633.b2; Shvedova AA, 2010, ANNU REV PHARMACOL, V50, P63, DOI 10.1146/annurev.pharmtox.010909.105819; Smith ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060904; Sommer AP, 2006, CHEMOTHERAPY, V52, P95, DOI 10.1159/000092475; Sommer AP, 2005, J PROTEOME RES, V4, P180, DOI 10.1021/pr0498382; Sommer AP, 2003, J PROTEOME RES, V2, P441, DOI 10.1021/pr034005h; SUZUKI M, 1994, J EXP ZOOL, V270, P501, DOI 10.1002/jez.1402700603; Thiele L, 2003, BIOMATERIALS, V24, P1409, DOI 10.1016/S0142-9612(02)00525-2; Tsurumoto T, 2006, J PROTEOME RES, V5, P1276, DOI 10.1021/pr050450w; Tsurumoto T, 2008, ENVIRON SCI TECHNOL, V42, P3324, DOI 10.1021/es702857s; Urbano P, 2007, PLOS PATHOG, V3, P567, DOI 10.1371/journal.ppat.0030055; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vallet-Regi M, 2000, CHEM MATER, V12, P961, DOI 10.1021/cm991110b; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Wang LM, 2006, DIGEST DIS SCI, V51, P1126, DOI 10.1007/s10620-006-8019-6; Wasdo SC, 2008, INT J NANOTECHNOL, V5, P92, DOI 10.1504/IJNT.2008.016550; Watari F, 2009, J R SOC INTERFACE, V6, pS371, DOI 10.1098/rsif.2008.0488.focus; Wong F, 2007, NAT CLIN PRACT GASTR, V4, P43, DOI 10.1038/ncpgasthep0680; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008058; Young J, 2009, BRIT J CRIMINOL, V49, P4, DOI 10.1093/bjc/azn074; Young JD, 2010, SCI AM, V302, P52, DOI 10.1038/scientificamerican0110-52; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004417; Zhang SM, 2009, J PERIODONTOL, V80, P1462, DOI 10.1902/jop.2009.080659; Zhou HD, 2006, MOL IMMUNOL, V43, P1864, DOI 10.1016/j.molimm.2005.10.021; Zhou L, 2008, SMALL, V4, P1566, DOI 10.1002/smll.200800520; Zhou ZS, 2008, UROLOGY, V71, P1091, DOI 10.1016/j.urology.2008.02.041	138	33	43	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75501	10.1371/journal.pone.0075501	http://dx.doi.org/10.1371/journal.pone.0075501			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086546	Green Published, gold, Green Submitted			2022-12-25	WOS:000325218700092
J	Piras, BA; O'Connor, DM; French, BA				Piras, Bryan A.; O'Connor, Daniel M.; French, Brent A.			Systemic Delivery of shRNA by AAV9 Provides Highly Efficient Knockdown of Ubiquitously Expressed GFP in Mouse Heart, but Not Liver	PLOS ONE			English	Article							DAMAGE-RESPONSE PROTEINS; GENE-EXPRESSION; IN-VIVO; TRANSDUCTION; VECTORS; MICE; RNA; DNA; INJECTION; SEROTYPES	AAV9 is a powerful gene delivery vehicle capable of providing long-term gene expression in a variety of cell types, particularly cardiomyocytes. The use of AAV-delivery for RNA interference is an intense area of research, but a comprehensive analysis of knockdown in cardiac and liver tissues after systemic delivery of AAV9 has yet to be reported. We sought to address this question by using AAV9 to deliver a short-hairpin RNA targeting the enhanced green fluorescent protein (GFP) in transgenic mice that constitutively overexpress GFP in all tissues. The expression cassette was initially tested in vitro and we demonstrated a 61% reduction in mRNA and a 90% reduction in GFP protein in dual-transfected 293 cells. Next, the expression cassette was packaged as single-stranded genomes in AAV9 capsids to test cardiac GFP knockdown with several doses ranging from 1.8x1010 to 1.8x10(11) viral genomes per mouse and a dose-dependent response was obtained. We then analyzed GFP expression in both heart and liver after delivery of 4.4x10(11) viral genomes per mouse. We found that while cardiac knockdown was highly efficient, with a 77% reduction in GFP mRNA and a 71% reduction in protein versus control-treated mice, there was no change in liver expression. This was despite a 4.5-fold greater number of viral genomes in the liver than in the heart. This study demonstrates that single-stranded AAV9 vectors expressing shRNA can be used to achieve highly efficient cardiacselective knockdown of GFP expression that is sustained for at least 7 weeks after the systemic injection of 8 day old mice, with no change in liver expression and no evidence of liver damage despite high viral genome presence in the liver.	[Piras, Bryan A.; O'Connor, Daniel M.; French, Brent A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA; [French, Brent A.] Univ Virginia, Dept Radiol, Charlottesville, VA USA; [French, Brent A.] Univ Virginia, Dept Med Cardiovasc Med, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia	French, BA (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.	bf4g@eservices.virginia.edu	O'Connor, Daniel M/J-9787-2015	O'Connor, Daniel M/0000-0001-5464-2031; Piras, Bryan/0000-0002-8352-2300	American Heart Association [09PRE2110007]; National Institutes of Health [NIH R01 HL058582]	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the American Heart Association (09PRE2110007 to BAP) and the National Institutes of Health (NIH R01 HL058582 to BAF). AHA: http://www.heart.org/HEARTORG/ NIH: http://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 2002, J BIOL CHEM, V277, P18979, DOI 10.1074/jbc.M201257200; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Cervelli T, 2008, J CELL SCI, V121, P349, DOI 10.1242/jcs.003632; Cunningham SC, 2008, MOL THER, V16, P1081, DOI 10.1038/mt.2008.72; Fechner H, 2008, J MOL MED, V86, P987, DOI 10.1007/s00109-008-0363-x; Flageul M, 2009, J GENE MED, V11, P689, DOI 10.1002/jgm.1343; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Konkalmatt PR, 2012, J GENE MED, V14, P609, DOI 10.1002/jgm.2673; Ku G, 2008, HUM GENE THER, V19, P17, DOI 10.1089/hum.2007.1226; Lovric J, 2012, MOL THER, V20, P2087, DOI 10.1038/mt.2012.144; Mayra A, 2011, BIOCHEM BIOPH RES CO, V405, P204, DOI 10.1016/j.bbrc.2011.01.009; Miyazaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035875; Park CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043282; Prasad KMR, 2011, GENE THER, V18, P43, DOI 10.1038/gt.2010.105; Prasad KMR, 2007, MOL THER, V15, P764, DOI 10.1038/sj.mt.6300071; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schwartz RA, 2007, J VIROL, V81, P12936, DOI 10.1128/JVI.01523-07; Shen S, 2012, J VIROL, V86, P10408, DOI 10.1128/JVI.01155-12; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Wu JC, 2002, CIRCULATION, V105, P1631, DOI 10.1161/01.CIR.0000014984.95520.AD; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	25	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75894	10.1371/journal.pone.0075894	http://dx.doi.org/10.1371/journal.pone.0075894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086659	gold, Green Published, Green Submitted			2022-12-25	WOS:000325025200069
J	Andersson, LS; Wilbe, M; Viluma, A; Cothran, G; Ekesten, B; Ewart, S; Lindgren, G				Andersson, Lisa S.; Wilbe, Maria; Viluma, Agnese; Cothran, Gus; Ekesten, Bjorn; Ewart, Susan; Lindgren, Gabriella			Equine Multiple Congenital Ocular Anomalies and Silver Coat Colour Result from the Pleiotropic Effects of Mutant PMEL	PLOS ONE			English	Article							ROCKY-MOUNTAIN HORSES; DOMINANT-WHITE; CORNEA GLOBOSA; LOCUS; MUTATION; GENE; INSERTION; VARIANTS; SEQUENCE; HOMOLOG	Equine Multiple Congenital Ocular Anomalies (MCOA) syndrome is a heritable eye disorder mainly affecting silver colored horses. Clinically, the disease manifests in two distinct classes depending on the horse genotype. Horses homozygous for the mutant allele present with a wide range of ocular defects, such as iris stromal hypoplasia, abnormal pectinate ligaments, megaloglobus, iridociliary cysts and cataracts. The phenotype of heterozygous horses is less severe and predominantly includes iridociliary cysts, which occasionally extend into the temporal retina. In order to determine the genetic cause of MCOA syndrome we sequenced the entire previously characterized 208 kilobase region on chromosome 6 in ten individuals; five MCOA affected horses from three different breeds, one horse with the intermediate Cyst phenotype and four unaffected controls from two different breeds. This was performed using Illumina TruSeq technology with paired-end reads. Through the systematic exclusion of all polymorphisms barring two SNPs in PMEL, a missense mutation previously reported to be associated with the silver coat colour and a non-conserved intronic SNP, we establish that this gene is responsible for MCOA syndrome. Our finding, together with recent advances that show aberrant protein function due to the coding mutation, suggests that the missense mutation is causative and has pleiotrophic effect, causing both the horse silver coat color and MCOA syndrome.	[Andersson, Lisa S.; Wilbe, Maria; Viluma, Agnese; Lindgren, Gabriella] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Cothran, Gus] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX USA; [Ekesten, Bjorn] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Ewart, Susan] Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA	Swedish University of Agricultural Sciences; Texas A&M University System; Texas A&M University College Station; Swedish University of Agricultural Sciences; Michigan State University	Lindgren, G (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.	Gabriella.Lindgren@slu.se		Ekesten, Bjorn/0000-0003-1003-6501; Lindgren, Gabriella/0000-0001-6046-9669	The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [221-2009-1631]; Swedish-Norwegian Foundation for Equine Research [H0947256, H0847211]; Carl Trygger Foundation [CTS 08:29]; Swedish Research Council	The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish-Norwegian Foundation for Equine Research; Carl Trygger Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Financial support was obtained from The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (221-2009-1631), Swedish-Norwegian Foundation for Equine Research (H0947256 and H0847211) and Carl Trygger Foundation (CTS 08:29). Sequencing was performed by the SNP&SEQ Technology Platform in Uppsala. The platform is part of Science for Life Laboratory at Uppsala University and supported as a national infrastructure by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson LS, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-21; Andersson LS, 2011, MAMM GENOME, V22, P353, DOI 10.1007/s00335-011-9325-7; Andersson LS, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-88; Bellone RR, 2010, ANIM GENET, V41, P100, DOI 10.1111/j.1365-2052.2010.02116.x; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Brunberg E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-46; Chakraborty AK, 1996, EUR J BIOCHEM, V236, P180, DOI 10.1111/j.1432-1033.1996.t01-1-00180.x; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; DAUSCH D, 1978, A GRAEF ARCH KLIN EX, V206, P135, DOI 10.1007/BF00414621; Ewart SL, 2000, J HERED, V91, P93, DOI 10.1093/jhered/91.2.93; Fowler Douglas M, 2006, PLoS Biol, V4, pe6; GELATT KN, 1981, AM J VET RES, V42, P1686; Grahn BH, 2008, CAN VET J, V49, P675; Hauswirth R, 2012, PLOS GENET, V8, P404, DOI 10.1371/journal.pgen.1002653; Hellstrom AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002285; Kaps S, 2010, PFERDEHEILKUNDE, V26, P536, DOI 10.21836/PEM20100407; Karlsson AC, 2009, VET OPHTHALMOL, V12, P292, DOI 10.1111/j.1463-5224.2009.00714.x; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; Komaromy AM, 2011, VET OPHTHALMOL, V14, P313, DOI 10.1111/j.1463-5224.2011.00878.x; Kuehn C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-335; KWON BS, 1995, NUCLEIC ACIDS RES, V23, P154, DOI 10.1093/nar/23.1.154; Lee ZH, 1996, J INVEST DERMATOL, V106, P605, DOI 10.1111/1523-1747.ep12345163; Lenhard Boris, 2003, J Biol, V2, P13, DOI 10.1186/1475-4924-2-13; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Martinez-Esparza MM, 1999, MAMM GENOME, V10, P1168, DOI 10.1007/s003359901184; Pinard CL, 2011, VET OPHTHALMOL, V14, P100, DOI 10.1111/j.1463-5224.2010.00847.x; Plummer CE, 2011, VET OPHTHALMOL, V14, P239, DOI 10.1111/j.1463-5224.2010.00868.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramsey David T., 1999, Veterinary Ophthalmology, V2, P47; Ramsey DT, 2000, INVEST OPHTH VIS SCI, V41, pS135; Ramsey DT, 1999, AM J VET RES, V60, P1317; Reissmann M, 2007, ANIM GENET, V38, P1, DOI 10.1111/j.1365-2052.2006.01553.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmutz SM, 2013, ANIM GENET, V44, P9, DOI 10.1111/j.1365-2052.2012.02361.x; Schonthaler HB, 2005, DEV BIOL, V284, P421, DOI 10.1016/j.ydbio.2005.06.001; Solano F, 2000, PIGM CELL RES, V13, P118, DOI 10.1111/j.0893-5785.2000.130821.x; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Truve K, 2011, EMBNET J, V17, P38; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; WAHL JMB, 2008, GENETICS MERLE PATTE; Watt B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002286	42	26	28	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75639	10.1371/journal.pone.0075639	http://dx.doi.org/10.1371/journal.pone.0075639			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086599	Green Submitted, Green Published, gold			2022-12-25	WOS:000326520200116
J	Daigneault, J; Klemetsaune, L; Wasserman, SA				Daigneault, Jessica; Klemetsaune, Liv; Wasserman, Steven A.			The IRAK Homolog Pelle Is the Functional Counterpart of I kappa B Kinase in the Drosophila Toll Pathway	PLOS ONE			English	Article							REL PROTEIN DORSAL; IMMUNE-RESPONSE; DEGRADATION ESTABLISHES; DORSOVENTRAL POLARITY; NUCLEAR-LOCALIZATION; CACTUS; COMPLEX; EMBRYO; TUBE; PHOSPHORYLATION	Toll receptors transduce signals that activate Rel-family transcription factors, such as NF-kappa B, by directing proteolytic degradation of inhibitor proteins. In mammals, the I kappa B Kinase (IKK) phosphorylates the inhibitor I kappa B alpha. A beta TrCP protein binds to phosphorylated I kappa B alpha, triggering ubiquitination and proteasome mediated degradation. In Drosophila, Toll signaling directs Cactus degradation via a sequence motif that is highly similar to that in I kappa B alpha, but without involvement of IKK. Here we show that Pelle, the homolog of a mammalian regulator of IKK, acts as a Cactus kinase. We further find that the fly beta TrCP protein Slimb is required in cultured cells to mediate Cactus degradation. These findings enable us for the first time to trace an uninterrupted pathway from the cell surface to the nucleus for Drosophila Toll signaling.	[Daigneault, Jessica; Klemetsaune, Liv; Wasserman, Steven A.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wasserman, SA (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	stevenw@ucsd.edu			NIH [RO1 GM05054516]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding provided by NIH RO1 GM05054516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; BARROGA CF, 1995, P NATL ACAD SCI USA, V92, P7637, DOI 10.1073/pnas.92.17.7637; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Bergmann A, 1996, MECH DEVELOP, V60, P109, DOI 10.1016/S0925-4773(96)00607-7; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Drier EA, 2000, CURR BIOL, V10, P23, DOI 10.1016/S0960-9822(99)00267-5; Edwards DN, 1997, DEVELOPMENT, V124, P3855; Elling RA, 2007, PROTEIN EXPRES PURIF, V54, P139, DOI 10.1016/j.pep.2007.03.002; Fernandez NQ, 2001, DEVELOPMENT, V128, P2963; GALINDO RL, 1995, DEVELOPMENT, V121, P2209; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; GILLESPIE SKH, 1994, MOL CELL BIOL, V14, P3559, DOI 10.1128/MCB.14.6.3559; GROSSHANS J, 1994, NATURE, V372, P563, DOI 10.1038/372563a0; HECHT PM, 1993, GENETICS, V135, P405; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang HR, 2010, P NATL ACAD SCI USA, V107, P8322, DOI 10.1073/pnas.1004031107; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; Kuttenkeuler D, 2010, J INNATE IMMUN, V2, P181, DOI 10.1159/000248649; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LETSOU A, 1993, EMBO J, V12, P3449, DOI 10.1002/j.1460-2075.1993.tb06019.x; Leulier F, 2003, EMBO REP, V4, P976, DOI 10.1038/sj.embor.embor936; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lindsay SA, 2013, DEV COMP IM IN PRESS; Liu ZP, 1997, GENE DEV, V11, P3413, DOI 10.1101/gad.11.24.3413; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Moncrieffe MC, 2008, J BIOL CHEM, V283, P33447, DOI 10.1074/jbc.M805427200; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; ROTH S, 1991, DEVELOPMENT, V112, P371; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; Shen BH, 2002, DEVELOPMENT, V129, P1925; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; Towb P, 1998, DEVELOPMENT, V125, P2443; Towb P, 2001, DEVELOPMENT, V128, P4729; Towb P, 2009, J INNATE IMMUN, V1, P309, DOI 10.1159/000200773; Valanne S, 2010, J IMMUNOL, V184, P6188, DOI 10.4049/jimmunol.1000261; Wang YH, 2006, BIOCHEM BIOPH RES CO, V346, P606, DOI 10.1016/j.bbrc.2006.05.180; Weijland A, 1996, EUR J BIOCHEM, V240, P756, DOI 10.1111/j.1432-1033.1996.0756h.x; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yang J, 1997, P NATL ACAD SCI USA, V94, P14524, DOI 10.1073/pnas.94.26.14524; ZHUO S, 1993, J BIOL CHEM, V268, P17754	54	25	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75150	10.1371/journal.pone.0075150	http://dx.doi.org/10.1371/journal.pone.0075150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086459	Green Published, gold			2022-12-25	WOS:000326520200086
J	Salema, V; Marin, E; Martinez-Arteaga, R; Ruano-Gallego, D; Fraile, S; Margolles, Y; Teira, X; Gutierrez, C; Bodelon, G; Fernandez, LA				Salema, Valencio; Marin, Elvira; Martinez-Arteaga, Rocio; Ruano-Gallego, David; Fraile, Sofia; Margolles, Yago; Teira, Xema; Gutierrez, Carlos; Bodelon, Gustavo; Fernandez, Luis Angel			Selection of Single Domain Antibodies from Immune Libraries Displayed on the Surface of E. coli Cells with Two beta-Domains of Opposite Topologies	PLOS ONE			English	Article							CHAIN FV ANTIBODIES; OUTER-MEMBRANE PROTEINS; ESCHERICHIA-COLI; BACTERIAL AUTOTRANSPORTERS; GENOME SEQUENCE; PHAGE; EXPRESSION; SECRETION; FRAGMENTS; TECHNOLOGY	Screening of antibody (Ab) libraries by direct display on the surface of E. coli cells is hampered by the presence of the outer membrane (OM). In this work we demonstrate that the native beta-domains of EhaA autotransporter and intimin, two proteins from enterohemorrhagic E. coli O157:H7 (EHEC) with opposite topologies in the OM, are effective systems for the display of immune libraries of single domain Abs (sdAbs) from camelids (nanobodies or V-HH) on the surface of E. coli K-12 cells and for the selection of high affinity sdAbs using magnetic cell sorting (MACS). We analyzed the capacity of EhaA and intimin beta-domains to display individual sdAbs and sdAb libraries obtained after immunization with the extracellular domain of the translocated intimin receptor from EHEC (TirM(EHEC)). We demonstrated that both systems displayed functional sdAbs on the surface of E. coli cells with little proteolysis and cellular toxicity, although E. coli cells displaying sdAbs with the beta-domain of intimin showed higher antigen-binding capacity. Both E. coli display libraries were screened for TirM(EHEC) binding clones by MACS. High affinity binders were selected by both display systems, although more efficiently with the intimin beta-domain. The specificity of the selected clones against TirM(EHEC) was demonstrated by flow cytometry of E. coli cells, along with ELISA and surface plasmon resonance with purified sdAbs. Finally, we employed the E. coli cell display systems to provide an estimation of the affinity of the selected sdAb by flow cytometry analysis under equilibrium conditions.	[Salema, Valencio; Marin, Elvira; Martinez-Arteaga, Rocio; Ruano-Gallego, David; Fraile, Sofia; Margolles, Yago; Teira, Xema; Bodelon, Gustavo; Fernandez, Luis Angel] CSIC, Dept Microbial Biotechnol, Ctr Nacl Biotecnol, Madrid, Spain; [Gutierrez, Carlos] Univ Las Palmas Gran Canaria UPGC, Fac Vet, Dept Anim Med & Surg, Las Palmas Gran Canaria, Canary Islands, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Fernandez, LA (corresponding author), CSIC, Dept Microbial Biotechnol, Ctr Nacl Biotecnol, Campus UAM Cantoblanco, Madrid, Spain.	lafdez@cnb.csic.es	Ruano-Gallego, David/ABB-4157-2021; Bodelon, Gustavo/H-2870-2013; Gutiérrez, Carlos/E-2989-2012; Fernández-Herrero, Luis Ángel/AAA-2583-2021; Fernández, Luis Ángel/D-2713-2009; Marin, Elvira/L-1701-2014; Ruano-Gallego, David/ABB-6273-2021; Ruano-Gallego, David/P-3734-2018	Bodelon, Gustavo/0000-0003-2815-7635; Gutiérrez, Carlos/0000-0003-0764-7408; Fernández-Herrero, Luis Ángel/0000-0001-5920-0638; Fernández, Luis Ángel/0000-0001-5920-0638; Marin, Elvira/0000-0003-2206-2328; Ruano-Gallego, David/0000-0002-2163-2088; Ruano-Gallego, David/0000-0002-2163-2088; SALEMA, VALENCIO/0000-0003-1359-2853	Spanish Ministry of "Economia y Competitividad" [BIO2011-26689]; Comunidad Autonoma de Madrid [S2010-BMD-2312]; "La Caixa" Foundation; contracts "Apoyo a la Investigacion" from the "Comunidad Autonoma de Madrid"	Spanish Ministry of "Economia y Competitividad"; Comunidad Autonoma de Madrid(Comunidad de Madrid); "La Caixa" Foundation(La Caixa Foundation); contracts "Apoyo a la Investigacion" from the "Comunidad Autonoma de Madrid"	Work in the laboratory of LAF is supported by Grants from the Spanish Ministry of "Economia y Competitividad" (BIO2011-26689) (http://www.mineco.gob.es/portal/site/mineco/) and the "Comunidad Autonoma de Madrid" (S2010-BMD-2312) (http://www.madrimasd.org/informacionidi/convocatorias/). VS is supported by an international PhD fellowship from the "La Caixa" Foundation (http://obrasocial.lacaixa.es/ambitos/home/becas_es.html). EM and DR were supported by contracts "Apoyo a la Investigacion" from the "Comunidad Autonoma de Madrid" (http://www.madrimasd.org/informacionidi/convocatorias/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbabi-Ghahroudi Mehdi, 2009, V525, P187, DOI 10.1007/978-1-59745-554-1_10; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Bernstein HD, 2007, TRENDS MICROBIOL, V15, P441, DOI 10.1016/j.tim.2007.09.007; Binder U, 2010, J MOL BIOL, V400, P783, DOI 10.1016/j.jmb.2010.05.049; Blanco-Toribio A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015227; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1439, DOI 10.1111/j.1365-2958.1991.tb00790.x; Bodelon G, 2013, FEMS MICROBIOL REV, V37, P204, DOI 10.1111/j.1574-6976.2012.00347.x; Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; CARTER P, 1985, NUCLEIC ACIDS RES, V13, P4431, DOI 10.1093/nar/13.12.4431; Daugherty PS, 1999, PROTEIN ENG, V12, P613, DOI 10.1093/protein/12.7.613; Daugherty PS, 1998, PROTEIN ENG, V11, P825, DOI 10.1093/protein/11.9.825; Dooley H, 2003, MOL IMMUNOL, V40, P25, DOI 10.1016/S0161-5890(03)00084-1; Fairman JW, 2012, STRUCTURE, V20, P1233, DOI 10.1016/j.str.2012.04.011; Fernandez LA, 2000, APPL ENVIRON MICROB, V66, P5024, DOI 10.1128/AEM.66.11.5024-5029.2000; Fleetwood F, 2013, CELL MOL LIFE SCI, V70, P1081, DOI 10.1007/s00018-012-1179-y; Fraile S, 2004, MOL MICROBIOL, V53, P1109, DOI 10.1111/j.1365-2958.2004.04205.x; FRANCISCO JA, 1993, P NATL ACAD SCI USA, V90, P10444, DOI 10.1073/pnas.90.22.10444; Frankel G, 2008, CELL MICROBIOL, V10, P549, DOI 10.1111/j.1462-5822.2007.01103.x; Georgiou G, 1996, PROTEIN ENG, V9, P239, DOI 10.1093/protein/9.2.239; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; Harvey BR, 2004, P NATL ACAD SCI USA, V101, P9193, DOI 10.1073/pnas.0400187101; He Mingyue, 2002, Briefings in Functional Genomics & Proteomics, V1, P204, DOI 10.1093/bfgp/1.2.204; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Hoogenboom Hennie R, 2002, Methods Mol Biol, V178, P1; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hussack G, 2012, PROTEIN ENG DES SEL, V25, P313, DOI 10.1093/protein/gzs014; Jakobovits A, 2007, NAT BIOTECHNOL, V25, P1134, DOI 10.1038/nbt1337; Jurado P, 2006, J MOL BIOL, V357, P49, DOI 10.1016/j.jmb.2005.12.058; Jurado P, 2002, J MOL BIOL, V320, P1, DOI 10.1016/S0022-2836(02)00405-9; KEEN NT, 1986, J BACTERIOL, V168, P595, DOI 10.1128/jb.168.2.595-606.1986; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Lofblom J, 2011, BIOTECHNOL J, V6, P1115, DOI 10.1002/biot.201100129; Marin E, 2010, J BACTERIOL, V192, P5588, DOI 10.1128/JB.00432-10; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Mazor Y, 2010, FEBS J, V277, P2291, DOI 10.1111/j.1742-4658.2010.07645.x; MCCAFFERTY J, 1994, APPL BIOCHEM BIOTECH, V47, P157, DOI 10.1007/BF02787932; McCafferty John, 1996, P79, DOI 10.1016/B978-012402380-2/50008-3; Monegal A, 2009, PROTEIN ENG DES SEL, V22, P273, DOI 10.1093/protein/gzp002; Munera D, 2008, MOL MICROBIOL, V69, P911, DOI 10.1111/j.1365-2958.2008.06325.x; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rutherford N, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-22; Ryckaert S, 2010, J BIOTECHNOL, V145, P93, DOI 10.1016/j.jbiotec.2009.10.010; SCHNAITMAN CA, 1973, ARCH BIOCHEM BIOPHYS, V157, P541, DOI 10.1016/0003-9861(73)90673-5; Stathopoulos C, 1996, APPL MICROBIOL BIOT, V45, P112, DOI 10.1007/s002530050657; Thie H, 2008, NEW BIOTECHNOL, V25, P49, DOI 10.1016/j.nbt.2008.01.001; Veiga E, 1999, MOL MICROBIOL, V33, P1232, DOI 10.1046/j.1365-2958.1999.01571.x; Veiga E, 2004, MOL MICROBIOL, V52, P1069, DOI 10.1111/j.1365-2958.2004.04014.x; Wentzel A, 2001, J BACTERIOL, V183, P7273, DOI 10.1128/JB.183.24.7273-7284.2001; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Yi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015285; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618; ZELL R, 1987, EMBO J, V6, P1809, DOI 10.1002/j.1460-2075.1987.tb02435.x	67	56	61	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75126	10.1371/journal.pone.0075126	http://dx.doi.org/10.1371/journal.pone.0075126			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086454	Green Submitted, Green Published, gold			2022-12-25	WOS:000326520200085
J	Ye, J; Chen, Z; Zhang, B; Miao, H; Zohaib, A; Xu, QP; Chen, HC; Cao, SB				Ye, Jing; Chen, Zheng; Zhang, Bo; Miao, Huan; Zohaib, Ali; Xu, Qiuping; Chen, Huanchun; Cao, Shengbo			Heat Shock Protein 70 Is Associated with Replicase Complex of Japanese Encephalitis Virus and Positively Regulates Viral Genome Replication	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MOLECULAR-MECHANISM; HSP70 CHAPERONES; RNA-POLYMERASE; INFECTED-CELLS; STEM-LOOP; APOPTOSIS; STRESS; NS5; BLOCKING	Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus that causes the most prevalent viral encephalitis in Asia. The NS5 protein of JEV is a key component of the viral replicase complex, which plays a crucial role in viral pathogenesis. In this study, tandem affinity purification (TAP) followed by mass spectrometry analysis was performed to identify novel host proteins that interact with NS5. Heat shock protein 70 (Hsp70), eukaryotic elongation factor 1-alpha (eEF-1 alpha) and ras-related nuclear protein (Ran) were demonstrated to interact with NS5. In addition to NS5, Hsp70 was also found to interact with NS3 which is another important member of the replicase complex. It was observed that the cytoplasmic Hsp70 partially colocalizes with the components of viral replicase complex including NS3, NS5 and viral dsRNA during JEV infection. Knockdown of Hsp70 resulted in a significantly reduced JEV genome replication. Further analysis reveals that Hsp70 enhances the stability of viral proteins in JEV replicase complex. These results suggest an important role for Hsp70 in regulating JEV replication, which provides a potential target for the development of anti-JEV therapies.	[Ye, Jing; Chen, Zheng; Miao, Huan; Zohaib, Ali; Xu, Qiuping; Chen, Huanchun; Cao, Shengbo] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Ye, Jing; Chen, Zheng; Miao, Huan; Zohaib, Ali; Xu, Qiuping; Chen, Huanchun; Cao, Shengbo] Huazhong Agr Univ, Lab Anim Virol, Coll Vet Med, Wuhan, Hubei, Peoples R China; [Zhang, Bo] Chinese Acad Sci, Wuhan Inst Viol, State Key Lab Virol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Chinese Academy of Sciences	Chen, HC (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	chenhch@mail.hzau.edu.cn; sbcao@mail.hzau.edu.cn	Chen, Zheng/GPJ-9937-2022; Zohaib, Ali/AAE-2342-2019	Zohaib, Ali/0000-0003-3998-6017	973 Project of China [2010CB530100]; National Natural Sciences Foundation of China [31172325, 81261160325]; New Century Excellent Talents in University [NCETNCET-10-0422]; Fundamental Research Funds for the Central Universities [2011PY002]	973 Project of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by 973 Project of China (2010CB530100), National Natural Sciences Foundation of China (31172325, 81261160325), New Century Excellent Talents in University (NCETNCET-10-0422) and Fundamental Research Funds for the Central Universities (2011PY002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Broquet AH, 2007, J VIROL, V81, P1297, DOI 10.1128/JVI.01336-06; Carsillo T, 2006, J VIROL, V80, P11031, DOI 10.1128/JVI.01438-06; Chen YJ, 2010, J BIOL CHEM, V285, P28183, DOI 10.1074/jbc.M110.118323; Chen Z, 2012, HYBRIDOMA, V31, P137, DOI 10.1089/hyb.2011.0107; Collins MO, 2008, CURR OPIN BIOTECH, V19, P324, DOI 10.1016/j.copbio.2008.06.002; Das S, 2009, VIROLOGY, V385, P47, DOI 10.1016/j.virol.2008.10.025; Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3; Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07; Dziembowski A, 2004, FEBS LETT, V556, P1, DOI 10.1016/S0014-5793(03)01357-7; HARRIS KS, 1994, J BIOL CHEM, V269, P27004; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; Iordanskiy S, 2004, J VIROL, V78, P9697, DOI 10.1128/JVI.78.18.9697-9704.2004; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Katoh H, 2011, J VIROL, V85, P10976, DOI 10.1128/JVI.00846-11; Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010; Lahaye X, 2012, J VIROL, V86, P4743, DOI 10.1128/JVI.06501-11; Li G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016546; Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05; Matsuda D, 2004, VIROLOGY, V321, P47, DOI 10.1016/j.virol.2003.10.028; Mayer MP, 2005, REV PHYSIOL BIOCH P, V153, P1, DOI 10.1007/s10254-004-0025-5; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Michels AA, 1999, J BIOL CHEM, V274, P36757, DOI 10.1074/jbc.274.51.36757; Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Padwad YS, 2010, VIRAL IMMUNOL, V23, P557, DOI 10.1089/vim.2010.0052; Pastorino B, 2010, ANTIVIR RES, V87, P281, DOI 10.1016/j.antiviral.2010.04.014; Pogany J, 2008, P NATL ACAD SCI USA, V105, P19956, DOI 10.1073/pnas.0810851105; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; Wang RYL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-471; Wu YP, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-128; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhu YZ, 2012, J GEN VIROL, V93, P61, DOI 10.1099/vir.0.034637-0	45	45	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75188	10.1371/journal.pone.0075188	http://dx.doi.org/10.1371/journal.pone.0075188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086464	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200088
J	Shah, CA; Bei, L; Wang, H; Platanias, LC; Eklund, EA				Shah, Chirag A.; Bei, Ling; Wang, Hao; Platanias, Leonidas C.; Eklund, Elizabeth A.			The Leukemia-associated Mll-Ell Oncoprotein Induces Fibroblast Growth Factor 2 (Fgf2)-dependent Cytokine Hypersensitivity in Myeloid Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Fibroblast Growth Factor (FGF); Gene Transcription; Growth Factors; Leukemia; hox; mll	BONE-MARROW-CELLS; GENE-EXPRESSION; IN-VITRO; ACTIVATES TRANSCRIPTION; ENCODING GP91(PHOX); DNA-BINDING; HOX; DIFFERENTIATION; SUBPOPULATIONS; OVEREXPRESSION	The subset of acute myeloid leukemias (AML) with chromosomal translocations involving the MLL gene have a poor prognosis (referred to as 11q23-AML). The MLL fusion proteins that are expressed in 11q23-AML facilitate transcription of a set of HOX genes, including HOXA9 and HOXA10. Because Hox proteins are transcription factors, this suggests the possibility that Hox target genes mediate the adverse effects of MLL fusion proteins in leukemia. Identifying such Hox target genes might provide insights to the pathogenesis and treatment of 11q23-AML. In the current study we found that Mll-Ell (an MLL fusion protein) induced transcriptional activation of the FGF2 gene in a HoxA9- and HoxA10-dependent manner. FGF2 encodes fibroblast growth factor 2 (also referred to as basic fibroblast growth factor). Fgf2 influences proliferation and survival of hematopoietic stem cells and myeloid progenitor cells, and increased Fgf2-expression has been described in AMLs. We determined that expression of Mll-Ell in myeloid progenitor cells resulted in autocrine production of Fgf2 and Fgf2-dependent cytokine hypersensitivity. Therefore, our results implicated increased Fgf2 expression in progenitor proliferation and expansion in 11q23-AML. Because small molecule inhibitors of Fgf-receptors are in human clinical trials, this suggested a potential therapeutic approach to this treatment refractory leukemia.	[Shah, Chirag A.; Bei, Ling; Wang, Hao; Platanias, Leonidas C.; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Shah, Chirag A.; Bei, Ling; Wang, Hao; Platanias, Leonidas C.; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bei, Ling; Platanias, Leonidas C.; Eklund, Elizabeth A.] Jesse Brown Vet Adm Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super St,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu		Wang, Hao/0000-0003-2131-0377	National Institutes of Health [HL87717, CA155566, CA77816]; Veterans Affairs Merit Reviews; Mander Foundation; Robert H. Lurie Comprehensive Cancer Center at Northwestern University; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA174205, R01CA077816, R01CA155566] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Reviews(US Department of Veterans Affairs); Mander Foundation; Robert H. Lurie Comprehensive Cancer Center at Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL87717 (to E.A.E.), CA155566 (to L.C.P.), and CA77816 (to L.C.P.). This work was also supported by Veterans Affairs Merit Reviews (to E.A.E. and L.C.P.), the Mander Foundation (to E.A.E.), and the Director's Research Fund of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University (to E.A.E.).	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bei L, 2005, J BIOL CHEM, V280, P12359, DOI 10.1074/jbc.M408138200; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bei L, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.402172; Bei L, 2011, J BIOL CHEM, V286, P19047, DOI 10.1074/jbc.M110.213983; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eklund E. A., 2011, Critical Reviews in Oncogenesis, V16, P65; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Li ZJ, 2009, CANCER RES, V69, P1109, DOI 10.1158/0008-5472.CAN-08-3381; Lindsey S, 2005, J IMMUNOL, V175, P5269, DOI 10.4049/jimmunol.175.8.5269; Lindsey S, 2007, J BIOL CHEM, V282, P2237, DOI 10.1074/jbc.M608642200; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Roche J, 2004, LEUKEMIA, V18, P1059, DOI 10.1038/sj.leu.2403366; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Schwind S, 2011, BLOOD, V118, P4188, DOI 10.1182/blood-2011-06-357764; Shah CA, 2012, J BIOL CHEM, V287, P18230, DOI 10.1074/jbc.M111.328401; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wang H, 2011, J BIOL CHEM, V286, P16832, DOI 10.1074/jbc.M110.213975; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; WILSON EL, 1991, BLOOD, V77, P954; Yoon SY, 2000, ACTA HAEMATOL-BASEL, V104, P151, DOI 10.1159/000046507	46	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32490	32505		10.1074/jbc.M113.496109	http://dx.doi.org/10.1074/jbc.M113.496109			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24089521	Green Published, hybrid			2022-12-25	WOS:000328681700033
J	Ferreira, D; Rocha, HC; Kreutz, LC; Loro, VL; Marqueze, A; Koakoski, G; da Rosa, JGS; Gusso, D; Oliveira, TA; de Abreu, MS; Barcellos, LJG				Ferreira, Daiane; Rocha, Helio Carlos; Kreutz, Luiz Carlos; Loro, Vania Lucia; Marqueze, Alessandra; Koakoski, Gessi; Santos da Rosa, Joao Gabriel; Gusso, Darlan; Oliveira, Thiago Acosta; de Abreu, Murilo Sander; Gil Barcellos, Leonardo Jose			Bee Products Prevent Agrichemical-Induced Oxidative Damage in Fish	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; JUNDIA RHAMDIA-QUELEN; FRESH-WATER FISH; SUBLETHAL CONCENTRATIONS; HYDROGEN-PEROXIDE; EXPOSURE; STRESS; ACID; ANTIOXIDANTS; BIOMARKERS	In southern South America and other parts of the world, aquaculture is an activity that complements agriculture. Small amounts of agrichemicals can reach aquaculture ponds, which results in numerous problems caused by oxidative stress in non-target organisms. Substances that can prevent or reverse agrichemical-induced oxidative damage may be used to combat these effects. This study includes four experiments. In each experiment, 96 mixed-sex, 6-month-old Rhamdia quelen (118 +/- 15 g) were distributed into eight experimental groups: a control group that was not exposed to contaminated water, three groups that were exposed to various concentrations of bee products, three groups that were exposed to various concentrations of bee products plus tebuconazole (TEB; Folicur 200 CE (TM)) and a group that was exposed to 0.88 mg L-1 of TEB alone (corresponding to 16.6% of the 96-h LC50). We show that waterborne bee products, including royal jelly (RJ), honey (H), bee pollen (BP) and propolis (P), reversed the oxidative damage caused by exposure to TEB. These effects were likely caused by the high polyphenol contents of these bee-derived compounds. The most likely mechanism of action for the protective effects of bee products against tissue oxidation and the resultant damage is that the enzymatic activities of superoxide dismutase (SOD), catalase (CAT) and glutathione-S-transferase (GST) are increased.	[Ferreira, Daiane; Koakoski, Gessi; Santos da Rosa, Joao Gabriel; Gusso, Darlan; Oliveira, Thiago Acosta; de Abreu, Murilo Sander] Univ Fed Santa Maria, Programa Posgrad Farmacol, Santa Maria, RS, Brazil; [Rocha, Helio Carlos; Kreutz, Luiz Carlos; Gil Barcellos, Leonardo Jose] Univ Passo Fundo, Programa Posgrad Bioexpt, Passo Fundo, RS, Brazil; [Loro, Vania Lucia] Univ Fed Santa Maria, Programa Posgrad Bioquim Toxicol, Santa Maria, RS, Brazil; [Marqueze, Alessandra] Ctr Univ La Salle Unilasalle, Programa Posgrad Avaliacao & Impactos Ambientais, Canoas, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade de Passo Fundo; Universidade Federal de Santa Maria (UFSM); Centro Universitario La Salle	Barcellos, LJG (corresponding author), Univ Passo Fundo, Programa Posgrad Bioexpt, Passo Fundo, RS, Brazil.	lbarcellos@upf.br	Sander de Abreu, Murilo/J-9756-2015; Kreutz, Luiz C/A-3729-2015; Gusso, Darlan/ABA-6552-2021; Loro, Vania/E-9387-2015	Sander de Abreu, Murilo/0000-0001-5562-0715; Kreutz, Luiz C/0000-0002-7685-7401; Gusso, Darlan/0000-0003-0293-239X; Loro, Vania/0000-0003-2440-8791				Ahmad I, 2000, BBA-GEN SUBJECTS, V1523, P37, DOI 10.1016/S0304-4165(00)00098-2; Ahmad I, 2004, ECOTOX ENVIRON SAFE, V57, P290, DOI 10.1016/S0147-6513(03)00080-0; Almroth BC, 2005, AQUAT TOXICOL, V73, P171, DOI 10.1016/j.aquatox.2005.03.007; ANGELO P. M., 2007, REV I A LUTZ, V66, P232; [Anonymous], 2013, FICHA DADOS SEGURANC; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARR RS, 1983, ANAL CHEM, V55, P1229, DOI 10.1021/ac00259a012; Cericato L, 2008, COMP BIOCHEM PHYS C, V148, P281, DOI 10.1016/j.cbpc.2008.06.008; Cericato L, 2009, COMP BIOCHEM PHYS C, V149, P363, DOI 10.1016/j.cbpc.2008.09.002; Ferreira D, 2012, NEOTROP ICHTHYOL, V10, P215, DOI 10.1590/S1679-62252012000100021; Ferreira D, 2010, CHEMOSPHERE, V79, P914, DOI 10.1016/j.chemosphere.2010.03.024; FOURNIER D, 1992, J BIOL CHEM, V267, P1840; GAETANI GF, 1989, BLOOD, V73, P334; Gheldof N, 2002, J AGR FOOD CHEM, V50, P3050, DOI 10.1021/jf0114637; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Kreutz LC, 2008, CIENC RURAL, V38, P1050, DOI 10.1590/S0103-84782008000400022; Lushchak OV, 2009, AQUAT TOXICOL, V93, P45, DOI 10.1016/j.aquatox.2009.03.007; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MORSE RA, 1990, ABC XYZ BEE CULTURE; Nakajima Y, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-4; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Neves LC, 2009, BRAZIL J FOOD TECHN; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oruc EO, 2004, COMP BIOCHEM PHYS C, V137, P43, DOI 10.1016/j.cca.2003.11.006; Sancho E, 2010, ECOTOX ENVIRON SAFE, V73, P370, DOI 10.1016/j.ecoenv.2009.09.020; Sayeed I, 2003, ECOTOX ENVIRON SAFE, V56, P295, DOI 10.1016/S0147-6513(03)00009-5; Schonbaum G. R., 1976, ENZYMES, V13, P363, DOI [10.1016/S1874-6047(08)60245-0, DOI 10.1016/S1874-6047(08)60245-0]; Secretaria da Agricultura e do Abastecimento, INT TRIFL TEB; Shallaja MS, 2003, CHEMOSPHERE, V53, P835, DOI 10.1016/S0045-6535903)00667-2; Simonato JD, 2006, B ENVIRON CONTAM TOX, V76, P505, DOI 10.1007/s00128-006-0949-3; Soso AB, 2007, ENVIRON TOXICOL PHAR, V23, P308, DOI 10.1016/j.etap.2006.11.008; SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P381, DOI 10.1016/S0025-6196(12)64861-7; Toni C, 2011, CHEMOSPHERE, V83, P579, DOI 10.1016/j.chemosphere.2010.12.022; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Viuda-Martos M, 2008, J FOOD SCI, V73, pR117, DOI 10.1111/j.1750-3841.2008.00966.x; WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6; YAN LJ, 1995, ANAL BIOCHEM, V228, P349, DOI 10.1006/abio.1995.1362; Zamocky M, 1999, PROG BIOPHYS MOL BIO, V72, P19, DOI 10.1016/S0079-6107(98)00058-3; Zanella R, 2003, J SEP SCI, V26, P935, DOI 10.1002/jssc.200301309; Zhao YG, 2008, J CHINA NAT KNOWL IN, V4	41	11	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74499	10.1371/journal.pone.0074499	http://dx.doi.org/10.1371/journal.pone.0074499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098336	gold, Green Published, Green Submitted			2022-12-25	WOS:000325483600004
J	Pochon, S; Simoneau, P; Pigne, S; Balidas, S; Bataille-Simoneau, N; Campion, C; Jaspard, E; Calmes, B; Hamon, B; Berruyer, R; Juchaux, M; Guillemette, T				Pochon, Stephanie; Simoneau, Philippe; Pigne, Sandrine; Balidas, Samuel; Bataille-Simoneau, Nelly; Campion, Claire; Jaspard, Emmanuel; Calmes, Benoit; Hamon, Bruno; Berruyer, Romain; Juchaux, Marjorie; Guillemette, Thomas			Dehydrin-like Proteins in the Necrotrophic Fungus Alternaria brassicicola Have a Role in Plant Pathogenesis and Stress Response	PLOS ONE			English	Article							FILAMENTOUS FUNGI; GENE; IDENTIFICATION; KINASE; PATHOGENICITY; PHYTOALEXINS; ARABIDOPSIS; METABOLISM; PATHWAYS; REGIONS	In this study, the roles of fungal dehydrin-like proteins in pathogenicity and protection against environmental stresses were investigated in the necrotrophic seed-borne fungus Alternaria brassicicola. Three proteins (called AbDhn1, AbDhn2 and AbDhn3), harbouring the asparagine-proline-arginine (DPR) signature pattern and sharing the characteristic features of fungal dehydrin-like proteins, were identified in the A. brassicicola genome. The expression of these genes was induced in response to various stresses and found to be regulated by the AbHog1 mitogen-activated protein kinase (MAPK) pathway. A knock-out approach showed that dehydrin-like proteins have an impact mainly on oxidative stress tolerance and on conidial survival upon exposure to high and freezing temperatures. The subcellular localization revealed that AbDhn1 and AbDhn2 were associated with peroxisomes, which is consistent with a possible perturbation of protective mechanisms to counteract oxidative stress and maintain the redox balance in AbDhn mutants. Finally, we show that the double deletion mutant Delta Delta abdhn1-abdhn2 was highly compromised in its pathogenicity. By comparison to the wild-type, this mutant exhibited lower aggressiveness on B. oleracea leaves and a reduced capacity to be transmitted to Arabidopsis seeds via siliques. The double mutant was also affected with respect to conidiation, another crucial step in the epidemiology of the disease.	[Pochon, Stephanie; Simoneau, Philippe; Pigne, Sandrine; Balidas, Samuel; Bataille-Simoneau, Nelly; Campion, Claire; Jaspard, Emmanuel; Calmes, Benoit; Hamon, Bruno; Berruyer, Romain; Guillemette, Thomas] Univ Angers, UMR IRHS 1345, SFR QUASAV, Angers, France; [Pochon, Stephanie; Simoneau, Philippe; Pigne, Sandrine; Balidas, Samuel; Bataille-Simoneau, Nelly; Campion, Claire; Jaspard, Emmanuel; Calmes, Benoit; Hamon, Bruno; Berruyer, Romain; Guillemette, Thomas] INRA, UMR IRHS 1345, F-49000 Angers, France; [Pochon, Stephanie; Simoneau, Philippe; Pigne, Sandrine; Balidas, Samuel; Bataille-Simoneau, Nelly; Campion, Claire; Jaspard, Emmanuel; Calmes, Benoit; Hamon, Bruno; Berruyer, Romain; Guillemette, Thomas] Agrocampus Ouest, UMR IRHS 1345, Angers, France; [Juchaux, Marjorie] Univ Angers, SFR QUASAV, IMAC, Beaucouze, France	Universite d'Angers; INRAE; Universite d'Angers; Institut Agro; Agrocampus Ouest; Universite d'Angers; Universite d'Angers	Guillemette, T (corresponding author), Univ Angers, UMR IRHS 1345, SFR QUASAV, Angers, France.	thomas.guillemette@univ-angers.fr	Simoneau, Philippe/GPG-0546-2022; guillemette, thomas/H-2097-2011; Simoneau, Philippe/AAV-4324-2021	guillemette, thomas/0000-0002-5649-974X; Simoneau, Philippe/0000-0002-3890-9848; Simoneau, Nelly/0000-0001-6200-4259	French Region Pays de la Loire (QUALISEM research program)	French Region Pays de la Loire (QUALISEM research program)(Region Pays de la Loire)	This work was supported by the French Region Pays de la Loire (QUALISEM research program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba' S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-39; AYER WA, 1992, TETRAHEDRON, V48, P2919, DOI 10.1016/S0040-4020(01)90973-1; Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; Calmes B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00131; Chen KT, 2012, PLANT SCI, V183, P27, DOI 10.1016/j.plantsci.2011.11.002; Cho YR, 2006, MOL PLANT MICROBE IN, V19, P7, DOI 10.1094/MPMI-19-0007; Close TJ, 1993, CUR TOP PL, V10, P104; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dongo A, 2009, APPL ENVIRON MICROB, V75, P127, DOI 10.1128/AEM.00993-08; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Eaton CJ, 2008, CURR GENET, V53, P163, DOI 10.1007/s00294-007-0174-6; Elleuche S, 2008, FUNGAL GENET BIOL, V45, P1458, DOI 10.1016/j.fgb.2008.08.005; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Hoi JWS, 2012, FUNGAL GENET BIOL, V49, P210, DOI 10.1016/j.fgb.2012.01.005; Hoi JWS, 2011, MOL BIOL CELL, V22, P1896, DOI 10.1091/mbc.E10-11-0914; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Joachimiak MP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-225; Joubert A, 2011, MOL MICROBIOL, V79, P1305, DOI 10.1111/j.1365-2958.2010.07522.x; Joubert A, 2011, CELL MICROBIOL, V13, P62, DOI 10.1111/j.1462-5822.2010.01520.x; Joubert A, 2010, BIOTECHNIQUES, V48, P399, DOI 10.2144/000113399; Kawasaki L, 2002, MOL MICROBIOL, V45, P1153, DOI 10.1046/j.1365-2958.2002.03087.x; Kutschy P, 1998, TETRAHEDRON, V54, P3549, DOI 10.1016/S0040-4020(98)00088-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; Malonek S, 2004, J BIOL CHEM, V279, P25075, DOI 10.1074/jbc.M308517200; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Parent C, 2008, CR BIOL, V331, P255, DOI 10.1016/j.crvi.2008.02.001; Pochon S, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-16; Rahman LN, 2010, BIOCHEM CELL BIOL, V88, P791, DOI [10.1139/O10-026, 10.1139/o10-026]; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; SWEIGARD JA, 1995, PLANT CELL, V7, P1221, DOI 10.1105/tpc.7.8.1221; TAKASUGI M, 1988, B CHEM SOC JPN, V61, P285, DOI 10.1246/bcsj.61.285; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; van den Bosch F, 2010, P ROY SOC B-BIOL SCI, V277, P1735, DOI 10.1098/rspb.2009.2211; Wartenberg D, 2012, J PROTEOMICS, V75, P4038, DOI 10.1016/j.jprot.2012.05.023; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wise MJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-52; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Yang YZ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-140	43	16	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e75143	10.1371/journal.pone.0075143	http://dx.doi.org/10.1371/journal.pone.0075143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098369	gold, Green Submitted, Green Published			2022-12-25	WOS:000325434500022
J	Wright, DW; Deuzing, IP; Flandre, P; van den Eede, P; Govaert, M; Setiawan, L; Coveney, PV; Marcelin, AG; Calvez, V; Boucher, CAB; Beerens, N				Wright, David W.; Deuzing, Ilona P.; Flandre, Philippe; van den Eede, Peter; Govaert, Micheline; Setiawan, Laurentia; Coveney, Peter V.; Marcelin, Anne-Genevieve; Calvez, Vincent; Boucher, Charles A. B.; Beerens, Nancy			A Polymorphism at Position 400 in the Connection Subdomain of HIV-1 Reverse Transcriptase Affects Sensitivity to NNRTIs and RNaseH Activity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEOSIDE ANALOG INHIBITORS; NUCLEIC-ACID STRUCTURES; DRUG-RESISTANCE; NONNUCLEOSIDE INHIBITORS; H DOMAINS; MOLECULAR-MECHANISMS; PRIMER UNBLOCKING; CRYSTAL-STRUCTURE; DUAL RESISTANCE	Reverse transcriptase (RT) plays an essential role in HIV-1 replication, and inhibition of this enzyme is a key component of HIV-treatment. However, the use of RT inhibitors can lead to the emergence of drug-resistant variants. Until recently, most clinically relevant resistance mutations were found in the polymerase domain of RT. Lately, an increasing number of resistance mutations has been identified in the connection and RNaseH domain. To further explore the role of these domains we analyzed the complete RT sequence of HIV-1 subtype B patients failing therapy. Position A/T400 in the connection subdomain is polymorphic, but the proportion of T400 increases from 41% in naive patients to 72% in patients failing therapy. Previous studies suggested a role for threonine in conferring resistance to nucleoside RT inhibitors. Here we report that T400 also mediates resistance to non-nucleoside RT inhibitors. The susceptibility to NVP and EFV was reduced 5-fold and 2-fold, respectively, in the wild-type subtype B NL4.3 background. We show that substitution A400T reduces the RNaseH activity. The changes in enzyme activity are remarkable given the distance to both the polymerase and RNaseH active sites. Molecular dynamics simulations were performed, which provide a novel atomistic mechanism for the reduction in RNaseH activity induced by T400. Substitution A400T was found to change the conformation of the RNaseH primer grip region. Formation of an additional hydrogen bond between residue T400 and E396 may play a role in this structural change. The slower degradation of the viral RNA genome may provide more time for dissociation of the bound NNRTI from the stalled RT-template/primer complex, after which reverse transcription can resume.	[Wright, David W.; Coveney, Peter V.] UCL, Dept Chem, Ctr Computat Sci, London WC1E 6BT, England; [Deuzing, Ilona P.; Setiawan, Laurentia; Boucher, Charles A. B.; Beerens, Nancy] Erasmus MC, Dept Virol, ViroscienceLab, Rotterdam, Netherlands; [Flandre, Philippe; Marcelin, Anne-Genevieve; Calvez, Vincent] INSERM, UMR S 943, Paris, France; [Flandre, Philippe; Marcelin, Anne-Genevieve; Calvez, Vincent] Univ Paris 06, Paris, France; [van den Eede, Peter; Govaert, Micheline] Janssen Diagnost BVBA, Beerse, Belgium	University of London; University College London; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Beerens, N (corresponding author), Erasmus MC, Dept Virol, ViroscienceLab, Rotterdam, Netherlands.	n.beerens@erasmusmc.nl	Marcelin, Anne-Genevieve/D-8272-2014; Flandre, Philippe/N-6314-2017	Marcelin, Anne-Genevieve/0000-0003-4808-8999; Flandre, Philippe/0000-0002-2612-3522; Wright, David/0000-0002-5124-8044	EU FP7 CHAIN [HEALTH-2007 223131]; National Science Foundation under NRAC B CHAIN [MCA04N014]; Office of Science and Technology through EPSRC's High End Computing Programme; VPH-SHARE [FP7-ICT 269978]; EPSRC [EP/I034602/1, EP/L00030X/1] Funding Source: UKRI; Medical Research Council [MR/K006584/1] Funding Source: researchfish	EU FP7 CHAIN; National Science Foundation under NRAC B CHAIN; Office of Science and Technology through EPSRC's High End Computing Programme; VPH-SHARE; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research project was funded by EU FP7 CHAIN (HEALTH-2007 223131). This work made use of the facilities of HECToR, the UK's national high-performance computing service and the Kraken machine on the U.S. TeraGrid/XSEDE (access to which was made available by the National Science Foundation under NRAC B CHAIN grant MCA04N014). HECToR is provided by UoE HPCx Ltd at the University of Edinburgh, Cray Inc and NAG Ltd, and funded by the Office of Science and Technology through EPSRC's High End Computing Programme. Additional computation was performed on the UCL Legion cluster. DWW and PVC would also like to acknowledge the support of the VPH-SHARE (FP7-ICT 269978) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Biondi MJ, 2010, J BIOL CHEM, V285, P26966, DOI 10.1074/jbc.M110.105775; BOUCHER CAB, 1992, J INFECT DIS, V165, P105, DOI 10.1093/infdis/165.1.105; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231; BOYER PL, 1995, ANTIMICROB AGENTS CH, V39, P1624, DOI 10.1128/AAC.39.7.1624; Braz VA, 2010, BIOCHEMISTRY-US, V49, P601, DOI 10.1021/bi901579y; Brehm JH, 2007, J VIROL, V81, P7852, DOI 10.1128/JVI.02203-06; Buxton P, 2005, J VIROL, V79, P6338, DOI 10.1128/JVI.79.10.6338-6348.2005; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Ceccherini-Silberstein F, 2007, J VIROL, V81, P11507, DOI 10.1128/JVI.00303-07; Cihlar T, 2010, ANTIVIR RES, V85, P39, DOI 10.1016/j.antiviral.2009.09.014; Das K, 2004, J MED CHEM, V47, P2550, DOI 10.1021/jm030558s; Dash C, 2008, NUCLEIC ACIDS RES, V36, P6363, DOI 10.1093/nar/gkn678; de Bethune MP, 2010, ANTIVIR RES, V85, P75, DOI 10.1016/j.antiviral.2009.09.008; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; deJong MD, 1996, P NATL ACAD SCI USA, V93, P5501, DOI 10.1073/pnas.93.11.5501; Delviks-Frankenberry KA, 2013, VIROLOGY, V435, P433, DOI 10.1016/j.virol.2012.09.021; Delviks-Frankenberry KA, 2010, VIRUSES-BASEL, V2, P1476, DOI 10.3390/v2071476; Delviks-Frankenberry KA, 2009, J VIROL, V83, P8502, DOI 10.1128/JVI.00859-09; Domaoal RA, 2004, INT J BIOCHEM CELL B, V36, P1735, DOI 10.1016/j.biocel.2004.02.026; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; Ehteshami M, 2008, AIDS REV, V10, P224; Frankel FA, 2007, AIDS, V21, P665, DOI 10.1097/QAD.0b013e3280187505; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Gonzales MJ, 2003, AIDS, V17, P791, DOI 10.1097/00002030-200304110-00003; GU ZX, 1995, P NATL ACAD SCI USA, V92, P2760, DOI 10.1073/pnas.92.7.2760; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Harrigan PR, 2002, J VIROL, V76, P6836, DOI 10.1128/JVI.76.13.6836-6840.2002; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kemp SD, 1998, J VIROL, V72, P5093, DOI 10.1128/JVI.72.6.5093-5098.1998; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Krebs R, 1997, BIOCHEMISTRY-US, V36, P10292, DOI 10.1021/bi970512z; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Marcelin AG, 2006, ANTIVIR THER, V11, P693; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Menendez-Arias L, 2011, ANTIVIR RES, V92, P139, DOI 10.1016/j.antiviral.2011.08.020; Menendez-Arias Luis, 2003, Current Drug Targets - Infectious Disorders, V3, P355, DOI 10.2174/1568005033481033; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nikolenko GN, 2010, J VIROL, V84, P5238, DOI 10.1128/JVI.01545-09; Nikolenko GN, 2005, P NATL ACAD SCI USA, V102, P2093, DOI 10.1073/pnas.0409823102; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Noy A, 2005, J AM CHEM SOC, V127, P4910, DOI 10.1021/ja043293v; Painter GR, 2004, CURR TOP MED CHEM, V4, P1035, DOI 10.2174/1568026043388358; Pattery T, 2012, INTERVIROLOGY, V55, P138, DOI 10.1159/000332013; Pelemans H, 1998, J BIOL CHEM, V273, P34234, DOI 10.1074/jbc.273.51.34234; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Radzio J, 2010, AIDS, V24, P659, DOI 10.1097/QAD.0b013e328336781d; Ren JS, 2008, VIRUS RES, V134, P157, DOI 10.1016/j.virusres.2007.12.018; Roquebert B, 2008, J ANTIMICROB CHEMOTH, V61, P973, DOI 10.1093/jac/dkn060; Roquebert B, 2007, J MED VIROL, V79, P207, DOI 10.1002/jmv.20788; Santos AFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001781; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schuckmann MM, 2010, J BIOL CHEM, V285, P38700, DOI 10.1074/jbc.M110.153783; Selmi B, 2003, ANTIVIR THER, V8, P143; Sluis-Cremer N, 2004, CURR HIV RES, V2, P323, DOI 10.2174/1570162043351093; Sluis-Cremer N, 2010, AIDS, V24, P317, DOI 10.1097/QAD.0b013e3283315697; Tanuma J, 2010, MICROBES INFECT, V12, P1170, DOI 10.1016/j.micinf.2010.08.003; Turner KB, 2009, RNA, V15, P1605, DOI 10.1261/rna.1615409; UENO T, 1995, J BIOL CHEM, V270, P23605, DOI 10.1074/jbc.270.40.23605; van Westen GJP, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002899; von Wyl V, 2010, J INFECT DIS, V201, P1054, DOI 10.1086/651168; Wainberg Mark A, 2004, Expert Rev Anti Infect Ther, V2, P147, DOI 10.1586/14787210.2.1.147; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; White KL, 2002, ANTIMICROB AGENTS CH, V46, P3437, DOI 10.1128/AAC.46.11.3437-3446.2002; Wright David W, 2012, Biology (Basel), V1, P222, DOI 10.3390/biology1020222; Xia Q, 2007, PROTEIN SCI, V16, P1728, DOI 10.1110/ps.072829007; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335	76	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74078	10.1371/journal.pone.0074078	http://dx.doi.org/10.1371/journal.pone.0074078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098331	Green Submitted, Green Published, gold			2022-12-25	WOS:000325434500008
J	Lee, HS; Schlereth, S; Khandelwal, P; Saban, DR				Lee, Hyun Soo; Schlereth, Simona; Khandelwal, Payal; Saban, Daniel R.			Ocular Allergy Modulation to Hi-Dose Antigen Sensitization Is a Treg-Dependent Process	PLOS ONE			English	Article							REGULATORY T-CELLS; MURINE MODEL; AIRWAY INFLAMMATION; FOXP3; RESOLUTION; DEPLETION; RESPONSES; ANTIBODY; IMPAIRS; IL-17	A reproducible method to inhibit allergic immune responses is accomplished with hi-dose Ag sensitization, via intraperitoneal (IP) injection. However, the role of CD4+ CD25+ FoxP3+ T regulatory cells (Treg) in this process is unknown, as is whether such modulation extends to ocular allergy. We therefore determined herein whether hi-dose sensitization modulates ocular allergy, and whether CD4+ CD25+ FoxP3+ Treg are involved. C57BL/6 mice were IP sensitized via low-dose (100 mu g) versus hi-dose (1000 mu g) ovalbumin (OVA), in aluminum hydroxide (1 mg) and pertussis-toxin (300 ng). Other mice received anti-CD25 Ab (PC61) to ablate Treg during sensitization. In another experiment, Treg from hi-dose sensitized mice were adoptively transferred into low-dose sensitized mice. Once daily OVA challenges were administered. Clinical signs, IgE, T cell cytokines, and eosinophils were assessed. Data revealed that hi-dose, but not low-dose, sensitization led to allergy modulation, indicated by decreased clinical signs, serum IgE levels, Th2 recall responses, and eosinophil recruitment. T cells from hi-dose sensitized mice showed a robust increase in TGF-b production, and Treg from these mice were able to efficiently suppress effector T cell proliferation in vitro. In addition, in vivo Treg ablation in hi-dose sensitized mice revoked allergy modulation. Lastly, Treg from hi-dose sensitized mice were able to adoptively transfer allergy modulation to their low-dose sensitized counterparts. Collectively, these findings indicate that modulation to hi-dose sensitization, which is extended to ocular allergy, occurs in a Treg-dependent manner. In addition, our data suggest that hi-dose sensitization may henceforth facilitate the further examination of CD4+ CD25+ FoxP3+ Treg in allergic disease.	[Saban, Daniel R.] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27705 USA; [Saban, Daniel R.] Duke Univ, Sch Med, Dept Immunol, Durham, NC USA; [Lee, Hyun Soo; Schlereth, Simona; Khandelwal, Payal] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Schepens Eye Res Inst, Boston, MA USA	Duke University; Duke University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Saban, DR (corresponding author), Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC 27705 USA.	daniel.saban@duke.edu			National Institutes of Health [R01EY021798]; NATIONAL EYE INSTITUTE [R01EY021798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health R01EY021798 (Saban DR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Pimentel JA, 2010, AM J RESP CRIT CARE, V181, P7, DOI 10.1164/rccm.200902-0190OC; Arps V, 1998, EUR J IMMUNOL, V28, P681, DOI 10.1002/(SICI)1521-4141(199802)28:02<681::AID-IMMU681>3.3.CO;2-1; Barwig C, 2010, CLIN EXP ALLERGY, V40, P891, DOI 10.1111/j.1365-2222.2010.03476.x; Boudousquie C, 2009, CLIN EXP ALLERGY, V39, P1415, DOI 10.1111/j.1365-2222.2009.03314.x; Chauhan SK, 2009, J IMMUNOL, V182, P148, DOI 10.4049/jimmunol.182.1.148; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fukushima A, 2008, INT ARCH ALLERGY IMM, V147, P206, DOI 10.1159/000142043; Guery JC, 1996, J EXP MED, V183, P485, DOI 10.1084/jem.183.2.485; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Khandelwal P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064193; Leech MD, 2007, J IMMUNOL, V179, P7050, DOI 10.4049/jimmunol.179.10.7050; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Mcgee HS, 2009, AM J RESP CRIT CARE, V180, P211, DOI 10.1164/rccm.200809-1505OC; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Morokata T, 2000, IMMUNOL LETT, V72, P119, DOI 10.1016/S0165-2478(00)00188-7; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; Randolph DA, 1999, J CLIN INVEST, V104, P1021, DOI 10.1172/JCI7631; Ray A, 2010, MUCOSAL IMMUNOL, V3, P216, DOI 10.1038/mi.2010.4; Saban DR, 2013, CURR EYE RES, V38, P317, DOI 10.3109/02713683.2012.747617; Sakai K, 1999, CLIN EXP IMMUNOL, V118, P9; Schlereth S, 2012, AM J PATHOL, V180, P2351, DOI 10.1016/j.ajpath.2012.02.015; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Stern ME, 2005, CURR OPIN ALLERGY CL, V5, P446, DOI 10.1097/01.all.0000182547.60595.64; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Wang LF, 1996, J IMMUNOL, V156, P4079	29	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75769	10.1371/journal.pone.0075769	http://dx.doi.org/10.1371/journal.pone.0075769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086630	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900062
J	Shah, S; Conlin, LK; Gomez, L; Aagenaes, O; Eiklid, K; Knisely, AS; Mennuti, MT; Matthews, RP; Spinner, NB; Bull, LN				Shah, Sohela; Conlin, Laura K.; Gomez, Luis; Aagenaes, Oystein; Eiklid, Kristin; Knisely, A. S.; Mennuti, Michael T.; Matthews, Randolph P.; Spinner, Nancy B.; Bull, Laura N.			CCBE1 Mutation in Two Siblings, One Manifesting Lymphedema-Cholestasis Syndrome, and the Other, Fetal Hydrops	PLOS ONE			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; HEREDITARY CHOLESTASIS; RENAL DYSFUNCTION; ABC TRANSPORTER; GENE; HYPERCHOLANEMIA; ARTHROGRYPOSIS; EXPRESSION; DYSPLASIA; DISEASE	Background: Lymphedema-cholestasis syndrome (LCS; Aagenaes syndrome) is a rare autosomal recessive disorder, characterized by 1) neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age, and 2) severe chronic lymphedema, mainly lower limb. LCS was originally described in a Norwegian kindred in which a locus, LCS1, was mapped to a 6.6cM region on chromosome 15. Mutations in CCBE1 on chromosome 18 have been reported in some cases of lymphatic dysplasia, but not in LCS. Methods: Consanguineous parents of Mexican ancestry had a child with LCS who did not exhibit extended homozygosity in the LCS1 region. A subsequent pregnancy was electively terminated due to fetal hydrops. We performed whole-genome single nucleotide polymorphism genotyping to identify regions of homozygosity in these siblings, and sequenced promising candidate genes. Results: Both siblings harbored a homozygous mutation in CCBE1, c.398 T>C, predicted to result in the missense change p.L133P. Regions containing known 'cholestasis genes' did not demonstrate homozygosity in the LCS patient. Conclusions: Mutations in CCBE1 may yield a phenotype not only of lymphatic dysplasia, but also of LCS or fetal hydrops; however, the possibility that the sibling with LCS also carries a homozygous mutation in an unidentified gene influencing cholestasis cannot be excluded.	[Shah, Sohela; Bull, Laura N.] Univ Calif San Francisco, Dept Med, Liver Ctr Lab, San Francisco, CA USA; [Conlin, Laura K.; Spinner, Nancy B.] Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Conlin, Laura K.; Spinner, Nancy B.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gomez, Luis; Mennuti, Michael T.] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Aagenaes, Oystein] Oslo Univ Hosp, Oslo, Norway; [Eiklid, Kristin] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Knisely, A. S.] Kings Coll Hosp London, Inst Liver Studies, London, England; [Matthews, Randolph P.] Univ Penn, Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Matthews, Randolph P.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Bull, Laura N.] Univ Calif San Francisco, Dept Med, Inst Human Genet, San Francisco, CA USA	University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Oslo; University of Oslo; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco	Bull, LN (corresponding author), Univ Calif San Francisco, Dept Med, Liver Ctr Lab, San Francisco, CA USA.	lbull@medsfgh.ucsf.edu			National Institutes of Health [R01 DK58214]; Genome Institute at Washington University School of Medicine as part of the NHGRI Medical Sequencing Program [2U54HG003079-09]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058214, P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Institute at Washington University School of Medicine as part of the NHGRI Medical Sequencing Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health R01 DK58214 to LNB. Initial sequencing of LCS1 in Patient 1, which suggested locus heterogeneity, was performed by the Genome Institute at Washington University School of Medicine as part of the NHGRI Medical Sequencing Program (2U54HG003079-09 to R. K. Wilson). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAGENAES O, 1970, ARCH DIS CHILD, V45, P690, DOI 10.1136/adc.45.243.690; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alders M, 2013, MOL SYNDROMOL, V4, P107, DOI [10.1159/000342486, 10.1159/000354097]; Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; Bellini C, 2010, AM J MED GENET A, V152A, P1189, DOI 10.1002/ajmg.a.33191; Bos FL, 2011, CIRC RES, V109, P486, DOI 10.1161/CIRCRESAHA.111.250738; Bull LN, 2000, AM J HUM GENET, V67, P994, DOI 10.1086/303080; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Carlton VEH, 2004, ANN MED, V36, P606, DOI 10.1080/07853890410018916; Carlton VEH, 2003, NAT GENET, V34, P91, DOI 10.1038/ng1147; Chagnon P, 2002, AM J HUM GENET, V71, P1443, DOI 10.1086/344580; Chong CPK, 2012, J INHERIT METAB DIS, V35, P521, DOI 10.1007/s10545-011-9416-3; Connell FC, 2012, CLIN GENET, V81, P191, DOI 10.1111/j.1399-0004.2011.01731.x; Connell F, 2010, HUM GENET, V127, P231, DOI 10.1007/s00439-009-0766-y; Cullinane AR, 2010, NAT GENET, V42, P303, DOI 10.1038/ng.538; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; Fabris L, 2006, HEPATOLOGY, V43, P1001, DOI 10.1002/hep.21143; Facucho-Oliveira J, 2011, INT J DEV BIOL, V55, P1007, DOI 10.1387/ijdb.113394jf; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fruhwirth M, 2003, J PEDIATR-US, V142, P441, DOI 10.1067/mpd.2003.148; Gissen P, 2004, NAT GENET, V36, P400, DOI 10.1038/ng1325; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hadj-Rabia S, 2004, GASTROENTEROLOGY, V127, P1386, DOI 10.1053/j.gastro.2004.07.022; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Jin ZW, 2010, J ANAT, V216, P671, DOI 10.1111/j.1469-7580.2010.01229.x; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Lemonde HA, 2003, GUT, V52, P1494, DOI 10.1136/gut.52.10.1494; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Schwarz M, 2000, J CLIN INVEST, V106, P1175, DOI 10.1172/JCI10902; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; Van Mil SWC, 2007, GASTROENTEROLOGY, V133, P507, DOI 10.1053/j.gastro.2007.05.015; Wada M, 1998, HUM MOL GENET, V7, P203, DOI 10.1093/hmg/7.2.203; Zhu QS, 2003, BBA-MOL BASIS DIS, V1638, P208, DOI 10.1016/S0925-4439(03)00085-1; Zollner G, 2006, WIEN MED WOCHENSCHR, V156, P380, DOI 10.1007/s10354-006-0312-7; Zou ZY, 2013, BLOOD, V121, P3228, DOI 10.1182/blood-2012-10-462689	35	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75770	10.1371/journal.pone.0075770	http://dx.doi.org/10.1371/journal.pone.0075770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086631	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000042
J	Gruber, T; Zuberbuhler, K				Gruber, Thibaud; Zuberbuehler, Klaus			Vocal Recruitment for Joint Travel in Wild Chimpanzees	PLOS ONE			English	Article							PAN-TROGLODYTES-SCHWEINFURTHII; USE COPULATION CALLS; REFERENTIAL GESTURES; BUDONGO FOREST; COMMUNICATION; COMMUNITY; BEHAVIOR; SCREAMS	Joint travel is a common social activity of many group-living animals, which requires some degree of coordination, sometimes through communication signals. Here, we studied the use of an acoustically distinct vocalisation in chimpanzees, the 'travel hoo', a signal given specifically in the travel context. We were interested in how this call type was produced to coordinate travel, whether it was aimed at specific individuals and how recipients responded. We found that 'travel hoos' were regularly given prior to impending departures and that silent travel initiations were less successful in recruiting than vocal initiations. Other behaviours associated with departure were unrelated to recruitment, suggesting that 'travel hoos' facilitated joint travel. Crucially, 'travel hoos' were more often produced in the presence of allies than other individuals, with high rates of recruitment success. We discuss these findings as evidence for how motivation to perform a specific social activity can lead to the production of a vocal signal that qualifies as 'intentional' according to most definitions, suggesting that a key psychological component of human language may have already been present in the common ancestor of chimpanzees and humans.	[Gruber, Thibaud] EHESS, Ctr Norbert Elias, Marseille, France; [Gruber, Thibaud; Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Gruber, Thibaud] Univ Zurich, Inst Anthropol, Zurich, Switzerland; [Zuberbuehler, Klaus] Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland; [Gruber, Thibaud; Zuberbuehler, Klaus] Budongo Conservat Field Stn, Masindi, Uganda	UDICE-French Research Universities; Aix-Marseille Universite; University of St Andrews; University of Zurich; University of Neuchatel	Gruber, T (corresponding author), EHESS, Ctr Norbert Elias, Marseille, France.	thibaud.gruber@gmail.com	Zuberbühler, Klaus/A-9053-2011; Gruber, Thibaud/D-1628-2014	Zuberbühler, Klaus/0000-0001-8378-088X; Gruber, Thibaud/0000-0002-6766-3947	Leverhulme Trust (UK); Wissenschaftskolleg zu Berlin; European Research Council; Fyssen Foundation	Leverhulme Trust (UK)(Leverhulme Trust); Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); Fyssen Foundation	The study was funded by the Leverhulme Trust (UK) with additional support by the Wissenschaftskolleg zu Berlin, the European Research Council and the Fyssen Foundation during the writing of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; BARD KA, 1992, CHILD DEV, V63, P1186, DOI 10.2307/1131526; Bates LA, 2009, BEHAV ECOL SOCIOBIOL, V64, P247, DOI 10.1007/s00265-009-0841-3; Boesch C, 2000, CHIMPANZEES TAI FORE; Boinski S, 1999, MOVE WHY ANIMALS TRA; Call J., 2007, GESTURAL COMMUNICATI; Clay Z, 2011, BIOL LETTERS, V7, P513, DOI 10.1098/rsbl.2010.1227; Crockford C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2765; Crockford C, 2012, CURR BIOL, V22, P142, DOI 10.1016/j.cub.2011.11.053; Deschner T, 2003, ANIM BEHAV, V66, P551, DOI 10.1006/anbe.2003.2210; DEWAAL F, 1982, CHIMPANZEE POLITICS; EGGELING WJ, 1947, J ECOL, V34, P20, DOI 10.2307/2256760; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hare B, 2010, CURR BIOL, V20, pR230, DOI 10.1016/j.cub.2009.12.038; HAUSER MD, 1992, P NATL ACAD SCI USA, V89, P12137, DOI 10.1073/pnas.89.24.12137; Hobaiter C, 2011, ANIM COGN, V14, P827, DOI 10.1007/s10071-011-0416-3; Laporte MNC, 2010, ANIM BEHAV, V80, P467, DOI 10.1016/j.anbehav.2010.06.005; Leavens DA, 2004, J COMP PSYCHOL, V118, P48, DOI 10.1037/0735-7036.118.1.48; Liebal K, 2004, AM J PRIMATOL, V64, P377, DOI 10.1002/ajp.20087; Moore JW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00023; Murray CM, 2007, ANIM BEHAV, V74, P1795, DOI 10.1016/j.anbehav.2007.03.024; Newton-Fisher NE, 2003, AFR J ECOL, V41, P150, DOI 10.1046/j.1365-2028.2003.00408.x; Owren MJ, 2011, AM J PRIMATOL, V73, P530, DOI 10.1002/ajp.20913; Pika S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1567; Plumptre A. J., 2003, ALBERTINE RIFT TECHN, V2; Plumptre AJ, 1996, FOREST ECOL MANAG, V89, P101, DOI 10.1016/S0378-1127(96)03854-6; Reynolds V., 2005, CHIMPANZEES BUDONGO; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; Slocombe KE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1959, DOI 10.1007/s00265-010-1006-0; Slocombe KE, 2005, J COMP PSYCHOL, V119, P67, DOI 10.1037/0735-7036.119.1.67; Slocombe KE, 2005, AM J PRIMATOL, V65, P385, DOI 10.1002/ajp.20123; Tomasello M, 2008, JEAN NICOD LECT, P1; Townsend SW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002431; TUTIN CEG, 1979, BEHAV ECOL SOCIOBIOL, V6, P29, DOI 10.1007/BF00293242; Vail AL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2781; Williams JM, 2008, AM J PRIMATOL, V70, P766, DOI 10.1002/ajp.20573; Wrangham R., 1996, DEMONIC MALES; Zuberbuhler K, 2008, CURR BIOL, V18, pR189, DOI 10.1016/j.cub.2007.12.041	38	41	41	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76073	10.1371/journal.pone.0076073	http://dx.doi.org/10.1371/journal.pone.0076073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086688	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000325218700120
J	Issur, M; Bougie, I; Despins, S; Bisaillon, M				Issur, Moheshwarnath; Bougie, Isabelle; Despins, Simon; Bisaillon, Martin			Enzymatic Synthesis of RNAs Capped with Nucleotide Analogues Reveals the Molecular Basis for Substrate Selectivity of RNA Capping Enzyme: Impacts on RNA Metabolism	PLOS ONE			English	Article							TRANSLATION FACTOR EIF4E; INITIATION-FACTOR EIF4E; CHLORELLA-VIRUS PBCV-1; MESSENGER-RNA; BINDING-PROTEIN; SCHIZOSACCHAROMYCES-POMBE; DNA-LIGASE; GUANYLYLTRANSFERASE; TRIPHOSPHATASE; EFFICIENCY	RNA cap binding proteins have evolved to specifically bind to the N7-methyl guanosine cap structure found at the 5' ends of eukaryotic mRNAs. The specificity of RNA capping enzymes towards GTP for the synthesis of this structure is therefore crucial for mRNA metabolism. The fact that ribavirin triphosphate was described as a substrate of a viral RNA capping enzyme, raised the possibility that RNAs capped with nucleotide analogues could be generated in cellulo. Owing to the fact that this prospect potentially has wide pharmacological implications, we decided to investigate whether the active site of the model Paramecium bursaria Chlorella virus-1 RNA capping enzyme was flexible enough to accommodate various purine analogues. Using this approach, we identified several key structural determinants at each step of the RNA capping reaction and generated RNAs harboring various different cap analogues. Moreover, we monitored the binding affinity of these novel capped RNAs to the eIF4E protein and evaluated their translational properties in cellulo. Overall, this study establishes a molecular rationale for the specific selection of GTP over other NTPs by RNA capping enzyme It also demonstrates that RNAs can be enzymatically capped with certain purine nucleotide analogs, and it also describes the impacts of modified RNA caps on specific steps involved in mRNA metabolism. For instance, our results indicate that the N7-methyl group of the classical N7-methyl guanosine cap is not always indispensable for binding to eIF4E and subsequently for translation when compensatory modifications are present on the capped residue. Overall, these findings have important implications for our understanding of the molecular determinants involved in both RNA capping and RNA metabolism.	[Issur, Moheshwarnath; Bougie, Isabelle; Despins, Simon; Bisaillon, Martin] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Bisaillon, M (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	Martin.Bisaillon@USherbrooke.ca			Canadian Institutes for Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); CIHR; Universite de Sherbrooke; Fonds de Recherche en Sante du Quebec	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); Universite de Sherbrooke; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work as supported by the following: Canadian Institutes for Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (NSERC) grants to MB; CIHR and Universite de Sherbrooke grant to RNA group; M. B is a Chercheur Boursier Senior from the Fonds de recherche en sante du Quebec; Doctoral training award from the Fonds de Recherche en Sante du Quebec to M. I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS BL, 1978, J BIOL CHEM, V253, P2589; Bachand F, 2006, MOL CELL BIOL, V26, P1731, DOI 10.1128/MCB.26.5.1731-1742.2006; Benzaghou I, 2006, FEBS LETT, V580, P867, DOI 10.1016/j.febslet.2006.01.006; Bougie I, 2004, J BIOL CHEM, V279, P22124, DOI 10.1074/jbc.M400908200; Bougie I, 2006, BIOCHEM J, V398, P557, DOI 10.1042/BJ20060198; Brown CJ, 2007, J MOL BIOL, V372, P7, DOI 10.1016/j.jmb.2007.06.033; Doherty AJ, 1997, ACTA CRYSTALLOGR D, V53, P482, DOI 10.1107/S090744499700231X; Fabrega C, 2003, MOL CELL, V11, P1549, DOI 10.1016/S1097-2765(03)00187-4; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Fischer PM, 2009, CELL CYCLE, V8, P2535, DOI 10.4161/cc.8.16.9301; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Grudzien E, 2004, RNA, V10, P1479, DOI 10.1261/rna.7380904; Grudzien-Nogalska E, 2007, METHOD ENZYMOL, V431, P203, DOI 10.1016/S0076-6879(07)31011-2; Grudzien-Nogalska E, 2007, RNA, V13, P1745, DOI 10.1261/rna.701307; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Ho CK, 1996, J VIROL, V70, P6658, DOI 10.1128/JVI.70.10.6658-6664.1996; Jemielity J, 2003, RNA, V9, P1108, DOI 10.1261/rna.5430403; Kalek M, 2005, NUCLEOS NUCLEOT NUCL, V24, P615, DOI 10.1081/NCN-200060091; Kampf G, 2002, J CHEM SOC PERK T 2, P1320, DOI 10.1039/b202023h; Kore AR, 2008, BIOORG MED CHEM LETT, V18, P880, DOI 10.1016/j.bmcl.2007.12.049; Kore AR, 2009, J AM CHEM SOC, V131, P6364, DOI 10.1021/ja901655p; Kowalska J, 2008, RNA, V14, P1119, DOI 10.1261/rna.990208; Kuhn AN, 2010, GENE THER, V17, P961, DOI 10.1038/gt.2010.52; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Mao XD, 1996, MOL CELL BIOL, V16, P475; Marcotrigiano J, 1997, Nucleic Acids Symp Ser, P8; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Niedzwiecka A, 2003, NUCLEOS NUCLEOT NUCL, V22, P1557, DOI 10.1081/NCN-120023033; Niedzwiecka A, 2002, BIOCHEMISTRY-US, V41, P12140, DOI 10.1021/bi0258142; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Roitzsch M, 2010, NAT CHEM BIOL, V6, P218, DOI 10.1038/NCHEMBIO.312; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Saha N, 1999, J BIOL CHEM, V274, P16553, DOI 10.1074/jbc.274.23.16553; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; SHUMAN S, 1994, P NATL ACAD SCI USA, V91, P12046, DOI 10.1073/pnas.91.25.12046; SHUMAN S, 1995, MOL MICROBIOL, V17, P405, DOI 10.1111/j.1365-2958.1995.mmi_17030405.x; Slepenkov SV, 2006, J BIOL CHEM, V281, P14927, DOI 10.1074/jbc.M601653200; Sonenberg N, 2008, BIOCHEM CELL BIOL, V86, P178, DOI 10.1139/O08-034; Souliere MF, 2008, BIOCHEMISTRY-US, V47, P3863, DOI 10.1021/bi702054a; Stepinski J, 2005, NUCLEOS NUCLEOT NUCL, V24, P629, DOI 10.1081/NCN-200060103; UEDA H, 1991, J BIOCHEM-TOKYO, V109, P882, DOI 10.1093/oxfordjournals.jbchem.a123475; VENKATESAN S, 1980, J BIOL CHEM, V255, P903; VENKATESAN S, 1982, P NATL ACAD SCI-BIOL, V79, P340, DOI 10.1073/pnas.79.2.340	46	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75310	10.1371/journal.pone.0075310	http://dx.doi.org/10.1371/journal.pone.0075310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086504	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700073
J	Antelmi, E; Cardone, RA; Greco, MR; Rubino, R; Di Sole, F; Martino, NA; Casavola, V; Carcangiu, M; Moro, L; Reshkin, SJ				Antelmi, Ester; Cardone, Rosa A.; Greco, Maria R.; Rubino, Rosa; Di Sole, Francesca; Martino, Nicola A.; Casavola, Valeria; Carcangiu, MariaLuisa; Moro, Loredana; Reshkin, Stephan J.			beta 1 Integrin Binding Phosphorylates Ezrin at T567 to Activate a Lipid Raft Signalsome Driving Invadopodia Activity and Invasion	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; SCAFFOLDING PROTEIN EBP50; NA+-H+ EXCHANGER; BREAST-CANCER; CELL INVASION; ERM PROTEINS; NASOPHARYNGEAL CARCINOMA; OSTEOSARCOMA CELLS; CARDIAC MYOCYTES; LOCAL RECURRENCE	Extracellular matrix (ECM) degradation is a critical process in tumor cell invasion and requires matrix degrading protrusions called invadopodia. The Na+/H+ exchanger (NHE1) has recently been shown to be fundamental in the regulation of invadopodia actin cytoskeleton dynamics and activity. However, the structural link between the invadopodia cytoskeleton and NHE1 is still unknown. A candidate could be ezrin, a linker between the NHE1 and the actin cytoskeleton known to play a pivotal role in invasion and metastasis. However, the mechanistic basis for its role remains unknown. Here, we demonstrate that ezrin phosphorylated at T567 is highly overexpressed in the membrane of human breast tumors and positively associated with invasive growth and HER2 overexpression. Further, in the metastatic cell line, MDA-MB-231, p-ezrin was almost exclusively expressed in invadopodia lipid rafts where it co-localized in a functional complex with NHE1, EGFR, beta 1-integrin and phosphorylated-NHERF1. Manipulation by mutation of ezrins T567 phosphorylation state and/or PIP2 binding capacity or of NHE1s binding to ezrin or PIP2 demonstrated that p-ezrin expression and binding to PIP2 are required for invadopodia-mediated ECM degradation and invasion and identified NHE1 as the membrane protein that p-ezrin regulates to induce invadopodia formation and activity.	[Antelmi, Ester; Cardone, Rosa A.; Greco, Maria R.; Rubino, Rosa; Casavola, Valeria; Reshkin, Stephan J.] Univ Bari, Dept Biosci Biotechnol & Biopharmacol, Bari, Italy; [Antelmi, Ester; Carcangiu, MariaLuisa] Ist Nazl Tumori, Dept Pathol, Anat Pathol Unit A, I-20133 Milan, Italy; [Di Sole, Francesca] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Di Sole, Francesca] Dept Vet Affairs Med Ctr, Med Serv, Baltimore, MD USA; [Martino, Nicola A.] Univ Bari, Dept Anim Prod, Fac Biotechnol Sci, Bari, Italy; [Moro, Loredana] CNR, Inst Biomembranes & Bioenerget IBBE, I-70126 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Fondazione IRCCS Istituto Nazionale Tumori Milan; University System of Maryland; University of Maryland Baltimore; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR)	Reshkin, SJ (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmacol, Bari, Italy.	reshkin@biologia.uniba.it	Martino, Nicola/AAP-9891-2020; Reshkin, Stephan/AAI-6680-2020; Antelmi, Elena/K-3252-2018; Martino, Nicola Antonio/N-4096-2014	Reshkin, Stephan/0000-0001-9757-5908; CASAVOLA, Valeria/0000-0003-4471-4948; Martino, Nicola Antonio/0000-0001-6853-2757; Antelmi, Elena/0000-0003-1739-6139; Antelmi, Ester/0000-0003-0685-4827; GRECO, Maria Raffaella/0000-0001-7454-8990	"Associazione Italiana per la Ricerca sul Cancro" (AIRC) [11348]; PRIN Grant [N.1341]; American Society of Nephrology	"Associazione Italiana per la Ricerca sul Cancro" (AIRC)(Fondazione AIRC per la ricerca sul cancro); PRIN Grant(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); American Society of Nephrology	This work was funded by the "Associazione Italiana per la Ricerca sul Cancro" (AIRC) grant #11348 to SJR and PRIN Grant 2009 N.1341 to SJR and LM. Dr. F. Di Sole was supported by a Carl W. Gottschalk Research Scholar Award from the American Society of Nephrology and MLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou AG, 2011, ANN DIAGN PATHOL, V15, P394, DOI 10.1016/j.anndiagpath.2011.05.005; Agarwal SR, 2011, J MOL CELL CARDIOL, V50, P500, DOI 10.1016/j.yjmcc.2010.11.015; Akisawa N, 1999, BIOCHEM BIOPH RES CO, V258, P395, DOI 10.1006/bbrc.1999.0653; Lacalle RA, 2007, J CELL BIOL, V179, P1539, DOI 10.1083/jcb.200705044; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Arslan AA, 2012, BREAST CANCER RES TR, V134, P981, DOI 10.1007/s10549-012-2017-5; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Brambilla D, 2009, INT J CANCER, V125, P2239, DOI 10.1002/ijc.24734; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Brisson L, 2012, EUR J CELL BIOL, V91, P847, DOI 10.1016/j.ejcb.2012.04.004; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; Bulut G, 2012, ONCOGENE, V31, P269, DOI 10.1038/onc.2011.245; Busco G, 2010, FASEB J, V24, P3903, DOI 10.1096/fj.09-149518; Caldieri G, 2012, EUR J CELL BIOL, V91, P961, DOI 10.1016/j.ejcb.2012.03.005; Caldieri G, 2009, J CELL MOL MED, V13, P1728, DOI 10.1111/j.1582-4934.2008.00568.x; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Cardone RA, 2005, MOL BIOL CELL, V16, P3117, DOI 10.1091/mbc.e04-10-0945; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; Cardone RA, 2012, MOL BIOL CELL, V23, P2028, DOI 10.1091/mbc.E11-11-0911; Carneiro A, 2011, J CLIN PATHOL, V64, P689, DOI 10.1136/jcp.2011.089805; Chabadel A, 2007, MOL BIOL CELL, V18, P4899, DOI 10.1091/mbc.E07-04-0378; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Cornez I, 2010, FEBS LETT, V584, P2681, DOI 10.1016/j.febslet.2010.04.056; Damodaran Senthilkumar, 2012, Hosp Pract (1995), V40, P7, DOI 10.3810/hp.2012.10.997; Darmellah A, 2009, CARDIOVASC RES, V81, P294, DOI 10.1093/cvr/cvn320; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Di Sole F, 2009, J AM SOC NEPHROL, V20, P1776, DOI 10.1681/ASN.2008121255; Donatello S, 2012, AM J PATHOL, V181, P2172, DOI 10.1016/j.ajpath.2012.08.025; Elzagheid A, 2008, HUM PATHOL, V39, P1737, DOI 10.1016/j.humpath.2008.04.020; Endo K, 2009, ONCOGENE, V28, P1725, DOI 10.1038/onc.2009.20; Favia M, 2010, MOL BIOL CELL, V21, P73, DOI 10.1091/mbc.E09-03-0185; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; Geiger KD, 2000, AM J PATHOL, V157, P1785, DOI 10.1016/S0002-9440(10)64816-X; Greene FL, 2002, J SURG ONCOL, V80, P119, DOI 10.1002/jso.10114; Harvey RD, 2012, J MOL CELL CARDIOL, V52, P366, DOI 10.1016/j.yjmcc.2011.07.007; Jorgren F, 2012, INT J COLORECTAL DIS, V27, P893, DOI 10.1007/s00384-011-1397-z; Khan S, 2006, CELL MOL BIOL, V52, P115, DOI 10.1170/T769; Kobel M, 2006, MODERN PATHOL, V19, P581, DOI 10.1038/modpathol.3800567; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; Lau SKM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036753; Li L, 2011, PATHOL ONCOL RES, V17, P909, DOI 10.1007/s12253-011-9402-y; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li QC, 2012, TUMOR BIOL, V33, P1493, DOI 10.1007/s13277-012-0400-9; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Lucien F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028851; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; Makitie T, 2001, INVEST OPHTH VIS SCI, V42, P2442; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Morello V, 2011, ONCOGENE, V30, P4087, DOI 10.1038/onc.2011.107; Morozevich GE, 2012, AGING-US, V4, P368, DOI 10.18632/aging.100457; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Ohtani K, 2002, CANCER LETT, V179, P79, DOI 10.1016/S0304-3835(01)00857-6; Patara M, 2011, PATHOL ONCOL RES, V17, P827, DOI 10.1007/s12253-011-9389-4; Pignochino Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-118; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Rebillard A, 2007, CANCER RES, V67, P7865, DOI 10.1158/0008-5472.CAN-07-0353; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; Ren L, 2012, CANCER RES, V72, P1001, DOI 10.1158/0008-5472.CAN-11-0210; Reshkin SJ, 2013, RECENT PAT ANTI-CANC, V8, P85; Ringner Markus, 2013, Methods Mol Biol, V973, P279, DOI 10.1007/978-1-62703-281-0_18; Sarrio D, 2006, BREAST CANCER RES TR, V98, P71, DOI 10.1007/s10549-005-9133-4; Schlecht NF, 2012, HEAD NECK PATHOL, V6, P232, DOI 10.1007/s12105-011-0328-1; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Shang XF, 2012, MOL CELL BIOCHEM, V364, P363, DOI 10.1007/s11010-012-1238-6; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Song J, 2005, CANCER LETT, V220, P57, DOI 10.1016/j.canlet.2004.04.024; Stamenkovic I, 2010, CURR PROTEIN PEPT SC, V11, P471, DOI 10.2174/138920310791824011; Sundquist M, 1999, BREAST CANCER RES TR, V53, P1, DOI 10.1023/A:1006052115874; Tan J, 2011, TUMOR BIOL, V32, P1241, DOI 10.1007/s13277-011-0228-8; Tang FQ, 2011, J BIOL CHEM, V286, P36956, DOI 10.1074/jbc.M111.259234; Tang FQ, 2009, J BIOL CHEM, V284, P27456, DOI 10.1074/jbc.M109.033795; Tekpli X, 2008, J CELL PHYSIOL, V216, P207, DOI 10.1002/jcp.21395; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wei YC, 2009, MODERN PATHOL, V22, P1351, DOI 10.1038/modpathol.2009.107; Wu B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-527; Xie JJ, 2011, J SURG ONCOL, V104, P538, DOI 10.1002/jso.21909; Yamaguchi H, 2012, EUR J CELL BIOL, V91, P902, DOI 10.1016/j.ejcb.2012.04.005; Yamaguchi H, 2010, CANCER SCI, V101, P1632, DOI 10.1111/j.1349-7006.2010.01574.x; Yamaguchi H, 2009, CANCER RES, V69, P8594, DOI 10.1158/0008-5472.CAN-09-2305; Yamaguchi H, 2010, PHYSCS PROC, V9, P1, DOI 10.1016/j.phpro.2010.11.001; Yi YH, 2009, J BIOL CHEM, V284, P3855, DOI 10.1074/jbc.M804334200; Yonemura S, 2002, J CELL SCI, V115, P2569; Zhao J, 2011, HISTOL HISTOPATHOL, V26, P1111, DOI 10.14670/HH-26.1111	92	28	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75113	10.1371/journal.pone.0075113	http://dx.doi.org/10.1371/journal.pone.0075113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086451	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200026
J	Veedin-Rajan, VB; Fischer, RM; Raible, F; Tessmar-Raible, K				Veedin-Rajan, Vinoth Babu; Fischer, Ruth M.; Raible, Florian; Tessmar-Raible, Kristin			Conditional and Specific Cell Ablation in the Marine Annelid Platynereis dumerilii	PLOS ONE			English	Article							COMMON ORIGIN; ZEBRAFISH; BRAIN; PHOTORECEPTORS; TRANSGENESIS; REGENERATION; BILATERIA; EVOLUTION; LIGHT	The marine annelid Platynereis dumerilii has become a model system for evo-devo, neurobiology and marine biology. The functional assessment of its cell types, however, has so far been very limited. Here we report on the establishment of a generally applicable, cell type specific ablation technique to overcome this restriction. Using a transgenic strain expressing the bacterial enzyme nitroreductase (ntr) under the control of the worm's r-opsin1 locus, we show that the demarcated photoreceptor cells can be specifically ablated by the addition of the prodrug metronidazole (mtz). TUNEL staining indicates that ntr expressing cells undergo apoptotic cell death. As we used a transgenic strain co-expressing ntr with enhanced green fluorescent protein (egfp) coding sequence, we were able to validate the ablation of photoreceptors not only in fixed tissue, using r-opsin1 riboprobes, but also by monitoring eGFP+ cells in live animals. The specificity of the ablation was demonstrated by the normal presence of the eye pigment cells, as well as of neuronal markers expressed in other cells of the brain, such as phc2, tyrosine hydroxylase and brn1/2/4. Additional analyses of the position of DAPI stained nuclei, the brain's overall neuronal scaffold, as well as the positions and projections of serotonergic neurons further confirmed that mtz treatment did not induce general abnormalities in the worm's brain. As the prodrug is administered by adding it to the water, targeted ablation of specific cell types can be achieved throughout the life of the animal. We show that ablation conditions need to be adjusted to the size of the worms, likely due to differences in the penetration of the prodrug, and establish ablation conditions for worms containing 10 to 55 segments. Our results establish mtz/ntr mediated conditional cell ablation as a powerful functional tool in Platynereis.	[Veedin-Rajan, Vinoth Babu; Fischer, Ruth M.; Raible, Florian; Tessmar-Raible, Kristin] Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Veedin-Rajan, Vinoth Babu; Fischer, Ruth M.; Raible, Florian; Tessmar-Raible, Kristin] Res Platform Marine Rhythms Life, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Tessmar-Raible, K (corresponding author), Univ Vienna, Max F Perutz Labs, Vienna, Austria.	kristin.tessmar@mfpl.ac.at	Raible, Florian/G-6019-2011; Tessmar-Raible, Kristin/F-9642-2011	Tessmar-Raible, Kristin/0000-0002-8038-1741; Raible, Florian/0000-0002-4515-6485; Veedin Rajan, Vinoth Babu/0000-0002-2430-7395	PhD fellowship of the Bohringer Ingelheim Foundation; Max F. Perutz Laboratories; START award [AY0041321]; HFSP [RGY0082/2010]; European Research Council under the European Community [260304]; Austrian Science Fund (FWF) [Y 413] Funding Source: researchfish	PhD fellowship of the Bohringer Ingelheim Foundation; Max F. Perutz Laboratories; START award; HFSP(Human Frontier Science Program); European Research Council under the European Community(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a PhD fellowship of the Bohringer Ingelheim Foundation (http://www.bifonds.de/homepage.html) to RMF, funds of the Max F. Perutz Laboratories (http://www.mfpl.ac.at/home.html), the research platform "Marine rhythms of Life" of the University of Vienna, a FWF (http://www. fwf.ac.at/) START award (# AY0041321) and HFSP(http://www.hfsp.org/) research grant (# RGY0082/2010) to KTR. The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement 260304 (to FR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Arendt D, 2002, DEVELOPMENT, V129, P1143; Backfisch B, 2013, P NATL ACAD SCI USA, V110, P193, DOI 10.1073/pnas.1209657109; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Dray N, 2010, SCIENCE, V329, P339, DOI 10.1126/science.1188913; Ejsmont RK, 2009, NAT METHODS, V6, P435, DOI [10.1038/NMETH.1334, 10.1038/nmeth.1334]; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Fischer AHL, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-31; Hauenschild C., 1969, PLATYNEREIS DUMERILI, P1; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Michal G, 1999, BIOCH PATHWAYS; Palermo AM, 2013, CURRENT DRUG SAF; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043; White YAR, 2011, DEV DYNAM, V240, P1929, DOI 10.1002/dvdy.22695	20	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75811	10.1371/journal.pone.0075811	http://dx.doi.org/10.1371/journal.pone.0075811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086637	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200063
J	Ioerger, TR; O'Malley, T; Liao, R; Guinn, KM; Hickey, MJ; Mohaideen, N; Murphy, KC; Boshoff, HIM; Mizrahi, V; Rubin, EJ; Sassetti, CM; Barry, CE; Sherman, DR; Parish, T; Sacchettini, JC				Ioerger, Thomas R.; O'Malley, Theresa; Liao, Reiling; Guinn, Kristine M.; Hickey, Mark J.; Mohaideen, Nilofar; Murphy, Kenan C.; Boshoff, Helena I. M.; Mizrahi, Valerie; Rubin, Eric J.; Sassetti, Christopher M.; Barry, Clifton E., III; Sherman, David R.; Parish, Tanya; Sacchettini, James C.			Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASE; EFFLUX PUMP; MYCOLIC ACIDS; ETHIONAMIDE; INHIBITORS; ACTIVATION; DISCOVERY; SYNTHASE; PROTEIN; PERSISTENCE	Identification of new drug targets is vital for the advancement of drug discovery against Mycobacterium tuberculosis, especially given the increase of resistance worldwide to first-and second-line drugs. Because traditional target-based screening has largely proven unsuccessful for antibiotic discovery, we have developed a scalable platform for target identification in M. tuberculosis that is based on whole-cell screening, coupled with whole-genome sequencing of resistant mutants and recombineering to confirm. The method yields targets paired with whole-cell active compounds, which can serve as novel scaffolds for drug development, molecular tools for validation, and/or as ligands for co-crystallization. It may also reveal other information about mechanisms of action, such as activation or efflux. Using this method, we identified resistance-linked genes for eight compounds with anti-tubercular activity. Four of the genes have previously been shown to be essential: AspS, aspartyl-tRNA synthetase, Pks13, a polyketide synthase involved in mycolic acid biosynthesis, MmpL3, a membrane transporter, and EccB3, a component of the ESX-3 type VII secretion system. AspS and Pks13 represent novel targets in protein translation and cell-wall biosynthesis. Both MmpL3 and EccB3 are involved in membrane transport. Pks13, AspS, and EccB3 represent novel candidates not targeted by existing TB drugs, and the availability of whole-cell active inhibitors greatly increases their potential for drug discovery.	[Ioerger, Thomas R.] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX USA; [O'Malley, Theresa; Parish, Tanya] Infect Dis Res Inst, Seattle, WA USA; [Liao, Reiling; Hickey, Mark J.; Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Guinn, Kristine M.; Rubin, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Mohaideen, Nilofar; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Murphy, Kenan C.; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Boshoff, Helena I. M.; Barry, Clifton E., III] NIAID, Lab Clin Infect Dis, TB Res Sect, Bethesda, MD 20892 USA; [Mizrahi, Valerie] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Sassetti, Christopher M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Texas A&M University System; Texas A&M University College Station; Center for Infectious Disease Research; Harvard University; Harvard T.H. Chan School of Public Health; Texas A&M University System; Texas A&M University College Station; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cape Town; Howard Hughes Medical Institute	Sacchettini, JC (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	jim.sacchettini@gmail.com	Murphy, Kenan/AHB-4771-2022; Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020	Murphy, Kenan/0000-0002-3677-2876; Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; Rubin, Eric/0000-0001-5120-962X	Bill & Melinda Gates Foundation; Paul G. Allen Family Foundation; NIH [U01GM094568]; Robert A. Welch Foundation [A-0015]; NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135, ZIAAI000693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094568] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Paul G. Allen Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the Bill & Melinda Gates Foundation, the Paul G. Allen Family Foundation (to DRS), NIH grant U01GM094568 (JCS, EJR, TRI), grant A-0015 from the Robert A. Welch Foundation (JCS), and the intramural research program of NIAID, NIH (to CEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Ballell L, 2013, CHEMMEDCHEM, V8, P313, DOI 10.1002/cmdc.201200428; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Baulard AR, 2000, J BIOL CHEM, V275, P28326; Belisle John T., 2008, V465, P1, DOI 10.1007/978-1-59745-207-6_1; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Braibant M, 2000, FEMS MICROBIOL REV, V24, P449, DOI 10.1111/j.1574-6976.2000.tb00550.x; Briand C, 2000, J MOL BIOL, V299, P1051, DOI 10.1006/jmbi.2000.3819; Carroll P, 2011, APPL ENVIRON MICROB, V77, P5040, DOI 10.1128/AEM.02880-10; Colangeli R, 2005, MOL MICROBIOL, V55, P1829, DOI 10.1111/j.1365-2958.2005.04510.x; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; De Rossi Edda, 2002, Molecular Medicine (Baltimore), V8, P714; DeBarber AE, 2000, P NATL ACAD SCI USA, V97, P9677, DOI 10.1073/pnas.97.17.9677; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; ERIANI G, 1993, P NATL ACAD SCI USA, V90, P10816, DOI 10.1073/pnas.90.22.10816; Freundlich JS, 2009, CHEMMEDCHEM, V4, P241, DOI 10.1002/cmdc.200800261; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Ghanekar K, 1999, MOL MICROBIOL, V33, P982, DOI 10.1046/j.1365-2958.1999.01539.x; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Hanoulle X, 2006, J ANTIMICROB CHEMOTH, V58, P768, DOI 10.1093/jac/dkl332; Hasan A, 2011, MOLECULES, V16, P1297, DOI 10.3390/molecules16021297; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Jarvest RL, 2002, J MED CHEM, V45, P1959, DOI 10.1021/jm025502x; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Maddry JA, 2009, TUBERCULOSIS, V89, P354, DOI 10.1016/j.tube.2009.07.006; Manos-Turvey A, 2010, CHEMMEDCHEM, V5, P1067, DOI 10.1002/cmdc.201000137; McEvoy CRE, 2007, TUBERCULOSIS, V87, P393, DOI 10.1016/j.tube.2007.05.010; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Murphy Kenan C, 2010, F1000 Biol Rep, V2, P56; Pasca MR, 2004, ANTIMICROB AGENTS CH, V48, P3175, DOI 10.1128/AAC.48.8.3175-3178.2004; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Ramon-Garcia S, 2006, J ANTIMICROB CHEMOTH, V57, P252, DOI 10.1093/jac/dki436; Ramon-Garcia S, 2007, J ANTIMICROB CHEMOTH, V59, P544, DOI 10.1093/jac/dkl510; Ramon-Garcia S, 2009, ANTIMICROB AGENTS CH, V53, P3675, DOI 10.1128/AAC.00550-09; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Timmers LFSM, 2008, ARCH BIOCHEM BIOPHYS, V479, P28, DOI 10.1016/j.abb.2008.08.015; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Sirgel Frederick A., 2008, V465, P173, DOI 10.1007/978-1-59745-207-6_11; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Teo JWP, 2006, ANTIMICROB AGENTS CH, V50, P3665, DOI 10.1128/AAC.00555-06; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Vannelli TA, 2002, J BIOL CHEM, V277, P12824, DOI 10.1074/jbc.M110751200; Vasan M, 2010, CHEMMEDCHEM, V5, P2079, DOI 10.1002/cmdc.201000275; Verma A, 2008, EUR J MED CHEM, V43, P897, DOI 10.1016/j.ejmech.2007.07.017; Vilcheze C, 2005, ANTIMICROB AGENTS CH, V49, P708, DOI 10.1128/AAC.49.2.708-720.2005; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; Wilson R, 2013, NAT CHEM BIOL, V9, P499, DOI 10.1038/nchembio.1277; World Health Organization, 2010, WHOHTMTB20103; YANAGISAWA T, 1994, J BIOL CHEM, V269, P24304; Yano T, 2006, J BIOL CHEM, V281, P11456, DOI 10.1074/jbc.M508844200	71	154	157	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75245	10.1371/journal.pone.0075245	http://dx.doi.org/10.1371/journal.pone.0075245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086479	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200093
J	Li, YP; Aparicio, C				Li, Yuping; Aparicio, Conrado			Discerning the Subfibrillar Structure of Mineralized Collagen Fibrils: A Model for the Ultrastructure of Bone	PLOS ONE			English	Article							AMORPHOUS CALCIUM-PHOSPHATE; 3 DIMENSIONS; CRYSTALS; ZEBRAFISH; COMPONENT; CELL	Biomineralization templated by organic molecules to produce inorganic-organic nanocomposites is a fascinating example of nature using bottom-up strategies at nanoscale to accomplish highly ordered multifunctional materials. One such nanocomposite is bone, composed primarily of hydroxyapatite (HA) nanocrystals that are embedded within collagen fibrils with their c-axes arranged roughly parallel to the long axis of the fibrils. Here we discern the ultrastructure of biomimetic mineralized collagen fibrils (MCFs) as consisting of bundles of subfibrils with approximately 10 nm diameter; each one with an organic-inorganic core-shell structure. Through an amorphous calcium phosphate precursor phase the HA nanocrystals were specifically grown along the longitudinal direction of the collagen microfibrils and encapsulated them within the crystal lattice. They intercalated throughout the collagen fibrils such that the mineral phase surrounded the surface of collagen microfibrils forming an interdigitated network. It appears that this arrangement of collagen microfibrils in collagen fibrils is responsible for the observed ultrastructure. Such a subfibrillar nanostructure in MCFs was identified in both synthetic and natural bone, suggesting this is the basic building block of collagen-based hard tissues. Insights into the ultrastructure of mineralized collagen fibrils have the potential to advance our understanding on the biomineralization principles and the relationship between bone's structure and mechanical properties, including fracture toughness mechanisms. We anticipate that these principles from biological systems can be applied to the rational design of new nanocomposites with improved performance.	[Li, Yuping; Aparicio, Conrado] Univ Minnesota, Sch Dent, Dept Restorat Sci, MDRCBB, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Aparicio, C (corresponding author), Univ Minnesota, Sch Dent, Dept Restorat Sci, MDRCBB, Minneapolis, MN 55455 USA.	apari003@umn.edu	Li, Yuping/H-5259-2013; Aparicio, Conrado/J-9903-2012	Li, Yuping/0000-0002-2506-1155; Aparicio, Conrado/0000-0003-2969-6067	3M Foundation through a 3M Non-tenured Faculty Award; NSF through the MRSEC program	3M Foundation through a 3M Non-tenured Faculty Award(3M); NSF through the MRSEC program(National Science Foundation (NSF))	The work was supported by 3M Foundation through a 3M Non-tenured Faculty Award (CA). Parts of this work were carried out in the University of Minnesota I.T. Characterization Facility, which receives partial support from NSF through the MRSEC program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buehler MJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/29/295102; Deshpande AS, 2008, CRYST GROWTH DES, V8, P3084, DOI 10.1021/cg800252f; Eppell SJ, 2001, J ORTHOPAED RES, V19, P1027, DOI 10.1016/S0736-0266(01)00034-1; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; FRATZL P, 1992, J BONE MINER RES, V7, P329; Fratzl P, 1996, J CLIN INVEST, V97, P396, DOI 10.1172/JCI118428; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Gao HJ, 2006, INT J FRACTURE, V138, P101, DOI 10.1007/s10704-006-7156-4; Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u; Goh MC, 1997, PHYSICA A, V239, P95, DOI 10.1016/S0378-4371(96)00472-4; GOWER LB, 2010, ACTA BIOMATER, V6, P3676, DOI DOI 10.1016/J.ACTBI0.2010.03.036.PUBMED:20359554; Holmes DF, 2001, P NATL ACAD SCI USA, V98, P7307, DOI 10.1073/pnas.111150598; Jager I, 2000, BIOPHYS J, V79, P1737, DOI 10.1016/S0006-3495(00)76426-5; LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003; Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192; LANDIS WJ, 1991, J STRUCT BIOL, V107, P116, DOI 10.1016/1047-8477(91)90015-O; LEES S, 1986, CALCIFIED TISSUE INT, V39, P291, DOI 10.1007/BF02555221; Li YP, 2012, BIOMACROMOLECULES, V13, P49, DOI 10.1021/bm201070g; Liu Y, 2011, ADV MATER, V23, P975, DOI 10.1002/adma.201003882; Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105; Mahamid J, 2010, P NATL ACAD SCI USA, V107, P6316, DOI 10.1073/pnas.0914218107; NIMNI ME, 1988, MOL STRUCTURES FUNCT, P1; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; PIEZ KA, 1981, BIOSCIENCE REP, V1, P801, DOI 10.1007/BF01114803; ROBINSON RA, 1952, J BONE JOINT SURG AM, V34-A, P389, DOI 10.2106/00004623-195234020-00013; Su X, 2003, BONE, V32, P150, DOI 10.1016/S8756-3282(02)00945-6; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; TRAUB W, 1989, P NATL ACAD SCI USA, V86, P9822, DOI 10.1073/pnas.86.24.9822; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271	31	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e76782	10.1371/journal.pone.0076782	http://dx.doi.org/10.1371/journal.pone.0076782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086763	gold, Green Published, Green Submitted			2022-12-25	WOS:000326520200140
J	Ouyang, H; Gore, J; Deitz, S; Korc, M				Ouyang, H.; Gore, J.; Deitz, S.; Korc, M.			microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-beta actions	ONCOGENE			English	Article						pancreatic cancer; miR-10b; EGF receptor; cell invasion	EPIDERMAL-GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; DUCTAL ADENOCARCINOMA; FACTOR RECEPTOR; SIGNALING PATHWAYS; BREAST-CANCER; LUNG-CANCER; MOUSE MODEL; METASTASIS; TUMORIGENESIS	Increased microRNA-10b (miR-10b) expression in the cancer cells in pancreatic ductal adenocarcinoma (PDAC) is a marker of disease aggressiveness. In the present study, we determined that plasma miR-10b levels are significantly increased in PDAC patients by comparison with normal controls. By gene profiling, we identified potential targets downregulated by miR-10b, including Tat-interacting protein 30 (TIP30). Immunoblotting and luciferase reporter assays confirmed that TIP30 was a direct miR-10b target. Downregulation of TIP30 by miR-10b or siRNA-mediated silencing of TIP30 enhanced epidermal growth factor (EGF)-dependent invasion. The actions of miR-10b were abrogated by expressing a modified TIP30 cDNA resistant to miR-10b. EGF-induced EGF receptor (EGFR) tyrosine phosphorylation and extracellular signal-regulated kinase phosphorylation were enhanced by miR-10b, and these effects were mimicked by TIP30 silencing. The actions of EGF in the presence of miR-10b were blocked by EGFR kinase inhibition with erlotinib and by dual inhibition of PI3K (phosphatidylinositol 3'-kinase) and MEK. Moreover, miR-10b, EGF and transforming growth factor-beta (TGF-beta) combined to markedly increase cell invasion, and this effect was blocked by the combination of erlotinib and SB505124, a type I TGF-beta receptor inhibitor. miR-10b also enhanced the stimulatory effects of EGF and TGF-beta on cell migration and epithelial-mesenchymal transition (EMT) and decreased the expression of RAP2A, EPHB2, KLF4 and NF1. Moreover, miR-10b overexpression accelerated pancreatic cancer cell (PCC) proliferation and tumor growth in an orthotopic model. Thus, plasma miR-10b levels may serve as a diagnostic marker in PDAC, whereas intra-tumoral miR-10b promotes PCC proliferation and invasion by suppressing TIP30, which enhances EGFR signaling, facilitates EGF-TGF-beta cross-talk and enhances the expression of EMT-promoting genes, whereas decreasing the expression of several metastasis-suppressing genes. Therefore, therapeutic targeting of miR-10b in PDAC may interrupt growth-promoting deleterious EGF-TGF-beta interactions and antagonize the metastatic process at various levels.	Indiana Univ Sch Med, Dept Med, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Biochem, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Mol Biol, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Pancreat Canc Signature Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Korc, M (corresponding author), Indiana Univ Sch Med, Dept Med, 980 W Walnut St, Indianapolis, IN 46202 USA.	mkorc@iupui.edu			NIH [R37-CA-075059]; NATIONAL CANCER INSTITUTE [R37CA075059, R01CA075059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is dedicated to the fond memory of Victor Fung, Ph.D., a former Program Officer at NCI and former Scientific Review Officer of the Cancer Etiology study section of CSR, NIH, for his wisdom, compassion, integrity, his love of sciences and the arts, his incredible culinary skills, and above all, his contributions to the career development of so many investigators during his own distinguished career. The work was supported, in part, by an NIH grant R37-CA-075059 to M K. HO was a Ph.D. candidate in the Program in Experimental and Molecular Medicine at the Geisel School of Medicine at Dartmouth. We thank the IUSCC Cancer Center at Indiana University School of Medicine for the use of the Tissue Procurement and Distribution Core, which provided pancreatic tissues and patient plasma for microRNA assays. We also thank Dr Hua Xiao at the Michigan State University for generously providing the anti-TIP30 antibody.	Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Carriere C, 2011, GASTROENTEROLOGY, V141, P1091, DOI 10.1053/j.gastro.2011.05.041; Chai GL, 2010, CANCER SCI, V101, P1997, DOI 10.1111/j.1349-7006.2010.01616.x; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Danilov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026815; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; du Rieu MC, 2010, CLIN CHEM, V56, P603, DOI 10.1373/clinchem.2009.137364; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang Y, 2010, P NATL ACAD SCI USA, V107, P13450, DOI 10.1073/pnas.1002120107; Friess H, 1995, CLIN CANCER RES, V1, P1413; FRIESS H, 1993, GASTROENTEROLOGY, V105, P1846, DOI 10.1016/0016-5085(93)91084-U; Gloerich M, 2012, NAT CELL BIOL, V14, P793, DOI 10.1038/ncb2537; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Hata A, 2010, ADV EXP MED BIOL, V700, P15, DOI 10.1007/978-1-4419-7823-3_2; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hinoda Y, 2003, J GASTROENTEROL, V38, P1162, DOI 10.1007/s00535-003-1224-6; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; Ito M, 2003, CANCER RES, V63, P8763; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900; KORC M, 1992, J CLIN INVEST, V90, P1352, DOI 10.1172/JCI116001; Korc M, 1998, Surg Oncol Clin N Am, V7, P25; KORC M, 1986, P NATL ACAD SCI USA, V83, P5141, DOI 10.1073/pnas.83.14.5141; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Lau SKM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036753; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Leveille N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1519; Li A, 2013, ONCOGENE, V32, P2273, DOI 10.1038/onc.2012.253; Li QJ, 2012, TUMOR BIOL, V33, P1455, DOI 10.1007/s13277-012-0396-1; Lim JE, 2003, ANN SURG, V237, P74, DOI 10.1097/00000658-200301000-00011; Lin J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.134; Liu F, 2012, MOL CANCER THER, V11, P2138, DOI 10.1158/1535-7163.MCT-12-0562; Liu LX, 2012, FEBS J, V279, P3800, DOI 10.1111/j.1742-4658.2012.08741.x; Luga V, 2009, BIOCHEM J, V421, P119, DOI 10.1042/BJ20081131; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Matsuda K, 2002, CANCER RES, V62, P5611; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moriarty CH, 2010, J BIOL CHEM, V285, P20541, DOI 10.1074/jbc.M110.121012; Nakata K, 2011, SURGERY, V150, P916, DOI 10.1016/j.surg.2011.06.017; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Neupane D, 2008, CLIN CANCER RES, V14, P7614, DOI 10.1158/1078-0432.CCR-08-1366; Nishida N, 2013, CELL RES, V23, P1157, DOI 10.1038/cr.2013.87; Nishida N, 2012, ANN SURG ONCOL, V19, P3065, DOI 10.1245/s10434-012-2246-1; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Preis M, 2011, CRIT REV EUKAR GENE, V21, P115, DOI 10.1615/CritRevEukarGeneExpr.v21.i2.20; Preis M, 2011, CLIN CANCER RES, V17, P5812, DOI 10.1158/1078-0432.CCR-11-0695; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Sempere LF, 2011, CANCER BIOL THER, V12, P198, DOI 10.4161/cbt.12.3.15979; Senior PV, 2010, INT J COLORECTAL DIS, V25, P687, DOI 10.1007/s00384-010-0916-7; Setoyama T, 2011, CLIN CANCER RES, V17, P5527, DOI 10.1158/1078-0432.CCR-11-1477; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Szafranska AE, 2008, CLIN CHEM, V54, P1716, DOI 10.1373/clinchem.2008.109603; Teixeira Ana L., 2012, Frontiers in Genetics, V3, P286, DOI 10.3389/fgene.2012.00286; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Tong X, 2009, AM J PATHOL, V174, P1931, DOI 10.2353/ajpath.2009.080846; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wagner JP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003994; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; YAMANAKA Y, 1993, HUM PATHOL, V24, P1127, DOI 10.1016/0046-8177(93)90194-L; Yori JL, 2011, NEOPLASIA, V13, P601, DOI 10.1593/neo.11260; Yu GZ, 2011, J CANCER RES CLIN, V137, P73, DOI 10.1007/s00432-010-0861-4; Zhang CL, 2011, J BIOL CHEM, V286, P9373, DOI 10.1074/jbc.M110.207720; Zhang CL, 2010, CANCER RES, V70, P10224, DOI 10.1158/0008-5472.CAN-10-3057; Zhang H, 2008, INT J CANCER, V123, P810, DOI 10.1002/ijc.23638; Zhao J, 2007, HUM PATHOL, V38, P293, DOI 10.1016/j.humpath.2006.08.005	81	106	114	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 18	2014	33	38					4664	4674		10.1038/onc.2013.405	http://dx.doi.org/10.1038/onc.2013.405			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AP3VX	24096486	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000342007200005
J	Shao, JF; He, K; Wang, H; Ho, WS; Ren, XL; An, XM; Wong, MK; Yan, B; Xie, DY; Stamatoyannopoulos, J; Zhao, ZY				Shao, Jiaofang; He, Kan; Wang, Hao; Ho, Wing Sze; Ren, Xiaoliang; An, Xiaomeng; Wong, Ming Kin; Yan, Bin; Xie, Dongying; Stamatoyannopoulos, John; Zhao, Zhongying			Collaborative Regulation of Development but Independent Control of Metabolism by Two Epidermis-specific Transcription Factors in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; elegans; Cell Differentiation; Chromatin Immunoprecipitation (ChIP); Epithelium; Gene Expression; Gene Regulation	NUCLEAR HORMONE-RECEPTORS; GENE-EXPRESSION; INTEGRATIVE ANALYSIS; CELL FATE; LINEAGE; GENOME; NHR-25; DIFFERENTIATION; EMBRYOGENESIS; PROLIFERATION	Cell fate specification is typically initiated by a master regulator, which is relayed by tissue-specific regulatory proteins (usually transcription factors) for further enforcement of cell identities, but how the factors are coordinated among each other to finish up the specification remains poorly understood. Caenorhabditis elegans epidermis specification is initiated by a master regulator, ELT-1, that activates its targets, NHR-25 and ELT-3, two epidermis-specific transcription factors that are important for development but not for initial specification of epidermis, thus providing a unique paradigm for illustrating how the tissue-specific regulatory proteins work together to enforce cell fate specification. Here we addressed the question through contrasting genome-wide in vivo binding targets between NHR-25 and ELT-3. We demonstrate that the two factors bind discrete but conserved DNA motifs, most of which remain in proximity, suggesting formation of a complex between the two. In agreement with this, gene ontology analysis of putative target genes suggested differential regulation of metabolism but coordinated control of epidermal development between the two factors, which is supported by quantitative analysis of expression of their specific or common targets in the presence or absence of either protein. Functional validation of a subset of the target genes showed both activating and inhibitory roles of NHR-25 and ELT-3 in regulating their targets. We further demonstrated differential control of specification of AB and C lineage-derived epidermis. The results allow us to assemble a comprehensive gene network underlying C. elegans epidermis development that is likely to be widely used across species and provides insights into how tissue-specific transcription factors coordinate with one another to enforce cell fate specification initiated by its master regulator.	[Shao, Jiaofang; He, Kan; Ho, Wing Sze; Ren, Xiaoliang; An, Xiaomeng; Wong, Ming Kin; Yan, Bin; Xie, Dongying; Zhao, Zhongying] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Wang, Hao; Stamatoyannopoulos, John] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Hong Kong Baptist University; University of Washington; University of Washington Seattle	Stamatoyannopoulos, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@u.washington.edu; zyzhao@hkbu.edu.hk	Zhao, Zhongying/C-3261-2015; He, Kan/AAG-6325-2020; Zhao, Zhongying/ABF-9458-2021	Zhao, Zhongying/0000-0003-2743-9008; /0000-0002-2168-3379; He, Kan/0000-0002-3385-7129	Collaborative Research Fund of the Research Grants Council in Hong Kong; Hong Kong Baptist University	Collaborative Research Fund of the Research Grants Council in Hong Kong; Hong Kong Baptist University	This work was supported by the Collaborative Research Fund of the Research Grants Council in Hong Kong and a faculty research grant from Hong Kong Baptist University.	Asahina M, 2000, GENES CELLS, V5, P711, DOI 10.1046/j.1365-2443.2000.00361.x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baugh LR, 2005, DEVELOPMENT, V132, P1843, DOI 10.1242/dev.01782; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; CHEN L, 1992, SCIENCE, V256, P240, DOI 10.1126/science.1314423; CHEN LS, 1994, DEVELOPMENT, V120, P1631; Chen Z, 2004, MOL CELL BIOL, V24, P7345, DOI 10.1128/MCB.24.17.7345-7358.2004; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Djabrayan NJV, 2012, GENE DEV, V26, P2386, DOI 10.1101/gad.199588.112; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gilleard JS, 2001, MOL CELL BIOL, V21, P2533, DOI 10.1128/MCB.21.7.2533-2544.2001; Gilleard JS, 1999, DEV BIOL, V208, P265, DOI 10.1006/dbio.1999.9202; Gissendanner CR, 2000, DEV BIOL, V221, P259, DOI 10.1006/dbio.2000.9679; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hajduskova M, 2009, J CELL SCI, V122, P3051, DOI 10.1242/jcs.052373; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hayes GD, 2006, DEVELOPMENT, V133, P4631, DOI 10.1242/dev.02655; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Kuntz SG, 2012, GENOME RES, V22, P1907, DOI 10.1101/gr.133306.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Liu X, 2009, CELL, V139, P623, DOI 10.1016/j.cell.2009.08.044; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Maduro MF, 2009, BBA-GENE REGUL MECH, V1789, P250, DOI 10.1016/j.bbagrm.2008.07.013; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; McClay DR, 2011, DEVELOPMENT, V138, P2639, DOI 10.1242/dev.048967; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mullaney BC, 2010, CELL METAB, V12, P398, DOI 10.1016/j.cmet.2010.08.013; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Murray JI, 2006, NAT PROTOC, V1, P1468, DOI 10.1038/nprot.2006.222; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Nelson MD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002010; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Page BD, 1997, GENE DEV, V11, P1651, DOI 10.1101/gad.11.13.1651; Priess James R, 2005, WormBook, P1; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Sluder AE, 1999, GENOME RES, V9, P103; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Taubert S, 2011, MOL CELL ENDOCRINOL, V334, P49, DOI 10.1016/j.mce.2010.04.021; Tonsaker T, 2012, MECH AGEING DEV, V133, P50, DOI 10.1016/j.mad.2011.09.006; Ulvklo C, 2012, DEVELOPMENT, V139, P678, DOI 10.1242/dev.074500; Venkatesan K, 2003, NUCLEIC ACIDS RES, V31, P4304, DOI 10.1093/nar/gkg644; Walston TD, 2006, SEMIN CELL DEV BIOL, V17, P204, DOI 10.1016/j.semcdb.2006.04.005; Yamada M, 2000, DEVELOPMENT, V127, P5083; Yanai I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.6; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao G, 2012, G3-GENES GENOM GENET, V2, P469, DOI 10.1534/g3.111.001081; Zhao ZY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001089; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848	58	16	19	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33411	33426		10.1074/jbc.M113.487975	http://dx.doi.org/10.1074/jbc.M113.487975			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097988	hybrid, Green Published			2022-12-25	WOS:000328841700054
J	Villa, N; Do, A; Hershey, JWB; Fraser, CS				Villa, Nancy; Do, Angelie; Hershey, John W. B.; Fraser, Christopher S.			Human Eukaryotic Initiation Factor 4G (eIF4G) Protein Binds to eIF3c, -d, and -e to Promote mRNA Recruitment to the Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; Protein Cross-linking; Protein-Protein Interactions; Ribosomes; Translation; Initiation; eIF3; eIF4G	PHOTO-CROSS-LINKING; TRANSLATION FACTOR EIF3; HELICASE ACTIVITY; ESCHERICHIA-COLI; IN-VIVO; DEPENDENT STIMULATION; MASS-SPECTROMETRY; CORE DOMAIN; AMINO-ACID; SUBUNIT	Background: The interaction between eukaryotic initiation factor 4G (eIF4G) and eIF3 promotes translation initiation in mammals. Results: Human eIF3 subunits -c, -d, and -e interact with two subdomains in eIF4G. Conclusion: Multiple contacts between eIF3 and eIF4G are required for mRNA recruitment to the human ribosome. Significance: Characterizing the eIF3-eIF4G interface might reveal a new regulatory mechanism and provide novel therapeutic targets. Recruitment of mRNA to the 40S ribosomal subunit requires the coordinated interaction of a large number of translation initiation factors. In mammals, the direct interaction between eukaryotic initiation factor 4G (eIF4G) and eIF3 is thought to act as the molecular bridge between the mRNA cap-binding complex and the 40S subunit. A discrete approximate to 90 amino acid domain in eIF4G is responsible for binding to eIF3, but the identity of the eIF3 subunit(s) involved is less clear. The eIF3e subunit has been shown to directly bind eIF4G, but the potential role of other eIF3 subunits in stabilizing this interaction has not been investigated. It is also not clear if the eIF4A helicase plays a role in stabilizing the interaction between eIF4G and eIF3. Here, we have used a fluorescence anisotropy assay to demonstrate that eIF4G binds to eIF3 independently of eIF4A binding to the middle region of eIF4G. By using a site-specific cross-linking approach, we unexpectedly show that the eIF4G-binding surface in eIF3 is comprised of the -c, -d and -e subunits. Screening multiple cross-linker positions reveals that eIF4G contains two distinct eIF3-binding subdomains within the previously identified eIF3-binding domain. Finally, by employing an eIF4G-dependent translation assay, we establish that both of these subdomains are required for efficient mRNA recruitment to the ribosome and stimulate translation. Our study reveals unexpected complexity to the eIF3-eIF4G interaction that provides new insight into the regulation of mRNA recruitment to the human ribosome.	[Villa, Nancy; Do, Angelie; Fraser, Christopher S.] Univ Calif Davis, Dept Mol & Cell Biol, Coll Biol Sci, Davis, CA 95616 USA; [Hershey, John W. B.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Fraser, CS (corresponding author), Univ Calif Davis, Dept Mol & Cell Biol, Coll Biol Sci, Davis, CA 95616 USA.	csfraser@ucdavis.edu			National Institutes of Health [R01GM092927]; NIGMS [T32 GM007377]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377, R01GM092927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM092927 and Training Grant T32 GM007377 from the NIGMS (to N. V.).	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; ABRAMSON RD, 1988, J BIOL CHEM, V263, P6016; Bi XP, 2000, BIOCHEMISTRY-US, V39, P5758, DOI 10.1021/bi992322p; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; De Gregorio E, 2001, RNA, V7, P106, DOI 10.1017/S1355838201000577; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Farrelli IS, 2005, NAT METHODS, V2, P377, DOI 10.1038/nmeth0505-377; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; Fraser CS, 2009, PROG MOL BIOL TRANSL, V90, P1, DOI 10.1016/S1877-1173(09)90001-1; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Grunbeck A, 2011, BIOCHEMISTRY-US, V50, P3411, DOI 10.1021/bi200214r; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hinnebusch AG, 2012, COLD SPRING HARB PER, V4; Hinton TM, 2007, J BIOL CHEM, V282, P1695, DOI 10.1074/jbc.M602780200; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; KAUER JC, 1986, J BIOL CHEM, V261, P695; Korneeva NL, 2001, J BIOL CHEM, V276, P2872, DOI 10.1074/jbc.M006345200; Korneeva NL, 2000, J BIOL CHEM, V275, P41369, DOI 10.1074/jbc.M007525200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Morino S, 2000, MOL CELL BIOL, V20, P468, DOI 10.1128/MCB.20.2.468-477.2000; Morris-Desbois C, 2001, J BIOL CHEM, V276, P45988, DOI 10.1074/jbc.M104966200; Ozes AR, 2011, J MOL BIOL, V412, P674, DOI 10.1016/j.jmb.2011.08.004; Ozawa K, 2013, NUCLEIC ACIDS RES, V41, P5354, DOI 10.1093/nar/gkt162; Park EH, 2011, EMBO J, V30, P302, DOI 10.1038/emboj.2010.312; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Prevot D, 2003, EMBO J, V22, P1909, DOI 10.1093/emboj/cdg175; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Searfoss A, 2001, MOL CELL BIOL, V21, P4900, DOI 10.1128/MCB.21.15.4900-4908.2001; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; WEEKS KM, 1992, BIOCHEMISTRY-US, V31, P10281, DOI 10.1021/bi00157a015; Wu CC, 2011, MOL CELL BIOL, V31, P2715, DOI 10.1128/MCB.05151-11; Yanagiya A, 2009, MOL CELL BIOL, V29, P1661, DOI 10.1128/MCB.01187-08; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Yu DM, 2013, J BACTERIOL, V195, P2817, DOI 10.1128/JB.02269-12; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	47	92	96	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32932	32940		10.1074/jbc.M113.517011	http://dx.doi.org/10.1074/jbc.M113.517011			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24092755	Green Published, hybrid			2022-12-25	WOS:000328841700011
J	Minagawa, Y; Ueno, H; Hara, M; Ishizuka-Katsura, Y; Ohsawa, N; Terada, T; Shirouzu, M; Yokoyama, S; Yamato, I; Muneyuki, E; Noji, H; Murata, T; Iino, R				Minagawa, Yoshihiro; Ueno, Hiroshi; Hara, Mayu; Ishizuka-Katsura, Yoshiko; Ohsawa, Noboru; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki; Yamato, Ichiro; Muneyuki, Eiro; Noji, Hiroyuki; Murata, Takeshi; Iino, Ryota			Basic Properties of Rotary Dynamics of the Molecular Motor Enterococcus hirae V-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Enzyme Mechanisms; Molecular Motors; Single-molecule Biophysics; Vacuolar ATPase; V-1-ATPase; V0V1	THERMUS-THERMOPHILUS; PROTON PUMPS; C-SUBUNIT; ROTATION; F-1-ATPASE; ATPASE; RESOLUTION; MECHANISM; CATALYSIS; PURIFICATION	Background: The chemomechanical coupling scheme of the rotary motor V-1-ATPase is incompletely understood. Results:Enterococcus hirae V-1-ATPase (EhV(1)) showed 120 degrees steps of rotation without substeps, as commonly seen with F-1-ATPase. Conclusion: The basic properties of rotary dynamics of EhV(1) are similar to those of Thermus thermophilus V-1-ATPase. Significance: This study revealed the common properties of V-1-ATPases as rotary molecular motors, distinct from those of F-1-ATPases. V-ATPases are rotary molecular motors that generally function as proton pumps. We recently solved the crystal structures of the V-1 moiety of Enterococcus hirae V-ATPase (EhV(1)) and proposed a model for its rotation mechanism. Here, we characterized the rotary dynamics of EhV(1) using single-molecule analysis employing a load-free probe. EhV(1) rotated in a counterclockwise direction, exhibiting two distinct rotational states, namely clear and unclear, suggesting unstable interactions between the rotor and stator. The clear state was analyzed in detail to obtain kinetic parameters. The rotation rates obeyed Michaelis-Menten kinetics with a maximal rotation rate (V-max) of 107 revolutions/s and a Michaelis constant (K-m) of 154 m at 26 degrees C. At all ATP concentrations tested, EhV(1) showed only three pauses separated by 120 degrees/turn, and no substeps were resolved, as was the case with Thermus thermophilus V-1-ATPase (TtV(1)). At 10 m ATP (?K-m), the distribution of the durations of the ATP-waiting pause fit well with a single-exponential decay function. The second-order binding rate constant for ATP was 2.3 x 10(6) m(-1) s(-1). At 40 mm ATP (?K-m), the distribution of the durations of the catalytic pause was reproduced by a consecutive reaction with two time constants of 2.6 and 0.5 ms. These kinetic parameters were similar to those of TtV(1). Our results identify the common properties of rotary catalysis of V-1-ATPases that are distinct from those of F-1-ATPases and will further our understanding of the general mechanisms of rotary molecular motors.	[Minagawa, Yoshihiro; Hara, Mayu; Noji, Hiroyuki; Iino, Ryota] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; [Ueno, Hiroshi; Muneyuki, Eiro] Chuo Univ, Fac Sci & Engn, Dept Phys, Tokyo 1128551, Japan; [Ishizuka-Katsura, Yoshiko; Ohsawa, Noboru; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Yamato, Ichiro] Tokyo Univ Sci, Dept Biol Sci & Technol, Tokyo 1258585, Japan; [Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan; [Murata, Takeshi] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Chiba 2638522, Japan	University of Tokyo; Chuo University; RIKEN; Tokyo University of Science; Chiba University; Japan Science & Technology Agency (JST)	Murata, T (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan.	t.murata@faculty.chiba-u.jp; iino@appchem.t.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Iino, Ryota/B-7746-2011; Murata, Takeshi/J-6181-2017; Shirouzu, Mikako/A-6521-2016	Yokoyama, Shigeyuki/0000-0003-3133-7338; Iino, Ryota/0000-0003-0110-5704; Murata, Takeshi/0000-0002-5748-4670; 	Ministry of Education, Culture, Sports, Science and Technology of Japan;  [24651167];  [23370047]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; 	This work was supported in part by Grants-in-aid for Scientific Research 24651167 (to R. I.) and 23370047 (to T. M.) and the Target Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bilyard T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0023; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Furuike S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1215; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Iino R, 2013, IUBMB LIFE, V65, P238, DOI 10.1002/iub.1120; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; KAKINUMA Y, 1994, J BIOCHEM-TOKYO, V116, P1302, DOI 10.1093/oxfordjournals.jbchem.a124679; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Murata T, 1997, J BIOL CHEM, V272, P24885, DOI 10.1074/jbc.272.40.24885; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Tanigawara M, 2012, BIOPHYS J, V103, P970, DOI 10.1016/j.bpj.2012.06.054; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; Uner NE, 2012, J BIOL CHEM, V287, P28327, DOI 10.1074/jbc.M112.381194; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	27	42	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32700	32707		10.1074/jbc.M113.506329	http://dx.doi.org/10.1074/jbc.M113.506329			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24089518	Green Published, hybrid			2022-12-25	WOS:000328681700054
J	Bendjilali, N; Kim, H; Weinsheimer, S; Guo, DE; Kwok, PY; Zaroff, JG; Sidney, S; Lawton, MT; McCulloch, CE; Koeleman, BPC; Klijn, CJM; Young, WL; Pawlikowska, L				Bendjilali, Nasrine; Kim, Helen; Weinsheimer, Shantel; Guo, Diana E.; Kwok, Pui-Yan; Zaroff, Jonathan G.; Sidney, Stephen; Lawton, Michael T.; McCulloch, Charles E.; Koeleman, Bobby P. C.; Klijn, Catharina J. M.; Young, William L.; Pawlikowska, Ludmila			A Genome-Wide Investigation of Copy Number Variation in Patients with Sporadic Brain Arteriovenous Malformation	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; POLYMORPHISMS; RISK; GENE; ASSOCIATION; SUSCEPTIBILITY; MUTATIONS; IMPACT; NUCLEOTIDE; EXPRESSION	Background: Brain arteriovenous malformations (BAVM) are clusters of abnormal blood vessels, with shunting of blood from the arterial to venous circulation and a high risk of rupture and intracranial hemorrhage. Most BAVMs are sporadic, but also occur in patients with Hereditary Hemorrhagic Telangiectasia, a Mendelian disorder caused by mutations in genes in the transforming growth factor beta (TGF beta) signaling pathway. Methods: To investigate whether copy number variations (CNVs) contribute to risk of sporadic BAVM, we performed a genome-wide association study in 371 sporadic BAVM cases and 563 healthy controls, all Caucasian. Cases and controls were genotyped using the Affymetrix 6.0 array. CNVs were called using the PennCNV and Birdsuite algorithms and analyzed via segment-based and gene-based approaches. Common and rare CNVs were evaluated for association with BAVM. Results: A CNV region on 1p36.13, containing the neuroblastoma breakpoint family, member 1 gene (NBPF1), was significantly enriched with duplications in BAVM cases compared to controls (P = 2.2x10(-9)); NBPF1 was also significantly associated with BAVM in gene-based analysis using both PennCNV and Birdsuite. We experimentally validated the 1p36.13 duplication; however, the association did not replicate in an independent cohort of 184 sporadic BAVM cases and 182 controls (OR = 0.81, P = 0.8). Rare CNV analysis did not identify genes significantly associated with BAVM. Conclusion: We did not identify common CNVs associated with sporadic BAVM that replicated in an independent cohort. Replication in larger cohorts is required to elucidate the possible role of common or rare CNVs in BAVM pathogenesis.	[Bendjilali, Nasrine; Kim, Helen; Weinsheimer, Shantel; Guo, Diana E.; Young, William L.; Pawlikowska, Ludmila] Univ Calif San Francisco, Cerebrovasc Res Ctr, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Kim, Helen; Kwok, Pui-Yan; Pawlikowska, Ludmila] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Kim, Helen; McCulloch, Charles E.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kwok, Pui-Yan] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Zaroff, Jonathan G.; Sidney, Stephen] Kaiser Northern Calif Div Res, San Francisco, CA USA; [Lawton, Michael T.; Young, William L.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Koeleman, Bobby P. C.] Univ Med Ctr, Dept Med Genet, Utrecht, Netherlands; [Klijn, Catharina J. M.] Univ Med Ctr, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Young, William L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco	Pawlikowska, L (corresponding author), Univ Calif San Francisco, Cerebrovasc Res Ctr, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	pawlikowskal@anesthesia.ucsf.edu	Klijn, C.J.M./E-1700-2016; s, s/GYR-2278-2022; s, s/HIK-1178-2022; Kwok, Pui-Yan/F-7725-2014; s, s/HHD-0404-2022	Klijn, C.J.M./0000-0002-8495-4578; Kwok, Pui-Yan/0000-0002-5087-3059; Weinsheimer, Shantel/0000-0001-7486-9110; Bendjilali, Nasrine/0000-0003-1000-0605; Kim, Helen/0000-0002-1937-354X	National Institutes of Health (NIH) [P01 NS044155, R01 NS034949, K23 NS058357]; private Dutch foundation; NIH [P50 NS2372, U19 AI063603]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI063603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044155, K23NS058357, R01NS034949] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); private Dutch foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants: P01 NS044155 (WLY), R01 NS034949 (WLY), and K23 NS058357 (HK). Additional support was provided by "Running for Nona,'' a private Dutch foundation (CJMK). Control cohorts were supported by NIH grants P50 NS2372 (to E. Mignot) and U19 AI063603 (to D. Salomon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achrol AS, 2006, STROKE, V37, P231, DOI 10.1161/01.STR.0000195133.98378.4b; Baross A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-368; Bayrak-Toydemir P, 2006, AM J MED GENET A, V140A, P463, DOI 10.1002/ajmg.a.31101; Blauw Hylke M, 2008, Lancet Neurol, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Bremer A, 2011, AM J MED GENET B, V156B, P115, DOI 10.1002/ajmg.b.31142; Cox D.G., 2012, J BIOTECHNOL BIOMATE, V1, P7, DOI [10.4172/2155-952x.1000119, DOI 10.4172/2155-952X.1000119]; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Eckel-Passow JE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-220; Flechner SM, 2007, TRANSPLANTATION, V83, P883, DOI 10.1097/01.tp.0000258586.52777.4c; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Hao Q, 2010, TRANSL STROKE RES, V1, P197, DOI 10.1007/s12975-010-0020-x; Inoue S, 2007, STROKE, V38, P1368, DOI 10.1161/01.STR.0000260094.03782.59; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kim H, 2011, ACTA NEUROCHIR SUPPL, V111, P83, DOI 10.1007/978-3-7091-0693-8_14; Kim H, 2009, CEREBROVASC DIS, V27, P176, DOI 10.1159/000185609; Kim H, 2009, STROKE, V40, pS95, DOI 10.1161/STROKEAHA.108.533216; Kim J, 2012, J APPL TOXICOL, V32, P342, DOI 10.1002/jat.1677; Koike A, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-29; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lesca G, 2008, EUR J HUM GENET, V16, P742, DOI 10.1038/ejhg.2008.3; Letteboer TGW, 2005, HUM GENET, V116, P8, DOI 10.1007/s00439-004-1196-5; Mamtani M, 2010, GENES IMMUN, V11, P155, DOI 10.1038/gene.2009.71; Marenne G, 2011, HUM MUTAT, V32, P240, DOI 10.1002/humu.21398; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McDonald J, 2011, GENET MED, V13, P607, DOI 10.1097/GIM.0b013e3182136d32; Mikhak B, 2011, CEREBROVASC DIS, V31, P338, DOI 10.1159/000322601; Murphy PA, 2008, P NATL ACAD SCI USA, V105, P10901, DOI 10.1073/pnas.0802743105; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Oikawa M, 2010, EUR J MED GENET, V53, P244, DOI 10.1016/j.ejmg.2010.06.007; Pawlikowska L, 2005, STROKE, V36, P2278, DOI 10.1161/01.STR.0000182253.91167.fa; Pawlikowska L, 2004, STROKE, V35, P2294, DOI 10.1161/01.STR.0000141932.44613.b1; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SABA HI, 1994, NEW ENGL J MED, V330, P1789, DOI 10.1056/NEJM199406233302504; Schwab M, 1996, GENE CHROMOSOME CANC, V16, P211, DOI 10.1002/(SICI)1098-2264(199608)16:4<211::AID-GCC1>3.0.CO;2-0; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sturiale CL, 2013, BRAIN, V136, P665, DOI 10.1093/brain/aws180; Su H, 2010, AM J PATHOL, V176, P1018, DOI 10.2353/ajpath.2010.090453; Tsuang DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014456; van Beijnum J, 2007, J NEUROL NEUROSUR PS, V78, P1213, DOI 10.1136/jnnp.2006.112227; Vandepoele K, 2010, EXP CELL RES, V316, P1225, DOI 10.1016/j.yexcr.2010.01.019; Wain LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008175; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Zhang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014511; ZhuGe QC, 2009, BRAIN, V132, P3231, DOI 10.1093/brain/awp246	56	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e71434	10.1371/journal.pone.0071434	http://dx.doi.org/10.1371/journal.pone.0071434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098321	Green Published, gold, Green Submitted			2022-12-25	WOS:000325483600001
J	Ramos, A; Santos, C; Mateiu, L; Gonzalez, MD; Alvarez, L; Azevedo, L; Amorim, A; Aluja, MP				Ramos, Amanda; Santos, Cristina; Mateiu, Ligia; del Mar Gonzalez, Maria; Alvarez, Luis; Azevedo, Luisa; Amorim, Antonio; Pilar Aluja, Maria			Frequency and Pattern of Heteroplasmy in the Complete Human Mitochondrial Genome	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; DNA CONTROL REGION; NONCODING REGIONS; POINT MUTATION; PROTEIN MODELS; TRANSFER-RNA; HAIR ROOTS; MTDNA; EVOLUTION; SELECTION	Determining the levels of human mitochondrial heteroplasmy is of utmost importance in several fields. In spite of this, there are currently few published works that have focused on this issue. In order to increase the knowledge of mitochondrial DNA (mtDNA) heteroplasmy, the main goal of this work is to investigate the frequency and the mutational spectrum of heteroplasmy in the human mtDNA genome. To address this, a set of nine primer pairs designed to avoid co-amplification of nuclear DNA (nDNA) sequences of mitochondrial origin (NUMTs) was used to amplify the mitochondrial genome in 101 individuals. The analysed individuals represent a collection with a balanced representation of genders and mtDNA haplogroup distribution, similar to that of a Western European population. The results show that the frequency of heteroplasmic individuals exceeds 61%. The frequency of point heteroplasmy is 28.7%, with a widespread distribution across the entire mtDNA. In addition, an excess of transitions in heteroplasmy were detected, suggesting that genetic drift and/or selection may be acting to reduce its frequency at population level. In fact, heteroplasmy at highly stable positions might have a greater impact on the viability of mitochondria, suggesting that purifying selection must be operating to prevent their fixation within individuals. This study analyses the frequency of heteroplasmy in a healthy population, carrying out an evolutionary analysis of the detected changes and providing a new perspective with important consequences in medical, evolutionary and forensic fields.	[Ramos, Amanda; Santos, Cristina; del Mar Gonzalez, Maria; Pilar Aluja, Maria] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Unitat Antropol Biol, E-08193 Barcelona, Spain; [Mateiu, Ligia] Katholieke Univ Leuven, Dept Human Genet, Lab Reprod Genom, Louvain, Belgium; [Alvarez, Luis; Azevedo, Luisa; Amorim, Antonio] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Amorim, Antonio] Univ Porto, Fac Sci, P-4100 Oporto, Portugal	Autonomous University of Barcelona; KU Leuven; Universidade do Porto; Universidade do Porto	Ramos, A (corresponding author), Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Unitat Antropol Biol, E-08193 Barcelona, Spain.	amanda.ramos.reche@gmail.com; cristina.santos@uab.cat	Aluja, Maria Pilar/K-1952-2014; Santos, Cristina/AAE-7665-2020; Mateiu, Ligia/Z-2118-2019; Azevedo, Luisa/J-4051-2013; Amorim, Antonio/A-7938-2008; Ramos, Amanda/K-3739-2014; Alvarez, Luis/J-6022-2013; santos, cristina/K-2348-2014	Aluja, Maria Pilar/0000-0002-0407-9356; Santos, Cristina/0000-0002-7014-8014; Mateiu, Ligia/0000-0002-2655-3581; Azevedo, Luisa/0000-0002-3157-7342; Amorim, Antonio/0000-0002-7518-6247; Ramos, Amanda/0000-0002-9806-6651; Alvarez, Luis/0000-0003-1311-4536; santos, cristina/0000-0002-7014-8014	MEC [CGL2009-08205, CGL2006-07374, CGL2008-03408-E]; Generalitat de Catalunya [2009 SGR 566]; Fundacao para a Ciencia e a Tecnologia; FCT; POPH - QREN - Typology 4.2 - Promoting Scientific Employment; MCTES; European Social Fund	MEC(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); POPH - QREN - Typology 4.2 - Promoting Scientific Employment; MCTES; European Social Fund(European Social Fund (ESF))	This work was supported by MEC (projects: CGL2009-08205; CGL2006-07374; CGL2008-03408-E) and by Generalitat de Catalunya (Ref. 2009 SGR 566). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Education and Science, and is partially supported by Fundacao para a Ciencia e a Tecnologia. L. Alvarez is a FCT postdoctoral fellow (SFRH/BPD/65000/2009) at the IPATIMUP. L. Azevedo is supported by FCT through the program Ciencia2007 (Hiring of PhDs forthe SCTN - financed by POPH - QREN - Typology 4.2 - Promoting Scientific Employment, co-financed by MCTES national funding and The European Social Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 1998, J FORENSIC SCI, V43, P453; Alvarez L, 2010, AM J PHYS ANTHROPOL, V142, P531, DOI 10.1002/ajpa.21252; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Avital G, 2012, HUM MOL GENET, V21, P4214, DOI 10.1093/hmg/dds245; Azevedo L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-266; Bendall KE, 1997, AM J HUM GENET, V61, P1303, DOI 10.1086/301636; Calloway CD, 2000, AM J HUM GENET, V66, P1384, DOI 10.1086/302844; Cavelier L, 2000, HUM GENET, V107, P45, DOI 10.1007/s004390050009; de Camargo MA, 2011, MOL BIOL REP, V38, P1219, DOI 10.1007/s11033-010-0220-1; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; Fauser S, 2002, BIOCHEM BIOPH RES CO, V295, P342, DOI 10.1016/S0006-291X(02)00672-1; Gasparre G, 2013, COLD SPRING HARB PER, V5; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Goto H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r59; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Grzybowski T, 2003, ELECTROPHORESIS, V24, P1159, DOI 10.1002/elps.200390149; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; HOLM L, 1992, J MOL BIOL, V225, P93, DOI 10.1016/0022-2836(92)91028-N; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Howell N, 2000, J NEUROL SCI, V172, P1, DOI 10.1016/S0022-510X(99)00207-5; Irwin JA, 2009, J MOL EVOL, V68, P516, DOI 10.1007/s00239-009-9227-4; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382; Kirches E, 2001, J MED GENET, V38, P312, DOI 10.1136/jmg.38.5.312; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Leo-Kottler B, 2002, GRAEF ARCH CLIN EXP, V240, P758, DOI 10.1007/s00417-002-0494-7; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Miller WG, 2008, OPENSTAT; Nachman MW, 1996, GENETICS, V142, P953; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Parr RL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-185; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Putz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407; Ramos A, 2011, ELECTROPHORESIS, V32, P782, DOI 10.1002/elps.201000583; Ramos A, 2009, ELECTROPHORESIS, V30, P1587, DOI 10.1002/elps.200800601; Rand DM, 2001, ANNU REV ECOL SYST, V32, P415, DOI 10.1146/annurev.ecolsys.32.081501.114109; Raymond M, 2001, GENEPOP 3 3 POPULATI; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141; Santos C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-167; Santos C, 2008, J MOL EVOL, V67, P191, DOI 10.1007/s00239-008-9138-9; Schriner SE, 2000, FREE RADICAL BIO MED, V29, P664, DOI 10.1016/S0891-5849(00)00352-X; Schrodinger L., 2020, PYMOL; SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Sobenin IA, 2013, CURR PHARM DES; *SPSS INC, 1989, SPSS 15 0 1 WIND; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; Wei YL, 2009, CLIN EXP PHARMACOL P, V36, P933, DOI 10.1111/j.1440-1681.2009.05183.x; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606	60	57	60	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74636	10.1371/journal.pone.0074636	http://dx.doi.org/10.1371/journal.pone.0074636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098342	gold, Green Submitted, Green Published			2022-12-25	WOS:000325434500013
J	Alvarez, LAJ; Bourke, B; Pircalabioru, G; Georgiev, AY; Knaus, UG; Daff, S; Corcionivoschi, N				Alvarez, Luis A. J.; Bourke, Billy; Pircalabioru, Gratiela; Georgiev, Atanas Y.; Knaus, Ulla G.; Daff, Simon; Corcionivoschi, Nicolae			Cj1411c Encodes for a Cytochrome P450 Involved in Campylobacter jejuni 81-176 Pathogenicity	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; LIPOPOLYSACCHARIDE; IDENTIFICATION; COMPLEMENT; VIRULENCE; GENE	Cytochrome P450s are b-heme-containing enzymes that are able to introduce oxygen atoms into a wide variety of organic substrates. They are extremely widespread in nature having diverse functions at both biochemical and physiological level. The genome of C. jejuni 81-176 encodes a single cytochrome P450 (Cj1411c) that has no close homologues. Cj1411c is unusual in its genomic location within a cluster involved in the biosynthesis of outer surface structures. Here we show that E. coli expressed and affinity-purified C. jejuni cytochrome P450 is lipophilic, containing one equivalent Cys-ligated heme. Immunoblotting confirmed the association of cytochrome P450 with membrane fractions. A Cj1411c deletion mutant had significantly reduced ability to infect human cells and was less able to survive following exposure to human serum when compared to the wild type strain. Phenotypically following staining with Alcian blue, we show that a Cj1411c deletion mutant produces significantly less capsular polysaccharide. This study describes the first known membrane-bound bacterial cytochrome P450 and its involvement in Campylobacter virulence.	[Alvarez, Luis A. J.; Bourke, Billy; Knaus, Ulla G.; Corcionivoschi, Nicolae] Our Ladys Childrens Hosp Crumlin, Natl Childrens Res Ctr, Dublin, Ireland; [Bourke, Billy; Pircalabioru, Gratiela; Knaus, Ulla G.] Univ Coll Dublin, Conway Inst, Sch Med & Med Sci, Dublin 2, Ireland; [Georgiev, Atanas Y.; Daff, Simon] Univ Edinburgh, Sch Chem, Edinburgh, Midlothian, Scotland; [Corcionivoschi, Nicolae] Banats Univ Agr Sci & Vet Med, Sch Anim Sci & Biotechnol, Timisoara, Romania	National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University College Dublin; University of Edinburgh; Banat University of Agricultural Sciences & Veterinary Medicine	Corcionivoschi, N (corresponding author), Our Ladys Childrens Hosp Crumlin, Natl Childrens Res Ctr, Dublin, Ireland.	nicolae.corcionivoschi@ucd.ie	Corcionivoschi, nicolae/L-8778-2019; Gradisteanu, Gratiela/GYJ-6972-2022; Alvarez, Luis/H-1946-2012; Gradisteanu, Gratiela/AAE-1875-2019	Alvarez, Luis/0000-0003-1316-1906; Corcionivoschi, Nicolae/0000-0002-3011-3108; GRADISTEANU PIRCALABIORU, GRATIELA/0000-0002-6384-1822	National Children's Research Centre [K12/2]	National Children's Research Centre	This work was supported by the National Children's Research Centre, grant K12/2 awarded to NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachtiar BM, 2007, FEMS IMMUNOL MED MIC, V49, P149, DOI 10.1111/j.1574-695X.2006.00182.x; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; BLASER MJ, 1985, J INFECT DIS, V151, P227, DOI 10.1093/infdis/151.2.227; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; Corcionivoschi N, 2009, INFECT IMMUN, V77, P1959, DOI 10.1128/IAI.01239-08; Corcionivoschi N, 2012, CELL HOST MICROBE, V12, P47, DOI 10.1016/j.chom.2012.05.018; Cordwell SJ, 2008, PROTEOMICS, V8, P122, DOI 10.1002/pmic.200700561; Davis L, 2008, GENETIC MANIPULATION; Davydov R, 2013, BIOCHEMISTRY-US, V52, P667, DOI 10.1021/bi301527c; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Hansen CR, 2007, LETT APPL MICROBIOL, V45, P599, DOI 10.1111/j.1472-765X.2007.02232.x; HITCHCOCK PJ, 1983, EUR J BIOCHEM, V133, P685, DOI 10.1111/j.1432-1033.1983.tb07517.x; Karlyshev AV, 2001, J CLIN MICROBIOL, V39, P279, DOI 10.1128/JCM.39.1.279-284.2001; Lamb DC, 2002, J BIOL CHEM, V277, P24000, DOI 10.1074/jbc.M111109200; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12410, DOI 10.1021/bi049132l; Li ZZ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-130; Luthra A, 2013, Methods Mol Biol, V987, P115, DOI 10.1007/978-1-62703-321-3_10; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; McLennan MK, 2008, J BACTERIOL, V190, P1097, DOI 10.1128/JB.00516-07; Ost TWB, 2003, J AM CHEM SOC, V125, P15010, DOI 10.1021/ja035731o; Rahn A, 1999, J BACTERIOL, V181, P2307, DOI 10.1128/JB.181.7.2307-2313.1999; ROBERSON EB, 1992, APPL ENVIRON MICROB, V58, P1284, DOI 10.1128/AEM.58.4.1284-1291.1992; Verma S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025273; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771	27	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75534	10.1371/journal.pone.0075534	http://dx.doi.org/10.1371/journal.pone.0075534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086558	Green Submitted, gold, Green Published			2022-12-25	WOS:000325220000025
J	Wei, Q; Wang, HH; Tian, YH; Xu, FC; Chen, XW; Wang, K				Wei, Qiang; Wang, Honghao; Tian, Yanghua; Xu, Fangcheng; Chen, Xianwen; Wang, Kai			Reduced Serum Levels of Triglyceride, Very Low Density Lipoprotein Cholesterol and Apolipoprotein B in Parkinson's Disease Patients	PLOS ONE			English	Article							RISK-FACTORS; ADRENOCORTICOTROPIC HORMONE; ISCHEMIC-STROKE; LIPIDS; ATHEROSCLEROSIS; HYPERTENSION; CORTISOL	Background: Previous studies have shown a lower incidence of stroke in Parkinson's disease (PD) patients. The role of the lipids and lipoproteins as risk factors for stroke is uncertain in the lower prevalence of stroke in PD patients. Objectives: To explore the lipids and lipoproteins serum levels in PD patients. Methods: A retrospective study was performed on 110 PD patients (PD group), 130 controls with non-cerebrovascular neurological diseases (OD group), 140 acute intracerebral hemorrhage patients (ICH group) and 140 acute cerebral infarction patients (CI group). The records about serum levels of lipids and lipoproteins were analyzed. Results: There were significant differences for the serum level of triglyceride (F = 5.031, p=0.002), very low density lipoprotein cholesterol (F = 5.313, p=0.001), apolipoprotein B (F = 16.038, p<0.0001) in the four groups. PD group had a significantly lower serum level of triglyceride (TG) than the OD (p=0.032), ICH (p=0.00047) and CI (p=0.001) groups. Very low density lipoprotein cholesterol (VLDL-C) serum level was significantly lower in PD group than in OD (p=0.039), ICH (p=0.00021) and CI (p=0.001) groups. There was a significantly lower serum level of apolipoprotein B (apo B) in PD group than in OD (p=0.002), ICH (p<0.0001) and CI (p<0.0001) groups. Conclusions: There are reduced serum levels of TG, VLDL-C and apo B in PD patients, which may be related to the decreased prevalence of stroke in PD patients.	[Wei, Qiang; Wang, Honghao; Tian, Yanghua; Xu, Fangcheng; Chen, Xianwen; Wang, Kai] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China	Anhui Medical University	Wang, K (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China.	wangkai1964@126.com	wang, honghao/AAF-5764-2020	wang, honghao/0000-0002-1215-6219; Tian, Yanghua/0000-0001-5038-0599				Ahmed E, 1999, STROKE, V30, P2541, DOI 10.1161/01.STR.30.12.2541; Barichella M, 2003, EUR J CLIN NUTR, V57, P543, DOI 10.1038/sj.ejcn.1601581; BELLOMO G, 1991, J NEUROL, V238, P19, DOI 10.1007/BF00319704; Benson RT, 2000, NEUROL CLIN, V18, P309, DOI 10.1016/S0733-8619(05)70194-8; Berg AL, 2006, METABOLISM, V55, P1083, DOI 10.1016/j.metabol.2006.04.001; Bhatia M, 2006, CEREBROVASC DIS, V21, P323, DOI 10.1159/000091537; CALNE DB, 1992, ANN NEUROL, V32, pS125, DOI 10.1002/ana.410320721; Cannon CP, 2008, AM J CARDIOL, V102, p5L, DOI 10.1016/j.amjcard.2008.09.067; Cui K, 2012, CELL IMMUNOL, V272, P290, DOI 10.1016/j.cellimm.2011.09.013; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gorelick PB, 1997, NEUROEPIDEMIOLOGY, V16, P107, DOI 10.1159/000109679; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Holme I, 2009, J INTERN MED, V265, P275, DOI 10.1111/j.1365-2796.2008.02016.x; Kimura Takashi, 2002, Masui, V51, P286; Korten A, 2001, MOVEMENT DISORD, V16, P119, DOI 10.1002/1531-8257(200101)16:1<119::AID-MDS1024>3.0.CO;2-W; Krauss RM, 1998, AM J CARDIOL, V81, p13B, DOI 10.1016/S0002-9149(98)00032-0; Labreuche J, 2009, ATHEROSCLEROSIS, V203, P331, DOI 10.1016/j.atherosclerosis.2008.08.040; Laloux P, 2004, ACTA NEUROL BELG, V104, P13; LEVINE RL, 1992, STROKE, V23, P839, DOI 10.1161/01.STR.23.6.839; MURAI A, 1986, TOHOKU J EXP MED, V148, P57, DOI 10.1620/tjem.148.57; Nataraj A, 2005, MOVEMENT DISORD, V20, P1476, DOI 10.1002/mds.20608; Norata GD, 2009, ATHEROSCLEROSIS, V206, P556, DOI 10.1016/j.atherosclerosis.2009.03.017; Nutt JG, 2005, NEW ENGL J MED, V353, P1021, DOI 10.1056/NEJMcp043908; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Pfeiffer RF, 2009, NAT REV NEUROL, V5, P531, DOI 10.1038/nrneurol.2009.156; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Scigliano G, 2006, STROKE, V37, P1184, DOI 10.1161/01.STR.0000217384.03237.9c; Scigliano G, 2009, PARKINSONISM RELAT D, V15, P138, DOI 10.1016/j.parkreldis.2008.04.036; SHIEH S-M, 1985, Proceedings of the National Science Council Republic of China Part B Life Sciences, V9, P298; STRUCK LK, 1990, STROKE, V21, P1395, DOI 10.1161/01.STR.21.10.1395; van der Marck MA, 2012, PARKINSONISM RELAT D, V18, P263, DOI 10.1016/j.parkreldis.2011.10.016; WOO J, 1991, STROKE, V22, P203, DOI 10.1161/01.STR.22.2.203	33	30	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75743	10.1371/journal.pone.0075743	http://dx.doi.org/10.1371/journal.pone.0075743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086623	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000037
J	Liang, W; Tonini, G; Mulder, P; Kelder, T; van Erk, M; van den Hoek, AM; Mariman, R; Wielinga, PY; Baccini, M; Kooistra, T; Biggeri, A; Kleemann, R				Liang, Wen; Tonini, Giulia; Mulder, Petra; Kelder, Thomas; van Erk, Marjan; van den Hoek, Anita M.; Mariman, Rob; Wielinga, Peter Y.; Baccini, Michela; Kooistra, Teake; Biggeri, Annibale; Kleemann, Robert			Coordinated and Interactive Expression of Genes of Lipid Metabolism and Inflammation in Adipose Tissue and Liver during Metabolic Overload	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; FAT; INSULIN; OBESITY; SP1; DIET; PPAR; CERAMIDE; BIOLOGY; DISEASE	Background: Chronic metabolic overload results in lipid accumulation and subsequent inflammation in white adipose tissue (WAT), often accompanied by non-alcoholic fatty liver disease (NAFLD). In response to metabolic overload, the expression of genes involved in lipid metabolism and inflammatory processes is adapted. However, it still remains unknown how these adaptations in gene expression in expanding WAT and liver are orchestrated and whether they are interrelated. Methodology/Principal Findings: ApoE*3Leiden mice were fed HFD or chow for different periods up to 12 weeks. Gene expression in WAT and liver over time was evaluated by micro-array analysis. WAT hypertrophy and inflammation were analyzed histologically. Bayesian hierarchical cluster analysis of dynamic WAT gene expression identified groups of genes ('clusters') with comparable expression patterns over time. HFD evoked an immediate response of five clusters of 'lipid metabolism' genes in WAT, which did not further change thereafter. At a later time point (>6 weeks), inflammatory clusters were induced. Promoter analysis of clustered genes resulted in specific key regulators which may orchestrate the metabolic and inflammatory responses in WAT. Some master regulators played a dual role in control of metabolism and inflammation. When WAT inflammation developed (>6 weeks), genes of lipid metabolism and inflammation were also affected in corresponding livers. These hepatic gene expression changes and the underlying transcriptional responses in particular, were remarkably similar to those detected in WAT. Conclusion: In WAT, metabolic overload induced an immediate, stable response on clusters of lipid metabolism genes and induced inflammatory genes later in time. Both processes may be controlled and interlinked by specific transcriptional regulators. When WAT inflammation began, the hepatic response to HFD resembled that in WAT. In all, WAT and liver respond to metabolic overload by adaptations in expression of gene clusters that control lipid metabolism and inflammatory processes in an orchestrated and interrelated manner.	[Liang, Wen; Mulder, Petra; van den Hoek, Anita M.; Mariman, Rob; Wielinga, Peter Y.; Kooistra, Teake; Kleemann, Robert] TNO, Dept Metab Hlth Res, Leiden, Netherlands; [Tonini, Giulia; Baccini, Michela; Kooistra, Teake] Canc Prevent & Res Inst, Biostat Unit, Florence, Italy; [Kelder, Thomas; van Erk, Marjan] TNO, Dept Microbiol & Syst Biol, NL-3700 AJ Zeist, Netherlands; [Tonini, Giulia; Baccini, Michela; Biggeri, Annibale] Univ Florence, Dept Stat Informat & Applicat G Parenti, Florence, Italy	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; University of Florence	Kleemann, R (corresponding author), TNO, Dept Metab Hlth Res, Leiden, Netherlands.	Robert.kleemann@tno.nl		Mulder, Petra/0000-0002-0982-4466; Mariman, Rob/0000-0001-6405-1091	TNO research program Biomedical Innovations 'Personalized health/Op Maat'; European Nutrigenomics Organisation (NuGO) [CT-2004-505944]; Center for Translational Molecular Medicine [01C-104]; Dutch Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation	TNO research program Biomedical Innovations 'Personalized health/Op Maat'; European Nutrigenomics Organisation (NuGO); Center for Translational Molecular Medicine; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation	This present study was mainly sponsored by the TNO research program Biomedical Innovations 'Personalized health/Op Maat' (to WL, RM, PM, T. Kooistra, MvE, AvdH, T. Kelder, PW, RK). The authors gratefully acknowledge additional grant support from the European Nutrigenomics Organisation (NuGO, CT-2004-505944 to GT, AB, MB, MvE, RK). WL was sponsored by the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (grant 01C-104), supported by the Dutch Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2006, ANNU REV GENOM HUM G, V7, P175, DOI 10.1146/annurev.genom.7.080505.115715; Anghel SI, 2007, CELL RES, V17, P486, DOI 10.1038/cr.2007.48; Baccini M, 2008, GENES NUTR, V3, P147, DOI 10.1007/s12263-008-0102-5; Boini KM, 2010, J PHARMACOL EXP THER, V334, P839, DOI 10.1124/jpet.110.168815; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Caesar R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011525; Catelan D, 2010, BIOMETRICAL J, V52, P784, DOI 10.1002/bimj.200900209; Chaput JP, 2012, OBES REV, V13, P681, DOI 10.1111/j.1467-789X.2012.00992.x; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cooke EJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-399; De Groot PJ, 2008, GENES NUTR, V3, P143, DOI 10.1007/s12263-008-0093-2; de Wit NJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019145; Duan R, 1998, ENDOCRINOLOGY, V139, P1981, DOI 10.1210/en.139.4.1981; Duivenvoorden I, 2006, AM J CLIN NUTR, V84, P312; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Hotamisligil GS, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.238; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Keophiphath M, 2010, ARTERIOSCL THROM VAS, V30, P39, DOI 10.1161/ATVBAHA.109.197442; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Kleemann R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-125; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Krasowski MD, 2011, MOL CELL ENDOCRINOL, V334, P39, DOI 10.1016/j.mce.2010.06.016; Kreeft AJ, 2005, ATHEROSCLEROSIS, V182, P249, DOI 10.1016/j.atherosclerosis.2005.01.049; Li C, 2001, ENDOCRINOLOGY, V142, P1546, DOI 10.1210/en.142.4.1546; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mollica MP, 2011, NUTR METAB CARDIOVAS, V21, P222, DOI 10.1016/j.numecd.2010.10.012; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pihlajamaki J, 2012, J HEPATOL, V56, P663, DOI 10.1016/j.jhep.2011.10.005; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Shah C, 2008, J BIOL CHEM, V283, P13538, DOI 10.1074/jbc.M709950200; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; SONDERGAARD L, 1993, TRENDS GENET, V9, P193, DOI 10.1016/0168-9525(93)90113-V; Strissel KJ, 2010, OBESITY, V18, P1918, DOI 10.1038/oby.2010.1; Sun GL, 1998, MOL ENDOCRINOL, V12, P882, DOI 10.1210/me.12.6.882; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Ulven SM, 2005, PROSTAG LEUKOTR ESS, V73, P59, DOI 10.1016/j.plefa.2005.04.009; van Erk MJ, 2008, GENES NUTR, V3, P127, DOI 10.1007/s12263-008-0096-z; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Verschuren L, 2009, J LIPID RES, V50, P301, DOI 10.1194/jlr.M800374-JLR200; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wielinga PY, 2012, MOL NUTR FOOD RES, V56, P1081, DOI 10.1002/mnfr.201100762; Zadelaar ASM, 2006, ARTERIOSCL THROM VAS, V26, P2560, DOI 10.1161/01.ATV.0000242904.34700.66	54	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75290	10.1371/journal.pone.0075290	http://dx.doi.org/10.1371/journal.pone.0075290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086498	Green Published, gold			2022-12-25	WOS:000325218700070
J	Moodley, D; Geerts, S; Richardson, DM; Wilson, JRU				Moodley, Desika; Geerts, Sjirk; Richardson, David M.; Wilson, John R. U.			Different Traits Determine Introduction, Naturalization and Invasion Success In Woody Plants: Proteaceae as a Test Case	PLOS ONE			English	Article							ALIEN PLANTS; PROPAGULE PRESSURE; AUSTRALIAN ACACIAS; INVASIVENESS; BANKSIA; ATTRIBUTES; LESSONS; BIOLOGY; SPREAD; PINUS	A major aim of invasion ecology is to identify characteristics of successful invaders. However, most plant groups studied in detail (e. g. pines and acacias) have a high percentage of invasive taxa. Here we examine the global introduction history and invasion ecology of Proteaceae-a large plant family with many taxa that have been widely disseminated by humans, but with few known invaders. To do this we compiled a global list of species and used boosted regression tree models to assess which factors are important in determining the status of a species (not introduced, introduced, naturalized or invasive). At least 402 of 1674 known species (24%) have been moved by humans out of their native ranges, 58 species (14%) have become naturalized but not invasive, and 8 species (2%) are invasive. The probability of naturalization was greatest for species with large native ranges, low susceptibility to Phytophthora root-rot fungus, large mammal-dispersed seeds, and with the capacity to resprout. The probability of naturalized species becoming invasive was greatest for species with large native ranges, those used as barrier plants, tall species, species with small seeds, and serotinous species. The traits driving invasiveness of Proteaceae were similar to those for acacias and pines. However, while some traits showed a consistent influence at introduction, naturalization and invasion, others appear to be influential at one stage only, and some have contrasting effects at different stages. Trait-based analyses therefore need to consider different invasion stages separately. On their own, these observations provide little predictive power for risk assessment, but when the causative mechanisms are understood (e. g. Phytophthora susceptibility) they provide valuable insights. As such there is considerable value in seeking the correlates and mechanisms underlying invasions for particular taxonomic or functional groups.	[Moodley, Desika; Geerts, Sjirk; Richardson, David M.; Wilson, John R. U.] Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, ZA-7600 Stellenbosch, South Africa; [Moodley, Desika; Geerts, Sjirk; Wilson, John R. U.] Kirstenbosch Res Ctr, South African Natl Biodivers Inst, Invas Species Programme, Cape Town, South Africa	Stellenbosch University; South African National Biodiversity Institute	Moodley, D (corresponding author), Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, ZA-7600 Stellenbosch, South Africa.	desikamoodley29@gmail.com	Geerts, Sjirk/AAQ-6375-2021; Geerts, Sjirk/B-9659-2011; Wilson, John/B-4101-2008; Richardson, David M/A-1495-2008	Wilson, John/0000-0003-0174-3239; Richardson, David M/0000-0001-9574-8297; Geerts, Sjirk/0000-0003-0149-2783; Moodley, Desika/0000-0002-0788-2136	South African National Biodiversity Institute's Invasive Species Programme; Working for Water Programme of the Natural Resources Management Programmes (Department of Environmental Affairs); DST-NRF Centre of Excellence for Invasion Biology; National Research Foundation	South African National Biodiversity Institute's Invasive Species Programme; Working for Water Programme of the Natural Resources Management Programmes (Department of Environmental Affairs); DST-NRF Centre of Excellence for Invasion Biology(Department of Science & Technology (India)); National Research Foundation	The authors acknowledge financial support from the South African National Biodiversity Institute's Invasive Species Programme, the Working for Water Programme of the Natural Resources Management Programmes (Department of Environmental Affairs), and the DST-NRF Centre of Excellence for Invasion Biology. DMR also acknowledges funding from the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bufford J.L., 2011, ENCY BIOL INVASIONS, P437; Cadotte MW, 2006, BIOL INVASIONS, V8, P809, DOI 10.1007/s10530-005-3839-4; Coetzee JH, 2001, PROTEACEOUS ORNAMENT, P77; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; COLLINS BG, 1987, AUST J ECOL, V12, P387, DOI 10.1111/j.1442-9993.1987.tb00958.x; COWLING RM, 1985, AUST J ECOL, V10, P345, DOI 10.1111/j.1442-9993.1985.tb00895.x; Dawson W, 2009, J ECOL, V97, P657, DOI 10.1111/j.1365-2745.2009.01519.x; Dehnen-Schmutz K, 2007, CONSERV BIOL, V21, P224, DOI 10.1111/j.1523-1739.2006.00538.x; Diez JM, 2012, BIOL INVASIONS, V14, P681, DOI 10.1007/s10530-011-0109-5; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Geerts S, AUSTRAL ECOLOGY; Gravuer K, 2008, P NATL ACAD SCI USA, V105, P6344, DOI 10.1073/pnas.0712026105; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Higgins SI, 2008, J ECOL, V96, P679, DOI 10.1111/j.1365-2745.2008.01391.x; HONIG MA, 1992, AUST J ECOL, V17, P305, DOI 10.1111/j.1442-9993.1992.tb00812.x; Hui C, 2011, DIVERS DISTRIB, V17, P872, DOI 10.1111/j.1472-4642.2011.00804.x; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kuster EC, 2008, J ECOL, V96, P860, DOI 10.1111/j.1365-2745.2008.01406.x; Lambers H, 2011, PLANT PHYSIOL, V156, P1058, DOI 10.1104/pp.111.174318; Leonhardt K, 1999, PERSPECTIVES NEW CRO; Lloret F, 2005, J ECOL, V93, P512, DOI 10.1111/j.1365-2745.2005.00979.x; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Mast AR, 2007, AUST SYST BOT, V20, P63, DOI 10.1071/SB06016; McGregor KF, 2012, DIVERS DISTRIB, V18, P1013, DOI 10.1111/j.1472-4642.2012.00942.x; Middelmann M., 2012, PROTEAS BIRTH WORLDW; Milbau A, 2008, CONSERV BIOL, V22, P308, DOI 10.1111/j.1523-1739.2007.00877.x; Myerscough P. J., 2000, Cunninghamia, V6, P951; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek P, 2008, INVASIVE PLANTS, P2011; Pysek Petr, 2007, V193, P97; Pysek P, 2009, ECOLOGY, V90, P2734, DOI 10.1890/08-0857.1; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; R Development Core Team, 2009, R FDN STAT COMP; REBELO AG, 1995, SASOL PROTEAS FIELD; Reichard SH, 2001, BIOSCIENCE, V51, P103, DOI 10.1641/0006-3568(2001)051[0103:HAAPOI]2.0.CO;2; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rejmanek M, 1996, BIOL CONSERV, V78, P171, DOI 10.1016/0006-3207(96)00026-2; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson DM, 2012, NEW PHYTOL, V196, P383, DOI 10.1111/j.1469-8137.2012.04292.x; Richardson DM, 2011, DIVERS DISTRIB, V17, P771, DOI 10.1111/j.1472-4642.2011.00824.x; Richardson DM, 2011, DIVERS DISTRIB, V17, P788, DOI 10.1111/j.1472-4642.2011.00782.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; RICHARDSON DM, 1990, J VEG SCI, V1, P629, DOI 10.2307/3235569; Ridgeway G, 2012, GBM GEN BOOSTED REGR; Schmidt JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017391; Sedgley M, 2007, PROTEACEOUS ORNAMENT; Simberloff D, 2010, AUSTRAL ECOL, V35, P489, DOI 10.1111/j.1442-9993.2009.02058.x; Swart, 2004, CULTIVATION DIS PROT; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Van Kleunen M, 2007, J ECOL, V95, P674, DOI 10.1111/j.1365-2745.2007.01250.x; Vila M, 2011, LANDSCAPE ECOL, V26, P461, DOI 10.1007/s10980-011-9585-3; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Weston Peter H., 2006, Telopea, V11, P314	58	59	61	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75078	10.1371/journal.pone.0075078	http://dx.doi.org/10.1371/journal.pone.0075078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086442	Green Submitted, Green Published, gold			2022-12-25	WOS:000325025200023
J	Rollason, R; Dunstan, K; Billcliff, PG; Bishop, P; Gleeson, P; Wise, H; Digard, P; Banting, G				Rollason, Ruth; Dunstan, Katie; Billcliff, Peter G.; Bishop, Paul; Gleeson, Paul; Wise, Helen; Digard, Paul; Banting, George			Expression of HIV-1 Vpu Leads to Loss of the Viral Restriction Factor CD317/Tetherin from Lipid Rafts and Its Enhanced Lysosomal Degradation	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; STROMAL CELL ANTIGEN-2; TRANSMEMBRANE DOMAIN; PROTEIN; BST-2/TETHERIN; RELEASE; SURFACE; BST-2; BST2/TETHERIN; SENSITIVITY	CD317/tetherin (aka BST2 or HM1.24 antigen) is an interferon inducible membrane protein present in regions of the lipid bilayer enriched in sphingolipids and cholesterol (often termed lipid rafts). It has been implicated in an eclectic mix of cellular processes including, most notably, the retention of fully formed viral particles at the surface of cells infected with HIV and other enveloped viruses. Expression of the HIV viral accessory protein Vpu has been shown to lead to intracellular sequestration and degradation of tetherin, thereby counteracting the inhibition of viral release. There is evidence that tetherin interacts directly with Vpu, but it remains unclear where in the cell this interaction occurs or if Vpu expression affects the lipid raft localisation of tetherin. We have addressed these points using biochemical and cell imaging approaches focused on endogenous rather than ectopically over-expressed tetherin. We find i) no evidence for an interaction between Vpu and endogenous tetherin at the cell surface, ii) the vast majority of endogenous tetherin that is at the cell surface in control cells is in lipid rafts, iii) internalised tetherin is present in non-raft fractions, iv) expression of Vpu in cells expressing endogenous tetherin leads to the loss of tetherin from lipid rafts, v) internalised tetherin enters early endosomes, and late endosomes, in both control cells and cells expressing Vpu, but the proportion of tetherin molecules destined for degradation rather than recycling is increased in cells expressing Vpu vi) lysosomes are the primary site for degradation of endogenous tetherin in cells expressing Vpu. Our studies underlie the importance of studying endogenous tetherin and let us propose a model in which Vpu intercepts newly internalised tetherin and diverts it for lysosomal destruction rather than recycling to the cell surface.	[Rollason, Ruth; Dunstan, Katie; Billcliff, Peter G.; Bishop, Paul; Banting, George] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Gleeson, Paul] Univ Melbourne, Inst Bio21, Melbourne, Vic, Australia; [Wise, Helen; Digard, Paul] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland	University of Bristol; University of Melbourne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Banting, G (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	g.banting@bristol.ac.uk	Digard, Paul/B-7717-2008	Digard, Paul/0000-0002-0872-9440; Emery-Billcliff, Peter/0000-0002-4448-6175; Banting, George/0000-0001-8249-1621; Rollason, Ruth/0000-0001-5834-6360	Wellcome Trust [086783/Z/08/Z]; Leverhulme Trust [2009/0621]; Royal Society [TG101953]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864, BB/G021031/1] Funding Source: researchfish; BBSRC [BB/G021031/1, BBS/E/D/20241864] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by The Wellcome Trust http://www.wellcome.ac.uk (086783/Z/08/Z), the Leverhulme Trust http://www.leverhulme.ac.uk (2009/0621) and the Royal Society http://royalsociety.org (TG101953). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SM, 2002, STRUCTURE, V10, P1085, DOI 10.1016/S0969-2126(02)00808-0; Andrew A, 2010, MOL ASPECTS MED, V31, P407, DOI 10.1016/j.mam.2010.08.002; Andrew AJ, 2011, J BIOL CHEM, V286, P39967, DOI 10.1074/jbc.M111.287011; Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Bernal AL, 2007, SEMIN CELL DEV BIOL, V18, P340, DOI 10.1016/j.semcdb.2007.05.002; BERNAL AL, 2007, PRETERM BIRTH MECH M, P167; Billcliff PG, 2013, J CELL SCI, V126, P1553, DOI 10.1242/jcs.112953; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2011, TRAFFIC, V12, P1714, DOI 10.1111/j.1600-0854.2011.01277.x; Dube M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-114; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Elortza F, 2006, J PROTEOME RES, V5, P935, DOI 10.1021/pr050419u; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Florin EL, 1998, APPL PHYS A-MATER, V66, pS75, DOI 10.1007/s003390051103; GOTO T, 1994, BLOOD, V84, P1922; Hammonds J, 2010, CELL HOST MICROBE, V7, P261, DOI 10.1016/j.chom.2010.04.001; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Hussain A, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-81; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Lee CK, 2007, MICRON, V38, P446, DOI 10.1016/j.micron.2006.06.014; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lopez CF, 2002, BIOPHYS J, V83, P1259, DOI 10.1016/S0006-3495(02)73898-8; Lopez LA, 2010, J VIROL, V84, P7243, DOI 10.1128/JVI.02636-09; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Oakley FD, 2009, J BIOL CHEM, V284, P33255, DOI 10.1074/jbc.M109.042127; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; Ruiz A, 2010, VIROLOGY, V408, P89, DOI 10.1016/j.virol.2010.08.031; Schubert HL, 2010, P NATL ACAD SCI USA, V107, P17951, DOI 10.1073/pnas.1008206107; Swiecki M, 2011, J BIOL CHEM, V286, P2987, DOI 10.1074/jbc.M110.190538; Tischer C, 2001, APPL PHYS LETT, V79, P3878, DOI 10.1063/1.1423404; Tokarev Andrey, 2011, Cell Logist, V1, P90; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Vidal-Laliena M, 2005, CELL IMMUNOL, V236, P6, DOI 10.1016/j.cellimm.2005.08.002; Yang HT, 2010, P NATL ACAD SCI USA, V107, P18428, DOI 10.1073/pnas.1011485107	51	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75680	10.1371/journal.pone.0075680	http://dx.doi.org/10.1371/journal.pone.0075680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086611	Green Published, gold			2022-12-25	WOS:000325025200059
J	Sharma, R; Lomash, S; Salunke, DM				Sharma, Raghava; Lomash, Suvendu; Salunke, Dinakar M.			Putative Bioactive Motif of Tritrpticin Revealed by an Antibody with Biological Receptor-Like Properties	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE INDOLICIDIN; PROLINE-RICH MOTIFS; RECOGNITION DOMAINS; AUTOMATED DOCKING; ANTIBACTERIAL; ANALOGS; BINDING; TRYPTOPHAN; MEMBRANE; PROTEIN	Antimicrobial peptides represent one of the most promising future strategies for combating infections and microbial drug resistance. Tritrpticin is a 13mer tryptophan-rich cationic antimicrobial peptide with a broad spectrum of activity whose application in antimicrobial therapy has been hampered by ambiguity about its biological target and consequently the molecular interactions necessary for its antimicrobial activity. The present study provides clues about the mechanism of action of tritripticin by using a unique monoclonal antibody (mAb) as a 'physiological' structural scaffold. A pool of mAbs were generated against tritrpticin and based on its high affinity and ability to bind tritrpticin analogs, mAb 6C6D7 was selected and characterized further. In a screening of phage displayed random peptides, this antibody was able to identify a novel antimicrobial peptide with low sequence homology to tritrpticin, suggesting that the mAb possessed the physico-chemical characteristics mimicking the natural receptor. Subsequently, thermodynamics and molecular modeling identified a core group of hydrophobic residues in tritrpticin arranged in a distorted's' shaped conformation as critical for antibody binding. Comparison of the mAb induced conformation with the micelle bound structure of tritrpticin reveals how a common motif may be able to interact with multiple classes of biomolecules thus extending the target range of this innate immune peptide. Based on the concurrence between thermodynamic and structural data our results reveal a template that can be used to design novel antimicrobial pharmacophores while simultaneously demonstrating at a more fundamental level the potential of mAbs to act as receptor surrogates.	[Sharma, Raghava; Lomash, Suvendu; Salunke, Dinakar M.] Natl Inst Immunol, New Delhi 110067, India; [Salunke, Dinakar M.] Reg Ctr Biotechnol, Gurgaon, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology	Salunke, DM (corresponding author), Natl Inst Immunol, New Delhi 110067, India.	dinakar.salunke@gmail.com			Department of Biotechnology, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro JC, 1998, IMMUNOGENETICS, V47, P355, DOI 10.1007/s002510050370; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; Bikker FJ, 2006, CHEM BIOL DRUG DES, V68, P148, DOI 10.1111/j.1747-0285.2006.00424.x; Boman HG, 1996, SCAND J IMMUNOL, V43, P475, DOI 10.1046/j.1365-3083.1996.d01-76.x; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Freund C., 2008, V186, P407, DOI 10.1007/978-3-540-72843-6_17; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hilpert K, 2010, ANTIMICROB AGENTS CH, V54, P4480, DOI 10.1128/AAC.01664-09; Hsu CH, 2005, NUCLEIC ACIDS RES, V33, P4053, DOI 10.1093/nar/gki725; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kaur KJ, 2008, PROTEIN SCI, V17, P545, DOI 10.1110/ps.073145008; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lawyer C, 1996, FEBS LETT, V390, P95, DOI 10.1016/0014-5793(96)00637-0; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lomash S, 2010, J BIOL CHEM, V285, P35750, DOI 10.1074/jbc.M110.150516; Marchand C, 2006, NUCLEIC ACIDS RES, V34, P5157, DOI 10.1093/nar/gkl667; Mayer BJ, 2001, J CELL SCI, V114, P1253; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Nagpal S, 1999, J BIOL CHEM, V274, P23296, DOI 10.1074/jbc.274.33.23296; Nair DT, 2000, J IMMUNOL, V165, P6949, DOI 10.4049/jimmunol.165.12.6949; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Rozek A, 2000, BIOCHEMISTRY-US, V39, P15765, DOI 10.1021/bi000714m; Salay LC, 2004, FEBS LETT, V565, P171, DOI 10.1016/j.febslet.2004.03.093; Schibli DJ, 2006, BIOPHYS J, V91, P4413, DOI 10.1529/biophysj.106.085837; Schibli DJ, 1999, BIOCHEMISTRY-US, V38, P16749, DOI 10.1021/bi990701c; Scocchi M, 2011, CELL MOL LIFE SCI, V68, P2317, DOI 10.1007/s00018-011-0721-7; Sircar A, 2009, NUCLEIC ACIDS RES, V37, pW474, DOI 10.1093/nar/gkp387; Sitaram N, 2003, BIOCHEM BIOPH RES CO, V309, P879, DOI 10.1016/j.bbrc.2003.08.095; Sivasubramanian A, 2009, PROTEINS, V74, P497, DOI 10.1002/prot.22309; Sklute G, 2004, CHEM-EUR J, V10, P2159, DOI 10.1002/chem.200305034; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stura EA, 2002, ACTA CRYSTALLOGR D, V58, P1715, DOI 10.1107/S0907444902012829; Subbalakshmi C, 2000, BIOCHEM BIOPH RES CO, V274, P714, DOI 10.1006/bbrc.2000.3214; Xu JA, 1999, SCIENCE, V286, P2345, DOI 10.1126/science.286.5448.2345; Yang ST, 2003, FEBS LETT, V540, P229, DOI 10.1016/S0014-5793(03)00266-7; Yang ST, 2002, BIOCHEM BIOPH RES CO, V296, P1044, DOI 10.1016/S0006-291X(02)02048-X; Zarrinpar A, 2003, SCI STKE, V2003, pRE8; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu WL, 2006, BIOCHEMISTRY-US, V45, P13007, DOI 10.1021/bi060487+	50	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75582	10.1371/journal.pone.0075582	http://dx.doi.org/10.1371/journal.pone.0075582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086578	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200052
J	Tsubaki, S; Sugimura, K; Teramoto, Y; Yonemori, K; Azuma, J				Tsubaki, Shuntaro; Sugimura, Kazuki; Teramoto, Yoshikuni; Yonemori, Keizo; Azuma, Jun-ichi			Cuticular Membrane of Fuyu Persimmon Fruit Is Strengthened by Triterpenoid Nano-Fillers	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; MECHANICAL-PROPERTIES; PLANT CUTICLES; RHEOLOGICAL PROPERTIES; CHEMICAL-COMPOSITION; GAS-CHROMATOGRAPHY; URSOLIC ACID; MAS NMR; CUTIN; BIOMECHANICS	The mechanical defensive performance of fruit cuticular membranes (CMs) is largely dependent on the molecular arrangement of their constituents. Here, we elucidated nano-sized interactions between cutin and triterpenoids in the cuticular matrix of Fuyu persimmon fruits (Diospyros kaki Thunb. cv. Fuyu), focusing on the mechanical properties using a combination of polymer analyses. The fruit CMs of Fuyu were primarily composed of wax (34.7%), which was predominantly triterpenoids followed by higher aliphatic compounds, and cutin (48.4%), primarily consisting of 9,10-epoxy-18-hydroxyoctadecanoic acid and 9,10,18-trihydroxyoctadecanoic acid. Based on the tensile tests of the CM, the removal of wax lead to a considerable decrease in the maximum stress and elastic modulus accompanied by an increase in the maximum strain, indicating that wax is of significant importance for maintaining the mechanical strength of the CM. Wide-angle X-ray diffraction and relaxation time measurements using solid-state C-13 nuclear magnetic resonance indicated that the triterpenoids in the cuticular matrix construct a nanocomposite at a mixing scale below 20-24 nm; however, the higher aliphatic compounds did not exhibit clear interactions with cutin. The results indicated that the triterpenoids in the cuticular matrix endow toughness to the CM by functioning as a nanofiller.	[Tsubaki, Shuntaro] Kochi Univ, Ctr Sci Res, Kochi 780, Japan; [Sugimura, Kazuki; Yonemori, Keizo] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan; [Teramoto, Yoshikuni] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan; [Azuma, Jun-ichi] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan	Kochi University; Kyoto University; Gifu University; Osaka University	Tsubaki, S (corresponding author), Kochi Univ, Ctr Sci Res, Kochi 780, Japan.	stsubaki@kochi-u.ac.jp	Tsubaki, Shuntaro/W-9727-2019; TERAMOTO, Yoshikuni/A-1773-2013	Tsubaki, Shuntaro/0000-0002-9656-4470; TERAMOTO, Yoshikuni/0000-0003-3850-3570; Sugimura, Kazuki/0000-0003-2394-1420	Grant for Environmental Research Projects from the Sumitomo Foundation	Grant for Environmental Research Projects from the Sumitomo Foundation	This work was supported in part by Grant for Environmental Research Projects from the Sumitomo Foundation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargel H, 2004, J PLANT GROWTH REGUL, V23, P61, DOI 10.1007/s00344-004-0036-0; Bargel H, 2005, J EXP BOT, V56, P1049, DOI 10.1093/jxb/eri098; Bargel H, 2006, FUNCT PLANT BIOL, V33, P893, DOI 10.1071/FP06139; BATAL K M, 1970, Hortscience, V5, P223; Belding RD, 1998, J AM SOC HORTIC SCI, V123, P348, DOI 10.21273/JASHS.123.3.348; BURNOUFRADOSEVICH M, 1985, PHYTOCHEMISTRY, V24, P2063, DOI 10.1016/S0031-9422(00)83122-2; Buschhaus C, 2007, NEW PHYTOL, V176, P311, DOI 10.1111/j.1469-8137.2007.02190.x; Buschhaus C, 2011, J EXP BOT, V62, P841, DOI 10.1093/jxb/erq366; Casado CG, 1999, J EXP BOT, V50, P175, DOI 10.1093/jexbot/50.331.175; Deshmukh AP, 2003, PHYTOCHEMISTRY, V64, P1163, DOI 10.1016/S0031-9422(03)00505-3; Dominguez E, 2011, PLANT SCI, V181, P77, DOI 10.1016/j.plantsci.2011.04.016; Dominguez E, 2011, NEW PHYTOL, V189, P938, DOI 10.1111/j.1469-8137.2010.03553.x; Dominguez E, 2009, FUNCT PLANT BIOL, V36, P613, DOI 10.1071/FP09039; Edelmann HG, 2005, J PLANT GROWTH REGUL, V24, P116, DOI 10.1007/s00344-004-0015-5; Fang XH, 2001, PHYTOCHEMISTRY, V57, P1035, DOI 10.1016/S0031-9422(01)00106-6; GARBOW JR, 1990, MACROMOLECULES, V23, P2814, DOI 10.1021/ma00212a037; Graca J, 2010, J AGR FOOD CHEM, V58, P9666, DOI 10.1021/jf1015297; Heredia A, 2003, BBA-GEN SUBJECTS, V1620, P1, DOI 10.1016/S0304-4165(02)00510-X; Holloway P. J., 1982, The plant cuticle, P45; Jarvinen R, 2011, J FOOD COMPOS ANAL, V24, P334, DOI 10.1016/j.jfca.2010.09.022; Jeffree C. E, 1996, PLANT CUTICLES INTEG, P33; Johnson EJ, 2007, COMMUN SOIL SCI PLAN, V38, P2461, DOI 10.1080/00103620701588841; Lopez-Casado G, 2007, J EXP BOT, V58, P3875, DOI 10.1093/jxb/erm233; LUQUE P, 1994, Z NATURFORSCH C, V49, P273; Matas AJ, 2005, AM J BOT, V92, P462, DOI 10.3732/ajb.92.3.462; Pereira SI, 2005, PHYTOCHEM ANALYSIS, V16, P364, DOI 10.1002/pca.859; PETRACEK PD, 1995, PLANT PHYSIOL, V109, P675, DOI 10.1104/pp.109.2.675; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; REYNHARDT EC, 1991, J PHYS D APPL PHYS, V24, P478, DOI 10.1088/0022-3727/24/3/036; Round AN, 2000, BIOPHYS J, V79, P2761, DOI 10.1016/S0006-3495(00)76515-5; Seebacher W, 2003, MAGN RESON CHEM, V41, P636, DOI 10.1002/mrc.1214; Stark RE, 2008, PHYTOCHEMISTRY, V69, P2689, DOI 10.1016/j.phytochem.2008.08.016; STEJSKAL EO, 1981, MACROMOLECULES, V14, P275, DOI 10.1021/ma50003a010; Szakiel A, 2012, PHYTOCHEM REV, V11, P263, DOI 10.1007/s11101-012-9241-9; Takahashi Y, 2012, PLANT CELL ENVIRON, V35, P1201, DOI 10.1111/j.1365-3040.2012.02482.x; Thuong PT, 2008, J NAT PROD, V71, P1775, DOI 10.1021/np800298w; Tian SY, 2008, J AGR FOOD CHEM, V56, P10318, DOI 10.1021/jf801028g; Tsubaki S, 2008, J AGR FOOD CHEM, V56, P11293, DOI 10.1021/jf802253s; Tsubaki S, 2012, FOOD CHEM, V132, P2135, DOI 10.1016/j.foodchem.2011.12.039; Tulloch A. P., 1976, CHEM BIOCH NATURAL W, P235; WALTON TJ, 1972, BIOCHEMISTRY-US, V11, P1885, DOI 10.1021/bi00760a025; Wiedemann P, 1998, BOT ACTA, V111, P28, DOI 10.1111/j.1438-8677.1998.tb00673.x; Yeats TH, 2012, NAT CHEM BIOL, V8, P609, DOI [10.1038/NCHEMBIO.960, 10.1038/nchembio.960]; Zhou CH, 2010, MOLECULES, V15, P6580, DOI 10.3390/molecules15096580; ZLOTNIKMAZORI T, 1988, MACROMOLECULES, V21, P2412, DOI 10.1021/ma00186a019	45	47	47	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75275	10.1371/journal.pone.0075275	http://dx.doi.org/10.1371/journal.pone.0075275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086493	Green Published, gold, Green Submitted			2022-12-25	WOS:000325025200036
J	Hinojosa, CV; Galvan, MAL; Rodriguez, MT; Ortega, GL; Cervantes, MAC; Rodriguez, CAM; Cortes, PP; Mendez, LAM; Trejo, FJJ				Vela Hinojosa, Cristian; Leon Galvan, Miguel Angel; Tapia Rodriguez, Miguel; Lopez Ortega, Gerardo; Cerbon Cervantes, Marco Antonio; Mendoza Rodriguez, Carmen Adriana; Padilla Cortes, Patricia; Martinez Mendez, Luis Antonio; Jimenez Trejo, Francisco Javier			Differential Expression of Serotonin, Tryptophan Hydroxylase and Monoamine Oxidase A in the Mammary Gland of the Myotis velifer Bat	PLOS ONE			English	Article							REPRODUCTIVE-CYCLE; INHIBITION; LACTATION; BIOLOGY	The mammary gland has long drawn the attention of the scientific community due to the limited knowledge of some fundamental aspects involved in the control of its function. Myotis velifer, a microchiropteran species, provides an interesting model to study some of the regulatory factors involved in the control of the mammary gland cycle. Having an asynchronous, monoestrous reproductive pattern, female M. velifer bats undergo drastic morphological changes of the breast during the reproductive cycle. Current research on non-chiropteran mammals indicates that serotonin (5-HT) plays a major role in the intraluminal volume homeostasis of the mammary gland during lactation; however, an analysis of both the expression and localization of the main components of the serotonergic system in the bat mammary gland is lacking. Thus, the objectives of the present study were: to describe the gross and histological anatomy of the mammary gland of M. velifer to establish the lactation period for this species; to analyze the distribution and expression of the main serotonergic components in the mammary tissues of these bats under the physiological conditions of lactation, involution and the resting phase; and to provide information on the involvement of 5-HT in the regulation of the physiological function of this organ. To assess the expression and localization of serotonergic components, multiple immunofluorescence, Western blot and HPLC methods were used. 5-HT and the enzyme that catalyzes its synthesis (TPH) were located in both myoepithelial and luminal epithelial cells, while the enzyme responsible for the catabolism of this neurohormone (MAO A) was found in luminal epithelial cells as well as in secreted products. We also found an increased expression of serotonergic components during lactation, indicating that elements of the serotonergic system may play an important role in lactation in this species of bat in a way similar to that of other mammal species.	[Vela Hinojosa, Cristian; Cerbon Cervantes, Marco Antonio; Mendoza Rodriguez, Carmen Adriana; Jimenez Trejo, Francisco Javier] Univ Nacl Autonoma Mexico, Fac Chem, Mexico City 04510, DF, Mexico; [Leon Galvan, Miguel Angel; Lopez Ortega, Gerardo; Martinez Mendez, Luis Antonio] Univ Autonoma Metropolitana Iztapalapa, Dept Biol, Mexico City 09340, DF, Mexico; [Leon Galvan, Miguel Angel; Padilla Cortes, Patricia] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Microscopy Unit, Mexico City 04510, DF, Mexico; [Tapia Rodriguez, Miguel; Padilla Cortes, Patricia] Univ Nacl Autonoma Mexico, Inst Invest Biomed, HPLC Unit, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Autonoma Metropolitana - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Trejo, FJJ (corresponding author), Univ Nacl Autonoma Mexico, Fac Chem, Mexico City 04510, DF, Mexico.	trejofj@hotmail.com		Mendoza-Rodriguez, C. Adriana/0000-0002-7004-6712; Tapia-Rodriguez, Miguel/0000-0002-2248-6596	CONACYT, Mexico City, Mexico [80338, PAPIIT IN210412, PAIP 4194-08]; Universidad Nacional Autonoma de Mexico; Universidad Autonoma Metropolitana-Iztapalapa	CONACYT, Mexico City, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Universidad Autonoma Metropolitana-Iztapalapa	This work was supported by financial grants from CONACYT Number: 80338; PAPIIT IN210412; PAIP 4194-08, Mexico City, Mexico. The authors would also like to thank Universidad Nacional Autonoma de Mexico and Universidad Autonoma Metropolitana-Iztapalapa for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen H, 1880, P ACAD NAT SCI PHILA, V32, P133; Anthony E.L.P., 1988, P47; Barbour R.W., 1969, BATS AM; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Cabrera V, 2009, NEUROSCI LETT, V461, P136, DOI 10.1016/j.neulet.2009.06.017; DAVIS RB, 1962, ECOL MONOGR, V32, P311, DOI 10.2307/1942378; Evarts JL, 2004, BIOL REPROD, V70, P1573, DOI 10.1095/biolreprod.103.022988; FITCH J H, 1981, Mammalian Species, P1, DOI 10.2307/3504035; FRANCIS CM, 1994, NATURE, V367, P691, DOI 10.1038/367691a0; Gleiman D, 2003, GRZIMEKS ANIMAL LIFE; Haaksma CJ, 2011, BIOL REPROD, V85, P13, DOI 10.1095/biolreprod.110.090639; HARVEY M. J., 2011, BATS US CANADA; Hayward B. J., 1970, W NEW MEXICO U RES S, V1, P1; HEIDEMAN PD, 1988, J ZOOL, V215, P577, DOI 10.1111/j.1469-7998.1988.tb02396.x; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; IUCN, 2008, 2008 IUCN RED LIST T; Jimenez-Trejo F, 2007, J ANDROL, V28, P136, DOI 10.2164/jandrol.106.000653; Jimenez-Trejo F, 2013, J EXP ZOOL PART A, V319A, P249, DOI 10.1002/jez.1789; Jimenez-Trejo F, 2012, REPRODUCTION, V144, P677, DOI 10.1530/REP-12-0145; JOHANSEN PA, 1991, BIOCHEM PHARMACOL, V41, P625, DOI 10.1016/0006-2952(91)90636-J; Kortner G, 2000, CHRONOBIOL INT, V17, P103, DOI 10.1081/CBI-100101036; Krutzsch PH, 2009, ACTA CHIROPTEROL, V11, P89, DOI 10.3161/150811009X465712; Kunz TH, 1996, J TROP ECOL, V12, P121, DOI 10.1017/S0266467400009342; KUNZ TH, 1982, J MAMMAL, V63, P23, DOI 10.2307/1380667; Kunz TH, 2000, REPROD BIOL BATS; Laporta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057847; LAWRENCE RA, 1999, BREASTFEEDING GUIDE; Leon-Galvan MA, 2005, SOUTHWEST NAT, V50, P453, DOI 10.1894/0038-4909(2005)050[0453:MRCOMB]2.0.CO;2; Marshall AM, 2010, J CLIN ENDOCR METAB, V95, P837, DOI 10.1210/jc.2009-1575; Mateos A, 1995, THESIS U CASTILLA LA; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Mejia JM, 2002, BIOL PSYCHIAT, V52, P811, DOI 10.1016/S0006-3223(02)01418-X; Mepham TB, 1986, PHYSL LACTATION; Neuweiler G., 2000, BIOL BATS; Nowak RM, 1994, WALKERS BATS WORLD; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Secretaria del Medio Ambiente y Recursos Naturales (SEMARNAT), 2010, NOM059ECOL2010 SEMAR; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Vaibhav PP, 2011, COMMUN INTEGR BIOL, V4, P532; Villa RB, 1967, MURCIELAGOS MEXICO I; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; Whitaker-Azmitia PM, 1999, NEUROPSYCHOPHARMACOL, V21, pS2, DOI 10.1016/S0893-133X(99)00031-7; WILSON D. E., 1996, MEASURING MONITORING	44	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75062	10.1371/journal.pone.0075062	http://dx.doi.org/10.1371/journal.pone.0075062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086437	Green Submitted, Green Published, gold			2022-12-25	WOS:000325025200021
J	Wu, J; Kong, XY; Shi, C; Gu, YQ; Jin, CY; Gao, LZ; Jia, JZ				Wu, Jing; Kong, Xiuying; Shi, Chao; Gu, Yongqiang; Jin, Cuiyun; Gao, Lizhi; Jia, Jizeng			Dynamic Evolution of Rht-1 Homologous Regions in Grass Genomes	PLOS ONE			English	Article							ORYZA-SATIVA; BRACHYPODIUM-DISTACHYON; DRAFT SEQUENCE; WHEAT; GENE; LOCUS; MODEL; RICE; TRITICUM; COMPLEX	Hexaploid bread wheat contains A, B, and D three subgenomes with its well-characterized ancestral genomes existed at diploid and tetraploid levels, making the wheat act as a good model species for studying evolutionary genomic dynamics. Here, we performed intra- and inter-species comparative analyses of wheat and related grass genomes to examine the dynamics of homologous regions surrounding Rht-1, a well-known "green revolution" gene. Our results showed that the divergence of the two A genomes in the Rht-1 region from the diploid and tetraploid species is greater than that from the tetraploid and hexaploid wheat. The divergence of D genome between diploid and hexaploid is lower than those of A genome, suggesting that D genome diverged latter than others. The divergence among the A, B and D subgenomes was larger than that among different ploidy levels for each subgenome which mainly resulted from genomic structural variation of insertions and, perhaps deletions, of the repetitive sequences. Meanwhile, the repetitive sequences caused genome expansion further after the divergence of the three subgenomes. However, several conserved non-coding sequences were identified to be shared among the three subgenomes of wheat, suggesting that they may have played an important role to maintain the homolog of three subgenomes. This is a pilot study on evolutionary dynamics across the wheat ploids, subgenomes and differently related grasses. Our results gained new insights into evolutionary dynamics of Rht-1 region at sequence level as well as the evolution of wheat during the plolyploidization process.	[Wu, Jing; Kong, Xiuying; Jin, Cuiyun; Jia, Jizeng] Chinese Acad Agr Sci, Key Lab Crop Germplasm Resources & Utilizat, Natl Key Facil Crop Gene Resources & Genet Improv, Minist Agr,Inst Crop Sci, Beijing 100193, Peoples R China; [Shi, Chao; Gao, Lizhi] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species Southwest China, Kunming, Peoples R China; [Gu, Yongqiang] ARS, USDA, Western Reg Res Ctr, Albany, CA USA	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; United States Department of Agriculture (USDA)	Gao, LZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species Southwest China, Kunming, Peoples R China.	Lgao@mail.kib.ac.cn; Jiajizeng@caas.cn			863 project from Ministry of Science and Technology of China [2011AA100104]; Key Project of Natural Science Foundation of Yunnan Province [2008CC016]; Talents Program of Yunnan Province [20080A009]; Hundreds Talents Program of the Chinese Academy of Sciences (CAS); Chinese Academy of Science [KSCX2-YW-N-029]; Chinese Department of Science and Technology (973 Program) [2007CB815703]; Kunming Institute of Botany, CAS	863 project from Ministry of Science and Technology of China(National High Technology Research and Development Program of China); Key Project of Natural Science Foundation of Yunnan Province; Talents Program of Yunnan Province; Hundreds Talents Program of the Chinese Academy of Sciences (CAS); Chinese Academy of Science(Chinese Academy of Sciences); Chinese Department of Science and Technology (973 Program); Kunming Institute of Botany, CAS(Chinese Academy of Sciences)	The research was funded by 863 project (2011AA100104) from Ministry of Science and Technology of China, Key Project of Natural Science Foundation of Yunnan Province (2008CC016), Talents Program of Yunnan Province (20080A009), the Hundreds Talents Program of the Chinese Academy of Sciences (CAS), a grant from the Chinese Academy of Science (KSCX2-YW-N-029), a grant from Chinese Department of Science and Technology (973 Program 2007CB815703), and a start-up grant from Kunming Institute of Botany, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson O. D., 2003, Functional & Integrative Genomics, V3, P56; Bartos J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-155; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Carretero-Paulet L, 2012, MOL BIOL EVOL, V29, P3541, DOI 10.1093/molbev/mss162; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Duan JL, 2012, FUNCT INTEGR GENOMIC, V12, P489, DOI 10.1007/s10142-012-0283-2; Dubchak Inna, 2007, V395, P3; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gu YQ, 2003, GENOME, V46, P1084, DOI [10.1139/g03-071, 10.1139/G03-071]; Gupta P K, 2008, Int J Plant Genomics, V2008, P896451, DOI 10.1155/2008/896451; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Huo NX, 2006, GENOME, V49, P1099, DOI 10.1139/G06-087; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li W. H, 1997, MOL EVOLUTION; Li YY, 2012, NEW PHYTOL, V196, P282, DOI 10.1111/j.1469-8137.2012.04243.x; Massa AN, 2011, MOL BIOL EVOL, V28, P2537, DOI 10.1093/molbev/msr080; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Uchida N, 2007, P NATL ACAD SCI USA, V104, P15953, DOI 10.1073/pnas.0707577104; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wu J, 2011, PLANT PHYSIOL, V157, P2120, DOI 10.1104/pp.111.185272; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zheng WX, 2008, J BIOMOL STRUCT DYN, V26, P1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	40	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75544	10.1371/journal.pone.0075544	http://dx.doi.org/10.1371/journal.pone.0075544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086561	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200047
J	Deeni, YY; Ibbotson, SH; Woods, JA; Wolf, CR; Smith, G				Deeni, Yusuf Y.; Ibbotson, Sally H.; Woods, Julie A.; Wolf, C. Roland; Smith, Gillian			Cytochrome P450 CYP1B1 Interacts with 8-Methoxypsoralen (8-MOP) and Influences Psoralen-Ultraviolet A (PUVA) Sensitivity	PLOS ONE			English	Article							MECHANISM-BASED INACTIVATION; LIVER-MICROSOMES; GRAPEFRUIT JUICE; PLUS ULTRAVIOLET; FURANOCOUMARINS; POLYMORPHISMS; METABOLISM; PSORIASIS; 2A6; OXIDOREDUCTASE	Background: There are unpredictable inter-individual differences in sensitivity to psoralen-UVA (PUVA) photochemotherapy, used to treat skin diseases including psoriasis. Psoralens are metabolised by cytochrome P450 enzymes (P450), and we hypothesised that variability in cutaneous P450 expression may influence PUVA sensitivity. We previously showed that P450 CYP1B1 was abundantly expressed in human skin and regulated by PUVA, and described marked inter-individual differences in cutaneous CYP1B1 expression. Objectives: We investigated whether CYP1B1 made a significant contribution to 8-methoxypsoralen (8-MOP) metabolism, and whether individuality in CYP1B1 activity influenced PUVA sensitivity. Methods: We used E. coli membranes co-expressing various P450s and cytochrome P450 reductase (CPR) to study 8-MOP metabolism and cytotoxicity assays in CYP1B1-expressing mammalian cells to assess PUVA sensitivity. Results: We showed that P450s CYP1A1, CYP1A2, CYP1B1, CYP2A6 and CYP2E1 influence 8-MOP metabolism. As CYP1B1 is the most abundant P450 in human skin, we further demonstrated that: (i) CYP1B1 interacts with 8-MOP (ii) metabolism of the CYP1B1 substrates 7-ethoxyresorufin and 17-beta-estradiol showed concentration-dependent inhibition by 8-MOP and (iii) inhibition of 7-ethoxyresorufin metabolism by 8-MOP was influenced by CYP1B1 genotype. The influence of CYP1B1 on PUVA cytotoxicity was further investigated in a Chinese hamster ovary cell line, stably expressing CYP1B1 and CPR, which was more sensitive to PUVA than control cells, suggesting that CYP1B1 metabolises 8-MOP to a more phototoxic metabolite(s). Conclusion: Our data therefore suggest that CYP1B1 significantly contributes to cutaneous 8-MOP metabolism, and that individuality in CYP1B1 expression may influence PUVA sensitivity.	[Deeni, Yusuf Y.; Wolf, C. Roland; Smith, Gillian] Univ Dundee, Med Res Inst, Div Canc Res, Dundee, Scotland; [Ibbotson, Sally H.; Woods, Julie A.] Univ Dundee, Photobiol Unit, Dundee, Scotland; [Wolf, C. Roland] Univ Dundee, Ninewells Hosp & Med Sch, Canc Res UK Mol Pharmacol Unit, Dundee DD1 9SY, Scotland; [Deeni, Yusuf Y.] Univ Abertay Dundee, Sch Contemporary Sci, Dundee, Scotland	University of Dundee; University of Dundee; University of Dundee; University of Abertay Dundee	Smith, G (corresponding author), Univ Dundee, Med Res Inst, Div Canc Res, Dundee, Scotland.	g.smith@dundee.ac.uk	Ibbotson, Sally H/H-7061-2019	Ibbotson, Sally H/0000-0001-5685-752X; Deeni, Yusuf Y./0000-0002-8529-7469; Wolf, Charles Roland/0000-0002-6969-0113; Smith, Gillian/0000-0001-9288-7566	Medical Research Council [G0000281]; Cancer Research UK [10822] Funding Source: researchfish; MRC [G0000281] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors gratefully acknowledge funding from the Medical Research Council (Project Grant reference G0000281). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2004, J INVEST DERMATOL, V123, P417, DOI 10.1111/j.0022-202X.2004.23307.x; Bandiera S, 2005, MOL PHARMACOL, V67, P435, DOI 10.1124/mol.104.006056; BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7; Chen Q, 2011, CURR DRUG METAB, V12, P436, DOI 10.2174/138920011795495259; Deeni YY, 2001, ARCH BIOCHEM BIOPHYS, V396, P16, DOI 10.1006/abbi.2001.2585; DEWOLFF FA, 1986, CLIN PHARMACOKINET, V11, P62, DOI 10.2165/00003088-198611010-00004; Ding S, 2001, BIOCHEM J, V356, P613, DOI 10.1042/0264-6021:3560613; GASPARRO FP, 1988, J INVEST DERMATOL, V90, P234, DOI 10.1111/1523-1747.ep12462304; Girennavar B, 2006, BIOORGAN MED CHEM, V14, P2606, DOI 10.1016/j.bmc.2005.11.039; GOLDSTEIN DP, 1982, J INVEST DERMATOL, V78, P429, DOI 10.1111/1523-1747.ep12507768; Goto T, 2010, DRUG METAB DISPOS, V38, P2110, DOI 10.1124/dmd.110.034553; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; Guo LQ, 2004, ACTA PHARMACOL SIN, V25, P129; Ibbotson SH, 2012, BRIT J DERMATOL, V166, P380, DOI 10.1111/j.1365-2133.2011.10661.x; Inzinger M, 2011, BRIT J DERMATOL, V165, P640, DOI 10.1111/j.1365-2133.2011.10396.x; Kang AY, 2011, PROTEIN J, V30, P447, DOI 10.1007/s10930-011-9350-0; Kharasch ED, 2000, DRUG METAB DISPOS, V28, P28; Kleiner HE, 2002, CHEM RES TOXICOL, V15, P226, DOI 10.1021/tx010151v; Koenigs LL, 1998, BIOCHEMISTRY-US, V37, P13184, DOI 10.1021/bi981198r; Koenigs LL, 1998, BIOCHEMISTRY-US, V37, P10047, DOI 10.1021/bi980003c; Li DN, 2000, PHARMACOGENETICS, V10, P343, DOI 10.1097/00008571-200006000-00008; Li W, 2004, INSECT MOL BIOL, V13, P603, DOI 10.1111/j.0962-1075.2004.00518.x; Mammen JS, 2005, PHARMACOGENET GENOM, V15, P183, DOI 10.1097/01213011-200503000-00007; MARRAKCHI S, 1991, PHOTODERMATOL PHOTO, V8, P206; MAYS DC, 1987, DRUG METAB DISPOS, V15, P318; MCLELLAND J, 1991, BRIT J DERMATOL, V124, P585, DOI 10.1111/j.1365-2133.1991.tb04956.x; McNeilly AD, 2012, DRUG METAB DISPOS, V40, P283, DOI 10.1124/dmd.111.042085; Mukhtar H, 1996, PHOTOCHEM PHOTOBIOL, V63, P355, DOI 10.1111/j.1751-1097.1996.tb03040.x; Nebert DW, 2000, CLIN CHEM LAB MED, V38, P857, DOI 10.1515/CCLM.2000.124; NORRIS PG, 1994, BRIT J DERMATOL, V130, P246; Obach RS, 2002, DRUG METAB DISPOS, V30, P831, DOI 10.1124/dmd.30.7.831; OMURA T, 1964, J BIOL CHEM, V239, P2370; PAPADOPOULO D, 1985, MUTAT RES, V151, P281, DOI 10.1016/0027-5107(85)90081-8; Patel RV, 2009, J AM ACAD DERMATOL, V60, P1001, DOI 10.1016/j.jaad.2008.12.031; Shimada T, 1999, CARCINOGENESIS, V20, P1607, DOI 10.1093/carcin/20.8.1607; Smith G, 2003, J INVEST DERMATOL, V121, P390, DOI 10.1046/j.1523-1747.2003.12354.x; Smith G, 2003, LANCET, V361, P1336, DOI 10.1016/S0140-6736(03)13081-4; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; STERN RS, 1994, CANCER-AM CANCER SOC, V73, P2759, DOI 10.1002/1097-0142(19940601)73:11<2759::AID-CNCR2820731118>3.0.CO;2-C; Tantcheva-Poor I, 2001, BRIT J DERMATOL, V144, P1127, DOI 10.1046/j.1365-2133.2001.04233.x; TRIGLIA D, 1991, IN VITRO CELL DEV B, V27, P239; Ueng YF, 2011, BRIT J PHARMACOL, V163, P1250, DOI 10.1111/j.1476-5381.2011.01341.x; von Weymarn LB, 2006, CARCINOGENESIS, V27, P782, DOI 10.1093/carcin/bgi301; Wen ZM, 2003, INSECT BIOCHEM MOLEC, V33, P937, DOI 10.1016/S0965-1748(03)00100-0; Wolf CR, 1999, BRIT MED BULL, V55, P366, DOI 10.1258/0007142991902439	45	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75494	10.1371/journal.pone.0075494	http://dx.doi.org/10.1371/journal.pone.0075494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086543	Green Submitted, Green Published, gold			2022-12-25	WOS:000326520200105
J	Ounap, K; Kasper, L; Kurg, A; Kurg, R				Ounap, Kadri; Kaesper, Ly; Kurg, Ants; Kurg, Reet			The Human WBSCR22 Protein Is Involved in the Biogenesis of the 40S Ribosomal Subunits in Mammalian Cells	PLOS ONE			English	Article							NUCLEAR EXPORT; RNA; BYSTIN; YEAST; PRECURSORS; STEPS	The human WBSCR22 protein was previously shown to be up-regulated in invasive breast cancer and its ectopic expression enhances tumor cell survival in the vasculature. In the current study, we show that the WBSCR22 protein is important for cell growth. Knock-down of WBSCR22 with siRNA results in slower growth of WBSCR22-depleted cells. Treatment with siWBSCR22 causes defects in the processing of pre-rRNAs and reduces the level of free 40S ribosomal subunit, suggesting that WBSCR22 is involved in ribosome small subunit biosynthesis. The human WBSCR22 partially complements the growth of WBSCR22 yeast homologue, bud23 deletion mutant suggesting that the human WBSCR22 is a functional homologue of yeast Bud23. WBSCR22 is localized throughout the cell nucleus and is not stably associated with ribosomal subunits within the cell nucleus. We also show that the WBSCR22 protein level is decreased in lymphoblastoid cell lines derived from William-Beuren Syndrome (WBS) patients compared to healthy controls. Our data suggest that the WBSCR22 protein is a ribosome biogenesis factor involved in the biosynthesis of 40S ribosomal particles in mammalian cells.	[Ounap, Kadri; Kaesper, Ly; Kurg, Reet] Univ Tartu, Inst Technol, Ctr Biomed Technol, EE-50090 Tartu, Estonia; [Kurg, Ants] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	University of Tartu; University of Tartu	Kurg, R (corresponding author), Univ Tartu, Inst Technol, Ctr Biomed Technol, Ulikooli 18, EE-50090 Tartu, Estonia.	reet.kurg@ut.ee	Kurg, Ants/J-2616-2015; Kurg, Reet/J-2829-2015; Kurg, Ants/AAM-1292-2020	Kurg, Reet/0000-0001-7188-9693; Kurg, Ants/0000-0002-0829-1987; Ounap, Kadri/0000-0001-7397-3231	Estonian Ministry of Education and Research [SF0180175, SF0180027s10]; European Regional Development Fund through the Center of Excellence in Chemical Biology	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Regional Development Fund through the Center of Excellence in Chemical Biology(European Commission)	This work was supported by research programmes (SF0180175; SF0180027s10) from Estonian Ministry of Education and Research; and by the European Regional Development Fund through the Center of Excellence in Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M, 2010, SEMIN CELL DEV BIOL, V21, P209, DOI 10.1016/j.semcdb.2009.10.007; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007147; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Carron C, 2011, NUCLEIC ACIDS RES, V39, P280, DOI 10.1093/nar/gkq734; Figaro S, MOL CELL BIOL; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Henrichsen CN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001054; LAFONTAINE D, 1995, GENE DEV, V9, P2470, DOI 10.1101/gad.9.20.2470; Lafontaine DLJ, 1998, MOL CELL BIOL, V18, P2360, DOI 10.1128/MCB.18.4.2360; Leulliot N, 2008, NUCLEIC ACIDS RES, V36, P629, DOI 10.1093/nar/gkm1074; Li Z, 2009, PLOS BIOL, V10; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Miyoshi M, 2007, BIOCHEM J, V404, P373, DOI 10.1042/BJ20061597; Nakazawa Y, 2011, CANCER RES, V71, P1146, DOI 10.1158/0008-5472.CAN-10-2695; Ohbayashi I, 2011, PLANT J, V67, P49, DOI 10.1111/j.1365-313X.2011.04574.x; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Saijou E, 2004, NUCLEIC ACIDS RES, V32, P1028, DOI 10.1093/nar/gkh264; Sardana R, 2012, MOL BIOL CELL, V23, P4313, DOI 10.1091/mbc.E12-05-0370; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Scherer SW, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P221, DOI 10.1007/978-1-59745-039-3_15; Schubert C, 2009, CELL MOL LIFE SCI, V66, P1178, DOI 10.1007/s00018-008-8401-y; Tiedemann R, 2012, CANC RES IN PRESS; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Wang HZ, 2009, CELL RES, V19, P1150, DOI 10.1038/cr.2009.99; White J, 2008, MOL CELL BIOL, V28, P3151, DOI 10.1128/MCB.01674-07; Wild T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000522; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	30	38	39	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75686	10.1371/journal.pone.0075686	http://dx.doi.org/10.1371/journal.pone.0075686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086612	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200118
J	Yamauchi, K; Yamauchi, T; Mantuano, E; Murakami, K; Henry, K; Takahashi, K; Campana, WM				Yamauchi, Kazuyo; Yamauchi, Tomonori; Mantuano, Elisabetta; Murakami, Kenichi; Henry, Kenneth; Takahashi, Kazuhisa; Campana, Wendy Marie			Low-Density Lipoprotein Receptor Related protein-1 (LRP1)-Dependent Cell Signaling Promotes Neurotrophic Activity in Embryonic Sensory Neurons	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; SCHWANN-CELLS; PC12 CELLS; MAPK PATHWAY; KAPPA-B; SURVIVAL; BINDING; DIFFERENTIATION; ACTIVATION; PHOSPHORYLATION	Developing sensory neurons require neurotrophic support for survival, neurite outgrowth and myelination. The low-density lipoprotein receptor-related protein-1 (LRP1) transactivates Trk receptors and thereby functions as a putative neurotrophin. Herein, we show that LRP1 is abundantly expressed in developing dorsal root ganglia (DRG) and that LRP1-dependent cell signaling supports survival, neurite extension and receptivity to Schwann cells even in the absence of neurotrophins. Cultured embryonic DRG neurons (E15) were treated with previously characterized LRP1 ligands, LRP1-receptor binding domain of alpha 2-macroglobulin (RBD), hemopexin domain of MMP-9 (PEX) or controls (GST) for two weeks. These structurally diverse LRP1 ligands significantly activated and sustained extracellular signal-regulated kinases (ERK1/2) 5-fold (p<0.05), increased expression of growth-associated protein-43(GAP43) 15-fold (P<0.01), and increased neurite outgrowth 20-fold (P<0.01). Primary sensory neurons treated with LRP1 ligands survived >2 weeks in vitro, to an extent equaling NGF, a finding associated with canonical signaling mechanisms and blockade of caspase-3 cleavage. LRP1 ligand-induced survival and sprouting were blocked by co-incubation with the LRP1 antagonist, receptor associated protein (RAP), whereas RAP had no effect on NGF-induced activity. Site directed mutagenesis of the LRP1 ligand, RBD, in which Lys(1370) and Lys(1374) are converted to alanine to preclude LRP1 binding, were ineffective in promoting cell signaling, survival or inducing neurite extension in primary sensory neurons, confirming LRP1 specificity. Furthermore, LRP1-induced neurite sprouting was mediated by Src-family kinase (SFK) activation, suggesting transactivation of Trk receptors. Co-cultures of primary embryonic neurons and Schwann cells showed that LRP1 agonists promoted axonal receptivity to myelination to Schwann cells. Collectively, these findings identify LRP1 as a novel and perhaps essential trophic molecule for sensory neuronal survival and development.	[Yamauchi, Kazuyo; Yamauchi, Tomonori; Mantuano, Elisabetta; Murakami, Kenichi; Henry, Kenneth; Campana, Wendy Marie] Univ Calif San Diego, Sch Med, Dept Anesthesiol, La Jolla, CA 92093 USA; [Yamauchi, Kazuyo; Yamauchi, Tomonori; Murakami, Kenichi] Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chiba, Japan; [Campana, Wendy Marie] Univ Calif San Diego, Program Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Chiba University; University of California System; University of California San Diego	Campana, WM (corresponding author), Univ Calif San Diego, Sch Med, Dept Anesthesiol, La Jolla, CA 92093 USA.	wcampana@ucsd.edu	Yamauchi, Kazuyo/AAR-3549-2020; Mantuano, Elisabetta/C-1769-2015	Mantuano, Elisabetta/0000-0001-5728-9261; Sanyal, Subhabrata/0000-0003-2590-2732	NINDS [R01 NS-057456, R01 NS-054671, P30 NS047101]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS057456, R01NS054671] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NINDS R01 NS-057456, R01 NS-054671 and P30 NS047101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Bennett DLH, 1996, EUR J NEUROSCI, V8, P2204; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Campana WM, 1998, FASEB J, V12, P307, DOI 10.1096/fasebj.12.3.307; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chang JH, 2003, J BIOL CHEM, V278, P42877, DOI 10.1074/jbc.M308155200; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Davies Alun M., 1994, Progress in Growth Factor Research, V5, P263, DOI 10.1016/0955-2235(94)90010-8; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Ernsberger U, 2009, CELL TISSUE RES, V336, P349, DOI 10.1007/s00441-009-0784-z; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Geetha N, 2011, J BIOL CHEM, V286, P25663, DOI 10.1074/jbc.M111.221903; HAMBURGER V, 1949, J EXP ZOOL, V111, P457, DOI 10.1002/jez.1401110308; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; HEASLEY LE, 1992, MOL BIOL CELL, V3, P545, DOI 10.1091/mbc.3.5.545; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Howard GC, 1996, J BIOL CHEM, V271, P14105, DOI 10.1074/jbc.271.24.14105; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; KLEITMAN N, 1988, J NEUROSCI, V8, P653; KOO PH, 1994, J BIOL CHEM, V269, P5369; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; LEVIMONTALCINI R, 1956, P NATL ACAD SCI USA, V42, P695, DOI 10.1073/pnas.42.9.695; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Mantuano E, 2011, J NEUROSCI, V31, P13376, DOI 10.1523/JNEUROSCI.2850-11.2011; Melli G, 2009, EXPERT OPIN DRUG DIS, V4, P1035, DOI 10.1517/17460440903266829; Mettenburg JM, 2002, J BIOL CHEM, V277, P13338, DOI 10.1074/jbc.M106792200; Nickols JC, 2003, NAT NEUROSCI, V6, P161, DOI 10.1038/nn995; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; Orita S, 2013, J NEUROSCI, V33, P5590, DOI 10.1523/JNEUROSCI.3342-12.2013; Padmasekar M, 2007, CARDIOVASC RES, V75, P118, DOI 10.1016/j.cardiores.2007.03.003; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; WOOD PM, 1986, J NEUROL SCI, V74, P153, DOI 10.1016/0022-510X(86)90101-2; WYATT S, 1993, DEVELOPMENT, V119, P635; Yoon C, 2013, J BIOL CHEM; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008	50	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75497	10.1371/journal.pone.0075497	http://dx.doi.org/10.1371/journal.pone.0075497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086544	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200106
J	Ballesteros-Arias, L; Saavedra, V; Morata, G				Ballesteros-Arias, L.; Saavedra, V.; Morata, G.			Cell competition may function either as tumour-suppressing or as tumour-stimulating factor in Drosophila	ONCOGENE			English	Article						cell competition; apoptosis; Rab5; tumour development; imaginal discs	CASPASE DRONC; ENDOCYTIC CONTROL; APOPTOTIC CELLS; GENETIC SCREEN; JNK; PROLIFERATION; SURVIVAL; MUTANTS; DEATH; RAS	Drosophila endocytosis-defective cells develop tumour overgrowths in the imaginal discs. We have analysed the tumorigenic potential of cells mutant for Rab5, a gene involved in endocytosis. We found that while a compartment entirely made by Rab5 mutant cells can grow indefinitely, clones of Rab5 cells surrounded by normal cells are eliminated by cell competition. However, when a group of about 400 cells are simultaneously made mutant for Rab5, they form an overgrowing tumour: mutant cells in the periphery are eliminated, but those inside survive and continue proliferating because they are beyond the range of cell competition. These results identify group protection as a mechanism to evade the tumour-suppressing function of cell competition in Drosophila. Furthermore, we find that the growth of the tumour depends to a large extent on the presence of apoptosis inside the tumour: cells doubly mutant for Rab5 and the proapoptotic gene dronc do not form overgrowing tumours. These results suggest that the apoptosis caused by cell competition acts as a tumour-stimulating factor, bringing about high levels of Jun N-terminal kinase and subsequently Wg/Dpp signalling and high proliferation levels in the growing tumour. We conclude that under these circumstances cell competition facilitates the progression of the tumour, thus reversing its normal antitumour role.	[Ballesteros-Arias, L.; Saavedra, V.; Morata, G.] Univ Autonoma Madrid, CSIC, Ctr Biol Mol, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Morata, G (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol, Nicolas Cabrera 1, E-28049 Madrid, Spain.	gmorata@cbm.uam.es		Morata, Gines/0000-0003-3274-5173; Ballesteros-Arias, Luna/0000-0002-5701-699X	Ministerio de Economia y Competitividad [BFU2008-03196, CSD2007-00008]; Comunidad de Madrid [CELDEV S2006/SAL-0190]; Fundacion Ramon Areces	Ministerio de Economia y Competitividad(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Fundacion Ramon Areces	We thank Ernesto Sanchez-Herrero and the members of the Morata laboratory for help during the work and comments on the manuscript. We also thank Kenneth Irvine for comments on the manuscript. We also thank Angelica Cantarero for general help. The work has been supported by the grants BFU2008-03196, CSD2007-00008 from the Ministerio de Economia y Competitividad, and CELDEV S2006/SAL-0190 from the Comunidad de Madrid. We also acknowledge the institutional grant from the Fundacion Ramon Areces to the Centro de Biologia Molecular.	Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Chen CL, 2012, P NATL ACAD SCI USA, V109, P484, DOI 10.1073/pnas.1113882109; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; Daish TJ, 2004, DEV CELL, V7, P909, DOI 10.1016/j.devcel.2004.09.018; de Celis JF, 2009, INT J DEV BIOL, V53, P1385, DOI 10.1387/ijdb.072408jd; Devergne O, 2007, J CELL SCI, V120, P3457, DOI 10.1242/jcs.005926; Fischer JA, 2006, ANNU REV CELL DEV BI, V22, P181, DOI 10.1146/annurev.cellbio.22.010605.093205; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; Galliot B, 2010, TRENDS CELL BIOL, V20, P514, DOI 10.1016/j.tcb.2010.05.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Leong GR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-62; Li W, 2007, FLY, V1, P274, DOI 10.4161/fly.5247; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Martin FA, 2009, INT J DEV BIOL, V53, P1341, DOI 10.1387/ijdb.072447fm; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Menendez J, 2010, P NATL ACAD SCI USA, V107, P14651, DOI 10.1073/pnas.1009376107; Menut L, 2007, GENETICS, V177, P1667, DOI 10.1534/genetics.107.078360; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Morata G, 2011, DEV GROWTH DIFFER, V53, P168, DOI 10.1111/j.1440-169X.2010.01225.x; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Perez-Garijo A, 2009, DEVELOPMENT, V136, P1169, DOI 10.1242/dev.034017; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Shivas JM, 2010, TRENDS CELL BIOL, V20, P445, DOI 10.1016/j.tcb.2010.04.003; Shlevkov E, 2012, CELL DEATH DIFFER, V19, P451, DOI 10.1038/cdd.2011.113; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401	39	52	52	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 28	2014	33	35					4377	4384		10.1038/onc.2013.407	http://dx.doi.org/10.1038/onc.2013.407			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AO2MR	24096487				2022-12-25	WOS:000341157800002
J	Litvinov, RI; Yarovoi, SV; Rauova, L; Barsegov, V; Sachais, BS; Rux, AH; Hinds, JL; Arepally, GM; Cines, DB; Weisel, JW				Litvinov, Rustem I.; Yarovoi, Serge V.; Rauova, Lubica; Barsegov, Valeri; Sachais, Bruce S.; Rux, Ann H.; Hinds, Jillian L.; Arepally, Gowthami M.; Cines, Douglas B.; Weisel, John W.			Distinct Specificity and Single-molecule Kinetics Characterize the Interaction of Pathogenic and Non-pathogenic Antibodies against Platelet Factor 4-Heparin Complexes with Platelet Factor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Heparin-binding Protein; Platelets; Single Molecule Biophysics; Thrombosis	HEPARIN-INDUCED THROMBOCYTOPENIA; KNOB-HOLE INTERACTIONS; FORCE SPECTROSCOPY; BINDING; HIT; POLYMERIZATION; DISSOCIATION; ACTIVATION; STRENGTH; PEPTIDE	Background: Heparin-treated patients often develop antibodies, but only a subset cause heparin-induced thrombocytopenia. Results: In a single-molecule assay, a pathogenic monoclonal antibody bound more strongly to cross-linked platelet factor 4 than a non-pathogenic antibody. Conclusion: Oligomerization of platelet factor 4 may enhance binding of pathogenic antibodies. Significance: A molecular basis for specificity of pathogenic antibodies in heparin-induced thrombocytopenia is provided. Heparin-induced thrombocytopenia (HIT) is a thrombotic complication of heparin therapy mediated by antibodies to complexes between platelet factor 4 (PF4) and heparin or cellular glycosaminoglycans. However, only a fraction of patients with anti-PF4-heparin antibodies develop HIT, implying that only a subset of these antibodies is pathogenic. The basis for the pathogenic potential of anti-PF4-heparin antibodies remains unclear. To elucidate the intrinsic PF4-binding properties of HIT-like monoclonal antibody (KKO) versus non-pathogenic antibody (RTO) at the single-molecule level, we utilized optical trap-based force spectroscopy to measure the strength and probability of binding of surface-attached antibodies with oligomeric PF4 to simulate interactions on cells. To mimic the effect of heparin in bringing PF4 complexes into proximity, we chemically cross-linked PF4 tetramers using glutaraldehyde. Analysis of the force histograms revealed that KKO-PF4 interactions had approximate to 10-fold faster on-rates than RTO-PF4, and apparent equilibrium dissociation constants differed approximate to 10-fold with similar force-free off-rates (k(off) = 0.0031 and 0.0029 s(-1)). Qualitatively similar results were obtained for KKO and RTO interacting with PF4-heparin complexes. In contrast to WT PF4, KKO and RTO showed lower and similar binding probabilities to cross-linked PF4(K50E), which forms few if any oligomers. Thus, formation of stable PF4 polymers results in much stronger interactions with the pathogenic antibody without a significant effect on the binding of the non-pathogenic antibody. These results suggest a fundamental difference in the antigen-binding mechanisms between model pathogenic and non-pathogenic anti-PF4 antibodies that might underlie their distinct pathophysiological behaviors.	[Litvinov, Rustem I.; Yarovoi, Serge V.; Sachais, Bruce S.; Rux, Ann H.; Hinds, Jillian L.; Cines, Douglas B.; Weisel, John W.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Yarovoi, Serge V.; Sachais, Bruce S.; Rux, Ann H.; Hinds, Jillian L.; Cines, Douglas B.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Rauova, Lubica] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Arepally, Gowthami M.] Duke Univ, Div Hematol, Dept Med, Durham, NC 27710 USA; [Barsegov, Valeri] Univ Massachusetts, Dept Chem, Lowell, MA 01854 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Duke University; University of Massachusetts System; University of Massachusetts Lowell	Weisel, JW (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, 421 Curie Blvd,1154 BRB 2-3, Philadelphia, PA 19104 USA.	weisel@mail.med.upenn.edu	Litvinov, Rustem/E-5291-2011; Barsegov, Valeri/A-6203-2014	Litvinov, Rustem/0000-0003-0643-1496; Barsegov, Valeri/0000-0003-1994-3917; Cines, Douglas/0000-0001-5986-504X	National Institutes of Health [HL078726/HL078726-S1, HL099973/HL090774, HL084006, HL110860]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL090774, R01HL084006, RC1HL099973, R01HL078726, R01HL090774, P01HL110860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL078726/HL078726-S1 (to B. S. S.), HL099973/HL090774 (to J. W. W.), HL084006 (to D. B. C.), and HL110860 (to B. S. S., L. R., G. M. A., D. B. C., and J. W. W.).	AMIRAL J, 1995, THROMB HAEMOSTASIS, V73, P21; Arepally GM, 2000, BLOOD, V95, P1533, DOI 10.1182/blood.V95.5.1533.005k01_1533_1540; Arepally GM, 2006, NEW ENGL J MED, V355, P809, DOI 10.1056/NEJMcp052967; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; CHILKOTI A, 1995, J AM CHEM SOC, V117, P10622, DOI 10.1021/ja00148a003; Cines DB, 2007, J CLIN APHERESIS, V22, P31, DOI 10.1002/jca.20109; Cuker A, 2013, BLOOD, V121, P3727, DOI 10.1182/blood-2013-01-479576; Cuker A, 2012, BLOOD, V119, P2209, DOI 10.1182/blood-2011-11-376293; Evans EB, 1999, BIOPHYS CHEM, V82, P83, DOI 10.1016/S0301-4622(99)00108-8; Gorkun OV, 2006, BIOCHEMISTRY-US, V45, P14843, DOI 10.1021/bi061430q; Greinacher A, 2005, THROMB HAEMOSTASIS, V94, P132, DOI 10.1160/TH04-12-0825; Greinacher A, 2006, ARTERIOSCL THROM VAS, V26, P2386, DOI 10.1161/01.ATV.0000238350.89477.88; Jaax ME, 2013, BLOOD, V122, P272, DOI 10.1182/blood-2013-01-478966; Litvinov RI, 2003, J BIOL CHEM, V278, P51285, DOI 10.1074/jbc.M304581200; Litvinov RI, 2005, BLOOD, V106, P2944, DOI 10.1182/blood-2005-05-2039; Litvinov RI, 2005, BIOPHYS J, V89, P2824, DOI 10.1529/biophysj.105.061887; Litvinov RI, 2004, BLOOD, V104, P3979, DOI 10.1182/blood-2004-04-1411; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Litvinov RI, 2007, BIOCHEMISTRY-US, V46, P9133, DOI 10.1021/bi700944j; Litvinov RI, 2007, BLOOD, V109, P130, DOI 10.1182/blood-2006-07-033910; Litvinov RI, 2012, J BIOL CHEM, V287, P35275, DOI 10.1074/jbc.M112.404848; Litvinov RI, 2011, BIOPHYS J, V100, P165, DOI 10.1016/j.bpj.2010.11.019; MAYO KH, 1995, BIOCHEM J, V312, P357, DOI 10.1042/bj3120357; Pouplard C, 2001, BLOOD, V97, P3300, DOI 10.1182/blood.V97.10.3300; Rauova L, 2006, BLOOD, V107, P2346, DOI 10.1182/blood-2005-08-3122; Rauova L, 2005, BLOOD, V105, P131, DOI 10.1182/blood-2004-04-1544; Reilly MP, 2001, BLOOD, V98, P2442, DOI 10.1182/blood.V98.8.2442; Rinko LJ, 2004, BIOPHYS J, V86, P544, DOI 10.1016/S0006-3495(04)74133-8; Sachais BS, 2012, BLOOD, V120, P1137, DOI 10.1182/blood-2012-01-407262; Sachais BS, 2012, BLOOD, V119, P5955, DOI 10.1182/blood-2012-01-406801; Shandler SJ, 2011, J AM CHEM SOC, V133, P12378, DOI 10.1021/ja204215f; Sun JEP, 2012, INTEGR BIOL-UK, V4, P84, DOI 10.1039/c1ib00085c; Warkentin TE, 2011, J THROMB HAEMOST, V9, P105, DOI 10.1111/j.1538-7836.2011.04322.x; Warkentin TE, 2000, BLOOD, V96, P1703, DOI 10.1182/blood.V96.5.1703.h8001703_1703_1708; Warkentin TE, 2005, J LAB CLIN MED, V146, P341, DOI 10.1016/j.lab.2005.08.003; Zhu C, 2002, ANN BIOMED ENG, V30, P305, DOI 10.1114/1.1467923	36	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33060	33070		10.1074/jbc.M113.481598	http://dx.doi.org/10.1074/jbc.M113.481598			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097975	hybrid, Green Published			2022-12-25	WOS:000328841700022
J	Arachiche, A; Mumaw, MM; de la Fuente, M; Nieman, MT				Arachiche, Amal; Mumaw, Michele M.; de la Fuente, Maria; Nieman, Marvin T.			Protease-activated Receptor 1 (PAR1) and PAR4 Heterodimers Are Required for PAR1-enhanced Cleavage of PAR4 by alpha-Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioluminescence Resonance Energy Transfer (BRET); G-protein-coupled Receptors (GPCR); Protein-Protein Interactions; Receptor Regulation; Thrombin; PAR1; PAR4; Protease-activated Receptor	COUPLED RECEPTORS; SWISS-MODEL; CRYSTAL-STRUCTURE; HUMAN PLATELETS; RHODOPSIN; OLIGOMERIZATION; SPECIFICITY; TRANSDUCIN; COMPLEX; EXISTS	Thrombin is a potent platelet agonist that activates platelets and other cells of the cardiovascular system by cleaving its G-protein-coupled receptors, protease-activated receptor 1 (PAR1), PAR4, or both. We now show that cleaving PAR1 and PAR4 with -thrombin induces heterodimer formation. PAR1-PAR4 heterodimers were not detected when unstimulated; however, when the cells were stimulated with 10 nm -thrombin, we were able to detect a strong interaction between PAR1 and PAR4 by bioluminescence resonance energy transfer. In contrast, activating the receptors without cleavage using PAR1 and PAR4 agonist peptides (TFLLRN and AYPGKF, respectively) did not enhance heterodimer formation. Preventing PAR1 or PAR4 cleavage with point mutations or hirugen also prevented the induction of heterodimers. To further characterize the PAR1-PAR4 interactions, we mapped the heterodimer interface by introducing point mutations in transmembrane helix 4 of PAR1 or PAR4 that prevented heterodimer formation. Finally, we show that mutations in PAR1 or PAR4 at the heterodimer interface prevented PAR1-assisted cleavage of PAR4. These data demonstrate that PAR1 and PAR4 require allosteric changes induced via receptor cleavage by -thrombin to mediate heterodimer formation, and we have determined the PAR1-PAR4 heterodimer interface. Our findings show that PAR1 and PAR4 have dynamic interactions on the cell surface that should be taken into account when developing and characterizing PAR antagonists.	[Arachiche, Amal; Mumaw, Michele M.; de la Fuente, Maria; Nieman, Marvin T.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Nieman, MT (corresponding author), 10900 Euclid Ave,305C Wood Bldg, Cleveland, OH 44106 USA.	nieman@case.edu			National Institutes of Health [HL098217]; American Heart Association (AHA) [0865441D]; AHA Scientist Development Grant [10SDG2600021]; American Society for Hematology Scholar Award; Cytometry and Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center Grant [P30CA043703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); AHA Scientist Development Grant(American Heart Association); American Society for Hematology Scholar Award; Cytometry and Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL098217 (to M. N.). This work was also supported by American Heart Association (AHA) Beginning Grant-in-aid 0865441D, AHA Scientist Development Grant 10SDG2600021, an American Society for Hematology Scholar Award (to M. N.), and by the Cytometry and Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center Grant P30CA043703.	Arachiche A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055740; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Birdsall NJM, 2010, TRENDS PHARMACOL SCI, V31, P499, DOI 10.1016/j.tips.2010.08.003; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Covic L, 2002, THROMB HAEMOSTASIS, V87, P722, DOI 10.1055/s-0037-1613071; de la Fuente M, 2012, J BIOL CHEM, V287, P10414, DOI 10.1074/jbc.M112.341438; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Huntington JA, 2012, BBA-PROTEINS PROTEOM, V1824, P246, DOI 10.1016/j.bbapap.2011.07.005; Jacques SL, 2000, J BIOL CHEM, V275, P40671, DOI 10.1074/jbc.M004544200; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; LIU LW, 1991, J BIOL CHEM, V266, P16977; Lodowski DT, 2007, J STRUCT BIOL, V158, P455, DOI 10.1016/j.jsb.2007.01.017; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Mazharian A, 2007, J BIOL CHEM, V282, P5478, DOI 10.1074/jbc.M609881200; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nieman MT, 2007, BIOCHEMISTRY-US, V46, P8603, DOI 10.1021/bi700597p; Nieman MT, 2008, BIOCHEMISTRY-US, V47, P13279, DOI 10.1021/bi801334s; Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Riewald M, 2005, J BIOL CHEM, V280, P19808, DOI 10.1074/jbc.M500747200; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Soh UJK, 2011, P NATL ACAD SCI USA, V108, pE1372, DOI 10.1073/pnas.1112482108; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Voss B, 2007, MOL PHARMACOL, V71, P1399, DOI 10.1124/mol.106.033365; Wang HX, 2009, BIOCHEMISTRY-US, V48, P7132, DOI 10.1021/bi900424h; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	49	58	60	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32553	32562		10.1074/jbc.M113.472373	http://dx.doi.org/10.1074/jbc.M113.472373			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24097976	Green Published, hybrid			2022-12-25	WOS:000328681700038
J	Scorzeto, M; Giacomello, M; Toniolo, L; Canato, M; Blaauw, B; Paolini, C; Protasi, F; Reggiani, C; Stienen, GJM				Scorzeto, Michele; Giacomello, Marta; Toniolo, Luana; Canato, Marta; Blaauw, Bert; Paolini, Cecilia; Protasi, Feliciano; Reggiani, Carlo; Stienen, Ger J. M.			Mitochondrial Ca2+-Handling in Fast Skeletal Muscle Fibers from Wild Type and Calsequestrin-Null Mice	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM; SLOW-TWITCH; ESSENTIAL COMPONENT; CALCIUM TRANSIENTS; CA2+ DYNAMICS; MOUSE; CONTRACTION; INDICATORS; ENERGETICS; MOVEMENTS	Mitochondrial calcium handling and its relation with calcium released from sarcoplasmic reticulum (SR) in muscle tissue are subject of lively debate. In this study we aimed to clarify how the SR determines mitochondrial calcium handling using dCASQ-null mice which lack both isoforms of the major Ca2+-binding protein inside SR, calsequestrin. Mitochondrial free Ca2+-concentration ([Ca2+](mito)) was determined by means of a genetically targeted ratiometric FRET-based probe. Electron microscopy revealed a highly significant increase in intermyofibrillar mitochondria (+ 55%) and augmented coupling (+ 12%) between Ca2+ release units of the SR and mitochondria in dCASQ-null vs. WT fibers. Significant differences in the baseline [Ca2+](mito) were observed between quiescent WT and dCASQ-null fibers, but not in the resting cytosolic Ca2+ concentration. The rise in [Ca2+] mito during electrical stimulation occurred in 20230 ms, while the decline during and after stimulation was governed by 4 rate constants of approximately 40, 1.6, 0.2 and 0.03 s(-1). Accordingly, frequency- dependent increase in [Ca2+] mito occurred during sustained contractions. In dCASQ-null fibers the increases in [Ca2+] mito were less pronounced than in WT fibers and even lower when extracellular calcium was removed. The amplitude and duration of [Ca2+] mito transients were increased by inhibition of mitochondrial Na+/Ca2+ exchanger (mNCX). These results provide direct evidence for fast Ca2+ accumulation inside the mitochondria, involvement of the mNCX in mitochondrial Ca2+-handling and a dependence of mitochondrial Ca2+-handling on intracellular (SR) and external Ca2+ stores in fast skeletal muscle fibers. dCASQ-null mice represent a model for malignant hyperthermia. The differences in structure and in mitochondrial function observed relative to WT may represent compensatory mechanisms for the disease-related reduction of calcium storage capacity of the SR and/or SR Ca2+- leakage.	[Scorzeto, Michele; Toniolo, Luana; Canato, Marta; Blaauw, Bert; Reggiani, Carlo] Univ Padua, Dept Biomed Sci, Padua, Italy; [Scorzeto, Michele; Toniolo, Luana; Canato, Marta; Blaauw, Bert; Reggiani, Carlo] Univ Padua, IIM, Padua, Italy; [Giacomello, Marta; Blaauw, Bert] Venetian Inst Mol Med, Padua, Italy; [Paolini, Cecilia; Protasi, Feliciano] Univ G DAnnunzio, DNI, Chieti, Italy; [Paolini, Cecilia; Protasi, Feliciano] Univ G DAnnunzio, Ctr Res Ageing CeSI, Chieti, Italy; [Paolini, Cecilia; Protasi, Feliciano] Univ G DAnnunzio, IIM, Chieti, Italy; [Stienen, Ger J. M.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Physiol Lab, Amsterdam, Netherlands; [Stienen, Ger J. M.] Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands	University of Padua; University of Padua; Veneto Institute Molecular Medicine; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam	Stienen, GJM (corresponding author), Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Physiol Lab, Amsterdam, Netherlands.	g.stienen@vumc.nl	Paolini, Cecilia/AAI-4444-2021; Toniolo, Luana/B-9647-2014; GIACOMELLO, MARTA/HGB-1486-2022; Marta, Giacomello/B-6308-2013; blaauw, bert/A-7614-2014	Toniolo, Luana/0000-0001-7160-5638; blaauw, bert/0000-0002-3893-1463; Giacomello, Marta/0000-0002-0290-6602; Stienen, Ger/0000-0001-5829-0328; BLAAUW, BERT/0000-0002-4167-5106	Italian Telethon Foundation [GGP08153]; University G. d'Annunzio	Italian Telethon Foundation(Fondazione Telethon); University G. d'Annunzio	This study was supported by grant #GGP08153 from the Italian Telethon Foundation and by Research Funds from the University G. d'Annunzio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrienko TN, 2009, J MOL CELL CARDIOL, V46, P1027, DOI 10.1016/j.yjmcc.2009.03.015; Aydin J, 2009, HUM MOL GENET, V18, P278, DOI 10.1093/hmg/ddn355; Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082; BARCLAY CJ, 1993, J PHYSIOL-LONDON, V472, P61, DOI 10.1113/jphysiol.1993.sp019937; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Baylor SM, 2007, J GEN PHYSIOL, V130, P283, DOI 10.1085/jgp.200709827; Baylor SM, 2012, J GEN PHYSIOL, V139, P261, DOI 10.1085/jgp.201210773; BLINKS JR, 1978, J PHYSIOL-LONDON, V277, P291, DOI 10.1113/jphysiol.1978.sp012273; Bolanos P, 2008, PFLUG ARCH EUR J PHY, V455, P721, DOI 10.1007/s00424-007-0312-5; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Bruton JD, 2003, J PHYSIOL-LONDON, V552, P393, DOI 10.1113/jphysiol.org; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; Chikando AC, 2011, J MOL CELL CARDIOL, V51, P627, DOI 10.1016/j.yjmcc.2011.08.003; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Defranchi E, 2005, MICROSC RES TECHNIQ, V67, P27, DOI 10.1002/jemt.20177; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; DiFranco M, 2009, J VIS EXP, V32; Eisenberg B. R., 2010, COMPREHENSIVE PHYSL, P73; Filippin L, 2005, CELL CALCIUM, V37, P129, DOI 10.1016/j.ceca.2004.08.002; Franzini-Armstrong C, 2007, PHYSIOLOGY, V22, P261, DOI 10.1152/physiol.00017.2007; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; JUNG DW, 1995, J BIOL CHEM, V270, P672, DOI 10.1074/jbc.270.2.672; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; LOUD AV, 1965, LAB INVEST, V14, P996; MOBLEY BA, 1975, J GEN PHYSIOL, V66, P31, DOI 10.1085/jgp.66.1.31; Murphy RM, 2009, J PHYSIOL-LONDON, V587, P443, DOI 10.1113/jphysiol.2008.163162; O'Rourke B, 2009, J MOL CELL CARDIOL, V46, P767, DOI 10.1016/j.yjmcc.2008.12.011; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pan S, 2011, SCI CHINA LIFE SCI, V54, P763, DOI 10.1007/s11427-011-4203-9; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Paolini C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/634075; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rossi AE, 2011, AM J PHYSIOL-CELL PH, V301, pC1128, DOI 10.1152/ajpcell.00194.2011; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shkryl VM, 2006, J BIOL CHEM, V281, P1547, DOI 10.1074/jbc.M505024200; Tang S, 2011, P NATL ACAD SCI USA, V108, P16265, DOI 10.1073/pnas.1103015108; Tomasi M, 2012, AM J PHYSIOL-CELL PH, V302, pC575, DOI 10.1152/ajpcell.00119.2011; Yi JX, 2011, J BIOL CHEM, V286, P32436, DOI 10.1074/jbc.M110.217711; Zhao XL, 2010, BIOPHYS J, V99, P1556, DOI 10.1016/j.bpj.2010.06.050	45	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e74919	10.1371/journal.pone.0074919	http://dx.doi.org/10.1371/journal.pone.0074919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24098358	Green Submitted, gold, Green Published			2022-12-25	WOS:000325483600013
J	Ma, J; Li, XY; Xu, J; Zhang, Q; Liu, ZL; Jia, PP; Zhou, JM; Guo, F; You, XF; Yu, LY; Zhao, LX; Jiang, JD; Cen, S				Ma, Jing; Li, Xiaoyu; Xu, Jian; Zhang, Quan; Liu, Zhenlong; Jia, Pingping; Zhou, Jinming; Guo, Fei; You, Xuefu; Yu, Liyan; Zhao, Lixun; Jiang, Jiandong; Cen, Shan			The Roles of APOBEC3G Complexes in the Incorporation of APOBEC3G into HIV-1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; EDITING ENZYME APOBEC3G; VIF PROTEIN; RNA; GAG; ASSOCIATION; DEGRADATION; INFECTION; MEMBRANE; VIRIONS	Background: The incorporation of human APOBEC3G (hA3G) into HIV is required for exerting its antiviral activity, therefore the mechanism underlying hA3G virion encapsidation has been investigated extensively. hA3G was shown to form low-molecular-mass (LMM) and high-molecular-mass (HMM) complexes. The function of different forms of hA3G in its viral incorporation remains unclear. Methodology/Principal Findings: In this study, we investigated the subcellular distribution and lipid raft association of hA3G using subcellular fractionation, membrane floatation assay and pulse-chase radiolabeling experiments respectively, and studied the correlation between the ability of hA3G to form the different complex and its viral incorporation. Our work herein provides evidence that the majority of newly-synthesized hA3G interacts with membrane lipid raft domains to form Lipid raft-associated hA3G (RA hA3G), which serve as the precursor of mature HMM hA3G complex, while a minority of newly-synthesized hA3G remains in the cytoplasm as a soluble LMM form. The distribution of hA3G among the soluble LMM form, the RA LMM form and the mature forms of HMM is regulated by a mechanism involving the N-terminal part of the linker region and the C-terminus of hA3G. Mutagenesis studies reveal a direct correlation between the ability of hA3G to form the RA LMM complex and its viral incorporation. Conclusions/Significance: Together these data suggest that the Lipid raft-associated LMM A3G complex functions as the cellular source of viral hA3G.	[Ma, Jing; Li, Xiaoyu; Xu, Jian; Zhang, Quan; Liu, Zhenlong; Jia, Pingping; Zhou, Jinming; You, Xuefu; Yu, Liyan; Zhao, Lixun; Jiang, Jiandong; Cen, Shan] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China; [Guo, Fei] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Ma, Jing; Cen, Shan] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Ma, Jing; Cen, Shan] McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada; [Ma, Jing; Cen, Shan] McGill Univ, Montreal, PQ, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Lady Davis Institute; McGill University; McGill University; McGill University	Cen, S (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China.	shancen@imb.pumc.edu.cn	Liu, Zhenlong/AAE-7581-2021; yu, liyan/GYD-2950-2022	yu, liyan/0000-0002-8861-9806; Guo, Fei/0000-0003-3500-1006; Liu, Zhenlong/0000-0001-9149-7179	973 program [2012CB911102]; Nature Science Foundation of China [30973569]; National S&T Major Special Project on Major New Drug Innovation [2012ZX09102101-018]; Canadian Institutes for Health Research	973 program(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project on Major New Drug Innovation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by 973 program (2012CB911102) and Nature Science Foundation of China 30973569 (SC), The National S&T Major Special Project on Major New Drug Innovation 2012ZX09102101-018 (SC), and the Canadian Institutes for Health Research grant (SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chiu YL, 2009, PHILOS T R SOC B, V364, P689, DOI 10.1098/rstb.2008.0193; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Friew YN, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-56; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Halwani R, 2003, J VIROL, V77, P3973, DOI 10.1128/JVI.77.7.3973-3984.2003; Huang Y, 2001, J VIROL, V75, P4947, DOI 10.1128/JVI.75.10.4947-4951.2001; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Khan MN, 2007, SURFACTANT SCI SER, V133, P1; Khorchid A, 2002, J VIROL, V76, P4131, DOI 10.1128/JVI.76.8.4131-4137.2002; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Roy BB, 2006, J BIOL CHEM, V281, P12625, DOI 10.1074/jbc.M510596200; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; YU J, 1973, Journal of Supramolecular Structure, V1, P233, DOI 10.1002/jss.400010308; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378	32	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e74892	10.1371/journal.pone.0074892	http://dx.doi.org/10.1371/journal.pone.0074892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RG	24098356	Green Submitted, Green Published, gold			2022-12-25	WOS:000325434500016
J	Smith, WD; Miller, JA; Heppell, SS				Smith, Wade D.; Miller, Jessica A.; Heppell, Selina S.			Elemental Markers in Elasmobranchs: Effects of Environmental History and Growth on Vertebral Chemistry	PLOS ONE			English	Article							ROCKFISH SEBASTES-MELANOPS; OTOLITH CHEMISTRY; ROUND STINGRAY; TRACE-METALS; PARTITION-COEFFICIENTS; POPULATION-STRUCTURE; SPATIAL VARIATION; UROBATIS-HALLERI; WATER CHEMISTRY; ESTUARINE FISH	Differences in the chemical composition of calcified skeletal structures (e. g. shells, otoliths) have proven useful for reconstructing the environmental history of many marine species. However, the extent to which ambient environmental conditions can be inferred from the elemental signatures within the vertebrae of elasmobranchs (sharks, skates, rays) has not been evaluated. To assess the relationship between water and vertebral elemental composition, we conducted two laboratory studies using round stingrays, Urobatis halleri, as a model species. First, we examined the effects of temperature (16 degrees, 18 degrees, 24 degrees C) on vertebral elemental incorporation (Li/Ca, Mg/Ca, Mn/Ca, Zn/Ca, Sr/Ca, Ba/Ca). Second, we tested the relationship between water and subsequent vertebral elemental composition by manipulating dissolved barium concentrations (1x, 3x, 6x). We also evaluated the influence of natural variation in growth rate on elemental incorporation for both experiments. Finally, we examined the accuracy of classifying individuals to known environmental histories (temperature and barium treatments) using vertebral elemental composition. Temperature had strong, negative effects on the uptake of magnesium (D-Mg) and barium (D-Ba) and positively influenced manganese (D-Mn) incorporation. Temperature-dependent responses were not observed for lithium and strontium. Vertebral Ba/Ca was positively correlated with ambient Ba/Ca. Partition coefficients (D-Ba) revealed increased discrimination of barium in response to increased dissolved barium concentrations. There were no significant relationships between elemental incorporation and somatic growth or vertebral precipitation rates for any elements except Zn. Relationships between somatic growth rate and D-Zn were, however, inconsistent and inconclusive. Variation in the vertebral elemental signatures of U. halleri reliably distinguished individual rays from each treatment based on temperature (85%) and Ba exposure (96%) history. These results support the assumption that vertebral elemental composition reflects the environmental conditions during deposition and validates the use of vertebral elemental signatures as natural markers in an elasmobranch. Vertebral elemental analysis is a promising tool for the study of elasmobranch population structure, movement, and habitat use.	[Smith, Wade D.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Miller, Jessica A.] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Coastal Oregon Marine Expt Stn, Newport, OR 97365 USA; [Heppell, Selina S.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Smith, WD (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA.	wade.smith@oregonstate.edu		Miller, Jessica/0000-0002-6491-4085	National Science Foundation [OCE 0840860]; Mamie Markham Research Awards (HMSC-OSU); Thomas G. Scott Publication Fund	National Science Foundation(National Science Foundation (NSF)); Mamie Markham Research Awards (HMSC-OSU); Thomas G. Scott Publication Fund	Funding for this research was provided by a National Science Foundation Small Grant for Exploratory Research (OCE 0840860; http://www.nsf.gov/geo/oce/programs/biores.jsp) and Mamie Markham Research Awards (HMSC-OSU). Publication of this paper was supported, in part, by the Thomas G. Scott Publication Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOBA T, 1992, CALCIFIED TISSUE INT, V51, P143, DOI 10.1007/BF00298503; Ashhurst DE, 2004, MATRIX BIOL, V23, P15, DOI 10.1016/j.matbio.2004.02.001; Babel JS, 1967, BULLETIN, V137, P2; Balter V, 2004, GEOCHIM COSMOCHIM AC, V68, P423, DOI 10.1016/S0016-7037(03)00453-8; Balter V, 2010, GEOCHIM COSMOCHIM AC, V74, P3449, DOI 10.1016/j.gca.2010.03.015; Barnes TC, 2013, CAN J FISH AQUAT SCI, V70, P1159, DOI 10.1139/cjfas-2012-0442; Bath GE, 2000, GEOCHIM COSMOCHIM AC, V64, P1705, DOI 10.1016/S0016-7037(99)00419-6; BECK JW, 1992, SCIENCE, V257, P644, DOI 10.1126/science.257.5070.644; Cailliet G.M., 2004, BIOL SHARKS THEIR RE; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Chittaro PM, 2006, ESTUAR COAST SHELF S, V67, P673, DOI 10.1016/j.ecss.2005.12.014; Chowdhury MJ, 2012, FISH PHYSL SER B, V31B; CLEMENT JG, 1992, AUST J MAR FRESH RES, V43, P157; de Vries MC, 2005, GEOCHIM COSMOCHIM AC, V69, P4061, DOI 10.1016/j.gca.2005.03.052; Dean MN, 2006, ZOOLOGY, V109, P164, DOI 10.1016/j.zool.2006.03.002; Dean MN, 2009, J ANAT, V215, P227, DOI 10.1111/j.1469-7580.2009.01116.x; DELANEY ML, 1985, GEOCHIM COSMOCHIM AC, V49, P1327, DOI 10.1016/0016-7037(85)90284-4; DiMaria RA, 2010, ENVIRON BIOL FISH, V89, P453, DOI 10.1007/s10641-010-9665-2; Dorval E, 2007, CAN J FISH AQUAT SCI, V64, P411, DOI 10.1139/F07-015; Dove SG, 1996, J EXP MAR BIOL ECOL, V205, P15, DOI 10.1016/S0022-0981(96)02610-X; DOYLE J, 1968, COMP BIOCHEM PHYSIOL, V25, P201, DOI 10.1016/0010-406X(68)90927-4; Edmonds JS, 1996, SCI TOTAL ENVIRON, V192, P151, DOI 10.1016/S0048-9697(96)05311-9; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Elsdon TS, 2002, CAN J FISH AQUAT SCI, V59, P1796, DOI 10.1139/F02-154; Evans DH, 2004, BIOL SHARKS THEIR RE; FLEISHMAN DG, 1986, COMP BIOCHEM PHYS A, V84, P643, DOI 10.1016/0300-9629(86)90379-8; FOWLER AJ, 1995, CAN J FISH AQUAT SCI, V52, P1431, DOI 10.1139/f95-138; Friedrich LA, 2008, ENVIRON SCI TECHNOL, V42, P3514, DOI 10.1021/es072093r; Gaetani GA, 2006, GEOCHIM COSMOCHIM AC, V70, P4617, DOI 10.1016/j.gca.2006.07.008; Gelsleichter J, 1997, T AM FISH SOC, V126, P862, DOI 10.1577/1548-8659(1997)126<0862:UOCAAF>2.3.CO;2; Gillanders BM, 2002, CAN J FISH AQUAT SCI, V59, P669, DOI 10.1139/F02-040; Gosnell KJ, 2012, MAR CHEM, V132, P68, DOI 10.1016/j.marchem.2012.01.004; Hale LF, 2008, J FISH BIOL, V73, P510, DOI 10.1111/j.1095-8649.2008.01940.x; Hale LF, 2006, ENVIRON BIOL FISH, V77, P317, DOI 10.1007/s10641-006-9124-2; Hamer PA, 2007, J FISH BIOL, V71, P1035, DOI 10.1111/j.1095-8649.2007.01570.x; Hicks AS, 2010, J EXP MAR BIOL ECOL, V394, P86, DOI 10.1016/j.jembe.2010.07.018; Hobson KA, 2010, UNDERSTANDING MOVEME; HOFF GR, 1995, B MAR SCI, V56, P578; Hoisington G, 2005, MAR ENVIRON RES, V60, P437, DOI 10.1016/j.marenvres.2005.01.003; Hurst TP, 2010, FISH B-NOAA, V108, P382; KALISH JM, 1989, J EXP MAR BIOL ECOL, V132, P151, DOI 10.1016/0022-0981(89)90126-3; Kent AJR, 2006, AM MINERAL, V91, P1401, DOI 10.2138/am.2006.2030; Kerr LA, 2006, ENVIRON BIOL FISH, V77, P337, DOI 10.1007/s10641-006-9125-1; Lea DW, 2006, OCEANS MARINE GEOCHE, V6; Limburg KE, 2011, P NATL ACAD SCI USA, V108, pE177, DOI 10.1073/pnas.1100684108; Lloyd DC, 2008, MAR ECOL PROG SER, V353, P115, DOI 10.3354/meps07172; LOWENSTAM HA, 1954, J GEOL, V62, P284, DOI 10.1086/626163; MacNeill MA, 2005, MAR ECOL PROG SER, V302, P199, DOI 10.3354/meps302199; Madejczyk MS, 2009, COMP BIOCHEM PHYS C, V149, P566, DOI 10.1016/j.cbpc.2008.12.009; Marohn L, 2011, ANAL BIOANAL CHEM, V399, P2175, DOI 10.1007/s00216-010-4412-2; Marriott CS, 2004, EARTH PLANET SC LETT, V222, P615, DOI 10.1016/j.epsl.2004.02.031; Martin GB, 2005, MAR ECOL PROG SER, V293, P223; Martin GB, 2006, MAR ECOL PROG SER, V324, P229, DOI 10.3354/meps324229; Mathews T, 2009, SCI TOTAL ENVIRON, V407, P5156, DOI 10.1016/j.scitotenv.2009.06.003; MAYER I, 1986, CALCIFIED TISSUE INT, V38, P293, DOI 10.1007/BF02556609; Mayer I, 2003, EUR J INORG CHEM, P1445; McGarigal K., 2000, MULTIVARIATE STAT WI; McMahon KW, 2011, CAN J FISH AQUAT SCI, V68, P1330, DOI 10.1139/F2011-070; Miller JA, 2009, J FISH BIOL, V75, P39, DOI 10.1111/j.1095-8649.2009.02262.x; Miller JA, 2005, CAN J FISH AQUAT SCI, V62, P2189, DOI 10.1139/F05-133; Miller JA, 2004, CAN J FISH AQUAT SCI, V61, P1723, DOI 10.1139/F04-111; Miller MB, 2006, J EXP MAR BIOL ECOL, V329, P135, DOI 10.1016/j.jembe.2005.08.016; MILNER NJ, 1982, J FISH BIOL, V21, P325, DOI 10.1111/j.1095-8649.1982.tb02838.x; Milton DA, 2001, J EXP MAR BIOL ECOL, V264, P47, DOI 10.1016/S0022-0981(01)00301-X; MORSE JW, 1990, CHEM GEOL, V82, P265, DOI 10.1016/0009-2541(90)90085-L; MULLIGAN TJ, 1983, CAN J FISH AQUAT SCI, V40, P215, DOI 10.1139/f83-032; OKUMURA M, 1986, GEOCHIM COSMOCHIM AC, V50, P49, DOI 10.1016/0016-7037(86)90047-5; PENTREATH R J, 1973, Journal of Experimental Marine Biology and Ecology, V12, P327, DOI 10.1016/0022-0981(73)90062-2; Ranaldi MM, 2010, COMP BIOCHEM PHYS C, V152, P248, DOI 10.1016/j.cbpc.2010.04.012; Ridewood WG, 1921, PHILOS T R SOC LON B, V210, P311, DOI 10.1098/rstb.1921.0008; Rollion-Bard C, 2009, EARTH PLANET SC LETT, V286, P63, DOI 10.1016/j.epsl.2009.06.015; Rosenthal Y, 1997, GEOCHIM COSMOCHIM AC, V61, P3633, DOI 10.1016/S0016-7037(97)00181-6; Scheiner SM, 2001, DESIGN ANAL ECOLOGIC; SCHIFANO G, 1982, CHEM GEOL, V35, P321, DOI 10.1016/0009-2541(82)90009-2; SCHOENBE.HP, 1963, BIOCHIM BIOPHYS ACTA, V75, P96, DOI 10.1016/0006-3002(63)90583-3; Simkiss K, 1974, AGEING FISH; Simpfendorfer CA, 2000, FISH B-NOAA, V98, P811; Smith WD, 2007, MAR FRESHWATER RES, V58, P54, DOI 10.1071/MF06083; Sponaugle S, 2010, ENVIRON BIOL FISH, V89, P221, DOI 10.1007/s10641-010-9676-z; Stecher HA, 1996, GEOCHIM COSMOCHIM AC, V60, P3445, DOI 10.1016/0016-7037(96)00179-2; Strasser CA, 2008, J EXP MAR BIOL ECOL, V355, P153, DOI 10.1016/j.jembe.2007.12.022; Strasser CA, 2008, MAR ECOL PROG SER, V370, P155, DOI 10.3354/meps07658; Swearer SE, 2003, ESTUAR COAST SHELF S, V56, P1111, DOI 10.1016/S0272-7714(02)00317-7; Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043; THOMPSON THOMAS G., 1955, DEEP SEA RES, V3, P20; Thorrold SR, 1997, GEOCHIM COSMOCHIM AC, V61, P2909, DOI 10.1016/S0016-7037(97)00141-5; Tillett BJ, 2011, MAR ECOL PROG SER, V434, P133, DOI 10.3354/meps09222; TITUS K, 1984, AM MIDL NAT, V111, P1, DOI 10.2307/2425535; Vallee BL, 1983, ZINC ENZYMES METAL I, V5; Veinott GI, 1999, T AM FISH SOC, V128, P352, DOI 10.1577/1548-8659(1999)128&lt;0352:AEOESI&gt;2.0.CO;2; Walther BD, 2006, MAR ECOL PROG SER, V311, P125, DOI 10.3354/meps311125; Walther BD, 2010, ENVIRON BIOL FISH, V89, P441, DOI 10.1007/s10641-010-9661-6; Watanabe T, 1997, AQUACULTURE, V151, P185, DOI 10.1016/S0044-8486(96)01503-7; Webb SD, 2012, MAR ECOL PROG SER, V453, P189, DOI 10.3354/meps09653; Welden BA, 1987, AGE GROWTH FISH; Wells BK, 2000, CAN J FISH AQUAT SCI, V57, P2122, DOI 10.1139/cjfas-57-10-2122; Wells BK, 2003, CAN J FISH AQUAT SCI, V60, P361, DOI 10.1139/F03-028; Werry JM, 2011, MAR FRESHWATER RES, V62, P1421, DOI 10.1071/MF11136; WILLIS JN, 1984, MAR BIOL, V80, P273, DOI 10.1007/BF00392822; Zacherl DC, 2003, GEOCHIM COSMOCHIM AC, V67, P4091, DOI 10.1016/S0016-7037(03)00384-3; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zumholz K, 2007, MAR BIOL, V151, P1321, DOI 10.1007/s00227-006-0564-1; Zwolsman JJG, 1997, GEOCHIM COSMOCHIM AC, V61, P1635, DOI 10.1016/S0016-7037(97)00029-X	106	37	38	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e62423	10.1371/journal.pone.0062423	http://dx.doi.org/10.1371/journal.pone.0062423			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098320	gold, Green Published, Green Submitted			2022-12-25	WOS:000325427100001
J	Aschauer, DF; Kreuz, S; Rumpel, S				Aschauer, Dominik F.; Kreuz, Sebastian; Rumpel, Simon			Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS VECTORS; CENTRAL-NERVOUS-SYSTEM; GENE-TRANSFER; TRANSGENE EXPRESSION; GABAERGIC NEURONS; IMMUNE-RESPONSES; CELL TROPISM; MICE; RECEPTOR; PATHWAYS	Recombinant Adeno-associated virus vectors (rAAV) are widely used for gene delivery and multiple naturally occurring serotypes have been harnessed to target cells in different tissues and organs including the brain. Here, we provide a detailed and quantitative analysis of the transduction profiles of rAAV vectors based on six of the most commonly used serotypes (AAV1, AAV2, AAV5, AAV6, AAV8, AAV9) that allows systematic comparison and selection of the optimal vector for a specific application. In our studies we observed marked differences among serotypes in the efficiency to transduce three different brain regions namely the striatum, hippocampus and neocortex of the mouse. Despite the fact that the analyzed serotypes have the general ability to transduce all major cell types in the brain (neurons, microglia, astrocytes and oligodendrocytes), the expression level of a reporter gene driven from a ubiquitous promoter varies significantly for specific cell type / serotype combinations. For example, rAAV8 is particularly efficient to drive transgene expression in astrocytes while rAAV9 appears well suited for the transduction of cortical neurons. Interestingly, we demonstrate selective retrograde transport of rAAV5 along axons projecting from the ventral part of the entorhinal cortex to the dentate gyrus. Furthermore, we show that self-complementing rAAV can be used to significantly decrease the time required for the onset of transgene expression in the mouse brain.	[Aschauer, Dominik F.; Rumpel, Simon] Res Inst Mol Pathol IMP, Vienna, Austria; [Kreuz, Sebastian] Boehringer Ingelheim Pharma GmbH & Co KG, Target Discovery Res, Biberach, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Boehringer Ingelheim	Rumpel, S (corresponding author), Res Inst Mol Pathol IMP, Vienna, Austria.	rumpel@imp.ac.at			Boehringer Ingelheim Pharmaceuticals; Research Institute of Molecular Pathology (IMP)	Boehringer Ingelheim Pharmaceuticals(Boehringer Ingelheim); Research Institute of Molecular Pathology (IMP)	The research was funded by Boehringer Ingelheim Pharmaceuticals directly (SK) or through core funding of the Research Institute of Molecular Pathology (IMP) (DFA, SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Bantel-Schaal U, 2009, J GEN VIROL, V90, P317, DOI 10.1099/vir.0.005595-0; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; Berges BK, 2007, MOL THER, V15, P20, DOI 10.1038/sj.mt.6300018; Buie LK, 2010, INVEST OPHTH VIS SCI, V51, P236, DOI 10.1167/iovs.09-3847; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Carter BJ, 2004, MOL THER, V10, P981, DOI 10.1016/j.ymthe.2004.09.011; Cearley CN, 2006, MOL THER, V13, P528, DOI 10.1016/j.ymthe.2005.11.015; de Backer MWA, 2011, METHODS MOL BIOL, V789, P357, DOI 10.1007/978-1-61779-310-3_24; DEDEREN PJWC, 1994, HISTOCHEM J, V26, P856, DOI 10.1007/BF00162931; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; Ehrengruber MU, 1999, P NATL ACAD SCI USA, V96, P7041, DOI 10.1073/pnas.96.12.7041; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Fitzsimons HL, 2002, METHODS, V28, P227, DOI 10.1016/S1046-2023(02)00227-X; Fu HY, 2003, MOL THER, V8, P911, DOI 10.1016/j.ymthe.2003.08.021; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Harbison CE, 2008, TRENDS MICROBIOL, V16, P208, DOI 10.1016/j.tim.2008.01.012; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; He M, 2012, NEURON, V73, P35, DOI 10.1016/j.neuron.2011.11.010; Herzog RW, 2007, MOL THER, V15, P649, DOI 10.1038/sj.mt.6300123; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; HOGGAN MD, 1966, P NATL ACAD SCI USA, V55, P1467, DOI 10.1073/pnas.55.6.1467; Howard DB, 2008, VIROLOGY, V372, P24, DOI 10.1016/j.virol.2007.10.007; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Hueffer K, 2003, CURR OPIN MICROBIOL, V6, P392, DOI 10.1016/S1369-5274(03)00083-3; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; JOHNSON RT, 1965, AM J PATHOL, V46, P929; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Latimer CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026812; Lazarini F, 2012, J NEUROSCI, V32, P3652, DOI 10.1523/JNEUROSCI.6394-11.2012; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Ma WQ, 2011, HUM GENE THER, V22, P633, DOI 10.1089/hum.2010.243; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MARR D, 1970, PROC R SOC SER B-BIO, V176, P161, DOI 10.1098/rspb.1970.0040; Masamizu Y, 2011, NEUROSCIENCE, V193, P249, DOI 10.1016/j.neuroscience.2011.06.080; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muzyczka N, 2005, HUM GENE THER, V16, P408, DOI 10.1089/hum.2005.16.408; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Ohsawa K, 2000, J CELL SCI, V113, P3073; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Salegio EA, 2013, GENE THER, V20, P348, DOI 10.1038/gt.2012.27; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Urabe M, 2002, HUM GENE THER, V13, P1935, DOI 10.1089/10430340260355347; Vela JM, 2002, J NEUROTRAUM, V19, P1503, DOI 10.1089/089771502320914723; White MD, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00008; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Zabner J, 2000, J VIROL, V74, P3852, DOI 10.1128/JVI.74.8.3852-3858.2000; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	68	323	339	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76310	10.1371/journal.pone.0076310	http://dx.doi.org/10.1371/journal.pone.0076310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086725	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900096
J	Eriksen, MB; Nielsen, MFB; Brusgaard, K; Tan, QH; Andersen, MS; Glintborg, D; Gaster, M				Eriksen, Mette B.; Nielsen, Michael F. B.; Brusgaard, Klaus; Tan, Qihua; Andersen, Marianne S.; Glintborg, Dorte; Gaster, Michael			Genetic Alterations within the DENND1A Gene in Patients with Polycystic Ovary Syndrome (PCOS)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CHROMOSOME 2P16.3; BODY HAIR; PROTEIN; WOMEN; HIRSUTISM; VARIANTS; DOMAIN; PREMENOPAUSAL	Polycystic ovary syndrome (PCOS), the most common endocrine disease among premenopausal women, is caused by both genes and environment. We and others previously reported association between single nucleotide polymorphisms (SNPs) in the DENND1A gene and PCOS. We therefore sequenced the DENND1A gene in white patients with PCOS to identify possible alterations that may be implicated in the PCOS pathogenesis. Patients were referred with PCOS and/or hirsutism between 1998 and 2011 (n = 261). PCOS was diagnosed according to the Rotterdam criteria (n = 165). Sequence analysis was performed in 10 patients with PCOS. Additional patients (n = 251) and healthy female controls (n = 248) were included for SNP genotyping. Patients underwent clinical examination including Ferriman-Gallwey score (FG-score), biochemical analyses and transvaginal ultrasound. Mutation analysis was carried out by bidirectional sequencing. SNP genotyping was tested by allelic discrimination in real-time PCR in the additional patients and controls. Sequencing of the DENND1A gene identified eight SNPs; seven were not known to be associated with any diseases. One missense SNP was detected (rs189947178, A/C), potentially altering the structural conformation of the DENND1A protein. SNP genotyping of rs189947178 showed significantly more carriers among patients with PCOS and moderate hirsutism compared to controls. However, due to small sample size and lack of multiple regression analysis supporting an association between rs189947178 and FG-score or PCOS diagnosis, this could be a false positive finding. In conclusion, sequence analysis of the DENND1A gene of patients with PCOS did not identify alterations that alone could be responsible for the PCOS pathogenesis, but a missense SNP (rs189947178) was identified in one patient and significantly more carriers of rs189947178 were found among patients with PCOS and moderate hirsutism vs. controls. Additional studies with independent cohort are needed to confirm this due to the small sample size of this study.	[Eriksen, Mette B.; Andersen, Marianne S.; Glintborg, Dorte; Gaster, Michael] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark; [Eriksen, Mette B.; Nielsen, Michael F. B.; Gaster, Michael] Odense Univ Hosp, Dept Clin Pathol, DK-5000 Odense, Denmark; [Eriksen, Mette B.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Brusgaard, Klaus; Tan, Qihua] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Tan, Qihua] Univ Southern Denmark, Dept Epidemiol & Biostat, Inst Publ Hlth, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Eriksen, MB (corresponding author), Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark.	mette.eriksen@ouh.rsyd.dk	Brusgaard, Klaus/AGE-8988-2022; Andersen, Marianne Skovsager/AAE-1751-2019; Tan, Qihua/F-1349-2015; Glintborg, Dorte/AAE-3676-2019; Tan, Qihua/AAG-2582-2019	Andersen, Marianne Skovsager/0000-0002-4603-9504; Tan, Qihua/0000-0003-3194-0030; Glintborg, Dorte/0000-0002-8338-8025; Tan, Qihua/0000-0003-3194-0030; Nielsen, Michael Friberg Bruun/0000-0003-3244-9438; Brusgaard, Klaus/0000-0002-2096-4988; Brandt Eriksen, Mette/0000-0001-6785-261X	Region of Southern Denmark [09/13388]; University of Southern Denmark; Augustinus Foundation; A.P. Moller Foundation for the Advancement of Medical Science; Odense University Hospital; Aase og Ejner Danielsens Foundation; Brothers Hartmann Foundation; Vilhelm Bangs Foundation; Familien Hede Nielsens Foundation	Region of Southern Denmark; University of Southern Denmark; Augustinus Foundation; A.P. Moller Foundation for the Advancement of Medical Science; Odense University Hospital; Aase og Ejner Danielsens Foundation; Brothers Hartmann Foundation; Vilhelm Bangs Foundation; Familien Hede Nielsens Foundation	Region of Southern Denmark (grant no. 09/13388), University of Southern Denmark, the Augustinus Foundation, the A.P. Moller Foundation for the Advancement of Medical Science, the free research funds of Odense University Hospital, Aase og Ejner Danielsens Foundation, the Brothers Hartmann Foundation, Vilhelm Bangs Foundation and Familien Hede Nielsens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Api M, 2009, ARCH GYNECOL OBSTET, V279, P473, DOI 10.1007/s00404-008-0747-8; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Cook H, 2011, FERTIL STERIL, V96, P1266, DOI 10.1016/j.fertnstert.2011.08.022; Cui LL, 2013, HUM REPROD, V28, P538, DOI 10.1093/humrep/des424; DeUgarte CM, 2006, J CLIN ENDOCR METAB, V91, P1345, DOI 10.1210/jc.2004-2301; Diamanti-Kandarakis Evanthia, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000598; Eriksen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014469; Eriksen MB, 2012, EUR J OBSTET GYN R B, V163, P39, DOI 10.1016/j.ejogrb.2012.03.020; Eriksen MB, 2011, J CLIN ENDOCR METAB, V96, pE1298, DOI 10.1210/jc.2011-0278; Escobar-Morreale HF, 2012, HUM REPROD UPDATE, V18, P146, DOI 10.1093/humupd/dmr042; Ewens KG, 2011, FERTIL STERIL, V95, P2538, DOI 10.1016/j.fertnstert.2011.02.050; Ewens KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016390; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Glintborg D, 2005, J CLIN ENDOCR METAB, V90, P1347, DOI 10.1210/jc.2004-1214; Glintborg D, 2004, FERTIL STERIL, V82, P1570, DOI 10.1016/j.fertnstert.2004.06.040; Glintborg D, 2012, GYNECOL ENDOCRINOL, V28, P170, DOI 10.3109/09513590.2011.589926; Glintborg D, 2010, CLIN ENDOCRINOL, V73, P732, DOI 10.1111/j.1365-2265.2010.03873.x; Glintborg D, 2010, GYNECOL ENDOCRINOL, V26, P281, DOI 10.3109/09513590903247873; Goodarzi MO, 2012, J MED GENET, V49, P90, DOI 10.1136/jmedgenet-2011-100427; Jones MR, 2012, STEROIDS, V77, P317, DOI 10.1016/j.steroids.2011.12.005; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lerchbaum E, 2011, HORM METAB RES, V43, P743, DOI 10.1055/s-0031-1286279; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Moran C, 2010, GYNECOL OBSTET INVES, V69, P274, DOI 10.1159/000277640; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Ohdaira H, 2009, COMPUT BIOL CHEM, V33, P429, DOI 10.1016/j.compbiolchem.2009.09.003; Sagsoz N, 2004, YONSEI MED J, V45, P483; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Tellez R, 1995, REV MED CHILE, V123, P1349; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Welt CK, 2012, J CLIN ENDOCR METAB, V97, pE1342, DOI 10.1210/jc.2011-3478; Wu XD, 2011, P NATL ACAD SCI USA, V108, P18672, DOI 10.1073/pnas.1110415108; 2000, J CLIN ENDOCR METAB, V85, P2434, DOI DOI 10.1210/JC.85.7.2434.PUBMED:10902790; J CLIN ENDOCR METAB, V89, P2745, DOI DOI 10.1210/JC.2003-032046.PUBMED:15181052	45	28	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e77186	10.1371/journal.pone.0077186	http://dx.doi.org/10.1371/journal.pone.0077186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086769	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900113
J	Sakharwade, SC; Sharma, PK; Mukhopadhaya, A				Sakharwade, Sanica C.; Sharma, Praveen K.; Mukhopadhaya, Arunika			Vibrio cholerae Porin OmpU Induces Pro-Inflammatory Responses, but Down-Regulates LPS-Mediated Effects in RAW 264.7, THP-1 and Human PBMCs	PLOS ONE			English	Article							OUTER-MEMBRANE-PROTEIN; TNF-ALPHA; CYTOKINE PRODUCTION; EPITHELIAL-CELLS; NITRIC-OXIDE; EXPRESSION; RELEASE; VACCINE; RESISTANCE; TOLERANCE	Vibrio cholerae porin OmpU plays a crucial role in the survival of the organism in the human gut. Various observations suggest critical involvement of OmpU in V. cholerae pathogenesis. However, OmpU is poorly characterized in terms of its ability to evoke cellular responses, particularly in the context of host immune system. Therefore, towards characterizing V. cholerae OmpU for its host immunomodulatory functions, we have studied the ability of OmpU to elicit pro-inflammatory responses in a range of immune cells which include, mouse RAW 264.7 macrophages, human THP-1 monocytes and human PBMCs. We have observed that purified OmpU induces pro-inflammatory responses in terms of production of NO, TNF and IL-6. Interestingly, pre-treatment of the cells with OmpU suppresses the production of NO, TNF, IL-6 as well as IL-12 upon subsequent activation with LPS. Our results therefore suggest that V. cholerae OmpU may have a differential regulatory role in terms of host immunomodulatory function: it can induce pro-inflammatory responses in target host immune cells, whereas it can also exert suppressive effect on LPS-induced pro-inflammatory responses. In addition, our study indicates that purified OmpU may have the ability to skew the Th1 response towards the Th2 response, presumably via suppression of IL-12 production.	[Sakharwade, Sanica C.; Sharma, Praveen K.; Mukhopadhaya, Arunika] Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Mohali, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Mukhopadhaya, A (corresponding author), Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Mohali, Punjab, India.	arunika@iisermohali.ac.in		Mukhopadhaya, Arunika/0000-0003-2121-7885	Department of Biotechnology (DBT), India (DBT) [BT/PR1205/MED/29/318/2011]; IISER Mohali	Department of Biotechnology (DBT), India (DBT); IISER Mohali	This work was supported by a grant from the Department of Biotechnology (DBT), India (DBT Grant No. BT/PR1205/MED/29/318/2011) and funding from IISER Mohali. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARDINI ML, 1993, INFECT IMMUN, V61, P3625, DOI 10.1128/IAI.61.9.3625-3635.1993; Biancone L, 1997, EXP NEPHROL, V5, P330; Biswas T, 2000, FEMS IMMUNOL MED MIC, V29, P129; Burkart V, 2002, J IMMUNOL, V168, P1730, DOI 10.4049/jimmunol.168.4.1730; Cai SH, 2013, J FISH DIS, V36, P695, DOI 10.1111/jfd.12036; Chakrabarti Sr, 1996, J BACTERIOL, V178, P524, DOI 10.1128/jb.178.2.524-530.1996; Chan ED, 1999, J IMMUNOL, V162, P415; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; Domingos MO, 2009, TOXICON, V53, P570, DOI 10.1016/j.toxicon.2008.12.017; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; Duret G, 2006, J BIOL CHEM, V281, P19899, DOI 10.1074/jbc.M602426200; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; GALDIERO F, 1993, INFECT IMMUN, V61, P155, DOI 10.1128/IAI.61.1.155-161.1993; Galdiero M, 2003, FEMS MICROBIOL LETT, V226, P57, DOI 10.1016/S0378-1097(03)00562-7; Galdiero M, 2001, MICROBIOL-SGM, V147, P2697, DOI 10.1099/00221287-147-10-2697; Galdiero M, 2004, INFECT IMMUN, V72, P1204, DOI 10.1128/IAI.72.2.1204-1209.2004; Goel AK, 2010, WORLD J MICROB BIOT, V26, P281, DOI 10.1007/s11274-009-0171-7; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Gupta S, 1999, MOL CELL BIOCHEM, V194, P235, DOI 10.1023/A:1006971621653; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; HIRANO T, 1985, P NATL ACAD SCI USA, V82, P5490, DOI 10.1073/pnas.82.16.5490; Holm MM, 2004, INFECT IMMUN, V72, P1906, DOI 10.1128/IAI.72.4.1906-1913.2004; HOUSSIAU FA, 1989, J IMMUNOL, V143, P2520; Khan J, 2012, PROTEIN EXPRES PURIF, V85, P204, DOI 10.1016/j.pep.2012.08.005; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Latz E, 2004, J IMMUNOL, V172, P2431, DOI 10.4049/jimmunol.172.4.2431; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Mathur J, 2004, INFECT IMMUN, V72, P3577, DOI 10.1128/IAI.72.6.3577-3583.2004; Merrell DS, 2001, J BACTERIOL, V183, P2746, DOI 10.1128/JB.183.9.2746-2754.2001; Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339; Nakasone N, 1998, INFECT IMMUN, V66, P4726, DOI 10.1128/IAI.66.10.4726-4728.1998; Negm RS, 1999, CAN J MICROBIOL, V45, P658, DOI 10.1139/cjm-45-8-658; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Provenzano D, 2000, P NATL ACAD SCI USA, V97, P10220, DOI 10.1073/pnas.170219997; Provenzano D, 2001, J BACTERIOL, V183, P3652, DOI 10.1128/JB.183.12.3652-3662.2001; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Rolhion N, 2007, MOL MICROBIOL, V63, P1684, DOI 10.1111/j.1365-2958.2007.05638.x; Sarkar M, 2012, FEBS J, V279, P1464, DOI 10.1111/j.1742-4658.2012.08539.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SETRAKIAN JC, 1994, ARCH SURG-CHICAGO, V129, P187; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; SPERANDIO V, 1995, INFECT IMMUN, V63, P4433, DOI 10.1128/IAI.63.11.4433-4438.1995; TABARAIE B, 1994, MICROBIOL IMMUNOL, V38, P553, DOI 10.1111/j.1348-0421.1994.tb01822.x; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Tsatsanis C, 2005, BIOCHEM BIOPH RES CO, V335, P1254, DOI 10.1016/j.bbrc.2005.07.197; Viana CFG, 2002, TOXICON, V40, P1487, DOI 10.1016/S0041-0101(02)00170-8; Wang Q, 2011, LETT APPL MICROBIOL, V53, P22, DOI 10.1111/j.1472-765X.2011.03062.x; Whitaker WB, 2012, INFECT IMMUN, V80, P1834, DOI 10.1128/IAI.06284-11; Wibbenmeyer JA, 2002, INFECT IMMUN, V70, P121, DOI 10.1128/IAI.70.1.121-126.2002; Xiong XP, 2010, MAR BIOTECHNOL, V12, P686, DOI 10.1007/s10126-009-9256-4	53	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76583	10.1371/journal.pone.0076583	http://dx.doi.org/10.1371/journal.pone.0076583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086753	Green Published, gold, Green Submitted			2022-12-25	WOS:000325223900106
J	Smith, SB; Magid-Slav, M; Brown, JR				Smith, Steven B.; Magid-Slav, Michal; Brown, James R.			Host Response to Respiratory Bacterial Pathogens as Identified by Integrated Analysis of Human Gene Expression Data	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; INHIBITORY FACTOR MIF; PSEUDOMONAS-AERUGINOSA; STREPTOCOCCUS-PNEUMONIAE; CELLS; INVASION; SUSCEPTIBILITY; PATHWAY; PROTEIN; KINASE	Respiratory bacterial pathogens are one of the leading causes of infectious death in the world and a major health concern complicated by the rise of multi-antibiotic resistant strains. Therapeutics that modulate host genes essential for pathogen infectivity could potentially avoid multi-drug resistance and provide a wider scope of treatment options. Here, we perform an integrative analysis of published human gene expression data generated under challenges from the gram-negative and Gram-positive bacteria pathogens, Pseudomonas aeruginosa and Streptococcus pneumoniae, respectively. We applied a previously described differential gene and pathway enrichment analysis pipeline to publicly available host mRNA GEO datasets resulting from exposure to bacterial infection. We found 72 canonical human pathways common between four GEO datasets, representing P. aeruginosa and S. pneumoniae. Although the majority of these pathways are known to be involved with immune response, we found several interesting new interactions such as the SUMO1 pathway that might have a role in bacterial infections. Furthermore, 36 host-bacterial pathways were also shared with our previous results for respiratory virus host gene expression. Based on our pathway analysis we propose several drug-repurposing opportunities supported by the literature.	[Smith, Steven B.; Magid-Slav, Michal; Brown, James R.] GlaxoSmithKline, Quantitat Sci, Computat Biol, Collegeville, PA 19426 USA; [Smith, Steven B.] Univ Maryland, Inst Genome Sci, Baltimore, MD 21201 USA	GlaxoSmithKline; University System of Maryland; University of Maryland Baltimore	Brown, JR (corresponding author), GlaxoSmithKline, Quantitat Sci, Computat Biol, Collegeville, PA 19426 USA.	James.R.Brown@gsk.com		Smith, Steven/0000-0003-2799-6621; Brown, James/0000-0002-9368-627X	GlaxoSmithKline RD	GlaxoSmithKline RD(GlaxoSmithKline)	We acknowledge GlaxoSmithKline R&D for their support of this study. We also thank Jacques Ravel, University of Maryland, for his support and encouragement.	Ali S, 2006, CLIN EXP IMMUNOL, V144, P425, DOI 10.1111/j.1365-2249.2006.03087.x; Arnold R, 2005, J IMMUNOL, V174, P7359, DOI 10.4049/jimmunol.174.11.7359; Beran O, 2011, FOLIA MICROBIOL, V56, P138, DOI 10.1007/s12223-011-0001-9; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Bootsma HJ, 2007, INFECT IMMUN, V75, P5489, DOI 10.1128/IAI.01823-06; Breen EC, 2013, J CELL PHYSIOL, V228, P371, DOI 10.1002/jcp.24140; Brown JR, 2011, DRUG DISCOV TODAY, V16, P229, DOI 10.1016/j.drudis.2011.01.008; Burnham CAD, 2007, MICROBIOL-SGM, V153, P4240, DOI 10.1099/mic.0.2007/008417-0; Core R Team, 2012, R LANG ENV STAT COMP; Courval M, 2004, PHARMACOTHERAPY, V24, P558, DOI 10.1592/phco.24.6.558.34734; Dai JF, 2008, J VIROL, V82, P4164, DOI 10.1128/JVI.02621-07; Eberl M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000308; Esmon CT, 2011, J THROMB HAEMOST, V9, P182, DOI 10.1111/j.1538-7836.2011.04323.x; Esmon CT, 2013, THROMB HAEMOSTASIS, V109, P416, DOI 10.1160/TH12-08-0634; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fowler T, 2003, CELL MICROBIOL, V5, P417, DOI 10.1046/j.1462-5822.2003.00290.x; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Ghosh N, 2012, INT REV IMMUNOL, V31, P410, DOI 10.3109/08830185.2012.690794; Hajishengallis G, 2011, NAT REV IMMUNOL, V11, P187, DOI 10.1038/nri2918; Hasnain SZ, 2012, IMMUNOL CELL BIOL, V90, P260, DOI 10.1038/icb.2011.112; Hofman P, 2012, GUT MICROBES, V3, P176, DOI 10.4161/gmic.20288; Hoogendijk AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018519; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Ichikawa JK, 2005, CELL MICROBIOL, V7, P1635, DOI 10.1111/j.1462-5822.2005.00581.x; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jenkins Stephen G, 2008, Ann Clin Microbiol Antimicrob, V7, P1, DOI 10.1186/1476-0711-7-1; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Kung VL, 2012, P NATL ACAD SCI USA, V109, P1275, DOI 10.1073/pnas.1109285109; Li YL, 2012, CYTOKINE, V60, P64, DOI 10.1016/j.cyto.2012.06.010; Loeb L, 1904, J MED RES, V10, P407; Marriott HM, 2012, INFECT IMMUN, V80, P1140, DOI 10.1128/IAI.05697-11; Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134; McAdow M, 2012, J INNATE IMMUN, V4, P141, DOI 10.1159/000333447; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Moens L, 2008, J ALLERGY CLIN IMMUN, V122, P1231, DOI 10.1016/j.jaci.2008.09.006; Newton P, 2013, J BIOMOL SCREEN, V18, P237, DOI 10.1177/1087057112469047; *OM, 2011, ARR STUD VERS 4 1 1; Paolillo R, 2011, INT J IMMUNOPATH PH, V24, P961, DOI 10.1177/039463201102400414; Patel VS, 2013, AM J RESP CELL MOL, V48, P280, DOI 10.1165/rcmb.2012-0279OC; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/ERI.13.12, 10.1586/eri.13.12]; Petersen HJ, 2010, INFECT IMMUN, V78, P413, DOI 10.1128/IAI.00664-09; Petronilho F, 2012, MOL MED, V18, P1209, DOI 10.2119/molmed.2012.00083; Pfeifer P, 2013, AM J RESP CELL MOL, V48, P415, DOI 10.1165/rcmb.2012-0232OC; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Reglero-Real N, 2012, CELL MOL LIFE SCI, V69, P3079, DOI 10.1007/s00018-012-0987-4; Reidy T, 2013, J BIOL CHEM, V288, P8269, DOI 10.1074/jbc.M112.351064; Restrepo MI, 2013, CURR OPIN INFECT DIS, V26, P151, DOI 10.1097/QCO.0b013e32835ebc6d; Roger T, 2013, J INFECT DIS, V207, P331, DOI 10.1093/infdis/jis673; Sanagi T, 2005, NEUROSCI LETT, V380, P105, DOI 10.1016/j.neulet.2005.01.035; Scibelli A, 2007, VET J, V173, P482, DOI 10.1016/j.tvjl.2006.01.010; Sharron M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041549; Shin S, 2006, MICROB PATHOGENESIS, V41, P168, DOI 10.1016/j.micpath.2006.07.003; Sinigalia E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049630; Siranovic M, 2011, ACTA CLIN CROAT, V50, P345; Smith SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033174; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Tang ACL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032893; Um JW, 2006, J NEUROSCI RES, V84, P1543, DOI 10.1002/jnr.21041; van der Flier M, 2000, INFECT IMMUN, V68, P4792, DOI 10.1128/IAI.68.8.4792-4794.2000; Viasus D, 2013, CURR OPIN PULM MED, V19, P209, DOI 10.1097/MCP.0b013e32835f1c0b; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Weber SS, 2009, MOL MICROBIOL, V71, P1341, DOI 10.1111/j.1365-2958.2009.06608.x; Wilkosz S, 2012, AM J RESP CELL MOL, V46, P180, DOI 10.1165/rcmb.2011-0182OC; Wimmer P, 2012, J VIROL, V86, P642, DOI 10.1128/JVI.06227-11; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012; Worgall S, 2002, PEDIATR RES, V52, P636, DOI 10.1203/01.PDR.0000032382.17567.FB; Xing L, 2003, J VIROL, V77, P6101, DOI 10.1128/JVI.77.11.6101-6107.2003; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95; Yabe T, 2005, GLIA, V50, P223, DOI 10.1002/glia.20171; Zhang YR, 2012, SCI CHINA LIFE SCI, V55, P800, DOI 10.1007/s11427-012-4368-x	74	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e75607	10.1371/journal.pone.0075607	http://dx.doi.org/10.1371/journal.pone.0075607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086587	Green Submitted, Green Published, gold			2022-12-25	WOS:000325223900049
J	Xuan, JP; Song, YF; Zhang, HX; Liu, JX; Guo, ZR; Hua, YL				Xuan, Jiping; Song, Yufeng; Zhang, Hongxiao; Liu, Jianxiu; Guo, Zhongren; Hua, Yuelou			Comparative Proteomic Analysis of the Stolon Cold Stress Response between the C-4 Perennial Grass Species Zoysia japonica and Zoysia metrella	PLOS ONE			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; LOW-TEMPERATURE TOLERANCE; HIGH-SALINITY STRESSES; EXPRESSION PROFILES; FREEZE TOLERANCE; GENE-EXPRESSION; PROTEINS; ARABIDOPSIS; RICE; ACCLIMATION	Zoysiagrass, the most cold-tolerant grass among the warm-season turfgrasses, is often used as a model species for isolating cellular components related to cold stress. To understand the proteomic responses to cold stress in zoysiagrass stolons, we extracted stolon proteins from Zoysia japonica, cv. Meyer (cold-tolerant) and Z. metrella, cv. Diamond (cold-sensitive), which were grown with or without cold treatment. Approximately 700 proteins were resolved on 2-DE gels, and 70 protein spots were differentially accumulated. We further observed that 45 of the identified proteins participate in 10 metabolic pathways and cellular processes. A significantly greater number of proteins accumulated in the Meyer than in the Diamond and 15 increased proteins were detected only in the Meyer cultivar under cold stress. Furthermore, we propose a cold stress-responsive protein network composed of several different functional components that exhibits a balance between reactive oxygen species (ROS) production and scavenging, accelerated protein biosynthesis and proteolysis, reduced protein folding, enhanced photosynthesis, abundant energy supply and enhanced biosynthesis of carbohydrates and nucleotides. Generally, the cold-tolerant Meyer cultivar showed a greater ROS scavenging ability, more abundant energy supply and increased photosynthesis and protein synthesis than did the cold-sensitive Diamond cultivar, which may partly explain why Meyer is more cold tolerant.	[Xuan, Jiping; Liu, Jianxiu; Guo, Zhongren; Hua, Yuelou] Jiangsu Prov & Chinese Acad Sci, Inst Bot, Nanjing, Jiangsu, Peoples R China; [Song, Yufeng] Nanjing Agr Univ, Coll Life & Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Hongxiao] Henan Univ Sci & Technol, Coll Agr, Luoyang, Henan Province, Peoples R China	Nanjing Agricultural University; Henan University of Science & Technology	Liu, JX (corresponding author), Jiangsu Prov & Chinese Acad Sci, Inst Bot, 1 Qianhu Houcun, Nanjing, Jiangsu, Peoples R China.	turfunit@aliyun.com; zhongrenguo@cnbg.net			Jiangsu Provincial Key Lab for Plant EX Situ Conservation Fund [EX200901]	Jiangsu Provincial Key Lab for Plant EX Situ Conservation Fund	This research project was supported by Jiangsu Provincial Key Lab for Plant EX Situ Conservation Fund (EX200901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama F, 1994, B NAT GRASSL RES I; ALEXANDER C, 1995, J BIOL CHEM, V270, P14541, DOI 10.1074/jbc.270.24.14541; Andre CM, 2009, PHYTOCHEMISTRY, V70, P1107, DOI 10.1016/j.phytochem.2009.07.008; [Anonymous], 2012, FROST SURVIVAL PLANT, DOI DOI 10.1002/joc.4518; Bae MS, 2003, PLANT J, V36, P652, DOI 10.1046/j.1365-313X.2003.01907.x; Beard J. B., 1972, TURFGRASS SCI CULTUR; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Bouly JP, 1999, PLANT J, V18, P541, DOI 10.1046/j.1365-313X.1999.00476.x; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Cho SH, 2005, PHYSIOL MOL PLANT P, V67, P100, DOI 10.1016/j.pmpp.2005.09.011; Cui SX, 2005, PROTEOMICS, V5, P3162, DOI 10.1002/pmic.200401148; Degand H, 2009, PROTEOMICS, V9, P2903, DOI 10.1002/pmic.200800744; Dong WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022394; Dumont E, 2011, PLANT SCI, V180, P86, DOI 10.1016/j.plantsci.2010.09.006; Dunn JH, 1999, HORTSCIENCE, V34, P96, DOI 10.21273/HORTSCI.34.1.96; Fukazawa J, 2000, PLANT CELL, V12, P901, DOI 10.1105/tpc.12.6.901; Fuller R., 1999, LOW TEMPERATURE TOLE; Gao F, 2009, PLANTA, V230, P1033, DOI 10.1007/s00425-009-1003-6; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; GILMOUR SJ, 1988, PLANT PHYSIOL, V87, P745, DOI 10.1104/pp.87.3.745; Giraldo E, 2012, J PROTEOMICS, V75, P5774, DOI 10.1016/j.jprot.2012.08.005; Gollop R, 2002, J EXP BOT, V53, P1397, DOI 10.1093/jexbot/53.373.1397; Grove H, 2009, ELECTROPHORESIS, V30, P1856, DOI 10.1002/elps.200800568; Guera A, 2005, J EXP BOT, V56, P205; Guilfoyle TJ, 2001, J PLANT GROWTH REGUL, V20, P281, DOI 10.1007/s003440010026; Halford NG, 2000, ADV BOT RES, V32, P405, DOI 10.1016/S0065-2296(00)32031-6; Hashimoto M, 2007, PROTEOMICS, V7, P1293, DOI 10.1002/pmic.200600921; Hilt W, 1996, TRENDS BIOCHEM SCI, V21, P96, DOI 10.1016/S0968-0004(96)10012-8; Hoagland DR, 1950, CALIF AGR EXPSTA CIR, V347; Huang HK, 2005, MOL CELL BIOL, V25, P9000, DOI 10.1128/MCB.25.20.9000-9015.2005; Hughes M.A., 1990, BIOTECHNOL GENET, V8, P161, DOI DOI 10.1080/02648725.1990.10647868; Imin N, 2006, MOL CELL PROTEOMICS, V5, P274, DOI 10.1074/mcp.M500242-MCP200; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawamura Y, 2003, PLANT J, V36, P141, DOI 10.1046/j.1365-313X.2003.01864.x; Kosmala A, 2009, J EXP BOT, V60, P3595, DOI 10.1093/jxb/erp205; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee DG, 2007, CR BIOL, V330, P215, DOI 10.1016/j.crvi.2007.01.001; Lee DG, 2009, J PLANT PHYSIOL, V166, P1, DOI 10.1016/j.jplph.2008.02.001; LELIEVRE JM, 1995, POSTHARVEST BIOL TEC, V5, P11, DOI 10.1016/0925-5214(94)00004-C; Matsuba K, 1997, PLANT CELL ENVIRON, V20, P268, DOI 10.1046/j.1365-3040.1997.d01-55.x; MERRIL CR, 1982, ELECTROPHORESIS, V3, P17, DOI 10.1002/elps.1150030104; Miller I, 2006, PROTEOMICS, V6, P5385, DOI 10.1002/pmic.200600323; Molendijk AJ, 2004, CURR OPIN PLANT BIOL, V7, P694, DOI 10.1016/j.pbi.2004.09.014; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; Patton AJ, 2007, CROP SCI, V47, P2162, DOI 10.2135/cropsci2006.11.0739; Patton AJ, 2007, CROP SCI, V47, P2170, DOI 10.2135/cropsci2006.12.0784; Patton AJ, 2007, CROP SCI, V47, P1619, DOI 10.2135/cropsci2006.11.0737; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Ramagli LS, 1999, METH MOL B, V112, P99; SAKAI A, 1968, CRYOBIOLOGY, V5, P160, DOI 10.1016/S0011-2240(68)80161-0; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sinha P, 2001, PROTEOMICS, V1, P835, DOI 10.1002/1615-9861(200107)1:7<835::AID-PROT835>3.3.CO;2-U; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2001, PLANT PHYSIOL, V125, P89, DOI 10.1104/pp.125.1.89; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Wang XQ, 2009, PROTEOMICS, V9, P4529, DOI 10.1002/pmic.200900062; Xuan JP, 2009, TROP GRASSLANDS, V43, P118; Yamagami T, 2003, J BIOL CHEM, V278, P49102, DOI 10.1074/jbc.M308297200; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; Yan YS, 2011, MOL PLANT, V4, P190, DOI 10.1093/mp/ssq066; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x; Zhang HX, 2009, ANN BOT-LONDON, V103, P923, DOI 10.1093/aob/mcp012; Zhang Q, 2009, J AM SOC HORTIC SCI, V134, P322, DOI 10.21273/JASHS.134.3.322; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191; Zrenner R, 2009, NEW PHYTOL, V183, P117, DOI 10.1111/j.1469-8137.2009.02843.x	74	27	29	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e75705	10.1371/journal.pone.0075705	http://dx.doi.org/10.1371/journal.pone.0075705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086619	Green Published, Green Submitted, gold			2022-12-25	WOS:000325220000035
J	Baker, ME; Vidal-Dorsch, DE; Ribecco, C; Sprague, LJ; Angert, M; Lekmine, N; Ludka, C; Martella, A; Ricciardelli, E; Bay, SM; Gully, JR; Kelley, KM; Schlenk, D; Carnevali, O; Sasik, R; Hardiman, G				Baker, Michael E.; Vidal-Dorsch, Doris E.; Ribecco, Cataldo; Sprague, L. James; Angert, Mila; Lekmine, Narimene; Ludka, Colleen; Martella, Andrea; Ricciardelli, Eugenia; Bay, Steven M.; Gully, Joseph R.; Kelley, Kevin M.; Schlenk, Daniel; Carnevali, Oliana; Sasik, Roman; Hardiman, Gary			Molecular Analysis of Endocrine Disruption in Hornyhead Turbot at Wastewater Outfalls in Southern California Using a Second Generation Multi-Species Microarray	PLOS ONE			English	Article							REPRODUCTIVE STATUS; SEASONAL EVALUATION; ESTROGEN-RECEPTORS; EMERGING CONCERN; RISK-ASSESSMENT; ORANGE-COUNTY; BISPHENOL-A; EXPRESSION; FISH; BIOMARKERS	Sentinel fish hornyhead turbot (Pleuronichthys verticalis) captured near wastewater outfalls are used for monitoring exposure to industrial and agricultural chemicals of similar to 20 million people living in coastal Southern California. Although analyses of hormones in blood and organ morphology and histology are useful for assessing contaminant exposure, there is a need for quantitative and sensitive molecular measurements, since contaminants of emerging concern are known to produce subtle effects. We developed a second generation multi-species microarray with expanded content and sensitivity to investigate endocrine disruption in turbot captured near wastewater outfalls in San Diego, Orange County and Los Angeles California. Analysis of expression of genes involved in hormone [e.g., estrogen, androgen, thyroid] responses and xenobiotic metabolism in turbot livers was correlated with a series of phenotypic end points. Molecular analyses of turbot livers uncovered altered expression of vitellogenin and zona pellucida protein, indicating exposure to one or more estrogenic chemicals, as well as, alterations in cytochrome P450 (CYP) 1A, CYP3A and glutathione S-transferase-a indicating induction of the detoxification response. Molecular responses indicative of exposure to endocrine disruptors were observed in field-caught hornyhead turbot captured in Southern California demonstrating the utility of molecular methods for monitoring environmental chemicals in wastewater outfalls. Moreover, this approach can be adapted to monitor other sites for contaminants of emerging concern in other fish species for which there are few available gene sequences.	[Baker, Michael E.; Ribecco, Cataldo; Martella, Andrea; Ricciardelli, Eugenia; Sasik, Roman; Hardiman, Gary] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Vidal-Dorsch, Doris E.; Bay, Steven M.] Southern Calif Coastal Water Res Project, Costa Mesa, CA USA; [Ribecco, Cataldo; Martella, Andrea; Ricciardelli, Eugenia; Carnevali, Oliana] Univ Politecn Marche, Dept Life & Environm Sci, Ancona, Italy; [Sprague, L. James; Angert, Mila; Lekmine, Narimene; Ludka, Colleen; Sasik, Roman; Hardiman, Gary] Univ Calif San Diego, Sch Med, BIOGEM, La Jolla, CA 92093 USA; [Gully, Joseph R.] Los Angeles Cty Sanit Dist, Whittier, CA USA; [Kelley, Kevin M.] Calif State Univ Long Beach, Environm Endocrinol Lab, Long Beach, CA 90840 USA; [Schlenk, Daniel] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA	University of California System; University of California San Diego; Southern California Coastal Water Research Project; Marche Polytechnic University; University of California System; University of California San Diego; California State University System; California State University Long Beach; University of California System; University of California Riverside	Hardiman, G (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	gthardiman@ucsd.edu	Carnevali, Oliana/P-2751-2015; Baker, Michael/ABB-8508-2020	Carnevali, Oliana/0000-0001-5994-0572; Baker, Michael/0000-0003-4387-3269; Martella, Andrea/0000-0002-4680-7702; Hardiman, Gary/0000-0003-4558-0400	SCCWRP; USC Sea Grant Program (NOAA grant) [NA06OAR4170012, 11.417]; NIH [DK063491, CA023100, DK080506]; UC Senate [RK126H-HARDIMAN]; Campus World Program; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R24DK080506] Funding Source: NIH RePORTER	SCCWRP; USC Sea Grant Program (NOAA grant); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Senate; Campus World Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a contract from the SCCWRP and USC Sea Grant Program (NOAA grant #NA06OAR4170012, CFDA No. 11.417, Project CE-17). The authors also wish to acknowledge partial financial support and assistance from the Los Angeles Sanitation Districts, Orange County Sanitation District, City of San Diego Public Utilities Department, Wastewater Branch, Environmental Monitoring and Technical Services Division and the City of Los Angeles, Environmental Monitoring Division. GH gratefully acknowledge support from NIH grants DK063491, CA023100 and DK080506 and UC Senate grant RK126H-HARDIMAN. C. Ribecco and A. Martella were recipients of training grants from 'The Campus World Program'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Atanasov AG, 2005, ENVIRON HEALTH PERSP, V113, P1600, DOI 10.1289/ehp.8209; Baker ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046078; Baker ME, 2011, MOL CELL ENDOCRINOL, V334, P14, DOI 10.1016/j.mce.2010.07.013; Baker ME, 2009, ENVIRON HEALTH PERSP, V117, P223, DOI 10.1289/ehp.11627; Balesaria S, 2010, FEBS LETT, V584, P719, DOI 10.1016/j.febslet.2009.12.023; Bay SM, 2012, ENVIRON TOXICOL CHEM, V31, P2711, DOI 10.1002/etc.2007; Blanchette B, 2007, MAR BIOTECHNOL, V9, P513, DOI 10.1007/s10126-007-9034-0; Brar NK, 2010, AQUAT TOXICOL, V96, P203, DOI 10.1016/j.aquatox.2009.10.023; Brown JS, 2004, ECOL INDIC, V3, P263, DOI 10.1016/j.ecolind.2003.11.004; Deng X, 2007, ENVIRON TOXICOL, V22, P464, DOI 10.1002/tox.20287; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Filby AL, 2007, ENVIRON SCI TECHNOL, V41, P8187, DOI 10.1021/es071278v; Forsgren KL, 2012, ENVIRON TOXICOL CHEM, V31, P2701, DOI 10.1002/etc.2006; Fortunati N, 2010, MOL CELL ENDOCRINOL, V316, P86, DOI 10.1016/j.mce.2009.09.012; Hardiman G, 2004, PHARMACOGENOMICS, V5, P487, DOI 10.1517/14622416.5.5.487; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hutchinson TH, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI 10.1289/ehp.8062; Jin YX, 2010, COMP BIOCHEM PHYS C, V151, P258, DOI 10.1016/j.cbpc.2009.11.004; Jobling S, 2009, ENVIRON HEALTH PERSP, V117, P797, DOI 10.1289/ehp.0800197; Katchamart S, 2002, ENVIRON TOXICOL CHEM, V21, P2445, DOI 10.1897/1551-5028(2002)021<2445:EOXEOT>2.0.CO;2; Kirchner S, 2010, MOL ENDOCRINOL, V24, P526, DOI 10.1210/me.2009-0261; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lam SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000121; Larkin P, 2007, ENVIRON TOXICOL CHEM, V26, P1497, DOI 10.1897/06-501R.1; LeBlanc GA, 2007, ECOTOXICOLOGY, V16, P61, DOI 10.1007/s10646-006-0115-z; Li GY, 2008, AQUAT TOXICOL, V88, P75, DOI 10.1016/j.aquatox.2008.03.007; Li XY, 2005, NUCLEIC ACIDS RES, V33, P6114, DOI 10.1093/nar/gki914; Maradonna F, 2007, BIOMARKERS, V12, P240, DOI 10.1080/13547500601070859; Maruya KA, 2012, ENVIRON TOXICOL CHEM, V31, P2683, DOI 10.1002/etc.2003; Miguel-Queralt S, 2008, ENDOCRINOLOGY, V149, P4269, DOI 10.1210/en.2008-0384; Millan A, 2010, MAR BIOTECHNOL, V12, P452, DOI 10.1007/s10126-009-9231-0; Moens LN, 2006, TOXICOL SCI, V93, P298, DOI 10.1093/toxsci/kfl057; Monserrat JM, 2007, COMP BIOCHEM PHYS C, V146, P221, DOI 10.1016/j.cbpc.2006.08.012; Mortensen AS, 2007, AQUAT TOXICOL, V85, P113, DOI 10.1016/j.aquatox.2007.08.004; Nielsen HB, 2003, NUCLEIC ACIDS RES, V31, P3491, DOI 10.1093/nar/gkg622; Oehlmann J, 2008, ENVIRON RES, V108, P140, DOI 10.1016/j.envres.2008.07.016; Ollikainen N, 2006, INTEGR COMP BIOL, V46, P815, DOI 10.1093/icb/icl035; PAJOR AM, 1990, J EXP ZOOL, V253, P51, DOI 10.1002/jez.1402530108; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Ramirez AJ, 2009, ENVIRON TOXICOL CHEM, V28, P2587, DOI 10.1897/08-561.1; Rempel MA, 2006, AQUAT TOXICOL, V77, P241, DOI 10.1016/j.aquatox.2005.12.007; Rhee JS, 2009, ECOTOX ENVIRON SAFE, V72, P206, DOI 10.1016/j.ecoenv.2008.06.001; Robertson LS, 2009, FISH SHELLFISH IMMUN, V26, P898, DOI 10.1016/j.fsi.2009.03.023; Santos EM, 2007, AQUAT TOXICOL, V83, P134, DOI 10.1016/j.aquatox.2007.03.019; Sarkar A, 2006, ECOTOXICOLOGY, V15, P333, DOI 10.1007/s10646-006-0069-1; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Scholz S, 2008, MOL CELL ENDOCRINOL, V293, P57, DOI 10.1016/j.mce.2008.06.008; Shike H, 2002, EUR J BIOCHEM, V269, P2232, DOI 10.1046/j.1432-1033.2002.02881.x; Soto AM, 2008, BASIC CLIN PHARMACOL, V102, P125, DOI 10.1111/j.1742-7843.2007.00165.x; Sugiyama N, 2010, TRENDS ENDOCRIN MET, V21, P545, DOI 10.1016/j.tem.2010.05.001; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; Swan Shanna H, 2008, Fertil Steril, V89, pe45, DOI 10.1016/j.fertnstert.2007.12.027; Team RDC, 2005, R LANG ENV STAT COMP; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tyler Charles R., 2007, Environmental Sciences, V14, P235; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vidal-Dorsch DE, 2012, ENVIRON TOXICOL CHEM, V31, P2674, DOI 10.1002/etc.2004; Wernersson R, 2005, NUCLEIC ACIDS RES, V33, pW611, DOI 10.1093/nar/gki399; Williams TD, 2003, AQUAT TOXICOL, V65, P141, DOI 10.1016/S0166-445X(03)00119-X; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227	65	35	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75553	10.1371/journal.pone.0075553	http://dx.doi.org/10.1371/journal.pone.0075553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086568	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700100
J	Bobinet, M; Vignard, V; Florenceau, L; Lang, F; Labarriere, N; Moreau-Aubry, A				Bobinet, Mathilde; Vignard, Virginie; Florenceau, Laetitia; Lang, Francois; Labarriere, Nathalie; Moreau-Aubry, Agnes			Overexpression of Meloe Gene in Melanomas Is Controlled Both by Specific Transcription Factors and Hypomethylation	PLOS ONE			English	Article							MELANOCYTE DEVELOPMENT; PROMOTER; EXPRESSION; CELLS; MICROPHTHALMIA; ANTIGEN; FAMILY; MITF; ACTIVATION; SOX	The melanoma antigens MELOE-1 and MELOE-2 are encoded by a messenger, called meloe, overexpressed in melanomas compared with other tumour cell types and healthy tissues. They are both able to elicit melanoma-specific T cell responses in melanoma patients, and MELOE-1-specific CD8 T cells have been involved in melanoma immunosurveillance. With the aim to develop immunotherapies targeting this antigen, we investigated the transcriptional mechanisms leading to the preferential expression of meloe messenger in the melanocytic lineage. We defined the minimal promoter region of meloe gene and identified binding motifs for a set of transcription factors. Using mutagenesis, co-transfection experiments and chromatin immunoprecipitation, we showed that transcription factors involved in meloe promoter activity in melanomas were the melanocytic specific SOX9 and SOX10 proteins together with the activated P-CREB protein. Furthermore, we showed that meloe promoter was hypomethylated in melanomas and melanocytes, and hypermethylated in colon cancer cell lines and mesotheliomas, thus explaining the absence of P-CREB binding in these cell lines. This was a second key to explain the overerexpression of meloe messenger in the melanocytic lineage. To our knowledge, such a dual transcriptional control conferring tissue-specificity has never been described for the expression of tumour antigens.	[Bobinet, Mathilde; Vignard, Virginie; Florenceau, Laetitia; Lang, Francois; Labarriere, Nathalie; Moreau-Aubry, Agnes] INSERM, UMR 892, Nantes, France; [Bobinet, Mathilde; Vignard, Virginie; Florenceau, Laetitia; Lang, Francois; Labarriere, Nathalie; Moreau-Aubry, Agnes] Univ Nantes, Nantes, France; [Bobinet, Mathilde; Vignard, Virginie; Florenceau, Laetitia; Lang, Francois; Labarriere, Nathalie; Moreau-Aubry, Agnes] CNRS, UMR 6299, Nantes, France; [Vignard, Virginie] Univ Hosp Nantes, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; CHU de Nantes	Labarriere, N (corresponding author), INSERM, UMR 892, Nantes, France.	nathalie.labarriere@inserm.fr; Agnes.Aubry@univ-nantes.fr	LANG, François/K-7403-2015; Aubry, Agnes/K-8771-2015; Vignard, Virginie/K-7540-2015; Florenceau, Laetitia/K-7428-2015; Labarriere, Nathalie/H-8876-2015	LANG, François/0000-0002-0762-4647; Vignard, Virginie/0000-0002-6702-2824; Florenceau, Laetitia/0000-0003-1284-414X; Labarriere, Nathalie/0000-0002-1407-6546	"Ligue contre le cancer du Grand Ouest" committee 44; "Ligue contre le cancer du Grand Ouest" committee 85	"Ligue contre le cancer du Grand Ouest" committee 44; "Ligue contre le cancer du Grand Ouest" committee 85	This work was supported by the "Ligue contre le cancer du Grand Ouest" committee 44, and committee 85 for Mathilde Bobinet salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakos RM, 2010, EXP DERMATOL, V19, pE89, DOI 10.1111/j.1600-0625.2009.00991.x; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996; Bobinet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051716; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Butterfield LH, 1997, GENE, V191, P129, DOI 10.1016/S0378-1119(96)00789-5; Castillo SD, 2012, EXPERT OPIN THER TAR, V16, P903, DOI 10.1517/14728222.2012.709239; Chenchik A, 1996, BIOTECHNIQUES, V21, P526; De Smet C, 1999, MOL CELL BIOL, V19, P7327; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Flammiger A, 2009, J INVEST DERMATOL, V129, P945, DOI 10.1038/jid.2008.316; Godet Y, 2008, J EXP MED, V205, P2673, DOI 10.1084/jem.20081356; Godet Y, 2010, EUR J IMMUNOL, V40, P1786, DOI 10.1002/eji.200940132; Godet Y, 2010, CANCER IMMUNOL IMMUN, V59, P431, DOI 10.1007/s00262-009-0762-z; Goding CR, 2000, GENE DEV, V14, P1712; Gueugnon F, 2011, AM J PATHOL, V178, P1033, DOI 10.1016/j.ajpath.2010.12.014; Harris ML, 2010, PIGM CELL MELANOMA R, V23, P496, DOI 10.1111/j.1755-148X.2010.00711.x; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Huber WE, 2003, J BIOL CHEM, V278, P45224, DOI 10.1074/jbc.M309036200; Jean D, 2001, CRIT REV IMMUNOL, V21, P275; Kaneda A, 2004, CANCER SCI, V95, P58, DOI 10.1111/j.1349-7006.2004.tb03171.x; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; Kellerer S, 2006, DEVELOPMENT, V133, P2875, DOI 10.1242/dev.02477; LOWINGS P, 1992, MOL CELL BIOL, V12, P3653, DOI 10.1128/MCB.12.8.3653; Lucas S, 2012, INT J CANCER, V130, P1960, DOI 10.1002/ijc.26198; Madireddi MT, 2000, J CELL PHYSIOL, V185, P36, DOI 10.1002/1097-4652(200010)185:1<36::AID-JCP3>3.0.CO;2-V; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Melnikova VO, 2006, J BIOL CHEM, V281, P2911, DOI 10.1074/jbc.M508683200; Minev B, 2000, P NATL ACAD SCI USA, V97, P4796, DOI 10.1073/pnas.070560797; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; Passeron T, 2007, P NATL ACAD SCI USA, V104, P13984, DOI 10.1073/pnas.0705117104; Riva A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-33; Rogel A, 2011, CANCER IMMUNOL IMMUN, V60, P327, DOI 10.1007/s00262-010-0938-6; Ropke M, 1996, P NATL ACAD SCI USA, V93, P14704, DOI 10.1073/pnas.93.25.14704; Sato Y, 2001, CELL STRUCT FUNCT, V26, P19, DOI 10.1247/csf.26.19; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Tachibana M, 2000, PIGM CELL RES, V13, P230, DOI 10.1034/j.1600-0749.2000.130404.x; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058	43	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75421	10.1371/journal.pone.0075421	http://dx.doi.org/10.1371/journal.pone.0075421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086527	Green Published, Green Submitted, gold			2022-12-25	WOS:000325218700084
J	Jung, CR; Lin, YT; Hwang, BF				Jung, Chau-Ren; Lin, Yu-Ting; Hwang, Bing-Fang			Air Pollution and Newly Diagnostic Autism Spectrum Disorders: A Population-Based Cohort Study in Taiwan	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; NITROGEN-DIOXIDE; CHILDREN; EXPOSURE; OZONE; BRAIN; RISK; RAT; MECHANISMS	There is limited evidence that long-term exposure to ambient air pollution increases the risk of childhood autism spectrum disorder (ASD). The objective of the study was to investigate the associations between long-term exposure to air pollution and newly diagnostic ASD in Taiwan. We conducted a population-based cohort of 49,073 children age less than 3 years in 2000 that were retrieved from Taiwan National Insurance Research Database and followed up from 2000 through 2010. Inverse distance weighting method was used to form exposure parameter for ozone (O-3), carbon monoxide (CO), nitrogen dioxide (NO2), sulfur dioxide (SO2), and particles with aerodynamic diameter less than 10 mu m (PM10). Time-dependent Cox proportional hazards (PH) model was performed to evaluate the relationship between yearly average exposure air pollutants of preceding years and newly diagnostic ASD. The risk of newly diagnostic ASD increased according to increasing O-3, CO, NO2, and SO2 levels. The effect estimate indicating an approximately 59% risk increase per 10 ppb increase in O-3 level (95% CI 1.42-1.79), 37% risk increase per 10 ppb in CO (95% CI 1.31-1.44), 340% risk increase per 10 ppb increase in NO2 level (95% CI 3.31-5.85), and 17% risk increase per 1 ppb in SO2 level (95% CI 1.09-1.27) was stable with different combinations of air pollutants in the multi-pollutant models. Our results provide evident that children exposure to O-3, CO, NO2, and SO2 in the preceding 1 year to 4 years may increase the risk of ASD diagnosis.	[Jung, Chau-Ren; Lin, Yu-Ting; Hwang, Bing-Fang] China Med Univ, Coll Publ Hlth, Dept Occupat Safety & Hlth, Taichung, Taiwan	China Medical University Taiwan	Hwang, BF (corresponding author), China Med Univ, Coll Publ Hlth, Dept Occupat Safety & Hlth, Taichung, Taiwan.	bfhwang@mail.cmu.edu.tw	Hwang, Bing-Fang/O-2709-2015; Jung, Chau-Ren/I-7618-2019	Hwang, Bing-Fang/0000-0002-5951-9662; Jung, Chau-Ren/0000-0003-0673-9968	China Medical University [100-Award-07]	China Medical University(China Medical University)	This study was supported by grant CMU#100-Award-07 from China Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Avila-Costa MR, 1999, NEUROSCI LETT, V270, P107, DOI 10.1016/S0304-3940(99)00458-9; Banks WA, 2002, NEUROIMMUNOMODULAT, V10, P319, DOI 10.1159/000071472; Bayram H, 2001, J ALLERGY CLIN IMMUN, V107, P287, DOI 10.1067/mai.2001.111141; Becerra TA, 2013, ENVIRON HEALTH PERSP, V121, P380, DOI 10.1289/ehp.1205827; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bureau of National Health Insurance, 2012, NAT HLTH INS RES DAT; Chauhan A, 2004, LIFE SCI, V75, P2539, DOI 10.1016/j.lfs.2004.04.038; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Colin-Barenque L, 1999, NEUROSCI LETT, V274, P1, DOI 10.1016/S0304-3940(99)00639-4; Durkin MS, 2008, AM J EPIDEMIOL, V168, P1268, DOI 10.1093/aje/kwn250; Enstrom A, 2009, BRAIN BEHAV IMMUN, V23, P389, DOI 10.1016/j.bbi.2008.12.005; Gillberg C, 1998, J AUTISM DEV DISORD, V28, P415, DOI 10.1023/A:1026004505764; Hwang YS, 2013, RES DEV DISABIL, V34, P2462, DOI 10.1016/j.ridd.2013.05.019; James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926; Kalkbrenner AE, 2010, EPIDEMIOLOGY, V21, P631, DOI 10.1097/EDE.0b013e3181e65d76; Karalliedde L, 2012, ESSENTIALS TOXICOLOG, P157; Kelly FJ, 2003, OCCUP ENVIRON MED, V60, P612, DOI 10.1136/oem.60.8.612; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Leyfer OT, 2006, J AUTISM DEV DISORD, V36, P849, DOI 10.1007/s10803-006-0123-0; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; Lin HC, 2010, AUST NZ J PSYCHIAT, V44, P273, DOI 10.3109/00048670903487209; Matson JL, 2007, RES DEV DISABIL, V28, P341, DOI 10.1016/j.ridd.2005.12.004; Meng ZQ, 2003, INHAL TOXICOL, V15, P181, DOI 10.1080/08958370304476; Ming X, 2005, PROSTAG LEUKOTR ESS, V73, P379, DOI 10.1016/j.plefa.2005.06.002; Naira PM, 2006, J CHEM NEUROANAT, V31, P114, DOI 10.1016/j.jchemneu.2005.09.006; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.037; Rivas-Arancibia S, 2003, PHARMACOL BIOCHEM BE, V74, P891, DOI 10.1016/S0091-3057(03)00011-X; RODKEY FL, 1969, BLOOD-J HEMATOL, V33, P57, DOI 10.1182/blood.V33.1.57.57; Rosen NJ, 2007, PEDIATRICS, V119, pE61, DOI 10.1542/peds.2006-1788; Rutter M, 2005, ACTA PAEDIATR, V94, P2, DOI 10.1080/08035250410023124; Santiago-Lopez D, 2010, TOXICOL LETT, V197, P193, DOI 10.1016/j.toxlet.2010.05.020; Sogut S, 2003, CLIN CHIM ACTA, V331, P111, DOI 10.1016/S0009-8981(03)00119-0; Sorace A, 2001, ENVIRON RES, V85, P122, DOI 10.1006/enrs.2000.4097; Stroh E, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-19; TABACOVA S, 1985, NEUROTOXICOL TERATOL, V7, P785; Tamagawa E, 2006, CHEST, V130, P1631, DOI 10.1378/chest.130.6.1631; THOM SR, 1990, J APPL PHYSIOL, V68, P997, DOI 10.1152/jappl.1990.68.3.997; Volk HE, 2012, ENV HLTH PERSPECT, V119, P873; Volk HE, 2013, JAMA PSYCHIAT, V70, P71, DOI 10.1001/jamapsychiatry.2013.266; Windham GC, 2006, ENVIRON HEALTH PERSP, V114, P1438, DOI 10.1289/ehp.9120; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067; Yorbik O, 2002, PROSTAG LEUKOTR ESS, V67, P341, DOI 10.1054/plef.2002.0439; ZHANG J, 1992, J CLIN INVEST, V90, P1193, DOI 10.1172/JCI115980; Zoroglu SS, 2004, EUR ARCH PSY CLIN N, V254, P143, DOI 10.1007/s00406-004-0456-7	46	76	79	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e75510	10.1371/journal.pone.0075510	http://dx.doi.org/10.1371/journal.pone.0075510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086549	Green Submitted, gold, Green Published			2022-12-25	WOS:000325218700093
J	Riese, F; Grinschgl, S; Gersbacher, MT; Russi, N; Hock, C; Nitsch, RM; Konietzko, U				Riese, Florian; Grinschgl, Sonja; Gersbacher, Manuel T.; Russi, Natalie; Hock, Christoph; Nitsch, Roger M.; Konietzko, Uwe			Visualization and Quantification of APP Intracellular Domain-Mediated Nuclear Signaling by Bimolecular Fluorescence Complementation	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; TYROSINE; PHOSPHORYLATION; TRANSCRIPTION; DIMERIZATION; TRAFFICKING; INTERACTOME; HYPOTHESIS; MUTATION	Background: The amyloid precursor protein (APP) intracellular domain (AICD) is released from full-length APP upon sequential cleavage by either alpha- or beta-secretase followed by gamma-secretase. Together with the adaptor protein Fe65 and the histone acetyltransferase Tip60, AICD forms nuclear multiprotein complexes (AFT complexes) that function in transcriptional regulation. Objective: To develop a medium-throughput machine-based assay for visualization and quantification of AFT complex formation in cultured cells. Methods: We used cotransfection of bimolecular fluorescence complementation (BiFC) fusion constructs of APP and Tip60 for analysis of subcellular localization by confocal microscopy and quantification by flow cytometry (FC). Results: Our novel BiFC-constructs show a nuclear localization of AFT complexes that is identical to conventional fluorescence-tagged constructs. Production of the BiFC signal is dependent on the adaptor protein Fe65 resulting in fluorescence complementation only after Fe65-mediated nuclear translocation of AICD and interaction with Tip60. We applied the AFT-BiFC system to show that the Swedish APP familial Alzheimer's disease mutation increases AFT complex formation, consistent with the notion that AICD mediated nuclear signaling mainly occurs following APP processing through the amyloidogenic beta-secretase pathway. Next, we studied the impact of posttranslational modifications of AICD on AFT complex formation. Mutation of tyrosine 682 in the YENPTY motif of AICD to phenylalanine prevents phosphorylation resulting in increased nuclear AFT-BiFC signals. This is consistent with the negative impact of tyrosine phosphorylation on Fe65 binding to AICD. Finally, we studied the effect of oxidative stress. Our data shows that oxidative stress, at a level that also causes cell death, leads to a reduction in AFT-BiFC signals. Conclusion: We established a new method for visualization and FC quantification of the interaction between AICD, Fe65 and Tip60 in the nucleus based on BiFC. It enables flow cytometric analysis of AICD nuclear signaling and is characterized by scalability and low background fluorescence.	[Riese, Florian; Grinschgl, Sonja; Gersbacher, Manuel T.; Russi, Natalie; Hock, Christoph; Nitsch, Roger M.; Konietzko, Uwe] Univ Zurich, Div Psychiat Res & Psychogeriatr Med, Zurich, Switzerland	University of Zurich	Konietzko, U (corresponding author), Univ Zurich, Div Psychiat Res & Psychogeriatr Med, Zurich, Switzerland.	uwekon@bli.uzh.ch	Riese, Florian/I-1887-2019	Riese, Florian/0000-0001-5531-5833; Russi, Natalie/0000-0002-9121-8851	Swiss National Science Foundation (SNF) [31003A_130148]; SNF SPUM [33CM3O-124111]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SNF SPUM	This work was supported by the Swiss National Science Foundation (SNF) grant 31003A_130148 and the SNF SPUM grant 33CM3O-124111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390; Ben Khalifa N, 2012, FASEB J, V26, P855, DOI 10.1096/fj.11-190207; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Cacquevel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035133; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Chen CD, 2006, J NEUROCHEM, V97, P30, DOI 10.1111/j.1471-4159.2006.03705.x; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Gersbacher MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069363; Goncalves SA, 2010, TRENDS BIOCHEM SCI, V35, P643, DOI 10.1016/j.tibs.2010.05.007; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Iborra FJ, 1996, J CELL SCI, V109, P1427; Isbert S, 2012, CELL MOL LIFE SCI, V69, P1353, DOI 10.1007/s00018-011-0882-4; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; Konietzko U, 2012, CURR ALZHEIMER RES, V9, P200, DOI 10.2174/156720512799361673; Konietzko U, 2010, NEUROBIOL AGING, V31, P58, DOI 10.1016/j.neurobiolaging.2008.03.001; Matrone C, 2011, J NEUROSCI, V31, P11756, DOI 10.1523/JNEUROSCI.1960-11.2011; Minopoli G, 2007, NEURODEGENER DIS, V4, P94, DOI 10.1159/000101833; Morell M, 2008, NAT PROTOC, V3, P22, DOI 10.1038/nprot.2007.496; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Oh SY, 2010, J NEUROCHEM, V113, P262, DOI 10.1111/j.1471-4159.2010.06603.x; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; So Pauline Pl, 2013, Am J Neurodegener Dis, V2, P15; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tarr PE, 2002, BIOCHEM BIOPH RES CO, V295, P324, DOI 10.1016/S0006-291X(02)00678-2; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Ventura S, 2011, CURR MOL MED, V11, P582, DOI 10.2174/156652411800615117; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Waldron E, 2008, NEUROBIOL DIS, V31, P188, DOI 10.1016/j.nbd.2008.04.006; Weyer S.W., 2011, EMBO J; XU X, 2011, EMBO REP, V12, P1, DOI DOI 10.1038/EMB0R.2010.210.PUBMED:21293490; Zambrano N, 2001, J BIOL CHEM, V276, P19787, DOI 10.1074/jbc.M100792200; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970	46	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e76094	10.1371/journal.pone.0076094	http://dx.doi.org/10.1371/journal.pone.0076094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086696	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000325218700121
J	Parihar, SP; Guler, R; Lang, DM; Suzuki, H; Marais, AD; Brombacher, F				Parihar, Suraj P.; Guler, Reto; Lang, Dirk M.; Suzuki, Harukazu; Marais, A. David; Brombacher, Frank			Simvastatin Enhances Protection against Listeria monocytogenes Infection in Mice by Counteracting Listeria-Induced Phagosomal Escape	PLOS ONE			English	Article							HMG-COA REDUCTASE; LIPID RAFTS; CHOLESTEROL DEPLETION; STATINS; ACTIVATION; INHIBITION; PROLIFERATION; PHAGOCYTOSIS; MACROPHAGES; RESISTANCE	Statins are well-known cholesterol lowering drugs targeting HMG-CoA-reductase, reducing the risk of coronary disorders and hypercholesterolemia. Statins are also involved in immunomodulation, which might influence the outcome of bacterial infection. Hence, a possible effect of statin treatment on Listeriosis was explored in mice. Statin treatment prior to subsequent L. monocytogenes infection strikingly reduced bacterial burden in liver and spleen (up to 100-fold) and reduced histopathological lesions. Statin-treatment in infected macrophages resulted in increased IL-12p40 and TNF-alpha and up to 4-fold reduced bacterial burden within 6 hours post infection, demonstrating a direct effect of statins on limiting bacterial growth in macrophages. Bacterial uptake was normal investigated in microbeads and GFP-expressing Listeria experiments by confocal microscopy. However, intracellular membrane-bound cholesterol level was decreased, as analyzed by cholesterol-dependent filipin staining and cellular lipid extraction. Mevalonate supplementation restored statin-inhibited cholesterol biosynthesis and reverted bacterial growth in Listeria monocytogenes but not in listeriolysin O (LLO)-deficient Listeria. Together, these results suggest that statin pretreatment increases protection against L. monocytogenes infection by reducing membrane cholesterol in macrophages and thereby preventing effectivity of the cholesterol-dependent LLO-mediated phagosomal escape of bacteria.	[Parihar, Suraj P.; Guler, Reto; Brombacher, Frank] Univ Cape Town, Int Ctr Genet Engn & Biotechnol ICGEB, ZA-7925 Cape Town, South Africa; [Parihar, Suraj P.; Guler, Reto; Brombacher, Frank] Univ Cape Town, Fac Hlth Sci, Div Immunol, Inst Infect Dis & Mol Med IIDMM, ZA-7925 Cape Town, South Africa; [Lang, Dirk M.] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, ZA-7925 Cape Town, South Africa; [Suzuki, Harukazu] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Marais, A. David] Univ Cape Town, Fac Hlth Sci, Div Chem Pathol, ZA-7925 Cape Town, South Africa	International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; RIKEN; University of Cape Town	Brombacher, F (corresponding author), Univ Cape Town, Int Ctr Genet Engn & Biotechnol ICGEB, ZA-7925 Cape Town, South Africa.	fbrombac@mweb.co.za	Lang, Dirk/I-2554-2015; Suzuki, Harukazu/N-9553-2015; Parihar, Suraj/HCI-2597-2022	Lang, Dirk/0000-0003-3901-2079; Suzuki, Harukazu/0000-0002-8087-0836; Parihar, Suraj/0000-0002-4932-7990	International Centre for Genetic Engineering & Biotechnology (ICGEB), Cape Town; South African Medical Research Council (SAMRC) Unit on Immunology of Infectious Diseases; SAMRC; SAMRC research group development grant; University and Faculty Research Committee funding (URC/FRC); Kwazulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) South Africa; National Research Funding (NRF) South Africa; South African Research Chair initiative (SARChi)	International Centre for Genetic Engineering & Biotechnology (ICGEB), Cape Town; South African Medical Research Council (SAMRC) Unit on Immunology of Infectious Diseases; SAMRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SAMRC research group development grant; University and Faculty Research Committee funding (URC/FRC); Kwazulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) South Africa; National Research Funding (NRF) South Africa; South African Research Chair initiative (SARChi)	This work was supported by the International Centre for Genetic Engineering & Biotechnology (ICGEB), Cape Town with a PhD-fellowship to SPP, South African Medical Research Council (SAMRC) Unit on Immunology of Infectious Diseases (FB). A SAMRC self-initiated research grant (SIR), SAMRC research group development grant, University and Faculty Research Committee funding (URC/FRC) and grants from Kwazulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) South Africa to RG, National Research Funding (NRF) South Africa and the South African Research Chair initiative (SARChi) to FB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Bjorkhem-Bergman L, 2011, BRIT J CLIN PHARMACO, V72, P164, DOI 10.1111/j.1365-2125.2011.03907.x; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; Bochar DA, 1999, MOL GENET METAB, V66, P122, DOI 10.1006/mgme.1998.2786; Brombacher F, 1999, INT IMMUNOL, V11, P325, DOI 10.1093/intimm/11.3.325; Catron DM, 2004, INFECT IMMUN, V72, P1036, DOI 10.1128/IAI.72.2.1036-1042.2004; Catron DM, 2002, CELL MICROBIOL, V4, P315, DOI 10.1046/j.1462-5822.2002.00198.x; Chen X, 2002, J BIOL CHEM, V277, P49631, DOI 10.1074/jbc.M208327200; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; Djaldetti M, 2006, EXP MOL PATHOL, V80, P160, DOI 10.1016/j.yexmp.2005.09.009; Ehrenstein MR, 2005, NEW ENGL J MED, V352, P73, DOI 10.1056/NEJMe048326; Erkkila L, 2005, ANTIMICROB AGENTS CH, V49, P3959, DOI 10.1128/AAC.49.9.3959-3962.2005; FERRARI M, 1990, J IMMUNOL METHODS, V131, P165, DOI 10.1016/0022-1759(90)90187-Z; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; GINSBACH C, 1987, HISTOCHEMISTRY, V86, P241, DOI 10.1007/BF00490254; Glynn SA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-9; Guler R, 2011, VACCINE, V29, P1339, DOI 10.1016/j.vaccine.2010.10.045; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; Hedl M, 2004, PROTEIN SCI, V13, P1693, DOI 10.1110/ps.03597504; Hillyard DZ, 2004, ATHEROSCLEROSIS, V172, P219, DOI 10.1016/j.atherosclerosis.2003.11.004; Holscher C, 2006, J IMMUNOL, V176, P1115, DOI 10.4049/jimmunol.176.2.1115; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Katano H, 2004, P NATL ACAD SCI USA, V101, P4960, DOI 10.1073/pnas.0305149101; KATO K, 1989, MED MICROBIOL IMMUN, V178, P337; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Khanna KV, 2002, J CLIN INVEST, V109, P205; Khurana V, 2007, CHEST, V131, P1282, DOI 10.1378/chest.06-0931; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; Krause BR, 1998, ATHEROSCLEROSIS, V140, P15, DOI 10.1016/S0021-9150(98)00141-5; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Loike JD, 2004, ARTERIOSCL THROM VAS, V24, P2051, DOI 10.1161/01.ATV.0000143858.15909.29; Matsumoto M, 2004, J IMMUNOL, V172, P7377, DOI 10.4049/jimmunol.172.12.7377; NegreAminou P, 1997, BBA-LIPID LIPID MET, V1345, P259, DOI 10.1016/S0005-2760(96)00184-1; Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923; Port GC, 2007, INFECT IMMUN, V75, P5886, DOI 10.1128/IAI.00845-07; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Pucadyil TJ, 2004, MOL BIOCHEM PARASIT, V133, P145, DOI 10.1016/j.molbiopara.2003.10.002; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Rosch JW, 2010, J CLIN INVEST, V120, P627, DOI 10.1172/JCI39843; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Salman H, 2008, BIOMED PHARMACOTHER, V62, P41, DOI 10.1016/j.biopha.2007.07.007; Schwegmann A, 2007, P NATL ACAD SCI USA, V104, P16251, DOI 10.1073/pnas.0703496104; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; WAGNER RD, 1994, MICROB PATHOGENESIS, V17, P175, DOI 10.1006/mpat.1994.1064; Yilmaz A, 2006, J LEUKOCYTE BIOL, V79, P529, DOI 10.1189/jlb.0205064; Zou T, 2011, INFECT IMMUN, V79, P1526, DOI 10.1128/IAI.01195-10	51	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e75490	10.1371/journal.pone.0075490	http://dx.doi.org/10.1371/journal.pone.0075490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086542	Green Published, Green Submitted, gold			2022-12-25	WOS:000325025200044
J	Everett, KL; Cooper, DMF				Everett, Katy L.; Cooper, Dermot M. F.			An Improved Targeted cAMP Sensor to Study the Regulation of Adenylyl Cyclase 8 by Ca2+ Entry through Voltage-Gated Channels	PLOS ONE			English	Article							PROTEIN-KINASE-A; PULSATILE INSULIN-SECRETION; YELLOW FLUORESCENT PROTEIN; SINGLE BETA-CELLS; DIFFERENT ISOFORMS; SIGNALING COMPLEX; CALCIUM-CHANNELS; LIPID RAFTS; CYCLIC-AMP; GLUCOSE	Here we describe an improved sensor with reduced pH sensitivity tethered to adenylyl cyclase (AC) 8. The sensor was used to study cAMP dynamics in the AC8 microdomain of MIN6 cells, a pancreatic beta-cell line. In these cells, AC8 was activated by Ca2+ entry through L-type voltage-gated channels following depolarisation. This activation could be reconstituted in HEK293 cells co-expressing AC8 and either the alpha 1C or alpha 1D subunit of L-type voltage-gated Ca2+ channels. The development of this improved sensor opens the door to the study of cAMP microdomains in excitable cells that have previously been challenging due to the sensitivity of fluorescent proteins to pH changes.	[Everett, Katy L.; Cooper, Dermot M. F.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Cooper, DMF (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	dmfc2@cam.ac.uk			Wellcome Trust, UK; Newton Trust, University of Cambridge	Wellcome Trust, UK(Wellcome Trust); Newton Trust, University of Cambridge	Support for this work was provided by the Wellcome Trust, UK and the Newton Trust, University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; CALI JJ, 1994, J BIOL CHEM, V269, P12190; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Delmeire D, 2003, DIABETOLOGIA, V46, P1383, DOI 10.1007/s00125-003-1203-8; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; DiPilato LM, 2009, MOL BIOSYST, V5, P832, DOI 10.1039/b823243a; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Everett KL, 2012, BIOCHEM SOC T, V40, P179, DOI 10.1042/BST20110616; Fagan KA, 2000, J BIOL CHEM, V275, P26530, DOI 10.1074/jbc.M001369200; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Fagan KA, 2000, J BIOL CHEM, V275, P40187, DOI 10.1074/jbc.M006606200; GIBBS NK, 1992, J PHOTOCH PHOTOBIO B, V13, P275, DOI 10.1016/1011-1344(92)85067-5; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Halls ML, 2010, EMBO J, V29, P2772, DOI 10.1038/emboj.2010.168; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; IRWIN RP, 1994, J NEUROSCI, V14, P1352, DOI 10.1523/JNEUROSCI.14-03-01352.1994; Jacobo SMP, 2009, J PHARMACOL EXP THER, V330, P283, DOI 10.1124/jpet.109.150672; Kitaguchi T, 2013, BIOCHEM J, V450, P365, DOI 10.1042/BJ20121022; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Martin ACL, 2009, MOL PHARMACOL, V75, P830, DOI 10.1124/mol.108.051748; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Naraghi M, 1997, J NEUROSCI, V17, P6961; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Patterson G, 2001, J CELL SCI, V114, P837; Qu YX, 2005, AM J PHYSIOL-HEART C, V288, pH2123, DOI 10.1152/ajpheart.01023.2004; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Roger B, 2011, DIABETOLOGIA, V54, P390, DOI 10.1007/s00125-010-1955-x; Salonikidis PS, 2011, J BIOL CHEM, V286, P23419, DOI 10.1074/jbc.M111.236869; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; Wachten S, 2010, J CELL SCI, V123, P95, DOI 10.1242/jcs.058594; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Willoughby D, 2005, J BIOL CHEM, V280, P30864, DOI 10.1074/jbc.M414355200; Willoughby D, 2002, J PHYSIOL-LONDON, V544, P487, DOI 10.1113/jphysiol.2002.027508; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Willoughby D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002299; Willoughby D, 2010, J BIOL CHEM, V285, P20328, DOI 10.1074/jbc.M110.120725; Willoughby D, 2010, J CELL SCI, V123, P107, DOI 10.1242/jcs.062067; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888	56	25	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75942	10.1371/journal.pone.0075942	http://dx.doi.org/10.1371/journal.pone.0075942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086669	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200127
J	Lin, H; Shen, Q; Zhan, JM; Wang, Q; Zhao, YH				Lin, Hui; Shen, Qi; Zhan, Ju-Mei; Wang, Qun; Zhao, Yu-Hua			Evaluation of Bacterial Expansin EXLX1 as a Cellulase Synergist for the Saccharification of Lignocellulosic Agro-Industrial Wastes	PLOS ONE			English	Article							ENZYMATIC-HYDROLYSIS; CRYSTALLINE CELLULOSE; BACILLUS-SUBTILIS; CELL-WALLS; BINDING; BIOMASS; PROTEIN; STRAW; FERMENTATION; BSEXLX1	Various types of lignocellulosic wastes extensively used in biofuel production were provided to assess the potential of EXLX1 as a cellulase synergist. Enzymatic hydrolysis of natural wheat straw showed that all the treatments using mixtures of cellulase and an optimized amount of EXLX1, released greater quantities of sugars than those using cellulase alone, regardless of cellulase dosage and incubation time. EXLX1 exhibited different synergism and binding characteristics for different wastes, but this can be related to their lignocellulosic components. The cellulose proportion could be one of the important factors. However, when the cellulose proportion of different biomass samples exhibited no remarkable differences, a higher synergism of EXLX1 is prone to occur on these materials, with a high proportion of hemicellulose and a low proportion of lignin. The information could be favorable to assess whether EXLX1 is effective as a cellulase synergist for the hydrolysis of the used materials. Binding assay experiments further suggested that EXLX1 bound preferentially to alkali pretreated materials, as opposed to acid pretreated materials under the assay condition and the binding preference would be affected by incubation temperature.	[Lin, Hui; Shen, Qi; Wang, Qun; Zhao, Yu-Hua] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhan, Ju-Mei] Zhejiang Univ, Coll Life Sci, Inst Plant Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Hui] Zhejiang Acad Agr Sci, Inst Environm Resource Soil & Fertilizer, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang Academy of Agricultural Sciences	Zhao, YH (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	yhzhao225@zju.edu.cn	Lin, Hui/GQB-0146-2022	Lin, Hui/0000-0002-5446-8069	Science and Technology Project of Zhejiang Province [2011C13016]; National Natural Science Foundation of China [31070079, 41271335]; International Cooperation Project in Science and Technology of Zhejiang Province [2008C14038]; High Technology Research and Development Program of China (863 Program) [2012AA06A203]; National Key Technology Rand D Program [2012BAC17B04]	Science and Technology Project of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Project in Science and Technology of Zhejiang Province; High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Key Technology Rand D Program(National Key Technology R&D Program)	This study was supported by the Science and Technology Project of Zhejiang Province (2011C13016), National Natural Science Foundation of China (31070079; 41271335), the International Cooperation Project in Science and Technology of Zhejiang Province (2008C14038), High Technology Research and Development Program of China (863 Program)(2012AA06A203), and the National Key Technology Rand D Program (2012BAC17B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adney B., 1996, MEASUREMENT CELLULAS; Baker JO, 2000, APPL BIOCHEM BIOTECH, V84-6, P217, DOI 10.1385/ABAB:84-86:1-9:217; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Chen XA, 2010, APPL ENVIRON MICROB, V76, P2556, DOI 10.1128/AEM.02499-09; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; DETROY RW, 1983, CRC CR REV MICROBIOL, V10, P203; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Georgelis N, 2011, J BIOL CHEM, V286, P16814, DOI 10.1074/jbc.M111.225037; Gourlay K, 2013, BIORESOURCE TECHNOL, V142, P498, DOI 10.1016/j.biortech.2013.05.053; Gusakov AV, 2007, BIOTECHNOL BIOENG, V97, P1028, DOI 10.1002/bit.21329; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kim ES, 2009, BIOTECHNOL BIOENG, V102, P1342, DOI 10.1002/bit.22193; Kim IJ, 2013, APPL MICROBIOL BIOT, V97, P5381, DOI 10.1007/s00253-012-4412-6; Kim IJ, 2013, BIOTECHNOL BIOENG, V110, P401, DOI 10.1002/bit.24719; Lee HJ, 2010, MOL CELLS, V29, P379, DOI 10.1007/s10059-010-0033-z; Li LC, 2003, PLANT PHYSIOL, V132, P2073, DOI 10.1104/pp.103.020024; Lin H, 2011, BIORESOURCE TECHNOL, V102, P10569, DOI 10.1016/j.biortech.2011.08.095; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Quiroz-Castaneda RE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-8; Saha BC, 2010, NEW BIOTECHNOL, V27, P10, DOI 10.1016/j.nbt.2009.10.005; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Suwannarangsee S, 2012, BIORESOURCE TECHNOL, V119, P252, DOI 10.1016/j.biortech.2012.05.098; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wang YG, 2011, APPL MICROBIOL BIOT, V91, P1353, DOI 10.1007/s00253-011-3421-1; Whitney SEC, 2000, PLANT J, V22, P327, DOI 10.1046/j.1365-313x.2000.00742.x	27	16	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75022	10.1371/journal.pone.0075022	http://dx.doi.org/10.1371/journal.pone.0075022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086425	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200071
J	Mahendran, V; Tan, YS; Riordan, SM; Grimm, MC; Day, AS; Lemberg, DA; Octavia, S; Lan, RT; Zhang, L				Mahendran, Vikneswari; Tan, Ye Sing; Riordan, Stephen M.; Grimm, Michael C.; Day, Andrew S.; Lemberg, Daniel A.; Octavia, Sophie; Lan, Ruiting; Zhang, Li			The Prevalence and Polymorphisms of Zonula Occluden Toxin Gene in Multiple Campylobacter concisus Strains Isolated from Saliva of Patients with Inflammatory Bowel Disease and Controls	PLOS ONE			English	Article							INCREASED INTESTINAL PERMEABILITY; TIGHT JUNCTIONS; CROHNS-DISEASE; HELICOBACTER; ARCOBACTER; RELATIVES; SAMPLES; HUMANS; SPP.	Campylobacter concisus is an oral bacterium. A number of studies detected a significantly higher prevalence of C. concisus in the intestinal tract of patients with inflammatory bowel disease (IBD) as compared to controls. The prevalence of zonula occluden toxin (zot) gene, which encodes a toxin known to increase intestinal permeability, in oral C. concisus strains is unknown. Increased intestinal permeability is a feature of IBD. A total of 56 oral C. concisus strains isolated from 19 patients with IBD and 20 controls were examined (some individuals were colonized with multiple strains). A filtration method was used for isolation of C. concisus from saliva samples. SDS-PAGE was used to define strains. PCR was used to amplify zot from C. concisus strains. Positive PCR products were sequenced and the nucleotides and amino acids were compared. Of the 56 oral C. concisus strains examined, 17 strains (30.4%) were positive for zot. The prevalence of zot-positive oral C. concisus strains was 54.5% in patients with active IBD, which was not significantly different from that in healthy controls (40%). Polymorphisms of C. concisus zot were revealed. zot(808T), zot(350-351AC) and zot(Multiple) were detected only in patients with IBD, but not in healthy controls. Both zot(808T) and zot(Multiple) alleles resulted in substitution of valine at position 270, which occurred in 36.4% of patients with active IBD but not in healthy controls (P = 0.011). Furthermore, the prevalence of multiple oral C. concisus strains in patients with active IBD was significantly higher than that in healthy controls (P = 0.013). This is the first study reporting the prevalence of zot in human oral C. concisus strains and the polymorphisms of C. concisus zot gene. The data suggest that the possible role of C. concisus strains containing specific polymorphic forms of zot gene in human IBD should be investigated.	[Mahendran, Vikneswari; Tan, Ye Sing; Octavia, Sophie; Lan, Ruiting; Zhang, Li] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Riordan, Stephen M.] Prince Wales Hosp, Gastrointestinal & Liver Unit, Sydney, NSW, Australia; [Grimm, Michael C.] Univ New S Wales, St George Clin Sch, Sydney, NSW, Australia; [Day, Andrew S.; Lemberg, Daniel A.] Sydney Childrens Hosp, Dept Gastroenterol, Sydney, NSW, Australia; [Day, Andrew S.] Univ Otago, Dept Paediat, Christchurch, New Zealand; [Day, Andrew S.] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Riordan, Stephen M.] Univ New S Wales, Fac Med, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; University of Otago; University of New South Wales Sydney; University of New South Wales Sydney	Zhang, L (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	L.Zhang@unsw.edu.au		Zhang, Li/0000-0001-7506-8278; Grimm, Michael/0000-0001-9426-3917; Lemberg, Daniel/0000-0002-8583-0956; Lan, Ruiting/0000-0001-9834-5258; Octavia, Sophie/0000-0001-8506-9127	Faculty Research Grant of the University of New South Wales	Faculty Research Grant of the University of New South Wales	This work was supported by a Faculty Research Grant of the University of New South Wales awarded to Dr LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; FASANO A, 1995, J CLIN INVEST, V96, P710, DOI 10.1172/JCI118114; FASANO A, 1991, P NATL ACAD SCI USA, V88, P5242, DOI 10.1073/pnas.88.12.5242; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Goldblum SE, 2011, FASEB J, V25, P144, DOI 10.1096/fj.10-158972; Hansen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058825; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Irvine EJ, 2000, GASTROENTEROLOGY, V119, P1740, DOI 10.1053/gast.2000.20231; Ismail Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056888; Ismail Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038217; Kalischuk LD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-53; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lastovica A. J., 2006, Clinical Microbiology Newsletter, V28, P49, DOI 10.1016/j.clinmicnews.2006.03.004; LEVINE MM, 1988, INFECT IMMUN, V56, P161, DOI 10.1128/IAI.56.1.161-167.1988; LINDBLOM GB, 1995, SCAND J INFECT DIS, V27, P187, DOI 10.3109/00365549509019006; Lynch OA, 2011, INT J FOOD MICROBIOL, V150, P171, DOI 10.1016/j.ijfoodmicro.2011.07.037; Mahendran V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025417; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; MAY GR, 1993, GASTROENTEROLOGY, V104, P1627, DOI 10.1016/0016-5085(93)90638-S; Mukhopadhya I, 2011, PLOS ONE, V6; Nielsen HL, 2013, CLIN MICROBIOL INFEC, V19, P445, DOI 10.1111/j.1469-0691.2012.03852.x; Nielsen HL, 2012, CLIN MICROBIOL INFEC, V18, pE459, DOI 10.1111/j.1469-0691.2012.03990.x; Nielsen HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023858; Petersen RF, 2007, J APPL MICROBIOL, V103, P2601, DOI 10.1111/j.1365-2672.2007.03515.x; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TANNER ACR, 1981, INT J SYST BACTERIOL, V31, P432, DOI 10.1099/00207713-31-4-432; Vandamme P, 2005, BERGEYS MANUAL SYSTE, V2, P1147; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Welcker K, 2004, EUR J MED RES, V9, P456; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhang L, 2010, J CLIN MICROBIOL, V48, P2965, DOI 10.1128/JCM.02391-09; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08	36	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75525	10.1371/journal.pone.0075525	http://dx.doi.org/10.1371/journal.pone.0075525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086553	Green Published, gold, Green Submitted			2022-12-25	WOS:000326520200109
J	Meng, H; Zhang, XJ; Lee, SJ; Wang, MM				Meng, He; Zhang, Xiaojie; Lee, Soo Jung; Wang, Michael M.			Von Willebrand Factor Inhibits Mature Smooth Muscle Gene Expression through Impairment of Notch Signaling	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; WHITE-MATTER LESIONS; ISCHEMIC-STROKE; CELL DIFFERENTIATION; PARKINSONS-DISEASE; DEPENDENT PATHWAY; COGNITIVE DECLINE; ACTIN EXPRESSION; CADASIL PATIENTS; TRANSGENIC MICE	Von Willebrand factor (vWF), a hemostatic protein normally synthesized and stored by endothelial cells and platelets, has been localized beyond the endothelium in vascular disease states. Previous studies have implicated potential non-hemostatic functions of vWF, but signaling mechanisms underlying its effects are currently undefined. We present evidence that vWF breaches the endothelium and is expressed in a transmural distribution pattern in cerebral small vessel disease (SVD). To determine the potential molecular consequences of vWF permeation into the vessel wall, we also tested whether vWF impairs Notch regulation of key smooth muscle marker genes. In a co-culture system using Notch ligand expressing cells to stimulate Notch in A7R5 cells, vWF strongly inhibited both the Notch pathway and the activation of mature smooth muscle gene promoters. Similar repressive effects were observed in primary human cerebral vascular smooth muscle cells. Expression of the intracellular domain of NOTCH3 allowed cells to bypass the inhibitory effects of vWF. Moreover, vWF forms molecular complexes with all four mammalian Notch ectodomains, suggesting a novel function of vWF as an extracellular inhibitor of Notch signaling. In sum, these studies demonstrate vWF in the vessel wall as a common feature of cerebral SVD; furthermore, we provide a plausible mechanism by which non-hemostatic vWF may play a novel role in the promotion of vascular disease.	[Meng, He; Zhang, Xiaojie; Lee, Soo Jung; Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] VA Ann Arbor Healthcare Syst, Neurol Serv, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Wang, MM (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	micwang@umich.edu			National Iinstitutes of Health - National Institute of Neurological Disorders and Stroke [NS054724, NS062816]; VA Merit award [5I01BX000375]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062816, K02NS054724] Funding Source: NIH RePORTER	National Iinstitutes of Health - National Institute of Neurological Disorders and Stroke; VA Merit award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants NS054724 and NS062816 from National Iinstitutes of Health - National Institute of Neurological Disorders and Stroke, and VA Merit award 5I01BX000375. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamowitch S, 2009, NEUROLOGY, V73, P1873, DOI 10.1212/WNL.0b013e3181c3fd12; Bohnen NI, 2011, BRAIN, V134, P2358, DOI 10.1093/brain/awr139; Bohnen NI, 2011, NAT REV NEUROL, V7, P229, DOI 10.1038/nrneurol.2011.21; Bongers TN, 2006, STROKE, V37, P2672, DOI 10.1161/01.STR.0000244767.39962.f7; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Dang L, 2006, ONCOGENE, V25, P487, DOI 10.1038/sj.onc.1209074; de Groot JC, 2000, ANN NEUROL, V47, P145; De Meyer GRY, 1999, ARTERIOSCL THROM VAS, V19, P2524, DOI 10.1161/01.ATV.19.10.2524; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; DUBAND JL, 1993, DIFFERENTIATION, V55, P1, DOI 10.1111/j.1432-0436.1993.tb00027.x; Farkas E, 2000, ACTA NEUROPATHOL, V100, P395, DOI 10.1007/s004010000195; Folsom AR, 1999, CIRCULATION, V100, P736, DOI 10.1161/01.CIR.100.7.736; GABBIANI G, 1984, J CLIN INVEST, V73, P148, DOI 10.1172/JCI111185; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hungerford JE, 1996, DEV BIOL, V178, P375, DOI 10.1006/dbio.1996.0225; Jokinen H, 2011, NEUROLOGY, V76, P1872, DOI 10.1212/WNL.0b013e31821d752f; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; KOCKX MM, 1993, VIRCHOWS ARCH A, V422, P293, DOI 10.1007/BF01608338; Lammie GA, 1997, STROKE, V28, P2222, DOI 10.1161/01.STR.28.11.2222; Lammie GA, 2002, BRAIN PATHOL, V12, P358; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Mazzucato M, 1999, J BIOL CHEM, V274, P3033, DOI 10.1074/jbc.274.5.3033; Meng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044964; Meng H, 2010, J BIOL CHEM, V285, P23045, DOI 10.1074/jbc.M110.144634; Meng H, 2009, J BIOL CHEM, V284, P7866, DOI 10.1074/jbc.M803650200; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; Moessler H, 1996, DEVELOPMENT, V122, P2415; Mohlke KL, 1999, CELL, V96, P111, DOI 10.1016/S0092-8674(00)80964-2; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Norrving B, 2003, LANCET NEUROL, V2, P238, DOI 10.1016/S1474-4422(03)00352-1; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Qin F, 2003, J VASC SURG, V37, P433, DOI 10.1067/mva.2003.63; Qizilbash N, 1997, NEUROLOGY, V49, P1552, DOI 10.1212/WNL.49.6.1552; Sadler JE, 2005, J THROMB HAEMOST, V3, P1702, DOI 10.1111/j.1538-7836.2005.01369.x; Scheppke L, 2011, BLOOD; Sibon I, 2007, ANN NEUROL, V62, P177, DOI 10.1002/ana.21191; Small D, 2001, J BIOL CHEM, V276, P32022, DOI 10.1074/jbc.M100933200; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Tang YF, 2008, CIRC RES, V102, P661, DOI 10.1161/CIRCRESAHA.107.165134; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wannamethee SG, 2012, STROKE; Wen HM, 2004, STROKE, V35, P1826, DOI 10.1161/01.STR.0000133686.29320.58; Zhang XJ, 2012, TRANSL STROKE RES, V3, P138, DOI 10.1007/s12975-011-0112-2; Zhao N, 2012, J BIOL CHEM, V287, P16111, DOI 10.1074/jbc.M111.322107	52	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75808	10.1371/journal.pone.0075808	http://dx.doi.org/10.1371/journal.pone.0075808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086636	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200120
J	Odutola, A; Antonio, M; Owolabi, O; Bojang, A; Foster-Nyarko, E; Donkor, S; Adetifa, I; Taylor, S; Bottomley, C; Greenwood, B; Ota, M				Odutola, Aderonke; Antonio, Martin; Owolabi, Olumuyiwa; Bojang, Abdoulie; Foster-Nyarko, Ebenezer; Donkor, Simon; Adetifa, Ifedayo; Taylor, Sylvia; Bottomley, Christian; Greenwood, Brian; Ota, Martin			Comparison of the Prevalence of Common Bacterial Pathogens in the Oropharynx and Nasopharynx of Gambian Infants	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; UPPER RESPIRATORY-TRACT; STREPTOCOCCUS-PNEUMONIAE; HAEMOPHILUS-INFLUENZAE; STAPHYLOCOCCUS-AUREUS; CARRIAGE; CHILDREN; COLONIZATION; HEALTHY; YOUNGER	Background: CRM-based pneumococcal conjugate vaccines generally have little impact on the overall prevalence of pneumococcal carriage because of serotype replacement. In contrast, protein vaccines could substantially reduce the overall prevalence of pneumococcal carriage with potential microbiological and clinical consequences. Therefore, trials of pneumococcal protein vaccines need to evaluate their impact on carriage of other potentially pathogenic bacteria in addition to the pneumococcus. Methods: As a prelude to a trial of an investigational pneumococcal vaccine containing pneumococcal polysaccharide conjugates and pneumococcal proteins, the prevalence of carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella species and Staphylococcus aureus in the nasopharynx of 1030 Gambian infants (median age 35 weeks) was determined. An oropharyngeal swab was obtained at the same time from the first 371 infants enrolled. Standard microbiological techniques were used to evaluate the bacterial flora of the pharynx and to compare that found in the oropharynx and in the nasopharynx. Results: The overall pneumococcal carriage rate was high. Isolation rates of S. pneumoniae and Moraxella species were significantly higher using nasopharyngeal rather than oropharyngeal swabs (76.1% [95% CI 73.4%, 78.7%] vs. 21.3% [95% CI 17.2%, 25.8%] and 48.9% [95% CI 45.8%, 52.0%] vs. 20.5% % [95% CI 16.5%, 25.0%] respectively). In contrast, S. aureus and H. influenzae were isolated more frequently from oropharyngeal than from nasopharyngeal swabs (65.0% [95% CI 59.9%, 69.8%] vs. 33.6% [95% CI 30.7%, 36.5%] and 31.8% [95% CI 16.5%, 25.0%] vs. 22.4% [95% CI 19.9%, 25.1%] respectively). No group A beta haemolytic streptococci were isolated. Conclusion: Collection of an oropharyngeal swab in addition to a nasopharyngeal swab will provide little additional information on the impact of a novel pneumococcal vaccine on pneumococcal carriage but it might provide additional, valuable information on the impact of the vaccine on the overall microbiota of the pharynx.	[Odutola, Aderonke; Antonio, Martin; Owolabi, Olumuyiwa; Bojang, Abdoulie; Foster-Nyarko, Ebenezer; Donkor, Simon; Adetifa, Ifedayo; Ota, Martin] MRC Unit, Banjul, Gambia; [Taylor, Sylvia] GlaxoSmithKline Vaccines, Global Epidemiol, Wavre, Belgium; [Bottomley, Christian; Greenwood, Brian] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Ota, Martin] WHO, Reg Off Africa, Brazzaville, Rep Congo	University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Odutola, A (corresponding author), MRC Unit, Banjul, Gambia.	aaodutola@mrc.gm		Foster-Nyarko, Ebenezer/0000-0001-6620-9403; Bottomley, Christian/0000-0002-5241-8412	MRC UK; PATH, Seattle; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); PATH, Seattle; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by MRC UK and by a grant from PATH, Seattle. A steering committee which included staff employed by PATH or GSK in addition to representative of the partner academic organisations provided overall advice on the conduct of the trial but played no direct role in the analysis of data, its interpretation or in the writing of the paper.	Altman D.G., 1991, PRACTICAL STATISTIC; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; CAPEDING MRZ, 1995, J CLIN MICROBIOL, V33, P3077, DOI 10.1128/JCM.33.11.3077-3079.1995; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Greenberg D, 2004, J CLIN MICROBIOL, V42, P4604, DOI 10.1128/JCM.42.10.4604-4609.2004; Hare KM, 2011, J MICROBIOL METH, V86, P364, DOI 10.1016/j.mimet.2011.06.016; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; Kwambana BA, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-2; Lieberman D, 2006, J CLIN MICROBIOL, V44, P525, DOI 10.1128/JCM.44.2.525-528.2006; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; LloydEvans N, 1996, PEDIATR INFECT DIS J, V15, P866, DOI 10.1097/00006454-199610000-00007; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Madhi SA, 2007, J INFECT DIS, V196, P1662, DOI 10.1086/522164; MASTERS PL, 1958, BMJ-BRIT MED J, V1, P1200, DOI 10.1136/bmj.1.5081.1200; Morais L, 2007, J MED MICROBIOL, V56, P1181, DOI 10.1099/jmm.0.47346-0; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Prymula R, 2012, SAFETY IMMUNOGENICIT; Rapola S, 1997, J CLIN MICROBIOL, V35, P1077, DOI 10.1128/JCM.35.5.1077-1079.1997; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Spijkerman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039730; van der Veen EL, 2006, ARCH OTOLARYNGOL, V132, P752, DOI 10.1001/archotol.132.7.752; van Gils EJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020229; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8	28	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75558	10.1371/journal.pone.0075558	http://dx.doi.org/10.1371/journal.pone.0075558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086570	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000326520200112
J	Beck-Johnson, LM; Nelson, WA; Paaijmans, KP; Read, AF; Thomas, MB; Bjornstad, ON				Beck-Johnson, Lindsay M.; Nelson, William A.; Paaijmans, Krijn P.; Read, Andrew F.; Thomas, Matthew B.; Bjornstad, Ottar N.			The Effect of Temperature on Anopheles Mosquito Population Dynamics and the Potential for Malaria Transmission	PLOS ONE			English	Article							GAMBIAE GILES COMPLEX; CLIMATE-CHANGE; PLASMODIUM-FALCIPARUM; GENERATION SEPARATION; DEPENDENT DEVELOPMENT; IMMATURE STAGES; AQUATIC STAGES; BODY-SIZE; DIPTERA; MODEL	The parasites that cause malaria depend on Anopheles mosquitoes for transmission; because of this, mosquito population dynamics are a key determinant of malaria risk. Development and survival rates of both the Anopheles mosquitoes and the Plasmodium parasites that cause malaria depend on temperature, making this a potential driver of mosquito population dynamics and malaria transmission. We developed a temperature-dependent, stage-structured delayed differential equation model to better understand how climate determines risk. Including the full mosquito life cycle in the model reveals that the mosquito population abundance is more sensitive to temperature than previously thought because it is strongly influenced by the dynamics of the juvenile mosquito stages whose vital rates are also temperature-dependent. Additionally, the model predicts a peak in abundance of mosquitoes old enough to vector malaria at more accurate temperatures than previous models. Our results point to the importance of incorporating detailed vector biology into models for predicting the risk for vector borne diseases.	[Beck-Johnson, Lindsay M.; Paaijmans, Krijn P.; Read, Andrew F.; Thomas, Matthew B.; Bjornstad, Ottar N.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Beck-Johnson, Lindsay M.; Read, Andrew F.; Bjornstad, Ottar N.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Nelson, William A.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Paaijmans, Krijn P.; Read, Andrew F.; Thomas, Matthew B.; Bjornstad, Ottar N.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Read, Andrew F.; Bjornstad, Ottar N.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Queens University - Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Beck-Johnson, LM (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	lmb404@psu.edu	de Voogd, Nicole/I-9280-2012; Nelson, William A/D-1405-2013; Paaijmans, Krijn/ABC-9928-2020; Peijnenburg, Katja TCA/F-7176-2016	de Voogd, Nicole/0000-0002-7985-5604; Peijnenburg, Katja TCA/0000-0001-7544-1079; Erpenbeck, Dirk/0000-0003-2716-1085	United States Department of Agriculture National Research Initiative [2006-35302-17149]; National Science Foundation-EID program grant [EF-0914384]	United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); National Science Foundation-EID program grant	This research was supported by United States Department of Agriculture National Research Initiative 2006-35302-17149 to ONB, www.usda.gov, and by National Science Foundation-EID program grant EF-0914384 to MBT and AFR, www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amarasekare P, 2012, AM NAT, V179, P178, DOI 10.1086/663677; ANIEDU I, 1993, INSECT SCI APPL, V14, P39, DOI 10.1017/S1742758400013370; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Bayoh MN, 2001, THESIS U DURHAM; Beaty B.J., 1996, BIOL DIS VECTORS; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Bomblies A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-223; Bomblies A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006917; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; BRIGGS CJ, 1995, AM NAT, V145, P855, DOI 10.1086/285774; Centers for Disease Control and Prevention (CDC), 2012, MAL FACTS; Charlwood JD, 1997, B ENTOMOL RES, V87, P445, DOI 10.1017/S0007485300041304; Clements AN., 1992, BIOL MOSQUITOES DEV; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; de Roos AM, 2003, THEOR POPUL BIOL, V63, P1, DOI 10.1016/S0040-5809(02)00009-6; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Ellner S.P., 2006, DYNAMIC MODELS BIOL, DOI DOI 10.1139/F10-077; Frazier MR, 2006, AM NAT, V168, P512, DOI 10.1086/506977; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; Grech K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-130; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; GURNEY WSC, 1985, THEOR POPUL BIOL, V28, P150, DOI 10.1016/0040-5809(85)90026-7; Hancock PA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-98; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Lardeux FJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-141; LYIMO EO, 1992, PARASITOLOGY, V104, P233, DOI 10.1017/S0031182000061667; LYIMO EO, 1993, MED VET ENTOMOL, V7, P328, DOI 10.1111/j.1365-2915.1993.tb00700.x; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Mandal S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-202; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; McCauley E, 2008, NATURE, V455, P1240, DOI 10.1038/nature07220; Minakawa N, 2006, AM J TROP MED HYG, V75, P448, DOI 10.4269/ajtmh.2006.75.448; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Mukiama TK, 1989, FIELD STUDIES LARVAL; Munga S, 2007, J MED ENTOMOL, V44, P758, DOI 10.1603/0022-2585(2007)44[758:SOISOA]2.0.CO;2; Muriu SM, 2013, J ANIM ECOL, V82, P166, DOI 10.1111/1365-2656.12002; Mwangangi JM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-114; NISBET RM, 1983, THEOR POPUL BIOL, V23, P114, DOI 10.1016/0040-5809(83)90008-4; Okogun Godwin Ray Anugboba, 2005, Journal of Vector Borne Diseases, V42, P45; Paaijmans KP, 2008, HYDROL PROCESS, V22, P4789, DOI 10.1002/hyp.7099; Paaijmans KP, 2012, BIOL LETTERS, V8, P465, DOI 10.1098/rsbl.2011.1075; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parham PE, 2009, ENV HLTH PERSPECT, V118; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; REISEN WK, 1975, MOSQ NEWS, V35, P473; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Ross R., 1910, PREVENTION MALARIA; SERVICE MW, 1977, J MED ENTOMOL, V13, P535, DOI 10.1093/jmedent/13.4-5.535; SERVICE MW, 1973, B ENTOMOL RES, V62, P359, DOI 10.1017/S0007485300003862; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Timmermann S. E., 1993, Bulletin of the Society for Vector Ecology, V18, P174; Yamanaka T, 2012, AM NAT, V179, P95, DOI 10.1086/663201; [No title captured]	60	181	183	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e79276	10.1371/journal.pone.0079276	http://dx.doi.org/10.1371/journal.pone.0079276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24098416	gold, Green Submitted, Green Published			2022-12-25	WOS:000327143800053
J	Yang, WK; Kang, CK; Chang, CH; Hsu, AD; Lee, TH; Hwang, PP				Yang, Wen-Kai; Kang, Chao-Kai; Chang, Chia-Hao; Hsu, An-Di; Lee, Tsung-Han; Hwang, Pung-Pung			Expression Profiles of Branchial FXYD Proteins in the Brackish Medaka Oryzias dancena: A Potential Saltwater Fish Model for Studies of Osmoregulation	PLOS ONE			English	Article							PHOSPHOLEMMAN-LIKE PROTEIN; NA+/K+-ATPASE EXPRESSION; SHARK RECTAL GLANDS; FUNCTIONAL INTERACTION; ION REGULATION; GENUS ORYZIAS; SODIUM-PUMP; FRESH-WATER; K+-ATPASE; NA,K-ATPASE	FXYD proteins are novel regulators of Na+-K+-ATPase (NKA). In fish subjected to salinity challenges, NKA activity in osmoregulatory organs (e. g., gills) is a primary driving force for the many ion transport systems that act in concert to maintain a stable internal environment. Although teleostean FXYD proteins have been identified and investigated, previous studies focused on only a limited group of species. The purposes of the present study were to establish the brackish medaka (Oryzias dancena) as a potential saltwater fish model for osmoregulatory studies and to investigate the diversity of teleostean FXYD expression profiles by comparing two closely related euryhaline model teleosts, brackish medaka and Japanese medaka (O. latipes), upon exposure to salinity changes. Seven members of the FXYD protein family were identified in each medaka species, and the expression of most branchial fxyd genes was salinity-dependent. Among the cloned genes, fxyd11 was expressed specifically in the gills and at a significantly higher level than the other fxyd genes. In the brackish medaka, branchial fxyd11 expression was localized to the NKA-immunoreactive cells in gill epithelia. Furthermore, the FXYD11 protein interacted with the NKA a-subunit and was expressed at a higher level in freshwater-acclimated individuals relative to fish in other salinity groups. The protein sequences and tissue distributions of the FXYD proteins were very similar between the two medaka species, but different expression profiles were observed upon salinity challenge for most branchial fxyd genes. Salinity changes produced different effects on the FXYD11 and NKA a-subunit expression patterns in the gills of the brackish medaka. To our knowledge, this report is the first to focus on FXYD expression in the gills of closely related euryhaline teleosts. Given the advantages conferred by the well-developed Japanese medaka system, we propose the brackish medaka as a saltwater fish model for osmoregulatory studies.	[Yang, Wen-Kai; Kang, Chao-Kai; Chang, Chia-Hao; Hsu, An-Di; Lee, Tsung-Han] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Yang, Wen-Kai] MingDao Univ, Dept Biotechnol, Changhua, Taiwan; [Lee, Tsung-Han] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	National Chung Hsing University; Mingdao University; China Medical University Taiwan; Academia Sinica - Taiwan	Lee, TH (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	thlee@email.nchu.edu.tw	He, Xinhua/B-8047-2015; Hwang, Pung-Pung/AEQ-4633-2022; Gao 高程, Cheng/J-9586-2012; Hwang, Pung-Pung/AAH-1538-2022; Chang, Chia-Hao/AAW-2598-2020; GUO, Liang-dong/C-1407-2015; hwang, pp/A-3641-2011; Zheng, Yong/E-3947-2012; Zheng, Yong/AAN-8928-2021	He, Xinhua/0000-0002-5570-3454; Gao 高程, Cheng/0000-0003-2522-7909; Chang, Chia-Hao/0000-0002-7583-4291; Zheng, Yong/0000-0001-5239-9824; Zheng, Yong/0000-0001-5239-9824; Yang, Wen-Kai/0000-0001-8095-2420; Lee, Tsung-Han/0000-0002-3542-4335	Academia Sinica of Taiwan [AS-98-TP-B08]; ATU plan of the Ministry of Education, Taiwan [CC-97118]; NICHD, USA [N01-HD-6-2915]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD062915] Funding Source: NIH RePORTER	Academia Sinica of Taiwan(Academia Sinica - Taiwan); ATU plan of the Ministry of Education, Taiwan; NICHD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from the Academia Sinica of Taiwan to PPH and THL (AS-98-TP-B08). The work was also supported in part by a grant from the ATU plan of the Ministry of Education, Taiwan, to THL (CC-97118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The monoclonal antibody against the Na<SUP>+</SUP>-K<SUP>+</SUP>-ATPase alpha-subunit (alpha 5) was purchased from the Developmental Studies Hybridoma Bank maintained by the Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, and the Department of Biological Sciences, University of Iowa, Iowa City, IA 52242, under Contract N01-HD-6-2915, NICHD, USA.	Aperia A, 2007, J INTERN MED, V261, P44, DOI 10.1111/j.1365-2796.2006.01745.x; Beguin P, 2002, EMBO J, V21, P3264, DOI 10.1093/emboj/cdf330; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bystriansky JS, 2011, J EXP BIOL, V214, P2435, DOI 10.1242/jeb.050633; Chen XP, 2009, COMP BIOCHEM PHYS C, V149, P647, DOI 10.1016/j.cbpc.2009.01.009; Cornelius F, 2003, NEWS PHYSIOL SCI, V18, P119, DOI 10.1152/nips.01434.2003; Crambert Gilles, 2003, Sci STKE, V2003, pRE1, DOI 10.1126/stke.2003.166.re1; Cutler CP, 2000, AM J PHYSIOL-REG I, V279, pR222, DOI 10.1152/ajpregu.2000.279.1.R222; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Freire CA, 2008, COMP BIOCHEM PHYS A, V149, P435, DOI 10.1016/j.cbpa.2008.02.003; Garty H, 2002, AM J PHYSIOL-RENAL, V283, pF607, DOI 10.1152/ajprenal.00112.2002; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2005, J BIOENERG BIOMEMBR, V37, P387, DOI 10.1007/s10863-005-9476-x; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirose S, 2003, COMP BIOCHEM PHYS B, V136, P593, DOI 10.1016/S1096-4959(03)00287-2; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Inoue K, 2003, COMP BIOCHEM PHYS B, V136, P635, DOI 10.1016/S1096-4959(03)00204-5; Inoue K, 2002, ZOOL SCI, V19, P727, DOI 10.2108/zsj.19.727; Inoue K, 2012, ENVIRON BIOL FISH, V94, P559, DOI 10.1007/s10641-011-9852-9; Johansen MB, 2006, GLYCOBIOLOGY, V16, P844, DOI 10.1093/glycob/cwl009; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kang CK, 2013, COMP BIOCHEM PHYS A, V164, P181, DOI 10.1016/j.cbpa.2012.08.010; Kang CK, 2010, COMP BIOCHEM PHYS A, V157, P7, DOI 10.1016/j.cbpa.2010.05.013; Kang CK, 2008, COMP BIOCHEM PHYS A, V151, P566, DOI 10.1016/j.cbpa.2008.07.020; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Li CM, 2004, J BIOL CHEM, V279, P38895, DOI 10.1074/jbc.M406697200; Lin YM, 2003, COMP BIOCHEM PHYS A, V135, P489, DOI 10.1016/S1095-6433(03)00136-3; Mahmmoud YA, 2000, J BIOL CHEM, V275, P35969, DOI 10.1074/jbc.M005168200; Mahmmoud YA, 2005, J BIOL CHEM, V280, P27776, DOI 10.1074/jbc.M503150200; Mahmmoud YA, 2003, J BIOL CHEM, V278, P37427, DOI 10.1074/jbc.M305126200; Parenti LR, 2008, ZOOL J LINN SOC-LOND, V154, P494, DOI 10.1111/j.1096-3642.2008.00417.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Roberts TR, 1998, ICHTHYOL RES, V45, P213, DOI 10.1007/BF02673919; Saito K, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00129; Sakamoto T, 2001, AQUACULTURE, V193, P347, DOI 10.1016/S0044-8486(00)00471-3; Sasado T, 2010, EXP ANIM TOKYO, V59, P13, DOI 10.1538/expanim.59.13; Scheiner-Bobis G, 2002, EUR J BIOCHEM, V269, P2424, DOI 10.1046/j.1432-1033.2002.02909.x; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Takehana Y, 2005, MOL PHYLOGENET EVOL, V36, P417, DOI 10.1016/j.ympev.2005.01.016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang CH, 2012, COMP BIOCHEM PHYS A, V163, P302, DOI 10.1016/j.cbpa.2012.07.017; Tipsmark CK, 2011, J ENDOCRINOL, V209, P237, DOI 10.1530/JOE-10-0495; Tipsmark CK, 2010, AM J PHYSIOL-REG I, V299, pR1212, DOI 10.1152/ajpregu.00015.2010; Tipsmark CK, 2008, AM J PHYSIOL-REG I, V294, pR1367, DOI 10.1152/ajpregu.00454.2007; Toyoshima C, 2011, STRUCTURE, V19, P1732, DOI 10.1016/j.str.2011.10.016; Wang PJ, 2008, J EXP BIOL, V211, P3750, DOI 10.1242/jeb.018440; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yang WK, 2011, J COMP PHYSIOL B, V181, P953, DOI 10.1007/s00360-011-0568-0; Yang WK, 2009, J EXP MAR BIOL ECOL, V375, P41, DOI 10.1016/j.jembe.2009.05.004; Yusof S, 2012, ENVIRON BIOL FISH, V93, P43, DOI 10.1007/s10641-011-9888-x	55	118	135	11	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55470	10.1371/journal.pone.0055470	http://dx.doi.org/10.1371/journal.pone.0055470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	24086741	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600108
J	Kim, HS; Park, SH; Gunzl, A; Cross, GAM				Kim, Hee-Sook; Park, Sung Hee; Guenzl, Arthur; Cross, George A. M.			MCM-BP Is Required for Repression of Life-Cycle Specific Genes Transcribed by RNA Polymerase I in the Mammalian Infectious Form of Trypanosoma brucei	PLOS ONE			English	Article							VSG EXPRESSION SITE; ORIGIN RECOGNITION COMPLEX; BLOOD-STREAM FORMS; POLO-LIKE KINASE; DNA-REPLICATION; ANTIGENIC VARIATION; TOPOISOMERASE-II; DISTINCT ROLES; PROTEIN; TELOMERES	Trypanosoma brucei variant surface glycoprotein (VSG) expression is a classic example of allelic exclusion. While the genome of T. brucei contains >2,000 VSG genes and VSG pseudogenes, only one allele is expressed at the surface of each infectious trypanosome and the others are repressed. Along with recombinatorial VSG switching, allelic exclusion provides a major host evasion mechanism for trypanosomes, a phenomenon known as antigenic variation. To extend our understanding of how trypanosomes escape host immunity by differential expression of VSGs, we attempted to identify genes that contribute to VSG silencing, by performing a loss-of-silencing screen in T. brucei using a transposon-mediated random insertional mutagenesis. One identified gene, which we initially named LOS1, encodes a T. brucei MCM-Binding Protein (TbMCM-BP). Here we show that TbMCM-BP is essential for viability of infectious bloodstream-form (BF) trypanosome and is required for proper cell-cycle progression. Tandem affinity purification of TbMCM-BP followed by mass spectrometry identified four subunits (MCM4-MCM7) of the T. brucei MCM complex, a replicative helicase, and MCM8, a subunit that is uniquely co-purified with TbMCM-BP. TbMCM-BP is required not only for repression of subtelomeric VSGs but also for silencing of life-cycle specific, insect-stage genes, procyclin and procyclin-associated genes (PAGs), that are normally repressed in BF trypanosomes and are transcribed by RNA polymerase I. Our study uncovers a functional link between chromosome maintenance and RNA pol I-mediated gene silencing in T. brucei.	[Kim, Hee-Sook; Cross, George A. M.] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10021 USA; [Park, Sung Hee; Guenzl, Arthur] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Storrs, CT 06269 USA; [Guenzl, Arthur] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Storrs, CT 06269 USA	Rockefeller University; University of Connecticut; University of Connecticut	Kim, HS (corresponding author), Rockefeller Univ, Mol Parasitol Lab, New York, NY 10021 USA.	khee-sook@rockefeller.edu	; Cross, George/B-7444-2011	Gunzl, Arthur/0000-0002-7487-2261; Cross, George/0000-0003-1374-6955	Rockefeller University Women in Science Fellowship; U.S. National Institutes of Health (NIH) [R01 AI021729, R01 AI059377]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021729, R01AI059377] Funding Source: NIH RePORTER	Rockefeller University Women in Science Fellowship; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the Rockefeller University Women in Science Fellowship to HK and by grants R01 AI021729 (GAMC) and R01 AI059377 (AG) from the U.S. National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases (NIAID) or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARCON CM, 1994, MOL CELL BIOL, V14, P5579, DOI 10.1128/MCB.14.8.5579; Alsford S, 2007, MOL MICROBIOL, V63, P724, DOI 10.1111/j.1365-2958.2006.05553.x; Alsford S, 2012, NUCLEIC ACIDS RES, V40, P10150, DOI 10.1093/nar/gks813; Becker M, 2004, GENOME RES, V14, P2319, DOI 10.1101/gr.2955304; Benmerzouga I, 2013, MOL MICROBIOL, V87, P196, DOI 10.1111/mmi.12093; Biebinger S, 1996, NUCLEIC ACIDS RES, V24, P1202, DOI 10.1093/nar/24.7.1202; Boothroyd CE, 2009, NATURE, V459, P278, DOI 10.1038/nature07982; BRUN R, 1979, ACTA TROP, V36, P289; CROSS GAM, 1973, PARASITOLOGY, V67, P315, DOI 10.1017/S0031182000046540; DaFonseca CJ, 2001, P NATL ACAD SCI USA, V98, P3034, DOI 10.1073/pnas.061487598; Dang HQ, 2011, J BIOL CHEM, V286, P32424, DOI 10.1074/jbc.M111.240143; Godoy PDD, 2009, EUKARYOT CELL, V8, P1592, DOI 10.1128/EC.00161-09; Denninger V, 2010, MOL MICROBIOL, V78, P459, DOI 10.1111/j.1365-2958.2010.07350.x; Ding L, 2011, J BIOL CHEM, V286, P32918, DOI 10.1074/jbc.M111.282541; Dziak R, 2003, J BIOL CHEM, V278, P27372, DOI 10.1074/jbc.M301110200; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Figueiredo LM, 2008, PLOS BIOL, V6, P1539, DOI 10.1371/journal.pbio.0060161; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fox CA, 1997, SCIENCE, V276, P1547, DOI 10.1126/science.276.5318.1547; Germe T, 2009, EMBO J, V28, P2803, DOI 10.1038/emboj.2009.223; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GueirosFilho FJ, 1996, MOL CELL BIOL, V16, P5655; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Holland L, 2002, EUR J BIOCHEM, V269, P5192, DOI 10.1046/j.1432-1033.2002.03224.x; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Horn D, 1997, EMBO J, V16, P7422, DOI 10.1093/emboj/16.24.7422; HORN D, 1995, CELL, V83, P555, DOI 10.1016/0092-8674(95)90095-0; Horn D, 2010, CURR OPIN MICROBIOL, V13, P700, DOI 10.1016/j.mib.2010.08.009; Hughes K, 2007, EMBO J, V26, P2400, DOI 10.1038/sj.emboj.7601678; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Jagannathan M, 2012, J CELL SCI, V125, P133, DOI 10.1242/jcs.089938; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kawahara T, 2008, MOL MICROBIOL, V69, P1054, DOI 10.1111/j.1365-2958.2008.06346.x; Kim HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000992; Kim H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Landeira D, 2009, J CELL BIOL, V186, P243, DOI 10.1083/jcb.200902119; Leal S, 2004, J BIOL CHEM, V279, P28979, DOI 10.1074/jbc.M403479200; Li B, 2005, MOL CELL BIOL, V25, P5011, DOI 10.1128/MCB.25.12.5011-5021.2005; Li JJ, 2011, FEBS LETT, V585, P3850, DOI 10.1016/j.febslet.2011.10.033; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Lowell JE, 2004, J CELL SCI, V117, P5937, DOI 10.1242/jcs.01515; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Mancio-Silva L, 2008, J CELL SCI, V121, P2046, DOI 10.1242/jcs.026427; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; NAGOSHI YL, 1995, MOL BIOCHEM PARASIT, V72, P33, DOI 10.1016/0166-6851(95)00062-6; Narayanan MS, 2011, NUCLEIC ACIDS RES, V39, P2018, DOI 10.1093/nar/gkq950; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Peacock L, 2011, P NATL ACAD SCI USA, V108, P3671, DOI 10.1073/pnas.1019423108; Ploubidou A, 1999, J CELL SCI, V112, P4641; Pospiech H, 2010, SUBCELL BIOCHEM, V50, P79, DOI 10.1007/978-90-481-3471-7_5; Povelones ML, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003010; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Sakwe AM, 2007, MOL CELL BIOL, V27, P3044, DOI 10.1128/MCB.02384-06; Scahill MD, 2008, MOL BIOCHEM PARASIT, V157, P73, DOI 10.1016/j.molbiopara.2007.10.003; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Shareef MM, 2001, MOL BIOL CELL, V12, P1671, DOI 10.1091/mbc.12.6.1671; Sheader K, 2004, J BIOL CHEM, V279, P13363, DOI 10.1074/jbc.M312307200; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Stanne TM, 2011, EUKARYOT CELL, V10, P964, DOI 10.1128/EC.05048-11; Takahashi N, 2008, EMBO J, V27, P1840, DOI 10.1038/emboj.2008.107; Takahashi N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000817; Tiengwe C, 2012, CELL REP, V2, P185, DOI 10.1016/j.celrep.2012.06.007; Tiengwe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032674; Nguyen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035931; Tu XM, 2005, EUKARYOT CELL, V4, P755, DOI 10.1128/EC.4.4.755-764.2005; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; Vanhamme L, 2000, MOL MICROBIOL, V36, P328, DOI 10.1046/j.1365-2958.2000.01844.x; Wang QP, 2010, MOL MICROBIOL, V77, P1237, DOI 10.1111/j.1365-2958.2010.07284.x; Wickstead B, 2004, GENOME RES, V14, P1014, DOI 10.1101/gr.2227704; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yang XF, 2009, CELL, V137, P99, DOI 10.1016/j.cell.2009.01.037	80	100	102	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57001	10.1371/journal.pone.0057001	http://dx.doi.org/10.1371/journal.pone.0057001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	24086697	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849500052
J	Becking, LE; Erpenbeck, D; Peijnenburg, KTCA; de Voogd, NJ				Becking, Leontine E.; Erpenbeck, Dirk; Peijnenburg, Katja T. C. A.; de Voogd, Nicole J.			Phylogeography of the Sponge Suberites diversicolor in Indonesia: Insights into the Evolution of Marine Lake Populations	PLOS ONE			English	Article							OXIDASE SUBUNIT-I; HALOCARIDINA-RUBRA; LIFE-HISTORY; CORAL-REEFS; PORIFERA; BIODIVERSITY; DEMOSPONGIAE; SPECIATION; DYNAMICS; PATTERNS	The existence of multiple independently derived populations in landlocked marine lakes provides an opportunity for fundamental research into the role of isolation in population divergence and speciation in marine taxa. Marine lakes are landlocked water bodies that maintain a marine character through narrow submarine connections to the sea and could be regarded as the marine equivalents of terrestrial islands. The sponge Suberites diversicolor (Porifera: Demospongiae: Suberitidae) is typical of marine lake habitats in the Indo-Australian Archipelago. Four molecular markers (two mitochondrial and two nuclear) were employed to study genetic structure of populations within and between marine lakes in Indonesia and three coastal locations in Indonesia, Singapore and Australia. Within populations of S. diversicolor two strongly divergent lineages (A & B) (COI: p = 0.4% and ITS: p = 7.3%) were found, that may constitute cryptic species. Lineage A only occurred in Kakaban lake (East Kalimantan), while lineage B was present in all sampled populations. Within lineage B, we found low levels of genetic diversity in lakes, though there was spatial genetic population structuring. The Australian population is genetically differentiated from the Indonesian populations. Within Indonesia we did not record an East-West barrier, which has frequently been reported for other marine invertebrates. Kakaban lake is the largest and most isolated marine lake in Indonesia and contains the highest genetic diversity with genetic variants not observed elsewhere. Kakaban lake may be an area where multiple putative refugia populations have come into secondary contact, resulting in high levels of genetic diversity and a high number of endemic species.	[Becking, Leontine E.; Peijnenburg, Katja T. C. A.; de Voogd, Nicole J.] Naturalis Biodivers Ctr, Dept Marine Zool, Leiden, Netherlands; [Becking, Leontine E.] Inst Marine Resources & Ecosyst Studies IMARES, Maritime Dept, Den Helder, Netherlands; [Erpenbeck, Dirk] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany; [Erpenbeck, Dirk] Univ Munich, GeoBio Ctr, Munich, Germany; [Peijnenburg, Katja T. C. A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam IBED, Amsterdam, Netherlands	Naturalis Biodiversity Center; Wageningen University & Research; University of Munich; University of Munich; University of Amsterdam	Becking, LE (corresponding author), Naturalis Biodivers Ctr, Dept Marine Zool, Leiden, Netherlands.	lisa.becking@naturalis.nl	de Voogd, Nicole/I-9280-2012; Nelson, William A/D-1405-2013; Paaijmans, Krijn/ABC-9928-2020; Peijnenburg, Katja TCA/F-7176-2016	de Voogd, Nicole/0000-0002-7985-5604; Peijnenburg, Katja TCA/0000-0001-7544-1079; Erpenbeck, Dirk/0000-0003-2716-1085	Netherlands Organisation for Scientific Research (NWO) [817.01.008, 825.12.007]; NWO-VENI grant [863.08.024]; De Beukelaar- van der Hucht Stichting; World Wildlife Foundation Netherlands-INNO Fund; Schure-Beijerinck-Popping Fund of the Royal Dutch Academy of Science (KNAW); Conservation International Ecosystem Based Management program; David and Lucile Packard Foundation; Treub-Maatschappij Fund; Leiden University Fund (LUF)/Slingelands; Singapore Airlines; A.M. Buitendijk Fund; J.J. ter Pelkwijk Fund (Naturalis Biodiversity Center)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO-VENI grant; De Beukelaar- van der Hucht Stichting; World Wildlife Foundation Netherlands-INNO Fund; Schure-Beijerinck-Popping Fund of the Royal Dutch Academy of Science (KNAW); Conservation International Ecosystem Based Management program; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Treub-Maatschappij Fund; Leiden University Fund (LUF)/Slingelands; Singapore Airlines; A.M. Buitendijk Fund; J.J. ter Pelkwijk Fund (Naturalis Biodiversity Center)	L. Becking is supported by the Netherlands Organisation for Scientific Research (NWO) (ALW# 817.01.008; Rubicon# 825.12.007). K. Peijnenburg was supported by NWO-VENI grant #863.08.024. Fieldwork in Indonesia was made possible through additional financial support of De Beukelaar- van der Hucht Stichting, World Wildlife Foundation Netherlands-INNO Fund, the Schure-Beijerinck-Popping Fund of the Royal Dutch Academy of Science (KNAW), Conservation International Ecosystem Based Management program (funded by The David and Lucile Packard Foundation), the Treub-Maatschappij Fund, the Leiden University Fund (LUF)/Slingelands, Singapore Airlines, the A.M. Buitendijk Fund and the J.J. ter Pelkwijk Fund (Naturalis Biodiversity Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreakis N, 2012, ZOOL J LINN SOC-LOND, V166, P225, DOI 10.1111/j.1096-3642.2012.00848.x; Arp G, 1996, RES REPORTS S, V2, P1; Azzini Francesca, 2007, V28, P157; Barber PH, 2006, EVOLUTION, V60, P1825; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Bauza-Ribot MM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-221; Becking L. E., 2009, Zoologische Mededelingen (Leiden), V83, P853; Becking LE, 2013, MAR ECOL PROG SER, V481, P105, DOI 10.3354/meps10155; Becking LE, 2011, HYDROBIOLOGIA, V677, P89, DOI 10.1007/s10750-011-0742-0; Bellwood DR, 2009, J BIOGEOGR, V36, P569, DOI 10.1111/j.1365-2699.2008.02029.x; Blanquer A, 2008, MAR ECOL PROG SER, V371, P109, DOI 10.3354/meps07679; Botello A, 2010, BIOL J LINN SOC, V99, P315, DOI 10.1111/j.1095-8312.2009.01355.x; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Chen XY, 2009, ECOLOGY, V90, P39, DOI 10.1890/08-1520.1; Chombard C, 1998, SYST BIOL, V47, P351, DOI 10.1080/106351598260761; Chombard Catherine, 1999, Memoirs of the Queensland Museum, V44, P100; Colin P. L., 2009, MARINE ENV PALAU, P416; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Craft JD, 2008, LIMNOL OCEANOGR, V53, P675, DOI 10.4319/lo.2008.53.2.0675; Crandall ED, 2008, MOL ECOL, V17, P5276, DOI 10.1111/j.1365-294X.2008.03995.x; Dawson M. N., 2009, ENCY ISLANDS, P603; Dawson MN, 2005, J MAR BIOL ASSOC UK, V85, P679, DOI 10.1017/S0025315405011604; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P9235, DOI 10.1073/pnas.0503635102; Dawson MN, 2006, JMBA GLOBAL MARINE E, V3, P26; de Voogd NJ, 2009, MAR ECOL PROG SER, V396, P169, DOI 10.3354/meps08349; DeBiasse MB, 2010, CORAL REEFS, V29, P47, DOI 10.1007/s00338-009-0554-0; Duran S, 2006, MOL PHYLOGENET EVOL, V40, P292, DOI 10.1016/j.ympev.2006.02.018; Erpenbeck D, 2005, J ZOOL SYST EVOL RES, V43, P93, DOI 10.1111/j.1439-0469.2005.00306.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GEYH MA, 1979, NATURE, V278, P441, DOI 10.1038/278441a0; Goto TV, 2011, ZOOL SCI, V28, P568, DOI 10.2108/zsj.28.568; Gotoh RO, 2009, GENES GENET SYST, V84, P287, DOI 10.1266/ggs.84.287; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hamner WM, 1998, PHYS GEOGR, V19, P175, DOI 10.1080/02723646.1998.10642647; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Hoeksema Bert W., 2007, V29, P117; Holthuis L.B., 1973, Zoologische Verh Leiden, VNo. 128, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kano Y, 2004, ZOOL SCR, V33, P423, DOI 10.1111/j.0300-3256.2004.00159.x; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Lim SC, 2009, RAFFLES B ZOOL, P41; Lopez-Legentil S, 2009, CORAL REEFS, V28, P157, DOI 10.1007/s00338-008-0430-3; MAC ARTHUR ROBERT H., 1967; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; Maldonado M, 1999, NATURE, V398, P476, DOI 10.1038/19007; Mariani S, 2005, J PLANKTON RES, V27, P249, DOI 10.1093/plankt/fbh173; Mariani S, 2006, OECOLOGIA, V149, P174, DOI 10.1007/s00442-006-0429-9; McCormack GP, 2002, J NAT HIST, V36, P1009, DOI 10.1080/00222930110040394; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Morley R.J., 2000, ORIGIN EVOLUTION TRO, P378; Morrow CC, 2012, MOL PHYLOGENET EVOL, V62, P174, DOI 10.1016/j.ympev.2011.09.016; Nuryanto A, 2009, CORAL REEFS, V28, P607, DOI 10.1007/s00338-009-0483-y; Page TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001618; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Peijnenburg KTCA, 2013, ECOL EVOL, V3, P2765, DOI 10.1002/ece3.644; Peijnenburg KTCA, 2004, EVOLUTION, V58, P1472; Perez-Porro AR, 2012, HYDROBIOLOGIA, V687, P315, DOI 10.1007/s10750-011-0919-6; Poppe J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009950; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRONZATO R, 1994, B ZOOL, V61, P395, DOI 10.1080/11250009409355912; Rambaut A., 2007, TRACER V1 4; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Reveillaud J, 2010, MOL PHYLOGENET EVOL, V56, P104, DOI 10.1016/j.ympev.2010.03.034; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; Rua CPJ, 2011, J MAR BIOL ASSOC UK, V91, P1015, DOI 10.1017/S0025315410002122; Russ A, 2010, REV BIOL TROP, V58, P159; Santos SR, 2006, MOL ECOL, V15, P2699, DOI 10.1111/j.1365-294X.2006.02965.x; Santos SR, 2011, HYDROBIOLOGIA, V677, P53, DOI 10.1007/s10750-010-0588-x; SATHIAMURTHY E., 2006, NATURAL HIST J CHULA, V2, P1; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timm J, 2008, MOL ECOL, V17, P3999, DOI 10.1111/j.1365-294X.2008.03881.x; Tomascik T, 1997, ECOLOGY INDONESIA 2, P752; Tomascik Tomas, 1994, Tropical Biodiversity, V2, P385; Uriz MJ, 2012, ADV MAR BIOL, V61, P345, DOI 10.1016/B978-0-12-387787-1.00006-4; Vogler C, 2013, CORAL REEFS, V32, P515, DOI 10.1007/s00338-012-1003-z; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Whittaker RJ, 2008, ISLAND BIOGEOGRAPHY; Worheide G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-24; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Worheide G, 2005, INTEGR COMP BIOL, V45, P377, DOI 10.1093/icb/45.2.377; Worheide G, 2002, MOL ECOL, V11, P1753, DOI 10.1046/j.1365-294X.2002.01570.x; Worheide G, 2004, MOL PHYLOGENET EVOL, V33, P816, DOI 10.1016/j.ympev.2004.07.005; Wulff JL, 2006, BIOL BULL-US, V211, P83, DOI 10.2307/4134581; WULFF JL, 1995, CORAL REEFS, V14, P55, DOI 10.1007/BF00304073; WULFF JL, 1991, J EXP MAR BIOL ECOL, V149, P227, DOI 10.1016/0022-0981(91)90047-Z; Xavier JR, 2010, MOL PHYLOGENET EVOL, V56, P13, DOI 10.1016/j.ympev.2010.03.030; Xavier JR, 2010, CONTRIB ZOOL, V79, P119, DOI 10.1163/18759866-07903004; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	94	181	183	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75996	10.1371/journal.pone.0075996	http://dx.doi.org/10.1371/journal.pone.0075996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24098416	Green Published, Green Submitted, gold			2022-12-25	WOS:000325427100034
J	Tandon, M; Johnson, J; Li, ZH; Xu, SP; Wipf, P; Wang, QJ				Tandon, Manuj; Johnson, James; Li, Zhihong; Xu, Shuping; Wipf, Peter; Wang, Qiming Jane			New Pyrazolopyrimidine Inhibitors of Protein Kinase D as Potent Anticancer Agents for Prostate Cancer Cells	PLOS ONE			English	Article							IN-VIVO; C-MU; GROWTH; IDENTIFICATION; PROLIFERATION; ACTIVATION; EXPRESSION; SLINGSHOT; EPIDERMIS; INVASION	The emergence of protein kinase D (PKD) as a potential therapeutic target for several diseases including cancer has triggered the search for potent, selective, and cell-permeable small molecule inhibitors. In this study, we describe the identification, in vitro characterization, structure-activity analysis, and biological evaluation of a novel PKD inhibitory scaffold exemplified by 1-naphthyl PP1 (1-NA-PP1). 1-NA-PP1 and IKK-16 were identified as pan-PKD inhibitors in a small-scale targeted kinase inhibitor library assay. Both screening hits inhibited PKD isoforms at about 100 nM and were ATP-competitive inhibitors. Analysis of several related kinases indicated that 1-NA-PP1 was highly selective for PKD as compared to IKK-16. SAR analysis showed that 1-NA-PP1 was considerably more potent and showed distinct substituent effects at the pyrazolopyrimidine core. 1-NA-PP1 was cell-active, and potently blocked prostate cancer cell proliferation by inducing G2/M arrest. It also potently blocked the migration and invasion of prostate cancer cells, demonstrating promising anticancer activities on multiple fronts. Overexpression of PKD1 or PKD3 almost completely reversed the growth arrest and the inhibition of tumor cell invasion caused by 1-NA-PP1, indicating that its anti-proliferative and anti-invasive activities were mediated through the inhibition of PKD. Interestingly, a 12-fold increase in sensitivity to 1-NA-PP1 could be achieved by engineering a gatekeeper mutation in the active site of PKD1, suggesting that 1-NA-PP1 could be paired with the analog-sensitive PKD1(M659G) for dissecting PKD-specific functions and signaling pathways in various biological systems.	[Tandon, Manuj; Li, Zhihong; Xu, Shuping; Wang, Qiming Jane] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Johnson, James; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Johnson, James; Wipf, Peter] Univ Pittsburgh, Ctr Chem Methodol & Lib Dev, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wipf, P (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	pwipf@pitt.edu; qjw1@pitt.edu	Wang, Qiming Jane/B-6064-2012; Wipf, Peter/AAG-1771-2021; Johnson, Eric/C-5668-2012	Wang, Qiming Jane/0000-0002-9502-4851; Wipf, Peter/0000-0001-7693-5863; Johnson, Eric/0000-0001-7797-8347; Baker, Tom/0000-0002-0876-2312	National Institutes of Health [R01CA129127-01, R01CA142580-01, P50-GM067082]; NATIONAL CANCER INSTITUTE [R01CA142580, R01CA129127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (R01CA129127-01, R01CA142580-01, and P50-GM067082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Azoitei N, 2011, NEURO-ONCOLOGY, V13, P710, DOI 10.1093/neuonc/nor084; Barluenga J, 1999, PURE APPL CHEM, V71, P431, DOI 10.1351/pac199971030431; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Bishop AC, 1999, J AM CHEM SOC, V121, P627, DOI 10.1021/ja983267v; Biswas MHU, 2010, CANCER RES, V70, P2095, DOI 10.1158/0008-5472.CAN-09-4155; Bravo-Altamirano K, 2011, ACS MED CHEM LETT, V2, P154, DOI 10.1021/ml100230n; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Endo S, 2006, BIOCHEM BIOPH RES CO, V341, P261, DOI 10.1016/j.bbrc.2005.12.179; Evans IM, 2010, BIOCHEM J, V429, P565, DOI 10.1042/BJ20100578; Gamber GG, 2011, BIOORG MED CHEM LETT, V21, P1447, DOI 10.1016/j.bmcl.2011.01.014; George Kara M, 2011, Pharmaceutics, V3, P186, DOI 10.3390/pharmaceutics3020186; Guo J, 2012, CANC CHEMOTHER PHARM; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Huynh QK, 2006, ARCH BIOCHEM BIOPHYS, V450, P141, DOI 10.1016/j.abb.2006.02.014; Kuan YH, 2006, BIOCHEM PHARMACOL, V71, P1735, DOI 10.1016/j.bcp.2006.03.012; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Meredith EL, 2010, J MED CHEM, V53, P5400, DOI 10.1021/jm100075z; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Monovich L, 2010, FEBS LETT, V584, P631, DOI 10.1016/j.febslet.2009.12.014; Murphy RC, 2010, ACS MED CHEM LETT, V1, P331, DOI 10.1021/ml100096t; Niswender CM, 2002, J BIOL CHEM, V277, P28916, DOI 10.1074/jbc.M203327200; O'Dwyer M E, 2000, Lancet Oncol, V1, P207, DOI 10.1016/S1470-2045(00)00149-2; Ochi N, 2011, J CELL PHYSIOL, V226, P1074, DOI 10.1002/jcp.22421; Oumata N, 2008, J MED CHEM, V51, P5229, DOI 10.1021/jm800109e; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Rennecke J, 1999, INT J CANCER, V80, P98, DOI 10.1002/(SICI)1097-0215(19990105)80:1<98::AID-IJC19>3.3.CO;2-4; Ristich VL, 2006, BRIT J DERMATOL, V154, P586, DOI 10.1111/j.1365-2133.2005.07073.x; Sharlow ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025134; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Sreenivasan A, 2003, MOL CELL BIOL, V23, P6327, DOI 10.1128/MCB.23.17.6327-6337.2003; Tandon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044653; Todorovic N, 2011, TETRAHEDRON LETT, V52, P5761, DOI 10.1016/j.tetlet.2011.08.103; Verheijen JC, 2009, J MED CHEM, V52, P8010, DOI 10.1021/jm9013828; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Weiss EL, 2000, NAT CELL BIOL, V2, P677, DOI 10.1038/35036300	44	36	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75601	10.1371/journal.pone.0075601	http://dx.doi.org/10.1371/journal.pone.0075601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24367484	Green Published, Green Submitted, gold			2022-12-25	WOS:000326520200115
J	Yang, W; Zheng, Y; Gao, C; He, XH; Ding, Q; Kim, Y; Rui, YC; Wang, SP; Guo, LD				Yang, Wei; Zheng, Yong; Gao, Cheng; He, Xinhua; Ding, Qiong; Kim, Yongchan; Rui, Yichao; Wang, Shiping; Guo, Liang-Dong			The Arbuscular Mycorrhizal Fungal Community Response to Warming and Grazing Differs between Soil and Roots on the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							SPECIES COMPOSITION; ATMOSPHERIC CO2; CARBON ALLOCATION; ELEVATED CO2; PLANT; DIVERSITY; GRASSLAND; TEMPERATURE; SPORE; COLONIZATION	Arbuscular mycorrhizal (AM) fungi form symbiotic associations with most plant species in terrestrial ecosystems, and are affected by environmental variations. To reveal the impact of disturbance on an AM fungal community under future global warming, we examined the abundance and community composition of AM fungi in both soil and mixed roots in an alpine meadow on the Qinghai-Tibetan Plateau, China. Warming and grazing had no significant effect on AM root colonization, spore density and extraradical hyphal density. A total of 65 operational taxonomic units (OTUs) of AM fungi were identified from soil and roots using molecular techniques. AM fungal OTU richness was higher in soil (54 OTUs) than in roots (34 OTUs), and some AM fungi that differed between soil and roots, showed significantly biased occurrence to warming or grazing. Warming and grazing did not significantly affect AM fungal OTU richness in soil, but warming with grazing significantly increased AM fungal OTU richness in roots compared to the grazing-only treatment. Non-metric multidimensional scaling analysis showed that the AM fungal community composition was significantly different between soil and roots, and was significantly affected by grazing in roots, whereas in soil it was significantly affected by warming and plant species richness. The results suggest that the AM fungal community responds differently to warming and grazing in soil compared with roots. This study provides insights into the role of AM fungi under global environmental change scenarios in alpine meadows of the Qinghai-Tibetan Plateau.	[Yang, Wei; Zheng, Yong; Gao, Cheng; Ding, Qiong; Kim, Yongchan; Guo, Liang-Dong] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Yang, Wei; Kim, Yongchan; Rui, Yichao] Univ Chinese Acad Sci, Beijing, Peoples R China; [He, Xinhua] Univ Western Australia, Sch Plant Biol, Crawley, Australia; [Wang, Shiping] Chinese Acad Sci, Inst Tibetan Plateau Res, Lab Alpine Ecol & Biodivers, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Western Australia; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS	Guo, LD (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	guold@sun.im.ac.cn	He, Xinhua/B-8047-2015; Hwang, Pung-Pung/AEQ-4633-2022; Gao 高程, Cheng/J-9586-2012; Hwang, Pung-Pung/AAH-1538-2022; Chang, Chia-Hao/AAW-2598-2020; GUO, Liang-dong/C-1407-2015; hwang, pp/A-3641-2011; Zheng, Yong/E-3947-2012; Zheng, Yong/AAN-8928-2021	He, Xinhua/0000-0002-5570-3454; Gao 高程, Cheng/0000-0003-2522-7909; Chang, Chia-Hao/0000-0002-7583-4291; Zheng, Yong/0000-0001-5239-9824; Zheng, Yong/0000-0001-5239-9824; Yang, Wen-Kai/0000-0001-8095-2420; Lee, Tsung-Han/0000-0002-3542-4335	National Natural Science Foundation of China [31070434]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD062915] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Natural Science Foundation of China (No. 31070434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ba L, 2012, PLANT SOIL, V352, P143, DOI 10.1007/s11104-011-0985-6; Bai G, 2013, MYCORRHIZA, V23, P289, DOI 10.1007/s00572-012-0468-5; Barto EK, 2010, J ECOL, V98, P745, DOI 10.1111/j.1365-2745.2010.01658.x; Beauregard MS, 2013, MYCORRHIZA, V23, P143, DOI 10.1007/s00572-012-0459-6; Borstler B, 2006, BIOL FERT SOILS, V42, P286, DOI 10.1007/s00374-005-0026-9; Bunn R, 2009, ECOLOGY, V90, P1378, DOI 10.1890/07-2080.1; Clark NM, 2009, J ARID ENVIRON, V73, P834, DOI 10.1016/j.jaridenv.2009.03.004; Colwell RK, 2013, ESTIMATES STAT ESTIM; Daniels B. A., 1982, Methods and principles of mycorrhizal research., P29; Davison J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041938; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Eom AH, 2001, MYCOLOGIA, V93, P233, DOI 10.2307/3761643; Frank DA, 2003, OECOLOGIA, V137, P603, DOI 10.1007/s00442-003-1385-2; Gange AC, 2002, OECOLOGIA, V131, P103, DOI 10.1007/s00442-001-0863-7; Gosling P, 2013, NEW PHYTOL, V198, P546, DOI 10.1111/nph.12169; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hawkes CV, 2008, GLOBAL CHANGE BIOL, V14, P1181, DOI 10.1111/j.1365-2486.2007.01535.x; Heinemeyer A, 2004, GLOBAL CHANGE BIOL, V10, P52, DOI 10.1111/j.1365-2486.2003.00713.x; Hempel S, 2007, ENVIRON MICROBIOL, V9, P1930, DOI 10.1111/j.1462-2920.2007.01309.x; Holland JN, 1996, OECOLOGIA, V107, P87, DOI 10.1007/BF00582238; Hu YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057593, 10.1371/journal.pone.0056362, 10.1371/journal.pone.0073264, 10.1371/journal.pone.0056440]; Johnson D, 2004, NEW PHYTOL, V161, P503, DOI 10.1046/j.1469-8137.2003.00938.x; Johnson NC, 2005, GLOBAL CHANGE BIOL, V11, P1156, DOI 10.1111/j.1365-2486.2005.00967.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; Klironomos JN, 2005, NATURE, V433, P621, DOI 10.1038/nature03268; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Kula AAR, 2005, ECOL LETT, V8, P61, DOI 10.1111/j.1461-0248.2004.00690.x; Lekberg Y, 2008, BOTANY, V86, P1117, DOI 10.1139/B08-077; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Liu YJ, 2012, NEW PHYTOL, V194, P523, DOI 10.1111/j.1469-8137.2012.04050.x; Liu YJ, 2012, MYCORRHIZA, V22, P31, DOI 10.1007/s00572-011-0378-y; Liu Y, 2009, FEMS MICROBIOL ECOL, V67, P81, DOI 10.1111/j.1574-6941.2008.00597.x; Lugo MA, 2002, MYCOLOGIA, V94, P579, DOI 10.2307/3761709; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Martinez-Garcia LB, 2011, SOIL BIOL BIOCHEM, V43, P682, DOI 10.1016/j.soilbio.2010.12.006; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; Miller SP, 1999, OECOLOGIA, V119, P586, DOI 10.1007/s004420050823; MONZ CA, 1994, PLANT SOIL, V165, P75, DOI 10.1007/BF00009964; Murray TR, 2010, ECOLOGY, V91, P815, DOI 10.1890/09-0209.1; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Pringle A, 2002, AM J BOT, V89, P1439, DOI 10.3732/ajb.89.9.1439; R Development Core Team, 2010, R LANG ENV STAT COMP; Renker C, 2005, ENVIRON POLLUT, V135, P255, DOI 10.1016/j.envpol.2004.11.002; Rillig MC, 1999, OECOLOGIA, V119, P572, DOI 10.1007/s004420050821; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Rillig MC, 2002, OIKOS, V97, P52, DOI 10.1034/j.1600-0706.2002.970105.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rui YC, 2011, J SOIL SEDIMENT, V11, P903, DOI 10.1007/s11368-011-0388-6; Sanders IR, 2004, NEW PHYTOL, V164, P415, DOI 10.1111/j.1469-8137.2004.01208.x; Schwarzott D, 2001, MOL PHYLOGENET EVOL, V21, P190, DOI 10.1006/mpev.2001.1007; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Staddon PL, 2004, GLOBAL CHANGE BIOL, V10, P1909, DOI 10.1111/j.1365-2486.2004.00861.x; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Su YY, 2007, MYCORRHIZA, V17, P689, DOI 10.1007/s00572-007-0151-4; Swofford DL, 2001, PAUP PHYLOGENETIC AN; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 2004, NEW PHYTOL, V164, P201, DOI 10.1111/j.1469-8137.2004.01205.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van Diepen LTA, 2011, MOL ECOL, V20, P799, DOI 10.1111/j.1365-294X.2010.04969.x; Wagner H, 2009, VEGAN COMMUNITY ECOL; Wang SP, 2012, ECOLOGY, V93, P2365, DOI 10.1890/11-1408.1; Wilde P, 2009, ENVIRON MICROBIOL, V11, P1548, DOI 10.1111/j.1462-2920.2009.01882.x; Wolf J, 2003, NEW PHYTOL, V157, P579, DOI 10.1046/j.1469-8137.2003.00696.x; Zarei M, 2010, ENVIRON POLLUT, V158, P2757, DOI 10.1016/j.envpol.2010.04.017; Zavalloni C, 2012, PLANT SOIL, V359, P121, DOI 10.1007/s11104-012-1190-y; Zheng Y, 2012, APPL MICROBIOL BIOT, V93, P2193, DOI 10.1007/s00253-011-3535-5	74	118	135	11	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e76447	10.1371/journal.pone.0076447	http://dx.doi.org/10.1371/journal.pone.0076447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086741	Green Submitted, gold, Green Published			2022-12-25	WOS:000325220000067
J	Wang, RC; Kniazeva, M; Han, M				Wang, Rencheng; Kniazeva, Marina; Han, Min			Peroxisome Protein Transportation Affects Metabolism of Branched-Chain Fatty Acids That Critically Impact Growth and Development of C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; BIOSYNTHESIS; ROLES; DISORDERS; PATHWAY; GENES	The impact of specific lipid molecules, including fatty acid variants, on cellular and developmental regulation is an important research subject that remains under studied. Monomethyl branched-chain fatty acids (mmBCFAs) are commonly present in multiple organisms including mammals, however our understanding of mmBCFA functions is very limited. C. elegans has been the premier model system to study the functions of mmBCFAs and their derived lipids, as mmBCFAs have been shown to play essential roles in post-embryonic development in this organism. To understand more about the metabolism of mmBCFAs in C. elegans, we performed a genetic screen for suppressors of the L1 developmental arrest phenotype caused by mmBCFA depletion. Extensive characterization of one suppressor mutation identified prx-5, which encodes an ortholog of the human receptor for the type-1 peroxisomal targeting signal protein. Our study showed that inactivating prx-5 function compromised the peroxisome protein import, resulting in an increased level of branched-chain fatty acid C17ISO in animals lacking normal mmBCFA synthesis, thereby restoring wild-type growth and development. This work reveals a novel connection between peroxisomal functions and mmBCFA metabolism.	[Han, Min] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Han, M (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	mhan@colorado.edu		You, Hai-Lu/0000-0003-2203-6461	Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the Howard Hughes Medical Institute Investigator fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Heird WC, 2005, ANNU REV NUTR, V25, P549, DOI 10.1146/annurev.nutr.24.012003.132254; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; HRADEC J, 1994, J CHROMATOGR B, V660, P386, DOI 10.1016/0378-4347(94)00292-4; Jones LN, 1997, MICRON, V28, P469, DOI 10.1016/S0968-4328(97)00039-5; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; Jordan SD, 2010, CELL MOL LIFE SCI, V67, P3255, DOI 10.1007/s00018-010-0414-7; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2008, GENE DEV, V22, P2102, DOI 10.1101/gad.1692008; Kniazeva M, 2012, GENE DEV, V26, P554, DOI 10.1101/gad.187054.112; Moser HW, 1999, MOL GENET METAB, V68, P316, DOI 10.1006/mgme.1999.2926; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Seamen E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000589; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Thieringer H, 2003, J CELL SCI, V116, P1797, DOI 10.1242/jcs.00380; Vrablik TL, 2013, MOL REPROD DEV, V80, P244, DOI 10.1002/mrd.22167; Vrablik TL, 2012, GENE DEV, V26, P631, DOI 10.1101/gad.190777.112; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Webster CM, 2013, DEV BIOL, V373, P14, DOI 10.1016/j.ydbio.2012.10.002; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; YEAGLE PL, 1989, FASEB J, V3, P1833, DOI 10.1096/fasebj.3.7.2469614; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107; Zhang YR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-164; Zhu H, 2013, ELIFE IN PRESS; Zhu HH, 2013, ELIFE, V2, DOI 10.7554/eLife.00429; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	35	14	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76270	10.1371/journal.pone.0076270	http://dx.doi.org/10.1371/journal.pone.0076270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24204734	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900092
J	Li, X; Xu, F; Xie, L; Ji, YJ; Cheng, K; Zhou, QM; Wang, T; Shively, C; Wu, QY; Gong, W; Fang, L; Zhan, QL; Melgiri, ND; Xie, P				Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Shively, Carol; Wu, Qingyuan; Gong, Wei; Fang, Liang; Zhan, Qunlin; Melgiri, N. D.; Xie, Peng			Depression-Like Behavioral Phenotypes by Social and Social Plus Visual Isolation in the Adult Female Macaca fascicularis	PLOS ONE			English	Article							ANIMAL-MODELS; BODY-IMAGE; MACAQUES; THERMOREGULATION; ACTIVATION; ATTACHMENT; DISORDER; BRAIN; US	Major depressive disorder (MDD) is a debilitating psychiatric mood disorder that affects millions of individuals globally. Our understanding of the biological basis of MDD is poor, and current treatments are ineffective in a significant proportion of cases. This current situation may relate to the dominant rodent animal models of depression, which possess translational limitations due to limited homologies with humans. Therefore, a more homologous primate model of depression is needed to advance investigation into the pathophysiological mechanisms underlying depression and to conduct pre-clinical therapeutic trials. Here, we report two convenient methods - social isolation and social plus visual isolation - which can be applied to construct a non-human primate model of depression in the adult female cynomolgus monkey (Macaca fascicularis). Both social and social plus visual isolation were shown to be effective in inducing depression-like behavior by significantly reducing socially dominant aggressive conflict behavior, communicative behavior, sexual behavior, and parental behavior. The addition of visual isolation produced more profound behavioral changes than social isolation alone by further reducing parental behavior and sexual behavior. Thus, the degree of behavioral pathology may be manipulated by the degree of isolation. These methods can be applied to construct a non-human primate model of depression in order to assess physiological, behavioral, and social phenomena in a controlled laboratory setting.	[Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Wu, Qingyuan; Gong, Wei; Fang, Liang; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Wu, Qingyuan; Gong, Wei; Fang, Liang; Melgiri, N. D.; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Li, Xin; Xu, Fan; Xie, Liang; Ji, Yongjia; Cheng, Ke; Zhou, Qinmin; Wang, Tao; Wu, Qingyuan; Gong, Wei; Fang, Liang; Melgiri, N. D.; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Zhan, Qunlin] Fifth Peoples Hosp, Dept Neurol, Chongqing, Peoples R China; [Shively, Carol] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA	Chongqing Medical University; Chongqing Medical University; Wake Forest University	Xie, P (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	Cheng, Ke/HCH-8846-2022; Shively, Carol/L-2921-2019	Wong, Frank Y./0000-0001-5835-9938	National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [31271189]; Chongqing Postdoctoral Science Foundation [XM20120010]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Postdoctoral Science Foundation	This work was supported by the National Basic Research Program of China (973 Program) (Grant NO. 2009CB918300), the National Natural Science Foundation of China (Grant NO. 31271189), the Chongqing Postdoctoral Science Foundation (Grant No. XM20120010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bifulco A, 2004, BRIT J PSYCHIAT, V184, pS31, DOI 10.1192/bjp.184.46.s31; BROTHERS L, 1990, MOTIV EMOTION, V14, P81, DOI 10.1007/BF00991637; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; Canales JZ, 2010, REV BRAS PSIQUIATR, V32, P375, DOI 10.1590/S1516-44462010000400010; CLARKE AS, 1988, INT J PRIMATOL, V9, P347, DOI 10.1007/BF02737382; Clarke AS, 2005, AM J PRIMATOL, V14, P37; Ehlers CL, 1989, ANIMAL MODELS DEPRES; Ellgring H, 1989, NONVERBAL COMMUNICAT, P168; Fava M, 1997, J NERV MENT DIS, V185, P140, DOI 10.1097/00005053-199703000-00002; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Gelenberg AJ, 2010, J CLIN PSYCHIAT, V71, P6; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; GOTTMAN JM, 1977, CHILD DEV, V48, P513, DOI 10.1111/j.1467-8624.1977.tb01191.x; Grippo AJ, 2007, PSYCHOSOM MED, V69, P149, DOI 10.1097/PSY.0b013e31802f054b; Hanya G, 2007, AM J PRIMATOL, V69, P802, DOI 10.1002/ajp.20397; HARLOW HF, 1974, BEHAV BIOL, V12, P273, DOI 10.1016/S0091-6773(74)91475-8; Hayward BA, 2007, INT J MENT HEALTH NU, V16, P15, DOI 10.1111/j.1447-0349.2006.00439.x; Helms CM, 2012, PSYCHOPHARMACOLOGY, V224, P133, DOI 10.1007/s00213-012-2707-z; Kennedy SH, 2009, J CLIN PSYCHOPHARM, V29, P157, DOI 10.1097/JCP.0b013e31819c76e9; Kim JW, 1996, BIOL PSYCHIAT, V40, P918, DOI 10.1016/0006-3223(95)00546-3; Liu RT, 2010, CLIN PSYCHOL REV, V30, P582, DOI 10.1016/j.cpr.2010.04.010; Maestripieri D, 1997, EVOL COMMUN, V1, P193, DOI [10.1075/eoc.1.2.03mae, DOI 10.1075/E0C.1.2.03MAE]; Maestripieri D., 2005, GESTURE, V5, P57, DOI [DOI 10.1075/GEST.5.1.06MAE, 10.1075/gest.5.1.06mae]; Maestripieri D, 2009, PHYSIOL BEHAV, V96, P613, DOI 10.1016/j.physbeh.2008.12.016; Malkesman O, 2006, BEHAV BRAIN RES, V175, P408, DOI 10.1016/j.bbr.2006.09.017; Masayuki Nakamichi FC, 1990, PRIMATES, V31, P213; MAXIM PE, 1972, BRAIN RES, V42, P243, DOI 10.1016/0006-8993(72)90529-X; Michopoulos V, 2012, PSYCHONEUROENDOCRINO, V37, P1071, DOI 10.1016/j.psyneuen.2011.12.004; Nakamichi M, 2003, INT J PRIMATOL, V24, P607, DOI 10.1023/A:1023744515134; Noldus LPJJ, 2000, BEHAV RES METH INS C, V32, P197, DOI 10.3758/BF03200802; NOLES SW, 1985, J CONSULT CLIN PSYCH, V53, P88, DOI 10.1037/0022-006X.53.1.88; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; PETIT O, 1994, ANIM BEHAV, V48, P1427, DOI 10.1006/anbe.1994.1378; Rahaman H., 1968, Primates, V9, P259, DOI 10.1007/BF01730973; Reding K, 2012, HORM BEHAV, V62, P612, DOI 10.1016/j.yhbeh.2012.09.010; RUBIN KH, 1989, J PERS, V57, P237, DOI 10.1111/j.1467-6494.1989.tb00482.x; Rubin KH, 1998, SOCIAL NONSOCIAL PLA; Scaccianoce S, 2006, BEHAV BRAIN RES, V168, P323, DOI 10.1016/j.bbr.2005.04.024; SCHINO G, 1990, PHYSIOL BEHAV, V47, P1125, DOI 10.1016/0031-9384(90)90362-8; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Smolmsky AN, 2009, MOOD ANXIETY RELATED; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; SWARTZ KB, 1982, J HUM EVOL, V11, P237, DOI 10.1016/S0047-2484(82)80039-0; THIERRY B, 1986, INT J PRIMATOL, V7, P191, DOI 10.1007/BF02692318; Tse WS, 2002, PSYCHOPHARMACOLOGY, V161, P324, DOI 10.1007/s00213-002-1049-7; Vollmayr B, 2007, EUR ARCH PSY CLIN N, V257, P300, DOI 10.1007/s00406-007-0734-2; Watson SL, 1998, ATHEROSCLEROSIS, V137, P259, DOI 10.1016/S0021-9150(97)00277-3; Willard SL, 2012, AM J PRIMATOL, V74, P528, DOI 10.1002/ajp.21013; Xu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037486	50	43	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73293	10.1371/journal.pone.0073293	http://dx.doi.org/10.1371/journal.pone.0073293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24086565	Green Published, Green Submitted, gold			2022-12-25	WOS:000324515600094
